<collection>
  <source>PubTator</source>
  <date/>
  <key>BioC.key</key>
  <document>
    <id>4272814</id>
    <passage>
      <infon key="name_3">surname:O'Mahony;given-names:Jim</infon>
      <infon key="name_2">surname:Lucid;given-names:Alan</infon>
      <infon key="name_1">surname:Johnston;given-names:Christopher D</infon>
      <infon key="article-id_pmid">25530808</infon>
      <infon key="name_0">surname:Feeney;given-names:Audrey</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272814</infon>
      <infon key="article-id_publisher-id">46</infon>
      <infon key="article-id_doi">10.1186/s13099-014-0046-9</infon>
      <infon key="type">front</infon>
      <infon key="elocation-id">46</infon>
      <infon key="volume">6</infon>
      <infon key="license">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Gut Pathog; 2014; 6(1) 46. doi:10.1186/s13099-014-0046-9</infon>
      <infon key="name_6">surname:Sleator;given-names:Roy D</infon>
      <infon key="name_5">surname:Lucey;given-names:Brigid</infon>
      <infon key="name_4">surname:Coffey;given-names:Aidan</infon>
      <infon key="authors">Feeney A, Johnston CD, Lucid A, O Mahony J, Coffey A, Lucey B, Sleator RD</infon>
      <offset>0</offset>
      <text>The role of the Cronobacter sakazakii ProP C-terminal coiled coil domain in osmotolerance</text>
      <annotation id="1">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="16" length="21"/>
        <text>Cronobacter sakazakii</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>90</offset>
      <text>Background</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>101</offset>
      <text>We investigate the role of the C-terminal coiled coil of the secondary proline porter ProP in contributing to Cronobacter sakazakii osmotolerance.</text>
      <annotation id="4">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="211" length="21"/>
        <text>Cronobacter sakazakii</text>
      </annotation>
      <annotation id="5">
        <infon key="identifier">MESH:D011392</infon>
        <infon key="type">Chemical</infon>
        <location offset="172" length="7"/>
        <text>proline</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>248</offset>
      <text>Findings</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>257</offset>
      <text>The extended C-terminal domain of ProP1 (encoded by ESA_02131) was spliced onto the truncated C-terminal end of ProP2 (encoded by ESA_01706); creating a chimeric protein (ProPc) which exhibits increased osmotolerance relative to the wild type.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>501</offset>
      <text>Conclusions</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>513</offset>
      <text>It appears that the C-terminal coiled coil domain tunes ProP at low osmolality, whereas ProP transporters lacking the coiled coil domain are more active at a higher osmolality range.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>696</offset>
      <text>Introduction</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>709</offset>
      <text>Survival of the foodbourne pathogen Cronobacter sakazakii in low water activity (aw) environments, e.g. powdered infant formula (PIF), is largely attributed to the accumulation of organic compounds termed osmolytes or compatible solutes. Synthesised de novo, or transported from the bathing solution, compatible solutes function to increase cell turgor thereby counterbalancing the external osmotic upshift and preventing water loss from the cell, which if left unchecked can lead to plasmolysis and ultimately cell death.</text>
      <annotation id="10">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="745" length="21"/>
        <text>Cronobacter sakazakii</text>
      </annotation>
      <annotation id="11">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="822" length="6"/>
        <text>infant</text>
      </annotation>
      <annotation id="12">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="1131" length="5"/>
        <text>water</text>
      </annotation>
      <annotation id="13">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="774" length="5"/>
        <text>water</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1232</offset>
      <text>In Escherichia coli, a model organism for the study of bacterial osmoadaptation, the transmembrane protein ProP is perhaps the best characterised compatible solute uptake system; facilitating the uptake of both proline and glycine betaine. A member of the major facilitator superfamily (MFS), E. coli ProP is a 500-amino acid protein comprising of 12 transmembrane domains and a characteristic carboxy-terminal extension. In a previous in silico study we identified seven ProP homologues on the C. sakazakii BAA-894 genome; one of which, ESA_02131, encodes a protein exhibiting 90% identity to E. coli ProP. While the remaining six homologues encode proteins exhibiting features of classic secondary transporters, they are all 60-70 amino acids shorter than the E. coli ProP; lacking the extended carboxyl tail. Notwithstanding the lack of structural consistency, particularly at the C-terminal end, we have shown that six of the seven C. sakazakii proP homologues contribute to C. sakazakii osmotolerance, albeit to varying degrees.</text>
      <annotation id="23">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="1235" length="16"/>
        <text>Escherichia coli</text>
      </annotation>
      <annotation id="24">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="1525" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="25">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="1727" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
      <annotation id="26">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="1826" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="1994" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="28">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="2168" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
      <annotation id="29">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="2211" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
      <annotation id="30">
        <infon key="identifier">MESH:D011392</infon>
        <infon key="type">Chemical</infon>
        <location offset="1443" length="7"/>
        <text>proline</text>
      </annotation>
      <annotation id="31">
        <infon key="identifier">MESH:D001622</infon>
        <infon key="type">Chemical</infon>
        <location offset="1455" length="15"/>
        <text>glycine betaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2268</offset>
      <text>Culham et al. first described the E. coli ProP as harbouring unusual structural features which appeared unique within the transporter superfamily. This study predicted the formation of an alpha helical coiled coil resulting from the presence of the carboxyl terminal extension. Indeed, a synthetic polypeptide corresponding to the C-terminal extension of ProP formed a dimeric alpha helical coiled coil. Interestingly, when amino acid changes were introduced to the coiled coil, ProP required a larger osmotic upshift to become activated, suggesting that the C-terminal domain likely plays a role in osmosensing. Furthermore, a derivative of ProP which lacked the 26 amino acid C-terminal domain was expressed, but inactive. In contrast, despite the structural degeneracy observed between the homologues, C. sakazakii ProP homologues lacking the C-terminal extension do contribute to osmotolerance, albeit to a lesser extent than the extended ProP (which we designate Prop1) encoded by ESA_02131.</text>
      <annotation id="35">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="2302" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="36">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="3073" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
      <annotation id="37">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="2910" length="4"/>
        <text>ProP</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3265</offset>
      <text>While several studies have focused on elucidating the role of the carboxyl extension in E. coli, little is known about the role, if any, of the ProP1 carboxyl extension in the far more osmotolerant C. sakzakii. Herein, we investigate the role of the C-terminal coiled coil of ProP1 in contributing to C. sakazakii osmotolerance, by creating a chimeric protein (ProPc) in which the extended C-terminal domain of ProP1 (encoded by ESA_02131) is spliced onto the truncated C-terminal end of ProP2 (encoded by ESA_01706).</text>
      <annotation id="40">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="3353" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="41">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="3566" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>3783</offset>
      <text>Material and methods</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>3804</offset>
      <text>Bacterial strains and growth conditions</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>3844</offset>
      <text>Ampr. This strain is resistant to ampicillian.</text>
      <annotation id="43">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="3878" length="11"/>
        <text>ampicillian</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab1.xml</infon>
      <infon key="id">Tab1</infon>
      <infon key="type">table_caption</infon>
      <offset>3891</offset>
      <text> Bacterial strains and plasmids </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab1</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab1.xml</infon>
      <offset>3924</offset>
      <text> Strain or plasmid   Relevant genotype or characteristics   Source or reference   Plasmids    pUC18 Ampr, lacZ', pMB9 replicon  pUC18: ESA_02131 pUC18 harboring ESA_02131 gene under control of the native promoter  pUC18: ESA_01706 pUC18 harboring ESA_01706 gene under control the native promoter  pUC18: ESA_01706CTE pUC18 harboring chimeric ESA_01706 with fused C-terminal extension (ESA_02131) under control of the native promoter This work  Strains     Cronobacter sakazakii BAA-894  C.sakazakii strain isolated from powdered formula associated with neonatal intensive care unit   Escherichia coli DH5alpha Intermediate cloning host.supE44 DeltalacU169(80lacZDeltaM15)R17 recA1 endA1 gyrA96 thi-1 relA1 Invitrogen MKH13 MC4100Delta(putPA)101Delta(proP)2Delta(proU)  MKH13 pUC18:ESA_02131+ Host strain harbouring pUC18: ESA_02131 plasmid. Ampr   MKH13 pUC18:ESA_01706+ Host strain harbouring pUC18: ESA_01706 plasmid. Ampr   MKH13 pUC18:ESA_01706CTE Host strain harbouring pUC18: ESA_01706CTE plasmid. Ampr  This work </text>
      <annotation id="47">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="4380" length="21"/>
        <text>Cronobacter sakazakii</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="4411" length="11"/>
        <text>C.sakazakii</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">668369</infon>
        <infon key="type">Species</infon>
        <location offset="4508" length="25"/>
        <text>Escherichia coli DH5alpha</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4945</offset>
      <text>Bacterial strains and plasmids used in this study are listed in Table 1.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>5019</offset>
      <text>Creation of the chimeric ProPc protein</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab2.xml</infon>
      <infon key="id">Tab2</infon>
      <infon key="type">table_caption</infon>
      <offset>5058</offset>
      <text> Primers </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab2</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab2.xml</infon>
      <offset>5068</offset>
      <text> Primer name    Primer sequence (5' to 3')   Length   Characteristics  ESA_02131 F CATCGGCCGACAGGCCAGTCAATGAATGATGC 32 EagI cut site  R CATTCTAGAGAGTACAACGGAATGCGGGG 29 XbaI cut site ESA_01706 F CATTCTAGAGTCGGGCGGCTCTTTATCTGG 30 XbaI cut site  R CATGGATCCTTGACCAGATGACGCAGTCTTTC 32 BamHI cut site Chimeric-01706 F AATAAGCTTGTGGCTTTTTATGCCGGGCTGC 31 HindIII cut site  R CAGGCCAGTAATCAGCGCCGCGCCCATGAC 30 3' SOEing overhang Chimeric-02131CTE F CGCGGCGCTGATTACTGGCCTGACGATGAAAG 32 5' SOEing overhang  R AATGGATCCTTACTCGTTAATACGAGGATGCTGG 34 BamHI cut site pUC18 MCS Check F CATTAGCTCACTCATTAGGCACC 23 pUC18 insert check  R CATTGTAAAACGACGGCCAGTG 22 pUC18 insert check </text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5734</offset>
      <text>PCR primers (Table 2) were designed for each proP homologue based on C. sakazakii strain BAA-894 sequence data available from the NCBI database (NC_009778.1). The formation of the chimeric ProP protein (ProPc), which consists of the extended coiled coil region of ProP1 (amino acid position 422 to 505) fused to the C-terminus of ProP2 (encoded by ESA_01706), was performed using a modified SOEing (Splicing by overlap extension) technique. In silico comparative analysis of the native ProP1 and ProP2 sequences, revealed a point of amino acid homology within the twelfth predicted transmembrane domain, a leucine/isoleucine/threonine triplet (LIT) at position 422-424 and 437-439 respectively, which was selected as the splice site. Briefly, the fusion was performed using three separate PCR reactions: the first PCR (primer set Chimeric-01706) resulted in an ESA_01706 (proP2) amplicon lacking the C-terminal extension but containing a 15-bp 3'overhang corresponding to the LIT triplet of the ProP1 C- terminal extension. The second PCR (primer set Chimeric-02131CTE) formed an amplicon of 210-bp encoding ProP1 C-terminal extension with a 5'-overhang, also corresponding to the LIT triplet. The final PCR (primer set Chimeric-01706-F Chimeric-02131tail-R) was performed with the two previous amplicons as template; resulting in a final product of 1,623-bp, representing the ESA_01706 native promoter and modified coding region (encoding the fused ProP1 C-terminal extension after the LIT triplet). This product was digested with restriction enzymes BamHI and HindIII and ligated to a similarly digested pUC18 vector forming pUC18:ESA_01706CTE (C-Termini Extension). The integrity of the chimeric sequence was confirmed by sequencing (MWG Operon, Germany and GATC, Germany) and transformed into E. coli MKH13.</text>
      <annotation id="55">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="5803" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
      <annotation id="56">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="7531" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="57">
        <infon key="identifier">MESH:D007930</infon>
        <infon key="type">Chemical</infon>
        <location offset="6340" length="7"/>
        <text>leucine</text>
      </annotation>
      <annotation id="58">
        <infon key="identifier">MESH:D007532</infon>
        <infon key="type">Chemical</infon>
        <location offset="6348" length="10"/>
        <text>isoleucine</text>
      </annotation>
      <annotation id="59">
        <infon key="identifier">MESH:D013912</infon>
        <infon key="type">Chemical</infon>
        <location offset="6359" length="9"/>
        <text>threonine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>7555</offset>
      <text>Osmotolerance assay</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>7575</offset>
      <text>Overnight cultures of E. coli MKH13 clones expressing the wild-type and chimeric ProP proteins (ProP1, ProP2 and ProPC respectively) were grown at 37 C with shaking at 200 rpm in either 10 ml LB or M9 minimal media containing 0.5% glucose, 0.04% arginine, 0.04% isoleucine, 0.04% valine (Sigma-Aldrich Co.). Cells were pelleted by centrifugation at 5,000 g, washed and re-suspended in 200 mul 1/4 strength Ringer's solution. The cell suspension was added to the appropriate filter sterilized media with varying concentrations (0-10%) of added NaCl. Growth was monitored in the relevant media over a 48 hour period, with optical density (OD600) readings being taken every hour. Triplicate readings were taken and graphs were plotted using SigmaPlot version 11.0. E. coli MKH13 harbouring the empty pUC18 plasmid was used as a negative control.</text>
      <annotation id="69">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="7597" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="70">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="8337" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="71">
        <infon key="identifier">1239833</infon>
        <infon key="type">Species</infon>
        <location offset="7921" length="4"/>
        <text>at 5</text>
      </annotation>
      <annotation id="72">
        <infon key="identifier">MESH:D001120</infon>
        <infon key="type">Chemical</infon>
        <location offset="7821" length="8"/>
        <text>arginine</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="8118" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">MESH:D014633</infon>
        <infon key="type">Chemical</infon>
        <location offset="7855" length="6"/>
        <text>valine</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">MESH:D007532</infon>
        <infon key="type">Chemical</infon>
        <location offset="7837" length="10"/>
        <text>isoleucine</text>
      </annotation>
      <annotation id="76">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="8345" length="5"/>
        <text>MKH13</text>
      </annotation>
      <annotation id="77">
        <infon key="identifier">MESH:D005947</infon>
        <infon key="type">Chemical</infon>
        <location offset="7806" length="7"/>
        <text>glucose</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>8426</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>8434</offset>
      <text>C. sakazakii ProP structures</text>
      <annotation id="79">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="8434" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13099_2014_46_Fig1_HTML.jpg</infon>
      <infon key="id">Fig1</infon>
      <infon key="type">fig_caption</infon>
      <offset>8463</offset>
      <text> Predicted transmembrane and tertiary structures of A) ProP2 encoded by ESA_01706, B) ProP1 encoded by ESA_02131 and C) ProPc. </text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8591</offset>
      <text>Based on sequence similarity to the E. coli ProP protein, we identified ProP1 (the product of ESA_02131) as the most likely ProP homolog in C. sakazakii; exhibiting 90% amino acid sequence identity and structural features characteristic of E. coli ProP. Indeed, further analysis using TMHMM and TexTopo software predicted ProP1 to be a membrane protein with 12-transmembrane domains, an extended central hydrophilic loop and carboxy terminal extension (Figure 1). While the remaining five ProP homologues on the C. sakazakii BAA-894 genome were also predicted to encode proteins with 12 transmembrane domains and an extended central hydrophilic loop, they each lacked the extended carboxy-terminal domain identified in ProP1, a feature which likely affects the final protein structure and function.</text>
      <annotation id="84">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="8627" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="8731" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
      <annotation id="86">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="8831" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="87">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="9103" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9391</offset>
      <text>Figure 1B illustrates the tertiary structure for ProP1 (predicted using the I-TASSER server). Most notably the presence of a coiled coil domain is evident as a result of the extended carboxy-terminal identified by sequence analysis. The coiled coil domain likely protrudes into the intracellular cytoplasm of the organism where its function remains unclear. By contrast, the tertiary structure of ProP2 (Figure 1A), representative of the remaining 6 ProP homologues and exhibiting 40% identity to E. coli ProP and 49% identity to ProP1, lacks the coiled coil domain at the carboxy-terminal end.</text>
      <annotation id="89">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="9888" length="7"/>
        <text>E. coli</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>9988</offset>
      <text>Chimeric protein (ProPc) expression in E. coli MKH13</text>
      <annotation id="91">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="10027" length="7"/>
        <text>E. coli</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10041</offset>
      <text>The osmoprotective properties of ProP1, ProP2 and ProPc were measured and compared in E. coli MKH13; an osmosensitive mutant incapable of growth in high osmolality environments (&gt;=4%). The pUC18 plasmid containing each gene of interest was transformed to E. coli MKH13. Transformation efficiencies of 60 CFU/mug DNA were achieved, with successful transformation being confirmed by colony PCR, followed by sequencing. Transformants were screened for osmotolerance on media (both LB and M9 plus 1 mM proline) containing between 4% and 10% added NaCl.</text>
      <annotation id="96">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="10127" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="97">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="10296" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="98">
        <infon key="identifier">MESH:D011392</infon>
        <infon key="type">Chemical</infon>
        <location offset="10539" length="7"/>
        <text>proline</text>
      </annotation>
      <annotation id="99">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="10584" length="4"/>
        <text>NaCl</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>10593</offset>
      <text>Assessment of osmotolerance</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10621</offset>
      <text>To determine the effect of each ProP homologues, both native (ProP1 and ProP2) and chimeric (ProPc), on the osmotolerance of E. coli MKH13, each of the strains was grown in media containing varying concentrations of NaCl. Growth was monitored over a 48 hour period in minimal media supplemented with 1 mM proline and containing 0-10% added NaCl.</text>
      <annotation id="104">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="10746" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="105">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="10837" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="106">
        <infon key="identifier">MESH:D011392</infon>
        <infon key="type">Chemical</infon>
        <location offset="10926" length="7"/>
        <text>proline</text>
      </annotation>
      <annotation id="107">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="10961" length="4"/>
        <text>NaCl</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13099_2014_46_Fig2_HTML.jpg</infon>
      <infon key="id">Fig2</infon>
      <infon key="type">fig_caption</infon>
      <offset>10969</offset>
      <text> Physiological analysis of E. coli MKH13 expressing  ProP1,  ProP2,  ProPc and  the empty pUC18 plasmid. A) Optical density was measured over a 48 hour period in media supplemented with 0-10% added NaCl. B) The growth rate of E. coli MKH13 expressing each of the proteins of interest was measured in media supplemented with 0-10% added NaCl.</text>
      <annotation id="112">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="10996" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="113">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="11195" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="114">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="11167" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="11305" length="4"/>
        <text>NaCl</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11312</offset>
      <text>Media containing 5% NaCl yielded the most discriminatory results. While E. coli MKH13 expressing the empty pUC18 vector showed no growth at 5%, each of the other three strains tested conferred some degree of osmotolerance on the host (Figure 2A). The strain expressing ProP1 was the most osmotolerant, with a maximum optical density (OD600) of 0.326 after 37 hours growth at 5% NaCl. The strain possessing ProPc grew to an OD significantly higher than the strains expressing either ProP1 or ProP2. E. coli MKH13 expressing ProP2 in 5% NaCl grew to a maximum OD of 0.111 after 48 hours, whereas E. coli MKH13 containing ProPc grew to a final OD of 0.189 at the same time point. Interestingly, growth of the stains expressing ProP2 and the chimeric protein continued to increase up to 48 hours, while growth of E. coli MKH13 expressing ProP1 reached maximum OD after only 37 hours.</text>
      <annotation id="126">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="11384" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="127">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="11810" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="128">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="11906" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="129">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="12121" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="130">
        <infon key="identifier">1239833</infon>
        <infon key="type">Species</infon>
        <location offset="11449" length="4"/>
        <text>at 5</text>
      </annotation>
      <annotation id="131">
        <infon key="identifier">1239833</infon>
        <infon key="type">Species</infon>
        <location offset="11684" length="4"/>
        <text>at 5</text>
      </annotation>
      <annotation id="132">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="11332" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="11690" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="134">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="11847" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="11835" length="5"/>
        <text>ProP2</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab3.xml</infon>
      <infon key="id">Tab3</infon>
      <infon key="type">table_caption</infon>
      <offset>12197</offset>
      <text> Growth rate and optical density @ 600 nm </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab3</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab3.xml</infon>
      <offset>12241</offset>
      <text> Protein expressed   Gene locus tags   Name   5%   6%   7%   8%   9%   10%    Max. OD   Growth rate (hr -1 )   Max. OD   Growth rate (hr -1 )   Max. OD   Growth rate (hr -1 )   Max. OD   Growth rate (hr -1 )   Max. OD   Growth rate (hr -1 )   Max. OD   Growth rate (hr -1 )  Native ESA_02131 ProP1 0.326 0.009 0.144 0.005 0.152 0.004 0.177 0.004 0.181 0.004 0.204 0.004 Native ESA_01706 ProP2 0.111 0.003 0.096 0.002 0.083 0.002 0.074 0.002 0.127 0.002 0.171 0.002 Chimeric ESA_02131 ESA_01706 ProPc 0.189 0.004 0.130 0.003 0.113 0.003 0.117 0.003 0.124 0.003 0.141 0.003 </text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12826</offset>
      <text>Each E. coli MKH13 strain expressing a proP gene of interest conferred osmotolerance (Figure 2B). As expected, E. coli MKH13 demonstrated a significant reduction in growth rate as NaCl concentrations increased, with a final growth rate of 0.0004 hr-1 recorded in media supplemented with 4% NaCl and no subsequent growth recorded thereafter. E. coli MKH13 expressing ProP1 demonstrated the highest osmotolerance of all the strains tested with growth rates of 0.009 hr-1 to 0.004 hr-1 recorded in media supplemented with 5% to 10% NaCl respectively. The next most osmotolerant strain was that expressing ProPc. Growth rates of 0.004 hr-1 to 0.003 hr-1 were recorded in media supplemented with 5% to 10% NaCl respectively (Table 3). This was higher than the growth rates observed when E. coli MKH13 expressing the native ESA_01706 gene (ProP2) was grown in a high osmolality environment, suggesting an important role for the C. sakazakii ProP C-terminal extension in osmotolerance.</text>
      <annotation id="145">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="12831" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="146">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="12937" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="147">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="13167" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="148">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="13608" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="149">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="13748" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
      <annotation id="150">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="13527" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="151">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="13006" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="152">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="13355" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="153">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="13116" length="4"/>
        <text>NaCl</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>13822</offset>
      <text>Discussion</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13833</offset>
      <text>A unique feature of the neonatal pathogen C. sakazakii is its ability to survive for prolonged periods in environments of low aW, such as powdered infant formula (PIF), making it a significant cause for concern. Indeed, up to 80% of infants infected with C. sakazakii die within days of birth, while survivors often suffer delayed neurological symptoms, brain abscesses or hydrocephalus. However, despite this, little is known about the molecular mechanisms that allow this organism to survive in environments such as PIF where it is subject to extreme hyper-osmotic stress.</text>
      <annotation id="162">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="13875" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13980" length="6"/>
        <text>infant</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14066" length="7"/>
        <text>infants</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="14088" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
      <annotation id="166">
        <infon key="identifier">MESH:D006849</infon>
        <infon key="type">Disease</infon>
        <location offset="14206" length="13"/>
        <text>hydrocephalus</text>
      </annotation>
      <annotation id="167">
        <infon key="identifier">MESH:D001922</infon>
        <infon key="type">Disease</infon>
        <location offset="14187" length="15"/>
        <text>brain abscesses</text>
      </annotation>
      <annotation id="168">
        <infon key="identifier">MESH:D009422</infon>
        <infon key="type">Disease</infon>
        <location offset="14164" length="21"/>
        <text>neurological symptoms</text>
      </annotation>
      <annotation id="169">
        <infon key="identifier">MESH:D004194</infon>
        <infon key="type">Disease</infon>
        <location offset="14386" length="20"/>
        <text>hyper-osmotic stress</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>14408</offset>
      <text>In a previous in silico study we identified seven copies of an E. coli proP homolog on the BAA-894 genome. Physiological analysis confirmed that six of the proP homologues identified played a role in osmotolerance. The availability of osmolytes in the media also had an effect on the osmotolerance of the host, with growth rates varying depending on the type or variety of compatible solutes present. While all six ProP proteins exhibited features characteristic of classic secondary transporters, five of the proteins were between 60-70 amino acids shorter than ProP1; lacking the characteristic C-terminal cytoplasmic extension Previous studies in our lab have demonstrated that the six C. sakazakii ProP homologues lacking the C-terminal coiled coil are significantly less osmoprotective than ProP1, suggesting an important role for this domain in modulating C. sakazakii osmotolerance.</text>
      <annotation id="173">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="14471" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="174">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="15097" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="15270" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>15300</offset>
      <text>In the current study, the C. sakazakii ProP2 (encoded by ESA_01706) was chosen as the prototypical ProP homologue to study the role of the alpha helical coiled coil in osmotolerance. Genetic splicing yielded a chimeric protein structure (ProPc) possessing the native ProP2 domains in addition to the C-terminal alpha helical coiled coil domain from ProP1 (Figure 1C). E. coli MKH13 expressing ProPc grew to a higher OD in minimal media supplemented with proline, when compared to the native protein ProP2 which lacked the extended coiled coil domain (Figure 2A). These data demonstrate that the addition of the coiled coil domain from ProP1 to ProP2 results in a protein with an increased osmoprotective effect on the usually osmotically sensitive E. coli MKH13. However, as the osmolality of the medium increased, this trend appeared to reverse with OD readings becoming similar at 9% NaCl and the chimeric protein growing to a higher OD than the native in 10% NaCl, suggesting that the extent of osmotic pressure also has a role to play in the activity of the proteins.</text>
      <annotation id="183">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="15326" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
      <annotation id="184">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="15668" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="185">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="16048" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="186">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="16186" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="187">
        <infon key="identifier">MESH:D011392</infon>
        <infon key="type">Chemical</infon>
        <location offset="15754" length="7"/>
        <text>proline</text>
      </annotation>
      <annotation id="188">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="16262" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="189">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="16056" length="5"/>
        <text>MKH13</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16374</offset>
      <text>The role of the C-terminal domain of other osmolyte transporters, such as BetP (Corynebacterium glutamicum) and OpuA (Bacillus subtilis), was demonstrated to be important for the activation of these proteins during an increase in the osmolality of the surrounding medium. Furthermore, Culham et al. created a synthetic polypeptide corresponding to the C-terminal domain of E. coli ProP which formed a dimeric alpha helical coiled coil structure, similar to the coiled coil structure of ProP1 (illustrated in Figure 1A). In the same study ProP proteins from both E. coli and Agrobacterium tumefaciens, possessing the characteristic alpha helical coiled coil, were activated at a lower osmolality than orthologues lacking the coiled coil structure. C. glutamicum possesses a ProP protein which lacks the C-terminal alpha helical coiled coil domain and, presumably as a result of this, requires a higher osmolality for activation. E. coli ProP variants lacking the coiled coil or with an amino acid substitution disrupting the formation of the alpha helical coiled coil, also require a larger osmotic upshift than the wild-type transporter. This study demonstrates that the activity of these ProP orthologues is dependent on the osmolality of the surrounding medium, and the alpha helical coiled coil is believed to tune the transporter to osmoregulate the cell over a low osmolality range. These data may therefore offer an explanation for the increased growth observed in E. coli MKH13 expressing ProP2, which lacks the coiled coil domain, in media supplemented with 10% NaCl relative to either ProP1 or ProPc (Figure 2). It is likely that the coiled coil domain of C. sakazakii ProP1 has a similar tuning function. Furthermore, the presence of multiple ProP porters lacking the C-terminal coiled coil domain, and therefore only active at a higher osmolality, may well explain the extreme osmotolerance unique to C. sakazakii; allowing the pathogen to survive in environments like PIF. The ProP1 protein, on the other hand possessing the coiled coil, may be the only osmolyte transporter required to respond to low or moderate hyperosmotic challenge.</text>
      <annotation id="202">
        <infon key="identifier">1718</infon>
        <infon key="type">Species</infon>
        <location offset="16454" length="26"/>
        <text>Corynebacterium glutamicum</text>
      </annotation>
      <annotation id="203">
        <infon key="identifier">1423</infon>
        <infon key="type">Species</infon>
        <location offset="16492" length="17"/>
        <text>Bacillus subtilis</text>
      </annotation>
      <annotation id="204">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="16747" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="205">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="16936" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="206">
        <infon key="identifier">358</infon>
        <infon key="type">Species</infon>
        <location offset="16948" length="25"/>
        <text>Agrobacterium tumefaciens</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">1718</infon>
        <infon key="type">Species</infon>
        <location offset="17121" length="13"/>
        <text>C. glutamicum</text>
      </annotation>
      <annotation id="208">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="17302" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="209">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="17845" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="210">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="18039" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
      <annotation id="211">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="18286" length="12"/>
        <text>C. sakazakii</text>
      </annotation>
      <annotation id="212">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="17944" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="213">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="16448" length="4"/>
        <text>BetP</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>18526</offset>
      <text>Conclusion</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>18537</offset>
      <text>The addition of the coiled coil domain from ProP1 to ProP2 resulted in a chimeric protein (ProPc) which demonstrated higher osmotolerance compared to the native ProP2 (under moderate osmotic stress conditions). Furthermore, the growth rate of E. coli MKH13 expressing ProP2 increased in minimal media supplemented with 10% NaCl; suggesting that, as is the case in E. coli, the coiled coil domain tunes ProP at low osmolality, whereas ProP transporters lacking the coiled coil domain are more active at a higher osmolality range.</text>
      <annotation id="217">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="18780" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="218">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="18901" length="7"/>
        <text>E. coli</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="18860" length="4"/>
        <text>NaCl</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>19066</offset>
      <text>Audrey Feeney and Christopher D Johnston are contributed equally to this work.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>19145</offset>
      <text>Competing interests</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>19165</offset>
      <text>The authors declare that they have no competing interests.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>19224</offset>
      <text>Authors' contributions</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>19249</offset>
      <text>AF, CJ and AL carried out the the experimental work. AF drafted the manuscript together with together with CJ, AL and RDS. All authors read and approved the final manuscript.</text>
      <annotation id="224">
        <infon key="identifier">MESH:D001281</infon>
        <infon key="type">Disease</infon>
        <location offset="19249" length="2"/>
        <text>AF</text>
      </annotation>
      <annotation id="225">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="19360" length="2"/>
        <text>AL</text>
      </annotation>
      <annotation id="226">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="19260" length="2"/>
        <text>AL</text>
      </annotation>
      <annotation id="227">
        <infon key="identifier">MESH:D001281</infon>
        <infon key="type">Disease</infon>
        <location offset="19302" length="2"/>
        <text>AF</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>19424</offset>
      <text>References</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Bowlus;given-names:RD</infon>
      <infon key="name_2">surname:Hand;given-names:SC</infon>
      <infon key="name_1">surname:Clark;given-names:ME</infon>
      <infon key="name_0">surname:Yancey;given-names:PH</infon>
      <infon key="fpage">1214</infon>
      <infon key="issue">4566</infon>
      <infon key="pub-id_doi">10.1126/science.7112124</infon>
      <infon key="pub-id_pmid">7112124</infon>
      <infon key="year">1982</infon>
      <infon key="source">Science</infon>
      <infon key="type">ref</infon>
      <infon key="volume">217</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1222</infon>
      <infon key="name_4">surname:Somero;given-names:GN</infon>
      <offset>19435</offset>
      <text>Living with water stress: evolution of osmolyte systems</text>
      <annotation id="229">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="19447" length="5"/>
        <text>water</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">2</infon>
      <infon key="name_1">surname:Sleator;given-names:RD</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Feeney;given-names:A</infon>
      <infon key="fpage">260</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_doi">10.4161/bbug.2.5.17238</infon>
      <infon key="pub-id_pmid">21918371</infon>
      <infon key="year">2011</infon>
      <infon key="source">Bioeng Bugs</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">270</infon>
      <offset>19491</offset>
      <text>An in silico analysis of osmotolerance in the emerging gastrointestinal pathogen Cronobacter sakazakii</text>
    </passage>
    <passage>
      <infon key="name_2">surname:Hill;given-names:C</infon>
      <infon key="name_1">surname:Gahan;given-names:CG</infon>
      <infon key="name_0">surname:Sleator;given-names:RD</infon>
      <infon key="fpage">2571</infon>
      <infon key="issue">6</infon>
      <infon key="pub-id_doi">10.1128/AEM.67.6.2571-2577.2001</infon>
      <infon key="pub-id_pmid">11375165</infon>
      <infon key="year">2001</infon>
      <infon key="source">Appl Environ Microbiol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">67</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">2577</infon>
      <offset>19594</offset>
      <text>Identification and disruption of the proBA locus in Listeria monocytogenes: role of proline biosynthesis in salt tolerance and murine infection</text>
      <annotation id="234">
        <infon key="identifier">1639</infon>
        <infon key="type">Species</infon>
        <location offset="19646" length="22"/>
        <text>Listeria monocytogenes</text>
      </annotation>
      <annotation id="235">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="19721" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="236">
        <infon key="identifier">MESH:D011392</infon>
        <infon key="type">Chemical</infon>
        <location offset="19678" length="7"/>
        <text>proline</text>
      </annotation>
      <annotation id="237">
        <infon key="identifier">MESH:D012492</infon>
        <infon key="type">Chemical</infon>
        <location offset="19702" length="4"/>
        <text>salt</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">26</infon>
      <infon key="name_1">surname:Hill;given-names:C</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sleator;given-names:RD</infon>
      <infon key="fpage">49</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_doi">10.1111/j.1574-6976.2002.tb00598.x</infon>
      <infon key="pub-id_pmid">12007642</infon>
      <infon key="year">2002</infon>
      <infon key="source">FEMS Microbiol Rev</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">71</infon>
      <offset>19738</offset>
      <text>Bacterial osmoadaptation: the role of osmolytes in bacterial stress and virulence</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Milner;given-names:JL</infon>
      <infon key="name_2">surname:Marangoni;given-names:AG</infon>
      <infon key="name_1">surname:Lasby;given-names:B</infon>
      <infon key="name_0">surname:Culham;given-names:DE</infon>
      <infon key="fpage">268</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_doi">10.1006/jmbi.1993.1030</infon>
      <infon key="pub-id_pmid">8421314</infon>
      <infon key="year">1993</infon>
      <infon key="source">J Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">229</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">276</infon>
      <infon key="name_6">surname:Wood;given-names:JM</infon>
      <infon key="name_5">surname:Van Nues;given-names:RW</infon>
      <infon key="name_4">surname:Steer;given-names:BA</infon>
      <offset>19820</offset>
      <text>Isolation and sequencing of escherichia coli gene proP reveals unusual structural features of the osmoregulatory proline/betaine transporter, ProP</text>
      <annotation id="239">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="19848" length="16"/>
        <text>escherichia coli</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Voegele;given-names:RT</infon>
      <infon key="name_2">surname:Racher;given-names:KI</infon>
      <infon key="name_1">surname:Tripet;given-names:B</infon>
      <infon key="name_0">surname:Culham;given-names:DE</infon>
      <infon key="fpage">309</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_doi">10.1002/1099-1352(200009/10)13:5&lt;309::AID-JMR505&gt;3.0.CO;2-R</infon>
      <infon key="pub-id_pmid">10992293</infon>
      <infon key="year">2000</infon>
      <infon key="source">J Mol Recognit</infon>
      <infon key="type">ref</infon>
      <infon key="volume">13</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">322</infon>
      <infon key="name_5">surname:Wood;given-names:JM</infon>
      <infon key="name_4">surname:Hodges;given-names:RS</infon>
      <offset>19967</offset>
      <text>The role of the carboxyl terminal alpha-helical coiled-coil domain in osmosensing by transporter ProP of Escherichia coli</text>
    </passage>
    <passage>
      <infon key="name_3">surname:O'Mahony;given-names:J</infon>
      <infon key="name_2">surname:Govender;given-names:R</infon>
      <infon key="name_1">surname:Johnston;given-names:CD</infon>
      <infon key="name_0">surname:Feeney;given-names:A</infon>
      <infon key="fpage">15</infon>
      <infon key="pub-id_doi">10.1186/1757-4749-6-15</infon>
      <infon key="pub-id_pmid">24910715</infon>
      <infon key="year">2014</infon>
      <infon key="source">Gut Pathogens</infon>
      <infon key="type">ref</infon>
      <infon key="volume">6</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_5">surname:Sleator;given-names:RD</infon>
      <infon key="name_4">surname:Coffey;given-names:A</infon>
      <offset>20089</offset>
      <text>Analysis of the role of the Cronobacter sakazakii ProP homologues in osmotolerance</text>
      <annotation id="241">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="20117" length="21"/>
        <text>Cronobacter sakazakii</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Abee;given-names:T</infon>
      <infon key="name_2">surname:Rombouts;given-names:FM</infon>
      <infon key="name_1">surname:Wouters;given-names:JA</infon>
      <infon key="name_0">surname:Verheul;given-names:A</infon>
      <infon key="fpage">1036</infon>
      <infon key="issue">6</infon>
      <infon key="pub-id_doi">10.1111/j.1365-2672.1998.tb05269.x</infon>
      <infon key="pub-id_pmid">9871325</infon>
      <infon key="year">1998</infon>
      <infon key="source">J Appl Microbiol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">85</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1046</infon>
      <offset>20172</offset>
      <text>A possible role of ProP, ProU and CaiT in osmoprotection of Escherichia coli by carnitine</text>
      <annotation id="244">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="20232" length="16"/>
        <text>Escherichia coli</text>
      </annotation>
      <annotation id="245">
        <infon key="identifier">MESH:D002331</infon>
        <infon key="type">Chemical</infon>
        <location offset="20252" length="9"/>
        <text>carnitine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">19</infon>
      <infon key="name_1">surname:Messing;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Vieira;given-names:J</infon>
      <infon key="fpage">259</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_doi">10.1016/0378-1119(82)90015-4</infon>
      <infon key="pub-id_pmid">6295879</infon>
      <infon key="year">1982</infon>
      <infon key="source">Gene</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">268</infon>
      <offset>20262</offset>
      <text>The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Long;given-names:F</infon>
      <infon key="name_2">surname:Xia;given-names:X-Q</infon>
      <infon key="name_1">surname:Clifton;given-names:SW</infon>
      <infon key="name_0">surname:Kucerova;given-names:E</infon>
      <infon key="pub-id_doi">10.1371/journal.pone.0009556</infon>
      <infon key="pub-id_pmid">20221447</infon>
      <infon key="year">2010</infon>
      <infon key="source">PLoS One</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="fpage">e9556</infon>
      <infon key="issue">3</infon>
      <infon key="volume">5</infon>
      <infon key="name_10">surname:Fulton;given-names:R</infon>
      <infon key="name_13">surname:Shah;given-names:N</infon>
      <infon key="name_14">surname:Bhonagiri;given-names:V</infon>
      <infon key="name_11">surname:Feng;given-names:D</infon>
      <infon key="name_12">surname:Wollam;given-names:A</infon>
      <infon key="name_17">surname:Wilson;given-names:RK</infon>
      <infon key="name_18">surname:McClelland;given-names:M</infon>
      <infon key="name_15">surname:Nash;given-names:WE</infon>
      <infon key="name_9">surname:Warren;given-names:W</infon>
      <infon key="name_16">surname:Hallsworth-Pepin;given-names:K</infon>
      <infon key="name_8">surname:Kyung;given-names:K</infon>
      <infon key="name_7">surname:Minx;given-names:P</infon>
      <infon key="name_6">surname:Fronick;given-names:C</infon>
      <infon key="name_19">surname:Forsythe;given-names:SJ</infon>
      <infon key="name_5">surname:Fulton;given-names:L</infon>
      <infon key="name_4">surname:Porwollik;given-names:S</infon>
      <offset>20379</offset>
      <text>Genome sequence of Cronobacter sakazakii BAA-894 and comparative genomic hybridization analysis with other Cronobacter species</text>
      <annotation id="247">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="20398" length="21"/>
        <text>Cronobacter sakazakii</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">270</infon>
      <infon key="name_1">surname:Bremer;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kempf;given-names:B</infon>
      <infon key="fpage">16701</infon>
      <infon key="issue">28</infon>
      <infon key="pub-id_doi">10.1074/jbc.270.28.16701</infon>
      <infon key="pub-id_pmid">7622480</infon>
      <infon key="year">1995</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">16713</infon>
      <offset>20506</offset>
      <text>OpuA, an osmotically regulated binding protein-dependent transport system for the osmoprotectant glycine betaine in bacillus subtilis</text>
      <annotation id="250">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="20506" length="4"/>
        <text>OpuA</text>
      </annotation>
      <annotation id="251">
        <infon key="identifier">MESH:D001622</infon>
        <infon key="type">Chemical</infon>
        <location offset="20603" length="15"/>
        <text>glycine betaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hill;given-names:C</infon>
      <infon key="name_2">surname:O'Driscoll;given-names:B</infon>
      <infon key="name_1">surname:Gahan;given-names:CGM</infon>
      <infon key="name_0">surname:Sleator;given-names:RD</infon>
      <infon key="fpage">261</infon>
      <infon key="issue">2-3</infon>
      <infon key="pub-id_doi">10.1016/S0168-1605(00)00316-0</infon>
      <infon key="pub-id_pmid">11016615</infon>
      <infon key="year">2000</infon>
      <infon key="source">Int J Food Microbiol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">60</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">268</infon>
      <offset>20640</offset>
      <text>Analysis of the role of betL in contributing to the growth and survival of Listeria monocytogenes LO28</text>
      <annotation id="253">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="20664" length="4"/>
        <text>betL</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">9</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Zhang;given-names:Y</infon>
      <infon key="fpage">40</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_doi">10.1186/1471-2105-9-40</infon>
      <infon key="pub-id_pmid">18215316</infon>
      <infon key="year">2008</infon>
      <infon key="source">BMC Bioinformatics</infon>
      <infon key="type">ref</infon>
      <offset>20743</offset>
      <text>I-TASSER server for protein 3D structure prediction</text>
    </passage>
    <passage>
      <infon key="name_2">surname:Zhang;given-names:Y</infon>
      <infon key="name_1">surname:Kucukural;given-names:A</infon>
      <infon key="name_0">surname:Roy;given-names:A</infon>
      <infon key="fpage">725</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_doi">10.1038/nprot.2010.5</infon>
      <infon key="pub-id_pmid">20360767</infon>
      <infon key="year">2010</infon>
      <infon key="source">Nat Protoc</infon>
      <infon key="type">ref</infon>
      <infon key="volume">5</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">738</infon>
      <offset>20795</offset>
      <text>I-TASSER: a unified platform for automated protein structure and function prediction</text>
    </passage>
    <passage>
      <infon key="volume">7</infon>
      <infon key="name_1">surname:Sleator;given-names:RD</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Feeney;given-names:A</infon>
      <infon key="fpage">1235</infon>
      <infon key="issue">11</infon>
      <infon key="pub-id_doi">10.2217/fmb.12.105</infon>
      <infon key="pub-id_pmid">23075440</infon>
      <infon key="year">2012</infon>
      <infon key="source">Future Microbiol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1237</infon>
      <offset>20880</offset>
      <text>The human gut microbiome: the ghost in the machine</text>
      <annotation id="256">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20884" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="257">
        <infon key="identifier">749906</infon>
        <infon key="type">Species</infon>
        <location offset="20890" length="14"/>
        <text>gut microbiome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Lowe;given-names:J</infon>
      <infon key="name_2">surname:Gonzalez-Gomez;given-names:I</infon>
      <infon key="name_1">surname:Hurrell;given-names:E</infon>
      <infon key="name_0">surname:Townsend;given-names:SM</infon>
      <infon key="fpage">3538</infon>
      <infon key="issue">Pt 10</infon>
      <infon key="pub-id_doi">10.1099/mic.0.2007/009316-0</infon>
      <infon key="year">2007</infon>
      <infon key="source">Microbiol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">153</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">3547</infon>
      <infon key="name_6">surname:Badger;given-names:JL</infon>
      <infon key="name_5">surname:Forsythe;given-names:S</infon>
      <infon key="name_4">surname:Frye;given-names:JG</infon>
      <offset>20931</offset>
      <text>Enterobacter sakazakii invades brain capillary endothelial cells, persists in human macrophages influencing cytokine secretion and induces severe brain pathology in the neonatal rat</text>
      <annotation id="260">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="20931" length="22"/>
        <text>Enterobacter sakazakii</text>
      </annotation>
      <annotation id="261">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21009" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">30</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Burdette;given-names:JHSC</infon>
      <infon key="fpage">33</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_doi">10.1007/s002470050009</infon>
      <infon key="pub-id_pmid">10663506</infon>
      <infon key="year">2000</infon>
      <infon key="source">Pediatric Radiology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">34</infon>
      <offset>21113</offset>
      <text>Enterobacter sakazakii brain abscess in the neonate: the importance of neuroradiologic imaging</text>
      <annotation id="263">
        <infon key="identifier">28141</infon>
        <infon key="type">Species</infon>
        <location offset="21113" length="22"/>
        <text>Enterobacter sakazakii</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Zuiani;given-names:AJ</infon>
      <infon key="name_2">surname:Vernikovska;given-names:YI</infon>
      <infon key="name_1">surname:Culham;given-names:DE</infon>
      <infon key="name_0">surname:Keates;given-names:RAB</infon>
      <infon key="fpage">8847</infon>
      <infon key="issue">41</infon>
      <infon key="pub-id_doi">10.1021/bi101281f</infon>
      <infon key="pub-id_pmid">20828170</infon>
      <infon key="year">2010</infon>
      <infon key="source">Biochemistry</infon>
      <infon key="type">ref</infon>
      <infon key="volume">49</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">8856</infon>
      <infon key="name_5">surname:Wood;given-names:JM</infon>
      <infon key="name_4">surname:Boggs;given-names:JM</infon>
      <offset>21208</offset>
      <text>Transmembrane Helix I and Periplasmic Loop 1 of Escherichia coli ProP are involved in osmosensing and osmoprotectant transport</text>
      <annotation id="265">
        <infon key="identifier">562</infon>
        <infon key="type">Species</infon>
        <location offset="21256" length="16"/>
        <text>Escherichia coli</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Bogdanov;given-names:M</infon>
      <infon key="name_2">surname:Dobson;given-names:M</infon>
      <infon key="name_1">surname:Khambati;given-names:J</infon>
      <infon key="name_0">surname:Tsatskis;given-names:Y</infon>
      <infon key="fpage">41387</infon>
      <infon key="issue">50</infon>
      <infon key="pub-id_doi">10.1074/jbc.M508362200</infon>
      <infon key="pub-id_pmid">16239220</infon>
      <infon key="year">2005</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="type">ref</infon>
      <infon key="volume">280</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">41394</infon>
      <infon key="name_5">surname:Wood;given-names:JM</infon>
      <infon key="name_4">surname:Dowhan;given-names:W</infon>
      <offset>21335</offset>
      <text>The osmotic activation of transporter ProP is tuned by both its c-terminal coiled-coil and osmotically induced changes in phospholipid composition</text>
      <annotation id="267">
        <infon key="identifier">MESH:D010743</infon>
        <infon key="type">Chemical</infon>
        <location offset="21457" length="12"/>
        <text>phospholipid</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272815</id>
    <passage>
      <infon key="name_3">surname:Thompson;given-names:Bryony A</infon>
      <infon key="name_2">surname:Nunez;given-names:Andrea C</infon>
      <infon key="name_1">surname:Hesson;given-names:Luke B</infon>
      <infon key="article-id_pmid">25530820</infon>
      <infon key="name_0">surname:Sloane;given-names:Mathew A</infon>
      <infon key="issue">1</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272815</infon>
      <infon key="article-id_publisher-id">32</infon>
      <infon key="article-id_doi">10.1186/s13148-014-0032-6</infon>
      <infon key="title">Keywords</infon>
      <infon key="type">front</infon>
      <infon key="elocation-id">32</infon>
      <infon key="volume">6</infon>
      <infon key="license">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Clin Epigenetics; 2014; 6(1) 32. doi:10.1186/s13148-014-0032-6</infon>
      <infon key="kwd">Lynch syndrome Colorectal cancer Nucleosome Splice site Splicing Acceptor Donor Exon</infon>
      <infon key="name_4">surname:Ward;given-names:Robyn L</infon>
      <infon key="authors">Sloane MA, Hesson LB, Nunez AC, Thompson BA, Ward RL</infon>
      <offset>0</offset>
      <text>Nucleosome positioning is unaltered at MLH1 splice site mutations in cells derived from Lynch syndrome patients</text>
      <annotation id="2">
        <infon key="identifier">17350</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="39" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="3">
        <infon key="identifier">MESH:D003123</infon>
        <infon key="type">Disease</infon>
        <location offset="88" length="14"/>
        <text>Lynch syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>112</offset>
      <text>Background</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>123</offset>
      <text>Splicing is more efficient when coupled with transcription and it has been proposed that nucleosomes enriched in exons are important for splice site recognition. Lynch syndrome is a familial cancer syndrome that can be caused by the autosomal dominant inheritance of splice site mutations in the MutL homolog 1 (MLH1) gene. To better understand the role of nucleosomes in splicing, we used MLH1 splice site mutations in Lynch syndrome cases as a model to investigate if abnormal splicing was associated with altered nucleosome positioning at exon-intron boundaries.</text>
      <annotation id="10">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="419" length="14"/>
        <text>MutL homolog 1</text>
      </annotation>
      <annotation id="11">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="435" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="12">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="513" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="13">
        <infon key="identifier">MESH:D003123</infon>
        <infon key="type">Disease</infon>
        <location offset="543" length="14"/>
        <text>Lynch syndrome</text>
      </annotation>
      <annotation id="14">
        <infon key="identifier">MESH:D003123</infon>
        <infon key="type">Disease</infon>
        <location offset="285" length="14"/>
        <text>Lynch syndrome</text>
      </annotation>
      <annotation id="15">
        <infon key="identifier">MESH:D009386</infon>
        <infon key="type">Disease</infon>
        <location offset="305" length="24"/>
        <text>familial cancer syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>689</offset>
      <text>Findings</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>698</offset>
      <text>Nucleosome Occupancy and Methylome sequencing (NOMe-seq) was used to determine the allele-specific positioning of nucleosomes around heterozygous splice site mutations in lymphoblastoid cells lines (LCLs) derived from six Lynch syndrome patients. These mutations were previously shown to cause exon skipping in five of the six patients. Allele-specific high-resolution nucleosome mapping across exons and exon-intron boundaries revealed high levels of nucleosomes across all regions examined. Alleles containing donor or acceptor splice site mutations showed no consistent alteration in nucleosome positioning or occupancy.</text>
      <annotation id="20">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="935" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="21">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1025" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="22">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1210" length="5"/>
        <text>donor</text>
      </annotation>
      <annotation id="23">
        <infon key="identifier">MESH:D003123</infon>
        <infon key="type">Disease</infon>
        <location offset="920" length="14"/>
        <text>Lynch syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1322</offset>
      <text>Conclusion</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1333</offset>
      <text>Nucleosomes were enriched at MLH1 exons in LCLs derived from Lynch syndrome patients, and in this model system the positioning of nucleosomes was unaltered at exon-intron boundaries containing splice site mutations. Thus, these splice site mutations alone do not significantly change the local organisation of nucleosomes.</text>
      <annotation id="27">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="1362" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="28">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1409" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="29">
        <infon key="identifier">MESH:D003123</infon>
        <infon key="type">Disease</infon>
        <location offset="1394" length="14"/>
        <text>Lynch syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>1656</offset>
      <text>Findings</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>1665</offset>
      <text>Background</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>1676</offset>
      <text>Splicing removes introns from a longer pre-cursor RNA molecule to produce a final processed mRNA. Splice donor and acceptor sites located at the junctions between exons and introns contain conserved sequence elements that are necessary for splicing. Although in vitro splicing can occur, splicing is more efficient when coupled with transcription, suggesting that factors additional to the nucleic acid sequence are important for splice site recognition. It has been proposed that the positioning of nucleosomes at exons aids in splice-site recognition.</text>
      <annotation id="31">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1781" length="5"/>
        <text>donor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>2230</offset>
      <text>Nucleosome positioning describes the precise location of a given nucleosome, whereas nucleosome occupancy refers to the proportion of molecules bearing a nucleosome at a specific location, at any given instant. It is hypothesised that nucleosomes positioned within exons, especially those with weak splice sites, cause RNA Polymerase II (RNAPII) to pause, enabling an interaction with the spliceosome and more efficient splicing. In support of this, nucleosome occupancy is enriched across exons, which have a high GC content that favours nucleosome assembly, and the average size of an exon within the body of a human gene is 151 bp, that is similar in length to nucleosomal DNA (approximately 147 bp). Splicing factors associate with the C-terminal domain of RNA Polymerase II (RNAPII), while the histone modification H3K36me3 is enriched in exons, where it may act as a scaffold to recruit splicing factors. Taken together this indicates there is interplay between nucleosomes, the splicing machinery and the DNA sequence.</text>
      <annotation id="33">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2843" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>3256</offset>
      <text>Lynch syndrome is an autosomal dominant familial cancer syndrome characterised by early onset colorectal, endometrial and other cancers. It is most commonly caused by the inheritance of heterozygous loss-of-function mutations, including splice site mutations, in the DNA mismatch repair (MMR) genes MLH1 and MSH2. In this study we used MLH1 splice site mutations in Lynch syndrome as a model to better understand the role of nucleosomes in splicing. We investigated cells from Lynch syndrome patients with splice site mutations to determine whether splicing aberrations were associated with altered nucleosome positioning at exon-intron boundaries.</text>
      <annotation id="45">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="3555" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="46">
        <infon key="identifier">4436</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">210</infon>
        <location offset="3564" length="4"/>
        <text>MSH2</text>
      </annotation>
      <annotation id="47">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="3592" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3748" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">MESH:D003123</infon>
        <infon key="type">Disease</infon>
        <location offset="3622" length="14"/>
        <text>Lynch syndrome</text>
      </annotation>
      <annotation id="50">
        <infon key="identifier">MESH:D015179</infon>
        <infon key="type">Disease</infon>
        <location offset="3350" length="10"/>
        <text>colorectal</text>
      </annotation>
      <annotation id="51">
        <infon key="identifier">MESH:D003123</infon>
        <infon key="type">Disease</infon>
        <location offset="3733" length="14"/>
        <text>Lynch syndrome</text>
      </annotation>
      <annotation id="52">
        <infon key="identifier">MESH:D014591</infon>
        <infon key="type">Disease</infon>
        <location offset="3362" length="11"/>
        <text>endometrial</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">MESH:D003123</infon>
        <infon key="type">Disease</infon>
        <location offset="3256" length="14"/>
        <text>Lynch syndrome</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="3384" length="7"/>
        <text>cancers</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">MESH:D009386</infon>
        <infon key="type">Disease</infon>
        <location offset="3277" length="43"/>
        <text>autosomal dominant familial cancer syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>3905</offset>
      <text>Materials and methods</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>3927</offset>
      <text>Identification of MLH1 splice site mutations</text>
      <annotation id="57">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="3945" length="4"/>
        <text>MLH1</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab1.xml</infon>
      <infon key="id">Tab1</infon>
      <infon key="type">table_caption</infon>
      <offset>3972</offset>
      <text> Molecular features of MLH1 splice site mutations in six individuals with Lynch syndrome </text>
      <annotation id="60">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="3995" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="61">
        <infon key="identifier">MESH:D003123</infon>
        <infon key="type">Disease</infon>
        <location offset="4046" length="14"/>
        <text>Lynch syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab1</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab1.xml</infon>
      <offset>4062</offset>
      <text> Mutation   Mutation location (GRC37, Feb 2009)   Affected splice site   Nucleosome occlusion of splice site   Splicing error   Allele   Proportion of alleles  c.588 + 1G &gt; T Chr. 3: 37,053,354 Donor Wild-type (G) 19/20 Exon 7 skipping (r.546_588del) First bp of intron 7  Mutant (T) 21/22 Acceptor Homozygous 36/42 c.589-2A &gt; G Chr. 3: 37,053,500 Acceptor Wild-type (A) 17/20 4 bp deletion in cDNA (r.589_592del) 2nd last bp of intron 7 Mutant (G) 19/22 c.790 + 1G &gt; T Chr. 3: 37,056,036 Donor Wild-type (G) 33/34 Unknown 1st bp of intron 9 Mutant (T) 21/24 c.791-1G &gt; C Chr. 3: 37,058,996 Acceptor Wild-type (G) 30/30 Exon 10 skipping (r.791_884del) Last bp of intron 9 Mutant (C) 12/18 c.884G &gt; A Chr. 3: 37,059,090 Donor Wild-type (G) 42/42 Exon 10 skipping (r.791_884del) Last bp of exon 10  Mutant (A) 24/30 c.1559-2A &gt; T Chr. 3: 37,081,675 Acceptor Wild-type (A) 17/20 Two aberrant transcripts (Exon 14 skipping or exon 14 and 15 skipping - r.[1559_1667del, 1559_1731del]) Second last bp of intron 13  Mutant (T) 16/16 </text>
      <annotation id="77">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4256" length="5"/>
        <text>Donor</text>
      </annotation>
      <annotation id="78">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4551" length="5"/>
        <text>Donor</text>
      </annotation>
      <annotation id="79">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4781" length="5"/>
        <text>Donor</text>
      </annotation>
      <annotation id="80">
        <infon key="identifier">c.1559-2A&gt;T;RS#:267607836</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="4876" length="13"/>
        <text>c.1559-2A &gt; T</text>
      </annotation>
      <annotation id="81">
        <infon key="identifier">r.[1559_1667del</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="5010" length="15"/>
        <text>r.[1559_1667del</text>
      </annotation>
      <annotation id="82">
        <infon key="identifier">r.791_884del</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="4825" length="12"/>
        <text>r.791_884del</text>
      </annotation>
      <annotation id="83">
        <infon key="identifier">c.1G&gt;T</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="4230" length="6"/>
        <text>1G &gt; T</text>
      </annotation>
      <annotation id="84">
        <infon key="identifier">r.791_884del</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="4700" length="12"/>
        <text>r.791_884del</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">c.1559_1731del]</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="5027" length="13"/>
        <text>1559_1731del]</text>
      </annotation>
      <annotation id="86">
        <infon key="identifier">c.589-2A&gt;G;RS#:267607767</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="4378" length="12"/>
        <text>c.589-2A &gt; G</text>
      </annotation>
      <annotation id="87">
        <infon key="identifier">r.546_588del</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="4299" length="12"/>
        <text>r.546_588del</text>
      </annotation>
      <annotation id="88">
        <infon key="identifier">c.884G&gt;A;RS#:63750144</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="4751" length="10"/>
        <text>c.884G &gt; A</text>
      </annotation>
      <annotation id="89">
        <infon key="identifier">c.1G&gt;T</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="4525" length="6"/>
        <text>1G &gt; T</text>
      </annotation>
      <annotation id="90">
        <infon key="identifier">r.589_592del</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="4462" length="12"/>
        <text>r.589_592del</text>
      </annotation>
      <annotation id="91">
        <infon key="identifier">c.791-1G&gt;C;RS#:267607795</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="4621" length="12"/>
        <text>c.791-1G &gt; C</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5123</offset>
      <text>Bioinformatic analysis and in vitro assays previously showed that genetic mutations at exon-intron boundaries in the MLH1 gene generate aberrantly spliced transcripts (see Table 1). All mutations were classified as pathogenic (Class 5) according to the International Society for Gastrointestinal Hereditary Tumours Variant Interpretation Committee (InSiGHT VIC).</text>
      <annotation id="94">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="5240" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="95">
        <infon key="identifier">MESH:D004067</infon>
        <infon key="type">Disease</infon>
        <location offset="5402" length="35"/>
        <text>Gastrointestinal Hereditary Tumours</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>5487</offset>
      <text>Cell culture</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5500</offset>
      <text>LCLs were established from patient blood by transformation with Epstein-Barr Virus (as described previously), and cultured in RPMI with 10% fetal bovine serum (Gibco, Life Technologies) at 37 C in 5% CO2. Lymphocytes for transformation from five patients (c.588 + 1G &gt; T, c.589-2A &gt; G, c.791-1G &gt; C, c.884G &gt; A and c.1559-2A &gt; T) were obtained from the Australasian Colorectal Cancer Family Registry (ACCFR). Lymphocytes from the patient with the c.790 + 1G &gt; T mutation were obtained from the MCO collection.</text>
      <annotation id="109">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5527" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="110">
        <infon key="identifier">9913</infon>
        <infon key="type">Species</infon>
        <location offset="5646" length="6"/>
        <text>bovine</text>
      </annotation>
      <annotation id="111">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5746" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="112">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5930" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="113">
        <infon key="identifier">c.790+1G&gt;T;RS#:267607789</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="5947" length="14"/>
        <text>c.790 + 1G &gt; T</text>
      </annotation>
      <annotation id="114">
        <infon key="identifier">c.791-1G&gt;C;RS#:267607795</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="5786" length="12"/>
        <text>c.791-1G &gt; C</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">c.589-2A&gt;G;RS#:267607767</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="5772" length="12"/>
        <text>c.589-2A &gt; G</text>
      </annotation>
      <annotation id="116">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="5700" length="3"/>
        <text>CO2</text>
      </annotation>
      <annotation id="117">
        <infon key="identifier">c.588+1G&gt;T;RS#:267607772</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="5756" length="14"/>
        <text>c.588 + 1G &gt; T</text>
      </annotation>
      <annotation id="118">
        <infon key="identifier">c.884G&gt;A;RS#:63750144</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="5800" length="10"/>
        <text>c.884G &gt; A</text>
      </annotation>
      <annotation id="119">
        <infon key="identifier">c.1559-2A&gt;T;RS#:267607836</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="5815" length="13"/>
        <text>c.1559-2A &gt; T</text>
      </annotation>
      <annotation id="120">
        <infon key="identifier">MESH:D015179</infon>
        <infon key="type">Disease</infon>
        <location offset="5853" length="30"/>
        <text>Australasian Colorectal Cancer</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="5626" length="4"/>
        <text>RPMI</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>6043</offset>
      <text>NOMe-seq</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab2.xml</infon>
      <infon key="id">Tab2</infon>
      <infon key="type">table_caption</infon>
      <offset>6052</offset>
      <text> NOMe-seq primer sequences and amplification conditions </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab2</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab2.xml</infon>
      <offset>6109</offset>
      <text> Region   NOMe-seq primers   Annealing ( C)  c.588 + 1G &gt; T F:TTGATATTTAGTGTGTGTTTTTGGYAAT F/R = 54 C R:CACATAATATCTTAAAAAATTCCAAAATAATA F/RN = 56 C RN:ATACCRACTAACARCATTTCCAAAAATAA c.589-2A &gt; G F:TTAGGTATTTAGTATATAATGYAGG F/R = 51 C R:CACTATAAATATTTTCAAAACTAAAACCTTA F/RN = 52 C RN:CACAAAATCTAAAAAATTACATACACCTAA  c.790 + 1G &gt; T F:TAGGYATAGGAGGATTTTAAATGGATTAAGTT F/R = 52 C R:CAATTTCTTTAATAACAATRCCTATACCTAAA F/RN = 52 C RN:TTACTCRTAAAAACTCTAACACCATCAA c.791-1G &gt; C F:GATGTGATGTGYATATTATTATAGAAATGTT F/R = 55 C R:TATCARCACCTCCTAATAAAATGAARCATA F/RN = 56 C RN:ATCCTTTTRCCAATAATATATAAAATTCACTCTA c.884G &gt; A F:GGATGTGATGTGYATATTATTATAGAAATGTT F/R = 58 C R:CTATTATARCTTCCCAACTAACCCCARCAA F/RN = 58 C RN:CTACAARCTATCARCACCTCCTAATAA c.1559-2A &gt; T F:TATTAGGAGGYTTAATTTAGGYTTTTTTGYTTAT F/R = 58 C R:ACCCTCACCACCTAATTCACAACATTTATAA F/RN = 57 C RN:ACTAARCAACTACCAAAAACTAARCTTCTTA  HSPA5  F: GAGAAGAAAAAGTTTAGATTTTATA F/R = 56 C R: AAACACCCCAATAAATCAATC </text>
      <annotation id="129">
        <infon key="identifier">3309</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3908</infon>
        <location offset="6982" length="5"/>
        <text>HSPA5</text>
      </annotation>
      <annotation id="130">
        <infon key="identifier">c.1G&gt;T</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="6432" length="6"/>
        <text>1G &gt; T</text>
      </annotation>
      <annotation id="131">
        <infon key="identifier">c.1G&gt;T</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="6162" length="6"/>
        <text>1G &gt; T</text>
      </annotation>
      <annotation id="132">
        <infon key="identifier">c.589-2A&gt;G;RS#:267607767</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="6291" length="12"/>
        <text>c.589-2A &gt; G</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">c.1559-2A&gt;T;RS#:267607836</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="6838" length="13"/>
        <text>c.1559-2A &gt; T</text>
      </annotation>
      <annotation id="134">
        <infon key="identifier">c.791-1G&gt;C;RS#:267607795</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="6564" length="12"/>
        <text>c.791-1G &gt; C</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">c.884G&gt;A;RS#:63750144</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="6705" length="10"/>
        <text>c.884G &gt; A</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>7153</offset>
      <text>NOMe-seq was performed as described previously. Briefly, intact nuclei were treated with 200 to 300 U GpC methyltransferase M.CviPl and 160 to 320 muM S-adenosylmethionine for 15 min at 37 C followed by termination of the reaction with an equal volume of 20 mM Tris HCl pH 7.9, 600 mM NaCl, 1% (w/v) SDS and 10 mM EDTA. DNA was extracted using phenol chloroform followed by ethanol precipitation and bisulfite modified using the EZ DNA Methylation-Gold  Kit (Zymo Research). Regions incorporating the splice site mutation in each patient were amplified from 40 ng of bisulfite treated DNA using a nested PCR with the primers and annealing temperatures described in Table 2. Single molecule sequencing of PCR amplicons was performed as described previously. Wild-type and mutant alleles were distinguished using the splice site sequence alteration. The M.CviPI enzyme methylates accessible DNA at GpC sites, whereas nucleosome bound DNA is inaccessible and remains refractory to GpC methylation. Regions of M.CviPI inaccessibility of &gt;=150 bp (the length of DNA wrapped around a single nucleosome) within a single molecule were considered to represent regions of nucleosome occupancy. In addition, NOMe-seq retains the endogenous methylation status of the DNA allowing nucleosome positions and DNA methylation to be determined on each molecule.</text>
      <annotation id="151">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="7255" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="152">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="8049" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="153">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="8131" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="154">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7683" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="155">
        <infon key="identifier">MESH:C042345</infon>
        <infon key="type">Chemical</infon>
        <location offset="7553" length="9"/>
        <text>bisulfite</text>
      </annotation>
      <annotation id="156">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="7419" length="3"/>
        <text>HCl</text>
      </annotation>
      <annotation id="157">
        <infon key="identifier">MESH:D012436</infon>
        <infon key="type">Chemical</infon>
        <location offset="7304" length="20"/>
        <text>S-adenosylmethionine</text>
      </annotation>
      <annotation id="158">
        <infon key="identifier">MESH:D004492</infon>
        <infon key="type">Chemical</infon>
        <location offset="7467" length="4"/>
        <text>EDTA</text>
      </annotation>
      <annotation id="159">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="7438" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="160">
        <infon key="identifier">MESH:D002725</infon>
        <infon key="type">Chemical</infon>
        <location offset="7504" length="10"/>
        <text>chloroform</text>
      </annotation>
      <annotation id="161">
        <infon key="identifier">MESH:C042345</infon>
        <infon key="type">Chemical</infon>
        <location offset="7720" length="9"/>
        <text>bisulfite</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="7414" length="4"/>
        <text>Tris</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">MESH:D012967</infon>
        <infon key="type">Chemical</infon>
        <location offset="7453" length="3"/>
        <text>SDS</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">MESH:D019800</infon>
        <infon key="type">Chemical</infon>
        <location offset="7497" length="6"/>
        <text>phenol</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">MESH:D000431</infon>
        <infon key="type">Chemical</infon>
        <location offset="7527" length="7"/>
        <text>ethanol</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>8502</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13148_2014_32_Fig1_HTML.jpg</infon>
      <infon key="id">Fig1</infon>
      <infon key="type">fig_caption</infon>
      <offset>8510</offset>
      <text> Allele-specific positioning of nucleosomes at MLH1 variants. (A) The MLH1 gene with arrows showing the location of the splice site mutations investigated in the LCLs derived from the six patients. The numbers correspond to the NOMe-seq assays shown in panel B (exon, vertical bar; intron, horizontal bar with arrows). (B) Each panel shows the nucleosome occupancy on the wild-type allele (upper) and the allele harbouring the indicated splice site mutation (lower). Blue box = exon; blue arrows = intron and direction of transcription; yellow diamond = location of splice site mutation; vertical black bars below line = GpC sites; vertical black bars above line = CpG sites; the pink bar represents a single nucleosome (150 bp, drawn to scale); pink shading indicates the location of nucleosomes on individual DNA molecules as determined by GpC methyltransferase inaccessibility; black circles = methylated GpC/accessible to M.CviPI; white circles = unmethylated GpC/inaccessible to M.CviPI. CpG sites are depicted by triangles. Black triangle = methylated CpG; white triangle = unmethylated CpG.</text>
      <annotation id="173">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="8557" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="174">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="8580" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="9352" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="176">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="9418" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="177">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="9474" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="178">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="9131" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="179">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8698" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13148_2014_32_Fig2_HTML.jpg</infon>
      <infon key="id">Fig2</infon>
      <infon key="type">fig_caption</infon>
      <offset>9644</offset>
      <text> Nucleosome occupancy and endogenous CpG methylation at the HSPA5 gene. (A) Schematic showing the location of the NOMe-seq assay (black bar) in relation to the HSPA5 promoter. The arrow represents the transcriptional start site. (B) NOMe-seq was used to map the position of nucleosomes on individual DNA molecules at the HSPA5 gene in LCLs derived from the six individuals with splice site mutations in MLH1. Vertical black bars below line = GpC sites; vertical black bars above line = CpG sites; pink bars = the location of nucleosomes on individual DNA molecules as determined by GpC methyltransferase inaccessibility; black circles = methylated GpC/accessible to M.CviPI; white circles = unmethylated GpC/inaccessible to M.CviPI. All endogenous CpG sites were unmethylated and triangles are not shown to provide better clarity of GpC sites.</text>
      <annotation id="189">
        <infon key="identifier">3309</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3908</infon>
        <location offset="9704" length="5"/>
        <text>HSPA5</text>
      </annotation>
      <annotation id="190">
        <infon key="identifier">3309</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3908</infon>
        <location offset="9804" length="5"/>
        <text>HSPA5</text>
      </annotation>
      <annotation id="191">
        <infon key="identifier">3309</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3908</infon>
        <location offset="9965" length="5"/>
        <text>HSPA5</text>
      </annotation>
      <annotation id="192">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="10047" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="193">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="10226" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="194">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="10292" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="195">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="10348" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="196">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="10477" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="10086" length="3"/>
        <text>GpC</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10508</offset>
      <text>We determined the positioning of nucleosomes across exons 7, 8, 9, 10 or 14 of the MLH1 gene in LCLs derived from six Lynch syndrome patients. Splice site mutations within or near these exons affected splice donor or acceptor sites (Table 1). NOMe-seq and single molecule sequencing allowed us to distinguish mutant from wild-type alleles using the splice site sequence mutation. At all sites analysed the majority of molecules were inaccessible at GpC sites and methylated at CpG sites (Figure 1). NOMe-seq analysis of the control gene HSPA5, a constitutively active gene that maintains a nucleosome-depleted region at the transcription start site, showed that the CpG island was unmethylated (data not shown) and confirmed that GpC inaccessibility was due to nucleosome occupancy rather than incomplete M.CviPI treatment (Figure 2). This shows that the majority of molecules at the sites analysed are occupied by nucleosomes in these cells.</text>
      <annotation id="205">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="10591" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="206">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="10957" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">3309</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3908</infon>
        <location offset="11045" length="5"/>
        <text>HSPA5</text>
      </annotation>
      <annotation id="208">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="11238" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="209">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10641" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="210">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10716" length="5"/>
        <text>donor</text>
      </annotation>
      <annotation id="211">
        <infon key="identifier">MESH:D003123</infon>
        <infon key="type">Disease</infon>
        <location offset="10626" length="14"/>
        <text>Lynch syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11454</offset>
      <text>Separation of alleles by presence or absence of the splice site mutation showed no overall difference in either nucleosome positioning or occupancy between wild-type and mutant alleles (Figure 1 and Table 1). In the six splice site mutations analysed, three were located within donor splice sites and three were located within acceptor splice sites (Table 1). Though some difference in precise positioning between mutant and wild-type alleles was observed across some exons (for example, exons 7 and 10, Figure 1B) this was confined to a small subset of molecules, rather than the majority of molecules as would be expected if the mutations affected nucleosome positioning. Our study therefore shows that nucleosome occupancy is unaltered at exon-intron boundaries containing these splice site mutations.</text>
      <annotation id="213">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11732" length="5"/>
        <text>donor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>12263</offset>
      <text>Discussion</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12274</offset>
      <text>In this study, we show that nucleosome positioning is unaltered at exon-intron boundaries containing splice site mutations. This finding suggests that the positioning of nucleosomes at exon-intron boundaries containing splice site mutations does not play a role in the splicing defect.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12560</offset>
      <text>NOMe-seq has been used to measure nucleosome occupancy at gene promoters, CTCF binding sites and regulatory elements but this is the first study that has utilised the technique to measure nucleosome occupancy at splice sites. NOMe-seq previously showed that the active CpG island (CGI) promoter of HSPA5 has a nucleosome-depleted region (NDR) upstream of the transcriptional start site. This region was included as a control in each assay, and in all cases the NDR was present. This indicated that the absence of GpC methylation observed in MLH1 was caused by nucleosome occlusion, not an artefact caused by a defective M.CviPI enzyme. In addition, CpG methylation was absent from the HSPA5 NDR which is a feature of active CGI promoters. Finally, gene body methylation is a feature of human cells and the majority of CpG sites within the MLH1 exons and introns were methylated. Together, these controls indicated that the NOMe-seq assays captured the true state of nucleosome positioning at MLH1 splice sites.</text>
      <annotation id="222">
        <infon key="identifier">10664</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4786</infon>
        <location offset="12634" length="4"/>
        <text>CTCF</text>
      </annotation>
      <annotation id="223">
        <infon key="identifier">3309</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3908</infon>
        <location offset="12858" length="5"/>
        <text>HSPA5</text>
      </annotation>
      <annotation id="224">
        <infon key="identifier">2995</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">128415</infon>
        <location offset="13073" length="3"/>
        <text>GpC</text>
      </annotation>
      <annotation id="225">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="13101" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="226">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="13399" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="227">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="13552" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="228">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13346" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="229">
        <infon key="identifier">3309</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3908</infon>
        <location offset="13245" length="5"/>
        <text>HSPA5</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13571</offset>
      <text>Alternative splicing of MLH1 occurs in a range of normal tissues, but several pieces of evidence indicate that the transcripts observed in our study are caused by the mutation, rather than being normal splicing events. First, the splicing aberrations were predicted with bioinformatic splicing software, and second, although one of the aberrant transcripts (Delta10) has been reported among naturally occurring MLH1 splice transcripts, the clinical data associated with these variants are also indicative of pathogenicity as demonstrated by the results of previous multifactorial likelihood analyses.</text>
      <annotation id="233">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="13595" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="234">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="13982" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="235">
        <infon key="identifier">c.del10</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="13929" length="7"/>
        <text>Delta10</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>14172</offset>
      <text>One strength of our study was the ability to determine the allele-specific position of nucleosomes by incorporating a heterozygous single nucleotide variant into each NOMe-seq assay. Small changes in positioning were observed but these molecules constituted approximately the same small proportion of total molecules on both alleles. Subtle changes in nucleosome positioning have been considered important in regulating the expression of cell cycle-dependent genes and enhancer accessibility, but in those studies the subtle changes were observed on a significant number of molecules that resulted in an overall change in nucleosome occupancy. There was no consistent alteration in nucleosome occupancy between the wild-type and mutant alleles at a variety of donor and acceptor sites, which would be expected if nucleosome positioning at these sites played a role in mediating the effects of splice site mutations. Together our data shows that alleles containing a splice site mutation show no differences in nucleosome occupancy to wild-type alleles.</text>
      <annotation id="237">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14932" length="5"/>
        <text>donor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>15225</offset>
      <text>A limitation of the approach was that in most of the assays (assays 2 to 6) it was only possible to measure nucleosome positions at either the donor site or the acceptor site. Bisulfite conversion causes fragmentation of genomic DNA and it is technically challenging to amplify fragments greater than 500 bp in length. The donor and acceptor sites were separated by more than 2 kb of intronic sequence, making it impossible to concurrently determine the allele-specific position of nucleosomes at the donor and acceptor site on the same molecule. Although an independent NOMe-seq assay could be performed at the other donor or acceptor site, it would provide no information on allele-specificity. The data from one assay (c.588 + 1 G &gt; T), however, in which both splice sites were present in the one amplicon, showed no significant change in nucleosome occupancy at the donor or acceptor site in intron 7.</text>
      <annotation id="245">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15368" length="5"/>
        <text>donor</text>
      </annotation>
      <annotation id="246">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15548" length="5"/>
        <text>donor</text>
      </annotation>
      <annotation id="247">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15726" length="5"/>
        <text>donor</text>
      </annotation>
      <annotation id="248">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15843" length="5"/>
        <text>donor</text>
      </annotation>
      <annotation id="249">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16095" length="5"/>
        <text>donor</text>
      </annotation>
      <annotation id="250">
        <infon key="identifier">c.588+1G&gt;T;RS#:267607772</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="15947" length="15"/>
        <text>c.588 + 1 G &gt; T</text>
      </annotation>
      <annotation id="251">
        <infon key="identifier">MESH:C042345</infon>
        <infon key="type">Chemical</infon>
        <location offset="15401" length="9"/>
        <text>Bisulfite</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16139</offset>
      <text>Previous studies have utilised genome-wide datasets of micrococcal nuclease (MNase) digested chromatin to investigate nucleosome occupancy. Here we used NOMe-seq to map the position of nucleosomes relative to exons and splice sites in a single gene at single molecule resolution. This approach provides the most accurate possible measurement of nucleosome positioning and enables allele-specific mapping of nucleosomes. In agreement with previous reports in humans, Caenorhabditis elegans and Drosophila melanogaster, we observed high nucleosome occupancy at exons. Thus, the findings from genome-wide studies were supported by our independent, single-molecule approach at the MLH1 gene.</text>
      <annotation id="255">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="16816" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="256">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16597" length="6"/>
        <text>humans</text>
      </annotation>
      <annotation id="257">
        <infon key="type">Disease</infon>
        <location offset="16605" length="50"/>
        <text>Caenorhabditis elegans and Drosophila melanogaster</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16827</offset>
      <text>A key finding of our study was that nucleosome positioning was not significantly affected by mutations at the MLH1 splice sites investigated. Recent work with an in vitro IKBKAP mini-gene system found that alternative splicing changed chromatin organisation, with splice site strength and factors needed for splicing, such as U1 snSNP, playing a role in the regulation of nucleosome occupancy in exons. This and an earlier study indicate that splice site strength is an important determinant of nucleosome occupancy in exons. Exons with stronger polypyrimidine tracts (PPT; one of the conserved DNA elements located at 3' splice sites) have increased nucleosome occupancy compared to immediately adjacent introns, suggesting that nucleosomes act as a barrier that help to define the physical location of the 3' splice site. Although we investigated an equal number of donor and acceptor splice site mutations, nucleosome positioning was not significantly different between exons and the immediate 5' and 3' intronic sequence on the wild-type or mutant allele. The discrepancy between earlier studies and ours may in part relate to the strength of the MLH1 splice sites investigated. Alternatively, changes to chromatin organisation induced by splice mutations may be different to those caused by normal splicing events. Co-transcriptional splicing involves a complex interplay between RNAPII, the spliceosome and histone modifications and alterations in these factors, in addition to DNA sequence changes may be needed to alter nucleosome occupancy at exons.</text>
      <annotation id="264">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="16937" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="265">
        <infon key="identifier">8518</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">2699</infon>
        <location offset="16998" length="6"/>
        <text>IKBKAP</text>
      </annotation>
      <annotation id="266">
        <infon key="identifier">6863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">2394</infon>
        <location offset="17396" length="3"/>
        <text>PPT</text>
      </annotation>
      <annotation id="267">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="17978" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="268">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17695" length="5"/>
        <text>donor</text>
      </annotation>
      <annotation id="269">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="17373" length="14"/>
        <text>polypyrimidine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>18394</offset>
      <text>In summary this study used NOMe-seq to determine the allele-specific position of nucleosomes in relation to MLH1 splice site mutations. We conclude that splice site mutations that cause aberrant splicing of MLH1 do not alone significantly affect local nucleosome positioning in LCLs from Lynch syndrome patients.</text>
      <annotation id="274">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="18502" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="275">
        <infon key="identifier">4292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">208</infon>
        <location offset="18601" length="4"/>
        <text>MLH1</text>
      </annotation>
      <annotation id="276">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18697" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="277">
        <infon key="identifier">MESH:D003123</infon>
        <infon key="type">Disease</infon>
        <location offset="18682" length="14"/>
        <text>Lynch syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>18707</offset>
      <text>Competing interests</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>18727</offset>
      <text>The authors declare that they have no competing interests.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>18786</offset>
      <text>Authors' contributions</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>18811</offset>
      <text>MAS and LBH designed NOM-seq assays. ACN and MAS performed NOMe-seq assays. BAT provided LCL samples. RLW and LBH conceived the study, participated in its coordination and helped to draft the manuscript. All authors read and approved the final manuscript.</text>
      <annotation id="283">
        <infon key="identifier">81606</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">12687</infon>
        <location offset="18921" length="3"/>
        <text>LBH</text>
      </annotation>
      <annotation id="284">
        <infon key="identifier">81606</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">12687</infon>
        <location offset="18819" length="3"/>
        <text>LBH</text>
      </annotation>
      <annotation id="285">
        <infon key="identifier">MESH:D005357</infon>
        <infon key="type">Disease</infon>
        <location offset="18856" length="3"/>
        <text>MAS</text>
      </annotation>
      <annotation id="286">
        <infon key="identifier">MESH:D005357</infon>
        <infon key="type">Disease</infon>
        <location offset="18811" length="3"/>
        <text>MAS</text>
      </annotation>
      <annotation id="287">
        <infon key="identifier">MESH:C084683</infon>
        <infon key="type">Chemical</infon>
        <location offset="18848" length="3"/>
        <text>ACN</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>19067</offset>
      <text>References</text>
    </passage>
    <passage>
      <infon key="volume">72</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Black;given-names:DL</infon>
      <infon key="fpage">291</infon>
      <infon key="pub-id_doi">10.1146/annurev.biochem.72.121801.161720</infon>
      <infon key="pub-id_pmid">12626338</infon>
      <infon key="year">2003</infon>
      <infon key="source">Annu Rev Biochem</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">336</infon>
      <offset>19078</offset>
      <text>Mechanisms of alternative pre-messenger RNA splicing</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Feldt;given-names:M</infon>
      <infon key="name_2">surname:Romney;given-names:B</infon>
      <infon key="name_1">surname:Dufu;given-names:K</infon>
      <infon key="name_0">surname:Das;given-names:R</infon>
      <infon key="fpage">1100</infon>
      <infon key="pub-id_doi">10.1101/gad.1397406</infon>
      <infon key="pub-id_pmid">16651655</infon>
      <infon key="year">2006</infon>
      <infon key="source">Genes Dev</infon>
      <infon key="type">ref</infon>
      <infon key="volume">20</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1109</infon>
      <infon key="name_5">surname:Reed;given-names:R</infon>
      <infon key="name_4">surname:Elenko;given-names:M</infon>
      <offset>19131</offset>
      <text>Functional coupling of RNAP II transcription to spliceosome assembly</text>
    </passage>
    <passage>
      <infon key="volume">16</infon>
      <infon key="name_2">surname:Ast;given-names:G</infon>
      <infon key="name_1">surname:Meshorer;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Schwartz;given-names:S</infon>
      <infon key="fpage">990</infon>
      <infon key="pub-id_doi">10.1038/nsmb.1659</infon>
      <infon key="pub-id_pmid">19684600</infon>
      <infon key="year">2009</infon>
      <infon key="source">Nat Struct Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">995</infon>
      <offset>19200</offset>
      <text>Chromatin organization marks exon-intron structure</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Sammeth;given-names:M</infon>
      <infon key="name_2">surname:Althammer;given-names:S</infon>
      <infon key="name_1">surname:Nikolaou;given-names:C</infon>
      <infon key="name_0">surname:Tilgner;given-names:H</infon>
      <infon key="fpage">996</infon>
      <infon key="pub-id_doi">10.1038/nsmb.1658</infon>
      <infon key="pub-id_pmid">19684599</infon>
      <infon key="year">2009</infon>
      <infon key="source">Nat Struct Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">16</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1001</infon>
      <infon key="name_6">surname:Guigo;given-names:R</infon>
      <infon key="name_5">surname:Valcarcel;given-names:J</infon>
      <infon key="name_4">surname:Beato;given-names:M</infon>
      <offset>19251</offset>
      <text>Nucleosome positioning as a determinant of exon recognition</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Ptashne;given-names:M</infon>
      <infon key="name_2">surname:Warpinski;given-names:K</infon>
      <infon key="name_1">surname:Bryant;given-names:GO</infon>
      <infon key="name_0">surname:Berrozpe;given-names:G</infon>
      <infon key="fpage">445</infon>
      <infon key="pub-id_doi">10.1016/j.celrep.2013.07.001</infon>
      <infon key="pub-id_pmid">23911283</infon>
      <infon key="year">2013</infon>
      <infon key="source">Cell Rep</infon>
      <infon key="type">ref</infon>
      <infon key="volume">4</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">453</infon>
      <offset>19311</offset>
      <text>Regulation of a mammalian gene bearing a CpG island promoter and a distal enhancer</text>
      <annotation id="289">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19327" length="9"/>
        <text>mammalian</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Moore;given-names:IK</infon>
      <infon key="name_2">surname:Fondufe-Mittendorf;given-names:Y</infon>
      <infon key="name_1">surname:Kaplan;given-names:N</infon>
      <infon key="name_0">surname:Field;given-names:Y</infon>
      <infon key="fpage">e1000216</infon>
      <infon key="pub-id_doi">10.1371/journal.pcbi.1000216</infon>
      <infon key="pub-id_pmid">18989395</infon>
      <infon key="year">2008</infon>
      <infon key="source">PLoS Comput Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">4</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Segal;given-names:E</infon>
      <infon key="name_6">surname:Widom;given-names:J</infon>
      <infon key="name_5">surname:Lubling;given-names:Y</infon>
      <infon key="name_4">surname:Sharon;given-names:E</infon>
      <offset>19394</offset>
      <text>Distinct modes of regulation by chromatin encoded through nucleosome positioning signals</text>
    </passage>
    <passage>
      <infon key="volume">14</infon>
      <infon key="name_1">surname:Burge;given-names:CB</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Wang;given-names:Z</infon>
      <infon key="fpage">802</infon>
      <infon key="pub-id_doi">10.1261/rna.876308</infon>
      <infon key="pub-id_pmid">18369186</infon>
      <infon key="year">2008</infon>
      <infon key="source">RNA</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">813</infon>
      <offset>19483</offset>
      <text>Splicing regulation: from a parts list of regulatory elements to an integrated splicing code</text>
    </passage>
    <passage>
      <infon key="volume">582</infon>
      <infon key="name_1">surname:Carmo-Fonseca;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:de Almeida;given-names:SF</infon>
      <infon key="fpage">1971</infon>
      <infon key="pub-id_doi">10.1016/j.febslet.2008.04.019</infon>
      <infon key="pub-id_pmid">18435923</infon>
      <infon key="year">2008</infon>
      <infon key="source">FEBS Lett</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1976</infon>
      <offset>19576</offset>
      <text>The CTD role in cotranscriptional RNA processing and surveillance</text>
      <annotation id="291">
        <infon key="identifier">1283</infon>
        <infon key="type">Gene</infon>
        <location offset="19580" length="3"/>
        <text>CTD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Liu;given-names:T</infon>
      <infon key="name_2">surname:Latorre;given-names:I</infon>
      <infon key="name_1">surname:Down;given-names:T</infon>
      <infon key="name_0">surname:Kolasinska-Zwierz;given-names:P</infon>
      <infon key="fpage">376</infon>
      <infon key="pub-id_doi">10.1038/ng.322</infon>
      <infon key="pub-id_pmid">19182803</infon>
      <infon key="year">2009</infon>
      <infon key="source">Nat Genet</infon>
      <infon key="type">ref</infon>
      <infon key="volume">41</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">381</infon>
      <infon key="name_5">surname:Ahringer;given-names:J</infon>
      <infon key="name_4">surname:Liu;given-names:XS</infon>
      <offset>19642</offset>
      <text>Differential chromatin marking of introns and expressed exons by H3K36me3</text>
    </passage>
    <passage>
      <infon key="volume">71</infon>
      <infon key="name_1">surname:Lynch;given-names:HT</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Watson;given-names:P</infon>
      <infon key="fpage">677</infon>
      <infon key="pub-id_doi">10.1002/1097-0142(19930201)71:3&lt;677::AID-CNCR2820710305&gt;3.0.CO;2-#</infon>
      <infon key="pub-id_pmid">8431847</infon>
      <infon key="year">1993</infon>
      <infon key="source">Cancer</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">685</infon>
      <offset>19716</offset>
      <text>Extracolonic cancer in hereditary nonpolyposis colorectal cancer</text>
      <annotation id="294">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="19729" length="6"/>
        <text>cancer</text>
      </annotation>
      <annotation id="295">
        <infon key="identifier">MESH:D003123</infon>
        <infon key="type">Disease</infon>
        <location offset="19739" length="41"/>
        <text>hereditary nonpolyposis colorectal cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">36</infon>
      <infon key="name_1">surname:de la Chapelle;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Lynch;given-names:HT</infon>
      <infon key="fpage">801</infon>
      <infon key="pub-id_pmid">10544223</infon>
      <infon key="year">1999</infon>
      <infon key="source">J Med Genet</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">818</infon>
      <offset>19781</offset>
      <text>Genetic susceptibility to non-polyposis colorectal cancer</text>
      <annotation id="297">
        <infon key="identifier">MESH:D015179</infon>
        <infon key="type">Disease</infon>
        <location offset="19807" length="31"/>
        <text>non-polyposis colorectal cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Greenblatt;given-names:MS</infon>
      <infon key="name_2">surname:Plazzer;given-names:JP</infon>
      <infon key="name_1">surname:Spurdle;given-names:AB</infon>
      <infon key="name_0">surname:Thompson;given-names:BA</infon>
      <infon key="pub-id_doi">10.1038/ng.2854</infon>
      <infon key="pub-id_pmid">24362816</infon>
      <infon key="year">2014</infon>
      <infon key="source">Nat Genet</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Robinson;given-names:KL</infon>
      <infon key="name_21">surname:Leung;given-names:SY</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_24">surname:Morak;given-names:M</infon>
      <infon key="name_25">surname:Nystrom;given-names:M</infon>
      <infon key="name_22">surname:Martins;given-names:A</infon>
      <infon key="name_23">surname:Moller;given-names:P</infon>
      <infon key="name_28">surname:Qi;given-names:M</infon>
      <infon key="name_29">surname:Ramesar;given-names:R</infon>
      <infon key="name_26">surname:Peltomaki;given-names:P</infon>
      <infon key="name_27">surname:Pineda;given-names:M</infon>
      <infon key="lpage">115</infon>
      <infon key="fpage">107</infon>
      <infon key="volume">46</infon>
      <infon key="name_10">surname:du Sart;given-names:D</infon>
      <infon key="name_13">surname:Farrington;given-names:SM</infon>
      <infon key="name_14">surname:Frayling;given-names:IM</infon>
      <infon key="name_11">surname:Fabre;given-names:A</infon>
      <infon key="name_12">surname:Farrell;given-names:MP</infon>
      <infon key="name_17">surname:Heinen;given-names:CD</infon>
      <infon key="name_18">surname:Holinski-Feder;given-names:E</infon>
      <infon key="name_15">surname:Frebourg;given-names:T</infon>
      <infon key="name_9">surname:den Dunnen;given-names:JT</infon>
      <infon key="name_16">surname:Goldgar;given-names:DE</infon>
      <infon key="name_8">surname:Capella;given-names:G</infon>
      <infon key="name_7">surname:Bernstein;given-names:I</infon>
      <infon key="name_6">surname:Bapat;given-names:B</infon>
      <infon key="name_19">surname:Kohonen-Corish;given-names:M</infon>
      <infon key="name_5">surname:Al-Mulla;given-names:F</infon>
      <infon key="name_4">surname:Akagi;given-names:K</infon>
      <offset>19839</offset>
      <text>Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Clendenning;given-names:M</infon>
      <infon key="name_2">surname:Paterson;given-names:C</infon>
      <infon key="name_1">surname:Goldgar;given-names:DE</infon>
      <infon key="name_0">surname:Thompson;given-names:BA</infon>
      <infon key="pub-id_doi">10.1002/humu.22213</infon>
      <infon key="pub-id_pmid">22949379</infon>
      <infon key="year">2013</infon>
      <infon key="source">Hum Mutat</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Spurdle;given-names:AB</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">209</infon>
      <infon key="fpage">200</infon>
      <infon key="volume">34</infon>
      <infon key="name_10">surname:Hopper;given-names:JL</infon>
      <infon key="name_13">surname:Lindor;given-names:NM</infon>
      <infon key="name_14">surname:Newcomb;given-names:PA</infon>
      <infon key="name_11">surname:Jenkins;given-names:MA</infon>
      <infon key="name_12">surname:Lemarchand;given-names:L</infon>
      <infon key="name_17">surname:Young;given-names:JP</infon>
      <infon key="name_18">surname:Buchanan;given-names:DD</infon>
      <infon key="name_15">surname:Thibodeau;given-names:SN</infon>
      <infon key="name_9">surname:Haile;given-names:RW</infon>
      <infon key="name_16">surname:Colon Cancer Family;given-names:R</infon>
      <infon key="name_8">surname:Gallinger;given-names:S</infon>
      <infon key="name_7">surname:Michael;given-names:DW</infon>
      <infon key="name_6">surname:Parsons;given-names:MT</infon>
      <infon key="name_19">surname:Tavtigian;given-names:SV</infon>
      <infon key="name_5">surname:Arnold;given-names:S</infon>
      <infon key="name_4">surname:Walters;given-names:R</infon>
      <offset>19989</offset>
      <text>A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry</text>
      <annotation id="300">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="20124" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="301">
        <infon key="identifier">MESH:D015179</infon>
        <infon key="type">Disease</infon>
        <location offset="20165" length="12"/>
        <text>Colon Cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>20194</offset>
      <text>Australasian Colorectal Cancer Family Registry [http://www.pedigree.org.au/pedigree-studies/accfr.aspx]</text>
      <annotation id="303">
        <infon key="identifier">MESH:D015179</infon>
        <infon key="type">Disease</infon>
        <location offset="20194" length="30"/>
        <text>Australasian Colorectal Cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>20298</offset>
      <text>MCO study tumour collection [http://researchdata.ands.org.au/mco-study-tumour-collection]</text>
      <annotation id="306">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="20369" length="6"/>
        <text>tumour</text>
      </annotation>
      <annotation id="307">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="20308" length="6"/>
        <text>tumour</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Sharma;given-names:S</infon>
      <infon key="name_2">surname:Han;given-names:HF</infon>
      <infon key="name_1">surname:Byun;given-names:HM</infon>
      <infon key="name_0">surname:Wolff;given-names:EM</infon>
      <infon key="fpage">e1000917</infon>
      <infon key="pub-id_doi">10.1371/journal.pgen.1000917</infon>
      <infon key="pub-id_pmid">20421991</infon>
      <infon key="year">2010</infon>
      <infon key="source">PLoS Genet</infon>
      <infon key="type">ref</infon>
      <infon key="volume">6</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Liang;given-names:G</infon>
      <infon key="name_7">surname:Jones;given-names:PA</infon>
      <infon key="name_6">surname:Yang;given-names:AS</infon>
      <infon key="name_5">surname:Siegmund;given-names:KD</infon>
      <infon key="name_4">surname:Nichols;given-names:PW</infon>
      <offset>20388</offset>
      <text>Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer</text>
      <annotation id="309">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="20496" length="6"/>
        <text>cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">1167</infon>
      <infon key="name_1">surname:Ward;given-names:RL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hesson;given-names:LB</infon>
      <infon key="fpage">265</infon>
      <infon key="pub-id_doi">10.1007/978-1-4939-0835-6_18</infon>
      <infon key="pub-id_pmid">24823784</infon>
      <infon key="year">2014</infon>
      <infon key="source">Methods Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">274</infon>
      <offset>20503</offset>
      <text>Discrimination of pseudogene and parental gene DNA methylation using allelic bisulfite sequencing</text>
      <annotation id="311">
        <infon key="identifier">MESH:C042345</infon>
        <infon key="type">Chemical</infon>
        <location offset="20580" length="9"/>
        <text>bisulfite</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Berman;given-names:BP</infon>
      <infon key="name_2">surname:Liang;given-names:G</infon>
      <infon key="name_1">surname:Miranda;given-names:TB</infon>
      <infon key="name_0">surname:Kelly;given-names:TK</infon>
      <infon key="fpage">901</infon>
      <infon key="pub-id_doi">10.1016/j.molcel.2010.08.026</infon>
      <infon key="pub-id_pmid">20864037</infon>
      <infon key="year">2010</infon>
      <infon key="source">Mol Cell</infon>
      <infon key="type">ref</infon>
      <infon key="volume">39</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">911</infon>
      <infon key="name_6">surname:Jones;given-names:PAPA</infon>
      <infon key="name_5">surname:Tanay;given-names:A</infon>
      <infon key="name_4">surname:Lin;given-names:JC</infon>
      <offset>20601</offset>
      <text>H2A.Z maintenance during mitosis reveals nucleosome shifting on mitotically silenced genes</text>
      <annotation id="314">
        <infon key="identifier">3015</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">80218</infon>
        <location offset="20601" length="5"/>
        <text>H2A.Z</text>
      </annotation>
      <annotation id="315">
        <infon key="type">Disease</infon>
        <location offset="20626" length="7"/>
        <text>mitosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Liang;given-names:G</infon>
      <infon key="name_2">surname:Lay;given-names:FD</infon>
      <infon key="name_1">surname:Liu;given-names:Y</infon>
      <infon key="name_0">surname:Kelly;given-names:TK</infon>
      <infon key="fpage">2497</infon>
      <infon key="pub-id_doi">10.1101/gr.143008.112</infon>
      <infon key="pub-id_pmid">22960375</infon>
      <infon key="year">2012</infon>
      <infon key="source">Genome Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">22</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">2506</infon>
      <infon key="name_5">surname:Jones;given-names:PA</infon>
      <infon key="name_4">surname:Berman;given-names:BP</infon>
      <offset>20692</offset>
      <text>Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>20790</offset>
      <text>Taberlay PC, Statham AL, Kelly TK, Clark SJ, Jones PA: Reconfiguration of nucleosome depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer.Genome Res 2014, Epub ahead of print.</text>
      <annotation id="317">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="20981" length="6"/>
        <text>cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">25</infon>
      <infon key="name_1">surname:Bird;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Deaton;given-names:AM</infon>
      <infon key="fpage">1010</infon>
      <infon key="pub-id_doi">10.1101/gad.2037511</infon>
      <infon key="pub-id_pmid">21576262</infon>
      <infon key="year">2011</infon>
      <infon key="source">Genes Dev</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1022</infon>
      <offset>21026</offset>
      <text>CpG islands and the regulation of transcription</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Lee;given-names:JH</infon>
      <infon key="name_2">surname:Gao;given-names:Y</infon>
      <infon key="name_1">surname:Li;given-names:JB</infon>
      <infon key="name_0">surname:Ball;given-names:MP</infon>
      <infon key="fpage">361</infon>
      <infon key="pub-id_doi">10.1038/nbt.1533</infon>
      <infon key="pub-id_pmid">19329998</infon>
      <infon key="year">2009</infon>
      <infon key="source">Nat Biotechnol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">27</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Church;given-names:GM</infon>
      <infon key="name_7">surname:Daley;given-names:GQ</infon>
      <infon key="lpage">368</infon>
      <infon key="name_6">surname:Xie;given-names:B</infon>
      <infon key="name_5">surname:Park;given-names:IH</infon>
      <infon key="name_4">surname:LeProust;given-names:EM</infon>
      <offset>21074</offset>
      <text>Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells</text>
      <annotation id="319">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21154" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Chen;given-names:PY</infon>
      <infon key="name_2">surname:Bernatavichute;given-names:YV</infon>
      <infon key="name_1">surname:Feng;given-names:S</infon>
      <infon key="name_0">surname:Chodavarapu;given-names:RK</infon>
      <infon key="pub-id_doi">10.1038/nature09147</infon>
      <infon key="pub-id_pmid">20512117</infon>
      <infon key="year">2010</infon>
      <infon key="source">Nature</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">392</infon>
      <infon key="fpage">388</infon>
      <infon key="volume">466</infon>
      <infon key="name_10">surname:Casero;given-names:D</infon>
      <infon key="name_13">surname:Clark;given-names:AT</infon>
      <infon key="name_14">surname:Kramer;given-names:U</infon>
      <infon key="name_11">surname:Bernal;given-names:M</infon>
      <infon key="name_12">surname:Huijser;given-names:P</infon>
      <infon key="name_17">surname:Jacobsen;given-names:SE</infon>
      <infon key="name_18">surname:Pellegrini;given-names:M</infon>
      <infon key="name_15">surname:Merchant;given-names:SS</infon>
      <infon key="name_9">surname:Cokus;given-names:SJ</infon>
      <infon key="name_16">surname:Zhang;given-names:X</infon>
      <infon key="name_8">surname:Kim;given-names:J</infon>
      <infon key="name_7">surname:Kuo;given-names:F</infon>
      <infon key="name_6">surname:Hetzel;given-names:JA</infon>
      <infon key="name_5">surname:Yu;given-names:Y</infon>
      <infon key="name_4">surname:Stroud;given-names:H</infon>
      <offset>21166</offset>
      <text>Relationship between nucleosome positioning and DNA methylation</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>21230</offset>
      <text>Thompson BA, Martins A, Spurdle AB: A review of mismatch repair gene transcripts: issues for interpretation of mRNA splicing assays.Clin Genet 2014. Epub ahead of print.</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Frenkel;given-names:B</infon>
      <infon key="name_2">surname:Berman;given-names:BP</infon>
      <infon key="name_1">surname:Lai;given-names:J</infon>
      <infon key="name_0">surname:Andreu-Vieyra;given-names:C</infon>
      <infon key="fpage">4648</infon>
      <infon key="pub-id_doi">10.1128/MCB.05934-11</infon>
      <infon key="pub-id_pmid">21969603</infon>
      <infon key="year">2011</infon>
      <infon key="source">Mol Cell Bio</infon>
      <infon key="type">ref</infon>
      <infon key="volume">31</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">4662</infon>
      <infon key="name_6">surname:Coetzee;given-names:GA</infon>
      <infon key="name_5">surname:Jones;given-names:PA</infon>
      <infon key="name_4">surname:Jia;given-names:L</infon>
      <offset>21400</offset>
      <text>Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells</text>
      <annotation id="321">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="21495" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">29</infon>
      <infon key="name_2">surname:Rosenthal;given-names:A</infon>
      <infon key="name_1">surname:Clark;given-names:SJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Grunau;given-names:C</infon>
      <infon key="fpage">E65</infon>
      <infon key="pub-id_doi">10.1093/nar/29.13.e65</infon>
      <infon key="pub-id_pmid">11433041</infon>
      <infon key="year">2001</infon>
      <infon key="source">Nucleic Acids Res</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">5</infon>
      <offset>21517</offset>
      <text>Bisulfite genomic sequencing: systematic investigation of critical experimental parameters</text>
      <annotation id="323">
        <infon key="identifier">MESH:C042345</infon>
        <infon key="type">Chemical</infon>
        <location offset="21517" length="9"/>
        <text>Bisulfite</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">8</infon>
      <infon key="name_2">surname:Ast;given-names:G</infon>
      <infon key="name_1">surname:Lev-Maor;given-names:G</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Keren-Shaul;given-names:H</infon>
      <infon key="fpage">e53506</infon>
      <infon key="pub-id_doi">10.1371/journal.pone.0053506</infon>
      <infon key="pub-id_pmid">23326444</infon>
      <infon key="year">2013</infon>
      <infon key="source">PLoS One</infon>
      <infon key="type">ref</infon>
      <offset>21608</offset>
      <text>Pre-mRNA splicing is a determinant of nucleosome organization</text>
    </passage>
  </document>
  <document>
    <id>4272816</id>
    <passage>
      <infon key="name_3">surname:Nacci;given-names:Diane</infon>
      <infon key="name_2">surname:Franks;given-names:Diana G.</infon>
      <infon key="name_1">surname:Karchner;given-names:Sibel I.</infon>
      <infon key="article-id_pmid">25481785</infon>
      <infon key="name_0">surname:Aluru;given-names:Neelakanteswar</infon>
      <infon key="fpage">192</infon>
      <infon key="year">2015</infon>
      <infon key="article-id_pmc">4272816</infon>
      <infon key="article-id_doi">10.1016/j.aquatox.2014.11.016</infon>
      <infon key="type">front</infon>
      <infon key="volume">0</infon>
      <infon key="license">           This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.         </infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Aquat. Toxicol.; 2015 Jan; 158192-201. doi:10.1016/j.aquatox.2014.11.016</infon>
      <infon key="kwd">non-model organisms gene knock-outs mummichog adaptation zinc finger nucleases CRISPR-Cas9</infon>
      <infon key="lpage">201</infon>
      <infon key="name_5">surname:Hahn;given-names:Mark E.</infon>
      <infon key="article-id_manuscript">NIHMS645550</infon>
      <infon key="name_4">surname:Champlin;given-names:Denise</infon>
      <infon key="authors">Aluru N, Karchner SI, Franks DG, Nacci D, Champlin D, Hahn ME</infon>
      <offset>0</offset>
      <text>Targeted mutagenesis of aryl hydrocarbon receptor 2a and 2b genes in Atlantic killifish (Fundulus heteroclitus)</text>
      <annotation id="2">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="69" length="18"/>
        <text>Atlantic killifish</text>
      </annotation>
      <annotation id="3">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="89" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>112</offset>
      <text>Understanding molecular mechanisms of toxicity is facilitated by experimental manipulations, such as disruption of function by gene targeting, that are especially challenging in non-standard model species with limited genomic resources. While loss-of-function approaches have included gene knock-down using morpholino-modified oligonucleotides and random mutagenesis using mutagens or retroviruses, more recent approaches include targeted mutagenesis using zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALENs) and clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 technology. These latter methods provide more accessible opportunities to explore gene function in non-traditional model species. To facilitate evaluations of toxic mechanisms for important categories of aryl hydrocarbon pollutants, whose actions are known to be receptor mediated, we used ZFN and CRISPR-Cas9 approaches to generate aryl hydrocarbon receptor 2a (AHR2a) and AHR2b gene mutations in Atlantic killifish (Fundulus heteroclitus) embryos. This killifish is a particularly valuble non-traditional model for this study, with multiple paralogs of AHR whose functions are not well characterized. In addition, some populations of this species have evolved resistance to toxicants such as halogenated aromatic hydrocarbons. AHR-null killifish will be valuable for characterizing the role of the individual AHR paralogs in evolved resistance, as well as in normal development. We first used five-finger ZFNs targeting exons 1 and 3 of AHR2a. Subsequently, CRISPR-Cas9 guide RNAs were designed to target regions in exon 2 and 3 of AHR2a and AHR2b. We successfully induced frameshift mutations in AHR2a exon 3 with ZFN and CRISPR-Cas9 guide RNAs, with mutation frequencies of 10% and 16%, respectively. In AHR2b, mutations were induced using CRISPR-Cas9 guide RNAs targeting sites in both exon 2 (17%) and exon 3 (63%). We screened AHR2b exon 2 CRISPR-Cas9-injected embryos for off-target effects in AHR paralogs. No mutations were observed in closely related AHR genes (AHR1a, AHR1b, AHR2a, AHRR) in the CRISPR-Cas9-injected embryos. Overall, our results demonstrate that targeted genome-editing methods are efficient in inducing mutations at specific loci in embryos of a non-traditional model species, without detectable off-target effects in paralogous genes.</text>
      <annotation id="13">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="2063" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="14">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="2223" length="4"/>
        <text>AHRR</text>
      </annotation>
      <annotation id="15">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="1127" length="18"/>
        <text>Atlantic killifish</text>
      </annotation>
      <annotation id="16">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="1147" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
      <annotation id="17">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="1184" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="18">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="1467" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="19">
        <infon key="identifier">MESH:D009841</infon>
        <infon key="type">Chemical</infon>
        <location offset="439" length="16"/>
        <text>oligonucleotides</text>
      </annotation>
      <annotation id="20">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="150" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="21">
        <infon key="identifier">MESH:D006841</infon>
        <infon key="type">Chemical</infon>
        <location offset="1435" length="21"/>
        <text>aromatic hydrocarbons</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>2495</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2511</offset>
      <text>The Atlantic killifish (Fundulus heteroclitus) is one of the most ecologically and environmentally important estuarine fish distributed along the East coast of the United States. Their ability to tolerate wide changes in environmental conditions, including temperature, salinity, oxygen and pH, have made them an ideal model species to investigate the biochemical, physiological and evolutionary basis of environmental adaptation. Some populations of killifish are also valuable models for understanding the mechanisms of evolved resistance to toxicants. Populations of killifish inhabiting contaminated coastal waters along the North Atlantic U.S. coast have evolved resistance to some contaminants representing major categories of aryl hydrocarbon pollutants, such as polynuclear aromatic hydrocarbons (PAHs), and halogenated aromatic hydrocarbons such as polychlorinated biphenyls (PCBs), 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, 'dioxin') and other dioxin-like compounds (DLCs). This evolved resistance involves alterations in signaling through the aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor through which some PAHs, PCBs, and TCDD alter gene expression and cause toxicity. Killifish express four AHR paralogs (AHR1a, AHR1b, AHR2a and AHR2b), the products of distinct loci. Although the respective functions of these AHRs are not well understood, AHR2 proteins appear to play a major role in mediating the developmental effects of PAHs and PCBs in fish.</text>
      <annotation id="47">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="3894" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="2515" length="18"/>
        <text>Atlantic killifish</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="2535" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
      <annotation id="50">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="2962" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="51">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="3081" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="52">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="3721" length="9"/>
        <text>Killifish</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">29154</infon>
        <infon key="type">Species</infon>
        <location offset="3146" length="8"/>
        <text>Atlantic</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="3690" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">MESH:D010100</infon>
        <infon key="type">Chemical</infon>
        <location offset="2791" length="6"/>
        <text>oxygen</text>
      </annotation>
      <annotation id="56">
        <infon key="identifier">MESH:D011084</infon>
        <infon key="type">Chemical</infon>
        <location offset="3978" length="4"/>
        <text>PAHs</text>
      </annotation>
      <annotation id="57">
        <infon key="identifier">MESH:D011078</infon>
        <infon key="type">Chemical</infon>
        <location offset="3369" length="25"/>
        <text>polychlorinated biphenyls</text>
      </annotation>
      <annotation id="58">
        <infon key="identifier">MESH:D011078</infon>
        <infon key="type">Chemical</infon>
        <location offset="3664" length="4"/>
        <text>PCBs</text>
      </annotation>
      <annotation id="59">
        <infon key="identifier">MESH:D000072317</infon>
        <infon key="type">Chemical</infon>
        <location offset="3440" length="4"/>
        <text>TCDD</text>
      </annotation>
      <annotation id="60">
        <infon key="identifier">MESH:D011084</infon>
        <infon key="type">Chemical</infon>
        <location offset="3658" length="4"/>
        <text>PAHs</text>
      </annotation>
      <annotation id="61">
        <infon key="identifier">MESH:D006838</infon>
        <infon key="type">Chemical</infon>
        <location offset="3249" length="11"/>
        <text>hydrocarbon</text>
      </annotation>
      <annotation id="62">
        <infon key="identifier">MESH:D011084</infon>
        <infon key="type">Chemical</infon>
        <location offset="3316" length="4"/>
        <text>PAHs</text>
      </annotation>
      <annotation id="63">
        <infon key="identifier">MESH:D011078</infon>
        <infon key="type">Chemical</infon>
        <location offset="3396" length="4"/>
        <text>PCBs</text>
      </annotation>
      <annotation id="64">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="3711" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="65">
        <infon key="identifier">MESH:D000072317</infon>
        <infon key="type">Chemical</infon>
        <location offset="3674" length="4"/>
        <text>TCDD</text>
      </annotation>
      <annotation id="66">
        <infon key="identifier">MESH:D006841</infon>
        <infon key="type">Chemical</infon>
        <location offset="3339" length="21"/>
        <text>aromatic hydrocarbons</text>
      </annotation>
      <annotation id="67">
        <infon key="identifier">MESH:D011084</infon>
        <infon key="type">Chemical</infon>
        <location offset="3281" length="33"/>
        <text>polynuclear aromatic hydrocarbons</text>
      </annotation>
      <annotation id="68">
        <infon key="identifier">MESH:D004147</infon>
        <infon key="type">Chemical</infon>
        <location offset="3447" length="6"/>
        <text>dioxin</text>
      </annotation>
      <annotation id="69">
        <infon key="identifier">MESH:D004147</infon>
        <infon key="type">Chemical</infon>
        <location offset="3466" length="6"/>
        <text>dioxin</text>
      </annotation>
      <annotation id="70">
        <infon key="identifier">MESH:D000072317</infon>
        <infon key="type">Chemical</infon>
        <location offset="3403" length="35"/>
        <text>2,3,7,8-tetrachlorodibenzo-p-dioxin</text>
      </annotation>
      <annotation id="71">
        <infon key="identifier">MESH:D011078</infon>
        <infon key="type">Chemical</infon>
        <location offset="3987" length="4"/>
        <text>PCBs</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4005</offset>
      <text>While there is a great deal of understanding about the physiological and biochemical basis of environmental adaptation in killifish, very little is known about its genetic basis, mainly due to the lack of genetic tools to evaluate gene function. Recently, the antisense morpholino oligonucleotide (MO)-based gene knockdown method was adapted to killifish to determine the role of aryl hydrocarbon receptors and cytochrome P4501A (CYP1A) in developmental toxicity, and to study the role of aquaporins in adult killifish. However, MOs are effective only for a limited period of time and do not completely eliminate gene expression. In order to conclusively demonstrate the function of any protein, gene knockouts are essential.</text>
      <annotation id="80">
        <infon key="identifier">105930482</infon>
        <infon key="type">Gene</infon>
        <location offset="4416" length="17"/>
        <text>cytochrome P4501A</text>
      </annotation>
      <annotation id="81">
        <infon key="identifier">105930482</infon>
        <infon key="type">Gene</infon>
        <location offset="4435" length="5"/>
        <text>CYP1A</text>
      </annotation>
      <annotation id="82">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="4127" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="83">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="4350" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="84">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="4514" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="4623" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="86">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="4445" length="22"/>
        <text>developmental toxicity</text>
      </annotation>
      <annotation id="87">
        <infon key="identifier">MESH:D060172</infon>
        <infon key="type">Chemical</infon>
        <location offset="4275" length="26"/>
        <text>morpholino oligonucleotide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4731</offset>
      <text>In the past decade, several targeted genome-editing methods have been successfully employed to manipulate genes in a variety of model and non-model organisms. They include zinc-finger nucleases (ZFNs), transactivator-like effector nucleases (TALENs) and the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 system (Fig. 1). ZFN and TALENs utilize engineered nucleases consisting of a sequence-specific DNA-binding domain fused to a nonspecific DNA cleavage module. The DNA-binding domains can be customized to recognize any sequence of interest. Distinct from the site-specific nucleases, CRISPR-Cas9 is an RNA-guided DNA nuclease (RGN), where a small guide RNA (sgRNA) complementary to a 20 base target DNA sequence guides Cas9, a bacterially derived nuclease, to induce a double-strand break (DSB) at the target site. Because the DSB repair process by non-homologous end-joining (NHEJ) is error prone, it leaves insertions or deletions (indels) at the target site. The relative ease of generating target-specific mutations using these techniques has opened up new avenues for conducting functional studies in any organism of interest. Several studies have demonstrated the efficacy of ZFNs, TALENs and RGNs in producing heritable mutations in non-model organisms such as rainbow trout, medaka, tilapia and yellow catfish (Table 1). Mutagenesis rates of up to 95% have been observed with CRISPR-Cas9. So far, there are no studies describing the generation of gene knock-outs in killifish or of targeted AHR mutants in any non-mammalian vertebrate. In this study, we utilized ZFN and CRISPR-Cas9 approaches to induce mutations in paralogous killifish AHR2a and AHR2b genes, and we observed indels in the injected embryos. We discuss strategies for the application of this method to knock out closely related paralogs in a species with a long generation time.</text>
      <annotation id="95">
        <infon key="identifier">8022</infon>
        <infon key="type">Species</infon>
        <location offset="6027" length="13"/>
        <text>rainbow trout</text>
      </annotation>
      <annotation id="96">
        <infon key="identifier">8090</infon>
        <infon key="type">Species</infon>
        <location offset="6042" length="6"/>
        <text>medaka</text>
      </annotation>
      <annotation id="97">
        <infon key="identifier">1234273</infon>
        <infon key="type">Species</infon>
        <location offset="6062" length="14"/>
        <text>yellow catfish</text>
      </annotation>
      <annotation id="98">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="6233" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="99">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6281" length="9"/>
        <text>mammalian</text>
      </annotation>
      <annotation id="100">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="6395" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="101">
        <infon key="type">Disease</infon>
        <location offset="6050" length="7"/>
        <text>tilapia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>6613</offset>
      <text>2. MATERIALS AND METHODS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>6638</offset>
      <text>2.1. Killifish adults and embryos</text>
      <annotation id="103">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="6643" length="9"/>
        <text>Killifish</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6672</offset>
      <text>Mature male and female Atlantic killifish were collected from Scorton Creek (Sandwich, MA) during full moon and new moon in Spring and Summer of each year (2011-2014) using minnow traps, as described previously. Although killifish populations are known to vary dramatically in their sensitivity to DLCs, this source population is known to be relatively sensitive to DLCs, characteristic of other populations of this species resident to similarly uncontaminated sites. Fish were maintained in tanks with continuous flow-through seawater (SW) at 18-20 C and 14h:10h light/dark photoperiod conditions. The animal husbandry practices were approved by the Animal Care and Use Committee of the Woods Hole Oceanographic Institution. Female fish were lightly anesthetized with Tricaine (MS222; buffered with sodium bicarbonate, Sigma-Aldrich, St. Louis, MO, USA) and oocytes were obtained for in vitro fertilization (IVF) by gently squeezing the abdomen. Oocytes were collected in glass petri dishes with filtered SW (25 parts per thousand; ppt). Milt was obtained by euthanizing mature males in MS222, dissecting out the gonads, and chopping them with a scalpel blade in seawater. A few drops of milt were added to the oocytes for fertilization. Each IVF experiment included a pool of oocytes stripped from at least 2-3 females and milt from 1 or 2 males. Approximately 20 minutes after the addition of milt, embryos were rinsed with filtered SW to remove any excess sperm. Fertilized embryos were maintained at 23 C until further use.</text>
      <annotation id="112">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="6695" length="18"/>
        <text>Atlantic killifish</text>
      </annotation>
      <annotation id="113">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="6893" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="114">
        <infon key="identifier">MESH:C537182</infon>
        <infon key="type">Disease</infon>
        <location offset="7916" length="3"/>
        <text>IVF</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">MESH:C003636</infon>
        <infon key="type">Chemical</infon>
        <location offset="7441" length="8"/>
        <text>Tricaine</text>
      </annotation>
      <annotation id="116">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="7228" length="3"/>
        <text>14h</text>
      </annotation>
      <annotation id="117">
        <infon key="identifier">MESH:C537182</infon>
        <infon key="type">Disease</infon>
        <location offset="7581" length="3"/>
        <text>IVF</text>
      </annotation>
      <annotation id="118">
        <infon key="identifier">MESH:D017693</infon>
        <infon key="type">Chemical</infon>
        <location offset="7472" length="18"/>
        <text>sodium bicarbonate</text>
      </annotation>
      <annotation id="119">
        <infon key="identifier">MESH:C003636</infon>
        <infon key="type">Chemical</infon>
        <location offset="7451" length="5"/>
        <text>MS222</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>8209</offset>
      <text>2.2. Zinc Finger Nuclease design</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>8242</offset>
      <text>AHR2a exon 2 and 3 (Fig. 2) were each targeted with a five-finger ZFN pair using the CompoZr  custom ZFN service (Sigma-Aldrich, St. Louis, MO, USA) (Table 2; Fig. 2). Left- and right-ZFN plasmids were in vitro transcribed and polyadenylated using the mMessage mMachine T7 kit (Life Technologies, Carlsbad, CA, USA). ZFN mRNA from each half-site was diluted to a concentration of 100-400 ng/microl and 2.5 nl of each was co-injected into 1 or 2-cell stage killifish embryos, as described below.</text>
      <annotation id="122">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="8242" length="18"/>
        <text>AHR2a exon 2 and 3</text>
      </annotation>
      <annotation id="123">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="8698" length="9"/>
        <text>killifish</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>8737</offset>
      <text>2.3. CRISPR-Cas guide RNA design and construction</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>8787</offset>
      <text>Guide RNAs (gRNA) targeting AHR2a and AHR2b were designed using the ZiFiT Targeter website (http://zifit.partners.org/ZiFiT_Cas9). Exons 1, 2 and 3 of AHR2a and AHR2b were searched for target sites in order to obtain the shortest truncated mutant protein. A single target site was found in each exon. The AHR2a exon 1 target site did not begin with GG residues, which prevented it from being cloned into the gRNA expression vector. The AHR2b exon 1 target site was not optimal due to repetitive sequences. Therefore, the target sites for exons 2 and 3 of AHR2a and AHR2b were selected for gRNA synthesis (Table 2). PAGE-purified complementary oligonucleotides (Eurofins Genomics, Huntsville, AL, USA) were annealed and cloned into an expression vector following a published protocol. The gRNA oligonucleotide sequences are provided in Table 2. Expression vectors for guide RNA (pDR274) and Cas9 endonuclease (MLM3613) were obtained from Addgene (https://www.addgene.org/). The gRNA was transcribed using the MAXIscript T7 kit, and the Cas9 mRNA was transcribed and poly(A)-tailed with the mMESSAGE mMACHINE T7 ULTRA kit (Life Technologies, Carlsbad, CA, USA). gRNA and Cas9 mRNA were mixed at a ratio of 1:12 for the microinjections.</text>
      <annotation id="130">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="9223" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="131">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="9631" length="18"/>
        <text>Expression vectors</text>
      </annotation>
      <annotation id="132">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="9200" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="9521" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="134">
        <infon key="identifier">MESH:D009841</infon>
        <infon key="type">Chemical</infon>
        <location offset="9580" length="15"/>
        <text>oligonucleotide</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">MESH:D009841</infon>
        <infon key="type">Chemical</infon>
        <location offset="9430" length="16"/>
        <text>oligonucleotides</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>10021</offset>
      <text>2.4. Microinjection of ZFN mRNA and CRISPR-Cas9 gRNA</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>10074</offset>
      <text>Microinjection of killifish embryos was performed following a previously established protocol with some modifications. Briefly, prior to microinjection, 1-cell stage embryos were rolled on wet paper towels to prevent the filaments on the chorion from adhering to the microinjection needle. They were subsequently placed on custom-made agarose microinjection embryo trays and oriented so that the cell directly faces the microinjection needle. The microinjection setup consisted of a Zeiss Stemi 2000-C stereomicroscope, Narishige IM-300 microinjector and a micromanipulator (Narishige International, East Meadow, NY, USA). Aluminosilicate glass tubes (1.0 mm outer diameter, 0.64 mm inner diameter) were used to prepare microinjection needles. This type of needle was found to be superior to borosilicate needles for microinjection of killifish embryo, which have a thick chorion. A P-30 vertical micropipette puller (Sutter Instruments, Novato, CA, USA) at a heater output setting of 97 was used to pull aluminosilicate glass tubing into microinjection needles. The injection volume was calibrated by injecting the solution into mineral oil and measuring the diameter of the droplet using a stage micrometer. The microinjection volume was approximately 5 nL per embryo. To compensate for variations in needle opening size, injection time and pressure were altered during microinjection. Injected embryos were maintained in filtered SW at 23 C. Some of the injected embryos were transferred to the fish-rearing facility at the National Health and Environmental Effects Research Laboratory, Atlantic Ecology Division, Environmental Protection Agency, Narragansett, RI, to be raised to adulthood. The numbers of injected fish that are being raised for identifying founders are provided in Supplementary Table 1.</text>
      <annotation id="145">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="10092" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="146">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="10909" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="147">
        <infon key="identifier">29154</infon>
        <infon key="type">Species</infon>
        <location offset="11664" length="8"/>
        <text>Atlantic</text>
      </annotation>
      <annotation id="148">
        <infon key="identifier">MESH:D012685</infon>
        <infon key="type">Chemical</infon>
        <location offset="10409" length="7"/>
        <text>agarose</text>
      </annotation>
      <annotation id="149">
        <infon key="identifier">MESH:D008899</infon>
        <infon key="type">Chemical</infon>
        <location offset="11204" length="11"/>
        <text>mineral oil</text>
      </annotation>
      <annotation id="150">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="10866" length="12"/>
        <text>borosilicate</text>
      </annotation>
      <annotation id="151">
        <infon key="identifier">MESH:C049037</infon>
        <infon key="type">Chemical</infon>
        <location offset="11079" length="15"/>
        <text>aluminosilicate</text>
      </annotation>
      <annotation id="152">
        <infon key="identifier">MESH:D005597</infon>
        <infon key="type">Disease</infon>
        <location offset="11384" length="7"/>
        <text>opening</text>
      </annotation>
      <annotation id="153">
        <infon key="identifier">MESH:C049037</infon>
        <infon key="type">Chemical</infon>
        <location offset="10697" length="15"/>
        <text>Aluminosilicate</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>11885</offset>
      <text>2.5. ZFN protein expression</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>11913</offset>
      <text>ZFN-injected and uninjected embryos were sampled at 3, 6, 9 and 24 hours post-injection to determine the temporal profile of ZFN protein expression. At each time point, one pool of 10 embryos was sampled. Embryos were homogenized in 1x sample treatment buffer with beta-mercaptoethanol and boiled for 5 minutes to denature the protein. Samples were separated on an 8% polyacrylamide gel using the discontinuous buffer system. The proteins were transferred onto a nitrocellulose membrane with a semi-dry transfer unit (BioRad, Waltham, MA, USA), and the membrane was blocked with 5% milk in TBST (20 mM Tris pH 7.5, 300 mM NaCl and 0.1% (v/v) Tween 20) overnight. ZFN protein was detected using a mouse monoclonal anti-Flag antibody (Sigma, St. Louis, MO, USA) at 1:5000 dilution. The secondary antibody used was horseradish peroxidase (HRP)-conjugated goat anti-mouse antibody (Santa Cruz Biotechnology, Dallas, TX, USA) at 1:5000 dilution. The membranes were incubated in the primary antibody for 60 min at room temperature, washed with TBST twice (10 min each), incubated with secondary antibody for 60 min, and finally washed with TBST (15 min). Detection was done using the ECL Prime Western blotting reagent (GE Healthcare, Pittsburgh, PA, USA).</text>
      <annotation id="168">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="12609" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="169">
        <infon key="identifier">3704</infon>
        <infon key="type">Species</infon>
        <location offset="12725" length="11"/>
        <text>horseradish</text>
      </annotation>
      <annotation id="170">
        <infon key="identifier">9925</infon>
        <infon key="type">Species</infon>
        <location offset="12765" length="4"/>
        <text>goat</text>
      </annotation>
      <annotation id="171">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="12775" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="172">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="12050" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="173">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="12515" length="4"/>
        <text>Tris</text>
      </annotation>
      <annotation id="174">
        <infon key="identifier">MESH:C016679</infon>
        <infon key="type">Chemical</infon>
        <location offset="12281" length="14"/>
        <text>polyacrylamide</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="12535" length="4"/>
        <text>NaCl</text>
      </annotation>
      <annotation id="176">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="12951" length="4"/>
        <text>TBST</text>
      </annotation>
      <annotation id="177">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="13047" length="4"/>
        <text>TBST</text>
      </annotation>
      <annotation id="178">
        <infon key="identifier">MESH:D011136</infon>
        <infon key="type">Chemical</infon>
        <location offset="12555" length="8"/>
        <text>Tween 20</text>
      </annotation>
      <annotation id="179">
        <infon key="identifier">MESH:D015352</infon>
        <infon key="type">Disease</infon>
        <location offset="12407" length="22"/>
        <text>semi-dry transfer unit</text>
      </annotation>
      <annotation id="180">
        <infon key="identifier">MESH:D008623</infon>
        <infon key="type">Chemical</infon>
        <location offset="12178" length="20"/>
        <text>beta-mercaptoethanol</text>
      </annotation>
      <annotation id="181">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="12503" length="4"/>
        <text>TBST</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>13164</offset>
      <text>2.6. Surveyor endonuclease assay</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>13197</offset>
      <text>Somatic mutations were determined using the Surveyor  mutation detection kit (Transgenomic Inc., Omaha, NE, USA) following the manufacturer's instructions. Embryos (pool of 5 embryos per replicate) were sampled at 48 hours post-injection and genomic DNA was isolated using the proteinase K digestion method. The AHR2a and AHR2b target regions were amplified by polymerase chain reaction (PCR) using Advantage polymerase (Clontech, Mountain View, CA, USA). The primer sequences are given in Table 2. PCR cycling conditions were 94 C for 1 min, followed by 35 cycles of [94 C for 5 s, 68 C for 1 min], followed by 72 C for 7 min. The PCR products were melted and re-annealed to form hetero-duplex DNA and digested with Surveyor nuclease for 20 min at 42 C. The resulting products were electrophoresed on a 15% TBE gel and visualized by ethidium bromide staining.</text>
      <annotation id="184">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="14005" length="3"/>
        <text>TBE</text>
      </annotation>
      <annotation id="185">
        <infon key="identifier">MESH:D004996</infon>
        <infon key="type">Chemical</infon>
        <location offset="14031" length="16"/>
        <text>ethidium bromide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>14066</offset>
      <text>2.7. DNA sequencing</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>14086</offset>
      <text>PCR products from samples that were positive in the Surveyor endonuclease assay were cloned into the pGEM-T easy vector (Promega, Madison, WI, USA) and sequenced in 96-well plates (Functional Biosciences, Madison, WI, USA). Insertions and deletions were identified by aligning the sequences with the wildtype AHR sequence (Sequencher 5.1, Gene Codes Corp., Ann Arbor, MI, USA). Off-target screening for AHR2b CRISPR-Cas9 exon2 was done by direct-sequencing of PCR products. The amplification reactions were purified using the GeneClean kit (MP Biomedicals, Santa Ana, CA, USA). Direct-sequencing of the amplicons for AHR1a, AHR2a, and AHRR was done with primers Fh2a-ex2rev, 2b-1aF, and RR-ex2fwd, respectively (Table 2). The chromatograms were visually inspected for regions of double peaks indicating insertions or deletions.</text>
      <annotation id="188">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="14489" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="189">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="14721" length="4"/>
        <text>AHRR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>14914</offset>
      <text>3. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>14925</offset>
      <text>3.1. ZFN-induced AHR2a mutations</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14958</offset>
      <text>We tested different concentrations of ZFN mRNA on killifish embryos by injecting 500, 1000 and 2000 pg per embryo. No overt toxic effects or phenotypic abnormalities were observed at any of the concentrations as determined by microscopic observation of embryos during development. Hence, we selected 2000 pg to inject in subsequent experiments. ZFN protein expression was confirmed in the embryos injected with 2000 pg ZFN mRNA. Embryos were sampled at 3, 6, 9 and 24 hours post-microinjection. The maximum ZFN protein expression was observed at 6 hours post-microinjection (Fig. 3A). At 3 and 9 hours, ZFN protein expression was much lower, and at 24 hours, no expression was detected. These results suggest that the maximum efficiency of ZFNs in inducing DSBs in killifish is around 6 hours post-injection.</text>
      <annotation id="197">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="15008" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="15723" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="15315" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="200">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="15477" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="201">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="15573" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="202">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="15620" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="203">
        <infon key="identifier">MESH:C007563</infon>
        <infon key="type">Chemical</infon>
        <location offset="15715" length="4"/>
        <text>DSBs</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>15767</offset>
      <text>Approximately 400 embryos were injected with the ZFN pair targeting exon 2 of AHR2a, and all were screened for mutations using the Surveyor mutation detection assay. We did not detect any insertions or deletions in these embryos; therefore, we next tested the ZFN pair targeting exon 3. Using the Surveyor assay, we analyzed 14 pools of ZFN-injected embryos (5 embryos per pool), and detected the presence of mutations in 4 pools (Fig. 3B). Endonuclease digestion resulted in fragments of approximately 240 bp and 95 bp (Fig. 2B, 3B). The PCR product from one of the embryo pools that was positive in the Surveyor assay was cloned into the pGEM-T Easy vector. Sequencing of multiple clones revealed 6 mutant sequences out of 59 (10%), represented by four different types of deletions at the target site (2, 4, 5 and 28-base pair deletions) (Fig. 3C). We did not observe any cuts with the Surveyor endonuclease in the 2 pools of uninjected embryos. The remaining fish have been raised to adulthood, and their progeny are being screened to identify potential founders (Supplemental Table 1).</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>16857</offset>
      <text>3.2. CRISPR-Cas9-induced AHR2a mutations</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>16898</offset>
      <text>Microinjection of the CRISPR-Cas9 guide RNA targeting exon 2 of AHR2a was not successful in generating mutations (20 pools of 5 embryos/pool were analyzed). However, for the guide RNA targeting exon 3, Surveyor mutation detection assay results were positive in 2 out of 6 pools of injected embryos analyzed (30 embryos total; 5 embryos per pool) (Fig. 4A). The mutated target sites resulted in fragments of approximately 160 bp and 95 bp (Fig. 2B, 4A). The PCR products from the two positive samples (10 embryos total) were combined, cloned into the pGEM-T Easy vector, and sequenced. We observed 13 deletions in 81 sequences (16%). The 13 deletions varied in length from 1 to 58 bp, representing 10 distinct deletions (Fig. 4B).</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>17628</offset>
      <text>3.3. CRISPR-Cas9-induced AHR2b mutations</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>17669</offset>
      <text>CRISPR-Cas9 guide RNAs targeting exon 2 and 3 of the AHR2b locus were both efficient at generating mutations in the microinjected embryos. Surveyor mutation detection assay showed the presence of mutations in all 4 pools of AHR2b exon 2 CRISPR-Cas-injected embryos analyzed (20 embryos total; 5 embryos per pool) (Fig. 5A). The PCR products from these 4 pools were combined and cloned into the pGEM-T Easy vector. Sequencing results revealed that 16 sequences out of 70 (23%) had indels at the target site, represented by 8 distinct mutations (5 deletions and 3 insertions) (Fig. 5B).</text>
      <annotation id="205">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="17893" length="4"/>
        <text>AHR2</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>18254</offset>
      <text>Similarly, injection of guide RNA targeting exon 3 of AHR2b induced mutations as observed with Surveyor mutation detection assay (Fig. 5C). All 4 pools of injected embryos showed the presence of mutations (5 embryos per pool). PCR products from two of the samples were combined, cloned into the pGEM-T easy vector and sequenced. We observed 55 sequences with indels out of 87 (63%). There were 20 different deletions and 7 different insertion mutants (Fig. 5D).</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>18716</offset>
      <text>3.4. Screening for CRISPR-Cas9 off-target effects</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>18766</offset>
      <text>In order to assess potential off-target effects of the CRISPR-Cas9 experiments, we chose one of the guide RNAs that gave positive results (exon 2 of AHR2b) to screen for possible mutations in other AHR paralogs and AHRR. The multiple AHR paralogs and the AHRR are closely related genes and share substantial sequence identity, especially in the N-terminus. Alignment of the AHR2b CRISPR-Cas9 target sequence with the other genes is shown in Fig. 6A. The numbers of mismatches between the 20 bp AHR2b target site and AHR1a, AHR2a, AHR1b, and AHRR are 4, 4, 6, and 3, respectively. These corresponding regions were amplified from the uninjected and AHR2b CRISPR-Cas9-injected embryo genomic DNA samples in which AHR2b mutations were observed. The PCR products were analyzed for mutations using the Surveyor endonuclease assay. The AHR1a, AHR2a, and AHRR samples contained small fragments indicating endonuclease digestion of the PCR products (Fig. 6B). These fragments were also present in the AHR2a and AHRR reactions from the uninjected embryos. These amplification reactions were purified and analyzed by direct-sequencing. The chromatograms of the AHR1a and AHR2a sequencing reactions contained double peaks at previously characterized SNP locations (#141 and #159 for AHR1a, and #156 for AHR2a). Surveyor endonuclease is sensitive to even a single nucleotide mismatch between the two DNA strands, therefore it will cleave DNA at the SNP sites. The sizes of the observed Surveyor endonuclease fragments in these samples (Fig. 6B) can be explained by these SNPs, thereby suggesting that they do not represent off-target mutations. On the other hand, we did not detect a SNP in the AHRR sequences that would explain the fragments observed in the Surveyor assay. However the presence of these fragments in both uninjected and injected samples suggest that they are rare SNPs that may not be detected by direct sequencing.</text>
      <annotation id="215">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="18981" length="4"/>
        <text>AHRR</text>
      </annotation>
      <annotation id="216">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="19021" length="4"/>
        <text>AHRR</text>
      </annotation>
      <annotation id="217">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="19140" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="218">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="19413" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="19476" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="220">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="19613" length="4"/>
        <text>AHRR</text>
      </annotation>
      <annotation id="221">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="19768" length="4"/>
        <text>AHRR</text>
      </annotation>
      <annotation id="222">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="20448" length="4"/>
        <text>AHRR</text>
      </annotation>
      <annotation id="223">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="19307" length="4"/>
        <text>AHRR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>20687</offset>
      <text>4. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>20701</offset>
      <text>In this study, we demonstrated the feasibility of targeted mutagenesis approaches in inducing mutations in an environmental model species with limited genomic and genetic resources. The ease with which ZFN and CRISPR-Cas9 methods can be utilized to cleave specific genomic DNA sequences has led to the generation of gene knockouts in species not traditionally used for conducting genetic and functional studies (Table 1). Using these methods, we produced mutations in AHR2a and AHR2b loci in killifish embryos. These embryos are currently being raised to adulthood, and their progeny will be screened to identify potential founders. As killifish have a long generation time (2 years minimum) and lack established breeding techniques, the time it takes to generate homozygous mutants is relatively long. Here, we propose some strategies to expedite the process of generating homozygous mutants in killifish. AHR-null killifish will be valuable for characterizing the role of the individual AHR paralogs in evolved resistance, as well as in normal development.</text>
      <annotation id="228">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="21193" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="229">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="21337" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="230">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="21597" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="231">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="21617" length="9"/>
        <text>killifish</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>21760</offset>
      <text>We initially adopted the ZFN approach for generating mutations, as their design and activity are well characterized. In addition, ZFNs were the first targeted mutagenesis approach that was successfully used in generating mutations in a number of model and non-model organisms. ZFNs are assembled using zinc finger motifs, each of which recognizes a unique 3-bp DNA sequence. Initial studies with ZFNs used 3-finger zinc-finger proteins (ZFPs), but recent studies have used up to six fingers per ZFP to increase specificity and target rare cleavage sites. We used five-finger zinc finger proteins that enabled ZFN dimers to specifically target a 30-bp region in exon 2 and exon 3 of AHR2a (Table 2).</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>22459</offset>
      <text>In order to determine the translational efficiency of the injected ZFN mRNA, we measured ZFN protein expression in embryos using an anti-FLAG antibody. Our results demonstrated that maximal ZFN protein expression is observed at 6 hours post-injection, suggesting that ZFN protein binding to the target site and creating DSBs occurs around this time. In comparison, in zebrafish embryos injected with a ZFN targeting the aryl hydrocarbon receptor repressor (ahrra) gene, we observed maximal ZFN protein expression at 3 hours post-injection. These species-specific differences in ZFN protein expression could be linked to the developmental rate in the two species. The developmental period for zebrafish from fertilization to hatching is 2 days, whereas killifish hatch at 15 days post-fertilization. Another factor that could contribute to the differences in protein expression is the water temperature at which embryos are incubated. Zebrafish embryos are reared at a higher temperature (28 C) than killifish (23 C), which may affect the rate of transcription and translation.</text>
      <annotation id="244">
        <infon key="identifier">641291</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">123929</infon>
        <location offset="22916" length="5"/>
        <text>ahrra</text>
      </annotation>
      <annotation id="245">
        <infon key="identifier">7955</infon>
        <infon key="type">Species</infon>
        <location offset="22827" length="9"/>
        <text>zebrafish</text>
      </annotation>
      <annotation id="246">
        <infon key="identifier">7955</infon>
        <infon key="type">Species</infon>
        <location offset="23151" length="9"/>
        <text>zebrafish</text>
      </annotation>
      <annotation id="247">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="23211" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="248">
        <infon key="identifier">7955</infon>
        <infon key="type">Species</infon>
        <location offset="23393" length="9"/>
        <text>Zebrafish</text>
      </annotation>
      <annotation id="249">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="23458" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="250">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="22560" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="251">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="22661" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="252">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="22961" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="253">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="23049" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="254">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="23325" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="255">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="23343" length="5"/>
        <text>water</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>23538</offset>
      <text>We were successful in obtaining mutations in the AHR2a gene with a ZFN targeting exon 3. Sequencing results revealed the presence of 4 different deletions at the target site in 10% of the sequenced clones. These results are comparable to the frequencies observed in other species. The CRISPR-Cas9 method has been reported to result in higher mutation frequencies in comparison to ZFNs or TALENs. Therefore, we used the CRISPR-Cas9 approach to target AHR2a and observed indels in 16% of the sequences from embryos microinjected with a gRNA targeting exon 3. We detected mutations in the CRISPR-Cas9 injected embryos in the very first trial compared to several ZFN trials, even though the proportion of indels showed only a modest increase with the CRISPR-Cas9 method. Similarly, microinjection of gRNAs targeting exon 2 and exon 3 of AHR2b produced indels in 17% and 63% of the sequences. We are currently raising the ZFN-AHR2a, CRISPR-Cas9-AHR2a and -AHR2b fish to reproductive maturity so that we can screen for founders (Supplemental Table 1). To our knowledge, this is the first study comparing the effectiveness of two different targeted genome-editing methods (protein and gRNA based) in a species with limited genomic resources. Additional comparisons with other target loci will be necessary to confirm our observations.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>24866</offset>
      <text>Genome-editing methods have become a powerful resource for generating mutants in non-model species, but there are some concerns with regard to their off-target effects. ZFNs, as well as CRISPR-Cas9, have been associated with cytotoxicity, presumably due to binding and cleavage at non-target sites, although toxic effects could also result from the target gene disruption. Screening the genome for off-target effects a priori by blast searches with the target sequence is not feasible for species that do not have sequenced genomes. However, paralogs and closely related genes that have been characterized can be screened for mutations, as these represent likely targets. We checked for off-target effects of CRISPR-Cas9 in all AHR paralogs, as well as AHRR, a gene closely related to AHR (Fig. 6). Based on the Surveyor assay and sequencing results, no off-target effects were detected, even though the number of sequence mismatches among these genes was as low as 3 residues. If genomic resources are available, several tools exist for in silico identification of potential off-target sites. Alternatively, potential off-target sites can be searched using the fuzznuc algorithm (http://embossgui.sourceforge.net/demo/manual/fuzznuc.html) in RNAseq data, if available.</text>
      <annotation id="258">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="25619" length="4"/>
        <text>AHRR</text>
      </annotation>
      <annotation id="259">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="25091" length="12"/>
        <text>cytotoxicity</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>26136</offset>
      <text>In ZFN and CRISPR-Cas9 injected embryos we did not observe any developmental toxicity, including the highest concentration of ZFN (2000 pg of ZFN mRNA/embryo). These results are in contrast to studies in other fish species, in which overt developmental phenotypes were observed at these concentrations. One reason for the lack of toxicity could be the relative size of the killifish embryos in comparison to zebrafish embryos, in which most of these methods have been optimized. Freshly fertilized killifish embryos are 2 mm in diameter, and are larger than zebrafish (0.7 mm), where ZFNs above 100 pg per embryo have been shown to cause embryo toxicity. Similarly, in medaka with an egg diameter (1.2 mm), 160 pg of ZFN caused embryo toxicity. In addition to the size of the embryo, rapid turnover of the ZFN protein might be responsible for the lack of embryo toxicity in killifish. Our results suggest that the ZFN protein is expressed transiently around 6 hours post-injection and is degraded by 9 hours (Fig. 3A), suggesting faster degradation of the injected mRNA in killifish. We cannot rule out the possibility of additional factors, yet to be determined, contributing to the low toxicity of injected mRNA in killifish.</text>
      <annotation id="274">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="26509" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="275">
        <infon key="identifier">7955</infon>
        <infon key="type">Species</infon>
        <location offset="26544" length="9"/>
        <text>zebrafish</text>
      </annotation>
      <annotation id="276">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="26634" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="277">
        <infon key="identifier">7955</infon>
        <infon key="type">Species</infon>
        <location offset="26694" length="9"/>
        <text>zebrafish</text>
      </annotation>
      <annotation id="278">
        <infon key="identifier">8090</infon>
        <infon key="type">Species</infon>
        <location offset="26805" length="6"/>
        <text>medaka</text>
      </annotation>
      <annotation id="279">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="27010" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="280">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="27209" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="281">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="27353" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="282">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="26781" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="283">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="26466" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="284">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="26213" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="285">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="27324" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="286">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="26998" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="287">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="26871" length="8"/>
        <text>toxicity</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>27364</offset>
      <text>Our results demonstrate the utility of the ZFN and CRISPR-Cas9 approaches in generating mutations in an ecologically relevant fish species that have successfully adapted to environments contaminated with PCBs and PAHs. Generating AHR knockout mutants will provide a powerful tool to functionally characterize the role of these proteins in evolved resistance to PCBs and PAHs. We are currently raising the ZFN- and CRISPR-Cas9-injected fish to adults. The numbers of injected animals that are being raised and the breeding strategy that will be followed are provided in the supplemental information (Supp. Table 1 and Supp. Fig. 1). Killifish mature in 1 year; however, larger fish, producing sufficient offspring per pair for testing, require &gt; 2 years of laboratory rearing. Most organisms in which these approaches are extensively used to generate mutants have short life history cycles (e.g. 2-3 months). However, in the past few years targeted mutagenesis approaches have been successfully used in species with longer life cycles such as yellow catfish, rainbow trout and Atlantic salmon. In order to expedite the process of obtaining homozygous mutants, several strategies can be followed. During certain steps of the homozygous mutant breeding, fin-clips from juvenile fish can be screened by direct-sequencing to identify mutants (Supp. Fig. 1). Direct-sequencing allows screening a single DNA sample per fish, as opposed to cloning the PCR product and screening multiple clones. Another possible approach to accelerate the identification of founders is to screen gametes stripped from juveniles. Once the founder animals are identified, it is possible to artificially induce precocious maturation of gametes by treating the founders with gonadotropins, a common practice in breeding aquaculture species.</text>
      <annotation id="296">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="27996" length="9"/>
        <text>Killifish</text>
      </annotation>
      <annotation id="297">
        <infon key="identifier">1234273</infon>
        <infon key="type">Species</infon>
        <location offset="28406" length="14"/>
        <text>yellow catfish</text>
      </annotation>
      <annotation id="298">
        <infon key="identifier">8022</infon>
        <infon key="type">Species</infon>
        <location offset="28422" length="13"/>
        <text>rainbow trout</text>
      </annotation>
      <annotation id="299">
        <infon key="identifier">8030</infon>
        <infon key="type">Species</infon>
        <location offset="28440" length="15"/>
        <text>Atlantic salmon</text>
      </annotation>
      <annotation id="300">
        <infon key="identifier">MESH:D011078</infon>
        <infon key="type">Chemical</infon>
        <location offset="27725" length="4"/>
        <text>PCBs</text>
      </annotation>
      <annotation id="301">
        <infon key="identifier">MESH:D011084</infon>
        <infon key="type">Chemical</infon>
        <location offset="27734" length="4"/>
        <text>PAHs</text>
      </annotation>
      <annotation id="302">
        <infon key="identifier">MESH:D011084</infon>
        <infon key="type">Chemical</infon>
        <location offset="27577" length="4"/>
        <text>PAHs</text>
      </annotation>
      <annotation id="303">
        <infon key="identifier">MESH:D011078</infon>
        <infon key="type">Chemical</infon>
        <location offset="27568" length="4"/>
        <text>PCBs</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>29178</offset>
      <text>Other strategies to consider while generating mutants in species with long life history cycles is to generate at least two mutant lines targeting different sites in each gene. As it is time consuming to raise embryos to reproductive maturity, targeting multiple regions of the same gene confirms the specificity of the observed phenotypes associated with the gene knockout. In addition, if a frameshift mutation is not produced in one of the targets, the other target will serve as an alternative. We followed these approaches and designed CRISPR-Cas9 guide RNAs against AHR2a, in addition to the ZFN method. Similarly, we designed two different gRNAs against AHR2b, and observed mutations at both target sites. Another important consideration in target site selection in species such as the Atlantic killifish is to avoid regions with known single nucleotide polymorphisms (SNPs). Killifish have high genetic diversity, and if the target site has multiple mismatches due to SNPs, the efficacy of the ZFN proteins or guide RNAs will be reduced. In addition, SNPs interfere with the mutation detection assays such as Surveyor endonuclease by creating cuts at polymorphic sites. An additional strategy to consider is optimizing injection conditions to maximize the chances for mutating both alleles at the target locus simultaneously. Such bi-allelic mutations in CRISPR-Cas9-injected embryos have been demonstrated previously. The presence of bi-allelic mutations in the germline will expedite the process of generating homozygous individuals.</text>
      <annotation id="306">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="29970" length="18"/>
        <text>Atlantic killifish</text>
      </annotation>
      <annotation id="307">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="30060" length="9"/>
        <text>Killifish</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>30721</offset>
      <text>Overall, targeted mutagenesis approaches have provided new opportunities for conducting functional studies in non-traditional model organisms. As a proof of concept, we and others (Table 1) have demonstrated that it is feasible to generate mutants in non-traditional model species. The relative ease of these methods, as well as the open-source sharing of reagents, have made these methods accessible to a wide range of laboratories.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>31155</offset>
      <text>5. CONCLUSIONS</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>31170</offset>
      <text>In this study we demonstrated the utility of targeted gene-editing methods for generating ahr mutants in Atlantic killifish. We observed higher frequency of mutations with CRISPR-Cas9 compared to ZFN mRNA injected embryos. We are currently raising the injected embryos to identify potential germ line mutants. Some of the challenges in generating homozygous mutants in killifish include long generation time and lack of established breeding methods. We have proposed some strategies to overcome these challenges and expedite the process of identifying the founders and generating ahr-null mutants. The strategies proposed here are applicable to any fish species with limited aquaculture resources, providing an opportunity to conduct functional studies.</text>
      <annotation id="310">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="31275" length="18"/>
        <text>Atlantic killifish</text>
      </annotation>
      <annotation id="311">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="31539" length="9"/>
        <text>killifish</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">title_1</infon>
      <offset>31924</offset>
      <text>Supplementary Material</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>31947</offset>
      <text>This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>32420</offset>
      <text>                </text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>32437</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Franks;given-names:D</infon>
      <infon key="name_2">surname:Jenny;given-names:MJ</infon>
      <infon key="name_1">surname:Karchner;given-names:SI</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Aluru;given-names:N</infon>
      <infon key="year">2013</infon>
      <infon key="type">ref</infon>
      <infon key="name_4">surname:Hahn;given-names:ME</infon>
      <offset>32448</offset>
      <text>Understanding the physiological role of aryl hydrocarbon receptor repressor (AHRR) using gene knock-down and targeted mutagenesis in zebrafish</text>
      <annotation id="313">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="32525" length="4"/>
        <text>AHRR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Schartl;given-names:M</infon>
      <infon key="name_2">surname:Yoshiura;given-names:Y</infon>
      <infon key="name_1">surname:Inohaya;given-names:K</infon>
      <infon key="name_0">surname:Ansai;given-names:S</infon>
      <infon key="fpage">98</infon>
      <infon key="pub-id_pmid">24286287</infon>
      <infon key="year">2014</infon>
      <infon key="source">Dev Growth Differ</infon>
      <infon key="type">ref</infon>
      <infon key="volume">56</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">107</infon>
      <infon key="name_6">surname:Kinoshita;given-names:M</infon>
      <infon key="name_5">surname:Takahashi;given-names:R</infon>
      <infon key="name_4">surname:Uemura;given-names:N</infon>
      <offset>32591</offset>
      <text>Design, evaluation, and screening methods for efficient targeted mutagenesis with transcription activator-like effector nucleases in medaka</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Kamei;given-names:Y</infon>
      <infon key="name_2">surname:Kanie;given-names:Y</infon>
      <infon key="name_1">surname:Ochiai;given-names:H</infon>
      <infon key="name_0">surname:Ansai;given-names:S</infon>
      <infon key="fpage">546</infon>
      <infon key="pub-id_pmid">22642582</infon>
      <infon key="year">2012</infon>
      <infon key="source">Dev Growth Differ</infon>
      <infon key="type">ref</infon>
      <infon key="volume">54</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Kinoshita;given-names:M</infon>
      <infon key="lpage">556</infon>
      <infon key="name_6">surname:Yamamoto;given-names:T</infon>
      <infon key="name_5">surname:Kitano;given-names:T</infon>
      <infon key="name_4">surname:Gou;given-names:Y</infon>
      <offset>32731</offset>
      <text>Targeted disruption of exogenous EGFP gene in medaka using zinc-finger nucleases</text>
      <annotation id="315">
        <infon key="identifier">8090</infon>
        <infon key="type">Species</infon>
        <location offset="32777" length="6"/>
        <text>medaka</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ariga;given-names:H</infon>
      <infon key="name_2">surname:Yamamoto;given-names:T</infon>
      <infon key="name_1">surname:Sakuma;given-names:T</infon>
      <infon key="name_0">surname:Ansai;given-names:S</infon>
      <infon key="fpage">739</infon>
      <infon key="pub-id_pmid">23288935</infon>
      <infon key="year">2013</infon>
      <infon key="source">Genetics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">193</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">749</infon>
      <infon key="name_6">surname:Kinoshita;given-names:M</infon>
      <infon key="name_5">surname:Takahashi;given-names:R</infon>
      <infon key="name_4">surname:Uemura;given-names:N</infon>
      <offset>32812</offset>
      <text>Efficient targeted mutagenesis in medaka using custom-designed transcription activatorlike effector nucleases</text>
      <annotation id="317">
        <infon key="identifier">8090</infon>
        <infon key="type">Species</infon>
        <location offset="32846" length="6"/>
        <text>medaka</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">128</infon>
      <infon key="name_1">surname:Child;given-names:JS</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Armstrong;given-names:PB</infon>
      <infon key="fpage">143</infon>
      <infon key="year">1965</infon>
      <infon key="source">Biol Bull</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">168</infon>
      <offset>32922</offset>
      <text>Stages in Normal Development of Fundulus heteroclitus</text>
      <annotation id="319">
        <infon key="type">Disease</infon>
        <location offset="32954" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Adelman;given-names:ZN</infon>
      <infon key="volume">3</infon>
      <infon key="name_2">surname:Myles;given-names:KM</infon>
      <infon key="name_1">surname:Anderson;given-names:MA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Aryan;given-names:A</infon>
      <infon key="fpage">1603</infon>
      <infon key="pub-id_pmid">23549343</infon>
      <infon key="year">2013a</infon>
      <infon key="source">Sci Rep</infon>
      <infon key="type">ref</infon>
      <offset>32976</offset>
      <text>Germline excision of transgenes in Aedes aegypti by homing endonucleases</text>
      <annotation id="321">
        <infon key="identifier">7159</infon>
        <infon key="type">Species</infon>
        <location offset="33011" length="13"/>
        <text>Aedes aegypti</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Adelman;given-names:ZN</infon>
      <infon key="volume">8</infon>
      <infon key="name_2">surname:Myles;given-names:KM</infon>
      <infon key="name_1">surname:Anderson;given-names:MA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Aryan;given-names:A</infon>
      <infon key="fpage">e60082</infon>
      <infon key="pub-id_pmid">23555893</infon>
      <infon key="year">2013b</infon>
      <infon key="source">PLoS One</infon>
      <infon key="type">ref</infon>
      <offset>33049</offset>
      <text>TALEN-based gene disruption in the dengue vector Aedes aegypti</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Lohs;given-names:C</infon>
      <infon key="name_2">surname:Polo;given-names:A</infon>
      <infon key="name_1">surname:Antonova;given-names:O</infon>
      <infon key="name_0">surname:Bannister;given-names:S</infon>
      <infon key="fpage">77</infon>
      <infon key="pub-id_pmid">24653002</infon>
      <infon key="year">2014</infon>
      <infon key="source">Genetics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">197</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Tessmar-Raible;given-names:K</infon>
      <infon key="lpage">89</infon>
      <infon key="name_6">surname:Raible;given-names:F</infon>
      <infon key="name_5">surname:Valinciute;given-names:A</infon>
      <infon key="name_4">surname:Hallay;given-names:N</infon>
      <offset>33112</offset>
      <text>TALENs mediate efficient and heritable mutation of endogenous genes in the marine annelid Platynereis dumerilii</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Hahn;given-names:ME</infon>
      <infon key="volume">60</infon>
      <infon key="name_2">surname:Stegeman;given-names:JJ</infon>
      <infon key="name_1">surname:Franks;given-names:DG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bello;given-names:SM</infon>
      <infon key="fpage">77</infon>
      <infon key="pub-id_pmid">11222875</infon>
      <infon key="year">2001</infon>
      <infon key="source">Toxicol Sci</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">91</infon>
      <offset>33224</offset>
      <text>Acquired resistance to Ah receptor agonists in a population of Atlantic killifish (Fundulus heteroclitus) inhabiting a marine superfund site: In vivo and in vitro studies on the inducibility of xenobiotic metabolizing enzymes</text>
      <annotation id="324">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="33287" length="18"/>
        <text>Atlantic killifish</text>
      </annotation>
      <annotation id="325">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="33307" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Carroll;given-names:D</infon>
      <infon key="volume">300</infon>
      <infon key="name_2">surname:Trautman;given-names:JK</infon>
      <infon key="name_1">surname:Beumer;given-names:K</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bibikova;given-names:M</infon>
      <infon key="fpage">764</infon>
      <infon key="pub-id_pmid">12730594</infon>
      <infon key="year">2003</infon>
      <infon key="source">Science</infon>
      <infon key="type">ref</infon>
      <offset>33450</offset>
      <text>Enhancing gene targeting with designed zinc finger nucleases</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Carroll;given-names:D</infon>
      <infon key="volume">161</infon>
      <infon key="name_2">surname:Golic;given-names:KG</infon>
      <infon key="name_1">surname:Golic;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bibikova;given-names:M</infon>
      <infon key="fpage">1169</infon>
      <infon key="pub-id_pmid">12136019</infon>
      <infon key="year">2002</infon>
      <infon key="source">Genetics</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1175</infon>
      <offset>33511</offset>
      <text>Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases</text>
      <annotation id="327">
        <infon key="identifier">7227</infon>
        <infon key="type">Species</infon>
        <location offset="33560" length="10"/>
        <text>Drosophila</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Cho;given-names:KW</infon>
      <infon key="volume">51</infon>
      <infon key="name_2">surname:Xie;given-names:X</infon>
      <infon key="name_1">surname:Biesinger;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Blitz;given-names:IL</infon>
      <infon key="fpage">827</infon>
      <infon key="pub-id_pmid">24123579</infon>
      <infon key="year">2013</infon>
      <infon key="source">Genesis</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">834</infon>
      <offset>33599</offset>
      <text>Biallelic genome modification in F(0) Xenopus tropicalis embryos using the CRISPR/Cas system</text>
      <annotation id="329">
        <infon key="identifier">8364</infon>
        <infon key="type">Species</infon>
        <location offset="33637" length="18"/>
        <text>Xenopus tropicalis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Callard;given-names:GV</infon>
      <infon key="name_2">surname:Baldwin;given-names:WS</infon>
      <infon key="name_1">surname:Bain;given-names:LJ</infon>
      <infon key="name_0">surname:Burnett;given-names:KG</infon>
      <infon key="pub-id_pmid">18071578</infon>
      <infon key="year">2007</infon>
      <infon key="source">Comp Biochem Physiol Part D Genomics Proteomics</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Towle;given-names:DW</infon>
      <infon key="name_21">surname:Van Veld;given-names:PA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_24">surname:Winn;given-names:RN</infon>
      <infon key="name_25">surname:Crawford;given-names:DL</infon>
      <infon key="name_22">surname:Vogelbein;given-names:WK</infon>
      <infon key="name_23">surname:Whitehead;given-names:A</infon>
      <infon key="lpage">286</infon>
      <infon key="fpage">257</infon>
      <infon key="volume">2</infon>
      <infon key="name_10">surname:Karchner;given-names:SI</infon>
      <infon key="name_13">surname:Marshall;given-names:WS</infon>
      <infon key="name_14">surname:Meyer;given-names:JN</infon>
      <infon key="name_11">surname:Katoh;given-names:F</infon>
      <infon key="name_12">surname:Maclatchy;given-names:DL</infon>
      <infon key="name_17">surname:Rees;given-names:BB</infon>
      <infon key="name_18">surname:Singer;given-names:TD</infon>
      <infon key="name_15">surname:Nacci;given-names:DE</infon>
      <infon key="name_9">surname:Hoover;given-names:CA</infon>
      <infon key="name_16">surname:Oleksiak;given-names:MF</infon>
      <infon key="name_8">surname:Hahn;given-names:ME</infon>
      <infon key="name_7">surname:Gomez-Chiarri;given-names:M</infon>
      <infon key="name_6">surname:Evans;given-names:DH</infon>
      <infon key="name_19">surname:Stegeman;given-names:JJ</infon>
      <infon key="name_5">surname:Di Giulio;given-names:RT</infon>
      <infon key="name_4">surname:Cohen;given-names:S</infon>
      <offset>33692</offset>
      <text>Fundulus as the premier teleost model in environmental biology: opportunities for new insights using genomics</text>
      <annotation id="331">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="33692" length="8"/>
        <text>Fundulus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">195</infon>
      <infon key="name_2">surname:Joy;given-names:KP</infon>
      <infon key="name_1">surname:Singh;given-names:RK</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Chaube;given-names:R</infon>
      <infon key="fpage">190</infon>
      <infon key="pub-id_pmid">24246310</infon>
      <infon key="year">2014</infon>
      <infon key="source">Gen Comp Endocrinol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">200</infon>
      <offset>33802</offset>
      <text>Effects of ovaprim, a commercial spawning inducer, on vasotocin and steroid hormone profiles in the catfish Heteropneustes fossilis: in vivo and in vitro studies</text>
      <annotation id="336">
        <infon key="identifier">71179</infon>
        <infon key="type">Species</infon>
        <location offset="33902" length="7"/>
        <text>catfish</text>
      </annotation>
      <annotation id="337">
        <infon key="identifier">93621</infon>
        <infon key="type">Species</infon>
        <location offset="33910" length="23"/>
        <text>Heteropneustes fossilis</text>
      </annotation>
      <annotation id="338">
        <infon key="identifier">MESH:D014668</infon>
        <infon key="type">Chemical</infon>
        <location offset="33856" length="9"/>
        <text>vasotocin</text>
      </annotation>
      <annotation id="339">
        <infon key="identifier">MESH:D013256</infon>
        <infon key="type">Chemical</infon>
        <location offset="33870" length="15"/>
        <text>steroid hormone</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Di Giulio;given-names:RT</infon>
      <infon key="volume">99</infon>
      <infon key="name_2">surname:Jung;given-names:D</infon>
      <infon key="name_1">surname:Matson;given-names:CW</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Clark;given-names:BW</infon>
      <infon key="fpage">232</infon>
      <infon key="pub-id_pmid">20605646</infon>
      <infon key="year">2010</infon>
      <infon key="source">Aquat Toxicol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">240</infon>
      <offset>33964</offset>
      <text>AHR2 mediates cardiac teratogenesis of polycyclic aromatic hydrocarbons and PCB-126 in Atlantic killifish (Fundulus heteroclitus)</text>
      <annotation id="345">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="33964" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="346">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="34051" length="18"/>
        <text>Atlantic killifish</text>
      </annotation>
      <annotation id="347">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="34071" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
      <annotation id="348">
        <infon key="identifier">MESH:D011078</infon>
        <infon key="type">Chemical</infon>
        <location offset="34040" length="3"/>
        <text>PCB</text>
      </annotation>
      <annotation id="349">
        <infon key="identifier">MESH:D011084</infon>
        <infon key="type">Chemical</infon>
        <location offset="34003" length="32"/>
        <text>polycyclic aromatic hydrocarbons</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Xu;given-names:Z</infon>
      <infon key="name_2">surname:Li;given-names:K</infon>
      <infon key="name_1">surname:Ge;given-names:J</infon>
      <infon key="name_0">surname:Dong;given-names:Z</infon>
      <infon key="fpage">e28897</infon>
      <infon key="pub-id_pmid">22194943</infon>
      <infon key="year">2011</infon>
      <infon key="source">PLoS One</infon>
      <infon key="type">ref</infon>
      <infon key="volume">6</infon>
      <infon key="name_10">surname:Wang;given-names:X</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Pan;given-names:J</infon>
      <infon key="name_12">surname:Zhao;given-names:Q</infon>
      <infon key="name_9">surname:Cao;given-names:S</infon>
      <infon key="name_8">surname:Dong;given-names:X</infon>
      <infon key="name_7">surname:Li;given-names:Y</infon>
      <infon key="name_6">surname:Jia;given-names:W</infon>
      <infon key="name_5">surname:Li;given-names:J</infon>
      <infon key="name_4">surname:Liang;given-names:D</infon>
      <offset>34094</offset>
      <text>Heritable targeted inactivation of myostatin gene in yellow catfish (Pelteobagrus fulvidraco) using engineered zinc finger nucleases</text>
      <annotation id="352">
        <infon key="identifier">1234273</infon>
        <infon key="type">Species</infon>
        <location offset="34147" length="14"/>
        <text>yellow catfish</text>
      </annotation>
      <annotation id="353">
        <infon key="identifier">1234273</infon>
        <infon key="type">Species</infon>
        <location offset="34163" length="23"/>
        <text>Pelteobagrus fulvidraco</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Faraji;given-names:F</infon>
      <infon key="name_2">surname:Miller;given-names:JC</infon>
      <infon key="name_1">surname:McCammon;given-names:JM</infon>
      <infon key="name_0">surname:Doyon;given-names:Y</infon>
      <infon key="fpage">702</infon>
      <infon key="pub-id_pmid">18500334</infon>
      <infon key="year">2008</infon>
      <infon key="source">Nat Biotechnol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">26</infon>
      <infon key="name_10">surname:Gregory;given-names:PD</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Urnov;given-names:FD</infon>
      <infon key="name_12">surname:Amacher;given-names:SL</infon>
      <infon key="name_9">surname:Rebar;given-names:EJ</infon>
      <infon key="name_8">surname:Zhang;given-names:L</infon>
      <infon key="name_7">surname:Hocking;given-names:TD</infon>
      <infon key="lpage">708</infon>
      <infon key="name_6">surname:Amora;given-names:R</infon>
      <infon key="name_5">surname:Katibah;given-names:GE</infon>
      <infon key="name_4">surname:Ngo;given-names:C</infon>
      <offset>34227</offset>
      <text>Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases</text>
      <annotation id="355">
        <infon key="identifier">7955</infon>
        <infon key="type">Species</infon>
        <location offset="34265" length="9"/>
        <text>zebrafish</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Skaftnesmo;given-names:KO</infon>
      <infon key="volume">9</infon>
      <infon key="name_2">surname:Kleppe;given-names:L</infon>
      <infon key="name_1">surname:Leininger;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Edvardsen;given-names:RB</infon>
      <infon key="fpage">e108622</infon>
      <infon key="pub-id_pmid">25254960</infon>
      <infon key="year">2014</infon>
      <infon key="source">PLoS One</infon>
      <infon key="type">ref</infon>
      <infon key="name_4">surname:Wargelius;given-names:A</infon>
      <offset>34312</offset>
      <text>Targeted Mutagenesis in Atlantic Salmon (Salmo salar L.) Using the CRISPR/Cas9 System Induces Complete Knockout Individuals in the F0 Generation</text>
      <annotation id="358">
        <infon key="identifier">8030</infon>
        <infon key="type">Species</infon>
        <location offset="34336" length="15"/>
        <text>Atlantic Salmon</text>
      </annotation>
      <annotation id="359">
        <infon key="identifier">8030</infon>
        <infon key="type">Species</infon>
        <location offset="34353" length="11"/>
        <text>Salmo salar</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Stegeman;given-names:JJ</infon>
      <infon key="volume">45</infon>
      <infon key="name_2">surname:McElroy;given-names:AE</infon>
      <infon key="name_1">surname:Monosson;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Elskus;given-names:AA</infon>
      <infon key="fpage">99</infon>
      <infon key="year">1999</infon>
      <infon key="source">Aquat Toxicol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">113</infon>
      <infon key="name_4">surname:Woltering;given-names:DS</infon>
      <offset>34457</offset>
      <text>Altered CYP1A expression in Fundulus heteroclitus adults and larvae: a sign of pollutant resistance?</text>
      <annotation id="363">
        <infon key="identifier">105930482</infon>
        <infon key="type">Gene</infon>
        <location offset="34465" length="5"/>
        <text>CYP1A</text>
      </annotation>
      <annotation id="364">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="34485" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
      <annotation id="365">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="34471" length="10"/>
        <text>expression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Lin;given-names:Y</infon>
      <infon key="volume">42</infon>
      <infon key="name_2">surname:Zhao;given-names:CL</infon>
      <infon key="name_1">surname:Cradick;given-names:TJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Fine;given-names:EJ</infon>
      <infon key="fpage">e42</infon>
      <infon key="pub-id_pmid">24381193</infon>
      <infon key="year">2014</infon>
      <infon key="source">Nucleic Acids Res</infon>
      <infon key="type">ref</infon>
      <infon key="name_4">surname:Bao;given-names:G</infon>
      <offset>34558</offset>
      <text>An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Monaghan;given-names:JR</infon>
      <infon key="name_2">surname:McLean;given-names:KC</infon>
      <infon key="name_1">surname:Timberlake;given-names:AT</infon>
      <infon key="name_0">surname:Flowers;given-names:GP</infon>
      <infon key="fpage">2165</infon>
      <infon key="pub-id_pmid">24764077</infon>
      <infon key="year">2014</infon>
      <infon key="source">Development</infon>
      <infon key="type">ref</infon>
      <infon key="volume">141</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">2171</infon>
      <infon key="name_4">surname:Crews;given-names:CM</infon>
      <offset>34647</offset>
      <text>Highly efficient targeted mutagenesis in axolotl using Cas9 RNA-guided nuclease</text>
      <annotation id="367">
        <infon key="identifier">8296</infon>
        <infon key="type">Species</infon>
        <location offset="34688" length="7"/>
        <text>axolotl</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">31</infon>
      <infon key="name_2">surname:Barbas;given-names:CF;suffix:3rd</infon>
      <infon key="name_1">surname:Gersbach;given-names:CA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Gaj;given-names:T</infon>
      <infon key="fpage">397</infon>
      <infon key="pub-id_pmid">23664777</infon>
      <infon key="year">2013</infon>
      <infon key="source">Trends Biotechnol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">405</infon>
      <offset>34727</offset>
      <text>ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Altwegg;given-names:M</infon>
      <infon key="volume">4</infon>
      <infon key="name_2">surname:Ritzler;given-names:M</infon>
      <infon key="name_1">surname:Perschil;given-names:I</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Goldenberger;given-names:D</infon>
      <infon key="fpage">368</infon>
      <infon key="pub-id_pmid">7580932</infon>
      <infon key="year">1995</infon>
      <infon key="source">PCR Methods Appl</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">370</infon>
      <offset>34791</offset>
      <text>A simple "universal" DNA extraction procedure using SDS and proteinase K is compatible with direct PCR amplification</text>
      <annotation id="369">
        <infon key="identifier">MESH:D012967</infon>
        <infon key="type">Chemical</infon>
        <location offset="34843" length="3"/>
        <text>SDS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Zhang;given-names:Y</infon>
      <infon key="name_2">surname:Hu;given-names:Z</infon>
      <infon key="name_1">surname:Zhang;given-names:T</infon>
      <infon key="name_0">surname:Guo;given-names:X</infon>
      <infon key="fpage">707</infon>
      <infon key="pub-id_pmid">24401372</infon>
      <infon key="year">2014</infon>
      <infon key="source">Development</infon>
      <infon key="type">ref</infon>
      <infon key="volume">141</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Chen;given-names:Y</infon>
      <infon key="name_8">surname:Zhao;given-names:H</infon>
      <infon key="name_7">surname:Wang;given-names:F</infon>
      <infon key="lpage">714</infon>
      <infon key="name_6">surname:Cui;given-names:Y</infon>
      <infon key="name_5">surname:Wang;given-names:Q</infon>
      <infon key="name_4">surname:Shi;given-names:Z</infon>
      <offset>34908</offset>
      <text>Efficient RNA/Cas9-mediated genome editing in Xenopus tropicalis</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Lawson;given-names:ND</infon>
      <infon key="name_2">surname:Zhu;given-names:LJ</infon>
      <infon key="name_1">surname:Meng;given-names:X</infon>
      <infon key="name_0">surname:Gupta;given-names:A</infon>
      <infon key="fpage">381</infon>
      <infon key="pub-id_pmid">20843781</infon>
      <infon key="year">2011</infon>
      <infon key="source">Nucleic Acids Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">39</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">392</infon>
      <infon key="name_4">surname:Wolfe;given-names:SA</infon>
      <offset>34973</offset>
      <text>Zinc finger protein-dependent and -independent contributions to the in vivo off-target activity of zinc finger nucleases</text>
    </passage>
    <passage>
      <infon key="volume">39</infon>
      <infon key="name_2">surname:Arnold;given-names:CR</infon>
      <infon key="name_1">surname:Strawn;given-names:K</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Gwo;given-names:JC</infon>
      <infon key="fpage">353</infon>
      <infon key="pub-id_pmid">16727215</infon>
      <infon key="year">1993</infon>
      <infon key="source">Theriogenology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">361</infon>
      <offset>35094</offset>
      <text>Induced ovulation in Atlantic croaker (Sciaenidae) using hCG and an LHRH analog: A preliminary study</text>
      <annotation id="371">
        <infon key="identifier">29154</infon>
        <infon key="type">Species</infon>
        <location offset="35115" length="16"/>
        <text>Atlantic croaker</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">2</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hahn;given-names:ME</infon>
      <infon key="fpage">395</infon>
      <infon key="year">1998</infon>
      <infon key="source">Reviews in Toxicology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">443</infon>
      <offset>35195</offset>
      <text>Mecahnisms of innate and acquired resistance to dioxin-like compounds</text>
      <annotation id="373">
        <infon key="identifier">MESH:D004147</infon>
        <infon key="type">Chemical</infon>
        <location offset="35243" length="6"/>
        <text>dioxin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Perera;given-names:SA</infon>
      <infon key="volume">94</infon>
      <infon key="name_2">surname:Shapiro;given-names:MA</infon>
      <infon key="name_1">surname:Karchner;given-names:SI</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hahn;given-names:ME</infon>
      <infon key="fpage">13743</infon>
      <infon key="pub-id_pmid">9391097</infon>
      <infon key="year">1997</infon>
      <infon key="source">Proc Natl Acad Sci U S A</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">13748</infon>
      <offset>35265</offset>
      <text>Molecular evolution of two vertebrate aryl hydrocarbon (dioxin) receptors (AHR1 and AHR2) and the PAS family</text>
      <annotation id="377">
        <infon key="identifier">105937232</infon>
        <infon key="type">Gene</infon>
        <location offset="35340" length="4"/>
        <text>AHR1</text>
      </annotation>
      <annotation id="378">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="35349" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="379">
        <infon key="identifier">MESH:D011478</infon>
        <infon key="type">Chemical</infon>
        <location offset="35363" length="3"/>
        <text>PAS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Yokotani;given-names:N</infon>
      <infon key="name_2">surname:Sakuma;given-names:T</infon>
      <infon key="name_1">surname:Sakamoto;given-names:K</infon>
      <infon key="name_0">surname:Hayashi;given-names:T</infon>
      <infon key="fpage">115</infon>
      <infon key="pub-id_pmid">24329771</infon>
      <infon key="year">2014</infon>
      <infon key="source">Dev Growth Differ</infon>
      <infon key="type">ref</infon>
      <infon key="volume">56</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Takeuchi;given-names:T</infon>
      <infon key="name_7">surname:Yamamoto;given-names:T</infon>
      <infon key="lpage">121</infon>
      <infon key="name_6">surname:Agata;given-names:K</infon>
      <infon key="name_5">surname:Kawaguchi;given-names:E</infon>
      <infon key="name_4">surname:Inoue;given-names:T</infon>
      <offset>35374</offset>
      <text>Transcription activator-like effector nucleases efficiently disrupt the target gene in Iberian ribbed newts (Pleurodeles waltl), an experimental model animal for regeneration</text>
      <annotation id="382">
        <infon key="identifier">8319</infon>
        <infon key="type">Species</infon>
        <location offset="35461" length="20"/>
        <text>Iberian ribbed newts</text>
      </annotation>
      <annotation id="383">
        <infon key="identifier">8319</infon>
        <infon key="type">Species</infon>
        <location offset="35483" length="17"/>
        <text>Pleurodeles waltl</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Yamamoto;given-names:T</infon>
      <infon key="volume">56</infon>
      <infon key="name_2">surname:Sakamoto;given-names:N</infon>
      <infon key="name_1">surname:Sakuma;given-names:T</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hosoi;given-names:S</infon>
      <infon key="fpage">92</infon>
      <infon key="pub-id_pmid">24262038</infon>
      <infon key="year">2014</infon>
      <infon key="source">Dev Growth Differ</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">97</infon>
      <offset>35549</offset>
      <text>Targeted mutagenesis in sea urchin embryos using TALENs</text>
      <annotation id="385">
        <infon key="identifier">7656</infon>
        <infon key="type">Species</infon>
        <location offset="35573" length="10"/>
        <text>sea urchin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Maeder;given-names:ML</infon>
      <infon key="name_2">surname:Reyon;given-names:D</infon>
      <infon key="name_1">surname:Fu;given-names:Y</infon>
      <infon key="name_0">surname:Hwang;given-names:WY</infon>
      <infon key="fpage">227</infon>
      <infon key="pub-id_pmid">23360964</infon>
      <infon key="year">2013</infon>
      <infon key="source">Nat Biotechnol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">31</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Joung;given-names:JK</infon>
      <infon key="name_7">surname:Yeh;given-names:JR</infon>
      <infon key="lpage">229</infon>
      <infon key="name_6">surname:Peterson;given-names:RT</infon>
      <infon key="name_5">surname:Sander;given-names:JD</infon>
      <infon key="name_4">surname:Tsai;given-names:SQ</infon>
      <offset>35605</offset>
      <text>Efficient genome editing in zebrafish using a CRISPR-Cas system</text>
      <annotation id="387">
        <infon key="identifier">7955</infon>
        <infon key="type">Species</infon>
        <location offset="35633" length="9"/>
        <text>zebrafish</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">917</infon>
      <infon key="name_2">surname:Amaya;given-names:E</infon>
      <infon key="name_1">surname:Kroll;given-names:KL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Ishibashi;given-names:S</infon>
      <infon key="fpage">185</infon>
      <infon key="pub-id_pmid">22956089</infon>
      <infon key="year">2012</infon>
      <infon key="source">Methods Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">203</infon>
      <offset>35669</offset>
      <text>Generating transgenic frog embryos by restriction enzyme mediated integration (REMI)</text>
    </passage>
    <passage>
      <infon key="volume">110</infon>
      <infon key="name_2">surname:Chen;given-names:W</infon>
      <infon key="name_1">surname:Wente;given-names:SR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Jao;given-names:LE</infon>
      <infon key="fpage">13904</infon>
      <infon key="pub-id_pmid">23918387</infon>
      <infon key="year">2013</infon>
      <infon key="source">Proc Natl Acad Sci U S A</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">13909</infon>
      <offset>35754</offset>
      <text>Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system</text>
      <annotation id="389">
        <infon key="identifier">7955</infon>
        <infon key="type">Species</infon>
        <location offset="35784" length="9"/>
        <text>zebrafish</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hahn;given-names:ME</infon>
      <infon key="name_2">surname:Woodin;given-names:BR</infon>
      <infon key="name_1">surname:Jenny;given-names:MJ</infon>
      <infon key="name_0">surname:Jonsson;given-names:ME</infon>
      <infon key="fpage">180</infon>
      <infon key="pub-id_pmid">17686920</infon>
      <infon key="year">2007</infon>
      <infon key="source">Toxicol Sci</infon>
      <infon key="type">ref</infon>
      <infon key="volume">100</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">193</infon>
      <infon key="name_4">surname:Stegeman;given-names:JJ</infon>
      <offset>35840</offset>
      <text>Role of AHR2 in the expression of novel cytochrome P450 1 family genes, cell cycle genes, and morphological defects in developing zebra fish exposed to 3,3',4,4',5-pentachlorobiphenyl or 2,3,7,8-tetrachlorodibenzo-p-dioxin</text>
      <annotation id="395">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="35848" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="396">
        <infon key="identifier">7955</infon>
        <infon key="type">Species</infon>
        <location offset="35970" length="10"/>
        <text>zebra fish</text>
      </annotation>
      <annotation id="397">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="35860" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="398">
        <infon key="identifier">MESH:D000072317</infon>
        <infon key="type">Chemical</infon>
        <location offset="36027" length="35"/>
        <text>2,3,7,8-tetrachlorodibenzo-p-dioxin</text>
      </annotation>
      <annotation id="399">
        <infon key="identifier">MESH:C023035</infon>
        <infon key="type">Chemical</infon>
        <location offset="35992" length="31"/>
        <text>3,3',4,4',5-pentachlorobiphenyl</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">274</infon>
      <infon key="name_2">surname:Hahn;given-names:ME</infon>
      <infon key="name_1">surname:Powell;given-names:WH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Karchner;given-names:SI</infon>
      <infon key="fpage">33814</infon>
      <infon key="pub-id_pmid">10559277</infon>
      <infon key="year">1999</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">33824</infon>
      <offset>36063</offset>
      <text>Identification and functional characterization of two highly divergent aryl hydrocarbon receptors (AHR1 and AHR2) in the teleost Fundulus heteroclitus Evidence for a novel subfamily of ligand-binding basic helix loop helix-Per-ARNT-Sim (bHLH-PAS) factors</text>
      <annotation id="403">
        <infon key="identifier">105937232</infon>
        <infon key="type">Gene</infon>
        <location offset="36162" length="4"/>
        <text>AHR1</text>
      </annotation>
      <annotation id="404">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="36171" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="405">
        <infon key="type">Disease</infon>
        <location offset="36184" length="29"/>
        <text>teleost Fundulus heteroclitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Yamada;given-names:L</infon>
      <infon key="name_2">surname:Sakuma;given-names:T</infon>
      <infon key="name_1">surname:Ochiai;given-names:H</infon>
      <infon key="name_0">surname:Kawai;given-names:N</infon>
      <infon key="fpage">535</infon>
      <infon key="pub-id_pmid">22640377</infon>
      <infon key="year">2012</infon>
      <infon key="source">Dev Growth Differ</infon>
      <infon key="type">ref</infon>
      <infon key="volume">54</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">545</infon>
      <infon key="name_6">surname:Sasakura;given-names:Y</infon>
      <infon key="name_5">surname:Yamamoto;given-names:T</infon>
      <infon key="name_4">surname:Sawada;given-names:H</infon>
      <offset>36318</offset>
      <text>Efficient targeted mutagenesis of the chordate Ciona intestinalis genome with zinc-finger nucleases</text>
      <annotation id="407">
        <infon key="identifier">7719</infon>
        <infon key="type">Species</infon>
        <location offset="36365" length="18"/>
        <text>Ciona intestinalis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">15</infon>
      <infon key="name_1">surname:Kim;given-names:JS</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kim;given-names:H</infon>
      <infon key="fpage">321</infon>
      <infon key="pub-id_pmid">24690881</infon>
      <infon key="year">2014</infon>
      <infon key="source">Nat Rev Genet</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">334</infon>
      <offset>36418</offset>
      <text>A guide to genome engineering with programmable nucleases</text>
    </passage>
    <passage>
      <infon key="volume">7</infon>
      <infon key="name_2">surname:Carroll;given-names:D</infon>
      <infon key="name_1">surname:Lee;given-names:HJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kim;given-names:JS</infon>
      <infon key="fpage">91</infon>
      <infon key="pub-id_pmid">20111032</infon>
      <infon key="year">2010</infon>
      <infon key="source">Nat Methods</infon>
      <infon key="type">ref</infon>
      <offset>36476</offset>
      <text>Genome editing with modularly assembled zinc-finger nucleases</text>
    </passage>
    <passage>
      <infon key="volume">227</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Laemmli;given-names:UK</infon>
      <infon key="fpage">680</infon>
      <infon key="pub-id_pmid">5432063</infon>
      <infon key="year">1970</infon>
      <infon key="source">Nature</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">685</infon>
      <offset>36538</offset>
      <text>Cleavage of structural proteins during the assembly of the head of bacteriophage T4</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Cao;given-names:Y</infon>
      <infon key="name_2">surname:Liu;given-names:Y</infon>
      <infon key="name_1">surname:Guo;given-names:X</infon>
      <infon key="name_0">surname:Lei;given-names:Y</infon>
      <infon key="fpage">17484</infon>
      <infon key="pub-id_pmid">23045671</infon>
      <infon key="year">2012</infon>
      <infon key="source">Proc Natl Acad Sci U S A</infon>
      <infon key="type">ref</infon>
      <infon key="volume">109</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Zhao;given-names:H</infon>
      <infon key="name_8">surname:Chen;given-names:Y</infon>
      <infon key="name_7">surname:Dawid;given-names:IB</infon>
      <infon key="lpage">17489</infon>
      <infon key="name_6">surname:Cheng;given-names:CH</infon>
      <infon key="name_5">surname:Chen;given-names:X</infon>
      <infon key="name_4">surname:Deng;given-names:Y</infon>
      <offset>36622</offset>
      <text>Efficient targeted gene disruption in Xenopus embryos using engineered transcription activator-like effector nucleases (TALENs)</text>
      <annotation id="409">
        <infon key="identifier">8364</infon>
        <infon key="type">Species</infon>
        <location offset="36660" length="7"/>
        <text>Xenopus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Fang;given-names:L</infon>
      <infon key="name_2">surname:Zhao;given-names:J</infon>
      <infon key="name_1">surname:Yang;given-names:H</infon>
      <infon key="name_0">surname:Li;given-names:M</infon>
      <infon key="fpage">591</infon>
      <infon key="pub-id_pmid">24709635</infon>
      <infon key="year">2014</infon>
      <infon key="source">Genetics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">197</infon>
      <infon key="name_10">surname:Wang;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Zhou;given-names:L</infon>
      <infon key="name_8">surname:Jiang;given-names:D</infon>
      <infon key="name_7">surname:Zhang;given-names:X</infon>
      <infon key="lpage">599</infon>
      <infon key="name_6">surname:Sun;given-names:Y</infon>
      <infon key="name_5">surname:Li;given-names:M</infon>
      <infon key="name_4">surname:Shi;given-names:H</infon>
      <offset>36750</offset>
      <text>Efficient and Heritable Gene Targeting in Tilapia by CRISPR/Cas9</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Sun;given-names:YL</infon>
      <infon key="name_2">surname:Li;given-names:MR</infon>
      <infon key="name_1">surname:Yang;given-names:HH</infon>
      <infon key="name_0">surname:Li;given-names:MH</infon>
      <infon key="fpage">4814</infon>
      <infon key="pub-id_pmid">24105480</infon>
      <infon key="year">2013</infon>
      <infon key="source">Endocrinology</infon>
      <infon key="type">ref</infon>
      <infon key="volume">154</infon>
      <infon key="name_10">surname:Wang;given-names:DS</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Zhou;given-names:LY</infon>
      <infon key="name_8">surname:Sun;given-names:LN</infon>
      <infon key="name_7">surname:Shi;given-names:HJ</infon>
      <infon key="lpage">4825</infon>
      <infon key="name_6">surname:Wang;given-names:TR</infon>
      <infon key="name_5">surname:Xie;given-names:QP</infon>
      <infon key="name_4">surname:Jiang;given-names:XL</infon>
      <offset>36815</offset>
      <text>Antagonistic roles of Dmrt1 and Foxl2 in sex differentiation via estrogen production in tilapia as demonstrated by TALENs</text>
      <annotation id="413">
        <infon key="identifier">105938153</infon>
        <infon key="type">Gene</infon>
        <location offset="36837" length="5"/>
        <text>Dmrt1</text>
      </annotation>
      <annotation id="414">
        <infon key="identifier">105926779</infon>
        <infon key="type">Gene</infon>
        <location offset="36847" length="5"/>
        <text>Foxl2</text>
      </annotation>
      <annotation id="415">
        <infon key="type">Disease</infon>
        <location offset="36903" length="7"/>
        <text>tilapia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Deshmukh;given-names:H</infon>
      <infon key="name_2">surname:Brown;given-names:MT</infon>
      <infon key="name_1">surname:Cradick;given-names:TJ</infon>
      <infon key="name_0">surname:Lin;given-names:Y</infon>
      <infon key="fpage">7473</infon>
      <infon key="pub-id_pmid">24838573</infon>
      <infon key="year">2014</infon>
      <infon key="source">Nucleic Acids Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">42</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Bao;given-names:G</infon>
      <infon key="name_8">surname:Stewart;given-names:FJ</infon>
      <infon key="name_7">surname:Vertino;given-names:PM</infon>
      <infon key="lpage">7485</infon>
      <infon key="name_6">surname:Wile;given-names:BM</infon>
      <infon key="name_5">surname:Sarode;given-names:N</infon>
      <infon key="name_4">surname:Ranjan;given-names:P</infon>
      <offset>36937</offset>
      <text>CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences</text>
    </passage>
    <passage>
      <infon key="name_3">surname:MacLatchy;given-names:D</infon>
      <infon key="volume">154</infon>
      <infon key="name_2">surname:Rutherford;given-names:R</infon>
      <infon key="name_1">surname:Van Der Kraak;given-names:GJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Lister;given-names:AL</infon>
      <infon key="fpage">278</infon>
      <infon key="pub-id_pmid">21771666</infon>
      <infon key="year">2011</infon>
      <infon key="source">Comp Biochem Physiol C Toxicol Pharmacol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">287</infon>
      <offset>37054</offset>
      <text>Fundulus heteroclitus: ovarian reproductive physiology and the impact of environmental contaminants</text>
      <annotation id="417">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="37054" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hu;given-names:W</infon>
      <infon key="name_2">surname:Lei;given-names:Y</infon>
      <infon key="name_1">surname:Luo;given-names:D</infon>
      <infon key="name_0">surname:Liu;given-names:Y</infon>
      <infon key="fpage">58</infon>
      <infon key="pub-id_pmid">24556556</infon>
      <infon key="year">2014</infon>
      <infon key="source">Methods</infon>
      <infon key="type">ref</infon>
      <infon key="volume">69</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">66</infon>
      <infon key="name_5">surname:Cheng;given-names:CH</infon>
      <infon key="name_4">surname:Zhao;given-names:H</infon>
      <offset>37154</offset>
      <text>A highly effective TALEN-mediated approach for targeted gene disruption in Xenopus tropicalis and zebrafish</text>
      <annotation id="419">
        <infon key="identifier">8364</infon>
        <infon key="type">Species</infon>
        <location offset="37229" length="18"/>
        <text>Xenopus tropicalis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ralston;given-names:EJ</infon>
      <infon key="name_2">surname:Lin;given-names:S</infon>
      <infon key="name_1">surname:Pickle;given-names:CS</infon>
      <infon key="name_0">surname:Lo;given-names:TW</infon>
      <infon key="fpage">331</infon>
      <infon key="pub-id_pmid">23934893</infon>
      <infon key="year">2013</infon>
      <infon key="source">Genetics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">195</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Meyer;given-names:BJ</infon>
      <infon key="name_7">surname:Doudna;given-names:JA</infon>
      <infon key="lpage">348</infon>
      <infon key="name_6">surname:Bian;given-names:Q</infon>
      <infon key="name_5">surname:Schartner;given-names:CM</infon>
      <infon key="name_4">surname:Gurling;given-names:M</infon>
      <offset>37262</offset>
      <text>Precise and heritable genome editing in evolutionarily diverse nematodes using TALENs and CRISPR/Cas9 to engineer insertions and deletions</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Liu;given-names:Y</infon>
      <infon key="name_2">surname:Wang;given-names:F</infon>
      <infon key="name_1">surname:Zhang;given-names:S</infon>
      <infon key="name_0">surname:Ma;given-names:S</infon>
      <infon key="fpage">e45035</infon>
      <infon key="pub-id_pmid">23028749</infon>
      <infon key="year">2012</infon>
      <infon key="source">PLoS One</infon>
      <infon key="type">ref</infon>
      <infon key="volume">7</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Xia;given-names:Q</infon>
      <infon key="name_7">surname:Zhao;given-names:P</infon>
      <infon key="name_6">surname:Lin;given-names:Y</infon>
      <infon key="name_5">surname:Liu;given-names:C</infon>
      <infon key="name_4">surname:Xu;given-names:H</infon>
      <offset>37401</offset>
      <text>Highly efficient and specific genome editing in silkworm using custom TALENs</text>
      <annotation id="421">
        <infon key="identifier">7091</infon>
        <infon key="type">Species</infon>
        <location offset="37449" length="8"/>
        <text>silkworm</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Fleming;given-names:CR</infon>
      <infon key="name_2">surname:Jenny;given-names:MJ</infon>
      <infon key="name_1">surname:Clark;given-names:BW</infon>
      <infon key="name_0">surname:Matson;given-names:CW</infon>
      <infon key="fpage">289</infon>
      <infon key="pub-id_pmid">18378331</infon>
      <infon key="year">2008</infon>
      <infon key="source">Aquat Toxicol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">87</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">295</infon>
      <infon key="name_5">surname:Di Giulio;given-names:RT</infon>
      <infon key="name_4">surname:Hahn;given-names:ME</infon>
      <offset>37478</offset>
      <text>Development of the morpholino gene knockdown technique in Fundulus heteroclitus: a tool for studying molecular mechanisms in an established environmental model</text>
      <annotation id="423">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="37536" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">649</infon>
      <infon key="name_1">surname:Amacher;given-names:SL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McCammon;given-names:JM</infon>
      <infon key="fpage">281</infon>
      <infon key="pub-id_pmid">20680842</infon>
      <infon key="year">2010</infon>
      <infon key="source">Methods Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">298</infon>
      <offset>37638</offset>
      <text>Using zinc finger nucleases for efficient and heritable gene disruption in zebrafish</text>
    </passage>
    <passage>
      <infon key="volume">770</infon>
      <infon key="name_2">surname:Amacher;given-names:SL</infon>
      <infon key="name_1">surname:Doyon;given-names:Y</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McCammon;given-names:JM</infon>
      <infon key="fpage">505</infon>
      <infon key="pub-id_pmid">21805278</infon>
      <infon key="year">2011</infon>
      <infon key="source">Methods Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">527</infon>
      <offset>37723</offset>
      <text>Inducing high rates of targeted mutagenesis in zebrafish using zinc finger nucleases (ZFNs)</text>
      <annotation id="425">
        <infon key="identifier">7955</infon>
        <infon key="type">Species</infon>
        <location offset="37770" length="9"/>
        <text>zebrafish</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Nacci;given-names:DE</infon>
      <infon key="volume">15</infon>
      <infon key="name_2">surname:Jackson;given-names:SA</infon>
      <infon key="name_1">surname:Bagley;given-names:MJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McMillan;given-names:AM</infon>
      <infon key="fpage">539</infon>
      <infon key="pub-id_pmid">16988885</infon>
      <infon key="year">2006</infon>
      <infon key="source">Ecotoxicology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">548</infon>
      <offset>37815</offset>
      <text>Genetic diversity and structure of an estuarine fish (Fundulus heteroclitus) indigenous to sites associated with a highly contaminated urban harbor</text>
      <annotation id="427">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="37869" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Wolfe;given-names:SA</infon>
      <infon key="name_2">surname:Taylor;given-names:OR</infon>
      <infon key="name_1">surname:Beaver;given-names:LE</infon>
      <infon key="name_0">surname:Merlin;given-names:C</infon>
      <infon key="fpage">159</infon>
      <infon key="pub-id_pmid">23009861</infon>
      <infon key="year">2013</infon>
      <infon key="source">Genome Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">23</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">168</infon>
      <infon key="name_4">surname:Reppert;given-names:SM</infon>
      <offset>37963</offset>
      <text>Efficient targeted mutagenesis in the monarch butterfly using zinc-finger nucleases</text>
      <annotation id="429">
        <infon key="identifier">13037</infon>
        <infon key="type">Species</infon>
        <location offset="38001" length="17"/>
        <text>monarch butterfly</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">68</infon>
      <infon key="name_2">surname:Di Giulio;given-names:RT</infon>
      <infon key="name_1">surname:Nacci;given-names:DE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Meyer;given-names:JN</infon>
      <infon key="fpage">69</infon>
      <infon key="pub-id_pmid">12075112</infon>
      <infon key="year">2002</infon>
      <infon key="source">Toxicol Sci</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">81</infon>
      <offset>38047</offset>
      <text>Cytochrome P4501A (CYP1A) in killifish (Fundulus heteroclitus): Heritability of altered expression and relationship to survival in contaminated sediments</text>
      <annotation id="435">
        <infon key="identifier">105930482</infon>
        <infon key="type">Gene</infon>
        <location offset="38066" length="5"/>
        <text>CYP1A</text>
      </annotation>
      <annotation id="436">
        <infon key="identifier">105930482</infon>
        <infon key="type">Gene</infon>
        <location offset="38047" length="17"/>
        <text>Cytochrome P4501A</text>
      </annotation>
      <annotation id="437">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="38076" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="438">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="38087" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
      <annotation id="439">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="38135" length="10"/>
        <text>expression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Jayaraman;given-names:S</infon>
      <infon key="name_2">surname:Champlin;given-names:D</infon>
      <infon key="name_1">surname:Coiro;given-names:L</infon>
      <infon key="name_0">surname:Nacci;given-names:D</infon>
      <infon key="fpage">9</infon>
      <infon key="year">1999</infon>
      <infon key="source">Mar Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">134</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Cooper;given-names:KR</infon>
      <infon key="name_7">surname:Specker;given-names:JL</infon>
      <infon key="lpage">17</infon>
      <infon key="name_6">surname:Munns;given-names:WR</infon>
      <infon key="name_5">surname:Gleason;given-names:TR</infon>
      <infon key="name_4">surname:McKinney;given-names:R</infon>
      <offset>38201</offset>
      <text>Adaptations of wild populations of the estuarine fish Fundulus heteroclitus to persistent environmental contaminants</text>
      <annotation id="441">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="38255" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">33</infon>
      <infon key="name_2">surname:Jayaraman;given-names:S</infon>
      <infon key="name_1">surname:Champlin;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Nacci;given-names:DE</infon>
      <infon key="fpage">853</infon>
      <infon key="year">2010</infon>
      <infon key="source">Estuar Coast</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">864</infon>
      <offset>38318</offset>
      <text>Adaptation of the Estuarine Fish Fundulus heteroclitus (Atlantic Killifish) to Polychlorinated Biphenyls (PCBs)</text>
      <annotation id="446">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="38374" length="18"/>
        <text>Atlantic Killifish</text>
      </annotation>
      <annotation id="447">
        <infon key="identifier">MESH:D011078</infon>
        <infon key="type">Chemical</infon>
        <location offset="38397" length="25"/>
        <text>Polychlorinated Biphenyls</text>
      </annotation>
      <annotation id="448">
        <infon key="identifier">MESH:D011078</infon>
        <infon key="type">Chemical</infon>
        <location offset="38424" length="4"/>
        <text>PCBs</text>
      </annotation>
      <annotation id="449">
        <infon key="identifier">MESH:D005393</infon>
        <infon key="type">Disease</infon>
        <location offset="38346" length="26"/>
        <text>Fish Fundulus heteroclitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Yaoita;given-names:Y</infon>
      <infon key="volume">54</infon>
      <infon key="name_2">surname:Takase;given-names:M</infon>
      <infon key="name_1">surname:Nakajima;given-names:T</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Nakajima;given-names:K</infon>
      <infon key="fpage">777</infon>
      <infon key="pub-id_pmid">23106502</infon>
      <infon key="year">2012</infon>
      <infon key="source">Dev Growth Differ</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">784</infon>
      <offset>38430</offset>
      <text>Generation of albino Xenopus tropicalis using zinc-finger nucleases</text>
      <annotation id="451">
        <infon key="identifier">8364</infon>
        <infon key="type">Species</infon>
        <location offset="38451" length="18"/>
        <text>Xenopus tropicalis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">2</infon>
      <infon key="name_1">surname:Yaoita;given-names:Y</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Nakajima;given-names:K</infon>
      <infon key="fpage">1364</infon>
      <infon key="pub-id_pmid">24285709</infon>
      <infon key="year">2013</infon>
      <infon key="source">Biol Open</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1370</infon>
      <offset>38498</offset>
      <text>Comparison of TALEN scaffolds in Xenopus tropicalis</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Oomen-Hajagos;given-names:J</infon>
      <infon key="name_2">surname:Fisher;given-names:M</infon>
      <infon key="name_1">surname:Fish;given-names:MB</infon>
      <infon key="name_0">surname:Nakayama;given-names:T</infon>
      <infon key="fpage">835</infon>
      <infon key="pub-id_pmid">24123613</infon>
      <infon key="year">2013</infon>
      <infon key="source">Genesis</infon>
      <infon key="type">ref</infon>
      <infon key="volume">51</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">843</infon>
      <infon key="name_5">surname:Grainger;given-names:RM</infon>
      <infon key="name_4">surname:Thomsen;given-names:GH</infon>
      <offset>38550</offset>
      <text>Simple and efficient CRISPR/Cas9-mediated targeted mutagenesis in Xenopus tropicalis</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Dzioba;given-names:M</infon>
      <infon key="volume">6</infon>
      <infon key="name_2">surname:Coutermarsh;given-names:BA</infon>
      <infon key="name_1">surname:Shaw;given-names:JR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Notch;given-names:EG</infon>
      <infon key="fpage">e29462</infon>
      <infon key="pub-id_pmid">22216285</infon>
      <infon key="year">2011</infon>
      <infon key="source">PLoS One</infon>
      <infon key="type">ref</infon>
      <infon key="name_4">surname:Stanton;given-names:BA</infon>
      <offset>38635</offset>
      <text>Morpholino gene knockdown in adult Fundulus heteroclitus: role of SGK1 in seawater acclimation</text>
      <annotation id="454">
        <infon key="identifier">105930542</infon>
        <infon key="type">Gene</infon>
        <location offset="38701" length="4"/>
        <text>SGK1</text>
      </annotation>
      <annotation id="455">
        <infon key="identifier">MESH:C538052</infon>
        <infon key="type">Disease</infon>
        <location offset="38664" length="27"/>
        <text>adult Fundulus heteroclitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Nishikawa;given-names:M</infon>
      <infon key="name_2">surname:Suzuki;given-names:K</infon>
      <infon key="name_1">surname:Fujita;given-names:K</infon>
      <infon key="name_0">surname:Ochiai;given-names:H</infon>
      <infon key="fpage">875</infon>
      <infon key="pub-id_pmid">20604805</infon>
      <infon key="year">2010</infon>
      <infon key="source">Genes Cells</infon>
      <infon key="type">ref</infon>
      <infon key="volume">15</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">885</infon>
      <infon key="name_6">surname:Yamamoto;given-names:T</infon>
      <infon key="name_5">surname:Sakamoto;given-names:N</infon>
      <infon key="name_4">surname:Shibata;given-names:T</infon>
      <offset>38730</offset>
      <text>Targeted mutagenesis in the sea urchin embryo using zinc-finger nucleases</text>
      <annotation id="457">
        <infon key="identifier">7656</infon>
        <infon key="type">Species</infon>
        <location offset="38758" length="10"/>
        <text>sea urchin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Panetta;given-names:MR</infon>
      <infon key="name_2">surname:Campbell;given-names:JM</infon>
      <infon key="name_1">surname:Clark;given-names:KJ</infon>
      <infon key="name_0">surname:Peng;given-names:Y</infon>
      <infon key="fpage">4042</infon>
      <infon key="pub-id_pmid">25336735</infon>
      <infon key="year">2014</infon>
      <infon key="source">Development</infon>
      <infon key="type">ref</infon>
      <infon key="volume">141</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">4054</infon>
      <infon key="name_5">surname:Ekker;given-names:SC</infon>
      <infon key="name_4">surname:Guo;given-names:Y</infon>
      <offset>38804</offset>
      <text>Making designer mutants in model organisms</text>
    </passage>
    <passage>
      <infon key="volume">13</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Porteus;given-names:MH</infon>
      <infon key="fpage">438</infon>
      <infon key="pub-id_pmid">16169774</infon>
      <infon key="year">2006</infon>
      <infon key="source">Mol Ther</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">446</infon>
      <offset>38847</offset>
      <text>Mammalian gene targeting with designed zinc finger nucleases</text>
      <annotation id="459">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="38847" length="9"/>
        <text>Mammalian</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">300</infon>
      <infon key="name_1">surname:Baltimore;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Porteus;given-names:MH</infon>
      <infon key="fpage">763</infon>
      <infon key="pub-id_pmid">12730593</infon>
      <infon key="year">2003</infon>
      <infon key="source">Science</infon>
      <infon key="type">ref</infon>
      <offset>38908</offset>
      <text>Chimeric nucleases stimulate gene targeting in human cells</text>
      <annotation id="461">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="38955" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hahn;given-names:ME</infon>
      <infon key="volume">57</infon>
      <infon key="name_2">surname:Bello;given-names:SM</infon>
      <infon key="name_1">surname:Bright;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Powell;given-names:WH</infon>
      <infon key="fpage">229</infon>
      <infon key="pub-id_pmid">11006353</infon>
      <infon key="year">2000</infon>
      <infon key="source">Toxicol Sci</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">239</infon>
      <offset>38967</offset>
      <text>Developmental and tissue-specific expression of AHR1, AHR2, and ARNT2 in dioxin-sensitive and -resistant populations of the marine fish Fundulus heteroclitus</text>
      <annotation id="467">
        <infon key="identifier">105937232</infon>
        <infon key="type">Gene</infon>
        <location offset="39015" length="4"/>
        <text>AHR1</text>
      </annotation>
      <annotation id="468">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="39021" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="469">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="39001" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="470">
        <infon key="type">Disease</infon>
        <location offset="39103" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
      <annotation id="471">
        <infon key="identifier">MESH:D004147</infon>
        <infon key="type">Chemical</infon>
        <location offset="39040" length="6"/>
        <text>dioxin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Dong;given-names:W</infon>
      <infon key="name_2">surname:Carney;given-names:SA</infon>
      <infon key="name_1">surname:Teraoka;given-names:H</infon>
      <infon key="name_0">surname:Prasch;given-names:AL</infon>
      <infon key="fpage">138</infon>
      <infon key="pub-id_pmid">12883077</infon>
      <infon key="year">2003</infon>
      <infon key="source">Toxicol Sci</infon>
      <infon key="type">ref</infon>
      <infon key="volume">76</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Peterson;given-names:RE</infon>
      <infon key="lpage">150</infon>
      <infon key="name_6">surname:Heideman;given-names:W</infon>
      <infon key="name_5">surname:Stegeman;given-names:JJ</infon>
      <infon key="name_4">surname:Hiraga;given-names:T</infon>
      <offset>39125</offset>
      <text>Aryl hydrocarbon receptor 2 mediates 2,3,7,8-tetrachlorodibenzo-p-dioxin developmental toxicity in zebrafish</text>
      <annotation id="475">
        <infon key="identifier">30517</infon>
        <infon key="type">Gene</infon>
        <location offset="39125" length="27"/>
        <text>Aryl hydrocarbon receptor 2</text>
      </annotation>
      <annotation id="476">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="39212" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="477">
        <infon key="identifier">MESH:D000072317</infon>
        <infon key="type">Chemical</infon>
        <location offset="39162" length="35"/>
        <text>2,3,7,8-tetrachlorodibenzo-p-dioxin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Joung;given-names:JK</infon>
      <infon key="name_2">surname:Maeder;given-names:ML</infon>
      <infon key="name_1">surname:Connelly;given-names:JP</infon>
      <infon key="name_0">surname:Pruett-Miller;given-names:SM</infon>
      <infon key="fpage">707</infon>
      <infon key="pub-id_pmid">18334988</infon>
      <infon key="year">2008</infon>
      <infon key="source">Mol Ther</infon>
      <infon key="type">ref</infon>
      <infon key="volume">16</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">717</infon>
      <infon key="name_4">surname:Porteus;given-names:MH</infon>
      <offset>39234</offset>
      <text>Comparison of zinc finger nucleases for use in gene targeting in mammalian cells</text>
      <annotation id="479">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="39299" length="9"/>
        <text>mammalian</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:O'Connor;given-names:K</infon>
      <infon key="name_2">surname:D'Alessio;given-names:JM</infon>
      <infon key="name_1">surname:Shandilya;given-names:H</infon>
      <infon key="name_0">surname:Qiu;given-names:P</infon>
      <infon key="fpage">702</infon>
      <infon key="pub-id_pmid">15088388</infon>
      <infon key="year">2004</infon>
      <infon key="source">Biotechniques</infon>
      <infon key="type">ref</infon>
      <infon key="volume">36</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">707</infon>
      <infon key="name_5">surname:Gerard;given-names:GF</infon>
      <infon key="name_4">surname:Durocher;given-names:J</infon>
      <offset>39315</offset>
      <text>Mutation detection using Surveyor nuclease</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Evans;given-names:BR</infon>
      <infon key="name_2">surname:Franks;given-names:DG</infon>
      <infon key="name_1">surname:Karchner;given-names:SI</infon>
      <infon key="name_0">surname:Reitzel;given-names:AM</infon>
      <infon key="fpage">6</infon>
      <infon key="pub-id_pmid">24422594</infon>
      <infon key="year">2014</infon>
      <infon key="source">BMC Evol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">14</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Hahn;given-names:ME</infon>
      <infon key="name_6">surname:Vieira;given-names:VM</infon>
      <infon key="name_5">surname:Champlin;given-names:D</infon>
      <infon key="name_4">surname:Nacci;given-names:D</infon>
      <offset>39358</offset>
      <text>Genetic variation at aryl hydrocarbon receptor (AHR) loci in populations of Atlantic killifish (Fundulus heteroclitus) inhabiting polluted and reference habitats</text>
      <annotation id="482">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="39434" length="18"/>
        <text>Atlantic killifish</text>
      </annotation>
      <annotation id="483">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="39454" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Uchino;given-names:K</infon>
      <infon key="name_2">surname:Tamura;given-names:T</infon>
      <infon key="name_1">surname:Takasu;given-names:Y</infon>
      <infon key="name_0">surname:Sajwan;given-names:S</infon>
      <infon key="fpage">17</infon>
      <infon key="pub-id_pmid">23142190</infon>
      <infon key="year">2013</infon>
      <infon key="source">Insect Biochem Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">43</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">23</infon>
      <infon key="name_5">surname:Zurovec;given-names:M</infon>
      <infon key="name_4">surname:Sezutsu;given-names:H</infon>
      <offset>39520</offset>
      <text>Efficient disruption of endogenous Bombyx gene by TAL effector nucleases</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Cade;given-names:L</infon>
      <infon key="name_2">surname:Goodwin;given-names:MJ</infon>
      <infon key="name_1">surname:Dahlborg;given-names:EJ</infon>
      <infon key="name_0">surname:Sander;given-names:JD</infon>
      <infon key="pub-id_pmid">21151135</infon>
      <infon key="year">2011</infon>
      <infon key="source">Nat Methods</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Peterson;given-names:RT</infon>
      <infon key="name_21">surname:Yeh;given-names:JR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_22">surname:Joung;given-names:JK</infon>
      <infon key="lpage">69</infon>
      <infon key="fpage">67</infon>
      <infon key="volume">8</infon>
      <infon key="name_10">surname:Pierick;given-names:CJ</infon>
      <infon key="name_13">surname:Khayter;given-names:C</infon>
      <infon key="name_14">surname:Reyon;given-names:D</infon>
      <infon key="name_11">surname:Hoffman;given-names:E</infon>
      <infon key="name_12">surname:Maeder;given-names:ML</infon>
      <infon key="name_17">surname:Stupar;given-names:RM</infon>
      <infon key="name_18">surname:Giraldez;given-names:AJ</infon>
      <infon key="name_15">surname:Dobbs;given-names:D</infon>
      <infon key="name_9">surname:Qi;given-names:Y</infon>
      <infon key="name_16">surname:Langenau;given-names:DM</infon>
      <infon key="name_8">surname:Thibodeau-Beganny;given-names:S</infon>
      <infon key="name_7">surname:Blackburn;given-names:JS</infon>
      <infon key="name_6">surname:Curtin;given-names:SJ</infon>
      <infon key="name_19">surname:Voytas;given-names:DF</infon>
      <infon key="name_5">surname:Cifuentes;given-names:D</infon>
      <infon key="name_4">surname:Zhang;given-names:F</infon>
      <offset>39593</offset>
      <text>Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA)</text>
    </passage>
    <passage>
      <infon key="volume">32</infon>
      <infon key="name_1">surname:Joung;given-names:JK</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sander;given-names:JD</infon>
      <infon key="fpage">347</infon>
      <infon key="pub-id_pmid">24584096</infon>
      <infon key="year">2014</infon>
      <infon key="source">Nat Biotechnol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">355</infon>
      <offset>39678</offset>
      <text>CRISPR-Cas systems for editing, regulating and targeting genomes</text>
    </passage>
    <passage>
      <infon key="volume">217</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Schulte;given-names:PM</infon>
      <infon key="fpage">23</infon>
      <infon key="pub-id_pmid">24353201</infon>
      <infon key="year">2014</infon>
      <infon key="source">J Exp Biol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">34</infon>
      <offset>39743</offset>
      <text>What is environmental stress? Insights from fish living in a variable environment</text>
    </passage>
    <passage>
      <infon key="volume">51</infon>
      <infon key="name_2">surname:Fangue;given-names:NA</infon>
      <infon key="name_1">surname:Healy;given-names:TM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Schulte;given-names:PM</infon>
      <infon key="fpage">691</infon>
      <infon key="pub-id_pmid">21841184</infon>
      <infon key="year">2011</infon>
      <infon key="source">Integr Comp Biol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">702</infon>
      <offset>39825</offset>
      <text>Thermal performance curves, phenotypic plasticity, and the time scales of temperature exposure</text>
    </passage>
    <passage>
      <infon key="volume">23</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Scott;given-names:CT</infon>
      <infon key="fpage">915</infon>
      <infon key="pub-id_pmid">16082353</infon>
      <infon key="year">2005</infon>
      <infon key="source">Nat Biotechnol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">918</infon>
      <offset>39920</offset>
      <text>The zinc finger nuclease monopoly</text>
    </passage>
    <passage>
      <infon key="volume">22</infon>
      <infon key="name_1">surname:Brix;given-names:KV</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Scott;given-names:GR</infon>
      <infon key="fpage">3656</infon>
      <infon key="pub-id_pmid">24003453</infon>
      <infon key="year">2013</infon>
      <infon key="source">Mol Ecol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">3658</infon>
      <offset>39954</offset>
      <text>Evolution of salinity tolerance from transcriptome to physiological system</text>
    </passage>
    <passage>
      <infon key="volume">8</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Segal;given-names:DJ</infon>
      <infon key="fpage">53</infon>
      <infon key="pub-id_pmid">21191373</infon>
      <infon key="year">2011</infon>
      <infon key="source">Nat Methods</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">55</infon>
      <offset>40029</offset>
      <text>Zinc-finger nucleases transition to the CoDA</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Osanai-Futahashi;given-names:M</infon>
      <infon key="name_2">surname:Daimon;given-names:T</infon>
      <infon key="name_1">surname:Sajwan;given-names:S</infon>
      <infon key="name_0">surname:Takasu;given-names:Y</infon>
      <infon key="fpage">e73458</infon>
      <infon key="pub-id_pmid">24058473</infon>
      <infon key="year">2013</infon>
      <infon key="source">PLoS One</infon>
      <infon key="type">ref</infon>
      <infon key="volume">8</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Zurovec;given-names:M</infon>
      <infon key="name_6">surname:Tamura;given-names:T</infon>
      <infon key="name_5">surname:Sezutsu;given-names:H</infon>
      <infon key="name_4">surname:Uchino;given-names:K</infon>
      <offset>40074</offset>
      <text>Efficient TALEN construction for Bombyx mori gene targeting</text>
      <annotation id="485">
        <infon key="identifier">7091</infon>
        <infon key="type">Species</infon>
        <location offset="40107" length="11"/>
        <text>Bombyx mori</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Sasaki;given-names:H</infon>
      <infon key="name_2">surname:Sakuma;given-names:T</infon>
      <infon key="name_1">surname:Yoshida;given-names:K</infon>
      <infon key="name_0">surname:Treen;given-names:N</infon>
      <infon key="fpage">481</infon>
      <infon key="pub-id_pmid">24353063</infon>
      <infon key="year">2014</infon>
      <infon key="source">Development</infon>
      <infon key="type">ref</infon>
      <infon key="volume">141</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">487</infon>
      <infon key="name_6">surname:Sasakura;given-names:Y</infon>
      <infon key="name_5">surname:Yamamoto;given-names:T</infon>
      <infon key="name_4">surname:Kawai;given-names:N</infon>
      <offset>40134</offset>
      <text>Tissue-specific and ubiquitous gene knockouts by TALEN electroporation provide new approaches to investigating gene function in Ciona</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Zhang;given-names:HS</infon>
      <infon key="name_2">surname:Holmes;given-names:MC</infon>
      <infon key="name_1">surname:Rebar;given-names:EJ</infon>
      <infon key="name_0">surname:Urnov;given-names:FD</infon>
      <infon key="fpage">636</infon>
      <infon key="pub-id_pmid">20717154</infon>
      <infon key="year">2010</infon>
      <infon key="source">Nat Rev Genet</infon>
      <infon key="type">ref</infon>
      <infon key="volume">11</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">646</infon>
      <infon key="name_4">surname:Gregory;given-names:PD</infon>
      <offset>40268</offset>
      <text>Genome editing with engineered zinc finger nucleases</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Hinton;given-names:DE</infon>
      <infon key="name_2">surname:Di Giulio;given-names:RT</infon>
      <infon key="name_1">surname:Nacci;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Van Veld;given-names:PA</infon>
      <infon key="fpage">597</infon>
      <infon key="year">2008</infon>
      <infon key="source">The Toxicology of Fishes</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">644</infon>
      <offset>40321</offset>
      <text>Chemical Tolerance: Acclimation and adaptations to chemical stress</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Duan;given-names:J</infon>
      <infon key="name_2">surname:Xu;given-names:H</infon>
      <infon key="name_1">surname:Ma;given-names:S</infon>
      <infon key="name_0">surname:Wang;given-names:F</infon>
      <infon key="fpage">683</infon>
      <infon key="pub-id_pmid">24077893</infon>
      <infon key="year">2013</infon>
      <infon key="source">Mol Genet Genomics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">288</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Xia;given-names:Q</infon>
      <infon key="name_8">surname:Zhao;given-names:P</infon>
      <infon key="name_7">surname:Wang;given-names:X</infon>
      <infon key="lpage">690</infon>
      <infon key="name_6">surname:Liu;given-names:Y</infon>
      <infon key="name_5">surname:Ding;given-names:H</infon>
      <infon key="name_4">surname:Wang;given-names:Y</infon>
      <offset>40388</offset>
      <text>High efficiency system for construction and evaluation of customized TALENs for silkworm genome editing</text>
      <annotation id="487">
        <infon key="identifier">7091</infon>
        <infon key="type">Species</infon>
        <location offset="40468" length="8"/>
        <text>silkworm</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">543</infon>
      <infon key="name_1">surname:Hong;given-names:Y</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Wang;given-names:T</infon>
      <infon key="fpage">28</infon>
      <infon key="pub-id_pmid">24713411</infon>
      <infon key="year">2014</infon>
      <infon key="source">Gene</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">33</infon>
      <offset>40492</offset>
      <text>Direct gene disruption by TALENs in medaka embryos</text>
      <annotation id="489">
        <infon key="identifier">8090</infon>
        <infon key="type">Species</infon>
        <location offset="40528" length="6"/>
        <text>medaka</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Horch;given-names:HW</infon>
      <infon key="name_2">surname:Sakuma;given-names:T</infon>
      <infon key="name_1">surname:Ochiai;given-names:H</infon>
      <infon key="name_0">surname:Watanabe;given-names:T</infon>
      <infon key="fpage">1017</infon>
      <infon key="pub-id_pmid">22910363</infon>
      <infon key="year">2012</infon>
      <infon key="source">Nat Commun</infon>
      <infon key="type">ref</infon>
      <infon key="volume">3</infon>
      <infon key="name_10">surname:Mito;given-names:T</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Noji;given-names:S</infon>
      <infon key="name_8">surname:Yamamoto;given-names:T</infon>
      <infon key="name_7">surname:Ohuchi;given-names:H</infon>
      <infon key="name_6">surname:Bando;given-names:T</infon>
      <infon key="name_5">surname:Nakamura;given-names:T</infon>
      <infon key="name_4">surname:Hamaguchi;given-names:N</infon>
      <offset>40543</offset>
      <text>Non-transgenic genome modifications in a hemimetabolous insect using zinc-finger and TAL effector nucleases</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Wood;given-names:AL</infon>
      <infon key="name_2">surname:Graves;given-names:JS</infon>
      <infon key="name_1">surname:Hill;given-names:JE</infon>
      <infon key="name_0">surname:Watson;given-names:CA</infon>
      <infon key="fpage">143</infon>
      <infon key="pub-id_pmid">21798183</infon>
      <infon key="year">2009</infon>
      <infon key="source">Mar Genomics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">2</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">146</infon>
      <infon key="name_4">surname:Kilgore;given-names:KH</infon>
      <offset>40651</offset>
      <text>Use of a novel induced spawning technique for the first reported captive spawning of Tetraodon nigroviridis</text>
    </passage>
    <passage>
      <infon key="volume">64</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Whitehead;given-names:A</infon>
      <infon key="fpage">2070</infon>
      <infon key="pub-id_pmid">20100216</infon>
      <infon key="year">2010</infon>
      <infon key="source">Evolution</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2085</infon>
      <offset>40759</offset>
      <text>The evolutionary radiation of diverse osmotolerant physiologies in killifish (Fundulus sp.)</text>
      <annotation id="492">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="40826" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="493">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="40837" length="8"/>
        <text>Fundulus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Galvez;given-names:F</infon>
      <infon key="volume">215</infon>
      <infon key="name_2">surname:Zhang;given-names:S</infon>
      <infon key="name_1">surname:Roach;given-names:JL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Whitehead;given-names:A</infon>
      <infon key="fpage">1293</infon>
      <infon key="pub-id_pmid">22442367</infon>
      <infon key="year">2012</infon>
      <infon key="source">J Exp Biol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1305</infon>
      <offset>40851</offset>
      <text>Salinity- and population-dependent genome regulatory response during osmotic acclimation in the killifish (Fundulus heteroclitus) gill</text>
      <annotation id="496">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="40947" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="497">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="40958" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">552</infon>
      <infon key="name_1">surname:Waldman;given-names:JR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Wirgin;given-names:I</infon>
      <infon key="fpage">73</infon>
      <infon key="pub-id_pmid">15288543</infon>
      <infon key="year">2004</infon>
      <infon key="source">Mutat Res</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">100</infon>
      <offset>40986</offset>
      <text>Resistance to contaminants in North American fish populations</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Huang;given-names:X</infon>
      <infon key="volume">9</infon>
      <infon key="name_2">surname:Zhang;given-names:C</infon>
      <infon key="name_1">surname:Shen;given-names:B</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Xie;given-names:S</infon>
      <infon key="fpage">e100448</infon>
      <infon key="pub-id_pmid">24956386</infon>
      <infon key="year">2014</infon>
      <infon key="source">PLoS One</infon>
      <infon key="type">ref</infon>
      <infon key="name_4">surname:Zhang;given-names:Y</infon>
      <offset>41048</offset>
      <text>sgRNAcas9: a software package for designing CRISPR sgRNA and evaluating potential off-target cleavage sites</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Guiguen;given-names:Y</infon>
      <infon key="volume">16</infon>
      <infon key="name_2">surname:Jouanno;given-names:E</infon>
      <infon key="name_1">surname:Nicol;given-names:B</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Yano;given-names:A</infon>
      <infon key="fpage">243</infon>
      <infon key="pub-id_pmid">24085607</infon>
      <infon key="year">2014</infon>
      <infon key="source">Mar Biotechnol (NY)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">250</infon>
      <offset>41156</offset>
      <text>Heritable targeted inactivation of the rainbow trout (Oncorhynchus mykiss) master sex-determining gene using zinc-finger nucleases</text>
      <annotation id="500">
        <infon key="identifier">8022</infon>
        <infon key="type">Species</infon>
        <location offset="41195" length="13"/>
        <text>rainbow trout</text>
      </annotation>
      <annotation id="501">
        <infon key="identifier">8022</infon>
        <infon key="type">Species</infon>
        <location offset="41210" length="19"/>
        <text>Oncorhynchus mykiss</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Sakuma;given-names:T</infon>
      <infon key="name_2">surname:Hozumi;given-names:A</infon>
      <infon key="name_1">surname:Treen;given-names:N</infon>
      <infon key="name_0">surname:Yoshida;given-names:K</infon>
      <infon key="fpage">431</infon>
      <infon key="pub-id_pmid">24619765</infon>
      <infon key="year">2014</infon>
      <infon key="source">Genesis</infon>
      <infon key="type">ref</infon>
      <infon key="volume">52</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">439</infon>
      <infon key="name_5">surname:Sasakura;given-names:Y</infon>
      <infon key="name_4">surname:Yamamoto;given-names:T</infon>
      <offset>41287</offset>
      <text>Germ cell mutations of the ascidian Ciona intestinalis with TALE nucleases</text>
      <annotation id="503">
        <infon key="identifier">7719</infon>
        <infon key="type">Species</infon>
        <location offset="41323" length="18"/>
        <text>Ciona intestinalis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ankoudinova;given-names:I</infon>
      <infon key="name_2">surname:Doyon;given-names:Y</infon>
      <infon key="name_1">surname:Cherone;given-names:JM</infon>
      <infon key="name_0">surname:Young;given-names:JJ</infon>
      <infon key="fpage">7052</infon>
      <infon key="pub-id_pmid">21471457</infon>
      <infon key="year">2011</infon>
      <infon key="source">Proc Natl Acad of Sci U S A</infon>
      <infon key="type">ref</infon>
      <infon key="volume">108</infon>
      <infon key="name_10">surname:Zhang;given-names:L</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:Urnov;given-names:FD</infon>
      <infon key="name_14">surname:Harland;given-names:RM</infon>
      <infon key="name_11">surname:Rebar;given-names:EJ</infon>
      <infon key="name_12">surname:Gregory;given-names:PD</infon>
      <infon key="name_15">surname:Zeitler;given-names:B</infon>
      <infon key="name_9">surname:Miller;given-names:JC</infon>
      <infon key="name_8">surname:Paschon;given-names:DE</infon>
      <infon key="name_7">surname:Guschin;given-names:DY</infon>
      <infon key="lpage">7057</infon>
      <infon key="name_6">surname:Ngo;given-names:C</infon>
      <infon key="name_5">surname:Lee;given-names:AH</infon>
      <infon key="name_4">surname:Faraji;given-names:FM</infon>
      <offset>41362</offset>
      <text>Efficient targeted gene disruption in the soma and germ line of the frog Xenopus tropicalis using engineered zinc-finger nucleases</text>
      <annotation id="506">
        <infon key="identifier">8364</infon>
        <infon key="type">Species</infon>
        <location offset="41435" length="18"/>
        <text>Xenopus tropicalis</text>
      </annotation>
      <annotation id="507">
        <infon key="type">Disease</infon>
        <location offset="41404" length="4"/>
        <text>soma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Naruse;given-names:K</infon>
      <infon key="name_2">surname:Chen;given-names:J</infon>
      <infon key="name_1">surname:Guan;given-names:G</infon>
      <infon key="name_0">surname:Zhang;given-names:X</infon>
      <infon key="fpage">125</infon>
      <infon key="pub-id_pmid">24149659</infon>
      <infon key="year">2014</infon>
      <infon key="source">Mar Biotechnol (NY)</infon>
      <infon key="type">ref</infon>
      <infon key="volume">16</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">134</infon>
      <infon key="name_4">surname:Hong;given-names:Y</infon>
      <offset>41493</offset>
      <text>Parameters and efficiency of direct gene disruption by zinc finger nucleases in medaka embryos</text>
      <annotation id="509">
        <infon key="identifier">8090</infon>
        <infon key="type">Species</infon>
        <location offset="41573" length="6"/>
        <text>medaka</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms645550f1.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>41588</offset>
      <text>Outline of the targeted mutagenesis techniques currently used in generating mutants. A. Zinc finger nucleases B. TALENs and C. CRISPR-Cas system.</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms645550f2.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption</infon>
      <offset>41734</offset>
      <text>AHR target sites. A. Functional domain structure of the AHR protein. The location of the targeted exons 2 and 3 in relation to the functional domains is shown as red bars. DBD: DNA-binding domain, LBD: ligand-binding domain, TAD: transcriptional activation domain. B. Schematic representations of the ZFN and CRISPR-Cas target regions in AHR2a and AHR2b loci. Arrows represent the primers used in the PCR amplification of genomic DNA for screening. Surveyor nuclease fragments are shown below the target regions.</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms645550f3.jpg</infon>
      <infon key="id">F3</infon>
      <infon key="type">fig_caption</infon>
      <offset>42247</offset>
      <text>ZFN-mediated mutagenesis of killifish AHR2a. A. ZFN protein expression in killifish embryos. Uninjected (-) or ZFN-injected (+) embryos were sampled at 3, 6, 9, and 24 hours after micro-injection. Homogenates were resolved on SDS-PAGE and probed with a Flag-tag antibody. Lysate from COS-7 cells transfected with the ZFN expression plasmid was run as a positive control. B. Surveyor nuclease detection of mutations in the ZFN target region of AHR2a. Each lane represents a pool of 5 embryos from which a 335 bp genomic DNA fragment was amplified. U: uninjected control, ZFN: injected embryos. Lanes 1 and 2 are two representative samples that were positive in the mutation detection assay. Approximate sizes of the Surveyor nuclease-digested fragments containing the deletions are shown (240 and 95 bp). The full-length PCR product from sample 2 was cloned and sequenced. C. AHR2a exon 3 sequence surrounding the ZFN target site (in red). Four types of deletion mutants were observed among the sequenced clones (deletions of 2, 4, 5, and 28 nucleotides).</text>
      <annotation id="516">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="42275" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="517">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="42321" length="9"/>
        <text>killifish</text>
      </annotation>
      <annotation id="518">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="42307" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="519">
        <infon key="identifier">29278</infon>
        <infon key="type">Species</infon>
        <location offset="42568" length="10"/>
        <text>expression</text>
      </annotation>
      <annotation id="520">
        <infon key="identifier">CVCL:0224</infon>
        <infon key="type">CellLine</infon>
        <location offset="42531" length="5"/>
        <text>COS-7</text>
      </annotation>
      <annotation id="521">
        <infon key="identifier">MESH:D012967</infon>
        <infon key="type">Chemical</infon>
        <location offset="42473" length="3"/>
        <text>SDS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms645550f4.jpg</infon>
      <infon key="id">F4</infon>
      <infon key="type">fig_caption</infon>
      <offset>43304</offset>
      <text>CRISPR-Cas9-mediated mutagenesis of killifish AHR2a targeting exon 3. A. Surveyor nuclease detection of mutations in the CRISPR-Cas9 target region of AHR2a exon 3. Each lane represents a pool of 5 embryos from which a 255 bp genomic DNA fragment was amplified. U: uninjected, lanes 1 and 2: CRISPR-Cas9-injected embryos. Approximate sizes of the digested fragments containing the deletions and insertions are shown (160 and 95 bp). The full-length PCR products from samples 1 and 2 were pooled, cloned, and sequenced. B. AHR2a exon 3 sequence surrounding the CRISPR-Cas9 target site (in red). Ten different deletion mutants were observed among the sequenced clones.</text>
      <annotation id="523">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="43340" length="9"/>
        <text>killifish</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms645550f5.jpg</infon>
      <infon key="id">F5</infon>
      <infon key="type">fig_caption</infon>
      <offset>43970</offset>
      <text>CRISPR-Cas9-mediated mutagenesis of killifish AHR2b targeting exon 2 and exon 3. A. Surveyor nuclease detection of mutations in the AHR2b CRISPR-Cas9 target region. Each lane represents a pool of 5 embryos from which a 309 bp genomic DNA fragment was amplified. U: uninjected control, lanes 1-4: CRISPR-Cas9-injected embryos. Approximate sizes of the digested fragments containing the deletions and insertions are shown (175 and 135 bp). The full-length PCR products from samples 1-4 were pooled, cloned, and sequenced. B. AHR2b exon 2 sequence surrounding the CRISPR-Cas9 target site (in red). Five types of deletion mutants and 3 types of insertions were observed among the sequenced clones. C. Surveyor nuclease detection of mutations in the CRISPR-Cas9 target region of AHR2b exon 3. Each lane represents a pool of 5 embryos from which a 198 bp genomic DNA fragment was amplified. U: uninjected, lanes 1 and 2: CRISPR-Cas9-injected embryos. Approximate sizes of the digested fragments containing the deletions and insertions are shown (110 and 90 bp). The full-length PCR products from samples 1 and 2 were pooled, cloned, and sequenced. D. AHR2b exon 3 sequence surrounding the CRISPR-Cas9 target site (in red). Twenty different types of deletion mutants and seven types of insertion mutants were observed among the sequenced clones.</text>
      <annotation id="529">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="44102" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="530">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="44493" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="531">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="44744" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="532">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="45115" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="533">
        <infon key="identifier">8078</infon>
        <infon key="type">Species</infon>
        <location offset="44006" length="9"/>
        <text>killifish</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms645550f6.jpg</infon>
      <infon key="id">F6</infon>
      <infon key="type">fig_caption</infon>
      <offset>45313</offset>
      <text>AHR2b CRISPR-Cas9 off-target analysis. A. Nucleotide sequence alignment of the AHR2b CRISPR-Cas9 target sequence with the corresponding regions of closely related genes. AHR1a, AHR2a, AHR1b, and AHRR have 4, 4, 6, and 3 mismatches to AHR2b in this region, respectively. B. Surveyor nuclease detection of mutations in AHR1a, AHR2a, AHR1b, and AHRR in the AHR2b CRISPR-Cas9 target region. Digested fragments are indicated by a *. Each lane represents a pool of 5 embryos from which genomic DNA fragments were amplified. U: uninjected control, 1-4: CRISPR-Cas9 injected embryos. AHR1a, AHR2a, and AHRR PCR products from uninjected and injected embryos were sequenced.</text>
      <annotation id="540">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="45313" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="541">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="45392" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="542">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="45508" length="4"/>
        <text>AHRR</text>
      </annotation>
      <annotation id="543">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="45655" length="4"/>
        <text>AHRR</text>
      </annotation>
      <annotation id="544">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="45667" length="4"/>
        <text>AHR2</text>
      </annotation>
      <annotation id="545">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="45907" length="4"/>
        <text>AHRR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>45980</offset>
      <text>Published studies employing gene targeting in non-traditional model species.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">T1</infon>
      <infon key="type">table</infon>
      <infon key="File">T1.xml</infon>
      <offset>46057</offset>
      <text>                                 Gene-editingapproach              Species              Reference                                                       ZFN              Monarch butterfly (Danaus plexippus)Two-spotted cricket (Gryllus bimaculatus)Sea urchin (Hemicentrotus pulcherrimus)Ascidian (Ciona intestinalis)Western clawed frog (Xenopus tropicalis)Yellow catfish (Pelteobagrus fulvidraco)Medaka (Oryzias melastigma)Rainbow trout (Oncorhynchus mykiss)                                                   TALEN              Nematode (Pristionchus pacificus)Marine polycheate (Platyneries dumerilii)Culicine mosquito (Aedes aegypti)Silk worm (Bombyx mori)Sea urchin (Hemicentrotus pulcherrimus)Ascidian (Ciona intestinalis)Western clawed frog (Xenopus tropicalis)Iberian ribbed newts (Pleurodeles waltl)Tilapia (Oreochromis niloticus)Medaka (Oryzias melastigma)Yellow catfish (Pelteobagrus fulvidraco)                                                   CRISPR-Cas9              Western clawed frog (Xenopus tropicalis)Axolotl (Ambystoma mexicanum)Atlantic Salmon (Salmo salar)Tilapia (Oreochromis mossambicus)              (Ji-Feng et al., 2014)                             </text>
      <annotation id="575">
        <infon key="identifier">13037</infon>
        <infon key="type">Species</infon>
        <location offset="46226" length="17"/>
        <text>Monarch butterfly</text>
      </annotation>
      <annotation id="576">
        <infon key="identifier">13037</infon>
        <infon key="type">Species</infon>
        <location offset="46245" length="16"/>
        <text>Danaus plexippus</text>
      </annotation>
      <annotation id="577">
        <infon key="identifier">6999</infon>
        <infon key="type">Species</infon>
        <location offset="46262" length="19"/>
        <text>Two-spotted cricket</text>
      </annotation>
      <annotation id="578">
        <infon key="identifier">6999</infon>
        <infon key="type">Species</infon>
        <location offset="46283" length="19"/>
        <text>Gryllus bimaculatus</text>
      </annotation>
      <annotation id="579">
        <infon key="identifier">7656</infon>
        <infon key="type">Species</infon>
        <location offset="46303" length="10"/>
        <text>Sea urchin</text>
      </annotation>
      <annotation id="580">
        <infon key="identifier">7650</infon>
        <infon key="type">Species</infon>
        <location offset="46315" length="26"/>
        <text>Hemicentrotus pulcherrimus</text>
      </annotation>
      <annotation id="581">
        <infon key="identifier">7719</infon>
        <infon key="type">Species</infon>
        <location offset="46352" length="18"/>
        <text>Ciona intestinalis</text>
      </annotation>
      <annotation id="582">
        <infon key="identifier">8364</infon>
        <infon key="type">Species</infon>
        <location offset="46371" length="19"/>
        <text>Western clawed frog</text>
      </annotation>
      <annotation id="583">
        <infon key="identifier">8364</infon>
        <infon key="type">Species</infon>
        <location offset="46392" length="18"/>
        <text>Xenopus tropicalis</text>
      </annotation>
      <annotation id="584">
        <infon key="identifier">1234273</infon>
        <infon key="type">Species</infon>
        <location offset="46411" length="14"/>
        <text>Yellow catfish</text>
      </annotation>
      <annotation id="585">
        <infon key="identifier">1234273</infon>
        <infon key="type">Species</infon>
        <location offset="46427" length="23"/>
        <text>Pelteobagrus fulvidraco</text>
      </annotation>
      <annotation id="586">
        <infon key="identifier">8090</infon>
        <infon key="type">Species</infon>
        <location offset="46451" length="6"/>
        <text>Medaka</text>
      </annotation>
      <annotation id="587">
        <infon key="identifier">54126</infon>
        <infon key="type">Species</infon>
        <location offset="46593" length="22"/>
        <text>Pristionchus pacificus</text>
      </annotation>
      <annotation id="588">
        <infon key="identifier">7159</infon>
        <infon key="type">Species</infon>
        <location offset="46676" length="13"/>
        <text>Aedes aegypti</text>
      </annotation>
      <annotation id="589">
        <infon key="identifier">7091</infon>
        <infon key="type">Species</infon>
        <location offset="46701" length="11"/>
        <text>Bombyx mori</text>
      </annotation>
      <annotation id="590">
        <infon key="identifier">7656</infon>
        <infon key="type">Species</infon>
        <location offset="46713" length="10"/>
        <text>Sea urchin</text>
      </annotation>
      <annotation id="591">
        <infon key="identifier">7650</infon>
        <infon key="type">Species</infon>
        <location offset="46725" length="26"/>
        <text>Hemicentrotus pulcherrimus</text>
      </annotation>
      <annotation id="592">
        <infon key="identifier">7719</infon>
        <infon key="type">Species</infon>
        <location offset="46762" length="18"/>
        <text>Ciona intestinalis</text>
      </annotation>
      <annotation id="593">
        <infon key="identifier">8364</infon>
        <infon key="type">Species</infon>
        <location offset="46781" length="19"/>
        <text>Western clawed frog</text>
      </annotation>
      <annotation id="594">
        <infon key="identifier">8364</infon>
        <infon key="type">Species</infon>
        <location offset="46802" length="18"/>
        <text>Xenopus tropicalis</text>
      </annotation>
      <annotation id="595">
        <infon key="identifier">8319</infon>
        <infon key="type">Species</infon>
        <location offset="46821" length="20"/>
        <text>Iberian ribbed newts</text>
      </annotation>
      <annotation id="596">
        <infon key="identifier">8319</infon>
        <infon key="type">Species</infon>
        <location offset="46843" length="17"/>
        <text>Pleurodeles waltl</text>
      </annotation>
      <annotation id="597">
        <infon key="identifier">1234273</infon>
        <infon key="type">Species</infon>
        <location offset="46935" length="23"/>
        <text>Pelteobagrus fulvidraco</text>
      </annotation>
      <annotation id="598">
        <infon key="identifier">8364</infon>
        <infon key="type">Species</infon>
        <location offset="47035" length="19"/>
        <text>Western clawed frog</text>
      </annotation>
      <annotation id="599">
        <infon key="identifier">8364</infon>
        <infon key="type">Species</infon>
        <location offset="47056" length="18"/>
        <text>Xenopus tropicalis</text>
      </annotation>
      <annotation id="600">
        <infon key="identifier">8296</infon>
        <infon key="type">Species</infon>
        <location offset="47075" length="7"/>
        <text>Axolotl</text>
      </annotation>
      <annotation id="601">
        <infon key="identifier">8127</infon>
        <infon key="type">Species</infon>
        <location offset="47142" length="23"/>
        <text>Oreochromis mossambicus</text>
      </annotation>
      <annotation id="602">
        <infon key="type">Disease</infon>
        <location offset="46459" length="53"/>
        <text>Oryzias melastigma)Rainbow trout (Oncorhynchus mykiss</text>
      </annotation>
      <annotation id="603">
        <infon key="identifier">MESH:D015004</infon>
        <infon key="type">Disease</infon>
        <location offset="46861" length="72"/>
        <text>Tilapia (Oreochromis niloticus)Medaka (Oryzias melastigma)Yellow catfish</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>47232</offset>
      <text>AHR2a and AHR2b target regions and oligonucleotides used in ZFN and CRISPR-Cas9-based mutagenesis. The ZFN target site is shown in capital letters. The sequence flanking the target sites are recognized by the ZFN proteins.</text>
      <annotation id="605">
        <infon key="identifier">MESH:D009841</infon>
        <infon key="type">Chemical</infon>
        <location offset="47267" length="16"/>
        <text>oligonucleotides</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">T2</infon>
      <infon key="type">table</infon>
      <infon key="File">T2.xml</infon>
      <offset>47455</offset>
      <text>                                 Name              Description              Sequence                                                       AHR2a exon 2              ZFN target site              ctgcgcctcagcgtgGGATAcctgagggtcaagag                                     AHR2a exon 3              ZFN target site              gactcattcagcttcTCTGAaggagagctgctgct                                     AHR2a exon 2              CRISPR-Cas9 target site              GGAGCGAATCTCATCAGGGA                                     AHR2a exon 3              CRISPR-Cas9 target site              GGGTGGCTCCTGGAGTCAAC                                     AHR2b exon2              CRISPR-Cas9 target site              GGACCGTCTGAACGGCGAGC                                     AHR2b exon3              CRISPR-Cas9 target site              GGGCGAAGGTCTGAGCGGTC                                     2-ex3Fwd              AHR2a ZFN pair3 screening              TGTTTCACCTCCTGCACAGCTTCC                                     1XRR1              AHR2a ZFN pair3 screening              TACTAGCTAAACGTGACCTGTCG                                     2a-ex3CrF              AHR2a CRISPR-Cas exon3 screening              CTGTTCTATCAGGTGGAGAGTCC                                     2a-ex3CrR              AHR2a CRISPR-Cas exon3 screening              GTTGTTGGATGAGTATGCAGGTGG                                     AHR2b-CrF              AHR2b CRISPR-Cas9 exon2 screening              AATCTTTGATCCGGTCTGATCTGG                                     AHR2b-CrR              AHR2b CRISPR-Cas9 exon2 screening              AGACACAACCAAGCAGCAACACG                                     2bex3-Fwd              AHR2b CRISPR-Cas9 exon3 screening              ATCGCCCAGCCTTAGCTTCCAGTCG                                     2bex3-Rev              AHR2b CRISPR-Cas9 exon3 screening              GCGTTTTTGCTTTGTCTGCTGTCGG                                     Fh2A-ex3-CR1              AHR2a exon3 gRNA oligo1              TAGGGTGGCTCCTGGAGTCAAC                                     Fh2A-ex3-CR2              AHR2a exon3 gRNA oligo2              AAACGTTGACTCCAGGAGCCAC                                     FhAHR2b-CR1              AHR2b exon2 gRNA oligo1              TAGGACCGTCTGAACGGCGAGC                                     FhAHR2b-CR2              AHR2b exon2 gRNA oligo2              AAACGCTCGCCGTTCAGACGGT                                     Fh2B-ex3-CR1              AHR2b exon3 gRNA oligo1              TAGGGCGAAGGTCTGAGCGGTC                                     Fh2B-ex3-CR2              AHR2b exon3 gRNA oligo2              AAACGACCGCTCAGACCTTCGC                                     2b-1aF              AHR1a off-target screening              GCTTAATCCTGCTTTCGTCTCTGC                                     Fh1a-ex2rev              AHR1a off-target screening              AAGAAGTGTTTGGCTCGTAGGTAGC                                     2b-2aF              AHR2a off-target screening              TTTTACCCCTCACGGAAGAAGATGG                                     Fh2a-ex2rev              AHR2a off-target screening              GTAGCTCTTGACCCTCAGGTATCC                                     2b-1bF              AHR1b off-target screening              TTTCCTCCTCTCCAGAGCCAAACC                                     Fh1b-ex2rev              AHR1b off-target screening              AAGAAGCTCTTGGTGCGCAGGTAGC                                     RR-ex2fwd              AHRR off-target screening              CTCATCCCTTCTGCCGTCTCGTCC                                     RR-ex2rev              AHRR off-target screening              AAGAAGCTTTTGACGCGGAGGTAGG                             </text>
      <annotation id="611">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="50847" length="4"/>
        <text>AHRR</text>
      </annotation>
      <annotation id="612">
        <infon key="identifier">105920361</infon>
        <infon key="type">Gene</infon>
        <location offset="50970" length="4"/>
        <text>AHRR</text>
      </annotation>
      <annotation id="613">
        <infon key="identifier">2498238</infon>
        <infon key="type">Species</infon>
        <location offset="49481" length="3"/>
        <text>CR2</text>
      </annotation>
      <annotation id="614">
        <infon key="identifier">2498238</infon>
        <infon key="type">Species</infon>
        <location offset="49723" length="3"/>
        <text>CR2</text>
      </annotation>
      <annotation id="615">
        <infon key="identifier">2498238</infon>
        <infon key="type">Species</infon>
        <location offset="49967" length="3"/>
        <text>CR2</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title_caption</infon>
      <offset>51064</offset>
      <text>Highlights</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">paragraph</infon>
      <offset>51075</offset>
      <text>AHR2 genes were mutated without detectable off-target effects in paralogs.</text>
      <annotation id="617">
        <infon key="identifier">105937229</infon>
        <infon key="type">Gene</infon>
        <location offset="51075" length="4"/>
        <text>AHR2</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">paragraph</infon>
      <offset>51150</offset>
      <text>CRISPR-Cas9 method was more efficient in inducing mutations compared to ZFN.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">paragraph</infon>
      <offset>51227</offset>
      <text>We suggest strategies for generating knockouts in non-traditional fish models.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">paragraph</infon>
      <offset>51306</offset>
      <text>AHR knockouts will be valuable for understanding evolved resistance to toxicants.</text>
    </passage>
  </document>
  <document>
    <id>4272818</id>
    <passage>
      <infon key="name_3">surname:Haynes;given-names:R Brian</infon>
      <infon key="name_2">surname:Law;given-names:Mary</infon>
      <infon key="name_1">surname:Chesworth;given-names:Bert M</infon>
      <infon key="article-id_pmid">25495467</infon>
      <infon key="name_0">surname:Shi;given-names:Qiyun</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272818</infon>
      <infon key="article-id_publisher-id">263</infon>
      <infon key="article-id_doi">10.1186/s12909-014-0263-4</infon>
      <infon key="title">Keywords</infon>
      <infon key="type">front</infon>
      <infon key="elocation-id">263</infon>
      <infon key="volume">14</infon>
      <infon key="license">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">BMC Med Educ; 2014 Dec 14; 14263. doi:10.1186/s12909-014-0263-4</infon>
      <infon key="kwd">Evidence-based Scale Self-reported Validation Clinician</infon>
      <infon key="name_4">surname:MacDermid;given-names:Joy C</infon>
      <infon key="authors">Shi Q, Chesworth BM, Law M, Haynes RB, MacDermid JC</infon>
      <offset>0</offset>
      <text>A modified evidence-based practice- knowledge, attitudes, behaviour and decisions/outcomes questionnaire is valid across multiple professions involved in pain management</text>
      <annotation id="1">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="154" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>170</offset>
      <text>Background</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>181</offset>
      <text>A validated and reliable instrument was developed to knowledge, attitudes and behaviours with respect to evidence-based practice (EBB-KABQ) in medical trainees but requires further adaptation and validation to be applied across different health professionals.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>441</offset>
      <text>Methods</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>449</offset>
      <text>A modified 33-item evidence-based practice scale (EBP-KABQ) was developed to evaluate EBP perceptions and behaviors in clinicians. An international sample of 673 clinicians interested in treatment of pain (mean age = 45 years, 48% occupational therapists/physical therapists, 25% had more than 5 years of clinical training) completed an online English version of the questionnaire and demographics. Scaling properties (internal consistency, floor/ceiling effects) and construct validity (association with EBP activities, comparator constructs) were examined. A confirmatory factor analysis was used to assess the 4-domain structure EBP knowledge, attitudes, behavior, outcomes/decisions).</text>
      <annotation id="3">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="649" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1144</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1152</offset>
      <text>The EBP-KABQ scale demonstrated high internal consistency (Cronbach's alpha = 0.85), no evident floor/ceiling effects, and support for a priori construct validation hypotheses. A 4-factor structure provided the best fit statistics (CFI =0.89, TLI =0.86, and RMSEA = 0.06).</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1435</offset>
      <text>Conclusions</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1447</offset>
      <text>The EBP-KABQ scale demonstrates promising psychometric properties in this sample. Areas for improvement are described.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1566</offset>
      <text>Electronic supplementary material</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1600</offset>
      <text>The online version of this article (doi:10.1186/s12909-014-0263-4) contains supplementary material, which is available to authorized users.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1740</offset>
      <text>Background</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1751</offset>
      <text>Evidence-based practice (EBP) is defined as the integration of the best research evidence with patients' interests and clinical circumstances in decision making. As EBP is associated with improved clinical decision-making and patient care, health professional organizations have advocated for increased training in EBP for all health care professionals at all levels of education. Understanding how EBP is understood and implemented across different health professionals can identify educational needs and outcomes, and predict where new research evidence is more likely to be implemented. As such, a validated and reliable instrument is required to evaluate an individual's perceptions of EBP.</text>
      <annotation id="6">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1846" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="7">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1977" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2450</offset>
      <text>A systematic review which studied 104 instruments on EBP suggested that evaluation of EBP could be divided into the following definable components: EBP knowledge, attitudes toward EBP, application/use of EBP and practitioners' EBP behaviors in the clinical setting. Knowledge about EBP means that clinicians have knowledge of fundamental EBP concepts and terminology and concepts related to quality or levels of evidence. It also includes the ability to search the literature and critically appraise the evidence for its validity, impact and applicability. Attitude toward EBP includes the intuitive appeal of EBP, the likelihood of adopting EBP given professional requirements to do so, openness to new practices, and the perceived divergence between research-based/academically developed interventions versus current practice. Application and use of EBP refers to whether health professionals are able to apply their EBP knowledge to the specific clinical scenarios. This includes: capability to generate clinical question(s) regarding disease prevention, diagnosis and management as well as implementation of evidence with integrity of clinical circumstances. EBP behaviors refer to practitioners' performance of the instrumental activities associated with EBP such as searching and obtaining higher quality evidence in their own practice.</text>
      <annotation id="9">
        <infon key="identifier">MESH:D005597</infon>
        <infon key="type">Disease</infon>
        <location offset="3138" length="8"/>
        <text>openness</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3797</offset>
      <text>Although the rise of EBP awareness has led to the development of instruments to assess its integration into clinical practice, there are gaps in the evidence supporting these tools. There is a lack of empirical data that can be applied to a wider range of experience and types of clinicians, in particular nurses and allied health professionals. Moreover, as most scales have targeted samples with minimal experience in clinical practice, the questionnaires may not accurately reflect the perception of EBP by clinicians who have been practicing in different clinical settings.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4375</offset>
      <text>Among available scales, one that has taken a multi-dimensional approach and shown early promise is the The knowledge, attitude and behavior questionnaire (KAB) originally developed by Johnson and colleagues. The KAB scale was designed to evaluate EBP teaching and learning in the undergraduate medical education setting. With permission from the developers, two study authors (JMD and ML) developed a modified KAB scale (EBP-KABQ), to be applicable to health professionals other than physicians using expert review and pilot testing. This process resulted in removal of items that were perceived by users as redundant or unclear.</text>
      <annotation id="12">
        <infon key="identifier">MESH:C537366</infon>
        <infon key="type">Disease</infon>
        <location offset="4760" length="2"/>
        <text>ML</text>
      </annotation>
      <annotation id="13">
        <infon key="type">Disease</infon>
        <location offset="4752" length="3"/>
        <text>JMD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>5005</offset>
      <text>The goal of this study was to validate the modified scale (EBP-KABQ) for use in a multidisciplinary group of clinicians by determining: (1) Scaling properties- internal consistency, floor/ceiling effects, and (2) Construct validity- based on predetermined hypotheses on the relationship of subcomponents of EBP, and (3) Structural validity: the integrity of a 4-domain structure based on confirmatory factor analysis.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>5423</offset>
      <text>Methods</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5431</offset>
      <text>The EBP-KABQ incorporates 33 items in four domains of EBP: knowledge (8 items, 6 ordinal items), attitudes (14 items, 14 ordinal items), behaviour (8 items, 5 ordinal items) and outcomes/decisions (3 items, 3 ordinal items) (KABQ). The knowledge items retain a 7-point Likert scale with lower scores indicating a lower level of EBP knowledge. The Attitudes towards EBP items retain a 7-point Likert scale. High scores indicate positive attitude after several items were reversely scored. For EBP behaviour, lower scores indicate a lower frequency of using EBP in current practice. A 6-point Likert scale is used for responses to the items in the outcomes/decisions domain. Lower scores indicate unfavorable patient outcomes and poor clinical evidence-based decision making. Detail of the EBP-KABQ scale and a summary of the changes to original scale are presented in Additional files 1 and 2.</text>
      <annotation id="15">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6138" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>6324</offset>
      <text>Subject recruitment and data collection</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6364</offset>
      <text>All participants were recruited from a clinical trial assessing use of pain research evidence about pain. Eligible practitioners were (1) physicians, nurses, occupational therapists (OTs), physical therapists (PTs), or psychologists who were currently working in clinical practice at least one day/week; (2) fluent in English; (3) able to access a computer at home or at work that provided unrestricted access to the World Wide Web; (4) possessed an active email account;(5) consent to participate in this research studyA total of 870 clinicians met the inclusion criteria and were invited to participate. From August 2011 to February 2013, 673 clinicians (physicians, nurses, OTs/PTs, psychologists etc.) completed an online EBP-KABQ scale prior to receiving new pain information. Demographic and practice characteristics were also obtained. The study received Ethics Approval from the McMaster University Research Ethics Board.</text>
      <annotation id="20">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6368" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="21">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="7128" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="22">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="6435" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="23">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="6464" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>7294</offset>
      <text>Data analysis</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>7308</offset>
      <text>Quality checks, descriptive statistics and checks for normality were completed prior to analysis. Item 33 "I don't use evidence-based practice for another reason (specify)" was removed from the analyses because the specified reason varied across respondents, making it a nonstandard item. Therefore, 27 ordinal items across the following four domains of EBP were analyzed in this study: knowledge (n = 6 items), attitudes (n = 13 items), behavior (n = 5 items) and outcomes/decisions (n = 3 items).</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>7829</offset>
      <text>Scaling properties (internal consistency and floor/ceiling effects)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>7897</offset>
      <text>Internal consistency reliability scores were assessed for both the full EBP-KABQ scale and its corresponding 4 subscales using Cronbach's alpha, where &gt;0.7 was considered as minimum and &gt;0.9 was desirable. Scaling properties such as floor/ceiling effects, which was observed in &gt;15% of scores at minimum or maximum scale/subscale were also assessed.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>8249</offset>
      <text>Construct validation</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>8270</offset>
      <text>Four hypotheses were tested to assess the construct validation of EBP-KABQ scale. First, we hypothesized that the mean item score in "knowledge" would be higher than those in "behaviour", "outcomes/decisions" and "attitude" domains because knowledge is considered a necessary precursor, but not a sufficient guarantee, for changes in practice and outcomes. Secondly, we hypothesized that the domain of "outcomes/decisions" would be more strongly correlated to the other 3 domains since it focuses on how EBP influences the decision making process. Thirdly, we hypothesized that EBP-KABQ subscale scores would be correlated with corresponding EBP activities assessed by relevant open ended questions. For example, the frequency that clinicians search for evidence should be correlated with subtotal score of "behaviour" to a greater extent than other domains such as "knowledge" or "EBP outcomes/decisions". Finally, we hypothesized that following demographic variables would be associated with total EBP-KABQ scale score in the multivariate modeling: age, highest level of education, and possession of advanced clinical training since these have been suggested in the literature on EBP. Details of all construct validity testing and a priori hypotheses are provided in the Results section.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>9592</offset>
      <text>Structural validity</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>9612</offset>
      <text>Confirmatory factor analysis (CFA, maximum likelihood estimation) was conducted to examine our proposed 4-domain model. Four conceptual domains of EBP (knowledge, attitudes, behavior and outcomes/decisions) were tested as second-order factors (latent variables) based on the originally defined conceptual framework. We evaluated the model fit with a number of goodness-of-fit statistics including Root Mean Square Error of Approximation (RMSEA) &lt;0.06 (ideal) and &lt;0.08 (acceptable), comparative fit index (CFI) &gt;=0.90-0.95 (acceptable), Tucker Lewis Index (TLI) &gt;=0.90-0.95 (acceptable) and Chi-square test (P &gt; 0.05, acceptable). We considered RMSEA, CFI and TLI as primary statistics because Chi-square is vulnerable to a large sample size (sample size &gt; 300). We also examined modification indices to identify the potential to improve the model fit. We modified our model when it was indicated by theoretical and statistical findings. We considered standardized coefficients (i.e., factor loadings) &gt;=0.30 (p &lt; 0.05) as 'representing' a hypothesized dimension.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>10699</offset>
      <text>All analyses except CFA were conducted by SAS (version 9.3, SAS Institute Inc, Cary, NC, USA). We used IBM SPSS v20 Amos statistical software for CFA.</text>
      <annotation id="26">
        <infon key="identifier">6302</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4359</infon>
        <location offset="10741" length="3"/>
        <text>SAS</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">6302</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4359</infon>
        <location offset="10759" length="3"/>
        <text>SAS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>10850</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>10858</offset>
      <text>Sample characteristics</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>10881</offset>
      <text>Years of clinical experience: Mean = 17.96 years (SD = 11.23 years; range = 0-52).</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab1.xml</infon>
      <infon key="id">Tab1</infon>
      <infon key="type">table_caption</infon>
      <offset>10980</offset>
      <text> Characteristics of 673 participants of EBP-KABQ study </text>
      <annotation id="29">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11004" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab1</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab1.xml</infon>
      <offset>11036</offset>
      <text> Characteristics   N (%)   Age   20-35 178 (26.4) 36-45 158 (23.4) 46-55 221 (32.8) 56+ 116 (17.2)  Clinical designation   MD 131 (19.5) OT/PT 326 (48.4) RN 127 (18.8) RPsych or CPsych 52 (7.7) Others 37 (5.5)  Highest education level   Diploma/BA 234 (34.8) MA/MSC 222 (33.0) MD 122 (18.1) Ph.D. 95 (14.1)  Received advanced clinical certifications  364 (54.1)  Years of clinical training   Less than 2 years 190 (28.2) 2-5 years 295 (43.8) Above 5 years 188 (27.9)  Location of practice   Urban 463 (68.8) Rural 101 (15.0) Both 109 (16.2) </text>
      <annotation id="31">
        <infon key="type">Disease</infon>
        <location offset="11273" length="7"/>
        <text>Diploma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11588</offset>
      <text>In total, 673 health professionals completed EBP-KABQ questionnaire. The description of demographic characteristics is presented in Table 1. Half of participants were age 45 or younger. Nearly half of clinicians were OTs or PTs, while 1/4 were nurses and 1/5 were physicians. One quarter of the sample had more than 5 years of clinical training; and they had a mean time in clinical practice of almost 18 years. Most participants practiced in an urban setting, while 15% were in a rural practice area.</text>
      <annotation id="34">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11737" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12005" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>12093</offset>
      <text>Scaling properties (internal consistency and floor/ceiling effects)</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12161</offset>
      <text>Overall, EBP-KABQ scale achieved acceptable satisfactory internal consistency (Cronbach's alpha alpha = 0.85) although the subscale of "knowledge" still showed marginal acceptable internal consistency with Cronbach's alpha = 0.66 after removal of item 3. However, this was improved compared to the original 6-item "knowledge" subscale (Cronbach's alpha = 0.56). This finding supported the decision to remove item 3 ("Clinical trials and observational methods are equally valid in establishing treatment effectiveness").</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>12708</offset>
      <text>Bold indicated floor or ceiling effect. Item 3 was removed from the scale based on factor structure.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab2.xml</infon>
      <infon key="id">Tab2</infon>
      <infon key="type">table_caption</infon>
      <offset>12809</offset>
      <text> Descriptive statistics of the EBP-KABQ scale, scaling properties and internal consistency (n = 673) </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab2</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab2.xml</infon>
      <offset>12915</offset>
      <text> Scale   Item   Item mean(SD)   Median   Floor%   Ceiling%   Subscale mean(SD)   Floor%   Ceiling%   Cronbach's alpha at subscale/total level  Knowledge-5 items EBP-KABO1 5.79 (1.02) 6.00 0.1  23.8  29.57(3.62) 0.1 1.5 0.66 EBP-KABO2 6.01 (0.99) 6.00 0.3  34.0  EBP-KABO4 5.44 (1.41) 6.00 1.6  25.6  EBP-KABO5 6.08 (1.06) 6.00 0.6  41.0  EBP-KABO6 6.25 (1.12) 7.00 0.6  55.0  Behaviour-5 items EBP-KABO9 3.14 (1.16) 3.00 1.2  15.6  11.22(4.28) 0.1 0.3 0.77 EBP-KABO10 2.02 (1.15) 2.00  17.5  3.1 EBP-KABO11 2.42 (1.22) 2.00 7.0 5.8 EBP-KABO12 1.66 (1.11) 2.00  25.6  1.6 EBP-KABO13 1.98 (1.31) 2.00  34.3  5.9 Outcome/Decision-3 items EBP-KABO17 4.56 (0.94) 5.00 1.0 12.0 12.56(2.52) 0.3 0.4 0.83 EBP-KABO18 4.11 (1.04) 4.00 1.9 4.8 EBP-KABO19 3.88 (0.93) 4.00 0.3 3.4 Attitude-13 items EBP-KABO20 4.17 (0.69) 4.00 1.3  32.1  64.58(8.99) 0.1 0.3 0.75 EBP-KABO21 5.20 (1.53) 5.00  0.9   25.7  EBP-KABO22 3.94 (1.59) 4.00 3.9 4.2 EBP-KABO23 4.18 (1.56) 4.00 3.6 8.5 EBP-KABO24 4.88 (1.59) 5.00 1.8  18.6  EBP-KABO25 4.81 (1.39) 5.00 0.9 11.9 EBP-KABO26 6.22 (1.02) 7.00 0.7  50.1  EBP-KABO27 4.72 (1.51) 5.00 2.5 9.4 EBP-KABO28 5.77 (0.99) 6.00 0.3  25.3  EBP-KABO29 5.99 (0.98) 6.00 0.3  36.4  EBP-KABO30 3.80 (1.51) 4.00 10.1 2.1 EBP-KABO31 5.26 (1.66) 6.00 1.9  31.4  EBP-KABO32 5.66 (1.41) 6.00 0.6  38.0  MEBP-26 items Full version ----- 118.00 ----- ----- 117.93(15.10) 0.1 0.1 0.85 </text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14305</offset>
      <text>Table 2 presents a summary of the item-level properties of EBP-KABQ. The mean and median total score of EBP-KABQ scale was 117.93 (SD: 15.10) and 118 respectively, with no floor/ceiling effects detected. The mean scores of four subscales ranged from 11.22 to 64.58. Similarly, no obvious floor/ceiling effects were observed in all four subscales although some individual items particularly in "knowledge" presented a ceiling effect.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>14743</offset>
      <text>Construct validity</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>14762</offset>
      <text>*P &lt; 0.05.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>14777</offset>
      <text>Q 1: How often do you now look up evidence immediately before, or during patient treatment visit per week?</text>
      <annotation id="37">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14850" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>14884</offset>
      <text>Q 2: How many hours do you spend looking up evidence per week?</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>14947</offset>
      <text>Q 3: How many hours do you spend reading new research evidence per week?</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab3.xml</infon>
      <infon key="id">Tab3</infon>
      <infon key="type">table_caption</infon>
      <offset>15020</offset>
      <text> Results of construct validity against a series of theoretical constructs </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab3</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab3.xml</infon>
      <offset>15095</offset>
      <text> Theoretical constructs   A priori hypotheses   Results  1. EBP knowledge is more easily affected than other other aspects of EBP Mean item score in "knowledge" &gt; other domains  Knowledge: 5.91 Behaviour: 2.24 Outcome/Decision : 4.18 Attitude: 4.96 2. "Outcome/Decision" is correlated to other 3 domains Correlation coefficients between "outcome" and "knowledge"/"application"/"attitude" &gt; other correlation coefficients. routcome-knowledge=0.54*, routcome-behaviour=0.40*, routcome-attitude=0.57*; rattitude-knowledge=0.41*, rknowledge-application=0.33*, rapplication-attitude=0.26*; 3. MEBP subscale scores are correlated with corresponding EBP activities Correlation coefficients between "application" and 3 external questions evaluating EBP application &gt; other correlation coefficients. rapplication-Q1=0.32*, rknowledge-Q1=0.19*, routcome-Q1=0.28*; rattitude-Q1=0.19*; rapplication-Q2=0.41*, rknowledge-Q2=0.24*, routcome-Q2=0.30*; rattitude-Q2=0.19*; rapplication-Q3=0.35*, rknowledge-Q3=0.24*, routcome-Q3=0.26*; rattitude-Q3=0.16*; 4. Demographic variables would be associated with total MEBP scale score Age, highest education level, possession of advanced clinical training are significant factors are associated with in multivariate modeling Adjusted beta coefficients of following variable: Age: beta = -0.32 Higher education level (ref: diploma/BA): beta =4.63* Years of clinical training (ref: less than 2 years): beta =2.36* Advanced clinical training (ref: No): beta =4.37* Practice setting (ref: urban): beta =1.87* </text>
      <annotation id="40">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="15569" length="8"/>
        <text>routcome</text>
      </annotation>
      <annotation id="41">
        <infon key="type">Disease</infon>
        <location offset="16445" length="7"/>
        <text>diploma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>16664</offset>
      <text>*P &lt; 0.05, variables were selected if p value &lt;0.2 in univariate model.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab4.xml</infon>
      <infon key="id">Tab4</infon>
      <infon key="type">table_caption</infon>
      <offset>16740</offset>
      <text> Unadjusted and adjusted linear regression coefficients for EBP-KABQ total score </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab4</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab4.xml</infon>
      <offset>16822</offset>
      <text>  Unadjusted   Adjusted   Characteristics   B   SD   P value   B   SD   P value  Age (years) -0.32 0.59 0.60 -- -- -- Education (ref: diploma/BA) 5.08 0.73  &lt;0.01*  4.63 0.73  &lt;0.01*  Clinical designation (ref: MD) 0.06 0.06 0.27 -- -- -- Years of clinical training (ref: less than 2 years) 3.57 0.73  &lt;0.01*  2.36 0.81  &lt;0.01*  Advanced clinical training (ref: No) 5.68 1.23  &lt;0.01*  4.37 1.21  &lt;0.01*  Practice setting (ref: urban) 1.24 0.82 0.13 1.87 0.79  0.02*  Constant -- -- -- 106.2 2.43  &lt;0.01*  </text>
      <annotation id="43">
        <infon key="type">Disease</infon>
        <location offset="16956" length="7"/>
        <text>diploma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>17331</offset>
      <text>Details of the construct validity testing and a priori hypotheses were provided in Table 3. As we expected, mean item score in "knowledge" was 5.91, significantly higher than the rest of the domains (p &lt; 0.05). Our constructed hypotheses were supported in that the correlation coefficients between "outcomes/decision" and "knowledge", "behaviour" and "attitude" were 0.54, 0.40 and 0.57 respectively, which were higher correlations than observed between other subscales. Construct validity was also supported in that there was a significant relationship between the frequency of searching reported by clinicians and the "behaviour" score, with correlation coefficient ranges from 0.32 to 0.41 (hypothesis 3). Regression analyses supported our a priori hypothesis that health professionals who had higher levels of education (beta = 4.63, P &lt; 0.01), longer years in clinical training (beta = 2.36, P &lt; 0.01) and possession of advanced clinical training (beta = 4.37, P &lt; 0.01) were more likely to use EBP (Table 4). Although younger age was related to EBP practice in the direction anticipated, it did not reach statistical significance (beta = -0.32, P = 0.06).</text>
      <annotation id="47">
        <infon key="identifier">10242</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4257</infon>
        <location offset="18215" length="8"/>
        <text>beta = 2</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">10381</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">68503</infon>
        <location offset="18284" length="8"/>
        <text>beta = 4</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">10381</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">68503</infon>
        <location offset="18156" length="8"/>
        <text>beta = 4</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>18549</offset>
      <text>Structural validity</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">12909_2014_263_Fig1_HTML.jpg</infon>
      <infon key="id">Fig1</infon>
      <infon key="type">fig_caption</infon>
      <offset>18569</offset>
      <text> Standardized parameter estimates for the refined EBP-KABQ factor structure model. Rectangles represent the scale items and ellipses represent the proposed factor constructs. Values on the single-headed arrows leading from the factors are standardized factor loadings. Values on the curved double-headed arrows between rectangles are correlations between error terms. Values on the curved double-headed arrows between ellipses are correlations between latent variables.</text>
      <annotation id="53">
        <infon key="identifier">301928</infon>
        <infon key="type">Species</infon>
        <location offset="18693" length="8"/>
        <text>ellipses</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">301928</infon>
        <infon key="type">Species</infon>
        <location offset="18987" length="8"/>
        <text>ellipses</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">MESH:D000069451</infon>
        <infon key="type">Disease</infon>
        <location offset="18924" length="11"/>
        <text>error terms</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>19039</offset>
      <text>The Initial second-order model demonstrated poor model fit (x2 = 1838.24, df = 269, P &lt; 0.001, CFI = 0.73, TLI = 0.70, RMSEA = 0.093). Modification indices suggested overall model fit would be improved by adding the correlation of six pairs of error terms (item 4 &amp; 5 within "knowledge", 12 &amp; 13 in "application", 21 &amp; 24, 23 &amp; 31, 27 &amp; 30, and 31 &amp; 32 in "attitude"). After the modification was executed, statistical fit of the model was improved to as follows: x2 = 1205.20, df = 312, P &lt; 0.001, CFI = 0.86, TLI = 0.84, RMSEA = 0.065. Although the overall fit improved, model fit indices especially CFI and TLI were still inadequate. We observed factor loading (beta = 0.05) of the item 3 ("Clinical trials and observational methods are equally valid in establishing treatment effectiveness") was significantly lower than the other five items on the dimension of knowledge. After removing this item from the scale, goodness-of-fit statistics improved to x2 = 1056.65, df = 287, P &lt; 0.001, CFI = 0.89, TLI = 0.86, RMSEA = 0.06 (Figure 1) which was very close to our a priori threshold (CFI/TLI &gt;= 0.90, RMSEA &lt; 0.08).</text>
      <annotation id="57">
        <infon key="identifier">MESH:D000069451</infon>
        <infon key="type">Disease</infon>
        <location offset="19283" length="11"/>
        <text>error terms</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>20260</offset>
      <text>Discussion</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>20271</offset>
      <text>This study provided support for the use of a modified EBQ-KABQ questionnaire to understand different aspects of EBP knowledge, attitudes, behavior and outcomes/decisions in a variety of healthcare professionals with respect to EBP. We confirmed that the 26 ordinal items in the modified EBP-KABQ exhibit a four-domain construct consistent with the proposed four aspects of EBP. Our scale was modified based on our need to change wording to make the scale more broadly applicable to different disciplines since the original version targeted medical students. We also made changes based our experiences in pilot testing the measure since an expert committee and pilot users found some items to be redundant or difficult to understand. Our work builds on that of the developers who targeted medical trainees by providing a more broadly applicable and validated version. The newly proposed subscale construct of "outcomes/decisions" contains the items previously termed "future use" in the original scale. Outcomes/decisions more accurately reflect the item content and the targeting of the EBP-KABQ. Whereas, as the original instrument was focused on trainees who might be responding about future use, experienced clinicians will be reporting how they use EBP in current clinical decision-making and whether they attribute better outcomes to their evidence-based decisions. This domain is considered an important aspect of self-reported EBP since its focuses on the impact on practice and outcomes. We found the "outcomes/decisions" domain was moderately correlated with the other three domains, suggesting it played a role in perception of EBP. The shorter measure has improved measurement characteristics, retains conceptual domains and may be save administration time.</text>
      <annotation id="59">
        <infon key="identifier">MESH:D008569</infon>
        <infon key="type">Disease</infon>
        <location offset="20700" length="7"/>
        <text>wording</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>22052</offset>
      <text>We found the EBP-KABQ scale demonstrates promising psychometric properties when measuring EBP in practicing health professionals because our analysis supported hypotheses posed for construct validity, and we found appropriate scaling properties. The overall Cronbach's alpha (0.85) was superior to that of the original KAB scale (0.75) which may be attributed to deletion of problematic items.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>22448</offset>
      <text>The correlation between the knowledge and attitude/application domains was relatively weak. This suggests that these are relatively distinct domains. One explanation for this low correlation may be that increased focus on EBP in entry-level and post-professional education may have had more impact on knowledge than on attitudes and application of EBP. However, measurement error may also have contributed. We observed lower internal consistency of the "knowledge" domain compared to other subscales and compared to the original KAB. Low internal consistency suggested that the six items within the construct of "knowledge" were not adequately correlated. As item 3 (Clinical trials and observational methods are equally valid in establishing treatment effectiveness) demonstrated low factor loading to domain of "knowledge", we questioned the content validity of this item. One explanation for this misfit item could be that clinicians might have confused the words "observational study" with "clinical observation". However, we suspect that controversy over the "level of evidence" or "quality" of observational studies may have contributed to misfit on this item. In fact, more recent trends in evidence rating have acknowledged large observational studies as offering high quality evidence. Respondents may value large observational studies more than small trials and not endorse this item despite strong knowledge of EBP. Since this item does not appear to reflect the domain of "knowledge", and did not fit in CFA, we proposed removal. We suggest caution when using the "knowledge" subscale on its own to evaluate EBP knowledge, as further investigation is warranted to improve this sub-scale.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>24184</offset>
      <text>We found items in EBP knowledge skewed to the high extreme, whereas the others subscales did not demonstrate this. As evidence-based practice has become accepted around the world, it is now commonly integrated in the clinical training of many professionals. Hence, knowledge about what evidence-based practice is, becomes prevalent over time. Our finding may be explained by the fact that traditional evidence-based training focuses on providing knowledge to help practitioners enhance their techniques and skill level when searching and appraising evidence but less consistently focuses on implementation behaviours for integrating EBP into daily clinical activities nor resolving attitudinal barriers towards EBP. For instance, clinicians may enhance their knowledge of methods to find and appraise evidence, including the importance of systematic reviews in the evidence-based practice paradigm, but not be willing to able to incorporate this into their day-to-day clinical decision-making. Continuing medical education events often focus on providing content knowledge rather than active approaches, although the latter is more effective in promoting behavior change. This may contribute to the findings observed in the study.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>25415</offset>
      <text>We found several factors were associated with better uptake of EBP. People with a higher level of education, more years of training, completion of advanced clinical training and those practicing in rural areas reported a greater willingness to implement EBP in their daily practice. Our findings were consistent with other studies that also found health professionals with a higher level of education were more willing to adopt evidence-based practice. On the other hand, our finding that age was not a factor influencing EBP is in contrast to the literature that shows recent graduates are more likely to accept EBP than clinicians who are older. Our findings were narrowly insignificant (p &lt; 0.06) suggesting a small effect of age may not have reached significance. However, age may be less important over time as EBP spreads through post-professional training.</text>
      <annotation id="61">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25483" length="6"/>
        <text>People</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>26283</offset>
      <text>Out findings suggest clinicians who practices in rural areas are more amenable to EBP which was an unexpected finding. This may be explained by several reasons. First, clinicians in rural areas are more likely to seek evidence because they have fewer colleagues in their work environment to discuss clinical issues when questions emerge in day-to-day practice. As a consequence, they would be more accustomed to going to the Internet looking for online evidence as a medical resource. Secondly, geography is no longer a barrier for clinicians to acquire evidence based education. McColl reported only 16% of physicians in England received official education regarding literature search techniques. Therefore, clinicians in rural areas may have access to gaining skills in EBP during their professional training, or through other avenues and be motivated to use these skills to solve their clinical questions.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>27192</offset>
      <text>Our study has some limitations. While it was a strength that we had different professions and a geographically diverse sample, we were unable to explore how contextual factors contributed to our findings. Local differences regarding the EBP training, culture and language among these participants were not captured in our data collection and we could not test for the influence of many potential covariates and limited covariate testing to factors suggested as important in the literature. However, h a broader sample improves the generalizability of our findings. Since the survey was only offered in English, our findings may not represent contexts where English was not a common language. A further consideration is that the data were self-reported. We have no external criterion to examine whether the self-reported evidence-based practice behaviors are consistent with actual practice. The impact of EBP decisions on patient outcomes may be overestimated if physicians overestimate their ability to improve outcome. Studies of EBP that measure patient outcomes by patient-report or objective measures are preferable indicators of the impact of EBP, but can be challenging to measure. We had to make decisions about deletion of items based on expert review and statistical performance. Studies of the reasons for poor item performance that included qualitative techniques such as cognitive interviewing may have identified ways to reform problematic items or captured new concepts. However, since our goal was to stay true to the original KABQ, if possible, our approach was reasonable. Finally, since our sample was derived from clinicians interested in pain, it may not reflect all. Since pain is the most common patient complaint and one relevant across different professions it represented an ideal context to test the EBP-KABQ across professions and contexts.</text>
      <annotation id="69">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27476" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="70">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28114" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="71">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28241" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="72">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28261" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28911" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="28851" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="28887" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>29061</offset>
      <text>Conclusion</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>29072</offset>
      <text>This study provides evidence in a large sample of experienced clinicians from a range of professions interested in pain management that the EBP-KABQ can be used to assess four domains of EBP: Knowledge, attitude, behavior, outcomes/decisions.</text>
      <annotation id="77">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="29187" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>29315</offset>
      <text>Additional files</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">title</infon>
      <offset>29332</offset>
      <text>Abbreviations</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>29346</offset>
      <text>CFA</text>
      <annotation id="79">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="29346" length="3"/>
        <text>CFA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>29350</offset>
      <text>Confirmatory factor analysis</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>29379</offset>
      <text>CFI</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>29383</offset>
      <text>Comparative fit index</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>29405</offset>
      <text>EBP</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>29409</offset>
      <text>Evidence-based practice</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>29435</offset>
      <text>KAB</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>29439</offset>
      <text>Knowledge, attitudes, behavior</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>29470</offset>
      <text>RMSEA</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>29476</offset>
      <text>Root mean square error of approximation</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>29516</offset>
      <text>TLI</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>29520</offset>
      <text>Tucker Lewis index</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">footnote</infon>
      <offset>29539</offset>
      <text>Competing interests</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">footnote</infon>
      <offset>29559</offset>
      <text>The authors declare that they have no competing interests.</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">footnote</infon>
      <offset>29618</offset>
      <text>Authors' contributions</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">footnote</infon>
      <offset>29643</offset>
      <text>JCM, ML and RBH conceived the study. QS and JCM designed the study. QS created the analytic model with contributions from JCM and BC. QS undertook the statistical analysis. QS contributed to the writing of the first draft of the manuscript. All of the authors contributed to and have approved the final manuscript.</text>
      <annotation id="81">
        <infon key="identifier">MESH:C537366</infon>
        <infon key="type">Disease</infon>
        <location offset="29648" length="2"/>
        <text>ML</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>29958</offset>
      <text>References</text>
    </passage>
    <passage>
      <infon key="volume">7</infon>
      <infon key="name_2">surname:Guyatt;given-names:GH</infon>
      <infon key="name_1">surname:Devereaux;given-names:PJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Haynes;given-names:RB</infon>
      <infon key="fpage">36</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_doi">10.1136/ebm.7.2.36</infon>
      <infon key="year">2002</infon>
      <infon key="source">Evid Base Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">38</infon>
      <offset>29969</offset>
      <text>Clinical expertise in the era of evidence-based medicine and patient choice</text>
      <annotation id="83">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="30030" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Titler;given-names:MG</infon>
      <infon key="fpage">113</infon>
      <infon key="year">2008</infon>
      <infon key="source">Patient Safety and Quality: An Evidence-Based Handbook for Nurses. Volume 1</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">161</infon>
      <offset>30045</offset>
      <text>The evidence for evidence-based practice implementation</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Knebel;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Greiner;given-names:A</infon>
      <infon key="year">2003</infon>
      <infon key="source">Committee on the Health Professions Education Summit. Health Professions Education: A Bridge to Quality</infon>
      <infon key="type">ref</infon>
      <offset>30101</offset>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>30102</offset>
      <text>Association of American Medical Colleges (Ed): Contemporary Issues in Medicine, II: Medical Informatics and Population Health. Washington, DC; 1998.</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Feldstein;given-names:D</infon>
      <infon key="name_2">surname:Bell;given-names:D</infon>
      <infon key="name_1">surname:Baum;given-names:KD</infon>
      <infon key="name_0">surname:Shaneyfelt;given-names:T</infon>
      <infon key="fpage">1116</infon>
      <infon key="issue">9</infon>
      <infon key="pub-id_doi">10.1001/jama.296.9.1116</infon>
      <infon key="pub-id_pmid">16954491</infon>
      <infon key="year">2006</infon>
      <infon key="source">JAMA</infon>
      <infon key="type">ref</infon>
      <infon key="volume">296</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Green;given-names:M</infon>
      <infon key="lpage">1127</infon>
      <infon key="name_6">surname:Whelan;given-names:C</infon>
      <infon key="name_5">surname:Kaatz;given-names:S</infon>
      <infon key="name_4">surname:Houston;given-names:TK</infon>
      <offset>30251</offset>
      <text>Instruments for evaluating education in evidence-based practice</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Kelleher;given-names:K</infon>
      <infon key="name_2">surname:Hoagwood;given-names:K</infon>
      <infon key="name_1">surname:Glisson;given-names:C</infon>
      <infon key="name_0">surname:Aarons;given-names:GA</infon>
      <infon key="fpage">356</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_doi">10.1037/a0019188</infon>
      <infon key="pub-id_pmid">20528063</infon>
      <infon key="year">2010</infon>
      <infon key="source">Psychol Assess</infon>
      <infon key="type">ref</infon>
      <infon key="volume">22</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_5">surname:Cafri;given-names:G</infon>
      <infon key="name_4">surname:Landsverk;given-names:J</infon>
      <offset>30315</offset>
      <text>Psychometric properties and US national norms of the evidence-based practice attitude scale (EBPAS)</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Tin;given-names:KY</infon>
      <infon key="name_2">surname:Fielding;given-names:R</infon>
      <infon key="name_1">surname:Leung;given-names:GM</infon>
      <infon key="name_0">surname:Johnston;given-names:JM</infon>
      <infon key="fpage">992</infon>
      <infon key="issue">11</infon>
      <infon key="pub-id_doi">10.1046/j.1365-2923.2003.01678.x</infon>
      <infon key="pub-id_pmid">14629412</infon>
      <infon key="year">2003</infon>
      <infon key="source">Med Educ</infon>
      <infon key="type">ref</infon>
      <infon key="volume">37</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1000</infon>
      <infon key="name_4">surname:Ho;given-names:LM</infon>
      <offset>30415</offset>
      <text>The development and validation of a knowledge, attitude and behaviour questionnaire to assess undergraduate evidence-based practice teaching and learning</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Haynes;given-names:RB</infon>
      <infon key="volume">7</infon>
      <infon key="name_2">surname:Buckley;given-names:N</infon>
      <infon key="name_1">surname:Law;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:MacDermid;given-names:JC</infon>
      <infon key="fpage">115</infon>
      <infon key="pub-id_doi">10.1186/1748-5908-7-115</infon>
      <infon key="pub-id_pmid">23176444</infon>
      <infon key="year">2012</infon>
      <infon key="source">Implement Sci</infon>
      <infon key="type">ref</infon>
      <offset>30569</offset>
      <text>"Push" versus "Pull" for mobilizing pain evidence into practice across different health professions: a protocol for a randomized trial</text>
      <annotation id="85">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="30605" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_1">surname:Titler;given-names:MG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hughes;given-names:RG</infon>
      <infon key="year">2008</infon>
      <infon key="source">The Evidence for Evidence-Based Practice Implementation</infon>
      <infon key="type">ref</infon>
      <offset>30712</offset>
    </passage>
    <passage>
      <infon key="name_3">surname:van der Windt;given-names:DA</infon>
      <infon key="name_2">surname:de Boer;given-names:MR</infon>
      <infon key="name_1">surname:Bot;given-names:SD</infon>
      <infon key="name_0">surname:Terwee;given-names:CB</infon>
      <infon key="fpage">34</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_doi">10.1016/j.jclinepi.2006.03.012</infon>
      <infon key="pub-id_pmid">17161752</infon>
      <infon key="year">2007</infon>
      <infon key="source">J Clin Epidemiol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">60</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:de Vet;given-names:HC</infon>
      <infon key="lpage">42</infon>
      <infon key="name_6">surname:Bouter;given-names:LM</infon>
      <infon key="name_5">surname:Dekker;given-names:J</infon>
      <infon key="name_4">surname:Knol;given-names:DL</infon>
      <offset>30713</offset>
      <text>Quality criteria were proposed for measurement properties of health status questionnaires</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Norman;given-names:GR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Streiner;given-names:DL</infon>
      <infon key="year">2008</infon>
      <infon key="source">Health Measurement Scales: A Practical Guide to Their Development and Use</infon>
      <infon key="type">ref</infon>
      <offset>30803</offset>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>30804</offset>
      <text>Kline RB. Principles and Practice of Structural Equation Modeling: Guilford Press; 2010.</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Streiner;given-names:DL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Norman;given-names:GR</infon>
      <infon key="year">2007</infon>
      <infon key="source">Biostatistics: The Bare Essentials</infon>
      <infon key="type">ref</infon>
      <offset>30893</offset>
    </passage>
    <passage>
      <infon key="volume">3</infon>
      <infon key="name_1">surname:Bentler;given-names:PM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hu;given-names:L</infon>
      <infon key="fpage">424</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_doi">10.1037/1082-989X.3.4.424</infon>
      <infon key="year">1998</infon>
      <infon key="source">Psychol Methods</infon>
      <infon key="type">ref</infon>
      <offset>30894</offset>
      <text>Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecification</text>
    </passage>
    <passage>
      <infon key="volume">6</infon>
      <infon key="name_1">surname:Bentler;given-names:PM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hu;given-names:L</infon>
      <infon key="fpage">1</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_doi">10.1080/10705519909540118</infon>
      <infon key="year">1999</infon>
      <infon key="source">Struct Equ Modeling</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">55</infon>
      <offset>30997</offset>
      <text>Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives</text>
    </passage>
    <passage>
      <infon key="volume">154</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Joreskog;given-names:KG</infon>
      <infon key="fpage">294</infon>
      <infon key="year">1993</infon>
      <infon key="source">Sage Focus Editions</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">294</infon>
      <offset>31109</offset>
      <text>Testing structural equation models</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>31144</offset>
      <text>Brown TA: Confirmatory Factor Analysis for Applied Research: Guilford Press; 2006.</text>
    </passage>
    <passage>
      <infon key="volume">329</infon>
      <infon key="name_1">surname:Khan;given-names:KS</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Coomarasamy;given-names:A</infon>
      <infon key="fpage">1017</infon>
      <infon key="issue">7473</infon>
      <infon key="pub-id_doi">10.1136/bmj.329.7473.1017</infon>
      <infon key="pub-id_pmid">15514348</infon>
      <infon key="year">2004</infon>
      <infon key="source">BMJ</infon>
      <infon key="type">ref</infon>
      <offset>31227</offset>
      <text>What is the evidence that postgraduate teaching in evidence based medicine changes anything? A systematic review</text>
    </passage>
    <passage>
      <infon key="volume">363</infon>
      <infon key="name_1">surname:Horwitz;given-names:RI</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Concato;given-names:J</infon>
      <infon key="fpage">1660</infon>
      <infon key="issue">9422</infon>
      <infon key="pub-id_doi">10.1016/S0140-6736(04)16285-5</infon>
      <infon key="pub-id_pmid">15158623</infon>
      <infon key="year">2004</infon>
      <infon key="source">Lancet</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1661</infon>
      <offset>31340</offset>
      <text>Beyond randomised versus observational studies</text>
    </passage>
    <passage>
      <infon key="volume">1</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Concato;given-names:J</infon>
      <infon key="fpage">341</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_doi">10.1602/neurorx.1.3.341</infon>
      <infon key="pub-id_pmid">15717036</infon>
      <infon key="year">2004</infon>
      <infon key="source">NeuroRx</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">347</infon>
      <offset>31387</offset>
      <text>Observational versus experimental studies: what's the evidence for a hierarchy?</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Kunz;given-names:R</infon>
      <infon key="name_2">surname:Vist;given-names:GE</infon>
      <infon key="name_1">surname:Oxman;given-names:AD</infon>
      <infon key="name_0">surname:Guyatt;given-names:GH</infon>
      <infon key="fpage">924</infon>
      <infon key="issue">7650</infon>
      <infon key="pub-id_doi">10.1136/bmj.39489.470347.AD</infon>
      <infon key="pub-id_pmid">18436948</infon>
      <infon key="year">2008</infon>
      <infon key="source">BMJ</infon>
      <infon key="type">ref</infon>
      <infon key="volume">336</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">926</infon>
      <infon key="name_6">surname:Schunemann;given-names:HJ</infon>
      <infon key="name_5">surname:Alonso-Coello;given-names:P</infon>
      <infon key="name_4">surname:Falck-Ytter;given-names:Y</infon>
      <offset>31469</offset>
      <text>GRADE: an emerging consensus on rating quality of evidence and strength of recommendations</text>
    </passage>
    <passage>
      <infon key="volume">79</infon>
      <infon key="name_1">surname:Rundall;given-names:TG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Walshe;given-names:K</infon>
      <infon key="fpage">429</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_doi">10.1111/1468-0009.00214</infon>
      <infon key="pub-id_pmid">11565163</infon>
      <infon key="year">2001</infon>
      <infon key="source">Milbank Q</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">457</infon>
      <offset>31560</offset>
      <text>Evidence-based management: from theory to practice in health care</text>
    </passage>
    <passage>
      <infon key="volume">413</infon>
      <infon key="name_2">surname:Bhandari;given-names:M</infon>
      <infon key="name_1">surname:Tornetta;given-names:P</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Dirschl;given-names:DR</infon>
      <infon key="fpage">146</infon>
      <infon key="pub-id_doi">10.1097/01.blo.0000081203.51121.25</infon>
      <infon key="pub-id_pmid">12897604</infon>
      <infon key="year">2003</infon>
      <infon key="source">Clin Orthop Relat Res</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">157</infon>
      <offset>31628</offset>
      <text>Designing, conducting, and evaluating journal clubs in orthopaedic surgery</text>
    </passage>
    <passage>
      <infon key="name_2">surname:Mangrulkar;given-names:RS</infon>
      <infon key="name_1">surname:Frohna;given-names:JG</infon>
      <infon key="name_0">surname:Fliegel;given-names:JE</infon>
      <infon key="fpage">1157</infon>
      <infon key="issue">11</infon>
      <infon key="pub-id_doi">10.1097/00001888-200211000-00022</infon>
      <infon key="pub-id_pmid">12431934</infon>
      <infon key="year">2002</infon>
      <infon key="source">Acad Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">77</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1158</infon>
      <offset>31703</offset>
      <text>A computer-based OSCE station to measure competence in evidence-based medicine skills in medical students</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Herbert;given-names:RD</infon>
      <infon key="name_2">surname:Elkins;given-names:M</infon>
      <infon key="name_1">surname:Sherrington;given-names:C</infon>
      <infon key="name_0">surname:Maher;given-names:CG</infon>
      <infon key="fpage">644</infon>
      <infon key="issue">7</infon>
      <infon key="pub-id_pmid">15225083</infon>
      <infon key="year">2004</infon>
      <infon key="source">Phys Ther</infon>
      <infon key="type">ref</infon>
      <infon key="volume">84</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">654</infon>
      <infon key="name_4">surname:Moseley;given-names:AM</infon>
      <offset>31809</offset>
      <text>Challenges for evidence-based physical therapy: accessing and interpreting high-quality evidence on therapy</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Chambliss;given-names:ML</infon>
      <infon key="name_2">surname:Ebell;given-names:MH</infon>
      <infon key="name_1">surname:Osheroff;given-names:JA</infon>
      <infon key="name_0">surname:Ely;given-names:JW</infon>
      <infon key="fpage">710</infon>
      <infon key="issue">7339</infon>
      <infon key="pub-id_doi">10.1136/bmj.324.7339.710</infon>
      <infon key="pub-id_pmid">11909789</infon>
      <infon key="year">2002</infon>
      <infon key="source">BMJ</infon>
      <infon key="type">ref</infon>
      <infon key="volume">324</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_6">surname:Pifer;given-names:EA</infon>
      <infon key="name_5">surname:Stevermer;given-names:JJ</infon>
      <infon key="name_4">surname:Vinson;given-names:DC</infon>
      <offset>31917</offset>
      <text>Obstacles to answering doctors' questions about patient care with evidence: qualitative study</text>
      <annotation id="87">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="31965" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">50</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McCluskey;given-names:A</infon>
      <infon key="fpage">3</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_doi">10.1046/j.1440-1630.2003.00303.x</infon>
      <infon key="year">2003</infon>
      <infon key="source">Aust Occup Ther J</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">12</infon>
      <offset>32013</offset>
      <text>Occupational therapists report a low level of knowledge, skill and involvement in evidence-based practice</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Taylor;given-names:RJ</infon>
      <infon key="name_2">surname:Ewings;given-names:PE</infon>
      <infon key="name_1">surname:Reeves;given-names:BC</infon>
      <infon key="name_0">surname:Taylor;given-names:RS</infon>
      <infon key="fpage">30</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_doi">10.1186/1472-6920-4-30</infon>
      <infon key="pub-id_pmid">15585061</infon>
      <infon key="year">2004</infon>
      <infon key="source">BMC Med Educ</infon>
      <infon key="type">ref</infon>
      <infon key="volume">4</infon>
      <infon key="section_type">REF</infon>
      <offset>32121</offset>
      <text>Critical appraisal skills training for health care professionals: a randomized controlled trial [ISRCTN46272378]</text>
    </passage>
    <passage>
      <infon key="name_2">surname:Khan;given-names:K</infon>
      <infon key="name_1">surname:Taylor;given-names:R</infon>
      <infon key="name_0">surname:Coomarasamy;given-names:A</infon>
      <infon key="fpage">77</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_doi">10.1080/0142159021000061468</infon>
      <infon key="pub-id_pmid">14741863</infon>
      <infon key="year">2003</infon>
      <infon key="source">Med Teach</infon>
      <infon key="type">ref</infon>
      <infon key="volume">25</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">81</infon>
      <offset>32234</offset>
      <text>A systematic review of postgraduate teaching in evidence-based medicine and critical appraisal</text>
    </passage>
    <passage>
      <infon key="volume">5</infon>
      <infon key="name_1">surname:Lovarini;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McCluskey;given-names:A</infon>
      <infon key="fpage">40</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_doi">10.1186/1472-6920-5-40</infon>
      <infon key="pub-id_pmid">16364181</infon>
      <infon key="year">2005</infon>
      <infon key="source">BMC Med Educ</infon>
      <infon key="type">ref</infon>
      <offset>32329</offset>
      <text>Providing education on evidence-based practice improved knowledge but did not change behaviour: a before and after study</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Haynes;given-names:RB</infon>
      <infon key="name_2">surname:Oxman;given-names:AD</infon>
      <infon key="name_1">surname:Thomson;given-names:MA</infon>
      <infon key="name_0">surname:Davis;given-names:DA</infon>
      <infon key="fpage">1111</infon>
      <infon key="issue">9</infon>
      <infon key="pub-id_doi">10.1001/jama.1992.03490090053014</infon>
      <infon key="pub-id_pmid">1501333</infon>
      <infon key="year">1992</infon>
      <infon key="source">JAMA</infon>
      <infon key="type">ref</infon>
      <infon key="volume">268</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1117</infon>
      <offset>32450</offset>
      <text>Evidence for the effectiveness of CME. A review of 50 randomized controlled trials</text>
    </passage>
    <passage>
      <infon key="volume">57</infon>
      <infon key="name_1">surname:Rubin;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Parrish;given-names:DE</infon>
      <infon key="fpage">201</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_doi">10.1093/sw/sws016</infon>
      <infon key="pub-id_pmid">23252312</infon>
      <infon key="year">2012</infon>
      <infon key="source">Soc Work</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">210</infon>
      <offset>32533</offset>
      <text>Social workers' orientations toward the evidence-based practice process: a comparison with psychologists and licensed marriage and family therapists</text>
    </passage>
    <passage>
      <infon key="volume">33</infon>
      <infon key="name_2">surname:Williams;given-names:JI</infon>
      <infon key="name_1">surname:Jaglal;given-names:SB</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Salbach;given-names:NM</infon>
      <infon key="fpage">33</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_doi">10.1002/chp.21164</infon>
      <infon key="year">2013</infon>
      <infon key="source">J Contin Educ Heal Prof</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">40</infon>
      <offset>32684</offset>
      <text>Reliability and validity of the evidence-based practice confidence (EPIC) scale</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Middleton;given-names:PM</infon>
      <infon key="name_2">surname:Patterson;given-names:J</infon>
      <infon key="name_1">surname:Bendall;given-names:JC</infon>
      <infon key="name_0">surname:Simpson;given-names:PM</infon>
      <infon key="fpage">197</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_doi">10.1111/j.1744-1609.2012.00273.x</infon>
      <infon key="year">2012</infon>
      <infon key="source">Int J Evid Base Healthc</infon>
      <infon key="type">ref</infon>
      <infon key="volume">10</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">203</infon>
      <offset>32764</offset>
      <text>Beliefs and expectations of paramedics towards evidence-based practice and research</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Field;given-names:J</infon>
      <infon key="name_2">surname:White;given-names:P</infon>
      <infon key="name_1">surname:Smith;given-names:H</infon>
      <infon key="name_0">surname:McColl;given-names:A</infon>
      <infon key="fpage">361</infon>
      <infon key="issue">7128</infon>
      <infon key="pub-id_doi">10.1136/bmj.316.7128.361</infon>
      <infon key="pub-id_pmid">9487174</infon>
      <infon key="year">1998</infon>
      <infon key="source">BMJ</infon>
      <infon key="type">ref</infon>
      <infon key="volume">316</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">365</infon>
      <offset>32848</offset>
      <text>General practitioners' perceptions of the route to evidence based medicine: a questionnaire survey</text>
    </passage>
    <passage>
      <infon key="name_2">surname:Manning;given-names:PR</infon>
      <infon key="name_1">surname:Uman;given-names:GC</infon>
      <infon key="name_0">surname:Covell;given-names:DG</infon>
      <infon key="fpage">596</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_doi">10.7326/0003-4819-103-4-596</infon>
      <infon key="pub-id_pmid">4037559</infon>
      <infon key="year">1985</infon>
      <infon key="source">Ann Intern Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">103</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">599</infon>
      <offset>32949</offset>
      <text>Information needs in office practice: are they being met?</text>
    </passage>
    <passage>
      <infon key="volume">362</infon>
      <infon key="name_1">surname:Grimshaw;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Grol;given-names:R</infon>
      <infon key="fpage">1225</infon>
      <infon key="issue">9391</infon>
      <infon key="pub-id_doi">10.1016/S0140-6736(03)14546-1</infon>
      <infon key="pub-id_pmid">14568747</infon>
      <infon key="year">2003</infon>
      <infon key="source">Lancet</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1230</infon>
      <offset>33007</offset>
      <text>From best evidence to best practice: effective implementation of change in patients' care</text>
      <annotation id="89">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="33082" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">310</infon>
      <infon key="name_1">surname:Donald;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rosenberg;given-names:W</infon>
      <infon key="fpage">1122</infon>
      <infon key="issue">6987</infon>
      <infon key="pub-id_doi">10.1136/bmj.310.6987.1122</infon>
      <infon key="pub-id_pmid">7742682</infon>
      <infon key="year">1995</infon>
      <infon key="source">BMJ</infon>
      <infon key="type">ref</infon>
      <offset>33099</offset>
      <text>Evidence based medicine: an approach to clinical problem-solving</text>
    </passage>
  </document>
  <document>
    <id>4272820</id>
    <passage>
      <infon key="name_3">surname:Denninghoff;given-names:Kurt</infon>
      <infon key="name_2">surname:Barnhart;given-names:Bruce</infon>
      <infon key="name_1">surname:Jones;given-names:Elizabeth</infon>
      <infon key="article-id_pmid">24548058</infon>
      <infon key="name_0">surname:McMullan;given-names:Jason T.</infon>
      <infon key="fpage">368</infon>
      <infon key="issue">3</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272820</infon>
      <infon key="article-id_doi">10.3109/10903127.2013.869642</infon>
      <infon key="type">front</infon>
      <infon key="volume">18</infon>
      <infon key="license">           This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.         </infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Prehosp Emerg Care; 2014 Jul-Sep; 18(3) 368-74. doi:10.3109/10903127.2013.869642</infon>
      <infon key="kwd">emergency medical services benzodiazepines temperature</infon>
      <infon key="lpage">374</infon>
      <infon key="name_6">surname:Silbergleit;given-names:Robert</infon>
      <infon key="name_5">surname:Zaleski;given-names:Erin</infon>
      <infon key="article-id_manuscript">NIHMS644369</infon>
      <infon key="name_4">surname:Spaite;given-names:Daniel</infon>
      <infon key="authors">McMullan JT, Jones E, Barnhart B, Denninghoff K, Spaite D, Zaleski E, Silbergleit R</infon>
      <offset>0</offset>
      <text>Degradation of Benzodiazepines after 120 Days of EMS Deployment</text>
      <annotation id="1">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="15" length="15"/>
        <text>Benzodiazepines</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>64</offset>
      <text>Introduction</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>77</offset>
      <text>EMS treatment of status epilepticus improves outcomes, but the benzodiazepine best suited for EMS use is unclear, given potential high environmental temperature exposures.</text>
      <annotation id="4">
        <infon key="identifier">MESH:D013226</infon>
        <infon key="type">Disease</infon>
        <location offset="94" length="18"/>
        <text>status epilepticus</text>
      </annotation>
      <annotation id="5">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="140" length="14"/>
        <text>benzodiazepine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>249</offset>
      <text>Objective</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>259</offset>
      <text>To describe the degradation of diazepam, lorazepam, and midazolam as a function of temperature exposure and time over 120 days of storage on active EMS units.</text>
      <annotation id="9">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="315" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="10">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="290" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="11">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="300" length="9"/>
        <text>lorazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>418</offset>
      <text>Methods</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>426</offset>
      <text>Study boxes containing vials of diazepam, lorazepam, and midazolam were distributed to 4 active EMS units in each of 2 EMS systems in the southwestern United States during May-August 2011. The boxes logged temperature every minute and were stored in EMS units per local agency policy. Two vials of each drug were removed from each box at 30-day intervals and underwent high-performance liquid chromatography to determine drug concentration. Concentration was analyzed as mean (and 95%CI) percent of initial labeled concentration as a function of time and mean kinetic temperature (MKT).</text>
      <annotation id="15">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="458" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="16">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="468" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="17">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="483" length="9"/>
        <text>midazolam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1015</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1023</offset>
      <text>192 samples were collected (2 samples of each drug from each of 4 units per city at 4 time-points). After 120 days, the mean relative concentration (95%CI) of diazepam was 97.0% (95.7-98.2%) and of midazolam was 99.0% (97.7-100.2%). Lorazepam experienced modest degradation by 60 days (95.6% [91.6-99.5%]) and substantial degradation at 90 days (90.3% [85.2-95.4%]) and 120 days (86.5% [80.7-92.3%]). Mean MKT was 31.6 C (95%CI 27.1-36.1). Increasing MKT was associated with greater degradation of lorazepam, but not midazolam or diazepam.</text>
      <annotation id="24">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="1182" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="25">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="1553" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="26">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="1540" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="1521" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="28">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="1256" length="9"/>
        <text>Lorazepam</text>
      </annotation>
      <annotation id="29">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="1221" length="9"/>
        <text>midazolam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1574</offset>
      <text>Conclusions</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1586</offset>
      <text>Midazolam and diazepam experienced minimal degradation throughout 120 days of EMS deployment in high-heat environments. Lorazepam experienced significant degradation over 120 days and appeared especially sensitive to higher MKT exposure.</text>
      <annotation id="33">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="1706" length="9"/>
        <text>Lorazepam</text>
      </annotation>
      <annotation id="34">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="1600" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="1586" length="9"/>
        <text>Midazolam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1824</offset>
      <text>Introduction</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1837</offset>
      <text>Emergency medical services (EMS) treatment of status epilepticus with benzodiazepines improves outcomes. Recent evidence suggests that, among the commonly used benzodiazepines, midazolam may be the most effective in achieving seizure cessation prior to hospital arrival. EMS medications are frequently stored without temperature-control procedures, which may negatively impact the medication through degradation, and heat stability is an important factor in determining which benzodiazepine to deploy in an EMS system. Diazepam and lorazepam experience some heat-dependent degradation while midazolam is heat-stable for at least 60 days. The effect of longer storage, especially in extreme heat conditions, is unknown.</text>
      <annotation id="45">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="2369" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="46">
        <infon key="identifier">MESH:D013226</infon>
        <infon key="type">Disease</infon>
        <location offset="1883" length="18"/>
        <text>status epilepticus</text>
      </annotation>
      <annotation id="47">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="2313" length="14"/>
        <text>benzodiazepine</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="2356" length="8"/>
        <text>Diazepam</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="1997" length="15"/>
        <text>benzodiazepines</text>
      </annotation>
      <annotation id="50">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="2014" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="51">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="2428" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="52">
        <infon key="identifier">MESH:D012640</infon>
        <infon key="type">Disease</infon>
        <location offset="2063" length="7"/>
        <text>seizure</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="1907" length="15"/>
        <text>benzodiazepines</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2556</offset>
      <text>We sought to expand on our previous work by describing the degradation of diazepam, lorazepam, and midazolam as a function of temperature exposure and time over a longer, 120-day storage period on active EMS units during the summer months in the southwestern United States.</text>
      <annotation id="57">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="2630" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="58">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="2655" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="59">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="2640" length="9"/>
        <text>lorazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>2830</offset>
      <text>Methods</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>2838</offset>
      <text>Study Design and Setting</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>2863</offset>
      <text>This experimental pharmaco-stability study of medications stored in active EMS units was designed as an independent extension of our previous work that demonstrated heat-dependant degradation of lorazepam over 60 days. The present study was conducted during the summer of 2011 (May through August) and focused on two EMS agencies in the southwestern United States with historically high ambient temperatures. We extended the period of observation to 120 days and added diazepam as a comparator to give insight on the behavior of all benzodiazepines currently available for prehospital use.</text>
      <annotation id="63">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="3058" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="64">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="3396" length="15"/>
        <text>benzodiazepines</text>
      </annotation>
      <annotation id="65">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="3332" length="8"/>
        <text>diazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>3453</offset>
      <text>Vials of diazepam, lorazepam, and midazolam were distributed to 4 active EMS units in each of the two EMS systems. Instrumented boxes logged temperature every minute and were stored in EMS units per local agency policy alongside other routine medications. Use of temperature-control systems beyond normal vehicle air conditioning or garaging practices were not specified in the study protocol. Mirroring routine EMS practices, some vehicles were kept in station garages unless responding to an emergency call, while others were constantly exposed to ambient temperatures during work shifts. Two samples of each benzodiazepine were removed from each box after 30, 60, 90, and 120 days of deployment.</text>
      <annotation id="71">
        <infon key="identifier">32644</infon>
        <infon key="type">Species</infon>
        <location offset="3810" length="13"/>
        <text>not specified</text>
      </annotation>
      <annotation id="72">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="3487" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="3472" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="3462" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="4064" length="14"/>
        <text>benzodiazepine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4152</offset>
      <text>The methods of measurement, data collection, and data processing were identical to our previous study. Briefly, the instrumented study boxes measured and recorded temperature every minute. Temperatures were analyzed and summarized by determination of the mean kinetic temperature (MKT), which is commonly used in the pharmaceutical industry to describe the overall effects of temperature changes on heat-sensitive materials. MKT expresses the cumulative heat stress to which a medication has been exposed over time and is not a simple average of ambient temperatures.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4720</offset>
      <text>Samples were analyzed in a commercial laboratory (DynaLabs, St. Louis, MO) by high-performance liquid chromatography (HPLC) to determine the concentration of the active drug. Samples were refrigerated after removal from the field, including during shipping, to minimize further heat-related degradation.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5024</offset>
      <text>Data were managed within Microsoft Excel (Microsoft, Redmond, WA) and analyzed using SPSS version 19 (International Business Machines, Armonk, NY).</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>5172</offset>
      <text>Outcome Measures</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5189</offset>
      <text>The primary outcome was the relative reduction in medication concentration from labeled concentration after 30-120 days of exposure.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>5324</offset>
      <text>Primary Data Analysis</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5346</offset>
      <text>Concentration was analyzed as a function of time and MKT. For each benzodiazepine, the mean relative concentration at 60, 90, and 120 days was compared to the 30-day measurement using the Student t-test. The influence of MKT and time on each medication's degradation was determined with linear regression and oneway analysis of covariance (ANCOVA), respectively.</text>
      <annotation id="77">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="5413" length="14"/>
        <text>benzodiazepine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>5709</offset>
      <text>Sample Size Determination</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5735</offset>
      <text>Sample size was estimated to provide a significance of 0.05 and a power of 0.8, assuming a mean difference of 7.5% between the 120-day relative concentrations of lorazepam compared to midazolam or diazepam. The assumed within-group sample variability (standard deviation) was 5%.</text>
      <annotation id="81">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="5932" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="82">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="5919" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="83">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="5897" length="9"/>
        <text>lorazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>6015</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6023</offset>
      <text>A total of 192 samples were collected (2 samples in each of 4 units per city at 4 timepoints for each drug) and underwent HPLC. The cumulative mean MKT over the 120-day period was 31.6 C (95%CI 27.1-36.1 C) (Table 1).</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6245</offset>
      <text>Benzodiazepine concentration over time is shown in Table 1 and the impact of time on degradation was significantly different among the benzodiazepines (ANCOVA p &lt; 0.01). Diazepam and midazolam experienced minimal degradation at each time point. At 120 days, the mean relative concentration (95%CI) of diazepam was 97.0% (95.7-98.2%) and of midazolam was 99.0% (97.7-100.2%). Lorazepam experienced significant degradation by 60 days (95.6% [91.6-99.5]) with the concentration in half of all samples being less than 95% of labeled concentration. Relative concentration of lorazepam was 90.3% (85.2-95.4) at 90 days and 86.5% (80.7-92.3) at 120 days.</text>
      <annotation id="92">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="6585" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="93">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="6415" length="8"/>
        <text>Diazepam</text>
      </annotation>
      <annotation id="94">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="6815" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="95">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="6620" length="9"/>
        <text>Lorazepam</text>
      </annotation>
      <annotation id="96">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="6546" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="97">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="6380" length="15"/>
        <text>benzodiazepines</text>
      </annotation>
      <annotation id="98">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="6428" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="99">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="6245" length="14"/>
        <text>Benzodiazepine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6903</offset>
      <text>Midazolam and diazepam were stable across the range of mean kinetic temperatures, whereas increasing MKT was associated with greater degradation of lorazepam after 120 days (Figure 1; lorazepam R2 = 0.98). The mean (95%CI) daily ambient temperature for each site was not significantly different (30.6 C [23.3-37.2 C] vs. 33.3 C [26.7-40.0 C]; p = 0.83). However, there was a greater than expected observed difference of MKT between sites over the 120 days (27.0 C [22.9-31.1 C] vs. 35.0 C [30.3-39.8 C]; p = 0.009). There was no significant intersite difference in the relative concentrations of midazolam or diazepam at any timepoint. Lorazepam experienced statistically significant degradation at 60, 90, and 120 days (p = 0.009) at each site, and the magnitude of the temperature effect was different between the two sites (ANCOVA p = 0.001) (Figure 2).</text>
      <annotation id="107">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="7512" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="108">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="6917" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="109">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="7499" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="110">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="7539" length="9"/>
        <text>Lorazepam</text>
      </annotation>
      <annotation id="111">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="7051" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="112">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="7087" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="113">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="6903" length="9"/>
        <text>Midazolam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>7776</offset>
      <text>DIscussion</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>7787</offset>
      <text>In this study, we found that midazolam and diazepam experienced minimal degradation during 120 days of EMS deployment in high-heat environments. Lorazepam maintained acceptable concentrations of active drug for at least 30 days. However, when exposed to high heat stress, many samples experienced significant and progressive degradation by 60 days.</text>
      <annotation id="117">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="7830" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="118">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="7816" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="119">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="7932" length="9"/>
        <text>Lorazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>8136</offset>
      <text>We have previously evaluated rates of degradation for lorazepam and midazolam over 60 days of EMS field deployment at multiple sites during the conduct of a multicenter clinical trial. In that study we found that midazolam remained stable at 60 days, but that lorazepam showed slight time- and temperature-dependent degradation. The current study builds upon this work by extending the period of observation to 120 days, by focusing on EMS systems with very high heat stress, and by including diazepam, the most common benzodiazepine in EMS use. The current study confirms the stability of midazolam for at least 120 days and that lorazepam is time and heat sensitive.</text>
      <annotation id="128">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="8204" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="129">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="8629" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="130">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="8726" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="131">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="8767" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="132">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="8190" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="8349" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="134">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="8396" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="8655" length="14"/>
        <text>benzodiazepine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>8805</offset>
      <text>Gottwald et al. previously reported some experience with the degradation of diazepam and lorazepam deployed on two ambulances in San Francisco. Interestingly, despite higher ambient temperatures, we found that diazepam was more resilient than first reported, with no diazepam samples determined to have &lt;90% of labeled concentration. Lorazepam's degradation was greater at 60 days and beyond, as well, reaffirming the relationship between heat stress and medication decomposition.</text>
      <annotation id="141">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="9139" length="9"/>
        <text>Lorazepam</text>
      </annotation>
      <annotation id="142">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="9072" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="8894" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="144">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="9015" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="145">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="8881" length="8"/>
        <text>diazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9286</offset>
      <text>Ambient temperatures were similar between the two sites. However, there was an unexpected difference in the MKTs encountered at each site (27.0 vs. 35.0 C). Although unplanned, this difference allows additional insight into lorazepam's instability in the prehospital setting. Post hoc evaluation of this difference found that the agency with the lower MKT frequently keeps EMS units running with the vehicle's air conditioning system engaged, while the other agency routinely turns off the EMS units and parks them in station garages between calls. It is probable that a combination of operational and environmental factors contributed to the higher degradation rate at one site. However, it appears that altering the deployment and storage procedures for vehicles does not prevent lorazepam degradation in hot environments and further temperature-control methods, such as on-board refrigeration units, may be needed to extend useful shelf life.</text>
      <annotation id="148">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="10068" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="149">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="9510" length="9"/>
        <text>lorazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10233</offset>
      <text>It is notable that ambient temperature cannot be used as a surrogate for MKT when assessing whether, or for how long, lorazepam can be stored in an EMS unit. MKT is a dynamic variable that accounts for the potential stress caused by changing temperatures, which is one reason that the pharmacology literature supports the use of MKT, rather than simple temperature means, for evaluating heat stability of drugs. These data support the notion that EMS agencies should take multiple variables into consideration, including temperature exposure and length of field deployment, when determining medication storage and restocking policies.</text>
      <annotation id="153">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="10562" length="3"/>
        <text>MKT</text>
      </annotation>
      <annotation id="154">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="10391" length="3"/>
        <text>MKT</text>
      </annotation>
      <annotation id="155">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="10351" length="9"/>
        <text>lorazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10868</offset>
      <text>Based on our findings here and previously, EMS systems choosing to deploy lorazepam should employ lorazepam storage methods to limit high heat exposures and maintain controlled room temperature (MKT &lt; 25 C) environments. Otherwise, it may be prudent to limit field deployment time of lorazepam to 30 days to minimize degradation risks. In some systems, preferential use of midazolam or diazepam may be warranted.</text>
      <annotation id="161">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="11152" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="11241" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="10942" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="11254" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="10966" length="9"/>
        <text>lorazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>11282</offset>
      <text>Limitations And Future Research</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11314</offset>
      <text>This study has limitations. First, baseline (day 0) samples were not obtained because our previous work demonstrated consistent baseline concentrations for midazolam and lorazepam. Furthermore, the differences in the pair of samples taken from each EMS unit for testing were insignificant. This is consistent with the quality controls and USP specifications expected in these commercial pharmaceuticals.</text>
      <annotation id="168">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="11470" length="9"/>
        <text>midazolam</text>
      </annotation>
      <annotation id="169">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="11484" length="9"/>
        <text>lorazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11718</offset>
      <text>Second, we did not perform duplicate measures from each sample; instead, we performed redundant single measurements from independent but identically stored samples. Previous work has demonstrated the reliability of the HPLC testing, and our duplicate sample testing reduces the bias that an outlier may cause.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12028</offset>
      <text>Finally, this study was not designed to evaluate the impact of different vehicle deployment or medication storage practices on drug degradation. The impact of medication refrigerators and other techniques to control heat exposure and MKT may be more important for lorazepam than the other benzodiazepines and is a topic suitable for further study.</text>
      <annotation id="172">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="12317" length="15"/>
        <text>benzodiazepines</text>
      </annotation>
      <annotation id="173">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="12292" length="9"/>
        <text>lorazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12376</offset>
      <text>Evaluating the impact of heat exposure on other medications commonly used by EMS should be a priority.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>12479</offset>
      <text>Conclusion</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>12490</offset>
      <text>Midazolam and diazepam experienced minimal degradation throughout 120 days of EMS deployment in high-heat environments. In contrast, lorazepam degraded significantly over this time and appeared especially sensitive to higher mean kinetic temperatures.</text>
      <annotation id="177">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="12623" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="178">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="12490" length="9"/>
        <text>Midazolam</text>
      </annotation>
      <annotation id="179">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="12504" length="8"/>
        <text>diazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>12742</offset>
      <text>Author contributions: JM and RS conceived the study and designed the trial. All authors supervised the conduct of the trial and data collection. JM and RS analyzed the data. JM drafted the manuscript, and all authors contributed substantially to its revision. JM takes responsibility for the paper as a whole.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>13052</offset>
      <text>                </text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>13069</offset>
      <text>The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>13190</offset>
      <text>                </text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>13207</offset>
      <text>This work was presented in oral and poster format at the Society for Academic Emergency Medicine annual meeting (May 2013, Atlanta).</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>13340</offset>
      <text>                </text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title</infon>
      <offset>13357</offset>
      <text>The Neurological Emergencies Treatment Trials investigators</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>13417</offset>
      <text>Clinical Coordinating Center</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>13446</offset>
      <text>Robert Silbergleit, MD, Daniel Lowenstein, MD, William Barsan, MD, Arthur Pancioli, MD, Valerie Stevenson, BAS, RRT, CCRP, Erin Zaleski, MA, Deneil</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>13594</offset>
      <text>Harney, MPH, MSW, Donna Harsh, MS, Joy Pinkerton, BSN, RN, MS, Allison Kade, BA, Nicholas Siewert, BA, Ashley Pinawin, BS, Catherin Ring, Phebe Brenne</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>13745</offset>
      <text>National EMS Coordinator</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>13770</offset>
      <text>Kay Vonderschmidt, MPA, MS-EM, NREMT-P</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>13809</offset>
      <text>Statistical Data Management Center</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>13844</offset>
      <text>Valerie Durkalski, PhD, Yuko Palesch, PhD, Catherine Dillon, Keith Pauls, Qi Wu, Wenle Zhao, PhD</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>13941</offset>
      <text>National Institutes of Health</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>13971</offset>
      <text>Robin Conwit, MD, Scott Janis, PhD, David Jett, PhD, Brandy Fureman, PhD</text>
      <annotation id="181">
        <infon key="identifier">9188</infon>
        <infon key="type">Species</infon>
        <location offset="13971" length="5"/>
        <text>Robin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>14044</offset>
      <text>Hubs (ordered by number of subjects enrolled)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>14090</offset>
      <text>Wayne State University (178)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>14119</offset>
      <text>Hub Principal Investigator: Robert D. Welch, MD, MS Primary Study Coordinators: Lynnmarie Mango, MPH, Valerie H. Mika, MS EMS Director(s)/Coordinator: Jenny Atas, MD Other Site Investigators: Robert Dunne, MD, Douglas Wheaton, MD, Phillip Levy, MD, MPH, Marc-Anthony Velilla, MD, Robert Sherwin, MD, Brian O'Neil, MD, Angela Groves, MD, Marc Rosenthal, DO, PhD Participating EMS Service: Detroit EMS</text>
      <annotation id="185">
        <infon key="identifier">29780</infon>
        <infon key="type">Species</infon>
        <location offset="14209" length="5"/>
        <text>Mango</text>
      </annotation>
      <annotation id="186">
        <infon key="identifier">301693</infon>
        <infon key="type">Species</infon>
        <location offset="14276" length="4"/>
        <text>Atas</text>
      </annotation>
      <annotation id="187">
        <infon key="identifier">MESH:D004881</infon>
        <infon key="type">Disease</infon>
        <location offset="14373" length="20"/>
        <text>Marc-Anthony Velilla</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>14519</offset>
      <text>University of Cincinnati (133)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>14550</offset>
      <text>Hub Principal Investigator: Arthur Pancioli, MD Primary Study Coordinators: Irene Ewing, RN, BSN, Peggy Waymeyer, RN EMS Director(s)/Coordinator: M. Kay Vonderschmidt, MPA, MS-EM, NREMT-P, Jason McMullan, MD Other Site Investigators: Hamilton Schwartz, MD, Brian Stettler, MD, William Knight, MD, Opeolu Adeoye, MD, Rhonda Cadena, MD, Jordan Bonomo, MD, Erin Grise, MD, Laura Heitsch, MD, George Shaw, MD, Nick Gagai, CCRP, Pamela Schmit, RN BSN, Sara Stark, Med, Traci Doellman, RN Participating EMS Services: Cincinnati Fire Department, BlueAsh Fire Department, Forest Park Fire Department, Green Township Fire Department, Florence Fire Department, Independence Fire Department</text>
      <annotation id="189">
        <infon key="type">CellLine</infon>
        <location offset="14920" length="13"/>
        <text>Laura Heitsch</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>15230</offset>
      <text>University of California San Francisco (121)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>15275</offset>
      <text>Hub Principal Investigator: J. Claude Hemphill, III, MD, MAS Primary Study Coordinators: Michele Meeker, RN, BSN, Kelley Rosborough, BA EMS Director(s)/Coordinator: Jeany Duncan EMT-P Other Site Investigators: Karl Sporer, MD, FACEP, FACP, Alan Gelb, MD; Wade Smith, MD, PhD, Prasanthi Ramanujam, MD, Kazuma Nakagawa, MD, Asma Moheet, MD, Hooman Kamel, MD, Bharath Naravetla, MD, Mary Mercer, MD, Christine Wong, MD Participating EMS Services: San Francisco Fire Department, EMS Division</text>
      <annotation id="191">
        <infon key="identifier">MESH:D020526</infon>
        <infon key="type">Disease</infon>
        <location offset="15306" length="15"/>
        <text>Claude Hemphill</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>15763</offset>
      <text>University of Texas - Houston (81)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>15800</offset>
      <text>Hub Principal Investigator: Elizabeth Jones, MD Trial Principal Investigator: Truman J. Milling, MD Primary Study Coordinators: Misty Ottman, RN, BSN, Ben King, Laura LaChance EMS Directors/Coordinators: Jeff Brockman, RN, Pete Didonato, EMT-P Other Site Investigator: Paul Hinchey, MD Participating EMS Service: Austin-Travis County EMS</text>
      <annotation id="193">
        <infon key="identifier">CVCL:0030</infon>
        <infon key="type">CellLine</infon>
        <location offset="15961" length="8"/>
        <text>Laura La</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>16138</offset>
      <text>Emory University (75)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>16160</offset>
      <text>Hub Principal Investigator: David W. Wright, MD Trial Principal Investigators: Matthew D. Bitner, MD, Gerald W. Beltran, DO Primary Study Coordinator: Harriet Nevarez, RN, CCRC EMS Director/Coordinator: Rachel Barnhard, Andrea G. McDougal Other Site Investigators: Jeffrey F. Linzer Sr, MD, Lisa H. Merck, MD MPH, Tamara Espinoza, MD Participating EMS Service: Grady EMS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>16531</offset>
      <text>Henry Ford Health System (64)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>16561</offset>
      <text>Hub Principal Investigator: Christopher A. Lewandowski, MD Trial Principal Investigator: Taher T. Vohra, MD Primary Study Coordinators: Paula L. Crouse, RN, BSN., MA., Anna E. Baker, RN, BSN EMS Director/Coordinator: Dean R. Creech EMT-P, I/C Other Site Investigator: Andrew N. Russman, DO, Joseph B. Miller, MD, Jumana Nagarwala, MD, Daniel J. Miller, MD, Raymond Fowkes, MD, Anne Marie Lundell, RN, BSN Participating EMS Services: Detroit EMS, West Bloom-field Fire and EMS Services</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>17046</offset>
      <text>Stanford University (62)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>17071</offset>
      <text>Hub Principal Investigator: James V. Quinn, MD, MS Primary Study Coordinators: Stephanie Casal. RN, CNS, Anke Hebig, Mark Liao EMS Director/Coordinator: Peter D'souza, MD Participating EMS Services: Palo Alto Fire Department, San Jose Fire Department, Redwood City Fire Department, San Mateo Fire Department</text>
      <annotation id="195">
        <infon key="identifier">28980</infon>
        <infon key="type">Species</infon>
        <location offset="17323" length="7"/>
        <text>Redwood</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>17379</offset>
      <text>University of Arizona (58)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>17406</offset>
      <text>Hub Principal Investigator: Kurt R. Denninghoff, MD Trial Principal Investigator: Daniel W. Spaite, MD Primary Study Coordinator: Bruce Barnhart, RN, CEP EMS Director(s)/Coordinator: Willie Haro, CEP Other Site Investigator: Bentley J. Bobrow, MD Participating EMS Service: Glendale Fire Department</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>17705</offset>
      <text>Virginia Commonwealth University (55)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>17743</offset>
      <text>Hub Principal Investigator: Joseph P. Ornato, MD Primary Study Coordinator: Sallie L. Noe, RN</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>17837</offset>
      <text>EMS Director/Coordinator: Alan D. Payne, CCEMTP Other Site Investigators: Alan R. Towne, MD, Michael C. Kurz, MD, John T. Carmack, MD Participating EMS Service: Richmond Ambulance Authority</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>18027</offset>
      <text>University of Minnesota (47)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>18056</offset>
      <text>Hub Principal Investigator: Michelle Biros, MD Trial Principal Investigator: Brian Mahoney, MD Primary Study Coordinators: Corey Sargent, Kathleen Miller, BSN, CCRC Other Site Investigators: David Hildebrandt, Chris Kummer, Doug Gesme Participating EMS Services: Hennepin County EMS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>18339</offset>
      <text>Medical College of Wisconsin (47)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>18373</offset>
      <text>Hub Principal Investigator: Tom P. Aufderheide, MD Primary Study Coordinator: Joseph T. Brandt Jr., BS, EMT-P EMS Director/Coordinator: M. Riccardo Colella, DO Other Site Investigators: Ron Pirrallo, MD, MHSA, Walter Bialkowski, MS, Benjamin Hermanson, BS, Christopher Sandoval, BS, EMT-P, Kevin Morrow, MFA, Kelly McCormick, BS, MBA, Katherine Burpee, BA, Geri Price, BS, Dawn Kawa, BA Participating EMS Services: Milwaukee County EMS, Milwaukee Fire Department, Franklin Fire Department, Greenfield Fire Department, North Shore Fire Department, Oak Creek Fire Department, South Milwaukee Fire Department, Wauwatosa Fire Department, West Allis Fire Department</text>
      <annotation id="197">
        <infon key="type">Disease</infon>
        <location offset="18512" length="16"/>
        <text>Riccardo Colella</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>19034</offset>
      <text>University of Kentucky (31)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>19062</offset>
      <text>Hub Principal Investigator: Roger L. Humphries, MD Primary Study Coordinator: Linda Dechtenberg, RN, BSN, CCRC EMS Director/Coordinator: Christofer Sweat Other Site Investigator: L. Creed Pettigrew, MD,MPH Participating EMS Service: Lexington-Fayette Urban County Government Division of Fire &amp; Emergency Services</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>19375</offset>
      <text>University of Pennsylvania (26)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>19407</offset>
      <text>Hub Principal Investigator: Jill M. Baren, MD, MBE Trial Principal Investigator: R. Daniel Bledsoe, MD Primary Study Coordinator: Barbie Stahlman, MS, Katherine Lamond, BA, Pamela G. Nathanson, MBE Other Site Investigator: Scott E. Kasner, MD, MSCE, Peter D. Le Roux, MD Participating EMS Services: York Hospital Medic 97, White Rose Ambulance, Grantley Fire Company, Jacobus Lions Ambulance Club, West York Ambulance</text>
      <annotation id="199">
        <infon key="identifier">9689</infon>
        <infon key="type">Species</infon>
        <location offset="19783" length="5"/>
        <text>Lions</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>19825</offset>
      <text>Oregon Health &amp; Science University (24)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>19865</offset>
      <text>Hub Principal Investigators: Craig R. Warden, MD, MPH, Robert A. Lowe, MD, MPH Primary Study Coordinator: Rachel N. Stone, CCRP Participating EMS Service: Clackamas Fire District #1</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>20047</offset>
      <text>New York Presbyterian Hospital (10)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>20083</offset>
      <text>Hub Principal Investigator: Stephan Mayer, MD, FCCM Trial Principal Investigator: Neal Flomenbaum, MD Primary Study Coordinators: M. Cristina Falo, PhD, Lisa-Vanessa Magitbay, RN, Chirag Surti EMS Directors/Coordinators: Heidi Cordi, MD, Daniel Ribaudo Other Site Investigators: Axel Rosengart, MD, PhD, Matthew Vibbert, MD, Santiago Ortega-Gutierrez, MD, H. Alex Choi, MD, Emily Gilmore, MD, Rishi Malhotra, MD, Lawrence Berger Participating EMS Services: New York Presbyterian</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>20562</offset>
      <text>Temple University(8)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>20583</offset>
      <text>Hub Principal Investigator: Nina T. Gentile, MD Trial Principal Investigators: Alvin Wang, DO, Christopher Vates, MD, Ben Usatch, MD Primary Study Coordinators: Brent B. Freeman, Stacey L. Cleary Participating EMS Services: Volunteer Medical Services Corps of Lower Merion and Narberth (Narberth Ambulance), Life Lion EMS</text>
      <annotation id="201">
        <infon key="identifier">9689</infon>
        <infon key="type">Species</infon>
        <location offset="20896" length="4"/>
        <text>Lion</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>20905</offset>
      <text>University of Maryland (3)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>20932</offset>
      <text>Hub Principal Investigator: Barney Stern, MD Trial Principal Investigators: Tricia Ting, MD, Gregory Krauss, MD Primary Study Coordinators: Virginia Ganley, RN, Susan Rice, RN, Jennifer Ronald EMS Director/Coordinator: Michelle Stevens, RN Other Site Investigators: Brian Browne, MD, Robert Rosenthal, MD, Peter Hill, MD Participating EMS Services: Maryland Institute for Emergency Medical Services Systems (MIEMSS), Baltimore City EMS</text>
      <annotation id="203">
        <infon key="identifier">4530</infon>
        <infon key="type">Species</infon>
        <location offset="21099" length="4"/>
        <text>Rice</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>21368</offset>
      <text>References</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Corry;given-names:MD</infon>
      <infon key="name_2">surname:Isaacs;given-names:SM</infon>
      <infon key="name_1">surname:Gelb;given-names:AM</infon>
      <infon key="name_0">surname:Alldredge;given-names:BK</infon>
      <infon key="fpage">631</infon>
      <infon key="pub-id_pmid">11547716</infon>
      <infon key="year">2001</infon>
      <infon key="source">N Engl J Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">345</infon>
      <infon key="name_10">surname:Lowenstein;given-names:DH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Segal;given-names:MR</infon>
      <infon key="name_8">surname:Neuhaus;given-names:JM</infon>
      <infon key="name_7">surname:O'Neil;given-names:N</infon>
      <infon key="lpage">7</infon>
      <infon key="name_6">surname:Gottwald;given-names:MD</infon>
      <infon key="name_5">surname:Ulrich;given-names:S</infon>
      <infon key="name_4">surname:Allen;given-names:F</infon>
      <offset>21379</offset>
      <text>A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus.</text>
      <annotation id="207">
        <infon key="identifier">MESH:D013226</infon>
        <infon key="type">Disease</infon>
        <location offset="21465" length="18"/>
        <text>status epilepticus</text>
      </annotation>
      <annotation id="208">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="21406" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="209">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="21395" length="9"/>
        <text>lorazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Conwit;given-names:R</infon>
      <infon key="name_2">surname:Lowenstein;given-names:D</infon>
      <infon key="name_1">surname:Durkalski;given-names:V</infon>
      <infon key="name_0">surname:Silbergleit;given-names:R</infon>
      <infon key="fpage">591</infon>
      <infon key="pub-id_pmid">22335736</infon>
      <infon key="year">2012</infon>
      <infon key="source">N Engl J Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">366</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">600</infon>
      <infon key="name_6">surname:Barsan;given-names:W</infon>
      <infon key="name_5">surname:Palesch;given-names:Y</infon>
      <infon key="name_4">surname:Pancioli;given-names:A</infon>
      <offset>21485</offset>
      <text>Intramuscular versus intravenous therapy for prehospital status epilepticus.</text>
      <annotation id="211">
        <infon key="identifier">MESH:D013226</infon>
        <infon key="type">Disease</infon>
        <location offset="21542" length="18"/>
        <text>status epilepticus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Silbergleit;given-names:R</infon>
      <infon key="volume">17</infon>
      <infon key="name_2">surname:Pancioli;given-names:A</infon>
      <infon key="name_1">surname:Sasson;given-names:C</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McMullan;given-names:J</infon>
      <infon key="fpage">575</infon>
      <infon key="pub-id_pmid">20624136</infon>
      <infon key="year">2010</infon>
      <infon key="source">Acad Emerg Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">82</infon>
      <offset>21562</offset>
      <text>Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis.</text>
      <annotation id="216">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21631" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="217">
        <infon key="identifier">MESH:D013226</infon>
        <infon key="type">Disease</infon>
        <location offset="21609" length="18"/>
        <text>status epilepticus</text>
      </annotation>
      <annotation id="218">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="21579" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="21562" length="9"/>
        <text>Midazolam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">34</infon>
      <infon key="name_1">surname:Campagna;given-names:JD</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Brown;given-names:LH</infon>
      <infon key="fpage">3 90</infon>
      <infon key="issue">71</infon>
      <infon key="year">2005</infon>
      <infon key="source">Emerg Med Serv</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">7</infon>
      <offset>21675</offset>
      <text>Medication storage in the EMS environment: understanding the science and meeting the standards.</text>
    </passage>
    <passage>
      <infon key="volume">8</infon>
      <infon key="name_2">surname:Fullagar;given-names:CJ</infon>
      <infon key="name_1">surname:Krumperman;given-names:K</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Brown;given-names:LH</infon>
      <infon key="fpage">200</infon>
      <infon key="pub-id_pmid">15060857</infon>
      <infon key="year">2004</infon>
      <infon key="source">Prehosp Emerg Care</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">6</infon>
      <offset>21771</offset>
      <text>Out-of-hospital medication storage temperatures: a review of the literature and directions for the future.</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Darlington;given-names:DN</infon>
      <infon key="name_2">surname:Sondeen;given-names:JL</infon>
      <infon key="name_1">surname:Polykratis;given-names:IA</infon>
      <infon key="name_0">surname:de Guzman;given-names:R</infon>
      <infon key="fpage">394</infon>
      <infon key="pub-id_pmid">23734991</infon>
      <infon key="year">2013</infon>
      <infon key="source">Prehosp Emerg Care</infon>
      <infon key="type">ref</infon>
      <infon key="volume">17</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">400</infon>
      <infon key="name_5">surname:Dubick;given-names:MA</infon>
      <infon key="name_4">surname:Cap;given-names:AP</infon>
      <offset>21878</offset>
      <text>Stability of tranexamic acid after 12-week storage at temperatures from -20 degrees C to 50 degrees C.</text>
      <annotation id="221">
        <infon key="identifier">MESH:D014148</infon>
        <infon key="type">Chemical</infon>
        <location offset="21891" length="15"/>
        <text>tranexamic acid</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Payton;given-names:TF</infon>
      <infon key="volume">16</infon>
      <infon key="name_2">surname:Green;given-names:P</infon>
      <infon key="name_1">surname:Shayhorn;given-names:MA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kupas;given-names:DF</infon>
      <infon key="fpage">67</infon>
      <infon key="pub-id_pmid">22035224</infon>
      <infon key="year">2012</infon>
      <infon key="source">Prehosp Emerg Care</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">75</infon>
      <offset>21983</offset>
      <text>Structured inspection of medications carried and stored by emergency medical services agencies identifies practices that may lead to medication errors.</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Orsulak;given-names:PJ</infon>
      <infon key="name_2">surname:Liu;given-names:PK</infon>
      <infon key="name_1">surname:Akers;given-names:LC</infon>
      <infon key="name_0">surname:Gottwald;given-names:MD</infon>
      <infon key="fpage">333</infon>
      <infon key="pub-id_pmid">10452426</infon>
      <infon key="year">1999</infon>
      <infon key="source">Am J Emerg Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">17</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Alldredge;given-names:BK</infon>
      <infon key="name_7">surname:Lowenstein;given-names:DH</infon>
      <infon key="lpage">7</infon>
      <infon key="name_6">surname:Fields;given-names:SM</infon>
      <infon key="name_5">surname:Bacchetti;given-names:P</infon>
      <infon key="name_4">surname:Corry;given-names:MD</infon>
      <offset>22135</offset>
      <text>Prehospi tal stability of diazepam and lorazepam.</text>
      <annotation id="224">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="22161" length="8"/>
        <text>diazepam</text>
      </annotation>
      <annotation id="225">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="22174" length="9"/>
        <text>lorazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Denninghoff;given-names:K</infon>
      <infon key="name_2">surname:Jones;given-names:E</infon>
      <infon key="name_1">surname:Pinnawin;given-names:A</infon>
      <infon key="name_0">surname:McMullan;given-names:JT</infon>
      <infon key="fpage">1</infon>
      <infon key="pub-id_pmid">23148574</infon>
      <infon key="year">2013</infon>
      <infon key="source">Prehosp Emerg Care</infon>
      <infon key="type">ref</infon>
      <infon key="volume">17</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Silbergleit;given-names:R</infon>
      <infon key="lpage">7</infon>
      <infon key="name_6">surname:Zaleski;given-names:E</infon>
      <infon key="name_5">surname:Spaite;given-names:DW</infon>
      <infon key="name_4">surname:Siewart;given-names:N</infon>
      <offset>22185</offset>
      <text>The 60-day temperature-dependent degradation of midazolam and lorazepam in the prehospital environment.</text>
      <annotation id="228">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="22247" length="9"/>
        <text>lorazepam</text>
      </annotation>
      <annotation id="229">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="22233" length="9"/>
        <text>midazolam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Grady;given-names:LT</infon>
      <infon key="volume">57</infon>
      <infon key="name_2">surname:Medwick;given-names:T</infon>
      <infon key="name_1">surname:Bailey;given-names:L</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Okeke;given-names:CC</infon>
      <infon key="fpage">1441</infon>
      <infon key="pub-id_pmid">10938985</infon>
      <infon key="year">2000</infon>
      <infon key="source">Am J Health Syst Pharm</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">5</infon>
      <offset>22289</offset>
      <text>Revised USP standards for product dating, packaging, and temperature monitoring.</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms-644369-f0001.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>22370</offset>
      <text>Relative concentrations of benzodiazepines at 120 days as a function of cumulative mean kinetic temperatures (MKT).</text>
      <annotation id="231">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="22397" length="15"/>
        <text>benzodiazepines</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms-644369-f0002.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption</infon>
      <offset>22486</offset>
      <text>Comparison by site of relative concentration of lorazepam and cumulative mean kinetic temperature (MKT) at 30, 60, 90, and 120 days.</text>
      <annotation id="233">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="22534" length="9"/>
        <text>lorazepam</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>22619</offset>
      <text>p = 0.014</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>22629</offset>
      <text>                               </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>22661</offset>
      <text>p &lt; 0.001 when compared to 30-day concentration.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>22710</offset>
      <text>                               </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>22742</offset>
      <text>                         </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>22768</offset>
      <text>Average mean kinetic temperature (MKT) and relative concentration of benzodiazepines compared to label at each measured timepoint.</text>
      <annotation id="235">
        <infon key="identifier">MESH:D001569</infon>
        <infon key="type">Chemical</infon>
        <location offset="22837" length="15"/>
        <text>benzodiazepines</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">T1</infon>
      <infon key="type">table</infon>
      <infon key="File">T1.xml</infon>
      <offset>22899</offset>
      <text>                                               Concentration, mean % (95% CI)                                                   30-day              60-day              90-day              120-day                                                       Diazepam              97.0 (96.3-97.6)              97.1 (96.6-97.6)              97.4 (96.6-98.3)              97.0 (95.7-98.2)                                     Lorazepam              101.0 (99.0-102.9)              95.6* (91.6-99.5)              90.3** (85.2-95.4)              86.5** (80.7-92.3)                                     Midazolam              101.0 (99.8-101.4)              100.6 (99.8-101.4)              99.0 (98.0-99.9)              99.0 (98.1-100.2)                                     MKT              28.1 (24.9-31.2)              30.4 (26.0-34.7)              31.0 (26.8-35.1)              31.6 (27.1-36.1)                             </text>
      <annotation id="239">
        <infon key="identifier">MESH:D008874</infon>
        <infon key="type">Chemical</infon>
        <location offset="23487" length="9"/>
        <text>Midazolam</text>
      </annotation>
      <annotation id="240">
        <infon key="identifier">MESH:D008140</infon>
        <infon key="type">Chemical</infon>
        <location offset="23314" length="9"/>
        <text>Lorazepam</text>
      </annotation>
      <annotation id="241">
        <infon key="identifier">MESH:D003975</infon>
        <infon key="type">Chemical</infon>
        <location offset="23149" length="8"/>
        <text>Diazepam</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272821</id>
    <passage>
      <infon key="name_3">surname:Braun;given-names:Thomas</infon>
      <infon key="name_2">surname:Nolte;given-names:Hendrik</infon>
      <infon key="name_1">surname:Wust;given-names:Stas</infon>
      <infon key="article-id_pmid">25530839</infon>
      <infon key="name_0">surname:Boettger;given-names:Thomas</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272821</infon>
      <infon key="article-id_publisher-id">23</infon>
      <infon key="article-id_doi">10.1186/s13395-014-0023-5</infon>
      <infon key="title">Keywords</infon>
      <infon key="type">front</infon>
      <infon key="elocation-id">23</infon>
      <infon key="volume">4</infon>
      <infon key="license">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Skelet Muscle; 2014; 4(1) 23. doi:10.1186/s13395-014-0023-5</infon>
      <infon key="kwd">miR-206 miR-133b miR-1 MDX Muscle regeneration Pax7</infon>
      <infon key="authors">Boettger T, W&#195;&#188;st S, Nolte H, Braun T</infon>
      <offset>0</offset>
      <text>The miR-206/133b cluster is dispensable for development, survival and regeneration of skeletal muscle</text>
      <annotation id="1">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="4" length="7"/>
        <text>miR-206</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>102</offset>
      <text>Background</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>113</offset>
      <text>Three different gene clusters code for the muscle-specific miRNAs miR-206, miR-1 and miR-133a/b. The two miR-1/133a clusters generate identical mature miR-1 and miR-133a miRNAs in heart and skeletal muscle, while the cognate miR-206/133b cluster is exclusively expressed in skeletal muscle. Since sequences of the miRNAs miR-133a and miR-133b are almost identical, it seems likely that they share potential targets. Similarly, miR-1 and miR-206 are structurally related and contain identical seed sequences important for miRNA-target recognition. In the past, different functions of these miRNAs were suggested for development, function and regeneration of skeletal muscle using different in vivo and in vitro models; however, mutants lacking the complete miR-206/133b cluster, which generates a single pri-miRNA constituting a functional unit, have not been analyzed.</text>
      <annotation id="14">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="179" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="15">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="338" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="16">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="447" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="17">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="550" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="18">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="869" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="19">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="540" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="20">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="434" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="21">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="274" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="22">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="264" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="23">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="218" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="24">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="198" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="25">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="188" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>982</offset>
      <text>Methods</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>990</offset>
      <text>We generated miR-206/133b knock-out mice and analyzed these mice morphologically; at the transcriptome and proteome level to elucidate the contribution of this miRNA cluster for skeletal muscle development, differentiation, regeneration in vivo; and by systematic analysis. In addition, we studied the consequences of a genetic loss of miR-206/133b for expression of Pax7 and satellite cell differentiation in vitro.</text>
      <annotation id="31">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="1003" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="32">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="1326" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="33">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="1357" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="34">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="1026" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="1050" length="4"/>
        <text>mice</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1407</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1415</offset>
      <text>Deletion of the miR-206/133b cluster did not reveal any obvious essential function of the miRNA-cluster for development and differentiation of skeletal muscle. Careful examination of skeletal muscles of miR-206/133b mutants revealed no structural alterations or molecular changes at the transcriptome and proteome level. In contrast to previous studies, deletion of the miR-206/133b cluster did not impair regeneration of skeletal muscle in mdx mice. Likewise, differentiation of miR-206/133b deficient satellite cells in vitro was unaffected and no change in Pax7 protein concentration was apparent.</text>
      <annotation id="43">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="1431" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="44">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="1618" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="45">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="1785" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="46">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="1895" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="47">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="1975" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="1856" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="1860" length="4"/>
        <text>mice</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>2016</offset>
      <text>Conclusions</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>2028</offset>
      <text>We conclude that the miR-206/133b cluster is dispensable for development, function and regeneration of skeletal muscle, probably due to overlapping functions of the related miR-1/133a clusters, which are strongly expressed in skeletal muscle. We reason that the miR-206/133b cluster alone is not an essential regulator of skeletal muscle regeneration, although more subtle functions might exist that are not apparent under laboratory conditions.</text>
      <annotation id="53">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="2049" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="2290" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="2201" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>2474</offset>
      <text>Background</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2485</offset>
      <text>miRNAs regulate protein expression at the post-transcriptional level by decreasing transcript abundance or inhibiting protein translation. The miRNAs miR-1, miR-206 and miR-133a/b are specifically expressed in striated muscle. The mouse genome contains two miR-1/133a gene clusters located on chromosome 2 and 18, giving rise to identical mature miR-1 and miR-133a miRNAs while the structurally related miR-206/133b cluster is located on mouse chromosome 1. The mature miR-133b differs in only one nucleotide from miR-133a and the primary sequence of miR-206 is highly related to miR-1. Importantly, miR-1 and miR-206 do not differ in the seed sequence that is assumed to determine target specificity of miRNAs. Deletion of both miR-1/133a clusters, which are expressed in heart and all skeletal muscles, results in early embryonic lethality due to defects in heart development caused by the failure to restrict myocardin expression and concomitant upregulation of smooth muscle genes. Deletion of both miR-1 copies leads to cardiac defects with partially penetrant neonatal lethality but did not cause a major skeletal muscle phenotype, which was attributed to the remaining expression of miR-206 in skeletal muscle. Deletion of both miR-133a copies affects cardiomyocyte proliferation and heart physiology and results in a centronuclear skeletal myopathy and a shift of muscle fiber identity from glycolytic to oxidative muscle fibers in the soleus muscle.</text>
      <annotation id="79">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="2642" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="80">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="2888" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="81">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="2954" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="82">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="3036" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="83">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="3095" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="84">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="3675" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">214384</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">17043</infon>
        <location offset="3397" length="9"/>
        <text>myocardin</text>
      </annotation>
      <annotation id="86">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="2716" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="87">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="2923" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="88">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="3720" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="89">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="3488" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="90">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="3214" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="91">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="3085" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="92">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="3065" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="93">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="2999" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="94">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="2841" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="95">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="2831" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="96">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="2742" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="97">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="2654" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="98">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="2635" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="99">
        <infon key="identifier">MESH:D009135</infon>
        <infon key="type">Disease</infon>
        <location offset="3833" length="8"/>
        <text>myopathy</text>
      </annotation>
      <annotation id="100">
        <infon key="identifier">MESH:D020964</infon>
        <infon key="type">Disease</infon>
        <location offset="3307" length="19"/>
        <text>embryonic lethality</text>
      </annotation>
      <annotation id="101">
        <infon key="identifier">MESH:D006331</infon>
        <infon key="type">Disease</infon>
        <location offset="3510" length="15"/>
        <text>cardiac defects</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3944</offset>
      <text>The miR-206/133b cluster is not expressed in the heart, but its expression is confined to developing skeletal muscle. In adult muscles miR-206/133b are preferentially found in slow myofibers. Expression of miR-206/133b is controlled by a network of myogenic regulatory genes, including MyoD, which binds to the miR-206/133b locus in C2C12 cells. The miR-206/133b locus not only encodes the miRNAs miR-206 and miR-133b, but also the long non-coding RNA linc-MD1, which is expressed during muscle development similar to miR-206 and miR-133b and assumed to act as a competing endogenous RNA or miRNA decoy. Genomic deletion of miR-206 did not cause an obvious clinical phenotype in mice, although it was determined that miR-206 is required for re-innervation of muscle tissue in mice with mutant Sod1. It was proposed that miR-1/206 repress Hdac4, which in turn might regulate genes involved in controlling muscle-derived signals that enhance synapse formation under pathological conditions. More recently, miR-206 was claimed to act as a modifier of muscular dystrophy. Deletion of miR-206 in the mdx mouse model of Duchenne muscular dystrophy led to increased lethality in compound mutants and accumulation of degenerated muscle fibers. Surprisingly, no defects in muscle innervation were observed after the loss of miR-206, although muscle fibers are continuously lost and replaced in mdx mice. The dramatic enhancement of muscle dystrophy in miR-206/mdx compound mutants was attributed to impaired differentiation of myofibers due to the up-regulation of Pax7, which contains identical binding sites for miR-206 and miR-1 in its 3' untranslated region (UTR). The presence of miR-206 target sites in Pax7 did also motivate other researchers to investigate a regulation of Pax7 by miR-206, revealing that overexpression or knock-down of miR-206 can affect Pax7 levels and thereby muscle differentiation in vitro.</text>
      <annotation id="142">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="3948" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="4150" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="144">
        <infon key="identifier">17927</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7857</infon>
        <location offset="4230" length="4"/>
        <text>MyoD</text>
      </annotation>
      <annotation id="145">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="4255" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="146">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="4294" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="147">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="4341" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="148">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="4353" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="149">
        <infon key="identifier">105661730</infon>
        <infon key="type">Gene</infon>
        <location offset="4396" length="8"/>
        <text>linc-MD1</text>
      </annotation>
      <annotation id="150">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="4462" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="151">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="4474" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="152">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="4568" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="153">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="4661" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="154">
        <infon key="identifier">20655</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">392</infon>
        <location offset="4737" length="4"/>
        <text>Sod1</text>
      </annotation>
      <annotation id="155">
        <infon key="identifier">208727</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55946</infon>
        <location offset="4782" length="5"/>
        <text>Hdac4</text>
      </annotation>
      <annotation id="156">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="4948" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="157">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="5024" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="158">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="5259" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="159">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="5387" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="160">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="5500" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="161">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="5549" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="5620" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="5644" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="5716" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="5724" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="166">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="5780" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="167">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="5799" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="168">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="4079" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="169">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="5395" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="170">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="5329" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="171">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="5039" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="172">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="4623" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="173">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="4720" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="174">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="5043" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="5333" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="176">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="5561" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="177">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="4764" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="178">
        <infon key="identifier">CVCL:0188</infon>
        <infon key="type">CellLine</infon>
        <location offset="4277" length="5"/>
        <text>C2C12</text>
      </annotation>
      <annotation id="179">
        <infon key="identifier">MESH:D009136</infon>
        <infon key="type">Disease</infon>
        <location offset="5367" length="16"/>
        <text>muscle dystrophy</text>
      </annotation>
      <annotation id="180">
        <infon key="identifier">MESH:D009136</infon>
        <infon key="type">Disease</infon>
        <location offset="4992" length="18"/>
        <text>muscular dystrophy</text>
      </annotation>
      <annotation id="181">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="5058" length="27"/>
        <text>Duchenne muscular dystrophy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>5858</offset>
      <text>Here, we analyzed mice with a targeted deletion of the miR-206/133b cluster. miR-206/133b are processed from a common precursor and thus might be regarded as a functional unit similar to the miR-1/133a clusters. Concomitant loss of miR-206 and miR-133b neither leads to an obvious clinical phenotype or causes detectable molecular changes in skeletal muscles nor impairs muscle regeneration in the MDX mouse model of muscular dystrophy. Surprisingly, lack of miR-206/133b and the miR-133 decoy, contained in the third exon of linc-MD1, did not have obvious effects on satellite cell proliferation and differentiation. Our findings differ from a previous analysis of miR-206 mutants, which might suggest that other products processed from the primary miR-206/133b transcript balance effects of miR-206 in vivo.</text>
      <annotation id="197">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="5913" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="6090" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="6102" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="200">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="6317" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="201">
        <infon key="identifier">105661730</infon>
        <infon key="type">Gene</infon>
        <location offset="6384" length="8"/>
        <text>linc-MD1</text>
      </annotation>
      <annotation id="202">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="6524" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="203">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="6651" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="204">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="5935" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="205">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="6608" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="206">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="6256" length="3"/>
        <text>MDX</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="5876" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="208">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="6260" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="209">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="6338" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="210">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="6049" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="211">
        <infon key="identifier">MESH:D009136</infon>
        <infon key="type">Disease</infon>
        <location offset="6275" length="18"/>
        <text>muscular dystrophy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>6668</offset>
      <text>Methods</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>6676</offset>
      <text>Ethics statement</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6693</offset>
      <text>Animal maintenance and animal experiments were in accordance with German animal protection laws and were approved by the local governmental animal protection committee (Regierungspraesidium Darmstadt, Federal State of Hessen).</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>6920</offset>
      <text>Deletion of miR-206/133b</text>
      <annotation id="213">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="6932" length="7"/>
        <text>miR-206</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6945</offset>
      <text>The miR-206/133b coding region was deleted from the mouse genome using a vector containing genomic sequences flanking the miRNA miR-206/133b gene and a PGK-neomycin selection cassette. The short arm (2.3 kb) used for recombination encompassed the miR-206 5' flanking region from TTAGGCATATAAAGTTTGCACGACC to GATATAAAGAAGCATGTGGCCTGGG). The long arm of the targeting vector consisted of a 5.9 kb NcoI fragment directly downstream of miR-133b. A DTA selection cassette was used for negative selection against nonhomologous insertion of the vector into the genome. Homologous recombination in mouse embryonic stem (ES) cells was ascertained by Southern blot analysis using a SphI digest and a 453 bp 5' probe amplified by the oligonucleotides (TAAGTCCTGATGCTTCTCAATACCC; GTTGATAAAGAAACTGTGTGTTACG), resulting in an 8.4-kb WT and an 11.8-kb knock-out signal. Although the inserted beta-galactosidase coding (lacZ) cassette contained an IRES sequence, no beta-galactosidase was expressed from the engineered locus. Genotyping of mdx mice followed the protocol described by Shin et al.. Primary sequences of mature miRNAs were derived from mirBase20 (MIMAT0000239, MIMAT0000123, MIMAT0000769 and MIMAT0000145).</text>
      <annotation id="226">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="6949" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="227">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="7073" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="228">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="7377" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="229">
        <infon key="identifier">12091</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">47922</infon>
        <location offset="7822" length="18"/>
        <text>beta-galactosidase</text>
      </annotation>
      <annotation id="230">
        <infon key="identifier">12091</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">47922</infon>
        <location offset="7895" length="18"/>
        <text>beta-galactosidase</text>
      </annotation>
      <annotation id="231">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="6997" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="232">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="7535" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="233">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="7973" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="234">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="7969" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="235">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="7192" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="236">
        <infon key="type">Disease</infon>
        <location offset="8090" length="40"/>
        <text>MIMAT0000239, MIMAT0000123, MIMAT0000769</text>
      </annotation>
      <annotation id="237">
        <infon key="identifier">MESH:D009355</infon>
        <infon key="type">Chemical</infon>
        <location offset="7101" length="8"/>
        <text>neomycin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>8153</offset>
      <text>RNAse protection assay and northern blot</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>8194</offset>
      <text>Total RNA was isolated from M. soleus of PBS perfused animals using the TRIZOL method (Invitrogen, Thermo Fisher Scientific, Darmstadt, Germany). The RNase protection assay was performed using the mirVana Probe construction Kit (Ambion, Thermo Fisher Scientific, Darmstadt, Germany; Cat#1550) using oligos (miR-206: TGGAATGTAAGGAAGTGTGTGG, miR-145: GTCCAGTTTTCCCAGGAATCCCTTTTTTTT) together with the mirVana miRNA Detection Kit (Ambion#1552) following the manufacturer's instructions. A polyT at the control oligo was added to allow size resolution of the control oligo. The sequence CCTGTCTC was added to the 3' end of the oligos to allow binding of the Ambion T7-Promoter Primer. Amersham alpha-32P UTP (GE Healthcare, Freiburg, Germany; PB20383, 800 Ci/mmol) was used for labeling. Probes were purified using a 15% Invitrogen TBE-Urea Gel (EC68855BOX), the gel was exposed to a Kodak X-ray film, labeled probes were excised und eluted 30 min in elution buffer. 5 mug of total RNA isolated from WT, heterozygous or KO-muscle or yeast-RNA (Roche, Mannheim, Germany), respectively was hybridized at 42 C overnight with approximately 104 cpm of probe in hybridization buffer in a total volume of 20 mul. Samples were analyzed using 15% TBE-Urea gels after RNase A/T1 digestion. Signals were detected using Kodak X-Ray film. Northern blot analysis was performed as previously described. Antisense oligonucleotides specific for miR-206 (CCACACACTTCCTTACATTCCA), miR-1 (ATACATACTTCTTTACATTCCA) and U6 (ATATGGAACGCTTCACGAATT) were used.</text>
      <annotation id="252">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="8501" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="253">
        <infon key="identifier">387163</infon>
        <infon key="type">Gene</infon>
        <location offset="8534" length="7"/>
        <text>miR-145</text>
      </annotation>
      <annotation id="254">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="9618" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="255">
        <infon key="identifier">4932</infon>
        <infon key="type">Species</infon>
        <location offset="9223" length="5"/>
        <text>yeast</text>
      </annotation>
      <annotation id="256">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="9652" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="257">
        <infon key="identifier">MESH:D009841</infon>
        <infon key="type">Chemical</infon>
        <location offset="9588" length="16"/>
        <text>oligonucleotides</text>
      </annotation>
      <annotation id="258">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="9428" length="3"/>
        <text>TBE</text>
      </annotation>
      <annotation id="259">
        <infon key="identifier">MESH:D014508</infon>
        <infon key="type">Chemical</infon>
        <location offset="9026" length="4"/>
        <text>Urea</text>
      </annotation>
      <annotation id="260">
        <infon key="identifier">MESH:D014508</infon>
        <infon key="type">Chemical</infon>
        <location offset="9432" length="4"/>
        <text>Urea</text>
      </annotation>
      <annotation id="261">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="8884" length="13"/>
        <text>alpha-32P UTP</text>
      </annotation>
      <annotation id="262">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="9022" length="3"/>
        <text>TBE</text>
      </annotation>
      <annotation id="263">
        <infon key="identifier">MESH:D007854</infon>
        <infon key="type">Chemical</infon>
        <location offset="8235" length="3"/>
        <text>PBS</text>
      </annotation>
      <annotation id="264">
        <infon key="identifier">c.1A&gt;T</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="9454" length="4"/>
        <text>A/T1</text>
      </annotation>
      <annotation id="265">
        <infon key="identifier">MESH:C411644</infon>
        <infon key="type">Chemical</infon>
        <location offset="8266" length="6"/>
        <text>TRIZOL</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>9732</offset>
      <text>Microarray analysis, quantitative reverse transcription PCR and small RNA sequencing</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>9817</offset>
      <text>RNA quality was analyzed with the Agilent Bioanalyzer and the RNA 6000 Nano Kit (Agilent Technologies, Santa Clara, CA). For RNA expression analysis, the Affymetrix GeneChip MouseGenome 430 2.0 Array was used, employing the one-cycle target labeling protocol. Data were analyzed using the Affymetrix expression console and the RMA algorithm. Microarray data have been submitted to Arrayexpress (Acc#E-MTAB-2439). TaqMan MicroRNA Expression Assays and the Applied Biosystems StepOnePlus system were used to quantify miR-206 and miR-1 expression. The RT reaction was done using the miR-206 and the U6 specific primer with the Taqman MicroRNA Reverse Transcription Kit (#4366596). qPCR assays were performed with three independent samples each with Taqman Universal PCR Master Mix (#4324018), FAM labeled miR-206 or miR-1 assay (#000510; #002222) and VIC labeled U6 assay (#001973) for normalization. Relative expression was calculated using the   Ct method. RNA isolated from a pool of M. soleus of five male C57Bl6 mice was sequenced using IonTorrent sequencing and analyzed as described. Data were submitted to the NCBI's Gene Expression Omnibus (Acc#GSE63342).</text>
      <annotation id="273">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="10332" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="274">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="10397" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="275">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="10619" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="276">
        <infon key="identifier">13615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1477</infon>
        <location offset="10665" length="3"/>
        <text>VIC</text>
      </annotation>
      <annotation id="277">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="10831" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="278">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="10630" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="279">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="10344" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>10985</offset>
      <text>Whole-mount in situ hybridization</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>11019</offset>
      <text>For whole mount in-situ hybridization, a myogenin cDNA corresponding to 307 to 1393 bp of ENSMUST00000027730 was used to synthesize a DIG-labeled antisense probe by T7-RNA-polymerase. E10.5 embryos were isolated and genotyped after mating of heterozygous parents.</text>
      <annotation id="282">
        <infon key="identifier">17928</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1854</infon>
        <location offset="11060" length="8"/>
        <text>myogenin</text>
      </annotation>
      <annotation id="283">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="11153" length="3"/>
        <text>DIG</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>11284</offset>
      <text>Fiber type determination, histology</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>11320</offset>
      <text>For histological analysis, muscle tissue was perfused in situ with 4% PFA, dissected, washed in PBS, dehydrated and embedded in paraffin, followed by preparation of 10 mum sections, deparaffinization and hydration in distilled water. Von Kossa staining was performed by incubating slides with 1% silver nitrate solution and exposed to light for 30 min. Slides were washed two times for 3 min in H2O and incubated in 5% sodium thiosulfate solution for 5 min. Thereafter, slides were washed two times in H2O, followed by counterstaining for 7 min in 0.1% EosinG (Merck, Darmstadt, Germany) with 0.05% acetic acid. Slides were dehydrated and mounted using Entellan. For Sirius red staining, slides were stained in Weigerts Iron-Hematoxylin solution (Sigma, Munich, Germany; Cat#HT1079) for 8 min, dipped twice in distilled water and stained one hour in 0.1% Direct Red 80 (Sigma#365548)/saturated picric acid. Subsequently, slides were washed using 0.5% acetic acid, dipped in distilled water, dehydrated and mounted using Entellan.</text>
      <annotation id="301">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="11715" length="3"/>
        <text>H2O</text>
      </annotation>
      <annotation id="302">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="12304" length="5"/>
        <text>water</text>
      </annotation>
      <annotation id="303">
        <infon key="identifier">MESH:C009798</infon>
        <infon key="type">Chemical</infon>
        <location offset="12175" length="13"/>
        <text>Direct Red 80</text>
      </annotation>
      <annotation id="304">
        <infon key="identifier">MESH:D007854</infon>
        <infon key="type">Chemical</infon>
        <location offset="11416" length="3"/>
        <text>PBS</text>
      </annotation>
      <annotation id="305">
        <infon key="identifier">MESH:D017245</infon>
        <infon key="type">Chemical</infon>
        <location offset="11390" length="3"/>
        <text>PFA</text>
      </annotation>
      <annotation id="306">
        <infon key="identifier">MESH:D012835</infon>
        <infon key="type">Chemical</infon>
        <location offset="11616" length="14"/>
        <text>silver nitrate</text>
      </annotation>
      <annotation id="307">
        <infon key="identifier">CVCL:5008</infon>
        <infon key="type">CellLine</infon>
        <location offset="12095" length="6"/>
        <text>HT1079</text>
      </annotation>
      <annotation id="308">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="12140" length="5"/>
        <text>water</text>
      </annotation>
      <annotation id="309">
        <infon key="identifier">MESH:C017717</infon>
        <infon key="type">Chemical</infon>
        <location offset="11739" length="18"/>
        <text>sodium thiosulfate</text>
      </annotation>
      <annotation id="310">
        <infon key="identifier">MESH:D019342</infon>
        <infon key="type">Chemical</infon>
        <location offset="12271" length="11"/>
        <text>acetic acid</text>
      </annotation>
      <annotation id="311">
        <infon key="identifier">MESH:C005858</infon>
        <infon key="type">Chemical</infon>
        <location offset="12214" length="11"/>
        <text>picric acid</text>
      </annotation>
      <annotation id="312">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="11547" length="5"/>
        <text>water</text>
      </annotation>
      <annotation id="313">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="11987" length="10"/>
        <text>Sirius red</text>
      </annotation>
      <annotation id="314">
        <infon key="identifier">MESH:D010232</infon>
        <infon key="type">Chemical</infon>
        <location offset="11448" length="8"/>
        <text>paraffin</text>
      </annotation>
      <annotation id="315">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="11822" length="3"/>
        <text>H2O</text>
      </annotation>
      <annotation id="316">
        <infon key="identifier">MESH:D019342</infon>
        <infon key="type">Chemical</infon>
        <location offset="11919" length="11"/>
        <text>acetic acid</text>
      </annotation>
      <annotation id="317">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="12040" length="16"/>
        <text>Iron-Hematoxylin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>12356</offset>
      <text>For determination and quantification of fiber types in the muscle tissue, tissue was perfused in situ with 4% PFA, isolated and incubated in 15% and 30% sucrose/PBS for 2 hours and overnight, respectively. Tissue was frozen on dry ice and cryotome-sectioned. Sections were mounted on Superfrost slides. Tissue was dried and subsequently treated with 4% PFA/0.1% sodium desoxycholate/0.02% NP-40 for 5 min, washed 3 times with PBS for 5 min, blocked in 2% FCS, 0.5% NP-40/PBS for 1 h and then incubated with monoclonal anti-myosin (skeletal, slow; Sigma, M8421) in 2% FCS/0.5% NP-40/PBS overnight at 4 C. Slides were washed three times with PBS for 5 min and then incubated with biotinylated secondary antibody (Vector Labs, Burlingame, CA; BA-1400) for 2 h at RT and further processed according to the Vectastain Elite ABC Kit.</text>
      <annotation id="321">
        <infon key="identifier">MESH:D007854</infon>
        <infon key="type">Chemical</infon>
        <location offset="12517" length="3"/>
        <text>PBS</text>
      </annotation>
      <annotation id="322">
        <infon key="identifier">MESH:D013395</infon>
        <infon key="type">Chemical</infon>
        <location offset="12509" length="7"/>
        <text>sucrose</text>
      </annotation>
      <annotation id="323">
        <infon key="identifier">MESH:D017245</infon>
        <infon key="type">Chemical</infon>
        <location offset="12466" length="3"/>
        <text>PFA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>13191</offset>
      <text>Satellite cell isolation and culture</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>13228</offset>
      <text>Satellite cells were isolated from the hind leg muscles of approximately 20 to 25-week-old wildtype and miR-206/133b knock-out animals by using the skeletal muscle dissociation kit (Miltenyi Biotech, Bergisch Gladbach, Germany, 130-098-305) and enriched by the satellite cell isolation Kit, mouse (Miltenyi Biotech, 130-104-268) according to the manufacturer's instructions. Isolated cells were plated on gelatin-coated muclear 96-well plates (Sigma#M0562). Satellite cells were grown in proliferation medium (40% DMEM, 40% Ham F-10; 20% FCS; Pen/Strep; 2.5 ng/ml human FGF-2, Miltenyi Biotech#130-093-840) for 3 days, followed by switch to differentiation medium (DMEM, 2% horse serum, and Pen/Strep). Cells were incubated for 5 min in fixative (4% PFA/PBS, 0.1% sodium desoxycholate, 0.2% NP-40), washed 3 times in PBS, blocked in carrier (PBS, 5% BSA, 0.5% NP-40) for 1 h and then incubated with MF 20 supernatant in carrier (1:100, DSHB, Iowa City, Iowa). Secondary antibody was goat anti-mouse IgG1 Alexa 488 (1:2000, Life technologies).</text>
      <annotation id="342">
        <infon key="identifier">27344</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">8315</infon>
        <location offset="13771" length="3"/>
        <text>Pen</text>
      </annotation>
      <annotation id="343">
        <infon key="identifier">2247</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1521</infon>
        <location offset="13798" length="5"/>
        <text>FGF-2</text>
      </annotation>
      <annotation id="344">
        <infon key="identifier">27344</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">8315</infon>
        <location offset="13919" length="3"/>
        <text>Pen</text>
      </annotation>
      <annotation id="345">
        <infon key="identifier">16017</infon>
        <infon key="type">Gene</infon>
        <location offset="14227" length="4"/>
        <text>IgG1</text>
      </annotation>
      <annotation id="346">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="13332" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="347">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="13519" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="348">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13792" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="349">
        <infon key="identifier">9796</infon>
        <infon key="type">Species</infon>
        <location offset="13902" length="5"/>
        <text>horse</text>
      </annotation>
      <annotation id="350">
        <infon key="identifier">9925</infon>
        <infon key="type">Species</infon>
        <location offset="14211" length="4"/>
        <text>goat</text>
      </annotation>
      <annotation id="351">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="14221" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="352">
        <infon key="identifier">MESH:D007854</infon>
        <infon key="type">Chemical</infon>
        <location offset="13982" length="3"/>
        <text>PBS</text>
      </annotation>
      <annotation id="353">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="13893" length="4"/>
        <text>DMEM</text>
      </annotation>
      <annotation id="354">
        <infon key="identifier">MESH:D003840</infon>
        <infon key="type">Chemical</infon>
        <location offset="13992" length="20"/>
        <text>sodium desoxycholate</text>
      </annotation>
      <annotation id="355">
        <infon key="identifier">MESH:D007854</infon>
        <infon key="type">Chemical</infon>
        <location offset="14045" length="3"/>
        <text>PBS</text>
      </annotation>
      <annotation id="356">
        <infon key="identifier">MESH:D007854</infon>
        <infon key="type">Chemical</infon>
        <location offset="14070" length="3"/>
        <text>PBS</text>
      </annotation>
      <annotation id="357">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="14232" length="9"/>
        <text>Alexa 488</text>
      </annotation>
      <annotation id="358">
        <infon key="identifier">MESH:D017245</infon>
        <infon key="type">Chemical</infon>
        <location offset="13978" length="3"/>
        <text>PFA</text>
      </annotation>
      <annotation id="359">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="13742" length="4"/>
        <text>DMEM</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>14277</offset>
      <text>Quantitative proteomics</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>14301</offset>
      <text>Soleus muscle was dissected from adult 13C6Lys-labeled (SILAC) WT and from nonlabeled WT and miR-206/133b mutant littermates. Protein extracts were processed and mass spectrometry was performed as described previously. Briefly, 30 mug protein extracts of soleus muscle of labeled and the respective unlabeled muscle were combined, size-fractionated into 10 fractions using SDS-PAGE, and the proteins were digested in-gel using the endoproteinase LysC. After digestion peptides were eluted from gel-fractions using an acetonitrile gradient. Peptides were desalted prior to LC-MS/MS analysis and loaded onto a 15 cm in-house packed column (75 mum ID, C18 Beads 3 mum diameter, Dr. Maisch, Germany) and eluted by an linear increase of buffer B within a binary buffer system: A) 0.5% acetic acid and B) 80% ACN, 0.5% acetic acid. The flow-rate was set to 200 nL/min and gradient time to 150 min. The Agilent 1200 nanoflow HPLC system was coupled to an LQT-Orbitrap XL (Thermo Scientific) via an electrospray ionization source (Thermo Fisher Scientific). The mass spectrometer was operated in the data-dependent mode to automatically measure full MS scans and MS/MS spectra. In detail, survey scans were measured after accumulation of 1E6 ions at a resolution of 60,000 and subsequently isolation and fragmentation (CID, 35% norm. collision energy, target value: 5,000) of the top five intense peaks was performed in the linear ion trap. Peptides were identified by correlation of acquired MS/MS spectra against the mouse IPI (ftp://ftp.ebi.ac.uk/pub/databases/IPI) using MaxQuant software. A FDR cutoff of 1% was set on the protein and peptide level. Two mis-cleavages were allowed. Amidomethylation at cysteine residues was set as fixed modification, while oxidation on methione residues and acetylation at the N-term of proteins were defined as variable modifications. Quantification of proteins was performed by MaxQuant software. Only peptides with a minimal length of six amino acids and at least two ratio counts for SILAC pairs were used for quantification. Using SILAC as an internal standard, ratios miR-206/133b KO/13C6Lys-WT and 13C6Lys-WT/WT were obtained and were used for calculation of the direct KO/WT ratios for relative protein abundance.</text>
      <annotation id="375">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="14394" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="376">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="16406" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="377">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="15812" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="378">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="14340" length="7"/>
        <text>13C6Lys</text>
      </annotation>
      <annotation id="379">
        <infon key="type">Disease</infon>
        <location offset="15612" length="3"/>
        <text>CID</text>
      </annotation>
      <annotation id="380">
        <infon key="identifier">MESH:D019342</infon>
        <infon key="type">Chemical</infon>
        <location offset="15114" length="11"/>
        <text>acetic acid</text>
      </annotation>
      <annotation id="381">
        <infon key="identifier">MESH:D003545</infon>
        <infon key="type">Chemical</infon>
        <location offset="16000" length="8"/>
        <text>cysteine</text>
      </annotation>
      <annotation id="382">
        <infon key="identifier">MESH:D019342</infon>
        <infon key="type">Chemical</infon>
        <location offset="15081" length="11"/>
        <text>acetic acid</text>
      </annotation>
      <annotation id="383">
        <infon key="identifier">MESH:C084683</infon>
        <infon key="type">Chemical</infon>
        <location offset="15104" length="3"/>
        <text>ACN</text>
      </annotation>
      <annotation id="384">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="16422" length="7"/>
        <text>13C6Lys</text>
      </annotation>
      <annotation id="385">
        <infon key="identifier">MESH:D012967</infon>
        <infon key="type">Chemical</infon>
        <location offset="14674" length="3"/>
        <text>SDS</text>
      </annotation>
      <annotation id="386">
        <infon key="identifier">MESH:C032159</infon>
        <infon key="type">Chemical</infon>
        <location offset="14818" length="12"/>
        <text>acetonitrile</text>
      </annotation>
      <annotation id="387">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="16068" length="8"/>
        <text>methione</text>
      </annotation>
      <annotation id="388">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="16437" length="7"/>
        <text>13C6Lys</text>
      </annotation>
      <annotation id="389">
        <infon key="identifier">MESH:D004194</infon>
        <infon key="type">Disease</infon>
        <location offset="15305" length="10"/>
        <text>ionization</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>16560</offset>
      <text>Western blot</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>16573</offset>
      <text>For western-blot analysis of embryonic tissue, the trunk of E10.5 embryos posterior of the otic placode was used. A total of 10 mug of protein extract were loaded onto a 9% SDS-PAGE and blotted onto nitrocellulose membranes. The following antibodies were used: anti-Pax7 (supernatant of DSHB#P3U1), anti-pan-actin (1:1000, CST, Frankfurt, Germany; Cat#4968), anti-GAPDH (1:1000, CST; Cat#2118), secondary antibodies were anti-mouse-HRP (1:1000, eBioscience, Affymetrix, Frankfurt Germany, Cat#18-8816-31) and anti-rabbit-HRP (1:5000, Pierce, Thermo Fisher Scientific, Darmstadt, Germany, Cat#1858415).</text>
      <annotation id="396">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="16839" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="397">
        <infon key="identifier">12854</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">997</infon>
        <location offset="16952" length="3"/>
        <text>CST</text>
      </annotation>
      <annotation id="398">
        <infon key="identifier">12854</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">997</infon>
        <location offset="16896" length="3"/>
        <text>CST</text>
      </annotation>
      <annotation id="399">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="16999" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="400">
        <infon key="identifier">9986</infon>
        <infon key="type">Species</infon>
        <location offset="17087" length="6"/>
        <text>rabbit</text>
      </annotation>
      <annotation id="401">
        <infon key="identifier">MESH:D012967</infon>
        <infon key="type">Chemical</infon>
        <location offset="16746" length="3"/>
        <text>SDS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>17176</offset>
      <text>Statistics</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>17187</offset>
      <text>Data are reported as mean +- SEM. Differences between groups were tested for statistical significance using the unpaired Student's. For microarray experiments the median of groups was used and statistical analysis using an unpaired t-test was performed using DNAStar Arraystar 11 software (annotation na33). The Benjamini-Hochberg FDR correction was used to control the multiple hypothesis testing in case of the microarray experiments.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>17630</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>17638</offset>
      <text>Deletion of the miR-206/133b cluster does not alter skeletal muscle morphology</text>
      <annotation id="403">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="17654" length="7"/>
        <text>miR-206</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13395_2014_23_Fig1_HTML.jpg</infon>
      <infon key="id">Fig1</infon>
      <infon key="type">fig_caption</infon>
      <offset>17717</offset>
      <text> Generation of miR-206/133b knock-out mice. The miRNAs miR-206, miR-1 and 133a/b are encoded in three clusters on mouse chromosome 1, 2 and 18. The primary sequence (A) of mature miR-1/133a encoded on chromosome 2 and 18 is identical, miR-206 differs in four bases from miR-1, and miR-133b differs in one base from miR-133a (red). The seed sequence, which is instrumental for target binding of miRNAs, is identical between the corresponding miRNAs (blue). Schematic representation of the miR-206/133b genomic region (B) with deleted parts indicated (red). Southern blot analysis (C) of genomic DNA isolated from wildtype (WT), heterozygous, and homozygous mutant animals proves deletion of the miR-206/133b locus. An SphI digest of genomic DNA and a probe hybridizing 5' prime of the targeting vector were used to monitor targeting of the miR-206/133b locus by homologous recombination. RNase protection assay (D) and northern blot (E) analysis demonstrates the loss of miR-206 in the soleus muscle of knock-out animals. Expression of miR-1 is not changed in soleus muscle of miR-206/133b knock-out mice.</text>
      <annotation id="421">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="17732" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="422">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="17772" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="423">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="17952" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="424">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="17998" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="425">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="18205" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="426">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="18411" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="427">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="18556" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="428">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="18687" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="429">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="18793" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="430">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="17755" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="431">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="17831" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="432">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="18816" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="433">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="18752" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="434">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="18032" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="435">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="17987" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="436">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="17896" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="437">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="17781" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>18824</offset>
      <text>Deletion of the miR-206/133b cluster does not lead to abnormalities in the Mendelian distribution of mutant animals (a) at the time of weaning. Additional mdx mutation of the dystrophin gene does not lead to further lethality in double mutant animals (b). Distribution of male offspring after mating of male miR-206/133b+/- mdxy/+ or miR-206/133b+/- mdx+/+ to female miR-206/133b+/- mdx+/- is presented.</text>
      <annotation id="446">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="18840" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="447">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="18999" length="10"/>
        <text>dystrophin</text>
      </annotation>
      <annotation id="448">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="19132" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="449">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="19158" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="450">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="19191" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="451">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="19207" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="452">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="19174" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="453">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="18979" length="3"/>
        <text>mdx</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab1.xml</infon>
      <infon key="id">Tab1</infon>
      <infon key="type">table_caption</infon>
      <offset>19236</offset>
      <text> Normal Mendelian distribution of offspring at the time of weaning </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab1</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab1.xml</infon>
      <offset>19304</offset>
      <text> Genotype   N   % observed   Expected  miR-206/133b+/+ mdxy/+  29 13.0% 12.5% miR-206/133b+/+ mdxy/-  25 11.2% 12.5% miR-206/133b+/- mdxy/+  57 25.6% 25.0% miR-206/133b+/- mdxy/-  41 18.4% 25.0% miR-206/133b-/- mdxy/+ (a)  35 15.7% 12.5% miR-206/133b-/- mdxy/- (b)  36 16.1% 12.5%  Total   223   100.0%   100.0%  </text>
      <annotation id="460">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="19460" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="461">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="19499" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="462">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="19542" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="463">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="19421" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="464">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="19382" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="465">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="19343" length="7"/>
        <text>miR-206</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13395_2014_23_Fig2_HTML.jpg</infon>
      <infon key="id">Fig2</infon>
      <infon key="type">fig_caption</infon>
      <offset>19630</offset>
      <text> Deletion of miR-206/133b does not impair myogenesis during somite development. miR-206/133b knock-out animals are born with the expected Mendelian distribution (see text), whole mount in situ hybridization indicates normal myogenin expression in wildtype (WT; A, C) and knock-out embryos (KO; B, D) at embryonic day 10.5. Sections (C, D) are at the level of the forelimbs.</text>
      <annotation id="469">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="19643" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="470">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="19710" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="471">
        <infon key="identifier">17928</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1854</infon>
        <location offset="19854" length="8"/>
        <text>myogenin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>20004</offset>
      <text>To analyze the function of the miR-206/133b miRNA cluster we deleted the coding region of the miR-206/133b gene on mouse chromosome 1 by homologous recombination (Figure 1A, B). The targeting strategy also removed the last exon of the ncRNA linc-MD1 including the putative miR-133a/b binding site in linc-MD1, which is identical to the miR-133b* sequence. Neither the putative miR-135 binding sites in the second exon of linc-MD1, nor the described distal or proximal regulatory elements, identified by myogenin or myoD ChIP-seq approaches in C2C12 myocytes, were affected by the targeting strategy. Targeted deletion of the miR-206/133b coding region was validated by southern blot analysis (Figure 1C). Viable knock-out mice were obtained by breeding of heterozygous animals. Deletion of the miR-206/133b cluster did not impair embryonic or early postnatal survival of homozygous animals (Table 1; mdxY/+ mice). To exclude a function of miR-206/133b in early development that might be compensated during later stages we analyzed the spatial distribution of myogenin transcripts at the embryonic stage E10.5. No differences in somite morphology and myogenin expression were detected (Figure 2). Development of body weights and survival rate of miR-206/133b knock-out mice was indistinguishable from WT animals. RNase protection analysis as well as northern blot analysis using RNA isolated from hind limb muscle confirmed the absence of miR-206 in homozygous mutant animals (Figure 1D, E). Due to the presence of miR-133a in skeletal muscles, which differs by only one nucleotide from miR-133b, it was not possible to demonstrate the absence of mature miR-133b in homozygous mutant animals.</text>
      <annotation id="497">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="20035" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="498">
        <infon key="identifier">387202;723817</infon>
        <infon key="type">Gene</infon>
        <location offset="20098" length="12"/>
        <text>miR-206/133b</text>
      </annotation>
      <annotation id="499">
        <infon key="identifier">105661730</infon>
        <infon key="type">Gene</infon>
        <location offset="20304" length="8"/>
        <text>linc-MD1</text>
      </annotation>
      <annotation id="500">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="20340" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="501">
        <infon key="identifier">105661730</infon>
        <infon key="type">Gene</infon>
        <location offset="20425" length="8"/>
        <text>linc-MD1</text>
      </annotation>
      <annotation id="502">
        <infon key="identifier">17928</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1854</infon>
        <location offset="20507" length="8"/>
        <text>myogenin</text>
      </annotation>
      <annotation id="503">
        <infon key="identifier">17927</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7857</infon>
        <location offset="20519" length="4"/>
        <text>myoD</text>
      </annotation>
      <annotation id="504">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="20629" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="505">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="20798" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="506">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="20943" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="507">
        <infon key="identifier">17928</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1854</infon>
        <location offset="21063" length="8"/>
        <text>myogenin</text>
      </annotation>
      <annotation id="508">
        <infon key="identifier">17928</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1854</infon>
        <location offset="21154" length="8"/>
        <text>myogenin</text>
      </annotation>
      <annotation id="509">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="21249" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="510">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="21442" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="511">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="21590" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="512">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="21657" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="513">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="20119" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="514">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="20726" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="515">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="20911" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="516">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="21272" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="517">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="21518" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="518">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="20381" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="519">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="20277" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="520">
        <infon key="identifier">105661730</infon>
        <infon key="type">Gene</infon>
        <location offset="20245" length="8"/>
        <text>linc-MD1</text>
      </annotation>
      <annotation id="521">
        <infon key="identifier">CVCL:0188</infon>
        <infon key="type">CellLine</infon>
        <location offset="20547" length="5"/>
        <text>C2C12</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13395_2014_23_Fig3_HTML.jpg</infon>
      <infon key="id">Fig3</infon>
      <infon key="type">fig_caption</infon>
      <offset>21701</offset>
      <text> Expression of miR-206 is confined to skeletal muscle. Expression of miR-206 (A) is detected by quantitative reverse transcription PCR (qRT-PCR) in tissues isolated from wildtype (WT) (open bars), miR-206/133b knock-out and mdxy/- (gray bars) mice. Expression of miR-206 is detected in skeletal muscle of the WT mice. miR-206 is not detected in muscles isolated from knock-out mice, confirming the loss of miR-206 in the knock-out tissue and specificity of the Taqman assay. miR-206 was at the qRT-PCR detection limit in heart and brain of WT mice. In WT mice, miR-206 was strongly expressed in the soleus muscle, which has a high content of type 1/oxidative skeletal muscle fibers. A lower amount of miR-206 was detected in the diaphragm, as well as in other skeletal muscles. In mdx mice, the expression of miR-206 was not increased in soleus muscle. Increased miR-206 expression was detected in the diaphragm and other skeletal muscles. Expression of miR-1 (B) was also analyzed in the respective muscles and appeared unchanged in the soleus muscle of miR-206/133b knock-out mice (black bar). Mdx mutation did not cause significant changes in the expression of miR-1. Samples were isolated from &gt;=3 different animals each, and qRT-PCR was performed in triplicate for each of the samples.</text>
      <annotation id="545">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="21716" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="546">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="21770" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="547">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="21898" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="548">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="21964" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="549">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="22019" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="550">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="22107" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="551">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="22176" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="552">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="22262" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="553">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="22402" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="554">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="22510" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="555">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="22564" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="556">
        <infon key="identifier">100316783</infon>
        <infon key="type">Gene</infon>
        <location offset="22655" length="9"/>
        <text>miR-1 (B)</text>
      </annotation>
      <annotation id="557">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="22756" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="558">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="22797" length="3"/>
        <text>Mdx</text>
      </annotation>
      <annotation id="559">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="22482" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="560">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="21944" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="561">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="22013" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="562">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="22078" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="563">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="22244" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="564">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="22256" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="565">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="22486" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="566">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="22779" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="567">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="22865" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13395_2014_23_Fig4_HTML.jpg</infon>
      <infon key="id">Fig4</infon>
      <infon key="type">fig_caption</infon>
      <offset>22993</offset>
      <text> No alterations in fiber type identity and fibers size in miR-206/133b knock-out mice. Sections of the soleus muscle isolated from adult wildtype (WT) (A) and mutant mice (B) were stained for markers of slow myofibers. No changes in fiber size of slow and fast muscle fibers were detected (C; n &gt;=8 per group, 30 fibers per animals). The ratio of slow/fast muscle fibers was unchanged in the soleus muscle of knock-out compared to WT mice (D). The scale bar in A corresponds to 100 mum in A and B.</text>
      <annotation id="572">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="23051" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="573">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="23074" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="574">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="23159" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="575">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="23427" length="4"/>
        <text>mice</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>23493</offset>
      <text>The miR-206/133b cluster is predominantly expressed in muscles with a high content of oxidative type I myofibers such as the soleus muscle and less abundant in muscles with only few oxidative fibers (Figure 3A). Analysis of published small RNA sequencing results reveals that miR-206 is much less abundant in skeletal muscle than the related miR-1 (GSM539875; 20124 miR-206 versus 745064 miR-1 tags per million miRNA tags). Small RNA sequencing of mouse soleus muscle revealed that even in the muscle with highest expression of miR-206 miR-1 is by far the most abundant miRNA (GSE63342; 30812 miR-206 versus 281944 miR-1 tags per million miRNA tags). The expression of miR-1 was not significantly altered after loss of miR-206 (Figure 3B, M. soleus samples). Histological examination of M. soleus did not reveal obvious morphological alterations. We detected no changes in fiber size, fiber type distribution (Figure 4) or localization of myofiber nuclei. Similar results were obtained for other skeletal muscles (data not shown).</text>
      <annotation id="588">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="23497" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="589">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="23769" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="590">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="24212" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="591">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="24086" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="592">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="23859" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="593">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="23941" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="594">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="24021" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="595">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="24162" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="596">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="24108" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="597">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="24029" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="598">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="23881" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="599">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="23835" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>24527</offset>
      <text>miR-206/133b mutant skeletal muscles do not show significant molecular abnormalities</text>
      <annotation id="602">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="24527" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="603">
        <infon key="identifier">MESH:C567116</infon>
        <infon key="type">Disease</infon>
        <location offset="24588" length="23"/>
        <text>molecular abnormalities</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13395_2014_23_Fig5_HTML.jpg</infon>
      <infon key="id">Fig5</infon>
      <infon key="type">fig_caption</infon>
      <offset>24612</offset>
      <text> No transcriptional changes in the soleus muscle of miR-206/133b knock-out (KO) mice. The scatter blot of the median of the log2 signals of wildtype (WT) (n = 9) versus KO (n = 8) indicates only few genes with expression changes more than twofold (green lines). The probe set 1446563_at detects RNA originating from the genome between miR-206 and miR-133b most likely the pri-miRNA of these miRNAs. The weak signal for this probe set in WT samples is reduced to the detection limit in the KO samples. Only a few of the detected changes in gene expression are significant after statistical analysis using Student's t-test. None of these changes could be verified by quantitative reverse transcription PCR (qRT-PCR) or analysis of protein expression. After false discovery rate correction by the Benjamini-Hochberg algorithm, only one gene directly downstream of the manipulated genomic locus significantly changed expression.</text>
      <annotation id="608">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="24664" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="609">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="24947" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="610">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="24959" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="611">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="24692" length="4"/>
        <text>mice</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>25547</offset>
      <text>To investigate whether the loss of expression of miR-206/133b leads to changes of gene expression levels we performed Affymetrix GeneChip analysis using RNA isolated from M. soleus and mouse genome 430 2.0 arrays (n = 9 WT, n = 8 KO). Only few and subtle changes were detected by this type of analysis (Figure 5). The strongly and significantly downregulated probe set 1446563_at detects RNA transcribed from the miR-206/133b locus with the probes binding between the both miRNAs but not within the known linc-MD1 exons. This finding additionally confirms the successful knock-out strategy and suggests that this probe set detects the common miR-206/133b precursor RNA. The only gene that was significantly (2.5-fold) upregulated after false discovery rate correction was IL-17a, which is located downstream of the miR-206/133b locus, suggesting a cis-regulatory mechanism caused by manipulation of the neighboring miRNA locus. No other gene was significantly deregulated in soleus muscle. In particular, we did not observe up-regulation of predicted miR-206 or miR-133b target genes.</text>
      <annotation id="621">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="25596" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="622">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="25960" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="623">
        <infon key="identifier">105661730</infon>
        <infon key="type">Gene</infon>
        <location offset="26052" length="8"/>
        <text>linc-MD1</text>
      </annotation>
      <annotation id="624">
        <infon key="identifier">16171</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1651</infon>
        <location offset="26319" length="6"/>
        <text>IL-17a</text>
      </annotation>
      <annotation id="625">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="26362" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="626">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="26598" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="627">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="26609" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="628">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="26189" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="629">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="25732" length="5"/>
        <text>mouse</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13395_2014_23_Fig6_HTML.jpg</infon>
      <infon key="id">Fig6</infon>
      <infon key="type">fig_caption</infon>
      <offset>26641</offset>
      <text> miR-206/133b does not modulate abundance of PAX7 in E10.5 embryos. SILAC-based screening of changes in protein abundance based on two independent pairs of miR-206/133b knock-out / wildtype (WT) samples revealed few changes that were greater than 1.5 fold up or down in miR-206/133b knock-out versus WT M. soleus (A). Not one of the proteins expected to be potentially upregulated was a predicted target of miR-206 or miR-133b (microRNA.org). In accordance with transcriptome data, no change in protein abundance could be confirmed in western blot analysis. Loss of miR-206/133b does not change the abundance of PAX7 protein in the trunk of E10.5 embryos (B, C). Analysis of the 3' untranslated region (UTR) of Pax7 using miRanda indicates identical binding sites for miR-206 and miR-1. Differences in the primary sequence of miR-206 and miR-1 do not lead to substantial changes in the predicted miRNA-Pax7 UTR interaction (D).</text>
      <annotation id="644">
        <infon key="identifier">387202;723817</infon>
        <infon key="type">Gene</infon>
        <location offset="26642" length="12"/>
        <text>miR-206/133b</text>
      </annotation>
      <annotation id="645">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="26686" length="4"/>
        <text>PAX7</text>
      </annotation>
      <annotation id="646">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="26797" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="647">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="27048" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="648">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="27059" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="649">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="27207" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="650">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="27253" length="4"/>
        <text>PAX7</text>
      </annotation>
      <annotation id="651">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="27352" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="652">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="27409" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="653">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="27467" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="654">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="27543" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="655">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="26911" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="656">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="27479" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="657">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="27421" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>27571</offset>
      <text>Since microRNAs regulate expression on the transcript or protein level, we performed an unbiased SILAC based proteomics screen to detect potential miRNA targets that are regulated at the translational level. Proteins were isolated from M. soleus of WT and miR-206/133b mutant mice and combined with proteins obtained from soleus muscles of 13C6Lys-labled mice, which serve as a reference for relative quantification. In total, we identified 1,500 proteins and 805 were quantified in two independent experiments. SILAC ratios of WT/13C6-Lys-WT and in knock-out/13C6-Lys-WT were used to calculate the direct KO/WT ratios for each of the experiments. In accordance with our transcriptome analysis, only few changes in protein concentrations between knock-out and WT soleus muscle were observed (Figure 6A). Although we quantified 94 potential miR-206 targets that displayed a good score according to the miRanda based microRNA.org target prediction database (August 2010 release), none of the potential target protein was upregulated more than 1.5 fold in the knock-out tissue. Likewise, none of the 57 proteins found in our SILAC data set that were predicted as miR-133b targets according to the microRNA.org database were upregulated.</text>
      <annotation id="668">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="27827" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="669">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="28411" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="670">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="28731" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="671">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="27847" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="672">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="27926" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="673">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="28102" length="4"/>
        <text>13C6</text>
      </annotation>
      <annotation id="674">
        <infon key="identifier">MESH:D008239</infon>
        <infon key="type">Chemical</infon>
        <location offset="28107" length="3"/>
        <text>Lys</text>
      </annotation>
      <annotation id="675">
        <infon key="identifier">MESH:D008239</infon>
        <infon key="type">Chemical</infon>
        <location offset="28136" length="3"/>
        <text>Lys</text>
      </annotation>
      <annotation id="676">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="28131" length="4"/>
        <text>13C6</text>
      </annotation>
      <annotation id="677">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="27911" length="7"/>
        <text>13C6Lys</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>28806</offset>
      <text>Although no alterations in skeletal muscle development of miR-206/133b mutants were apparent, we investigated the potential regulatory interaction between miR-206 and Pax7 in somites of E10.5 embryos. No changes in Pax7 protein expression were detected in mutant compared to WT embryos indicating that miR-206 is not required to suppress expression of Pax7 in somites (Figure 6B, C), probably due to the presence of miR-1, which shows a similar expression pattern as miR-206 during skeletal muscle development but is more widely expressed compared to miR-206 in adult muscles. In fact, the seed sequences of miR-1 and miR-206 are identical, which predicts a comparable repression of Pax7 by either miR-206 or miR-1 (Figure 6D) according to target algorithms like miRanda. Taken together, neither transcriptome nor proteome analysis revealed significant changes in gene expression between WT and KO mice, which is in line with the lack of a muscle specific phenotype in miR-206/133b knock-out mice.</text>
      <annotation id="695">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="28864" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="696">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="28961" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="697">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="28973" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="698">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="29021" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="699">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="29108" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="700">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="29158" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="701">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="29273" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="702">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="29357" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="703">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="29424" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="704">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="29489" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="705">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="29504" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="706">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="29775" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="707">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="29704" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="708">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="29798" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="709">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="29515" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="710">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="29414" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="711">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="29222" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>29806</offset>
      <text>Loss of the miR-206/133 cluster does not affect skeletal muscle regeneration in Duchenne muscular dystrophy model mice</text>
      <annotation id="714">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="29818" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="715">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="29886" length="27"/>
        <text>Duchenne muscular dystrophy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13395_2014_23_Fig7_HTML.jpg</infon>
      <infon key="id">Fig7</infon>
      <infon key="type">fig_caption</infon>
      <offset>29925</offset>
      <text> No difference in body weight and survival of miR-206/133b and mdx mutant mice. (A) The body weight of male animals is not different at 6 weeks of age (n &gt;=11/group); however, at later ages (B), the mdx mutation leads to an increase in body weight that is not further modified by mutation of the miRNA cluster (wildtype (WT): miR-206/133b+/+, knock-out (KO): miR-206/133b-/-; MDX: mdxY/-; n &gt;=5/group). (C) Survival of miR-206/133b mutants is not impaired. The mdx mutation does not affect survival of miR-206/133b knock-out mice.</text>
      <annotation id="727">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="29971" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="728">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="30251" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="729">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="30284" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="730">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="30344" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="731">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="30427" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="732">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="30386" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="733">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="30301" length="3"/>
        <text>MDX</text>
      </annotation>
      <annotation id="734">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="30124" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="735">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="29988" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="736">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="29999" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="737">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="30450" length="4"/>
        <text>mice</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13395_2014_23_Fig8_HTML.jpg</infon>
      <infon key="id">Fig8</infon>
      <infon key="type">fig_caption</infon>
      <offset>30463</offset>
      <text> Loss of miR-206/133b does not change serum creatine kinase activity. Creatine kinase activity in the serum in miR-206/133b mice knock-out mice is not altered. The mdx mutation leads to strong increase of creatine kinase activity. No differences were observed in mdx versus miR-206/133b KO / MDX mice (n &gt;=6/group).</text>
      <annotation id="747">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="30472" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="748">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="30737" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="749">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="30755" length="3"/>
        <text>MDX</text>
      </annotation>
      <annotation id="750">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="30574" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="751">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="30726" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="752">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="30627" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="753">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="30587" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="754">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="30602" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="755">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="30759" length="4"/>
        <text>mice</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13395_2014_23_Fig9_HTML.jpg</infon>
      <infon key="id">Fig9</infon>
      <infon key="type">fig_caption</infon>
      <offset>30780</offset>
      <text> miR-206/133b mutation does not modulate muscle loss or regeneration in Mdx mice. No histological changes are observed in diaphragm or M. quadriceps after loss of miR-206/133b. Mutation of the mouse dystrophin gene (MDX) leads to increased muscle mass, calcifications (von Kossa staining) and increased fibrosis (red signal in Sirius red staining). Additional loss of miR-206/133b does not lead to changes of the mdx phenotype. Sections obtained from 12 weeks old animals are shown, similar results are obtained using tissue from 6-week- and 9-month-old mice. The scale bar corresponds to 200 mum in the upper three rows and to 50 mum in the lower two rows.</text>
      <annotation id="769">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="30781" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="770">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="30943" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="771">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="30979" length="10"/>
        <text>dystrophin</text>
      </annotation>
      <annotation id="772">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="31148" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="773">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="30996" length="3"/>
        <text>MDX</text>
      </annotation>
      <annotation id="774">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="31193" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="775">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="30852" length="3"/>
        <text>Mdx</text>
      </annotation>
      <annotation id="776">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="30856" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="777">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="30973" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="778">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31334" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="779">
        <infon key="identifier">MESH:D005355</infon>
        <infon key="type">Disease</infon>
        <location offset="31083" length="8"/>
        <text>fibrosis</text>
      </annotation>
      <annotation id="780">
        <infon key="identifier">MESH:D009133</infon>
        <infon key="type">Disease</infon>
        <location offset="30821" length="11"/>
        <text>muscle loss</text>
      </annotation>
      <annotation id="781">
        <infon key="identifier">MESH:D014842</infon>
        <infon key="type">Disease</infon>
        <location offset="31049" length="3"/>
        <text>von</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>31441</offset>
      <text>Previously, miR-206 has been implicated in muscle fiber stability and regeneration of skeletal muscles, although the miR-206 seems dispensable for specification, proliferation and differentiation of skeletal muscle. To analyze the potential function of miR-206/133b miRNAs and their targets in maintenance and regeneration of muscle fibers we generated miR-206/133b-/-//mdxY/- compound mutant mice. Mdx mice carry a point mutation in the dystrophin gene on the X-chromosome leading to constant damage and loss of muscle fibers, which is compensated by increased regeneration. miR-206/133b-/-/mdx mutant mice were born at the expected Mendelian ratio (Table 1) and developed normally, which is in contrast to the previously described miR-206-/-/mdx mutant mice. Body weight development (Figure 7A, B) and survival (Figure 7C) of compound mutant animals was indistinguishable from mdx mice. Regeneration of skeletal muscles in mdx mice leads to increased expression of the miR-206/133b cluster in muscles with a low content of type I muscle fibers that express only low levels of miR-206/133b under normal conditions (Figure 3A,). In contrast we observed a moderate, not significant reduction of miR-1 in some mdx muscles (Figure 3B), possibly related to the emergence of other non-muscle cell types in the dystrophic muscles. Hence, it seems possible that such muscle might be affected by inactivation of miR-206/133b in conditions of constant regeneration. Loss of dystrophin expression results in the release of muscle creatine kinase (MCK) from muscle fibers into the blood, which serves as an indicator of muscle injury or muscle degenerative processes. To access the degree of muscle damage in miR-206/133b-/-/mdx mutant mice we determined MCK activity in serum of adult mice. Only very low MCK activity was detected in WT and miR-206/133b mice, which did not differ significantly between WT (297 +- 85 U/l, n = 6) and mutants (152 +- 62 U/l, n = 11). Importantly, we observed much higher MCK activities in mdx mice (8590 +- 1507 U/l, n = 6), which were not increased any further in miR-206/133b/mdx mutants (8024 +- 2464 U/l, n = 6; Figure 8) indicating that compound mutants do not suffer from increased muscle fiber damage compared to mdx mice. Next, we performed a comprehensive histological analysis of different muscles of the hind limb, as well as of the diaphragm from WT, miR-206/133b-/-, mdxY/- and miR-206/133b-/-//mdxY/- mice. Trichrome- and Sirius Red-, and von Kossa staining were used to determine myofiber organization, fibrosis, and intramuscular calcifications often present in mdx mice (Figure 9). No differences were found between WT and miR-206/133b skeletal muscle based on Trichrome- (not shown), von Kossa or Sirius red staining including absence of fibrosis and calcifications. Mutation of dystrophin caused the typical signs of muscle dystrophy, namely massive thickening of the diaphragm, enhanced fibrosis and patches of calcified tissue within the diaphragm and the M. quadriceps (Figure 9). No calcified fibers were observed in the soleus muscle. Deletion of miR-206/133b in mdx mice did not cause a more severe phenotype in the soleus, quadriceps or diaphragm muscles compared to single mutant mdx mice. Together these data indicate that loss of miR-206/133b cluster does not increase muscle damage in mdx mice or compromise skeletal muscle regeneration in constantly renewing muscle tissue.</text>
      <annotation id="849">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="31453" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="850">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="31558" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="851">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="31694" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="852">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="31794" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="853">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="31879" length="10"/>
        <text>dystrophin</text>
      </annotation>
      <annotation id="854">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="32174" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="855">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="32412" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="856">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="32519" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="857">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="32845" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="858">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="32906" length="10"/>
        <text>dystrophin</text>
      </annotation>
      <annotation id="859">
        <infon key="identifier">12715</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20432</infon>
        <location offset="32954" length="22"/>
        <text>muscle creatine kinase</text>
      </annotation>
      <annotation id="860">
        <infon key="identifier">12715</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20432</infon>
        <location offset="32978" length="3"/>
        <text>MCK</text>
      </annotation>
      <annotation id="861">
        <infon key="identifier">12715</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20432</infon>
        <location offset="33185" length="3"/>
        <text>MCK</text>
      </annotation>
      <annotation id="862">
        <infon key="identifier">12715</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20432</infon>
        <location offset="33236" length="3"/>
        <text>MCK</text>
      </annotation>
      <annotation id="863">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="33272" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="864">
        <infon key="identifier">12715</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20432</infon>
        <location offset="33434" length="3"/>
        <text>MCK</text>
      </annotation>
      <annotation id="865">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="33826" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="866">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="33854" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="867">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="34103" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="868">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="34260" length="10"/>
        <text>dystrophin</text>
      </annotation>
      <annotation id="869">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="34534" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="870">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="34722" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="871">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="33528" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="872">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="33139" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="873">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="32017" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="874">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="34778" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="875">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="34670" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="876">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="34550" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="877">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="34041" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="878">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="33683" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="879">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="33541" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="880">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="33452" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="881">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="33155" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="882">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="32649" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="883">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="32366" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="884">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="32320" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="885">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="32185" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="886">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="32033" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="887">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="31840" length="3"/>
        <text>Mdx</text>
      </annotation>
      <annotation id="888">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31834" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="889">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31844" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="890">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32044" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="891">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32196" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="892">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32324" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="893">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32370" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="894">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33166" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="895">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33216" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="896">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33285" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="897">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33456" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="898">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33687" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="899">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33878" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="900">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="34045" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="901">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="34554" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="902">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="34674" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="903">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="34782" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="904">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="32635" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="905">
        <infon key="identifier">MESH:D009136</infon>
        <infon key="type">Disease</infon>
        <location offset="32746" length="18"/>
        <text>dystrophic muscles</text>
      </annotation>
      <annotation id="906">
        <infon key="identifier">MESH:D009136</infon>
        <infon key="type">Disease</infon>
        <location offset="34299" length="16"/>
        <text>muscle dystrophy</text>
      </annotation>
      <annotation id="907">
        <infon key="identifier">MESH:D005355</infon>
        <infon key="type">Disease</infon>
        <location offset="34370" length="8"/>
        <text>fibrosis</text>
      </annotation>
      <annotation id="908">
        <infon key="identifier">MESH:D014842</infon>
        <infon key="type">Disease</infon>
        <location offset="33916" length="3"/>
        <text>von</text>
      </annotation>
      <annotation id="909">
        <infon key="identifier">MESH:D009135</infon>
        <infon key="type">Disease</infon>
        <location offset="33050" length="13"/>
        <text>muscle injury</text>
      </annotation>
      <annotation id="910">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="34178" length="10"/>
        <text>Sirius red</text>
      </annotation>
      <annotation id="911">
        <infon key="identifier">MESH:D005355</infon>
        <infon key="type">Disease</infon>
        <location offset="34219" length="8"/>
        <text>fibrosis</text>
      </annotation>
      <annotation id="912">
        <infon key="identifier">MESH:D005355</infon>
        <infon key="type">Disease</infon>
        <location offset="33981" length="8"/>
        <text>fibrosis</text>
      </annotation>
      <annotation id="913">
        <infon key="identifier">MESH:D009135</infon>
        <infon key="type">Disease</infon>
        <location offset="33122" length="13"/>
        <text>muscle damage</text>
      </annotation>
      <annotation id="914">
        <infon key="identifier">MESH:D009135</infon>
        <infon key="type">Disease</infon>
        <location offset="34761" length="13"/>
        <text>muscle damage</text>
      </annotation>
      <annotation id="915">
        <infon key="identifier">MESH:D014842</infon>
        <infon key="type">Disease</infon>
        <location offset="34165" length="9"/>
        <text>von Kossa</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13395_2014_23_Fig10_HTML.jpg</infon>
      <infon key="id">Fig10</infon>
      <infon key="type">fig_caption</infon>
      <offset>34932</offset>
      <text> No differences in differentiation of muscle progenitor cells in vitro . Proliferating muscle stem cells isolated from hind limb muscles of wildtype (WT) and miR-206/133b knock-out mice (KO) were induced to differentiate and stained after 3 or 5 days in differentiation medium (DM) for expression of myosin (green: MF20 staining, blue: nuclear staining; the scale bar corresponds to 50 mum). No differences in cell morphology or differences in the expression of myosin were detected between WT and mutant cells (A). Formation of fused myotubes from differentiating myoblasts was not impaired by the loss of the miR-206/133b cluster (B). Pax7 expression in differentiating myogenic progenitor cells was detected by western blot. No differences in Pax7 expression were detected after loss of miR-206/133b (C).</text>
      <annotation id="923">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="35090" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="924">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="35543" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="925">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="35569" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="926">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="35678" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="927">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="35722" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="928">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="35113" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="929">
        <infon key="identifier">MESH:D009223</infon>
        <infon key="type">Disease</infon>
        <location offset="35210" length="2"/>
        <text>DM</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>35742</offset>
      <text>To further analyze a possible function of the miR-206/133b cluster in the differentiation of muscle stem cells, we isolated muscle satellite cells from WT and miR-206/133b mutant mice. Loss of the miR-206/133b cluster did not impair the ability of muscle stem cells to differentiate to myotubes in vitro (Figure 10A). We did not observe reduced differentiation as accessed by the number of MF20 positive cells nor changes in the fusion of myocytes as accessed by the number of myotubes with more than one nucleus (Figure 10B). Moreover, we found that the lack of miR-206/133b did not increase the concentration of the potential miR-206 and miR-1 target Pax7 in differentiating satellite cells on the 5th day after induction of differentiation (Figure 10C).</text>
      <annotation id="938">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="35788" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="939">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="35901" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="940">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="35939" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="941">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="36305" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="942">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="36370" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="943">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="36395" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="944">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="35921" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="945">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="36382" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>36502</offset>
      <text>Discussion</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>36513</offset>
      <text>Physiological properties of skeletal muscle cells including specification, differentiation, function and regeneration are controlled by an extensive network of regulatory molecules. Many key genes have been identified that are essential for specification and differentiation of muscle precursor cells during development. Commitment of muscle cells is controlled by a core program of myogenic regulatory factors of the MyoD family, which also control transcription of the miR-1/206/133 miRNA clusters resulting in a prominent expression of these miRNAs in muscle cells. Yet, important differences in the expression pattern of miR-1/206/133 miRNA clusters exist: the miR-1/133a clusters are expressed in heart and all skeletal muscles, while expression of miR-206/133b becomes restricted to a subset of oxidative muscle fibers by hitherto unknown molecular mechanisms. Since the two miR-1/133a clusters display virtually identical expression patterns, partially overlapping or redundant functions of these miRNAs seem likely. In contrast, the miR-206/133b cluster shows a more restricted expression, which might argue for a distinct function of this cluster albeit muscle cells expressing miR-206/133b also transcribe miR-1/133a. In addition, the primary sequence of miR-206 differs from miR-1 while miR-133b is very similar to miR-133a. However, the seed sequences of miR-206 and miR-1 important for target recognition are identical, indicating only limited differences in the target specificity of miR-206 and miR-1. The miR-206/133b locus also directs expression of the long non-coding RNA linc-MD1, which was postulated to act as a competing endogenous RNA or miRNA decoy adding a further potential function to the miR-206/133b locus.</text>
      <annotation id="966">
        <infon key="identifier">17927</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7857</infon>
        <location offset="36931" length="4"/>
        <text>MyoD</text>
      </annotation>
      <annotation id="967">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="37267" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="968">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="37554" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="969">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="37700" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="970">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="37778" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="971">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="37811" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="972">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="37880" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="973">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="38011" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="974">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="38034" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="975">
        <infon key="identifier">105661730</infon>
        <infon key="type">Gene</infon>
        <location offset="38104" length="8"/>
        <text>linc-MD1</text>
      </annotation>
      <annotation id="976">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="38230" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="977">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="38023" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="978">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="37892" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="979">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="37839" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="980">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="37799" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="981">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="37729" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="982">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="37394" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="983">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="37178" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="984">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="37138" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="985">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="36984" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>38250</offset>
      <text>We have generated a miR-206/133b knock-out allele by deletion of the genomic region spanning from miR-206 to miR-133b and resulting in removal of the third exon of the linc-MD1 that might act as a miR-133 sponge. Surprisingly, homozygous deletion of the miR-206/133b locus did not cause an apparent phenotype in adult mice. No changes in the morphology and distribution of muscle fiber types were apparent and the transcriptional and proteomics signatures of miR-206/133b mutant muscles were virtually unchanged, ruling out that miR-206 and/or 133b alone play an essential role in muscle physiology. These observations are consistent with to observations made in miR-206 knock-out mice, which also show no obvious phenotype under baseline conditions. Apparently, the concomitant loss of miR-206, miR-133b and the potential miR-133 sponge in linc-MD1 is compatible with normal muscle development and functions, which might be explained by expression of the miR-1/133a clusters in type I myofibers compensating for deletion of miR-206/133b. Theoretically, the inactivation of miR-133b might also be counteracted by the loss of the miR-133 sponge function, although the physiological relevance of endogenous competing RNAs has been questioned making this explanation less likely.</text>
      <annotation id="1005">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="38270" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1006">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="38348" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1007">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="38359" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="1008">
        <infon key="identifier">105661730</infon>
        <infon key="type">Gene</infon>
        <location offset="38418" length="8"/>
        <text>linc-MD1</text>
      </annotation>
      <annotation id="1009">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="38504" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1010">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="38709" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1011">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="38779" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1012">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="39037" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1013">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="39046" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="1014">
        <infon key="identifier">105661730</infon>
        <infon key="type">Gene</infon>
        <location offset="39091" length="8"/>
        <text>linc-MD1</text>
      </annotation>
      <annotation id="1015">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="39275" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1016">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="39324" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="1017">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="38568" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="1018">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="38931" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="1019">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="38913" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1020">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="39379" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="1021">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="39206" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="1022">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="39073" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="1023">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="38447" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>39527</offset>
      <text>We found a more widespread and abundant expression of the miR-206/133b cluster in regenerating muscles, which confirms previous findings. It seems possible that the expression of miR-206 in regenerating muscle reflects a specific function of the miR-206/133b in the regenerative response. However, it is important to point out that miR-206/133b is broadly expressed during development in immature muscle cells. Hence, it is difficult to exclude that the increased expression of miR-206/133b during skeletal muscle regeneration simply mirrors the immature state of newly formed myofibers that have not yet terminated expression of the miR-206/133b cluster in the majority of mature type II fibers. The lack of a more severe phenotype in miR-206/133b-/-//mdxY/- compound mutants compared to mdxY/- mice clearly argues against an important role of the miR-206/133b cluster for skeletal muscle regeneration. Moreover, we did not see an increase in lethality or an increase in serum creatine kinase levels in compound mutant mice, which also excludes an important role of the miR-206/133b cluster in restricting myofiber damage.</text>
      <annotation id="1035">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="39585" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1036">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="39706" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1037">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="39773" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1038">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="39859" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1039">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="40005" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1040">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="40161" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1041">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="40376" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1042">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="40598" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1043">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="40263" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1044">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="40323" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="1045">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="40547" length="4"/>
        <text>mice</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>40655</offset>
      <text>miR-206 has been claimed to suppress Pax7 expression thereby regulating muscle stem cell renewal and differentiation. The normal expression of Pax7 in isolated miR-206/133b mutant satellite cells and the normal differentiation of mutant satellite cells to myotubes in vitro do not argue for an important role of miR-206 in Pax7 expression. These results are in contrast to previous publications mostly relying on the inhibition of miR-206 by anti-miRs, overexpression of miR-206, or by correlation of expression profiles. It seems possible that previous anti-miR approaches were biased by off-target effects or affected expression of miR-1, which can also suppress Pax7. Generation of skeletal muscle specific miR-1/miR133a//miR-206/133b triple mutants will probably solve this controversy in the future. We do not have a convincing explanation for the attenuation of Pax7 down-regulation in differentiating miR-206-deficient satellite cells reported by Liu et al.. The same authors also described that miR-206/mdx mutant mice suffer from increased muscle degeneration, impaired regeneration and premature death, which was all not seen in our miR-206/133b mutants. In principle, it is feasible that the concomitant loss of mir-206 and miR-133b in our model accounts for these differences, which would strengthen the notion that the miR-206/133b cluster acts as a functional unit targeting similar biological processes sometimes in parallel and sometimes in opposing directions. Alternatively, subtle differences in the genetic background and/or strain-depended differences in the expression of miR-1/133a compensating for the loss of miR-206/133b might differentially affect the course of muscular dystrophy in miR-206/133b-/-//mdxy/- and miR-206-/-//mdxy/- compound mutants.</text>
      <annotation id="1075">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="40655" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1076">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="40692" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="1077">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="40798" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="1078">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="40815" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1079">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="40967" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1080">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="40978" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="1081">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="41086" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1082">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="41126" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1083">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="41320" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="1084">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="41380" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1085">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="41523" length="4"/>
        <text>Pax7</text>
      </annotation>
      <annotation id="1086">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="41563" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1087">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="41658" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1088">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="41798" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1089">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="41878" length="7"/>
        <text>mir-206</text>
      </annotation>
      <annotation id="1090">
        <infon key="identifier">723817</infon>
        <infon key="type">Gene</infon>
        <location offset="41890" length="8"/>
        <text>miR-133b</text>
      </annotation>
      <annotation id="1091">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="41987" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1092">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="42289" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1093">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="42394" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1094">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="42366" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1095">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="41214" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="1096">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="41666" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="1097">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="41677" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="1098">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="42249" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="1099">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="41365" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="1100">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="41289" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="1101">
        <infon key="identifier">MESH:D009422</infon>
        <infon key="type">Disease</infon>
        <location offset="41725" length="41"/>
        <text>impaired regeneration and premature death</text>
      </annotation>
      <annotation id="1102">
        <infon key="identifier">MESH:D009135</infon>
        <infon key="type">Disease</infon>
        <location offset="41704" length="19"/>
        <text>muscle degeneration</text>
      </annotation>
      <annotation id="1103">
        <infon key="identifier">MESH:D009136</infon>
        <infon key="type">Disease</infon>
        <location offset="42344" length="18"/>
        <text>muscular dystrophy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>42439</offset>
      <text>Conclusion</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>42450</offset>
      <text>Taken together, our results question a major role of the miR-206/133b cluster in development, function and regeneration of skeletal muscle in mouse and argue for overlapping functions of the miR-206/133b and miR-1/133a gene clusters during myogenesis. Our findings are in line with the hypothesis that individual miRNAs often fine-tune biological processes and play modulatory roles. Further genetic studies targeting the miR-1/133a together with the miR-206/133b gene clusters specifically in skeletal muscle will probably reveal the prevalent physiological function of miR-1/206/133 in mammals.</text>
      <annotation id="1111">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="42507" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1112">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="42641" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1113">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="42901" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1114">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="42592" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="1115">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="43021" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="1116">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="42872" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="1117">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="42658" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">title</infon>
      <offset>43047</offset>
      <text>Abbreviations</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43061</offset>
      <text>BSA</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43065</offset>
      <text>bovine serum albumin</text>
      <annotation id="1119">
        <infon key="identifier">9913</infon>
        <infon key="type">Species</infon>
        <location offset="43065" length="6"/>
        <text>bovine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43086</offset>
      <text>ChIP</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43091</offset>
      <text>chromatin immunoprecipitation</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43121</offset>
      <text>DM</text>
      <annotation id="1121">
        <infon key="identifier">MESH:D009223</infon>
        <infon key="type">Disease</infon>
        <location offset="43121" length="2"/>
        <text>DM</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43124</offset>
      <text>differentiation medium</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43147</offset>
      <text>DSHB</text>
      <annotation id="1123">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="43147" length="4"/>
        <text>DSHB</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43152</offset>
      <text>developmental studies hybridoma bank</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43189</offset>
      <text>DTA</text>
      <annotation id="1125">
        <infon key="identifier">MESH:C042899</infon>
        <infon key="type">Chemical</infon>
        <location offset="43189" length="3"/>
        <text>DTA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43193</offset>
      <text>diphtheria toxin A</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43212</offset>
      <text>ES cell</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43220</offset>
      <text>embryonic stem cell</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43240</offset>
      <text>FCS</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43244</offset>
      <text>fetal calf serum</text>
      <annotation id="1127">
        <infon key="identifier">9913</infon>
        <infon key="type">Species</infon>
        <location offset="43250" length="4"/>
        <text>calf</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43261</offset>
      <text>FDR</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43265</offset>
      <text>false discovery rate</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43286</offset>
      <text>HRP</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43290</offset>
      <text>horseradish peroxidase</text>
      <annotation id="1129">
        <infon key="identifier">3704</infon>
        <infon key="type">Species</infon>
        <location offset="43290" length="11"/>
        <text>horseradish</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43313</offset>
      <text>IRES</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43318</offset>
      <text>internal ribosome entry site</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43347</offset>
      <text>KO</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43350</offset>
      <text>knock-out</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43360</offset>
      <text>lacZ</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43365</offset>
      <text>beta-galactosidase coding</text>
      <annotation id="1131">
        <infon key="identifier">12091</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">47922</infon>
        <location offset="43365" length="18"/>
        <text>beta-galactosidase</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43391</offset>
      <text>MCK</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43395</offset>
      <text>creatine kinase, muscle</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43419</offset>
      <text>MDX</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43423</offset>
      <text>mouse model of Duchenne Muscular Dystrophy, X-linked</text>
      <annotation id="1134">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="43423" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="1135">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="43438" length="27"/>
        <text>Duchenne Muscular Dystrophy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43476</offset>
      <text>miR</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43480</offset>
      <text>miRNA</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43486</offset>
      <text>PBS</text>
      <annotation id="1137">
        <infon key="identifier">MESH:D007854</infon>
        <infon key="type">Chemical</infon>
        <location offset="43486" length="3"/>
        <text>PBS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43490</offset>
      <text>phosphate buffered saline</text>
      <annotation id="1139">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="43490" length="25"/>
        <text>phosphate buffered saline</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43516</offset>
      <text>PFA</text>
      <annotation id="1141">
        <infon key="identifier">MESH:D017245</infon>
        <infon key="type">Chemical</infon>
        <location offset="43516" length="3"/>
        <text>PFA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43520</offset>
      <text>paraformaldehyde</text>
      <annotation id="1143">
        <infon key="identifier">MESH:C003043</infon>
        <infon key="type">Chemical</infon>
        <location offset="43520" length="16"/>
        <text>paraformaldehyde</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43537</offset>
      <text>qRT-PCR</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43545</offset>
      <text>quantitative reverse transcription polymerase chain reaction</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43606</offset>
      <text>SDS-PAGE</text>
      <annotation id="1145">
        <infon key="identifier">MESH:D012967</infon>
        <infon key="type">Chemical</infon>
        <location offset="43606" length="3"/>
        <text>SDS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43615</offset>
      <text>sodium dodecyl sulfate polyacrylamide gel electrophoresis</text>
      <annotation id="1148">
        <infon key="identifier">MESH:C016679</infon>
        <infon key="type">Chemical</infon>
        <location offset="43638" length="14"/>
        <text>polyacrylamide</text>
      </annotation>
      <annotation id="1149">
        <infon key="identifier">MESH:D012967</infon>
        <infon key="type">Chemical</infon>
        <location offset="43615" length="22"/>
        <text>sodium dodecyl sulfate</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43673</offset>
      <text>SEM</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43677</offset>
      <text>standard error of the mean</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43704</offset>
      <text>SILAC</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43710</offset>
      <text>stable isotope labeling by amino acids in cell culture</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43765</offset>
      <text>UTR</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43769</offset>
      <text>untranslated region</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43789</offset>
      <text>WT</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>43792</offset>
      <text>wildtype</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">footnote</infon>
      <offset>43801</offset>
      <text>Competing interests</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">footnote</infon>
      <offset>43821</offset>
      <text>The authors declare that they have no competing interests.</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">footnote</infon>
      <offset>43880</offset>
      <text>Authors' contributions</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">footnote</infon>
      <offset>43905</offset>
      <text>TBo, SW, and HN conducted the experiments. TBo and TBr designed and interpreted the experiments and wrote the manuscript. All authors read and approved the final manuscript.</text>
      <annotation id="1151">
        <infon key="identifier">CVCL:R777</infon>
        <infon key="type">CellLine</infon>
        <location offset="43910" length="2"/>
        <text>SW</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>44079</offset>
      <text>References</text>
    </passage>
    <passage>
      <infon key="volume">136</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bartel;given-names:DP</infon>
      <infon key="fpage">215</infon>
      <infon key="pub-id_doi">10.1016/j.cell.2009.01.002</infon>
      <infon key="pub-id_pmid">19167326</infon>
      <infon key="year">2009</infon>
      <infon key="source">Cell</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">233</infon>
      <offset>44090</offset>
      <text>MicroRNAs: target recognition and regulatory functions</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Boettger;given-names:T</infon>
      <infon key="name_2">surname:Bachmann;given-names:A</infon>
      <infon key="name_1">surname:Besser;given-names:J</infon>
      <infon key="name_0">surname:Wystub;given-names:K</infon>
      <infon key="fpage">e1003793</infon>
      <infon key="pub-id_doi">10.1371/journal.pgen.1003793</infon>
      <infon key="pub-id_pmid">24068960</infon>
      <infon key="year">2013</infon>
      <infon key="source">PLoS Genet</infon>
      <infon key="type">ref</infon>
      <infon key="volume">9</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_4">surname:Braun;given-names:T</infon>
      <offset>44145</offset>
      <text>miR-1/133a clusters cooperatively specify the cardiomyogenic lineage by adjustment of myocardin levels during embryonic heart development</text>
      <annotation id="1154">
        <infon key="identifier">214384</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">17043</infon>
        <location offset="44231" length="9"/>
        <text>myocardin</text>
      </annotation>
      <annotation id="1155">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="44145" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Huang;given-names:Y</infon>
      <infon key="name_2">surname:Carver-Moore;given-names:K</infon>
      <infon key="name_1">surname:Saxby;given-names:C</infon>
      <infon key="name_0">surname:Heidersbach;given-names:A</infon>
      <infon key="fpage">e01323</infon>
      <infon key="pub-id_doi">10.7554/eLife.01323</infon>
      <infon key="pub-id_pmid">24252873</infon>
      <infon key="year">2013</infon>
      <infon key="source">eLife</infon>
      <infon key="type">ref</infon>
      <infon key="volume">2</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Srivastava;given-names:D</infon>
      <infon key="name_6">surname:Ivey;given-names:KN</infon>
      <infon key="name_5">surname:de Jong;given-names:PJ</infon>
      <infon key="name_4">surname:Ang;given-names:YS</infon>
      <offset>44283</offset>
      <text>microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart</text>
      <annotation id="1157">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="44376" length="9"/>
        <text>mammalian</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Qi;given-names:X</infon>
      <infon key="name_2">surname:Williams;given-names:AH</infon>
      <infon key="name_1">surname:Bezprozvannaya;given-names:S</infon>
      <infon key="name_0">surname:Liu;given-names:N</infon>
      <infon key="fpage">3242</infon>
      <infon key="pub-id_doi">10.1101/gad.1738708</infon>
      <infon key="pub-id_pmid">19015276</infon>
      <infon key="year">2008</infon>
      <infon key="source">Genes Dev</infon>
      <infon key="type">ref</infon>
      <infon key="volume">22</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">3254</infon>
      <infon key="name_6">surname:Olson;given-names:EN</infon>
      <infon key="name_5">surname:Bassel-Duby;given-names:R</infon>
      <infon key="name_4">surname:Richardson;given-names:JA</infon>
      <offset>44392</offset>
      <text>microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Frisard;given-names:MI</infon>
      <infon key="name_2">surname:Shelton;given-names:JM</infon>
      <infon key="name_1">surname:Bezprozvannaya;given-names:S</infon>
      <infon key="name_0">surname:Liu;given-names:N</infon>
      <infon key="fpage">3258</infon>
      <infon key="pub-id_doi">10.1172/JCI46267</infon>
      <infon key="pub-id_pmid">21737882</infon>
      <infon key="year">2011</infon>
      <infon key="source">J Clin Invest</infon>
      <infon key="type">ref</infon>
      <infon key="volume">121</infon>
      <infon key="name_10">surname:Bassel-Duby;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Olson;given-names:EN</infon>
      <infon key="name_9">surname:Richardson;given-names:JA</infon>
      <infon key="name_8">surname:Grange;given-names:RW</infon>
      <infon key="name_7">surname:Voelker;given-names:KA</infon>
      <infon key="lpage">3268</infon>
      <infon key="name_6">surname:Wu;given-names:Y</infon>
      <infon key="name_5">surname:McMillan;given-names:RP</infon>
      <infon key="name_4">surname:Hulver;given-names:MW</infon>
      <offset>44502</offset>
      <text>Mice lacking microRNA 133a develop dynamin 2-dependent centronuclear myopathy</text>
      <annotation id="1161">
        <infon key="identifier">13430</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">90883</infon>
        <location offset="44537" length="9"/>
        <text>dynamin 2</text>
      </annotation>
      <annotation id="1162">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="44502" length="4"/>
        <text>Mice</text>
      </annotation>
      <annotation id="1163">
        <infon key="identifier">MESH:D009135</infon>
        <infon key="type">Disease</infon>
        <location offset="44571" length="8"/>
        <text>myopathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Baskerville;given-names:S</infon>
      <infon key="name_2">surname:Farkhondeh;given-names:M</infon>
      <infon key="name_1">surname:Kumar;given-names:RM</infon>
      <infon key="name_0">surname:Rao;given-names:PK</infon>
      <infon key="fpage">8721</infon>
      <infon key="pub-id_doi">10.1073/pnas.0602831103</infon>
      <infon key="pub-id_pmid">16731620</infon>
      <infon key="year">2006</infon>
      <infon key="source">Proc Natl Acad Sci U S A</infon>
      <infon key="type">ref</infon>
      <infon key="volume">103</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">8726</infon>
      <infon key="name_4">surname:Lodish;given-names:HF</infon>
      <offset>44580</offset>
      <text>Myogenic factors that regulate expression of muscle-specific microRNAs</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Oustanina;given-names:S</infon>
      <infon key="name_2">surname:Rathjen;given-names:T</infon>
      <infon key="name_1">surname:Goljanek;given-names:K</infon>
      <infon key="name_0">surname:Sweetman;given-names:D</infon>
      <infon key="fpage">491</infon>
      <infon key="pub-id_doi">10.1016/j.ydbio.2008.06.019</infon>
      <infon key="pub-id_pmid">18619954</infon>
      <infon key="year">2008</infon>
      <infon key="source">Dev Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">321</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">499</infon>
      <infon key="name_6">surname:Munsterberg;given-names:A</infon>
      <infon key="name_5">surname:Dalmay;given-names:T</infon>
      <infon key="name_4">surname:Braun;given-names:T</infon>
      <offset>44651</offset>
      <text>Specific requirements of MRFs for the expression of muscle specific microRNAs, miR-1, miR-206 and miR-133</text>
      <annotation id="1167">
        <infon key="identifier">387202</infon>
        <infon key="type">Gene</infon>
        <location offset="44737" length="7"/>
        <text>miR-206</text>
      </annotation>
      <annotation id="1168">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="44749" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="1169">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="44730" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ren;given-names:B</infon>
      <infon key="name_2">surname:Hardison;given-names:R</infon>
      <infon key="name_1">surname:Snyder;given-names:M</infon>
      <infon key="name_0">surname:Stamatoyannopoulos;given-names:JA</infon>
      <infon key="pub-id_doi">10.1186/gb-2012-13-8-418</infon>
      <infon key="pub-id_pmid">22889292</infon>
      <infon key="year">2012</infon>
      <infon key="source">Genome Biol</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Weissman;given-names:SM</infon>
      <infon key="name_21">surname:Cayting;given-names:P</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_24">surname:Cheng;given-names:Y</infon>
      <infon key="name_25">surname:Landt;given-names:SG</infon>
      <infon key="name_22">surname:Hariharan;given-names:M</infon>
      <infon key="name_23">surname:Lian;given-names:J</infon>
      <infon key="name_28">surname:Dekker;given-names:J</infon>
      <infon key="name_29">surname:Crawford;given-names:GE</infon>
      <infon key="name_26">surname:Ma;given-names:Z</infon>
      <infon key="name_27">surname:Wold;given-names:BJ</infon>
      <infon key="fpage">418</infon>
      <infon key="volume">13</infon>
      <infon key="name_10">surname:Giste;given-names:E</infon>
      <infon key="name_13">surname:Balasundaram;given-names:G</infon>
      <infon key="name_14">surname:Byron;given-names:R</infon>
      <infon key="name_11">surname:Johnson;given-names:A</infon>
      <infon key="name_12">surname:Zhang;given-names:M</infon>
      <infon key="name_17">surname:Sandstrom;given-names:R</infon>
      <infon key="name_18">surname:Stehling;given-names:AS</infon>
      <infon key="name_15">surname:Roach;given-names:V</infon>
      <infon key="name_9">surname:Canfield;given-names:T</infon>
      <infon key="name_16">surname:Sabo;given-names:PJ</infon>
      <infon key="name_8">surname:Kaul;given-names:R</infon>
      <infon key="name_7">surname:Bender;given-names:M</infon>
      <infon key="name_6">surname:Groudine;given-names:M</infon>
      <infon key="name_19">surname:Thurman;given-names:RE</infon>
      <infon key="name_5">surname:Gilbert;given-names:DM</infon>
      <infon key="name_4">surname:Gingeras;given-names:T</infon>
      <offset>44757</offset>
      <text>An encyclopedia of mouse DNA elements (Mouse ENCODE)</text>
      <annotation id="1172">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="44776" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="1173">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="44796" length="5"/>
        <text>Mouse</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Santini;given-names:T</infon>
      <infon key="name_2">surname:Legnini;given-names:I</infon>
      <infon key="name_1">surname:Cacchiarelli;given-names:D</infon>
      <infon key="name_0">surname:Cesana;given-names:M</infon>
      <infon key="fpage">358</infon>
      <infon key="pub-id_doi">10.1016/j.cell.2011.09.028</infon>
      <infon key="pub-id_pmid">22000014</infon>
      <infon key="year">2011</infon>
      <infon key="source">Cell</infon>
      <infon key="type">ref</infon>
      <infon key="volume">147</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Bozzoni;given-names:I</infon>
      <infon key="lpage">369</infon>
      <infon key="name_6">surname:Tramontano;given-names:A</infon>
      <infon key="name_5">surname:Chinappi;given-names:M</infon>
      <infon key="name_4">surname:Sthandier;given-names:O</infon>
      <offset>44810</offset>
      <text>A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Qi;given-names:X</infon>
      <infon key="name_2">surname:Moresi;given-names:V</infon>
      <infon key="name_1">surname:Valdez;given-names:G</infon>
      <infon key="name_0">surname:Williams;given-names:AH</infon>
      <infon key="fpage">1549</infon>
      <infon key="pub-id_doi">10.1126/science.1181046</infon>
      <infon key="pub-id_pmid">20007902</infon>
      <infon key="year">2009</infon>
      <infon key="source">Science</infon>
      <infon key="type">ref</infon>
      <infon key="volume">326</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Olson;given-names:EN</infon>
      <infon key="name_7">surname:Sanes;given-names:JR</infon>
      <infon key="lpage">1554</infon>
      <infon key="name_6">surname:Bassel-Duby;given-names:R</infon>
      <infon key="name_5">surname:Elliott;given-names:JL</infon>
      <infon key="name_4">surname:McAnally;given-names:J</infon>
      <offset>44908</offset>
      <text>MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Wu;given-names:Q</infon>
      <infon key="name_2">surname:Thomson;given-names:JM</infon>
      <infon key="name_1">surname:Mandel;given-names:EM</infon>
      <infon key="name_0">surname:Chen;given-names:JF</infon>
      <infon key="fpage">228</infon>
      <infon key="pub-id_doi">10.1038/ng1725</infon>
      <infon key="pub-id_pmid">16380711</infon>
      <infon key="year">2006</infon>
      <infon key="source">Nat Genet</infon>
      <infon key="type">ref</infon>
      <infon key="volume">38</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Wang;given-names:DZ</infon>
      <infon key="lpage">233</infon>
      <infon key="name_6">surname:Conlon;given-names:FL</infon>
      <infon key="name_5">surname:Hammond;given-names:SM</infon>
      <infon key="name_4">surname:Callis;given-names:TE</infon>
      <offset>45004</offset>
      <text>The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Bezprozvannaya;given-names:S</infon>
      <infon key="name_2">surname:Maxeiner;given-names:JM</infon>
      <infon key="name_1">surname:Williams;given-names:AH</infon>
      <infon key="name_0">surname:Liu;given-names:N</infon>
      <infon key="fpage">2054</infon>
      <infon key="pub-id_doi">10.1172/JCI62656</infon>
      <infon key="pub-id_pmid">22546853</infon>
      <infon key="year">2012</infon>
      <infon key="source">J Clin Invest</infon>
      <infon key="type">ref</infon>
      <infon key="volume">122</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Olson;given-names:EN</infon>
      <infon key="lpage">2065</infon>
      <infon key="name_6">surname:Bassel-Duby;given-names:R</infon>
      <infon key="name_5">surname:Richardson;given-names:JA</infon>
      <infon key="name_4">surname:Shelton;given-names:JM</infon>
      <offset>45097</offset>
      <text>microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice</text>
      <annotation id="1175">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="45174" length="27"/>
        <text>Duchenne muscular dystrophy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">84</infon>
      <infon key="name_1">surname:Chamberlain;given-names:JS</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Banks;given-names:GB</infon>
      <infon key="fpage">431</infon>
      <infon key="pub-id_doi">10.1016/S0070-2153(08)00609-1</infon>
      <infon key="pub-id_pmid">19186250</infon>
      <infon key="year">2008</infon>
      <infon key="source">Curr Top Dev Biol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">453</infon>
      <offset>45210</offset>
      <text>The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies</text>
      <annotation id="1178">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="45223" length="9"/>
        <text>mammalian</text>
      </annotation>
      <annotation id="1179">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="45244" length="27"/>
        <text>duchenne muscular dystrophy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Barnard;given-names:EA</infon>
      <infon key="name_2">surname:Ryder-Cook;given-names:AS</infon>
      <infon key="name_1">surname:Geng;given-names:Y</infon>
      <infon key="name_0">surname:Sicinski;given-names:P</infon>
      <infon key="fpage">1578</infon>
      <infon key="pub-id_doi">10.1126/science.2662404</infon>
      <infon key="pub-id_pmid">2662404</infon>
      <infon key="year">1989</infon>
      <infon key="source">Science</infon>
      <infon key="type">ref</infon>
      <infon key="volume">244</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1580</infon>
      <infon key="name_5">surname:Barnard;given-names:PJ</infon>
      <infon key="name_4">surname:Darlison;given-names:MG</infon>
      <offset>45309</offset>
      <text>The molecular basis of muscular dystrophy in the mdx mouse: a point mutation</text>
      <annotation id="1183">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="45358" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="1184">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="45362" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="1185">
        <infon key="identifier">MESH:D009136</infon>
        <infon key="type">Disease</infon>
        <location offset="45332" length="18"/>
        <text>muscular dystrophy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">31</infon>
      <infon key="name_2">surname:Dutta;given-names:A</infon>
      <infon key="name_1">surname:Gagan;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Dey;given-names:BK</infon>
      <infon key="fpage">203</infon>
      <infon key="pub-id_doi">10.1128/MCB.01009-10</infon>
      <infon key="pub-id_pmid">21041476</infon>
      <infon key="year">2011</infon>
      <infon key="source">Mol Cell Biol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">214</infon>
      <offset>45386</offset>
      <text>miR-206 and -486 induce myoblast differentiation by downregulating Pax7</text>
      <annotation id="1187">
        <infon key="identifier">387202;723876</infon>
        <infon key="type">Gene</infon>
        <location offset="45386" length="16"/>
        <text>miR-206 and -486</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Deng;given-names:Z</infon>
      <infon key="name_2">surname:Li;given-names:J</infon>
      <infon key="name_1">surname:Tao;given-names:Y</infon>
      <infon key="name_0">surname:Chen;given-names:JF</infon>
      <infon key="fpage">867</infon>
      <infon key="pub-id_doi">10.1083/jcb.200911036</infon>
      <infon key="pub-id_pmid">20819939</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Cell Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">190</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">879</infon>
      <infon key="name_6">surname:Wang;given-names:DZ</infon>
      <infon key="name_5">surname:Xiao;given-names:X</infon>
      <infon key="name_4">surname:Yan;given-names:Z</infon>
      <offset>45460</offset>
      <text>microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Duan;given-names:D</infon>
      <infon key="name_2">surname:Zhang;given-names:K</infon>
      <infon key="name_1">surname:Hakim;given-names:CH</infon>
      <infon key="name_0">surname:Shin;given-names:JH</infon>
      <infon key="fpage">283</infon>
      <infon key="pub-id_doi">10.1002/mus.21873</infon>
      <infon key="pub-id_pmid">21254096</infon>
      <infon key="year">2011</infon>
      <infon key="source">Muscle Nerve</infon>
      <infon key="type">ref</infon>
      <infon key="volume">43</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">286</infon>
      <offset>45581</offset>
      <text>Genotyping mdx, mdx3cv, and mdx4cv mice by primer competition polymerase chain reaction</text>
      <annotation id="1190">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="45592" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="1191">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="45616" length="4"/>
        <text>mice</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">39</infon>
      <infon key="name_1">surname:Griffiths-Jones;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kozomara;given-names:A</infon>
      <infon key="fpage">D152</infon>
      <infon key="pub-id_doi">10.1093/nar/gkq1027</infon>
      <infon key="pub-id_pmid">21037258</infon>
      <infon key="year">2011</infon>
      <infon key="source">Nucleic Acids Res</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">D157</infon>
      <offset>45669</offset>
      <text>miRBase: integrating microRNA annotation and deep-sequencing data</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Schneider;given-names:J</infon>
      <infon key="name_2">surname:Kostin;given-names:S</infon>
      <infon key="name_1">surname:Beetz;given-names:N</infon>
      <infon key="name_0">surname:Boettger;given-names:T</infon>
      <infon key="fpage">2634</infon>
      <infon key="pub-id_doi">10.1172/JCI38864</infon>
      <infon key="pub-id_pmid">19690389</infon>
      <infon key="year">2009</infon>
      <infon key="source">J Clin Invest</infon>
      <infon key="type">ref</infon>
      <infon key="volume">119</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">2647</infon>
      <infon key="name_6">surname:Braun;given-names:T</infon>
      <infon key="name_5">surname:Hein;given-names:L</infon>
      <infon key="name_4">surname:Kruger;given-names:M</infon>
      <offset>45735</offset>
      <text>Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster</text>
      <annotation id="1194">
        <infon key="identifier">387161;387163</infon>
        <infon key="type">Gene</infon>
        <location offset="45830" length="10"/>
        <text>Mir143/145</text>
      </annotation>
      <annotation id="1195">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="45779" length="6"/>
        <text>murine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Braun;given-names:T</infon>
      <infon key="name_2">surname:Herzog;given-names:M</infon>
      <infon key="name_1">surname:Preussner;given-names:J</infon>
      <infon key="name_0">surname:Kuenne;given-names:C</infon>
      <infon key="fpage">3412</infon>
      <infon key="pub-id_doi">10.1093/bioinformatics/btu573</infon>
      <infon key="pub-id_pmid">25165094</infon>
      <infon key="year">2014</infon>
      <infon key="source">Bioinformatics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">30</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">3413</infon>
      <infon key="name_4">surname:Looso;given-names:M</infon>
      <offset>45854</offset>
      <text>MIRPIPE: quantification of microRNAs in niche model organisms</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Thievessen;given-names:I</infon>
      <infon key="name_2">surname:Ussar;given-names:S</infon>
      <infon key="name_1">surname:Moser;given-names:M</infon>
      <infon key="name_0">surname:Kruger;given-names:M</infon>
      <infon key="fpage">353</infon>
      <infon key="pub-id_doi">10.1016/j.cell.2008.05.033</infon>
      <infon key="pub-id_pmid">18662549</infon>
      <infon key="year">2008</infon>
      <infon key="source">Cell</infon>
      <infon key="type">ref</infon>
      <infon key="volume">134</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Mann;given-names:M</infon>
      <infon key="name_8">surname:Fassler;given-names:R</infon>
      <infon key="name_7">surname:Zanivan;given-names:S</infon>
      <infon key="lpage">364</infon>
      <infon key="name_6">surname:Schmidt;given-names:S</infon>
      <infon key="name_5">surname:Forner;given-names:F</infon>
      <infon key="name_4">surname:Luber;given-names:CA</infon>
      <offset>45916</offset>
      <text>SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function</text>
      <annotation id="1198">
        <infon key="identifier">108101</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">12877</infon>
        <location offset="45965" length="9"/>
        <text>kindlin-3</text>
      </annotation>
      <annotation id="1199">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="45922" length="5"/>
        <text>mouse</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">26</infon>
      <infon key="name_1">surname:Mann;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Cox;given-names:J</infon>
      <infon key="fpage">1367</infon>
      <infon key="pub-id_doi">10.1038/nbt.1511</infon>
      <infon key="pub-id_pmid">19029910</infon>
      <infon key="year">2008</infon>
      <infon key="source">Nat Biotechnol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1372</infon>
      <offset>46026</offset>
      <text>MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification</text>
    </passage>
    <passage>
      <infon key="volume">57</infon>
      <infon key="name_1">surname:Hochberg;given-names:Y</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Benjamini;given-names:Y</infon>
      <infon key="fpage">289</infon>
      <infon key="year">1995</infon>
      <infon key="source">J Roy Stat Soc B Met</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">300</infon>
      <offset>46163</offset>
      <text>Controlling the false discovery rate - a practical and powerful approach to multiple testing</text>
    </passage>
    <passage>
      <infon key="volume">5</infon>
      <infon key="name_1">surname:Myers;given-names:RM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Wold;given-names:B</infon>
      <infon key="fpage">19</infon>
      <infon key="pub-id_doi">10.1038/nmeth1157</infon>
      <infon key="pub-id_pmid">18165803</infon>
      <infon key="year">2008</infon>
      <infon key="source">Nat Methods</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">21</infon>
      <offset>46256</offset>
      <text>Sequence census methods for functional genomics</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Kuo;given-names:N</infon>
      <infon key="name_2">surname:Yamane;given-names:A</infon>
      <infon key="name_1">surname:Resch;given-names:W</infon>
      <infon key="name_0">surname:Kuchen;given-names:S</infon>
      <infon key="pub-id_doi">10.1016/j.immuni.2010.05.009</infon>
      <infon key="pub-id_pmid">20605486</infon>
      <infon key="year">2010</infon>
      <infon key="source">Immunity</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Rajewsky;given-names:K</infon>
      <infon key="name_21">surname:Casellas;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">839</infon>
      <infon key="fpage">828</infon>
      <infon key="volume">32</infon>
      <infon key="name_10">surname:Hu-Li;given-names:J</infon>
      <infon key="name_13">surname:Kitamura;given-names:Y</infon>
      <infon key="name_14">surname:Charles;given-names:N</infon>
      <infon key="name_11">surname:Lu;given-names:K</infon>
      <infon key="name_12">surname:Dubois;given-names:W</infon>
      <infon key="name_17">surname:Schwartzberg;given-names:PL</infon>
      <infon key="name_18">surname:Paul;given-names:WE</infon>
      <infon key="name_15">surname:Sun;given-names:HW</infon>
      <infon key="name_9">surname:Peng;given-names:S</infon>
      <infon key="name_16">surname:Muljo;given-names:S</infon>
      <infon key="name_8">surname:Yasuda;given-names:T</infon>
      <infon key="name_7">surname:Laurence;given-names:A</infon>
      <infon key="name_6">surname:Wei;given-names:L</infon>
      <infon key="name_19">surname:O'Shea;given-names:J</infon>
      <infon key="name_5">surname:Chakraborty;given-names:T</infon>
      <infon key="name_4">surname:Li;given-names:Z</infon>
      <offset>46304</offset>
      <text>Regulation of microRNA expression and abundance during lymphopoiesis</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Bartel;given-names:DP</infon>
      <infon key="name_2">surname:Weissman;given-names:JS</infon>
      <infon key="name_1">surname:Ingolia;given-names:NT</infon>
      <infon key="name_0">surname:Guo;given-names:H</infon>
      <infon key="fpage">835</infon>
      <infon key="pub-id_doi">10.1038/nature09267</infon>
      <infon key="pub-id_pmid">20703300</infon>
      <infon key="year">2010</infon>
      <infon key="source">Nature</infon>
      <infon key="type">ref</infon>
      <infon key="volume">466</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">840</infon>
      <offset>46373</offset>
      <text>Mammalian microRNAs predominantly act to decrease target mRNA levels</text>
      <annotation id="1201">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="46373" length="9"/>
        <text>Mammalian</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">21</infon>
      <infon key="name_1">surname:Filipowicz;given-names:W</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Chekulaeva;given-names:M</infon>
      <infon key="fpage">452</infon>
      <infon key="pub-id_doi">10.1016/j.ceb.2009.04.009</infon>
      <infon key="pub-id_pmid">19450959</infon>
      <infon key="year">2009</infon>
      <infon key="source">Curr Opin Cell Biol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">460</infon>
      <offset>46442</offset>
      <text>Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Tuschl;given-names:T</infon>
      <infon key="name_2">surname:Gaul;given-names:U</infon>
      <infon key="name_1">surname:John;given-names:B</infon>
      <infon key="name_0">surname:Enright;given-names:AJ</infon>
      <infon key="fpage">R1</infon>
      <infon key="pub-id_doi">10.1186/gb-2003-5-1-r1</infon>
      <infon key="pub-id_pmid">14709173</infon>
      <infon key="year">2003</infon>
      <infon key="source">Genome Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">5</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_5">surname:Marks;given-names:DS</infon>
      <infon key="name_4">surname:Sander;given-names:C</infon>
      <offset>46519</offset>
      <text>MicroRNA targets in Drosophila</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Marks;given-names:DS</infon>
      <infon key="name_2">surname:Gabow;given-names:A</infon>
      <infon key="name_1">surname:Wilson;given-names:M</infon>
      <infon key="name_0">surname:Betel;given-names:D</infon>
      <infon key="fpage">D149</infon>
      <infon key="pub-id_doi">10.1093/nar/gkm995</infon>
      <infon key="pub-id_pmid">18158296</infon>
      <infon key="year">2008</infon>
      <infon key="source">Nucleic Acids Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">36</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">D153</infon>
      <infon key="name_4">surname:Sander;given-names:C</infon>
      <offset>46550</offset>
      <text>The microRNA.org resource: targets and expression</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Moore;given-names:KJ</infon>
      <infon key="name_2">surname:Wight;given-names:PA</infon>
      <infon key="name_1">surname:Siller;given-names:WG</infon>
      <infon key="name_0">surname:Bulfield;given-names:G</infon>
      <infon key="fpage">1189</infon>
      <infon key="pub-id_doi">10.1073/pnas.81.4.1189</infon>
      <infon key="pub-id_pmid">6583703</infon>
      <infon key="year">1984</infon>
      <infon key="source">Proc Natl Acad Sci U S A</infon>
      <infon key="type">ref</infon>
      <infon key="volume">81</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1192</infon>
      <offset>46600</offset>
      <text>X chromosome-linked muscular dystrophy (mdx) in the mouse</text>
      <annotation id="1204">
        <infon key="identifier">13405</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">20856</infon>
        <location offset="46640" length="3"/>
        <text>mdx</text>
      </annotation>
      <annotation id="1205">
        <infon key="type">Disease</infon>
        <location offset="46600" length="38"/>
        <text>X chromosome-linked muscular dystrophy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">48</infon>
      <infon key="name_2">surname:Maffulli;given-names:N</infon>
      <infon key="name_1">surname:Lippi;given-names:G</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Brancaccio;given-names:P</infon>
      <infon key="fpage">757</infon>
      <infon key="pub-id_doi">10.1515/CCLM.2010.179</infon>
      <infon key="pub-id_pmid">20518645</infon>
      <infon key="year">2010</infon>
      <infon key="source">Clin Chem Lab Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">767</infon>
      <offset>46658</offset>
      <text>Biochemical markers of muscular damage</text>
      <annotation id="1207">
        <infon key="identifier">MESH:D009135</infon>
        <infon key="type">Disease</infon>
        <location offset="46681" length="15"/>
        <text>muscular damage</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="name_1">surname:Rigby;given-names:PW</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Buckingham;given-names:M</infon>
      <infon key="fpage">225</infon>
      <infon key="pub-id_doi">10.1016/j.devcel.2013.12.020</infon>
      <infon key="pub-id_pmid">24525185</infon>
      <infon key="year">2014</infon>
      <infon key="source">Dev Cell</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">238</infon>
      <offset>46697</offset>
      <text>Gene regulatory networks and transcriptional mechanisms that control myogenesis</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Analau;given-names:E</infon>
      <infon key="name_2">surname:Asawachaicharn;given-names:A</infon>
      <infon key="name_1">surname:Georges;given-names:SA</infon>
      <infon key="name_0">surname:Rosenberg;given-names:MI</infon>
      <infon key="fpage">77</infon>
      <infon key="pub-id_doi">10.1083/jcb.200603039</infon>
      <infon key="pub-id_pmid">17030984</infon>
      <infon key="year">2006</infon>
      <infon key="source">J Cell Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">175</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">85</infon>
      <infon key="name_4">surname:Tapscott;given-names:SJ</infon>
      <offset>46777</offset>
      <text>MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206</text>
      <annotation id="1212">
        <infon key="identifier">17927</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7857</infon>
        <location offset="46777" length="4"/>
        <text>MyoD</text>
      </annotation>
      <annotation id="1213">
        <infon key="identifier">14314</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">5144</infon>
        <location offset="46791" length="5"/>
        <text>Fstl1</text>
      </annotation>
      <annotation id="1214">
        <infon key="identifier">22288</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">21398</infon>
        <location offset="46801" length="4"/>
        <text>Utrn</text>
      </annotation>
      <annotation id="1215">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="46846" length="3"/>
        <text>miR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Bartel;given-names:DP</infon>
      <infon key="name_2">surname:Stefano;given-names:J</infon>
      <infon key="name_1">surname:Agarwal;given-names:V</infon>
      <infon key="name_0">surname:Denzler;given-names:R</infon>
      <infon key="fpage">766</infon>
      <infon key="pub-id_doi">10.1016/j.molcel.2014.03.045</infon>
      <infon key="pub-id_pmid">24793693</infon>
      <infon key="year">2014</infon>
      <infon key="source">Mol Cell</infon>
      <infon key="type">ref</infon>
      <infon key="volume">54</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">776</infon>
      <infon key="name_4">surname:Stoffel;given-names:M</infon>
      <offset>46854</offset>
      <text>Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Nakamura;given-names:A</infon>
      <infon key="name_2">surname:Ando;given-names:M</infon>
      <infon key="name_1">surname:Hagiwara;given-names:Y</infon>
      <infon key="name_0">surname:Yuasa;given-names:K</infon>
      <infon key="fpage">163</infon>
      <infon key="pub-id_doi">10.1247/csf.08022</infon>
      <infon key="pub-id_pmid">18827405</infon>
      <infon key="year">2008</infon>
      <infon key="source">Cell Struct Funct</infon>
      <infon key="type">ref</infon>
      <infon key="volume">33</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">169</infon>
      <infon key="name_5">surname:Hijikata;given-names:T</infon>
      <infon key="name_4">surname:Takeda;given-names:S</infon>
      <offset>46946</offset>
      <text>MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy</text>
      <annotation id="1217">
        <infon key="identifier">MESH:D009136</infon>
        <infon key="type">Disease</infon>
        <location offset="47085" length="18"/>
        <text>muscular dystrophy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Shibuya;given-names:H</infon>
      <infon key="name_2">surname:Shi;given-names:M</infon>
      <infon key="name_1">surname:Ishikawa;given-names:M</infon>
      <infon key="name_0">surname:Nakasa;given-names:T</infon>
      <infon key="fpage">2495</infon>
      <infon key="pub-id_doi">10.1111/j.1582-4934.2009.00898.x</infon>
      <infon key="pub-id_pmid">19754672</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Cell Mol Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">14</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">2505</infon>
      <infon key="name_5">surname:Ochi;given-names:M</infon>
      <infon key="name_4">surname:Adachi;given-names:N</infon>
      <offset>47104</offset>
      <text>Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model</text>
      <annotation id="1220">
        <infon key="identifier">10116</infon>
        <infon key="type">Species</infon>
        <location offset="47191" length="3"/>
        <text>rat</text>
      </annotation>
      <annotation id="1221">
        <infon key="identifier">MESH:D009135</infon>
        <infon key="type">Disease</infon>
        <location offset="47204" length="13"/>
        <text>muscle injury</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Di Filippo;given-names:ES</infon>
      <infon key="name_2">surname:Pietrangelo;given-names:T</infon>
      <infon key="name_1">surname:Quattrocelli;given-names:M</infon>
      <infon key="name_0">surname:La Rovere;given-names:RM</infon>
      <infon key="fpage">90</infon>
      <infon key="pub-id_doi">10.3389/fnagi.2014.00090</infon>
      <infon key="pub-id_pmid">24860499</infon>
      <infon key="year">2014</infon>
      <infon key="source">Front Aging Neurosci</infon>
      <infon key="type">ref</infon>
      <infon key="volume">6</infon>
      <infon key="name_10">surname:Fulle;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Sampaolesi;given-names:M</infon>
      <infon key="name_8">surname:Blot;given-names:S</infon>
      <infon key="name_7">surname:Barthelemy;given-names:I</infon>
      <infon key="name_6">surname:Mascarello;given-names:F</infon>
      <infon key="name_5">surname:Cassano;given-names:M</infon>
      <infon key="name_4">surname:Maccatrozzo;given-names:L</infon>
      <offset>47224</offset>
      <text>Myogenic potential of canine craniofacial satellite cells</text>
      <annotation id="1223">
        <infon key="identifier">9615</infon>
        <infon key="type">Species</infon>
        <location offset="47246" length="6"/>
        <text>canine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Chen;given-names:L</infon>
      <infon key="name_2">surname:Sneh;given-names:A</infon>
      <infon key="name_1">surname:Malik;given-names:V</infon>
      <infon key="name_0">surname:Rosales;given-names:XQ</infon>
      <infon key="fpage">731</infon>
      <infon key="pub-id_doi">10.1002/mus.23669</infon>
      <infon key="pub-id_pmid">23553538</infon>
      <infon key="year">2013</infon>
      <infon key="source">Muscle Nerve</infon>
      <infon key="type">ref</infon>
      <infon key="volume">47</infon>
      <infon key="name_10">surname:Rodino-Klapac;given-names:LR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:Sahenk;given-names:Z</infon>
      <infon key="name_11">surname:Clark;given-names:KR</infon>
      <infon key="name_12">surname:Mendell;given-names:JR</infon>
      <infon key="name_9">surname:Reshmi;given-names:S</infon>
      <infon key="name_8">surname:Pyatt;given-names:R</infon>
      <infon key="name_7">surname:Astbury;given-names:C</infon>
      <infon key="lpage">739</infon>
      <infon key="name_6">surname:Gastier-Foster;given-names:JM</infon>
      <infon key="name_5">surname:Kota;given-names:J</infon>
      <infon key="name_4">surname:Lewis;given-names:S</infon>
      <offset>47282</offset>
      <text>Impaired regeneration in LGMD2A supported by increased PAX7-positive satellite cell content and muscle-specific microrna dysregulation</text>
      <annotation id="1225">
        <infon key="identifier">18509</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55665</infon>
        <location offset="47337" length="4"/>
        <text>PAX7</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272822</id>
    <passage>
      <infon key="name_3">surname:Yu;given-names:Juanjuan</infon>
      <infon key="name_2">surname:Liu;given-names:Kaidong</infon>
      <infon key="name_1">surname:Li;given-names:Hegang</infon>
      <infon key="article-id_pmid">25511509</infon>
      <infon key="name_0">surname:Liu;given-names:Nan</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272822</infon>
      <infon key="article-id_publisher-id">144</infon>
      <infon key="article-id_doi">10.1186/s12863-014-0144-1</infon>
      <infon key="title">Keywords</infon>
      <infon key="type">front</infon>
      <infon key="elocation-id">144</infon>
      <infon key="volume">15</infon>
      <infon key="license">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">BMC Genet.; 2014 Dec 16; 15144. doi:10.1186/s12863-014-0144-1</infon>
      <infon key="kwd">Microarray Proteomic technology Wool growth Differential expression</infon>
      <infon key="name_9">surname:Zhao;given-names:Jinshan</infon>
      <infon key="name_8">surname:He;given-names:Guangling</infon>
      <infon key="name_7">surname:Liu;given-names:Jifeng</infon>
      <infon key="name_6">surname:De;given-names:Wei</infon>
      <infon key="name_5">surname:Cheng;given-names:Ming</infon>
      <infon key="name_4">surname:Bu;given-names:Ran</infon>
      <infon key="authors">Liu N, Li H, Liu K, Yu J, Bu R, Cheng M, De W, Liu J, He G, Zhao J</infon>
      <offset>0</offset>
      <text>Identification of skin-expressed genes possibly associated with wool growth regulation of Aohan fine wool sheep</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>112</offset>
      <text>Background</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>123</offset>
      <text>Sheep are valuable resources for the animal fibre industry. Therefore, identifying genes which regulate wool growth would offer strategies for improving the quality of fine wool. In this study, we employed Agilent sheep gene expression microarray and proteomic technology to compare the gene expression patterns of the body side (hair-rich) and groin (hairless) skins of Aohan fine wool sheep (a Chinese indigenous breed).</text>
      <annotation id="3">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="123" length="5"/>
        <text>Sheep</text>
      </annotation>
      <annotation id="4">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="337" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="5">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="510" length="5"/>
        <text>sheep</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>546</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>554</offset>
      <text>Comparing the body side to the groin skins (S/G) of Aohan fine wool sheep, the microarray study revealed that 1494 probes were differentially expressed, including 602 more highly expressed and 892 less highly expressed probes. The microarray results were verified by means of quantitative PCR. Cluster analysis could distinguish the body side skin and the groin skin. Based on the Database for Annotation, Visualization and Integrated Discovery (DAVID), 38 of the differentially expressed genes were classified into four categories, namely regulation of receptor binding, multicellular organismal process, protein binding and macromolecular complex. Proteomic study revealed that 187 protein spots showed significant (p &lt; 0.05) differences in their respective expression levels. Among them, 46 protein entries were further identified by MALDI-TOF/MS analyses.</text>
      <annotation id="7">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="622" length="5"/>
        <text>sheep</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1418</offset>
      <text>Conclusions</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1430</offset>
      <text>Microarray analysis revealed thousands of differentially expressed genes, many of which were possibly associated with wool growth. Several potential gene families might participate in hair growth regulation. Proteomic analysis also indentified hundreds of differentially expressed proteins.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1721</offset>
      <text>Electronic supplementary material</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1755</offset>
      <text>The online version of this article (doi:10.1186/s12863-014-0144-1) contains supplementary material, which is available to authorized users.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1895</offset>
      <text>Background</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1906</offset>
      <text>Sheep are valuable resources for the animal fibre industry. Identifying genes which regulate wool growth offers the opportunity to improve the wool production efficiency, product quality and diversity in breeding programs. It can also offer the opportunity to develop transgenic lines and to develop therapeutic agents that can be used to tailor for desirable fibre attributes by altering gene expression. The genetic polymorphisms and their mechanisms of wool and cashmere growth and regulation have been thoroughly studied. In mammals, several gene families, such as WNTs, tumor necrosis factors (TNFs), fibroblast growth factors (FGFs) and transforming growth factor(TGFs), have been implicated in hair follicle initiation, morphogenesis and cycling. Recently, the molecular characteristics of primary wool follicle initiation in Merino sheep have been reported recently.</text>
      <annotation id="11">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="1906" length="5"/>
        <text>Sheep</text>
      </annotation>
      <annotation id="12">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="2746" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="13">
        <infon key="identifier">MESH:D009336</infon>
        <infon key="type">Disease</infon>
        <location offset="2481" length="14"/>
        <text>tumor necrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2781</offset>
      <text>Transcriptomic research such as microarray analysis, has been successfully applied to investigate the characteristics of hair follicle stem cells in mice. Microarray studies have been reported for different traits in sheep and goats, such as resistance to parasites, mammary development and milk quality, wool follicle development, natural fleece rot resistance and pigmentation traits of skin and wool. A subset of skin-expressed microRNAs with possible roles in goat and sheep hair growth has also been reported. Several studies have demonstrated the usefulness of cDNA microarray for expression profiling of wool follicle growth cycles in whole skin. More recently the RNA-seq method was also used to determine the genes differentially expressed among various tissues (including whole skin) of sheep.</text>
      <annotation id="20">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="2930" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="21">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="2998" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="22">
        <infon key="identifier">9925</infon>
        <infon key="type">Species</infon>
        <location offset="3008" length="5"/>
        <text>goats</text>
      </annotation>
      <annotation id="23">
        <infon key="identifier">9925</infon>
        <infon key="type">Species</infon>
        <location offset="3245" length="4"/>
        <text>goat</text>
      </annotation>
      <annotation id="24">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="3578" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="25">
        <infon key="identifier">MESH:D012757</infon>
        <infon key="type">Disease</infon>
        <location offset="3254" length="17"/>
        <text>sheep hair growth</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3585</offset>
      <text>The Aohan fine wool sheep, bred in Inner Mongolia, is an outstanding breed, providing both wool and meat. The major characteristics of this breed are high quality wool,high disease resistance, and high adaptability. According to figures, Aohan fine wool sheep can provide up to 9 kg of quality wool per year (fiber length up to 10.5 cm, fibre diameter less than 22 mum). Therefore, Aohan fine wool sheep are considered as a valuable genetic resource for fine wool production. Wang et al. demonstrated that seasonal factors significantly influenced the wool growth of Aohan fine wool sheep. The peak of the growth rate occurs in summer and the low in winter. The expression profiling of immune genes and type I inner root sheath (IRS) keratin genes in the whole skin of Aohan fine wool sheep has previously been reported by our laboratory team.</text>
      <annotation id="32">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="3605" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="33">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="3839" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="34">
        <infon key="identifier">1214577</infon>
        <infon key="type">Species</infon>
        <location offset="3860" length="4"/>
        <text>to 9</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="3983" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="36">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="4168" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="37">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="4370" length="5"/>
        <text>sheep</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4432</offset>
      <text>However, to our knowledge, as of yet no microarray or proteomic study at a genome-wide level has been reported on protein-coding genes which are possibly responsible for regulating hair growth of adult sheep so far. The aims of the present work are to investigate and compare the gene expression level of the body side skin and groin skin using microarray and proteomic technology, and to identify the possible genes and proteins responsible for the wool growth regulation of Aohan fine wool sheep.</text>
      <annotation id="40">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="4634" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="41">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="4924" length="5"/>
        <text>sheep</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>4931</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>4939</offset>
      <text>Summary of microarray analysis</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>4970</offset>
      <text>A total of 1494 probes were differentially expressed comparing the body side to groin skins (S/G) in Aohan fine wool sheep, including 602 up-regulated and 892 down-regulated probes, as shown in Additional file 1: Table S1. Most probes (1110) were not assigned to unique transcripts, due to the lack of information. The number of distinct genes/transcripts (annotated) was 331, of which 112 were up-regulated and 219 were down-regulated. In S/G, 7 genes (CYP1A1, LOC100137068, LOC443300, LOC101106865, Connexin 43, SCD and LOC101122398) were down-regulated by more than 10-fold.</text>
      <annotation id="47">
        <infon key="identifier">100170113</infon>
        <infon key="type">Gene</infon>
        <location offset="5424" length="6"/>
        <text>CYP1A1</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">443455</infon>
        <infon key="type">Gene</infon>
        <location offset="5471" length="11"/>
        <text>Connexin 43</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">443185</infon>
        <infon key="type">Gene</infon>
        <location offset="5484" length="3"/>
        <text>SCD</text>
      </annotation>
      <annotation id="50">
        <infon key="identifier">101122398</infon>
        <infon key="type">Gene</infon>
        <location offset="5492" length="12"/>
        <text>LOC101122398</text>
      </annotation>
      <annotation id="51">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="5087" length="5"/>
        <text>sheep</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>5548</offset>
      <text>Furthermore, many gene families which regulate different aspects of hair follicle growth showed differential expression in S/G (see Additional file 2: Table S3), such as growth factors, immune cytokines, Keratins (KRT) and Keratin-associated proteins (KAP), and so on.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>5817</offset>
      <text>Selective verification for microarray data by QPCR</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">12863_2014_144_Fig1_HTML.jpg</infon>
      <infon key="id">Fig1</infon>
      <infon key="type">fig_caption</infon>
      <offset>5868</offset>
      <text> Q-PCR validation of the microarray data. P values (T-test) of the Q-PCR data are 0.036 (FGF10), 0.019 (LOC443300), 0.028 (FGF18), 0.018 (Connexin 43), 0.044 (SCD) and 0.019 (ZO1), respectively. S/G represent body side skin group/groin skin group, respectively.</text>
      <annotation id="57">
        <infon key="identifier">443074</infon>
        <infon key="type">Gene</infon>
        <location offset="5957" length="5"/>
        <text>FGF10</text>
      </annotation>
      <annotation id="58">
        <infon key="identifier">780460</infon>
        <infon key="type">Gene</infon>
        <location offset="5991" length="5"/>
        <text>FGF18</text>
      </annotation>
      <annotation id="59">
        <infon key="identifier">443455</infon>
        <infon key="type">Gene</infon>
        <location offset="6006" length="11"/>
        <text>Connexin 43</text>
      </annotation>
      <annotation id="60">
        <infon key="identifier">443185</infon>
        <infon key="type">Gene</infon>
        <location offset="6027" length="3"/>
        <text>SCD</text>
      </annotation>
      <annotation id="61">
        <infon key="identifier">443200</infon>
        <infon key="type">Gene</infon>
        <location offset="6043" length="3"/>
        <text>ZO1</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6130</offset>
      <text>In order to verify the microarray results, we selected 10 genes, namely FGF10, LOC443300, FGF18, Connexin43, SCD, ZO1, MMP2, ITGB1, PAG11 and CRYAB, to comparatively analyze their expression patterns by qPCR. As shown in Figure 1, the qPCR results for the selected seven genes were consistent with the microarray results, except for FGF10, ZO1 and CRYAB, thus reflecting the reliability of our microarray data.</text>
      <annotation id="74">
        <infon key="identifier">443074</infon>
        <infon key="type">Gene</infon>
        <location offset="6202" length="5"/>
        <text>FGF10</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">780460</infon>
        <infon key="type">Gene</infon>
        <location offset="6220" length="5"/>
        <text>FGF18</text>
      </annotation>
      <annotation id="76">
        <infon key="identifier">443455</infon>
        <infon key="type">Gene</infon>
        <location offset="6227" length="10"/>
        <text>Connexin43</text>
      </annotation>
      <annotation id="77">
        <infon key="identifier">443185</infon>
        <infon key="type">Gene</infon>
        <location offset="6239" length="3"/>
        <text>SCD</text>
      </annotation>
      <annotation id="78">
        <infon key="identifier">443200</infon>
        <infon key="type">Gene</infon>
        <location offset="6244" length="3"/>
        <text>ZO1</text>
      </annotation>
      <annotation id="79">
        <infon key="identifier">443115</infon>
        <infon key="type">Gene</infon>
        <location offset="6249" length="4"/>
        <text>MMP2</text>
      </annotation>
      <annotation id="80">
        <infon key="identifier">443141</infon>
        <infon key="type">Gene</infon>
        <location offset="6255" length="5"/>
        <text>ITGB1</text>
      </annotation>
      <annotation id="81">
        <infon key="identifier">100034671</infon>
        <infon key="type">Gene</infon>
        <location offset="6262" length="5"/>
        <text>PAG11</text>
      </annotation>
      <annotation id="82">
        <infon key="identifier">497274</infon>
        <infon key="type">Gene</infon>
        <location offset="6272" length="5"/>
        <text>CRYAB</text>
      </annotation>
      <annotation id="83">
        <infon key="identifier">443074</infon>
        <infon key="type">Gene</infon>
        <location offset="6463" length="5"/>
        <text>FGF10</text>
      </annotation>
      <annotation id="84">
        <infon key="identifier">443200</infon>
        <infon key="type">Gene</infon>
        <location offset="6470" length="3"/>
        <text>ZO1</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">497274</infon>
        <infon key="type">Gene</infon>
        <location offset="6478" length="5"/>
        <text>CRYAB</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>6542</offset>
      <text>Hierarchical cluster analysis, biological process gene ontology (GO) analyses and putative gene networks</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">12863_2014_144_Fig2_HTML.jpg</infon>
      <infon key="id">Fig2</infon>
      <infon key="type">fig_caption</infon>
      <offset>6647</offset>
      <text> Hierarchical cluster analysis of data between different skin areas of the Aohan fine wool sheep in anagen phase. Each column represents one sheep, and each horizontal line refers to a gene. Color legend is on the top of the figure. Red indicates genes with a greater expression relative to the geometrical means, green indicates genes with a lower expression relative to the geometrical means. S1, S2 and S3 represent 3 repeats of body side skin group, and G1, G2, G3 represent 3 repeats of groin skin group.</text>
      <annotation id="88">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="6738" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="89">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="6788" length="5"/>
        <text>sheep</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7157</offset>
      <text>To further investigate the similarity in the expression patterns of protein-coding genes between the two skin areas, we performed cluster analysis using the Cluster 3.0 tool. As shown in Figure 2, cluster analysis could make a distinction between the body side skin and the groin skin.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7444</offset>
      <text>Based on the Database for Annotation, Visualization and Integrated Discovery (DAVID), 38 of the differentially expressed genes were classified into four categories, many of which shared the same genes, according to their functional correlation (Additional file 3: Table S2). The majority of the genes possibly related to the wool growth control could be assigned into four categories including regulation of receptor binding, multicellular organismal process, protein binding and macromolecular complex.</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">12863_2014_144_Fig3_HTML.jpg</infon>
      <infon key="id">Fig3</infon>
      <infon key="type">fig_caption</infon>
      <offset>7948</offset>
      <text> Biological pathways having more differentially expressed genes. A: PI3K-AKT Pathway; B: JAK-STAT Pathway. Gene name in red in the gene box indicates higher gene expression in S/G, green indicates lower gene expression, and black indicates no change of the gene expression.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8222</offset>
      <text>Two singnaling pathways, PI3K-AKT pathway and JAK-STAT pathway, were identified as biological pathways having more differentially expressed genes. Figure 3 displayed the putative interactions related to the differentially expressed genes of the two pathways. These interactions were intensively involved in cell cycle and apoptosis processes.</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">12863_2014_144_Fig4_HTML.jpg</infon>
      <infon key="id">Fig4</infon>
      <infon key="type">fig_caption</infon>
      <offset>8566</offset>
      <text> Selected factors with possible hair growth regulatory roles . In the hair growth cycle, some factors play roles in anagen promotion or maintenance (left), some factors play roles in catagen-telogen promotion or maintenance (middle), and others have unkown funtions (right). The differentially expressed genes in this study was highlighted in colour (green or red). Genes in green represent that their regulation direction were in agreement with their putative function, while genes in red represent the opposite situation.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9092</offset>
      <text>We speculate that wool growth regulation shared similar gene networks with hair. So particular differentially expressed genes, which also appeared in the conclusion of factors with known hair growth regulatory roles, were included in the putative gene lists of wool growth regulation (Figure 4). In the networks, 3 genes (FGF7, IGFBP3 and PRL) were contained in the category of anagen promotion and maintenance, 3 genes (IL1A, IL6 and TAC1) were contained in the category of catagen-telogen promotion and maintenance, while 2 genes (CDKN1B and FGF18) were contained in the category of function unknown.</text>
      <annotation id="98">
        <infon key="identifier">443095</infon>
        <infon key="type">Gene</infon>
        <location offset="9414" length="4"/>
        <text>FGF7</text>
      </annotation>
      <annotation id="99">
        <infon key="identifier">100286737</infon>
        <infon key="type">Gene</infon>
        <location offset="9420" length="6"/>
        <text>IGFBP3</text>
      </annotation>
      <annotation id="100">
        <infon key="identifier">443317</infon>
        <infon key="type">Gene</infon>
        <location offset="9431" length="3"/>
        <text>PRL</text>
      </annotation>
      <annotation id="101">
        <infon key="identifier">443404</infon>
        <infon key="type">Gene</infon>
        <location offset="9513" length="4"/>
        <text>IL1A</text>
      </annotation>
      <annotation id="102">
        <infon key="identifier">443406</infon>
        <infon key="type">Gene</infon>
        <location offset="9519" length="3"/>
        <text>IL6</text>
      </annotation>
      <annotation id="103">
        <infon key="identifier">100034669</infon>
        <infon key="type">Gene</infon>
        <location offset="9527" length="4"/>
        <text>TAC1</text>
      </annotation>
      <annotation id="104">
        <infon key="identifier">100127219</infon>
        <infon key="type">Gene</infon>
        <location offset="9625" length="6"/>
        <text>CDKN1B</text>
      </annotation>
      <annotation id="105">
        <infon key="identifier">780460</infon>
        <infon key="type">Gene</infon>
        <location offset="9636" length="5"/>
        <text>FGF18</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>9696</offset>
      <text>Quantitative comparison and identification of protein spots on 2-DE gels</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">12863_2014_144_Fig5_HTML.jpg</infon>
      <infon key="id">Fig5</infon>
      <infon key="type">fig_caption</infon>
      <offset>9769</offset>
      <text> Representative image of 2-DE silver stained polyacrylamide gel. </text>
      <annotation id="107">
        <infon key="identifier">MESH:C016679</infon>
        <infon key="type">Chemical</infon>
        <location offset="9814" length="14"/>
        <text>polyacrylamide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9835</offset>
      <text>To detect differential protein expression between the two skin areas, we constructed triplicate 2D maps of protein samples for each group were created. Figure 5 shows two representative 2-DE gel images of the protein expression patterns of the two groups. One hundred and eighty-seven protein spots showed significant (p &lt; 0.05, t-test) differences in expression levels between the body side skin group and the control. Of the 187, 85 protein spots were more highly expressed and 102 were less highly expressed in body side skin as compared to the groin skin. Some of them could not be identified because of incomplete polypeptide fragments or low abundance (beyond the identification limit). In total, 46 protein entries were identified by MALDI-TOF/MS analyses. An overview of these proteins is presented in Additional file 4: Table S4.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>10679</offset>
      <text>Discussion</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_2</infon>
      <offset>10690</offset>
      <text>Methodologies</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10704</offset>
      <text>This study is a pilot to establish microarray methodologies in the wool growth field. Our results contrasted the gene expressed in the skin cells from hair-rich and hairless regions at transcriptional and translational levels. The number and fold-change of DE genes in December were much lower than that in August (5605 probes were differentially expressed in August; data not shown). That was compatible with reduced follicle activities in winter. And most of DE genes in December were also differentially expressed in August (data not shown).</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11249</offset>
      <text>The advantage of this study is that samples could be obtained easily while the weakness of this study is the low specificity in the samples because the skin samples compose not only wool follicle, but also other parts of the skin.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_2</infon>
      <offset>11480</offset>
      <text>The limitations encountered during the study and how we determine the results</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11558</offset>
      <text>The small sample size is another weakness of this study. These three animals used in the study were half sibs (sharing the same father). The number of our resource population was not very large, so it was difficult to select more than three even-aged half sibs. It is unusual using only three animals, but this shortcoming could be partly made up for through using genetically related animals. Additionally, to confirm the reliability of the results from the microarray experiments, we conduct the qPCR validation for the expression levels of selected 10 genes, whose fold-changes between the two skin areas ranged from 2.15 to 19.42. Seven of these 10 genes displayed the same regulation directions compared to the microarray results, indicating our differential expression data had relatively reliable value in the field.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12382</offset>
      <text>The technical approach (microarrays) is another limitation of the study. First, the number of the probes (15208) designed by Agilent is limited compared to the RNA-seq method. Most of the probes were inadequately annotated. The full utility of the microarray data depends on the complete annotation of the whole sheep genome. Second, the specificity of the probes is relatively lower than RNA-sequencing, although using 60-mers long probes in our study. False positive and false negative phenomena exsit unavoidably in the microarray data.</text>
      <annotation id="110">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="12694" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="111">
        <infon key="identifier">1335626</infon>
        <infon key="type">Species</infon>
        <location offset="12805" length="4"/>
        <text>mers</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_2</infon>
      <offset>12922</offset>
      <text>Functional implication of differentially expressed genes in the microarray study</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13003</offset>
      <text>In the present study, we investigated the molecular events possibly related to sheep hair growth control using microarray and proteomic technologies. Transcriptomic analysis identified hundreds of differentially expressed genes displaying over 2-fold difference between the two sampled skin regions of Aohan fine wool sheep at December time point, and the number of less highly expressed transcripts (892) in body side skin was greater than that of the more highly expressed ones (602). The qPCR results validated the reliability of our microarray data.</text>
      <annotation id="114">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="13321" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">MESH:D012757</infon>
        <infon key="type">Disease</infon>
        <location offset="13082" length="10"/>
        <text>sheep hair</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13557</offset>
      <text>IL-1A and IL-1B inhibit hair growth in vitro as reported previously, but IL-1A has shown downregulation in body side skin in our study. One possibility is in vivo IL-1A controls wool growth in a time dependent or a negative feedback manner.</text>
      <annotation id="120">
        <infon key="identifier">443404</infon>
        <infon key="type">Gene</infon>
        <location offset="13557" length="5"/>
        <text>IL-1A</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">443539</infon>
        <infon key="type">Gene</infon>
        <location offset="13567" length="5"/>
        <text>IL-1B</text>
      </annotation>
      <annotation id="122">
        <infon key="identifier">443404</infon>
        <infon key="type">Gene</infon>
        <location offset="13630" length="5"/>
        <text>IL-1A</text>
      </annotation>
      <annotation id="123">
        <infon key="identifier">443404</infon>
        <infon key="type">Gene</infon>
        <location offset="13720" length="5"/>
        <text>IL-1A</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13798</offset>
      <text>The skin of skin-specific SCD1 knock-out (SKO) mice exhibited variable orthokeratotic hyperkeratosis and parakeratotic hyperkeratosis, occasional mal-aligned hair follicles, and instances of protrusion of hair shafts out of the hair follicle and into the surrounding connective tissue, with an infiltration of inflammatory cells surrounding the exposed hair shaft and keratin material. In our study, SCD was less highly expressed at 11.91 fold change in body side skin. This maybe indicate that the SCD could play an important role in groin skin.</text>
      <annotation id="129">
        <infon key="identifier">20249</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">74538</infon>
        <location offset="13824" length="4"/>
        <text>SCD1</text>
      </annotation>
      <annotation id="130">
        <infon key="identifier">443185</infon>
        <infon key="type">Gene</infon>
        <location offset="14198" length="3"/>
        <text>SCD</text>
      </annotation>
      <annotation id="131">
        <infon key="identifier">443185</infon>
        <infon key="type">Gene</infon>
        <location offset="14297" length="3"/>
        <text>SCD</text>
      </annotation>
      <annotation id="132">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="13845" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">MESH:D017488</infon>
        <infon key="type">Disease</infon>
        <location offset="13869" length="62"/>
        <text>orthokeratotic hyperkeratosis and parakeratotic hyperkeratosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>14345</offset>
      <text>MMP2 activity is associated with the disappearance of collagen VII during the invasion of epithelial cords of hair follicles and sweat glands in human skin. MMP2 plays a role in hair growth-associated extracellular matrix remodeling and cell migration, and may be a downstream effector through which thymosin ss4 exerts its effect on hair growth. However, MMP2 showed significant lower expression in body side skin. This may suggest sheep has a different hair growth regulatory mechanism than human.</text>
      <annotation id="140">
        <infon key="identifier">4313</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3329</infon>
        <location offset="14345" length="4"/>
        <text>MMP2</text>
      </annotation>
      <annotation id="141">
        <infon key="identifier">443115</infon>
        <infon key="type">Gene</infon>
        <location offset="14502" length="4"/>
        <text>MMP2</text>
      </annotation>
      <annotation id="142">
        <infon key="identifier">443115</infon>
        <infon key="type">Gene</infon>
        <location offset="14701" length="4"/>
        <text>MMP2</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14490" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="144">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="14778" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="145">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14838" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>14845</offset>
      <text>There is a log linear relationship between the relative level of beta 1 integrins (ITGB1) on the cell surface and proliferative capacity in keratinocytes. ITGB1-mediated signalling is also important in human hair growth control. Skin and hair follicle integrity is crucially dependent on ITGB1 expression in keratinocytes. In our study, however,ITGB1 expression in the body side skin was less highly expressed. The mechanism how it happens deserves further investigation.</text>
      <annotation id="151">
        <infon key="identifier">443141</infon>
        <infon key="type">Gene</infon>
        <location offset="14928" length="5"/>
        <text>ITGB1</text>
      </annotation>
      <annotation id="152">
        <infon key="identifier">3688</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">22999</infon>
        <location offset="15000" length="5"/>
        <text>ITGB1</text>
      </annotation>
      <annotation id="153">
        <infon key="identifier">443141</infon>
        <infon key="type">Gene</infon>
        <location offset="15133" length="5"/>
        <text>ITGB1</text>
      </annotation>
      <annotation id="154">
        <infon key="identifier">443141</infon>
        <infon key="type">Gene</infon>
        <location offset="15190" length="5"/>
        <text>ITGB1</text>
      </annotation>
      <annotation id="155">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15047" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>15317</offset>
      <text>Rowe et al. confirmed that predominantly CYP1A1 was located to the sebaceous gland surrounding the hair shaft. It is not known why CYP1A1 expression was less highly expressed more than 10 folds in the body side skin from our data. This interesting phenomenon is worth pursuing in future studies.</text>
      <annotation id="158">
        <infon key="identifier">100170113</infon>
        <infon key="type">Gene</infon>
        <location offset="15358" length="6"/>
        <text>CYP1A1</text>
      </annotation>
      <annotation id="159">
        <infon key="identifier">100170113</infon>
        <infon key="type">Gene</infon>
        <location offset="15448" length="6"/>
        <text>CYP1A1</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>15613</offset>
      <text>As development proceeds, GluD1 expression becomes restricted to the hippocampus, cochlear and vestibular hair cells, and spiral ganglion cells. Hair follicles are also derived from ectoderm. So why GLUD1 was less highly expressed in body side skin really deserves further investigation.</text>
      <annotation id="163">
        <infon key="identifier">443239</infon>
        <infon key="type">Gene</infon>
        <location offset="15638" length="5"/>
        <text>GluD1</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">443239</infon>
        <infon key="type">Gene</infon>
        <location offset="15811" length="5"/>
        <text>GLUD1</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">MESH:D015837</infon>
        <infon key="type">Disease</infon>
        <location offset="15707" length="21"/>
        <text>vestibular hair cells</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>15900</offset>
      <text>Connexin 43 (Cx43) is a gap junction protein expressed in the follicular dermal papilla (DP). A recent mouse model research suggested an important role for Cx43 in hair regeneration, growth, and cuticle formation. However, Connexin 43 was less highly expressed in body side skin in the microarray analysis of this study, and it was also confirmed by qPCR.</text>
      <annotation id="172">
        <infon key="identifier">443455</infon>
        <infon key="type">Gene</infon>
        <location offset="15900" length="11"/>
        <text>Connexin 43</text>
      </annotation>
      <annotation id="173">
        <infon key="identifier">443455</infon>
        <infon key="type">Gene</infon>
        <location offset="15913" length="4"/>
        <text>Cx43</text>
      </annotation>
      <annotation id="174">
        <infon key="identifier">14611</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">9670</infon>
        <location offset="16056" length="4"/>
        <text>Cx43</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">443455</infon>
        <infon key="type">Gene</infon>
        <location offset="16123" length="11"/>
        <text>Connexin 43</text>
      </annotation>
      <annotation id="176">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="16003" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="177">
        <infon key="identifier">MESH:D010211</infon>
        <infon key="type">Disease</infon>
        <location offset="15962" length="25"/>
        <text>follicular dermal papilla</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16256</offset>
      <text>Several papers indicated that prostaglandin induced hair growth, but in our results, one prostaglandin synthase (PGFS) were less highly expressed in body side skin. This interesting contradiction remains to be further elucidated.</text>
      <annotation id="180">
        <infon key="identifier">443108</infon>
        <infon key="type">Gene</infon>
        <location offset="16369" length="4"/>
        <text>PGFS</text>
      </annotation>
      <annotation id="181">
        <infon key="identifier">MESH:D011453</infon>
        <infon key="type">Chemical</infon>
        <location offset="16286" length="13"/>
        <text>prostaglandin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16486</offset>
      <text>We have indeed tried our best to find out differentially expressed genes associated with LCE and MOGAT as reported in a Science paper. However, we could find only a few genes (DGAT2, LPL, ZO1, GJB2 and ITGB1) that have the possibility to play roles in epidermal development complex (EDC) or skin lipid metabolism. One reason for limited DE genes is that what we compared were different regions of sheep skin tissue (which might share similar principles in EDC regulation and lipid synthesis), not distinct tissues such as rumen and skin. That might also be caused by inadequate annotation of the probes or less gene coverage redundancy of the Agilent microarray.</text>
      <annotation id="190">
        <infon key="identifier">101110535</infon>
        <infon key="type">Gene</infon>
        <location offset="16662" length="5"/>
        <text>DGAT2</text>
      </annotation>
      <annotation id="191">
        <infon key="identifier">443408</infon>
        <infon key="type">Gene</infon>
        <location offset="16669" length="3"/>
        <text>LPL</text>
      </annotation>
      <annotation id="192">
        <infon key="identifier">443200</infon>
        <infon key="type">Gene</infon>
        <location offset="16674" length="3"/>
        <text>ZO1</text>
      </annotation>
      <annotation id="193">
        <infon key="identifier">443345</infon>
        <infon key="type">Gene</infon>
        <location offset="16679" length="4"/>
        <text>GJB2</text>
      </annotation>
      <annotation id="194">
        <infon key="identifier">443141</infon>
        <infon key="type">Gene</infon>
        <location offset="16688" length="5"/>
        <text>ITGB1</text>
      </annotation>
      <annotation id="195">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="16883" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="196">
        <infon key="identifier">MESH:D008055</infon>
        <infon key="type">Chemical</infon>
        <location offset="16961" length="5"/>
        <text>lipid</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">MESH:D008055</infon>
        <infon key="type">Chemical</infon>
        <location offset="16782" length="5"/>
        <text>lipid</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_2</infon>
      <offset>17149</offset>
      <text>Functional implication of differentially expressed proteins in the proteomic study</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>17232</offset>
      <text>Most of the differentially expressed proteins were not listed above in the Discussion.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>17319</offset>
      <text>Cryab protein was detected in 2DE in groin skin but not in body side skin. But the Cryab transcripts was more highly expressed in body side skin by the microarray study, though the differential expression was not validated by qPCR. This gene, downregulated in the transcriptional level during the depilation-induced hair cycle, was considered to play a role in regulation of apoptosis.</text>
      <annotation id="200">
        <infon key="identifier">497274</infon>
        <infon key="type">Gene</infon>
        <location offset="17319" length="5"/>
        <text>Cryab</text>
      </annotation>
      <annotation id="201">
        <infon key="identifier">497274</infon>
        <infon key="type">Gene</infon>
        <location offset="17402" length="5"/>
        <text>Cryab</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>17705</offset>
      <text>FGF18 protein was less highly expressed in body side skin compared to the control. But the FGF18 transcripts was more highly expressed by the microarray study. Consistent to our microarray results, FGF18 is highly expressed in hair follicles and capable of inducing anagen from telogen stage hair follicles.</text>
      <annotation id="205">
        <infon key="identifier">780460</infon>
        <infon key="type">Gene</infon>
        <location offset="17705" length="5"/>
        <text>FGF18</text>
      </annotation>
      <annotation id="206">
        <infon key="identifier">780460</infon>
        <infon key="type">Gene</infon>
        <location offset="17796" length="5"/>
        <text>FGF18</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">780460</infon>
        <infon key="type">Gene</infon>
        <location offset="17903" length="5"/>
        <text>FGF18</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>18013</offset>
      <text>KRT14 and KRT2.11 proteins were both less highly expressed in body side skin compared to the control. But these proteins were expected to play roles in wool follicles.</text>
      <annotation id="210">
        <infon key="identifier">100303604</infon>
        <infon key="type">Gene</infon>
        <location offset="18013" length="5"/>
        <text>KRT14</text>
      </annotation>
      <annotation id="211">
        <infon key="identifier">443415</infon>
        <infon key="type">Gene</infon>
        <location offset="18023" length="7"/>
        <text>KRT2.11</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>18181</offset>
      <text>PADI3 played roles in the assembly of a globular S100A3 homotetramer,a putative Ca2+ modulator maturing human hair cuticle. But the PADI3 protein was less highly expressed in body side skin compared to the control in our study. This interesting contradiction remains to be further elucidated.</text>
      <annotation id="217">
        <infon key="identifier">51702</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7882</infon>
        <location offset="18181" length="5"/>
        <text>PADI3</text>
      </annotation>
      <annotation id="218">
        <infon key="identifier">443369</infon>
        <infon key="type">Gene</infon>
        <location offset="18313" length="5"/>
        <text>PADI3</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">6274</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">2223</infon>
        <location offset="18230" length="6"/>
        <text>S100A3</text>
      </annotation>
      <annotation id="220">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18285" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="221">
        <infon key="identifier">MESH:D000069285</infon>
        <infon key="type">Chemical</infon>
        <location offset="18261" length="4"/>
        <text>Ca2+</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>18474</offset>
      <text>FGFR3 RNA was detected in precuticle cells in the periphery of the hair bulb. But FGFR3 protein was less highly expressed in body side skin compared to the control in our study.</text>
      <annotation id="224">
        <infon key="identifier">554324</infon>
        <infon key="type">Gene</infon>
        <location offset="18474" length="5"/>
        <text>FGFR3</text>
      </annotation>
      <annotation id="225">
        <infon key="identifier">554324</infon>
        <infon key="type">Gene</infon>
        <location offset="18556" length="5"/>
        <text>FGFR3</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_2</infon>
      <offset>18652</offset>
      <text>Concordance between the results of transcriptomic and proteomic levels</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>18723</offset>
      <text>In the results of transcriptomic level (microarray), the number of more highly expressed genes was less than that of less highly expressed ones (602 versus 892). Consistently, more highly expressed protein spots were less than more lowly expressed ones (85 versus 102).</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>18993</offset>
      <text>The concordance between these two results from microarray and proteomic experiments was shown in Additional file 4: Table S4. Of the 46 identified proteins, 13 corresponding transcripts also shown differential expression. Among these 13 transcripts, the regulation trends of only 6 (in green) were consistent with their protein counterparts. The inconsistency of the two levels of other 7 DE genes (in red) might be produced by post transcriptional regulation or for unknown reasons.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_2</infon>
      <offset>19477</offset>
      <text>The confidence of the differentially expressed transcripts</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>19536</offset>
      <text>For the Agilent microarray, the probe number of each gene is indefinite, from 1 to 5. There exists alternative splicing after gene transcription, so the inconsistency between different probes for the same gene is sometimes reasonable. Certainly the confidence is higher if all probes for the same gene were differentially expressed. For example, there are 4 probes for FGF7 and LOC443300(YWHAE) separately, of which 2 were both less highly expressed in S/G. So we speculated that the reliabilities of differential expression of FGF7 and LOC443300 were close to each other. While MMP2 differential expression was only detected in one of three probes, then its confidence might be lower than the former two genes (FGF7 and LOC443300). Nevertheless, because of the inadequate annotation of most probes, we found it difficult to calculate probe number of all the differentially expressed genes.</text>
      <annotation id="231">
        <infon key="identifier">443095</infon>
        <infon key="type">Gene</infon>
        <location offset="19905" length="4"/>
        <text>FGF7</text>
      </annotation>
      <annotation id="232">
        <infon key="identifier">443300</infon>
        <infon key="type">Gene</infon>
        <location offset="19924" length="5"/>
        <text>YWHAE</text>
      </annotation>
      <annotation id="233">
        <infon key="identifier">443095</infon>
        <infon key="type">Gene</infon>
        <location offset="20064" length="4"/>
        <text>FGF7</text>
      </annotation>
      <annotation id="234">
        <infon key="identifier">443115</infon>
        <infon key="type">Gene</infon>
        <location offset="20115" length="4"/>
        <text>MMP2</text>
      </annotation>
      <annotation id="235">
        <infon key="identifier">443095</infon>
        <infon key="type">Gene</infon>
        <location offset="20248" length="4"/>
        <text>FGF7</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_2</infon>
      <offset>20427</offset>
      <text>Gene networks</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>20441</offset>
      <text>Figure 5 listed some of the factors which possibly play roles in wool growth regulation. We speculate that lower temperature and shorter day photoperiod were key causes of the downregulation of wool growth rate. So we could speculate that those 8 genes (IL1A,FGF7,TAC1,IGFBP3,CDKN1B,IL6,FGF18 and PRL) played roles in wool growth regulation during winter.</text>
      <annotation id="244">
        <infon key="identifier">443404</infon>
        <infon key="type">Gene</infon>
        <location offset="20695" length="4"/>
        <text>IL1A</text>
      </annotation>
      <annotation id="245">
        <infon key="identifier">443095</infon>
        <infon key="type">Gene</infon>
        <location offset="20700" length="4"/>
        <text>FGF7</text>
      </annotation>
      <annotation id="246">
        <infon key="identifier">100034669</infon>
        <infon key="type">Gene</infon>
        <location offset="20705" length="4"/>
        <text>TAC1</text>
      </annotation>
      <annotation id="247">
        <infon key="identifier">100286737</infon>
        <infon key="type">Gene</infon>
        <location offset="20710" length="6"/>
        <text>IGFBP3</text>
      </annotation>
      <annotation id="248">
        <infon key="identifier">100127219</infon>
        <infon key="type">Gene</infon>
        <location offset="20717" length="6"/>
        <text>CDKN1B</text>
      </annotation>
      <annotation id="249">
        <infon key="identifier">443406</infon>
        <infon key="type">Gene</infon>
        <location offset="20724" length="3"/>
        <text>IL6</text>
      </annotation>
      <annotation id="250">
        <infon key="identifier">780460</infon>
        <infon key="type">Gene</infon>
        <location offset="20728" length="5"/>
        <text>FGF18</text>
      </annotation>
      <annotation id="251">
        <infon key="identifier">443317</infon>
        <infon key="type">Gene</infon>
        <location offset="20738" length="3"/>
        <text>PRL</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>20798</offset>
      <text>Conclusions</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>20810</offset>
      <text>In summary, the data presented in this study suggested that the body side skin displays a differentially expressed pattern in comparison with the groin skin at December time point. The majority of these genes possibly related to the wool growth control, and they could be assigned into the categories including regulation of receptor binding, multicellular organismal process, protein binding and macromolecular complex. Several potential gene families might participate in hair growth regulation, including fibroblast growth factors, transforming growth factor-beta, insulin-like growth factor, and so on. Proteomic analysis also identified hundreds of differentially expressed proteins. This systematic analysis could lead to a better understanding of the wool growth control mechanism in Aohan fine wool sheep.</text>
      <annotation id="253">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="21617" length="5"/>
        <text>sheep</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>21624</offset>
      <text>Methods</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>21632</offset>
      <text>Animals and sample preparation</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>21663</offset>
      <text>All animals were treated in accordance with the animal protocols defined by national and local animal welfare bodies, and all animal work was approved by the Shandong Province Biological Studies Animal Care and Use Committee.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>21889</offset>
      <text>Sampling methods were described previously. One ram and two ewes of 16-month-old Aohan fine wool sheep were used in the microarray study. These animals were half sibs (sharing the same father). In December 2010, two areas of full-thickness skin were sampled from the same animal under local anaesthesia: body side skin (wool bearing) and groin skin (non-wool bearing) for microarray and proteomic experiments. The area of each sample was about 1 cm2. All samples were immediately put into collection tubes and stored in liquid nitrogen for RNA and protein extraction. A total of 15, 208 probes were spotted on this Agilent Sheep Gene Expression Microarray (Santa Clara, CA, USA).</text>
      <annotation id="257">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="21986" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="258">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="22512" length="5"/>
        <text>Sheep</text>
      </annotation>
      <annotation id="259">
        <infon key="identifier">MESH:D009584</infon>
        <infon key="type">Chemical</infon>
        <location offset="22416" length="8"/>
        <text>nitrogen</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>22570</offset>
      <text>RNA extraction and microarray hybridization</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>22614</offset>
      <text>TRIzol (Invitrogen) was used for total RNA extractions according to the manufacturer's protocol. RNA quantity and quality were measured by NanoDrop ND-1000. Its OD260/OD280 ratio was confirmed to be higher than 1.8. RNA integrity was assessed by standard denaturing agarose gel electrophoresis. The RNA samples were sent to Kangchen Biotechnology Limited Company (Shanghai, China) for hybridization to the Agilent Sheep Gene Expression Microarray (Santa Clara, CA, USA). Each RNA sample was hybridized to one microarray slide. 1 mug of total RNA from each sample was amplified and transcribed into fluorescent cRNA with using the manufacturer's Agilent's Quick Amp Labeling protocol (version 5.7, Agilent Technologies). The labeled cRNAs were hybridized onto the Whole Genome Oligo Array (4x44K, Agilent Technologies).</text>
      <annotation id="264">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="23028" length="5"/>
        <text>Sheep</text>
      </annotation>
      <annotation id="265">
        <infon key="identifier">MESH:D012685</infon>
        <infon key="type">Chemical</infon>
        <location offset="22880" length="7"/>
        <text>agarose</text>
      </annotation>
      <annotation id="266">
        <infon key="identifier">MESH:D000249</infon>
        <infon key="type">Chemical</infon>
        <location offset="23275" length="3"/>
        <text>Amp</text>
      </annotation>
      <annotation id="267">
        <infon key="identifier">MESH:C411644</infon>
        <infon key="type">Chemical</infon>
        <location offset="22614" length="6"/>
        <text>TRIzol</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>23440</offset>
      <text>Microarrays data analysis</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>23466</offset>
      <text>After hybridization and washing, the microarray slides were scanned with the Agilent Scanner G2505B. The resulting text files extracted from Agilent Feature Extraction Software (version 10.5.1.1) were imported into the Agilent GeneSpring GX software (version 11.0) for further analysis. Quantile normalization, probe annotation and subsequent data processing were performed using the GeneSpring GX v11.0 software package (Agilent Technologies). After Quantile normalization of the raw data, genes that at least 1 out of 6 samples have flags in Present ("All Targets Value") were chosen for differentially expressed genes screening. Gene expression levels were quantified relative to the expression of GAPDH. Differentially expressed genes were identified through fold-change screening. The fold-change of 2.0 and a false discovery rate of approximately 5% were set as the threshold. All data have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE62552 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc). Clustering analysis of all differentially expressed genes was performed using Cluster 3.0 to analyze the similarity in the expression patterns among different skin sites. The functional annotation of differentially expressed genes was performed by the DAVID (The Database for Annotation, Visualization and Integrated Discovery) gene annotation tool (http://david.abcc.ncifcrf.gov/). The KEGG pathway analysis was done manually (http://www.genome.jp/kegg/).</text>
      <annotation id="270">
        <infon key="identifier">443005</infon>
        <infon key="type">Gene</infon>
        <location offset="24167" length="5"/>
        <text>GAPDH</text>
      </annotation>
      <annotation id="271">
        <infon key="identifier">34205</infon>
        <infon key="type">Species</infon>
        <location offset="24001" length="5"/>
        <text>flags</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>24992</offset>
      <text>Particular differentially expressed genes, which also appeared in the Figure 1 of reference No. 29 summarizing selective factors with known hair growth regulatory roles, were included in the putative gene networks of wool growth regulation. The networks contained genes possibly playing roles in anagen promotion and maintenance, in catagen-telogen promotion and maintenance, or with function unknown.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>25395</offset>
      <text>QPCR</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>25400</offset>
      <text> aThe annealing temperature represents the optimal temperature during quantitative PCR.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>25488</offset>
      <text> bRNA levels of GAPDH was assayed for normalization during quantitative PCR.</text>
      <annotation id="273">
        <infon key="identifier">443005</infon>
        <infon key="type">Gene</infon>
        <location offset="25504" length="5"/>
        <text>GAPDH</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab1.xml</infon>
      <infon key="id">Tab1</infon>
      <infon key="type">table_caption</infon>
      <offset>25565</offset>
      <text> Primers used for Q-PCR validation </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab1</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab1.xml</infon>
      <offset>25601</offset>
      <text> Gene   Primer sequence (5'-3')   Tm ( C) a   Target size (bp)  GAPDHb  Forward: ATGCCTCCTGCACCACCA 60 76 Reverse: AGTCCCTCCACGATGCCAA FGF10 Forward: GATCCGAGAAAGGAGCGAGG 60 554 Reverse: TCCAGGATACTGTACGGGCA LOC443300 Forward: ACCAACACATCCCATTCGCT 60 140 Reverse: CACTCAGCGTGTCCAGTTCT FGF18 Forward: AAGTCCGGATCAAGGGCAAG 60 98 Reverse: CACACACTCTTTGCTGGTGC Connexin43 Forward: GTCGTGTCGTTGGTGTCTCT 60 291 Reverse: CACTCAGCGTGTCCAGTTCT SCD Forward: AAGAGTGGCTGAGTTTCTGGTC 60 277 Reverse: GAAAGGAAGGTGATAGGGACAA Zo1 Forward: AGATAGCCCTGCAGCCAAAG 60 117 Reverse: GGGAGGTCAAGCAGGAAGAG MMP2 Forward: AACGCCATCCCTGATAACCT 60 126 Reverse: GCTTCCGAACTTCACGCTC ITGB1 Forward: AGCACGGATGAGGTGAACAG 60 407 Reverse: CCAAGGCAGGTCTGACACAT PAG11 Forward: AGCGTCGCCTACGAATCTG 60 120 Reverse: CTCAAACCCATATTCCGTCACA CRYAB Forward: CACCCAGCTGGATTGACACT 60 147 Reverse: CCTCATGTTTGCCATGCACC </text>
      <annotation id="283">
        <infon key="identifier">443074</infon>
        <infon key="type">Gene</infon>
        <location offset="25736" length="5"/>
        <text>FGF10</text>
      </annotation>
      <annotation id="284">
        <infon key="identifier">780460</infon>
        <infon key="type">Gene</infon>
        <location offset="25886" length="5"/>
        <text>FGF18</text>
      </annotation>
      <annotation id="285">
        <infon key="identifier">443455</infon>
        <infon key="type">Gene</infon>
        <location offset="25958" length="10"/>
        <text>Connexin43</text>
      </annotation>
      <annotation id="286">
        <infon key="identifier">443115</infon>
        <infon key="type">Gene</infon>
        <location offset="26182" length="4"/>
        <text>MMP2</text>
      </annotation>
      <annotation id="287">
        <infon key="identifier">443141</infon>
        <infon key="type">Gene</infon>
        <location offset="26253" length="5"/>
        <text>ITGB1</text>
      </annotation>
      <annotation id="288">
        <infon key="identifier">100034671</infon>
        <infon key="type">Gene</infon>
        <location offset="26326" length="5"/>
        <text>PAG11</text>
      </annotation>
      <annotation id="289">
        <infon key="identifier">497274</infon>
        <infon key="type">Gene</infon>
        <location offset="26400" length="5"/>
        <text>CRYAB</text>
      </annotation>
      <annotation id="290">
        <infon key="identifier">443200</infon>
        <infon key="type">Gene</infon>
        <location offset="26111" length="3"/>
        <text>Zo1</text>
      </annotation>
      <annotation id="291">
        <infon key="identifier">443185</infon>
        <infon key="type">Gene</infon>
        <location offset="26036" length="3"/>
        <text>SCD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>26479</offset>
      <text>The total RNA samples prepared for microarray analysis were also used for qPCR analysis. Reverse transcriptions were performed using RevertAid First Strand cDNA Synthesis Kit (MBI Fermentas, Vilnius, Lithuania) according to the manufacturer's protocols. The primers were designed with the Oligo 6.0 program. The primer sequences, melting temperatures and product sizes are shown in Table 1. Gene expression levels were quantified relative to the expression of GAPDH.</text>
      <annotation id="293">
        <infon key="identifier">443005</infon>
        <infon key="type">Gene</infon>
        <location offset="26939" length="5"/>
        <text>GAPDH</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>26949</offset>
      <text>Tissue protein extraction</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>26975</offset>
      <text>Lysis buffer preparation: 42% Urea, 15.2% Thiourea, 4% CHAPS, 1% DTT. Sampled tissues were homogenziated in lysis buffer (containing 1% cocktail and 2% IPG-buffer, added right before use) at the ratio of 1:7 (weight/volume). The tissues were cut into small pieces by ophthalmic scissors, and left at 4 C for 1 h, vortexed it every 15 min. Then, the tissue homogenate was centrifuge at 40,000 g for 30 min. Supernatants were collected and stored at -80 C. Protein concerntrations were determined by Bradford method.</text>
      <annotation id="299">
        <infon key="identifier">MESH:C028213</infon>
        <infon key="type">Chemical</infon>
        <location offset="27030" length="5"/>
        <text>CHAPS</text>
      </annotation>
      <annotation id="300">
        <infon key="identifier">MESH:D004229</infon>
        <infon key="type">Chemical</infon>
        <location offset="27040" length="3"/>
        <text>DTT</text>
      </annotation>
      <annotation id="301">
        <infon key="identifier">MESH:D013890</infon>
        <infon key="type">Chemical</infon>
        <location offset="27017" length="8"/>
        <text>Thiourea</text>
      </annotation>
      <annotation id="302">
        <infon key="identifier">MESH:D014508</infon>
        <infon key="type">Chemical</infon>
        <location offset="27005" length="4"/>
        <text>Urea</text>
      </annotation>
      <annotation id="303">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="27127" length="3"/>
        <text>IPG</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>27498</offset>
      <text>One-dimensional electrophoresis</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>27530</offset>
      <text>0.5% IPG-buffer was added into each 150 mug protein sample (in a final volume of 400-600 muL), and was loaded in the One-dimensional electrophoresis instrument. The progamme is as follows: Step-n-hold (S1, 30 V for 6 h; S2, 60 V for 6 h); Gradient (S3, 500 V for 1 h;S4,1000 V for 1 h; S5, 3000 V for 3 h; S6, 8000 V for 3 h); Step-n-hold (S7, 8000 V for 20 h).</text>
      <annotation id="305">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="27535" length="3"/>
        <text>IPG</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>27908</offset>
      <text>2-dimensional (2-D) SDS-PAGE preparation</text>
      <annotation id="307">
        <infon key="identifier">MESH:D012967</infon>
        <infon key="type">Chemical</infon>
        <location offset="27928" length="3"/>
        <text>SDS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>27949</offset>
      <text>Tris-HCl (PH = 8.8), Monomer storage (30% Acrylamid and 0.8% NN'-methy lenebisacry lamid), 10 x electrophoresis buffer (3.03% Tris-Base, 14.4% Glycine, 1% SDS), balanced solution (36.05% Urea, 5% Tris-HCl, 2% SDS, 34.5% Glycerine).</text>
      <annotation id="318">
        <infon key="identifier">MESH:D005990</infon>
        <infon key="type">Chemical</infon>
        <location offset="28169" length="9"/>
        <text>Glycerine</text>
      </annotation>
      <annotation id="319">
        <infon key="identifier">MESH:D005998</infon>
        <infon key="type">Chemical</infon>
        <location offset="28092" length="7"/>
        <text>Glycine</text>
      </annotation>
      <annotation id="320">
        <infon key="identifier">MESH:D014325</infon>
        <infon key="type">Chemical</infon>
        <location offset="28075" length="9"/>
        <text>Tris-Base</text>
      </annotation>
      <annotation id="321">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="28145" length="8"/>
        <text>Tris-HCl</text>
      </annotation>
      <annotation id="322">
        <infon key="identifier">MESH:D012967</infon>
        <infon key="type">Chemical</infon>
        <location offset="28104" length="3"/>
        <text>SDS</text>
      </annotation>
      <annotation id="323">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="28010" length="27"/>
        <text>NN'-methy lenebisacry lamid</text>
      </annotation>
      <annotation id="324">
        <infon key="identifier">MESH:D012967</infon>
        <infon key="type">Chemical</infon>
        <location offset="28158" length="3"/>
        <text>SDS</text>
      </annotation>
      <annotation id="325">
        <infon key="identifier">MESH:D020106</infon>
        <infon key="type">Chemical</infon>
        <location offset="27991" length="9"/>
        <text>Acrylamid</text>
      </annotation>
      <annotation id="326">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="27949" length="8"/>
        <text>Tris-HCl</text>
      </annotation>
      <annotation id="327">
        <infon key="identifier">MESH:D014508</infon>
        <infon key="type">Chemical</infon>
        <location offset="28136" length="4"/>
        <text>Urea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>28196</offset>
      <text>The second dimensional SDS-PAGE</text>
      <annotation id="329">
        <infon key="identifier">MESH:D012967</infon>
        <infon key="type">Chemical</infon>
        <location offset="28219" length="3"/>
        <text>SDS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>28228</offset>
      <text>Transfer: Voltage 300v, Current 50 mA, Time 1 h.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>28279</offset>
      <text>Separation: Voltage 300v, Current 200 ~ 250 mA, Time 4 ~ 5 h.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>28351</offset>
      <text>Fixative preparation: 40% Ethanol and 10% Acetic acid.</text>
      <annotation id="332">
        <infon key="identifier">MESH:D019342</infon>
        <infon key="type">Chemical</infon>
        <location offset="28393" length="11"/>
        <text>Acetic acid</text>
      </annotation>
      <annotation id="333">
        <infon key="identifier">MESH:D000431</infon>
        <infon key="type">Chemical</infon>
        <location offset="28377" length="7"/>
        <text>Ethanol</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>28406</offset>
      <text>Electrophoresis was carried out until the blue dye front had just disappeared from the bottom of the gel.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>28512</offset>
      <text>Fixation: take out the rubber strip and put it into Fixative for 1 h.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>28583</offset>
      <text>The electrophoresis programme is as follows:</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>28628</offset>
      <text>Staining and visualization</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>28655</offset>
      <text>Sensitizing solution preparation: 30% Ethanol, 0.314% Na2S2O3, 6.8%NaAc.</text>
      <annotation id="337">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="28709" length="7"/>
        <text>Na2S2O3</text>
      </annotation>
      <annotation id="338">
        <infon key="identifier">MESH:D000431</infon>
        <infon key="type">Chemical</infon>
        <location offset="28693" length="7"/>
        <text>Ethanol</text>
      </annotation>
      <annotation id="339">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="28722" length="4"/>
        <text>NaAc</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>28728</offset>
      <text>Sensitizing: the gels were sensitized for 30 min.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>28779</offset>
      <text>Washing: the gels were washed for three times using ddH2O. Ten minutes each time.</text>
      <annotation id="341">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="28831" length="5"/>
        <text>ddH2O</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>28861</offset>
      <text>Ilver staining: Silver staining solution was prepared (1.25 AgNO3 and 200 muL Formaldehyde in 500 mL ddH2O). The gels were stained by the solution for 20 min.</text>
      <annotation id="345">
        <infon key="identifier">MESH:D012835</infon>
        <infon key="type">Chemical</infon>
        <location offset="28921" length="5"/>
        <text>AgNO3</text>
      </annotation>
      <annotation id="346">
        <infon key="identifier">MESH:D005557</infon>
        <infon key="type">Chemical</infon>
        <location offset="28939" length="12"/>
        <text>Formaldehyde</text>
      </annotation>
      <annotation id="347">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="28962" length="5"/>
        <text>ddH2O</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>29023</offset>
      <text>Washing: the gels were washed for 2 min using ddH2O.</text>
      <annotation id="349">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="29069" length="5"/>
        <text>ddH2O</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>29077</offset>
      <text>Visualizing solution preparation: 12.5 g Na2CO3 and 100 muL Formaldehyde in 500 mL ddH2O.</text>
      <annotation id="353">
        <infon key="identifier">MESH:C005686</infon>
        <infon key="type">Chemical</infon>
        <location offset="29118" length="6"/>
        <text>Na2CO3</text>
      </annotation>
      <annotation id="354">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="29160" length="5"/>
        <text>ddH2O</text>
      </annotation>
      <annotation id="355">
        <infon key="identifier">MESH:D005557</infon>
        <infon key="type">Chemical</infon>
        <location offset="29137" length="12"/>
        <text>Formaldehyde</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>29170</offset>
      <text>Termination solution preparation: 2 g Glycine in 50 ml ddH2O.</text>
      <annotation id="358">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="29225" length="5"/>
        <text>ddH2O</text>
      </annotation>
      <annotation id="359">
        <infon key="identifier">MESH:D005998</infon>
        <infon key="type">Chemical</infon>
        <location offset="29208" length="7"/>
        <text>Glycine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>29234</offset>
      <text>Visualization until the solution became muddy, then terminating for 30 min.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>29311</offset>
      <text>Determination of relative protein expression</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>29356</offset>
      <text>Gels were then scanned and analyzed using ImageMaster TM 2D platinum software (Version 5.0, GE Healthcare, San Francisco, CA, USA). The expression level was determined by the relative volume of each spot in the gel and expressed as %Vol (%Vol = [spot volume/Sigmavolumes of all spots resolved in the gel]). The means and standard deviations of both sample groups were calculated. Statistical significance with Student's t-tests using ImageMaster TM 2D platinum software. P values &lt;0.05 were considered statistically significant.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>29888</offset>
      <text>Identification of differentially expressed proteins by mass spectrometry (MS)</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>29966</offset>
      <text>Protein spots with significant differences between the two groups were excised, dehydrated in acetonitrile, and dried at room temperature. Gel pieces were denatured, alkylated, trypsin digested and analyzed by an Ultraflex II MALDI-TOF-TOF mass spectrometer (Bruker Daltonics GmbH, Bremen, Germany) under the control of FlexControl TM 2.4 software (Bruker Daltonics GmbH). Acquired peptide mass fingerprint (PMF) were processed using the software FlexAnalysis  3.0 (Bruker Daltonics, Bremen, Germany). The peak detection algorithm was: SNAP (Sort Neaten Assign and Place); S/N threshold: 1.5; Quality Factor Threshold: 50. The tryptic auto-digestion ion picks (trypsin [108-115] 842.5094 Da, trypsin [58-77] 2211.104 Da) were used as internal standards. The resulting peptide mass lists were used to search the Matrixscience database (http://www.matrixscience.com). The following search parameter criteria were used: mass tolerance 100 ppm, miss cleavage 1, modification comprises carbamidomethyl and methionine oxidation. Matched peptides number between experimental PMF and theoretical PMF 5. All MS data have been deposited in PeptideAtlas and are accessible through Dataset Identifier PASS00597 (http://www.peptideatlas.org/PASS/PASS00597).</text>
      <annotation id="363">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="30947" length="15"/>
        <text>carbamidomethyl</text>
      </annotation>
      <annotation id="364">
        <infon key="identifier">MESH:C032159</infon>
        <infon key="type">Chemical</infon>
        <location offset="30060" length="12"/>
        <text>acetonitrile</text>
      </annotation>
      <annotation id="365">
        <infon key="identifier">MESH:D008715</infon>
        <infon key="type">Chemical</infon>
        <location offset="30967" length="10"/>
        <text>methionine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">title_1</infon>
      <offset>31224</offset>
      <text>Availability of supporting data</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">paragraph</infon>
      <offset>31256</offset>
      <text>All cDNA microarray data have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE62552 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62552).</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">paragraph</infon>
      <offset>31463</offset>
      <text>Proteomic data have been deposited in PeptideAtlas and are accessible through Dataset Identifier PASS00597 (http://www.peptideatlas.org/PASS/PASS00597).</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">title_1</infon>
      <offset>31616</offset>
      <text>Additional files</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>31633</offset>
      <text>Nan Liu and Hegang Li contributed equally to this work.</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>31689</offset>
      <text>Competing interests</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>31709</offset>
      <text>The authors declare that they have no competing interests.</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>31768</offset>
      <text>Authors' contributions</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>31793</offset>
      <text>JZ and HL carried out data collection and analysis and manuscript preparation. KL carried out data analysis. JY participated in data analysis. MC, participated in data collection. WD participated in data discussion and manuscript preparation. RB participated in manuscript preparation. JL and GH participated in discussion of the study. NL participated in the design of the study, coordination, data analysis and manuscript preparation. All authors read and approved the final manuscript.</text>
      <annotation id="368">
        <infon key="identifier">CVCL:2492</infon>
        <infon key="type">CellLine</infon>
        <location offset="31800" length="2"/>
        <text>HL</text>
      </annotation>
      <annotation id="369">
        <infon key="identifier">MESH:D006527</infon>
        <infon key="type">Disease</infon>
        <location offset="31973" length="2"/>
        <text>WD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>32282</offset>
      <text>References</text>
    </passage>
    <passage>
      <infon key="volume">37</infon>
      <infon key="name_1">surname:Franklin;given-names:IR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Purvis;given-names:IW</infon>
      <infon key="fpage">S97</infon>
      <infon key="issue">S1</infon>
      <infon key="pub-id_doi">10.1186/1297-9686-37-S1-S97</infon>
      <infon key="pub-id_pmid">15601598</infon>
      <infon key="year">2005</infon>
      <infon key="source">Genet Sel Evol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">S107</infon>
      <offset>32293</offset>
      <text>Major genes and QTL influencing wool production and quality: a review</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Hulme;given-names:DJ</infon>
      <infon key="name_2">surname:Leish;given-names:Z</infon>
      <infon key="name_1">surname:Callaghan;given-names:MJ</infon>
      <infon key="name_0">surname:Beh;given-names:KJ</infon>
      <infon key="fpage">88</infon>
      <infon key="year">2001</infon>
      <infon key="source">Wool Technol Sheep Breed</infon>
      <infon key="type">ref</infon>
      <infon key="volume">49</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">89</infon>
      <infon key="name_5">surname:Maddox;given-names:JF</infon>
      <infon key="name_4">surname:Lenane;given-names:I</infon>
      <offset>32363</offset>
      <text>A genome scan for QTL affecting fleece and wool traits in Merino sheep</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Cano;given-names:EM</infon>
      <infon key="name_2">surname:Dodero;given-names:AM</infon>
      <infon key="name_1">surname:Roldan;given-names:DL</infon>
      <infon key="name_0">surname:Bidinost;given-names:F</infon>
      <infon key="fpage">113</infon>
      <infon key="pub-id_doi">10.1016/j.smallrumres.2007.04.005</infon>
      <infon key="year">2008</infon>
      <infon key="source">Small Ruminant Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">74</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">118</infon>
      <infon key="name_6">surname:Poli;given-names:MA</infon>
      <infon key="name_5">surname:Mueller;given-names:JP</infon>
      <infon key="name_4">surname:Taddeo;given-names:HR</infon>
      <offset>32434</offset>
      <text>Wool quantitative trait loci in Merino sheep</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Bidinost;given-names:F</infon>
      <infon key="name_2">surname:Roldan;given-names:DL</infon>
      <infon key="name_1">surname:Marrube;given-names:G</infon>
      <infon key="name_0">surname:Cano;given-names:EM</infon>
      <infon key="fpage">158</infon>
      <infon key="pub-id_doi">10.1016/j.smallrumres.2006.06.002</infon>
      <infon key="year">2007</infon>
      <infon key="source">Small Ruminant Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">71</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Bray;given-names:AR</infon>
      <infon key="name_8">surname:Poli;given-names:MA</infon>
      <infon key="name_7">surname:Taddeo;given-names:H</infon>
      <infon key="lpage">164</infon>
      <infon key="name_6">surname:Vaiman;given-names:D</infon>
      <infon key="name_5">surname:Allain;given-names:D</infon>
      <infon key="name_4">surname:Abad;given-names:M</infon>
      <offset>32479</offset>
      <text>QTL affecting fleece traits in Angora goats</text>
    </passage>
    <passage>
      <infon key="name_3">surname:McKenzie;given-names:GW</infon>
      <infon key="volume">39</infon>
      <infon key="name_2">surname:Forrest;given-names:RH</infon>
      <infon key="name_1">surname:Hickford;given-names:JG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Itenge;given-names:TO</infon>
      <infon key="fpage">219</infon>
      <infon key="year">2009</infon>
      <infon key="source">South Afr J Animal Sci</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">223</infon>
      <infon key="name_4">surname:Frampton;given-names:CM</infon>
      <offset>32523</offset>
      <text>Improving the quality of wool through the use of gene markers</text>
    </passage>
    <passage>
      <infon key="volume">4</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Galbraith;given-names:H</infon>
      <infon key="fpage">1490</infon>
      <infon key="pub-id_doi">10.1017/S175173111000025X</infon>
      <infon key="pub-id_pmid">22444696</infon>
      <infon key="year">2010</infon>
      <infon key="source">Animal</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1509</infon>
      <offset>32585</offset>
      <text>Fundamental hair follicle biology and fine fibre production in animals</text>
    </passage>
    <passage>
      <infon key="volume">27</infon>
      <infon key="name_1">surname:Paus;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Schmidt-Ullrich;given-names:R</infon>
      <infon key="fpage">247</infon>
      <infon key="pub-id_doi">10.1002/bies.20184</infon>
      <infon key="pub-id_pmid">15714560</infon>
      <infon key="year">2005</infon>
      <infon key="source">Bioessays</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">261</infon>
      <offset>32656</offset>
      <text>Molecular principles of hair follicle induction and morphogenesis</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McGrice;given-names:HA</infon>
      <infon key="year">2010</infon>
      <infon key="source">Molecular Characterisation of Primary Wool Follicle Initiation in Merino Sheep</infon>
      <infon key="type">ref</infon>
      <offset>32722</offset>
    </passage>
    <passage>
      <infon key="name_3">surname:Batlle;given-names:E</infon>
      <infon key="name_2">surname:Merlos-Suarez;given-names:A</infon>
      <infon key="name_1">surname:Pascual;given-names:G</infon>
      <infon key="name_0">surname:Janich;given-names:P</infon>
      <infon key="fpage">209</infon>
      <infon key="pub-id_doi">10.1038/nature10649</infon>
      <infon key="pub-id_pmid">22080954</infon>
      <infon key="year">2011</infon>
      <infon key="source">Nature</infon>
      <infon key="type">ref</infon>
      <infon key="volume">480</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Benitah;given-names:SA</infon>
      <infon key="name_7">surname:Di Croce;given-names:L</infon>
      <infon key="lpage">214</infon>
      <infon key="name_6">surname:Obrietan;given-names:K</infon>
      <infon key="name_5">surname:Albrecht;given-names:U</infon>
      <infon key="name_4">surname:Ripperger;given-names:J</infon>
      <offset>32723</offset>
      <text>The circadian molecular clock creates epidermal stem cell heterogeneity</text>
    </passage>
    <passage>
      <infon key="volume">312</infon>
      <infon key="name_2">surname:Fuchs;given-names:E</infon>
      <infon key="name_1">surname:Polak;given-names:L</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rhee;given-names:H</infon>
      <infon key="fpage">1946</infon>
      <infon key="pub-id_doi">10.1126/science.1128004</infon>
      <infon key="pub-id_pmid">16809539</infon>
      <infon key="year">2006</infon>
      <infon key="source">Science</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1949</infon>
      <offset>32795</offset>
      <text>Lhx2 maintains stem cell character in hair follicles</text>
      <annotation id="371">
        <infon key="identifier">101108898</infon>
        <infon key="type">Gene</infon>
        <location offset="32795" length="4"/>
        <text>Lhx2</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">116</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Cotsarelis;given-names:G</infon>
      <infon key="fpage">19</infon>
      <infon key="pub-id_doi">10.1172/JCI27490</infon>
      <infon key="pub-id_pmid">16395398</infon>
      <infon key="year">2006</infon>
      <infon key="source">J Clin Invest</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">22</infon>
      <offset>32848</offset>
      <text>Gene expression profiling gets to the root of human hair follicle stem cells</text>
      <annotation id="373">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="32894" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Radonovich;given-names:MF</infon>
      <infon key="name_2">surname:Tock;given-names:CL</infon>
      <infon key="name_1">surname:Terunuma;given-names:A</infon>
      <infon key="name_0">surname:Ohyama;given-names:M</infon>
      <infon key="fpage">249</infon>
      <infon key="pub-id_doi">10.1172/JCI26043</infon>
      <infon key="pub-id_pmid">16395407</infon>
      <infon key="year">2006</infon>
      <infon key="source">J Clin Invest</infon>
      <infon key="type">ref</infon>
      <infon key="volume">116</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Vogel;given-names:JC</infon>
      <infon key="name_7">surname:Udey;given-names:MC</infon>
      <infon key="lpage">260</infon>
      <infon key="name_6">surname:Brady;given-names:JN</infon>
      <infon key="name_5">surname:Hopping;given-names:SB</infon>
      <infon key="name_4">surname:Pise-Masison;given-names:CA</infon>
      <offset>32925</offset>
      <text>Characterization and isolation of stem cell-enriched human hair follicle bulge cells</text>
      <annotation id="375">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="32978" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hyndman;given-names:DL</infon>
      <infon key="name_2">surname:Wilson;given-names:T</infon>
      <infon key="name_1">surname:Zadissa;given-names:A</infon>
      <infon key="name_0">surname:Keane;given-names:OM</infon>
      <infon key="fpage">42</infon>
      <infon key="pub-id_doi">10.1186/1471-2164-7-42</infon>
      <infon key="pub-id_pmid">16515715</infon>
      <infon key="year">2006</infon>
      <infon key="source">BMC Genomics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">7</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:McEwan;given-names:JC</infon>
      <infon key="name_7">surname:Crawford;given-names:AM</infon>
      <infon key="name_6">surname:McCulloch;given-names:AF</infon>
      <infon key="name_5">surname:Baird;given-names:DB</infon>
      <infon key="name_4">surname:Greer;given-names:GJ</infon>
      <offset>33010</offset>
      <text>Gene expression profiling of naive sheep genetically resistant and susceptible to gastrointestinal nematodes</text>
      <annotation id="378">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="33045" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="379">
        <infon key="identifier">MESH:D009349</infon>
        <infon key="type">Disease</infon>
        <location offset="33092" length="26"/>
        <text>gastrointestinal nematodes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Notter;given-names:DR</infon>
      <infon key="name_2">surname:Zajac;given-names:AM</infon>
      <infon key="name_1">surname:Burton;given-names:JL</infon>
      <infon key="name_0">surname:MacKinnon;given-names:KM</infon>
      <infon key="fpage">210</infon>
      <infon key="pub-id_doi">10.1016/j.vetimm.2009.02.013</infon>
      <infon key="pub-id_pmid">19346008</infon>
      <infon key="year">2009</infon>
      <infon key="source">Vet Immunol Immunopathol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">130</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">220</infon>
      <offset>33119</offset>
      <text>Microarray analysis reveals difference in gene expression profiles of hair and wool sheep infected with Haemonchus contortus</text>
      <annotation id="381">
        <infon key="identifier">MESH:D012757</infon>
        <infon key="type">Disease</infon>
        <location offset="33203" length="14"/>
        <text>sheep infected</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Bueno;given-names:S</infon>
      <infon key="name_2">surname:Prosperini;given-names:G</infon>
      <infon key="name_1">surname:Chillemi;given-names:G</infon>
      <infon key="name_0">surname:Bongiorni;given-names:S</infon>
      <infon key="fpage">235</infon>
      <infon key="pub-id_doi">10.3390/nu1020235</infon>
      <infon key="pub-id_pmid">22253981</infon>
      <infon key="year">2009</infon>
      <infon key="source">Nutrients</infon>
      <infon key="type">ref</infon>
      <infon key="volume">1</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">250</infon>
      <infon key="name_5">surname:Pariset;given-names:L</infon>
      <infon key="name_4">surname:Valentini;given-names:A</infon>
      <offset>33244</offset>
      <text>A tool for sheep product quality: custom microarrays from public databases</text>
      <annotation id="383">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="33255" length="5"/>
        <text>sheep</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Helbling;given-names:JC</infon>
      <infon key="name_2">surname:Bevilacqua;given-names:C</infon>
      <infon key="name_1">surname:Rebours;given-names:E</infon>
      <infon key="name_0">surname:Faucon;given-names:F</infon>
      <infon key="fpage">61</infon>
      <infon key="pub-id_doi">10.1152/physiolgenomics.00032.2009</infon>
      <infon key="pub-id_pmid">19843654</infon>
      <infon key="year">2009</infon>
      <infon key="source">Physiol Genomics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">40</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Martin;given-names:P</infon>
      <infon key="name_7">surname:Robin;given-names:S</infon>
      <infon key="lpage">82</infon>
      <infon key="name_6">surname:Dhorne-Pollet;given-names:S</infon>
      <infon key="name_5">surname:Makhzami;given-names:S</infon>
      <infon key="name_4">surname:Aubert;given-names:J</infon>
      <offset>33319</offset>
      <text>Terminal differentiation of goat mammary tissue during pregnancy requires the expression of genes involved in immune functions</text>
      <annotation id="385">
        <infon key="identifier">9925</infon>
        <infon key="type">Species</infon>
        <location offset="33347" length="4"/>
        <text>goat</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Chilliard;given-names:Y</infon>
      <infon key="name_2">surname:Bernard;given-names:L</infon>
      <infon key="name_1">surname:Robert-Granie;given-names:C</infon>
      <infon key="name_0">surname:Ollier;given-names:S</infon>
      <infon key="fpage">560</infon>
      <infon key="pub-id_pmid">17311940</infon>
      <infon key="year">2007</infon>
      <infon key="source">J Nutr</infon>
      <infon key="type">ref</infon>
      <infon key="volume">137</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">567</infon>
      <infon key="name_4">surname:Leroux;given-names:C</infon>
      <offset>33446</offset>
      <text>Mammary transcriptome analysis of food-deprived lactating goats highlights genes involved in milk secretion and programmed cell death</text>
      <annotation id="387">
        <infon key="identifier">9925</infon>
        <infon key="type">Species</infon>
        <location offset="33504" length="5"/>
        <text>goats</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Cam;given-names:GR</infon>
      <infon key="name_2">surname:Smith;given-names:WJ</infon>
      <infon key="name_1">surname:Bower;given-names:NI</infon>
      <infon key="name_0">surname:Norris;given-names:BJ</infon>
      <infon key="fpage">867</infon>
      <infon key="pub-id_doi">10.1071/EA05050</infon>
      <infon key="year">2005</infon>
      <infon key="source">Aust J Exp Agr</infon>
      <infon key="type">ref</infon>
      <infon key="volume">45</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">877</infon>
      <infon key="name_4">surname:Reverter;given-names:A</infon>
      <offset>33580</offset>
      <text>Gene expression profiling of ovine skin and wool follicle development using a combined ovine-bovine skin cDNA microarray</text>
      <annotation id="389">
        <infon key="identifier">9913</infon>
        <infon key="type">Species</infon>
        <location offset="33673" length="6"/>
        <text>bovine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Collis;given-names:E</infon>
      <infon key="name_2">surname:Ingham;given-names:A</infon>
      <infon key="name_1">surname:Li;given-names:Y</infon>
      <infon key="name_0">surname:Smith;given-names:WJ</infon>
      <infon key="fpage">27</infon>
      <infon key="pub-id_doi">10.1186/1746-6148-6-27</infon>
      <infon key="pub-id_pmid">20500888</infon>
      <infon key="year">2010</infon>
      <infon key="source">BMC Vet Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">6</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Reverter;given-names:A</infon>
      <infon key="name_8">surname:Moore;given-names:RJ</infon>
      <infon key="name_7">surname:Mortimer;given-names:SI</infon>
      <infon key="name_6">surname:Norris;given-names:BJ</infon>
      <infon key="name_5">surname:Dixon;given-names:TJ</infon>
      <infon key="name_4">surname:McWilliam;given-names:SM</infon>
      <offset>33701</offset>
      <text>A genomics-informed, SNP association study reveals FBLN1 and FABP4 as contributing to resistance to fleece rot in Australian Merino sheep</text>
      <annotation id="392">
        <infon key="identifier">100037704</infon>
        <infon key="type">Gene</infon>
        <location offset="33752" length="5"/>
        <text>FBLN1</text>
      </annotation>
      <annotation id="393">
        <infon key="identifier">100137067</infon>
        <infon key="type">Gene</infon>
        <location offset="33762" length="5"/>
        <text>FABP4</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Robello;given-names:C</infon>
      <infon key="name_2">surname:Naya;given-names:H</infon>
      <infon key="name_1">surname:Zorrilla;given-names:P</infon>
      <infon key="name_0">surname:Penagaricano;given-names:F</infon>
      <infon key="fpage">99</infon>
      <infon key="pub-id_doi">10.1007/s13353-011-0066-9</infon>
      <infon key="pub-id_pmid">21952730</infon>
      <infon key="year">2012</infon>
      <infon key="source">J Appl Genet</infon>
      <infon key="type">ref</infon>
      <infon key="volume">53</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">106</infon>
      <infon key="name_4">surname:Urioste;given-names:JI</infon>
      <offset>33839</offset>
      <text>Gene expression analysis identifies new candidate genes associated with the development of black skin spots in Corriedale sheep</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Yashizawa;given-names:M</infon>
      <infon key="name_2">surname:Jinquan;given-names:L</infon>
      <infon key="name_1">surname:Jianghong;given-names:W</infon>
      <infon key="name_0">surname:Wenguang;given-names:Z</infon>
      <infon key="fpage">385</infon>
      <infon key="pub-id_doi">10.1089/omi.2006.0031</infon>
      <infon key="pub-id_pmid">18092910</infon>
      <infon key="year">2007</infon>
      <infon key="source">OMICS</infon>
      <infon key="type">ref</infon>
      <infon key="volume">11</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">396</infon>
      <offset>33967</offset>
      <text>A subset of skin-expressed microRNAs with possible roles in goat and sheep hair growth based on expression profiling of mammalian microRNAs</text>
      <annotation id="397">
        <infon key="identifier">9925</infon>
        <infon key="type">Species</infon>
        <location offset="34027" length="4"/>
        <text>goat</text>
      </annotation>
      <annotation id="398">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="34087" length="9"/>
        <text>mammalian</text>
      </annotation>
      <annotation id="399">
        <infon key="identifier">MESH:D012757</infon>
        <infon key="type">Disease</infon>
        <location offset="34036" length="17"/>
        <text>sheep hair growth</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Nixon;given-names:AJ</infon>
      <infon key="name_2">surname:Henderson;given-names:HV</infon>
      <infon key="name_1">surname:Bawden;given-names:CS</infon>
      <infon key="name_0">surname:Yu;given-names:Z-D</infon>
      <infon key="fpage">129</infon>
      <infon key="year">2006</infon>
      <infon key="source">Proc New Zeal SocAnimal Prod</infon>
      <infon key="type">ref</infon>
      <infon key="volume">66</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">133</infon>
      <infon key="name_5">surname:Pearson;given-names:AJ</infon>
      <infon key="name_4">surname:Gordon;given-names:SW</infon>
      <offset>34107</offset>
      <text>Micro-arrays as a discovery tool for wool genomics</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Henderson;given-names:HV</infon>
      <infon key="name_2">surname:Pearson;given-names:AJ</infon>
      <infon key="name_1">surname:Gordon;given-names:SW</infon>
      <infon key="name_0">surname:Yu;given-names:Z-D</infon>
      <infon key="fpage">39</infon>
      <infon key="year">2008</infon>
      <infon key="source">Proc New Zeal SocAnimal Prod</infon>
      <infon key="type">ref</infon>
      <infon key="volume">68</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">42</infon>
      <infon key="name_5">surname:Nixon;given-names:AJ</infon>
      <infon key="name_4">surname:Craven;given-names:AJ</infon>
      <offset>34158</offset>
      <text>Gene expression profiling of wool follicle growth cycles by cDNA microarray</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>34234</offset>
      <text>Liu N, Li H, Liu K, Yu J, Cheng M, De W, Liu J, Shi S, He Y, Zhao J: Differential expression of genes and proteins associated with wool follicle cycling.Mol Biol Rep 2014, published online in advance of the print edition.</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Talbot;given-names:R</infon>
      <infon key="name_2">surname:Chen;given-names:W</infon>
      <infon key="name_1">surname:Xie;given-names:M</infon>
      <infon key="name_0">surname:Jiang;given-names:Y</infon>
      <infon key="pub-id_doi">10.1126/science.1252806</infon>
      <infon key="pub-id_pmid">24904168</infon>
      <infon key="year">2014</infon>
      <infon key="source">Science</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Cheng;given-names:S</infon>
      <infon key="name_21">surname:DeSilva;given-names:U</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_24">surname:Fan;given-names:G</infon>
      <infon key="name_25">surname:Franklin;given-names:IR</infon>
      <infon key="name_22">surname:Dixen;given-names:K</infon>
      <infon key="name_23">surname:Dong;given-names:Y</infon>
      <infon key="name_28">surname:Guan;given-names:R</infon>
      <infon key="name_29">surname:Highland;given-names:MA</infon>
      <infon key="name_26">surname:Fu;given-names:S</infon>
      <infon key="name_27">surname:Fuentes-Utrilla;given-names:P</infon>
      <infon key="lpage">1173</infon>
      <infon key="fpage">1168</infon>
      <infon key="issue">6188</infon>
      <infon key="volume">344</infon>
      <infon key="name_10">surname:Stanton;given-names:JA</infon>
      <infon key="name_13">surname:Hourlier;given-names:T</infon>
      <infon key="name_14">surname:Aken;given-names:BL</infon>
      <infon key="name_11">surname:Brauning;given-names:R</infon>
      <infon key="name_12">surname:Barris;given-names:WC</infon>
      <infon key="name_17">surname:Bian;given-names:C</infon>
      <infon key="name_18">surname:Cam;given-names:GR</infon>
      <infon key="name_15">surname:Searle;given-names:SM</infon>
      <infon key="name_9">surname:Zhang;given-names:W</infon>
      <infon key="name_16">surname:Adelson;given-names:DL</infon>
      <infon key="name_8">surname:Li;given-names:Y</infon>
      <infon key="name_7">surname:Muzny;given-names:DM</infon>
      <infon key="name_6">surname:Wu;given-names:C</infon>
      <infon key="name_19">surname:Chen;given-names:Y</infon>
      <infon key="name_5">surname:Faraut;given-names:T</infon>
      <infon key="name_4">surname:Maddox;given-names:JF</infon>
      <offset>34456</offset>
      <text>The sheep genome illuminates biology of the rumen and lipid metabolism</text>
      <annotation id="402">
        <infon key="identifier">9940</infon>
        <infon key="type">Species</infon>
        <location offset="34460" length="5"/>
        <text>sheep</text>
      </annotation>
      <annotation id="403">
        <infon key="identifier">MESH:D008055</infon>
        <infon key="type">Chemical</infon>
        <location offset="34510" length="5"/>
        <text>lipid</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ren;given-names:JK</infon>
      <infon key="volume">3</infon>
      <infon key="name_2">surname:Du;given-names:M</infon>
      <infon key="name_1">surname:Feng;given-names:ZC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Wang;given-names:HR</infon>
      <infon key="fpage">1</infon>
      <infon key="year">1994</infon>
      <infon key="source">Inner Mongolia Animal Sci</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">3</infon>
      <infon key="name_4">surname:Li;given-names:HR</infon>
      <offset>34527</offset>
      <text>Initial research for seasonal variation of wool growth of Aohan fine wool sheep</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Cheng;given-names:M</infon>
      <infon key="name_2">surname:Zhao;given-names:JS</infon>
      <infon key="name_1">surname:Liu;given-names:JF</infon>
      <infon key="name_0">surname:Yu;given-names:JJ</infon>
      <infon key="fpage">1171</infon>
      <infon key="year">2012</infon>
      <infon key="source">Agr Scie Technol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">13</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1174</infon>
      <infon key="name_5">surname:Liu;given-names:N</infon>
      <infon key="name_4">surname:Liu;given-names:KD</infon>
      <offset>34607</offset>
      <text>Gene chip analysis of expression pattern of type I Inner Root Sheath (IRS) keratin in AoHan wool sheep</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Liu;given-names:N</infon>
      <infon key="volume">13</infon>
      <infon key="name_2">surname:Liu;given-names:KD</infon>
      <infon key="name_1">surname:Li;given-names:HG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Zhao;given-names:JS</infon>
      <infon key="fpage">2475</infon>
      <infon key="year">2012</infon>
      <infon key="source">Agr Scie Technol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2479</infon>
      <infon key="name_4">surname:Li;given-names:JQ</infon>
      <offset>34710</offset>
      <text>Differential expression of immune genes between body side skin and groin skin of Aohan fine wool sheep</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Sinclair;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McElwee;given-names:KJ</infon>
      <infon key="fpage">e163</infon>
      <infon key="year">2008</infon>
      <infon key="source">Hair Physiology and its Disorders. Drug Discovery Today: Disease Mechanisms</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">e171</infon>
      <offset>34813</offset>
    </passage>
    <passage>
      <infon key="volume">124</infon>
      <infon key="name_1">surname:Komi-Kuramochi;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kawano;given-names:M</infon>
      <infon key="fpage">877</infon>
      <infon key="pub-id_doi">10.1111/j.0022-202X.2005.23693.x</infon>
      <infon key="pub-id_pmid">15854025</infon>
      <infon key="year">2005</infon>
      <infon key="source">J Invest Dermatol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">885</infon>
      <offset>34814</offset>
      <text>Comprehensive analysis of FGF and FGFR expression in skin</text>
    </passage>
    <passage>
      <infon key="volume">81</infon>
      <infon key="name_1">surname:Paus;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Stenn;given-names:KS</infon>
      <infon key="fpage">449</infon>
      <infon key="pub-id_pmid">11152763</infon>
      <infon key="year">2001</infon>
      <infon key="source">Physiol Rev</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">494</infon>
      <offset>34872</offset>
      <text>Controls of hair follicle cycling</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Paton;given-names:CM</infon>
      <infon key="name_2">surname:Liu;given-names:X</infon>
      <infon key="name_1">surname:Flowers;given-names:MT</infon>
      <infon key="name_0">surname:Sampath;given-names:H</infon>
      <infon key="fpage">19961</infon>
      <infon key="pub-id_doi">10.1074/jbc.M109.014225</infon>
      <infon key="pub-id_pmid">19429677</infon>
      <infon key="year">2009</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="type">ref</infon>
      <infon key="volume">284</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Ntambi;given-names:JM</infon>
      <infon key="lpage">19973</infon>
      <infon key="name_6">surname:Zhao;given-names:M</infon>
      <infon key="name_5">surname:Chu;given-names:K</infon>
      <infon key="name_4">surname:Sullivan;given-names:R</infon>
      <offset>34906</offset>
      <text>Skin-specific deletion of stearoyl-CoA desaturase-1 alters skin lipid composition and protects mice from high fat diet-induced obesity</text>
      <annotation id="408">
        <infon key="identifier">20249</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">74538</infon>
        <location offset="34932" length="25"/>
        <text>stearoyl-CoA desaturase-1</text>
      </annotation>
      <annotation id="409">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="35001" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="410">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="35033" length="7"/>
        <text>obesity</text>
      </annotation>
      <annotation id="411">
        <infon key="identifier">MESH:D008055</infon>
        <infon key="type">Chemical</infon>
        <location offset="34970" length="5"/>
        <text>lipid</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">114</infon>
      <infon key="name_2">surname:Eisen;given-names:AZ</infon>
      <infon key="name_1">surname:Bannikov;given-names:GA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Karelina;given-names:TV</infon>
      <infon key="fpage">371</infon>
      <infon key="pub-id_doi">10.1046/j.1523-1747.2000.00886.x</infon>
      <infon key="pub-id_pmid">10652000</infon>
      <infon key="year">2000</infon>
      <infon key="source">J Invest Dermatol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">375</infon>
      <offset>35041</offset>
      <text>Basement membrane zone remodeling during appendageal development in human fetal skin: the absence of type VII collagen is associated with gelatinase-A (MMP2) activity</text>
      <annotation id="414">
        <infon key="identifier">4313</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3329</infon>
        <location offset="35193" length="4"/>
        <text>MMP2</text>
      </annotation>
      <annotation id="415">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="35109" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:St-Surin;given-names:S</infon>
      <infon key="name_2">surname:Scheremeta;given-names:B</infon>
      <infon key="name_1">surname:Nguyen;given-names:M</infon>
      <infon key="name_0">surname:Philp;given-names:D</infon>
      <infon key="fpage">385</infon>
      <infon key="pub-id_pmid">14657002</infon>
      <infon key="year">2004</infon>
      <infon key="source">FASEB J</infon>
      <infon key="type">ref</infon>
      <infon key="volume">18</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Elkin;given-names:M</infon>
      <infon key="lpage">387</infon>
      <infon key="name_6">surname:Kleinman;given-names:HK</infon>
      <infon key="name_5">surname:Orgel;given-names:A</infon>
      <infon key="name_4">surname:Villa;given-names:AM</infon>
      <offset>35208</offset>
      <text>Thymosin beta4 increases hair growth by activation of hair follicle stem cells</text>
      <annotation id="418">
        <infon key="identifier">101106384</infon>
        <infon key="type">Gene</infon>
        <location offset="35208" length="14"/>
        <text>Thymosin beta4</text>
      </annotation>
      <annotation id="419">
        <infon key="identifier">MESH:D006130</infon>
        <infon key="type">Disease</infon>
        <location offset="35223" length="21"/>
        <text>increases hair growth</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">73</infon>
      <infon key="name_1">surname:Watt;given-names:FM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Jones;given-names:PH</infon>
      <infon key="fpage">713</infon>
      <infon key="pub-id_doi">10.1016/0092-8674(93)90251-K</infon>
      <infon key="pub-id_pmid">8500165</infon>
      <infon key="year">1993</infon>
      <infon key="source">Cell</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">724</infon>
      <offset>35287</offset>
      <text>Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression</text>
      <annotation id="421">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="35301" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Tiede;given-names:S</infon>
      <infon key="name_2">surname:Bodo;given-names:E</infon>
      <infon key="name_1">surname:Hendrix;given-names:S</infon>
      <infon key="name_0">surname:Kloepper;given-names:JE</infon>
      <infon key="fpage">498</infon>
      <infon key="pub-id_doi">10.1016/j.yexcr.2007.10.030</infon>
      <infon key="pub-id_pmid">18155697</infon>
      <infon key="year">2008</infon>
      <infon key="source">Exp Cell Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">314</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Paus;given-names:R</infon>
      <infon key="lpage">508</infon>
      <infon key="name_6">surname:Fassler;given-names:R</infon>
      <infon key="name_5">surname:Philpott;given-names:MP</infon>
      <infon key="name_4">surname:Humphries;given-names:MJ</infon>
      <offset>35422</offset>
      <text>Functional role of beta 1 integrin-mediated signalling in the human hair follicle</text>
      <annotation id="424">
        <infon key="identifier">3688</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">22999</infon>
        <location offset="35441" length="15"/>
        <text>beta 1 integrin</text>
      </annotation>
      <annotation id="425">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="35484" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ramirez;given-names:A</infon>
      <infon key="name_2">surname:Quondamatteo;given-names:F</infon>
      <infon key="name_1">surname:Grose;given-names:R</infon>
      <infon key="name_0">surname:Brakebusch;given-names:C</infon>
      <infon key="fpage">3990</infon>
      <infon key="pub-id_doi">10.1093/emboj/19.15.3990</infon>
      <infon key="pub-id_pmid">10921880</infon>
      <infon key="year">2000</infon>
      <infon key="source">EMBO J</infon>
      <infon key="type">ref</infon>
      <infon key="volume">19</infon>
      <infon key="name_10">surname:Werner;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Fassler;given-names:R</infon>
      <infon key="name_9">surname:Timpl;given-names:R</infon>
      <infon key="name_8">surname:Sasaki;given-names:T</infon>
      <infon key="name_7">surname:Herken;given-names:R</infon>
      <infon key="lpage">4003</infon>
      <infon key="name_6">surname:Svensson;given-names:M</infon>
      <infon key="name_5">surname:Pirro;given-names:A</infon>
      <infon key="name_4">surname:Jorcano;given-names:JL</infon>
      <offset>35504</offset>
      <text>Skin and hair follicle integrity is crucially dependent on beta 1 integrin expression on keratinocytes</text>
      <annotation id="427">
        <infon key="identifier">3688</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">22999</infon>
        <location offset="35563" length="15"/>
        <text>beta 1 integrin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Wolf;given-names:CR</infon>
      <infon key="name_2">surname:Pena;given-names:RN</infon>
      <infon key="name_1">surname:Welsh;given-names:C</infon>
      <infon key="name_0">surname:Rowe;given-names:JM</infon>
      <infon key="fpage">1866</infon>
      <infon key="pub-id_doi">10.1038/sj.jid.5701236</infon>
      <infon key="pub-id_pmid">18185528</infon>
      <infon key="year">2008</infon>
      <infon key="source">J Invest Dermatol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">128</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1868</infon>
      <infon key="name_5">surname:Whitelaw;given-names:CB</infon>
      <infon key="name_4">surname:Brown;given-names:K</infon>
      <offset>35607</offset>
      <text>Illuminating role of CYP1A1 in skin function</text>
      <annotation id="429">
        <infon key="identifier">100170113</infon>
        <infon key="type">Gene</infon>
        <location offset="35628" length="6"/>
        <text>CYP1A1</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hirano;given-names:T</infon>
      <infon key="name_2">surname:Yamashita;given-names:M</infon>
      <infon key="name_1">surname:Yokoyama;given-names:M</infon>
      <infon key="name_0">surname:Ryu;given-names:K</infon>
      <infon key="fpage">157</infon>
      <infon key="pub-id_doi">10.1016/j.bbrc.2011.11.075</infon>
      <infon key="pub-id_pmid">22138648</infon>
      <infon key="year">2012</infon>
      <infon key="source">Biochem Biophys Res Commun</infon>
      <infon key="type">ref</infon>
      <infon key="volume">417</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">161</infon>
      <offset>35652</offset>
      <text>Induction of excitatory and inhibitory presynaptic differentiation by GluD1</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Ayres;given-names:M</infon>
      <infon key="name_2">surname:Ao;given-names:N</infon>
      <infon key="name_1">surname:Hawrylycz;given-names:MJ</infon>
      <infon key="name_0">surname:Lein;given-names:ES</infon>
      <infon key="pub-id_doi">10.1038/nature05453</infon>
      <infon key="pub-id_pmid">17151600</infon>
      <infon key="year">2007</infon>
      <infon key="source">Nature</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Desta;given-names:T</infon>
      <infon key="name_21">surname:Diep;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_24">surname:Dong;given-names:HW</infon>
      <infon key="name_25">surname:Dougherty;given-names:JG</infon>
      <infon key="name_22">surname:Dolbeare;given-names:TA</infon>
      <infon key="name_23">surname:Donelan;given-names:MJ</infon>
      <infon key="name_28">surname:Eichele;given-names:G</infon>
      <infon key="name_29">surname:Estin;given-names:LK</infon>
      <infon key="name_26">surname:Duncan;given-names:BJ</infon>
      <infon key="name_27">surname:Ebbert;given-names:AJ</infon>
      <infon key="lpage">176</infon>
      <infon key="fpage">168</infon>
      <infon key="volume">445</infon>
      <infon key="name_10">surname:Chen;given-names:L</infon>
      <infon key="name_13">surname:Chong;given-names:J</infon>
      <infon key="name_14">surname:Crook;given-names:BE</infon>
      <infon key="name_11">surname:Chen;given-names:TM</infon>
      <infon key="name_12">surname:Chin;given-names:MC</infon>
      <infon key="name_17">surname:Datta;given-names:S</infon>
      <infon key="name_18">surname:Dee;given-names:NR</infon>
      <infon key="name_15">surname:Czaplinska;given-names:A</infon>
      <infon key="name_9">surname:Byrnes;given-names:EJ</infon>
      <infon key="name_16">surname:Dang;given-names:CN</infon>
      <infon key="name_8">surname:Brockway;given-names:KS</infon>
      <infon key="name_7">surname:Boguski;given-names:MS</infon>
      <infon key="name_6">surname:Boe;given-names:AF</infon>
      <infon key="name_19">surname:Desaki;given-names:AL</infon>
      <infon key="name_5">surname:Bernard;given-names:A</infon>
      <infon key="name_4">surname:Bensinger;given-names:A</infon>
      <offset>35728</offset>
      <text>Genome-wide atlas of gene expression in the adult mouse brain</text>
      <annotation id="431">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="35778" length="5"/>
        <text>mouse</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Seal;given-names:A</infon>
      <infon key="name_2">surname:Brumwell;given-names:CL</infon>
      <infon key="name_1">surname:Jensen;given-names:P</infon>
      <infon key="name_0">surname:Magdaleno;given-names:S</infon>
      <infon key="fpage">e86</infon>
      <infon key="pub-id_doi">10.1371/journal.pbio.0040086</infon>
      <infon key="pub-id_pmid">16602821</infon>
      <infon key="year">2006</infon>
      <infon key="source">PLoS Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">4</infon>
      <infon key="name_10">surname:Norland;given-names:SM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:Shakya;given-names:S</infon>
      <infon key="name_14">surname:Mehta;given-names:P</infon>
      <infon key="name_11">surname:Rice;given-names:DS</infon>
      <infon key="name_12">surname:Dosooye;given-names:N</infon>
      <infon key="name_15">surname:Curran;given-names:T</infon>
      <infon key="name_9">surname:Eden;given-names:C</infon>
      <infon key="name_8">surname:Batten;given-names:DM</infon>
      <infon key="name_7">surname:Cornelius;given-names:T</infon>
      <infon key="name_6">surname:Cheung;given-names:T</infon>
      <infon key="name_5">surname:Asbury;given-names:A</infon>
      <infon key="name_4">surname:Lehman;given-names:K</infon>
      <offset>35790</offset>
      <text>BGEM: an in situ hybridization database of gene expression in the embryonic and adult mouse nervous system</text>
      <annotation id="434">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="35876" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="435">
        <infon key="identifier">MESH:D009373</infon>
        <infon key="type">Disease</infon>
        <location offset="35856" length="9"/>
        <text>embryonic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Westgate;given-names:GE</infon>
      <infon key="name_2">surname:Ferdinando;given-names:D</infon>
      <infon key="name_1">surname:Richardson;given-names:GD</infon>
      <infon key="name_0">surname:Higgins;given-names:CA</infon>
      <infon key="fpage">546</infon>
      <infon key="pub-id_doi">10.1111/j.1600-0625.2009.01007.x</infon>
      <infon key="pub-id_pmid">20456497</infon>
      <infon key="year">2010</infon>
      <infon key="source">Exp Dermatol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">19</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">548</infon>
      <infon key="name_4">surname:Jahoda;given-names:CA</infon>
      <offset>35897</offset>
      <text>Modelling the hair follicle dermal papilla using spheroid cell cultures</text>
      <annotation id="437">
        <infon key="identifier">MESH:D010211</infon>
        <infon key="type">Disease</infon>
        <location offset="35897" length="42"/>
        <text>Modelling the hair follicle dermal papilla</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Laird;given-names:DW</infon>
      <infon key="name_2">surname:Shao;given-names:Q</infon>
      <infon key="name_1">surname:Chan;given-names:J</infon>
      <infon key="name_0">surname:Churko;given-names:JM</infon>
      <infon key="fpage">2197</infon>
      <infon key="pub-id_doi">10.1038/jid.2011.183</infon>
      <infon key="pub-id_pmid">21716323</infon>
      <infon key="year">2011</infon>
      <infon key="source">J Invest Dermatol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">131</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">2204</infon>
      <offset>35969</offset>
      <text>The G60S connexin43 mutant regulates hair growth and hair fiber morphology in a mouse model of human oculodentodigital dysplasia</text>
      <annotation id="444">
        <infon key="identifier">14609</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">136</infon>
        <location offset="35978" length="10"/>
        <text>connexin43</text>
      </annotation>
      <annotation id="445">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="36049" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="446">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="36064" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="447">
        <infon key="identifier">p.G60S</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="35973" length="4"/>
        <text>G60S</text>
      </annotation>
      <annotation id="448">
        <infon key="identifier">MESH:D006201</infon>
        <infon key="type">Disease</infon>
        <location offset="36006" length="37"/>
        <text>hair growth and hair fiber morphology</text>
      </annotation>
      <annotation id="449">
        <infon key="identifier">MESH:C563160</infon>
        <infon key="type">Disease</infon>
        <location offset="36070" length="27"/>
        <text>oculodentodigital dysplasia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Bernard;given-names:BA</infon>
      <infon key="name_2">surname:Michelet;given-names:JF</infon>
      <infon key="name_1">surname:Vindrios;given-names:A</infon>
      <infon key="name_0">surname:Colombe;given-names:L</infon>
      <infon key="fpage">762</infon>
      <infon key="pub-id_doi">10.1111/j.1600-0625.2007.00586.x</infon>
      <infon key="pub-id_pmid">17697149</infon>
      <infon key="year">2007</infon>
      <infon key="source">Exp Dermatol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">16</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">769</infon>
      <offset>36098</offset>
      <text>Prostaglandin metabolism in human hair follicle</text>
      <annotation id="452">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="36126" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="453">
        <infon key="identifier">MESH:D011453</infon>
        <infon key="type">Chemical</infon>
        <location offset="36098" length="13"/>
        <text>Prostaglandin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">47</infon>
      <infon key="name_1">surname:Albert;given-names:DM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Johnstone;given-names:MA</infon>
      <infon key="fpage">S185</infon>
      <infon key="issue">S1</infon>
      <infon key="pub-id_doi">10.1016/S0039-6257(02)00307-7</infon>
      <infon key="pub-id_pmid">12204716</infon>
      <infon key="year">2002</infon>
      <infon key="source">Surv Ophthalmol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">S202</infon>
      <offset>36146</offset>
      <text>Prostaglandin-induced hair growth</text>
      <annotation id="455">
        <infon key="identifier">MESH:D011453</infon>
        <infon key="type">Chemical</infon>
        <location offset="36146" length="13"/>
        <text>Prostaglandin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">10</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Umeda-Ikawa;given-names:A</infon>
      <infon key="fpage">1967</infon>
      <infon key="pub-id_doi">10.3390/ijms10051967</infon>
      <infon key="pub-id_pmid">19564932</infon>
      <infon key="year">2009</infon>
      <infon key="source">Int J Mol Sci</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1977</infon>
      <offset>36180</offset>
      <text>Time-course expression profiles of hair cycle-associated genes in male mini rats after depilation of telogen-phase hairs</text>
      <annotation id="457">
        <infon key="identifier">10116</infon>
        <infon key="type">Species</infon>
        <location offset="36256" length="4"/>
        <text>rats</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">102</infon>
      <infon key="name_1">surname:Beltrame;given-names:JS</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Powell;given-names:BC</infon>
      <infon key="fpage">171</infon>
      <infon key="pub-id_doi">10.1111/1523-1747.ep12371758</infon>
      <infon key="pub-id_pmid">7508962</infon>
      <infon key="year">1994</infon>
      <infon key="source">J Invest Dermatol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">177</infon>
      <offset>36301</offset>
      <text>Characterization of a hair (wool) keratin intermediate filament gene domain</text>
      <annotation id="459">
        <infon key="identifier">100141298</infon>
        <infon key="type">Gene</infon>
        <location offset="36335" length="29"/>
        <text>keratin intermediate filament</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Bawden;given-names:CS</infon>
      <infon key="name_2">surname:Nixon;given-names:AJ</infon>
      <infon key="name_1">surname:Gordon;given-names:SW</infon>
      <infon key="name_0">surname:Yu;given-names:Z</infon>
      <infon key="fpage">307</infon>
      <infon key="pub-id_doi">10.1016/j.diff.2008.10.009</infon>
      <infon key="pub-id_pmid">19272529</infon>
      <infon key="year">2009</infon>
      <infon key="source">Differentiation</infon>
      <infon key="type">ref</infon>
      <infon key="volume">77</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Pearson;given-names:AJ</infon>
      <infon key="lpage">316</infon>
      <infon key="name_6">surname:Maqbool;given-names:NJ</infon>
      <infon key="name_5">surname:Wildermoth;given-names:JE</infon>
      <infon key="name_4">surname:Rogers;given-names:MA</infon>
      <offset>36377</offset>
      <text>Expression patterns of keratin intermediate filament and keratin associated protein genes in wool follicles</text>
      <annotation id="461">
        <infon key="identifier">100141298</infon>
        <infon key="type">Gene</infon>
        <location offset="36400" length="29"/>
        <text>keratin intermediate filament</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Kumarasinghe;given-names:P</infon>
      <infon key="name_2">surname:Gan;given-names:WH</infon>
      <infon key="name_1">surname:Common;given-names:JE</infon>
      <infon key="name_0">surname:Goh;given-names:BK</infon>
      <infon key="fpage">340</infon>
      <infon key="pub-id_doi">10.1111/j.1365-2230.2008.02950.x</infon>
      <infon key="pub-id_pmid">19040520</infon>
      <infon key="year">2009</infon>
      <infon key="source">Clin Exp Dermatol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">34</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">343</infon>
      <offset>36485</offset>
      <text>A case of dermatopathia pigmentosa reticularis with wiry scalp hair and digital fibromatosis resulting from a recurrent KRT14 mutation</text>
      <annotation id="465">
        <infon key="identifier">100303604</infon>
        <infon key="type">Gene</infon>
        <location offset="36605" length="5"/>
        <text>KRT14</text>
      </annotation>
      <annotation id="466">
        <infon key="identifier">MESH:C563765</infon>
        <infon key="type">Disease</infon>
        <location offset="36537" length="40"/>
        <text>wiry scalp hair and digital fibromatosis</text>
      </annotation>
      <annotation id="467">
        <infon key="identifier">MESH:C535374</infon>
        <infon key="type">Disease</infon>
        <location offset="36495" length="36"/>
        <text>dermatopathia pigmentosa reticularis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Holland;given-names:K</infon>
      <infon key="name_2">surname:Ishida-Yamamoto;given-names:A</infon>
      <infon key="name_1">surname:Itin;given-names:P</infon>
      <infon key="name_0">surname:Lugassy;given-names:J</infon>
      <infon key="fpage">724</infon>
      <infon key="pub-id_doi">10.1086/507792</infon>
      <infon key="pub-id_pmid">16960809</infon>
      <infon key="year">2006</infon>
      <infon key="source">Am J Hum Genet</infon>
      <infon key="type">ref</infon>
      <infon key="volume">79</infon>
      <infon key="name_10">surname:Bergman;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:Sprecher;given-names:E</infon>
      <infon key="name_11">surname:McGrath;given-names:JA</infon>
      <infon key="name_12">surname:Richard;given-names:G</infon>
      <infon key="name_9">surname:Jouni;given-names:U</infon>
      <infon key="name_8">surname:Dani;given-names:B</infon>
      <infon key="name_7">surname:Margarita;given-names:I</infon>
      <infon key="lpage">730</infon>
      <infon key="name_6">surname:Hennies;given-names:HC</infon>
      <infon key="name_5">surname:Geiger;given-names:D</infon>
      <infon key="name_4">surname:Huson;given-names:S</infon>
      <offset>36620</offset>
      <text>Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis: two allelic ectodermal dysplasias caused by dominant mutations in KRT14</text>
      <annotation id="471">
        <infon key="identifier">MESH:C538331</infon>
        <infon key="type">Disease</infon>
        <location offset="36620" length="40"/>
        <text>Naegeli-Franceschetti-Jadassohn syndrome</text>
      </annotation>
      <annotation id="472">
        <infon key="identifier">MESH:D004476</infon>
        <infon key="type">Disease</infon>
        <location offset="36707" length="29"/>
        <text>allelic ectodermal dysplasias</text>
      </annotation>
      <annotation id="473">
        <infon key="identifier">MESH:C535374</infon>
        <infon key="type">Disease</infon>
        <location offset="36665" length="36"/>
        <text>dermatopathia pigmentosa reticularis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Lynch;given-names:PJ</infon>
      <infon key="volume">17</infon>
      <infon key="name_2">surname:Kaye;given-names:V</infon>
      <infon key="name_1">surname:Parkinson;given-names:KE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Horner;given-names:ME</infon>
      <infon key="fpage">1</infon>
      <infon key="pub-id_pmid">21810386</infon>
      <infon key="year">2011</infon>
      <infon key="source">Dermatol Online J</infon>
      <infon key="type">ref</infon>
      <offset>36775</offset>
      <text>Dowling-Degos disease involving the vulva and back: case report and review of the literature</text>
      <annotation id="475">
        <infon key="identifier">MESH:C562924</infon>
        <infon key="type">Disease</infon>
        <location offset="36775" length="21"/>
        <text>Dowling-Degos disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Kleinert;given-names:P</infon>
      <infon key="name_2">surname:Troxler;given-names:H</infon>
      <infon key="name_1">surname:Takahara;given-names:H</infon>
      <infon key="name_0">surname:Kizawa;given-names:K</infon>
      <infon key="fpage">5004</infon>
      <infon key="pub-id_doi">10.1074/jbc.M709357200</infon>
      <infon key="pub-id_pmid">18083705</infon>
      <infon key="year">2008</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="type">ref</infon>
      <infon key="volume">283</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">5013</infon>
      <infon key="name_5">surname:Heizmann;given-names:CW</infon>
      <infon key="name_4">surname:Mochida;given-names:U</infon>
      <offset>36868</offset>
      <text>Specific citrullination causes assembly of a globular S100A3 homotetramer: a putative Ca2+ modulator matures human hair cuticle</text>
      <annotation id="479">
        <infon key="identifier">6274</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">2223</infon>
        <location offset="36922" length="6"/>
        <text>S100A3</text>
      </annotation>
      <annotation id="480">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="36977" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="481">
        <infon key="identifier">MESH:D000069285</infon>
        <infon key="type">Chemical</infon>
        <location offset="36954" length="4"/>
        <text>Ca2+</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Schulte;given-names:K</infon>
      <infon key="name_2">surname:Wirths;given-names:C</infon>
      <infon key="name_1">surname:Huber;given-names:O</infon>
      <infon key="name_0">surname:Lueking;given-names:A</infon>
      <infon key="fpage">1382</infon>
      <infon key="pub-id_doi">10.1074/mcp.T500004-MCP200</infon>
      <infon key="pub-id_pmid">15939964</infon>
      <infon key="year">2005</infon>
      <infon key="source">Mol Cell Proteomics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">4</infon>
      <infon key="name_10">surname:Meyer;given-names:HE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Cahill;given-names:DJ</infon>
      <infon key="name_9">surname:Lehrach;given-names:H</infon>
      <infon key="name_8">surname:Tauber;given-names:R</infon>
      <infon key="name_7">surname:Hensel-Wiegel;given-names:K</infon>
      <infon key="lpage">1390</infon>
      <infon key="name_6">surname:Kowald;given-names:A</infon>
      <infon key="name_5">surname:Blume-Peytavi;given-names:U</infon>
      <infon key="name_4">surname:Stieler;given-names:KM</infon>
      <offset>36996</offset>
      <text>Profiling of alopecia areata autoantigens based on protein microarray technology</text>
    </passage>
    <passage>
      <infon key="volume">205</infon>
      <infon key="name_1">surname:Martin;given-names:GR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rosenquist;given-names:TA</infon>
      <infon key="fpage">379</infon>
      <infon key="pub-id_doi">10.1002/(SICI)1097-0177(199604)205:4&lt;379::AID-AJA2&gt;3.0.CO;2-F</infon>
      <infon key="pub-id_pmid">8901049</infon>
      <infon key="year">1996</infon>
      <infon key="source">Dev Dyn</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">386</infon>
      <offset>37077</offset>
      <text>Fibroblast growth factor signalling in the hair growth cycle: expression of the fibroblast growth factor receptor and ligand genes in the murine hair follicle</text>
      <annotation id="483">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="37215" length="6"/>
        <text>murine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Fujii;given-names:T</infon>
      <infon key="name_2">surname:Gao;given-names:Y</infon>
      <infon key="name_1">surname:Dracheva;given-names:T</infon>
      <infon key="name_0">surname:Nacht;given-names:M</infon>
      <infon key="pub-id_doi">10.1073/pnas.261414598</infon>
      <infon key="pub-id_pmid">11752463</infon>
      <infon key="year">2001</infon>
      <infon key="source">Proc Natl Acad Sci U S A</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">15208</infon>
      <infon key="fpage">15203</infon>
      <infon key="volume">98</infon>
      <infon key="name_10">surname:Zhang;given-names:W</infon>
      <infon key="name_13">surname:Han;given-names:S</infon>
      <infon key="name_14">surname:Sidransky;given-names:D</infon>
      <infon key="name_11">surname:Guo;given-names:M</infon>
      <infon key="name_12">surname:Curran;given-names:J</infon>
      <infon key="name_17">surname:Jen;given-names:J</infon>
      <infon key="name_15">surname:Buetow;given-names:K</infon>
      <infon key="name_9">surname:Zhang;given-names:M</infon>
      <infon key="name_16">surname:Madden;given-names:SL</infon>
      <infon key="name_8">surname:Dufault;given-names:M</infon>
      <infon key="name_7">surname:Cook;given-names:B</infon>
      <infon key="name_6">surname:Akmaev;given-names:V</infon>
      <infon key="name_5">surname:Player;given-names:A</infon>
      <infon key="name_4">surname:Chen;given-names:Y</infon>
      <offset>37236</offset>
      <text>Molecular characteristics of non-small cell lung cancer</text>
      <annotation id="485">
        <infon key="identifier">MESH:D002289</infon>
        <infon key="type">Disease</infon>
        <location offset="37265" length="26"/>
        <text>non-small cell lung cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Li;given-names:X</infon>
      <infon key="name_2">surname:Wan;given-names:P</infon>
      <infon key="name_1">surname:Li;given-names:Y</infon>
      <infon key="name_0">surname:Tang;given-names:Z</infon>
      <infon key="fpage">R115</infon>
      <infon key="pub-id_doi">10.1186/gb-2007-8-6-r115</infon>
      <infon key="pub-id_pmid">17573972</infon>
      <infon key="year">2007</infon>
      <infon key="source">Genome Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">8</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Li;given-names:K</infon>
      <infon key="name_8">surname:Yu;given-names:M</infon>
      <infon key="name_7">surname:Zhu;given-names:M</infon>
      <infon key="name_6">surname:Fan;given-names:B</infon>
      <infon key="name_5">surname:Liu;given-names:B</infon>
      <infon key="name_4">surname:Zhao;given-names:S</infon>
      <offset>37292</offset>
      <text>LongSAGE analysis of skeletal muscle at three prenatal stages in Tongcheng and Landrace pigs</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Yang;given-names:J</infon>
      <infon key="name_2">surname:Hosack;given-names:DA</infon>
      <infon key="name_1">surname:Sherman;given-names:BT</infon>
      <infon key="name_0">surname:Dennis;given-names:G;suffix:Jr</infon>
      <infon key="fpage">P3</infon>
      <infon key="pub-id_doi">10.1186/gb-2003-4-5-p3</infon>
      <infon key="pub-id_pmid">12734009</infon>
      <infon key="year">2003</infon>
      <infon key="source">Genome Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">4</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_6">surname:Lempicki;given-names:RA</infon>
      <infon key="name_5">surname:Lane;given-names:HC</infon>
      <infon key="name_4">surname:Gao;given-names:W</infon>
      <offset>37385</offset>
      <text>DAVID: database for annotation, visualization, and integrated discovery</text>
    </passage>
    <passage>
      <infon key="volume">20</infon>
      <infon key="name_2">surname:Langen;given-names:H</infon>
      <infon key="name_1">surname:Hobohm;given-names:U</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Berndt;given-names:P</infon>
      <infon key="fpage">3521</infon>
      <infon key="pub-id_doi">10.1002/(SICI)1522-2683(19991201)20:18&lt;3521::AID-ELPS3521&gt;3.0.CO;2-8</infon>
      <infon key="pub-id_pmid">10612278</infon>
      <infon key="year">1999</infon>
      <infon key="source">Electrophoresis</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">3526</infon>
      <offset>37457</offset>
      <text>Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints</text>
    </passage>
  </document>
  <document>
    <id>4272823</id>
    <passage>
      <infon key="name_3">surname:Bhagat;given-names:Aditi</infon>
      <infon key="name_2">surname:Porter;given-names:Gerald</infon>
      <infon key="name_1">surname:Chen;given-names:Leonard N</infon>
      <infon key="article-id_pmid">25497602</infon>
      <infon key="name_0">surname:Joh;given-names:Daniel Y</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272823</infon>
      <infon key="article-id_publisher-id">277</infon>
      <infon key="article-id_doi">10.1186/s13014-014-0277-4</infon>
      <infon key="title">Keywords</infon>
      <infon key="type">front</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Radiat Oncol; 2014 Dec 12; 9277. doi:10.1186/s13014-014-0277-4</infon>
      <infon key="elocation-id">277</infon>
      <infon key="volume">9</infon>
      <infon key="license">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</infon>
      <infon key="name_10">surname:Ju;given-names:Andrew W</infon>
      <infon key="name_13">surname:Lynch;given-names:John H</infon>
      <infon key="name_14">surname:Dritschilo;given-names:Anatoly</infon>
      <infon key="name_11">surname:Suy;given-names:Simeng</infon>
      <infon key="name_12">surname:Carroll;given-names:John</infon>
      <infon key="kwd">Prostate cancer SBRT Rectal endoscopy Telangiectasias CyberKnife Expanded prostate index composite Bother Proctitis Rectal bleeding Vienna rectoscopy score</infon>
      <infon key="name_15">surname:Collins;given-names:Sean P</infon>
      <infon key="name_9">surname:Collins;given-names:Brian T</infon>
      <infon key="name_8">surname:Lei;given-names:Siyuan</infon>
      <infon key="name_7">surname:Yung;given-names:Thomas</infon>
      <infon key="name_6">surname:Moures;given-names:Rudy</infon>
      <infon key="name_5">surname:Kim;given-names:Joy S</infon>
      <infon key="name_4">surname:Sood;given-names:Sumit</infon>
      <infon key="authors">Joh DY, Chen LN, Porter G, Bhagat A, Sood S, Kim JS, Moures R, Yung T, Lei S, Collins BT, Ju AW, Suy S, Carroll J, Lynch JH, Dritschilo A, Collins SP</infon>
      <offset>0</offset>
      <text>Proctitis following stereotactic body radiation therapy for prostate cancer</text>
      <annotation id="2">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="0" length="9"/>
        <text>Proctitis</text>
      </annotation>
      <annotation id="3">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="60" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>76</offset>
      <text>Background</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>87</offset>
      <text>Proctitis after radiation therapy for prostate cancer remains an ongoing clinical challenge and critical quality of life issue. SBRT could minimize rectal toxicity by reducing the volume of rectum receiving high radiation doses and offers the potential radiobiologic benefits of hypofractionation. This study sought to evaluate the incidence and severity of proctitis following SBRT for prostate cancer.</text>
      <annotation id="9">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="445" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="10">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="242" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="11">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="474" length="15"/>
        <text>prostate cancer</text>
      </annotation>
      <annotation id="12">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="125" length="15"/>
        <text>prostate cancer</text>
      </annotation>
      <annotation id="13">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="87" length="9"/>
        <text>Proctitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>491</offset>
      <text>Methods</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>499</offset>
      <text>Between February 2008 and July 2011, 269 men with clinically localized prostate cancer were treated definitively with SBRT monotherapy at Georgetown University Hospital. All patients were treated to 35-36.25Gy in 5 fractions delivered with the CyberKnife Radiosurgical System (Accuray). Rectal bleeding was recorded and scored using the CTCAE v.4. Telangiectasias were graded using the Vienna Rectoscopy Score (VRS). Proctitis was assessed via the Bowel domain of the Expanded Prostate Index Composite (EPIC)-26 at baseline and at 1, 3, 6, 9, 12, 18 and 24 months post-SBRT.</text>
      <annotation id="21">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="540" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="22">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="673" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="23">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="560" length="25"/>
        <text>localized prostate cancer</text>
      </annotation>
      <annotation id="24">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="916" length="9"/>
        <text>Proctitis</text>
      </annotation>
      <annotation id="25">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="786" length="15"/>
        <text>Rectal bleeding</text>
      </annotation>
      <annotation id="26">
        <infon key="identifier">MESH:D013684</infon>
        <infon key="type">Disease</infon>
        <location offset="847" length="15"/>
        <text>Telangiectasias</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="617" length="4"/>
        <text>SBRT</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1075</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1083</offset>
      <text>The median age was 69 years with a median prostate volume of 39 cc. The median follow-up was 3.9 years with a minimum follow-up of two years. The 2-year actuarial incidence of late rectal bleeding &gt;= grade 2 was 1.5%. Endoscopy revealed VRS Grade 2 rectal telangiectasias in 11% of patients. All proctitis symptoms increased at one month post-SBRT but returned to near-baseline with longer follow-up. The most bothersome symptoms were bowel urgency and frequency. At one month post-SBRT, 11.2% and 8.5% of patients reported a moderate to big problem with bowel urgency and frequency, respectively. The EPIC bowel summary scores declined transiently at 1 month and experienced a second, more protracted decline between 6 months and 18 months before returning to near-baseline at two years post-SBRT. Prior to treatment, 4.1% of men felt their bowel function was a moderate to big problem which increased to 11.5% one month post-SBRT but returned to near-baseline at two years post-SBRT.</text>
      <annotation id="37">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1365" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="38">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1589" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="39">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1910" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="40">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="1379" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="41">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="1259" length="20"/>
        <text>late rectal bleeding</text>
      </annotation>
      <annotation id="42">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="1518" length="13"/>
        <text>bowel urgency</text>
      </annotation>
      <annotation id="43">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="1638" length="13"/>
        <text>bowel urgency</text>
      </annotation>
      <annotation id="44">
        <infon key="identifier">MESH:D013684</infon>
        <infon key="type">Disease</infon>
        <location offset="1339" length="15"/>
        <text>telangiectasias</text>
      </annotation>
      <annotation id="45">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="1925" length="14"/>
        <text>bowel function</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>2070</offset>
      <text>Conclusions</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>2082</offset>
      <text>In this single institution cohort, the rate and severity of proctitis observed following SBRT is low. QOL decreased on follow-up; however, our results compare favorably to those reported for patients treated with alternative radiation modalities. Future prospective randomized studies are needed to confirm these observations.</text>
      <annotation id="48">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2273" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="2142" length="9"/>
        <text>proctitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>2409</offset>
      <text>Background</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2420</offset>
      <text>Post-treatment bowel function is a primary determinant of quality of life following radiation therapy for prostate cancer. Late proctitis occurs at a frequency of 5-20% with conventionally fractionated treatment. The incidence of proctitis is dependent on the assessment method and whether it is patient or physician reported. Patients with radiation-induced proctitis report increased bowel frequency/urgency, incontinence, bleeding and pain. These symptoms occur months to years after treatment with the large majority of patients reporting symptoms within two years following radiation therapy. Patient characteristics such as age, comorbidities, hemorrhoids, inflammatory bowel disease and/or anticoagulation may increase an individual's risk of radiation-induced proctitis. Unfortunately, treatment options for radiation proctitis are limited and of unclear clinical benefit.</text>
      <annotation id="66">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2716" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="67">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2747" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="68">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2944" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="69">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3018" length="7"/>
        <text>Patient</text>
      </annotation>
      <annotation id="70">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="3083" length="26"/>
        <text>inflammatory bowel disease</text>
      </annotation>
      <annotation id="71">
        <infon key="identifier">MESH:D006484</infon>
        <infon key="type">Disease</infon>
        <location offset="3070" length="11"/>
        <text>hemorrhoids</text>
      </annotation>
      <annotation id="72">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="2526" length="15"/>
        <text>prostate cancer</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="2845" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="2650" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="2435" length="14"/>
        <text>bowel function</text>
      </annotation>
      <annotation id="76">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="3246" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="77">
        <infon key="identifier">MESH:D014549</infon>
        <infon key="type">Disease</infon>
        <location offset="2831" length="12"/>
        <text>incontinence</text>
      </annotation>
      <annotation id="78">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="2858" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="79">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="2548" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="80">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="3188" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="81">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="2779" length="9"/>
        <text>proctitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3305</offset>
      <text>Proctitis is the principle dose-limiting toxicity of prostate radiotherapy. Acute proctitis has been attributed to radiation-induced injury to the epithelial lining of the rectal mucosa, leading to mucosal sloughing, acute inflammatory infiltrates, and vascular permeability leading to edema. These early changes are associated with bowel frequency, bowel urgency and rectal pain. Chronic proctitis results from epithelial atrophy and obliterative endarteritis, resulting in tissue ischemia, rectal fibrosis, stricture formation, and neovascularization; this presents clinically with bowel frequency, urgency and rectal bleeding. Historically, endoscopic findings in patients with proctitis include telangiectasia, congested mucosa, and ulcers. Telangiectasias are observed in 20-80% of patients receiving conventionally fractionated radiation therapy.</text>
      <annotation id="101">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3972" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="102">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4092" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="103">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="3680" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="104">
        <infon key="identifier">MESH:D058186</infon>
        <infon key="type">Disease</infon>
        <location offset="3438" length="6"/>
        <text>injury</text>
      </annotation>
      <annotation id="105">
        <infon key="identifier">MESH:D013684</infon>
        <infon key="type">Disease</infon>
        <location offset="4004" length="14"/>
        <text>telangiectasia</text>
      </annotation>
      <annotation id="106">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="3986" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="107">
        <infon key="identifier">MESH:D005355</infon>
        <infon key="type">Disease</infon>
        <location offset="3804" length="8"/>
        <text>fibrosis</text>
      </annotation>
      <annotation id="108">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="3655" length="13"/>
        <text>bowel urgency</text>
      </annotation>
      <annotation id="109">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="3346" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="110">
        <infon key="identifier">MESH:D007511</infon>
        <infon key="type">Disease</infon>
        <location offset="3787" length="8"/>
        <text>ischemia</text>
      </annotation>
      <annotation id="111">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="3925" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="112">
        <infon key="identifier">MESH:D002277</infon>
        <infon key="type">Disease</infon>
        <location offset="3717" length="18"/>
        <text>epithelial atrophy</text>
      </annotation>
      <annotation id="113">
        <infon key="identifier">MESH:D004487</infon>
        <infon key="type">Disease</infon>
        <location offset="3591" length="5"/>
        <text>edema</text>
      </annotation>
      <annotation id="114">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="3387" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="3686" length="17"/>
        <text>Chronic proctitis</text>
      </annotation>
      <annotation id="116">
        <infon key="identifier">MESH:D014456</infon>
        <infon key="type">Disease</infon>
        <location offset="4042" length="6"/>
        <text>ulcers</text>
      </annotation>
      <annotation id="117">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="3305" length="9"/>
        <text>Proctitis</text>
      </annotation>
      <annotation id="118">
        <infon key="identifier">MESH:D004692</infon>
        <infon key="type">Disease</infon>
        <location offset="3753" length="12"/>
        <text>endarteritis</text>
      </annotation>
      <annotation id="119">
        <infon key="identifier">MESH:D013684</infon>
        <infon key="type">Disease</infon>
        <location offset="4050" length="15"/>
        <text>Telangiectasias</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4158</offset>
      <text>The risk of proctitis appears to be dependent upon both the total radiation dose and the volume of the rectum in the high dose area. Technical factors such as treatment of the proximal seminal vesicles and expansion of planning target volume (PTV) to compensate for intra-fraction prostate motion may contribute to the severity of rectal toxicities. To minimize bowel toxicity, it is currently recommended that the volume of the rectum receiving &gt; 75 Gray (Gy) be limited to &lt; 10% with conventionally fractionated radiation therapy. Studies have shown that advanced radiation technologies such as intensity modulated radiation therapy (IMRT) may decrease the dose to the rectum and potentially decrease proctitis.</text>
      <annotation id="124">
        <infon key="identifier">MESH:D012002</infon>
        <infon key="type">Disease</infon>
        <location offset="4489" length="17"/>
        <text>rectal toxicities</text>
      </annotation>
      <annotation id="125">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="4170" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="126">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="4861" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="127">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="4520" length="14"/>
        <text>bowel toxicity</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4880</offset>
      <text>Recent data suggest that large radiation fraction sizes are radiobiologically favorable over lower fraction sizes in prostate cancer. The alpha/beta for prostate cancer may be as low as 1.5 Gy. If the alpha/beta for prostate cancer is less than 3-5 Gy, which is generally the value accepted for late rectal complications, the linear-quadratic model predicts that delivering large radiation fraction sizes will result in improved local control with a similar rate of bowel complications. Therefore, using large fraction sizes in SBRT provides an attractive modality to leverage the potential radiobiologic benefits of hypofractionation with the minimal invasiveness of an external-beam treatment modality. Furthermore, by reducing the number of treatment visits, hypofractionated therapy can also be logistically favorable for patients and reduce financial burden, ultimately decreasing barriers to care.</text>
      <annotation id="133">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5706" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="134">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="5346" length="19"/>
        <text>bowel complications</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="5096" length="15"/>
        <text>prostate cancer</text>
      </annotation>
      <annotation id="136">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="5033" length="15"/>
        <text>prostate cancer</text>
      </annotation>
      <annotation id="137">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="4997" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>5784</offset>
      <text>The safety and efficacy of SBRT in the treatment of clinically localized prostate cancer has been established in a number of studies. The use of large fraction sizes in SBRT offers the potential radiobiological benefits of hypofractionation and potentially may minimize radiation proctitis by reducing the volume of the rectum receiving high radiation doses. The CyberKnife robotic radiosurgical system uses image guidance to track implanted fiducials to account for intrafraction prostatic motion. This reduces the uncertainty of the location of the prostate and allows treatment to be delivered with a smaller PTV expansion, which may reduce the doses delivered to the anterior rectal wall. The goal of this study is to report the bowel outcomes following SBRT for clinically localized prostate cancer.</text>
      <annotation id="141">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="6064" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="142">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="5847" length="25"/>
        <text>localized prostate cancer</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="6562" length="25"/>
        <text>localized prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>6589</offset>
      <text>Methods</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>6597</offset>
      <text>Patient selection</text>
      <annotation id="145">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6597" length="7"/>
        <text>Patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6615</offset>
      <text>Patients eligible for study inclusion had histologically-confirmed prostate cancer treated per our institutional protocol. Clinical stage was defined according to the 6th edition of the American Joint Committee on Cancer criteria. Risk groups were defined using the D'Amico criteria. Internal Review Board (IRB)-approval was obtained for retrospective review of data that was prospectively collected in our institutional database.</text>
      <annotation id="148">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6615" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="149">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="6682" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>7048</offset>
      <text>SBRT treatment planning and delivery</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>7085</offset>
      <text>SBRT was delivered using the CyberKnife robotic radiosurgical system (Accuray Inc., Sunnyvale, CA). The fiducial placement and computed tomography (CT)/magnetic resonance (MR) simulation procedures have been previously described in Lei et al.. The clinical target volume (CTV) was defined as the prostatic capsule and proximal seminal vesicles (to the point where the seminal vesicles separate). To cover areas of potential ECE, the expansion from the CTV to the PTV was 5 mm in all directions except 3 mm posteriorly into the rectum. There was no difference in the target volume delineation for different risk groups. Fiducial-based tracking was used to account for interfraction and intrafraction prostate motion. Treatment planning was performed using Multiplan (Accuray Inc., Sunnyvale, CA). Patients were treated with 35 or 36.25 Gy of radiotherapy delivered in 5 fractions of 7-7.25 Gy each to the PTV, administered over a timespan of 1-2 weeks. This corresponds to a tumor equivalent dose in 2-Gy fractions (EQD2) of approximately 85-90 Gy assuming an alpha/beta ratio of 1.5. The rectum was contoured as a solid structure from the anus (at the level of the ischial tuberosities) to the rectosigmoid flexure and evaluated with dose-volume histogram analysis during treatment planning using Multiplan (Accuray Inc., Sunnyvale, CA) inverse treatment planning. Rectal volume receiving 36 Gy was limited to &lt;= 1 cc. Assuming an alpha/beta of 3 Gy for late bowel complications, this is biologically equivalent to approximately 74 Gy administered in 2 Gy fractions. The rectal dose-volume histogram (DVH) goals were &lt;50% rectal volume receiving 50% of the prescribed dose, &lt;20% receiving 80% of the dose, &lt;10% receiving 90% of the dose, and &lt; 5% receiving 100% of the dose. Typical dose distributions have been previously described. Patients were placed on a low-residual diet and given enemas prior to simulation and treatment delivery to maximize the potential distance between the prostate and the rectal wall and minimize intrafraction prostate motion.</text>
      <annotation id="157">
        <infon key="identifier">1889</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1068</infon>
        <location offset="7509" length="3"/>
        <text>ECE</text>
      </annotation>
      <annotation id="158">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7881" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="159">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8919" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="160">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="8539" length="24"/>
        <text>late bowel complications</text>
      </annotation>
      <annotation id="161">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="7989" length="3"/>
        <text>PTV</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="8059" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">MESH:D014402</infon>
        <infon key="type">Disease</infon>
        <location offset="8250" length="20"/>
        <text>ischial tuberosities</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>9154</offset>
      <text>Follow-up and statistical analysis</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>9189</offset>
      <text>Rectal bleeding was prospectively documented at follow-up visits using the National Cancer Institute (NCI) Common Toxicity Criteria (CTC) version 4.0. Acute rectal bleeding was defined as experiencing toxicity within 6 months of radiation therapy. Late rectal bleeding was defined as occurring at least 6 months after delivery of radiation therapy. Grade 1 represents minimal bleeding not requiring medications for symptom control. Grade 2 indicates rectal bleeding requiring new medication (i.e. steroid suppository) or minor laser coagulation. Telangiectasia were graded using the Vienna Rectoscopy Score (VRS): Grade 1 (a single telangiectasia), Grade 2 (multiple non-confluent telangiectasia) and Grade 3 (multiple confluent telangiectasia).</text>
      <annotation id="176">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="9390" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="177">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="9353" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="178">
        <infon key="identifier">MESH:D013684</infon>
        <infon key="type">Disease</infon>
        <location offset="9918" length="14"/>
        <text>telangiectasia</text>
      </annotation>
      <annotation id="179">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="9449" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="180">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="9646" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="181">
        <infon key="identifier">MESH:D013684</infon>
        <infon key="type">Disease</infon>
        <location offset="9870" length="14"/>
        <text>telangiectasia</text>
      </annotation>
      <annotation id="182">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="9303" length="17"/>
        <text>Toxicity Criteria</text>
      </annotation>
      <annotation id="183">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="9565" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="184">
        <infon key="identifier">MESH:D013684</infon>
        <infon key="type">Disease</infon>
        <location offset="9735" length="14"/>
        <text>Telangiectasia</text>
      </annotation>
      <annotation id="185">
        <infon key="identifier">MESH:D013256</infon>
        <infon key="type">Chemical</infon>
        <location offset="9686" length="7"/>
        <text>steroid</text>
      </annotation>
      <annotation id="186">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="9189" length="15"/>
        <text>Rectal bleeding</text>
      </annotation>
      <annotation id="187">
        <infon key="identifier">MESH:D013684</infon>
        <infon key="type">Disease</infon>
        <location offset="9821" length="14"/>
        <text>telangiectasia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>9937</offset>
      <text>Proctitis was assessed via the bowel domain of the Expanded Prostate Index Composite (EPIC)-26 at baseline and at 1, 3, 6, 9, 12, 18 and 24 months. The timing of the quality of life (QOL) assessments was relative to the last day of SBRT treatment. The EPIC-26 bowel domain includes five questions related to individual symptoms (questions 6a-e: urgency, frequency, pain, bloody stool, incontinence) and one question (question 7) related to overall bother (degree of interference or annoyance caused by bowel symptoms.</text>
      <annotation id="189">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="9937" length="9"/>
        <text>Proctitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>10456</offset>
      <text>Wilcoxon signed-rank test and chi-square analysis were used to assess differences in ongoing quality of life scores in comparison to baseline. For each EPIC question, the responses were grouped into three clinically relevant categories (no problem, very small-small problem and moderate to big problem). To statistically compare changes between time points, the levels of responses were assigned a score and the significance of the mean changes in the scores was assessed by Wilcoxon rank test. EPIC scores for the bowel domain and its individual questions range from 0 - 100 with lower values representing worsening bowel symptoms. The minimally important difference (MID) in EPIC score was defined as a change of one-half standard deviation (SD) from the baseline. To limit the effect of attrition bias, statistical analysis was limited to time points in which &gt;= 80% of the patient data were available.</text>
      <annotation id="195">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11333" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="196">
        <infon key="type">Disease</infon>
        <location offset="11125" length="3"/>
        <text>MID</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">MESH:D051271</infon>
        <infon key="type">Disease</infon>
        <location offset="11073" length="14"/>
        <text>bowel symptoms</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">MESH:D019217</infon>
        <infon key="type">Disease</infon>
        <location offset="11246" length="14"/>
        <text>attrition bias</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">MESH:D029461</infon>
        <infon key="type">Disease</infon>
        <location offset="11200" length="2"/>
        <text>SD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>11367</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab1.xml</infon>
      <infon key="id">Tab1</infon>
      <infon key="type">table_caption</infon>
      <offset>11375</offset>
      <text> Baseline patient characteristics and treatment </text>
      <annotation id="201">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11385" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab1</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab1.xml</infon>
      <offset>11424</offset>
      <text> % Patients (N = 269)   Age (y/o)  Median 69 (44-90)   &lt;60 8.20%  60-69 42.40%  70-79 41.30%  &gt;=80 8.20%  Race     White 55.80%  Black 37.20%  Other 7.10%  Prostate volume (cc)  Median 39.04  (11.56-138.69)   Charlson comorbidity index (CCI)     0 66.9%  1 22.7%  2 6.7%  &gt;=3 3.7%  Body mass index     BMI &lt;25 21.9%  25 &lt;= BMI &lt; 30 47.2%  30 &lt;= BMI &lt; 35 21.9%  BMI &gt;=35 8.9%  Use of anticoagulants  Yes 35.3%  No 64.7%  Risk group     Low 36.80%  Intermediate 53.20%  High 10.00%  Hormonal therapy     Yes 16.40%  No 83.60%  Dose     36.25 Gy 83.30%  35 Gy 16.40%  Other 0.40% </text>
      <annotation id="203">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11427" length="8"/>
        <text>Patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12029</offset>
      <text>From February 2008 to July 2011, 269 prostate cancer patients were treated per our institutional SBRT monotherapy protocol (Table 1). The median follow-up was 3.9 years. The median age was 69 years and 44.2% were of non-Caucasian ancestry. Comorbidities were common with 35% were taking anticoagulants (including aspirin) prior to treatment. The median prostate volume was 39 cc. By D'Amico classification, 99 patients were low-, 143 intermediate-, and 27 high-risk. 16.4% also received androgen deprivation therapy (ADT) at the discretion of the treating Urologist. 83.3% of the patients were treated with 36.25 Gy in five 7.25 Gy fractions.</text>
      <annotation id="210">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12082" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="211">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12439" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="212">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12609" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="213">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="12546" length="3"/>
        <text>ADT</text>
      </annotation>
      <annotation id="214">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="12066" length="15"/>
        <text>prostate cancer</text>
      </annotation>
      <annotation id="215">
        <infon key="identifier">MESH:D001241</infon>
        <infon key="type">Chemical</infon>
        <location offset="12342" length="7"/>
        <text>aspirin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12680</offset>
      <text>A total of 61 (22.7%) patients reported rectal bleeding after SBRT, with 28 (10.4%) patients reporting acute bleeding and 38 patients (14.1%) reporting late bleeding. Overall, Grade 2 acute and late rectal bleeding were observed in 0 (0%) and 4 (1.5%) of patients, respectively. There was no Grade 3 or higher rectal bleeds. The majority of acute rectal bleeding occurred within 1-month post-SBRT treatment (79%). The bleeding completely resolved in the majority of the patients by the subsequent follow-up visit. Likewise, the majority of late rectal bleeding was observed at one specific follow-up appointment and did not persist on subsequent follow-ups.</text>
      <annotation id="228">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12702" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="229">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12764" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="230">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12805" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="231">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12935" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="232">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13150" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="233">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="12837" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="234">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="12727" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="235">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="13232" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="236">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="12886" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="237">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="13034" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="238">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="13098" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="239">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="12789" length="8"/>
        <text>bleeding</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13338</offset>
      <text>Seventy-three patients had one or more rectal endoscopies during the follow-up period. Endoscopy was performed as a part of normal colorectal cancer screening or if patient had clinically significant rectal bleeding. The median interval from completion of SBRT to endoscopy was 24 months (3 months to 53 months). On endoscopy, rectal telangiectasias were found in 8 (11.0%) patients. All 8 patients were observed to have multiple non-confluent telangiectasias (VRS Grade 2). No patient had confluent or circumferential telangiectasia. Minor laser coagulation was performed in three patients. No rectal ulcerations, strictures, or fistulas were observed.</text>
      <annotation id="252">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13352" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="253">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13503" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="254">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13712" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="255">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13728" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="256">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13816" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="257">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13920" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="258">
        <infon key="identifier">MESH:D013684</infon>
        <infon key="type">Disease</infon>
        <location offset="13857" length="14"/>
        <text>telangiectasia</text>
      </annotation>
      <annotation id="259">
        <infon key="identifier">MESH:D013684</infon>
        <infon key="type">Disease</infon>
        <location offset="13672" length="15"/>
        <text>telangiectasias</text>
      </annotation>
      <annotation id="260">
        <infon key="identifier">MESH:D015179</infon>
        <infon key="type">Disease</infon>
        <location offset="13469" length="17"/>
        <text>colorectal cancer</text>
      </annotation>
      <annotation id="261">
        <infon key="identifier">MESH:D005402</infon>
        <infon key="type">Disease</infon>
        <location offset="13968" length="8"/>
        <text>fistulas</text>
      </annotation>
      <annotation id="262">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="13545" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="263">
        <infon key="identifier">MESH:D013684</infon>
        <infon key="type">Disease</infon>
        <location offset="13782" length="15"/>
        <text>telangiectasias</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>13995</offset>
      <text>Patient-reported responses to EPIC-26 questions 6A (Urgency to have a bowel movement), 6B (Frequency of bowel movements), 6C (Losing control of your stools), 6D (Bloody stools) and 6E (Abdominal, pelvic or rectal pain).</text>
      <annotation id="268">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13995" length="7"/>
        <text>Patient</text>
      </annotation>
      <annotation id="269">
        <infon key="identifier">MESH:D009069</infon>
        <infon key="type">Disease</infon>
        <location offset="14099" length="15"/>
        <text>bowel movements</text>
      </annotation>
      <annotation id="270">
        <infon key="identifier">MESH:D009069</infon>
        <infon key="type">Disease</infon>
        <location offset="14065" length="14"/>
        <text>bowel movement</text>
      </annotation>
      <annotation id="271">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="14208" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab2.xml</infon>
      <infon key="id">Tab2</infon>
      <infon key="type">table_caption</infon>
      <offset>14215</offset>
      <text> Bowel symptoms following SBRT for prostate cancer </text>
      <annotation id="273">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="14250" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab2</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab2.xml</infon>
      <offset>14267</offset>
      <text>   Start   1   3   6   9   12   18   24   Bowel urgency  No problem  77.2% 49.8% 62.0% 60.2% 64.5% 62.3% 64.7% 66.8% Very small-small problem  21.0% 39.0% 33.7% 34.1% 29.8% 31.6% 29.5% 31.1% Moderate-big problem  1.9% 11.2% 4.3% 5.6% 5.6% 6.1% 5.8% 2.1%   p value  &lt;0.0001 0.0002 &lt;0.0001 0.0002 0.0001 0.0004 0.01568  Bowel frequency  No problem  82.0% 57.0% 71.9% 71.5% 70.6% 72.5% 76.3% 77.4% Very small-small problem  15.7% 34.5% 25.0% 25.3% 23.4% 23.0% 18.8% 19.7% Moderate-big problem  2.2% 8.5% 3.1% 3.2% 6.0% 4.5% 4.9% 2.9%   p value  &lt;0.0001 0.0079 0.0038 0.0031 0.0214 0.0169 0.2508  Incontinence  No problem  94.8% 79.5% 85.2% 86.7% 88.3% 85.2% 85.7% 89.5% Very small-small problem  4.1% 17.0% 14.5% 11.2% 9.7% 12.3% 11.6% 8.8% Moderate-big problem  1.1% 3.5% 0.4% 2.0% 2.0% 2.5% 2.7% 1.7%   p value  &lt;0.0001 0.0033 0.0021 0.03 0.0001 0.0001 0.0147  Bloody stools  No problem  98.1% 90.8% 96.9% 95.6% 96.0% 96.3% 94.2% 94.2% Very small-small problem  1.9% 8.1% 2.3% 3.6% 2.4% 2.5% 5.4% 5.8% Moderate-big problem  0.0% 1.2% 0.8% 0.8% 1.6% 1.2% 0.4% 0.0%   p value  0.0002 0.1677 0.0934 0.0574 0.0906 0.0066 0.0258  Pain (abdominal, pelvic or rectal)  No problem  86.1% 76.8% 89.8% 86.7% 86.7% 88.5% 86.6% 90.3% Very small-small problem  12.4% 17.8% 7.8% 10.4% 9.7% 8.2% 12.1% 7.1% Moderate-big problem  1.5% 5.4% 2.3% 2.8% 3.6% 3.3% 1.3% 2.5%   p value  0.0002 0.5516 0.6606 0.232 0.5713 0.8565 0.7498   N=   267   259   255   249   248   244   224   238  </text>
      <annotation id="275">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="15391" length="4"/>
        <text>Pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab3.xml</infon>
      <infon key="id">Tab3</infon>
      <infon key="type">table_caption</infon>
      <offset>15733</offset>
      <text> Changes in EPIC bowel summary and overall bowel bother scores following SBRT for prostate cancer </text>
      <annotation id="277">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="15815" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab3</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab3.xml</infon>
      <offset>15832</offset>
      <text> EPIC criteria   Baseline   1 Month   6 Month   12 Month   18 Month   24 Month     Change   S.D.   Change   S.D.   Change   S.D.   Change   S.D.   Change   S.D.   Bloody stool bother  99.5 -2.9 12.26 -1.1 8.54 -1.3 9.86 -2.1 10.93 -1.4 8.03  Bowel summary  94.8 -9.8 17.89 -3.2 12.21 -3.5 13.04 -3.3 13.40 -1.6 10.73  Bowel bother  90.7 -14.8 26.98 -2.6 20.82 -5.5 23.95 -3.5 20.91 -0.9 18.86 </text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13014_2014_277_Fig1_HTML.jpg</infon>
      <infon key="id">Fig1</infon>
      <infon key="type">fig_caption</infon>
      <offset>16256</offset>
      <text> Individual EPIC-26 bowel symptoms (Questions 6a-e). Average individual symptom EPIC bother scores at baseline and following SBRT for prostate cancer: (a) urgency to have a bowel movement-Question 6a of the EPIC-26; (b) increase frequency of bowel movements- Question 6b of the EPIC-26; (c) losing control of stools- Question 6c of the EPIC-26; (d) bloody stools- Question 6d of the EPIC-26; (e) abdominal/pelvic/rectal pain- Question 6e of the EPIC-26. Thresholds for clinically significant changes in scores (1/2 standard deviation above and below the baseline) are marked with dashed lines. EPIC scores range from 0-100 with higher values representing a more favorable health-related QOL.</text>
      <annotation id="283">
        <infon key="identifier">MESH:D009069</infon>
        <infon key="type">Disease</infon>
        <location offset="16498" length="15"/>
        <text>bowel movements</text>
      </annotation>
      <annotation id="284">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="16676" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="285">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="16390" length="15"/>
        <text>prostate cancer</text>
      </annotation>
      <annotation id="286">
        <infon key="identifier">MESH:D009069</infon>
        <infon key="type">Disease</infon>
        <location offset="16429" length="14"/>
        <text>bowel movement</text>
      </annotation>
      <annotation id="287">
        <infon key="identifier">MESH:D051271</infon>
        <infon key="type">Disease</infon>
        <location offset="16276" length="14"/>
        <text>bowel symptoms</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>16949</offset>
      <text>At baseline, 1.9% of our cohort reported some level of annoyance due to bloody stools, however no patient felt it was a moderate to big problem (Table 2). The mean changes in EPIC bloody stool bother scores from baseline to 2 years of follow-up are shown in Table 3. The mean EPIC bloody stool bother score was 99.5 at baseline (Table 3). Bloody stool bother increased following treatment with the mean score decreasing to 96.6 at 1 month post-treatment (mean change, -2.9) (p = 0.0002) (Table 3, Figure 1d). However, only 1.2% of patients felt that that bloody stools were a moderate to big problem at 1 month following treatment (Table 2). Although bloody stool bother declined quickly, a second late increase in bloody stool bother was observed with the mean bloody stool bother score decreasing to 97.4 at 18 months (mean change from baseline, -2.1) (p = 0.0066) (Table 3, Figure 1d). Both declines met the threshold for clinically significant change (MID = 1.7). However, only 1.2% of patients felt that that bloody stools were a moderate to big problem at 12 months following treatment (Table 2). By two years following SBRT, bloody stool bother returned to near-baseline with bloody stool bother score of 98.1 (mean change from baseline, -1.4). By two years post-SBRT, no patient felt that blood stools was a moderate to big problem (Table 2).</text>
      <annotation id="293">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17047" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="294">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17480" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="295">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17939" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="296">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18228" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="297">
        <infon key="type">Disease</infon>
        <location offset="17905" length="3"/>
        <text>MID</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>18327</offset>
      <text>Baseline proctitis symptoms were uncommon in our patients (Table 2). All proctitis symptoms increased at one month post-SBRT. The most bothersome symptoms were bowel urgency and frequency. At one month post SBRT, 11.2% and 8.5% of patients reported moderate to big problems with bowel urgency and frequency, respectively (Table 2). 9.7% of patients required anti-diarrheals within the first month post-SBRT.</text>
      <annotation id="305">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18376" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="306">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18558" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="307">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18667" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="308">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="18487" length="13"/>
        <text>bowel urgency</text>
      </annotation>
      <annotation id="309">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="18400" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="310">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="18336" length="18"/>
        <text>proctitis symptoms</text>
      </annotation>
      <annotation id="311">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="18606" length="13"/>
        <text>bowel urgency</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13014_2014_277_Fig2_HTML.jpg</infon>
      <infon key="id">Fig2</infon>
      <infon key="type">fig_caption</infon>
      <offset>18737</offset>
      <text> Average EPIC bowel summary scores at baseline and following SBRT for prostate cancer. Thresholds for clinically significant changes in scores (1/2 standard deviation above and below the baseline) are marked with dashed lines. EPIC scores range from 0-100 with higher values representing a more favorable health-related QOL.</text>
      <annotation id="313">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="18807" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>19063</offset>
      <text>Likewise, the EPIC bowel summary score declined transiently at 1 month (mean change, -9.8) (Table 3). In addition, a second more protracted decline occurred between 6 and 18 months (mean change from baseline at 12 months, -3.5). Bowel declines at 1 month and 12 months were statistically significant (p &lt; 0.0001); however, only the 1 month change met the threshold for clinically significant change (MID = 4.6) (Figure 2). The EPIC bowel summary score returned to near-baseline at two years post-SBRT (mean change from baseline, -1.6). Individual bowel symptoms changed with time in a similar manner (Figure 1).</text>
      <annotation id="316">
        <infon key="type">Disease</infon>
        <location offset="19463" length="3"/>
        <text>MID</text>
      </annotation>
      <annotation id="317">
        <infon key="identifier">MESH:D051271</infon>
        <infon key="type">Disease</infon>
        <location offset="19610" length="14"/>
        <text>bowel symptoms</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">Tab4.xml</infon>
      <infon key="id">Tab4</infon>
      <infon key="type">table_caption</infon>
      <offset>19692</offset>
      <text> Overall bowel bother following SBRT for prostate cancer (Patient-reported responses to Question 7 of the EPIC-26) </text>
      <annotation id="320">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19750" length="7"/>
        <text>Patient</text>
      </annotation>
      <annotation id="321">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="19733" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">Tab4</infon>
      <infon key="type">table</infon>
      <infon key="File">Tab4.xml</infon>
      <offset>19808</offset>
      <text>   Start   1   3   6   9   12   18   24  No problem  76.0% 44.6% 68.0% 69.1% 63.7% 63.5% 66.1% 70.4% Very small-small problem  19.9% 43.8% 28.9% 26.9% 30.2% 29.5% 29.5% 26.3% Moderate-big problem  4.1% 11.5% 3.1% 4.0% 6.0% 7.0% 4.5% 3.3%   p value - &lt;0.0001 0.1044 0.0828 0.0051 0.0005 0.0172 0.3499   N=   267   260   256   249   248   244   224   240  </text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13014_2014_277_Fig3_HTML.jpg</infon>
      <infon key="id">Fig3</infon>
      <infon key="type">fig_caption</infon>
      <offset>20163</offset>
      <text> Overall bowel bother score (baseline and following SBRT; Question 7 of EPIC-26). Thresholds for clinically significant changes in scores (1/2 standard deviation above and below the baseline) are marked with dashed lines. EPIC scores range from 0-100 with higher values representing a more favorable health-related QOL.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>20484</offset>
      <text>Overall bowel bother showed a similar pattern as the bowel summary score. At baseline, 24.0% of patients reported some level of annoyance due to bowel symptoms with 4.1% of patients feeling that bowel function was a moderate to big problem (Table 4). The mean EPIC bowel bother score was 90.7 at baseline (Table 3). Overall bowel bother worsened post-treatment and the mean score decreased to 75 at 1 month (mean change, -14.8) (Table 3, Figure 3). However, only 11.5% of patients felt that their bowel function was a moderate to big problem at 1 month following SBRT (Table 4). Bowel bother scores worsened over a second, more protracted time period (Figure 3). Once again, only the first decline met the threshold for clinically significant change (MID = 9.8). Only 7% of patients felt that bowel symptoms were a moderate to big problem at 12 month following treatment (Table 4). By two years following SBRT, overall bowel bother returned to near baseline with a bowel bother score of 89.8 (mean change from baseline, -0.9) (Table 3) and 3.3% of patients feeling bowel symptoms were a moderate to big problem (Table 4).</text>
      <annotation id="333">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20580" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="334">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20657" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="335">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20956" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="336">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21258" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="337">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21532" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="338">
        <infon key="type">Disease</infon>
        <location offset="21235" length="3"/>
        <text>MID</text>
      </annotation>
      <annotation id="339">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="20981" length="14"/>
        <text>bowel function</text>
      </annotation>
      <annotation id="340">
        <infon key="identifier">MESH:D051271</infon>
        <infon key="type">Disease</infon>
        <location offset="21277" length="14"/>
        <text>bowel symptoms</text>
      </annotation>
      <annotation id="341">
        <infon key="identifier">MESH:D051271</infon>
        <infon key="type">Disease</infon>
        <location offset="20629" length="14"/>
        <text>bowel symptoms</text>
      </annotation>
      <annotation id="342">
        <infon key="identifier">MESH:D051271</infon>
        <infon key="type">Disease</infon>
        <location offset="21541" length="22"/>
        <text>feeling bowel symptoms</text>
      </annotation>
      <annotation id="343">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="20679" length="14"/>
        <text>bowel function</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>21622</offset>
      <text>Discussion</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>21633</offset>
      <text>Proctitis following prostate cancer radiotherapy is a critical quality of life issue and the principle dose-limiting toxicity. Currently, there is limited data on proctitis following SBRT for prostate cancer. A better understanding of bowel symptoms following SBRT would enable clinicians to provide more realistic expectations to patients as they weigh their treatment options. Our prior paper reported the prevalence, severity and overall incidence of bowel frequency/urgency, rectal pain and rectal bleeding following SBRT. However, it is reliant on physician reporting which may under report the incidence of bowel symptoms and provides no information on the associated bother. In this study, we utilized the EPIC-26 bowel domain to evaluate bowel symptoms but also assess related bother.</text>
      <annotation id="354">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21964" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="355">
        <infon key="identifier">MESH:D051271</infon>
        <infon key="type">Disease</infon>
        <location offset="21868" length="14"/>
        <text>bowel symptoms</text>
      </annotation>
      <annotation id="356">
        <infon key="identifier">MESH:D051271</infon>
        <infon key="type">Disease</infon>
        <location offset="22379" length="14"/>
        <text>bowel symptoms</text>
      </annotation>
      <annotation id="357">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="22119" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="358">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="21750" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="359">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="21825" length="15"/>
        <text>prostate cancer</text>
      </annotation>
      <annotation id="360">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="21633" length="35"/>
        <text>Proctitis following prostate cancer</text>
      </annotation>
      <annotation id="361">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="21796" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="362">
        <infon key="identifier">MESH:D051271</infon>
        <infon key="type">Disease</infon>
        <location offset="22246" length="14"/>
        <text>bowel symptoms</text>
      </annotation>
      <annotation id="363">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="22135" length="8"/>
        <text>bleeding</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>22426</offset>
      <text>Stereotactic body radiation therapy (SBRT) offers to minimize radiation-associated rectal toxicity by reducing the volume of rectum receiving high radiation doses. The overall incidence of post-SBRT rectal bleeding in this series was 23%. The low rate of late Grade &gt;= 2 rectal bleeding (1.5%) seen in this study is consistent with the results from a prior review by our institution and results from other institutions which all report a rate of late Grade &gt;= 2 rectal bleeding of &lt; 5%. In fact, many of the bleeds were acute and transient suggestive of acute anal irritation or hemorrhoid exacerbation due to bowel frequency. Furthermore, the incidence of telangiectasia in patients who completed post-SBRT rectal endoscopy for the assessment of rectal bleeding or cancer screening was 11% which is significantly lower than the rates reported in prospective studies that looked at endoscopic outcomes after conventionally fractionated radiation therapy.</text>
      <annotation id="374">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23101" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="375">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="22632" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="376">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="22704" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="377">
        <infon key="identifier">MESH:D006484</infon>
        <infon key="type">Disease</infon>
        <location offset="23005" length="10"/>
        <text>hemorrhoid</text>
      </annotation>
      <annotation id="378">
        <infon key="identifier">MESH:D013684</infon>
        <infon key="type">Disease</infon>
        <location offset="23083" length="14"/>
        <text>telangiectasia</text>
      </annotation>
      <annotation id="379">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="23192" length="6"/>
        <text>cancer</text>
      </annotation>
      <annotation id="380">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="22895" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="381">
        <infon key="identifier">MESH:D001523</infon>
        <infon key="type">Disease</infon>
        <location offset="22991" length="10"/>
        <text>irritation</text>
      </annotation>
      <annotation id="382">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="22516" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="383">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="23180" length="8"/>
        <text>bleeding</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>23395</offset>
      <text>These findings are particularly significant given that rectal bleeding is one of the principle dose-limiting toxicities, and is thus a potential barrier to administering radiation at appropriately therapeutic levels. In the work by Sanda et al, the proportion of patients reporting rectal bleeding as a moderate-big problem on the EPIC 26 survey progressively increased over time (reaching 5% at 12 and 24 months), ultimately manifesting as a late complication post-treatment. However, we observed that with SBRT rectal bleeding occurred at lower rates and presented as a relatively earlier complication: the incidence of patients reporting rectal bleeding as a moderate-big problem in this study reached a peak at 9 months at 1.6%, and by 24 months the incidence dropped to null. Additionally, in our series the rate of Grade 2-3 late rectal bleeding was 1.5%. This compares favorably to the 5%-15% seen with contemporary high-dose IMRT. We speculate that this reassuring profile with SBRT may be a result of the enhanced accuracy with fiducial tracking and narrowed target volumes, thus enhancing our efforts to spare normal tissue from inadvertent irradiation.</text>
      <annotation id="392">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23658" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="393">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="24017" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="394">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="23504" length="10"/>
        <text>toxicities</text>
      </annotation>
      <annotation id="395">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="23457" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="396">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="24226" length="20"/>
        <text>late rectal bleeding</text>
      </annotation>
      <annotation id="397">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="23915" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="398">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="24043" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="399">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="23684" length="8"/>
        <text>bleeding</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">13014_2014_277_Fig4_HTML.jpg</infon>
      <infon key="id">Fig4</infon>
      <infon key="type">fig_caption</infon>
      <offset>24562</offset>
      <text> Radar plots showing the distribution of individual symptom bother following SBRT for prostate cancer. EPIC scores range from 0-100 with higher values representing a more favorable health-related QOL. Points further out from the center indicate higher levels of bother with a given symptom.</text>
      <annotation id="401">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="24648" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>24855</offset>
      <text>The pattern seen in bowel QOL after SBRT in our study is similar to the pattern seen after conventionally fractionated radiotherapy, proton therapy or brachytherapy. The bowel QOL score is at its lowest 1 or 2 months after treatment, but improves slowly thereafter to near baseline by 1-2 years after treatment. In our series, most moderate to big problems were seen at 1 month post-SBRT with approximately 10% of patients reporting moderate to big problems with bowel urgency and/or frequency (Figure 4). This compares favorably with 15-19% incidence of moderate to severe bowel urgency and frequency seen two months after conventionally fractionated external beam radiation therapy or brachytherapy. Unlike conventional modalities, this increase in bowel bother was transient and returned to near baseline by 3 months post-SBRT. A second transient increase in bowel bother occurred at 12 months with approximately 7% of patients reporting moderate to big problems. Unlike the pattern seen with conventional modalities, post-SBRT bowel bother returned to near baseline by two years. The mean bowel summary score change from baseline to 24 months in this study was -1.6. This change compares favorably to that seen at 24 months with conventionally fractionated IMRT and proton therapy -7.4 and -3.7, respectively.</text>
      <annotation id="408">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25269" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="409">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25777" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="410">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="25429" length="13"/>
        <text>bowel urgency</text>
      </annotation>
      <annotation id="411">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="24875" length="9"/>
        <text>bowel QOL</text>
      </annotation>
      <annotation id="412">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="25318" length="13"/>
        <text>bowel urgency</text>
      </annotation>
      <annotation id="413">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="25025" length="9"/>
        <text>bowel QOL</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>26176</offset>
      <text>The present study has several identifiable limitations. The patient population was derived from a single high-volume institution cohort that can limit the translation of our work to the general population. Nevertheless, our work utilized a fairly large patient population with excellent follow-up rates, and was heterogeneous with respect to ethnicity and risk stratification, and considered key patient characteristics such as comorbidity, body mass index, and use of anticoagulants and hormonal therapy. It is conceivable, however, that institutions without the same experience may have a learning curve before they can achieve similar results. Also noteworthy is that our analysis was conducted without a concurrent comparator arm and thus must be carefully weighed against previously published work. Reassuringly, given that the observed toxicity rates in the acute phase are within range of previous studies, the superior toxicity profile at two years follow-up with SBRT compared to other modalities offers intriguing insight to guide subsequent trials for a more comprehensive assessments of SBRT-related proctitis in the future.</text>
      <annotation id="420">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26236" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="421">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26429" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="422">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26572" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="423">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="27103" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="424">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="27288" length="9"/>
        <text>proctitis</text>
      </annotation>
      <annotation id="425">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="27018" length="8"/>
        <text>toxicity</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>27313</offset>
      <text>Conclusions</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>27325</offset>
      <text>In this single institution cohort, the rate and severity of proctitis observed following SBRT is low. QOL tended to improve with longer follow-up and was near baseline at two years post-SBRT. Our results compare favorably to those reported for patients treated with alternative radiation modalities. Future prospective randomized studies are needed to confirm these observations.</text>
      <annotation id="428">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27569" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="429">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="27385" length="9"/>
        <text>proctitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_2</infon>
      <offset>27705</offset>
      <text>Consent</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>27713</offset>
      <text>This study was a retrospective review of prospectively collected data that was approved by the Georgetown University Institutional Review Board.</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">title</infon>
      <offset>27858</offset>
      <text>Abbreviations</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>27872</offset>
      <text>ADT</text>
      <annotation id="431">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="27872" length="3"/>
        <text>ADT</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>27876</offset>
      <text>Androgen deprivation therapy</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>27905</offset>
      <text>CT</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>27908</offset>
      <text>Computed tomography</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>27928</offset>
      <text>CTC</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>27932</offset>
      <text>Common toxicity criteria</text>
      <annotation id="433">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="27939" length="8"/>
        <text>toxicity</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>27957</offset>
      <text>CTV</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>27961</offset>
      <text>Clinical target volume</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>27984</offset>
      <text>DVH</text>
      <annotation id="435">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="27984" length="3"/>
        <text>DVH</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>27988</offset>
      <text>Dose-volume histogram</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28010</offset>
      <text>EQD2</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28015</offset>
      <text>Equivalent dose in 2-Gy fractions</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28049</offset>
      <text>EPIC</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28054</offset>
      <text>Expanded prostate index composite</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28088</offset>
      <text>GTV</text>
      <annotation id="437">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="28088" length="3"/>
        <text>GTV</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28092</offset>
      <text>Gross target volume</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28112</offset>
      <text>Gy</text>
      <annotation id="439">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="28112" length="2"/>
        <text>Gy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28115</offset>
      <text>Gray</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28120</offset>
      <text>IMRT</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28125</offset>
      <text>Intensity modulated radiation therapy</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28163</offset>
      <text>IRB</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28167</offset>
      <text>Internal review board</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28189</offset>
      <text>PTV</text>
      <annotation id="441">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="28189" length="3"/>
        <text>PTV</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28193</offset>
      <text>Planning target volume</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28216</offset>
      <text>QoL</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28220</offset>
      <text>Quality of life</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28236</offset>
      <text>MID</text>
      <annotation id="443">
        <infon key="type">Disease</infon>
        <location offset="28236" length="3"/>
        <text>MID</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28240</offset>
      <text>Minimally important difference</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28271</offset>
      <text>MR</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28274</offset>
      <text>Magnetic resonance</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28293</offset>
      <text>NCI</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28297</offset>
      <text>National cancer institute</text>
      <annotation id="445">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="28306" length="6"/>
        <text>cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28323</offset>
      <text>SD</text>
      <annotation id="447">
        <infon key="identifier">MESH:D029461</infon>
        <infon key="type">Disease</infon>
        <location offset="28323" length="2"/>
        <text>SD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28326</offset>
      <text>Standard deviation</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28345</offset>
      <text>SBRT</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28350</offset>
      <text>Stereotactic body radiation therapy</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28386</offset>
      <text>VRS</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">paragraph</infon>
      <offset>28390</offset>
      <text>Vienna rectoscopy score</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">footnote</infon>
      <offset>28414</offset>
      <text>Daniel Y Joh and Leonard N Chen contributed equally to this work.</text>
      <annotation id="449">
        <infon key="identifier">MESH:C536108</infon>
        <infon key="type">Disease</infon>
        <location offset="28431" length="9"/>
        <text>Leonard N</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">footnote</infon>
      <offset>28480</offset>
      <text>Competing interests</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">footnote</infon>
      <offset>28500</offset>
      <text>SP Collins and BT Collins serve as clinical consultants to Accuray Inc. The Department of Radiation Medicine at Georgetown University Hospital receives a grant from Accuray to support a research coordinator. The other authors declare that they have no competing interests.</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">footnote</infon>
      <offset>28773</offset>
      <text>Authors' contributions</text>
    </passage>
    <passage>
      <infon key="section_type">ABBR</infon>
      <infon key="type">footnote</infon>
      <offset>28798</offset>
      <text>DJ and LC are lead authors, who participated in data collection, data analysis, manuscript drafting, table/figure creation, and manuscript revision. GP participated in data analysis and manuscript drafting. AB, SS, RM, and JK aided in the quality of life data collection and maintaining the patient database. TY aided in clinical data collection. SL is the dosimetrist who developed the majority of patients' treatment plans, and contributed to the dosimetric data analysis and interpretation. BC and AJ participated in the design and coordination of the study. SS is a senior author who collected the dosimetric data, participated in its analysis, and helped draft the manuscript. JC, AD, and JL are senior authors who aided in drafting the manuscript. SC was the principal investigator who initially developed the concept of the study and the design, aided in data collection, drafted and revised the manuscript. All authors read and approved the final manuscript.</text>
      <annotation id="453">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="29089" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="454">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="29197" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="455">
        <infon key="identifier">MESH:D000544</infon>
        <infon key="type">Disease</infon>
        <location offset="29484" length="2"/>
        <text>AD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>29767</offset>
      <text>References</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Glass;given-names:TA</infon>
      <infon key="name_2">surname:Testa;given-names:M</infon>
      <infon key="name_1">surname:Giovannucci;given-names:E</infon>
      <infon key="name_0">surname:Bacon;given-names:CG</infon>
      <infon key="fpage">862</infon>
      <infon key="pub-id_doi">10.1002/cncr.10248</infon>
      <infon key="pub-id_pmid">11857323</infon>
      <infon key="year">2002</infon>
      <infon key="source">Cancer</infon>
      <infon key="type">ref</infon>
      <infon key="volume">94</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">871</infon>
      <infon key="name_4">surname:Kawachi;given-names:I</infon>
      <offset>29778</offset>
      <text>The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients</text>
      <annotation id="457">
        <infon key="identifier">MESH:D011472</infon>
        <infon key="type">Disease</infon>
        <location offset="29858" length="28"/>
        <text>localized prostate carcinoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Erber;given-names:C</infon>
      <infon key="name_2">surname:Thamm;given-names:R</infon>
      <infon key="name_1">surname:Zimmermann;given-names:FB</infon>
      <infon key="name_0">surname:Geinitz;given-names:H</infon>
      <infon key="fpage">341</infon>
      <infon key="pub-id_doi">10.1016/j.radonc.2006.05.004</infon>
      <infon key="pub-id_pmid">16733072</infon>
      <infon key="year">2006</infon>
      <infon key="source">Radiother Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">79</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Molls;given-names:M</infon>
      <infon key="lpage">347</infon>
      <infon key="name_6">surname:Busch;given-names:R</infon>
      <infon key="name_5">surname:Keller;given-names:M</infon>
      <infon key="name_4">surname:Muller;given-names:T</infon>
      <offset>29896</offset>
      <text>Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer</text>
      <annotation id="459">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="29975" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Sandler;given-names:HM</infon>
      <infon key="name_2">surname:Michalski;given-names:J</infon>
      <infon key="name_1">surname:Dunn;given-names:RL</infon>
      <infon key="name_0">surname:Sanda;given-names:MG</infon>
      <infon key="pub-id_doi">10.1056/NEJMoa074311</infon>
      <infon key="pub-id_pmid">18354103</infon>
      <infon key="year">2008</infon>
      <infon key="source">N Engl J Med</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1261</infon>
      <infon key="fpage">1250</infon>
      <infon key="volume">358</infon>
      <infon key="name_10">surname:Mahadevan;given-names:A</infon>
      <infon key="name_13">surname:Pisters;given-names:LL</infon>
      <infon key="name_14">surname:Kuban;given-names:D</infon>
      <infon key="name_11">surname:Klein;given-names:E</infon>
      <infon key="name_12">surname:Kibel;given-names:A</infon>
      <infon key="name_17">surname:Ciezki;given-names:J</infon>
      <infon key="name_18">surname:Shah;given-names:N</infon>
      <infon key="name_15">surname:Kaplan;given-names:I</infon>
      <infon key="name_9">surname:Saigal;given-names:CS</infon>
      <infon key="name_16">surname:Wood;given-names:D</infon>
      <infon key="name_8">surname:Litwin;given-names:MS</infon>
      <infon key="name_7">surname:Greenfield;given-names:TK</infon>
      <infon key="name_6">surname:Lin;given-names:X</infon>
      <infon key="name_19">surname:Wei;given-names:JT</infon>
      <infon key="name_5">surname:Hembroff;given-names:L</infon>
      <infon key="name_4">surname:Northouse;given-names:L</infon>
      <offset>29991</offset>
      <text>Quality of life and satisfaction with outcome among prostate-cancer survivors</text>
      <annotation id="461">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="30043" length="15"/>
        <text>prostate-cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Sanda;given-names:MG</infon>
      <infon key="name_2">surname:Yeap;given-names:BY</infon>
      <infon key="name_1">surname:Paly;given-names:JJ</infon>
      <infon key="name_0">surname:Gray;given-names:PJ</infon>
      <infon key="fpage">1729</infon>
      <infon key="pub-id_doi">10.1002/cncr.27956</infon>
      <infon key="pub-id_pmid">23436283</infon>
      <infon key="year">2013</infon>
      <infon key="source">Cancer</infon>
      <infon key="type">ref</infon>
      <infon key="volume">119</infon>
      <infon key="name_10">surname:Hahn;given-names:SM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:Efstathiou;given-names:JA</infon>
      <infon key="name_11">surname:Zietman;given-names:AL</infon>
      <infon key="name_12">surname:Bekelman;given-names:JE</infon>
      <infon key="name_9">surname:Shipley;given-names:WU</infon>
      <infon key="name_8">surname:Hamstra;given-names:DA</infon>
      <infon key="name_7">surname:Coen;given-names:JJ</infon>
      <infon key="lpage">1735</infon>
      <infon key="name_6">surname:Talcott;given-names:JA</infon>
      <infon key="name_5">surname:Michalski;given-names:JM</infon>
      <infon key="name_4">surname:Sandler;given-names:HM</infon>
      <offset>30069</offset>
      <text>Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer</text>
      <annotation id="464">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="30069" length="7"/>
        <text>Patient</text>
      </annotation>
      <annotation id="465">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="30179" length="25"/>
        <text>localized prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Morris;given-names:CG</infon>
      <infon key="name_2">surname:Mendenhall;given-names:NP</infon>
      <infon key="name_1">surname:Michalski;given-names:JM</infon>
      <infon key="name_0">surname:Hoppe;given-names:BS</infon>
      <infon key="fpage">1076</infon>
      <infon key="pub-id_doi">10.1002/cncr.28536</infon>
      <infon key="pub-id_pmid">24382757</infon>
      <infon key="year">2013</infon>
      <infon key="source">Cancer</infon>
      <infon key="type">ref</infon>
      <infon key="volume">120</infon>
      <infon key="name_10">surname:Crociani;given-names:CM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:Hamstra;given-names:DA</infon>
      <infon key="name_11">surname:Sandler;given-names:HM</infon>
      <infon key="name_12">surname:Sanda;given-names:MG</infon>
      <infon key="name_9">surname:Chipman;given-names:JJ</infon>
      <infon key="name_8">surname:Regan;given-names:MM</infon>
      <infon key="name_7">surname:Williams;given-names:CR</infon>
      <infon key="lpage">1082</infon>
      <infon key="name_6">surname:Mendenhall;given-names:WM</infon>
      <infon key="name_5">surname:Nichols;given-names:RC</infon>
      <infon key="name_4">surname:Henderson;given-names:RH</infon>
      <offset>30205</offset>
      <text>Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer</text>
      <annotation id="468">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="30240" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="469">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="30327" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Grant;given-names:WH;suffix:3rd</infon>
      <infon key="name_2">surname:McGary;given-names:JE</infon>
      <infon key="name_1">surname:Mai;given-names:WY</infon>
      <infon key="name_0">surname:Garg;given-names:AK</infon>
      <infon key="fpage">1294</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2006.07.1386</infon>
      <infon key="pub-id_pmid">17126204</infon>
      <infon key="year">2006</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">66</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1305</infon>
      <infon key="name_5">surname:Teh;given-names:BS</infon>
      <infon key="name_4">surname:Butler;given-names:EB</infon>
      <offset>30343</offset>
      <text>Radiation proctopathy in the treatment of prostate cancer</text>
      <annotation id="472">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="30385" length="15"/>
        <text>prostate cancer</text>
      </annotation>
      <annotation id="473">
        <infon key="identifier">MESH:D004194</infon>
        <infon key="type">Disease</infon>
        <location offset="30343" length="21"/>
        <text>Radiation proctopathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Widmark;given-names:A</infon>
      <infon key="name_2">surname:Wibe;given-names:A</infon>
      <infon key="name_1">surname:Kaasa;given-names:S</infon>
      <infon key="name_0">surname:Lund;given-names:JA</infon>
      <infon key="fpage">727</infon>
      <infon key="pub-id_doi">10.3109/0284186X.2013.747695</infon>
      <infon key="pub-id_pmid">23398595</infon>
      <infon key="year">2013</infon>
      <infon key="source">Acta Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">52</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">735</infon>
      <infon key="name_4">surname:Fransson;given-names:P</infon>
      <offset>30401</offset>
      <text>Late radiation effects to the rectum and anus after treatment for prostate cancer; validity of the LENT/SOMA score</text>
      <annotation id="475">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="30467" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Litwin;given-names:MS</infon>
      <infon key="name_2">surname:Presti;given-names:JC</infon>
      <infon key="name_1">surname:Sadetsky;given-names:N</infon>
      <infon key="name_0">surname:Sonn;given-names:GA</infon>
      <infon key="fpage">2296</infon>
      <infon key="pub-id_doi">10.1016/j.juro.2009.07.027</infon>
      <infon key="pub-id_pmid">19758610</infon>
      <infon key="year">2009</infon>
      <infon key="source">J Urol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">182</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">2302</infon>
      <offset>30516</offset>
      <text>Differing perceptions of quality of life in patients with prostate cancer and their doctors</text>
      <annotation id="478">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="30560" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="479">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="30574" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Oswald;given-names:MJ</infon>
      <infon key="name_2">surname:Wharton;given-names:JT</infon>
      <infon key="name_1">surname:Levenback;given-names:C</infon>
      <infon key="name_0">surname:Eifel;given-names:PJ</infon>
      <infon key="fpage">1289</infon>
      <infon key="pub-id_doi">10.1016/0360-3016(95)00118-I</infon>
      <infon key="pub-id_pmid">7635768</infon>
      <infon key="year">1995</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">32</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1300</infon>
      <offset>30608</offset>
      <text>Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix</text>
      <annotation id="482">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="30659" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="483">
        <infon key="identifier">MESH:D002277</infon>
        <infon key="type">Disease</infon>
        <location offset="30717" length="9"/>
        <text>carcinoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Litzenberg;given-names:D</infon>
      <infon key="name_2">surname:Ritter;given-names:T</infon>
      <infon key="name_1">surname:Stenmark;given-names:MH</infon>
      <infon key="name_0">surname:Hamstra;given-names:DA</infon>
      <infon key="fpage">1246</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2012.10.042</infon>
      <infon key="pub-id_pmid">23265567</infon>
      <infon key="year">2013</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">85</infon>
      <infon key="name_10">surname:Halverson;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:Feng;given-names:FY</infon>
      <infon key="name_11">surname:Marsh;given-names:R</infon>
      <infon key="name_12">surname:Olson;given-names:K</infon>
      <infon key="name_9">surname:Blas;given-names:K</infon>
      <infon key="name_8">surname:Phelps;given-names:L</infon>
      <infon key="name_7">surname:Donaghy;given-names:A</infon>
      <infon key="lpage">1253</infon>
      <infon key="name_6">surname:Albrecht-Unger;given-names:L</infon>
      <infon key="name_5">surname:Johnson;given-names:S</infon>
      <infon key="name_4">surname:Jackson;given-names:W</infon>
      <offset>30749</offset>
      <text>Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer</text>
      <annotation id="486">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="30862" length="15"/>
        <text>prostate cancer</text>
      </annotation>
      <annotation id="487">
        <infon key="identifier">MESH:D012002</infon>
        <infon key="type">Disease</infon>
        <location offset="30794" length="20"/>
        <text>late rectal toxicity</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Menon;given-names:V</infon>
      <infon key="name_2">surname:Zietman;given-names:AL</infon>
      <infon key="name_1">surname:Ooi;given-names:CJ</infon>
      <infon key="name_0">surname:Willett;given-names:CG</infon>
      <infon key="fpage">995</infon>
      <infon key="pub-id_doi">10.1016/S0360-3016(99)00374-0</infon>
      <infon key="pub-id_pmid">10705022</infon>
      <infon key="year">2000</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">46</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">998</infon>
      <infon key="name_6">surname:Podolsky;given-names:DK</infon>
      <infon key="name_5">surname:Sands;given-names:BE</infon>
      <infon key="name_4">surname:Goldberg;given-names:S</infon>
      <offset>30878</offset>
      <text>Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms</text>
      <annotation id="492">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="30905" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="493">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="30994" length="9"/>
        <text>neoplasms</text>
      </annotation>
      <annotation id="494">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="30893" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="495">
        <infon key="identifier">MESH:D015212</infon>
        <infon key="type">Disease</infon>
        <location offset="30919" length="26"/>
        <text>inflammatory bowel disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">76</infon>
      <infon key="name_2">surname:Liauw;given-names:SL</infon>
      <infon key="name_1">surname:Jani;given-names:AB</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Choe;given-names:KS</infon>
      <infon key="fpage">755</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2009.02.026</infon>
      <infon key="pub-id_pmid">19464123</infon>
      <infon key="year">2010</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">760</infon>
      <offset>31004</offset>
      <text>External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?</text>
      <annotation id="499">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="31051" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="500">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="31111" length="17"/>
        <text>bleeding toxicity</text>
      </annotation>
      <annotation id="501">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="31035" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">19</infon>
      <infon key="name_1">surname:Morris;given-names:AI</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Leiper;given-names:K</infon>
      <infon key="fpage">724</infon>
      <infon key="pub-id_doi">10.1016/j.clon.2007.07.008</infon>
      <infon key="pub-id_pmid">17728120</infon>
      <infon key="year">2007</infon>
      <infon key="source">Clin Oncol (R Coll Radiol)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">729</infon>
      <offset>31130</offset>
      <text>Treatment of radiation proctitis</text>
      <annotation id="503">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="31153" length="9"/>
        <text>proctitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Starkschall;given-names:G</infon>
      <infon key="name_2">surname:Dong;given-names:L</infon>
      <infon key="name_1">surname:Tucker;given-names:SL</infon>
      <infon key="name_0">surname:Kuban;given-names:DA</infon>
      <infon key="fpage">67</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2007.06.054</infon>
      <infon key="pub-id_pmid">17765406</infon>
      <infon key="year">2008</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">70</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Pollack;given-names:A</infon>
      <infon key="lpage">74</infon>
      <infon key="name_6">surname:Lee;given-names:AK</infon>
      <infon key="name_5">surname:Cheung;given-names:MR</infon>
      <infon key="name_4">surname:Huang;given-names:EH</infon>
      <offset>31163</offset>
      <text>Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer</text>
      <annotation id="505">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="31240" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Aird;given-names:EG</infon>
      <infon key="name_2">surname:Graham;given-names:JD</infon>
      <infon key="name_1">surname:Sydes;given-names:MR</infon>
      <infon key="name_0">surname:Dearnaley;given-names:DP</infon>
      <infon key="pub-id_doi">10.1016/S1470-2045(07)70143-2</infon>
      <infon key="pub-id_pmid">17482880</infon>
      <infon key="year">2007</infon>
      <infon key="source">Lancet Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">487</infon>
      <infon key="fpage">475</infon>
      <infon key="volume">8</infon>
      <infon key="name_10">surname:Moore;given-names:AR</infon>
      <infon key="name_13">surname:Scrase;given-names:CD</infon>
      <infon key="name_14">surname:Stephens;given-names:RJ</infon>
      <infon key="name_11">surname:Morgan;given-names:RC</infon>
      <infon key="name_12">surname:Russell;given-names:JM</infon>
      <infon key="name_15">surname:Syndikus;given-names:I</infon>
      <infon key="name_9">surname:Millar;given-names:J</infon>
      <infon key="name_16">surname:Parmar;given-names:MK</infon>
      <infon key="name_8">surname:Matthews;given-names:JH</infon>
      <infon key="name_7">surname:Jose;given-names:CC</infon>
      <infon key="name_6">surname:Huddart;given-names:RA</infon>
      <infon key="name_5">surname:Cowan;given-names:RA</infon>
      <infon key="name_4">surname:Bottomley;given-names:D</infon>
      <offset>31256</offset>
      <text>Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial</text>
      <annotation id="508">
        <infon key="identifier">CVCL:D923</infon>
        <infon key="type">CellLine</infon>
        <location offset="31358" length="8"/>
        <text>MRC RT01</text>
      </annotation>
      <annotation id="509">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="31318" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:van Leenders;given-names:GJ</infon>
      <infon key="name_2">surname:Heemsbergen;given-names:WD</infon>
      <infon key="name_1">surname:van Putten;given-names:WL</infon>
      <infon key="name_0">surname:Al-Mamgani;given-names:A</infon>
      <infon key="fpage">980</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2008.02.073</infon>
      <infon key="pub-id_pmid">18495377</infon>
      <infon key="year">2008</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">72</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Lebesque;given-names:JV</infon>
      <infon key="lpage">988</infon>
      <infon key="name_6">surname:Incrocci;given-names:L</infon>
      <infon key="name_5">surname:Dielwart;given-names:MF</infon>
      <infon key="name_4">surname:Slot;given-names:A</infon>
      <offset>31395</offset>
      <text>Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer</text>
      <annotation id="511">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="31465" length="25"/>
        <text>localized prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Geinitz;given-names:H</infon>
      <infon key="name_2">surname:Becker;given-names:G</infon>
      <infon key="name_1">surname:Tomicek;given-names:B</infon>
      <infon key="name_0">surname:Goldner;given-names:G</infon>
      <infon key="fpage">78</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2006.08.055</infon>
      <infon key="pub-id_pmid">17189064</infon>
      <infon key="year">2007</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">67</infon>
      <infon key="name_10">surname:Feldmann;given-names:H</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:Potter;given-names:R</infon>
      <infon key="name_11">surname:Potzi;given-names:R</infon>
      <infon key="name_12">surname:Molls;given-names:M</infon>
      <infon key="name_9">surname:Bamberg;given-names:M</infon>
      <infon key="name_8">surname:Glocker;given-names:S</infon>
      <infon key="name_7">surname:Reibenwein;given-names:J</infon>
      <infon key="lpage">83</infon>
      <infon key="name_6">surname:Wachter-Gerstner;given-names:N</infon>
      <infon key="name_5">surname:Zimmermann;given-names:F</infon>
      <infon key="name_4">surname:Wachter;given-names:S</infon>
      <offset>31491</offset>
      <text>Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients</text>
      <annotation id="515">
        <infon key="identifier">MESH:D011349</infon>
        <infon key="type">Disease</infon>
        <location offset="31491" length="9"/>
        <text>Proctitis</text>
      </annotation>
      <annotation id="516">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="31645" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="517">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="31538" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Tucker;given-names:SL</infon>
      <infon key="name_2">surname:Jackson;given-names:A</infon>
      <infon key="name_1">surname:Gay;given-names:H</infon>
      <infon key="name_0">surname:Michalski;given-names:JM</infon>
      <infon key="fpage">S123</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2009.03.078</infon>
      <infon key="pub-id_pmid">20171506</infon>
      <infon key="year">2010</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">76</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">S129</infon>
      <infon key="name_4">surname:Deasy;given-names:JO</infon>
      <offset>31714</offset>
      <text>Radiation dose-volume effects in radiation-induced rectal injury</text>
      <annotation id="519">
        <infon key="identifier">MESH:D012002</infon>
        <infon key="type">Disease</infon>
        <location offset="31765" length="13"/>
        <text>rectal injury</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">19</infon>
      <infon key="name_1">surname:Wylie;given-names:JP</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bayman;given-names:NA</infon>
      <infon key="fpage">302</infon>
      <infon key="pub-id_doi">10.1016/j.clon.2007.03.005</infon>
      <infon key="pub-id_pmid">17448647</infon>
      <infon key="year">2007</infon>
      <infon key="source">Clin Oncol (R Coll Radiol)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">307</infon>
      <offset>31779</offset>
      <text>When should the seminal vesicles be included in the target volume in prostate radiotherapy?</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Morton;given-names:G</infon>
      <infon key="name_2">surname:Franssen;given-names:E</infon>
      <infon key="name_1">surname:Mah;given-names:K</infon>
      <infon key="name_0">surname:Dawson;given-names:LA</infon>
      <infon key="fpage">1155</infon>
      <infon key="pub-id_doi">10.1016/S0360-3016(98)00265-X</infon>
      <infon key="pub-id_pmid">9869243</infon>
      <infon key="year">1998</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">42</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1161</infon>
      <offset>31871</offset>
      <text>Target position variability throughout prostate radiotherapy</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Bosch;given-names:WR</infon>
      <infon key="name_2">surname:Michalski;given-names:JM</infon>
      <infon key="name_1">surname:Dong;given-names:L</infon>
      <infon key="name_0">surname:Tucker;given-names:SL</infon>
      <infon key="fpage">390</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2011.11.073</infon>
      <infon key="pub-id_pmid">22342302</infon>
      <infon key="year">2012</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">84</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Mohan;given-names:R</infon>
      <infon key="lpage">395</infon>
      <infon key="name_6">surname:Purdy;given-names:JA</infon>
      <infon key="name_5">surname:Cox;given-names:JD</infon>
      <infon key="name_4">surname:Winter;given-names:K</infon>
      <offset>31932</offset>
      <text>Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06</text>
      <annotation id="521">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="31990" length="8"/>
        <text>toxicity</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Dunn;given-names:RL</infon>
      <infon key="name_2">surname:Daignault;given-names:S</infon>
      <infon key="name_1">surname:Conlon;given-names:AS</infon>
      <infon key="name_0">surname:Hamstra;given-names:DA</infon>
      <infon key="fpage">546</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2013.01.036</infon>
      <infon key="pub-id_pmid">23561651</infon>
      <infon key="year">2013</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">86</infon>
      <infon key="name_10">surname:Wei;given-names:JT</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Sanda;given-names:MG</infon>
      <infon key="name_12">surname:Michalski;given-names:JM</infon>
      <infon key="name_9">surname:Kuban;given-names:DA</infon>
      <infon key="name_8">surname:Ciezki;given-names:J</infon>
      <infon key="name_7">surname:Kaplan;given-names:I</infon>
      <infon key="lpage">553</infon>
      <infon key="name_6">surname:Zietman;given-names:AL</infon>
      <infon key="name_5">surname:Hembroff;given-names:AL</infon>
      <infon key="name_4">surname:Sandler;given-names:HM</infon>
      <offset>32073</offset>
      <text>Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience</text>
      <annotation id="524">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="32199" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="525">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="32245" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Yamada;given-names:Y</infon>
      <infon key="name_2">surname:Hunt;given-names:M</infon>
      <infon key="name_1">surname:Levin;given-names:EJ</infon>
      <infon key="name_0">surname:Zelefsky;given-names:MJ</infon>
      <infon key="fpage">1124</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2007.11.044</infon>
      <infon key="pub-id_pmid">18313526</infon>
      <infon key="year">2008</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">70</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1129</infon>
      <infon key="name_6">surname:Amols;given-names:HI</infon>
      <infon key="name_5">surname:Jackson;given-names:A</infon>
      <infon key="name_4">surname:Shippy;given-names:AM</infon>
      <offset>32295</offset>
      <text>Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer</text>
      <annotation id="528">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="32431" length="25"/>
        <text>localized prostate cancer</text>
      </annotation>
      <annotation id="529">
        <infon key="identifier">MESH:D001745</infon>
        <infon key="type">Disease</infon>
        <location offset="32324" length="18"/>
        <text>urinary toxicities</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Bosch;given-names:WR</infon>
      <infon key="name_2">surname:Watkins-Bruner;given-names:D</infon>
      <infon key="name_1">surname:Yan;given-names:Y</infon>
      <infon key="name_0">surname:Michalski;given-names:JM</infon>
      <infon key="fpage">932</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2013.07.041</infon>
      <infon key="pub-id_pmid">24113055</infon>
      <infon key="year">2013</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">87</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Sandler;given-names:HM</infon>
      <infon key="name_8">surname:Parliament;given-names:MB</infon>
      <infon key="name_7">surname:Morton;given-names:GC</infon>
      <infon key="lpage">938</infon>
      <infon key="name_6">surname:Bahary;given-names:JP</infon>
      <infon key="name_5">surname:Galvin;given-names:JM</infon>
      <infon key="name_4">surname:Winter;given-names:K</infon>
      <offset>32457</offset>
      <text>Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial</text>
      <annotation id="532">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="32469" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="533">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="32643" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">44</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Fowler;given-names:JF</infon>
      <infon key="fpage">265</infon>
      <infon key="pub-id_doi">10.1080/02841860410002824</infon>
      <infon key="pub-id_pmid">16076699</infon>
      <infon key="year">2005</infon>
      <infon key="source">Acta Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">276</infon>
      <offset>32665</offset>
      <text>The radiobiology of prostate cancer including new aspects of fractionated radiotherapy</text>
      <annotation id="535">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="32685" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">43</infon>
      <infon key="name_1">surname:Hall;given-names:EJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Brenner;given-names:DJ</infon>
      <infon key="fpage">1095</infon>
      <infon key="pub-id_doi">10.1016/S0360-3016(98)00438-6</infon>
      <infon key="pub-id_pmid">10192361</infon>
      <infon key="year">1999</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1101</infon>
      <offset>32752</offset>
      <text>Fractionation and protraction for radiotherapy of prostate carcinoma</text>
      <annotation id="537">
        <infon key="identifier">MESH:D011472</infon>
        <infon key="type">Disease</infon>
        <location offset="32802" length="18"/>
        <text>prostate carcinoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Lawton;given-names:C</infon>
      <infon key="name_2">surname:Kupelian;given-names:P</infon>
      <infon key="name_1">surname:Forman;given-names:J</infon>
      <infon key="name_0">surname:Ritter;given-names:M</infon>
      <infon key="fpage">1</infon>
      <infon key="pub-id_doi">10.1097/PPO.0b013e3181976614</infon>
      <infon key="pub-id_pmid">19197165</infon>
      <infon key="year">2009</infon>
      <infon key="source">Cancer J</infon>
      <infon key="type">ref</infon>
      <infon key="volume">15</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">6</infon>
      <infon key="name_4">surname:Petereit;given-names:D</infon>
      <offset>32821</offset>
      <text>Hypofractionation for prostate cancer</text>
      <annotation id="539">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="32843" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Oermann;given-names:EK</infon>
      <infon key="name_2">surname:Uhm;given-names:S</infon>
      <infon key="name_1">surname:Suy;given-names:S</infon>
      <infon key="name_0">surname:Chen;given-names:LN</infon>
      <infon key="pub-id_doi">10.1186/1748-717X-8-58</infon>
      <infon key="pub-id_pmid">23497695</infon>
      <infon key="year">2013</infon>
      <infon key="source">Radiat Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Lynch;given-names:JH</infon>
      <infon key="name_21">surname:Collins;given-names:SP</infon>
      <infon key="section_type">REF</infon>
      <infon key="fpage">58</infon>
      <infon key="volume">8</infon>
      <infon key="name_10">surname:Batipps;given-names:GP</infon>
      <infon key="name_13">surname:Pahira;given-names:J</infon>
      <infon key="name_14">surname:McGeagh;given-names:KG</infon>
      <infon key="name_11">surname:Kowalczyk;given-names:K</infon>
      <infon key="name_12">surname:Bandi;given-names:G</infon>
      <infon key="name_17">surname:Dawson;given-names:NA</infon>
      <infon key="name_18">surname:Taylor;given-names:KL</infon>
      <infon key="name_15">surname:Collins;given-names:BT</infon>
      <infon key="name_9">surname:Lei;given-names:S</infon>
      <infon key="name_16">surname:Krishnan;given-names:P</infon>
      <infon key="name_8">surname:Kim;given-names:JS</infon>
      <infon key="name_7">surname:Laing;given-names:S</infon>
      <infon key="name_6">surname:Hanscom;given-names:HN</infon>
      <infon key="name_19">surname:Dritschilo;given-names:A</infon>
      <infon key="name_5">surname:Chen;given-names:V</infon>
      <infon key="name_4">surname:Ju;given-names:AW</infon>
      <offset>32859</offset>
      <text>Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience</text>
      <annotation id="541">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="32917" length="25"/>
        <text>localized prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ashley;given-names:R</infon>
      <infon key="volume">8</infon>
      <infon key="name_2">surname:Diblasio;given-names:F</infon>
      <infon key="name_1">surname:Santoro;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Katz;given-names:AJ</infon>
      <infon key="fpage">118</infon>
      <infon key="pub-id_doi">10.1186/1748-717X-8-118</infon>
      <infon key="pub-id_pmid">23668632</infon>
      <infon key="year">2013</infon>
      <infon key="source">Radiat Oncol</infon>
      <infon key="type">ref</infon>
      <offset>32981</offset>
      <text>Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years</text>
      <annotation id="543">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="33016" length="25"/>
        <text>localized prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Wang;given-names:P</infon>
      <infon key="name_2">surname:Fuller;given-names:D</infon>
      <infon key="name_1">surname:Collins;given-names:SP</infon>
      <infon key="name_0">surname:King;given-names:CR</infon>
      <infon key="fpage">939</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2013.08.019</infon>
      <infon key="pub-id_pmid">24119836</infon>
      <infon key="year">2013</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">87</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">945</infon>
      <infon key="name_6">surname:Katz;given-names:A</infon>
      <infon key="name_5">surname:Steinberg;given-names:M</infon>
      <infon key="name_4">surname:Kupelian;given-names:P</infon>
      <offset>33091</offset>
      <text>Health Related Quality of Life after Stereotactic Body Radiotherapy for Localized Prostate Cancer: Results from a Multi-Institutional Consortium of Prospective Trials</text>
      <annotation id="545">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="33163" length="25"/>
        <text>Localized Prostate Cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Fuller;given-names:D</infon>
      <infon key="name_2">surname:Kaplan;given-names:I</infon>
      <infon key="name_1">surname:Freeman;given-names:D</infon>
      <infon key="name_0">surname:King;given-names:CR</infon>
      <infon key="fpage">217</infon>
      <infon key="pub-id_doi">10.1016/j.radonc.2013.08.030</infon>
      <infon key="year">2013</infon>
      <infon key="source">Radiat Ther Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">109</infon>
      <infon key="name_10">surname:Katz;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Steinberg;given-names:M</infon>
      <infon key="name_8">surname:Kupelian;given-names:P</infon>
      <infon key="name_7">surname:Wang;given-names:J</infon>
      <infon key="lpage">221</infon>
      <infon key="name_6">surname:Meier;given-names:R</infon>
      <infon key="name_5">surname:Collins;given-names:SP</infon>
      <infon key="name_4">surname:Bolzicco;given-names:G</infon>
      <offset>33258</offset>
      <text>Stereotactic Body Radiotherapy for Localized Prostate Cancer: Pooled Analysis of Multi-Insitutional Prospective Trials</text>
      <annotation id="547">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="33293" length="25"/>
        <text>Localized Prostate Cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Presti;given-names:JC;suffix:Jr</infon>
      <infon key="name_2">surname:Gill;given-names:H</infon>
      <infon key="name_1">surname:Brooks;given-names:JD</infon>
      <infon key="name_0">surname:King;given-names:CR</infon>
      <infon key="fpage">877</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2010.11.054</infon>
      <infon key="pub-id_pmid">21300474</infon>
      <infon key="year">2011</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">82</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">882</infon>
      <offset>33377</offset>
      <text>Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer</text>
      <annotation id="549">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="33468" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Harkins;given-names:B</infon>
      <infon key="name_2">surname:Dombrowski;given-names:JJ</infon>
      <infon key="name_1">surname:Wong;given-names:DS</infon>
      <infon key="name_0">surname:McBride;given-names:SM</infon>
      <infon key="fpage">3681</infon>
      <infon key="pub-id_doi">10.1002/cncr.26699</infon>
      <infon key="pub-id_pmid">22170628</infon>
      <infon key="year">2012</infon>
      <infon key="source">Cancer</infon>
      <infon key="type">ref</infon>
      <infon key="volume">118</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Kaplan;given-names:ID</infon>
      <infon key="lpage">3690</infon>
      <infon key="name_6">surname:Collins;given-names:SP</infon>
      <infon key="name_5">surname:Hanscom;given-names:HN</infon>
      <infon key="name_4">surname:Tapella;given-names:P</infon>
      <offset>33484</offset>
      <text>Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: Preliminary results of a multi-institutional phase 1 feasibility trial</text>
      <annotation id="551">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="33544" length="23"/>
        <text>prostate adenocarcinoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Wang;given-names:H</infon>
      <infon key="name_2">surname:Lei;given-names:S</infon>
      <infon key="name_1">surname:Suy;given-names:S</infon>
      <infon key="name_0">surname:Ju;given-names:AW</infon>
      <infon key="fpage">30</infon>
      <infon key="pub-id_doi">10.1186/1748-717X-8-30</infon>
      <infon key="pub-id_pmid">23369294</infon>
      <infon key="year">2013</infon>
      <infon key="source">Radiat Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">8</infon>
      <infon key="name_10">surname:Dritschilo;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Collins;given-names:SP</infon>
      <infon key="name_9">surname:Lynch;given-names:JH</infon>
      <infon key="name_8">surname:Kim;given-names:JS</infon>
      <infon key="name_7">surname:Hanscom;given-names:HN</infon>
      <infon key="name_6">surname:Uhm;given-names:S</infon>
      <infon key="name_5">surname:Sherer;given-names:BA</infon>
      <infon key="name_4">surname:Oermann;given-names:EK</infon>
      <offset>33640</offset>
      <text>Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer. Radiation Oncology</text>
      <annotation id="553">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="33730" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hossain;given-names:S</infon>
      <infon key="name_2">surname:King;given-names:CR</infon>
      <infon key="name_1">surname:Djajaputra;given-names:D</infon>
      <infon key="name_0">surname:Xie;given-names:Y</infon>
      <infon key="fpage">236</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2008.04.051</infon>
      <infon key="pub-id_pmid">18722274</infon>
      <infon key="year">2008</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">72</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">246</infon>
      <infon key="name_5">surname:Xing;given-names:L</infon>
      <infon key="name_4">surname:Ma;given-names:L</infon>
      <offset>33766</offset>
      <text>Intrafractional motion of the prostate during hypofractionated radiotherapy</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Chen;given-names:V</infon>
      <infon key="name_2">surname:Oermann;given-names:EK</infon>
      <infon key="name_1">surname:Piel;given-names:N</infon>
      <infon key="name_0">surname:Lei;given-names:S</infon>
      <infon key="fpage">48</infon>
      <infon key="pub-id_doi">10.3389/fonc.2011.00048</infon>
      <infon key="pub-id_pmid">22655248</infon>
      <infon key="year">2011</infon>
      <infon key="source">Front Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">1</infon>
      <infon key="name_10">surname:Collins;given-names:BT</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:Suy;given-names:S</infon>
      <infon key="name_14">surname:Collins;given-names:SP</infon>
      <infon key="name_11">surname:Jha;given-names:R</infon>
      <infon key="name_12">surname:Dritschilo;given-names:A</infon>
      <infon key="name_9">surname:Zhang;given-names:G</infon>
      <infon key="name_8">surname:Yu;given-names:X</infon>
      <infon key="name_7">surname:Kim;given-names:JS</infon>
      <infon key="name_6">surname:Hanscom;given-names:HN</infon>
      <infon key="name_5">surname:Dahal;given-names:KN</infon>
      <infon key="name_4">surname:Ju;given-names:AW</infon>
      <offset>33842</offset>
      <text>Six-Dimensional Correction of Intra-Fractional Prostate Motion with CyberKnife Stereotactic Body Radiation Therapy</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Schultz;given-names:D</infon>
      <infon key="name_2">surname:Malkowicz;given-names:SB</infon>
      <infon key="name_1">surname:Whittington;given-names:R</infon>
      <infon key="name_0">surname:D'Amico;given-names:AV</infon>
      <infon key="fpage">969</infon>
      <infon key="pub-id_doi">10.1001/jama.280.11.969</infon>
      <infon key="pub-id_pmid">9749478</infon>
      <infon key="year">1998</infon>
      <infon key="source">Jama</infon>
      <infon key="type">ref</infon>
      <infon key="volume">280</infon>
      <infon key="name_10">surname:Wein;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Beard;given-names:CJ</infon>
      <infon key="name_8">surname:Kaplan;given-names:I</infon>
      <infon key="name_7">surname:Renshaw;given-names:AA</infon>
      <infon key="lpage">974</infon>
      <infon key="name_6">surname:Tomaszewski;given-names:JE</infon>
      <infon key="name_5">surname:Broderick;given-names:GA</infon>
      <infon key="name_4">surname:Blank;given-names:K</infon>
      <offset>33957</offset>
      <text>Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer</text>
      <annotation id="555">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="34088" length="25"/>
        <text>localized prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Lei;given-names:S</infon>
      <infon key="name_2">surname:Wang;given-names:H</infon>
      <infon key="name_1">surname:Ju;given-names:AW</infon>
      <infon key="name_0">surname:Sood;given-names:S</infon>
      <infon key="fpage">197</infon>
      <infon key="pub-id_doi">10.1186/1748-717X-8-197</infon>
      <infon key="pub-id_pmid">23937800</infon>
      <infon key="year">2013</infon>
      <infon key="source">Radiat Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">8</infon>
      <infon key="name_10">surname:Collins;given-names:SP</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Dritschilo;given-names:A</infon>
      <infon key="name_8">surname:Lynch;given-names:J</infon>
      <infon key="name_7">surname:Carroll;given-names:J</infon>
      <infon key="name_6">surname:Suy;given-names:S</infon>
      <infon key="name_5">surname:Zhang;given-names:G</infon>
      <infon key="name_4">surname:Uhm;given-names:S</infon>
      <offset>34114</offset>
      <text>Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer</text>
      <annotation id="557">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="34201" length="25"/>
        <text>localized prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Potzi;given-names:R</infon>
      <infon key="name_2">surname:Goldner;given-names:G</infon>
      <infon key="name_1">surname:Gerstner;given-names:N</infon>
      <infon key="name_0">surname:Wachter;given-names:S</infon>
      <infon key="fpage">11</infon>
      <infon key="pub-id_doi">10.1016/S0167-8140(99)00173-5</infon>
      <infon key="pub-id_pmid">10719695</infon>
      <infon key="year">2000</infon>
      <infon key="source">Radiother Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">54</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">19</infon>
      <infon key="name_5">surname:Potter;given-names:R</infon>
      <infon key="name_4">surname:Wambersie;given-names:A</infon>
      <offset>34227</offset>
      <text>Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma</text>
      <annotation id="560">
        <infon key="identifier">MESH:D011472</infon>
        <infon key="type">Disease</infon>
        <location offset="34309" length="19"/>
        <text>prostatic carcinoma</text>
      </annotation>
      <annotation id="561">
        <infon key="identifier">MESH:D009059</infon>
        <infon key="type">Disease</infon>
        <location offset="34261" length="14"/>
        <text>mucosal damage</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Sandler;given-names:HM</infon>
      <infon key="name_2">surname:Litwin;given-names:MS</infon>
      <infon key="name_1">surname:Dunn;given-names:RL</infon>
      <infon key="name_0">surname:Wei;given-names:JT</infon>
      <infon key="fpage">899</infon>
      <infon key="pub-id_doi">10.1016/S0090-4295(00)00858-X</infon>
      <infon key="pub-id_pmid">11113727</infon>
      <infon key="year">2000</infon>
      <infon key="source">Urology</infon>
      <infon key="type">ref</infon>
      <infon key="volume">56</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">905</infon>
      <infon key="name_4">surname:Sanda;given-names:MG</infon>
      <offset>34329</offset>
      <text>Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer</text>
      <annotation id="565">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="34477" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="566">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="34486" length="15"/>
        <text>prostate cancer</text>
      </annotation>
      <annotation id="567">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="34372" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">68</infon>
      <infon key="name_2">surname:Willis;given-names:GB</infon>
      <infon key="name_1">surname:Potosky;given-names:AL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Reeve;given-names:BB</infon>
      <infon key="fpage">599</infon>
      <infon key="pub-id_doi">10.1016/j.urology.2006.03.037</infon>
      <infon key="pub-id_pmid">16979720</infon>
      <infon key="year">2006</infon>
      <infon key="source">Urology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">603</infon>
      <offset>34502</offset>
      <text>Should function and bother be measured and reported separately for prostate cancer quality-of-life domains?</text>
      <annotation id="569">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="34569" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">41</infon>
      <infon key="name_2">surname:Wyrwich;given-names:KW</infon>
      <infon key="name_1">surname:Sloan;given-names:JA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Norman;given-names:GR</infon>
      <infon key="fpage">582</infon>
      <infon key="pub-id_pmid">12719681</infon>
      <infon key="year">2003</infon>
      <infon key="source">Med Care</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">592</infon>
      <offset>34610</offset>
      <text>Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Kwan;given-names:L</infon>
      <infon key="name_2">surname:Bergman;given-names:J</infon>
      <infon key="name_1">surname:Gollapudi;given-names:K</infon>
      <infon key="name_0">surname:Gore;given-names:JL</infon>
      <infon key="fpage">1309</infon>
      <infon key="pub-id_doi">10.1016/j.juro.2010.06.012</infon>
      <infon key="pub-id_pmid">20723914</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Urol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">184</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1315</infon>
      <infon key="name_5">surname:Litwin;given-names:MS</infon>
      <infon key="name_4">surname:Krupski;given-names:TL</infon>
      <offset>34728</offset>
      <text>Correlates of bother following treatment for clinically localized prostate cancer</text>
      <annotation id="571">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="34784" length="25"/>
        <text>localized prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Brandeis;given-names:JM</infon>
      <infon key="name_2">surname:Kwan;given-names:L</infon>
      <infon key="name_1">surname:Gore;given-names:JL</infon>
      <infon key="name_0">surname:Litwin;given-names:MS</infon>
      <infon key="fpage">2239</infon>
      <infon key="pub-id_doi">10.1002/cncr.22676</infon>
      <infon key="pub-id_pmid">17455209</infon>
      <infon key="year">2007</infon>
      <infon key="source">Cancer</infon>
      <infon key="type">ref</infon>
      <infon key="volume">109</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">2247</infon>
      <infon key="name_6">surname:Reiter;given-names:RE</infon>
      <infon key="name_5">surname:Withers;given-names:HR</infon>
      <infon key="name_4">surname:Lee;given-names:SP</infon>
      <offset>34810</offset>
      <text>Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer</text>
      <annotation id="573">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="34901" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Diblasio;given-names:F</infon>
      <infon key="name_2">surname:Ashley;given-names:R</infon>
      <infon key="name_1">surname:Santoro;given-names:M</infon>
      <infon key="name_0">surname:Katz;given-names:AJ</infon>
      <infon key="fpage">1</infon>
      <infon key="pub-id_doi">10.1186/1471-2490-10-1</infon>
      <infon key="pub-id_pmid">20122161</infon>
      <infon key="year">2010</infon>
      <infon key="source">BMC Urol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">10</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_4">surname:Witten;given-names:M</infon>
      <offset>34917</offset>
      <text>Stereotactic body radiotherapy for organ-confined prostate cancer</text>
      <annotation id="575">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="34967" length="15"/>
        <text>prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Deodato;given-names:F</infon>
      <infon key="name_2">surname:Digesu;given-names:C</infon>
      <infon key="name_1">surname:Massaccesi;given-names:M</infon>
      <infon key="name_0">surname:Ippolito;given-names:E</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2011.12.046</infon>
      <infon key="pub-id_pmid">22361084</infon>
      <infon key="year">2012</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">e195</infon>
      <infon key="fpage">e191</infon>
      <infon key="volume">83</infon>
      <infon key="name_10">surname:Mantini;given-names:G</infon>
      <infon key="name_13">surname:Cellini;given-names:N</infon>
      <infon key="name_14">surname:Ingrosso;given-names:M</infon>
      <infon key="name_11">surname:Pacelli;given-names:F</infon>
      <infon key="name_12">surname:Valentini;given-names:V</infon>
      <infon key="name_15">surname:Morganti;given-names:AG</infon>
      <infon key="name_9">surname:Mattiucci;given-names:GC</infon>
      <infon key="name_8">surname:Di Lallo;given-names:A</infon>
      <infon key="name_7">surname:Cuscuna;given-names:D</infon>
      <infon key="name_6">surname:Cilla;given-names:S</infon>
      <infon key="name_5">surname:Pirozzi;given-names:GA</infon>
      <infon key="name_4">surname:Macchia;given-names:G</infon>
      <offset>34983</offset>
      <text>Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy</text>
      <annotation id="577">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="35040" length="27"/>
        <text>toxicity in prostate cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:de Jong;given-names:DJ</infon>
      <infon key="name_2">surname:Philippens;given-names:ME</infon>
      <infon key="name_1">surname:Kristinsson;given-names:J</infon>
      <infon key="name_0">surname:van Lin;given-names:EN</infon>
      <infon key="fpage">799</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2006.09.034</infon>
      <infon key="pub-id_pmid">17161552</infon>
      <infon key="year">2007</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">67</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Visser;given-names:AG</infon>
      <infon key="lpage">811</infon>
      <infon key="name_6">surname:Leer;given-names:JW</infon>
      <infon key="name_5">surname:Kaanders;given-names:JH</infon>
      <infon key="name_4">surname:van der Vight;given-names:LP</infon>
      <offset>35094</offset>
      <text>Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy</text>
      <annotation id="579">
        <infon key="identifier">MESH:D054549</infon>
        <infon key="type">Disease</infon>
        <location offset="35191" length="18"/>
        <text>endorectal balloon</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Kollmeier;given-names:MA</infon>
      <infon key="name_2">surname:Yamada;given-names:J</infon>
      <infon key="name_1">surname:Pei;given-names:X</infon>
      <infon key="name_0">surname:Spratt;given-names:DE</infon>
      <infon key="fpage">686</infon>
      <infon key="pub-id_doi">10.1016/j.ijrobp.2012.05.023</infon>
      <infon key="pub-id_pmid">22795805</infon>
      <infon key="year">2013</infon>
      <infon key="source">Int J Radiat Oncol Biol Phys</infon>
      <infon key="type">ref</infon>
      <infon key="volume">85</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">692</infon>
      <infon key="name_5">surname:Zelefsky;given-names:MJ</infon>
      <infon key="name_4">surname:Cox;given-names:B</infon>
      <offset>35244</offset>
      <text>Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer</text>
      <annotation id="583">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="35279" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="584">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="35267" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="585">
        <infon key="identifier">MESH:D011471</infon>
        <infon key="type">Disease</infon>
        <location offset="35353" length="25"/>
        <text>localized prostate cancer</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272824</id>
    <passage>
      <infon key="name_2">surname:Banks;given-names:Matthew L.</infon>
      <infon key="name_1">surname:Negus;given-names:S. Stevens</infon>
      <infon key="article-id_pmid">25439054</infon>
      <infon key="name_0">surname:Hutsell;given-names:Blake A.</infon>
      <infon key="fpage">52</infon>
      <infon key="year">2015</infon>
      <infon key="article-id_pmc">4272824</infon>
      <infon key="article-id_doi">10.1016/j.drugalcdep.2014.11.003</infon>
      <infon key="type">front</infon>
      <infon key="volume">0</infon>
      <infon key="license">           This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.         </infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Drug Alcohol Depend; 2015 Jan 01; 14652-60. doi:10.1016/j.drugalcdep.2014.11.003</infon>
      <infon key="kwd">Cocaine Choice Rhesus monkey Monoamine releaser Generalized matching law Sensitivity to reinforcement</infon>
      <infon key="lpage">60</infon>
      <infon key="article-id_manuscript">NIHMS643973</infon>
      <infon key="authors">Hutsell BA, Negus SS, Banks ML</infon>
      <offset>0</offset>
      <text>A generalized matching law analysis of cocaine vs. food choice in rhesus monkeys: Effects of candidate 'agonist-based' medications on sensitivity to reinforcement </text>
      <annotation id="2">
        <infon key="identifier">9544</infon>
        <infon key="type">Species</infon>
        <location offset="66" length="14"/>
        <text>rhesus monkeys</text>
      </annotation>
      <annotation id="3">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="39" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>170</offset>
      <text>Background</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>181</offset>
      <text>We have previously demonstrated reductions in cocaine choice produced by either continuous 14-day phendimetrazine and D-amphetamine treatment or removing cocaine availability under a cocaine vs. food choice procedure in rhesus monkeys. The aim of the present investigation was to apply the concatenated generalized matching law (GML) to cocaine vs. food choice dose-effect functions incorporating sensitivity to both the relative magnitude and price of each reinforcer. Our goal was to determine potential behavioral mechanisms underlying pharmacological treatment efficacy to decrease cocaine choice.</text>
      <annotation id="12">
        <infon key="identifier">9544</infon>
        <infon key="type">Species</infon>
        <location offset="401" length="14"/>
        <text>rhesus monkeys</text>
      </annotation>
      <annotation id="13">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="767" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="14">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="518" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="15">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="335" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="16">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="279" length="15"/>
        <text>phendimetrazine</text>
      </annotation>
      <annotation id="17">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="227" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="18">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="364" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="19">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="299" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>783</offset>
      <text>Methods</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>791</offset>
      <text>A multi-model comparison approach was used to characterize dose- and time-course effects of both pharmacological and environmental manipulations on sensitivity to reinforcement.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>969</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>977</offset>
      <text>GML models provided an excellent fit of the cocaine choice dose-effect functions in individual monkeys. Reductions in cocaine choice by both pharmacological and environmental manipulations were principally produced by systematic decreases in sensitivity to reinforcer price and non-systematic changes in sensitivity to reinforcer magnitude.</text>
      <annotation id="23">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="1095" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="24">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="1021" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="25">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="977" length="3"/>
        <text>GML</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1318</offset>
      <text>Conclusions</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1330</offset>
      <text>The modeling approach used provides a theoretical link between the experimental analysis of choice and pharmacological treatments being evaluated as candidate 'agonist-based' medications for cocaine addiction. The analysis suggests that monoamine releaser treatment efficacy to decrease cocaine choice was mediated by selectively increasing the relative price of cocaine. Overall, the net behavioral effect of these pharmacological treatments was to increase substitutability of food pellets, a nondrug reinforcer, for cocaine.</text>
      <annotation id="31">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="1849" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="32">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="1567" length="9"/>
        <text>monoamine</text>
      </annotation>
      <annotation id="33">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="1693" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="34">
        <infon key="identifier">MESH:D019970</infon>
        <infon key="type">Disease</infon>
        <location offset="1521" length="17"/>
        <text>cocaine addiction</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="1617" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1862</offset>
      <text>1. Introduction</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1878</offset>
      <text>Preclinical self-administration models provide a measure of abuse-related reinforcing drug effects and have been the most reliable predictor of medication efficacy in clinical settings. In particular, drug self-administration procedures that involve the concurrent availability of an alternative nondrug reinforcer and determine treatment effects on behavior maintained by both drug and nondrug reinforcers may be especially predictive of medication effects. Important among these proposed advantages is the provision of a dependent variable, response allocation between two concurrently available reinforcers, which may be less sensitive to reinforcement-independent rate-altering effects and may more directly evince relative reinforcer value.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2624</offset>
      <text>Previous studies have examined the determinants of drug reinforcement in choice procedures in which subjects choose between drug (e.g., cocaine) and an alternative nondrug reinforcer (e.g., food; for review,). This literature body supports the general conclusion that choice between drug and food is sensitive to the magnitude, price, frequency, and delay dimensions of reinforcers. Although this research suggests that drug vs. food choice is sensitive to the relative value of drug reinforcement, relatively few studies have integrated these results with quantitative theories of operant choice.</text>
      <annotation id="37">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="2760" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3222</offset>
      <text>The generalized matching law (GML) is a quantitative framework, which predicts that behavior will be allocated among different reinforcers in proportion to their relative value. Relative reinforcer value has been quantified most effectively by the concatenated GML, which predicts that value is determined by a multiplicative combination of each reinforcer dimension listed above. A version of the GML suitable for drug vs. food choice may be written</text>
      <annotation id="39">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="3483" length="3"/>
        <text>GML</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3673</offset>
      <text>  where B represents behavior allocated to cocaine (Bc) or food (Bf), M represents the magnitude dimension of each reinforcer, and P represents the price dimension (fixed-ratio schedule) of each reinforcer. For cocaine, Mc equals the unit dose (mg/kg/injection) and for food Mf equals the value of food scaled in dose units of cocaine (Mf   Mc). On the basis of preliminary model simulations, the proportionality constant was set to 0.032 in the present study; consequently, the magnitude of a 1-g food pellet was set equal to a 0.032-mg/kg-cocaine injection. Furthermore, we have previously demonstrated comparable reinforcing effects of a 0.032-mg/kg cocaine injection and a 1-g food pellet in both progressive-ratio and choice procedures. The present approach of fixing the scaling parameter at a single value is equivalent to previous applications of the GML using a bias parameter to account for choice between qualitatively different reinforcers (e.g.,). The free parameters sm (sensitivity to magnitude) and sp (sensitivity to price) capture the extent of changes in drug vs. food choice with changes in the relative magnitude and price of cocaine vs. food for an individual subject. For example, in the case of strict matching, sm = sp = 1, the proportion of responses allocated to the drug alternative is equal to the multiplicative combination of magnitude and price proportions. Fig. 1 shows cocaine choice dose-effect functions simulated by Eq. (1) with relative reinforcer magnitude and price equal to the values used in the present study. The main focus of these simulations is to demonstrate that the slope and horizontal position of the cocaine choice dose-effect functions are determined independently by sensitivity to reinforcer magnitude and reinforcer price, respectively.</text>
      <annotation id="50">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="4214" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="51">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="5326" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="52">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="4326" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="4532" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">MESH:D008748</infon>
        <infon key="type">Chemical</infon>
        <location offset="3893" length="2"/>
        <text>Mc</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="3716" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="56">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="4820" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="57">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="4000" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="58">
        <infon key="identifier">MESH:C000604007</infon>
        <infon key="type">Chemical</infon>
        <location offset="4688" length="2"/>
        <text>sp</text>
      </annotation>
      <annotation id="59">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="3884" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>5469</offset>
      <text>The purpose of the present investigation was to determine monoamine releaser treatment effects in a cocaine vs. food choice procedure on sensitivity parameters of the GML. We reanalyzed data from demonstrating reductions in cocaine vs. food choice produced by continuous 14-day D-amphetamine, phendimetrazine, and phenmetrazine treatment. A version of the concatenated GML incorporating the relative magnitude and price of cocaine and food reinforcers was fit to the cocaine choice dose-effect curves of individual monkeys. A multi-model comparison approach was used to evaluate competing hypotheses regarding dose- and time-course effects on sensitivity to reinforcement. For comparison, we also modeled 7-day effects of extinction on cocaine- or food-maintained responding during the choice procedure.</text>
      <annotation id="68">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="5569" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="69">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="5747" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="70">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="5762" length="15"/>
        <text>phendimetrazine</text>
      </annotation>
      <annotation id="71">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="5527" length="9"/>
        <text>monoamine</text>
      </annotation>
      <annotation id="72">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="5693" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">MESH:D010633</infon>
        <infon key="type">Chemical</infon>
        <location offset="5783" length="13"/>
        <text>phenmetrazine</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="5838" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="5636" length="3"/>
        <text>GML</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>6273</offset>
      <text>2. Methods</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>6284</offset>
      <text>2.1. Study design and methods</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6314</offset>
      <text>The experimental methods have been previously described in detail in). Briefly, studies were conducted in four-six adult male rhesus monkeys (Macaca mulatta) surgically implanted with a double-lumen catheter inserted in a major vein. The catheter was connected to a fluid swivel attached to the top of each subject's cage and was protected by a custom jacket and stainless steel tether. Animal research and maintenance were conducted according to the 8th edition of the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the National Institutes of Health (National Academies Press, 2011). Animal facilities were licensed by the United States Department of Agriculture and accredited by the Association for Assessment and Accreditation of Laboratory Animal Care. The Institutional Animal Care and Use Committee approved the research protocol. Monkeys had visual, auditory, and olfactory contact with other monkeys throughout the study. Operant procedures and foraging toys were provided for environmental manipulation and enrichment. Videos were played daily in animal housing rooms to provide additional environmental enrichment.</text>
      <annotation id="78">
        <infon key="identifier">9544</infon>
        <infon key="type">Species</infon>
        <location offset="6440" length="14"/>
        <text>rhesus monkeys</text>
      </annotation>
      <annotation id="79">
        <infon key="identifier">9544</infon>
        <infon key="type">Species</infon>
        <location offset="6456" length="14"/>
        <text>Macaca mulatta</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>7476</offset>
      <text>Experimental sessions were conducted in each monkey's home cage. Monkeys responded in daily 2 h choice sessions (0900-1100 h) that consisted of a five-component concurrent schedule of food pellet and intravenous cocaine availability as described in detail previously. During each component, responses on the left key were reinforced with food (1-g banana-flavored pellets; Test Diets, Richmond, IN) according to a fixed-ratio (FR) 100 schedule, and responses on the right key were reinforced with intravenous cocaine (0-0.1 mg/kg/injection) according to an FR 10 schedule. A response on one key reset the ratio requirement on the alternative key. Each reinforcer delivery was followed by a 3-s timeout during which all stimulus lights were extinguished, and responding had no programmed consequences. During each component, the food key was transilluminated red. The stimulus lights for the cocaine key were flashed on and off in 3 s cycles, and longer flashes were associated with higher unit cocaine doses. Across components of the choice procedure, a different unit cocaine dose was available (0, 0.0032, 0.01, 0.032, and 0.1 mg/kg/injection during components 1-5, respectively) by manipulating the injection volume (0, 0.01, 0.03, 0.1, and 0.3 ml/injection, respectively) delivered via the 'cocaine' pump. Each component was in effect until 10 total reinforcers were earned or 20 min elapsed, whichever occurred first.</text>
      <annotation id="85">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="7688" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="86">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="7985" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="87">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="8470" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="88">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="8545" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="89">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="8367" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>8911</offset>
      <text>Once cocaine choice was stable, tests sessions were initiated. Subsequently, a 14-day treatment period was initiated during which a test solution was administered via the 'treatment' pump for 23 h/day. The treatment solutions and doses examined were D-amphetamine (0.032-0.1 mg/kg/h), (+)-phendimetrazine (0.32-1.0 mg/kg/h) or (+)-phenmetrazine (0.1-0.32 mg/kg/h). At the conclusion of each 14-day test period, a saline control treatment period was reinstated for at least 5 days and until cocaine choice returned to pretest levels. For the extinction studies, separate 7-day treatment periods were initiated where either cocaine was removed from the syringe or food pellets were removed from the dispenser. All other component-correlated stimuli were retained.</text>
      <annotation id="96">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="9324" length="6"/>
        <text>saline</text>
      </annotation>
      <annotation id="97">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="9533" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="98">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="9401" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="99">
        <infon key="identifier">MESH:D010633</infon>
        <infon key="type">Chemical</infon>
        <location offset="9238" length="17"/>
        <text>(+)-phenmetrazine</text>
      </annotation>
      <annotation id="100">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="9196" length="19"/>
        <text>(+)-phendimetrazine</text>
      </annotation>
      <annotation id="101">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="9161" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>9683</offset>
      <text>2.2. Modeling approach and dose-effect models</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>9729</offset>
      <text>The dependent measure of interest was the proportion of cocaine choices (number of completed ratios on the cocaine-associated key/total completed ratios) for days 5-7 (7 days) and days 12-14 (14 days) of the continuous 14-day treatments or days 5-7 for the 7-day extinction condition. These data were then plotted as a function of unit cocaine dose. In the modeling presented below, the value of a single food pellet was held constant at 0.032 mg/kg/injection cocaine as in Fig. 1. Changes in response allocation produced by removal of cocaine or food availability were modeled using baseline reinforcer magnitudes. This approach allowed reinforcer sensitivity parameters to account for changes in response allocation and facilitated comparison with pharmacological manipulations. Parameters of Eq. (1) were estimated for individual monkeys by minimizing the residual sum of squares (RSS) using the Solver add-in of Microsoft Excel for Mac 2011. Model fitting was conducted separately for each manipulation. Data from a monkey were not included if (1) the monkey did not complete each dose of a treatment drug and (2) a choice proportion could not be calculated for two or more cocaine doses. The number of data points fit for individual monkeys are included in Table 1. Within a monkey and a treatment drug, a total RSS was computed by summing the RSS across each dose and treatment week. Therefore, if a monkey completed 14-day treatments for each test drug dose, the total RSS was computed from five cocaine choice dose-effect functions.</text>
      <annotation id="112">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="9836" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="113">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="9785" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="114">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="10065" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="10189" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="116">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="11078" length="3"/>
        <text>RSS</text>
      </annotation>
      <annotation id="117">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="10907" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="118">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="10265" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="119">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="11046" length="3"/>
        <text>RSS</text>
      </annotation>
      <annotation id="120">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="11232" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="11205" length="3"/>
        <text>RSS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>11276</offset>
      <text>Different versions of Eq. (1) were fit to the data for days 5-7 (7 days) and days 12-14 (14 days) of each continuous 14-day pharmacological treatment to test different hypotheses regarding treatment effects on sensitivity to reinforcement. Thus, different combinations of the free parameters (k) were either allowed to vary or were constrained to determine whether dose had no effect on sensitivity to reinforcement (the Null model, H0), affected sensitivity to both reinforcer dimensions (Full model), or selectively affected sensitivity to a single reinforcer dimension. In the Null model, sensitivity to reinforcer magnitude and price (si) in Eq. (1) were constrained (e.g., k = 2; s(BL) = s(Dose 1) = s(Dose)). The Full model placed no restrictions on estimated sensitivity to reinforcement parameters (k = 10). The Magnitude model allowed sensitivity to reinforcer magnitude (sm(BL)   / sm(Dose 1)   / sm(Dose 2)) to vary across doses while sensitivity to reinforcer price (sp(BL)   sp(Dose 1)   sp(Dose 2)) was constrained (k = 6). The Price model constrained sensitivity to reinforcer magnitude (sm(BL) = sm(Dose 1) = sm(Dose 2)) while sensitivity to reinforcer price (sp(BL)   / sp(Dose 1)   / sp(Dose 2)) was allowed to vary across doses (k = 6).</text>
      <annotation id="126">
        <infon key="identifier">MESH:C000604007</infon>
        <infon key="type">Chemical</infon>
        <location offset="12463" length="2"/>
        <text>sp</text>
      </annotation>
      <annotation id="127">
        <infon key="identifier">MESH:C000604007</infon>
        <infon key="type">Chemical</infon>
        <location offset="12277" length="2"/>
        <text>sp</text>
      </annotation>
      <annotation id="128">
        <infon key="identifier">MESH:C000604007</infon>
        <infon key="type">Chemical</infon>
        <location offset="12452" length="2"/>
        <text>sp</text>
      </annotation>
      <annotation id="129">
        <infon key="identifier">MESH:C000604007</infon>
        <infon key="type">Chemical</infon>
        <location offset="12478" length="2"/>
        <text>sp</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>12548</offset>
      <text>The minimum corrected Akaike information criterion (AICc) score indicates the best model after correcting for the number of free parameters (see Supplement for further explanation). Multi-model comparison was used to characterize dose-effects of pharmacological treatments on sensitivity to reinforcement. The corrected Akaike information criterion (AICc) was used to compare different models and DeltaAICc [i.e., DeltaAICc (H0) - DeltaAICc (H1) &gt; 4.0] was used to select the best model for each monkey. The model-comparison approach is analogous to a significance test; therefore, the parameters of the selected model were treated as a significant effect of a specific experimental manipulation for an individual monkey. Because an alternative model was the selected model in 18/19 cases, we focused on the magnitude of systematic parameter changes below. Cocaine vs. food choice and sensitivity to reinforcement dose-effect curves were constructed by averaging the individual, best-fitting parameter estimates.</text>
      <annotation id="131">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="13405" length="7"/>
        <text>Cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>13561</offset>
      <text>3. Results</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13572</offset>
      <text>A summary of the multi-model comparison for all treatment drugs and extinction is provided in Table 1 (see Supplemental Table S1 for raw AICc scores1). Overall, the null model was never the selected model for the group data and only for one experimental manipulation was this model selected for an individual monkey. These results indicate that in all but one instance, the treatment drug or extinction condition altered drug choice sufficiently to infer changes in reinforcer sensitivity. In addition, the selected model always fit the individual monkey and group data well, accounting for at least 97% of the variance.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14193</offset>
      <text>Fig. 2 shows continuous 14-day D-amphetamine treatment effects on (A) and (B) cocaine vs. food choice and (C) and (D) best-fitting parameter estimates of Eq. (1) plotted as a function of D-amphetamine dose. The GML model accurately described the cocaine choice dose-effect functions across each D-amphetamine dose and each treatment week (Table 1). The best-fit model for D-amphetamine effects differed somewhat between monkeys with the Full and Price models being selected. In 5/6 monkeys that were sensitive to pharmacological treatment, however, 0.1 mg/kg/h D-amphetamine produced an approximate 10-fold decrease in sensitivity to reinforcer price. Changes were less systematic across monkeys producing a 1.5-fold increase in sensitivity to reinforcer magnitude.</text>
      <annotation id="140">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="14404" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="141">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="14224" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="142">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="14754" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="14271" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="144">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="14488" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="145">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="14565" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="146">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="14439" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="147">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="14380" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14959</offset>
      <text>Fig. 3 shows continuous 14-day (+)-phendimetrazine treatment effects on (A) and (B) cocaine vs. food choice and (C) and (D) best-fitting parameter estimates of Eq. (1) plotted as a function of phendimetrazine dose. The GML model provided an accurate description of the cocaine choice dose-effect functions across each (+)-phendimetrazine dose and each treatment week (Table 1). The best-fit model was consistent for four of the five monkeys and indicated that (+)-phendimetrazine produced a selective decrease in sensitivity to reinforcer price. The best-fit model for the other monkey suggested (+)-phendimetrazine increased sensitivity to reinforcer magnitude during 0.32/mg/kg/h treatment and decreased sensitivity to reinforcer magnitude during 1.0/mg/kg/h treatment. The multi-model comparison suggested that sensitivity to reinforcer price decreased dose-dependently and these decreases were more pronounced after 14 days of treatment.</text>
      <annotation id="156">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="15555" length="19"/>
        <text>(+)-phendimetrazine</text>
      </annotation>
      <annotation id="157">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="14990" length="19"/>
        <text>(+)-phendimetrazine</text>
      </annotation>
      <annotation id="158">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="15152" length="15"/>
        <text>phendimetrazine</text>
      </annotation>
      <annotation id="159">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="15043" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="160">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="15277" length="19"/>
        <text>(+)-phendimetrazine</text>
      </annotation>
      <annotation id="161">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="15178" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="15228" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="15419" length="19"/>
        <text>(+)-phendimetrazine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>15901</offset>
      <text>Fig. 4 shows continuous 14-day (+)-phenmetrazine treatment effects on (A) and (B) cocaine vs. food choice and (C) and (D) best-fitting parameter estimates of Eq. (1) plotted as a function of phenmetrazine dose The GML model provided an accurate description of the cocaine choice dose-effect functions across each (+)-phenmetrazine dose and each treatment week (Table 1). The best-fit model for three monkeys was the Full model and for the other three monkeys was the price sensitivity model. Decreases in sensitivity to reinforcer magnitude and price were apparent at 0.32 mg/kg/h (+)-phenmetrazine following 14 treatment days.</text>
      <annotation id="171">
        <infon key="identifier">MESH:D010633</infon>
        <infon key="type">Chemical</infon>
        <location offset="16482" length="17"/>
        <text>(+)-phenmetrazine</text>
      </annotation>
      <annotation id="172">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="16115" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="173">
        <infon key="identifier">MESH:D010633</infon>
        <infon key="type">Chemical</infon>
        <location offset="16092" length="13"/>
        <text>phenmetrazine</text>
      </annotation>
      <annotation id="174">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="15983" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">MESH:D010633</infon>
        <infon key="type">Chemical</infon>
        <location offset="16214" length="17"/>
        <text>(+)-phenmetrazine</text>
      </annotation>
      <annotation id="176">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="16165" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="177">
        <infon key="identifier">MESH:D010633</infon>
        <infon key="type">Chemical</infon>
        <location offset="15932" length="17"/>
        <text>(+)-phenmetrazine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>16529</offset>
      <text>Fig. 5 shows the effects of extinguishing either cocaine- or food-maintained responding for 7 days on (A) and (B) cocaine vs. food choice and (C) and (D) best-fitting parameter estimates of Eq. (1). Substituting 0.001 for food or cocaine in the GML model during removal of each reinforcer provided an accurate description of the cocaine choice dose-effect functions (Table 1). The best-fit model was consistent between monkeys (note that the AICc values for full and price models are not significantly different for monkey M1414). Cocaine removal produced a greater than 8-fold decrease in sensitivity to reinforcer price, whereas food removal produced an approximately 2-fold increase in sensitivity to reinforcer price.</text>
      <annotation id="184">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="16643" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="185">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="16578" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="186">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="17060" length="7"/>
        <text>Cocaine</text>
      </annotation>
      <annotation id="187">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="16774" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="188">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="16858" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="189">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="16759" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>17251</offset>
      <text>4. Discussion</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>17265</offset>
      <text>The aim of the present investigation was to determine monoamine releaser treatment effects on sensitivity to reinforcement parameters of the GML. A multi-model comparison approach was used to evaluate competing hypotheses regarding dose- and time-course effects on sensitivity to relative reinforcer magnitude and price. There were two main findings. First, the GML models provided excellent fits to the cocaine choice dose-effect functions. In addition, in 18/19 fits to individual monkey data models assuming an effect of a manipulation on sensitivity to reinforcement were superior to the null hypothesis model justifying the use of additional model parameters. Second, pharmacological and environmental manipulations altered cocaine vs. food choice in 18/19 monkeys and did so by decreasing sensitivity to reinforcer price in 16/18 monkeys.</text>
      <annotation id="196">
        <infon key="identifier">MESH:D012640</infon>
        <infon key="type">Disease</infon>
        <location offset="17729" length="4"/>
        <text>fits</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="17406" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="17319" length="9"/>
        <text>monoamine</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="17627" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="200">
        <infon key="identifier">MESH:D012640</infon>
        <infon key="type">Disease</infon>
        <location offset="17657" length="4"/>
        <text>fits</text>
      </annotation>
      <annotation id="201">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="17994" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_2</infon>
      <offset>18110</offset>
      <text>4.1. The generalized matching law model - comparison approach</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>18174</offset>
      <text>Previous studies have employed the model comparison approach to determine the specificity of pharmacological and neurobiological manipulations on reinforcement-related processes. The present study applied a well-known model of choice that incorporates various reinforcer dimensions to construct a relative value of the available reinforcers. provided rhesus monkeys a choice between alternatives that differed in both reinforcer magnitude and price, and GML model comparison allowed us to determine which reinforcer dimension(s) were affected by pharmacological and environmental manipulations. Taken together, these studies suggest the model comparison provides a unique approach for testing competing hypotheses regarding the behavioral mechanisms of pharmacological and environmental manipulations.</text>
      <annotation id="203">
        <infon key="identifier">9544</infon>
        <infon key="type">Species</infon>
        <location offset="18525" length="14"/>
        <text>rhesus monkeys</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>18976</offset>
      <text>The results of the present study are consistent with prior reports demonstrating GML framework applicability to drug choice procedures with rhesus monkeys (e.g.,). The estimates of sensitivity to reinforcer magnitude obtained in the present study, however, differ markedly from modal values of sensitivity to reinforcer rate established in earlier reviews (e.g.,). Sensitivity to reinforcer magnitude estimates displayed substantial overmatching, often 5-10-fold greater than in previous reports (cf.,). There are at least two possible reasons for this difference. First, this study employed qualitatively different reinforcers, which may have enhanced discrimination of the choice alternatives. A previous study by, however, reported undermatching (s &lt; 1.0) to reinforcer rate in a cocaine vs. food choice procedure employing concurrent variable interval schedules (see also,). Second, the present procedure employed ratio schedules of reinforcement and an additional reset contingency following changeover responses. Concurrent ratio schedules generally produce exclusive preference for the choice alternative associated with the lower ratio requirement (; see also). In studies where choices are made between qualitatively different reinforcers, preference is determined by the relative magnitude and price of each reinforcer. The present findings are consistent with concurrent ratio schedules producing behavior allocation that maximizes relative reinforcer value.</text>
      <annotation id="207">
        <infon key="identifier">9544</infon>
        <infon key="type">Species</infon>
        <location offset="19116" length="14"/>
        <text>rhesus monkeys</text>
      </annotation>
      <annotation id="208">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="19057" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="209">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="19759" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>20448</offset>
      <text>Two potential limitations from the present GML analysis should be considered. One limitation is the scaling factor for the food reinforcer was held constant across all monkeys and, therefore, did not permit an assessment of individual differences. Although we chose the scaling factor based on previous studies, exploratory modeling with scaling factors of 0.032 +- 0.5 log units produced similar relative changes in parameter estimates, but provided a poorer fit to the data. A second limitation concerns the approach to modeling the effects of extinction. To model data from extinction and facilitate comparison to the pharmacological manipulations, we used non-zero values to predict the observed nonexclusive preference. Moreover, a single reinforcer magnitude (e.g., 0.001 mg/kg/injection for saline) could not predict the cocaine dose dependency still evident in the cocaine choice dose-effect function after 7 days of cocaine and food removal.</text>
      <annotation id="215">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="21321" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="216">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="20491" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="217">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="21276" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="218">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="21373" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="21246" length="6"/>
        <text>saline</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>21399</offset>
      <text>Therefore, while this ad hoc approach does not provide insight into the mechanisms by which the component-correlated stimuli maintained dose-dependent cocaine choice, model comparison suggests that the effects of extinction on price sensitivity were similar to the effects of pharmacological manipulations.</text>
      <annotation id="221">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="21550" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_2</infon>
      <offset>21706</offset>
      <text>4.2. Effects of pharmacological treatments on sensitivity to reinforcement</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>21781</offset>
      <text>Pharmacological manipulations that decreased cocaine vs. food preference did so mostly by decreasing sensitivity to reinforcer price. Changes in sensitivity to reinforcer magnitude were less consistent across monkeys compared to price changes. When changes in magnitude sensitivity did occur in individual monkeys, magnitude sensitivity decreased suggesting that total reinforcer consumption decreased (see below).) proposed that the sensitivity parameter in the GML might serve as an index of economic substitutability between qualitatively different reinforcers (see also). The cocaine vs. food choice procedure employed in the present study systematically varied unit cocaine price (UP, fixed ratio/dose) by increasing the available cocaine dose and provided a measure of the own-price elasticity of cocaine demand and the cross-price elasticity of food demand. Therefore, changes in sensitivity to reinforcer price observed in the present study may be related to parameter values in behavioral economic models of choice.</text>
      <annotation id="228">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="22584" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="229">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="22244" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="230">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="21826" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="231">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="22452" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="232">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="22361" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="233">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="22517" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>22806</offset>
      <text>To examine the relationship between GML and economic approaches, choice data from each 7-day period of the continuous 14-day D-amphetamine (0.032-0.1 mg/kg/h) treatment are presented in Fig. 6 as demand curves; consumption is plotted as a function of the unit price of cocaine. The continuous curves are the predictions of the GML model and the interpolated unit cocaine price (UP50) at which cocaine and food consumption are predicted to be equal is given in each panel. Consistent with previous demand analyses of cocaine vs. food choice procedures, cocaine consumption was a decreasing function of UP of cocaine. At the end of the 14-day treatment, 0.1-mg/kg/h D-amphetamine produced a ten-fold decrease in UP50 and the GML model predicted an increase in cocaine elasticity and a corresponding decrease in food elasticity. Therefore, according to the substitutability interpretation of GML sensitivity to reinforcement, cocaine and food were imperfect economic substitutes under baseline conditions, and the effects of pharmacological and environmental manipulations increased the elasticity of cocaine preference.</text>
      <annotation id="247">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="23075" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="248">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="23470" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="249">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="23358" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="250">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="23169" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="251">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="23695" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="252">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="23413" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="253">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="22842" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="254">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="23199" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="255">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="23729" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="256">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="22931" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="257">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="23322" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="258">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="23529" length="3"/>
        <text>GML</text>
      </annotation>
      <annotation id="259">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="23133" length="3"/>
        <text>GML</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>23926</offset>
      <text>There was concordance among the effects of pharmacological treatment and extinction of cocaine-maintained behavior on sensitivity to reinforcer price. Consistent with previous studies, elasticity of demand for saline was greater than demand for drug. Model comparison suggested that sensitivity to reinforcer magnitude was not altered over the 7 days of each extinction manipulation. This result is consistent with the dose-dependent increase in cocaine choice maintained by the component-correlated stimuli throughout extinction. Taken together, these findings suggest that pharmacological treatments and extinction may affect behavior allocation in the presence of cocaine-associated stimuli through a common behavioral mechanism.</text>
      <annotation id="264">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="24372" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="265">
        <infon key="identifier">MESH:D012965</infon>
        <infon key="type">Chemical</infon>
        <location offset="24136" length="6"/>
        <text>saline</text>
      </annotation>
      <annotation id="266">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="24013" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="267">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="24593" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>24659</offset>
      <text>Finally, the extension of the GML presented here is closely related to Shizgal and colleagues' 'reinforcement mountain' model of brain stimulation reinforcement in intracranial self-stimulation (ICSS) procedures. Their approach employs a single-operant matching model along with generalized matching reinforcement sensitivity parameters (see also). An intriguing similarity between the present and Shizgal approaches is that matching law analyses suggest that pharmacological manipulations affecting dopaminergic neurotransmission selectively alter sensitivity to reinforcement. For example, reported that the cocaine-induced increases in low baseline rates of responding maintained by low frequencies of brain stimulation were consistent with a decreased sensitivity to the price of brain stimulation. Cocaine-induced facilitation of ICSS also correlates with self-administration procedures and has been interpreted as an abuse-related effect. In turn, the blunted expression of abuse-related cocaine effects on ICSS produced by chronic D-amphetamine treatment may also be attributable to altered reinforcer price sensitivity, consistent with the effects reported here on cocaine self-administration.</text>
      <annotation id="270">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="25697" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="271">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="25462" length="7"/>
        <text>Cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_2</infon>
      <offset>25867</offset>
      <text>4.3. Implications for preclinical behavioral studies assessing candidate anti-drug addiction medication efficacy</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>25980</offset>
      <text>Cocaine addiction continues to present a significant public health problem, and the development of effective medications remains a priority of preclinical drug addiction research. The goal of 'agonist-based' medication research is to develop pharmacotherapies that decrease drug use by identifying compounds that share mechanisms of action with cocaine. In a recent review, Haney and Spealman concluded that preclinical self-administration procedures are the most reliable predictor of clinical medication outcomes (; see also). This conclusion suggests the success of preclinical self-administration procedures to accurately predict medication efficacy in humans resides in the neuropharmacological and behavioral mechanisms of reinforcement. Model comparison results of the present study suggest that chronic D-amphetamine and phendimetrazine treatment may function as economic substitutes that selectively increase cocaine demand elasticity by increasing the effective price. Moreover, when a substitutable non-drug reinforcer is concurrently available during chronic D-amphetamine and phendimetrazine treatment, preference for an alternative therapeutic reinforcer will reciprocally increase.</text>
      <annotation id="280">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26637" length="6"/>
        <text>humans</text>
      </annotation>
      <annotation id="281">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="27069" length="15"/>
        <text>phendimetrazine</text>
      </annotation>
      <annotation id="282">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="25980" length="7"/>
        <text>Cocaine</text>
      </annotation>
      <annotation id="283">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="27051" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="284">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="26809" length="15"/>
        <text>phendimetrazine</text>
      </annotation>
      <annotation id="285">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="26791" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="286">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="26325" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="287">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="26898" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">title_1</infon>
      <offset>27181</offset>
      <text>Supplementary Material</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>27204</offset>
      <text>Supplementary material can be found by accessing the online version of this paper at: http://dx.doi.org/10.1016/j.drugalcdep.2014.11.003.</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>27342</offset>
      <text>                         </text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>27368</offset>
      <text>Supplementary material can be found by accessing the online version of this paper at http://dx.doi.org/10.1016/j.drugalcdep.2014.11.003.</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>27505</offset>
      <text>                         </text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>27531</offset>
      <text>           Contributors         </text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>27564</offset>
      <text>Banks, Blough, and Negus designed the original study. Hutsell developed the modeling approach. Hutsell, Banks, and Negus wrote or contributed to the manuscript. All authors critically reviewed the content and approved the final version for publication.</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>27817</offset>
      <text>                         </text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>27843</offset>
      <text>           Conflicts of interest         </text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>27885</offset>
      <text>None of the authors have any conflict of interest to declare.</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>27947</offset>
      <text>                         </text>
    </passage>
    <passage>
      <infon key="volume">163</infon>
      <infon key="name_2">surname:Woolverton;given-names:WL</infon>
      <infon key="name_1">surname:Velkey;given-names:AJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Anderson;given-names:KG</infon>
      <infon key="fpage">319</infon>
      <infon key="pub-id_pmid">12373433</infon>
      <infon key="year">2002</infon>
      <infon key="source">Psychopharmacology (Berl)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">326</infon>
      <offset>27973</offset>
      <text>The generalized matching law as a predictor of choice between cocaine and food in rhesus monkeys</text>
      <annotation id="289">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="28035" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">11</infon>
      <infon key="name_1">surname:Woolverton;given-names:WL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Anderson;given-names:KG</infon>
      <infon key="fpage">413</infon>
      <infon key="pub-id_pmid">11103893</infon>
      <infon key="year">2000</infon>
      <infon key="source">Behav Pharmacol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">420</infon>
      <offset>28070</offset>
      <text>Concurrent variable-interval drug self-administration and the generalized matching law: a drug-class comparison</text>
    </passage>
    <passage>
      <infon key="volume">122</infon>
      <infon key="name_1">surname:Shizgal;given-names:P</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Arvanitogiannis;given-names:A</infon>
      <infon key="fpage">1126</infon>
      <infon key="pub-id_pmid">18823168</infon>
      <infon key="year">2008</infon>
      <infon key="source">Behav Neurosci</infon>
      <infon key="type">ref</infon>
      <offset>28182</offset>
      <text>The reinforcement mountain: allocation of behavior as a function of the rate and intensity of rewarding brain stimulation</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Posadas-Sanchez;given-names:D</infon>
      <infon key="name_2">surname:Sanabria;given-names:F</infon>
      <infon key="name_1">surname:Reilly;given-names:MP</infon>
      <infon key="name_0">surname:Avila;given-names:I</infon>
      <infon key="fpage">298</infon>
      <infon key="pub-id_pmid">19073222</infon>
      <infon key="year">2009</infon>
      <infon key="source">Behav Brain Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">198</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Castaneda;given-names:E</infon>
      <infon key="lpage">305</infon>
      <infon key="name_6">surname:Killeen;given-names:P</infon>
      <infon key="name_5">surname:Banerjee;given-names:N</infon>
      <infon key="name_4">surname:Chavez;given-names:CL</infon>
      <offset>28304</offset>
      <text>Modeling operant behavior in the Parkinsonian rat</text>
      <annotation id="291">
        <infon key="identifier">MESH:D010302</infon>
        <infon key="type">Disease</infon>
        <location offset="28337" length="12"/>
        <text>Parkinsonian</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">231</infon>
      <infon key="name_2">surname:Negus;given-names:SS</infon>
      <infon key="name_1">surname:Banks;given-names:ML</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bauer;given-names:CT</infon>
      <infon key="fpage">2461</infon>
      <infon key="pub-id_pmid">24408209</infon>
      <infon key="year">2014</infon>
      <infon key="source">Psychopharmacology (Berl)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2470</infon>
      <offset>28354</offset>
      <text>The effect of chronic amphetamine treatment on cocaine-induced facilitation of intracranial self-stimulation in rats</text>
      <annotation id="294">
        <infon key="identifier">MESH:D000661</infon>
        <infon key="type">Chemical</infon>
        <location offset="28376" length="11"/>
        <text>amphetamine</text>
      </annotation>
      <annotation id="295">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="28401" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">22</infon>
      <infon key="name_2">surname:Negus;given-names:SS</infon>
      <infon key="name_1">surname:Blough;given-names:BE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Banks;given-names:ML</infon>
      <infon key="fpage">824</infon>
      <infon key="pub-id_pmid">22015808</infon>
      <infon key="year">2011</infon>
      <infon key="source">Behav Pharmacol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">836</infon>
      <offset>28471</offset>
      <text>Effects of monoamine releasers with varying selectivity for releasing dopamine/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys</text>
      <annotation id="301">
        <infon key="identifier">MESH:D009638</infon>
        <infon key="type">Chemical</infon>
        <location offset="28550" length="14"/>
        <text>norepinephrine</text>
      </annotation>
      <annotation id="302">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="28482" length="9"/>
        <text>monoamine</text>
      </annotation>
      <annotation id="303">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="28600" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="304">
        <infon key="identifier">MESH:D012701</infon>
        <infon key="type">Chemical</infon>
        <location offset="28572" length="9"/>
        <text>serotonin</text>
      </annotation>
      <annotation id="305">
        <infon key="identifier">MESH:D004298</infon>
        <infon key="type">Chemical</infon>
        <location offset="28541" length="8"/>
        <text>dopamine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_1">surname:Negus;given-names:SS</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Banks;given-names:ML</infon>
      <infon key="year">2012</infon>
      <infon key="comment">             http://dx.doi.org/10.1155/2012/281768           </infon>
      <infon key="source">Adv Pharmacol Sci</infon>
      <infon key="type">ref</infon>
      <offset>28635</offset>
      <text>Preclinical determinants of drug choice under concurrent schedules of drug self-administration</text>
    </passage>
    <passage>
      <infon key="volume">38</infon>
      <infon key="name_2">surname:Negus;given-names:SS</infon>
      <infon key="name_1">surname:Blough;given-names:BE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Banks;given-names:ML</infon>
      <infon key="fpage">395</infon>
      <infon key="pub-id_pmid">22968813</infon>
      <infon key="year">2013a</infon>
      <infon key="source">Neuropsychopharmacology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">404</infon>
      <offset>28730</offset>
      <text>Interaction between behavioral and pharmacological treatment strategies to decrease cocaine choice in rhesus monkeys</text>
      <annotation id="307">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="28814" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">131</infon>
      <infon key="name_2">surname:Negus;given-names:SS</infon>
      <infon key="name_1">surname:Blough;given-names:BE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Banks;given-names:ML</infon>
      <infon key="fpage">204</infon>
      <infon key="pub-id_pmid">23726979</infon>
      <infon key="year">2013b</infon>
      <infon key="source">Drug Alcohol Depend</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">213</infon>
      <offset>28847</offset>
      <text>Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys</text>
      <annotation id="310">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="28907" length="15"/>
        <text>phendimetrazine</text>
      </annotation>
      <annotation id="311">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="28941" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">22</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Baum;given-names:WM</infon>
      <infon key="fpage">231</infon>
      <infon key="pub-id_pmid">16811782</infon>
      <infon key="year">1974</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">242</infon>
      <offset>28976</offset>
      <text>On two types of deviation from the matching law: bias and undermatching</text>
    </passage>
    <passage>
      <infon key="volume">32</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Baum;given-names:WM</infon>
      <infon key="fpage">269</infon>
      <infon key="pub-id_pmid">501274</infon>
      <infon key="year">1979</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">281</infon>
      <offset>29048</offset>
      <text>Matching, undermatching, and overmatching in studies of choice</text>
    </passage>
    <passage>
      <infon key="volume">12</infon>
      <infon key="name_1">surname:Rachlin;given-names:HC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Baum;given-names:WM</infon>
      <infon key="fpage">861</infon>
      <infon key="pub-id_pmid">16811415</infon>
      <infon key="year">1969</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">874</infon>
      <offset>29111</offset>
      <text>Choice as time allocation</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Anderson;given-names:DR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Burnham;given-names:KP</infon>
      <infon key="year">2002</infon>
      <infon key="source">Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach</infon>
      <infon key="type">ref</infon>
      <offset>29137</offset>
    </passage>
    <passage>
      <infon key="name_3">surname:Johanson;given-names:CE</infon>
      <infon key="name_2">surname:Foltin;given-names:RW</infon>
      <infon key="name_1">surname:Ashworth;given-names:JB</infon>
      <infon key="name_0">surname:Comer;given-names:SD</infon>
      <infon key="fpage">1</infon>
      <infon key="pub-id_pmid">18436394</infon>
      <infon key="year">2008</infon>
      <infon key="source">Drug Alcohol Depend</infon>
      <infon key="type">ref</infon>
      <infon key="volume">96</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">15</infon>
      <infon key="name_5">surname:Walsh;given-names:SL</infon>
      <infon key="name_4">surname:Zacny;given-names:JP</infon>
      <offset>29138</offset>
      <text>The role of human drug self-administration procedures in the development of medications</text>
      <annotation id="313">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="29150" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">52</infon>
      <infon key="name_1">surname:Shizgal;given-names:P</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Conover;given-names:KL</infon>
      <infon key="fpage">283</infon>
      <infon key="year">2005</infon>
      <infon key="source">Game Econ Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">304</infon>
      <offset>29226</offset>
      <text>Employing labor-supply theory to measure the reward value of electrical brain stimulation</text>
    </passage>
    <passage>
      <infon key="volume">13</infon>
      <infon key="name_1">surname:Jenkins;given-names:PE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Davison;given-names:M</infon>
      <infon key="fpage">77</infon>
      <infon key="year">1985</infon>
      <infon key="source">Anim Learn Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">84</infon>
      <offset>29316</offset>
      <text>Stimulus discriminability, contingency discriminability, and schedule performance</text>
    </passage>
    <passage>
      <infon key="volume">90</infon>
      <infon key="name_2">surname:Landon;given-names:J</infon>
      <infon key="name_1">surname:Davison;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Elliffe;given-names:D</infon>
      <infon key="fpage">169</infon>
      <infon key="pub-id_pmid">18831124</infon>
      <infon key="year">2008</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">185</infon>
      <offset>29398</offset>
      <text>Relative reinforcer rates and magnitudes do not control concurrent choice independently</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Woods;given-names:JH</infon>
      <infon key="volume">86</infon>
      <infon key="name_2">surname:Hursh;given-names:SR</infon>
      <infon key="name_1">surname:Winger;given-names:G</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Galuska;given-names:CM</infon>
      <infon key="fpage">181</infon>
      <infon key="pub-id_pmid">17002226</infon>
      <infon key="year">2006</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">195</infon>
      <offset>29486</offset>
      <text>Assessing unit-price related remifentanil choice in rhesus monkeys</text>
      <annotation id="315">
        <infon key="identifier">MESH:D000077208</infon>
        <infon key="type">Chemical</infon>
        <location offset="29515" length="12"/>
        <text>remifentanil</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">60</infon>
      <infon key="name_1">surname:Freed;given-names:DE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Green;given-names:L</infon>
      <infon key="fpage">141</infon>
      <infon key="pub-id_pmid">16812696</infon>
      <infon key="year">1993</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">158</infon>
      <offset>29553</offset>
      <text>The substitutability of reinforcers</text>
    </passage>
    <passage>
      <infon key="volume">199</infon>
      <infon key="name_1">surname:Spealman;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Haney;given-names:M</infon>
      <infon key="fpage">403</infon>
      <infon key="pub-id_pmid">18283437</infon>
      <infon key="year">2008</infon>
      <infon key="source">Psychopharmacology (Berl)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">419</infon>
      <offset>29589</offset>
      <text>Controversies in translational research: drug self-administration</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Shizgal;given-names:P</infon>
      <infon key="volume">5</infon>
      <infon key="name_2">surname:Conover;given-names:K</infon>
      <infon key="name_1">surname:Breton;given-names:YA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hernandez;given-names:G</infon>
      <infon key="fpage">e15081</infon>
      <infon key="pub-id_pmid">21152097</infon>
      <infon key="year">2010</infon>
      <infon key="source">PLoS ONE</infon>
      <infon key="type">ref</infon>
      <offset>29655</offset>
      <text>At what stage of neural processing does cocaine act to boost pursuit of rewards?</text>
      <annotation id="317">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="29695" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">24</infon>
      <infon key="name_1">surname:Loveland;given-names:DH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Herrnstein;given-names:RJ</infon>
      <infon key="fpage">107</infon>
      <infon key="pub-id_pmid">16811858</infon>
      <infon key="year">1975</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">116</infon>
      <offset>29736</offset>
      <text>Maximizing and matching on concurrent ratio schedules</text>
    </passage>
    <passage>
      <infon key="volume">3</infon>
      <infon key="name_1">surname:Oldfather;given-names:CM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Heyman;given-names:GM</infon>
      <infon key="fpage">122</infon>
      <infon key="year">1992</infon>
      <infon key="source">Psychol Sci</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">130</infon>
      <offset>29790</offset>
      <text>Inelastic preference for ethanol in rats: an analysis of ethanol's reinforcing effects</text>
      <annotation id="321">
        <infon key="identifier">10116</infon>
        <infon key="type">Species</infon>
        <location offset="29826" length="4"/>
        <text>rats</text>
      </annotation>
      <annotation id="322">
        <infon key="identifier">MESH:D000431</infon>
        <infon key="type">Chemical</infon>
        <location offset="29815" length="7"/>
        <text>ethanol</text>
      </annotation>
      <annotation id="323">
        <infon key="identifier">MESH:D000431</infon>
        <infon key="type">Chemical</infon>
        <location offset="29847" length="7"/>
        <text>ethanol</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">16</infon>
      <infon key="name_1">surname:Davison;given-names:MC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hollard;given-names:V</infon>
      <infon key="fpage">375</infon>
      <infon key="pub-id_pmid">16811552</infon>
      <infon key="year">1971</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">380</infon>
      <offset>29879</offset>
      <text>Preference for qualitatively different reinforcers</text>
    </passage>
    <passage>
      <infon key="name_3">surname:DeLeon;given-names:IG</infon>
      <infon key="name_2">surname:Spiga;given-names:R</infon>
      <infon key="name_1">surname:Madden;given-names:GJ</infon>
      <infon key="name_0">surname:Hursh;given-names:SR</infon>
      <infon key="fpage">191</infon>
      <infon key="year">2013</infon>
      <infon key="source">APA Handbook of Behavior Analysis, Volume 2: Translating Principles Into Practice</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Lattal;given-names:KA</infon>
      <infon key="name_7">surname:Hanley;given-names:GP</infon>
      <infon key="lpage">224</infon>
      <infon key="name_6">surname:Dube;given-names:WV</infon>
      <infon key="name_5">surname:Madden;given-names:G</infon>
      <infon key="name_4">surname:Francisco;given-names:MT</infon>
      <offset>29930</offset>
      <text>The translational utility of behavioral economics: the experimental analysis of consumption and choice</text>
    </passage>
    <passage>
      <infon key="volume">99</infon>
      <infon key="name_1">surname:Roma;given-names:PG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hursh;given-names:SR</infon>
      <infon key="fpage">98</infon>
      <infon key="pub-id_pmid">23344991</infon>
      <infon key="year">2013</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">124</infon>
      <offset>30033</offset>
      <text>Behavioral economics and empirical public policy</text>
    </passage>
    <passage>
      <infon key="volume">17</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Killeen;given-names:P</infon>
      <infon key="fpage">489</infon>
      <infon key="pub-id_pmid">16811604</infon>
      <infon key="year">1972</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">495</infon>
      <offset>30082</offset>
      <text>The matching law</text>
    </passage>
    <passage>
      <infon key="volume">73</infon>
      <infon key="name_2">surname:Jacobs;given-names:EA</infon>
      <infon key="name_1">surname:Bickel;given-names:WK</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Madden;given-names:GJ</infon>
      <infon key="fpage">45</infon>
      <infon key="pub-id_pmid">10682339</infon>
      <infon key="year">1999</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">64</infon>
      <offset>30099</offset>
      <text>Three predictions of the economic concept of unit price</text>
    </passage>
    <passage>
      <infon key="volume">229</infon>
      <infon key="name_2">surname:France;given-names:CP</infon>
      <infon key="name_1">surname:Gerak;given-names:LR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Maguire;given-names:DR</infon>
      <infon key="fpage">323</infon>
      <infon key="pub-id_pmid">23636304</infon>
      <infon key="year">2013</infon>
      <infon key="source">Psychopharmacology (Berl)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">330</infon>
      <offset>30155</offset>
      <text>Delay discounting of food and remifentanil in rhesus monkeys</text>
      <annotation id="325">
        <infon key="identifier">MESH:D000077208</infon>
        <infon key="type">Chemical</infon>
        <location offset="30185" length="12"/>
        <text>remifentanil</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">75</infon>
      <infon key="name_1">surname:Blampied;given-names:NM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McLean;given-names:AP</infon>
      <infon key="fpage">25</infon>
      <infon key="pub-id_pmid">11256865</infon>
      <infon key="year">2001</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">42</infon>
      <offset>30216</offset>
      <text>Sensitivity to relative reinforcer rate in concurrent schedules: independence from relative and absolute reinforcer duration</text>
    </passage>
    <passage>
      <infon key="volume">14</infon>
      <infon key="name_1">surname:Stevens Negus;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Mello;given-names:NK</infon>
      <infon key="fpage">375</infon>
      <infon key="pub-id_pmid">8726752</infon>
      <infon key="year">1996</infon>
      <infon key="source">Neuropsychopharmacology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">424</infon>
      <offset>30341</offset>
      <text>Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures</text>
      <annotation id="328">
        <infon key="identifier">MESH:D009293</infon>
        <infon key="type">Disease</infon>
        <location offset="30414" length="12"/>
        <text>opioid abuse</text>
      </annotation>
      <annotation id="329">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="30402" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">45</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McDowell;given-names:JJ</infon>
      <infon key="fpage">63</infon>
      <infon key="pub-id_pmid">3950535</infon>
      <infon key="year">1986</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">74</infon>
      <offset>30469</offset>
      <text>On the falsifiability of matching theory</text>
    </passage>
    <passage>
      <infon key="volume">139</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McDowell;given-names:JJ</infon>
      <infon key="fpage">1000</infon>
      <infon key="pub-id_pmid">22946881</infon>
      <infon key="year">2013</infon>
      <infon key="source">Psychol Bull</infon>
      <infon key="type">ref</infon>
      <offset>30510</offset>
      <text>On the theoretical and empirical status of the matching law and matching theory</text>
    </passage>
    <passage>
      <infon key="volume">26</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Miller;given-names:HL</infon>
      <infon key="fpage">335</infon>
      <infon key="pub-id_pmid">16811952</infon>
      <infon key="year">1976</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">347</infon>
      <offset>30590</offset>
      <text>Matching-based hedonic scaling in the pigeon</text>
    </passage>
    <passage>
      <infon key="volume">27</infon>
      <infon key="name_1">surname:Myers;given-names:LE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Myers;given-names:DL</infon>
      <infon key="fpage">203</infon>
      <infon key="pub-id_pmid">16811977</infon>
      <infon key="year">1977</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">214</infon>
      <offset>30635</offset>
      <text>Undermatching: a reappraisal of performance on concurrent variable-interval schedules of reinforcement</text>
    </passage>
    <passage>
      <infon key="volume">33</infon>
      <infon key="name_2">surname:Woolverton;given-names:WL</infon>
      <infon key="name_1">surname:Hedeker;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Nader;given-names:MA</infon>
      <infon key="fpage">193</infon>
      <infon key="pub-id_pmid">8261883</infon>
      <infon key="year">1993</infon>
      <infon key="source">Drug Alcohol Depend</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">199</infon>
      <offset>30738</offset>
      <text>Behavioral economics and drug choice: effects of unit price on cocaine self-administration by monkeys</text>
      <annotation id="331">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="30801" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">105</infon>
      <infon key="name_1">surname:Woolverton;given-names:WL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Nader;given-names:MA</infon>
      <infon key="fpage">169</infon>
      <infon key="pub-id_pmid">1796123</infon>
      <infon key="year">1991</infon>
      <infon key="source">Psychopharmacology (Berl)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">174</infon>
      <offset>30840</offset>
      <text>Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure</text>
    </passage>
    <passage>
      <infon key="volume">108</infon>
      <infon key="name_1">surname:Woolverton;given-names:WL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Nader;given-names:MA</infon>
      <infon key="fpage">295</infon>
      <infon key="pub-id_pmid">1523280</infon>
      <infon key="year">1992</infon>
      <infon key="source">Psychopharmacology (Berl)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">300</infon>
      <offset>30958</offset>
      <text>Effects of increasing response requirement on choice between cocaine and food in rhesus monkeys</text>
      <annotation id="333">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="31019" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">167</infon>
      <infon key="name_1">surname:Mello;given-names:NK</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Negus;given-names:SS</infon>
      <infon key="fpage">324</infon>
      <infon key="pub-id_pmid">12652348</infon>
      <infon key="year">2003</infon>
      <infon key="source">Psychopharmacology (Berl)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">332</infon>
      <offset>31054</offset>
      <text>Effects of chronic D-amphetamine treatment on cocaine-and food-maintained responding under a progressive-ratio schedule in rhesus monkeys</text>
      <annotation id="336">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="31073" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="337">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="31100" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">66</infon>
      <infon key="name_1">surname:Miller;given-names:LL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Negus;given-names:SS</infon>
      <infon key="fpage">869</infon>
      <infon key="pub-id_pmid">24973197</infon>
      <infon key="year">2014</infon>
      <infon key="source">Pharmacol Rev</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">917</infon>
      <offset>31192</offset>
      <text>Intracranial self-stimulation to evaluate abuse potential of drugs</text>
    </passage>
    <passage>
      <infon key="volume">16</infon>
      <infon key="name_2">surname:Stevenson;given-names:GW</infon>
      <infon key="name_1">surname:Schrode;given-names:K</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Negus;given-names:SS</infon>
      <infon key="fpage">386</infon>
      <infon key="year">2008</infon>
      <infon key="source">Exp Clin Psychopharm</infon>
      <infon key="type">ref</infon>
      <offset>31259</offset>
      <text>Mu/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability</text>
      <annotation id="340">
        <infon key="identifier">9544</infon>
        <infon key="type">Species</infon>
        <location offset="31291" length="14"/>
        <text>rhesus monkeys</text>
      </annotation>
      <annotation id="341">
        <infon key="identifier">MESH:D000699</infon>
        <infon key="type">Disease</infon>
        <location offset="31324" length="9"/>
        <text>analgesia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Weber;given-names:SM</infon>
      <infon key="name_2">surname:Thiel;given-names:KJ</infon>
      <infon key="name_1">surname:Sanabria;given-names:F</infon>
      <infon key="name_0">surname:Peartree;given-names:NA</infon>
      <infon key="fpage">63</infon>
      <infon key="pub-id_pmid">22243759</infon>
      <infon key="year">2012</infon>
      <infon key="source">Drug Alcohol Depend</infon>
      <infon key="type">ref</infon>
      <infon key="volume">124</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">69</infon>
      <infon key="name_5">surname:Neisewander;given-names:JL</infon>
      <infon key="name_4">surname:Cheung;given-names:TH</infon>
      <offset>31354</offset>
      <text>A new criterion for acquisition of nicotine self-administration in rats</text>
      <annotation id="343">
        <infon key="identifier">MESH:D009538</infon>
        <infon key="type">Chemical</infon>
        <location offset="31389" length="8"/>
        <text>nicotine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">15</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rachlin;given-names:H</infon>
      <infon key="fpage">249</infon>
      <infon key="pub-id_pmid">16811511</infon>
      <infon key="year">1971</infon>
      <infon key="source">J Exp Anal Behav</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">251</infon>
      <offset>31426</offset>
      <text>On the tautology of the matching law</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Green;given-names:L</infon>
      <infon key="volume">4</infon>
      <infon key="name_2">surname:Kagel;given-names:J</infon>
      <infon key="name_1">surname:Battalio;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rachlin;given-names:H</infon>
      <infon key="fpage">371</infon>
      <infon key="year">1981</infon>
      <infon key="source">Behav Brain Sci</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">388</infon>
      <offset>31463</offset>
      <text>Maximization theory in behavioral psychology</text>
    </passage>
    <passage>
      <infon key="volume">87</infon>
      <infon key="name_2">surname:Battalio;given-names:RC</infon>
      <infon key="name_1">surname:Kagel;given-names:JH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rachlin;given-names:H</infon>
      <infon key="fpage">355</infon>
      <infon key="year">1980</infon>
      <infon key="source">Psychol Rev</infon>
      <infon key="type">ref</infon>
      <offset>31508</offset>
      <text>Substitutability in time allocation</text>
    </passage>
    <passage>
      <infon key="volume">231</infon>
      <infon key="name_2">surname:Shizgal;given-names:P</infon>
      <infon key="name_1">surname:Conover;given-names:K</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Trujillo-Pisanty;given-names:I</infon>
      <infon key="fpage">1351</infon>
      <infon key="year">2014</infon>
      <infon key="source">Psychopharmacology (Berl)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1364</infon>
      <offset>31544</offset>
      <text>A new view of the effect of dopamine receptor antagonism on operant performance for rewarding brain stimulation in the rat</text>
    </passage>
    <passage>
      <infon key="volume">127</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Woolverton;given-names:WL</infon>
      <infon key="fpage">195</infon>
      <infon key="pub-id_pmid">8912397</infon>
      <infon key="year">1996</infon>
      <infon key="source">Psychopharmacology (Berl)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">203</infon>
      <offset>31667</offset>
      <text>Intravenous self-administration of cocaine under concurrent VI schedules of reinforcement</text>
      <annotation id="345">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="31702" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">186</infon>
      <infon key="name_1">surname:Anderson;given-names:KG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Woolverton;given-names:WL</infon>
      <infon key="fpage">99</infon>
      <infon key="pub-id_pmid">16568283</infon>
      <infon key="year">2006</infon>
      <infon key="source">Psychopharmacology (Berl)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">106</infon>
      <offset>31757</offset>
      <text>Effects of delay to reinforcement on the choice between cocaine and food in rhesus monkeys</text>
      <annotation id="347">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="31813" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">title</infon>
      <offset>31848</offset>
      <text>Appendix A. Supplementary data</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">paragraph</infon>
      <offset>31879</offset>
      <text>Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.drugalcdep.2014.11.003.</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms643973f1.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>32019</offset>
      <text>Simulated cocaine vs. food choice dose-effect functions. (A) The effects of changing sensitivity to magnitude with sensitivity to price held constant at 1.0. (B) The effects of changing sensitivity to price with sensitivity to magnitude held constant at 5.0. Ordinates: proportion of cocaine choices. Abscissae: unit cocaine dose (mg/kg/injection).</text>
      <annotation id="350">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="32336" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="351">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="32303" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms643973f2.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption</infon>
      <offset>32368</offset>
      <text>Continuous 14-day D-amphetamine treatment effects on (A) and (B) cocaine vs. food choice and (C) and (D) best-fitting parameter estimates of Eq. (1) plotted as a function of D-amphetamine dose. (A) and (B) Ordinates: obtained and predicted (solid curves) proportion cocaine choice. Abscissae: unit dose cocaine in mg/kg/injection (log scale). (C) and (D) Ordinates: sensitivity to reinforcer magnitude (sm) or price (sp). Abscissae: D-amphetamine dose in mg/kg/h. Model predictions (A) and (B) and parameter estimates (C) and (D) were derived from averaging the parameter estimates of the best-fitting model for individual monkeys. Note different ordinate scales in (C) and (D).</text>
      <annotation id="357">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="32433" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="358">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="32801" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="359">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="32386" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="360">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="32542" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="361">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="32671" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms643973f3.jpg</infon>
      <infon key="id">F3</infon>
      <infon key="type">fig_caption</infon>
      <offset>33047</offset>
      <text>Continuous 14-day (+)-phendimetrazine treatment effects on (A) and (B) cocaine vs. food choice and (C) and (D) best-fitting parameter estimates of Eq. (1) plotted as a function of (+)-phendimetrazine dose. (A) and (B) Ordinates: obtained and predicted (solid curves) proportion cocaine choice. Abscissae: unit dose cocaine in mg/kg/injection (log scale). (C) and (D) Ordinates: sensitivity to reinforcer magnitude (sm) or price (sp). Abscissae: (+)-phendimetrazine dose in mg/kg/h. Model predictions (A) and (B) and parameter estimates (C) and (D) were derived from averaging the parameter estimates of the best-fitting model for individual monkeys. Note different ordinate scales in (C) and (D).</text>
      <annotation id="367">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="33492" length="19"/>
        <text>(+)-phendimetrazine</text>
      </annotation>
      <annotation id="368">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="33065" length="19"/>
        <text>(+)-phendimetrazine</text>
      </annotation>
      <annotation id="369">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="33362" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="370">
        <infon key="identifier">MESH:C100294</infon>
        <infon key="type">Chemical</infon>
        <location offset="33227" length="19"/>
        <text>(+)-phendimetrazine</text>
      </annotation>
      <annotation id="371">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="33118" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms643973f4.jpg</infon>
      <infon key="id">F4</infon>
      <infon key="type">fig_caption</infon>
      <offset>33744</offset>
      <text>Continuous 14-day (+)-phenmetrazine treatment effects on (A) and (B) cocaine vs. food choice and (C) and (D) best-fitting parameter estimates of Eq. (1) plotted as a function of (+)-phenmetrazine dose. (A) and (B) Ordinates: obtained and predicted (solid curves) proportion cocaine choice. Abscissae: unit dose cocaine in mg/kg/injection (log scale). (C) and (D) Ordinates: sensitivity to reinforcer magnitude (sm) or price (sp). Abscissae: (+)-phenmetrazine dose in mg/kg/h. Model predictions (A) and (B) and parameter estimates (C) and (D) were derived from averaging the parameter estimates of the best-fitting model for individual monkeys. Note different ordinate scales in (C) and (D).</text>
      <annotation id="377">
        <infon key="identifier">MESH:D010633</infon>
        <infon key="type">Chemical</infon>
        <location offset="33922" length="17"/>
        <text>(+)-phenmetrazine</text>
      </annotation>
      <annotation id="378">
        <infon key="identifier">MESH:D010633</infon>
        <infon key="type">Chemical</infon>
        <location offset="34185" length="17"/>
        <text>(+)-phenmetrazine</text>
      </annotation>
      <annotation id="379">
        <infon key="identifier">MESH:D010633</infon>
        <infon key="type">Chemical</infon>
        <location offset="33762" length="17"/>
        <text>(+)-phenmetrazine</text>
      </annotation>
      <annotation id="380">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="34055" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="381">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="33813" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms643973f5.jpg</infon>
      <infon key="id">F5</infon>
      <infon key="type">fig_caption</infon>
      <offset>34435</offset>
      <text>Effect of 7-day cocaine or food removal on (A) cocaine vs. food choice and (B) and (C) best-fitting parameter estimates of Eq. (1) plotted as a function of extinction manipulation. (A) Ordinate: obtained and predicted (solid curves) proportion cocaine choice. Abscissa: unit dose cocaine in mg/kg/injection (log scale). (B) and (C) Ordinates: sensitivity to reinforcer magnitude (sm) or price (sp). Abscissae: (+)-phenmetrazine dose in mg/kg/h. Model predictions (A) and parameter estimates (B) and (C) were derived from averaging the parameter estimates of the best-fitting model for individual monkeys. Note different ordinate scales in (B) and (C).</text>
      <annotation id="386">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="34451" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="387">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="34482" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="388">
        <infon key="identifier">MESH:D010633</infon>
        <infon key="type">Chemical</infon>
        <location offset="34845" length="17"/>
        <text>(+)-phenmetrazine</text>
      </annotation>
      <annotation id="389">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="34715" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms643973f6.jpg</infon>
      <infon key="id">F6</infon>
      <infon key="type">fig_caption</infon>
      <offset>35087</offset>
      <text>Continuous 14-day D-amphetamine treatment effects on demand for cocaine and food. Model predictions were derived from averaging the parameter estimates of the best-fitting model for individual monkeys. Ordinates: normalized consumption (reinforcers earned/total reinforcers). Abscissae: unit price of cocaine (UP = FR/dose). The unit price at which cocaine and food consumption are predicted to be equal is indicated in the insets as UP50.</text>
      <annotation id="394">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="35388" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="395">
        <infon key="identifier">MESH:D003913</infon>
        <infon key="type">Chemical</infon>
        <location offset="35105" length="13"/>
        <text>D-amphetamine</text>
      </annotation>
      <annotation id="396">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="35151" length="7"/>
        <text>cocaine</text>
      </annotation>
      <annotation id="397">
        <infon key="identifier">MESH:D003042</infon>
        <infon key="type">Chemical</infon>
        <location offset="35436" length="7"/>
        <text>cocaine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>35527</offset>
      <text>Multi-model comparison and selection for individual monkeys. The first column specifies the pharmacological or environmental manipulation. Each sub-column gives the AICc of the Null model and the DeltaAICc of competing models. A DeltaAICc &gt; 4 is significantly better than the Null model. The best model (lowest AICc) is indicated in bold, n is the number of observations and R2 is the proportion of variance accounted for by the best model.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>35968</offset>
      <text>                    </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>35989</offset>
      <text>                </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>36006</offset>
      <text>Multi-model comparison and selection for individual monkeys. The first column specifies the pharmacological or environmental manipulation. Each sub-column gives the AICc of the Null model and the DeltaAICc of competing models. A DeltaAICc &gt; 4 is significantly better than the Null model. The best model (lowest AICc) is indicated in bold, n is the number of observations and R2 is the proportion of variance accounted for by the best model.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">T1</infon>
      <infon key="type">table</infon>
      <infon key="File">T1.xml</infon>
      <offset>36447</offset>
      <text>                                               Mean              M1452              M1473              M1504              M1488              M1478              M1480              M1412              M1414                                                       D-Amphetamine                                      AICc (Null, H0)              -428.2              -62.4              -99.4              -239.3              -104.5              -57.0              -63.0                                                                  Delta (Full, sm, sp)                             602.0                                          22.4                                          107.1                           -12.9                             122.8                           262.2              129.0                                                                  Delta (Magnitude, sm)              -4.4              18.0              -24.0              -4.4              13.3              3.1              -3.2                                                                  Delta (Price sp)              473.5              15.1              78.2              -1.7              47.1                             291.7                                          167.0                                                                               n                                           15                                          25                                          19                                          25                                          25                                          24                                                                               R2              0.999              0.983              0.996              0.999              0.991              0.999              0.999                                                                 (+)-Phendimetrazine                                      AICc (Null, H0)              -276.7              -67.6              -50.8              -136.8              -70.3                                                                                              Delta (Full, sm, sp)              271.1              57.8              118.1              172.7              46.9                                                                                              Delta (Magnitude, sm)              63.5              0.2                             131.0                           -1.1              -3.3                                                                                              Delta (Price sp)                             298.2                                          93.2                           89.3                             184.5                                          58.8                                                                                                           n                                           20                                          23                                          25                                          25                                                                                                           R2              0.991              0.999              0.999              0.999              0.977                                                                                             (+)-Phenmetrazine                                      AICc (Null, H0)              -425.8              -106.8              -74.4              -73.8              -104.6                            -83.5                                                                  Delta (Full, sm, sp)              163.7                             30.7                                          170.5                           3.0              128.1                                           145.5                                                                               Delta (Magnitude, sm)              58.2              28.2              4.2              4.7              -4.5                            144.4                                                                 Delta (Price sp)                             203.8                           30.4              136.0                             14.8                                          139.9                                         93.1                                                                  n                                           25                                          25                                          25                                          25                                                        25                                                                               R2              0.997              0.982              0.999              0.999              0.999                            0.997                                                                 Extinction                                      AICc (Null, H0)              -234.5              -30.4                                                                      -29.1              -45.0              -33.9                                      Delta (Full, sm, sp)              235.6              150.1                                                                      83.2              226.4                             21.3                                                   Delta (Magnitude, sm)              13.2              -1.6                                                                      -8.4              34.2              3.1                                     Delta (Price sp)                             239.1                                          157.3                                                                                                  90.5                                          238.0                           18.4                                      n                                           15                                                                                                  15                                          15                                          15                                                   R2              0.996              0.999                                                                      0.999              0.999              0.900                             </text>
      <annotation id="400">
        <infon key="identifier">MESH:D010633</infon>
        <infon key="type">Chemical</infon>
        <location offset="39820" length="17"/>
        <text>(+)-Phenmetrazine</text>
      </annotation>
      <annotation id="401">
        <infon key="identifier">MESH:C000604007</infon>
        <infon key="type">Chemical</infon>
        <location offset="40104" length="2"/>
        <text>sp</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272825</id>
    <passage>
      <infon key="name_3">surname:Esther;given-names:Charles R.;suffix:Jr</infon>
      <infon key="name_2">surname:Fulcher;given-names:M. Leslie</infon>
      <infon key="name_1">surname:Quinney;given-names:Nancy L.</infon>
      <infon key="article-id_pmid">25101886</infon>
      <infon key="name_0">surname:Cholon;given-names:Deborah M.</infon>
      <infon key="fpage">246ra96</infon>
      <infon key="issue">246</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272825</infon>
      <infon key="article-id_doi">10.1126/scitranslmed.3008680</infon>
      <infon key="type">front</infon>
      <infon key="volume">6</infon>
      <infon key="license">           This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.         </infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Sci Transl Med; 2014 Jul 23; 6(246) 246. doi:10.1126/scitranslmed.3008680</infon>
      <infon key="name_8">surname:Gentzsch;given-names:Martina</infon>
      <infon key="name_7">surname:Boucher;given-names:Richard C.</infon>
      <infon key="lpage">246ra96</infon>
      <infon key="name_6">surname:Randell;given-names:Scott H.</infon>
      <infon key="name_5">surname:Dokholyan;given-names:Nikolay V.</infon>
      <infon key="article-id_manuscript">NIHMS623565</infon>
      <infon key="name_4">surname:Das;given-names:Jhuma</infon>
      <infon key="authors">Cholon DM, Quinney NL, Fulcher ML, Esther CR, Das J, Dokholyan NV, Randell SH, Boucher RC, Gentzsch M</infon>
      <offset>0</offset>
      <text>Potentiator Ivacaftor Abrogates Pharmacological Correction of DeltaF508 CFTR in Cystic Fibrosis</text>
      <annotation id="3">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="72" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="4">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="80" length="15"/>
        <text>Cystic Fibrosis</text>
      </annotation>
      <annotation id="5">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="12" length="9"/>
        <text>Ivacaftor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>96</offset>
      <text>Cystic Fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR). Newly developed "correctors" such as lumacaftor (VX-809) that improve CFTR maturation and trafficking and "potentiators" such as ivacaftor (VX-770) that enhance channel activity may provide important advances in CF therapy. Although VX-770 has demonstrated substantial clinical efficacy in the small subset of patients with a mutation (G551D) that affects only channel activity, a single compound is not sufficient to treat patients with the more common CFTR mutation, DeltaF508. Thus, patients with DeltaF508 will likely require treatment with both correctors and potentiators to achieve clinical benefit. However, whereas the effectiveness of acute treatment with this drug combination has been demonstrated in vitro, the impact of chronic therapy has not been established. In studies of human primary airway epithelial cells, we found that both acute and chronic treatment with VX-770 improved CFTR function in cells with the G551D mutation, consistent with clinical studies. In contrast, chronic VX-770 administration caused a dose-dependent reversal of VX-809-mediated CFTR correction in DeltaF508 homozygous cultures. This result reflected the destabilization of corrected DeltaF508 CFTR by VX-770, dramatically increasing its turnover rate. Chronic VX-770 treatment also reduced mature wild-type CFTR levels and function. These findings demonstrate that chronic treatment with CFTR potentiators and correctors may have unexpected effects that cannot be predicted from short-term studies. Combining of these drugs to maximize rescue of DeltaF508 CFTR may require changes in dosing and/or development of new potentiator compounds that do not interfere with CFTR stability.</text>
      <annotation id="26">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="187" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="264" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="28">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="648" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="29">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="1091" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="30">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="1268" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="31">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="1497" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="32">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="1578" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="33">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="1746" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="34">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="1856" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="1383" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="36">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="504" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="37">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="618" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="38">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="680" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="39">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="984" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="40">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="1123" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="41">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="96" length="15"/>
        <text>Cystic Fibrosis</text>
      </annotation>
      <annotation id="42">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="323" length="9"/>
        <text>ivacaftor</text>
      </annotation>
      <annotation id="43">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="243" length="6"/>
        <text>VX-809</text>
      </annotation>
      <annotation id="44">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="231" length="10"/>
        <text>lumacaftor</text>
      </annotation>
      <annotation id="45">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="530" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1872</offset>
      <text>Introduction</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1885</offset>
      <text>The most common autosomal recessive genetic disease of the Caucasian population in the United States and Europe, cystic fibrosis (CF), is characterized by abnormal epithelial ion transport. Mutations in the CF transmembrane conductance regulator (CFTR) result in loss of CFTR-mediated Cl- and HCO3- transport by secretory and absorptive epithelial cells in multiple organs, including lungs, pancreas, liver, and intestine. In the lung, disturbances of airway surface liquid homeostasis produce thick and viscous mucus that leads to mucus stasis, airway obstruction, persistent infection, inflammation, and a progressive decline in lung function. These features are the hallmarks of CF lung disease and result in limited life expectancy.</text>
      <annotation id="56">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="2132" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="57">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="2156" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="58">
        <infon key="identifier">MESH:D001639</infon>
        <infon key="type">Chemical</infon>
        <location offset="2178" length="4"/>
        <text>HCO3</text>
      </annotation>
      <annotation id="59">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="2462" length="9"/>
        <text>infection</text>
      </annotation>
      <annotation id="60">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="2567" length="15"/>
        <text>CF lung disease</text>
      </annotation>
      <annotation id="61">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="1998" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
      <annotation id="62">
        <infon key="identifier">MESH:D000402</infon>
        <infon key="type">Disease</infon>
        <location offset="2431" length="18"/>
        <text>airway obstruction</text>
      </annotation>
      <annotation id="63">
        <infon key="identifier">MESH:D010190</infon>
        <infon key="type">Disease</infon>
        <location offset="2276" length="8"/>
        <text>pancreas</text>
      </annotation>
      <annotation id="64">
        <infon key="identifier">MESH:D007249</infon>
        <infon key="type">Disease</infon>
        <location offset="2473" length="12"/>
        <text>inflammation</text>
      </annotation>
      <annotation id="65">
        <infon key="identifier">MESH:D030342</infon>
        <infon key="type">Disease</infon>
        <location offset="1901" length="35"/>
        <text>autosomal recessive genetic disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2626</offset>
      <text>In 1989, the identification of the CFTR gene on chromosome 7 and its most common mutation, DeltaF508 CFTR, raised hope for a cure that would address the underlying cause of CF. Intense high-throughput screening approaches over the last decade have yielded compounds that modulate mutant CFTR function. Small-molecule compounds that rescue mutant CFTR can be assigned to 2 groups: 1) "corrector" compounds that promote maturation and delivery of CFTR proteins to the apical surface and 2) "potentiator" compounds that activate apical CFTR by increasing the open time of the channel.</text>
      <annotation id="72">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="2661" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="2913" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="2972" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="3071" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="76">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="3159" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="77">
        <infon key="identifier">c.508DELTA&gt;CFTR</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="2717" length="14"/>
        <text>DeltaF508 CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3213</offset>
      <text>The FDA recently approved the CFTR potentiator compound VX-770 (ivacaftor; trade name Kalydeco) as the first drug that directly restores CFTR activity in CF patients who carry a G551D mutation. G551D CFTR reaches the plasma membrane of epithelial cells, but the protein exhibits a gating defect that abolishes ATP-dependent channel opening and causes severe CF. In patients carrying a G551D mutation, VX-770 has proven to be effective in clinical trials, in which treated patients exhibited marked improvements in sweat chloride values and pulmonary function. The development of a CFTR-targeted drug that benefits CF patients marked a breakthrough in the treatment of CF. Unfortunately, because less than 5% of the CF population have the G551D mutation, this specific therapy helps only a limited number of patients. 90% of CF patients carry the DeltaF508 mutation, which produces a protein that does not mature normally and does not traffic to the plasma membrane. VX-770 treatment did not benefit CF subjects with the DeltaF508 mutation, likely because this compound only acts on protein that has trafficked to the plasma membrane. Based on these findings, an attractive therapeutic strategy for the DeltaF508 CF patient population is to promote transfer of the ER-retained DeltaF508 CFTR protein to the plasma membrane using small-molecule corrector compounds. Studies have estimated that the extent of correction in DeltaF508 airway epithelial cells must approximate 10-25% of wild-type (WT) CFTR function to provide therapeutic benefit. In vitro treatment of CF airway epithelial cultures homozygous for the DeltaF508 mutation with the most promising corrector compound, VX-809 (lumacaftor), resulted in CFTR function of ~14% relative to non-CF ("wild-type") human airway epithelial cells. However, administration of VX-809 did not provide a significant therapeutic benefit for DeltaF508 CF patients in recent clinical trials, most likely because DeltaF508 CFTR correction in vivo was less than 10% of wild-type levels, the lower limit of detection, and thus no mature DeltaF508 CFTR protein was observed. Therefore, a logical next step was to combine corrector and potentiator therapies to rescue DeltaF508 and increase protein function. One of the most promising current clinical trials designed to optimize DeltaF508 CFTR function involved the administration of the corrector VX-809 with the potentiator VX-770. Increases in VX-809-rescued DeltaF508 CFTR function have been demonstrated after acute administration of VX-770 in primary human airway epithelial cells from CF patients and human organoids derived from CF (DeltaF508/DeltaF508) intestinal tissue. Surprisingly, chronic co-administration of VX-809 and VX-770 in Phase 2 and 3 studies produced only small improvements in lung function in CF patients homozygous for the DeltaF508 CFTR mutation.</text>
      <annotation id="114">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="3243" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="3350" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="116">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="3413" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="117">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="3794" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="118">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="4499" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="119">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="4709" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="120">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="4922" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="5175" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="122">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="5297" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="123">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="5671" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="124">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="6060" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="125">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3370" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="126">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3578" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="127">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3685" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="128">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3830" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="129">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4020" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="130">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4040" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="131">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4428" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="132">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4977" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5109" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="134">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5756" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5794" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="136">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5807" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="137">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6022" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="138">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="4889" length="6"/>
        <text>VX-809</text>
      </annotation>
      <annotation id="139">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="3391" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="140">
        <infon key="identifier">MESH:D002712</infon>
        <infon key="type">Chemical</infon>
        <location offset="3733" length="8"/>
        <text>chloride</text>
      </annotation>
      <annotation id="141">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="3269" length="6"/>
        <text>VX-770</text>
      </annotation>
      <annotation id="142">
        <infon key="identifier">c.508DELTA&gt;CFTR</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="5528" length="14"/>
        <text>DeltaF508 CFTR</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="3277" length="9"/>
        <text>ivacaftor</text>
      </annotation>
      <annotation id="144">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="3818" length="11"/>
        <text>benefits CF</text>
      </annotation>
      <annotation id="145">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="5035" length="6"/>
        <text>VX-809</text>
      </annotation>
      <annotation id="146">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="3598" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="147">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="3407" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="148">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="4897" length="10"/>
        <text>lumacaftor</text>
      </annotation>
      <annotation id="149">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="3951" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>6075</offset>
      <text>The aim of this study was to elucidate the molecular mechanism(s) underlying the limited improvement in DeltaF508 CFTR function when a corrector, VX-809 and a potentiator, VX-770 were co-administered to CF patients. We therefore investigated whether there were unexpected effects of chronically exposing CF cultures in vitro to VX-809 and VX-770, as would be achieved by oral dosing in clinical trials. A combination of CFTR bioelectric and biochemical approaches were utilized to investigate this interaction. Human bronchial epithelial (HBE) cells were used for these studies and exposed for 48 hrs to clinically relevant concentrations of both compounds. In addition, because of the success of VX-770 in CF patients with the G551D mutation, it has recently been suggested that treatment with VX-770 may be a pharmacological approach to enhance CFTR function in patients with chronic obstructive pulmonary disease (COPD). Accordingly, similar experimental approaches were utilized to explore the effects of VX-770 on WT CFTR, which matures normally and traffics to the plasma membrane.</text>
      <annotation id="162">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="6189" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="6495" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="6922" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6281" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="166">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6586" length="5"/>
        <text>Human</text>
      </annotation>
      <annotation id="167">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6785" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="168">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6939" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="169">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="7097" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="170">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="6992" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="171">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="6803" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="172">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="6953" length="37"/>
        <text>chronic obstructive pulmonary disease</text>
      </annotation>
      <annotation id="173">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="6870" length="6"/>
        <text>VX-770</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>7163</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>7171</offset>
      <text>Acute and chronic VX-770 treatments rescue G551D CFTR function</text>
      <annotation id="176">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="7220" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="177">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="7214" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7234</offset>
      <text>It has been recently demonstrated that acute VX-770 administration increased CFTR function in cell lines expressing G551D CFTR and augmented Cl- secretion in primary human bronchial epithelial (HBE) cells derived from CF patients with the G551D mutation on one allele and the DeltaF508 mutation on the other allele. To compare the effects of chronic versus acute VX-770 drug administration in CF airway epithelia with a G551D mutation, we used well-differentiated primary CF HBE cultures (G551D/DeltaF508) as a model. Cultures were treated chronically for 48 hrs with VX-770 or vehicle in the basolateral medium, and then transepithelial short-circuit currents (ISC) were measured in Ussing chambers (Fig. 1). Cultures were exposed to amiloride to inhibit the epithelial Na+ channel (ENaC) and subsequently forskolin to stimulate Cl- secretion by CFTR. As previously reported, acute administration of VX-770 (aVX770) raised Cl- secretion after forskolin administration (Fig. 1A). Chronic VX-770 (cVX770) administration raised forskolin responsiveness but eliminated subsequent responses to acute VX-770 administration (Fig. 1A,B,C, Table S1). Cultures chronically treated with VX-770 exhibited total CFTR-mediated responses (Fig. 1D) and inhibition with CFTRinh-172 (Fig. 1E) equal to cultures treated with forskolin and acute VX-770.</text>
      <annotation id="195">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="7311" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="196">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="7356" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="8081" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="8434" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7400" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="200">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7455" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="201">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="7706" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="202">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="8041" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="203">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="8178" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="204">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="7723" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="205">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="8541" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="206">
        <infon key="identifier">MESH:C482900</infon>
        <infon key="type">Chemical</infon>
        <location offset="8488" length="11"/>
        <text>CFTRinh-172</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">MESH:D000584</infon>
        <infon key="type">Chemical</infon>
        <location offset="7969" length="9"/>
        <text>amiloride</text>
      </annotation>
      <annotation id="208">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="8260" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="209">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="7654" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="210">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="7627" length="19"/>
        <text>CF airway epithelia</text>
      </annotation>
      <annotation id="211">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="7473" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8569</offset>
      <text>Chronically VX-770-treated G551D/DeltaF508 HBE cultures also exhibited a decrease in amiloride-sensitive currents (Fig. S1A, Table S2), suggesting decreased ENaC function. This finding is consistent with restoration of CFTR-mediated ENaC inhibitory activity because cleavage of ENaC was diminished in chronically VX-770-treated CF cultures (Fig. S1B). The average UTP responsiveness, an index of Ca2+ activated Cl- channel (CaCC) activity, was reduced with chronic as compared to acute VX-770 administration (Fig. S1C, Table S2).</text>
      <annotation id="218">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="8788" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">55107</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">75079</infon>
        <location offset="8965" length="26"/>
        <text>Ca2+ activated Cl- channel</text>
      </annotation>
      <annotation id="220">
        <infon key="identifier">55107</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">75079</infon>
        <location offset="8993" length="4"/>
        <text>CaCC</text>
      </annotation>
      <annotation id="221">
        <infon key="identifier">MESH:D014544</infon>
        <infon key="type">Chemical</infon>
        <location offset="8933" length="3"/>
        <text>UTP</text>
      </annotation>
      <annotation id="222">
        <infon key="identifier">c.551G&gt;D,D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="8596" length="7"/>
        <text>G551D/D</text>
      </annotation>
      <annotation id="223">
        <infon key="identifier">MESH:D000584</infon>
        <infon key="type">Chemical</infon>
        <location offset="8654" length="9"/>
        <text>amiloride</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9099</offset>
      <text>In sum, these results demonstrate that both acute and chronic treatment with VX-770 improved CFTR function in HBE cells with the G551D mutation, consistent with clinical studies.</text>
      <annotation id="226">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="9192" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="227">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="9228" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>9278</offset>
      <text>Chronic VX-770 treatment inhibits functional rescue of DeltaF508 CFTR</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9348</offset>
      <text>CF patients harboring the DeltaF508 CFTR mutation, which produces protein maturation and trafficking defects, have little/no CFTR at the cell surface. Consequently, treatment with a corrector compound, such as VX-809, is required for VX-770 to potentiate surface-localized DeltaF508 CFTR. To mimic clinical administration of VX-809 and VX-770 as a combination therapy for the DeltaF508 CF patients, primary CF HBE cultures (DeltaF508/DeltaF508) were treated with both pharmacological agents for 48 hrs and then Ussing chamber experiments were performed to measure DeltaF508 CFTR function (Fig. 2, Table S3).</text>
      <annotation id="237">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="9384" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="238">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="9473" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="239">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="9631" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="240">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9351" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="241">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9737" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="242">
        <infon key="identifier">DeltaF508/DeltaF508</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="9772" length="19"/>
        <text>DeltaF508/DeltaF508</text>
      </annotation>
      <annotation id="243">
        <infon key="identifier">c.508DELTA&gt;CFTR</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="9912" length="14"/>
        <text>DeltaF508 CFTR</text>
      </annotation>
      <annotation id="244">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="9755" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="245">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="9558" length="6"/>
        <text>VX-809</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9956</offset>
      <text>Anion efflux across the apical epithelial membrane of airway epithelia in response to cAMP is mediated by CFTR and was not substantial in vehicle-treated DeltaF508/DeltaF508 CF HBE cultures Fig. 2A,B; Vehicle). However, VX-809 administration produced DeltaF508 CFTR correction as evidenced by stimulation of Cl- secretion (Fig. 2). Specifically, correction by VX-809 produced responses to forskolin (Fig. 2A, B; VX809) that were enhanced by acute administration of VX-770 (Fig. 2A,C). These data indicate that acutely applied VX-770 further activated ("potentiated") VX-809-rescued DeltaF508 CFTR. However, the CFTR-mediated ISC increase after addition of VX-770 to corrector-rescued DeltaF508 CFTR was transient. The ISC decrease over time may be indicative of a rapidly decreasing quantity of functional protein at the apical membrane.</text>
      <annotation id="256">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="10062" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="257">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="10567" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="258">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="10650" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="259">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="10217" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="260">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="10548" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="261">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="10130" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="262">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="10345" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="263">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="10316" length="6"/>
        <text>VX-809</text>
      </annotation>
      <annotation id="264">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="10042" length="4"/>
        <text>cAMP</text>
      </annotation>
      <annotation id="265">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="10176" length="6"/>
        <text>VX-809</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10794</offset>
      <text>In contrast, rescue of DeltaF508 CFTR function was dramatically decreased in cultures that had been chronically treated with VX-809 and VX-770 compared to VX-809 alone (Fig. 2A: VX809 vs. VX809+VX770). This loss of "corrected" function was reflected in reduced Cl- secretion responses to forskolin (Fig. 2B) and reduced inhibition of stimulated CFTR Cl- secretion with CFTRinh-172 (Fig. 2D). Thus, these data contrast with the significant (P = 0.0177) acute VX-770 responses in VX-809-treated cultures (Fig. 2C). Again, we noticed that the response to UTP-stimulated ISC decreased upon chronic VX-770 treatment (Figs. 2A and S1D).</text>
      <annotation id="271">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="10827" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="272">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="11139" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="273">
        <infon key="identifier">MESH:D014544</infon>
        <infon key="type">Chemical</infon>
        <location offset="11346" length="3"/>
        <text>UTP</text>
      </annotation>
      <annotation id="274">
        <infon key="identifier">MESH:C482900</infon>
        <infon key="type">Chemical</infon>
        <location offset="11163" length="11"/>
        <text>CFTRinh-172</text>
      </annotation>
      <annotation id="275">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="11082" length="9"/>
        <text>forskolin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11430</offset>
      <text>We also tested the impact of chronic VX-770 treatment on DeltaF508 correction in CF HBE cultures (DeltaF508/DeltaF508) by corrector compound VX-661. Similar to VX-809-treated CF cells, VX-661-corrected CF HBE cells showed a drastic reduction in forskolin-mediated CFTR function when VX-770 was chronically added (Fig. S2, Table S4).</text>
      <annotation id="281">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="11694" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="282">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="11632" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="283">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="11675" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="284">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="11590" length="6"/>
        <text>VX-809</text>
      </annotation>
      <annotation id="285">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="11511" length="6"/>
        <text>CF HBE</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>11763</offset>
      <text>Chronic VX-770 administration hinders correction by decreasing the stability of corrected DeltaF508 CFTR</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11868</offset>
      <text>To explore the mechanism(s) mediating the VX-770-induced reduction of VX-809-corrected DeltaF508 CFTR function, we used Western blotting techniques to analyze protein maturation and turnover. In normal HBE cells, we detected a mature, complex glycosylated form, band C (Fig. 3A, NL: *), with a substantially greater molecular weight than the immature band B (Fig. 3A, NL:  ). In contrast, only band B could be detected in vehicle-treated DeltaF508/DeltaF508 CF HBE cells (Fig. 3A, CF). As previously reported, treatment with VX-809 alone resulted in formation of a modest amount of mature band C in CF HBE cultures, which was not present in vehicle- or VX-770-treated CF cells (Fig. 3A, CF). However, when CF cells were treated chronically with both VX-809 and VX-770, the amount of mature DeltaF508 CFTR was diminished, and instead the DeltaF508 CFTR protein appeared almost exclusively as immature band B. These data suggest that chronic VX-770 treatment impeded correction of DeltaF508 CFTR by VX-809. We investigated the impact of chronic VX-770 treatment on protein stability by measuring the turnover rate of corrected DeltaF508 CFTR. DeltaF508 CFTR was stably expressed in baby hamster kidney (BHK-21) cells and corrected with VX-809 in the presence and absence of VX-770. Rescue with VX-809 was performed at 27 C for 24 hrs because VX-770 prevented VX-809 mediated correction of DeltaF508 CFTR at 37 C (Fig. 3A). After rescue, cells were shifted to 37 C and protein biosynthesis was inhibited by addition of cycloheximide. The amount of remaining mature DeltaF508 CFTR was then measured after 3 and 6 hrs. The turnover rate of rescued DeltaF508 CFTR band C increased and the half-life accordingly decreased by ~2.5 fold in the presence of VX-770 (Fig. 3B,C, Table S5), whereas the decrease in band B levels was not affected by the presence of VX-770 (Fig. 3B). These data clearly show that VX-770 decreased the stability, and thus increased the turnover rate, of VX-809-rescued DeltaF508 CFTR.</text>
      <annotation id="302">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="11965" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="303">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="12668" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="304">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="12715" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="305">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="13003" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="306">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="13019" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="307">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="13265" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="308">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="13440" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="309">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="13521" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="310">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="13864" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="311">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="12857" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="312">
        <infon key="identifier">10034</infon>
        <infon key="type">Species</infon>
        <location offset="13053" length="7"/>
        <text>hamster</text>
      </annotation>
      <annotation id="313">
        <infon key="identifier">CVCL:1914</infon>
        <infon key="type">CellLine</infon>
        <location offset="13069" length="6"/>
        <text>BHK-21</text>
      </annotation>
      <annotation id="314">
        <infon key="identifier">MESH:D003513</infon>
        <infon key="type">Chemical</infon>
        <location offset="13384" length="13"/>
        <text>cycloheximide</text>
      </annotation>
      <annotation id="315">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="12326" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="316">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="12467" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="317">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="12393" length="6"/>
        <text>VX-809</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>13870</offset>
      <text>VX-770 affects correction of DeltaF508 CFTR in a dose-dependent relationship</text>
      <annotation id="319">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="13909" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13947</offset>
      <text>Lower concentrations of VX-770 were chronically administered to DeltaF508/DeltaF508 CF HBE cells to study the dose effect on VX-809-rescued DeltaF508 CFTR (Fig. 4). To obtain an average measure of CFTR-mediated ISC for the period spanning forskolin stimulation to CFTR inhibition, the area under the curve (AUC) was calculated for this interval. Dividing AUC by time yielded average CFTR DeltaISC between activation and inhibition. When 1 microM VX-770 was administered chronically with VX-809, the forskolin responses of CF HBE cells were intermediate between cells treated with VX-809 alone and cells treated with 5 microM VX-770 and VX-809 (Fig. 4A,B, Table S6). There was a significant reduction in AUC in corrector-treated cells with 1 microM versus 5 microM VX-770 (P =0.0049). Although there was not a significant difference in AUC of VX-809-treated cells with 50 nM VX-770 versus VX-809 alone (Fig. 4B), this low dose of VX-770 caused a rapid decline of the slope after forskolin treatment (Fig 4C, Table S7). Chronic treatment with either 50 nM or 1 microM VX-770 eliminated responses to acute VX-770 (Fig. 4A,C). Western blots to detect mature band C protein in CF HBE cells confirmed that VX-809 rescue was inhibited by VX-770 in a dose-dependent manner. As the concentration of VX-770 increased, the amount of VX-809-corrected DeltaF508 CFTR decreased (Fig. 4D, E, Table S8).</text>
      <annotation id="331">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="14097" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="332">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="14144" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="333">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="14211" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="334">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="14330" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="335">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="15296" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="336">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="14031" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="337">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="14186" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="338">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="14446" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="339">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="15119" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="340">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="14469" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="341">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="14925" length="9"/>
        <text>forskolin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>15335</offset>
      <text>Chronic VX-770 treatment decreases function of normal (wild-type) CFTR</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>15406</offset>
      <text>To investigate the effects of chronic VX-770 treatment on normal (NL) CFTR, we measured anion secretion of NL primary HBE cultures treated with VX-770 for 48 hrs (Fig. 5). Strikingly, administration of 5 microM VX-770 reduced CFTR-mediated Cl- secretion, as reflected by decreased forskolin responses (Fig. 5A,B,C, Table S9) and decreased inhibition of CFTR-mediated current by CFTRinh-172 (Fig. 5A,D). These functional responses were paralleled by a decrease in CFTR band C (Fig. 5E). In cells chronically treated with VX-770, we also observed a consistent reduction in amiloride-sensitive current (Fig. S3A, Table S2) and a substantial inhibition of UTP-sensitive current (Fig. S3B, Table S2) similar to that observed in CF HBE cells (Fig. S1A,C,D, Table S2).</text>
      <annotation id="352">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="15476" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="353">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="15632" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="354">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="15759" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="355">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="15869" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="356">
        <infon key="identifier">MESH:C482900</infon>
        <infon key="type">Chemical</infon>
        <location offset="15784" length="11"/>
        <text>CFTRinh-172</text>
      </annotation>
      <annotation id="357">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="16129" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="358">
        <infon key="identifier">MESH:D000584</infon>
        <infon key="type">Chemical</infon>
        <location offset="15977" length="9"/>
        <text>amiloride</text>
      </annotation>
      <annotation id="359">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="15687" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="360">
        <infon key="identifier">MESH:D014544</infon>
        <infon key="type">Chemical</infon>
        <location offset="16058" length="3"/>
        <text>UTP</text>
      </annotation>
      <annotation id="361">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="15926" length="6"/>
        <text>VX-770</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>16168</offset>
      <text>Chronic treatment with VX-770 does not alter HBE cell integrity or barrier functions</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>16253</offset>
      <text>As a test for the specificity of chronic VX-770 effects, we analyzed whether fundamental epithelial parameters were altered in HBE cultures chronically treated with VX-770 (Fig. 6). The morphology of highly differentiated ciliated HBE cultures was identical in cells treated with vehicle (DMSO) or VX-770 (Fig. 6A). Transepithelial resistance (Rt) of primary HBE cultures was also not affected by chronic VX-770 exposure (Fig. 6B, Table S10). The inhibition by VX-770 of both Na+ absorption (amiloride-sensitive ISC) and Cl- secretion and currents (CFTR- and CaCC-mediated ISC) raised the possibility that driving forces for ion transport, in part generated by Na+/K+ ATPase activity, were perturbed by VX-770. Nystatin, a polyene antibiotic that enables monovalent cations to permeate biological membranes and raise Na+/K+ ATPase activity, did not produce significantly different ISC responses when applied to vehicle- or VX-770-treated HBE cultures (Fig. 6C, Table S10), suggesting intact Na+/K+ ATPase activity. Measurements of intracellular concentrations of VX-809 and VX-770 by mass spectrometry confirmed the presence of these compounds in treated HBE cultures and indicated that cellular VX-809 concentrations were not affected by the presence of VX-770 (Fig. S4, Table S11).</text>
      <annotation id="371">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="16802" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="372">
        <infon key="identifier">55107</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">75079</infon>
        <location offset="16812" length="4"/>
        <text>CaCC</text>
      </annotation>
      <annotation id="373">
        <infon key="identifier">6267</infon>
        <infon key="type">Gene</infon>
        <location offset="17531" length="3"/>
        <text>S11</text>
      </annotation>
      <annotation id="374">
        <infon key="identifier">6204</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">788</infon>
        <location offset="17220" length="3"/>
        <text>S10</text>
      </annotation>
      <annotation id="375">
        <infon key="identifier">6204</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">788</infon>
        <location offset="16690" length="3"/>
        <text>S10</text>
      </annotation>
      <annotation id="376">
        <infon key="identifier">MESH:D004121</infon>
        <infon key="type">Chemical</infon>
        <location offset="16542" length="4"/>
        <text>DMSO</text>
      </annotation>
      <annotation id="377">
        <infon key="identifier">MESH:D011090</infon>
        <infon key="type">Chemical</infon>
        <location offset="16976" length="7"/>
        <text>polyene</text>
      </annotation>
      <annotation id="378">
        <infon key="identifier">MESH:D000584</infon>
        <infon key="type">Chemical</infon>
        <location offset="16745" length="9"/>
        <text>amiloride</text>
      </annotation>
      <annotation id="379">
        <infon key="identifier">MESH:D009761</infon>
        <infon key="type">Chemical</infon>
        <location offset="16964" length="8"/>
        <text>Nystatin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>17539</offset>
      <text>Destabilization by VX-770 is beneficial for G551D, but not for wild-type, or DeltaF508 CFTR function</text>
      <annotation id="382">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="17626" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="383">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="17583" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>17640</offset>
      <text>A high C:B band ratio indicates normal CFTR protein maturation. Biochemical analysis by Western blotting showed that chronic VX-770 treatment dramatically reduced the amount of mature CFTR in both NL cultures expressing wild-type CFTR (Figs. 5E and 7A) and VX-809-rescued DeltaF508 CFTR in CF HBE cells (Figs. 3A and 4E). Indeed, the C:B band ratio decreased with chronic VX-770 exposure by more than 50% in NL cultures (Fig. 7B, NL, Table S12). In contrast, the levels of mature (band C) G551D CFTR detected in G551D/DeltaF508 CF HBE cultures were not significantly diminished by chronic exposure to 5 microM VX-770, suggesting that G551D was resistant to the destabilizing effects of VX-770 (Fig 7A, G551D/DeltaF508).</text>
      <annotation id="395">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="17679" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="396">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="17824" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="397">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="17870" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="398">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="17922" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="399">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="18135" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="400">
        <infon key="identifier">6268</infon>
        <infon key="type">Gene</infon>
        <location offset="18080" length="3"/>
        <text>S12</text>
      </annotation>
      <annotation id="401">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="17930" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="402">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="18274" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="403">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="18168" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="404">
        <infon key="identifier">c.551G&gt;D,D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="18152" length="7"/>
        <text>G551D/D</text>
      </annotation>
      <annotation id="405">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="18342" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>18360</offset>
      <text>To explore the relationship between VX-770, VX-809, and CFTR protein stability, we performed calculations of thermodynamic stability of CFTR protein utilizing a structural homology model. This model revealed that CFTR amino acid F508 is located at the nucleotide binding domain 1- cytoplasmic loop 4 (NBD1-CL4) interface (Fig. 7C), and therefore participates in important interdomain interactions. Thus, in DeltaF508 CFTR, the deletion of amino acid F508 not only reduces the stability of the NBD1 domain, but importantly, may destabilize multidomain assembly of CFTR. In contrast, in this structural model of CFTR, amino acid G551 is positioned between the 2 NBDs (Figs. 7C, S5), and the G551D mutation is thought to contort NBD dimer formation and abolish ATP-dependent channel opening by disrupting the signature sequence in NBD1. To evaluate whether the G551D mutation also affects the overall stability of CFTR by inducing conformational restructuring of the protein, we computationally estimated the DeltaDeltaG for G551D CFTR. We found that G551D had a stabilizing effect on the CFTR protein (DeltaDeltaG = -8.1 kcal/mol).</text>
      <annotation id="423">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="18416" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="424">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="18496" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="425">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="18573" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="426">
        <infon key="identifier">100862696</infon>
        <infon key="type">Gene</infon>
        <location offset="18666" length="3"/>
        <text>CL4</text>
      </annotation>
      <annotation id="427">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="18777" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="428">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="18923" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="429">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="18970" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="430">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="19271" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="431">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="19388" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="432">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="19446" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="433">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="18799" length="15"/>
        <text>amino acid F508</text>
      </annotation>
      <annotation id="434">
        <infon key="identifier">MESH:D000255</infon>
        <infon key="type">Chemical</infon>
        <location offset="19118" length="3"/>
        <text>ATP</text>
      </annotation>
      <annotation id="435">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="18578" length="15"/>
        <text>amino acid F508</text>
      </annotation>
      <annotation id="436">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="19218" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="437">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="19049" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="438">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="19382" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="439">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="19408" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>19490</offset>
      <text>Discussion</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>19501</offset>
      <text>Potentiator compounds act on mutant CFTR channels that are on the surface of epithelial cells. VX-770 has been approved as a pharmacological agent to treat CF patients with at least one copy of the G551D mutation. However, the most common mutant protein in CF patients, DeltaF508 CFTR, is not found at the cell surface. DeltaF508 CFTR has a folding defect and is retained in the ER but can be partially rescued by corrector compounds that promote delivery of a small proportion of mutant DeltaF508 proteins to the cell surface. Corrector-rescued DeltaF508 CFTR is reported to have a shorter half-life at the cell surface and exhibits increased thermal inactivation as well as a gating defect when compared to WT CFTR.</text>
      <annotation id="448">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="19537" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="449">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="19781" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="450">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="19831" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="451">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="20057" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="452">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="20213" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="453">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19660" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="454">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19761" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="455">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="19699" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>20219</offset>
      <text>The efficacy of orally administered VX-770 was established in clinical trials in G551D CF patients by multiple outcome measurements. The clinical benefit of potentiation of G551D function was predicted from the effectiveness of acute administration of VX-770 in Ussing chambers, which measured rates of Cl- secretion across primary G551D/DeltaF508 CFTR airway epithelial cultures. Our studies confirmed that acute VX-770 administration restored CFTR Cl- secretion activity in HBE cells from patients carrying the G551D mutation. Further, our data demonstrated that G551D/DeltaF508 cultures chronically treated with VX-770 also exhibited increased Cl- secretion via G551D CFTR, but stimulation with forskolin, which raises intracellular cAMP, was required to activate Cl- secretion. This result could suggest a benefit from administering cAMP-raising beta2-adrenergic receptor agonists as a routine part of the treatment for G551D CF patients receiving VX-770. Overall, improvement in G551D CFTR activity with acute VX-770 in vitro was also observed with chronic in vitro VX-770 administration.</text>
      <annotation id="474">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="20567" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="475">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="20664" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="476">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="20890" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="477">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="21209" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="478">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20309" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="479">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20710" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="480">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21152" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="481">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="20917" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="482">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="20955" length="4"/>
        <text>cAMP</text>
      </annotation>
      <annotation id="483">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="20732" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="484">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="20300" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="485">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="21056" length="4"/>
        <text>cAMP</text>
      </annotation>
      <annotation id="486">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="21203" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="487">
        <infon key="identifier">c.551G&gt;D,D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="20551" length="7"/>
        <text>G551D/D</text>
      </annotation>
      <annotation id="488">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="20392" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="489">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="21143" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="490">
        <infon key="identifier">c.551G&gt;D,D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="20784" length="7"/>
        <text>G551D/D</text>
      </annotation>
      <annotation id="491">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="20884" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>21313</offset>
      <text>VX-809 appears to restore approximately 15% of normal function in DeltaF508/DeltaF508 CF HBE cells. However, 10-25% of CFTR function is estimated to be required to overcome CF symptoms. Therefore, a combination of VX-809 with a potentiator compound to further enhance DeltaF508 function may be necessary. Although acute treatment with VX-770 has been reported to enhance VX-809-rescued DeltaF508 activity, our data revealed that chronic application of VX-770 in combination with VX-809 or VX-661 did not. Chronic co-administration of VX-770 with either corrector to DeltaF508/DeltaF508 CF HBE cultures produced Cl- secretory responses that were smaller than responses to corrector alone. Our data suggest that the reduced capacity for Cl- secretion after chronic VX-770/VX-809 exposure reflected an increased turnover rate of corrected DeltaF508 CFTR. The VX-770-induced reduction of DeltaF508 correction observed in primary CF HBE cells was dose-dependent as measured by functional and biochemical approaches. We did not detect alterations in physiological properties of HBE cells that would suggest that toxic effects contributed to CFTR dysfunction after chronic VX-770/VX-809 treatment. Thus, our studies suggest that data describing the effectiveness of acute addition of VX-770 to VX-809-treated DeltaF508 CF HBE cells do not predict the outcome for chronic VX-770/VX-809 administration.</text>
      <annotation id="502">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="21432" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="503">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="22159" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="504">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="22448" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="505">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="21399" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="506">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="21527" length="6"/>
        <text>VX-809</text>
      </annotation>
      <annotation id="507">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="22238" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="508">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="21899" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="509">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="22625" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="510">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="21313" length="6"/>
        <text>VX-809</text>
      </annotation>
      <annotation id="511">
        <infon key="identifier">MESH:D006331</infon>
        <infon key="type">Disease</infon>
        <location offset="22453" length="11"/>
        <text>dysfunction</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>22707</offset>
      <text>DeltaF508 CFTR has been shown to exhibit an increased thermodynamic instability of NBD1 and improper assembly of NBD1 into a complex with intracellular loop 4 (ICL4) of the second membrane-spanning domain (MSD2). The recently published data on CFTR domain fragments strongly suggest that VX-809 targets MSD1 of CFTR to suppress folding defects of DeltaF508 CFTR by enhancing interactions among NBD1, MSD1 and MSD2. Thus, VX-809 is predicted to enhance function of DeltaF508 by increasing its stability (Fig. 7D). Importantly, chronic exposure to VX-770 appeared to reverse the stabilization effect of VX-809 in DeltaF508 CFTR. Chronic VX-770 treatment resulted in a severe reduction in rescued DeltaF508 CFTR protein due to destabilization of rescued protein as reflected by a 2.5x increase in turnover rate. In contrast, G551D CFTR was more resistant to destabilization and loss of mature CFTR protein with chronic VX-770 exposure than WT or DeltaF508 CFTR.</text>
      <annotation id="522">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="22717" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="523">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="22951" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="524">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="23018" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="525">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="23411" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="526">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="23535" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="527">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="23597" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="528">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="23660" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="529">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="23328" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="530">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="23064" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="531">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="23529" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>23666</offset>
      <text>Our CFTR computational structural model allows us to speculate how VX-770 may interact with WT or mutant CFTR proteins to alter protein stability. CFTR requires conformational flexibility to function properly. The flexibility and stability of the CFTR protein is finely tuned and precisely balanced, which is a requirement for its ability to function properly as a regulated ion channel. The inherent increase in stability of the G551D protein may render it too rigid and inflexible (stable) for proper channel opening under basal cAMP-stimulated conditions. However, a decrease in stability mediated by VX-770 may render the G551D molecule more flexible and allow it to function as a cAMP-regulated Cl- channel (Fig. 7D). In contrast, destabilization of WT (ideal stability) or VX-809-rescued DeltaF508 CFTR (low stability) by VX-770 bound to the CFTR molecule resulted in decreased WT CFTR function and absent DeltaF508 CFTR function. These considerations reveal that chemical correction of low stability CFTR mutants is complicated and necessitates precision.</text>
      <annotation id="545">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="23670" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="546">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="23771" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="547">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="23813" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="548">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="23913" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="549">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="24470" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="550">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="24514" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="551">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="24553" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="552">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="24588" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="553">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="24673" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="554">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="24292" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="555">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="24351" length="4"/>
        <text>cAMP</text>
      </annotation>
      <annotation id="556">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="24096" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="557">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="24197" length="4"/>
        <text>cAMP</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>24729</offset>
      <text>Some airway diseases such as chronic obstructive pulmonary disease (COPD) have been associated with lessened CFTR function and consequently VX-770 has been suggested as a potential therapy. In a study that modeled the effects of VX-770 on COPD patients, reduction of CFTR function was achieved by exposing primary HBE cultures to cigarette smoke extract, and these cultures were subsequently exposed to acute administration of VX-770, which led to augmented CFTR-mediated currents. The finding that acute VX-770 treatment enhanced WT CFTR function contrasts with our finding that chronic treatment with VX-770 reduced WT CFTR function. In addition, forskolin-stimulated ISC in NL HBE cultures chronically treated with VX-770 was not stable over time, as indicated by the downward sloping trace. These functional data, coupled with our observations that the amount of mature WT CFTR was reduced by the continuous presence of VX-770, do not favor VX-770 as a therapy to enhance CFTR function in COPD.</text>
      <annotation id="572">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="24838" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="573">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="24996" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="574">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="25187" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="575">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="25263" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="576">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="25350" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="577">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="25606" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="578">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="25705" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="579">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="24973" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="580">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="24968" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="581">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="24797" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="582">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="25406" length="6"/>
        <text>NL HBE</text>
      </annotation>
      <annotation id="583">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="25156" length="6"/>
        <text>VX-770</text>
      </annotation>
      <annotation id="584">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="25722" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="585">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="24758" length="37"/>
        <text>chronic obstructive pulmonary disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>25728</offset>
      <text>Although potentiation of more rare CFTR mutants with partial defects in CFTR processing was recently detected upon acute VX-770 treatment in Fisher rat thyroid (FRT) cells overexpressing these variants, our data raise the concern that potentiation with chronic VX-770 treatment may not be observed in airway epithelia expressing these rare mutations. To optimize combination therapy for both DeltaF508 and rare CFTR processing mutations, minimizing interference of potentiator with corrector activity is required. One approach may be to finely tune the dosing regimens for potentiator compounds. Studies by Van Goor et al. indicate that the EC50 for acute application of VX-770 differs remarkably in G551D/DeltaF508 (EC50: 236 +- 200 nM) and DeltaF508/DeltaF508 (EC50: 22 +- 10 nM) HBE cultures. These data together with our findings, which demonstrate that inhibition of correction by VX-770 is dose dependent, suggest that drug concentrations are very critical and attempts to optimize potentiator activity on channel function while minimally affecting turnover rate of mutant CFTR should be considered. As a second approach, improved potentiator compounds that do not interfere with DeltaF508 CFTR correction and turnover are needed.</text>
      <annotation id="593">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="25763" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="594">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="25800" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="595">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="26139" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="596">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="26807" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="597">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="26924" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="598">
        <infon key="identifier">10116</infon>
        <infon key="type">Species</infon>
        <location offset="25876" length="3"/>
        <text>rat</text>
      </annotation>
      <annotation id="599">
        <infon key="identifier">c.551G&gt;D,D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="26428" length="7"/>
        <text>G551D/D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>26965</offset>
      <text>After chronic VX-770 treatment, we also observed diminished Cl- secretory responses to additions of the P2Y2 receptor agonist, UTP. UTP-stimulated Cl- secretion is elevated in CF airway epithelia and may compensate for the lack of CFTR function in vivo. Reduction of UTP-stimulated CaCC activity may constitute a disadvantage in CF airways, particularly if insufficient amounts of CFTR have been rescued. Thus, monitoring CaCC activity may be useful in future clinical corrector/potentiator studies.</text>
      <annotation id="608">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="27196" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="609">
        <infon key="identifier">55107</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">75079</infon>
        <location offset="27247" length="4"/>
        <text>CaCC</text>
      </annotation>
      <annotation id="610">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="27346" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="611">
        <infon key="identifier">55107</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">75079</infon>
        <location offset="27387" length="4"/>
        <text>CaCC</text>
      </annotation>
      <annotation id="612">
        <infon key="identifier">MESH:D014544</infon>
        <infon key="type">Chemical</infon>
        <location offset="27092" length="3"/>
        <text>UTP</text>
      </annotation>
      <annotation id="613">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="27141" length="19"/>
        <text>CF airway epithelia</text>
      </annotation>
      <annotation id="614">
        <infon key="identifier">MESH:D014544</infon>
        <infon key="type">Chemical</infon>
        <location offset="27232" length="3"/>
        <text>UTP</text>
      </annotation>
      <annotation id="615">
        <infon key="identifier">MESH:D014544</infon>
        <infon key="type">Chemical</infon>
        <location offset="27097" length="3"/>
        <text>UTP</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>27469</offset>
      <text>We observed a decrease in amiloride responses in the presence of chronic VX-770. While the effects in CF cells can be explained by the restoration of CFTR inhibiting activity, the inhibition of ENaC-mediated Na+ absorption in NL HBE cells raises the possibility that VX-770 may have off-target effects. Thus, it may be useful to measure ENaC function in future VX-770 clinical trials. Although a decline in ENaC function may be beneficial for CF patients, diminution of Cl- channels other than CFTR may be a disadvantage for maintaining adequate hydration of CF airways. The recent observation that VX-770 has antimicrobial properties in vitro suggests that it may also display off-target effects in vivo.</text>
      <annotation id="621">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="27619" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="622">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="27963" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="623">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27915" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="624">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="27695" length="6"/>
        <text>NL HBE</text>
      </annotation>
      <annotation id="625">
        <infon key="identifier">MESH:D000584</infon>
        <infon key="type">Chemical</infon>
        <location offset="27495" length="9"/>
        <text>amiloride</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>28177</offset>
      <text>A limitation of our studies is that our experiments were performed in primary HBE cultures and not in vivo. However, primary HBE cultures are a well-established, near-physiologic system that is the most relevant model for studying CFTR function in airway epithelia, the tissue most affected by CF. Drug concentrations, turnover, and formation of metabolites may also differ in vitro and in vivo, which are crucial parameters to consider when extrapolating our data to the clinic. We therefore selected in vitro doses that mimicked clinically measured drug concentrations. For example, 5-day VX-770 treatments with 150 mg or 450 mg (administered as one dose/day) in patients resulted in VX-770 concentrations in blood plasma of 1.4 microg/ml and 5.5 microg/ml, respectively, which are equivalent to ~3.5 microM and ~14 microM. Current clinical trials test VX-770 doses in this range (250 mg taken twice per day). Thus, the concentrations tested in our studies in vitro appear relevant to the clinical experience.</text>
      <annotation id="628">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="28408" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="629">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28842" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>29189</offset>
      <text>We measured intracellular concentrations of VX-809 and VX-770, which revealed that these compounds (particularly VX-770) accumulated in cells and reached much higher concentrations than in the surrounding media. To determine whether the presence of VX-770 might have a negative impact on the intracellular concentration of VX-809, we obtained measurements of VX-809 concentrations in cell lysates with increasing concentrations of VX-770 and observed that the intracellular concentration of VX-809 was not affected by the presence of VX-770. Thus, comparisons of drug concentrations from in vitro and in vivo tissues may be useful in the future.</text>
      <annotation id="632">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="29723" length="6"/>
        <text>VX-770</text>
      </annotation>
      <annotation id="633">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="29680" length="6"/>
        <text>VX-809</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>29835</offset>
      <text>Because there are no corrector compounds available that provide sufficient rescue of DeltaF508 in CF airways in vivo to alleviate symptoms of CF, potentiation of the small amount of corrected DeltaF508 CFTR is required. However, combination approaches to restore DeltaF508 CFTR function in CF to date have not considered drug-drug interactions of clinically relevant co-administered modulator compounds. Based on our study and the confirmatory data of Veit et al., knowledge of the interactions and interference between corrector and potentiator compounds is essential for successful therapy of the most prevalent mutation in CF patients, most of whom carry at least one allele of the DeltaF508 mutation. Furthermore, understanding the impact that potentiator compounds, such as VX-770, have on the stability of apical WT CFTR may also be important for other airway diseases that would benefit from augmentation of CFTR function.</text>
      <annotation id="639">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="30037" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="640">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="30657" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="641">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="30750" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="642">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="30108" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="643">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="30464" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>30765</offset>
      <text>Materials and Methods</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>30787</offset>
      <text>Study design</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>30800</offset>
      <text>Simultaneous treatment with small-molecular compounds, VX-809 or VX-661, together with VX-770 (Selleck Chemicals), is currently being examined as therapy for CF patients with the mutation, DeltaF508. Although in vitro studies examining acute treatment with this drug combination have been conducted, we sought to determine the impact of chronic treatment (48 hrs) with these compounds in primary human bronchial epithelial (HBE) cells. Primary HBE cells from normal (NL) or CF patients were obtained from bronchi of human lung tissue, as previously described. To evaluate CFTR function HBE cultures chronically treated with compounds were mounted in Ussing chambers to measure short-circuit currents (ISC). We examined differentiated primary CF HBE cells from at least 3 individuals for each genotype. To visualize the amount of mature and immature CFTR protein from HBE cultures, CFTR from whole-cell lysates was immunoprecipitated as previously described and Western blots were performed. Previously created baby hamster kidney (BHK-21) stably expressing DeltaF508 CFTR, were used in cycloheximide chase studies to examine the rate of protein turnover.</text>
      <annotation id="656">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="31372" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="657">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="31649" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="658">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="31681" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="659">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="31867" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="660">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="30961" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="661">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="31196" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="662">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="31277" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="663">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="31316" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="664">
        <infon key="identifier">10034</infon>
        <infon key="type">Species</infon>
        <location offset="31815" length="7"/>
        <text>hamster</text>
      </annotation>
      <annotation id="665">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="31542" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="666">
        <infon key="identifier">CVCL:1914</infon>
        <infon key="type">CellLine</infon>
        <location offset="31831" length="6"/>
        <text>BHK-21</text>
      </annotation>
      <annotation id="667">
        <infon key="identifier">MESH:D003513</infon>
        <infon key="type">Chemical</infon>
        <location offset="31886" length="13"/>
        <text>cycloheximide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>31955</offset>
      <text>Cell culture</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>31968</offset>
      <text>Primary HBE cells were obtained from bronchi of human lung tissue under a protocol approved by the University of North Carolina Medical School Institutional Review Board. Primary NL and CF HBE cells were seeded at passage 2 on collagen-coated Millicell CM inserts (Millipore) and maintained at an air-liquid interface (ALI) at 37 C in 5% CO2 for 3-4 weeks, which allowed the cells to become fully differentiated.</text>
      <annotation id="671">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="32016" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="672">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="32154" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="673">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="32306" length="3"/>
        <text>CO2</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>32384</offset>
      <text>BHK-21 cells were obtained from the American Type Culture Collection and grown at 37 C in 5% CO2. BHK-21 cells stably expressing Extope-DeltaF508 CFTR were created previously and maintained as described.</text>
      <annotation id="678">
        <infon key="identifier">101831516</infon>
        <infon key="type">Gene</infon>
        <location offset="32530" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="679">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="32477" length="3"/>
        <text>CO2</text>
      </annotation>
      <annotation id="680">
        <infon key="identifier">CVCL:1914</infon>
        <infon key="type">CellLine</infon>
        <location offset="32384" length="6"/>
        <text>BHK-21</text>
      </annotation>
      <annotation id="681">
        <infon key="identifier">CVCL:1914</infon>
        <infon key="type">CellLine</infon>
        <location offset="32482" length="6"/>
        <text>BHK-21</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>32588</offset>
      <text>Immunoprecipitation and Western blotting</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>32629</offset>
      <text>Whole-cell lysates were prepared as described previously. CFTR was immunoprecipitated as described previously and isolated using Protein A/G PLUS agarose (Santa Cruz Biotechnology). Samples were separated on 4-20% gradient SDS-PAGE gels (Bio-Rad) and then transferred to nitrocellulose. Blots were probed with mouse monoclonal anti-CFTR antibodies and then with IR Dye 680-goat anti-mouse IgG (Molecular Probes). Anti-actin (Cell Signaling) or anti-tubulin (LI-COR) was used as a loading control. Protein bands were visualized using an Odyssey Infrared Imaging System (LI-COR).</text>
      <annotation id="690">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="32687" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="691">
        <infon key="identifier">6236</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3071</infon>
        <location offset="32871" length="3"/>
        <text>Rad</text>
      </annotation>
      <annotation id="692">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="32961" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="693">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32939" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="694">
        <infon key="identifier">9925</infon>
        <infon key="type">Species</infon>
        <location offset="33002" length="4"/>
        <text>goat</text>
      </annotation>
      <annotation id="695">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33012" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="696">
        <infon key="identifier">MESH:D012967</infon>
        <infon key="type">Chemical</infon>
        <location offset="32852" length="3"/>
        <text>SDS</text>
      </annotation>
      <annotation id="697">
        <infon key="identifier">MESH:D012685</infon>
        <infon key="type">Chemical</infon>
        <location offset="32775" length="7"/>
        <text>agarose</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>33209</offset>
      <text>Cycloheximide chase to study turnover of rescued DeltaF508 CFTR</text>
      <annotation id="699">
        <infon key="identifier">MESH:D003513</infon>
        <infon key="type">Chemical</infon>
        <location offset="33209" length="13"/>
        <text>Cycloheximide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>33273</offset>
      <text>BHK-21 cells expressing Extope-DeltaF508 CFTR were pretreated with compounds (VX-809, 5 microM; VX-770, 5 microM) for 24 hrs at 27 C before treatment with cycloheximide (200 microg/ml; Sigma) in the presence of compounds during chase times at 37 C. Whole-cell lysates were prepared and subjected to Western blotting.</text>
      <annotation id="704">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="33314" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="705">
        <infon key="identifier">CVCL:1914</infon>
        <infon key="type">CellLine</infon>
        <location offset="33273" length="6"/>
        <text>BHK-21</text>
      </annotation>
      <annotation id="706">
        <infon key="identifier">MESH:D003513</infon>
        <infon key="type">Chemical</infon>
        <location offset="33428" length="13"/>
        <text>cycloheximide</text>
      </annotation>
      <annotation id="707">
        <infon key="identifier">MESH:C569105</infon>
        <infon key="type">Chemical</infon>
        <location offset="33351" length="6"/>
        <text>VX-809</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>33590</offset>
      <text>Histology and microscopy</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>33615</offset>
      <text>Primary HBE cultures grown at ALI on Millicell inserts were washed in PBS and fixed in 10% neutral buffered formalin prior to being embedded in paraffin and hematoxylin-eosin stained at the UNC CF Histology Core. Slides were viewed on a Leica DMIRB Inverted Microscope with a 40x 1.0 numerical aperture oil objective.</text>
      <annotation id="713">
        <infon key="identifier">MESH:D011535</infon>
        <infon key="type">Disease</infon>
        <location offset="33685" length="3"/>
        <text>PBS</text>
      </annotation>
      <annotation id="714">
        <infon key="identifier">MESH:D004801</infon>
        <infon key="type">Chemical</infon>
        <location offset="33784" length="5"/>
        <text>eosin</text>
      </annotation>
      <annotation id="715">
        <infon key="identifier">MESH:D010232</infon>
        <infon key="type">Chemical</infon>
        <location offset="33759" length="8"/>
        <text>paraffin</text>
      </annotation>
      <annotation id="716">
        <infon key="identifier">MESH:D005557</infon>
        <infon key="type">Chemical</infon>
        <location offset="33723" length="8"/>
        <text>formalin</text>
      </annotation>
      <annotation id="717">
        <infon key="identifier">MESH:D006416</infon>
        <infon key="type">Chemical</infon>
        <location offset="33772" length="11"/>
        <text>hematoxylin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>33934</offset>
      <text>ISC Measurements in Ussing chambers</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>33970</offset>
      <text>In Ussing chambers (Physiological Instruments) HBE cultures were equilibrated to 37 C in a bilateral bath of Krebs-bicarbonate-Ringer buffer (KBR; in mM: 140 Na+, 120 Cl-, 5.2 K+, 1.2 Ca2+, 1.2 Mg2+, 2.4 HPO42-, 0.4 H2PO4-, 25 HCO3-, and 5 glucose, pH 7.4) and circulated with 95% O2-5% CO2. Short-circuit currents (ISC) were measured as previously described. All NL HBE cultures were measured in bilateral KBR. Unless noted otherwise, CF HBE cultures were measured with high potassium, low chloride (HKLC) buffer applied apically and KBR applied basolaterally, creating a Cl- gradient (5 mM/120 mM). Amiloride (100 microM) was added to block ENaC, followed by forskolin (10 microM), VX-770 (5 microM) and, if applicable, genistein (10 microM) to stimulate CFTR. CFTR was then inhibited with CFTRinh-172 (10 microM) and response to UTP (100 microM) was examined. In some experiments, nystatin (40 microM, apical) was added at the end of the measurements. Data were analyzed using Acquire and Analysis (version 2.3) software (Physiologic Instruments). ISC traces were imported to and processed in Origin 9.0.0. (OriginLab Corporation).</text>
      <annotation id="743">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="34727" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="744">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="34733" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="745">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="34257" length="3"/>
        <text>CO2</text>
      </annotation>
      <annotation id="746">
        <infon key="identifier">MESH:D000584</infon>
        <infon key="type">Chemical</infon>
        <location offset="34571" length="9"/>
        <text>Amiloride</text>
      </annotation>
      <annotation id="747">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="34164" length="4"/>
        <text>Mg2+</text>
      </annotation>
      <annotation id="748">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="34406" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="749">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="34079" length="5"/>
        <text>Krebs</text>
      </annotation>
      <annotation id="750">
        <infon key="identifier">MESH:D011188</infon>
        <infon key="type">Chemical</infon>
        <location offset="34446" length="9"/>
        <text>potassium</text>
      </annotation>
      <annotation id="751">
        <infon key="identifier">MESH:D001639</infon>
        <infon key="type">Chemical</infon>
        <location offset="34197" length="4"/>
        <text>HCO3</text>
      </annotation>
      <annotation id="752">
        <infon key="identifier">MESH:D014544</infon>
        <infon key="type">Chemical</infon>
        <location offset="34802" length="3"/>
        <text>UTP</text>
      </annotation>
      <annotation id="753">
        <infon key="identifier">MESH:D019833</infon>
        <infon key="type">Chemical</infon>
        <location offset="34692" length="9"/>
        <text>genistein</text>
      </annotation>
      <annotation id="754">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="34174" length="6"/>
        <text>HPO42-</text>
      </annotation>
      <annotation id="755">
        <infon key="identifier">MESH:D005947</infon>
        <infon key="type">Chemical</infon>
        <location offset="34210" length="7"/>
        <text>glucose</text>
      </annotation>
      <annotation id="756">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="34631" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="757">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="34654" length="6"/>
        <text>VX-770</text>
      </annotation>
      <annotation id="758">
        <infon key="identifier">MESH:D001639</infon>
        <infon key="type">Chemical</infon>
        <location offset="34085" length="11"/>
        <text>bicarbonate</text>
      </annotation>
      <annotation id="759">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="34186" length="5"/>
        <text>H2PO4</text>
      </annotation>
      <annotation id="760">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="34471" length="4"/>
        <text>HKLC</text>
      </annotation>
      <annotation id="761">
        <infon key="identifier">MESH:D000069285</infon>
        <infon key="type">Chemical</infon>
        <location offset="34154" length="4"/>
        <text>Ca2+</text>
      </annotation>
      <annotation id="762">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="34251" length="2"/>
        <text>O2</text>
      </annotation>
      <annotation id="763">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="34334" length="6"/>
        <text>NL HBE</text>
      </annotation>
      <annotation id="764">
        <infon key="identifier">MESH:C482900</infon>
        <infon key="type">Chemical</infon>
        <location offset="34762" length="11"/>
        <text>CFTRinh-172</text>
      </annotation>
      <annotation id="765">
        <infon key="identifier">MESH:C039004</infon>
        <infon key="type">Chemical</infon>
        <location offset="34505" length="3"/>
        <text>KBR</text>
      </annotation>
      <annotation id="766">
        <infon key="identifier">MESH:D009761</infon>
        <infon key="type">Chemical</infon>
        <location offset="34854" length="8"/>
        <text>nystatin</text>
      </annotation>
      <annotation id="767">
        <infon key="identifier">MESH:D002712</infon>
        <infon key="type">Chemical</infon>
        <location offset="34461" length="8"/>
        <text>chloride</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>35105</offset>
      <text>Detection of VX-770 and VX-809</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>35136</offset>
      <text>Mass spectrometric (MS) methods were developed to detect VX-770 and VX-809 using strategies similar to those previously described. VX-770 was detected by monitoring transition of parent to daughter ion of m/z 393.3 171.1 in positive mode MS, with VX-809 detected by monitoring the transition m/z 453.3 197.1. Each compound generated a single peak using previously described liquid-chromatography-tandem MS (LC-MS/MS) methods, with run times of 11.1 and 10.8 minutes, respectively. To quantify drug concentrations in epithelial cells, cell lysates were extracted x 2 with equal volume of MTBE (Sigma), which was then lyophilized to dryness under vacuum centrifugation. Lyophilized samples were resuspended in a volume of 20% methanol in water equal to the original lysate volume, extracted, and 5 microl analyzed by LC-MS/MS as above. To control for matrix effects and variable recovery during extraction, untreated lysates were spiked with known concentrations of VX-770 and VX-809 and extracted in parallel. Concentrations in cell lysates were assessed by examining signal relative to the spiked samples.</text>
      <annotation id="770">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="35872" length="5"/>
        <text>water</text>
      </annotation>
      <annotation id="771">
        <infon key="identifier">MESH:D000432</infon>
        <infon key="type">Chemical</infon>
        <location offset="35860" length="8"/>
        <text>methanol</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>36244</offset>
      <text>Computational stability calculation</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>36280</offset>
      <text>We computationally estimated the DeltaDeltaG of mutation for G551D mutant CFTR using the Eris suite as described previously. Eris algorithms re-pack the side chains and evaluate the new free energy according to a physical force field upon the substitution of the relevant residue.</text>
      <annotation id="776">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="36354" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="777">
        <infon key="identifier">340061</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">18868</infon>
        <location offset="36405" length="4"/>
        <text>Eris</text>
      </annotation>
      <annotation id="778">
        <infon key="identifier">340061</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">18868</infon>
        <location offset="36369" length="4"/>
        <text>Eris</text>
      </annotation>
      <annotation id="779">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="36341" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>36561</offset>
      <text>Statistical analysis</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>36582</offset>
      <text>Results are presented as means of average response per primary HBE cell donor and error bars are the standard error of the mean (SEM). Statistical analysis was performed by an unpaired two-tailed Student's t test in GraphPad Prism version 6.02 (GraphPad Software). P values of &lt; 0.05 were considered to indicate statistical significance.</text>
      <annotation id="781">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="36654" length="5"/>
        <text>donor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">title_1</infon>
      <offset>36922</offset>
      <text>Supplementary Material</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>36945</offset>
      <text>           Supplementary Materials         </text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>36989</offset>
      <text>Supplementary Figures:</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>37012</offset>
      <text>Fig. S1. Chronic VX-770 treatment alters responses to amiloride and UTP in CF HBE cells.</text>
      <annotation id="785">
        <infon key="identifier">MESH:D014544</infon>
        <infon key="type">Chemical</infon>
        <location offset="37080" length="3"/>
        <text>UTP</text>
      </annotation>
      <annotation id="786">
        <infon key="identifier">MESH:D000584</infon>
        <infon key="type">Chemical</infon>
        <location offset="37066" length="9"/>
        <text>amiloride</text>
      </annotation>
      <annotation id="787">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="37087" length="6"/>
        <text>CF HBE</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>37101</offset>
      <text>Fig. S2. Chronic VX-770 treatment inhibits functional rescue of DeltaF508 by VX-661.</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>37186</offset>
      <text>Fig. S3. Chronic VX-770 treatment alters responses to amiloride and UTP in NL HBE cells.</text>
      <annotation id="791">
        <infon key="identifier">MESH:D014544</infon>
        <infon key="type">Chemical</infon>
        <location offset="37254" length="3"/>
        <text>UTP</text>
      </annotation>
      <annotation id="792">
        <infon key="identifier">MESH:D000584</infon>
        <infon key="type">Chemical</infon>
        <location offset="37240" length="9"/>
        <text>amiloride</text>
      </annotation>
      <annotation id="793">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="37261" length="6"/>
        <text>NL HBE</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>37275</offset>
      <text>Fig. S4. VX-770 and VX-809 concentrations were measured in treated HBE cells.</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>37353</offset>
      <text>Fig. S5. G551D mutation in the NBD1 stabilizes CFTR protein.</text>
      <annotation id="795">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="37400" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>37414</offset>
      <text>Supplementary Tables:</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>37436</offset>
      <text>Table S1. VX-770 treatment restores G551D function.</text>
      <annotation id="797">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="37472" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>37488</offset>
      <text>Table S2. Chronic VX-770 treatment alters responses to amiloride and UTP.</text>
      <annotation id="800">
        <infon key="identifier">MESH:D014544</infon>
        <infon key="type">Chemical</infon>
        <location offset="37557" length="3"/>
        <text>UTP</text>
      </annotation>
      <annotation id="801">
        <infon key="identifier">MESH:D000584</infon>
        <infon key="type">Chemical</infon>
        <location offset="37543" length="9"/>
        <text>amiloride</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>37562</offset>
      <text>Table S3. Chronic VX-770 treatment inhibits functional rescue of DeltaF508 by VX-809.</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>37648</offset>
      <text>Table S4. Chronic VX-770 treatment inhibits functional rescue of DeltaF508 by VX-661.</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>37734</offset>
      <text>Table S5. VX-770 diminishes biochemical correction by increasing turnover of corrected DeltaF508 CFTR.</text>
      <annotation id="803">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="37831" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>37837</offset>
      <text>Table S6. VX-770-induced hindrance of DeltaF508 correction is dose dependent.</text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>37915</offset>
      <text>Table S7. VX-770 at low dose (50 nM) affects ISC of VX-809-corrected CF HBE cells (DeltaF508/DeltaF508).</text>
      <annotation id="806">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="37984" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="807">
        <infon key="identifier">DeltaF508/DeltaF508</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="37998" length="19"/>
        <text>DeltaF508/DeltaF508</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>38020</offset>
      <text>Table S8. VX-770 affects C:B band ratio in CF HBE cultures (DeltaF508/DeltaF508).</text>
      <annotation id="810">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="38063" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="811">
        <infon key="identifier">DeltaF508/DeltaF508</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="38080" length="19"/>
        <text>DeltaF508/DeltaF508</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>38102</offset>
      <text>Table S9. Chronic VX-770 treatment decreases the function of wild-type CFTR.</text>
      <annotation id="813">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="38173" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>38179</offset>
      <text>Table S10. Transepithelial resistance and nystatin responses were not altered in HBE cultures chronically treated with VX-770.</text>
      <annotation id="816">
        <infon key="identifier">6204</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">788</infon>
        <location offset="38185" length="3"/>
        <text>S10</text>
      </annotation>
      <annotation id="817">
        <infon key="identifier">MESH:D009761</infon>
        <infon key="type">Chemical</infon>
        <location offset="38221" length="8"/>
        <text>nystatin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>38306</offset>
      <text>Table S11. VX-770 and VX-809 concentrations were measured in HBE cell lysates.</text>
      <annotation id="819">
        <infon key="identifier">6267</infon>
        <infon key="type">Gene</infon>
        <location offset="38312" length="3"/>
        <text>S11</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>38385</offset>
      <text>Table S12. VX-770 reduces stability of CFTR.</text>
      <annotation id="822">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="38424" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="823">
        <infon key="identifier">6268</infon>
        <infon key="type">Gene</infon>
        <location offset="38391" length="3"/>
        <text>S12</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>38430</offset>
      <text>                                                                                                                                                                                           </text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>38618</offset>
      <text>Author contributions: DMC, NLQ, and MG performed the experiments and analyzed the data. MLF selected and cultured the primary CF and NL HBE cells. MGG, SHR and RCB discussed the overall design of experiments. MGG and DMC wrote the manuscript. CRE measured drug concentrations. JD and NVD determined DeltaDeltaG of the G551D protein. SHR and RCB provided reagents, technical advice and critical evaluation of the manuscript. All authors read and commented on the manuscript.</text>
      <annotation id="828">
        <infon key="identifier">MESH:C023025</infon>
        <infon key="type">Chemical</infon>
        <location offset="38835" length="3"/>
        <text>DMC</text>
      </annotation>
      <annotation id="829">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="38751" length="6"/>
        <text>NL HBE</text>
      </annotation>
      <annotation id="830">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="38936" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="831">
        <infon key="identifier">MESH:C023025</infon>
        <infon key="type">Chemical</infon>
        <location offset="38640" length="3"/>
        <text>DMC</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>39092</offset>
      <text>                </text>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>39109</offset>
      <text>Competing interests: RCB serves as the chairman of the board of Parion Sciences, a company which works on therapies designed to hydrate airway surfaces and also studies CFTR correctors; Parion Sciences does not have a potentiator program. The other authors declare that they have no competing interests.</text>
      <annotation id="833">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="39278" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">SUPPL</infon>
      <infon key="type">footnote</infon>
      <offset>39413</offset>
      <text>                </text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>39430</offset>
      <text>References and notes</text>
    </passage>
    <passage>
      <infon key="volume">23</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Boucher;given-names:RC</infon>
      <infon key="fpage">146</infon>
      <infon key="year">2004</infon>
      <infon key="source">The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">158</infon>
      <offset>39451</offset>
      <text>New concepts of the pathogenesis of cystic fibrosis lung disease</text>
      <annotation id="835">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="39487" length="28"/>
        <text>cystic fibrosis lung disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">3</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Accurso;given-names:FJ</infon>
      <infon key="fpage">400</infon>
      <infon key="pub-id_pmid">9391757</infon>
      <infon key="year">1997</infon>
      <infon key="source">Current opinion in pulmonary medicine</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">403</infon>
      <offset>39516</offset>
      <text>Early pulmonary disease in cystic fibrosis</text>
      <annotation id="838">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="39543" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
      <annotation id="839">
        <infon key="identifier">MESH:D008171</infon>
        <infon key="type">Disease</infon>
        <location offset="39522" length="17"/>
        <text>pulmonary disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">173</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Davis;given-names:PB</infon>
      <infon key="fpage">475</infon>
      <infon key="pub-id_pmid">16126935</infon>
      <infon key="year">2006</infon>
      <infon key="source">American journal of respiratory and critical care medicine</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">482</infon>
      <offset>39559</offset>
      <text>Cystic fibrosis since 1938</text>
      <annotation id="841">
        <infon key="identifier">MESH:D005355</infon>
        <infon key="type">Disease</infon>
        <location offset="39566" length="8"/>
        <text>fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Markiewicz;given-names:D</infon>
      <infon key="name_2">surname:Buchanan;given-names:JA</infon>
      <infon key="name_1">surname:Rommens;given-names:JM</infon>
      <infon key="name_0">surname:Kerem;given-names:B</infon>
      <infon key="fpage">1073</infon>
      <infon key="pub-id_pmid">2570460</infon>
      <infon key="year">1989</infon>
      <infon key="source">Science</infon>
      <infon key="type">ref</infon>
      <infon key="volume">245</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Tsui;given-names:LC</infon>
      <infon key="lpage">1080</infon>
      <infon key="name_6">surname:Buchwald;given-names:M</infon>
      <infon key="name_5">surname:Chakravarti;given-names:A</infon>
      <infon key="name_4">surname:Cox;given-names:TK</infon>
      <offset>39586</offset>
      <text>Identification of the cystic fibrosis gene: genetic analysis</text>
      <annotation id="843">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="39608" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Alon;given-names:N</infon>
      <infon key="name_2">surname:Kerem;given-names:B</infon>
      <infon key="name_1">surname:Rommens;given-names:JM</infon>
      <infon key="name_0">surname:Riordan;given-names:JR</infon>
      <infon key="fpage">1066</infon>
      <infon key="pub-id_pmid">2475911</infon>
      <infon key="year">1989</infon>
      <infon key="source">Science</infon>
      <infon key="type">ref</infon>
      <infon key="volume">245</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Chou;given-names:JL</infon>
      <infon key="name_8">surname:Plavsic;given-names:N</infon>
      <infon key="name_7">surname:Lok;given-names:S</infon>
      <infon key="lpage">1073</infon>
      <infon key="name_6">surname:Zielenski;given-names:J</infon>
      <infon key="name_5">surname:Grzelczak;given-names:Z</infon>
      <infon key="name_4">surname:Rozmahel;given-names:R</infon>
      <offset>39647</offset>
      <text>Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA</text>
      <annotation id="845">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="39669" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Drumm;given-names:ML</infon>
      <infon key="name_2">surname:Kerem;given-names:B</infon>
      <infon key="name_1">surname:Iannuzzi;given-names:MC</infon>
      <infon key="name_0">surname:Rommens;given-names:JM</infon>
      <infon key="fpage">1059</infon>
      <infon key="pub-id_pmid">2772657</infon>
      <infon key="year">1989</infon>
      <infon key="source">Science</infon>
      <infon key="type">ref</infon>
      <infon key="volume">245</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Hidaka;given-names:N</infon>
      <infon key="name_8">surname:Kennedy;given-names:D</infon>
      <infon key="name_7">surname:Cole;given-names:JL</infon>
      <infon key="lpage">1065</infon>
      <infon key="name_6">surname:Rozmahel;given-names:R</infon>
      <infon key="name_5">surname:Dean;given-names:M</infon>
      <infon key="name_4">surname:Melmer;given-names:G</infon>
      <offset>39741</offset>
      <text>Identification of the cystic fibrosis gene: chromosome walking and jumping</text>
      <annotation id="847">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="39763" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Burton;given-names:B</infon>
      <infon key="name_2">surname:Grootenhuis;given-names:PD</infon>
      <infon key="name_1">surname:Hadida;given-names:S</infon>
      <infon key="name_0">surname:Van Goor;given-names:F</infon>
      <infon key="pub-id_pmid">19846789</infon>
      <infon key="year">2009</infon>
      <infon key="source">Proc Natl Acad Sci U S A</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Negulescu;given-names:P</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">18830</infon>
      <infon key="fpage">18825</infon>
      <infon key="volume">106</infon>
      <infon key="name_10">surname:Zhou;given-names:J</infon>
      <infon key="name_13">surname:Decker;given-names:C</infon>
      <infon key="name_14">surname:Yang;given-names:J</infon>
      <infon key="name_11">surname:McCartney;given-names:J</infon>
      <infon key="name_12">surname:Arumugam;given-names:V</infon>
      <infon key="name_17">surname:Wine;given-names:JJ</infon>
      <infon key="name_18">surname:Frizzell;given-names:RA</infon>
      <infon key="name_15">surname:Young;given-names:C</infon>
      <infon key="name_9">surname:Hazlewood;given-names:A</infon>
      <infon key="name_16">surname:Olson;given-names:ER</infon>
      <infon key="name_8">surname:Joubran;given-names:J</infon>
      <infon key="name_7">surname:Singh;given-names:A</infon>
      <infon key="name_6">surname:Turnbull;given-names:A</infon>
      <infon key="name_19">surname:Ashlock;given-names:M</infon>
      <infon key="name_5">surname:Neuberger;given-names:T</infon>
      <infon key="name_4">surname:Cao;given-names:D</infon>
      <offset>39816</offset>
      <text>Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770</text>
      <annotation id="849">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="39875" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Burton;given-names:B</infon>
      <infon key="name_2">surname:Grootenhuis;given-names:PD</infon>
      <infon key="name_1">surname:Hadida;given-names:S</infon>
      <infon key="name_0">surname:Van Goor;given-names:F</infon>
      <infon key="fpage">18843</infon>
      <infon key="pub-id_pmid">21976485</infon>
      <infon key="year">2011</infon>
      <infon key="source">Proc Natl Acad Sci U S A</infon>
      <infon key="type">ref</infon>
      <infon key="volume">108</infon>
      <infon key="name_10">surname:Wine;given-names:JJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:Negulescu;given-names:PA</infon>
      <infon key="name_11">surname:Frizzell;given-names:RA</infon>
      <infon key="name_12">surname:Ashlock;given-names:M</infon>
      <infon key="name_9">surname:Olson;given-names:ER</infon>
      <infon key="name_8">surname:McCartney;given-names:J</infon>
      <infon key="name_7">surname:Miller;given-names:M</infon>
      <infon key="lpage">18848</infon>
      <infon key="name_6">surname:Decker;given-names:CJ</infon>
      <infon key="name_5">surname:Straley;given-names:KS</infon>
      <infon key="name_4">surname:Stack;given-names:JH</infon>
      <offset>39900</offset>
      <text>Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809</text>
      <annotation id="852">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="39926" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="853">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="39918" length="7"/>
        <text>F508del</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Gonzalez;given-names:J</infon>
      <infon key="name_2">surname:Cao;given-names:D</infon>
      <infon key="name_1">surname:Straley;given-names:KS</infon>
      <infon key="name_0">surname:Van Goor;given-names:F</infon>
      <infon key="pub-id_pmid">16443646</infon>
      <infon key="year">2006</infon>
      <infon key="source">Am J Physiol Lung Cell Mol Physiol</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">L1130</infon>
      <infon key="fpage">L1117</infon>
      <infon key="volume">290</infon>
      <infon key="name_10">surname:Neuberger;given-names:T</infon>
      <infon key="name_13">surname:Rader;given-names:J</infon>
      <infon key="name_14">surname:Singh;given-names:A</infon>
      <infon key="name_11">surname:Olson;given-names:E</infon>
      <infon key="name_12">surname:Panchenko;given-names:V</infon>
      <infon key="name_17">surname:Grootenhuis;given-names:PD</infon>
      <infon key="name_18">surname:Negulescu;given-names:P</infon>
      <infon key="name_15">surname:Stack;given-names:JH</infon>
      <infon key="name_9">surname:Miller;given-names:M</infon>
      <infon key="name_16">surname:Tung;given-names:R</infon>
      <infon key="name_8">surname:Makings;given-names:LR</infon>
      <infon key="name_7">surname:Knapp;given-names:T</infon>
      <infon key="name_6">surname:Joubran;given-names:J</infon>
      <infon key="name_5">surname:Hazlewood;given-names:A</infon>
      <infon key="name_4">surname:Hadida;given-names:S</infon>
      <offset>40001</offset>
      <text>Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules</text>
      <annotation id="857">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="40021" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="858">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="40052" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="859">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="40058" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Caci;given-names:E</infon>
      <infon key="name_2">surname:Du;given-names:K</infon>
      <infon key="name_1">surname:Lukacs;given-names:GL</infon>
      <infon key="name_0">surname:Pedemonte;given-names:N</infon>
      <infon key="fpage">2564</infon>
      <infon key="pub-id_pmid">16127463</infon>
      <infon key="year">2005</infon>
      <infon key="source">J Clin Invest</infon>
      <infon key="type">ref</infon>
      <infon key="volume">115</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">2571</infon>
      <infon key="name_6">surname:Verkman;given-names:AS</infon>
      <infon key="name_5">surname:Galietta;given-names:LJ</infon>
      <infon key="name_4">surname:Zegarra-Moran;given-names:O</infon>
      <offset>40117</offset>
      <text>Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening</text>
      <annotation id="861">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="40166" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Balghi;given-names:H</infon>
      <infon key="name_2">surname:Liao;given-names:J</infon>
      <infon key="name_1">surname:Carlile;given-names:GW</infon>
      <infon key="name_0">surname:Robert;given-names:R</infon>
      <infon key="fpage">922</infon>
      <infon key="pub-id_pmid">20200141</infon>
      <infon key="year">2010</infon>
      <infon key="source">Mol Pharmacol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">77</infon>
      <infon key="name_10">surname:Scholte;given-names:BJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Thomas;given-names:DY</infon>
      <infon key="name_12">surname:Hanrahan;given-names:JW</infon>
      <infon key="name_9">surname:de Jonge;given-names:HR</infon>
      <infon key="name_8">surname:Wilke;given-names:M</infon>
      <infon key="name_7">surname:Rotin;given-names:D</infon>
      <infon key="lpage">930</infon>
      <infon key="name_6">surname:Kus;given-names:B</infon>
      <infon key="name_5">surname:Liu;given-names:N</infon>
      <infon key="name_4">surname:Lesimple;given-names:P</infon>
      <offset>40231</offset>
      <text>Correction of the Delta phe508 cystic fibrosis transmembrane conductance regulator trafficking defect by the bioavailable compound glafenine</text>
      <annotation id="865">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="40262" length="51"/>
        <text>cystic fibrosis transmembrane conductance regulator</text>
      </annotation>
      <annotation id="866">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="40255" length="6"/>
        <text>phe508</text>
      </annotation>
      <annotation id="867">
        <infon key="identifier">MESH:D005897</infon>
        <infon key="type">Chemical</infon>
        <location offset="40362" length="9"/>
        <text>glafenine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Liu;given-names:N</infon>
      <infon key="name_2">surname:Pavel;given-names:C</infon>
      <infon key="name_1">surname:Carlile;given-names:GW</infon>
      <infon key="name_0">surname:Robert;given-names:R</infon>
      <infon key="fpage">478</infon>
      <infon key="pub-id_pmid">17975008</infon>
      <infon key="year">2008</infon>
      <infon key="source">Mol Pharmacol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">73</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Hanrahan;given-names:JW</infon>
      <infon key="name_8">surname:Thomas;given-names:DY</infon>
      <infon key="name_7">surname:Zhang;given-names:D</infon>
      <infon key="lpage">489</infon>
      <infon key="name_6">surname:Luo;given-names:Y</infon>
      <infon key="name_5">surname:Liao;given-names:J</infon>
      <infon key="name_4">surname:Anjos;given-names:SM</infon>
      <offset>40372</offset>
      <text>Structural analog of sildenafil identified as a novel corrector of the F508del-CFTR trafficking defect</text>
      <annotation id="871">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="40451" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="872">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="40443" length="7"/>
        <text>F508del</text>
      </annotation>
      <annotation id="873">
        <infon key="identifier">MESH:D000068677</infon>
        <infon key="type">Chemical</infon>
        <location offset="40393" length="10"/>
        <text>sildenafil</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Pedemonte;given-names:N</infon>
      <infon key="name_2">surname:Yang;given-names:H</infon>
      <infon key="name_1">surname:Vetrivel;given-names:L</infon>
      <infon key="name_0">surname:Ma;given-names:T</infon>
      <infon key="fpage">37235</infon>
      <infon key="pub-id_pmid">12161441</infon>
      <infon key="year">2002</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="type">ref</infon>
      <infon key="volume">277</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">37241</infon>
      <infon key="name_6">surname:Verkman;given-names:AS</infon>
      <infon key="name_5">surname:Galietta;given-names:LJ</infon>
      <infon key="name_4">surname:Zegarra-Moran;given-names:O</infon>
      <offset>40475</offset>
      <text>High-affinity activators of cystic fibrosis transmembrane conductance regulator (CFTR) chloride conductance identified by high-throughput screening</text>
      <annotation id="876">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="40503" length="51"/>
        <text>cystic fibrosis transmembrane conductance regulator</text>
      </annotation>
      <annotation id="877">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="40556" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Verkman;given-names:AS</infon>
      <infon key="volume">84</infon>
      <infon key="name_2">surname:Seo;given-names:Y</infon>
      <infon key="name_1">surname:Park;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Namkung;given-names:W</infon>
      <infon key="fpage">384</infon>
      <infon key="pub-id_pmid">23788656</infon>
      <infon key="year">2013</infon>
      <infon key="source">Mol Pharmacol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">392</infon>
      <offset>40623</offset>
      <text>Novel amino-carbonitrile-pyrazole identified in a small molecule screen activates wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator in the absence of a cAMP agonist</text>
      <annotation id="881">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="40729" length="51"/>
        <text>cystic fibrosis transmembrane conductance regulator</text>
      </annotation>
      <annotation id="882">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="40801" length="4"/>
        <text>cAMP</text>
      </annotation>
      <annotation id="883">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="40629" length="27"/>
        <text>amino-carbonitrile-pyrazole</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Wood;given-names:AB</infon>
      <infon key="name_2">surname:Knapp;given-names:JM</infon>
      <infon key="name_1">surname:Yang;given-names:B</infon>
      <infon key="name_0">surname:Phuan;given-names:PW</infon>
      <infon key="fpage">683</infon>
      <infon key="pub-id_pmid">21730204</infon>
      <infon key="year">2011</infon>
      <infon key="source">Mol Pharmacol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">80</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">693</infon>
      <infon key="name_6">surname:Verkman;given-names:AS</infon>
      <infon key="name_5">surname:Kurth;given-names:MJ</infon>
      <infon key="name_4">surname:Lukacs;given-names:GL</infon>
      <offset>40814</offset>
      <text>Cyanoquinolines with independent corrector and potentiator activities restore DeltaPhe508-cystic fibrosis transmembrane conductance regulator chloride channel function in cystic fibrosis</text>
      <annotation id="887">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="40904" length="51"/>
        <text>cystic fibrosis transmembrane conductance regulator</text>
      </annotation>
      <annotation id="888">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="40814" length="15"/>
        <text>Cyanoquinolines</text>
      </annotation>
      <annotation id="889">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="40985" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Gopinath;given-names:VS</infon>
      <infon key="name_2">surname:Guy;given-names:RK</infon>
      <infon key="name_1">surname:Shelat;given-names:AA</infon>
      <infon key="name_0">surname:Yang;given-names:H</infon>
      <infon key="fpage">35079</infon>
      <infon key="pub-id_pmid">12832418</infon>
      <infon key="year">2003</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="type">ref</infon>
      <infon key="volume">278</infon>
      <infon key="name_10">surname:Galietta;given-names:LJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Verkman;given-names:AS</infon>
      <infon key="name_9">surname:Pedemonte;given-names:N</infon>
      <infon key="name_8">surname:Folli;given-names:C</infon>
      <infon key="name_7">surname:Taddei;given-names:A</infon>
      <infon key="lpage">35085</infon>
      <infon key="name_6">surname:Lukacs;given-names:GL</infon>
      <infon key="name_5">surname:Du;given-names:K</infon>
      <infon key="name_4">surname:Ma;given-names:T</infon>
      <offset>41001</offset>
      <text>Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating</text>
      <annotation id="892">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="41070" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="893">
        <infon key="identifier">p.508delF</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="41059" length="10"/>
        <text>Delta F508</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">11</infon>
      <infon key="name_2">surname:Kirkpatrick;given-names:P</infon>
      <infon key="name_1">surname:Yasothan;given-names:U</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Davis;given-names:PB</infon>
      <infon key="fpage">349</infon>
      <infon key="year">2012</infon>
      <infon key="source">Nature reviews. Drug discovery</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">350</infon>
      <offset>41099</offset>
      <text>Ivacaftor</text>
      <annotation id="895">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="41099" length="9"/>
        <text>Ivacaftor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Boyle;given-names:MP</infon>
      <infon key="name_2">surname:Clancy;given-names:JP</infon>
      <infon key="name_1">surname:Rowe;given-names:SM</infon>
      <infon key="name_0">surname:Accurso;given-names:FJ</infon>
      <infon key="pub-id_pmid">21083385</infon>
      <infon key="year">2010</infon>
      <infon key="source">N Engl J Med</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Stone;given-names:AJ</infon>
      <infon key="name_21">surname:Olson;given-names:ER</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_24">surname:Ashlock;given-names:MA</infon>
      <infon key="name_25">surname:Ramsey;given-names:BW</infon>
      <infon key="name_22">surname:Ordonez;given-names:CL</infon>
      <infon key="name_23">surname:Campbell;given-names:PW</infon>
      <infon key="lpage">2003</infon>
      <infon key="fpage">1991</infon>
      <infon key="volume">363</infon>
      <infon key="name_10">surname:Moss;given-names:RB</infon>
      <infon key="name_13">surname:Uluer;given-names:AZ</infon>
      <infon key="name_14">surname:Aitken;given-names:ML</infon>
      <infon key="name_11">surname:Pilewski;given-names:JM</infon>
      <infon key="name_12">surname:Rubenstein;given-names:RC</infon>
      <infon key="name_17">surname:Mayer-Hamblett;given-names:N</infon>
      <infon key="name_18">surname:Dong;given-names:Q</infon>
      <infon key="name_15">surname:Freedman;given-names:SD</infon>
      <infon key="name_9">surname:Donaldson;given-names:SH</infon>
      <infon key="name_16">surname:Rose;given-names:LM</infon>
      <infon key="name_8">surname:Konstan;given-names:MW</infon>
      <infon key="name_7">surname:Hornick;given-names:DB</infon>
      <infon key="name_6">surname:Sagel;given-names:SD</infon>
      <infon key="name_19">surname:Zha;given-names:J</infon>
      <infon key="name_5">surname:Durie;given-names:PR</infon>
      <infon key="name_4">surname:Dunitz;given-names:JM</infon>
      <offset>41109</offset>
      <text>Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation</text>
      <annotation id="900">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="41172" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="901">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="41129" length="7"/>
        <text>persons</text>
      </annotation>
      <annotation id="902">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="41142" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
      <annotation id="903">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="41166" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Tullis;given-names:E</infon>
      <infon key="name_2">surname:McElvaney;given-names:NG</infon>
      <infon key="name_1">surname:Davies;given-names:J</infon>
      <infon key="name_0">surname:Ramsey;given-names:BW</infon>
      <infon key="pub-id_pmid">22047557</infon>
      <infon key="year">2011</infon>
      <infon key="source">N Engl J Med</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1672</infon>
      <infon key="fpage">1663</infon>
      <infon key="volume">365</infon>
      <infon key="name_10">surname:Moss;given-names:R</infon>
      <infon key="name_13">surname:Rowe;given-names:SM</infon>
      <infon key="name_14">surname:Dong;given-names:Q</infon>
      <infon key="name_11">surname:Ratjen;given-names:F</infon>
      <infon key="name_12">surname:Sermet-Gaudelus;given-names:I</infon>
      <infon key="name_17">surname:Ordonez;given-names:C</infon>
      <infon key="name_18">surname:Elborn;given-names:JS</infon>
      <infon key="name_15">surname:Rodriguez;given-names:S</infon>
      <infon key="name_9">surname:Konstan;given-names:MW</infon>
      <infon key="name_16">surname:Yen;given-names:K</infon>
      <infon key="name_8">surname:Wainwright;given-names:CE</infon>
      <infon key="name_7">surname:McKone;given-names:EF</infon>
      <infon key="name_6">surname:Griese;given-names:M</infon>
      <infon key="name_5">surname:Drevinek;given-names:P</infon>
      <infon key="name_4">surname:Bell;given-names:SC</infon>
      <offset>41186</offset>
      <text>A CFTR potentiator in patients with cystic fibrosis and the G551D mutation</text>
      <annotation id="908">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="41188" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="909">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="41208" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="910">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="41222" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
      <annotation id="911">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="41246" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">7</infon>
      <infon key="name_1">surname:Elphick;given-names:HE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:O'Reilly;given-names:R</infon>
      <infon key="fpage">929</infon>
      <infon key="year">2013</infon>
      <infon key="source">Drug design, development and therapy</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">937</infon>
      <offset>41261</offset>
      <text>Development, clinical utility, and place of ivacaftor in the treatment of cystic fibrosis</text>
      <annotation id="914">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="41335" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
      <annotation id="915">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="41305" length="9"/>
        <text>ivacaftor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Kaniecki;given-names:K</infon>
      <infon key="name_2">surname:Van Goor;given-names:F</infon>
      <infon key="name_1">surname:Siklosi;given-names:KR</infon>
      <infon key="name_0">surname:Sosnay;given-names:PR</infon>
      <infon key="pub-id_pmid">23974870</infon>
      <infon key="year">2013</infon>
      <infon key="source">Nature genetics</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Cutting;given-names:GR</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1167</infon>
      <infon key="fpage">1160</infon>
      <infon key="volume">45</infon>
      <infon key="name_10">surname:Masica;given-names:DL</infon>
      <infon key="name_13">surname:Thomas;given-names:PJ</infon>
      <infon key="name_14">surname:Patrinos;given-names:GP</infon>
      <infon key="name_11">surname:Karchin;given-names:R</infon>
      <infon key="name_12">surname:Millen;given-names:L</infon>
      <infon key="name_17">surname:Rommens;given-names:JM</infon>
      <infon key="name_18">surname:Castellani;given-names:C</infon>
      <infon key="name_15">surname:Corey;given-names:M</infon>
      <infon key="name_9">surname:Zielenski;given-names:J</infon>
      <infon key="name_16">surname:Lewis;given-names:MH</infon>
      <infon key="name_8">surname:Dorfman;given-names:R</infon>
      <infon key="name_7">surname:Amaral;given-names:MD</infon>
      <infon key="name_6">surname:Ramalho;given-names:AS</infon>
      <infon key="name_19">surname:Penland;given-names:CM</infon>
      <infon key="name_5">surname:Sharma;given-names:N</infon>
      <infon key="name_4">surname:Yu;given-names:H</infon>
      <offset>41351</offset>
      <text>Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene</text>
      <annotation id="917">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="41401" length="51"/>
        <text>cystic fibrosis transmembrane conductance regulator</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Farrell;given-names:PM</infon>
      <infon key="volume">19</infon>
      <infon key="name_2">surname:Fine;given-names:JP</infon>
      <infon key="name_1">surname:Macek;given-names:M;suffix:Jr</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bobadilla;given-names:JL</infon>
      <infon key="fpage">575</infon>
      <infon key="pub-id_pmid">12007216</infon>
      <infon key="year">2002</infon>
      <infon key="source">Human mutation</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">606</infon>
      <offset>41458</offset>
      <text>Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening</text>
      <annotation id="920">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="41499" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="921">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="41458" length="15"/>
        <text>Cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Li;given-names:H</infon>
      <infon key="name_2">surname:Borowitz;given-names:DS</infon>
      <infon key="name_1">surname:Liou;given-names:TG</infon>
      <infon key="name_0">surname:Flume;given-names:PA</infon>
      <infon key="fpage">718</infon>
      <infon key="pub-id_pmid">22383668</infon>
      <infon key="year">2012</infon>
      <infon key="source">Chest</infon>
      <infon key="type">ref</infon>
      <infon key="volume">142</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">724</infon>
      <infon key="name_6">surname:Geller;given-names:DE</infon>
      <infon key="name_5">surname:Ordonez;given-names:CL</infon>
      <infon key="name_4">surname:Yen;given-names:K</infon>
      <offset>41576</offset>
      <text>Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation</text>
      <annotation id="926">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="41654" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="927">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="41603" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
      <annotation id="928">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="41646" length="7"/>
        <text>F508del</text>
      </annotation>
      <annotation id="929">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="41576" length="9"/>
        <text>Ivacaftor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">34</infon>
      <infon key="name_2">surname:Thomas;given-names:DY</infon>
      <infon key="name_1">surname:Sampson;given-names:HM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hanrahan;given-names:JW</infon>
      <infon key="fpage">119</infon>
      <infon key="pub-id_pmid">23380248</infon>
      <infon key="year">2013</infon>
      <infon key="source">Trends in pharmacological sciences</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">125</infon>
      <offset>41668</offset>
      <text>Novel pharmacological strategies to treat cystic fibrosis</text>
      <annotation id="931">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="41710" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">50</infon>
      <infon key="name_2">surname:Bear;given-names:CE</infon>
      <infon key="name_1">surname:Eckford;given-names:PD</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kim Chiaw;given-names:P</infon>
      <infon key="fpage">233</infon>
      <infon key="pub-id_pmid">21967060</infon>
      <infon key="year">2011</infon>
      <infon key="source">Essays in biochemistry</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">248</infon>
      <offset>41726</offset>
      <text>Insights into the mechanisms underlying CFTR channel activity, the molecular basis for cystic fibrosis and strategies for therapy</text>
      <annotation id="934">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="41766" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="935">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="41813" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">16</infon>
      <infon key="name_1">surname:Rowe;given-names:SM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sloane;given-names:PA</infon>
      <infon key="fpage">591</infon>
      <infon key="pub-id_pmid">20829696</infon>
      <infon key="year">2010</infon>
      <infon key="source">Current opinion in pulmonary medicine</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">597</infon>
      <offset>41856</offset>
      <text>Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis</text>
      <annotation id="938">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="41856" length="51"/>
        <text>Cystic fibrosis transmembrane conductance regulator</text>
      </annotation>
      <annotation id="939">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="41952" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Palmer;given-names:DJ</infon>
      <infon key="name_2">surname:Ng;given-names:P</infon>
      <infon key="name_1">surname:Karp;given-names:PH</infon>
      <infon key="name_0">surname:Farmen;given-names:SL</infon>
      <infon key="fpage">L1123</infon>
      <infon key="pub-id_pmid">16085675</infon>
      <infon key="year">2005</infon>
      <infon key="source">Am J Physiol Lung Cell Mol Physiol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">289</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Welsh;given-names:MJ</infon>
      <infon key="name_7">surname:Zabner;given-names:J</infon>
      <infon key="lpage">L1130</infon>
      <infon key="name_6">surname:Beaudet;given-names:AL</infon>
      <infon key="name_5">surname:Hu;given-names:J</infon>
      <infon key="name_4">surname:Koehler;given-names:DR</infon>
      <offset>41968</offset>
      <text>Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR</text>
      <annotation id="941">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="41985" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Burkett;given-names:S</infon>
      <infon key="name_2">surname:Gabriel;given-names:SE</infon>
      <infon key="name_1">surname:Button;given-names:B</infon>
      <infon key="name_0">surname:Zhang;given-names:L</infon>
      <infon key="fpage">e1000155</infon>
      <infon key="pub-id_pmid">19621064</infon>
      <infon key="year">2009</infon>
      <infon key="source">PLoS Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">7</infon>
      <infon key="name_10">surname:Boucher;given-names:RC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Collins;given-names:PL</infon>
      <infon key="name_12">surname:Pickles;given-names:RJ</infon>
      <infon key="name_9">surname:Mengos;given-names:A</infon>
      <infon key="name_8">surname:McKay;given-names:T</infon>
      <infon key="name_7">surname:Vogel;given-names:LN</infon>
      <infon key="name_6">surname:Dang;given-names:YL</infon>
      <infon key="name_5">surname:Skiadopoulos;given-names:MH</infon>
      <infon key="name_4">surname:Yan;given-names:Y</infon>
      <offset>42125</offset>
      <text>CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium</text>
      <annotation id="945">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="42125" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="946">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="42218" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="947">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="42224" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Aitken;given-names:ML</infon>
      <infon key="name_2">surname:Accurso;given-names:FJ</infon>
      <infon key="name_1">surname:Rowe;given-names:SM</infon>
      <infon key="name_0">surname:Clancy;given-names:JP</infon>
      <infon key="pub-id_pmid">21825083</infon>
      <infon key="year">2012</infon>
      <infon key="source">Thorax</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Rosenbluth;given-names:DB</infon>
      <infon key="name_21">surname:Rubenstein;given-names:RC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_24">surname:Ordonez;given-names:CL</infon>
      <infon key="name_25">surname:Spencer-Green;given-names:GT</infon>
      <infon key="name_22">surname:Schechter;given-names:MS</infon>
      <infon key="name_23">surname:Botfield;given-names:M</infon>
      <infon key="name_28">surname:Yen;given-names:K</infon>
      <infon key="name_29">surname:Konstan;given-names:MW</infon>
      <infon key="name_26">surname:Vernillet;given-names:L</infon>
      <infon key="name_27">surname:Wisseh;given-names:S</infon>
      <infon key="lpage">18</infon>
      <infon key="fpage">12</infon>
      <infon key="volume">67</infon>
      <infon key="name_10">surname:De Boeck;given-names:K</infon>
      <infon key="name_13">surname:Dunitz;given-names:JM</infon>
      <infon key="name_14">surname:Durie;given-names:PR</infon>
      <infon key="name_11">surname:Donaldson;given-names:SH</infon>
      <infon key="name_12">surname:Dorkin;given-names:HL</infon>
      <infon key="name_17">surname:McCoy;given-names:KS</infon>
      <infon key="name_18">surname:Moss;given-names:RB</infon>
      <infon key="name_15">surname:Jain;given-names:M</infon>
      <infon key="name_9">surname:Campbell;given-names:PW</infon>
      <infon key="name_16">surname:Leonard;given-names:A</infon>
      <infon key="name_8">surname:Bronsveld;given-names:I</infon>
      <infon key="name_7">surname:Boyle;given-names:MP</infon>
      <infon key="name_6">surname:Ballmann;given-names:M</infon>
      <infon key="name_19">surname:Pilewski;given-names:JM</infon>
      <infon key="name_5">surname:Ashlock;given-names:MA</infon>
      <infon key="name_4">surname:Amin;given-names:RS</infon>
      <offset>42258</offset>
      <text>Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation</text>
      <annotation id="951">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="42317" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="952">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="42402" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="953">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="42359" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">143</infon>
      <infon key="name_1">surname:Ramsey;given-names:BW</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hoffman;given-names:LR</infon>
      <infon key="fpage">207</infon>
      <infon key="pub-id_pmid">23276843</infon>
      <infon key="year">2013</infon>
      <infon key="source">Chest</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">213</infon>
      <offset>42416</offset>
      <text>Cystic fibrosis therapeutics: the road ahead</text>
      <annotation id="955">
        <infon key="identifier">MESH:D005355</infon>
        <infon key="type">Disease</infon>
        <location offset="42423" length="8"/>
        <text>fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">15</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Galietta;given-names:LJ</infon>
      <infon key="fpage">393</infon>
      <infon key="pub-id_pmid">23757197</infon>
      <infon key="year">2013</infon>
      <infon key="source">Paediatric drugs</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">402</infon>
      <offset>42461</offset>
      <text>Managing the underlying cause of cystic fibrosis: a future role for potentiators and correctors</text>
      <annotation id="957">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="42494" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Bronsveld;given-names:I</infon>
      <infon key="name_2">surname:de Jonge;given-names:HR</infon>
      <infon key="name_1">surname:Wiegerinck;given-names:CL</infon>
      <infon key="name_0">surname:Dekkers;given-names:JF</infon>
      <infon key="fpage">939</infon>
      <infon key="year">2013</infon>
      <infon key="source">Nature medicine</infon>
      <infon key="type">ref</infon>
      <infon key="volume">19</infon>
      <infon key="name_10">surname:Nieuwenhuis;given-names:EE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:van der Ent;given-names:CK</infon>
      <infon key="name_14">surname:Middendorp;given-names:S</infon>
      <infon key="name_11">surname:van den Brink;given-names:S</infon>
      <infon key="name_12">surname:Clevers;given-names:H</infon>
      <infon key="name_15">surname:Beekman;given-names:JM</infon>
      <infon key="name_9">surname:Scholte;given-names:BJ</infon>
      <infon key="name_8">surname:Bijvelds;given-names:MJ</infon>
      <infon key="name_7">surname:de Jong;given-names:NW</infon>
      <infon key="lpage">945</infon>
      <infon key="name_6">surname:Brandsma;given-names:AM</infon>
      <infon key="name_5">surname:de Winter-de Groot;given-names:KM</infon>
      <infon key="name_4">surname:Janssens;given-names:HM</infon>
      <offset>42557</offset>
      <text>A functional CFTR assay using primary cystic fibrosis intestinal organoids</text>
      <annotation id="960">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="42570" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="961">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="42595" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Derichs;given-names:N</infon>
      <infon key="name_2">surname:Davies;given-names:J</infon>
      <infon key="name_1">surname:Kent;given-names:L</infon>
      <infon key="name_0">surname:De Boeck;given-names:K</infon>
      <infon key="year">2013</infon>
      <infon key="source">The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Vermeulen;given-names:F</infon>
      <infon key="name_21">surname:Hug;given-names:MJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_24">surname:Barreto;given-names:C</infon>
      <infon key="name_25">surname:Proesmans;given-names:M</infon>
      <infon key="name_22">surname:Rault;given-names:G</infon>
      <infon key="name_23">surname:Nguyen-Khoa;given-names:T</infon>
      <infon key="name_26">surname:Sermet-Gaudelus;given-names:I</infon>
      <infon key="name_27">surname:European;given-names:C</infon>
      <infon key="lpage">216</infon>
      <infon key="fpage">203</infon>
      <infon key="volume">41</infon>
      <infon key="name_10">surname:Melotti;given-names:P</infon>
      <infon key="name_13">surname:Fajac;given-names:I</infon>
      <infon key="name_14">surname:Southern;given-names:K</infon>
      <infon key="name_11">surname:Danner-Boucher;given-names:I</infon>
      <infon key="name_12">surname:Boerner;given-names:S</infon>
      <infon key="name_17">surname:de Rijke;given-names:Y</infon>
      <infon key="name_18">surname:de Wachter;given-names:E</infon>
      <infon key="name_15">surname:de Nooijer;given-names:RA</infon>
      <infon key="name_9">surname:Wilschanski;given-names:M</infon>
      <infon key="name_16">surname:Bot;given-names:A</infon>
      <infon key="name_8">surname:Bronsveld;given-names:I</infon>
      <infon key="name_7">surname:de Jonge;given-names:H</infon>
      <infon key="name_6">surname:Middleton;given-names:P</infon>
      <infon key="name_19">surname:Leal;given-names:T</infon>
      <infon key="name_5">surname:Rowe;given-names:SM</infon>
      <infon key="name_4">surname:Amaral;given-names:M</infon>
      <offset>42632</offset>
      <text>Cystic Fibrosis Society Clinical Trial Network Standardisation, CFTR biomarkers: time for promotion to surrogate end-point</text>
      <annotation id="964">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="42696" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="965">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="42632" length="15"/>
        <text>Cystic Fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Courville;given-names:C</infon>
      <infon key="name_2">surname:Wilhelm;given-names:A</infon>
      <infon key="name_1">surname:Shastry;given-names:S</infon>
      <infon key="name_0">surname:Sloane;given-names:PA</infon>
      <infon key="fpage">e39809</infon>
      <infon key="pub-id_pmid">22768130</infon>
      <infon key="year">2012</infon>
      <infon key="source">PLoS One</infon>
      <infon key="type">ref</infon>
      <infon key="volume">7</infon>
      <infon key="name_10">surname:Byan-Parker;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:Dransfield;given-names:MT</infon>
      <infon key="name_14">surname:Rowe;given-names:SM</infon>
      <infon key="name_11">surname:Grizzle;given-names:W</infon>
      <infon key="name_12">surname:Sorscher;given-names:EJ</infon>
      <infon key="name_9">surname:Mazur;given-names:M</infon>
      <infon key="name_8">surname:Li;given-names:Y</infon>
      <infon key="name_7">surname:Raju;given-names:SV</infon>
      <infon key="name_6">surname:Levin;given-names:E</infon>
      <infon key="name_5">surname:Backer;given-names:K</infon>
      <infon key="name_4">surname:Tang;given-names:LP</infon>
      <offset>42755</offset>
      <text>A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease</text>
      <annotation id="969">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="42792" length="51"/>
        <text>cystic fibrosis transmembrane conductance regulator</text>
      </annotation>
      <annotation id="970">
        <infon key="identifier">MESH:D008171</infon>
        <infon key="type">Disease</infon>
        <location offset="42875" length="12"/>
        <text>lung disease</text>
      </annotation>
      <annotation id="971">
        <infon key="identifier">MESH:D006331</infon>
        <infon key="type">Disease</infon>
        <location offset="42844" length="11"/>
        <text>dysfunction</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Garcia-Caballero;given-names:A</infon>
      <infon key="name_2">surname:Dang;given-names:Y</infon>
      <infon key="name_1">surname:Dang;given-names:H</infon>
      <infon key="name_0">surname:Gentzsch;given-names:M</infon>
      <infon key="fpage">32227</infon>
      <infon key="pub-id_pmid">20709758</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="type">ref</infon>
      <infon key="volume">285</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">32232</infon>
      <infon key="name_6">surname:Stutts;given-names:MJ</infon>
      <infon key="name_5">surname:Boucher;given-names:RC</infon>
      <infon key="name_4">surname:Suchindran;given-names:H</infon>
      <offset>42888</offset>
      <text>The cystic fibrosis transmembrane conductance regulator impedes proteolytic stimulation of the epithelial Na+ channel</text>
      <annotation id="973">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="42892" length="51"/>
        <text>cystic fibrosis transmembrane conductance regulator</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hamrick;given-names:M</infon>
      <infon key="name_2">surname:Olsen;given-names:JC</infon>
      <infon key="name_1">surname:Canessa;given-names:CM</infon>
      <infon key="name_0">surname:Stutts;given-names:MJ</infon>
      <infon key="fpage">847</infon>
      <infon key="pub-id_pmid">7543698</infon>
      <infon key="year">1995</infon>
      <infon key="source">Science</infon>
      <infon key="type">ref</infon>
      <infon key="volume">269</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">850</infon>
      <infon key="name_6">surname:Boucher;given-names:RC</infon>
      <infon key="name_5">surname:Rossier;given-names:BC</infon>
      <infon key="name_4">surname:Cohn;given-names:JA</infon>
      <offset>43006</offset>
      <text>CFTR as a cAMP-dependent regulator of sodium channels</text>
      <annotation id="976">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="43006" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="977">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="43016" length="4"/>
        <text>cAMP</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Boucher;given-names:RC</infon>
      <infon key="name_2">surname:Paradiso;given-names:AM</infon>
      <infon key="name_1">surname:Mall;given-names:M</infon>
      <infon key="name_0">surname:Livraghi;given-names:A</infon>
      <infon key="fpage">423</infon>
      <infon key="pub-id_pmid">17989361</infon>
      <infon key="year">2008</infon>
      <infon key="source">Am J Respir Cell Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">38</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">434</infon>
      <infon key="name_4">surname:Ribeiro;given-names:CM</infon>
      <offset>43060</offset>
      <text>Modelling dysregulated Na+ absorption in airway epithelial cells with mucosal nystatin treatment</text>
      <annotation id="979">
        <infon key="identifier">MESH:D009761</infon>
        <infon key="type">Chemical</infon>
        <location offset="43138" length="8"/>
        <text>nystatin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:He;given-names:L</infon>
      <infon key="name_2">surname:Aleksandrov;given-names:AA</infon>
      <infon key="name_1">surname:Hegedus;given-names:T</infon>
      <infon key="name_0">surname:Serohijos;given-names:AW</infon>
      <infon key="fpage">3256</infon>
      <infon key="pub-id_pmid">18305154</infon>
      <infon key="year">2008</infon>
      <infon key="source">Proc Natl Acad Sci U S A</infon>
      <infon key="type">ref</infon>
      <infon key="volume">105</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">3261</infon>
      <infon key="name_6">surname:Riordan;given-names:JR</infon>
      <infon key="name_5">surname:Dokholyan;given-names:NV</infon>
      <infon key="name_4">surname:Cui;given-names:L</infon>
      <offset>43157</offset>
      <text>Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function</text>
      <annotation id="982">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="43229" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="983">
        <infon key="identifier">MESH:D010649</infon>
        <infon key="type">Chemical</infon>
        <location offset="43157" length="13"/>
        <text>Phenylalanine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hegedus;given-names:T</infon>
      <infon key="name_2">surname:Serohijos;given-names:AW</infon>
      <infon key="name_1">surname:Aleksandrov;given-names:AA</infon>
      <infon key="name_0">surname:He;given-names:L</infon>
      <infon key="fpage">26383</infon>
      <infon key="pub-id_pmid">18658148</infon>
      <infon key="year">2008</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="type">ref</infon>
      <infon key="volume">283</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Riordan;given-names:JR</infon>
      <infon key="lpage">26390</infon>
      <infon key="name_6">surname:Dokholyan;given-names:NV</infon>
      <infon key="name_5">surname:Cui;given-names:L</infon>
      <infon key="name_4">surname:Aleksandrov;given-names:LA</infon>
      <offset>43288</offset>
      <text>Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating</text>
      <annotation id="986">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="43341" length="51"/>
        <text>cystic fibrosis transmembrane conductance regulator</text>
      </annotation>
      <annotation id="987">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="43394" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Cui;given-names:L</infon>
      <infon key="name_2">surname:Aleksandrov;given-names:AA</infon>
      <infon key="name_1">surname:Kota;given-names:P</infon>
      <infon key="name_0">surname:He;given-names:L</infon>
      <infon key="fpage">536</infon>
      <infon key="pub-id_pmid">23104983</infon>
      <infon key="year">2013</infon>
      <infon key="source">FASEB J</infon>
      <infon key="type">ref</infon>
      <infon key="volume">27</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">545</infon>
      <infon key="name_6">surname:Riordan;given-names:JR</infon>
      <infon key="name_5">surname:Dokholyan;given-names:NV</infon>
      <infon key="name_4">surname:Jensen;given-names:T</infon>
      <offset>43437</offset>
      <text>Correctors of DeltaF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein</text>
      <annotation id="989">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="43461" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Okiyoneda;given-names:T</infon>
      <infon key="name_2">surname:Xu;given-names:H</infon>
      <infon key="name_1">surname:Bossard;given-names:F</infon>
      <infon key="name_0">surname:Rabeh;given-names:WM</infon>
      <infon key="fpage">150</infon>
      <infon key="pub-id_pmid">22265408</infon>
      <infon key="year">2012</infon>
      <infon key="source">Cell</infon>
      <infon key="type">ref</infon>
      <infon key="volume">148</infon>
      <infon key="name_10">surname:Roldan;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Lukacs;given-names:GL</infon>
      <infon key="name_9">surname:Konermann;given-names:L</infon>
      <infon key="name_8">surname:Liu;given-names:Y</infon>
      <infon key="name_7">surname:di Bernardo;given-names:S</infon>
      <infon key="lpage">163</infon>
      <infon key="name_6">surname:Du;given-names:K</infon>
      <infon key="name_5">surname:Mulvihill;given-names:CM</infon>
      <infon key="name_4">surname:Bagdany;given-names:M</infon>
      <offset>43556</offset>
      <text>Correction of both NBD1 energetics and domain interface is required to restore DeltaF508 CFTR folding and function</text>
      <annotation id="991">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="43645" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hwang;given-names:TC</infon>
      <infon key="volume">129</infon>
      <infon key="name_2">surname:Li;given-names:M</infon>
      <infon key="name_1">surname:Sohma;given-names:Y</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bompadre;given-names:SG</infon>
      <infon key="fpage">285</infon>
      <infon key="pub-id_pmid">17353351</infon>
      <infon key="year">2007</infon>
      <infon key="source">The Journal of general physiology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">298</infon>
      <offset>43671</offset>
      <text>G551D and G1349D, two CF-associated mutations in the signature sequences of CFTR, exhibit distinct gating defects</text>
      <annotation id="995">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="43747" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="996">
        <infon key="identifier">p.G1349D;RS#:193922525</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="43681" length="6"/>
        <text>G1349D</text>
      </annotation>
      <annotation id="997">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="43671" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">15</infon>
      <infon key="name_2">surname:Dokholyan;given-names:NV</infon>
      <infon key="name_1">surname:Ding;given-names:F</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Yin;given-names:S</infon>
      <infon key="fpage">1567</infon>
      <infon key="pub-id_pmid">18073107</infon>
      <infon key="year">2007</infon>
      <infon key="source">Structure</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1576</infon>
      <offset>43785</offset>
      <text>Modeling backbone flexibility improves protein stability estimation</text>
    </passage>
    <passage>
      <infon key="volume">4</infon>
      <infon key="name_2">surname:Dokholyan;given-names:NV</infon>
      <infon key="name_1">surname:Ding;given-names:F</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Yin;given-names:S</infon>
      <infon key="fpage">466</infon>
      <infon key="pub-id_pmid">17538626</infon>
      <infon key="year">2007</infon>
      <infon key="source">Nature methods</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">467</infon>
      <offset>43853</offset>
      <text>Eris: an automated estimator of protein stability</text>
      <annotation id="999">
        <infon key="identifier">340061</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">18868</infon>
        <location offset="43853" length="4"/>
        <text>Eris</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Kartner;given-names:N</infon>
      <infon key="name_2">surname:Bear;given-names:C</infon>
      <infon key="name_1">surname:Chang;given-names:XB</infon>
      <infon key="name_0">surname:Lukacs;given-names:GL</infon>
      <infon key="fpage">21592</infon>
      <infon key="pub-id_pmid">7691813</infon>
      <infon key="year">1993</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="type">ref</infon>
      <infon key="volume">268</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">21598</infon>
      <infon key="name_6">surname:Grinstein;given-names:S</infon>
      <infon key="name_5">surname:Riordan;given-names:JR</infon>
      <infon key="name_4">surname:Mohamed;given-names:A</infon>
      <offset>43903</offset>
      <text>The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells</text>
      <annotation id="1002">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="43954" length="51"/>
        <text>cystic fibrosis transmembrane conductance regulator</text>
      </annotation>
      <annotation id="1003">
        <infon key="identifier">p.508delF</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="43907" length="10"/>
        <text>delta F508</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Rabeh;given-names:WM</infon>
      <infon key="name_2">surname:Bagdany;given-names:M</infon>
      <infon key="name_1">surname:Barriere;given-names:H</infon>
      <infon key="name_0">surname:Okiyoneda;given-names:T</infon>
      <infon key="fpage">805</infon>
      <infon key="pub-id_pmid">20595578</infon>
      <infon key="year">2010</infon>
      <infon key="source">Science</infon>
      <infon key="type">ref</infon>
      <infon key="volume">329</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Lukacs;given-names:GL</infon>
      <infon key="lpage">810</infon>
      <infon key="name_6">surname:Young;given-names:JC</infon>
      <infon key="name_5">surname:Hohfeld;given-names:J</infon>
      <infon key="name_4">surname:Du;given-names:K</infon>
      <offset>44090</offset>
      <text>Peripheral protein quality control removes unfolded CFTR from the plasma membrane</text>
      <annotation id="1005">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="44142" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Lukacs;given-names:GL</infon>
      <infon key="volume">276</infon>
      <infon key="name_2">surname:Hu;given-names:W</infon>
      <infon key="name_1">surname:Benharouga;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sharma;given-names:M</infon>
      <infon key="fpage">8942</infon>
      <infon key="pub-id_pmid">11124952</infon>
      <infon key="year">2001</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">8950</infon>
      <offset>44172</offset>
      <text>Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments</text>
      <annotation id="1008">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="44249" length="51"/>
        <text>cystic fibrosis transmembrane conductance regulator</text>
      </annotation>
      <annotation id="1009">
        <infon key="identifier">p.508delF</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="44238" length="10"/>
        <text>delta F508</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Wu;given-names:Y</infon>
      <infon key="name_2">surname:Cui;given-names:L</infon>
      <infon key="name_1">surname:Chang;given-names:XB</infon>
      <infon key="name_0">surname:Gentzsch;given-names:M</infon>
      <infon key="fpage">2684</infon>
      <infon key="pub-id_pmid">15075371</infon>
      <infon key="year">2004</infon>
      <infon key="source">Mol Biol Cell</infon>
      <infon key="type">ref</infon>
      <infon key="volume">15</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Riordan;given-names:JR</infon>
      <infon key="lpage">2696</infon>
      <infon key="name_6">surname:Pagano;given-names:RE</infon>
      <infon key="name_5">surname:Choudhury;given-names:A</infon>
      <infon key="name_4">surname:Ozols;given-names:VV</infon>
      <offset>44344</offset>
      <text>Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator</text>
      <annotation id="1011">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="44400" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Chen;given-names:L</infon>
      <infon key="name_2">surname:Jurkuvenaite;given-names:A</infon>
      <infon key="name_1">surname:Goldstein;given-names:RF</infon>
      <infon key="name_0">surname:Varga;given-names:K</infon>
      <infon key="fpage">555</infon>
      <infon key="pub-id_pmid">18052931</infon>
      <infon key="year">2008</infon>
      <infon key="source">Biochem J</infon>
      <infon key="type">ref</infon>
      <infon key="volume">410</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Collawn;given-names:JF</infon>
      <infon key="lpage">564</infon>
      <infon key="name_6">surname:Bebok;given-names:Z</infon>
      <infon key="name_5">surname:Sorscher;given-names:EJ</infon>
      <infon key="name_4">surname:Matalon;given-names:S</infon>
      <offset>44452</offset>
      <text>Enhanced cell-surface stability of rescued DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) by pharmacological chaperones</text>
      <annotation id="1014">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="44558" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1015">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="44505" length="51"/>
        <text>cystic fibrosis transmembrane conductance regulator</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Jensen;given-names:T</infon>
      <infon key="name_2">surname:Cui;given-names:L</infon>
      <infon key="name_1">surname:Kota;given-names:P</infon>
      <infon key="name_0">surname:Aleksandrov;given-names:AA</infon>
      <infon key="fpage">41</infon>
      <infon key="pub-id_pmid">22406676</infon>
      <infon key="year">2012</infon>
      <infon key="source">J Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">419</infon>
      <infon key="name_10">surname:Riordan;given-names:JR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Dokholyan;given-names:NV</infon>
      <infon key="name_8">surname:Aleksandrov;given-names:LA</infon>
      <infon key="name_7">surname:Gentzsch;given-names:M</infon>
      <infon key="lpage">60</infon>
      <infon key="name_6">surname:He;given-names:L</infon>
      <infon key="name_5">surname:Reyes;given-names:S</infon>
      <infon key="name_4">surname:Alekseev;given-names:AE</infon>
      <offset>44594</offset>
      <text>Allosteric modulation balances thermodynamic stability and restores function of DeltaF508 CFTR</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Seehausen;given-names:D</infon>
      <infon key="name_2">surname:Yang;given-names:Z</infon>
      <infon key="name_1">surname:Protasevich;given-names:I</infon>
      <infon key="name_0">surname:Wang;given-names:C</infon>
      <infon key="fpage">1932</infon>
      <infon key="pub-id_pmid">20687163</infon>
      <infon key="year">2010</infon>
      <infon key="source">Protein science : a publication of the Protein Society</infon>
      <infon key="type">ref</infon>
      <infon key="volume">19</infon>
      <infon key="name_10">surname:Hunt;given-names:JF</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Brouillette;given-names:CG</infon>
      <infon key="name_8">surname:Wetmore;given-names:DR</infon>
      <infon key="name_7">surname:Spencer Emtage;given-names:J</infon>
      <infon key="lpage">1947</infon>
      <infon key="name_6">surname:Atwell;given-names:S</infon>
      <infon key="name_5">surname:Zhao;given-names:X</infon>
      <infon key="name_4">surname:Skalak;given-names:T</infon>
      <offset>44689</offset>
      <text>Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis</text>
      <annotation id="1018">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="44759" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1019">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="44805" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hong;given-names:JS</infon>
      <infon key="name_2">surname:Tao;given-names:B</infon>
      <infon key="name_1">surname:Okeyo;given-names:GO</infon>
      <infon key="name_0">surname:Wang;given-names:W</infon>
      <infon key="fpage">41937</infon>
      <infon key="pub-id_pmid">21965669</infon>
      <infon key="year">2011</infon>
      <infon key="source">J Biol Chem</infon>
      <infon key="type">ref</infon>
      <infon key="volume">286</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">41948</infon>
      <infon key="name_4">surname:Kirk;given-names:KL</infon>
      <offset>44821</offset>
      <text>Thermally unstable gating of the most common cystic fibrosis mutant channel (DeltaF508): "rescue" by suppressor mutations in nucleotide binding domain 1 and by constitutive mutations in the cytosolic loops</text>
      <annotation id="1021">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="44866" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:He;given-names:L</infon>
      <infon key="name_2">surname:Aleksandrov;given-names:LA</infon>
      <infon key="name_1">surname:Kota;given-names:P</infon>
      <infon key="name_0">surname:Aleksandrov;given-names:AA</infon>
      <infon key="fpage">194</infon>
      <infon key="pub-id_pmid">20561529</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">401</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Riordan;given-names:JR</infon>
      <infon key="name_7">surname:Dokholyan;given-names:NV</infon>
      <infon key="lpage">210</infon>
      <infon key="name_6">surname:Gentzsch;given-names:M</infon>
      <infon key="name_5">surname:Cui;given-names:L</infon>
      <infon key="name_4">surname:Jensen;given-names:T</infon>
      <offset>45027</offset>
      <text>Regulatory insertion removal restores maturation, stability and function of DeltaF508 CFTR</text>
    </passage>
    <passage>
      <infon key="volume">170</infon>
      <infon key="name_2">surname:Bridges;given-names:RJ</infon>
      <infon key="name_1">surname:Frizzell;given-names:RA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Schultz;given-names:BD</infon>
      <infon key="fpage">51</infon>
      <infon key="pub-id_pmid">10398760</infon>
      <infon key="year">1999</infon>
      <infon key="source">The Journal of membrane biology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">66</infon>
      <offset>45118</offset>
      <text>Rescue of dysfunctional deltaF508-CFTR chloride channel activity by IBMX</text>
      <annotation id="1024">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="45152" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1025">
        <infon key="identifier">p.508delF</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="45142" length="9"/>
        <text>deltaF508</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Jallat;given-names:S</infon>
      <infon key="name_2">surname:Champigny;given-names:G</infon>
      <infon key="name_1">surname:Barbry;given-names:P</infon>
      <infon key="name_0">surname:Dalemans;given-names:W</infon>
      <infon key="fpage">526</infon>
      <infon key="pub-id_pmid">1722027</infon>
      <infon key="year">1991</infon>
      <infon key="source">Nature</infon>
      <infon key="type">ref</infon>
      <infon key="volume">354</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Lazdunski;given-names:M</infon>
      <infon key="name_8">surname:Lecocq;given-names:JP</infon>
      <infon key="name_7">surname:Pavirani;given-names:A</infon>
      <infon key="lpage">528</infon>
      <infon key="name_6">surname:Crystal;given-names:RG</infon>
      <infon key="name_5">surname:Dreyer;given-names:D</infon>
      <infon key="name_4">surname:Dott;given-names:K</infon>
      <offset>45191</offset>
      <text>Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation</text>
      <annotation id="1028">
        <infon key="identifier">p.508delF</infon>
        <infon key="type">DNAMutation</infon>
        <location offset="45249" length="10"/>
        <text>delta F508</text>
      </annotation>
      <annotation id="1029">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="45260" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">369</infon>
      <infon key="name_2">surname:Plant;given-names:BJ</infon>
      <infon key="name_1">surname:Murphy;given-names:DM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Harrison;given-names:MJ</infon>
      <infon key="fpage">1280</infon>
      <infon key="pub-id_pmid">24066763</infon>
      <infon key="year">2013</infon>
      <infon key="source">N Engl J Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1282</infon>
      <offset>45285</offset>
      <text>Ivacaftor in a G551D homozygote with cystic fibrosis</text>
      <annotation id="1033">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="45300" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="1034">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="45285" length="9"/>
        <text>Ivacaftor</text>
      </annotation>
      <annotation id="1035">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="45322" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">7</infon>
      <infon key="name_1">surname:Clancy;given-names:JP</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kotha;given-names:K</infon>
      <infon key="fpage">288</infon>
      <infon key="pub-id_pmid">24004658</infon>
      <infon key="year">2013</infon>
      <infon key="source">Therapeutic advances in respiratory disease</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">296</infon>
      <offset>45338</offset>
      <text>Ivacaftor treatment of cystic fibrosis patients with the G551D mutation: a review of the evidence</text>
      <annotation id="1040">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="45377" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="1041">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="45361" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
      <annotation id="1042">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="45338" length="9"/>
        <text>Ivacaftor</text>
      </annotation>
      <annotation id="1043">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="45395" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hathorne;given-names:H</infon>
      <infon key="name_2">surname:Hill;given-names:A</infon>
      <infon key="name_1">surname:Liu;given-names:B</infon>
      <infon key="name_0">surname:Rowe;given-names:SM</infon>
      <infon key="fpage">e66955</infon>
      <infon key="pub-id_pmid">23922647</infon>
      <infon key="year">2013</infon>
      <infon key="source">PLoS One</infon>
      <infon key="type">ref</infon>
      <infon key="volume">8</infon>
      <infon key="name_10">surname:Olson;given-names:ER</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Clancy;given-names:JP</infon>
      <infon key="name_9">surname:Stone;given-names:AJ</infon>
      <infon key="name_8">surname:Ordonez;given-names:CL</infon>
      <infon key="name_7">surname:Dong;given-names:Q</infon>
      <infon key="name_6">surname:Accurso;given-names:FJ</infon>
      <infon key="name_5">surname:Beamer;given-names:JR</infon>
      <infon key="name_4">surname:Cohen;given-names:M</infon>
      <offset>45436</offset>
      <text>Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR Mutation</text>
      <annotation id="1048">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="45487" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1049">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="45569" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1050">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="45563" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="1051">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="45529" length="9"/>
        <text>Ivacaftor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Skach;given-names:WR</infon>
      <infon key="name_2">surname:Landstrom;given-names:A</infon>
      <infon key="name_1">surname:O'Donnell;given-names:N</infon>
      <infon key="name_0">surname:Liu;given-names:X</infon>
      <infon key="fpage">5113</infon>
      <infon key="pub-id_pmid">22680785</infon>
      <infon key="year">2012</infon>
      <infon key="source">Biochemistry</infon>
      <infon key="type">ref</infon>
      <infon key="volume">51</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">5124</infon>
      <infon key="name_4">surname:Dawson;given-names:DC</infon>
      <offset>45583</offset>
      <text>Thermal Instability of DeltaF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channel Function: Protection by Single Suppressor Mutations and Inhibiting Channel Activity</text>
      <annotation id="1054">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="45669" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1055">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="45616" length="51"/>
        <text>Cystic Fibrosis Transmembrane Conductance Regulator</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">86</infon>
      <infon key="name_2">surname:Clarke;given-names:DM</infon>
      <infon key="name_1">surname:Bartlett;given-names:MC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Loo;given-names:TW</infon>
      <infon key="fpage">612</infon>
      <infon key="pub-id_pmid">23835419</infon>
      <infon key="year">2013</infon>
      <infon key="source">Biochem Pharmacol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">619</infon>
      <offset>45767</offset>
      <text>Corrector VX-809 stabilizes the first transmembrane domain of CFTR</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Houck;given-names:SA</infon>
      <infon key="name_2">surname:De La Rosa;given-names:O</infon>
      <infon key="name_1">surname:Grove;given-names:DE</infon>
      <infon key="name_0">surname:Ren;given-names:HY</infon>
      <infon key="fpage">3016</infon>
      <infon key="pub-id_pmid">23924900</infon>
      <infon key="year">2013</infon>
      <infon key="source">Mol Biol Cell</infon>
      <infon key="type">ref</infon>
      <infon key="volume">24</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Cyr;given-names:DM</infon>
      <infon key="lpage">3024</infon>
      <infon key="name_6">surname:Hoffman;given-names:BJ</infon>
      <infon key="name_5">surname:Van Goor;given-names:F</infon>
      <infon key="name_4">surname:Sopha;given-names:P</infon>
      <offset>45834</offset>
      <text>VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1</text>
      <annotation id="1057">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="45869" length="51"/>
        <text>cystic fibrosis transmembrane conductance regulator</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hoffman;given-names:BJ</infon>
      <infon key="volume">13</infon>
      <infon key="name_2">surname:Burton;given-names:B</infon>
      <infon key="name_1">surname:Yu;given-names:H</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Van Goor;given-names:F</infon>
      <infon key="fpage">29</infon>
      <infon key="pub-id_pmid">23891399</infon>
      <infon key="year">2014</infon>
      <infon key="source">J Cyst Fibros</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">36</infon>
      <offset>45974</offset>
      <text>Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function</text>
      <annotation id="1060">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="45997" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1061">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="45984" length="9"/>
        <text>ivacaftor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Schreiber;given-names:R</infon>
      <infon key="name_2">surname:Thomas;given-names:J</infon>
      <infon key="name_1">surname:Gonska;given-names:T</infon>
      <infon key="name_0">surname:Mall;given-names:M</infon>
      <infon key="fpage">608</infon>
      <infon key="pub-id_pmid">12612194</infon>
      <infon key="year">2003</infon>
      <infon key="source">Pediatr Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">53</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Kunzelmann;given-names:K</infon>
      <infon key="lpage">618</infon>
      <infon key="name_6">surname:Brandis;given-names:M</infon>
      <infon key="name_5">surname:Kuehr;given-names:J</infon>
      <infon key="name_4">surname:Seydewitz;given-names:HH</infon>
      <offset>46090</offset>
      <text>Modulation of Ca2+-activated Cl- secretion by basolateral K+ channels in human normal and cystic fibrosis airway epithelia</text>
      <annotation id="1065">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="46163" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="1066">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="46180" length="32"/>
        <text>cystic fibrosis airway epithelia</text>
      </annotation>
      <annotation id="1067">
        <infon key="identifier">MESH:D000069285</infon>
        <infon key="type">Chemical</infon>
        <location offset="46104" length="4"/>
        <text>Ca2+</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Olsen;given-names:JC</infon>
      <infon key="name_2">surname:Paradiso;given-names:AM</infon>
      <infon key="name_1">surname:Loewen;given-names:ME</infon>
      <infon key="name_0">surname:Tarran;given-names:R</infon>
      <infon key="fpage">407</infon>
      <infon key="pub-id_pmid">12198094</infon>
      <infon key="year">2002</infon>
      <infon key="source">The Journal of general physiology</infon>
      <infon key="type">ref</infon>
      <infon key="volume">120</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Gabriel;given-names:SE</infon>
      <infon key="lpage">418</infon>
      <infon key="name_6">surname:Boucher;given-names:RC</infon>
      <infon key="name_5">surname:Argent;given-names:BE</infon>
      <infon key="name_4">surname:Gray;given-names:MA</infon>
      <offset>46213</offset>
      <text>Regulation of murine airway surface liquid volume by CFTR and Ca2+-activated Cl- conductances</text>
      <annotation id="1071">
        <infon key="identifier">12638</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="46266" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1072">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="46227" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="1073">
        <infon key="identifier">MESH:D000069285</infon>
        <infon key="type">Chemical</infon>
        <location offset="46275" length="4"/>
        <text>Ca2+</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hardy;given-names:SP</infon>
      <infon key="name_2">surname:Makhlina;given-names:M</infon>
      <infon key="name_1">surname:Gabriel;given-names:SE</infon>
      <infon key="name_0">surname:Thomas;given-names:EJ</infon>
      <infon key="fpage">C1578</infon>
      <infon key="pub-id_pmid">11029305</infon>
      <infon key="year">2000</infon>
      <infon key="source">Am J Physiol Cell Physiol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">279</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">C1586</infon>
      <infon key="name_4">surname:Lethem;given-names:MI</infon>
      <offset>46309</offset>
      <text>Expression of nucleotide-regulated Cl(-) currents in CF and normal mouse tracheal epithelial cell lines</text>
      <annotation id="1075">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="46376" length="5"/>
        <text>mouse</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Gansemer;given-names:ND</infon>
      <infon key="name_2">surname:Dohrn;given-names:CL</infon>
      <infon key="name_1">surname:Abou Alaiwa;given-names:MH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Reznikov;given-names:LR</infon>
      <infon key="year">2014</infon>
      <infon key="source">J Cyst Fibros</infon>
      <infon key="type">ref</infon>
      <infon key="name_6">surname:Welsh;given-names:MJ</infon>
      <infon key="name_5">surname:Stoltz;given-names:DA</infon>
      <infon key="name_4">surname:Diekema;given-names:DJ</infon>
      <offset>46415</offset>
      <text>Antibacterial properties of the CFTR potentiator ivacaftor</text>
      <annotation id="1078">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="46447" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1079">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="46464" length="9"/>
        <text>ivacaftor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="comment">203188Orig1s000, http://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/203188Orig1s000OtherRedt.pdf.</infon>
      <infon key="source">Access data FDA</infon>
      <infon key="type">ref</infon>
      <offset>46474</offset>
    </passage>
    <passage>
      <infon key="name_3">surname:Phuan;given-names:PW</infon>
      <infon key="name_2">surname:Perdomo;given-names:D</infon>
      <infon key="name_1">surname:Avramescu;given-names:RG</infon>
      <infon key="name_0">surname:Veit;given-names:G</infon>
      <infon key="fpage">0</infon>
      <infon key="year">2014</infon>
      <infon key="source">Science Translational Medicine</infon>
      <infon key="type">ref</infon>
      <infon key="volume">0</infon>
      <infon key="name_10">surname:Hegedus;given-names:T</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Verkman;given-names:AS</infon>
      <infon key="name_12">surname:Lukacs;given-names:G</infon>
      <infon key="name_9">surname:Finkbeiner;given-names:WE</infon>
      <infon key="name_8">surname:Wu;given-names:YS</infon>
      <infon key="name_7">surname:Szollosi;given-names:D</infon>
      <infon key="lpage">0</infon>
      <infon key="name_6">surname:Borot;given-names:F</infon>
      <infon key="name_5">surname:Apaja;given-names:PM</infon>
      <infon key="name_4">surname:Bagdany;given-names:M</infon>
      <offset>46475</offset>
      <text>Some gating potentiators, including VX-770, diminish DeltaF508-CFTR functional expression</text>
      <annotation id="1081">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="46538" length="4"/>
        <text>CFTR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Yankaskas;given-names:JR</infon>
      <infon key="name_2">surname:Burns;given-names:KA</infon>
      <infon key="name_1">surname:Gabriel;given-names:S</infon>
      <infon key="name_0">surname:Fulcher;given-names:ML</infon>
      <infon key="fpage">183</infon>
      <infon key="pub-id_pmid">15492373</infon>
      <infon key="year">2005</infon>
      <infon key="source">Methods in molecular medicine</infon>
      <infon key="type">ref</infon>
      <infon key="volume">107</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">206</infon>
      <infon key="name_4">surname:Randell;given-names:SH</infon>
      <offset>46565</offset>
      <text>Well-differentiated human airway epithelial cell cultures</text>
      <annotation id="1083">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="46585" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">945</infon>
      <infon key="name_1">surname:Randell;given-names:SH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Fulcher;given-names:ML</infon>
      <infon key="fpage">109</infon>
      <infon key="pub-id_pmid">23097104</infon>
      <infon key="year">2013</infon>
      <infon key="source">Methods Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">121</infon>
      <offset>46623</offset>
      <text>Human nasal and tracheo-bronchial respiratory epithelial cell culture</text>
      <annotation id="1085">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="46623" length="5"/>
        <text>Human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Gentzsch;given-names:M</infon>
      <infon key="name_2">surname:Mengos;given-names:A</infon>
      <infon key="name_1">surname:Gabriel;given-names:SE</infon>
      <infon key="name_0">surname:Grubb;given-names:BR</infon>
      <infon key="fpage">355</infon>
      <infon key="pub-id_pmid">16284361</infon>
      <infon key="year">2006</infon>
      <infon key="source">Am J Respir Cell Mol Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">34</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Boucher;given-names:RC</infon>
      <infon key="name_8">surname:Riordan;given-names:JR</infon>
      <infon key="name_7">surname:Drumm;given-names:ML</infon>
      <infon key="lpage">363</infon>
      <infon key="name_6">surname:Knowles;given-names:MR</infon>
      <infon key="name_5">surname:Van Heeckeren;given-names:AM</infon>
      <infon key="name_4">surname:Randell;given-names:SH</infon>
      <offset>46693</offset>
      <text>SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis</text>
      <annotation id="1088">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="46763" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1089">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="46771" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Tatreau;given-names:JR</infon>
      <infon key="name_2">surname:Olsen;given-names:JC</infon>
      <infon key="name_1">surname:Gabriel;given-names:SE</infon>
      <infon key="name_0">surname:Fulcher;given-names:ML</infon>
      <infon key="fpage">L82</infon>
      <infon key="pub-id_pmid">18978040</infon>
      <infon key="year">2009</infon>
      <infon key="source">Am J Physiol Lung Cell Mol Physiol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">296</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Randell;given-names:SH</infon>
      <infon key="name_7">surname:Salmon;given-names:P</infon>
      <infon key="lpage">L91</infon>
      <infon key="name_6">surname:Saavedra;given-names:MT</infon>
      <infon key="name_5">surname:Livanos;given-names:E</infon>
      <infon key="name_4">surname:Gentzsch;given-names:M</infon>
      <offset>46787</offset>
      <text>Novel human bronchial epithelial cell lines for cystic fibrosis research</text>
      <annotation id="1092">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="46793" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="1093">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="46835" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Cui;given-names:L</infon>
      <infon key="name_2">surname:Hou;given-names:YX</infon>
      <infon key="name_1">surname:Mengos;given-names:A</infon>
      <infon key="name_0">surname:Chang;given-names:XB</infon>
      <infon key="fpage">2814</infon>
      <infon key="pub-id_pmid">18682497</infon>
      <infon key="year">2008</infon>
      <infon key="source">J Cell Sci</infon>
      <infon key="type">ref</infon>
      <infon key="volume">121</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Gentzsch;given-names:M</infon>
      <infon key="lpage">2823</infon>
      <infon key="name_6">surname:Riordan;given-names:JR</infon>
      <infon key="name_5">surname:Aleksandrov;given-names:A</infon>
      <infon key="name_4">surname:Jensen;given-names:TJ</infon>
      <offset>46860</offset>
      <text>Role of N-linked oligosaccharides in the biosynthetic processing of the cystic fibrosis membrane conductance regulator</text>
      <annotation id="1096">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="46868" length="25"/>
        <text>N-linked oligosaccharides</text>
      </annotation>
      <annotation id="1097">
        <infon key="identifier">MESH:D003550</infon>
        <infon key="type">Disease</infon>
        <location offset="46932" length="15"/>
        <text>cystic fibrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Riordan;given-names:JR</infon>
      <infon key="name_2">surname:Randell;given-names:SH</infon>
      <infon key="name_1">surname:O'Neal;given-names:WK</infon>
      <infon key="name_0">surname:Cholon;given-names:DM</infon>
      <infon key="fpage">L304</infon>
      <infon key="pub-id_pmid">20008117</infon>
      <infon key="year">2010</infon>
      <infon key="source">Am J Physiol Lung Cell Mol Physiol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">298</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">L314</infon>
      <infon key="name_4">surname:Gentzsch;given-names:M</infon>
      <offset>46979</offset>
      <text>Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures</text>
      <annotation id="1100">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="47039" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1101">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="47055" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ansede;given-names:JH</infon>
      <infon key="name_2">surname:Johnson;given-names:MR</infon>
      <infon key="name_1">surname:Boucher;given-names:RC</infon>
      <infon key="name_0">surname:Esther;given-names:CR;suffix:Jr</infon>
      <infon key="fpage">76</infon>
      <infon key="pub-id_pmid">23932897</infon>
      <infon key="year">2014</infon>
      <infon key="source">Pulm Pharmacol Ther</infon>
      <infon key="type">ref</infon>
      <infon key="volume">27</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Hirsh;given-names:AJ</infon>
      <infon key="lpage">82</infon>
      <infon key="name_6">surname:Ghio;given-names:AJ</infon>
      <infon key="name_5">surname:O'Riordan;given-names:TG</infon>
      <infon key="name_4">surname:Donn;given-names:KH</infon>
      <offset>47088</offset>
      <text>Airway drug pharmacokinetics via analysis of exhaled breath condensate</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Swenberg;given-names:JA</infon>
      <infon key="name_2">surname:Collins;given-names:LB</infon>
      <infon key="name_1">surname:Jasin;given-names:HM</infon>
      <infon key="name_0">surname:Esther;given-names:CR;suffix:Jr</infon>
      <infon key="fpage">701</infon>
      <infon key="pub-id_pmid">18257110</infon>
      <infon key="year">2008</infon>
      <infon key="source">Rapid communications in mass spectrometry : RCM</infon>
      <infon key="type">ref</infon>
      <infon key="volume">22</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">705</infon>
      <infon key="name_4">surname:Boysen;given-names:G</infon>
      <offset>47159</offset>
      <text>A mass spectrometric method to simultaneously measure a biomarker and dilution marker in exhaled breath condensate</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f1.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption_title</infon>
      <offset>47274</offset>
      <text>VX-770 treatment restores G551D function</text>
      <annotation id="1103">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="47300" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f1.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>47315</offset>
      <text>Electrophysiological properties of G551D/DeltaF508 cultures analyzed in Ussing chambers treated chronically with VX-770 (cVX770, 5 microM for 48 hrs) or with vehicle (0.1% DMSO). (A) Representative recording of ISC measured in Ussing chambers. Quantification of response to treatment with (B) forskolin (significant difference between vehicle and cVX770, *P = 0.0009), (C) acute VX-770 (aVX770) (significant difference between vehicle and cVX770, *P = 0.0054), (D) forskolin + aVX770, (E) CFTRinh-172. Primary CF HBE cultures (G551D/DeltaF508) were derived from 3 different patients, 3-4 replicates were performed per patient for a total of 10 measurements per treatment.</text>
      <annotation id="1112">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="47889" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="1113">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="47933" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="1114">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="47825" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1115">
        <infon key="identifier">MESH:D004121</infon>
        <infon key="type">Chemical</infon>
        <location offset="47487" length="4"/>
        <text>DMSO</text>
      </annotation>
      <annotation id="1116">
        <infon key="identifier">c.551G&gt;D,D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="47842" length="7"/>
        <text>G551D/D</text>
      </annotation>
      <annotation id="1117">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="47608" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="1118">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="47780" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="1119">
        <infon key="identifier">MESH:C482900</infon>
        <infon key="type">Chemical</infon>
        <location offset="47804" length="11"/>
        <text>CFTRinh-172</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f2.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption_title</infon>
      <offset>47987</offset>
      <text>Chronic VX-770 treatment inhibits functional rescue of DeltaF508</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f2.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption</infon>
      <offset>48052</offset>
      <text>(A) Representative ISC traces of CF HBE cells recorded in Ussing chambers. Primary CF HBE cells (DeltaF508/DeltaF508) were treated with vehicle (DMSO) or VX-809 +/-VX-770 for 48 hrs at 5 microM each. (B) DeltaISC response to forskolin observed in VX-809-treated CF HBE cells (*P = 0.0033, VX809 vs. vehicle) was prevented by chronic VX-770 treatment and significantly different from VX-809-treated cells (#P = 0.0147, VX809 vs. VX809+VX770). (C) CF HBE cells treated with VX-809 responded to acute VX-770 exposure (*P = 0.0177, VX809 vs. vehicle). This response was significantly abrogated in VX-809 + VX-770-treated cells (#P = 0.0031, VX809 vs. VX809+VX770). (D) The response to CFTRinh-172 observed in VX-809-treated cells (*P = 0.0209, VX809 vs. vehicle) was significantly decreased in VX809+VX770-treated cells (#P = 0.0006, VX809 vs. VX809+VX770). Primary HBE cultures (DeltaF508/DeltaF508) were derived from 6 different patients, 2-4 replicates were performed per patient for a total of 15 measurements per condition.</text>
      <annotation id="1130">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="48979" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="1131">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="49023" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="1132">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="48277" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="1133">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="48314" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1134">
        <infon key="identifier">DeltaF508/DeltaF508</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="48149" length="19"/>
        <text>DeltaF508/DeltaF508</text>
      </annotation>
      <annotation id="1135">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="48135" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1136">
        <infon key="identifier">MESH:D004121</infon>
        <infon key="type">Chemical</infon>
        <location offset="48197" length="4"/>
        <text>DMSO</text>
      </annotation>
      <annotation id="1137">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="48085" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1138">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="48498" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1139">
        <infon key="identifier">DeltaF508/DeltaF508</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="48928" length="19"/>
        <text>DeltaF508/DeltaF508</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f3.jpg</infon>
      <infon key="id">F3</infon>
      <infon key="type">fig_caption_title</infon>
      <offset>49077</offset>
      <text>VX-770 diminishes biochemical correction by increasing turnover of corrected DeltaF508 CFTR</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f3.jpg</infon>
      <infon key="id">F3</infon>
      <infon key="type">fig_caption</infon>
      <offset>49169</offset>
      <text>(A) CFTR Western blot of normal (NL) and CF HBE cultures treated with VX-809 (5 microM) +/-VX-770 (5 microM) for 48 hrs. * indicates the mature, complex glycosylated form of CFTR, band C;   indicates the immature band B. (B) Turnover of rescued DeltaF508 in BHK-21 cells. DeltaF508 was rescued at 27 C in the presence of VX-809 +/- VX-770 for 24 hrs. After adding cycloheximide (200 microg/ml, 37 C) cells were lysed at the indicated times and analyzed by Western blotting. (C) Quantification of remaining band C over time, normalized to actin (n = 3).</text>
      <annotation id="1144">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="49343" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1145">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="49173" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1146">
        <infon key="identifier">CVCL:1914</infon>
        <infon key="type">CellLine</infon>
        <location offset="49427" length="6"/>
        <text>BHK-21</text>
      </annotation>
      <annotation id="1147">
        <infon key="identifier">MESH:D003513</infon>
        <infon key="type">Chemical</infon>
        <location offset="49533" length="13"/>
        <text>cycloheximide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f4.jpg</infon>
      <infon key="id">F4</infon>
      <infon key="type">fig_caption_title</infon>
      <offset>49722</offset>
      <text>VX-770-induced hindrance of DeltaF508 correction is dose-dependent</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f4.jpg</infon>
      <infon key="id">F4</infon>
      <infon key="type">fig_caption</infon>
      <offset>49789</offset>
      <text>(A) ISC traces of CF HBE cells (DeltaF508/DeltaF508) recorded in Ussing chambers. CF HBE cells were treated as indicated (VX-809: 5 microM, VX-770: 1 or 5 microM) for 48 hrs. (B) CFTR function in VX-809-treated cells decreased as chronic VX-770 concentrations increased. Significant reduction of the area under the curve (AUC)/min calculated from the time period between CFTR stimulation by forskolin and CFTR inhibition by CFTRinh-172 (yields average DeltaIsc (microA/cm2)) was observed in CF cells chronically treated for 48 hrs with VX-809 when compared to VX-809 and 1 microM VX-770, (*P = 0.0352). A further reduction was detected when the chronic VX-770 concentration was increased to 5 microM (#P = 0.0049, VX-809 + 1 microM VX-770 vs. VX-809 + 5 microM VX-770). Primary CF HBE cultures were derived from at least 4 different CF patients; 2-5 replicates were performed per patient for a total of at least 14 measurements per condition. (C) In VX-809-corrected CF HBE cultures (DeltaF508/DeltaF508), the presence of chronic VX-770 at 50 nM caused a significant decline of the slope after forskolin treatment (*P = 0.0353, VX-809 vs. VX-809 + 50 nM VX-770). Primary CF HBE cultures were derived from 4 different patients; 3-5 replicates were performed per patient for a total of at least 15 measurements per condition. (D) Quantification of C:B band ratio in CF HBE cultures (DeltaF508/DeltaF508). CFTR C:B band ratio decreased in CF HBE cells as chronic VX-770 concentrations were increased. The C:B band ratio was significantly reduced in CF cells chronically treated for 48 hrs with VX-809 and 1 microM VX-770 compared to VX-809 alone (*P = 0.0181), and a further reduction was detected when the chronic VX-770 concentration was increased from 1 microM to 5 microM (#P = 0.0151, VX-809 + 1 microM VX-770 vs. VX-809 + 5 microM VX-770). Primary CF HBE cultures (DeltaF508/DeltaF508) from 4 different patients were analyzed. (E) Representative Western blot of CF HBE cells (DeltaF508/DeltaF508) showing decrease of VX-809-corrected DeltaF508 as chronic VX-770 concentrations were increased.</text>
      <annotation id="1174">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="49968" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1175">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="50160" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1176">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="50194" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1177">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="51192" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1178">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="50625" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="1179">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="50669" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="1180">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="51006" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="1181">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="51050" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="1182">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="51695" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="1183">
        <infon key="identifier">DeltaF508/DeltaF508</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="49821" length="19"/>
        <text>DeltaF508/DeltaF508</text>
      </annotation>
      <annotation id="1184">
        <infon key="identifier">DeltaF508/DeltaF508</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="51657" length="19"/>
        <text>DeltaF508/DeltaF508</text>
      </annotation>
      <annotation id="1185">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="50756" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1186">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="50567" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1187">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="50180" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="1188">
        <infon key="identifier">MESH:C482900</infon>
        <infon key="type">Chemical</infon>
        <location offset="50213" length="11"/>
        <text>CFTRinh-172</text>
      </annotation>
      <annotation id="1189">
        <infon key="identifier">DeltaF508/DeltaF508</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="51170" length="19"/>
        <text>DeltaF508/DeltaF508</text>
      </annotation>
      <annotation id="1190">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="51754" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1191">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="49807" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1192">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="50960" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1193">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="50883" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="1194">
        <infon key="identifier">DeltaF508/DeltaF508</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="50773" length="19"/>
        <text>DeltaF508/DeltaF508</text>
      </annotation>
      <annotation id="1195">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="51640" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1196">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="49871" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1197">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="51225" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1198">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="51153" length="6"/>
        <text>CF HBE</text>
      </annotation>
      <annotation id="1199">
        <infon key="identifier">DeltaF508/DeltaF508</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="51768" length="19"/>
        <text>DeltaF508/DeltaF508</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f5.jpg</infon>
      <infon key="id">F5</infon>
      <infon key="type">fig_caption_title</infon>
      <offset>51885</offset>
      <text>Chronic VX-770 treatment decreases function of wild-type CFTR</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f5.jpg</infon>
      <infon key="id">F5</infon>
      <infon key="type">fig_caption</infon>
      <offset>51947</offset>
      <text>(A) Representative ISC traces of NL HBE cells recorded in Ussing chambers. Cultures were treated with vehicle (DMSO) or 5 microM VX-770 for 48 hrs. HBE cells that were chronically treated with VX-770 showed significantly reduced response to (B,C) forskolin (*P = 0.0198 for forskolin peak and *P = 0.0008 for forskolin plateau) and (D) CFTRinh-172 (*P = 0.0014). Primary HBE cultures were derived from 6 different individuals, 2-4 replicates were performed per individual for a total of 17 measurements per condition. (E) Western blot of HBE cultures treated with VX-809 (5 microM) +/-VX-770 (5 microM) for 48 hrs. Mature CFTR was diminished in HBE cells that were chronically treated with VX770.</text>
      <annotation id="1207">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="52569" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1208">
        <infon key="identifier">MESH:D004121</infon>
        <infon key="type">Chemical</infon>
        <location offset="52058" length="4"/>
        <text>DMSO</text>
      </annotation>
      <annotation id="1209">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="52221" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="1210">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="52194" length="9"/>
        <text>forskolin</text>
      </annotation>
      <annotation id="1211">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="52140" length="6"/>
        <text>VX-770</text>
      </annotation>
      <annotation id="1212">
        <infon key="identifier">MESH:C482900</infon>
        <infon key="type">Chemical</infon>
        <location offset="52283" length="11"/>
        <text>CFTRinh-172</text>
      </annotation>
      <annotation id="1213">
        <infon key="identifier">MESH:D005576</infon>
        <infon key="type">Chemical</infon>
        <location offset="52256" length="9"/>
        <text>forskolin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f6.jpg</infon>
      <infon key="id">F6</infon>
      <infon key="type">fig_caption_title</infon>
      <offset>52644</offset>
      <text>Key physiological properties were not altered in chronically VX-770-treated HBE cultures</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f6.jpg</infon>
      <infon key="id">F6</infon>
      <infon key="type">fig_caption</infon>
      <offset>52733</offset>
      <text>(A) Microscopy after hematoxylin and eosin (H&amp;E) staining of HBE cultures did not reveal a detectable difference between VX-770- or vehicle-treated cells (bar = 10 m). (B) Transepithelial resistance (Rt) of primary HBE cultures was not altered after chronic treatment with VX-770. (C) Nystatin responses were not significantly different in primary HBE cultures that were treated with vehicle or VX-770 (48 hrs, 5 microM). Nystatin was added to the apical side in Ussing chambers. Primary HBE cultures were derived from 5 different individuals, and 2-4 replicates per individual were performed.</text>
      <annotation id="1218">
        <infon key="identifier">MESH:D006416</infon>
        <infon key="type">Chemical</infon>
        <location offset="52754" length="11"/>
        <text>hematoxylin</text>
      </annotation>
      <annotation id="1219">
        <infon key="identifier">MESH:D004801</infon>
        <infon key="type">Chemical</infon>
        <location offset="52770" length="5"/>
        <text>eosin</text>
      </annotation>
      <annotation id="1220">
        <infon key="identifier">MESH:D009761</infon>
        <infon key="type">Chemical</infon>
        <location offset="53155" length="8"/>
        <text>Nystatin</text>
      </annotation>
      <annotation id="1221">
        <infon key="identifier">MESH:D009761</infon>
        <infon key="type">Chemical</infon>
        <location offset="53018" length="8"/>
        <text>Nystatin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f7.jpg</infon>
      <infon key="id">F7</infon>
      <infon key="type">fig_caption_title</infon>
      <offset>53327</offset>
      <text>VX-770 reduces stability of CFTR</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms623565f7.jpg</infon>
      <infon key="id">F7</infon>
      <infon key="type">fig_caption</infon>
      <offset>53360</offset>
      <text>(A) The amount of mature CFTR was reduced when NL HBE cells were chronically treated with VX-770 (48 hrs, 5 microM). G551D is more stable than NL CFTR and the amount of mature G551D protein in CF cultures (G551D/DeltaF508) was not significantly reduced by 48 hrs treatment with 5 microM VX-770. (B) Quantification of C:B band ratio with chronic treatment of VX-770 at 5 microM. C:B band ratio was significantly decreased in NL cells chronically treated for 48 hrs with 5 microM VX-770, (*P = 0.008) (n = 3, cultures from 3 different NL individuals). The reduction of C:B band ratio in G551D/DeltaF508 cells chronically treated for 48 hrs with 5 microM VX-770 was not statistically significant (n = 3, cultures from 3 different CF patients (G551D/DeltaF508)). (C) Structural model showing positions of G551D and F508 in the CFTR molecule. (D) Illustration representing the proposed relationship between function and stability of CFTR variants. Wild-type CFTR has an intermediate stability that allows for optimal function. G551D CFTR is a more rigid protein that exhibits increased stability compared to wild-type CFTR but lacks sufficient function, presumably due to decreased flexibility. VX-770 decreases G551D CFTR stability and renders it a more flexible protein, resembling the stability and function of wild-type CFTR. However, VX-770 causes destabilization of wild-type CFTR and VX-809-corrected DeltaF508 CFTR, diminishing their function. VX-809 increases the stability of DeltaF508, bringing it closer to resembling wild-type CFTR, but this increased stability is diminished when VX-770 is present.</text>
      <annotation id="1245">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="53385" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1246">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="53506" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1247">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="54183" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1248">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="54288" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1249">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="54313" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1250">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="54388" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1251">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="54473" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1252">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="54573" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1253">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="54679" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1254">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="54737" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1255">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="54773" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1256">
        <infon key="identifier">1080</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55465</infon>
        <location offset="54895" length="4"/>
        <text>CFTR</text>
      </annotation>
      <annotation id="1257">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="54090" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="1258">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="53536" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="1259">
        <infon key="identifier">c.551G&gt;D,D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="54100" length="7"/>
        <text>G551D/D</text>
      </annotation>
      <annotation id="1260">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="53477" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="1261">
        <infon key="identifier">MESH:C545203</infon>
        <infon key="type">Chemical</infon>
        <location offset="53647" length="6"/>
        <text>VX-770</text>
      </annotation>
      <annotation id="1262">
        <infon key="identifier">CVCL:0287</infon>
        <infon key="type">CellLine</infon>
        <location offset="53407" length="6"/>
        <text>NL HBE</text>
      </annotation>
      <annotation id="1263">
        <infon key="identifier">c.551G&gt;D,D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="53945" length="7"/>
        <text>G551D/D</text>
      </annotation>
      <annotation id="1264">
        <infon key="identifier">c.551G&gt;D,D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="53566" length="7"/>
        <text>G551D/D</text>
      </annotation>
      <annotation id="1265">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="54382" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="1266">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="54567" length="5"/>
        <text>G551D</text>
      </annotation>
      <annotation id="1267">
        <infon key="identifier">p.G551D;RS#:75527207</infon>
        <infon key="type">ProteinMutation</infon>
        <location offset="54161" length="5"/>
        <text>G551D</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272826</id>
    <passage>
      <infon key="name_3">surname:Reddy;given-names:Poluru L.</infon>
      <infon key="name_2">surname:Bies;given-names:Juraj</infon>
      <infon key="name_1">surname:Anastasi;given-names:John</infon>
      <infon key="article-id_pmid">23910958</infon>
      <infon key="name_0">surname:Baron;given-names:Beverly W.</infon>
      <infon key="fpage">68</infon>
      <infon key="issue">1</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272826</infon>
      <infon key="article-id_doi">10.1016/j.bcmd.2013.07.003</infon>
      <infon key="type">front</infon>
      <infon key="volume">52</infon>
      <infon key="license">           This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.         </infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Blood Cells Mol. Dis.; 2014 Jan; 52(1) 68-75. doi:10.1016/j.bcmd.2013.07.003</infon>
      <infon key="kwd">BCL6 transgenic mice Cooperating genes Lymphoma development GFI1B EVI5 MYB</infon>
      <infon key="name_8">surname:Baron;given-names:Joseph M.</infon>
      <infon key="name_7">surname:Wolff;given-names:Linda</infon>
      <infon key="lpage">75</infon>
      <infon key="name_6">surname:Wroblewski;given-names:Kristen</infon>
      <infon key="name_5">surname:Thirman;given-names:Michael J.</infon>
      <infon key="article-id_manuscript">NIHMS648290</infon>
      <infon key="name_4">surname:Joseph;given-names:Loren</infon>
      <infon key="authors">Baron BW, Anastasi J, Bies J, Reddy PL, Joseph L, Thirman MJ, Wroblewski K, Wolff L, Baron JM</infon>
      <offset>0</offset>
      <text>GFI1B, EVI5, MYB:Additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas</text>
      <annotation id="6">
        <infon key="identifier">8328</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="0" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="7">
        <infon key="identifier">7813</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="7" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="8">
        <infon key="identifier">4602</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="13" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="9">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="64" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="10">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="58" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="11">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="104" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>116</offset>
      <text>The BCL6 gene, which is expressed in certain B- and T-cell human lymphomas, is involved with chromosomal rearrangements and mutations in a number of these neoplasms. Lymphomagenesis is believed to evolve through a multi-step accumulation of genetic alterations in these tumors. We used retroviral insertional mutagenesis in transgenic mice expressing the human BCL6 transgene in order to identify genes that cooperate with BCL6 during lymphomatous transformation. We previously reported PIM1 as the most frequently recurring cooperating gene in this model. We now report three newly identified cooperating genes:GFI1B, EVI5, and MYB:that we identified in the lymphomas of retroviral-injected BCL6 transgenic mice (but not in retroviral-injected non-transgenic controls); mRNA and protein expression of GFI1B and EVI5 were decreased in the murine tumors, whereas MYB mRNA and protein expression were increased or decreased. These findings correlated with protein expression in human lymphomas, both B- and T-cell. Improved therapy of lymphomas may necessitate the development of combinations of drugs that target the alterations specific to each neoplasm.</text>
      <annotation id="38">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="120" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="39">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="477" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="40">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="539" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="41">
        <infon key="identifier">18712</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">11214</infon>
        <location offset="603" length="4"/>
        <text>PIM1</text>
      </annotation>
      <annotation id="42">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="728" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="43">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="735" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="44">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="745" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="45">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="808" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="46">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="918" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="47">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="928" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="978" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="175" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="50">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="440" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="51">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="471" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="52">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="813" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="955" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1092" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="865" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="56">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="1261" length="8"/>
        <text>neoplasm</text>
      </annotation>
      <annotation id="57">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="181" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="58">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="1149" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="59">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="1098" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="60">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="386" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="61">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="271" length="9"/>
        <text>neoplasms</text>
      </annotation>
      <annotation id="62">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="962" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="63">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="775" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1275</offset>
      <text>Introduction</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1288</offset>
      <text>It has long been known that chromosomal rearrangements and/or mutations of the BCL6 gene are associated with diffuse large B-cell lymphomas (DLBLs) in humans. BCL6 expression also is known to occur in certain T-cell lymphomas. Because multiple oncogenic hits are believed to accumulate during lymphoma development, we used retroviral insertional mutagenesis in mice containing the human BCL6 transgene in an effort to identify mutated genes that cooperate with BCL6 during lymphoma development.</text>
      <annotation id="75">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="1367" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="76">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="1447" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="77">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="1675" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="78">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="1749" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="79">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1439" length="6"/>
        <text>humans</text>
      </annotation>
      <annotation id="80">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="1649" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="81">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1669" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="82">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="1761" length="8"/>
        <text>lymphoma</text>
      </annotation>
      <annotation id="83">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="1418" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="84">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="1581" length="8"/>
        <text>lymphoma</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="1497" length="16"/>
        <text>T-cell lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1783</offset>
      <text>We previously reported that retroviral insertional mutagenesis in mice transgenic for human BCL6 leads to enhanced lymphoma development, and we described the gene proviral integration site for Moloney murine leukemia virus 1 (PIM1) as the most frequently recurring gene cooperating with BCL6 to promote lymphoma development in this model. We now report additional recurring retroviral integration sites that we identified in the lymphomas which developed in retroviral-injected BCL6 transgenic mice but not in lymphomas from retroviral-injected non-transgenic controls. The mRNA and proteins encoded by two of the genes involved, growth factor independent 1B (GFI1B) and ecotropic viral integration site 5 (EVI5), each of which we identified in the lymphomas from three transgenic animals (three B-cell and three T-cell, respectively), showed decreased expression in the lymphomas from transgenic (BCL6-positive) mice as compared with the lymphomas from non-transgenic retroviral injected controls (BCL6-negative) as well as in BCL6-positive (as compared with BCL6-negative) human lymphomas. The mRNA and protein encoded by a third involved gene, myeloblastosis oncogene (MYB), which we also identified in the lymphomas from three transgenic animals (two B-cell, one T-cell) but not in controls, was variably increased or decreased. Although these three genes have been associated with lymphoma development, they have not been reported previously to cooperate with BCL6 in lymphomagenesis.</text>
      <annotation id="123">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="1875" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="124">
        <infon key="identifier">18712</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">11214</infon>
        <location offset="2009" length="4"/>
        <text>PIM1</text>
      </annotation>
      <annotation id="125">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="2070" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="126">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="2261" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="127">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="2413" length="28"/>
        <text>growth factor independent 1B</text>
      </annotation>
      <annotation id="128">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="2443" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="129">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="2454" length="34"/>
        <text>ecotropic viral integration site 5</text>
      </annotation>
      <annotation id="130">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="2490" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="131">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="2681" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="132">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="2782" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="2811" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="134">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="2843" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="2930" length="23"/>
        <text>myeloblastosis oncogene</text>
      </annotation>
      <annotation id="136">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="2955" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="137">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="3248" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="138">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="1849" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="139">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1869" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="140">
        <infon key="identifier">11801</infon>
        <infon key="type">Species</infon>
        <location offset="1976" length="29"/>
        <text>Moloney murine leukemia virus</text>
      </annotation>
      <annotation id="141">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="2266" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="142">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="2696" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2858" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="144">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="1854" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="145">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="2332" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="146">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="2553" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="147">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="2669" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="148">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="2741" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="149">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="3014" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="150">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="2086" length="8"/>
        <text>lymphoma</text>
      </annotation>
      <annotation id="151">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="2212" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="152">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="2864" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="153">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="2532" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="154">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="1898" length="8"/>
        <text>lymphoma</text>
      </annotation>
      <annotation id="155">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="2293" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="156">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="2993" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="157">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="3169" length="8"/>
        <text>lymphoma</text>
      </annotation>
      <annotation id="158">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="2654" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="159">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="2722" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>3273</offset>
      <text>Materials and methods</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>3295</offset>
      <text>BCL6 transgenic mice and retroviral insertional mutagenesis</text>
      <annotation id="162">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="3295" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="3300" length="15"/>
        <text>transgenic mice</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>3355</offset>
      <text>Our transgenic mice (described previously), which express BCL6 constitutively in B- and T-lymphocytes, contain two transgenes: tet-o-BCL6 (human BCL6 cDNA under control of the tetracycline-responsive minimal promoter), and EmuSR-tTA (the tetracycline- transactivating protein under control of the Ig heavy-chain enhancer and the SRalpha promoter). One of our transgenic lines contains four copies of the human BCL6 transgene, the other 20 copies. Under approved institutional protocols, neonatal animals from both transgenic lines and controls (non-transgenic mice of the same background, wild-type or positive for either the EmuSR-tTA or tet-o-BCL6 transgenes, but not both) were injected with 105 infectious units of the retrovirus MOL4070LTR intraperitoneally and followed until the need for euthanasia or natural death.</text>
      <annotation id="179">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="3413" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="180">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="3488" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="181">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="3500" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="182">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="3765" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="183">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="4000" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="184">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="3359" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="185">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3494" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="186">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3759" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="187">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="3904" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="188">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="3714" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="189">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="3869" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="190">
        <infon key="identifier">MESH:D013752</infon>
        <infon key="type">Chemical</infon>
        <location offset="3531" length="12"/>
        <text>tetracycline</text>
      </annotation>
      <annotation id="191">
        <infon key="identifier">MESH:C010349</infon>
        <infon key="type">Chemical</infon>
        <location offset="3482" length="3"/>
        <text>tet</text>
      </annotation>
      <annotation id="192">
        <infon key="identifier">MESH:D013752</infon>
        <infon key="type">Chemical</infon>
        <location offset="3593" length="12"/>
        <text>tetracycline</text>
      </annotation>
      <annotation id="193">
        <infon key="type">Disease</infon>
        <location offset="4150" length="10"/>
        <text>euthanasia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>4179</offset>
      <text>Histology, flow cytometry, inverse PCR, database searches, and real-time quantitative PCR</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4269</offset>
      <text>Processing of tissues, FACS analysis, inverse PCR, cloning, sequencing, database searches, total RNA extraction, and real-time RT-PCR methodologies have been described previously. The classification of murine lymphoid neoplasms was according to the Bethesda proposals. Primers included beta-actin as described or glyceraldehyde-3-phosphate dehydrogenase (Real Time Primers, Elkins Park, PA) and primers common to all transcript variants of the murine GFI1B, EVI5, or MYB genes (GFI1B, forward: 5'-CTCTCCAGGCATGGACACTT-3'; reverse: 5'-GACGTGAGTATGCTGCTCCA-3'; EVI5, forward: 5'-CCCATCAAAGTTG AGTCCAG-3'; reverse: 5'-TTCTTCCCCAGAGAATCCAA-3'; MYB, Real Time Primers, forward: 5'-CTGGACAGAAGAGGAGGACA-3'; reverse: 5'-TTGTT CTTCTGGAAGCTCGT-3').</text>
      <annotation id="206">
        <infon key="identifier">14081</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37561</infon>
        <location offset="4292" length="4"/>
        <text>FACS</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">14433</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">107053</infon>
        <location offset="4582" length="40"/>
        <text>glyceraldehyde-3-phosphate dehydrogenase</text>
      </annotation>
      <annotation id="208">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="4720" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="209">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="4727" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="210">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="4736" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="211">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="4747" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="212">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="4828" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="213">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="4909" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="214">
        <infon key="identifier">11461</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">110648</infon>
        <location offset="4555" length="10"/>
        <text>beta-actin</text>
      </annotation>
      <annotation id="215">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="4471" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="216">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="4713" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="217">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="4478" length="18"/>
        <text>lymphoid neoplasms</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>5031</offset>
      <text>Immunohistochemistry</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5052</offset>
      <text>Human lymphoma blocks were retrieved from the surgical pathology archives under an Institutional Review-Board approved protocol. Human and murine tissues were stained with anti-BCL6 as described previously. For additional immunohistochemistry, antigen retrieval was performed in pH 6 solution (Epitomics, Burlingame, CA) in a near boiling waterbath for 40 min. Anti-GFI1B (#HPA007012, for human tissues) and anti-EVI5 (#HPA027339, for human and murine tissues) were affinity-isolated Prestige antibodies produced in rabbit (Sigma-Aldrich, Saint Louis, MO). Anti-GFI1B was diluted 1:20 and anti-EVI5 1:35 for incubation overnight at 4  C. Murine tissues were stained with GFI1B affinity isolated antibody produced in rabbit (Sigma Aldrich, #AV30093), 20 mug/ml, overnight at 4  C. For immunohistochemistry with MYB antibody, human tissues were incubated overnight at 4  C with a 1:20 dilution of a rabbit monoclonal antibody (Epitomics, Burlingame, CA, cat. # 3195-1). Murine tissues were incubated with the same MYB antibody diluted 1:1000 for 1 h at room temperature. For all antibodies, antigen-antibody binding was detected with DAB chromogen, and tissues were counterstained with hematoxylin. Images were taken with a BX41 microscope (Olympus), a DP72 digital camera, and cellSens Standard imaging software (Olympus).</text>
      <annotation id="241">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="5229" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="242">
        <infon key="identifier">8328</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="5418" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="243">
        <infon key="identifier">7813</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="5465" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="244">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="5614" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="245">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="5646" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="246">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="5723" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="247">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="5862" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="248">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="6064" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="249">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5052" length="5"/>
        <text>Human</text>
      </annotation>
      <annotation id="250">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5181" length="5"/>
        <text>Human</text>
      </annotation>
      <annotation id="251">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="5191" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="252">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5441" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="253">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5487" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="254">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="5497" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="255">
        <infon key="identifier">9986</infon>
        <infon key="type">Species</infon>
        <location offset="5568" length="6"/>
        <text>rabbit</text>
      </annotation>
      <annotation id="256">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="5690" length="6"/>
        <text>Murine</text>
      </annotation>
      <annotation id="257">
        <infon key="identifier">9986</infon>
        <infon key="type">Species</infon>
        <location offset="5768" length="6"/>
        <text>rabbit</text>
      </annotation>
      <annotation id="258">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5876" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="259">
        <infon key="identifier">9986</infon>
        <infon key="type">Species</infon>
        <location offset="5949" length="6"/>
        <text>rabbit</text>
      </annotation>
      <annotation id="260">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="6020" length="6"/>
        <text>Murine</text>
      </annotation>
      <annotation id="261">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="5058" length="8"/>
        <text>lymphoma</text>
      </annotation>
      <annotation id="262">
        <infon key="identifier">MESH:C000469</infon>
        <infon key="type">Chemical</infon>
        <location offset="6184" length="3"/>
        <text>DAB</text>
      </annotation>
      <annotation id="263">
        <infon key="identifier">MESH:D006416</infon>
        <infon key="type">Chemical</infon>
        <location offset="6236" length="11"/>
        <text>hematoxylin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>6377</offset>
      <text>Statistical analysis</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6398</offset>
      <text>The data from real-time PCR were analyzed by the comparative CT method. Data from the study and control groups were compared by the Wilcoxon rank-sum test. Statistical analyses were performed with Stata software (version 12: StataCorp, College Station, TX).</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>6656</offset>
      <text>Results</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>6664</offset>
      <text>Lymphoma development in MOL4070LTR-infected mice</text>
      <annotation id="265">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="6664" length="8"/>
        <text>Lymphoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6713</offset>
      <text>As previously reported, 92 of 99 transgenic and 32 of 33 control mice infected with retrovirus were analyzable. Lymphomas developed in 24 of 53 animals (45.3%) in the four copy transgenic line (18 T-cell, six B-cell) and in 10 of 39 (25.6%) mice from the 20 copy line (three T-cell, seven B-cell). Additionally, as MOL4070LTR is known to cause lymphomas and leukemias in mice, lymphoid neoplasms also were expected in the control group; 11 of 32 retroviral-injected controls (34.4%) developed lymphomas (5 T-cell, 6 B-cell). The nature of the lymphomas (both B- and T-cell), mouse survival, and murine lymphoma-related mortality rates have been discussed previously. Briefly, the lymphomas usually were aggressive tumors; most of the B-cell lymphomas were mature B-cell, and most T-cell tumors were precursor T-cell lymphoblastic lymphoma/leukemias. The lymphomas from the transgenic mice contained three to 29 insertion sites (average 11), and the lymphomas from the controls contained eight to 20 insertion sites (average 12.7). Only one of the animals studied here (with an insertion site 5' to the GFI1B gene) also had an insertion site 3' to PIM1.</text>
      <annotation id="290">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="7815" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="291">
        <infon key="identifier">18712</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">11214</infon>
        <location offset="7860" length="4"/>
        <text>PIM1</text>
      </annotation>
      <annotation id="292">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="6778" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="293">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="6954" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="294">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="7084" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="295">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="7288" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="296">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="7308" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="297">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="7586" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="298">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="6746" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="299">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="6890" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="300">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="7567" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="301">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="7315" length="8"/>
        <text>lymphoma</text>
      </annotation>
      <annotation id="302">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="7522" length="39"/>
        <text>T-cell lymphoblastic lymphoma/leukemias</text>
      </annotation>
      <annotation id="303">
        <infon key="identifier">MESH:D007938</infon>
        <infon key="type">Disease</infon>
        <location offset="7071" length="9"/>
        <text>leukemias</text>
      </annotation>
      <annotation id="304">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="7256" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="305">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="7393" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="306">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="7057" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="307">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="7090" length="18"/>
        <text>lymphoid neoplasms</text>
      </annotation>
      <annotation id="308">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="7662" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="309">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="6825" length="9"/>
        <text>Lymphomas</text>
      </annotation>
      <annotation id="310">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="7206" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="311">
        <infon key="identifier">MESH:D001523</infon>
        <infon key="type">Disease</infon>
        <location offset="7416" length="17"/>
        <text>aggressive tumors</text>
      </annotation>
      <annotation id="312">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="7493" length="13"/>
        <text>T-cell tumors</text>
      </annotation>
      <annotation id="313">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="7454" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>7870</offset>
      <text>RNA expression in lymphomas containing retroviral insertions in or near the GFI1B, EVI5, and MYB genes</text>
      <annotation id="318">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="7946" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="319">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="7953" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="320">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="7963" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="321">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="7888" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7973</offset>
      <text>As previously described, PIM1 was the gene most commonly affected by viral insertion sites in this study. Here we have chosen to study the genes that were the next most commonly affected by viral insertions (after PIM1). The types of lymphomas, insert locations, and relative expression levels following real-time quantitative RT-PCR performed on RNA derived from the lymphomas of transgenic mice as compared with RNA from lymphomas of the same type (B or T) in the same organ from multiple randomly selected non-transgenic controls are shown in Table 1.</text>
      <annotation id="329">
        <infon key="identifier">18712</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">11214</infon>
        <location offset="7998" length="4"/>
        <text>PIM1</text>
      </annotation>
      <annotation id="330">
        <infon key="identifier">18712</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">11214</infon>
        <location offset="8187" length="4"/>
        <text>PIM1</text>
      </annotation>
      <annotation id="331">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="8354" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="332">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="8486" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="333">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="8341" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="334">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="8207" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="335">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="8396" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8528</offset>
      <text>The insertion sites near GFI1B were all within 7.9-8.7 kb 5' of the GFI1B gene, and these murine tumors were all large B-cell lymphomas. The transgenic animals were females, ranging in age from 4.2 mos to 7.3 mos (average, 6.2 mos), and included both BCL6 transgenic lines. In each case, relative GFI1B RNA expression level in the lymphomas from transgenic mice was decreased as compared with that in randomly selected B-cell lymphomas from retroviral-injected non-transgenic controls (none of which had inserts in or near GFI1B), see Table 1 (overall decrease, 2.71-fold; mean +- SEM = 0.041 +- 0.018 in the controls as compared with 0.015 +- 0.005 in the transgenics; P &lt; 0.05, Fig. 1a).</text>
      <annotation id="351">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="8553" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="352">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="8596" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="353">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="8779" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="354">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="8825" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="355">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="9051" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="356">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="8618" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="357">
        <infon key="identifier">1214577</infon>
        <infon key="type">Species</infon>
        <location offset="8730" length="4"/>
        <text>to 7</text>
      </annotation>
      <annotation id="358">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="8874" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="359">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="8669" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="360">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="8784" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="361">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="8993" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="362">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="8954" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="363">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="8859" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="364">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="8654" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="365">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="8625" length="6"/>
        <text>tumors</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9222</offset>
      <text>In contrast, the insertion sites involving EVI5 all occurred in T-cell tumors (precursor T-cell lymphoblastic lymphoma/leukemias) from the four copy BCL6 transgenic line. One of these insertions was in the terminal intron, and two were in the 3' untranslated region of the EVI5 gene. One mouse was female, two were males, and these animals ranged in age from 3.8 mos to 5.9 mos (average, 4.6 mos). Relative EVI5 RNA expression levels were decreased in the T-cell lymphomas from the transgenic mice as compared with T-cell tumors from randomly selected controls, none of which had inserts in or near EVI5 (overall decrease, 1.86-fold; mean +- SEM = 0.007 +- 0.001 in the controls as compared with 0.004 +- 0.0007 in the transgenics; P &lt; 0.05, Fig. 2a).</text>
      <annotation id="378">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="9265" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="379">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="9371" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="380">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="9495" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="381">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="9629" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="382">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="9821" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="383">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="9510" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="384">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="9704" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="385">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="9376" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="386">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="9685" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="387">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="9286" length="13"/>
        <text>T-cell tumors</text>
      </annotation>
      <annotation id="388">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="9737" length="13"/>
        <text>T-cell tumors</text>
      </annotation>
      <annotation id="389">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="9311" length="39"/>
        <text>T-cell lymphoblastic lymphoma/leukemias</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9976</offset>
      <text>The retroviral inserts near MYB were all 3' (34.8 to 73.7 kb) and occurred in three females ranging in age from 4.7 mos to 7.8 mos (average, 6.6 mos). Two were large B-cell lymphomas from the 20 copy transgenic line and one was a precursor T-cell lymphoblastic lymphoma/leukemia from the four copy transgenic line. Relative RNA expression in one of the B-cell tumors and in the T-cell lymphoma was increased &gt;=2-fold as compared with that in the three randomly selected control B-cell lymphomas and two randomly selected control precursor T-cell lymphoblastic lymphoma/leukemias, respectively (which did not contain inserts in or near the MYB gene), but relative RNA expression in the other B-cell lymphoma was 3.2-fold decreased as compared with that in the lymphomas from the three randomly selected B-cell controls. These data are depicted in Fig. 3a.</text>
      <annotation id="403">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="10004" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="404">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="10615" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="405">
        <infon key="identifier">1214577</infon>
        <infon key="type">Species</infon>
        <location offset="10096" length="4"/>
        <text>to 7</text>
      </annotation>
      <annotation id="406">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="10176" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="407">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="10274" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="408">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="10515" length="39"/>
        <text>T-cell lymphoblastic lymphoma/leukemias</text>
      </annotation>
      <annotation id="409">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="10354" length="15"/>
        <text>T-cell lymphoma</text>
      </annotation>
      <annotation id="410">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="10461" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="411">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="10336" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="412">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="10216" length="38"/>
        <text>T-cell lymphoblastic lymphoma/leukemia</text>
      </annotation>
      <annotation id="413">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="10674" length="8"/>
        <text>lymphoma</text>
      </annotation>
      <annotation id="414">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="10735" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="415">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="10149" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>10834</offset>
      <text>GFI1B, EVI5, and MYB protein levels in lymphomas from retroviral-injected BCL6 transgenic mice and controls, and in human BCL6-positive and negative lymphomas</text>
      <annotation id="425">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="10834" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="426">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="10841" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="427">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="10851" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="428">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="10908" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="429">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="10956" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="430">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="10913" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="431">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10950" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="432">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="10873" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="433">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="10983" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10993</offset>
      <text>Protein levels in murine lymphomas detected by immunohisto-chemistry correlated with RNA levels from murine tumors quantified by real-time PCR as described above, and human lymphomas had a similar staining pattern as the murine counterparts (Figs. 1b, 2b, 3b). Whereas GFI1B expression was detected in the cytoplasm, EVI5 and MYB had a nuclear localization.</text>
      <annotation id="444">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="11262" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="445">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="11310" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="446">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="11319" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="447">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="11011" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="448">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="11094" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="449">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11160" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="450">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="11214" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="451">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="11018" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="452">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="11166" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="453">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="11101" length="6"/>
        <text>tumors</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11351</offset>
      <text>Tissue sections from the lymphomas of the three transgenic mice containing retroviral inserts near GFI1B (all large B-cell) and from B-cell lymphomas of three randomly selected retroviral-injected nontransgenic controls (no control tumors contained inserts near GFI1B) were studied with anti-GFI1B. Representative sections, shown in Fig. 1b, panel I, indicate that GFI1B staining is decreased in transgenic tumors (nuclear staining is positive for BCL6) as compared with the tumors in non-transgenic retroviral-injected controls (nuclear staining is negative for BCL6). Additionally, sixteen human lymphomas were studied by immunohistochemistry for GFI1B. Nine were B-cell tumors, seven were T-cell neoplasms; eight were BCL6-positive (six B-cell, two T-cell), and eight were BCL6-negative (three B cell, five T-cell). GFI1B expression was decreased in the BCL6-positive lymphomas as compared with the BCL6-negative tumors, which showed strong cytoplasmic expression of GFI1B (Fig. 1b, panel II). Thus, the findings in human lymphomas paralleled those in mice. Additionally, whereas in mice inserts near GFI1B were noted only in BCL6-positive B-cell tumors (which demonstrated decreased expression of GFI1B RNA and protein levels as compared with BCL-negative murine lymphomas), in humans, BCL6-positive T-cell as well as B-cell neoplasms demonstrated decreased expression of GFI1B protein as compared with BCL-negative lymphomas of each cell type (Fig. 1b, panel II).</text>
      <annotation id="495">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="11450" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="496">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="11613" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="497">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="11643" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="498">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="11716" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="499">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="11799" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="500">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="11914" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="501">
        <infon key="identifier">8328</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="12000" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="502">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="12072" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="503">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="12127" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="504">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="12170" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="505">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="12208" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="506">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="12253" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="507">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="12321" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="508">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="12455" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="509">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="12480" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="510">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="12552" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="511">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="12641" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="512">
        <infon key="identifier">8328</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="12727" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="513">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="11399" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="514">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11943" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="515">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12370" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="516">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="12406" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="517">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="12437" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="518">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="12611" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="519">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12633" length="6"/>
        <text>humans</text>
      </annotation>
      <annotation id="520">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="11840" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="521">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="12043" length="16"/>
        <text>T-cell neoplasms</text>
      </annotation>
      <annotation id="522">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="12024" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="523">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="12501" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="524">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="12222" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="525">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="12376" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="526">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="12267" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="527">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="12618" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="528">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="11491" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="529">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="11583" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="530">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="12680" length="9"/>
        <text>neoplasms</text>
      </annotation>
      <annotation id="531">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="11747" length="17"/>
        <text>transgenic tumors</text>
      </annotation>
      <annotation id="532">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="12771" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="533">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="11949" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="534">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="11376" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="535">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="11826" length="6"/>
        <text>tumors</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12820</offset>
      <text>Representative immunohistochemical staining of the murine lymphomas containing retroviral inserts in the EVI5 gene (all precursor T-cell lymphoblastic lymphoma/leukemias) is shown in Fig. 2b, panel I and reveals that EVI5 staining (nuclear) is decreased in the BCL6-positive T-cell neoplasms as compared with the non-transgenic retroviral-injected BCL-negative T-cell controls, none of which contained inserts in or near EVI5. Twenty-seven human lymphomas were studied with anti-BCL6. Eight were negative for BCL6 (3 B-cell, 5 T-cell), 17 were BCL6-positive (13 B, 4 T), and two (T-cell) stained weakly with anti-BCL6. Representative sections (Fig. 2b, panel II) indicate that BCL6-positive lymphomas contain less EVI5 than do BCL-negative neoplasms. As in the case of GFI1B, findings for EVI5 in human lymphomas paralleled the findings in murine lymphomas, and, additionally, whereas in the mouse tumors inserts in the EVI5 gene were noted only in BCL6-positive T-cell tumors (which had decreased expression of EVI5 RNA and protein as compared with BCL-negative T-cell lymphomas), in human lymphomas, decreased levels of EVI5 protein were present in BCL6-positive B- as well as T-cell tumors as compared with BCL-negative controls (Fig. 2b, panel II). Non-neoplastic BCL6-positive germinal center cells also contained less EVI5 than the surrounding BCL-negative tumor cells (Fig. 2b, panel II, 4C).</text>
      <annotation id="576">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="12925" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="577">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="13037" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="578">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="13081" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="579">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="13241" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="580">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="13299" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="581">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="13329" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="582">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="13364" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="583">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="13433" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="584">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="13497" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="585">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="13534" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="586">
        <infon key="identifier">8328</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="13589" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="587">
        <infon key="identifier">7813</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="13609" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="588">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="13740" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="589">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="13769" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="590">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="13832" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="591">
        <infon key="identifier">7813</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="13942" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="592">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="14088" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="593">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="14144" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="594">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="12871" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="595">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13260" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="596">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13617" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="597">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="13660" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="598">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="13712" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="599">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13905" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="600">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="13137" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="601">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="13971" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="602">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="12878" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="603">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="13560" length="9"/>
        <text>neoplasms</text>
      </annotation>
      <annotation id="604">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="13511" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="605">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="13667" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="606">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="14183" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="607">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="12950" length="39"/>
        <text>T-cell lymphoblastic lymphoma/leukemias</text>
      </annotation>
      <annotation id="608">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="13266" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="609">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="13102" length="9"/>
        <text>neoplasms</text>
      </annotation>
      <annotation id="610">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="13623" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="611">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="13999" length="13"/>
        <text>T-cell tumors</text>
      </annotation>
      <annotation id="612">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="13783" length="13"/>
        <text>T-cell tumors</text>
      </annotation>
      <annotation id="613">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="13718" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="614">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="13883" length="16"/>
        <text>T-cell lymphomas</text>
      </annotation>
      <annotation id="615">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="13911" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14220</offset>
      <text>Representative immunohistochemistry of MYB staining (Fig. 3b, I) of two murine lymphomas from transgenic mice (a B-cell tumor, panel 1 and a T-cell tumor, panel 2), reveals that these BCL6-positive neoplasms also show nuclear staining for MYB, whereas two murine lymphomas from non-transgenic animals (B-cell, panel 3, and T-cell, panel 4) are BCL-negative (column B) as well as MYB-negative (column C). A third transgenic mouse with a large B-cell lymphoma (not shown) showed little to no staining for MYB. Murine lymphomas stained readily with anti-MYB, which was used in a dilution of 1:1000 for 1 h at room temperature. Human lymphomas were more difficult to stain, requiring a 1:20 dilution and overnight incubation, and even then, positive staining was often focal and noted in only six (24%) of the 25 lymphomas studied. Of the 25 human lymphomas (12 B-cell, 13 T-cell) studied, 17 were BCL6-positive (10 B-cell, seven T-cell), five were BCL-negative (one B-cell, four T-cell), and three stained weakly for BCL6 (one B-cell, two T-cell). In four BCL6-positive lymphomas (two B-cell, two T-cell), the MYB-positive cells were also BCL6-positive (Fig. 3b, II, panels 1 and 2); however, in two T-cell lymphomas, one BCL6-positive, but with variably weak BCL6 staining, and one BCL-negative (Fig. 3b, panels 3 and 4, respectively), the MYB-positive cells were BCL-negative. Our observations in human lymphomas paralleled those in murine tumors in the respect that MYB levels could be increased or decreased in BCL6-positive neoplasms, T- as well as B-cell, and in human tumors, MYB positivity could be demonstrated in BCL6-positive as well as BCL-negative neoplastic cells (Fig. 3b, panel II).</text>
      <annotation id="663">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="14259" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="664">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="14404" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="665">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="14459" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="666">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="14723" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="667">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="14771" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="668">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="15114" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="669">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="15234" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="670">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="15273" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="671">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="15327" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="672">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="15356" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="673">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="15439" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="674">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="15477" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="675">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="15558" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="676">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="15686" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="677">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="15732" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="678">
        <infon key="identifier">4602</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="15800" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="679">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="15840" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="680">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="14599" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="681">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="14292" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="682">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="14314" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="683">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="14476" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="684">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="14643" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="685">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="14728" length="6"/>
        <text>Murine</text>
      </annotation>
      <annotation id="686">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14844" length="5"/>
        <text>Human</text>
      </annotation>
      <annotation id="687">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15058" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="688">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15616" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="689">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="15652" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="690">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15786" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="691">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="14502" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="692">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="14632" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="693">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="15792" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="694">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="15064" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="695">
        <infon key="identifier">CVCL:4V27</infon>
        <infon key="type">CellLine</infon>
        <location offset="15086" length="9"/>
        <text>13 T-cell</text>
      </annotation>
      <annotation id="696">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="15287" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="697">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="14418" length="9"/>
        <text>neoplasms</text>
      </annotation>
      <annotation id="698">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="14340" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="699">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="15424" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="700">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="14359" length="14"/>
        <text>a T-cell tumor</text>
      </annotation>
      <annotation id="701">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="15659" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="702">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="15746" length="9"/>
        <text>neoplasms</text>
      </annotation>
      <annotation id="703">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="14669" length="8"/>
        <text>lymphoma</text>
      </annotation>
      <annotation id="704">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="14483" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="705">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="15029" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="706">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="14735" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="707">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="14850" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="708">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="15622" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="709">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="14299" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>15916</offset>
      <text>Recurring sites in BCL6-positive transgenic mice not found in nontransgenic controls</text>
      <annotation id="712">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="15935" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="713">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="15949" length="15"/>
        <text>transgenic mice</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>16001</offset>
      <text>Table 2 lists the genes nearest to recurring sites found in at least two transgenic animals but not in non-transgenic controls. Additional genes that may cooperate with BCL6 occurred in multiple retroviral-injected transgenic mice and also in at least one retroviral-injected non-transgenic (control) animal (e.g., MYC), and thus may have transforming properties on their own. These are not reported here.</text>
      <annotation id="720">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="16170" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="721">
        <infon key="identifier">17869</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31092</infon>
        <location offset="16316" length="3"/>
        <text>MYC</text>
      </annotation>
      <annotation id="722">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="16216" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="723">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="16074" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="724">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="16108" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="725">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="16281" length="10"/>
        <text>transgenic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>16407</offset>
      <text>We previously reported that the most frequent retroviral insertions in our BCL6 transgenic mice occurred in or near the PIM1 gene, and we showed overall higher levels of PIM1 RNA and protein (by immunohistochemistry) in lymphomas (B- or T-cell) containing these insertion sites. Here we have studied the genes involved by the next most common insertion sites (in or near GFI1B, EVI5, and MYB, which were observed in lymphomas from three transgenic mice in each case).</text>
      <annotation id="736">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="16482" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="737">
        <infon key="identifier">18712</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">11214</infon>
        <location offset="16527" length="4"/>
        <text>PIM1</text>
      </annotation>
      <annotation id="738">
        <infon key="identifier">18712</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">11214</infon>
        <location offset="16577" length="4"/>
        <text>PIM1</text>
      </annotation>
      <annotation id="739">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="16778" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="740">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="16785" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="741">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="16795" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="742">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="16487" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="743">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="16844" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="744">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="16823" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="745">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="16627" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>16875</offset>
      <text>Discussion</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16886</offset>
      <text>Although the BCL6 gene is best known for its association with DLBLs in humans (~40% of these neoplasms are associated with chromosomal rearrangements involving BCL6 and ~16% contain mutations disrupting autoregulation of the BCL6 gene), the role of BCL6 in T-cell development and function has gained increased attention. Through the use of retroviral insertional mutagenesis in BCL6 transgenic mice, we have identified three genes that have not been reported previously as cooperating with BCL6 to promote lymphomagenesis. All of these have been recognized as proto-oncogenes. Two (GFI1B and MYB) are transcription factors and the third (EVI5) is considered an essential regulator of cell membrane trafficking. Additionally, immunohistochemistry performed on B- and T-cell human lymphomas (16 in the case of GFI1B, 27 for EVI5, 25 for MYB), both BCL6-positive and negative, confirmed our observations in murine lymphomas at the RNA and protein level: GFI1B and EVI5 are downregulated in BCL6-positive lymphomas as compared with BCL-negative tumors, and MYB can be either up- or down-regulated in BCL6-positive lymphomas as compared with BCL-negative controls.</text>
      <annotation id="774">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="16899" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="775">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="17046" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="776">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="17111" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="777">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="17135" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="778">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="17264" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="779">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="17376" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="780">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="17468" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="781">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="17478" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="782">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="17524" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="783">
        <infon key="identifier">8328</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="17694" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="784">
        <infon key="identifier">7813</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="17708" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="785">
        <infon key="identifier">4602</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="17721" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="786">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="17732" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="787">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="17837" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="788">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="17847" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="789">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="17873" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="790">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="17939" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="791">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="17982" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="792">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16957" length="6"/>
        <text>humans</text>
      </annotation>
      <annotation id="793">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="17269" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="794">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17659" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="795">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="17790" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="796">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="17887" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="797">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="16979" length="9"/>
        <text>neoplasms</text>
      </annotation>
      <annotation id="798">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="17996" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="799">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="17665" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="800">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="17797" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="801">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="17927" length="6"/>
        <text>tumors</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>18046</offset>
      <text>The GFI1B gene, located on human chromosome 9q34.13, is not a common target in retroviral insertional mutagenesis. It encodes a transcriptional repressor with an N-terminal SNAG (Snail/Gfi1) domain and six C-terminal zinc fingers that are believed to have an important role in hematopoiesis. Of two transcripts in humans, the most frequent is a 330 amino acid protein which binds DNA and suppresses gene expression through recruitment of histone modifying enzymes at target promoters. It is expressed in myeloid progenitor cells as well as in B- and T-cell subsets, is known to control expression levels of genes critical for B-cell development, and is essential for erythroid and megakaryocytic development. It is not expressed in mature thymocytes.</text>
      <annotation id="807">
        <infon key="identifier">8328</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="18050" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="808">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18073" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="809">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18360" length="6"/>
        <text>humans</text>
      </annotation>
      <annotation id="810">
        <infon key="identifier">14581</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3854</infon>
        <location offset="18231" length="4"/>
        <text>Gfi1</text>
      </annotation>
      <annotation id="811">
        <infon key="identifier">MESH:C536227</infon>
        <infon key="type">Disease</infon>
        <location offset="18323" length="13"/>
        <text>hematopoiesis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>18797</offset>
      <text>The EVI5 gene, located on human chromosome 1p22, is a common viral integration site in T-cell lymphomas derived from AKXD mice. It encodes a coiled-coil protein that is considered essential for regulation of membrane trafficking and has been believed to be involved in T-cell disease. As we noted in our murine lymphomas, a common viral integration site is in a 3' intron, and integrations are opposite to the transcriptional orientation of the gene. Although real-time RT-PCR revealed decreased RNA expression in all of the lymphomas from the transgenic mice as compared with the nontransgenic controls, the differences were not large; however, it is known that even small perturbations in the expression level of a protein may lead to significant biological effects. Alternatively, as it is known that gene expression can be affected over hundreds of kilobases by retroviral integrations, it is possible that viral insertions in the EVI5 gene could affect another gene, e.g., growth factor independent 1 (GFI1), which is located 18 kb downstream from EVI5 and is known to be a transcription factor that is crucial for normal hematopoietic development. Thus, Schmidt et al., who could not detect a signal with an EVI5 probe on Northern blots prepared from total RNA of lymphomas bearing proviral EVI integrations in MYC/PIM bitransgenic mice, found that the tumors had enhanced GFI1 RNA expression. However, these authors indicate that other targets which are located several hundred kilobases apart also could be activated by EVI5 integrations.</text>
      <annotation id="833">
        <infon key="identifier">7813</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="18801" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="834">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="19732" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="835">
        <infon key="identifier">14581</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3854</infon>
        <location offset="19775" length="27"/>
        <text>growth factor independent 1</text>
      </annotation>
      <annotation id="836">
        <infon key="identifier">14581</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3854</infon>
        <location offset="19804" length="4"/>
        <text>GFI1</text>
      </annotation>
      <annotation id="837">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="19850" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="838">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="20011" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="839">
        <infon key="identifier">68151</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">11779</infon>
        <location offset="20094" length="3"/>
        <text>EVI</text>
      </annotation>
      <annotation id="840">
        <infon key="identifier">14581</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3854</infon>
        <location offset="20176" length="4"/>
        <text>GFI1</text>
      </annotation>
      <annotation id="841">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="20325" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="842">
        <infon key="identifier">17869</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31092</infon>
        <location offset="20114" length="3"/>
        <text>MYC</text>
      </annotation>
      <annotation id="843">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18823" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="844">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="18919" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="845">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="19101" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="846">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="19341" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="847">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="20135" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="848">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="20156" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="849">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="19066" length="14"/>
        <text>T-cell disease</text>
      </annotation>
      <annotation id="850">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="18891" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="851">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="19108" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="852">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="19322" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="853">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="20067" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>20346</offset>
      <text>MYB, a site of recurrent retroviral insertional mutagenesis in a number of murine hematopoietic malignancies, is a leucine zipper DNA-binding transcription factor with a short half-life that undergoes post-translational modifications, including ubiquitylation, phosphorylation, acetylation, and sumoylation. Human MYB, located on chromosome 6q23.3, contains 15 exons and encodes a family of related proteins. Alternative splicing leads to splice variants that are predicted to encode proteins with differing transcriptional activities and specificity domains. The MYB protein is expressed in all proliferating hematopoietic cells, is involved in the regulation of proliferation and differentiation of bone marrow progenitor cells (also of colon and adult brain), and is required for normal hematopoiesis, T-cell development, pro-B to pre-B transition, and survival of spleen B cells. In humans, expression of MYB is known to be relevant for the lymph node germinal center phenotype, and that expression is sustained by BCL6 repression of microRNA (miR)-155. Although, traditionally, MYB has been touted as a transcriptional activator, several corepressor molecules that interact through various MYB domains imply that MYB could act also as a repressor. In one study, about half of the genes found to be regulated by MYB were repressed. Its target genes have functions in cell cycle progression, cell differentiation, and survival. The gene is known to be translocated in T-cell acute lymphocytic leukemia, and its protein is overexpressed in that disease, in part through gene duplication.</text>
      <annotation id="871">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="20346" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="872">
        <infon key="identifier">4602</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="20660" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="873">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="20910" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="874">
        <infon key="identifier">4602</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="21255" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="875">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="21365" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="876">
        <infon key="identifier">406947</infon>
        <infon key="type">Gene</infon>
        <location offset="21384" length="18"/>
        <text>microRNA (miR)-155</text>
      </annotation>
      <annotation id="877">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="21429" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="878">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="21564" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="879">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="21662" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="880">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="20421" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="881">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20654" length="5"/>
        <text>Human</text>
      </annotation>
      <annotation id="882">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21233" length="6"/>
        <text>humans</text>
      </annotation>
      <annotation id="883">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="21541" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="884">
        <infon key="identifier">MESH:D015179</infon>
        <infon key="type">Disease</infon>
        <location offset="21085" length="5"/>
        <text>colon</text>
      </annotation>
      <annotation id="885">
        <infon key="identifier">MESH:C536227</infon>
        <infon key="type">Disease</infon>
        <location offset="21136" length="13"/>
        <text>hematopoiesis</text>
      </annotation>
      <annotation id="886">
        <infon key="identifier">MESH:D054218</infon>
        <infon key="type">Disease</infon>
        <location offset="21817" length="33"/>
        <text>T-cell acute lymphocytic leukemia</text>
      </annotation>
      <annotation id="887">
        <infon key="identifier">MESH:D019337</infon>
        <infon key="type">Disease</infon>
        <location offset="20428" length="26"/>
        <text>hematopoietic malignancies</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>21936</offset>
      <text>In addition to the three genes described above, additional genes of potential interest are listed in Table 2. Almost all of these are known to be involved in hematopoiesis or hematologic malignancies, lending validity to the notion that they may well cooperate with BCL6 in lymphomagenesis. For example, LMO2 is up-regulated in non-Hodgkin lymphomas and has been noted to be translocated in certain human T-cell acute lymphoblastic leukemias; MN1 is deregulated in human acute myeloid leukemia; AHI1 is an oncoprotein that interacts with BCR-ABL and Janus kinase 2 (JAK2) in chronic myelogenous leukemia cells and is expressed in cutaneous T-cell lymphomas with intermediate to poor prognosis; BCOR is part of a BCL6 repression complex that facilitates survival and proliferation of lymphomas; IKZF1 encodes the IKAROS transcription factor, which drives lymphoid development, and IKZF1 deletions have been noted in childhood B-cell precursor acute lymphoblastic leukemia; SYK was identified as a target in acute myeloid leukemia and, when involved in translocations with the interleukin 2-inducible T cell kinase (ITK) gene, it induces a T-cell lymphoproliferative disease in mice mimicking human disease; DNTT encodes a lymphoid regulator; and, finally, GATA1 encodes an erythroid transcription factor.</text>
      <annotation id="919">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="22202" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="920">
        <infon key="identifier">4005</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4072</infon>
        <location offset="22240" length="4"/>
        <text>LMO2</text>
      </annotation>
      <annotation id="921">
        <infon key="identifier">4330</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37620</infon>
        <location offset="22379" length="3"/>
        <text>MN1</text>
      </annotation>
      <annotation id="922">
        <infon key="identifier">54806</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">9762</infon>
        <location offset="22431" length="4"/>
        <text>AHI1</text>
      </annotation>
      <annotation id="923">
        <infon key="identifier">25</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3783</infon>
        <location offset="22474" length="7"/>
        <text>BCR-ABL</text>
      </annotation>
      <annotation id="924">
        <infon key="identifier">3717</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">21033</infon>
        <location offset="22486" length="14"/>
        <text>Janus kinase 2</text>
      </annotation>
      <annotation id="925">
        <infon key="identifier">3717</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">21033</infon>
        <location offset="22502" length="4"/>
        <text>JAK2</text>
      </annotation>
      <annotation id="926">
        <infon key="identifier">54880</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">9809</infon>
        <location offset="22630" length="4"/>
        <text>BCOR</text>
      </annotation>
      <annotation id="927">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="22648" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="928">
        <infon key="identifier">10320</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55948</infon>
        <location offset="22730" length="5"/>
        <text>IKZF1</text>
      </annotation>
      <annotation id="929">
        <infon key="identifier">10320</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55948</infon>
        <location offset="22816" length="5"/>
        <text>IKZF1</text>
      </annotation>
      <annotation id="930">
        <infon key="identifier">6850</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">2390</infon>
        <location offset="22908" length="3"/>
        <text>SYK</text>
      </annotation>
      <annotation id="931">
        <infon key="identifier">3702</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4051</infon>
        <location offset="23011" length="37"/>
        <text>interleukin 2-inducible T cell kinase</text>
      </annotation>
      <annotation id="932">
        <infon key="identifier">3702</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4051</infon>
        <location offset="23050" length="3"/>
        <text>ITK</text>
      </annotation>
      <annotation id="933">
        <infon key="identifier">1791</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3014</infon>
        <location offset="23142" length="4"/>
        <text>DNTT</text>
      </annotation>
      <annotation id="934">
        <infon key="identifier">2623</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1549</infon>
        <location offset="23191" length="5"/>
        <text>GATA1</text>
      </annotation>
      <annotation id="935">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="22335" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="936">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="22401" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="937">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="23112" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="938">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23127" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="939">
        <infon key="identifier">22778</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55948</infon>
        <location offset="22748" length="6"/>
        <text>IKAROS</text>
      </annotation>
      <annotation id="940">
        <infon key="identifier">MESH:D016410</infon>
        <infon key="type">Disease</infon>
        <location offset="22566" length="26"/>
        <text>cutaneous T-cell lymphomas</text>
      </annotation>
      <annotation id="941">
        <infon key="identifier">MESH:D015470</infon>
        <infon key="type">Disease</infon>
        <location offset="22407" length="22"/>
        <text>acute myeloid leukemia</text>
      </annotation>
      <annotation id="942">
        <infon key="identifier">MESH:D054198</infon>
        <infon key="type">Disease</infon>
        <location offset="22354" length="23"/>
        <text>lymphoblastic leukemias</text>
      </annotation>
      <annotation id="943">
        <infon key="identifier">MESH:D007951</infon>
        <infon key="type">Disease</infon>
        <location offset="22519" length="20"/>
        <text>myelogenous leukemia</text>
      </annotation>
      <annotation id="944">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="22719" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="945">
        <infon key="identifier">MESH:D015470</infon>
        <infon key="type">Disease</infon>
        <location offset="22942" length="22"/>
        <text>acute myeloid leukemia</text>
      </annotation>
      <annotation id="946">
        <infon key="identifier">MESH:D054198</infon>
        <infon key="type">Disease</infon>
        <location offset="22884" length="22"/>
        <text>lymphoblastic leukemia</text>
      </annotation>
      <annotation id="947">
        <infon key="identifier">MESH:D008232</infon>
        <infon key="type">Disease</infon>
        <location offset="23072" length="36"/>
        <text>a T-cell lymphoproliferative disease</text>
      </annotation>
      <annotation id="948">
        <infon key="identifier">MESH:D019337</infon>
        <infon key="type">Disease</infon>
        <location offset="22094" length="41"/>
        <text>hematopoiesis or hematologic malignancies</text>
      </annotation>
      <annotation id="949">
        <infon key="identifier">MESH:D008228</infon>
        <infon key="type">Disease</infon>
        <location offset="22264" length="21"/>
        <text>non-Hodgkin lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>23240</offset>
      <text>BCL6 is believed to exert its function by repressing hundreds of proteins. B- as well as T-cell lymphomas are aggressive hemato-logic neoplasms resulting from the malignant transformation of B- or T-cell progenitors, respectively. These transformation processes are believed to be multi-step events in which a series of heterogeneous genetic alterations cooperate to induce perturbations in normal lymphocyte growth and differentiation. DLBLs and T-cell acute lymphoblastic leukemias, for example, have been reported to harbor multiple genetic abnormalities (in the case of DLBLs, more than 30 clon-ally represented gene alterations per neoplasm) which differ from tumor to tumor, making approaches to therapeutic intervention diffi-cult. Nonetheless, therapies directed against MYB and the proteins encoded by a number of other genes known to be involved in lymphomatous transformation are currently under investigation. Our studies have added GFI1B, EVI5, and MYB to the list of genes cooperating with BCL6 during lymphomagenesis, thus expanding the arsenal of potential therapeutic targets for DLBL. The finding in this study of several down-regulated cooperating genes suggests that efforts to upregulate them, e.g., by target mRNA manipulation, may have some therapeutic benefit. Identification of the alterations in individual lymphomas, with selection of the appropriate combinations of agents targeting the specific lesions, may hold promise for therapy of these neoplasms. </text>
      <annotation id="965">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="23240" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="966">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="24019" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="967">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="24185" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="968">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="24192" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="969">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="24202" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="970">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="24244" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="971">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="23914" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="972">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="23374" length="9"/>
        <text>neoplasms</text>
      </annotation>
      <annotation id="973">
        <infon key="identifier">MESH:D030342</infon>
        <infon key="type">Disease</infon>
        <location offset="23776" length="21"/>
        <text>genetic abnormalities</text>
      </annotation>
      <annotation id="974">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="23877" length="8"/>
        <text>neoplasm</text>
      </annotation>
      <annotation id="975">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="24711" length="9"/>
        <text>neoplasms</text>
      </annotation>
      <annotation id="976">
        <infon key="identifier">MESH:D054218</infon>
        <infon key="type">Disease</infon>
        <location offset="23687" length="36"/>
        <text>T-cell acute lymphoblastic leukemias</text>
      </annotation>
      <annotation id="977">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="23905" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="978">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="24573" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="979">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="23329" length="16"/>
        <text>T-cell lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>24723</offset>
      <text>Authorship</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>24734</offset>
      <text>Contribution: B.W.B, L.J., and M.J.T. designed research; B.W.B., P.L.R., and J.M.B. performed research; J.B. and L.W. contributed new reagents/ analytic tools; B.W.B., J.A., M.J.T., K.W., and J.M.B. analyzed data; and B.W.B. and J.M.B. wrote the paper.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>24987</offset>
      <text>All authors have approved the final article.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>25032</offset>
      <text>                                  </text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>25067</offset>
      <text>Conflict-of-interest disclosure</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>25099</offset>
      <text>All authors declare no conflict of interests.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>25145</offset>
      <text>                         </text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>25171</offset>
      <text>Declaration</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>25183</offset>
      <text>The work has not been published previously and is not under consideration for publication elsewhere. The work is approved by all authors. The work, if accepted, will not be published elsewhere, including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>25510</offset>
      <text>                         </text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>25536</offset>
      <text>References</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Houldsworth;given-names:J</infon>
      <infon key="name_2">surname:Basso;given-names:K</infon>
      <infon key="name_1">surname:Migliazza;given-names:A</infon>
      <infon key="name_0">surname:Pasqualucci;given-names:L</infon>
      <infon key="fpage">2914</infon>
      <infon key="pub-id_pmid">12515714</infon>
      <infon key="year">2003</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="volume">101</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">2923</infon>
      <infon key="name_5">surname:Dalla-Favera;given-names:R</infon>
      <infon key="name_4">surname:Chaganti;given-names:RS</infon>
      <offset>25547</offset>
      <text>Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma</text>
      <annotation id="982">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="25564" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="983">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="25644" length="8"/>
        <text>lymphoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Cesarman;given-names:E</infon>
      <infon key="name_2">surname:Liu;given-names:YF</infon>
      <infon key="name_1">surname:Chadburn;given-names:A</infon>
      <infon key="name_0">surname:Hyjek;given-names:E</infon>
      <infon key="fpage">270</infon>
      <infon key="pub-id_pmid">11133771</infon>
      <infon key="year">2001</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="volume">97</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">276</infon>
      <infon key="name_4">surname:Knowles;given-names:DM</infon>
      <offset>25653</offset>
      <text>BCL6-protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and post-natal thymus</text>
      <annotation id="986">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="25653" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="987">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="25692" length="29"/>
        <text>T-cell lymphoblastic lymphoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Bies;given-names:J</infon>
      <infon key="name_2">surname:Hyjek;given-names:EM</infon>
      <infon key="name_1">surname:Anastasi;given-names:J</infon>
      <infon key="name_0">surname:Baron;given-names:BW</infon>
      <infon key="fpage">5735</infon>
      <infon key="pub-id_pmid">22451912</infon>
      <infon key="year">2012</infon>
      <infon key="source">Proc. Natl. Acad. Sci. U. S. A</infon>
      <infon key="type">ref</infon>
      <infon key="volume">109</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">5739</infon>
      <infon key="name_5">surname:Dong;given-names:J</infon>
      <infon key="name_4">surname:Reddy;given-names:PL</infon>
      <offset>25760</offset>
      <text>PIM1 gene cooperates with human BCL6 gene to promote the development of lymphomas</text>
      <annotation id="992">
        <infon key="identifier">5292</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">11214</infon>
        <location offset="25760" length="4"/>
        <text>PIM1</text>
      </annotation>
      <annotation id="993">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="25792" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="994">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25786" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="995">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="25832" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">109</infon>
      <infon key="name_1">surname:Kee;given-names:BL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Xu;given-names:W</infon>
      <infon key="fpage">4406</infon>
      <infon key="pub-id_pmid">17272506</infon>
      <infon key="year">2007</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">4414</infon>
      <offset>25842</offset>
      <text>Growth factor independent 1B (Gfi1b) is an E2A target gene that modulates Gata3 in T-cell lymphomas</text>
      <annotation id="1000">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="25842" length="28"/>
        <text>Growth factor independent 1B</text>
      </annotation>
      <annotation id="1001">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="25872" length="5"/>
        <text>Gfi1b</text>
      </annotation>
      <annotation id="1002">
        <infon key="identifier">14462</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1550</infon>
        <location offset="25916" length="5"/>
        <text>Gata3</text>
      </annotation>
      <annotation id="1003">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="25925" length="16"/>
        <text>T-cell lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Jenkins;given-names:NA</infon>
      <infon key="name_2">surname:Morse;given-names:HC;suffix:III</infon>
      <infon key="name_1">surname:Du;given-names:Y</infon>
      <infon key="name_0">surname:Liao;given-names:X</infon>
      <infon key="fpage">1023</infon>
      <infon key="pub-id_pmid">9070650</infon>
      <infon key="year">1997</infon>
      <infon key="source">Oncogene</infon>
      <infon key="type">ref</infon>
      <infon key="volume">14</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1029</infon>
      <infon key="name_4">surname:Copeland;given-names:NG</infon>
      <offset>25942</offset>
      <text>Proviral integrations at the Evi5 locus disrupt a novel 90 kDa protein with homology to the Tre2 oncogene and cell-cycle regulatory proteins</text>
      <annotation id="1005">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="25971" length="4"/>
        <text>Evi5</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Pan;given-names:J</infon>
      <infon key="name_2">surname:Dai;given-names:X</infon>
      <infon key="name_1">surname:Wang;given-names:Z</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Chen;given-names:S</infon>
      <infon key="year">2013</infon>
      <infon key="comment">(Epub ahead of print, in press)</infon>
      <infon key="source">Cancer Sci</infon>
      <infon key="type">ref</infon>
      <infon key="name_5">surname:Han;given-names:JX</infon>
      <infon key="name_4">surname:Ge;given-names:J</infon>
      <offset>26083</offset>
      <text>Re-expression of miR-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro</text>
      <annotation id="1009">
        <infon key="identifier">387168</infon>
        <infon key="type">Gene</infon>
        <location offset="26100" length="7"/>
        <text>miR-150</text>
      </annotation>
      <annotation id="1010">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="26176" length="5"/>
        <text>c-Myb</text>
      </annotation>
      <annotation id="1011">
        <infon key="identifier">MESH:D002051</infon>
        <infon key="type">Disease</infon>
        <location offset="26129" length="16"/>
        <text>Burkitt lymphoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Huo;given-names:D</infon>
      <infon key="name_2">surname:Montag;given-names:A</infon>
      <infon key="name_1">surname:Anastasi;given-names:J</infon>
      <infon key="name_0">surname:Baron;given-names:BW</infon>
      <infon key="fpage">14198</infon>
      <infon key="pub-id_pmid">15375218</infon>
      <infon key="year">2004</infon>
      <infon key="source">Proc. Natl. Acad. Sci. U. S. A</infon>
      <infon key="type">ref</infon>
      <infon key="volume">101</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">14203</infon>
      <infon key="name_5">surname:Karrison;given-names:T</infon>
      <infon key="name_4">surname:Baron;given-names:RM</infon>
      <offset>26191</offset>
      <text>The human BCL6 transgene promotes the development of lymphomas in the mouse</text>
      <annotation id="1015">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="26201" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1016">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26195" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="1017">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="26244" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Haines;given-names:DC</infon>
      <infon key="name_2">surname:Fredrickson;given-names:TN</infon>
      <infon key="name_1">surname:Anver;given-names:MR</infon>
      <infon key="name_0">surname:Morse;given-names:HC;suffix:III</infon>
      <infon key="fpage">246</infon>
      <infon key="pub-id_pmid">12070034</infon>
      <infon key="year">2002</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="volume">100</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">258</infon>
      <infon key="name_5">surname:Harris;given-names:NL</infon>
      <infon key="name_4">surname:Harris;given-names:AW</infon>
      <offset>26267</offset>
      <text>Bethesda proposals for classification of lymphoid neoplasms in mice</text>
      <annotation id="1019">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="26308" length="18"/>
        <text>lymphoid neoplasms</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">3</infon>
      <infon key="name_1">surname:Livak;given-names:KJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Schmittgen;given-names:TD</infon>
      <infon key="fpage">1101</infon>
      <infon key="pub-id_pmid">18546601</infon>
      <infon key="year">2008</infon>
      <infon key="source">Nat. Protoc</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1108</infon>
      <offset>26335</offset>
      <text>Analyzing real-time PCR data by the comparative CT method</text>
    </passage>
    <passage>
      <infon key="volume">77</infon>
      <infon key="name_2">surname:Anver;given-names:MR</infon>
      <infon key="name_1">surname:Koller;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Wolff;given-names:L</infon>
      <infon key="fpage">4965</infon>
      <infon key="pub-id_pmid">12663802</infon>
      <infon key="year">2003</infon>
      <infon key="source">J. Virol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">4971</infon>
      <offset>26393</offset>
      <text>A Moloney murine leukemia virus-based retrovirus with 4070A long terminal repeat sequences induces a high incidence of myeloid as well as lymphoid neoplasms</text>
      <annotation id="1022">
        <infon key="identifier">11801</infon>
        <infon key="type">Species</infon>
        <location offset="26395" length="29"/>
        <text>Moloney murine leukemia virus</text>
      </annotation>
      <annotation id="1023">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="26531" length="18"/>
        <text>lymphoid neoplasms</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Liu;given-names:Z</infon>
      <infon key="name_2">surname:D'Agati;given-names:VD</infon>
      <infon key="name_1">surname:Vlad;given-names:G</infon>
      <infon key="name_0">surname:Chang;given-names:CC</infon>
      <infon key="fpage">5714</infon>
      <infon key="pub-id_pmid">20935202</infon>
      <infon key="year">2010</infon>
      <infon key="source">J. Immunol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">185</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">5722</infon>
      <infon key="name_5">surname:Witkowski;given-names:P</infon>
      <infon key="name_4">surname:Zhang;given-names:QY</infon>
      <offset>26550</offset>
      <text>BCL6 is required for differentiation of Ig-like transcript 3-Fc-induced CD8+ T suppressor cells</text>
      <annotation id="1025">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="26550" length="4"/>
        <text>BCL6</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Nurieva;given-names:RI</infon>
      <infon key="name_2">surname:Zhong;given-names:B</infon>
      <infon key="name_1">surname:Yan;given-names:X</infon>
      <infon key="name_0">surname:Liu;given-names:X</infon>
      <infon key="fpage">1841</infon>
      <infon key="pub-id_pmid">22987803</infon>
      <infon key="year">2012</infon>
      <infon key="source">J. Exp. Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">209</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1852</infon>
      <infon key="name_5">surname:Wang;given-names:X</infon>
      <infon key="name_4">surname:Wang;given-names:A</infon>
      <offset>26646</offset>
      <text>Bcl6 expression specifies the T follicular helper cell program in vivo</text>
      <annotation id="1027">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="26646" length="4"/>
        <text>Bcl6</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">16</infon>
      <infon key="name_2">surname:Orkin;given-names:SH</infon>
      <infon key="name_1">surname:Cameron;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Saleque;given-names:S</infon>
      <infon key="fpage">301</infon>
      <infon key="pub-id_pmid">11825872</infon>
      <infon key="year">2002</infon>
      <infon key="source">Genes Dev</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">306</infon>
      <offset>26717</offset>
      <text>The zinc finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Verschuren;given-names:EW</infon>
      <infon key="name_2">surname:Hansen;given-names:DV</infon>
      <infon key="name_1">surname:Loktev;given-names:AV</infon>
      <infon key="name_0">surname:Eldridge;given-names:AG</infon>
      <infon key="fpage">367</infon>
      <infon key="pub-id_pmid">16439210</infon>
      <infon key="year">2006</infon>
      <infon key="source">Cell</infon>
      <infon key="type">ref</infon>
      <infon key="volume">124</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">380</infon>
      <infon key="name_5">surname:Jackson;given-names:PK</infon>
      <infon key="name_4">surname:Reimann;given-names:JD</infon>
      <offset>26829</offset>
      <text>The Evi5 oncogene regulates cyclin accumulation by stabilizing the anaphase-promoting complex inhibitor Emi1</text>
      <annotation id="1030">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="26833" length="4"/>
        <text>Evi5</text>
      </annotation>
      <annotation id="1031">
        <infon key="identifier">18538</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1945</infon>
        <location offset="26857" length="6"/>
        <text>cyclin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">84</infon>
      <infon key="name_2">surname:Reddy;given-names:EP</infon>
      <infon key="name_1">surname:Dugan;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rosson;given-names:D</infon>
      <infon key="fpage">3171</infon>
      <infon key="pub-id_pmid">3033638</infon>
      <infon key="year">1987</infon>
      <infon key="source">Proc. Natl. Acad. Sci. U. S. A</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">3175</infon>
      <offset>26938</offset>
      <text>Aberrant splicing events that are induced by proviral integration: implications for myb oncogene activation</text>
      <annotation id="1033">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="27022" length="3"/>
        <text>myb</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:McBride;given-names:PR</infon>
      <infon key="name_2">surname:Shafizadeh;given-names:E</infon>
      <infon key="name_1">surname:Hildick-Smith;given-names:GJ</infon>
      <infon key="name_0">surname:Cooney;given-names:JD</infon>
      <infon key="fpage">431</infon>
      <infon key="pub-id_pmid">22960038</infon>
      <infon key="year">2013</infon>
      <infon key="source">Dev. Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">373</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">441</infon>
      <infon key="name_5">surname:Anderson;given-names:H</infon>
      <infon key="name_4">surname:Carroll;given-names:KJ</infon>
      <offset>27046</offset>
      <text>Teleost growth factor independence (gfi) genes differentially regulate successive waves of hematopoiesis</text>
      <annotation id="1035">
        <infon key="identifier">MESH:C536227</infon>
        <infon key="type">Disease</infon>
        <location offset="27137" length="13"/>
        <text>hematopoiesis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Crinquette;given-names:A</infon>
      <infon key="name_2">surname:Kalota;given-names:A</infon>
      <infon key="name_1">surname:Cuccuini;given-names:W</infon>
      <infon key="name_0">surname:Clappier;given-names:E</infon>
      <infon key="fpage">1251</infon>
      <infon key="pub-id_pmid">17452517</infon>
      <infon key="year">2007</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="volume">110</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1261</infon>
      <infon key="name_5">surname:Dik;given-names:WA</infon>
      <infon key="name_4">surname:Cayuela;given-names:J-M</infon>
      <offset>27151</offset>
      <text>The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children</text>
      <annotation id="1040">
        <infon key="identifier">4602</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="27155" length="5"/>
        <text>C-MYB</text>
      </annotation>
      <annotation id="1041">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27236" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="1042">
        <infon key="identifier">MESH:D054218</infon>
        <infon key="type">Disease</infon>
        <location offset="27242" length="21"/>
        <text>T-cell acute leukemia</text>
      </annotation>
      <annotation id="1043">
        <infon key="identifier">MESH:D054218</infon>
        <infon key="type">Disease</infon>
        <location offset="27306" length="13"/>
        <text>T-ALL subtype</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Dorn;given-names:JF</infon>
      <infon key="name_2">surname:Ramel;given-names:D</infon>
      <infon key="name_1">surname:Assaker;given-names:G</infon>
      <infon key="name_0">surname:Laflamme;given-names:C</infon>
      <infon key="fpage">57</infon>
      <infon key="pub-id_pmid">22778279</infon>
      <infon key="year">2012</infon>
      <infon key="source">J. Cell Biol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">198</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">67</infon>
      <infon key="name_5">surname:Maddox;given-names:PS</infon>
      <infon key="name_4">surname:She;given-names:D</infon>
      <offset>27343</offset>
      <text>Evi5 promotes cell migration through its Rab-GAP activity</text>
      <annotation id="1045">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="27343" length="4"/>
        <text>Evi5</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Pilli;given-names:M</infon>
      <infon key="name_2">surname:Simon;given-names:GC</infon>
      <infon key="name_1">surname:Junutula;given-names:JR</infon>
      <infon key="name_0">surname:Westlake;given-names:CJ</infon>
      <infon key="fpage">1236</infon>
      <infon key="pub-id_pmid">17229837</infon>
      <infon key="year">2007</infon>
      <infon key="source">Proc. Natl. Acad. Sci. U. S. A</infon>
      <infon key="type">ref</infon>
      <infon key="volume">104</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1241</infon>
      <infon key="name_5">surname:Scheller;given-names:RH</infon>
      <infon key="name_4">surname:Prekeris;given-names:R</infon>
      <offset>27401</offset>
      <text>Identification of Rab11 as a small GTPase binding protein for the Evi5 oncogene</text>
      <annotation id="1048">
        <infon key="identifier">53869</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37903</infon>
        <location offset="27419" length="5"/>
        <text>Rab11</text>
      </annotation>
      <annotation id="1049">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="27467" length="4"/>
        <text>Evi5</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Moroy;given-names:T</infon>
      <infon key="volume">33</infon>
      <infon key="name_2">surname:Mahlmann;given-names:S</infon>
      <infon key="name_1">surname:Fiolka;given-names:K</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Vassen;given-names:L</infon>
      <infon key="fpage">987</infon>
      <infon key="pub-id_pmid">15718298</infon>
      <infon key="year">2005</infon>
      <infon key="source">Nucleic Acids Res</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">998</infon>
      <offset>27481</offset>
      <text>Direct transcriptional repression of the genes encoding the zinc-finger proteins Gfi1b and Gfi1 by Gfi1b</text>
      <annotation id="1053">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="27562" length="5"/>
        <text>Gfi1b</text>
      </annotation>
      <annotation id="1054">
        <infon key="identifier">14581</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3854</infon>
        <location offset="27572" length="4"/>
        <text>Gfi1</text>
      </annotation>
      <annotation id="1055">
        <infon key="identifier">14581</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3854</infon>
        <location offset="27580" length="4"/>
        <text>Gfi1</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">24</infon>
      <infon key="name_2">surname:van der Reijden;given-names:BA</infon>
      <infon key="name_1">surname:Jansen;given-names:JH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:van der Meer;given-names:LT</infon>
      <infon key="fpage">1834</infon>
      <infon key="pub-id_pmid">20861919</infon>
      <infon key="year">2010</infon>
      <infon key="source">Leukemia</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1843</infon>
      <offset>27586</offset>
      <text>Gfi1 and Gfi1b: key regulators of hematopoiesis</text>
      <annotation id="1059">
        <infon key="identifier">14581</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3854</infon>
        <location offset="27586" length="4"/>
        <text>Gfi1</text>
      </annotation>
      <annotation id="1060">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="27595" length="5"/>
        <text>Gfi1b</text>
      </annotation>
      <annotation id="1061">
        <infon key="identifier">MESH:C536227</infon>
        <infon key="type">Disease</infon>
        <location offset="27620" length="13"/>
        <text>hematopoiesis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:McWhirter;given-names:SM</infon>
      <infon key="name_2">surname:Chow;given-names:KT</infon>
      <infon key="name_1">surname:Vassen;given-names:L</infon>
      <infon key="name_0">surname:Schulz;given-names:D</infon>
      <infon key="fpage">187</infon>
      <infon key="pub-id_pmid">22201127</infon>
      <infon key="year">2011</infon>
      <infon key="source">J. Exp. Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">109</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">199</infon>
      <infon key="name_5">surname:Moroy;given-names:T</infon>
      <infon key="name_4">surname:Amin;given-names:RH</infon>
      <offset>27634</offset>
      <text>Gfi1b negatively regulates Rag expression directly and via the repression of FoxO1</text>
      <annotation id="1063">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="27634" length="5"/>
        <text>Gfi1b</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Singer;given-names:A</infon>
      <infon key="name_2">surname:Yu;given-names:Q</infon>
      <infon key="name_1">surname:Kitay;given-names:MK</infon>
      <infon key="name_0">surname:Doan;given-names:LL</infon>
      <infon key="fpage">2356</infon>
      <infon key="pub-id_pmid">12594258</infon>
      <infon key="year">2003</infon>
      <infon key="source">J. Immunol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">170</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">2366</infon>
      <infon key="name_5">surname:Hoang;given-names:T</infon>
      <infon key="name_4">surname:Herblot;given-names:S</infon>
      <offset>27717</offset>
      <text>Growth factor independence-1B expression leads to defects in T cell activation, IL-7 receptor alpha expression, and T cell lineage commitment</text>
    </passage>
    <passage>
      <infon key="volume">37</infon>
      <infon key="name_2">surname:Crawford;given-names:DL</infon>
      <infon key="name_1">surname:Roach;given-names:JL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Oleksiak;given-names:MF</infon>
      <infon key="fpage">67</infon>
      <infon key="pub-id_pmid">15568023</infon>
      <infon key="year">2005</infon>
      <infon key="source">Nat. Genet</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">72</infon>
      <offset>27859</offset>
      <text>Natural variation in cardiac metabolism and gene expression in Fundulus heteroclitus</text>
      <annotation id="1065">
        <infon key="type">Disease</infon>
        <location offset="27922" length="21"/>
        <text>Fundulus heteroclitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Thomas;given-names:H</infon>
      <infon key="volume">2</infon>
      <infon key="name_2">surname:Ryffel;given-names:GU</infon>
      <infon key="name_1">surname:Waldner;given-names:C</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Senkel;given-names:S</infon>
      <infon key="fpage">210</infon>
      <infon key="year">2009</infon>
      <infon key="source">B.M.C. Res. Notes</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">216</infon>
      <offset>27944</offset>
      <text>Improved conditional expression systems resulting in physiological level of HN4alpha expression confirm HN4alpha induced apoptosis in the pancreatic beta-cell line INS-1</text>
      <annotation id="1067">
        <infon key="identifier">MESH:D010195</infon>
        <infon key="type">Disease</infon>
        <location offset="28082" length="10"/>
        <text>pancreatic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">87</infon>
      <infon key="name_2">surname:Tsichlis;given-names:PN</infon>
      <infon key="name_1">surname:Lee;given-names:JS</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Lazo;given-names:PA</infon>
      <infon key="fpage">170</infon>
      <infon key="pub-id_pmid">1688653</infon>
      <infon key="year">1990</infon>
      <infon key="source">Proc. Natl. Acad. Sci. U. S. A</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">173</infon>
      <offset>28114</offset>
      <text>Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1or Mlvi-4 in rat T-cell lymphomas</text>
      <annotation id="1071">
        <infon key="identifier">24577</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31092</infon>
        <location offset="28146" length="3"/>
        <text>Myc</text>
      </annotation>
      <annotation id="1072">
        <infon key="identifier">10116</infon>
        <infon key="type">Species</infon>
        <location offset="28208" length="3"/>
        <text>rat</text>
      </annotation>
      <annotation id="1073">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="28219" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Moroy;given-names:T</infon>
      <infon key="volume">24</infon>
      <infon key="name_2">surname:Beneke;given-names:R</infon>
      <infon key="name_1">surname:Zornig;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Schmidt;given-names:T</infon>
      <infon key="fpage">2528</infon>
      <infon key="pub-id_pmid">8692692</infon>
      <infon key="year">1996</infon>
      <infon key="source">Nucleic Acids Res</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2534</infon>
      <offset>28229</offset>
      <text>MoMuLV proviral integrations identified by Sup-F selection in tumours from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene</text>
      <annotation id="1078">
        <infon key="identifier">14581</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3854</infon>
        <location offset="28372" length="5"/>
        <text>gfi-1</text>
      </annotation>
      <annotation id="1079">
        <infon key="identifier">17869</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31092</infon>
        <location offset="28313" length="3"/>
        <text>myc</text>
      </annotation>
      <annotation id="1080">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="28334" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="1081">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="28291" length="7"/>
        <text>tumours</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">27</infon>
      <infon key="name_1">surname:Gonda;given-names:TJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Pattabiraman;given-names:DR</infon>
      <infon key="fpage">269</infon>
      <infon key="pub-id_pmid">22874877</infon>
      <infon key="year">2013</infon>
      <infon key="source">Leukemia</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">277</infon>
      <offset>28383</offset>
      <text>Role and potential for therapeutic targeting of MYB in leukemia</text>
      <annotation id="1084">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="28431" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1085">
        <infon key="identifier">MESH:D007938</infon>
        <infon key="type">Disease</infon>
        <location offset="28438" length="8"/>
        <text>leukemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">122</infon>
      <infon key="name_1">surname:Ferrando;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Van Vlierberghe;given-names:P</infon>
      <infon key="fpage">3398</infon>
      <infon key="pub-id_pmid">23023710</infon>
      <infon key="year">2012</infon>
      <infon key="source">J. Clin. Invest</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">3406</infon>
      <offset>28447</offset>
      <text>The molecular basis of T cell acute lymphoblastic leukemia</text>
      <annotation id="1087">
        <infon key="identifier">MESH:D054218</infon>
        <infon key="type">Disease</infon>
        <location offset="28470" length="35"/>
        <text>T cell acute lymphoblastic leukemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">8</infon>
      <infon key="name_1">surname:Gonda;given-names:TJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Ramsay;given-names:RG</infon>
      <infon key="fpage">523</infon>
      <infon key="pub-id_pmid">18574464</infon>
      <infon key="year">2008</infon>
      <infon key="source">Nat. Rev. Cancer</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">534</infon>
      <offset>28506</offset>
      <text>MYB function in normal and cancer cells</text>
      <annotation id="1090">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="28506" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1091">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="28533" length="6"/>
        <text>cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="name_1">surname:Ness;given-names:SA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:O'Rourke;given-names:JP</infon>
      <infon key="fpage">2091</infon>
      <infon key="pub-id_pmid">18195038</infon>
      <infon key="year">2008</infon>
      <infon key="source">Mol. Cell. Biol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2101</infon>
      <offset>28546</offset>
      <text>Alternative RNA splicing produces multiple forms of c-Myb with unique transcriptional activities</text>
      <annotation id="1093">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="28598" length="5"/>
        <text>c-Myb</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Zeller;given-names:MS</infon>
      <infon key="volume">9</infon>
      <infon key="name_2">surname:Berberich;given-names:H</infon>
      <infon key="name_1">surname:Bouchard;given-names:C</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Streubel;given-names:G</infon>
      <infon key="year">2013</infon>
      <infon key="comment">(Epub ahead of print)</infon>
      <infon key="source">PLoS Genet</infon>
      <infon key="type">ref</infon>
      <infon key="name_5">surname:Adamkiewicz;given-names:J</infon>
      <infon key="name_4">surname:Teichmann;given-names:S</infon>
      <offset>28643</offset>
      <text>PRMT4 is a novel coactivator of c-Myb-dependent transcription in haematopoietic cell lines</text>
      <annotation id="1096">
        <infon key="identifier">59035</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">10990</infon>
        <location offset="28643" length="5"/>
        <text>PRMT4</text>
      </annotation>
      <annotation id="1097">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="28675" length="5"/>
        <text>c-Myb</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Rajewsky;given-names:K</infon>
      <infon key="name_2">surname:Ravichandran;given-names:KS</infon>
      <infon key="name_1">surname:Kremer;given-names:CS</infon>
      <infon key="name_0">surname:Thomas;given-names:MD</infon>
      <infon key="fpage">275</infon>
      <infon key="pub-id_pmid">16169500</infon>
      <infon key="year">2005</infon>
      <infon key="source">Immunity</infon>
      <infon key="type">ref</infon>
      <infon key="volume">23</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">286</infon>
      <infon key="name_4">surname:Bender;given-names:TP</infon>
      <offset>28734</offset>
      <text>c-Myb is critical for B cell development and maintenance of follicular B cells</text>
      <annotation id="1099">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="28734" length="5"/>
        <text>c-Myb</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Holmes;given-names:AB</infon>
      <infon key="name_2">surname:Shen;given-names:Q</infon>
      <infon key="name_1">surname:Schneider;given-names:C</infon>
      <infon key="name_0">surname:Basso;given-names:K</infon>
      <infon key="fpage">2455</infon>
      <infon key="pub-id_pmid">23166356</infon>
      <infon key="year">2012</infon>
      <infon key="source">J. Exp. Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">209</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">2465</infon>
      <infon key="name_5">surname:Leslie;given-names:C</infon>
      <infon key="name_4">surname:Setty;given-names:M</infon>
      <offset>28813</offset>
      <text>BCL6 positively regulates AID and germinal center expression via repression of miR-155</text>
      <annotation id="1103">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="28813" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1104">
        <infon key="identifier">735281</infon>
        <infon key="type">Gene</infon>
        <location offset="28892" length="3"/>
        <text>miR</text>
      </annotation>
      <annotation id="1105">
        <infon key="identifier">11628</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7623</infon>
        <location offset="28839" length="3"/>
        <text>AID</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Al-Owaidi;given-names:F</infon>
      <infon key="name_2">surname:Pattabiraman;given-names:DR</infon>
      <infon key="name_1">surname:Glazov;given-names:EA</infon>
      <infon key="name_0">surname:Zhao;given-names:L</infon>
      <infon key="fpage">4664</infon>
      <infon key="pub-id_pmid">21317192</infon>
      <infon key="year">2011</infon>
      <infon key="source">Nucleic Acids Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">39</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">4679</infon>
      <infon key="name_5">surname:Brown;given-names:MA</infon>
      <infon key="name_4">surname:Xhang;given-names:P</infon>
      <offset>28900</offset>
      <text>Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Natkunam;given-names:Y</infon>
      <infon key="name_2">surname:Huang;given-names:C</infon>
      <infon key="name_1">surname:Gentles;given-names:AJ</infon>
      <infon key="name_0">surname:Cubedo;given-names:E</infon>
      <infon key="fpage">5478</infon>
      <infon key="pub-id_pmid">22517897</infon>
      <infon key="year">2012</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="volume">119</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">5491</infon>
      <infon key="name_5">surname:Lu;given-names:X</infon>
      <infon key="name_4">surname:Bhatt;given-names:S</infon>
      <offset>29047</offset>
      <text>Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma</text>
      <annotation id="1108">
        <infon key="identifier">16909</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4072</infon>
        <location offset="29065" length="4"/>
        <text>LMO2</text>
      </annotation>
      <annotation id="1109">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="29124" length="8"/>
        <text>lymphoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Buijs-Gladdines;given-names:J</infon>
      <infon key="name_2">surname:Langerak;given-names:AW</infon>
      <infon key="name_1">surname:Vuerhard;given-names:MJ</infon>
      <infon key="name_0">surname:Homminga;given-names:I</infon>
      <infon key="fpage">258</infon>
      <infon key="pub-id_pmid">22058201</infon>
      <infon key="year">2012</infon>
      <infon key="source">Haematologica</infon>
      <infon key="type">ref</infon>
      <infon key="volume">97</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">261</infon>
      <infon key="name_5">surname:Meijerink;given-names:JP</infon>
      <infon key="name_4">surname:Pieters;given-names:R</infon>
      <offset>29133</offset>
      <text>Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements</text>
      <annotation id="1114">
        <infon key="identifier">4066</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4078</infon>
        <location offset="29227" length="4"/>
        <text>LYL1</text>
      </annotation>
      <annotation id="1115">
        <infon key="identifier">4005</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4072</infon>
        <location offset="29236" length="4"/>
        <text>LMO2</text>
      </annotation>
      <annotation id="1116">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="29201" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="1117">
        <infon key="identifier">MESH:D054198</infon>
        <infon key="type">Disease</infon>
        <location offset="29172" length="28"/>
        <text>acute lymphoblastic leukemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Neale;given-names:G</infon>
      <infon key="volume">8</infon>
      <infon key="name_2">surname:Janke;given-names:L</infon>
      <infon key="name_1">surname:Surtel;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kandilci;given-names:A</infon>
      <infon key="year">2013</infon>
      <infon key="comment">(Epub ahead of print)</infon>
      <infon key="source">PLoS One</infon>
      <infon key="type">ref</infon>
      <infon key="name_5">surname:Grosveld;given-names:GC</infon>
      <infon key="name_4">surname:Terranova;given-names:S</infon>
      <offset>29256</offset>
      <text>Mapping of MN1 sequences necessary for myeloid transformation</text>
      <annotation id="1119">
        <infon key="identifier">433938</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37620</infon>
        <location offset="29267" length="3"/>
        <text>MN1</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Sloma;given-names:I</infon>
      <infon key="name_2">surname:DeGeer;given-names:D</infon>
      <infon key="name_1">surname:Gallipoli;given-names:P</infon>
      <infon key="name_0">surname:Chen;given-names:M</infon>
      <infon key="fpage">405</infon>
      <infon key="pub-id_pmid">23446755</infon>
      <infon key="year">2013</infon>
      <infon key="source">J. Natl. Cancer Inst</infon>
      <infon key="type">ref</infon>
      <infon key="volume">105</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">423</infon>
      <infon key="name_5">surname:Chan;given-names:M</infon>
      <infon key="name_4">surname:Forrest;given-names:DL</infon>
      <offset>29318</offset>
      <text>Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex</text>
      <annotation id="1123">
        <infon key="identifier">16452</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">21033</infon>
        <location offset="29416" length="4"/>
        <text>JAK2</text>
      </annotation>
      <annotation id="1124">
        <infon key="identifier">25</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3783</infon>
        <location offset="29408" length="7"/>
        <text>BCR-ABL</text>
      </annotation>
      <annotation id="1125">
        <infon key="identifier">MESH:D007951</infon>
        <infon key="type">Disease</infon>
        <location offset="29346" length="16"/>
        <text>myeloid leukemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">21</infon>
      <infon key="name_2">surname:Sasseville;given-names:D</infon>
      <infon key="name_1">surname:Kupper;given-names:TS</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Litvinov;given-names:IV</infon>
      <infon key="fpage">964</infon>
      <infon key="pub-id_pmid">23171462</infon>
      <infon key="year">2012</infon>
      <infon key="source">Exp. Dermatol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">966</infon>
      <offset>29429</offset>
      <text>The role of AHI1 and CDKN1C in cutaneous T-cell lymphoma progression</text>
      <annotation id="1129">
        <infon key="identifier">52906</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">9762</infon>
        <location offset="29441" length="4"/>
        <text>AHI1</text>
      </annotation>
      <annotation id="1130">
        <infon key="identifier">12577</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">134519</infon>
        <location offset="29450" length="6"/>
        <text>CDKN1C</text>
      </annotation>
      <annotation id="1131">
        <infon key="identifier">MESH:D016410</infon>
        <infon key="type">Disease</infon>
        <location offset="29460" length="25"/>
        <text>cutaneous T-cell lymphoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Juszczynski;given-names:P</infon>
      <infon key="name_2">surname:Shaknovich;given-names:R</infon>
      <infon key="name_1">surname:Polo;given-names:JM</infon>
      <infon key="name_0">surname:Parekh;given-names:S</infon>
      <infon key="fpage">2067</infon>
      <infon key="pub-id_pmid">17545502</infon>
      <infon key="year">2007</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="volume">110</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">2074</infon>
      <infon key="name_5">surname:Ranuncolo;given-names:SM</infon>
      <infon key="name_4">surname:Lev;given-names:P</infon>
      <offset>29498</offset>
      <text>BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms</text>
      <annotation id="1134">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="29498" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1135">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="29512" length="8"/>
        <text>lymphoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hofmann;given-names:J</infon>
      <infon key="name_2">surname:Escherich;given-names:G</infon>
      <infon key="name_1">surname:Zur Stadt;given-names:U</infon>
      <infon key="name_0">surname:Meyer;given-names:C</infon>
      <infon key="fpage">165</infon>
      <infon key="pub-id_pmid">23675566</infon>
      <infon key="year">2013</infon>
      <infon key="source">Am. J. Blood Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">3</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">173</infon>
      <infon key="name_5">surname:Barbosa;given-names:TC</infon>
      <infon key="name_4">surname:Binato;given-names:R</infon>
      <offset>29600</offset>
      <text>Refinement of IKZF1 recombination hotspots in pediatric BCP-ALL patients</text>
      <annotation id="1138">
        <infon key="identifier">10320</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55948</infon>
        <location offset="29614" length="5"/>
        <text>IKZF1</text>
      </annotation>
      <annotation id="1139">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="29656" length="3"/>
        <text>BCP</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Silvestri;given-names:D</infon>
      <infon key="name_2">surname:Longinotti;given-names:G</infon>
      <infon key="name_1">surname:Valsecchi;given-names:MG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Palmi;given-names:C</infon>
      <infon key="year">2013</infon>
      <infon key="comment">(Epub ahead of print)</infon>
      <infon key="source">Haematologica</infon>
      <infon key="type">ref</infon>
      <infon key="name_5">surname:Conter;given-names:V</infon>
      <infon key="name_4">surname:Carrino;given-names:V</infon>
      <offset>29673</offset>
      <text>What is the relevance of Ikaros gene deletions as prognostic marker in pediatric Philadelphia negative B-cell precursor acute lymphoblastic leukemia?</text>
      <annotation id="1142">
        <infon key="identifier">22778</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55948</infon>
        <location offset="29698" length="6"/>
        <text>Ikaros</text>
      </annotation>
      <annotation id="1143">
        <infon key="identifier">MESH:D054198</infon>
        <infon key="type">Disease</infon>
        <location offset="29799" length="22"/>
        <text>lymphoblastic leukemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Kakoza;given-names:RM</infon>
      <infon key="name_2">surname:Ross;given-names:KN</infon>
      <infon key="name_1">surname:Berchuck;given-names:JE</infon>
      <infon key="name_0">surname:Hahn;given-names:CK</infon>
      <infon key="fpage">281</infon>
      <infon key="pub-id_pmid">19800574</infon>
      <infon key="year">2009</infon>
      <infon key="source">Cancer Cell</infon>
      <infon key="type">ref</infon>
      <infon key="volume">16</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">294</infon>
      <infon key="name_5">surname:Schinzel;given-names:AC</infon>
      <infon key="name_4">surname:Clauser;given-names:K</infon>
      <offset>29823</offset>
      <text>Proteomic and genetic approaches identify Syk as an AML target</text>
      <annotation id="1146">
        <infon key="identifier">20963</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">2390</infon>
        <location offset="29865" length="3"/>
        <text>Syk</text>
      </annotation>
      <annotation id="1147">
        <infon key="identifier">MESH:D015470</infon>
        <infon key="type">Disease</infon>
        <location offset="29875" length="3"/>
        <text>AML</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ma;given-names:H</infon>
      <infon key="name_2">surname:Fisch;given-names:P</infon>
      <infon key="name_1">surname:Adrian;given-names:F</infon>
      <infon key="name_0">surname:Dierks;given-names:C</infon>
      <infon key="fpage">6193</infon>
      <infon key="pub-id_pmid">20670954</infon>
      <infon key="year">2010</infon>
      <infon key="source">Cancer Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">70</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">6204</infon>
      <infon key="name_5">surname:Herchenback;given-names:D</infon>
      <infon key="name_4">surname:Maurer;given-names:H</infon>
      <offset>29886</offset>
      <text>The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human disease</text>
      <annotation id="1153">
        <infon key="identifier">16428</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4051</infon>
        <location offset="29890" length="3"/>
        <text>ITK</text>
      </annotation>
      <annotation id="1154">
        <infon key="identifier">20963</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">2390</infon>
        <location offset="29894" length="3"/>
        <text>SYK</text>
      </annotation>
      <annotation id="1155">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="29962" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="1156">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="29977" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="1157">
        <infon key="identifier">MESH:D008232</infon>
        <infon key="type">Disease</infon>
        <location offset="29922" length="36"/>
        <text>a T-cell lymphoproliferative disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Herold;given-names:T</infon>
      <infon key="name_2">surname:Metzeler;given-names:KH</infon>
      <infon key="name_1">surname:Konstandin;given-names:NP</infon>
      <infon key="name_0">surname:Greif;given-names:PA</infon>
      <infon key="fpage">1909</infon>
      <infon key="pub-id_pmid">22689681</infon>
      <infon key="year">2012</infon>
      <infon key="source">Haematologica</infon>
      <infon key="type">ref</infon>
      <infon key="volume">97</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1915</infon>
      <infon key="name_5">surname:Ksienzyk;given-names:B</infon>
      <infon key="name_4">surname:Pasalic;given-names:Z</infon>
      <offset>29991</offset>
      <text>RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes</text>
      <annotation id="1160">
        <infon key="identifier">12394</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1331</infon>
        <location offset="29991" length="5"/>
        <text>RUNX1</text>
      </annotation>
      <annotation id="1161">
        <infon key="identifier">MESH:D007951</infon>
        <infon key="type">Disease</infon>
        <location offset="30039" length="16"/>
        <text>myeloid leukemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Dale;given-names:R</infon>
      <infon key="name_2">surname:Cui;given-names:K</infon>
      <infon key="name_1">surname:Freudenberg;given-names:J</infon>
      <infon key="name_0">surname:Li;given-names:L</infon>
      <infon key="fpage">4575</infon>
      <infon key="pub-id_pmid">23610375</infon>
      <infon key="year">2013</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="volume">121</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">4585</infon>
      <infon key="name_5">surname:Dean;given-names:A</infon>
      <infon key="name_4">surname:Song;given-names:SH</infon>
      <offset>30129</offset>
      <text>Ldb1-nucleated transcription complexes function as primary mediators of global erythroid gene activation</text>
      <annotation id="1163">
        <infon key="identifier">16825</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">2891</infon>
        <location offset="30129" length="4"/>
        <text>Ldb1</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ma;given-names:J</infon>
      <infon key="name_2">surname:Fabbri;given-names:G</infon>
      <infon key="name_1">surname:Trifonov;given-names:V</infon>
      <infon key="name_0">surname:Pasqualucci;given-names:L</infon>
      <infon key="fpage">830</infon>
      <infon key="pub-id_pmid">21804550</infon>
      <infon key="year">2011</infon>
      <infon key="source">Nat. Genet</infon>
      <infon key="type">ref</infon>
      <infon key="volume">43</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">837</infon>
      <infon key="name_5">surname:Chiarenza;given-names:A</infon>
      <infon key="name_4">surname:Rossi;given-names:D</infon>
      <offset>30234</offset>
      <text>Analysis of the coding genome of diffuse large B-cell lymphoma</text>
      <annotation id="1165">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="30288" length="8"/>
        <text>lymphoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">3</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Vasudevan;given-names:S</infon>
      <infon key="fpage">311</infon>
      <infon key="pub-id_pmid">22072587</infon>
      <infon key="year">2012</infon>
      <infon key="source">Wiley Interdiscip. Rev. RNA</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">330</infon>
      <offset>30297</offset>
      <text>Posttranscriptional upregulation by microRNAs</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms-648290-f0001.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>30343</offset>
      <text>GFI1B: relative RNA levels in lymphomas from BCL6 transgenic and control mice and immunohistochemistry of BCL6-positive and -negative murine and human lymphomas. (a) The graph depicts average relative GFI1B RNA expression from the lymphomas (all large B-cell) of three retroviral-injected BCL6 transgenic mice (black bar) containing inserts 7.9 to 8.7 kb 5' to the GFI1B gene as compared with three randomly selected B-cell lymphomas from retroviral-injected non-transgenic controls that did not contain inserts in or near GFI1B (gray bar). Expression in each transgenic animal was decreased as compared with the controls [range, 1.8 to 5.7-fold (Table 1), overall decrease 2.71-fold; mean +- SEM = 0.041 +- 0.018 in the controls as compared with 0.015 +- 0.005 in the transgenics; P &lt; 0.05]. (b) I, Representative murine lymphomas from (1) a transgenic mouse (nuclei positive for BCL6, column B) and (2) a non-transgenic animal (nuclei negative for BCL6). The cytoplasmic staining, evident in the anti-GFI1B (C) column, is decreased in the transgenic mouse as compared with the non-transgenic control. II, Representative human lymphomas: (1) BCL6-positive (B-cell), (2) BCL6-positive (T-cell), (3) BCL6-negative (B-cell), (4) BCL6-negative (T-cell). As in the murine lymphomas, the GFI1B cytoplasmic staining (column C) is decreased in the BCL6-positive lymphomas as compared with the stronger expression in the BCL6-negative neoplasms. The bar (lowest right panel) indicates 50 mum.</text>
      <annotation id="1208">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="30343" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="1209">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="30388" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1210">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="30449" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1211">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="30544" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="1212">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="30632" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1213">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="30708" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="1214">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="30866" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="1215">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="31224" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1216">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="31293" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1217">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="31346" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="1218">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="31486" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1219">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="31514" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1220">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="31542" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1221">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="31570" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1222">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="31626" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="1223">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="31684" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1224">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="31756" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1225">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="30416" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="1226">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="30477" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="1227">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="30488" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="1228">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="30637" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="1229">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31158" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="1230">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31197" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="1231">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31395" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="1232">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="31465" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="1233">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31604" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="1234">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="30393" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1235">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="30806" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1236">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="30903" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1237">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31186" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1238">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31254" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1239">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31384" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1240">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31426" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1241">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="31770" length="9"/>
        <text>neoplasms</text>
      </annotation>
      <annotation id="1242">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="31698" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1243">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="31471" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1244">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="30494" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1245">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="31165" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1246">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="30574" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1247">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="31611" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1248">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="30373" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1249">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="30767" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms-648290-f0002.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption</infon>
      <offset>31830</offset>
      <text>EVI5: relative RNA levels in lymphomas from BCL6 transgenic and control mice and immunohistochemistry of BCL6-positive and -negative murine and human lymphomas. (a) The graph depicts average relative EVI5 RNA expression from the lymphomas (all T-cell) of three retroviral-injected BCL6 transgenic mice (black bar) containing inserts within the terminal intron or 3'-untranslated region of the EVI5 gene as compared with three randomly selected T-cell lymphomas from retroviral-injected non-transgenic controls that did not contain inserts in or near EVI5 (gray bar). Expression in each transgenic animal was decreased as compared with the controls [range, 1.3 to 2-fold (Table 1), overall decrease, 1.86-fold; mean +- SEM = 0.007 +- 0.001 in the controls as compared with 0.004 +- 0.0007 in the transgenics; P &lt; 0.05]. (b) I, Representative murine lymphomas from (1) a transgenic mouse (nuclei positive for BCL6, column B) and (2) a non-transgenic mouse (nuclei negative for BCL6). The nuclear staining evident in the anti-BCL6 (C) column is decreased in the transgenic mouse as compared with the non-transgenic control. II, Representative human lymphomas: (1) BCL6-positive B-cell, (2) BCL6-positive (T-cell), (3) BCL-negative (B-cell), (4) BCL-negative (T-cell); the cytoplasm of the tumor cells stains strongly positive with the T-cell marker CD3 (II, 4A). A germinal center in 4A (upper left corner) does not stain with CD3 and is BCL6-positive (column B), whereas the tumor cells around it are BCL-negative. As in the murine lymphomas, the EVI5 nuclear staining (column C) is decreased in BCL6-positive cells (tumors 1 and 2, or germinal center cells, tumor 4) as compared with the stronger expression in the BCL-negative tumor cells [tumors 3 and 4 (outside the germinal center)]. The length of the bar in the lowest right panel depicts 50 mum.</text>
      <annotation id="1297">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="31830" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="1298">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="31874" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1299">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="31935" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1300">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="32030" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="1301">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="32111" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1302">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="32223" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="1303">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="32380" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="1304">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="32737" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1305">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="32805" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1306">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="32853" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1307">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="32991" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1308">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="33017" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1309">
        <infon key="identifier">12501</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">586</infon>
        <location offset="33176" length="3"/>
        <text>CD3</text>
      </annotation>
      <annotation id="1310">
        <infon key="identifier">12501</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">586</infon>
        <location offset="33254" length="3"/>
        <text>CD3</text>
      </annotation>
      <annotation id="1311">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="33265" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1312">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="33375" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="1313">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="33424" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1314">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31902" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="1315">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31963" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="1316">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="31974" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="1317">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32116" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="1318">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32671" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="1319">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32710" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="1320">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32778" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="1321">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32900" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="1322">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="32970" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="1323">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33353" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="1324">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="31879" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1325">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32320" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1326">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32416" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1327">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32699" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1328">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32767" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1329">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32889" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1330">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="32931" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1331">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="33360" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1332">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="33445" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="1333">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="33116" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="1334">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="33570" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="1335">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="33487" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="1336">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="33303" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="1337">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="32678" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1338">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="32059" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1339">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="31980" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1340">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="33557" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="1341">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="32976" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1342">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="32281" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1343">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="31859" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">nihms-648290-f0003.jpg</infon>
      <infon key="id">F3</infon>
      <infon key="type">fig_caption</infon>
      <offset>33683</offset>
      <text>MYB: relative RNA levels in lymphomas from BCL6 transgenic and control mice and immunohistochemistry of BCL6-positive and -negative murine and human lymphomas. (a) The graph depicts average relative MYB RNA expression in the lymphomas of three retroviral-injected BCL6 transgenic mice (black bars, study mice S1, S2, S3) containing inserts ~35 to ~74 kb 3' to the MYB gene as compared with randomly selected B- or T-cell lymphomas (gray bars) from retroviral-injected control mice that did not contain inserts in or near MYB. S1 is a large B-cell lymphoma from a transgenic mouse whose relative expression is 2-fold higher than the mean of three randomly selected B-cell control tumors (S1 expression = 0.54 vs. control B-cell tumors, mean +- SEM = 0.27 +- 0.07), whereas the relative RNA expression of S2 (0.08), also a large B-cell lymphoma from a transgenic animal, is 3.2-fold decreased as compared with the mean of the three randomly selected control B-cell lymphomas (see above). S3 is a precursor T-cell lymphoblastic lymphoma/ leukemia from a transgenic mouse whose relative RNA expression is 2.2-fold higher than the mean of two randomly selected precursor T-cell lymphoblastic lymphoma/leukemia control tumors; S3 expression = 0.42 vs. control T-cell tumors, mean +- SEM = 0.19 +- 0.07. (b) I, Representative murine lymphomas: tumors (1) and (2) depict the B- and T-cell lymphomas, respectively, from transgenic mice (BCL6-positive nuclear staining, column B) with positive MYB nuclear staining (column C); tumors (3) and (4) show B- and T-cell lymphomas, respectively, from non-transgenic mice (nuclei do not stain with anti-BCL6, column B); staining with anti-MYB is also negative in these animals (column C). (b) II, Representative human lymphomas: tumors (1) and (2) show BCL6-positive (column B) B- and T-cell lymphomas, respectively, which show positive nuclear staining for MYB (column C). Tumor (3) is a T-cell lymphoma that is weakly BCL-6 positive (column B), and tumor (4) is a BCL-negative T-cell neoplasm; in tumors 3 and 4, the cells that are MYB positive (column C) are BCL-negative. The bar (lowest right panel) depicts 50 mum.</text>
      <annotation id="1401">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="33683" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1402">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="33726" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1403">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="33787" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1404">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="33882" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1405">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="33947" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1406">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="34047" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1407">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="34204" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1408">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="35111" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1409">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="35319" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1410">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="35355" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1411">
        <infon key="identifier">604</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="35469" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1412">
        <infon key="identifier">4602</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="35574" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1413">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="35636" length="5"/>
        <text>BCL-6</text>
      </annotation>
      <annotation id="1414">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="35750" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1415">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="35167" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1416">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33754" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="1417">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33815" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="1418">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="33826" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="1419">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33952" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="1420">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33987" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="1421">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="34159" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="1422">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="34257" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="1423">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="34745" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="1424">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="35002" length="6"/>
        <text>murine</text>
      </annotation>
      <annotation id="1425">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="35094" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="1426">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="35272" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="1427">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="35428" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="1428">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33731" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1429">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="34246" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1430">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="34533" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1431">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="34734" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1432">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="35667" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="1433">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="34646" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1434">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="35445" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="1435">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="34849" length="38"/>
        <text>T-cell lymphoblastic lymphoma/leukemia</text>
      </annotation>
      <annotation id="1436">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="34362" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="1437">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="34230" length="8"/>
        <text>lymphoma</text>
      </annotation>
      <annotation id="1438">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="35501" length="16"/>
        <text>T-cell lymphomas</text>
      </annotation>
      <annotation id="1439">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="35200" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="1440">
        <infon key="identifier">MESH:D007938</infon>
        <infon key="type">Disease</infon>
        <location offset="34718" length="8"/>
        <text>leukemia</text>
      </annotation>
      <annotation id="1441">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="35020" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="1442">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="34517" length="8"/>
        <text>lymphoma</text>
      </annotation>
      <annotation id="1443">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="35715" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="1444">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="33908" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1445">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="34896" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="1446">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="34937" length="13"/>
        <text>T-cell tumors</text>
      </annotation>
      <annotation id="1447">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="35702" length="8"/>
        <text>neoplasm</text>
      </annotation>
      <annotation id="1448">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="34410" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="1449">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="34097" length="16"/>
        <text>T-cell lymphomas</text>
      </annotation>
      <annotation id="1450">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="35434" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1451">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="34687" length="29"/>
        <text>T-cell lymphoblastic lymphoma</text>
      </annotation>
      <annotation id="1452">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="33832" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1453">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="35009" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1454">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="35605" length="15"/>
        <text>T-cell lymphoma</text>
      </annotation>
      <annotation id="1455">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="35231" length="16"/>
        <text>T-cell lymphomas</text>
      </annotation>
      <annotation id="1456">
        <infon key="identifier">MESH:D016399</infon>
        <infon key="type">Disease</infon>
        <location offset="35057" length="16"/>
        <text>T-cell lymphomas</text>
      </annotation>
      <annotation id="1457">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="33711" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>35839</offset>
      <text>Nucleotide position 108,201,513.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>35872</offset>
      <text>                               </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>35904</offset>
      <text>Nucleotide position 108,183,744.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>35937</offset>
      <text>                               </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>35969</offset>
      <text>Nucleotide position 108,182,569.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>36002</offset>
      <text>                               </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>36034</offset>
      <text>                                  </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>36069</offset>
      <text>Location of retroviral inserts in transgenic mice and relative RNA expression levels in lymphomas from BCL6 transgenic mice as compared with lymphomas from retroviral-injected non-transgenic (control) mice.</text>
      <annotation id="1465">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="36172" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1466">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="36103" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="1467">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="36177" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="1468">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="36270" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="1469">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="36249" length="10"/>
        <text>transgenic</text>
      </annotation>
      <annotation id="1470">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="36157" length="9"/>
        <text>lymphomas</text>
      </annotation>
      <annotation id="1471">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="36210" length="9"/>
        <text>lymphomas</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">T1</infon>
      <infon key="type">table</infon>
      <infon key="File">T1.xml</infon>
      <offset>36276</offset>
      <text>                                 Mouse gene (chromosome)              Lymphoma type              Location of insert              Expression level vs. control                                                       GFI1B (Chr 2)              B              8.692 kb 5' to GFI1B              5.7-fold decreased                                      GFI1B               B              8.686 kb 5' to GFI1B              2.6-fold decreased                                      GFI1B               B              7.877 kb 5' to GFI1B              1.8-fold decreased                                     EVI5 (Chr 5)              T              Terminal intron*              2.0-fold decreased                                      EVI5               T              3' untranslated region**              1.5-fold decreased                                      EVI5               T              3' untranslated region***              1.3-fold decreased                                     MYB (Chr 10)              T              34.794 kb 3' to MYB              2.2-fold increased                                      MYB               B              73.684 kb 3' to MYB              2.0-fold increased                                      MYB               B              70.687 kb 3' to MYB              3.2-fold decreased                             </text>
      <annotation id="1489">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="36488" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="1490">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="36545" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="1491">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="36620" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="1492">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="36670" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="1493">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="36745" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="1494">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="36795" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="1495">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="36869" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="1496">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="36996" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="1497">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="37124" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="1498">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="37252" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1499">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="37504" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1500">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="37382" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1501">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="37553" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1502">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="37431" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1503">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="37309" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1504">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="36309" length="5"/>
        <text>Mouse</text>
      </annotation>
      <annotation id="1505">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="36346" length="35"/>
        <text>Lymphoma type              Location</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>37634</offset>
      <text>Sequences have &gt;=98% identity to the murine databases described in the text.</text>
      <annotation id="1507">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="37671" length="6"/>
        <text>murine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>37712</offset>
      <text>                               </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>37744</offset>
      <text>In one lymphoma, the insert is within SYKb; in the other, SYKb is 61.3 kb 3' to the insert, but there is a gene closer to the insert at the 5' side [40.3 kb away, D/RAS2 (GTP-binding protein DI-RAS2)].</text>
      <annotation id="1512">
        <infon key="identifier">20963</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">2390</infon>
        <location offset="37782" length="4"/>
        <text>SYKb</text>
      </annotation>
      <annotation id="1513">
        <infon key="identifier">20963</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">2390</infon>
        <location offset="37802" length="4"/>
        <text>SYKb</text>
      </annotation>
      <annotation id="1514">
        <infon key="identifier">68203</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">56777</infon>
        <location offset="37915" length="27"/>
        <text>GTP-binding protein DI-RAS2</text>
      </annotation>
      <annotation id="1515">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="37751" length="8"/>
        <text>lymphoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>37950</offset>
      <text>                               </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>37982</offset>
      <text>MPPE (5') is closer to the insert in one lymphoma (17.8 kb vs. 50.2 kb), but IMPA2 (3') is closer to the insert in the other lymphoma (1 kb vs. 33.8 kb).</text>
      <annotation id="1519">
        <infon key="identifier">114663</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">22799</infon>
        <location offset="38059" length="5"/>
        <text>IMPA2</text>
      </annotation>
      <annotation id="1520">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="38107" length="8"/>
        <text>lymphoma</text>
      </annotation>
      <annotation id="1521">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="38023" length="8"/>
        <text>lymphoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table_footnote</infon>
      <offset>38140</offset>
      <text>                               </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="type">table</infon>
      <offset>38172</offset>
      <text>                                  </text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>38207</offset>
      <text>Recurring retroviral integration sites in BCL6 transgenic mice not found in non-transgenic controls.*</text>
      <annotation id="1525">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="38249" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1526">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="38254" length="15"/>
        <text>transgenic mice</text>
      </annotation>
      <annotation id="1527">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="38287" length="10"/>
        <text>transgenic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="id">T2</infon>
      <infon key="type">table</infon>
      <infon key="File">T2.xml</infon>
      <offset>38309</offset>
      <text>                                 Murine genes containing inserts or, if insert not within a gene, the nearest characterized gene (unless indicated)              Mouse chromosome              Number of mice              Lymphoma type                                                       PIM1 (proviral integration site for Moloney murine leukemia virus 1)              17              7              6T, 1B                                     GFI1B (growth factor independent 1B)              2              3              B                                     EVI5 (ecotropic viral integration site 5)              5              3              T                                     MYB (transcriptional activator MYB isoform 1)              10              3              2B, 1T                                     LMO2 (LIM domain only 2)              2              2              T                                     MN1 (probable tumor suppressor protein MN1)              5              2              T                                     AHI1 (jouberin isoform 1; Abelson helper integration site-1)              10              2              T                                     BCOR (BCL6 corepressor isoform d)              10              2              B                                     IKZF1 (DNA-binding protein Ikaros isoform a and b)              11              2              T                                     SYKb (tyrosine protein kinase SYK)              13              2**              T                                     MPPE (metallophosphoesterase 1); IMPA2 (inositol monophosphatase 2)              18              2***              B                                     DNTT (DNA nucleotidylexotransferase)              19              2              T                                     GATA1 (erythroid transcription factor)              X              2              B                             </text>
      <annotation id="1553">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="38752" length="5"/>
        <text>GFI1B</text>
      </annotation>
      <annotation id="1554">
        <infon key="identifier">14582</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31223</infon>
        <location offset="38759" length="28"/>
        <text>growth factor independent 1B</text>
      </annotation>
      <annotation id="1555">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="38870" length="4"/>
        <text>EVI5</text>
      </annotation>
      <annotation id="1556">
        <infon key="identifier">14020</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">121902</infon>
        <location offset="38876" length="34"/>
        <text>ecotropic viral integration site 5</text>
      </annotation>
      <annotation id="1557">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="38993" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1558">
        <infon key="identifier">4005</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4072</infon>
        <location offset="39126" length="4"/>
        <text>LMO2</text>
      </annotation>
      <annotation id="1559">
        <infon key="identifier">433938</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37620</infon>
        <location offset="39232" length="3"/>
        <text>MN1</text>
      </annotation>
      <annotation id="1560">
        <infon key="identifier">433938</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37620</infon>
        <location offset="39271" length="3"/>
        <text>MN1</text>
      </annotation>
      <annotation id="1561">
        <infon key="identifier">52906</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">9762</infon>
        <location offset="39357" length="4"/>
        <text>AHI1</text>
      </annotation>
      <annotation id="1562">
        <infon key="identifier">54880</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">9809</infon>
        <location offset="39500" length="4"/>
        <text>BCOR</text>
      </annotation>
      <annotation id="1563">
        <infon key="identifier">10320</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55948</infon>
        <location offset="39616" length="5"/>
        <text>IKZF1</text>
      </annotation>
      <annotation id="1564">
        <infon key="identifier">20963</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">2390</infon>
        <location offset="39749" length="4"/>
        <text>SYKb</text>
      </annotation>
      <annotation id="1565">
        <infon key="identifier">20963</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">2390</infon>
        <location offset="39779" length="3"/>
        <text>SYK</text>
      </annotation>
      <annotation id="1566">
        <infon key="identifier">114663</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">22799</infon>
        <location offset="39901" length="5"/>
        <text>IMPA2</text>
      </annotation>
      <annotation id="1567">
        <infon key="identifier">1791</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3014</infon>
        <location offset="40021" length="4"/>
        <text>DNTT</text>
      </annotation>
      <annotation id="1568">
        <infon key="identifier">2623</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1549</infon>
        <location offset="40140" length="5"/>
        <text>GATA1</text>
      </annotation>
      <annotation id="1569">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="38342" length="6"/>
        <text>Murine</text>
      </annotation>
      <annotation id="1570">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="38470" length="5"/>
        <text>Mouse</text>
      </annotation>
      <annotation id="1571">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="38510" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="1572">
        <infon key="identifier">11801</infon>
        <infon key="type">Species</infon>
        <location offset="38632" length="29"/>
        <text>Moloney murine leukemia virus</text>
      </annotation>
      <annotation id="1573">
        <infon key="identifier">17863</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">31311</infon>
        <location offset="39024" length="3"/>
        <text>MYB</text>
      </annotation>
      <annotation id="1574">
        <infon key="identifier">22778</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55948</infon>
        <location offset="39643" length="6"/>
        <text>Ikaros</text>
      </annotation>
      <annotation id="1575">
        <infon key="identifier">12053</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7640</infon>
        <location offset="39506" length="4"/>
        <text>BCL6</text>
      </annotation>
      <annotation id="1576">
        <infon key="identifier">MESH:D008223</infon>
        <infon key="type">Disease</infon>
        <location offset="38528" length="72"/>
        <text>Lymphoma type                                                       PIM1</text>
      </annotation>
      <annotation id="1577">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="39246" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272827</id>
    <passage>
      <infon key="name_3">surname:Sevim;given-names:Sezgin</infon>
      <infon key="name_2">surname:Celik;given-names:Merve</infon>
      <infon key="name_1">surname:Cevizci;given-names:Sibel</infon>
      <infon key="article-id_pmid">25568633</infon>
      <infon key="name_0">surname:Tanisman;given-names:Beyhan</infon>
      <infon key="fpage">329</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272827</infon>
      <infon key="article-id_publisher-id">MSM-26-329</infon>
      <infon key="article-id_doi">10.5455/msm.2014.26.329-334</infon>
      <infon key="type">front</infon>
      <infon key="volume">26</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Mater Sociomed; 2014 Oct; 26(5) 329-34. doi:10.5455/msm.2014.26.329-334</infon>
      <infon key="kwd">Health management trainees mental health stress GHQ-12</infon>
      <infon key="lpage">334</infon>
      <infon key="authors">Tan&#196;&#177;&#197;&#159;man B, Cevizci S, &#195;&#135;elik M, Sevim S</infon>
      <offset>0</offset>
      <text>Work Stress and Risk Factors For Health Management Trainees in Canakkale, Turkey</text>
      <annotation id="1">
        <infon key="identifier">MESH:D004194</infon>
        <infon key="type">Disease</infon>
        <location offset="5" length="6"/>
        <text>Stress</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>81</offset>
      <text>Aim:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>86</offset>
      <text>This study aims to investigate the general mental health situation, work-related stress and risk factors of health management trainees.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>222</offset>
      <text>Methods:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>231</offset>
      <text>This cross-sectional study was conducted on Health Management Musters students (N=96) in Canakkale Onsekiz Mart University Health Sciences Institute, May-June 2014. A total of 58 students who voluntarily participated in the study were reached (60.42%). Participants completed a 22-question sociodemographic survey form and a 12-item General Health Questionnaire in a face-to-face interview. Data were analyzed using the SPSS software version 20.0.</text>
      <annotation id="4">
        <infon key="identifier">5414</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">6107</infon>
        <location offset="338" length="4"/>
        <text>Mart</text>
      </annotation>
      <annotation id="5">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="484" length="12"/>
        <text>Participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>679</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>688</offset>
      <text>The average age of participants was 36.4+-6.2 (Min:24-Max:62) years. Thirty five of the participants were female (60.3%), 23 were male (39.7%). The number of people using cigarettes and alcohol were 23 (39.7%) and 9 (15.8%) respectively. In our study group according to GHQ scale 32 people (55.2%) were in the group at risk of depression. Eighty-six percent of participants reported experiencing work stress. The most frequently reported sources of stress were superiors (56.8%), work itself (41.3%), and work colleagues (25.8%). There was no significant difference between those at risk of depression and those not at risk in terms of gender, marital status, educational level, age, work-related factors (daily work, computer use, duration of sitting at desk), sleep duration, presence of chronic disease, substance use (cigarettes, alcohol), regular exercise, regular meals, fast-food consumption, sufficient family time and vacations (p&gt;0.05).</text>
      <annotation id="17">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="707" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="18">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="776" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="19">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="846" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="20">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="971" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="21">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1049" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="22">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="1279" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="23">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="1522" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="24">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="958" length="3"/>
        <text>GHQ</text>
      </annotation>
      <annotation id="25">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="1015" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="26">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="1478" length="15"/>
        <text>chronic disease</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="874" length="7"/>
        <text>alcohol</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1635</offset>
      <text>Conclusions:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1648</offset>
      <text>Our study results indicated that majority of participants reported experiencing work stress with more than half at high risk of developing depression. The most reported risk factors were superiors, the work itself and colleagues in the present study. Psychosocial risk factors at work environment should be investigated in terms of psychological, sociological and ergonomics in more detail to reduce the risk of health management trainees experiencing work stress and mental health problems.</text>
      <annotation id="30">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1693" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="31">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="1787" length="10"/>
        <text>depression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>2140</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2156</offset>
      <text>Stress, a psychosocial factor affecting work health and work productivity, is an important public health problem today. Work stress is an employee health problem that negatively affects the health of workers, disturbs public peace, and may cause harmful results for employee and employer. Work stress affects 22% of employees and threatens work health and safety. Physical and mental health problems damage the health of employees, and if necessary precautions are not taken against it, loss of work productivity may cause an increase in health spending. Work stress comprises 21.5% of health spending, 40% of hiring entry-exit costs, 50% of falls in work productivity, 50% of unplanned absences (absences caused by illness, etc.) and 33% of loss of manpower and employee compensation costs.</text>
      <annotation id="34">
        <infon key="identifier">MESH:D004194</infon>
        <infon key="type">Disease</infon>
        <location offset="2156" length="6"/>
        <text>Stress</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">MESH:C535569</infon>
        <infon key="type">Disease</infon>
        <location offset="2166" length="12"/>
        <text>psychosocial</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2948</offset>
      <text>Currently there is a significant increase in the psychological, psychiatric and physical diseases caused by work stress. Previous studies have shown that work stress is the primary cause of work-related health problems and may cause chronic diseases like cardiovascular diseases, musculoskeletal diseases, migraine and depression. Depression developing linked to work is one of the most important causes of long-term chronic diseases. Investigations of the relationship between depression and work environment have found an important increase. The cause of this increase is the continuous presence of depressive disorders in the work environment and it has an excessive negative effect on work productivity, performance, work absences and disability costs.</text>
      <annotation id="43">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="3549" length="20"/>
        <text>depressive disorders</text>
      </annotation>
      <annotation id="44">
        <infon key="identifier">MESH:D008881</infon>
        <infon key="type">Disease</infon>
        <location offset="3254" length="23"/>
        <text>migraine and depression</text>
      </annotation>
      <annotation id="45">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="3426" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="46">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="3279" length="10"/>
        <text>Depression</text>
      </annotation>
      <annotation id="47">
        <infon key="identifier">MESH:D009140</infon>
        <infon key="type">Disease</infon>
        <location offset="3228" length="24"/>
        <text>musculoskeletal diseases</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">MESH:D001523</infon>
        <infon key="type">Disease</infon>
        <location offset="3012" length="11"/>
        <text>psychiatric</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">MESH:D002318</infon>
        <infon key="type">Disease</infon>
        <location offset="3181" length="45"/>
        <text>chronic diseases like cardiovascular diseases</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3705</offset>
      <text>Work stress studies of occupational groups at risk have shown that physical, mental and social health problems that may develop after stress can be prevented. A study in Europe found that the occupational group with greatest risk of work stress was health personnel. To reduce the stress experienced linked to work by health personnel, especially nurses, or to prevent negative effects, it is very important to monitor risks in the work environment, increase work fulfilment and provide social support. Reducing the administration and clinical stress load of employees responsible for health management is advantageous to monitor work environment stressors to protect mental health. Studies of health workers and nurses in with work environment frequently use the 12-item General Health Questionnaire (GHQ-12) form to monitor risk of developing depression and anxiety, mental health situation and stress levels. Stress and depression resulting from working conditions are important mental health problems among health professionals. One of the groups at risk of developing this health problem in their working life is health management trainees.</text>
      <annotation id="55">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="4565" length="7"/>
        <text>anxiety</text>
      </annotation>
      <annotation id="56">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="4628" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="57">
        <infon key="identifier">MESH:D004194</infon>
        <infon key="type">Disease</infon>
        <location offset="4617" length="6"/>
        <text>Stress</text>
      </annotation>
      <annotation id="58">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="4550" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="59">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="4507" length="6"/>
        <text>GHQ-12</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4851</offset>
      <text>The aim of this study is to investigate the relationship between stress, risk of developing depression and risk factors of health management trainees.</text>
      <annotation id="61">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="4943" length="10"/>
        <text>depression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>5002</offset>
      <text>2. METHODS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5013</offset>
      <text>This was a cross-sectional study which was performed in the Health Science Institute of Canakkale Onsekiz Mart University, Canakkale, covering the period May-Jun 2014.</text>
      <annotation id="63">
        <infon key="identifier">5414</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">6107</infon>
        <location offset="5119" length="4"/>
        <text>Mart</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5181</offset>
      <text>Study population and sampling</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5211</offset>
      <text>The population of this cross-sectional study comprised 96 students enrolled in Canakkale Onsekiz Mart University Health Sciences Institute Health Management Department Non-Thesis Masters program. Sampling was not completed as the aim was to reach the whole population. Our study included 58 students (response rate for our study was 60.42%).</text>
      <annotation id="65">
        <infon key="identifier">5414</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">6107</infon>
        <location offset="5308" length="4"/>
        <text>Mart</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5553</offset>
      <text>Data collection</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5569</offset>
      <text>Participants completed a 22-question sociodemographic survey form and a 12-item General Health Questionnaire in a face-to-face interview. The sociodemographic survey form included questions about age, gender, educational level, marital status, cigarette and alcohol use, presence of chronic disease, working hours, work stress and causes, regular exercise and nutrition.</text>
      <annotation id="69">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5569" length="12"/>
        <text>Participants</text>
      </annotation>
      <annotation id="70">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="5852" length="15"/>
        <text>chronic disease</text>
      </annotation>
      <annotation id="71">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="5827" length="7"/>
        <text>alcohol</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5940</offset>
      <text>The General Health Questionnaire developed by Goldberg and Hillier (1979) is a short, easy-to-apply, self-evaluating survey for epidemiological research defining mental health problems used for societal scanning and first-stage health services. The Turkish validity and reliability studies were completed by Kilic. The GHQ-12 is widely used to research mental discomfort like depression or anxiety that may be triggered by stress factors. This study used the GHQ point method (0-0-1-1); according to this method a score of 2 points or above is accepted as the "high risk group" for mental health problems.</text>
      <annotation id="76">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="6399" length="3"/>
        <text>GHQ</text>
      </annotation>
      <annotation id="77">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="6259" length="6"/>
        <text>GHQ-12</text>
      </annotation>
      <annotation id="78">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="6330" length="7"/>
        <text>anxiety</text>
      </annotation>
      <annotation id="79">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="6316" length="10"/>
        <text>depression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6553</offset>
      <text>Ethics</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6560</offset>
      <text>The study received written permission from Canakkale Onsekiz Mart University Clinical Research Ethics Committee dated 28.05.2014 and numbered 2014/10-06.</text>
      <annotation id="81">
        <infon key="identifier">5414</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">6107</infon>
        <location offset="6621" length="4"/>
        <text>Mart</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6714</offset>
      <text>Statistical analysis</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6735</offset>
      <text>Data were analyzed using the SPSS software version 20.0. Descriptive statistics (frequencies, percentages, means, standard deviations) were used to describe groups of numerical data and the basic features of the data. The variables were investigated using visual (histograms, probability plots) and analytical methods (Kolmogorov-Simirnov/Shapiro-Wilk's test) to determine whether or not they are normally distributed. Chi-square test was used to examine the association between categorical variables. A p-value of less than 0.05 was considered statistically significant. In the present study, the dependent variable was "developing risk of mental health problem according to GHQ-12 scale. Independent variables were sociodemographic characteristics (gender, marital status, education, age), work-related factors (Daily work, computer use, duration of sitting at desk), having a chronic disease, healthy lifestyle behaviors (sleep duration, substance use (cigarettes, alcohol), regular exercise, regular meals, fast-food consumption, sufficient family timer and vacations).</text>
      <annotation id="84">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="7614" length="15"/>
        <text>chronic disease</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="7703" length="7"/>
        <text>alcohol</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>7811</offset>
      <text>3. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7822</offset>
      <text>The average age of participants was 36.4+-6.2 (Min:24-Max:62) years. Thirty five of the participants were female (60.3%), 23 were male (39.7%) with 48 married (82.8%), 10 single (17.2%) and 55 graduates of university (94.8%). When the substance use of participants was examined the number of people using cigarettes and alcohol were 23 (39.7%) and 9 (15.8%) respectively (Table 1). The rate of those considering giving up alcohol was 37.5% with 28.6% feeling guilty for using alcohol. There were 10 people with chronic diseases (17.2%). The most frequently reported chronic diseases were 3 people with hypertension (30%), 3 with asthma (30%), 2 with thyroid function disorders (20%) and 1 with diabetes (10%). When the occupations of participants were examined 22 (37.9%) were nurses, 6 (10.3%) were midwives, 4 (6.9%) were health officers and 26 (44.9%) were health workers from different occupational groups. When lifestyles were examined 16 participated in regular exercise (28.1%), 43 ate regular meals (75.4%) and 27 reported eating fast food (46.6%). Of participants 47 reported spending sufficient time with their families (81.0%). The workplace environmental factors were examined in the working group and the average working day, time at desk, computer use and sleeping durations are presented in Figure 1.</text>
      <annotation id="101">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7841" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="102">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7910" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="103">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8074" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="104">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8114" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="105">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8321" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="106">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8412" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="107">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8556" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="108">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8882" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="109">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="8516" length="8"/>
        <text>diabetes</text>
      </annotation>
      <annotation id="110">
        <infon key="identifier">MESH:D013959</infon>
        <infon key="type">Disease</infon>
        <location offset="8472" length="26"/>
        <text>thyroid function disorders</text>
      </annotation>
      <annotation id="111">
        <infon key="identifier">MESH:D006973</infon>
        <infon key="type">Disease</infon>
        <location offset="8424" length="12"/>
        <text>hypertension</text>
      </annotation>
      <annotation id="112">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="8298" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="113">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="8244" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="114">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="8142" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">MESH:D001249</infon>
        <infon key="type">Disease</infon>
        <location offset="8451" length="6"/>
        <text>asthma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>9138</offset>
      <text>Demographic characteristics of the study population, Canakkale, 2014 (*: The percentage of column)</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">MSM-26-329-g002.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>9238</offset>
      <text>Mean values +- standard deviations of work-related factors among study population, Canakkale, 2014</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9337</offset>
      <text>There were 39 people in the study group who had weekend holidays (68.4%). The average holiday duration was 1.7+-0.4 days. When the last date of blood pressure reading was questioned 6 people (10.3%) couldn't answer the question, 11 people (18.9%) couldn't remember, 2 people (3.4%) had never measured it, 1 person (1.7%) said 4 years previous, 2 people (3.4%) said 3 years previous, 3 people (5.1%) said 1 year previous, 2 people (3.4%) said 6 months previous, 1 person (1.7%) said 5 months previous, 3 people (5.1%) said 3 months previous, 3 people (5.1%) said 2 months previous, 7 people (12.0%) said 1 month previous, 5 people (8.6%) said 2-3 weeks previous, 5 people (8.6%) said 1 week previous and 7 people (12.0%) said within the last week. The number of the people who had consulted a physician regularly was 24 (41.4%).</text>
      <annotation id="132">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9351" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9521" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="134">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9569" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9605" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="136">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9644" length="6"/>
        <text>person</text>
      </annotation>
      <annotation id="137">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9683" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="138">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9722" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="139">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9760" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="140">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9800" length="6"/>
        <text>person</text>
      </annotation>
      <annotation id="141">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9840" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="142">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9880" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9920" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="144">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9960" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="145">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10001" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="146">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10042" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="147">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10102" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10169</offset>
      <text>In our study group according to GHQ points from the GHQ scale 32 people (55.2%) were in the group at risk of depression. Statistically, there was no significant difference between those at risk of depression and those not at risk according to the GSA scale in terms of gender, marital status, educational level, age, work-related factors (daily work, computer use, duration of sitting at desk), sleep duration, presence of chronic disease, substance use (cigarettes, alcohol), regular exercise, regular meals, fast-food consumption, sufficient family timer and vacations (p&gt;0.05). When experience work stress in work environment was questioned, 86.0% of participants reported experiencing work stress. Of participants in the study 33 reported superiors (56.8%), 24 said work itself (41.3%), and 15 said work colleagues (25.8%) had caused them to experience work stress. Insufficient definition of duties, human resources, profession and distance from occupation were other reported stressors result in work stress among participants (Figure 2).</text>
      <annotation id="160">
        <infon key="identifier">2778</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55534</infon>
        <location offset="10416" length="3"/>
        <text>GSA</text>
      </annotation>
      <annotation id="161">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10234" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10823" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10874" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11074" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11189" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="166">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="10278" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="167">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="10636" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="168">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="10592" length="15"/>
        <text>chronic disease</text>
      </annotation>
      <annotation id="169">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="10201" length="3"/>
        <text>GHQ</text>
      </annotation>
      <annotation id="170">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="10366" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="171">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="10221" length="3"/>
        <text>GHQ</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">MSM-26-329-g003.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption</infon>
      <offset>11214</offset>
      <text>Stressors reported by study population, Canakkale, 2014. (One more than options were marked).</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>11308</offset>
      <text>4. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11322</offset>
      <text>Our study aimed to investigate the general mental health and sociodemographic characteristics, work-related factors and factors like work stress in individuals pursuing a masters degree in health management. With this aim students in the Health Management Masters program of Canakkale Onsekiz Mart University, Health Sciences Institute, Health Management Department were included in the study. After the 2-year masters program is completed the health personnel will take the title Health management. The majority of participants were interviewed face-to-face and evaluated for general mental health with the 12-item General Health Questionnaire. Additionally sociodemographic factors and work-related factors that may affect mental health were investigated.</text>
      <annotation id="174">
        <infon key="identifier">5414</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">6107</infon>
        <location offset="11615" length="4"/>
        <text>Mart</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11838" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12080</offset>
      <text>In our working group there were more women than men and more married than single. When the occupations of participants are examined the majority were nurses, midwives, health officers and other health workers. The cigarette use among participants was high (39.7%) while the use of alcohol was lower (15.8%). When other behavior related to healthy lifestyle was examined 16 took regular exercises, 43 ate regular meals and 27 ate fast-food. It has been reported that work stress, high workload and depression can negatively affect the eating habits of workers and may cause obesity, especially in female workers. Sagara et al. showed a significant relationship between increase in weight and development of mental health complaints (high GHQ-12 point) in male employees. In the literature it is reported that increasing exercise and limiting calorie intake can prevent weight gain and development of psychological heatlh problems. In our study, different to the literature, there was no statistically significant difference between those at risk of developing depression according to GHQ-12 scores and those not at risk in terms of regular physical activity. We believe that as health personnel are societal role models their healthy lifestyle and behavior attracts more attention and it may be beneficial, especially for personnel who will play a role in management of health services such as our working group, to participate in internal education on behavior to protect and enhance health. While chronic disease was present in at least 10 people in our study group, the most frequently reported chronic diseases were hypertension, asthma, thyroid function disorders and diabetes. In the literature it is reported that work stress may lead to chronic diseases such as cardiovascular diseases and musculoskeletal diseases. In our study, we also asked to our participants the last date of blood pressure measurement and the last date of general checkup. The minority of the participants reported that they had measured their blood pressure and also consulted a physician regularly. This finding indicated that health management trainees overlooked their health such as measuring blood pressure. Therefore all health professions in this study must be educated to recognize their own health checks and health-promoting opportunities.</text>
      <annotation id="196">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12117" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12128" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12186" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12314" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="200">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13621" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="201">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13938" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="202">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14053" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="203">
        <infon key="identifier">MESH:D002318</infon>
        <infon key="type">Disease</infon>
        <location offset="13849" length="23"/>
        <text>cardiovascular diseases</text>
      </annotation>
      <annotation id="204">
        <infon key="identifier">MESH:D009140</infon>
        <infon key="type">Disease</infon>
        <location offset="13877" length="24"/>
        <text>musculoskeletal diseases</text>
      </annotation>
      <annotation id="205">
        <infon key="identifier">MESH:D001249</infon>
        <infon key="type">Disease</infon>
        <location offset="13713" length="6"/>
        <text>asthma</text>
      </annotation>
      <annotation id="206">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="12653" length="7"/>
        <text>obesity</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="12361" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="208">
        <infon key="identifier">MESH:D006973</infon>
        <infon key="type">Disease</infon>
        <location offset="13699" length="12"/>
        <text>hypertension</text>
      </annotation>
      <annotation id="209">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="13752" length="8"/>
        <text>diabetes</text>
      </annotation>
      <annotation id="210">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="12577" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="211">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="13139" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="212">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="13163" length="6"/>
        <text>GHQ-12</text>
      </annotation>
      <annotation id="213">
        <infon key="identifier">MESH:D015430</infon>
        <infon key="type">Disease</infon>
        <location offset="12948" length="11"/>
        <text>weight gain</text>
      </annotation>
      <annotation id="214">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="13578" length="15"/>
        <text>chronic disease</text>
      </annotation>
      <annotation id="215">
        <infon key="identifier">MESH:D013959</infon>
        <infon key="type">Disease</infon>
        <location offset="13721" length="26"/>
        <text>thyroid function disorders</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>14411</offset>
      <text>In a study evaluating the psychological health of health workers in New Zealand, the GHQ-12 was used and while the highest points were for pharmacists, general practitioners and surgeons had similar average points. In our study according to the GHQ socres 32 people (55.2%) were found to have high risk of developing depression and anxiety. Statistically, there was no significant difference between those at risk of depression and those not at risk according to the GSA scale in terms of gender, marital status, educational level, age, work-related factors (daily work, computer use, duration of sitting at desk), sleep duration, presence of chronic disease, substance use (cigarettes, alcohol), regular exercise, regular meals, fast-food consumption, sufficient family timer and vacations (p&gt;0.05). Tabolli et al. in as study of biomedical researchers at a research institute in Rome identified that according to GHQ-12 scores 15.1% of participants were at risk of depression and anxiety, 77.4% were at risk of developing stress and 66% were dissatisfied with work. The most important determinants of work dissatisfaction are reported to be work opportunities, communication between departments, material rewards and participation in departmental organization. Work dissatisfaction related to economic rewards was a risk factor for developing depression independent of gender, age and duration of work. Another Italian study used the GHQ-12 to investigate the psychological status of health workers and found one third of participants were at risk of developing depression and anxiety. The most basic solution to prevent and reduce mental health problems such as development of depression and anxiety linked to psychological stress in the work environment, is to reduce workload while increasing work fulfillment and social supports. A study of personnel managing a hospital in Rome used the GHQ-12 to investigate psychological health and found 37.8% of participants were at high risk of developing depression and anxiety. The same study found that determinants of work dissatisfaction were low control of work and lack of communication between departments. Job dissatisfaction among management personnel was independent of age, gender and duration of work and was reported to be associated with high levels of risk of developing depression/anxiety, low work control and weak communication.</text>
      <annotation id="242">
        <infon key="identifier">2778</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55534</infon>
        <location offset="14878" length="3"/>
        <text>GSA</text>
      </annotation>
      <annotation id="243">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14670" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="244">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15349" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="245">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15935" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="246">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16367" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="247">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="15756" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="248">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="14828" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="249">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="14496" length="6"/>
        <text>GHQ-12</text>
      </annotation>
      <annotation id="250">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="16091" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="251">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="15393" length="7"/>
        <text>anxiety</text>
      </annotation>
      <annotation id="252">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="14728" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="253">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="15990" length="7"/>
        <text>anxiety</text>
      </annotation>
      <annotation id="254">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="16743" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="255">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="15098" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="256">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="15975" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="257">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="16412" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="258">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="15326" length="6"/>
        <text>GHQ-12</text>
      </annotation>
      <annotation id="259">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="14743" length="7"/>
        <text>anxiety</text>
      </annotation>
      <annotation id="260">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="15378" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="261">
        <infon key="identifier">MESH:D004194</infon>
        <infon key="type">Disease</infon>
        <location offset="16106" length="38"/>
        <text>anxiety linked to psychological stress</text>
      </annotation>
      <annotation id="262">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="16427" length="7"/>
        <text>anxiety</text>
      </annotation>
      <annotation id="263">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="15847" length="6"/>
        <text>GHQ-12</text>
      </annotation>
      <annotation id="264">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="16305" length="6"/>
        <text>GHQ-12</text>
      </annotation>
      <annotation id="265">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="15054" length="15"/>
        <text>chronic disease</text>
      </annotation>
      <annotation id="266">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="16754" length="7"/>
        <text>anxiety</text>
      </annotation>
      <annotation id="267">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="14656" length="3"/>
        <text>GHQ</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16804</offset>
      <text>In the health sector, work stress presents as an important risk factor for health workers and at the same time is an important problem negatively affecting the quality of health services. In our study group, the majority of the participants reported that they had experienced work-related stress. Previous studies have emphasized the necessity of researching stress factors linked to work and psychosocial working environment in health workers, a high risk group for developing burnout, role conflict and work dissatisfaction. As a result of the stress factors linked to work in health workers (long working hours, stressful work conditions, etc.) they remain at risk of developing many mental health problems such as work stress, burnout, depression, anxiety and post-traumatic stress disorder. According to a study in an Italian hospital, working environment and ergonomy, shift-work and disruption of workflow are among the factors causing work-related stress. A study of 36 hospitals in America examined the stress factors in nurses and found that the top three stressors were workload, organizational pressure and role conflict. The most frequently reported sources of stress were superiors, the work itself and colleagues. Unclear description of duties, human resources, and distance from occupation and workplace were other reported causes of work stress. A study in Hungary emphasized that there is an important relationship between burnout, role conflict and mental health in the psychosocial work environment of health workers. A study of nurses in Belgium showed that workload, burnout, work satisfaction and expectations were factors affecting the relationship between workers in the work environment and between workers and management.</text>
      <annotation id="275">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17032" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="276">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18064" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="277">
        <infon key="identifier">MESH:C535569</infon>
        <infon key="type">Disease</infon>
        <location offset="17197" length="12"/>
        <text>psychosocial</text>
      </annotation>
      <annotation id="278">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="17556" length="7"/>
        <text>anxiety</text>
      </annotation>
      <annotation id="279">
        <infon key="identifier">MESH:C535569</infon>
        <infon key="type">Disease</infon>
        <location offset="18293" length="12"/>
        <text>psychosocial</text>
      </annotation>
      <annotation id="280">
        <infon key="identifier">MESH:D004194</infon>
        <infon key="type">Disease</infon>
        <location offset="17573" length="25"/>
        <text>traumatic stress disorder</text>
      </annotation>
      <annotation id="281">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="17544" length="10"/>
        <text>depression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>18553</offset>
      <text>In our study, workplace factors were examined and the average working day was 9.3+-3.3 hours, with 4.8+-1.9 hours sitting at a desk and 4.9+-3.1 hours computer use. In the literature it is reported that work environment factors like the duration of the working day, time spent sitting at work and time working on a computer may cause psychosocial factors (work stress, depression, anxiety, etc) and musculoskeletal diseases. In our study while the time for sitting at a desk and using computers were at acceptable levels, the average work day of participants was above the legal limit, more than 8 hours. But long working hours negatively affect the health of workers and has been shown to cause harmful results in sensitive individuals. Additionally increased working hours may trigger risk factors for developing depression such as heavy workload, smoking and sleep disorders. In our study the duration of sleep was 6.9+-0.1 hours. When the active working hours of health professionals are considered, heavy workloads, such as being on call, can reduce the duration of sleep and sleep quality. It is reported that middle managers in hospitals could be rewarded for intense workloads, heavy responsibilities and long working hours. However, heavy workloads may cause role conflict, tiredness, burnout and mistakes, interrupting patient care and negatively affecting family life. In our working group 39 of the participants had a weekend holiday and 47 declared they created sufficient time for family. Needs such as weekend holidays and sufficient time with family, which are relaxing and important from the point of view of social support, can reduce work stress and the risk of developing depression, aiding in protecting mental health.</text>
      <annotation id="293">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19099" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="294">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19882" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="295">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19964" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="296">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="18934" length="7"/>
        <text>anxiety</text>
      </annotation>
      <annotation id="297">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="18922" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="298">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="19368" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="299">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="20245" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="300">
        <infon key="identifier">MESH:C535569</infon>
        <infon key="type">Disease</infon>
        <location offset="18887" length="12"/>
        <text>psychosocial</text>
      </annotation>
      <annotation id="301">
        <infon key="identifier">MESH:D005221</infon>
        <infon key="type">Disease</infon>
        <location offset="19836" length="9"/>
        <text>tiredness</text>
      </annotation>
      <annotation id="302">
        <infon key="identifier">MESH:D009140</infon>
        <infon key="type">Disease</infon>
        <location offset="18952" length="24"/>
        <text>musculoskeletal diseases</text>
      </annotation>
      <annotation id="303">
        <infon key="identifier">MESH:D012893</infon>
        <infon key="type">Disease</infon>
        <location offset="19415" length="15"/>
        <text>sleep disorders</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>20293</offset>
      <text>In a study by Lao, factors affecting work satisfaction among health workers included solving conflict in the workplace, relationships with colleagues and organizational structure. In our working group among the leading causes of work stress were colleagues and superiors. Interpersonal communication and increased social opportunities may solve these problems. Recently new methods of managing hospitals have begun to be developed, and studies have been completed on groups of individuals with high work satisfaction, programs with experienced managers and improving communication levels to increase social support in the workplace and reduce stress factors. A study of managers in Switzerland found that though improving communication between workers and with patients with positive support for widespread communication at all levels, some health organizations may encounter violent consequences linked to not taking sufficient care with communication. According to a study in India, the most important motivation factor not requiring material resources that must be considered by managers and political structures was reported as the opportunity for workers to develop skills in the work environment.</text>
      <annotation id="306">
        <infon key="identifier">259307</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">22567</infon>
        <location offset="20307" length="3"/>
        <text>Lao</text>
      </annotation>
      <annotation id="307">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21054" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>21496</offset>
      <text>The result of this study was that those at risk of developing mental health problems like depression or those with other physical or social health problems were directed to psychiatry and other related branches. To protect work health, an important part of societal health, it is important to monitor risk groups. Additionally employers can periodically monitor and measure work environment factors in the workplace to prevent physical and mental chronic health problems that may accompany the development of work stress risk. Organizations and managers can organise social activities to strengthen inter team communication and reduce the stress levels among workers in the workplace.</text>
      <annotation id="309">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="21586" length="10"/>
        <text>depression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>22181</offset>
      <text>5. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>22195</offset>
      <text>In this study, the majority of participants reported experiencing work stress with more than half at high risk of developing depression according to the GHQ-12 scale. The top three risk factors affecting stress among individuals in the study were superiors, work and colleagues. In our study group while there was no difference found between those at risk of depression and those not at risk in terms of sociodemographic characteristics, work-related factors and health behavior, to reduce the risk of health management trainees experiencing work stress and mental health problems psychosocial risk factors in the work environment should be investigated in more detail.</text>
      <annotation id="314">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="22226" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="315">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="22320" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="316">
        <infon key="identifier">MESH:C535569</infon>
        <infon key="type">Disease</infon>
        <location offset="22776" length="12"/>
        <text>psychosocial</text>
      </annotation>
      <annotation id="317">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="22554" length="10"/>
        <text>depression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>22865</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>22902</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="volume">7</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Parlar;given-names:S</infon>
      <infon key="fpage">547</infon>
      <infon key="year">2008</infon>
      <infon key="source">TAF Prev Med Bull</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">554</infon>
      <offset>22913</offset>
      <text>Saglik calisanlarinda goz ardi edilen bir durum: Saglikli calisma ortami</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Soysal;given-names:A</infon>
      <infon key="name_2">surname:Kilic;given-names:B</infon>
      <infon key="name_1">surname:Unal;given-names:B</infon>
      <infon key="name_0">surname:Demiral;given-names:Y</infon>
      <infon key="fpage">11</infon>
      <infon key="year">2007</infon>
      <infon key="source">Toplum Hekimligi Bulteni</infon>
      <infon key="type">ref</infon>
      <infon key="volume">26</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">18</infon>
      <infon key="name_6">surname:ve;given-names:ark</infon>
      <infon key="name_5">surname:Ucku;given-names:R</infon>
      <infon key="name_4">surname:Bilgin;given-names:AC</infon>
      <offset>23001</offset>
      <text>Isstresi olceginin Izmir Konak Belediyesi' nde calisan erkek iscilerde gecerlik ve guvenilirliginin incelenmesi</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="year">2008</infon>
      <infon key="type">ref</infon>
      <offset>23129</offset>
      <text>Work-related stress: new challenges in a changing workplace. the European Risk Observatory (ERO), part of EU-OSHA, unveiled the emerging risks related to workplaces</text>
      <annotation id="319">
        <infon key="identifier">54719</infon>
        <infon key="type">Species</infon>
        <location offset="23238" length="4"/>
        <text>OSHA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Wang;given-names:S</infon>
      <infon key="volume">45</infon>
      <infon key="name_2">surname:Ozminkowski;given-names:RJ</infon>
      <infon key="name_1">surname:Hawkins;given-names:K</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Goetzel;given-names:RZ</infon>
      <infon key="fpage">5</infon>
      <infon key="pub-id_pmid">12553174</infon>
      <infon key="year">2003</infon>
      <infon key="source">J Occup Environ Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">14</infon>
      <offset>23294</offset>
      <text>The health and productivity cost burden of the "Top 10" physical and mental health conditions affecting six large U.S. employers in 1999</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="source">Recruiters World Special Reports</infon>
      <infon key="type">ref</infon>
      <offset>23435</offset>
      <text>Stress in the Workplace. What's eating your company?</text>
      <annotation id="321">
        <infon key="identifier">MESH:D004194</infon>
        <infon key="type">Disease</infon>
        <location offset="23435" length="6"/>
        <text>Stress</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">20</infon>
      <infon key="name_2">surname:Basim;given-names:HN</infon>
      <infon key="name_1">surname:Guler;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sahin;given-names:NH</infon>
      <infon key="fpage">243</infon>
      <infon key="pub-id_pmid">19757224</infon>
      <infon key="year">2009</infon>
      <infon key="source">Turk Psikiyatri Dergisi</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">254</infon>
      <offset>23488</offset>
      <text>A tipi kisilik oruntusunde bilissel ve duygusal zekanin stresle basa cikma ve stress belirtileri ile iliskisi</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Bongers;given-names:PM</infon>
      <infon key="volume">9</infon>
      <infon key="name_2">surname:Proper;given-names:KI</infon>
      <infon key="name_1">surname:Anema;given-names:JR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Driessen;given-names:MT</infon>
      <infon key="fpage">145</infon>
      <infon key="pub-id_pmid">18959799</infon>
      <infon key="year">2008</infon>
      <infon key="source">BMC Musculoskelet Disord</infon>
      <infon key="type">ref</infon>
      <infon key="name_4">surname:van der Beek;given-names:AJ</infon>
      <offset>23609</offset>
      <text>Stay@Work: Participatory Ergonomics to prevent low back and neck pain among workers: design of a randomised controlled trial to evaluate the (cost-)effectiveness</text>
      <annotation id="323">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="23656" length="22"/>
        <text>low back and neck pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Riihimai;given-names:H</infon>
      <infon key="name_2">surname:Luukkonen;given-names:R</infon>
      <infon key="name_1">surname:Leino-Arjas;given-names:P</infon>
      <infon key="name_0">surname:Kivimaki;given-names:M</infon>
      <infon key="fpage">857</infon>
      <infon key="pub-id_pmid">12386034</infon>
      <infon key="year">2002</infon>
      <infon key="source">British Medical Journal</infon>
      <infon key="type">ref</infon>
      <infon key="volume">325</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">863</infon>
      <infon key="name_5">surname:Kirjonen;given-names:J</infon>
      <infon key="name_4">surname:Vahtera;given-names:J</infon>
      <offset>23771</offset>
      <text>Work stress and risk of coronary mortality: Prospective cohort study of industrial employees</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>23864</offset>
      <text>Employment Relations &amp; Union Services. Health &amp; safety-workplace stress. ERUS H&amp;S 01 May 2004, The Chartered Society of Physiotherapy</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="year">2001</infon>
      <infon key="source">Mental health: New understanding</infon>
      <infon key="type">ref</infon>
      <offset>23998</offset>
      <text>World Health Organization</text>
    </passage>
    <passage>
      <infon key="volume">34</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Unger;given-names:HP</infon>
      <infon key="fpage">256</infon>
      <infon key="issue"> Suppl3</infon>
      <infon key="year">2007</infon>
      <infon key="source">Psychiatr Prax</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">260</infon>
      <offset>24024</offset>
      <text>Work-related depression</text>
      <annotation id="325">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="24037" length="10"/>
        <text>depression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">3</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Chopra;given-names:P</infon>
      <infon key="fpage">4</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">19232117</infon>
      <infon key="year">2009</infon>
      <infon key="source">Int J Ment Health Syst</infon>
      <infon key="type">ref</infon>
      <offset>24048</offset>
      <text>Mental health and the workplace: issues for developing countries</text>
    </passage>
    <passage>
      <infon key="volume">10</infon>
      <infon key="name_1">surname:Farvolden;given-names:P</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bender;given-names:A</infon>
      <infon key="fpage">73</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">18269898</infon>
      <infon key="year">2008</infon>
      <infon key="source">Curr Psychiatry Rep</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">79</infon>
      <offset>24113</offset>
      <text>Depression and the workplace: a progress report</text>
      <annotation id="327">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="24113" length="10"/>
        <text>Depression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">50</infon>
      <infon key="name_1">surname:Henke;given-names:RM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Lerner;given-names:D</infon>
      <infon key="fpage">401</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">18404013</infon>
      <infon key="year">2008</infon>
      <infon key="source">J Occup Environ Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">410</infon>
      <offset>24161</offset>
      <text>What does research tell us about depression, job performance, and work productivity?</text>
      <annotation id="329">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="24194" length="10"/>
        <text>depression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_2">surname:Gonzalez;given-names:ER</infon>
      <infon key="name_1">surname:Schneider;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Milczarek;given-names:M</infon>
      <infon key="fpage">20</infon>
      <infon key="year">2009</infon>
      <infon key="comment">ISBN 978-92-9191-224-7</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">21</infon>
      <offset>24246</offset>
      <text>European Risk Observatory Report. OSH in Figures: Stres at work-facts and figures. European Agency for Safety and Health at Work</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Hamilton;given-names:S</infon>
      <infon key="name_2">surname:McLeod;given-names:DK</infon>
      <infon key="name_1">surname:Westcott;given-names:T</infon>
      <infon key="name_0">surname:Dowell;given-names:AC</infon>
      <infon key="fpage">540</infon>
      <infon key="issue">1145</infon>
      <infon key="pub-id_pmid">11833946</infon>
      <infon key="year">2001</infon>
      <infon key="source">The New Zealand Medical Journal</infon>
      <infon key="type">ref</infon>
      <infon key="volume">114</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">543</infon>
      <offset>24375</offset>
      <text>A survey of job satisfaction, sources of stress and psychological symptoms among New Zealand health professionals</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Teixeira;given-names:PM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Gomes;given-names:AR</infon>
      <infon key="year">2014</infon>
      <infon key="comment">doi: 10.1002/smi.2583. [Epub ahead of print]</infon>
      <infon key="source">Stress Health</infon>
      <infon key="type">ref</infon>
      <offset>24489</offset>
      <text>Stress, Cognitive Appraisal and Psychological Health: Testing Instruments for Health Professionals</text>
      <annotation id="331">
        <infon key="identifier">MESH:D004194</infon>
        <infon key="type">Disease</infon>
        <location offset="24489" length="6"/>
        <text>Stress</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Yu;given-names:N</infon>
      <infon key="name_2">surname:Burton;given-names:G</infon>
      <infon key="name_1">surname:Besley;given-names:K</infon>
      <infon key="name_0">surname:Foureur;given-names:M</infon>
      <infon key="fpage">114</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">24099232</infon>
      <infon key="year">2013</infon>
      <infon key="source">Contemp Nurse</infon>
      <infon key="type">ref</infon>
      <infon key="volume">45</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">125</infon>
      <infon key="name_4">surname:Crisp;given-names:J</infon>
      <offset>24588</offset>
      <text>Enhancing the resilience of nurses and midwives: pilot of a mindfulness-based program for increased health, sense of coherence and decreased depression, anxiety and stress</text>
      <annotation id="334">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="24741" length="7"/>
        <text>anxiety</text>
      </annotation>
      <annotation id="335">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="24719" length="20"/>
        <text>decreased depression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Jutte;given-names:DP</infon>
      <infon key="volume">7</infon>
      <infon key="name_2">surname:Shwe Oo;given-names:EK</infon>
      <infon key="name_1">surname:Stock;given-names:L</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Lim;given-names:AG</infon>
      <infon key="fpage">15</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">23899166</infon>
      <infon key="year">2013</infon>
      <infon key="source">Confl Health</infon>
      <infon key="type">ref</infon>
      <offset>24760</offset>
      <text>Trauma and mental health of medics in eastern Myanmar's conflict zones: a cross-sectional and mixed methods investigation</text>
      <annotation id="337">
        <infon key="identifier">MESH:D014947</infon>
        <infon key="type">Disease</infon>
        <location offset="24760" length="6"/>
        <text>Trauma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">9</infon>
      <infon key="name_1">surname:Hillier;given-names:VF</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Goldberg;given-names:DP</infon>
      <infon key="fpage">139</infon>
      <infon key="pub-id_pmid">424481</infon>
      <infon key="year">1979</infon>
      <infon key="source">Psychol Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">145</infon>
      <offset>24882</offset>
      <text>A scaled version of the General Health Questionnaire</text>
    </passage>
    <passage>
      <infon key="volume">7</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kilic;given-names:C</infon>
      <infon key="fpage">3</infon>
      <infon key="year">1996</infon>
      <infon key="source">Turk Psikiyatri Dergisi</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">9</infon>
      <offset>24935</offset>
      <text>Genel Saglik Anketi: Guvenilirlik ve gecerlilik calismasi</text>
    </passage>
    <passage>
      <infon key="volume">25</infon>
      <infon key="name_2">surname:Akiyama;given-names:I</infon>
      <infon key="name_1">surname:Sakakibara;given-names:H</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Nishitani;given-names:N</infon>
      <infon key="fpage">45</infon>
      <infon key="pub-id_pmid">18834723</infon>
      <infon key="year">2009</infon>
      <infon key="source">Nutrition</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">50</infon>
      <offset>25001</offset>
      <text>Eating behavior related to obesity and job stress in male Japanese workers</text>
      <annotation id="339">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="25028" length="7"/>
        <text>obesity</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ding;given-names:L</infon>
      <infon key="name_2">surname:Zaslavsky;given-names:AM</infon>
      <infon key="name_1">surname:He;given-names:Y</infon>
      <infon key="name_0">surname:Block;given-names:JP</infon>
      <infon key="fpage">181</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">19465744</infon>
      <infon key="year">2009</infon>
      <infon key="source">American Journal of Epidemiology</infon>
      <infon key="type">ref</infon>
      <infon key="volume">170</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">192</infon>
      <infon key="name_4">surname:Ayanian;given-names:JZ</infon>
      <offset>25076</offset>
      <text>Psychosocial stress and change in weight among US adults</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Hibino;given-names:Y</infon>
      <infon key="name_2">surname:Kambayashi;given-names:Y</infon>
      <infon key="name_1">surname:Hitomi;given-names:Y</infon>
      <infon key="name_0">surname:Sagara;given-names:T</infon>
      <infon key="fpage">319</infon>
      <infon key="issue">6</infon>
      <infon key="pub-id_pmid">19655222</infon>
      <infon key="year">2009</infon>
      <infon key="source">Environ Health Prev Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">14</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">327</infon>
      <infon key="name_5">surname:Sasahara;given-names:S</infon>
      <infon key="name_4">surname:Matsuzaki;given-names:I</infon>
      <offset>25133</offset>
      <text>Common risk factors for changes in body weight and psychological well-being in Japanese male middle-aged workers</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Sogaard;given-names:K</infon>
      <infon key="name_2">surname:Hansen;given-names:EA</infon>
      <infon key="name_1">surname:Blangsted;given-names:AK</infon>
      <infon key="name_0">surname:Hansen;given-names:AM</infon>
      <infon key="fpage">143</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">19669784</infon>
      <infon key="year">2010</infon>
      <infon key="source">Int Arch Occup Environ Health</infon>
      <infon key="type">ref</infon>
      <infon key="volume">83</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">153</infon>
      <infon key="name_4">surname:Sjogaard;given-names:G</infon>
      <offset>25246</offset>
      <text>Physical activity, job demand-control, perceived stress-energy, and salivary cortisol in white-collar workers</text>
    </passage>
    <passage>
      <infon key="volume">11</infon>
      <infon key="name_1">surname:Ataoglu;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Canan;given-names:F</infon>
      <infon key="fpage">38</infon>
      <infon key="year">2010</infon>
      <infon key="source">Anadolu Psikiyatri Dergisi</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">43</infon>
      <offset>25356</offset>
      <text>Anksiyete, depresyon ve problem cozme becerisi algisiuzerine duzenli sporun etkisi</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Abeni;given-names:D</infon>
      <infon key="name_2">surname:Renzi;given-names:C</infon>
      <infon key="name_1">surname:Di Pietro;given-names:C</infon>
      <infon key="name_0">surname:Tabolli;given-names:S</infon>
      <infon key="fpage">B17</infon>
      <infon key="issue">3 Suppl B</infon>
      <infon key="pub-id_pmid">21302521</infon>
      <infon key="year">2010</infon>
      <infon key="source">G Ital Med Lav Ergon</infon>
      <infon key="type">ref</infon>
      <infon key="volume">32</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">B22</infon>
      <offset>25445</offset>
      <text>Job satisfaction and psychological wellbeing in bio-medical researchers</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Di Pietro;given-names:C</infon>
      <infon key="name_2">surname:Renzi;given-names:C</infon>
      <infon key="name_1">surname:Tabolli;given-names:S</infon>
      <infon key="name_0">surname:Ianni;given-names:A</infon>
      <infon key="fpage">245</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">15202674</infon>
      <infon key="year">2004</infon>
      <infon key="source">Recenti Prog Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">95</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">250</infon>
      <offset>25517</offset>
      <text>Job satisfaction, depressive and anxiety disorders among hospital personnel at IDI Sanita, Rome</text>
      <annotation id="342">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="25535" length="10"/>
        <text>depressive</text>
      </annotation>
      <annotation id="343">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="25550" length="17"/>
        <text>anxiety disorders</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Renzi;given-names:C</infon>
      <infon key="name_2">surname:Luigi;given-names:Aparo U</infon>
      <infon key="name_1">surname:di Pietro;given-names:C</infon>
      <infon key="name_0">surname:Tabolli;given-names:S</infon>
      <infon key="fpage">157</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">20476655</infon>
      <infon key="year">2010</infon>
      <infon key="source">Ann Ig</infon>
      <infon key="type">ref</infon>
      <infon key="volume">22</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">164</infon>
      <offset>25614</offset>
      <text>Psychological wellbeing in the hospital administrative personnel</text>
    </passage>
    <passage>
      <infon key="volume">34</infon>
      <infon key="name_2">surname:Filon;given-names:FL</infon>
      <infon key="name_1">surname:Peresson;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rizzo;given-names:M</infon>
      <infon key="fpage">716</infon>
      <infon key="issue">3 Suppl</infon>
      <infon key="pub-id_pmid">23405760</infon>
      <infon key="year">2012</infon>
      <infon key="source">G Ital Med Lav Ergon</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">719</infon>
      <offset>25679</offset>
      <text>Approach to the assessment of occupational stress at a hospital</text>
    </passage>
    <passage>
      <infon key="volume">43</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Piko;given-names:BF</infon>
      <infon key="fpage">311</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">15964005</infon>
      <infon key="year">2006</infon>
      <infon key="source">Int J Nurs Stud</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">318</infon>
      <offset>25743</offset>
      <text>Burnout, role conflict, job satisfaction and psychosocial health among Hungarian health care staff: a questionnaire survey</text>
      <annotation id="345">
        <infon key="identifier">MESH:C535569</infon>
        <infon key="type">Disease</infon>
        <location offset="25788" length="12"/>
        <text>psychosocial</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Di Pietro;given-names:C</infon>
      <infon key="name_2">surname:Ianni;given-names:A</infon>
      <infon key="name_1">surname:Tabolli;given-names:S</infon>
      <infon key="name_0">surname:Renzi;given-names:C</infon>
      <infon key="fpage">153</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">15752281</infon>
      <infon key="year">2005</infon>
      <infon key="source">J Eur Acad Dermatol Venereol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">19</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">157</infon>
      <infon key="name_4">surname:Puddu;given-names:P</infon>
      <offset>25866</offset>
      <text>Burnout and job satisfaction comparing healthcare staff of a dermatological hospital and a general hospital</text>
    </passage>
    <passage>
      <infon key="volume">50</infon>
      <infon key="name_2">surname:Uner;given-names:S</infon>
      <infon key="name_1">surname:Cayir;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sevencan;given-names:F</infon>
      <infon key="fpage">501</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">21375150</infon>
      <infon key="year">2010</infon>
      <infon key="source">Cah Sociol Demogr Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">515</infon>
      <offset>25974</offset>
      <text>Burnout status of interns and associated factors</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Violante;given-names:B</infon>
      <infon key="name_2">surname:Manconi;given-names:MP</infon>
      <infon key="name_1">surname:Gerbaudo;given-names:L</infon>
      <infon key="name_0">surname:Cortese;given-names:CG</infon>
      <infon key="fpage">141</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">23789520</infon>
      <infon key="year">2013</infon>
      <infon key="source">Med Lav</infon>
      <infon key="type">ref</infon>
      <infon key="volume">104</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">157</infon>
      <offset>26023</offset>
      <text>Identification of risk factors for work-related stress in a hospital: a qualitative and quantitative approach</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Sievers;given-names:A</infon>
      <infon key="name_2">surname:Ehrhart;given-names:MG</infon>
      <infon key="name_1">surname:Stichler;given-names:JF</infon>
      <infon key="name_0">surname:Kath;given-names:LM</infon>
      <infon key="fpage">1474</infon>
      <infon key="issue">11</infon>
      <infon key="pub-id_pmid">23522937</infon>
      <infon key="year">2013</infon>
      <infon key="source">Int J Nurs Stud</infon>
      <infon key="type">ref</infon>
      <infon key="volume">50</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1480</infon>
      <offset>26133</offset>
      <text>Predictors of nurse manager stress: a dominance analysis of potential work environment stressors</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Mondelaers;given-names:M</infon>
      <infon key="name_2">surname:Willems;given-names:R</infon>
      <infon key="name_1">surname:Clarke;given-names:S</infon>
      <infon key="name_0">surname:Van Bogaert;given-names:P</infon>
      <infon key="fpage">1515</infon>
      <infon key="issue">7</infon>
      <infon key="pub-id_pmid">22989323</infon>
      <infon key="year">2013</infon>
      <infon key="source">J Adv Nurs</infon>
      <infon key="type">ref</infon>
      <infon key="volume">69</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1524</infon>
      <offset>26230</offset>
      <text>Nurse practice environment, workload, burnout, job outcomes, and quality of care in psychiatric hospitals: a structural equation model approach</text>
      <annotation id="347">
        <infon key="identifier">MESH:D001523</infon>
        <infon key="type">Disease</infon>
        <location offset="26314" length="11"/>
        <text>psychiatric</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Schaefer;given-names:H</infon>
      <infon key="name_2">surname:Herrmann-Lingen;given-names:C</infon>
      <infon key="name_1">surname:Laptinskaya;given-names:D</infon>
      <infon key="name_0">surname:Blozik;given-names:E</infon>
      <infon key="fpage">13</infon>
      <infon key="pub-id_pmid">19171034</infon>
      <infon key="year">2009</infon>
      <infon key="source">BMC Musculoskelet Disord</infon>
      <infon key="type">ref</infon>
      <infon key="volume">10</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_5">surname:Himmel;given-names:W</infon>
      <infon key="name_4">surname:Kochen;given-names:MM</infon>
      <offset>26374</offset>
      <text>Depression and anxiety as major determinants of neck pain: a cross-sectional study in general practice</text>
      <annotation id="351">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="26374" length="10"/>
        <text>Depression</text>
      </annotation>
      <annotation id="352">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="26389" length="7"/>
        <text>anxiety</text>
      </annotation>
      <annotation id="353">
        <infon key="identifier">MESH:D019547</infon>
        <infon key="type">Disease</infon>
        <location offset="26422" length="9"/>
        <text>neck pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Rieger;given-names:MA</infon>
      <infon key="volume">9</infon>
      <infon key="name_2">surname:Liebers;given-names:F</infon>
      <infon key="name_1">surname:Gebhardt;given-names:H</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Klussmann;given-names:A</infon>
      <infon key="fpage">96</infon>
      <infon key="pub-id_pmid">18588677</infon>
      <infon key="year">2008</infon>
      <infon key="source">BMC Musculoskelet Disord</infon>
      <infon key="type">ref</infon>
      <offset>26477</offset>
      <text>Musculoskeletal symptoms of the upper extremities and the neck: A cross-sectional study on prevalence and symptom-predicting factors at visual display terminal (VDT) workstations</text>
      <annotation id="355">
        <infon key="identifier">MESH:D009140</infon>
        <infon key="type">Disease</infon>
        <location offset="26477" length="49"/>
        <text>Musculoskeletal symptoms of the upper extremities</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Toomingas;given-names:A</infon>
      <infon key="name_2">surname:Hagman;given-names:M</infon>
      <infon key="name_1">surname:Floderus;given-names:B</infon>
      <infon key="name_0">surname:Norman;given-names:K</infon>
      <infon key="fpage">201</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">18413936</infon>
      <infon key="year">2008</infon>
      <infon key="source">Work</infon>
      <infon key="type">ref</infon>
      <infon key="volume">30</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">214</infon>
      <infon key="name_4">surname:Tornqvist;given-names:EW</infon>
      <offset>26656</offset>
      <text>Musculoskeletal symptoms in relation to work exposures at call centre companies in Sweden</text>
      <annotation id="357">
        <infon key="identifier">MESH:D009140</infon>
        <infon key="type">Disease</infon>
        <location offset="26656" length="24"/>
        <text>Musculoskeletal symptoms</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Heitmann;given-names:A</infon>
      <infon key="name_2">surname:Eggerth;given-names:D</infon>
      <infon key="name_1">surname:Bushnell;given-names:T</infon>
      <infon key="name_0">surname:Caruso;given-names:CC</infon>
      <infon key="fpage">930</infon>
      <infon key="issue">11</infon>
      <infon key="pub-id_pmid">16948157</infon>
      <infon key="year">2006</infon>
      <infon key="source">Am J Ind Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">49</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">942</infon>
      <infon key="name_5">surname:Newman;given-names:K</infon>
      <infon key="name_4">surname:Kojola;given-names:B</infon>
      <offset>26746</offset>
      <text>Long working hours, safety, and health: toward a National Research Agenda</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Tsutsui;given-names:T</infon>
      <infon key="name_2">surname:Hoshuyama;given-names:T</infon>
      <infon key="name_1">surname:Horie;given-names:S</infon>
      <infon key="name_0">surname:Fujino;given-names:Y</infon>
      <infon key="fpage">87</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">16908956</infon>
      <infon key="year">2006</infon>
      <infon key="source">Sangyo Eiseigaku Zasshi</infon>
      <infon key="type">ref</infon>
      <infon key="volume">48</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">97</infon>
      <infon key="name_4">surname:Tanaka;given-names:Y</infon>
      <offset>26820</offset>
      <text>A systematic review of working hours and mental health burden</text>
    </passage>
    <passage>
      <infon key="volume">59</infon>
      <infon key="name_2">surname:Theriault;given-names:G</infon>
      <infon key="name_1">surname:Miyake;given-names:H</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sato;given-names:Y</infon>
      <infon key="fpage">14</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">19001069</infon>
      <infon key="year">2009</infon>
      <infon key="source">Occup Med (Lond)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">19</infon>
      <offset>26882</offset>
      <text>Overtime work and stress response in a group of Japanese workers</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Hojou;given-names:M</infon>
      <infon key="name_2">surname:Takahashi;given-names:M</infon>
      <infon key="name_1">surname:Nakata;given-names:A</infon>
      <infon key="name_0">surname:Ikeda;given-names:T</infon>
      <infon key="fpage">26</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">19057116</infon>
      <infon key="year">2009</infon>
      <infon key="source">J Occup Health</infon>
      <infon key="type">ref</infon>
      <infon key="volume">51</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">37</infon>
      <infon key="name_5">surname:Nishikido;given-names:N</infon>
      <infon key="name_4">surname:Haratani;given-names:T</infon>
      <offset>26947</offset>
      <text>Correlates of depressive symptoms among workers in small- and medium-scale manufacturing enterprises in Japan</text>
      <annotation id="359">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="26961" length="19"/>
        <text>depressive symptoms</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Moore;given-names:C</infon>
      <infon key="name_2">surname:Gascoigne;given-names:C</infon>
      <infon key="name_1">surname:Parry;given-names:E</infon>
      <infon key="name_0">surname:Buchanan;given-names:DA</infon>
      <infon key="fpage">646</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">24341181</infon>
      <infon key="year">2013</infon>
      <infon key="source">J Health Organ Manag</infon>
      <infon key="type">ref</infon>
      <infon key="volume">27</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">664</infon>
      <offset>27057</offset>
      <text>Are healthcare middle management jobs extreme jobs?</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Hirosawa;given-names:T</infon>
      <infon key="name_2">surname:Sarker;given-names:MA</infon>
      <infon key="name_1">surname:Harun-Or-Rashid;given-names:M</infon>
      <infon key="name_0">surname:Khamlub;given-names:S</infon>
      <infon key="fpage">233</infon>
      <infon key="issue">3-4</infon>
      <infon key="pub-id_pmid">24640179</infon>
      <infon key="year">2013</infon>
      <infon key="source">Nagoya J Med Sci</infon>
      <infon key="type">ref</infon>
      <infon key="volume">75</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">241</infon>
      <infon key="name_5">surname:Sakamoto;given-names:J</infon>
      <infon key="name_4">surname:Outavong;given-names:P</infon>
      <offset>27109</offset>
      <text>Job satisfaction of health-care workers at health centers in Vientiane Capital and Bolikhamsai Province, Lao PDR</text>
      <annotation id="361">
        <infon key="identifier">259307</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">22567</infon>
        <location offset="27214" length="3"/>
        <text>Lao</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">27</infon>
      <infon key="name_1">surname:West;given-names:MA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Buttigieg;given-names:SC</infon>
      <infon key="fpage">171</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">23802397</infon>
      <infon key="year">2013</infon>
      <infon key="source">J Health Organ Manag</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">192</infon>
      <offset>27222</offset>
      <text>Senior management leadership, social support, job design and stressor-to-strain relationships in hospital practice</text>
    </passage>
    <passage>
      <infon key="volume">115</infon>
      <infon key="name_2">surname:De Morgan;given-names:PE</infon>
      <infon key="name_1">surname:Heeb;given-names:JL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Haberey-Knuessi;given-names:V</infon>
      <infon key="fpage">8</infon>
      <infon key="pub-id_pmid">24490450</infon>
      <infon key="year">2013</infon>
      <infon key="source">Rech Soins Infirm</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">18</infon>
      <offset>27337</offset>
      <text>Communication among hospital leaders</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Steinhardt;given-names:L</infon>
      <infon key="volume">8</infon>
      <infon key="name_2">surname:Mahapatra;given-names:P</infon>
      <infon key="name_1">surname:Chakraborty;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Peters;given-names:DH</infon>
      <infon key="fpage">27</infon>
      <infon key="pub-id_pmid">21108833</infon>
      <infon key="year">2010</infon>
      <infon key="source">Hum Resour Health</infon>
      <infon key="type">ref</infon>
      <offset>27374</offset>
      <text>Job satisfaction and motivation of health workers in public and private sectors: cross-sectional analysis from two Indian states</text>
    </passage>
  </document>
  <document>
    <id>4272828</id>
    <passage>
      <infon key="article-id_pmid">25568626</infon>
      <infon key="name_0">surname:Cukic;given-names:Vesna</infon>
      <infon key="fpage">303</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272828</infon>
      <infon key="article-id_publisher-id">MSM-26-303</infon>
      <infon key="article-id_doi">10.5455/msm.2014.26.303-305</infon>
      <infon key="type">front</infon>
      <infon key="volume">26</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Mater Sociomed; 2014 Oct; 26(5) 303-5. doi:10.5455/msm.2014.26.303-305</infon>
      <infon key="kwd">postoperative pulmonary thromboembolism surgery</infon>
      <infon key="lpage">305</infon>
      <infon key="authors">Cukic V</infon>
      <offset>0</offset>
      <text>The Pulmonary Thromboembolism as a Risk of Surgical Treatments and the Role of Anticoagulant Prophylaxiss</text>
      <annotation id="1">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="4" length="25"/>
        <text>Pulmonary Thromboembolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>106</offset>
      <text>Objective:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>117</offset>
      <text>Our objective is to show the number of patients with postoperative pulmonary thromboembolism (PPTE) treated in Intensive care unit of Clinic for pulmonary diseases an TB "Podhrastovi" in three-year period : from June 1, 2011 - June 1, 2014 and to indicate the importance of various surgical operations in the development of pulmonary thromboembolism (PTE).</text>
      <annotation id="6">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="156" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="7">
        <infon key="identifier">MESH:D008171</infon>
        <infon key="type">Disease</infon>
        <location offset="262" length="18"/>
        <text>pulmonary diseases</text>
      </annotation>
      <annotation id="8">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="441" length="25"/>
        <text>pulmonary thromboembolism</text>
      </annotation>
      <annotation id="9">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="170" length="39"/>
        <text>postoperative pulmonary thromboembolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>478</offset>
      <text>Material and methods:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>500</offset>
      <text>This is the retrospective study which shows the number of patients with PPTE treated in Intensive care unit of Clinic for pulmonary diseases an TB "Podhrastovi" in three-year period : from 01.06.2011.-01.06.2014. It represents the number of these patients, per cent of patients with PPTE of total patients with PTE, age and sex of patients, type of surgery, period expressed in days from surgery to diagnosis of PTE, presence of deep venous thrombosis (DVT) of lower extremities, massiveness of PPTE e.g. level of pulmonary artery with embolus.</text>
      <annotation id="19">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="558" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="20">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="747" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="21">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="769" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="22">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="797" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="23">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="831" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="24">
        <infon key="identifier">MESH:D004617</infon>
        <infon key="type">Disease</infon>
        <location offset="1036" length="7"/>
        <text>embolus</text>
      </annotation>
      <annotation id="25">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="929" length="22"/>
        <text>deep venous thrombosis</text>
      </annotation>
      <annotation id="26">
        <infon key="identifier">MESH:D008171</infon>
        <infon key="type">Disease</infon>
        <location offset="622" length="18"/>
        <text>pulmonary diseases</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">OMIM:612862</infon>
        <infon key="type">Disease</infon>
        <location offset="953" length="3"/>
        <text>DVT</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1049</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1058</offset>
      <text>In three-year period 232 patients with PTE were treated in Intensive care unit of Clinic "Podhrastovi". 60 of them or 25.86% were patients with 24 males or 40% middle-aged 58.5 years, and 36 females or 60% middle-aged 56.3 years. PPTE developed in 15 patients with abdominal, 11 with urologic, 8 with gynecologic, 15 with orthopedic, 4 with cardiologic, 2 with vascular, 3 with neurosurgical, 1 with glandular and 1 with orl operations. The average period from operation to diagnosis of PPTE was 10.5 days for women, and 13.8 days for men. Only two patients had acute DVT after operation (one man and one woman), and five had amnesias of previous DVT or PTE. The level or the site of pulmonary embolus was different from segmental to main branches of pulmonary artery.</text>
      <annotation id="42">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1083" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="43">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1188" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="44">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1309" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="45">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1568" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="46">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1593" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="47">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1607" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1651" length="3"/>
        <text>man</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1663" length="5"/>
        <text>woman</text>
      </annotation>
      <annotation id="50">
        <infon key="identifier">MESH:D000647</infon>
        <infon key="type">Disease</infon>
        <location offset="1684" length="8"/>
        <text>amnesias</text>
      </annotation>
      <annotation id="51">
        <infon key="identifier">MESH:D004617</infon>
        <infon key="type">Disease</infon>
        <location offset="1742" length="17"/>
        <text>pulmonary embolus</text>
      </annotation>
      <annotation id="52">
        <infon key="identifier">OMIM:612862</infon>
        <infon key="type">Disease</infon>
        <location offset="1626" length="3"/>
        <text>DVT</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="1545" length="4"/>
        <text>PPTE</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="1288" length="4"/>
        <text>PPTE</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">OMIM:612862</infon>
        <infon key="type">Disease</infon>
        <location offset="1705" length="3"/>
        <text>DVT</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1831</offset>
      <text>Conclusion:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1843</offset>
      <text>Different surgical operations are the big risk factor for the development of PTE. There is great significance of anticoagulant prophylaxis before surgery even in patients with no anamnesis of previous DVT or PTE.</text>
      <annotation id="58">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2005" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="59">
        <infon key="identifier">OMIM:612862</infon>
        <infon key="type">Disease</infon>
        <location offset="2044" length="3"/>
        <text>DVT</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>2056</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2072</offset>
      <text>Embolism of the pulmonary artery or one of its branches is the most striking and characteristic appearance of thromboembolic disease. According to textbooks and most of literature in most cases the starting point of the embolus is phlebothrombosis or thrombophlebitis of veins of lower extremities.</text>
      <annotation id="65">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="2072" length="32"/>
        <text>Embolism of the pulmonary artery</text>
      </annotation>
      <annotation id="66">
        <infon key="identifier">MESH:D004617</infon>
        <infon key="type">Disease</infon>
        <location offset="2292" length="7"/>
        <text>embolus</text>
      </annotation>
      <annotation id="67">
        <infon key="identifier">MESH:D013924</infon>
        <infon key="type">Disease</infon>
        <location offset="2323" length="16"/>
        <text>thrombophlebitis</text>
      </annotation>
      <annotation id="68">
        <infon key="identifier">MESH:D013923</infon>
        <infon key="type">Disease</infon>
        <location offset="2182" length="22"/>
        <text>thromboembolic disease</text>
      </annotation>
      <annotation id="69">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="2303" length="16"/>
        <text>phlebothrombosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2371</offset>
      <text>It is often difficult to determine the starting point of pulmonary emboli. Pulmonary embolism is very common nowadays, and favoring factors for its occurrence are the chronic diseases and therefore a long lying (bed rest), which leads to the development of phlebothrombosis and a large number of different surgical operations </text>
      <annotation id="73">
        <infon key="identifier">100653365</infon>
        <infon key="type">Gene</infon>
        <location offset="2583" length="3"/>
        <text>bed</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="2628" length="16"/>
        <text>phlebothrombosis</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="2446" length="18"/>
        <text>Pulmonary embolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_2</infon>
      <offset>2698</offset>
      <text>1.1. The etiology of pulmonary thromboembolism:</text>
      <annotation id="77">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="2719" length="25"/>
        <text>pulmonary thromboembolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2746</offset>
      <text>  Phlebothrombosis and thrombophlebitis of lower extremities veins</text>
      <annotation id="80">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="2748" length="16"/>
        <text>Phlebothrombosis</text>
      </annotation>
      <annotation id="81">
        <infon key="identifier">MESH:D013924</infon>
        <infon key="type">Disease</infon>
        <location offset="2769" length="43"/>
        <text>thrombophlebitis of lower extremities veins</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2815</offset>
      <text>  Phlebothrombosis of pelvic and abdominal veins usually after surgery</text>
      <annotation id="83">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="2817" length="26"/>
        <text>Phlebothrombosis of pelvic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2888</offset>
      <text>  Thrombophlebitis and phlebothrombosis of veins of lower extremities after trauma and various surgical operations</text>
      <annotation id="87">
        <infon key="identifier">MESH:D013924</infon>
        <infon key="type">Disease</infon>
        <location offset="2890" length="16"/>
        <text>Thrombophlebitis</text>
      </annotation>
      <annotation id="88">
        <infon key="identifier">MESH:D014947</infon>
        <infon key="type">Disease</infon>
        <location offset="2964" length="6"/>
        <text>trauma</text>
      </annotation>
      <annotation id="89">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="2911" length="46"/>
        <text>phlebothrombosis of veins of lower extremities</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3005</offset>
      <text>  Intracardiac thrombosis of the right cardiac ventricle</text>
      <annotation id="91">
        <infon key="identifier">MESH:D013927</infon>
        <infon key="type">Disease</infon>
        <location offset="3020" length="10"/>
        <text>thrombosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3064</offset>
      <text>  Thrombosis of the pulmonary artery or some of its branches in situ</text>
      <annotation id="93">
        <infon key="identifier">MESH:D013927</infon>
        <infon key="type">Disease</infon>
        <location offset="3066" length="34"/>
        <text>Thrombosis of the pulmonary artery</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3135</offset>
      <text>  There are other, less common types of emboli: e.g. tissue cells, fat, oil, gas embolism and the like </text>
      <annotation id="96">
        <infon key="identifier">MESH:D004618</infon>
        <infon key="type">Disease</infon>
        <location offset="3212" length="12"/>
        <text>gas embolism</text>
      </annotation>
      <annotation id="97">
        <infon key="identifier">MESH:D009821</infon>
        <infon key="type">Chemical</infon>
        <location offset="3207" length="3"/>
        <text>oil</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_2</infon>
      <offset>3241</offset>
      <text>1.2. Risk factors for deep vein thrombosis and pulmonary thromboembolism</text>
      <annotation id="100">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="3263" length="20"/>
        <text>deep vein thrombosis</text>
      </annotation>
      <annotation id="101">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="3288" length="25"/>
        <text>pulmonary thromboembolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3314</offset>
      <text>Factors dependent on the patient:</text>
      <annotation id="103">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3339" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3348</offset>
      <text>  Age over 40 years</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3370</offset>
      <text>  Obesity</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3382</offset>
      <text>  Immobilization / bed rest/- lying in bed for longer than 4 days</text>
      <annotation id="106">
        <infon key="identifier">100653365</infon>
        <infon key="type">Gene</infon>
        <location offset="3401" length="3"/>
        <text>bed</text>
      </annotation>
      <annotation id="107">
        <infon key="identifier">100653365</infon>
        <infon key="type">Gene</infon>
        <location offset="3421" length="3"/>
        <text>bed</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3450</offset>
      <text>  Deep vein thrombosis or pulmonary embolism in history</text>
      <annotation id="110">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="3476" length="18"/>
        <text>pulmonary embolism</text>
      </annotation>
      <annotation id="111">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="3457" length="15"/>
        <text>vein thrombosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3508</offset>
      <text>  Thrombophilia, deficiency of antithrombin(AT) III factor, protein C, protein S; lupus anticoagulant, resistance to activated protein C, hemocistinemia </text>
      <annotation id="115">
        <infon key="type">Disease</infon>
        <location offset="3552" length="2"/>
        <text>AT</text>
      </annotation>
      <annotation id="116">
        <infon key="type">Disease</infon>
        <location offset="3646" length="14"/>
        <text>hemocistinemia</text>
      </annotation>
      <annotation id="117">
        <infon key="identifier">MESH:D019851</infon>
        <infon key="type">Disease</infon>
        <location offset="3510" length="25"/>
        <text>Thrombophilia, deficiency</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3664</offset>
      <text>Factors dependent on the type of illness or surgery</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3716</offset>
      <text>  Trauma or surgery: especially the pelvis, hip, leg</text>
      <annotation id="119">
        <infon key="identifier">MESH:D014947</infon>
        <infon key="type">Disease</infon>
        <location offset="3718" length="6"/>
        <text>Trauma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3771</offset>
      <text>  Malignant processes-particularly in the pelvis, abdomen, primary or metastatic</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3854</offset>
      <text>  Heart failure</text>
      <annotation id="121">
        <infon key="identifier">MESH:D006333</infon>
        <infon key="type">Disease</infon>
        <location offset="3856" length="13"/>
        <text>Heart failure</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3872</offset>
      <text>  Recent myocardial infarction</text>
      <annotation id="123">
        <infon key="identifier">MESH:D009203</infon>
        <infon key="type">Disease</infon>
        <location offset="3881" length="21"/>
        <text>myocardial infarction</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3905</offset>
      <text>  Hormonal therapy (estrogen, progesterone)</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3951</offset>
      <text>  Using the contraceptive pills</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3985</offset>
      <text>  Paraplegia</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4000</offset>
      <text>  Severe infection</text>
      <annotation id="125">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="4009" length="9"/>
        <text>infection</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4021</offset>
      <text>  Intestinal inflammations</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4050</offset>
      <text>  Polycythemia</text>
      <annotation id="127">
        <infon key="identifier">MESH:D011086</infon>
        <infon key="type">Disease</infon>
        <location offset="4052" length="12"/>
        <text>Polycythemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4067</offset>
      <text>  Paraproteinemia</text>
      <annotation id="129">
        <infon key="identifier">MESH:D010265</infon>
        <infon key="type">Disease</infon>
        <location offset="4069" length="15"/>
        <text>Paraproteinemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4087</offset>
      <text>  Behcet's disease</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4108</offset>
      <text>  Paroxysmal nocturnal hemoglobinuria </text>
      <annotation id="131">
        <infon key="identifier">MESH:D006457</infon>
        <infon key="type">Disease</infon>
        <location offset="4110" length="35"/>
        <text>Paroxysmal nocturnal hemoglobinuria</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4149</offset>
      <text>Although etiology and common risk factors for pulmonary thromboembolism are well known there is little data about frequency of postoperative pulmonary thromboembolism after different surgical operations.</text>
      <annotation id="134">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="4195" length="25"/>
        <text>pulmonary thromboembolism</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="4276" length="39"/>
        <text>postoperative pulmonary thromboembolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>4353</offset>
      <text>2. OBJECTIVE</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4366</offset>
      <text>Our objective is to show the number of patients with postoperative pulmonary thromboembolism (PPTE) treated in Intensive care unit of Clinic for pulmonary diseases an TB "Podhrastovi" in three-year period : from June 1, 2011 - June 1, 2014 and to indicate the importance of various surgical operations in the development of pulmonary thromboembolism (PTE).</text>
      <annotation id="140">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4405" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="141">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="4690" length="25"/>
        <text>pulmonary thromboembolism</text>
      </annotation>
      <annotation id="142">
        <infon key="identifier">MESH:D008171</infon>
        <infon key="type">Disease</infon>
        <location offset="4511" length="18"/>
        <text>pulmonary diseases</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="4419" length="39"/>
        <text>postoperative pulmonary thromboembolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>4727</offset>
      <text>3. MATERIAL AND METHODS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4751</offset>
      <text>This is the retrospective study which shows the number of patients with postoperative pulmonary thromboembolism treated in Intensive care unit of Clinic for pulmonary diseases an TB "Podhrastovi" in three-year period: 01.06.2011.-01.06.2014. It represents the number of these patients, per cent of patients with postoperative pulmonary thromboembolism of total patients with pulmonary thromboembolism, age and sex of patients, type of surgery, period expressed in days from surgery to clinical presence of pulmonary thromboembolism, presence of deep venous thrombosis (DVT) of lower extremities, massiveness of PPTE e.g. level of pulmonary artery with embolus: segmental, lobar, main branches of pulmonary artery; unilateral, bilateral.</text>
      <annotation id="158">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4809" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="159">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5027" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="160">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5049" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="161">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5112" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5168" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="5296" length="22"/>
        <text>deep venous thrombosis</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="5362" length="4"/>
        <text>PPTE</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">MESH:D008171</infon>
        <infon key="type">Disease</infon>
        <location offset="4908" length="18"/>
        <text>pulmonary diseases</text>
      </annotation>
      <annotation id="166">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="5126" length="25"/>
        <text>pulmonary thromboembolism</text>
      </annotation>
      <annotation id="167">
        <infon key="identifier">MESH:D004617</infon>
        <infon key="type">Disease</infon>
        <location offset="5403" length="7"/>
        <text>embolus</text>
      </annotation>
      <annotation id="168">
        <infon key="identifier">OMIM:612862</infon>
        <infon key="type">Disease</infon>
        <location offset="5320" length="3"/>
        <text>DVT</text>
      </annotation>
      <annotation id="169">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="5257" length="25"/>
        <text>pulmonary thromboembolism</text>
      </annotation>
      <annotation id="170">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="5063" length="39"/>
        <text>postoperative pulmonary thromboembolism</text>
      </annotation>
      <annotation id="171">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="4823" length="39"/>
        <text>postoperative pulmonary thromboembolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>5492</offset>
      <text>4. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>5503</offset>
      <text>In three-year period 232 patients with PTE were treated in Intensive care unit of Clinic "Podhrastovi". 60 of them or 25.86% were patients with postoperative PTE. Among them there were 24 males or 40% middle-aged 58.5 years, and 36 females or 60% middle-aged 56.3 years.</text>
      <annotation id="174">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5528" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5633" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>5778</offset>
      <text>Only one man had DVT (deep venous phlebothrombosis) (after orthopedic surgery), and five of them had anamnesis about previous DVT (one with abdominal, one with vascular, one with orthopedic and two with cardiology surgery). Only one woman had DVT (after orthopedic surgery), and no one had anamnesis about previous DVT or PTE.</text>
      <annotation id="183">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5787" length="3"/>
        <text>man</text>
      </annotation>
      <annotation id="184">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6011" length="5"/>
        <text>woman</text>
      </annotation>
      <annotation id="185">
        <infon key="identifier">OMIM:612862</infon>
        <infon key="type">Disease</infon>
        <location offset="6093" length="3"/>
        <text>DVT</text>
      </annotation>
      <annotation id="186">
        <infon key="identifier">OMIM:612862</infon>
        <infon key="type">Disease</infon>
        <location offset="5904" length="3"/>
        <text>DVT</text>
      </annotation>
      <annotation id="187">
        <infon key="identifier">OMIM:612862</infon>
        <infon key="type">Disease</infon>
        <location offset="5795" length="3"/>
        <text>DVT</text>
      </annotation>
      <annotation id="188">
        <infon key="identifier">OMIM:612862</infon>
        <infon key="type">Disease</infon>
        <location offset="6021" length="3"/>
        <text>DVT</text>
      </annotation>
      <annotation id="189">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="5800" length="28"/>
        <text>deep venous phlebothrombosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6105</offset>
      <text>Patients were subjected to different types of surgical operations which are presented on Figure 1. PTE developed in different interval after operation which is presented on the Figure 2.</text>
      <annotation id="191">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6105" length="8"/>
        <text>Patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">MSM-26-303-g001.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>6292</offset>
      <text>Type and number of surgical operations before development of PTE. PTE developed in 15 patients with abdominal, 11with urologic, 8 with gynecologic, 15 with orthopedic, 4 with cardiologic. 2 with vascular, 3 with neurosurgical, 1 with glandular (breast) and 1 with orl operations</text>
      <annotation id="193">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6378" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">MSM-26-303-g002.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption</infon>
      <offset>6571</offset>
      <text>The average period in days from surgery to the development of PTE. PTE developed in one to thirty days after operation, on average for abdominal operations it was 19 days, for urologic 5, for gynecologic 10, for orthopedic 15.5, for cardiologic 13, for vascular 4.5, for neurosurgical 18.5, for glandular 10 and for orl operations 10 days after operation. PPTE developed on average 10 days in women, and 14 days after operation in men.</text>
      <annotation id="196">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6964" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7002" length="3"/>
        <text>men</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7007</offset>
      <text>Massiveness of PPTE e.g., the site or level of embolus was different-from segmental to main branches of pulmonary artery which is shown on Figure 3 and Figure 4.</text>
      <annotation id="200">
        <infon key="identifier">MESH:D004617</infon>
        <infon key="type">Disease</infon>
        <location offset="7054" length="7"/>
        <text>embolus</text>
      </annotation>
      <annotation id="201">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="7022" length="4"/>
        <text>PPTE</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">MSM-26-303-g003.jpg</infon>
      <infon key="id">F3</infon>
      <infon key="type">fig_caption</infon>
      <offset>7169</offset>
      <text>The level or site of pulmonary embolus according to the type of surgery in women. The level of pulmonary embolism is different, from segmental to main branches of pulmonary artery with different number of patients according to operation.</text>
      <annotation id="206">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7244" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7374" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="208">
        <infon key="identifier">MESH:D004617</infon>
        <infon key="type">Disease</infon>
        <location offset="7190" length="17"/>
        <text>pulmonary embolus</text>
      </annotation>
      <annotation id="209">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="7264" length="18"/>
        <text>pulmonary embolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">MSM-26-303-g004.jpg</infon>
      <infon key="id">F4</infon>
      <infon key="type">fig_caption</infon>
      <offset>7407</offset>
      <text>The level or site of pulmonary embolus according to the type of surgery in men. The level of pulmonary embolism is different, from segmental to main branches of pulmonary artery with different number of patients according to operation</text>
      <annotation id="214">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7482" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="215">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7610" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="216">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="7500" length="18"/>
        <text>pulmonary embolism</text>
      </annotation>
      <annotation id="217">
        <infon key="identifier">MESH:D004617</infon>
        <infon key="type">Disease</infon>
        <location offset="7428" length="17"/>
        <text>pulmonary embolus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>7642</offset>
      <text>5. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>7656</offset>
      <text>There is notably increasing number of patients with pulmonary thromboembolism in recent years treated in Clinic for pulmonary diseases and TB "Podhrastovi" We are not yet sure whether it is real increasing or it is matter of better diagnostics. In three-year period 232 patients with PTE were treated in Intensive care unit of this clinic. 60 of them or 25.86% were patients where PTE developed after different types of surgical operations. We intended with this study to point out the significance and frequency of postoperative pulmonary thromboembolism, and to indicate that surgical operations of different type are significant etiologic and risk factor for the development of PTE.</text>
      <annotation id="224">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7694" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="225">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7926" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="226">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8022" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="227">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="8172" length="39"/>
        <text>postoperative pulmonary thromboembolism</text>
      </annotation>
      <annotation id="228">
        <infon key="identifier">MESH:D008171</infon>
        <infon key="type">Disease</infon>
        <location offset="7772" length="18"/>
        <text>pulmonary diseases</text>
      </annotation>
      <annotation id="229">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="7708" length="25"/>
        <text>pulmonary thromboembolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>8346</offset>
      <text>This study has several limitations. First of all we did not have real data about regularity of preoperative and postoperative prophylaxis with anticoagulants, early rising from bed after surgery (mechanical prophylaxis), we did not have data about intraoperative or early postoperative deaths caused possibly by PTE. Furthermore, not small number of patients with postoperative PTE was treated in corresponding surgical clinic under the control of pulmonologist from our clinic, and released home to continue anticoagulant therapy under the control of pulmonologist in outpatient department.</text>
      <annotation id="234">
        <infon key="identifier">100653365</infon>
        <infon key="type">Gene</infon>
        <location offset="8523" length="3"/>
        <text>bed</text>
      </annotation>
      <annotation id="235">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8696" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="236">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8915" length="10"/>
        <text>outpatient</text>
      </annotation>
      <annotation id="237">
        <infon key="identifier">MESH:D010149</infon>
        <infon key="type">Disease</infon>
        <location offset="8618" length="20"/>
        <text>postoperative deaths</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>8938</offset>
      <text>Although common risk factors for the development of PTE are well known, studied and confirmed in clinical practice there are no enough data in literature about postoperative DVT or PTE out of controlled studies. Many authors indicate the significance of preoperative anticoagulant prophylaxis.</text>
      <annotation id="239">
        <infon key="identifier">OMIM:612862</infon>
        <infon key="type">Disease</infon>
        <location offset="9112" length="3"/>
        <text>DVT</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9232</offset>
      <text>One big prospective study was done by group of authors on 75 771 patients with vascular and orthopedic operations from 1996 to 2001 in Veteran Health Administration Hospital. The average age was 65 years and 96% of patients were males. Major comorbidities included diabetes mellitus, chronic obstructive pulmonary disease, and congestive heart failure. Symptomatic PTE was diagnosed in 805 patients (0.68%) and varied significantly with procedures: 0.14% for carotid endarterectomy to 1.34% for total hip arthroplasty. In our study we dealt with patients of both sex (60% of them women), average age was 58.5 years for men, and aged 56.3 years for women, and patients were subjected to different types of surgery. We did not examine comorbidities before operation. We dealt with patients not prospectively, but only with surgical treated patients with different operations with diagnosed PPTE to indicate the importance of surgery to the development of PTE. These authors indicate the postoperative importance of pneumonia and other infections, including urinary tract infection, myocardial infarction. We did not find such factors of such importance before the development of PPTE.</text>
      <annotation id="258">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9297" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="259">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9447" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="260">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9622" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="261">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9778" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="262">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9812" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="263">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9851" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="264">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9880" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="265">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9891" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="266">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10011" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="267">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10070" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="268">
        <infon key="identifier">MESH:D006618</infon>
        <infon key="type">Disease</infon>
        <location offset="9733" length="16"/>
        <text>hip arthroplasty</text>
      </annotation>
      <annotation id="269">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="9516" length="37"/>
        <text>chronic obstructive pulmonary disease</text>
      </annotation>
      <annotation id="270">
        <infon key="identifier">MESH:D014552</infon>
        <infon key="type">Disease</infon>
        <location offset="10287" length="23"/>
        <text>urinary tract infection</text>
      </annotation>
      <annotation id="271">
        <infon key="identifier">MESH:D009203</infon>
        <infon key="type">Disease</infon>
        <location offset="10312" length="21"/>
        <text>myocardial infarction</text>
      </annotation>
      <annotation id="272">
        <infon key="identifier">MESH:D006333</infon>
        <infon key="type">Disease</infon>
        <location offset="9559" length="24"/>
        <text>congestive heart failure</text>
      </annotation>
      <annotation id="273">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="10265" length="10"/>
        <text>infections</text>
      </annotation>
      <annotation id="274">
        <infon key="identifier">MESH:D011014</infon>
        <infon key="type">Disease</infon>
        <location offset="10245" length="9"/>
        <text>pneumonia</text>
      </annotation>
      <annotation id="275">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="9497" length="17"/>
        <text>diabetes mellitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10415</offset>
      <text>Only two patients in our study had DVT after operation (one man and one woman), but in all others were not be able to find the starting point of embolus. So we think that the preoperative and postoperative prophylaxis (either anticoagulant, or mechanical-early rise from bed) is of the most significance, especially in patients with risk factors for DVT or PTE, even it is only the expected lying in bed (bed-rest) longer than 4 days. There is the need for one long prospective study in different surgical clinic for the assessment of more factors (age, sex, preoperative diseases, type and site of operation, postoperative complications, duration of bed-rest, anticoagulant and mechanical prophylaxis etc.) to give the more realistic picture of postoperative pulmonary thromboembolism.</text>
      <annotation id="288">
        <infon key="identifier">100653365</infon>
        <infon key="type">Gene</infon>
        <location offset="11066" length="3"/>
        <text>bed</text>
      </annotation>
      <annotation id="289">
        <infon key="identifier">100653365</infon>
        <infon key="type">Gene</infon>
        <location offset="10820" length="3"/>
        <text>bed</text>
      </annotation>
      <annotation id="290">
        <infon key="identifier">100653365</infon>
        <infon key="type">Gene</infon>
        <location offset="10815" length="3"/>
        <text>bed</text>
      </annotation>
      <annotation id="291">
        <infon key="identifier">100653365</infon>
        <infon key="type">Gene</infon>
        <location offset="10686" length="3"/>
        <text>bed</text>
      </annotation>
      <annotation id="292">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10424" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="293">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10475" length="3"/>
        <text>man</text>
      </annotation>
      <annotation id="294">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10487" length="5"/>
        <text>woman</text>
      </annotation>
      <annotation id="295">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10734" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="296">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="11161" length="39"/>
        <text>postoperative pulmonary thromboembolism</text>
      </annotation>
      <annotation id="297">
        <infon key="identifier">OMIM:612862</infon>
        <infon key="type">Disease</infon>
        <location offset="10450" length="3"/>
        <text>DVT</text>
      </annotation>
      <annotation id="298">
        <infon key="identifier">OMIM:612862</infon>
        <infon key="type">Disease</infon>
        <location offset="10765" length="3"/>
        <text>DVT</text>
      </annotation>
      <annotation id="299">
        <infon key="identifier">MESH:D004617</infon>
        <infon key="type">Disease</infon>
        <location offset="10560" length="7"/>
        <text>embolus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>11202</offset>
      <text>6. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>11216</offset>
      <text>Different surgical operations are the big risk factor for the development of PTE. There is great significance of anticoagulant prophylaxis before surgery even in patients with no anamnesis of previous DVT or PTE.</text>
      <annotation id="302">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11378" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="303">
        <infon key="identifier">OMIM:612862</infon>
        <infon key="type">Disease</infon>
        <location offset="11417" length="3"/>
        <text>DVT</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>11429</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>11466</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Dordevic;given-names:BS</infon>
      <infon key="fpage">563</infon>
      <infon key="year">1982</infon>
      <infon key="source">Medicinska knjiga Beograd-Zagreb</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">574</infon>
      <offset>11477</offset>
      <text>Akutno plucno srce i plucna tromboemblija. U: Plucne bolesti</text>
      <annotation id="305">
        <infon key="type">Disease</infon>
        <location offset="11498" length="20"/>
        <text>plucna tromboemblija</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">353</infon>
      <infon key="name_2">surname:De;given-names:Rosa</infon>
      <infon key="name_1">surname:Visani;given-names:L</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Goldhaber;given-names:SZ</infon>
      <infon key="fpage">1386</infon>
      <infon key="pub-id_pmid">10227218</infon>
      <infon key="year">1999</infon>
      <infon key="source">Lancet</infon>
      <infon key="type">ref</infon>
      <offset>11541</offset>
      <text>Acute pulmonary thromboembolism. Clinical outcomes in the International Cooperative Pulmonary Registry (ICOPER)</text>
      <annotation id="307">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="11547" length="25"/>
        <text>pulmonary thromboembolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">94</infon>
      <infon key="name_1">surname:Le Moine;given-names:JR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Moser;given-names:KM</infon>
      <infon key="fpage">949</infon>
      <infon key="year">1991</infon>
      <infon key="source">Ann Intern Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">952</infon>
      <offset>11653</offset>
      <text>Is embolism risk condition by location of deep venous thrombosis?</text>
      <annotation id="310">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="11695" length="22"/>
        <text>deep venous thrombosis</text>
      </annotation>
      <annotation id="311">
        <infon key="identifier">MESH:D004617</infon>
        <infon key="type">Disease</infon>
        <location offset="11656" length="8"/>
        <text>embolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">100</infon>
      <infon key="name_2">surname:Hales;given-names:CA</infon>
      <infon key="name_1">surname:Terrin;given-names:ML</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Stein;given-names:PD</infon>
      <infon key="fpage">598</infon>
      <infon key="pub-id_pmid">1909617</infon>
      <infon key="year">1991</infon>
      <infon key="source">Chest</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">603</infon>
      <offset>11719</offset>
      <text>Clinical, roendgenographic and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease</text>
      <annotation id="315">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11783" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="316">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="11797" length="24"/>
        <text>acute pulmonary embolism</text>
      </annotation>
      <annotation id="317">
        <infon key="identifier">MESH:D008171</infon>
        <infon key="type">Disease</infon>
        <location offset="11853" length="17"/>
        <text>pulmonary disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">330</infon>
      <infon key="name_1">surname:Righini;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Le Gal;given-names:Teztuz A</infon>
      <infon key="fpage">452</infon>
      <infon key="pub-id_pmid">15684025</infon>
      <infon key="year">2005</infon>
      <infon key="source">BMJ</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">455</infon>
      <offset>11871</offset>
      <text>Reproduction of chest pain by palpation: diagnostic accuracy in suspected pulmonary embolism</text>
      <annotation id="320">
        <infon key="identifier">MESH:D002637</infon>
        <infon key="type">Disease</infon>
        <location offset="11887" length="10"/>
        <text>chest pain</text>
      </annotation>
      <annotation id="321">
        <infon key="identifier">MESH:D011655</infon>
        <infon key="type">Disease</infon>
        <location offset="11945" length="18"/>
        <text>pulmonary embolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">53</infon>
      <infon key="name_2">surname:Konjic;given-names:M</infon>
      <infon key="name_1">surname:Maglajlic;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Cukic;given-names:V</infon>
      <infon key="fpage">57</infon>
      <infon key="issue">suppl. 3</infon>
      <infon key="pub-id_pmid">10870628</infon>
      <infon key="year">1999</infon>
      <infon key="source">Med Arh</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">58</infon>
      <offset>11964</offset>
      <text>Postoperative pulmonary thromoboembolism</text>
      <annotation id="323">
        <infon key="identifier">MESH:D001261</infon>
        <infon key="type">Disease</infon>
        <location offset="11964" length="40"/>
        <text>Postoperative pulmonary thromoboembolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Wakenfield;given-names:TW</infon>
      <infon key="name_2">surname:Upcruch;given-names:GR</infon>
      <infon key="name_1">surname:Rectenvald;given-names:JR</infon>
      <infon key="name_0">surname:Gangreddy;given-names:C</infon>
      <infon key="fpage">335</infon>
      <infon key="pub-id_pmid">17264013</infon>
      <infon key="year">2007</infon>
      <infon key="source">Journal of Vascular Surgery</infon>
      <infon key="type">ref</infon>
      <infon key="volume">45</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">342</infon>
      <infon key="name_4">surname:Kuri;given-names:SH</infon>
      <offset>12005</offset>
      <text>Risk factors and clinical impact of postoperative symptomatic venous thromboembolism</text>
      <annotation id="325">
        <infon key="identifier">MESH:D054556</infon>
        <infon key="type">Disease</infon>
        <location offset="12067" length="22"/>
        <text>venous thromboembolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Bergvist;given-names:MR</infon>
      <infon key="volume">126</infon>
      <infon key="name_2">surname:Hail;given-names:D</infon>
      <infon key="name_1">surname:Pineo;given-names:JA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Geerts;given-names:WH</infon>
      <infon key="fpage">338s</infon>
      <infon key="pub-id_pmid">15383478</infon>
      <infon key="year">2004</infon>
      <infon key="source">Chest</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">400s</infon>
      <offset>12090</offset>
      <text>Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy</text>
      <annotation id="327">
        <infon key="identifier">MESH:D054556</infon>
        <infon key="type">Disease</infon>
        <location offset="12104" length="22"/>
        <text>venous thromboembolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">24</infon>
      <infon key="name_2">surname:Pham;given-names:R</infon>
      <infon key="name_1">surname:Middleton;given-names:G</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Tooher;given-names:R</infon>
      <infon key="fpage">397</infon>
      <infon key="year">2005</infon>
      <infon key="source">Am Surg</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">415</infon>
      <offset>12199</offset>
      <text>A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals</text>
      <annotation id="329">
        <infon key="identifier">MESH:D054556</infon>
        <infon key="type">Disease</infon>
        <location offset="12260" length="22"/>
        <text>venous thromboembolism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Desjantis;given-names:A</infon>
      <infon key="volume">341</infon>
      <infon key="name_2">surname:Darmon;given-names:L</infon>
      <infon key="name_1">surname:Cohen;given-names:JY</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Samama;given-names:MM</infon>
      <infon key="fpage">793</infon>
      <infon key="pub-id_pmid">10477777</infon>
      <infon key="year">1999</infon>
      <infon key="source">N Engl J Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">800</infon>
      <offset>12296</offset>
      <text>A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with enoxaparin study group</text>
      <annotation id="335">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12404" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="336">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12437" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="337">
        <infon key="identifier">MESH:D017984</infon>
        <infon key="type">Chemical</infon>
        <location offset="12451" length="10"/>
        <text>enoxaparin</text>
      </annotation>
      <annotation id="338">
        <infon key="identifier">MESH:D054556</infon>
        <infon key="type">Disease</infon>
        <location offset="12358" length="22"/>
        <text>venous thromboembolism</text>
      </annotation>
      <annotation id="339">
        <infon key="identifier">MESH:D017984</infon>
        <infon key="type">Chemical</infon>
        <location offset="12312" length="10"/>
        <text>enoxaparin</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272829</id>
    <passage>
      <infon key="name_3">surname:Thaci;given-names:Shpetim</infon>
      <infon key="name_2">surname:Qorraj-Bytyqi;given-names:Hasime</infon>
      <infon key="name_1">surname:Islami;given-names:Hilmi</infon>
      <infon key="article-id_pmid">25568627</infon>
      <infon key="name_0">surname:Hoxha;given-names:Rexhep</infon>
      <infon key="fpage">306</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272829</infon>
      <infon key="article-id_publisher-id">MSM-26-306</infon>
      <infon key="article-id_doi">10.5455/msm.2014.26.306-308</infon>
      <infon key="type">front</infon>
      <infon key="volume">26</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Mater Sociomed; 2014 Oct; 26(5) 306-8. doi:10.5455/msm.2014.26.306-308</infon>
      <infon key="kwd">Body mass index weight bone mineral density men</infon>
      <infon key="lpage">308</infon>
      <infon key="name_4">surname:Bahtiri;given-names:Elton</infon>
      <infon key="authors">Hoxha R, Islami H, Qorraj-Bytyqi H, Tha&#195;&#167;i S, Bahtiri E</infon>
      <offset>0</offset>
      <text>Relationship of Weight and Body Mass Index with Bone Mineral Density in Adult Men from Kosovo</text>
      <annotation id="1">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="78" length="3"/>
        <text>Men</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>94</offset>
      <text>Background and objective:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>120</offset>
      <text>Body weight and body mass index (BMI) are considered strong predictors of osteoporotic fractures, though optimal BMI levels remain unsettled. There are several studies conducted on women about the relationship between BMI and bone mineral density (BMD), and just a few so far on men. Therefore, the objective of current study was to analyze the relationship between weight and BMI and BMD measured in lumbar spine (L1-L4), femur neck and total hip in 64 men from Kosovo.</text>
      <annotation id="8">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="301" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="9">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="399" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="10">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="574" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="11">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="368" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="12">
        <infon key="identifier">MESH:D058866</infon>
        <infon key="type">Disease</infon>
        <location offset="194" length="22"/>
        <text>osteoporotic fractures</text>
      </annotation>
      <annotation id="13">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="505" length="3"/>
        <text>BMD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>591</offset>
      <text>Methods:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>600</offset>
      <text>This cross-sectional study included a population of 64 men divided into three BMI groups. Dual-energy X-ray absorptiometry (DEXA) measurements were done in all the study participants.</text>
      <annotation id="16">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="655" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="17">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="770" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>784</offset>
      <text> Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>794</offset>
      <text>Pearson's correlation analysis showed a significant positive correlation between weight and BMI and BMD in femur neck and in total hip, and a significant negative correlation between age and femur neck BMD. Age-adjusted linear regression analysis showed that weight and BMI had a significant positive association with BMD levels.</text>
      <annotation id="21">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="996" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="22">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="1112" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="23">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="894" length="3"/>
        <text>BMD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1124</offset>
      <text>Conclusion:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1136</offset>
      <text>Although the results show significant relationship between BMI and BMD, the negative relationship between age and femur neck BMD may serve as guidance to initiate early assessment of the BMD in this region as well as preventive measures of osteoporosis and fractures among ageing men population</text>
      <annotation id="30">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1416" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="31">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="1393" length="9"/>
        <text>fractures</text>
      </annotation>
      <annotation id="32">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="1323" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="33">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="1261" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="34">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="1203" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">MESH:D010024</infon>
        <infon key="type">Disease</infon>
        <location offset="1376" length="12"/>
        <text>osteoporosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1431</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1447</offset>
      <text>Fractures accompanying osteoporosis have become serious health problem. There are many modifiable factors influencing bone mineral density (BMD), which is recognized as a surrogate marker of bone strength. Among them, body weight and body mass index (BMI) are considered strong predictors of osteoporotic fractures. Optimal BMI levels remain still unsettled, though a BMI of 26-28 kg/m2 has been suggested. Overweight and obesity have been considered protective to bone health, while higher BMI levels to be associated with higher BMD score. Beyond the simple mechanism of mechanical load related to body weight on bone density, there are some other assumed mechanisms not yet fully elucidated of interaction between adipose tissue and skeleton through several adipokines. However, recent studies have questioned this traditional view concluding non-linear relationship between BMI and BMD. Some studies reported no association or even lower BMD or increased risk of fractures, sometimes site dependent, in obese patients.</text>
      <annotation id="47">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2460" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="2454" length="5"/>
        <text>obese</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">MESH:D058866</infon>
        <infon key="type">Disease</infon>
        <location offset="1739" length="22"/>
        <text>osteoporotic fractures</text>
      </annotation>
      <annotation id="50">
        <infon key="identifier">MESH:D010024</infon>
        <infon key="type">Disease</infon>
        <location offset="1470" length="12"/>
        <text>osteoporosis</text>
      </annotation>
      <annotation id="51">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="1587" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="52">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="1869" length="7"/>
        <text>obesity</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="1978" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="1447" length="9"/>
        <text>Fractures</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="2414" length="9"/>
        <text>fractures</text>
      </annotation>
      <annotation id="56">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="2333" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="57">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="2389" length="3"/>
        <text>BMD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2470</offset>
      <text>The objective of this study was to analyze the relationship between body mass index (BMI) and weight and bone mineral density (BMD) measured in lumbar spine (L1-L4), femur neck and total hip in a population of 64 men from Kosovo. The interest of several studies has been focused on women, but there are only few recent studies worldwide focused on this issue on men and, to our best knowledge, this is the first one undertaken among Kosovo men.</text>
      <annotation id="63">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2683" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="64">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2752" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="65">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2832" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="66">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2910" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="67">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="2597" length="3"/>
        <text>BMD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>2915</offset>
      <text>Descriptive characteristics of the study subjects. BMD bone mineral density, BMI body mass index. *p &lt;0.05, **p&lt;0.01 compared to normal weight,   p &lt;0.05,    p&lt;0.01 compared to overweight</text>
      <annotation id="69">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="2966" length="3"/>
        <text>BMD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>3106</offset>
      <text>2. MATERIAL AND METHODS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>3130</offset>
      <text>2.1. Study population</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>3152</offset>
      <text>The study population consisted of 64 men who were divided into three groups according to standard World Health Organization (WHO) Body Mass Index (BMI) classification: Normal Weight group (n=23), Overweight group (n=26) and Obese group (n=15). Subjects were not included in the study if they had history of diseases that might affect bone metabolism or had taken drugs that might influence BMD (glucocortiocids, bisphosphonates). Written informed consent was obtained from all participants and the study protocol was approved by local Ethical Committees. The research was conducted in accordance to guidelines in Declaration of Helsinki.</text>
      <annotation id="75">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3189" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="76">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3629" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="77">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="3542" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="78">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="3547" length="15"/>
        <text>glucocortiocids</text>
      </annotation>
      <annotation id="79">
        <infon key="identifier">MESH:D004164</infon>
        <infon key="type">Chemical</infon>
        <location offset="3564" length="15"/>
        <text>bisphosphonates</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>3790</offset>
      <text>2.2. Anthropometric and bone mineral density measurements</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>3848</offset>
      <text>Height (m) and weight (kg) were measured in light clothing and no shoes before performing DEXA, and body mass index (BMI) was calculated as the ratio of subjects' weight to height squared (kg/m2). According to WHO criteria, participants were categorized into three BMI groups: normal weight (BMI &lt;24.9 kg/m2), overweight (BMI=25.0-29.9 kg/m2) and obese (BMI&gt;30 kg/m2). Dual-energy X-ray absorptiometry (DEXA; Hologic QDR-4500, USA) was used to measure bone mineral density (BMD) in lumbar vertebrae (L1-L4), femoral neck and total hip in all study participants. DEXA was calibrated daily using a phantom provided by the manufacturer. The diagnosis of osteoporosis and osteopenia was done according to WHO T-score criteria (osteoporosis if T-score &lt;= -2.5 SD, osteopenia if T-score between -2.5 SD and -1 SD, and normal BMD if T-score &gt; -1SD).</text>
      <annotation id="89">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4072" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="90">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4396" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="91">
        <infon key="identifier">MESH:D010024</infon>
        <infon key="type">Disease</infon>
        <location offset="4571" length="12"/>
        <text>osteoporosis</text>
      </annotation>
      <annotation id="92">
        <infon key="identifier">MESH:D010024</infon>
        <infon key="type">Disease</infon>
        <location offset="4499" length="12"/>
        <text>osteoporosis</text>
      </annotation>
      <annotation id="93">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="4322" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="94">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="4195" length="5"/>
        <text>obese</text>
      </annotation>
      <annotation id="95">
        <infon key="identifier">MESH:D001851</infon>
        <infon key="type">Disease</infon>
        <location offset="4516" length="10"/>
        <text>osteopenia</text>
      </annotation>
      <annotation id="96">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="4667" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="97">
        <infon key="identifier">MESH:D001851</infon>
        <infon key="type">Disease</infon>
        <location offset="4607" length="10"/>
        <text>osteopenia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>4694</offset>
      <text>2.3. Statistical analysis</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4720</offset>
      <text>SPSS version 16.0 (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. All p-values in statistical analyses were two-tailed with a significance level of 0.05. Continuous variables are expressed as the means +- standard deviations (SD), while categorical variables as percentages. One-way analysis of variance (ANOVA) with Tukey test for Post Hoc Multiple Comparisons for continuous variables and Chi square test for categorical variables were used to compare characteristics of the three groups created on the basis of BMI. Person's correlation test was performed to assess correlation between age, weight, BMI and BMD. Age-adjusted linear regression analysis was calculated with BMI and weight as independent variables and BMD in L1-L4 vertebra, femoral neck and total hip as dependent variables.</text>
      <annotation id="101">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5256" length="6"/>
        <text>Person</text>
      </annotation>
      <annotation id="102">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="5456" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="103">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="5347" length="3"/>
        <text>BMD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>5530</offset>
      <text>3. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>5541</offset>
      <text>Descriptive characteristics of the study population in total and according to BMI groups are summarized in The recruited study subjects consisted of 64 males with a mean age of 42.17+-14.86 (SD). There were 23 subjects (36.3+-15.81 years) in normal weight group,26 subjects (42.92+-13.9 years) in overweight group and 15 subjects (49.87+-11.59 years) in obese group. Most men in this study were overweight or obese (n=41 or 64%).</text>
      <annotation id="107">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5913" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="108">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="5950" length="5"/>
        <text>obese</text>
      </annotation>
      <annotation id="109">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="5895" length="5"/>
        <text>obese</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>5971</offset>
      <text>Comparison of BMI groups by using one way ANOVA found no statistically significant difference for L1-L4 BMD, femur neck BMD and total hip BMD levels (p&gt;0.05). Despite the fact that a statistically significant difference was not observed among BMI groups regarding BMD levels, Pearson's correlation analysis shown in table 2 reveals a significant positive correlation between weight and BMI and BMD in femur neck (r=0.445, p&lt;0.01) and in total hip (r=0.502, p&lt;0.01). No statistically significant correlation was shown between weight and BMI and L1-L4 BMD, while a significant negative correlation was observed between age and femur neck BMD (r=-0.302, p&lt;0.05).</text>
      <annotation id="117">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="6521" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="118">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="6075" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="119">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="6365" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="120">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="6091" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="6235" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="122">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="6607" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="123">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="6109" length="3"/>
        <text>BMD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>6631</offset>
      <text>Pearson's correlation analysis between age, weight, BMI and BMD (r) *p &lt;0.05; **p&lt;0.01</text>
      <annotation id="125">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="6691" length="3"/>
        <text>BMD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6718</offset>
      <text>Age-adjusted linear regression analysis showed that weight and BMI as explanatory variables had a significant positive association with L1-L4 BMD, FN BMD and TH BMD levels (Table 3). When weight was compared to BMI, it was observed a tendency of differences in L1-L4 BMD and FN BMD (beta=0.308 vs. 0.305 and beta=0.563 vs. beta= 0.559), whereas BMI showed greater difference in total hip BMD (beta=0.577 vs. 0.540). Weight and BMI had highest squared R values for femur neck BMD, where these variables can explain 38.6% and 35.4% of the variation in FN BMD (R2=0.386 and R2=0.354, respectively).</text>
      <annotation id="134">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="6879" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="7106" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="136">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="6985" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="137">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="6860" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="138">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="7193" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="139">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="6993" length="6"/>
        <text>FN BMD</text>
      </annotation>
      <annotation id="140">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="7268" length="6"/>
        <text>FN BMD</text>
      </annotation>
      <annotation id="141">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="6865" length="6"/>
        <text>FN BMD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T3.xml</infon>
      <infon key="id">T3</infon>
      <infon key="type">table_caption</infon>
      <offset>7314</offset>
      <text>Age-adjusted linear regression analysis for BMD with weight and BMI as predictors.*p&lt;0.05;**p&lt;0.01; ***p&lt;0.001</text>
      <annotation id="143">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="7358" length="3"/>
        <text>BMD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>7425</offset>
      <text>4. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>7439</offset>
      <text>Body weight and body mass index as potentially modifiable factors are generally considered essential determinants of bone mineral density. Several studies demonstrated positive association of elevated body weight and/or BMI with bone mineral density or even protective effect against osteoporosis and fractures. Principal explanation of this association was heavier mechanical loading on bones with subsequent bone remodelation to resist this loading. Some of other putative mechanisms are increased estrogen synthesis (in women), increased secretion of insulin and increased plasma levels of leptin. However, there are other published studies focused on the impact of fat mass on BMD that demonstrated negative association of obesity with BMD; the assumed mechanisms are secretion of pro-inflammatory cytokines that stimulate bone resorption, decreased levels of adiponectins and increased parathormone levels.</text>
      <annotation id="151">
        <infon key="identifier">3630</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">173</infon>
        <location offset="7993" length="7"/>
        <text>insulin</text>
      </annotation>
      <annotation id="152">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7962" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="153">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="8179" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="154">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="7740" length="9"/>
        <text>fractures</text>
      </annotation>
      <annotation id="155">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="8120" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="156">
        <infon key="identifier">MESH:D010024</infon>
        <infon key="type">Disease</infon>
        <location offset="7723" length="12"/>
        <text>osteoporosis</text>
      </annotation>
      <annotation id="157">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="8166" length="7"/>
        <text>obesity</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>8351</offset>
      <text>In accordance with results of Dogan A et al., Salamat M et al. and Lloyd J et al. results of this cross-sectional study demonstrate a positive correlation of weight and body mass index with both femur neck BMD and total hip BMD in all male subjects included in the study, but, in contrary to them, compared to normal weight, BMD levels of overweight and obese groups were not significantly different; the lack of significant difference between BMI groups might be as limitation of the small sample size. Contrary to results of our study and above mentioned studies, Greco et al. reported low lumbar BMD in obese patients, while a recent study by Emaus N et al. demonstrated a nonlinear relationship between body mass index and bone mineral density. Every unit increase in BMI was associated with an increase of 0.008 g/cm2 in L1-L4 BMD, 0.017 g/cm2 in femur neck BMD and 0.018 g/cm2 in total hip BMD. Interestingly, age was negatively correlated only with femur neck BMD in all subjects.</text>
      <annotation id="169">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8963" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="170">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="9214" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="171">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="8557" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="172">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="8676" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="173">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="9318" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="174">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="9247" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="8957" length="5"/>
        <text>obese</text>
      </annotation>
      <annotation id="176">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="8705" length="5"/>
        <text>obese</text>
      </annotation>
      <annotation id="177">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="9183" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="178">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="8575" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="179">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="8950" length="3"/>
        <text>BMD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>9339</offset>
      <text>5. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>9353</offset>
      <text>In conclusion, we demonstrated a highly significant relationship between body mass index and bone mineral density in femur neck and total hip in this sample of men. Negative relationship between age and femur neck BMD may serve as guidance to focus the evaluation of the bone mineral density in this region and to initiate early preventive measures of osteoporosis and fractures among aging male population.</text>
      <annotation id="184">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9513" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="185">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="9567" length="3"/>
        <text>BMD</text>
      </annotation>
      <annotation id="186">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="9722" length="9"/>
        <text>fractures</text>
      </annotation>
      <annotation id="187">
        <infon key="identifier">MESH:D010024</infon>
        <infon key="type">Disease</infon>
        <location offset="9705" length="12"/>
        <text>osteoporosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>9761</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>9798</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="volume">66</infon>
      <infon key="name_1">surname:Bianchi;given-names:G</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Giusti;given-names:A</infon>
      <infon key="fpage">136</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">25069495</infon>
      <infon key="year">2014</infon>
      <infon key="comment">doi: 10.4081/reumatismo.2014.786</infon>
      <infon key="source">Reumatismo</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">43</infon>
      <offset>9809</offset>
      <text>Male osteoporosis</text>
      <annotation id="189">
        <infon key="identifier">MESH:D010024</infon>
        <infon key="type">Disease</infon>
        <location offset="9814" length="12"/>
        <text>osteoporosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Zhang;given-names:H</infon>
      <infon key="name_2">surname:Wang;given-names:Y</infon>
      <infon key="name_1">surname:Liu;given-names:Z</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kang;given-names:D</infon>
      <infon key="year">2014</infon>
      <infon key="comment">Epub ahead of print</infon>
      <infon key="source">J Endocrinol Invest</infon>
      <infon key="type">ref</infon>
      <infon key="name_6">surname:Wang;given-names:P</infon>
      <infon key="name_5">surname:Cao;given-names:W</infon>
      <infon key="name_4">surname:Feng;given-names:X</infon>
      <offset>9827</offset>
      <text>Relationship of body composition with bone mineral density in northern Chinese men by body mass index levels</text>
      <annotation id="191">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9906" length="3"/>
        <text>men</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Khosla;given-names:S</infon>
      <infon key="name_2">surname:Amin;given-names:S</infon>
      <infon key="name_1">surname:Beck;given-names:TJ</infon>
      <infon key="name_0">surname:Melton;given-names:LJ;suffix:3rd</infon>
      <infon key="fpage">460</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">15688123</infon>
      <infon key="year">2005</infon>
      <infon key="source">Osteoporos Int</infon>
      <infon key="type">ref</infon>
      <infon key="volume">16</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">467</infon>
      <infon key="name_6">surname:Riggs;given-names:BL</infon>
      <infon key="name_5">surname:Oberg;given-names:AL</infon>
      <infon key="name_4">surname:Achenbach;given-names:SJ</infon>
      <offset>9936</offset>
      <text>Contributions of bone density and structure to fracture risk assessment in men and women</text>
      <annotation id="194">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10011" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="195">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="9983" length="8"/>
        <text>fracture</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_2">surname:Ahmed;given-names:LA</infon>
      <infon key="name_1">surname:Wilsgaard;given-names:T</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Emaus;given-names:N</infon>
      <infon key="year">2014</infon>
      <infon key="comment">doi: 10.1002/jbmr.2232. [Epub ahead of print]</infon>
      <infon key="source">J Bone Miner Res</infon>
      <infon key="type">ref</infon>
      <offset>10025</offset>
      <text>Impacts of Body Mass Index, Physical Activity, and Smoking on Femoral Bone Loss. The TromsoStudy</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Lee;given-names:WJ</infon>
      <infon key="name_2">surname:Liu;given-names:PH</infon>
      <infon key="name_1">surname:Sheu;given-names:WH</infon>
      <infon key="name_0">surname:Tang;given-names:YJ</infon>
      <infon key="fpage">54</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">17187194</infon>
      <infon key="year">2007</infon>
      <infon key="source">J Bone Miner Metab</infon>
      <infon key="type">ref</infon>
      <infon key="volume">25</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">59</infon>
      <infon key="name_4">surname:Chen;given-names:YT</infon>
      <offset>10123</offset>
      <text>Positive associations of bone mineral density with body mass index, physical activity, and blood triglyceride level in men over 70 years old: a TCVGHAGE study</text>
      <annotation id="198">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10242" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">MESH:D014280</infon>
        <infon key="type">Chemical</infon>
        <location offset="10220" length="12"/>
        <text>triglyceride</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">20</infon>
      <infon key="name_1">surname:Leslie;given-names:WD</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Morin;given-names:S</infon>
      <infon key="fpage">1267</infon>
      <infon key="issue">7</infon>
      <infon key="pub-id_pmid">19034375</infon>
      <infon key="year">2009</infon>
      <infon key="comment">doi: 10.1007/s00198-008-0797-6</infon>
      <infon key="source">Osteoporos Int</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">71</infon>
      <offset>10282</offset>
      <text>Manitoba Bone Density Program, High bone mineral density is associated with high body mass index</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Lauro;given-names:D</infon>
      <infon key="name_2">surname:Celi;given-names:M</infon>
      <infon key="name_1">surname:Bazzocchi;given-names:A</infon>
      <infon key="name_0">surname:Andreoli;given-names:A</infon>
      <infon key="fpage">1115</infon>
      <infon key="issue">7</infon>
      <infon key="pub-id_pmid">21643640</infon>
      <infon key="year">2011</infon>
      <infon key="source">Radiol Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">116</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1123</infon>
      <infon key="name_6">surname:Guglielmi;given-names:G</infon>
      <infon key="name_5">surname:Tarantino;given-names:U</infon>
      <infon key="name_4">surname:Sorge;given-names:R</infon>
      <offset>10379</offset>
      <text>Relationship between body composition, body mass index and bone mineral density in a large population of normal, osteopenic and osteoporotic women</text>
      <annotation id="202">
        <infon key="identifier">MESH:C567172</infon>
        <infon key="type">Disease</infon>
        <location offset="10492" length="10"/>
        <text>osteopenic</text>
      </annotation>
      <annotation id="203">
        <infon key="identifier">MESH:D058866</infon>
        <infon key="type">Disease</infon>
        <location offset="10507" length="12"/>
        <text>osteoporotic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Davison;given-names:KS</infon>
      <infon key="name_2">surname:Kingwell;given-names:EJ</infon>
      <infon key="name_1">surname:Hitchcock;given-names:CL</infon>
      <infon key="name_0">surname:Langsetmo;given-names:L</infon>
      <infon key="fpage">401</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">22154839</infon>
      <infon key="year">2012</infon>
      <infon key="source">Bone</infon>
      <infon key="type">ref</infon>
      <infon key="volume">50</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.1016/j.bone.2011.11.009</infon>
      <infon key="name_8">surname:Prior;given-names:JC</infon>
      <infon key="name_7">surname:Kreiger;given-names:N</infon>
      <infon key="lpage">408</infon>
      <infon key="name_6">surname:Zhou;given-names:W</infon>
      <infon key="name_5">surname:Forsmo;given-names:S</infon>
      <infon key="name_4">surname:Berger;given-names:C</infon>
      <offset>10526</offset>
      <text>Physical activity, body mass index and bone mineral density-associations in a prospective population-based cohort of women and men: the Canadian Multicentre Osteoporosis Study (CaMos)</text>
      <annotation id="207">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10643" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="208">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10653" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="209">
        <infon key="identifier">MESH:D010024</infon>
        <infon key="type">Disease</infon>
        <location offset="10671" length="24"/>
        <text>Multicentre Osteoporosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Janghorbani;given-names:M</infon>
      <infon key="name_2">surname:Abedi;given-names:I</infon>
      <infon key="name_1">surname:Salamat;given-names:AH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Salamat;given-names:MR</infon>
      <infon key="fpage">205963</infon>
      <infon key="year">2013</infon>
      <infon key="comment">doi: 10.1155/2013/205963</infon>
      <infon key="source">J Osteoporos 2013</infon>
      <infon key="type">ref</infon>
      <offset>10710</offset>
      <text>Relationship between Weight, Body Mass Index, and Bone Mineral Density in Men Referred for Dual-Energy X-Ray Absorptiometry Scan in Isfahan, Iran</text>
      <annotation id="211">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10784" length="3"/>
        <text>Men</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Lim;given-names:CT</infon>
      <infon key="name_2">surname:Shen;given-names:L</infon>
      <infon key="name_1">surname:Sng;given-names:BY</infon>
      <infon key="name_0">surname:Wee;given-names:J</infon>
      <infon key="fpage">162</infon>
      <infon key="issue">1-2</infon>
      <infon key="pub-id_pmid">24281832</infon>
      <infon key="year">2013</infon>
      <infon key="source">Arch Osteoporos</infon>
      <infon key="type">ref</infon>
      <infon key="volume">8</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.1007/s11657-013-0162-z</infon>
      <infon key="name_5">surname:Das;given-names:De S</infon>
      <infon key="name_4">surname:Singh;given-names:G</infon>
      <offset>10856</offset>
      <text>The relationship between body mass index and physical activity levels in relation to bone mineral density in premenopausal and postmenopausal women</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Rosen;given-names:CJ</infon>
      <infon key="name_2">surname:Miller;given-names:KK</infon>
      <infon key="name_1">surname:Mendes;given-names:N</infon>
      <infon key="name_0">surname:Russell;given-names:M</infon>
      <infon key="fpage">1247</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">20080853</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Clin Endocrinol Metab</infon>
      <infon key="type">ref</infon>
      <infon key="volume">95</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.1210/jc.2009-1475</infon>
      <infon key="lpage">1255</infon>
      <infon key="name_6">surname:Misra;given-names:M</infon>
      <infon key="name_5">surname:Klibanski;given-names:A</infon>
      <infon key="name_4">surname:Lee;given-names:H</infon>
      <offset>11004</offset>
      <text>Visceral fat is a negative predictor of bone density measures in obese adolescent girls</text>
      <annotation id="213">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="11069" length="5"/>
        <text>obese</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ozgirgin;given-names:N</infon>
      <infon key="name_2">surname:Yildizgoren;given-names:MT</infon>
      <infon key="name_1">surname:Nakipoglu-Yuzer;given-names:GF</infon>
      <infon key="name_0">surname:Dogan;given-names:A</infon>
      <infon key="fpage">338</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">20202698</infon>
      <infon key="year">2010</infon>
      <infon key="source">Arch Gerontol Geriatr</infon>
      <infon key="type">ref</infon>
      <infon key="volume">51</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.1016/j.archger.2010.01.015</infon>
      <infon key="lpage">341</infon>
      <offset>11092</offset>
      <text>Is age or the body mass index (BMI) more determinant of the bone mineral density (BMD) in geriatric women and men?</text>
      <annotation id="217">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11192" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="218">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11202" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">MESH:D020388</infon>
        <infon key="type">Disease</infon>
        <location offset="11174" length="3"/>
        <text>BMD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">11</infon>
      <infon key="name_2">surname:Nuti;given-names:R</infon>
      <infon key="name_1">surname:Caffarelli;given-names:C</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Gonnelli;given-names:S</infon>
      <infon key="fpage">9</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">25002873</infon>
      <infon key="year">2014</infon>
      <infon key="source">Clin Cases Miner Bone Metab</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">14</infon>
      <offset>11207</offset>
      <text>Obesity and fracture risk</text>
      <annotation id="221">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="11219" length="8"/>
        <text>fracture</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Santiemma;given-names:V</infon>
      <infon key="name_2">surname:Rossi;given-names:F</infon>
      <infon key="name_1">surname:Fornari;given-names:R</infon>
      <infon key="name_0">surname:Greco;given-names:EA</infon>
      <infon key="fpage">817</infon>
      <infon key="issue">6</infon>
      <infon key="pub-id_pmid">20518955</infon>
      <infon key="year">2010</infon>
      <infon key="source">Int J Clin Pract</infon>
      <infon key="type">ref</infon>
      <infon key="volume">64</infon>
      <infon key="name_10">surname:Spera;given-names:G</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:Migliaccio;given-names:S</infon>
      <infon key="name_11">surname:Lenzi;given-names:A</infon>
      <infon key="name_12">surname:Lubrano;given-names:C</infon>
      <infon key="comment">doi: 10.1111/j.1742-1241.2009.02301.x</infon>
      <infon key="name_9">surname:Donini;given-names:LM</infon>
      <infon key="name_8">surname:Marini;given-names:M</infon>
      <infon key="name_7">surname:Brama;given-names:M</infon>
      <infon key="lpage">820</infon>
      <infon key="name_6">surname:Aversa;given-names:A</infon>
      <infon key="name_5">surname:Annoscia;given-names:C</infon>
      <infon key="name_4">surname:Prossomariti;given-names:G</infon>
      <offset>11233</offset>
      <text>Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index</text>
      <annotation id="224">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="11236" length="7"/>
        <text>obesity</text>
      </annotation>
      <annotation id="225">
        <infon key="identifier">MESH:D010024</infon>
        <infon key="type">Disease</infon>
        <location offset="11259" length="12"/>
        <text>osteoporosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_2">surname:Ryu;given-names:OH</infon>
      <infon key="name_1">surname:Lee;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Chung;given-names:W</infon>
      <infon key="year">2013</infon>
      <infon key="comment">Epub ahead of print</infon>
      <infon key="source">J Bone Miner Metab</infon>
      <infon key="type">ref</infon>
      <offset>11349</offset>
      <text>Is the negative relationship between obesity and bone mineral content greater for olderwomen?</text>
      <annotation id="227">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="11386" length="7"/>
        <text>obesity</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Cooper;given-names:C</infon>
      <infon key="name_2">surname:Chapurlat;given-names:R</infon>
      <infon key="name_1">surname:Watts;given-names:NB</infon>
      <infon key="name_0">surname:Compston;given-names:JE</infon>
      <infon key="pub-id_pmid">22017783</infon>
      <infon key="year">2011</infon>
      <infon key="source">Am J Med</infon>
      <infon key="type">ref</infon>
      <infon key="name_20">surname:Siris;given-names:ES</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1050</infon>
      <infon key="fpage">1043</infon>
      <infon key="issue">11</infon>
      <infon key="volume">124</infon>
      <infon key="name_10">surname:Saag;given-names:KG</infon>
      <infon key="name_13">surname:Hooven;given-names:FH</infon>
      <infon key="name_14">surname:Flahive;given-names:J</infon>
      <infon key="name_11">surname:Netelenbos;given-names:JC</infon>
      <infon key="name_12">surname:Gehlbach;given-names:S</infon>
      <infon key="name_17">surname:Lacroix;given-names:AZ</infon>
      <infon key="name_18">surname:Roux;given-names:C</infon>
      <infon key="comment">doi: 10.1016/j.amjmed.2011.06.013</infon>
      <infon key="name_15">surname:Adachi;given-names:JD</infon>
      <infon key="name_9">surname:Lindsay;given-names:R</infon>
      <infon key="name_16">surname:Rossini;given-names:M</infon>
      <infon key="name_8">surname:Diez-Perez;given-names:A</infon>
      <infon key="name_7">surname:Silverman;given-names:S</infon>
      <infon key="name_6">surname:Pfeilschifter;given-names:J</infon>
      <infon key="name_19">surname:Sambrook;given-names:PN</infon>
      <infon key="name_5">surname:Greenspan;given-names:S</infon>
      <infon key="name_4">surname:Boonen;given-names:S</infon>
      <offset>11443</offset>
      <text>Obesity is not protective against fracture in postmenopausal women: GLOW</text>
      <annotation id="230">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11504" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="231">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="11477" length="8"/>
        <text>fracture</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">1</infon>
      <infon key="name_2">surname:Samos;given-names:LF</infon>
      <infon key="name_1">surname:Malphurs;given-names:JE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Paniagua;given-names:MA</infon>
      <infon key="fpage">283</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">18046882</infon>
      <infon key="year">2006</infon>
      <infon key="source">Clin Interv Aging</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">287</infon>
      <offset>11516</offset>
      <text>BMI and low bone mass in an elderly male nursing home population</text>
    </passage>
    <passage>
      <infon key="name_3">surname:LeBlanc;given-names:ES</infon>
      <infon key="name_2">surname:Adams;given-names:AL</infon>
      <infon key="name_1">surname:Marshall;given-names:LM</infon>
      <infon key="name_0">surname:Nielson;given-names:CM</infon>
      <infon key="fpage">496</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">20814955</infon>
      <infon key="year">2011</infon>
      <infon key="source">J Bone Miner Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">26</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.1002/jbmr.235</infon>
      <infon key="name_8">surname:Orwoll;given-names:ES</infon>
      <infon key="name_7">surname:Barrett-Connor;given-names:E</infon>
      <infon key="lpage">502</infon>
      <infon key="name_6">surname:Stefanick;given-names:ML</infon>
      <infon key="name_5">surname:Ensrud;given-names:K</infon>
      <infon key="name_4">surname:Cawthon;given-names:PM</infon>
      <offset>11581</offset>
      <text>BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS)</text>
      <annotation id="237">
        <infon key="identifier">8011</infon>
        <infon key="type">Gene</infon>
        <location offset="11658" length="4"/>
        <text>MrOS</text>
      </annotation>
      <annotation id="238">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11612" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="239">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11647" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="240">
        <infon key="identifier">MESH:D058866</infon>
        <infon key="type">Disease</infon>
        <location offset="11621" length="22"/>
        <text>osteoporotic fractures</text>
      </annotation>
      <annotation id="241">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="11589" length="8"/>
        <text>fracture</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Hermosilla;given-names:E</infon>
      <infon key="name_2">surname:Fina;given-names:Aviles F</infon>
      <infon key="name_1">surname:Premaor;given-names:MO</infon>
      <infon key="name_0">surname:Prieto-Alhambra;given-names:D</infon>
      <infon key="fpage">294</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">22095911</infon>
      <infon key="year">2012</infon>
      <infon key="source">J Bone Miner Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">27</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.1002/jbmr.1466</infon>
      <infon key="name_8">surname:Diez-Perez;given-names:A</infon>
      <infon key="name_7">surname:Compston;given-names:JE</infon>
      <infon key="lpage">300</infon>
      <infon key="name_6">surname:Nogues;given-names:X</infon>
      <infon key="name_5">surname:Carbonell-Abella;given-names:C</infon>
      <infon key="name_4">surname:Martinez-Laguna;given-names:D</infon>
      <offset>11664</offset>
      <text>The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women</text>
      <annotation id="244">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="11688" length="8"/>
        <text>fracture</text>
      </annotation>
      <annotation id="245">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="11701" length="7"/>
        <text>obesity</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Pages-Castella;given-names:A</infon>
      <infon key="name_2">surname:Fina Aviles;given-names:F</infon>
      <infon key="name_1">surname:Compston;given-names:JE</infon>
      <infon key="name_0">surname:Premaor;given-names:MO</infon>
      <infon key="fpage">1771</infon>
      <infon key="issue">8</infon>
      <infon key="pub-id_pmid">23371035</infon>
      <infon key="year">2013</infon>
      <infon key="source">J Bone Miner Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">28</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.1002/jbmr.1878</infon>
      <infon key="lpage">1777</infon>
      <infon key="name_6">surname:Prieto-Alhambra;given-names:D</infon>
      <infon key="name_5">surname:Diez-Perez;given-names:A</infon>
      <infon key="name_4">surname:Nogues;given-names:X</infon>
      <offset>11777</offset>
      <text>The association between fracture site and obesity in men: a population-based cohort study</text>
      <annotation id="249">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11830" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="250">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="11801" length="8"/>
        <text>fracture</text>
      </annotation>
      <annotation id="251">
        <infon key="identifier">MESH:D009765</infon>
        <infon key="type">Disease</infon>
        <location offset="11819" length="7"/>
        <text>obesity</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="comment">Available at: </infon>
      <infon key="type">ref</infon>
      <offset>11867</offset>
      <text>BMI classification according to WHO</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Hochberg;given-names:MC</infon>
      <infon key="name_2">surname:Hawkes;given-names:WG</infon>
      <infon key="name_1">surname:Alley;given-names:DE</infon>
      <infon key="name_0">surname:Lloyd;given-names:JT</infon>
      <infon key="fpage">175</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">24664472</infon>
      <infon key="year">2014</infon>
      <infon key="source">Arch Osteoporos</infon>
      <infon key="type">ref</infon>
      <infon key="volume">9</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.1007/s11657-014-0175-2. Epub 2014 Mar 25</infon>
      <infon key="name_5">surname:Orwig;given-names:DL</infon>
      <infon key="name_4">surname:Waldstein;given-names:SR</infon>
      <offset>11903</offset>
      <text>Body mass index is positively associated with bone mineral density in US older adults</text>
    </passage>
  </document>
  <document>
    <id>4272830</id>
    <passage>
      <infon key="name_3">surname:Hoxha-Kamberi;given-names:Teuta</infon>
      <infon key="name_2">surname:Azemi;given-names:Mehmedali</infon>
      <infon key="name_1">surname:Shala;given-names:Muje</infon>
      <infon key="article-id_pmid">25568634</infon>
      <infon key="name_0">surname:Ismaili-Jaha;given-names:Vlora</infon>
      <infon key="fpage">335</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272830</infon>
      <infon key="article-id_publisher-id">MSM-26-335</infon>
      <infon key="article-id_doi">10.5455/msm.2014.26.335-338</infon>
      <infon key="type">front</infon>
      <infon key="volume">26</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Mater Sociomed; 2014 Oct; 26(5) 335-8. doi:10.5455/msm.2014.26.335-338</infon>
      <infon key="kwd">Acute diarrhea rotavirus Kosova</infon>
      <infon key="lpage">338</infon>
      <infon key="name_6">surname:Jaha;given-names:Luan</infon>
      <infon key="name_5">surname:Spahiu;given-names:Shqipe</infon>
      <infon key="name_4">surname:Avdiu;given-names:Muharrem</infon>
      <infon key="authors">Ismaili-Jaha V, Shala M, Azemi M, Hoxha-Kamberi T, Avdiu M, Spahiu S, Jaha L</infon>
      <offset>0</offset>
      <text>Characteristics of Rotavirus Diarrhea in Hospitalized Children in Kosovo</text>
      <annotation id="2">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="54" length="8"/>
        <text>Children</text>
      </annotation>
      <annotation id="3">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="19" length="18"/>
        <text>Rotavirus Diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>73</offset>
      <text>Background:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>85</offset>
      <text>Diarrhea is a leading cause of child mortality worldwide. Rotavirus is one of the most common causes of severe diarrhea and dehydration in children. Authors reviewed epidemiological and clinical data of the rotavirus diarrhea in Kosovo.</text>
      <annotation id="10">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="116" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="11">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="224" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="12">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="85" length="8"/>
        <text>Diarrhea</text>
      </annotation>
      <annotation id="13">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="209" length="11"/>
        <text>dehydration</text>
      </annotation>
      <annotation id="14">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="196" length="8"/>
        <text>diarrhea</text>
      </annotation>
      <annotation id="15">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="292" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>322</offset>
      <text>Methods:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>331</offset>
      <text>This is a prospective study carried between January 1st and December 31st 2011. All data, comprising demographics, nutrition, clinical presentation, laboratory findings, management and outcome of the rotavirus diarrhea are collected on the specially designed form.</text>
      <annotation id="17">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="531" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>596</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>605</offset>
      <text>116 children with rotavirus diarrhea are included in the study. The majority boys (74.4%) and children aged 0 - 12 months (82.75%). Mean age of children in the study was 16.38 months. Almost every third child in the study was hypotrophic (29.2%). More than half of the infants (55.2%) were on mixed food, somewhat more than every third was breast feeding (36.45%), and every twelfth (8.33%) was on artificial milk (animal or formula). Apart from diarrhea, present in all patients, vomiting (97.41%) and fever (43.96%) were characteristics of the clinical presentation of the diarrhea. Two thirds of the children had mild grade dehydration (70.7%). All patients recovered with no sequels.</text>
      <annotation id="33">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="609" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="34">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="682" length="4"/>
        <text>boys</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="699" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="36">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="749" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="37">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="808" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="38">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="874" length="7"/>
        <text>infants</text>
      </annotation>
      <annotation id="39">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1076" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="40">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1208" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="41">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1257" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="42">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="1232" length="11"/>
        <text>dehydration</text>
      </annotation>
      <annotation id="43">
        <infon key="identifier">MESH:D014839</infon>
        <infon key="type">Disease</infon>
        <location offset="1086" length="8"/>
        <text>vomiting</text>
      </annotation>
      <annotation id="44">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="1180" length="8"/>
        <text>diarrhea</text>
      </annotation>
      <annotation id="45">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="623" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
      <annotation id="46">
        <infon key="identifier">MESH:D005334</infon>
        <infon key="type">Disease</infon>
        <location offset="1108" length="5"/>
        <text>fever</text>
      </annotation>
      <annotation id="47">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="1051" length="8"/>
        <text>diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1295</offset>
      <text>Conclusion:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1307</offset>
      <text>Rotavirus continues to be responsible for a significant portion of acute diarrhea in Kosovo. Clinical features, epidemiological data and the agglutination test are safe enough to establish the diagnosis. Treated correctly rotavirus diarrhea has a favorable outcome.</text>
      <annotation id="50">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="1529" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
      <annotation id="51">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="1380" length="8"/>
        <text>diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1573</offset>
      <text>1. BACKGROUND</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1587</offset>
      <text>Since 1973 when discovered by Bishop, rotavirus was found responsible for one third of the children hospitalization for acute diarrhea worldwide. Rotavirus diarrhea is a cause of 440 thousand deaths, 2 million hospitalizations, 25 million outpatients visit and 111 million episodes of domiciliary diarrhea among children. The aim of this study is to analyze the epidemiology of the acute diarrhea inflicted by rotavirus, demographics of the patients and clinical presentation of the disease in children hospitalized at the Department of Pediatric Gastroenterology of the University Clinical Center of Kosovo in Prishtina, Republic of Kosovo.</text>
      <annotation id="60">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1678" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="61">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1899" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="62">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2028" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="63">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2081" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="64">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="1733" length="18"/>
        <text>Rotavirus diarrhea</text>
      </annotation>
      <annotation id="65">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="1713" length="8"/>
        <text>diarrhea</text>
      </annotation>
      <annotation id="66">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="1975" length="8"/>
        <text>diarrhea</text>
      </annotation>
      <annotation id="67">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="1884" length="8"/>
        <text>diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2229</offset>
      <text>It is a busy metropolitan center serving population of around 2 million inhabitants of the Republic of Kosovo. Country itself a decade ago emerged from the devastating war and is the poorest in Europe. As found by the Kosovo Agency of Statistics, 46% of the population in country is younger than 18 years, 28% is younger than 14 years and 8% younger than 5%.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>2588</offset>
      <text>2. METHODS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>2599</offset>
      <text>This is a prospective study carried between January 1st and December 31st 2011. All data, comprising demographics, nutrition, clinical presentation, laboratory findings, management and outcome of the rotavirus diarrhea are collected on the specially designed form.</text>
      <annotation id="69">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="2799" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>2864</offset>
      <text>Retrovirus is confirmed in the stool of patients using Latex agglutination test LTA s.r.l. - Via Milan with sensitivity and specify of 96%.</text>
      <annotation id="71">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2904" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>3006</offset>
      <text>3. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>3017</offset>
      <text>Of 1011 children admitted at the Hospital for acute diarrhea during the study period, every third is tested for rotavirus. Of 337 tested, 116 were positive on rotavirus (34.42%).</text>
      <annotation id="74">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3025" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="3069" length="8"/>
        <text>diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>3196</offset>
      <text>The majority of the children in the study were boys (74.4) and infants (82.75%). Average age of children in the study was 16.38 months. Almost every third child in study was hypotrophic (29.2%). The hypotrophy was more frequent in girls than in boys (41% vs. 23.5%).</text>
      <annotation id="83">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3216" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="84">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3243" length="4"/>
        <text>boys</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3259" length="7"/>
        <text>infants</text>
      </annotation>
      <annotation id="86">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3292" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="87">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3351" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="88">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3427" length="5"/>
        <text>girls</text>
      </annotation>
      <annotation id="89">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3441" length="4"/>
        <text>boys</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>3463</offset>
      <text>Only 20 children were not infants (17.2%). More than half of the infants (55.2%) were on mixed food, somewhat more than every third was breast feeding (36.45%), and every twelfth (8.33%) was on artificial milk (animal or formula).</text>
      <annotation id="93">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3471" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="94">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3489" length="7"/>
        <text>infants</text>
      </annotation>
      <annotation id="95">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3528" length="7"/>
        <text>infants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>3694</offset>
      <text>Data on demographics, nutritional status and feeding habits are presented in table 1.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>3780</offset>
      <text>Demographics, nutritional status and mode of feeding of the patient with rotavirus diarrhea in the study</text>
      <annotation id="98">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3840" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="99">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="3853" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>3885</offset>
      <text>Apart from diarrhea, present in all patients, vomiting (88.8%) and fever (43.96%) were characteristics of the clinical presentation of the diarrhea. Vomiting was more frequent in boys than in girls (97.4% vs. 71.8%) as well as temperature (46.7% vs. 38.5%). Two patients in the study (1.7%), one boy and one girl have had a convulsion at the admission The frequency of the convulsions was equal (each 1.7%)</text>
      <annotation id="113">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3921" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="114">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4064" length="4"/>
        <text>boys</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4077" length="5"/>
        <text>girls</text>
      </annotation>
      <annotation id="116">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4147" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="117">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4181" length="3"/>
        <text>boy</text>
      </annotation>
      <annotation id="118">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4193" length="4"/>
        <text>girl</text>
      </annotation>
      <annotation id="119">
        <infon key="identifier">MESH:D012640</infon>
        <infon key="type">Disease</infon>
        <location offset="4258" length="11"/>
        <text>convulsions</text>
      </annotation>
      <annotation id="120">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="4024" length="8"/>
        <text>diarrhea</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">MESH:D012640</infon>
        <infon key="type">Disease</infon>
        <location offset="4209" length="10"/>
        <text>convulsion</text>
      </annotation>
      <annotation id="122">
        <infon key="identifier">MESH:D014839</infon>
        <infon key="type">Disease</infon>
        <location offset="4034" length="8"/>
        <text>Vomiting</text>
      </annotation>
      <annotation id="123">
        <infon key="identifier">MESH:D014839</infon>
        <infon key="type">Disease</infon>
        <location offset="3931" length="8"/>
        <text>vomiting</text>
      </annotation>
      <annotation id="124">
        <infon key="identifier">MESH:D005334</infon>
        <infon key="type">Disease</infon>
        <location offset="3952" length="5"/>
        <text>fever</text>
      </annotation>
      <annotation id="125">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="3896" length="8"/>
        <text>diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>4292</offset>
      <text>All patients in the study had moderate or severe dehydration with the later present in almost every third patient in the study (29.3%). There are no significant differences in the degree of the dehydration between girls and boys.</text>
      <annotation id="132">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4296" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4398" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="134">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4506" length="5"/>
        <text>girls</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4516" length="4"/>
        <text>boys</text>
      </annotation>
      <annotation id="136">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="4486" length="11"/>
        <text>dehydration</text>
      </annotation>
      <annotation id="137">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="4341" length="11"/>
        <text>dehydration</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>4522</offset>
      <text>Clinical presentation of the rotavirus diarrhea and the degree of dehydration at the admission are presented in table 2.</text>
      <annotation id="140">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="4551" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
      <annotation id="141">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="4588" length="11"/>
        <text>dehydration</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>4643</offset>
      <text>Symptoms and degree of dehydration of the patient with rotavirus diarrhea at the admission</text>
      <annotation id="145">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4685" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="146">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="4698" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
      <annotation id="147">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="4666" length="11"/>
        <text>dehydration</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>4734</offset>
      <text>Only about one third of the patients with rotavirus diarrhea in our study had associated diseases (36.2%). The most frequent one was bronchopneumonia that was present in 31.9% of our patients. Less common were upper urinary tract infections (1.7%), upper respiratory tract infections (0.9%) and gastro esophageal reflux (1.7%). Both urinary tract infections in our study were in girls (5.1% of the girls).</text>
      <annotation id="158">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4762" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="159">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4917" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="160">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5113" length="5"/>
        <text>girls</text>
      </annotation>
      <annotation id="161">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5132" length="5"/>
        <text>girls</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">MESH:D012141</infon>
        <infon key="type">Disease</infon>
        <location offset="4989" length="28"/>
        <text>respiratory tract infections</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">MESH:D012141</infon>
        <infon key="type">Disease</infon>
        <location offset="5075" length="16"/>
        <text>tract infections</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">MESH:D005764</infon>
        <infon key="type">Disease</infon>
        <location offset="5029" length="24"/>
        <text>gastro esophageal reflux</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">MESH:D001996</infon>
        <infon key="type">Disease</infon>
        <location offset="4867" length="16"/>
        <text>bronchopneumonia</text>
      </annotation>
      <annotation id="166">
        <infon key="identifier">MESH:D014552</infon>
        <infon key="type">Disease</infon>
        <location offset="4944" length="30"/>
        <text>upper urinary tract infections</text>
      </annotation>
      <annotation id="167">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="4776" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>5140</offset>
      <text>Data on associated conditions and diseases in patients with rotavirus diarrhea are presented in table 3.</text>
      <annotation id="170">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5186" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="171">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="5200" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T3.xml</infon>
      <infon key="id">T3</infon>
      <infon key="type">table_caption</infon>
      <offset>5245</offset>
      <text>Associated conditions and diseases in patient with rotavirus diarrhea in our study</text>
      <annotation id="174">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5283" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="5296" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>5328</offset>
      <text>Paralytic ileus was the most common complication of the rotavirus diarrhea. In our study it occurred in 9.5% of patients or almost in every tenth patient. The incidence of this complication was for a little more frequent in girls than in boys (15.4% vs 6.5%). There was also a single case of ascites among our patients (0.86%). One patient presented with neurological symptoms (seizures).</text>
      <annotation id="187">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5440" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="188">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5474" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="189">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5552" length="5"/>
        <text>girls</text>
      </annotation>
      <annotation id="190">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5566" length="4"/>
        <text>boys</text>
      </annotation>
      <annotation id="191">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5638" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="192">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5660" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="193">
        <infon key="identifier">MESH:D007418</infon>
        <infon key="type">Disease</infon>
        <location offset="5328" length="15"/>
        <text>Paralytic ileus</text>
      </annotation>
      <annotation id="194">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="5384" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
      <annotation id="195">
        <infon key="identifier">MESH:D012640</infon>
        <infon key="type">Disease</infon>
        <location offset="5706" length="8"/>
        <text>seizures</text>
      </annotation>
      <annotation id="196">
        <infon key="identifier">MESH:D009422</infon>
        <infon key="type">Disease</infon>
        <location offset="5683" length="21"/>
        <text>neurological symptoms</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">MESH:D001201</infon>
        <infon key="type">Disease</infon>
        <location offset="5620" length="7"/>
        <text>ascites</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>5717</offset>
      <text>Little more than two of three patients in our study were treated without antibiotics (36.2%) and only eight patients (6.9%) were given concentrated erythrocytes or fresh frozen plasma. Ceftriaxone was the most commonly used antibiotic in our practice. The drug was given to 50% of the patients as the only antibiotic and in another 11.2% of patients combined with aminoglycosides - amikacin or gentamicin. Amikacin was given as the only drug in 2.6% of patients and Bactrim (sulfamethoxazole and trimethoprim) in 0.9% of patients.</text>
      <annotation id="212">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5747" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="213">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5825" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="214">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6002" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="215">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6058" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="216">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6170" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="217">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6238" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="218">
        <infon key="identifier">MESH:D000617</infon>
        <infon key="type">Chemical</infon>
        <location offset="6081" length="15"/>
        <text>aminoglycosides</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">MESH:D002443</infon>
        <infon key="type">Chemical</infon>
        <location offset="5902" length="11"/>
        <text>Ceftriaxone</text>
      </annotation>
      <annotation id="220">
        <infon key="identifier">MESH:D000583</infon>
        <infon key="type">Chemical</infon>
        <location offset="6099" length="8"/>
        <text>amikacin</text>
      </annotation>
      <annotation id="221">
        <infon key="identifier">MESH:D005839</infon>
        <infon key="type">Chemical</infon>
        <location offset="6111" length="10"/>
        <text>gentamicin</text>
      </annotation>
      <annotation id="222">
        <infon key="identifier">MESH:D013420</infon>
        <infon key="type">Chemical</infon>
        <location offset="6192" length="16"/>
        <text>sulfamethoxazole</text>
      </annotation>
      <annotation id="223">
        <infon key="identifier">MESH:D015662</infon>
        <infon key="type">Chemical</infon>
        <location offset="6183" length="7"/>
        <text>Bactrim</text>
      </annotation>
      <annotation id="224">
        <infon key="identifier">MESH:D000583</infon>
        <infon key="type">Chemical</infon>
        <location offset="6123" length="8"/>
        <text>Amikacin</text>
      </annotation>
      <annotation id="225">
        <infon key="identifier">MESH:D014295</infon>
        <infon key="type">Chemical</infon>
        <location offset="6213" length="12"/>
        <text>trimethoprim</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6250</offset>
      <text>Data on the use of antibiotics and blood derivates are presented in table 4.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T4.xml</infon>
      <infon key="id">T4</infon>
      <infon key="type">table_caption</infon>
      <offset>6327</offset>
      <text>The use of antibiotics, blood and blood derivates for the treatment of patients with rotavirus diarrhea in study. *Ceftriaxone in combination with amikacin or gentamicin</text>
      <annotation id="231">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6398" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="232">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="6412" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
      <annotation id="233">
        <infon key="identifier">MESH:D000583</infon>
        <infon key="type">Chemical</infon>
        <location offset="6474" length="8"/>
        <text>amikacin</text>
      </annotation>
      <annotation id="234">
        <infon key="identifier">MESH:D005839</infon>
        <infon key="type">Chemical</infon>
        <location offset="6486" length="10"/>
        <text>gentamicin</text>
      </annotation>
      <annotation id="235">
        <infon key="identifier">MESH:D002443</infon>
        <infon key="type">Chemical</infon>
        <location offset="6442" length="11"/>
        <text>Ceftriaxone</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6497</offset>
      <text>Assessment of the seasonal distribution of the rotavirus diarrhea has shown that the disease most commonly occurred in autumn, winter and early spring with peaks in September, November and January (Graph 1). All patients recovered without sequels.</text>
      <annotation id="238">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6709" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="239">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="6544" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">MSM-26-335-g005.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>6745</offset>
      <text>Seasonal distribution of the rotavirus diarrhea</text>
      <annotation id="241">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="6774" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>6793</offset>
      <text>4. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>6807</offset>
      <text>Rotavirus is the common cause of diarrhea of the infant worldwide. According to Parashar and associates, who reviewed the Global mortality associated with Rotavirus disease among children, rotavirus is responsible for 527,000 deaths (95% confidence interval, 475,000-580,000 deaths) annually or 29% of all deaths due to diarrhea among children &lt;5 years of age. This translates into approximately 1440 deaths due to rotavirus disease per day (1 of 237 children born each year would die of rotavirus disease by 5 years of age).</text>
      <annotation id="253">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6856" length="6"/>
        <text>infant</text>
      </annotation>
      <annotation id="254">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6986" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="255">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7142" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="256">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7258" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="257">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="6840" length="8"/>
        <text>diarrhea</text>
      </annotation>
      <annotation id="258">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="6962" length="17"/>
        <text>Rotavirus disease</text>
      </annotation>
      <annotation id="259">
        <infon key="identifier">MESH:C564120</infon>
        <infon key="type">Disease</infon>
        <location offset="7070" length="18"/>
        <text>000-580,000 deaths</text>
      </annotation>
      <annotation id="260">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="7295" length="17"/>
        <text>rotavirus disease</text>
      </annotation>
      <annotation id="261">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="7127" length="8"/>
        <text>diarrhea</text>
      </annotation>
      <annotation id="262">
        <infon key="identifier">MESH:D003643</infon>
        <infon key="type">Disease</infon>
        <location offset="7029" length="10"/>
        <text>000 deaths</text>
      </annotation>
      <annotation id="263">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="7222" length="17"/>
        <text>rotavirus disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>7333</offset>
      <text>Although rotavirus is ubiquitous and the incidence of disease is similar among children in industrialized and developing countries, there is a great disparity in mortality associated with rotavirus. Whereas very few deaths due to rotavirus disease occurred in affluent countries, countries with the greatest level of child mortality accounted for approximately 86% of all deaths due to rotavirus disease. In fact, 6 countries (India, Nigeria, China, Pakistan, Ethiopia, and Democratic Republic of Congo) accounted for &gt;50% of all deaths due to rotavirus disease, with India alone accounting for one-fourth of the deaths.</text>
      <annotation id="270">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7412" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="271">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7650" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="272">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="7719" length="17"/>
        <text>rotavirus disease</text>
      </annotation>
      <annotation id="273">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="7563" length="17"/>
        <text>rotavirus disease</text>
      </annotation>
      <annotation id="274">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="7877" length="17"/>
        <text>rotavirus disease</text>
      </annotation>
      <annotation id="275">
        <infon key="identifier">MESH:D006479</infon>
        <infon key="type">Disease</infon>
        <location offset="7807" length="28"/>
        <text>Democratic Republic of Congo</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>7954</offset>
      <text>Papers discussing the prevalence of diarrhea caused by rotavirus in the Republic of Kosovo are lacking. At the moment, there are only two papers, one presented by Azemi alone and another presented by Azemi with coworkers discussing this issue. According to the paper in year 1987, 24.27% of children hospitalized at the Department of Pediatric Gastroenterology of the University Clinical Center of Kosovo had acute diarrhea associated with severe dehydration (toxicosis), and, of them, 7% inflicted by rotavirus. In 2002, according to the second paper, rotavirus is found responsible for 16.8% of acute diarrhea.</text>
      <annotation id="282">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8245" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="283">
        <infon key="identifier">MESH:C565846</infon>
        <infon key="type">Disease</infon>
        <location offset="8414" length="9"/>
        <text>toxicosis</text>
      </annotation>
      <annotation id="284">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="8557" length="8"/>
        <text>diarrhea</text>
      </annotation>
      <annotation id="285">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="8401" length="11"/>
        <text>dehydration</text>
      </annotation>
      <annotation id="286">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="7990" length="8"/>
        <text>diarrhea</text>
      </annotation>
      <annotation id="287">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="8369" length="8"/>
        <text>diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>8567</offset>
      <text>In our study, the percentage is found to be significantly higher - 34.42%. It is rather reflection of better living standard of the Kosovars and health care provision than of the change in epidemiological behavior of the virus. Better feeding habits, better education of the mothers and better health care, no doubt, have made for other causes of the diarrhea to diminish.</text>
      <annotation id="289">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="8918" length="8"/>
        <text>diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>8942</offset>
      <text>With one third of acute diarrhea due to rotavirus (34.42%), prevalence of the disease in Kosovo is similar to the prevalence in other European countries. It is similar to the prevalence in Central and Southeastern Europe, that varies between 22% (Czech Republic) and 55.3% (Russia), with Bosnia and Hercegovina (23.9%), Hungary (27.1%), Albania (32.4%), Bulgaria (32.4%), Romania (42%) and Ukraine (42%) in between, as found by Ogilvie and coauthors in their study of burden of rotavirus gastroenteritis in the pediatric population in this region. But, also similar to the prevalence found in REVEAL study that have found prevalence ranging between 27.8% in Germany and 52% in Sweden, with Spain (31.2%), France (33.5%), Great Britain (35.9%), Italy (43.6%) and Belgium (44.7%) in between.</text>
      <annotation id="294">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="9420" length="25"/>
        <text>rotavirus gastroenteritis</text>
      </annotation>
      <annotation id="295">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="8966" length="8"/>
        <text>diarrhea</text>
      </annotation>
      <annotation id="296">
        <infon key="type">Disease</infon>
        <location offset="9230" length="6"/>
        <text>Bosnia</text>
      </annotation>
      <annotation id="297">
        <infon key="type">Disease</infon>
        <location offset="9314" length="7"/>
        <text>Romania</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9732</offset>
      <text>The majority of children with acute diarrhea in our study were infants (48%) and boys (66%). The higher infliction of the boys with rotavirus diarrhea is noted in several other studies, both local and worldwide, but, up to day, there are no known reasons established. Furthermore, there are studies as well, stating the opposite.</text>
      <annotation id="304">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9748" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="305">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9795" length="7"/>
        <text>infants</text>
      </annotation>
      <annotation id="306">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9813" length="4"/>
        <text>boys</text>
      </annotation>
      <annotation id="307">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9854" length="4"/>
        <text>boys</text>
      </annotation>
      <annotation id="308">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="9864" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
      <annotation id="309">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="9768" length="8"/>
        <text>diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10062</offset>
      <text>Vomiting, diarrhea and temperature usually occurred at the second day after exposition, following an exposition period of less than 48 hours. Consequently, in our study, dehydration was present in all children. In almost every third child, this dehydration was severe.</text>
      <annotation id="316">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10263" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="317">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10295" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="318">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="10307" length="11"/>
        <text>dehydration</text>
      </annotation>
      <annotation id="319">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="10232" length="11"/>
        <text>dehydration</text>
      </annotation>
      <annotation id="320">
        <infon key="identifier">MESH:D014839</infon>
        <infon key="type">Disease</infon>
        <location offset="10062" length="8"/>
        <text>Vomiting</text>
      </annotation>
      <annotation id="321">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="10072" length="8"/>
        <text>diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10331</offset>
      <text>The REVEAL study reported that the proportion of children with dehydration due to acute RVGE varied between 11.1% (Spain) and 71.4% (Sweden), and in most countries, was considerably higher than for those with rotavirus-negative disease. In Belgium and the UK, the prevalence of dehydration was comparable among children with or without RVGE, whereas the dehydration prevalence ratio of rotavirus versus non-rotavirus disease was 1.82, 5.54, 3.27, 3.47, and 2.18, respectively, in France, Germany, Italy, Spain, and Sweden. A second prospective multicenter study from France, Germany, Italy, Spain, and the UK reported that dehydration was evident in 75.7% of patients with RVGE, and was severe in 11.3% of them. In comparison, only 54.5% of children with non-RVGE were dehydrated, while 4.7% had severe dehydration (25). Another study from France confirmed this trend, showing significant differences in dehydration between rotavirus-positive and negative gastroenteritis (26.8% vs.14.7%, P &lt; .0001) as did a study from Greece. Further, one Italian community-based study showed that dehydration at initial presentation in primary care was associated with a higher likelihood of RVGE (OR: 1.8; 95% CI, 1.1-3; P = 0.02).</text>
      <annotation id="335">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10380" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="336">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10642" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="337">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10990" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="338">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11072" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="339">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="10609" length="11"/>
        <text>dehydration</text>
      </annotation>
      <annotation id="340">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="10717" length="38"/>
        <text>rotavirus versus non-rotavirus disease</text>
      </annotation>
      <annotation id="341">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="11414" length="11"/>
        <text>dehydration</text>
      </annotation>
      <annotation id="342">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="11235" length="11"/>
        <text>dehydration</text>
      </annotation>
      <annotation id="343">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="10394" length="11"/>
        <text>dehydration</text>
      </annotation>
      <annotation id="344">
        <infon key="identifier">MESH:D005759</infon>
        <infon key="type">Disease</infon>
        <location offset="11287" length="15"/>
        <text>gastroenteritis</text>
      </annotation>
      <annotation id="345">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="11134" length="11"/>
        <text>dehydration</text>
      </annotation>
      <annotation id="346">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="10685" length="11"/>
        <text>dehydration</text>
      </annotation>
      <annotation id="347">
        <infon key="identifier">MESH:D003681</infon>
        <infon key="type">Disease</infon>
        <location offset="10954" length="11"/>
        <text>dehydration</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11550</offset>
      <text>It is interesting to find that about every third patients in our study has bronchopneumonia as associated disease and every tenth had paralytic ileus.</text>
      <annotation id="351">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11599" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="352">
        <infon key="identifier">MESH:D007418</infon>
        <infon key="type">Disease</infon>
        <location offset="11684" length="15"/>
        <text>paralytic ileus</text>
      </annotation>
      <annotation id="353">
        <infon key="identifier">MESH:D001996</infon>
        <infon key="type">Disease</infon>
        <location offset="11625" length="16"/>
        <text>bronchopneumonia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11701</offset>
      <text>Although affection of the central nervous system is not common in children with rotavirus diarrhea, it occurred in two our patients. First to report association of this disease with rotavirus diarrhea were Day and coauthors. They reported neurological symptoms and stool virology positive for rotavirus in four children, presented within 4 weeks in Barnet and Chase Farm Hospitals NHS Trust, London, UK. Similar to our patients, all four made a quick recovery and were discharged home after a few days without medication. At 6 weeks all were well, with no further neurological episodes.</text>
      <annotation id="361">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11767" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="362">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11824" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="363">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12012" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="364">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12120" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="365">
        <infon key="identifier">MESH:D009422</infon>
        <infon key="type">Disease</infon>
        <location offset="11940" length="21"/>
        <text>neurological symptoms</text>
      </annotation>
      <annotation id="366">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="11781" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
      <annotation id="367">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="11883" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12288</offset>
      <text>Later, Fuchigami and coauthors reported a case of encephalopathy in 4 year old girl at the Department of General Pediatrics, Nihon University Nerima Hikarigaoka Hospital, Tokyo. Probably there will be more such reports in the future.</text>
      <annotation id="370">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12367" length="4"/>
        <text>girl</text>
      </annotation>
      <annotation id="371">
        <infon key="identifier">MESH:D001927</infon>
        <infon key="type">Disease</infon>
        <location offset="12338" length="14"/>
        <text>encephalopathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12522</offset>
      <text>Use of antibiotics, blood and blood derivates in rotavirus diarrhea is a matter of a worldwide discussion. In out study almost two thirds of the patients were treated with antibiotics and about every twentieth was given blood or blood derivates. High association with bronchopneumonia may explain why.</text>
      <annotation id="375">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12667" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="376">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="12571" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
      <annotation id="377">
        <infon key="identifier">MESH:D001996</infon>
        <infon key="type">Disease</infon>
        <location offset="12790" length="16"/>
        <text>bronchopneumonia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12824</offset>
      <text>Rotavirus diarrhea most commonly occurred in autumn, winter and early spring with peaks in September, November and January.</text>
      <annotation id="379">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="12824" length="18"/>
        <text>Rotavirus diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>12948</offset>
      <text>5. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>12962</offset>
      <text>Rotavirus diarrhea continues to be a serious health problem in Kosovo. Epidemiological and clinical features of the disease and Latex agglutination test are essential tools to establish the diagnosis at the time.</text>
      <annotation id="381">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="12962" length="18"/>
        <text>Rotavirus diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>13175</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>13212</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Ruck;given-names:BJ</infon>
      <infon key="volume">1</infon>
      <infon key="name_2">surname:Holmes;given-names:IH</infon>
      <infon key="name_1">surname:Davidson;given-names:GP</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bishop;given-names:RF</infon>
      <infon key="fpage">1281</infon>
      <infon key="pub-id_pmid">4127639</infon>
      <infon key="year">1973</infon>
      <infon key="source">Lancet</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1284</infon>
      <offset>13223</offset>
      <text>Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis</text>
      <annotation id="384">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13283" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="385">
        <infon key="identifier">MESH:D005759</infon>
        <infon key="type">Disease</infon>
        <location offset="13317" length="15"/>
        <text>gastroenteritis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">4</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Parashar;given-names:U</infon>
      <infon key="fpage">4</infon>
      <infon key="year">1998</infon>
      <infon key="source">Emerging Infectious Diseases</infon>
      <infon key="type">ref</infon>
      <offset>13333</offset>
      <text>Rotavirus</text>
    </passage>
    <passage>
      <infon key="volume">63</infon>
      <infon key="name_1">surname:Feachem;given-names:RV</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:de Zoysa;given-names:I</infon>
      <infon key="fpage">569</infon>
      <infon key="pub-id_pmid">3876173</infon>
      <infon key="year">1985</infon>
      <infon key="source">Bull World Health Organ</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">683</infon>
      <offset>13343</offset>
      <text>Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunisation</text>
      <annotation id="388">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13408" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="389">
        <infon key="identifier">MESH:D004194</infon>
        <infon key="type">Disease</infon>
        <location offset="13376" length="19"/>
        <text>diarrhoeal diseases</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>13453</offset>
      <text>Kosovo Agency of Statistics</text>
    </passage>
    <passage>
      <infon key="volume">200</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Parashar;given-names:U</infon>
      <infon key="fpage">S9</infon>
      <infon key="issue">Supplement 1</infon>
      <infon key="pub-id_pmid">19817620</infon>
      <infon key="year">2009</infon>
      <infon key="source">J Infect Dis</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">S15</infon>
      <offset>13481</offset>
      <text>Global Mortality Associated with Rotavirus Disease among Children in 2004</text>
      <annotation id="392">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13538" length="8"/>
        <text>Children</text>
      </annotation>
      <annotation id="393">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="13514" length="17"/>
        <text>Rotavirus Disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Azemi;given-names:M</infon>
      <infon key="year">1987</infon>
      <infon key="comment">article in Albanian</infon>
      <infon key="source">PHD tesis, Faculty of Medicine</infon>
      <infon key="type">ref</infon>
      <offset>13555</offset>
      <text>The corelation of the etiological agent and acidobasic status in children with toxicosis</text>
      <annotation id="396">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13620" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="397">
        <infon key="identifier">MESH:C565846</infon>
        <infon key="type">Disease</infon>
        <location offset="13634" length="9"/>
        <text>toxicosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Begolli;given-names:M</infon>
      <infon key="name_2">surname:Koci;given-names:R</infon>
      <infon key="name_1">surname:Zejnullahu;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Azemi;given-names:M</infon>
      <infon key="year">2002</infon>
      <infon key="source">Book of abstracts (article in Albanian)</infon>
      <infon key="name_7">surname:dhe;given-names:Gashi N</infon>
      <infon key="type">ref</infon>
      <infon key="name_6">surname:Gojani;given-names:Xh</infon>
      <infon key="name_5">surname:Ismaili-Jaha;given-names:V</infon>
      <infon key="name_4">surname:Avdiu;given-names:M</infon>
      <offset>13644</offset>
      <text>Clinical and biochemical features of the acute diarrhea from rotavirus</text>
      <annotation id="399">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="13691" length="8"/>
        <text>diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Goetghebeur;given-names:M</infon>
      <infon key="name_2">surname:El Khoury;given-names:A</infon>
      <infon key="name_1">surname:Khoury;given-names:H</infon>
      <infon key="name_0">surname:Ogilvie;given-names:I</infon>
      <infon key="fpage">523</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">21422818</infon>
      <infon key="year">2011</infon>
      <infon key="source">Hum Vaccin</infon>
      <infon key="type">ref</infon>
      <infon key="volume">7</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">533</infon>
      <offset>13715</offset>
      <text>Burden of rotavirus gastroenteritis in the pediatric population in Central and Eastern Europe. Serotype distribution and burden of illness</text>
      <annotation id="401">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="13725" length="25"/>
        <text>rotavirus gastroenteritis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">195</infon>
      <infon key="section_type">REF</infon>
      <infon key="fpage">S4</infon>
      <infon key="issue">Supplement 1</infon>
      <infon key="pub-id_pmid">17387650</infon>
      <infon key="year">2007</infon>
      <infon key="source">J Infect Dis</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">S16</infon>
      <offset>13854</offset>
      <text>Multicenter Prospective Study of the Burden of Rotavirus Acute Gastroenteritis in Europe 2004 - 2005: The Reveal Study</text>
      <annotation id="403">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="13901" length="31"/>
        <text>Rotavirus Acute Gastroenteritis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Begolli;given-names:M</infon>
      <infon key="name_2">surname:Koci;given-names:R</infon>
      <infon key="name_1">surname:Zejnullahu;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Azemi;given-names:M</infon>
      <infon key="year">2002</infon>
      <infon key="source">Book of abstracts (article in Albanian)</infon>
      <infon key="name_7">surname:dhe;given-names:Gashi N</infon>
      <infon key="type">ref</infon>
      <infon key="name_6">surname:Gojani;given-names:Xh</infon>
      <infon key="name_5">surname:Ismaili-Jaha;given-names:V</infon>
      <infon key="name_4">surname:Avdiu;given-names:M</infon>
      <offset>13975</offset>
      <text>Clinical and biochemical features of the acute diarrhea from rotavirus</text>
      <annotation id="405">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="14022" length="8"/>
        <text>diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_1">surname:Raic;given-names:F</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Votava;given-names:A</infon>
      <infon key="year">1982</infon>
      <infon key="comment">article in Croatian</infon>
      <infon key="source">PHD thesis</infon>
      <infon key="type">ref</infon>
      <offset>14046</offset>
      <text>Impact of diseases afecting gastrointestinal system in pediatric toxicosis</text>
      <annotation id="408">
        <infon key="identifier">MESH:D005767</infon>
        <infon key="type">Disease</infon>
        <location offset="14056" length="41"/>
        <text>diseases afecting gastrointestinal system</text>
      </annotation>
      <annotation id="409">
        <infon key="identifier">MESH:C565846</infon>
        <infon key="type">Disease</infon>
        <location offset="14111" length="9"/>
        <text>toxicosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_2">surname:Apostolov;given-names:D</infon>
      <infon key="name_1">surname:Sosev;given-names:B</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Stojanovski;given-names:N</infon>
      <infon key="fpage">444</infon>
      <infon key="year">1979</infon>
      <infon key="comment">article in Bosnian</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">445</infon>
      <offset>14121</offset>
      <text>Acidobasic amd electrolitic disorders in pediatric toxicosis and their role in treatment</text>
      <annotation id="411">
        <infon key="identifier">MESH:D063766</infon>
        <infon key="type">Disease</infon>
        <location offset="14162" length="19"/>
        <text>pediatric toxicosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_2">surname:Predokevic;given-names:L</infon>
      <infon key="name_1">surname:Anic;given-names:O</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hodzic;given-names:L</infon>
      <infon key="fpage">147</infon>
      <infon key="year">1983</infon>
      <infon key="comment">article in Serbian</infon>
      <infon key="source">Novi Sad, Republic of Serbia</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">148</infon>
      <offset>14210</offset>
      <text>Prognosis of the children with diarrhea toxicosis.12th Congress of the pediatritian of the Yugoslavia</text>
      <annotation id="414">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14227" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="415">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="14241" length="32"/>
        <text>diarrhea toxicosis.12th Congress</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">99</infon>
      <infon key="name_2">surname:de Villiers;given-names:GK</infon>
      <infon key="name_1">surname:Sawyerr;given-names:TN</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:de Villiers;given-names:FP</infon>
      <infon key="fpage">249</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">19588778</infon>
      <infon key="year">2009</infon>
      <infon key="source">S Afr Med J</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">252</infon>
      <offset>14312</offset>
      <text>The incidence and clinical presentation of infantile rotavirus diarrhoea in Sierra Leone</text>
      <annotation id="417">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="14355" length="29"/>
        <text>infantile rotavirus diarrhoea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Sarikaya;given-names:S</infon>
      <infon key="name_2">surname:Gurol;given-names:Y</infon>
      <infon key="name_1">surname:Izbirak;given-names:G</infon>
      <infon key="name_0">surname:Akan;given-names:H</infon>
      <infon key="fpage">8</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">19943964</infon>
      <infon key="source">Asia Pac Fam Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">8</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Vitrinel;given-names:A</infon>
      <infon key="name_6">surname:Hayran;given-names:O</infon>
      <infon key="name_5">surname:Yilmaz;given-names:G</infon>
      <infon key="name_4">surname:Gunduz;given-names:TS</infon>
      <offset>14401</offset>
      <text>Rotavirus and adenovirus frequency among patients with acute gastroenteritis and their relationship to clinical parameters: a retrospective study in Turkey</text>
      <annotation id="420">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14442" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="421">
        <infon key="identifier">MESH:D005759</infon>
        <infon key="type">Disease</infon>
        <location offset="14456" length="21"/>
        <text>acute gastroenteritis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">31</infon>
      <infon key="name_2">surname:Unicomb;given-names:LE</infon>
      <infon key="name_1">surname:Tzipori;given-names:SR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Jarecki-Khan;given-names:K</infon>
      <infon key="fpage">484</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">8458940</infon>
      <infon key="year">1993</infon>
      <infon key="source">J Clin Microbiol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">489</infon>
      <offset>14557</offset>
      <text>Enteric adenovirus infection among infants with diarrhea in rural Bangladesh</text>
      <annotation id="425">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14592" length="7"/>
        <text>infants</text>
      </annotation>
      <annotation id="426">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="14605" length="8"/>
        <text>diarrhea</text>
      </annotation>
      <annotation id="427">
        <infon key="identifier">MESH:D000257</infon>
        <infon key="type">Disease</infon>
        <location offset="14565" length="20"/>
        <text>adenovirus infection</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Catal;given-names:F</infon>
      <infon key="name_2">surname:Avci;given-names:Z</infon>
      <infon key="name_1">surname:Acikgoz;given-names:ZC</infon>
      <infon key="name_0">surname:Karadag;given-names:A</infon>
      <infon key="fpage">269</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">15804663</infon>
      <infon key="year">2005</infon>
      <infon key="source">Scand J Infect Dis</infon>
      <infon key="type">ref</infon>
      <infon key="volume">37</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">275</infon>
      <infon key="name_6">surname:Uras;given-names:N</infon>
      <infon key="name_5">surname:Gamberzade;given-names:S</infon>
      <infon key="name_4">surname:Gocer;given-names:S</infon>
      <offset>14634</offset>
      <text>Childhood diarrhoea in Ankara, Turkey: epidemiological and clinical features of rotavirus-positive versus rotavirus-negative cases</text>
      <annotation id="430">
        <infon key="identifier">9103</infon>
        <infon key="type">Species</infon>
        <location offset="14665" length="6"/>
        <text>Turkey</text>
      </annotation>
      <annotation id="431">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="14644" length="9"/>
        <text>diarrhoea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Lwin;given-names:T</infon>
      <infon key="name_2">surname:Oo;given-names:WM</infon>
      <infon key="name_1">surname:Hummelman;given-names:EG</infon>
      <infon key="name_0">surname:Moe;given-names:K</infon>
      <infon key="fpage">S111</infon>
      <infon key="issue">Suppl 1</infon>
      <infon key="pub-id_pmid">16088793</infon>
      <infon key="year">2005</infon>
      <infon key="source">J Infect Dis</infon>
      <infon key="type">ref</infon>
      <infon key="volume">192</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">113</infon>
      <infon key="name_4">surname:Htwe;given-names:TT</infon>
      <offset>14765</offset>
      <text>Hospital-based surveillance for rotavirus diarrhea in children in Yangon, Myanmar</text>
      <annotation id="434">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14819" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="435">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="14797" length="18"/>
        <text>rotavirus diarrhea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Marek;given-names:A</infon>
      <infon key="name_2">surname:Ratajczak;given-names:B</infon>
      <infon key="name_1">surname:Bako;given-names:W</infon>
      <infon key="name_0">surname:Rytlewska;given-names:M</infon>
      <infon key="fpage">117</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">11208297</infon>
      <infon key="year">2000</infon>
      <infon key="source">Med Sci Monit</infon>
      <infon key="type">ref</infon>
      <infon key="volume">6</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">article in Polish</infon>
      <infon key="name_8">surname:Korzon;given-names:M</infon>
      <infon key="name_7">surname:Tyl;given-names:J</infon>
      <infon key="lpage">122</infon>
      <infon key="name_6">surname:Swiatkowska;given-names:H</infon>
      <infon key="name_5">surname:Czarnecka-Rudnik;given-names:D</infon>
      <infon key="name_4">surname:Gwizdek;given-names:A</infon>
      <offset>14847</offset>
      <text>Epidemiological and clinical characteristics of rotaviral diarrhoea in children from Gdansk, Gdynia and Sopot</text>
      <annotation id="439">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14918" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="440">
        <infon key="type">Disease</infon>
        <location offset="14940" length="6"/>
        <text>Gdynia</text>
      </annotation>
      <annotation id="441">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="14895" length="19"/>
        <text>rotaviral diarrhoea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Mathew;given-names:MM</infon>
      <infon key="name_2">surname:Mathan;given-names:MM</infon>
      <infon key="name_1">surname:Zhen;given-names:LG</infon>
      <infon key="name_0">surname:Huilan;given-names:S</infon>
      <infon key="fpage">549</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">1659953</infon>
      <infon key="year">1991</infon>
      <infon key="source">Bull World Health Organ</infon>
      <infon key="type">ref</infon>
      <infon key="volume">69</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Sami;given-names:Z</infon>
      <infon key="name_8">surname:Khan;given-names:MA</infon>
      <infon key="name_7">surname:Ghafoor;given-names:MA</infon>
      <infon key="lpage">555</infon>
      <infon key="name_6">surname:Khin;given-names:Maung U</infon>
      <infon key="name_5">surname:Espejo;given-names:R</infon>
      <infon key="name_4">surname:Olarte;given-names:J</infon>
      <offset>14958</offset>
      <text>Etiology of acute diarrhoea among children in developing countries: a multicentre study in five countries</text>
      <annotation id="444">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14992" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="445">
        <infon key="identifier">MESH:D003967</infon>
        <infon key="type">Disease</infon>
        <location offset="14976" length="9"/>
        <text>diarrhoea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_2">surname:King;given-names:BR</infon>
      <infon key="name_1">surname:Awad;given-names:SH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Nguyen;given-names:DD</infon>
      <infon key="year">2005</infon>
      <infon key="source">Ne: eMedicine Specialties, Emergency Medicine, Pediatrics</infon>
      <infon key="type">ref</infon>
      <offset>15064</offset>
      <text>Rotavirus gastroenteritis</text>
      <annotation id="447">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="15064" length="25"/>
        <text>Rotavirus gastroenteritis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">12</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Ogilvie</infon>
      <infon key="fpage">62</infon>
      <infon key="pub-id_pmid">22429601</infon>
      <infon key="year">2012</infon>
      <infon key="source">BMC Infectious Diseases</infon>
      <infon key="type">ref</infon>
      <offset>15090</offset>
      <text>Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review</text>
      <annotation id="449">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="15123" length="36"/>
        <text>nosocomial rotavirus gastroenteritis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_2">surname:Bryant;given-names:PA</infon>
      <infon key="name_1">surname:Jackson;given-names:C</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Day;given-names:TG</infon>
      <infon key="year">2012</infon>
      <infon key="source">BMJ Case Rep, 2012</infon>
      <infon key="type">ref</infon>
      <offset>15224</offset>
      <text>Cluster of neurological manifestations of rotavirus infection in children</text>
      <annotation id="451">
        <infon key="identifier">MESH:D012400</infon>
        <infon key="type">Disease</infon>
        <location offset="15266" length="19"/>
        <text>rotavirus infection</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ismaili-Jaha;given-names:V</infon>
      <infon key="name_2">surname:Avdiu;given-names:M</infon>
      <infon key="name_1">surname:Azemi;given-names:M</infon>
      <infon key="name_0">surname:Hoxha;given-names:TF</infon>
      <infon key="fpage">300</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="source">Med Arh</infon>
      <infon key="type">ref</infon>
      <infon key="volume">68</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.5455/medarh.2014.68.300-303</infon>
      <infon key="lpage">303</infon>
      <infon key="name_5">surname:Petrela;given-names:E</infon>
      <infon key="name_4">surname:Gragjevci;given-names:V</infon>
      <offset>15298</offset>
      <text>The Usefulness of Clinical and Laboratory Parameters for Predicting Severity of Dehydratation in Children with Acute Gastroenteritis</text>
      <annotation id="454">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15395" length="8"/>
        <text>Children</text>
      </annotation>
      <annotation id="455">
        <infon key="identifier">MESH:D005759</infon>
        <infon key="type">Disease</infon>
        <location offset="15415" length="15"/>
        <text>Gastroenteritis</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272831</id>
    <passage>
      <infon key="name_3">surname:Lepara;given-names:Zahid</infon>
      <infon key="name_2">surname:Hasanbegovic;given-names:Munira</infon>
      <infon key="name_1">surname:Junuzovic;given-names:Dzelaludin</infon>
      <infon key="article-id_pmid">25568625</infon>
      <infon key="name_0">surname:Prstojevic;given-names:Jelena Kovacevic</infon>
      <infon key="fpage">297</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272831</infon>
      <infon key="article-id_publisher-id">MSM-26-297</infon>
      <infon key="article-id_doi">10.5455/msm.2014.26.297-302</infon>
      <infon key="type">front</infon>
      <infon key="volume">26</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Mater Sociomed; 2014 Oct; 26(5) 297-302. doi:10.5455/msm.2014.26.297-302</infon>
      <infon key="kwd">stone in urinary tract ESWL method of urinary stone treatment</infon>
      <infon key="lpage">302</infon>
      <infon key="name_4">surname:Selimovic;given-names:Mirsad</infon>
      <infon key="authors">Prstojevic JK, Junuzovic D, Hasanbegovic M, Lepara Z, Selimovic M</infon>
      <offset>0</offset>
      <text>Characteristics of Calculi in the Urinary Tract</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>48</offset>
      <text>Introduction:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>62</offset>
      <text>Elimination of stone is determined by size and its localization. Stone from the ureter in 80% of cases can be eliminated spontaneously. If the stone by its characteristics is not spontaneously eliminated, taken are further steps and therapeutic protocols to solve this problem.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>340</offset>
      <text>Material and methods:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>362</offset>
      <text>The study was prospective, open and comparative. It was conducted at the Urology Clinic Clinical Center of Sarajevo University in the period from 2007 to 2013. The study included 404 patients with urinary tract lithiasis treated by ESWL. ESWL treatment is performed on the machine Siemens Model Lithostar Multiline, which has a combined ultrasonographic and fluoroscopic display, large energy density in order to obtain optimum focus (without damaging surrounding tissue) and minimal pain that on rare occasions requires for mild sedation-sedation.</text>
      <annotation id="3">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="545" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="4">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="846" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="5">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="559" length="23"/>
        <text>urinary tract lithiasis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>911</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>920</offset>
      <text>From a total of 404 patients included in the study there were 234 (57.92%) male and 170 (42.08%) female patients. The most common type of stone both in female and male patients was calcium type. From a total of 262 calcium stones, 105 of them (40.07%) was present in female patients and 157 (59.92%) in male. Share of infectious type of stone in female patients was 63 (49.60%) and 64 among males (50.39%). Other stones were less abundant in both the gender groups and their total number was only 17. In women their frequency was 2 (13.33%) and 13 among males (86.67%). There was a significant difference in the frequency of different types of stones by gender (chi2 = 11.47, p = 0.009).</text>
      <annotation id="14">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="940" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="15">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1024" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="16">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1088" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="17">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1194" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="18">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1273" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="19">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1424" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="20">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="1135" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="21">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="1101" length="7"/>
        <text>calcium</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1608</offset>
      <text>Conclusion:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1620</offset>
      <text>There was no statistically significant correlation between the number of treatments and localization of stones in the ureter, as well as a statistically significant correlation between the size of the stone and the localization of calculus in the ureter.</text>
      <annotation id="23">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="1851" length="8"/>
        <text>calculus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1875</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1891</offset>
      <text>Every year between the 1200 to 1400 persons per million develop urinary calculosis with a male to female ratio of 3:1. Urology is probably the oldest branch of surgery, knowing that one of the first operations was safe and resolve stone jammed on the outer opening of the urethra.</text>
      <annotation id="26">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1927" length="7"/>
        <text>persons</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">MESH:D020347</infon>
        <infon key="type">Disease</infon>
        <location offset="1963" length="10"/>
        <text>calculosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2172</offset>
      <text>Creation of stones in the urinary organs (urolithiasis) is a very common disease. Urinary tract stones are sixth health problem. Epidemiological data suggest an increased prevalence of upper urinary tract calculi in developed countries. Various authors suggest that urinary calculi constitute 1-3 per thousand total hospitalized patients which makes 15-24% of patients in the urology departments. This disease have several names: nephrolithiasis-meaning kidney stone, nephrolithiasis and the word is derived from the Greek word nephros (kidney) and lithos (stone). Word of urolithiasis-urinary (urine) stone is derived from the French word urine and Greek ouron meaning urine. It is also used as renal calculus from the Latin word calculus (plural-calculi), which means gravel. Urolithiasis also affects animals: the stones were found in dogs, cats, rabbits, minks, etc., and the components are the same as in humans. Urolithiasis occurs during the most productive human age from 30 to 50 years of age, but has been described in all age groups. It was found in newborns and fetuses. However, urolithiasis in children is rare. Only 2-3% of cases occur in the pediatric age. It is believed that 12% of men and 4% of women in developed countries suffer from urinary stones. In case of a positive family history, this number doubles. One of the reasons for its frequent occurrence in men is explained by the increased endogenous production of oxalate in the liver under the influence of testosterone, while in the urine of women is on average higher concentration of citrate, otherwise, increase the solubility of calcium. Calculosa with women predominantly induced urinary infections and metabolic disorders, while in men predominate idiopathic lithiasis or calcium lithiasis and uric acid. Percentage of recurrent calculosis is 50% within 5 years and 70% over 10 years. Stones less than 2 mm easily pass through the ureter. Most calculi (90%) from 4 to 5 mm are eliminated spontaneously. Percentage decreases to 50% at stones of 4 to 6 mm and 20% at stones larger than 6 mm.</text>
      <annotation id="66">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2501" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="67">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2532" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="68">
        <infon key="identifier">9615</infon>
        <infon key="type">Species</infon>
        <location offset="3010" length="4"/>
        <text>dogs</text>
      </annotation>
      <annotation id="69">
        <infon key="identifier">9685</infon>
        <infon key="type">Species</infon>
        <location offset="3016" length="4"/>
        <text>cats</text>
      </annotation>
      <annotation id="70">
        <infon key="identifier">9986</infon>
        <infon key="type">Species</infon>
        <location offset="3022" length="7"/>
        <text>rabbits</text>
      </annotation>
      <annotation id="71">
        <infon key="identifier">9666</infon>
        <infon key="type">Species</infon>
        <location offset="3031" length="5"/>
        <text>minks</text>
      </annotation>
      <annotation id="72">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3082" length="6"/>
        <text>humans</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3137" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3280" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3372" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="76">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3386" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="77">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3552" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="78">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3691" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="79">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3806" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="80">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3887" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="81">
        <infon key="identifier">MESH:D008569</infon>
        <infon key="type">Disease</infon>
        <location offset="2737" length="4"/>
        <text>Word</text>
      </annotation>
      <annotation id="82">
        <infon key="identifier">MESH:D007669</infon>
        <infon key="type">Disease</infon>
        <location offset="2602" length="36"/>
        <text>nephrolithiasis-meaning kidney stone</text>
      </annotation>
      <annotation id="83">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="2745" length="20"/>
        <text>urolithiasis-urinary</text>
      </annotation>
      <annotation id="84">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="3264" length="12"/>
        <text>urolithiasis</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="2214" length="12"/>
        <text>urolithiasis</text>
      </annotation>
      <annotation id="86">
        <infon key="identifier">MESH:D008659</infon>
        <infon key="type">Disease</infon>
        <location offset="3857" length="19"/>
        <text>metabolic disorders</text>
      </annotation>
      <annotation id="87">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="3782" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="88">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="2913" length="14"/>
        <text>plural-calculi</text>
      </annotation>
      <annotation id="89">
        <infon key="identifier">MESH:D053040</infon>
        <infon key="type">Disease</infon>
        <location offset="2640" length="15"/>
        <text>nephrolithiasis</text>
      </annotation>
      <annotation id="90">
        <infon key="identifier">MESH:D010070</infon>
        <infon key="type">Chemical</infon>
        <location offset="3611" length="7"/>
        <text>oxalate</text>
      </annotation>
      <annotation id="91">
        <infon key="identifier">MESH:D014545</infon>
        <infon key="type">Disease</infon>
        <location offset="2357" length="27"/>
        <text>upper urinary tract calculi</text>
      </annotation>
      <annotation id="92">
        <infon key="identifier">MESH:D008569</infon>
        <infon key="type">Disease</infon>
        <location offset="2898" length="13"/>
        <text>word calculus</text>
      </annotation>
      <annotation id="93">
        <infon key="identifier">MESH:D020347</infon>
        <infon key="type">Disease</infon>
        <location offset="3984" length="10"/>
        <text>calculosis</text>
      </annotation>
      <annotation id="94">
        <infon key="identifier">MESH:D020347</infon>
        <infon key="type">Disease</infon>
        <location offset="3935" length="9"/>
        <text>lithiasis</text>
      </annotation>
      <annotation id="95">
        <infon key="identifier">MESH:D001745</infon>
        <infon key="type">Disease</infon>
        <location offset="3834" length="18"/>
        <text>urinary infections</text>
      </annotation>
      <annotation id="96">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="2950" length="12"/>
        <text>Urolithiasis</text>
      </annotation>
      <annotation id="97">
        <infon key="identifier">MESH:D013739</infon>
        <infon key="type">Chemical</infon>
        <location offset="3655" length="12"/>
        <text>testosterone</text>
      </annotation>
      <annotation id="98">
        <infon key="identifier">MESH:D007669</infon>
        <infon key="type">Disease</infon>
        <location offset="2868" length="14"/>
        <text>renal calculus</text>
      </annotation>
      <annotation id="99">
        <infon key="identifier">MESH:D020347</infon>
        <infon key="type">Disease</infon>
        <location offset="3903" length="20"/>
        <text>idiopathic lithiasis</text>
      </annotation>
      <annotation id="100">
        <infon key="identifier">MESH:D014527</infon>
        <infon key="type">Chemical</infon>
        <location offset="3949" length="9"/>
        <text>uric acid</text>
      </annotation>
      <annotation id="101">
        <infon key="identifier">MESH:D019343</infon>
        <infon key="type">Chemical</infon>
        <location offset="3735" length="7"/>
        <text>citrate</text>
      </annotation>
      <annotation id="102">
        <infon key="identifier">MESH:D008569</infon>
        <infon key="type">Disease</infon>
        <location offset="2695" length="12"/>
        <text>word nephros</text>
      </annotation>
      <annotation id="103">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="3090" length="12"/>
        <text>Urolithiasis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>4251</offset>
      <text>2. PROBLEM FORMULATION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4274</offset>
      <text>One of the most common pathological conditions in human medicine is the presence of a stone in the urinary tract, characterized more often as urolithiasis. In countries with developed industry this disease affects approximately 1500 to 2000 patients per million inhabitants. The disease usually affects people in the fourth and fifth decade of life who are working, and their absence from work due to healing has significant social and economic implications on the society. Stones can be localized in different areas of the urinary system. Localization of the stone is determined by several factors, including even the demographic characteristics. In developed countries, 97% of the stones are localized in the kidney and ureter where in 59% of cases in the ureter. Urethral stone is in 75% of cases located in the iliac and pelvic part of the ureter. Elimination of the calculi depends on size and its localization. Stones from the ureter in 80% of cases can be eliminated spontaneously. If the calculi in their characteristics are not spontaneously eliminated, taken are further steps and therapeutic protocols to solve this problem. Asperitan stone and stone larger than 7 mm in diameter, which practically cannot be spontaneously eliminated, threatening development of kidney urostasis and infection. Indications for an active therapeutic approach to ureter stones is stone diameter over 7 mm with low (below 20%) probability of spontaneous elimination or absence of spontaneous stone elimination of any size for a period longer than 30 days from the first renal colic, urinary infection develop, sepsis, calculous anuria, as well as the request of patients. Treatment of urolithiasis includes conservative, surgical treatment, and treatment with extracorporeal shock wave lithotripsy (ESWL) depending on the evaluation. Recently, endoscopic procedures, such as eretheroscopy (URS) and percutaneous lithotripsy (PCNL), together with the aforementioned ESWL, have been almost entirely replaced open surgery, so in just 30 years, radically changed the approach and functional outcome of this disease.</text>
      <annotation id="115">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4324" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="116">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4515" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="117">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4577" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="118">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5927" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="119">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="5950" length="12"/>
        <text>urolithiasis</text>
      </annotation>
      <annotation id="120">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="4416" length="12"/>
        <text>urolithiasis</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">MESH:D001745</infon>
        <infon key="type">Disease</infon>
        <location offset="5848" length="17"/>
        <text>urinary infection</text>
      </annotation>
      <annotation id="122">
        <infon key="identifier">MESH:D001002</infon>
        <infon key="type">Disease</infon>
        <location offset="5883" length="16"/>
        <text>calculous anuria</text>
      </annotation>
      <annotation id="123">
        <infon key="identifier">MESH:D014516</infon>
        <infon key="type">Disease</infon>
        <location offset="5629" length="13"/>
        <text>ureter stones</text>
      </annotation>
      <annotation id="124">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="5547" length="30"/>
        <text>kidney urostasis and infection</text>
      </annotation>
      <annotation id="125">
        <infon key="identifier">MESH:D018805</infon>
        <infon key="type">Disease</infon>
        <location offset="5875" length="6"/>
        <text>sepsis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>6377</offset>
      <text>ESWL treatment is the first-line treatment of urinary tract stones, but there are still no clearly defined limits and recommendations for its use in the treatment of urinary calculi, depending on its location, size and morphological structure. This raises the question of efficiency of ESWL depending on the characteristics of urinary calculi.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>6721</offset>
      <text>3. GOALS</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>6730</offset>
      <text>Determine characteristics of the patients with calculi in the urinary system, possibilities of disintegration of stones and its spontaneous elimination dependent on morphological structure of stones, their size and location in the urinary tract.</text>
      <annotation id="127">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6763" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>6976</offset>
      <text>4. MATERIAL AND METHODS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>7000</offset>
      <text>The study was prospective, open and comparative. It was conducted at the Urology Clinic Clinical Center of Sarajevo University in the period from 2007 to 2013. The study included 404 patients with urinary tract lithiasis. All patients prior to initiation of therapy-ESWL treatments were subjected to the following diagnostic procedures: anamnesis, clinical examination of patients, laboratory tests, ultrasound examination of the urinary tract and urinary tract X-ray, from which was derived chemical qualitative analysis of morphological stone composition. Diagnostics are used in the detection of complications such as obstruction with dilatation of the renal colorectal system, reduction of the renal parenchyma and in monitoring of renal obstruction during treatment. This type of diagnosis is not suitable for stones in the ureter and can make the difference between calcified and radiolucent concrement. ESWL treatment is performed on the machine Siemens Model Lithostar Multiline, which has a combined ultrasonographic and fluoroscopic display, large energy density in order to obtain optimum focus (without damaging surrounding tissue) and minimal pain that on rare occasions requires for mild sedation-sedation. For nominal and ordinal variables chi-square test was used. In cases when the frequency was lower than expected was used the Fisher's exact test. The degree of correlation was determined by means of the Spearman. P value of &lt;0.05 was considered statistically significant. Statistical analysis was performed using SPSS computer software for statistical analysis (SPSS Statistical Package for the Social Sciences) version 13.0.</text>
      <annotation id="137">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7183" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="138">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7226" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="139">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7372" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="140">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="8156" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="141">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="7197" length="23"/>
        <text>urinary tract lithiasis</text>
      </annotation>
      <annotation id="142">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="7736" length="17"/>
        <text>renal obstruction</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="7638" length="41"/>
        <text>dilatation of the renal colorectal system</text>
      </annotation>
      <annotation id="144">
        <infon key="identifier">MESH:D000402</infon>
        <infon key="type">Disease</infon>
        <location offset="7621" length="11"/>
        <text>obstruction</text>
      </annotation>
      <annotation id="145">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="7681" length="33"/>
        <text>reduction of the renal parenchyma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>8649</offset>
      <text>5. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8660</offset>
      <text>From a total of 404 patients included in the study there were 234 (57.92%) male and 170 (42.08%) female patients. The most common age group in the sample was at age from 35 to 45 years and consisted of 110 respondents (27.09%). The minimum number of respondents had the age over 65 years 19 respondents (4.67%).</text>
      <annotation id="148">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8680" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="149">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8764" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8972</offset>
      <text>The most common type of stone both in female and male patients was calcium type. From a total of 262 calcium stones, 105 of them (40.07%) was present in female patients and 157 (59.92%) in male. Share of infectious type of stone in female patients was 63 (49.60%) and 64 among males (50.39%). Other stones were less abundant in both the gender groups and their total number was only 17. In women their frequency was 2 (13.33%) and 13 among males (86.67%). There was a significant difference in the frequency of different types of stones by gender (chi2 = 11.47, p = 0.009).</text>
      <annotation id="156">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9026" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="157">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9132" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="158">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9211" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="159">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9362" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="160">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="9073" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="161">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="9039" length="7"/>
        <text>calcium</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9546</offset>
      <text>Due to the very low prevalence of other types of stones and inability to perform the chi-square test to a group of other stones are grouped stones which, by virtue were cystine, xanthine stones and uric acid stones. The incidence of cystine calculi was 4 (0.9%), frequency of xanthine stones 3 (0.7%) and uric acid 8 (1.9%). In the group of female respondents 74 (40.88%) had calculus size up to 10 mm, while in the group of male patients stone size up to 10 mm had 107 (59.12%). In the group of female respondents 96 of them (43.05%) had a size of stone exceeding 10 mm, while in the group of male patients stone size over 10 mm had 127 (56.95%). There was no statistically significant difference in the incidence of stones with sizes up to 10 and over 10 mm by gender (chi2 = 0.192, p = 0.661)</text>
      <annotation id="171">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9976" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="172">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10145" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="173">
        <infon key="identifier">MESH:D014527</infon>
        <infon key="type">Chemical</infon>
        <location offset="9744" length="9"/>
        <text>uric acid</text>
      </annotation>
      <annotation id="174">
        <infon key="identifier">MESH:D019820</infon>
        <infon key="type">Chemical</infon>
        <location offset="9724" length="8"/>
        <text>xanthine</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="9779" length="15"/>
        <text>cystine calculi</text>
      </annotation>
      <annotation id="176">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="9922" length="8"/>
        <text>calculus</text>
      </annotation>
      <annotation id="177">
        <infon key="identifier">MESH:D003553</infon>
        <infon key="type">Chemical</infon>
        <location offset="9715" length="7"/>
        <text>cystine</text>
      </annotation>
      <annotation id="178">
        <infon key="identifier">MESH:D019820</infon>
        <infon key="type">Chemical</infon>
        <location offset="9822" length="8"/>
        <text>xanthine</text>
      </annotation>
      <annotation id="179">
        <infon key="identifier">MESH:D014527</infon>
        <infon key="type">Chemical</infon>
        <location offset="9851" length="9"/>
        <text>uric acid</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10342</offset>
      <text>Number of stones localized in the upper pole of the kidney in women was 43 (48.86%), and among men was slightly lower and amounted to 45 (51.13%). Number localized in the lower pole of the kidney in women was 22 (61.11%), and among men was slightly lower and amounted to 14 (38.88%). Number of stones localized medially among women was 38 (45.78%), and among men was slightly lower and amounted to 45 (54.21%). Number of localized in the renal pyelon in females was 27 (40.39%), and among men was slightly lower and amounted to 40 (59.70%). There was no statistically significant difference in the frequency of localization of stones by gender.</text>
      <annotation id="187">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10404" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="188">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10437" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="189">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10541" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="190">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10574" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="191">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10668" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="192">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10701" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="193">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10831" length="3"/>
        <text>men</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10987</offset>
      <text>The incidence of urolithiasis at the site of physiological narrowing of the ureter in female subjects was 22 (27.5%) and 58 in males (72.5%). The incidence of urolithiasis at the site of the physiological enlargement of the ureter in female subjects was 8 (50%), and the same among men 8 (50%). There was no statistically significant difference in the frequency of localization of calculi to physiological narrowing and widening of the ureter in relation to gender differences (p = 0.086).</text>
      <annotation id="197">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11269" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="11146" length="12"/>
        <text>urolithiasis</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="11004" length="12"/>
        <text>urolithiasis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11477</offset>
      <text>The most common size of the calculi in the sample was 15 mm. This size had 21.04% of respondents. The second most common size of the calculi in the sample was 9 mm, which had 14.6% of respondents, followed by the size of 20 mm, which had 14.38% of the respondents. The least frequent size calculi were 17 mm, which was only 0.25% of the respondents.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11827</offset>
      <text>Size of the calculi in women was 12 (8-15 mm), while in men it was 12 (8-15 mm). There was no statistically significant difference in the size of calculi between males and females (p = 0.557).</text>
      <annotation id="202">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11850" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="203">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11883" length="3"/>
        <text>men</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12020</offset>
      <text>There was a significant mild positive correlation between age and size of the stone in the total sample (rho = 0.240, p &lt;0.01), i.e. Increase with age slightly increases the size calculi.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12208</offset>
      <text>In the group of patients who had a negative family history of calculus size to 10 mm were present in 108 (59.67%), while in the group of subjects who had a family history size of stones up to 10 mm had 73 (40.33%). In the group of patients who had a negative family history of calculus size over 10 mm was registered in 160 (71.75%), while in the group of subjects who had a positive family history of calculus size over 10 mm was registered in 63 (28.25%). There was a statistically significant correlation between the size of stones and positive / negative family history (chi2 = 6.529, p = 0.011), respectively, in patients with a positive family history more often were present small stones (to 10 mm). Size of the calculi in patients who had a positive family history was 12 (9-15 mm), while the size of stones in patients who had a positive family history was 10 (8-15 cm). There was no statistically significant difference in the size of the stones between the groups of patients (p = 0.013).</text>
      <annotation id="213">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12224" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="214">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12439" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="215">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12826" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="216">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12938" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="217">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13027" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="218">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13186" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="12270" length="8"/>
        <text>calculus</text>
      </annotation>
      <annotation id="220">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="12610" length="8"/>
        <text>calculus</text>
      </annotation>
      <annotation id="221">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="12485" length="8"/>
        <text>calculus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13208</offset>
      <text>Size of calculus in patients without recurrent urolithiasis was 11 (9-15 mm), while the size of the calculus in patients who have had recurrent urolithiasis was 12 (8-15 mm). There was no statistically significant difference in the size of calculi between groups of patients (p = NS).</text>
      <annotation id="229">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13228" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="230">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13320" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="231">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13474" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="232">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="13216" length="8"/>
        <text>calculus</text>
      </annotation>
      <annotation id="233">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="13352" length="12"/>
        <text>urolithiasis</text>
      </annotation>
      <annotation id="234">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="13308" length="8"/>
        <text>calculus</text>
      </annotation>
      <annotation id="235">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="13255" length="12"/>
        <text>urolithiasis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13493</offset>
      <text>Frequency of localization in the upper pole of kidney which have the size of 10 mm was 30 (34.09%), while the frequency of localization in the top half of kidney s which had more than 10 mm in size was 58 (65.91%) (Table 1).</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>13718</offset>
      <text>The dependence of the calculus size and localization in relation to poles. Fisher exact test; p=0.003</text>
      <annotation id="237">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="13740" length="8"/>
        <text>calculus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13820</offset>
      <text>Frequency of localization in the lower pole of the calculi that had the size of 10 mm was in 3 cases (8.33%), while the frequency of localization in the lower pole of the calculi that had the size over 10 mm was present in 33 cases (91.67%). There was a significant dependence between the size of the stone and the same localization in renal pole (Fisher's exact test, p = 0.003).</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14201</offset>
      <text>Looking at the frequency of stones it is a lot bigger on the top half, but looking at their size, larger stones (over 10 mm) were significantly more often present in the lower half.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14383</offset>
      <text>Size of calculi localized medially was 14 (10-15 mm), while the localization pyelon was 15 (12-18 mm). There was a significant difference in size between the mentioned calculus localization (p = 0.022). Stones that occur in the renal pyelon are higher than the stones that are found in our study, in medial position.</text>
      <annotation id="239">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="14551" length="8"/>
        <text>calculus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14700</offset>
      <text>Frequency medial localization of calculi which size was less than 10 mm was 33 (39.75%), and frequency of 50 (60.25%) for stones ranging in size over 10 mm. Pyelon localization of calculi which size was less than 10 mm was 5 (7.46%), and frequency of 62 (92.53%) for stones ranging in size over 10 mm. There was a significant correlation between the size of the stone and localization of stones (medial / pyelon) (chi2 = 20.443, p &lt;0.001).</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>15140</offset>
      <text>Frequency of calculi localization at sites of physiological stricture site that had the size of 10 mm was 68 (85%), while the frequency of localization at sites of calculi physiological stricture site which had the size over 10 mm was 12 (15%). Frequency of localization at sites of calculi enlargement physiological ureter which had the size of 10 mm was 15 (93.75%), while the frequency of localization at sites of calculi enlargement physiological ureter which had the size over 10 mm, was 1 (6.25%). There was no statistically significant dependence between the size of tartar and calculus localization to physiological constriction and expansion of the ureter (p = 0.688) (Table 2).</text>
      <annotation id="243">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="15725" length="8"/>
        <text>calculus</text>
      </annotation>
      <annotation id="244">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="15557" length="19"/>
        <text>calculi enlargement</text>
      </annotation>
      <annotation id="245">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="15423" length="19"/>
        <text>calculi enlargement</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>15828</offset>
      <text>Dependence between the size of the stone and its localization in the ureter. Fisher exact test; p=0.688. E1- physiological narrowing of the ureter, E2 physiological enlargement of the ureter</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>16019</offset>
      <text>In the group of patients under 35 years the incidence of calcium stones was 88 (33.58%), while in the age group of 35-55 years the incidence of calcium type of calculi was 135 (51.52%). The frequency of this type of calculi in subjects older than 55 years was 39 (14.88%). In the group of patients under 35 years the incidence of infectious stones was 26 (20.47%), and at the age of 35 to 55 years the incidence of infectious types of calculi was 63 (49.60%). The frequency of this type of calculi in subjects older than 55 years was 38 (29.92%). In the group of patients under 35 years the incidence of other types of stones was 4 (26.66%), while in the age group of 35-55 years the incidence of other types of calculi was 7 (46.66%). The incidence of other types of calculi in subjects older than 55 years was 4 (26.66%). Statistically significant dependence between age and type of calculi (chi2 = 15.170, p = 0.004) (Table 3).</text>
      <annotation id="251">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16035" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="252">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16308" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="253">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16582" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="254">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="16076" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="255">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="16163" length="7"/>
        <text>calcium</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T3.xml</infon>
      <infon key="id">T3</infon>
      <infon key="type">table_caption</infon>
      <offset>16950</offset>
      <text>Dependence of age and types calculus. chi2=15.170 df=4; p=0.004</text>
      <annotation id="257">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="16978" length="8"/>
        <text>calculus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>17014</offset>
      <text>6. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>17028</offset>
      <text>Renal lithiasis is a disease in which the stones were formed in the collecting tubules, cups and pyelon. The incidence was similar in both kidneys, and about 40% of patients had bilateral stones. There is a wide range of risk factors that may be associated with the disease, including local and general factors. Of local risk factors that favor the emergence of this disease are: trail of urine, disorders of innervation, anomalies of drainage pathways, anatomical abnormalities (sponge kidney, horseshoe kidney), and recurrent infection. General risk factors are categorized as: metabolic (calciuria, cystinuria), hormonal (primary hyperparathyroidism, hyperthereodosis and hypovitaminosis) and other factors such as climatic conditions of life, feeding, pH of urine excretion of concentrated urine, prolonged immobilization, etc..</text>
      <annotation id="263">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17193" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="264">
        <infon key="identifier">MESH:D049950</infon>
        <infon key="type">Disease</infon>
        <location offset="17653" length="65"/>
        <text>primary hyperparathyroidism, hyperthereodosis and hypovitaminosis</text>
      </annotation>
      <annotation id="265">
        <infon key="identifier">MESH:D020347</infon>
        <infon key="type">Disease</infon>
        <location offset="17028" length="15"/>
        <text>Renal lithiasis</text>
      </annotation>
      <annotation id="266">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="17556" length="9"/>
        <text>infection</text>
      </annotation>
      <annotation id="267">
        <infon key="identifier">MESH:D003555</infon>
        <infon key="type">Disease</infon>
        <location offset="17630" length="10"/>
        <text>cystinuria</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>17861</offset>
      <text>Formation of kidney stones attempted to explain many theories but none fully explains the mechanism of occurrence. Urine is in the usual conditions supersaturated solution in which the particles are held in solution influence crystallization inhibitor and colloids. If these factors are disrupted leads to precipitation and aggregation of crystals. The organic matrix, which consists of cellular detritus, blood and bacteria may be the main factor that leads to nucleation and crystal growth. One theory in the spotlight puts deficit of crystallization inhibitors. There is a theory which states that the formation of stones occurs when the crystals, which are constantly being created in the urine oversaturated with salts, are not washed away in the urine. This may occur due to damage to the epithelial duct to which it adheres crystal.</text>
      <annotation id="269">
        <infon key="identifier">MESH:D007669</infon>
        <infon key="type">Disease</infon>
        <location offset="17874" length="13"/>
        <text>kidney stones</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>18701</offset>
      <text>Changes in the socio-economic conditions have influenced the changes in the frequency and type of urolithiasis in terms of localization and physico-chemical properties of stones. Major variations on the occurrence of urolithiasis in the world are presented to the public in terms of geographical areas. Annual incidence in England is 22 cases per 100,000 inhabitants, in Kuwait 23.9 per 100,000 population. However, in some countries there are significant differences in the incidence, such as Sweden, where the incidence of 140 per 100,000 inhabitants, Italy 168 per 100,000 inhabitants and United States with high prevalence of 277 per 100,000 population. In Europe, urinary stones are found mainly in the upper urinary tract, while the proportion of stones in the bladder does not exceed 10.0%. It is shown that the urinary bladder calculi more common in the elderly.</text>
      <annotation id="273">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="18918" length="12"/>
        <text>urolithiasis</text>
      </annotation>
      <annotation id="274">
        <infon key="identifier">MESH:D001744</infon>
        <infon key="type">Disease</infon>
        <location offset="19520" length="23"/>
        <text>urinary bladder calculi</text>
      </annotation>
      <annotation id="275">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="18791" length="20"/>
        <text>type of urolithiasis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>19572</offset>
      <text>The disease is more common in men and usually occurs after the third decade of life. It is shown that Caucasians are more likely to develop kidney stones than African Americans, and men more often than women patients. A possible explanation why men are more frequent in patients than in females lies in the fact that men in performing physical activities much sweat and lose a lot of fluid, which is also the main reason for the formation of a kidney stone or a stone in the bladder.</text>
      <annotation id="285">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19602" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="286">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19754" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="287">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19774" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="288">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19780" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="289">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19817" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="290">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19842" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="291">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19889" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="292">
        <infon key="identifier">MESH:D007669</infon>
        <infon key="type">Disease</infon>
        <location offset="19712" length="13"/>
        <text>kidney stones</text>
      </annotation>
      <annotation id="293">
        <infon key="identifier">MESH:D007669</infon>
        <infon key="type">Disease</infon>
        <location offset="20016" length="12"/>
        <text>kidney stone</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>20056</offset>
      <text>Some new studies are mostly directed of change in the relationship of occurrence calculi in men and women. In the United States-and the data showed that the overall incidence of urolithiasis 10.6% for men and 7.1% for women. This is explained by balancing risks for both men and women today, compared to the past when they were significantly different.</text>
      <annotation id="301">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20148" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="302">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20156" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="303">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20257" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="304">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20274" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="305">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20327" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="306">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20335" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="307">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="20234" length="12"/>
        <text>urolithiasis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>20411</offset>
      <text>Results of this study showed that the total number of subjects included higher percentage occupied by male respondents and 57.92%, while the remaining 42.08% are occupied by the respondents are female. The results are consistent with published data showing a higher incidence of this disease in male patients compared to female respondents.</text>
      <annotation id="309">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20711" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>20752</offset>
      <text>Greater tendency of men to concentrate urine compared to the opposite sex, may be the reason for higher incidence of this disease in men. It is shown that the higher the osmolality in men also work super saturation which is responsible for the crystallization of poorly soluble compounds. Even if the concentration of poorly soluble compounds reaches the threshold of saturation of the total 24-h urine, then it can exceed during transient episodes, the way to increase the intake of foods rich in protein, at night, or during intense exercise, especially in the summer months, or season in which men showed a significant decrease in urine volume. Although urolithiasis 2-3 times more common in men, there are no studies that clearly define the reasons for variations incidence of this disease.</text>
      <annotation id="316">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20772" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="317">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20885" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="318">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20936" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="319">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21349" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="320">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21447" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="321">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="21409" length="12"/>
        <text>urolithiasis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>21547</offset>
      <text>Daudon and colleagues show that men older than 80 years constitute 40.0% of the analyzed patients with urinary bladder calculi. Prostatic hyperplasia is more common in the elderly and causes an obstruction in the urinary tract. This may be a possible explanation for the high incidence of stones in the bladder in the elderly. Women are also at risk calculus appears in the lower parts of the urinary tract. This suggests the existence of other risk factors, such as changes in bladder function associated with relaxation of smooth muscle tone in the elderly, with an efficiency reduction bladder emptying favoring stagnation of urine and the occurrence of tartar.</text>
      <annotation id="330">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21579" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="331">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21636" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="332">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21874" length="5"/>
        <text>Women</text>
      </annotation>
      <annotation id="333">
        <infon key="identifier">MESH:D000402</infon>
        <infon key="type">Disease</infon>
        <location offset="21741" length="11"/>
        <text>obstruction</text>
      </annotation>
      <annotation id="334">
        <infon key="identifier">MESH:D001744</infon>
        <infon key="type">Disease</infon>
        <location offset="21650" length="23"/>
        <text>urinary bladder calculi</text>
      </annotation>
      <annotation id="335">
        <infon key="identifier">MESH:D011470</infon>
        <infon key="type">Disease</infon>
        <location offset="21675" length="21"/>
        <text>Prostatic hyperplasia</text>
      </annotation>
      <annotation id="336">
        <infon key="identifier">MESH:D001745</infon>
        <infon key="type">Disease</infon>
        <location offset="22115" length="28"/>
        <text>efficiency reduction bladder</text>
      </annotation>
      <annotation id="337">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="21897" length="8"/>
        <text>calculus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>22212</offset>
      <text>When it comes to the size calculi, the results of our study showed a statistically significant positive correlation between age and size of the stone in the total sample (rho = 0.240, p &lt;0.01). Classifying respondents into three age groups, our results showed that the highest incidence of stones measuring greater than 10 mm was represented at the age between 35 and 55 years. Chi-square test showed a statistically significant correlation between age and size of the stone (chi2 = 40.287, p &lt;0.00005).</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>22716</offset>
      <text>The study by Alaya and associates, who analyzed the sample of 1301 urinary tract stones, it has been proven that the highest percentage share of 58.6% occupied stones of calcium type, that type of calcium oxalate, but they also recorded an increase in the incidence and types of stones uric acid. The authors believe that in the last 50 years there has been a change in eating habits associated with an increase in foods rich in purines (animal proteins projections and seafood), which correlates the increase in uric acid in the urine, and increasing incidence of this type of calculi. Their results show a clear increase in uric acid stones in both sexes.</text>
      <annotation id="344">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="22886" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="345">
        <infon key="identifier">MESH:D014527</infon>
        <infon key="type">Chemical</infon>
        <location offset="23229" length="9"/>
        <text>uric acid</text>
      </annotation>
      <annotation id="346">
        <infon key="identifier">MESH:D014527</infon>
        <infon key="type">Chemical</infon>
        <location offset="23342" length="9"/>
        <text>uric acid</text>
      </annotation>
      <annotation id="347">
        <infon key="identifier">MESH:D002129</infon>
        <infon key="type">Chemical</infon>
        <location offset="22913" length="15"/>
        <text>calcium oxalate</text>
      </annotation>
      <annotation id="348">
        <infon key="identifier">MESH:D014527</infon>
        <infon key="type">Chemical</infon>
        <location offset="23002" length="9"/>
        <text>uric acid</text>
      </annotation>
      <annotation id="349">
        <infon key="identifier">MESH:D011687</infon>
        <infon key="type">Chemical</infon>
        <location offset="23145" length="7"/>
        <text>purines</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>23374</offset>
      <text>The results of our study showed that the group of patients under 35 years the incidence of calcium stones was 33.58%, the incidence of infectious stones 20.47%, while the incidence of other types of stones was 26.66%. At the age of 35 to 55 years the incidence of a calcium type of calculi was 51.52%, the frequency of the infectious type of calculi was 49.60%, and the prevalence of other types of stones was 46.66%. The frequency of this type of calcium calculi in subjects older than 55 years was 14.88%, infectious stones were 29.92%, while the incidence of other types of calculi in subjects older than 55 years was 26.66%. There was a statistically significant correlation between age and type of calculi (chi2 = 15.170, p = 0.004), i.e. among younger patients are the most common types of calcium stones, while the incidence of infectious types of stones rarer. Increasing age leads to equalization of the frequency of calcium and infectious stones.</text>
      <annotation id="357">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23424" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="358">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="24132" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="359">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="23465" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="360">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="23822" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="361">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="23640" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="362">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="24300" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="363">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="24170" length="7"/>
        <text>calcium</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>24331</offset>
      <text>Differences in the incidence of age and stones were analyzed through a large number of epidemiological studies. There are certain variations according to geographical areas. In 1993, Baker et al reported that in Australia peak incidence of urolithiasis calcium oxalate sampled observed in individuals between 50 and 60 years of age. In Europe, research shows that the stones which are chemically calcium oxalate more common in people between 40 and 50 years of age. In Asia, the highest prevalence of calcium oxalate stone formation occurs at an earlier age range 30 to 50 years.</text>
      <annotation id="369">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="24758" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="370">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="24571" length="12"/>
        <text>urolithiasis</text>
      </annotation>
      <annotation id="371">
        <infon key="identifier">MESH:D002129</infon>
        <infon key="type">Chemical</infon>
        <location offset="24727" length="15"/>
        <text>calcium oxalate</text>
      </annotation>
      <annotation id="372">
        <infon key="identifier">MESH:D002129</infon>
        <infon key="type">Chemical</infon>
        <location offset="24832" length="15"/>
        <text>calcium oxalate</text>
      </annotation>
      <annotation id="373">
        <infon key="identifier">MESH:D002129</infon>
        <infon key="type">Chemical</infon>
        <location offset="24584" length="15"/>
        <text>calcium oxalate</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>24911</offset>
      <text>Certain hereditary disorders that run in the family increases the risk of recurrent kidney stones. A rare hereditary disease, renal tubular acidosis, increases the acidity of urine, which is favorable for the occurrence of kidney stones. Cystinuria is a hereditary disorder of the metabolism of amino acids, which results in high levels of cystine in the urine and blood, leading to frequent formation of cystine kidney stones. Second, a hereditary disorder of metabolism, hyperoxaluria, is resulting in high levels of oxalate salt in the body, which is combined with calcium in the form of kidney stones. Hypercalciuria causes high accumulation of calcium in the body, which increases the incidence of kidney stones. Hiperuricosuria increased level of uric acid in the urine, which leads to the formation of uric acid stones.</text>
      <annotation id="394">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="25560" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="395">
        <infon key="type">Disease</infon>
        <location offset="25629" length="15"/>
        <text>Hiperuricosuria</text>
      </annotation>
      <annotation id="396">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="25479" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="397">
        <infon key="identifier">MESH:D007669</infon>
        <infon key="type">Disease</infon>
        <location offset="25316" length="21"/>
        <text>cystine kidney stones</text>
      </annotation>
      <annotation id="398">
        <infon key="identifier">MESH:D007669</infon>
        <infon key="type">Disease</infon>
        <location offset="25502" length="13"/>
        <text>kidney stones</text>
      </annotation>
      <annotation id="399">
        <infon key="identifier">MESH:D014527</infon>
        <infon key="type">Chemical</infon>
        <location offset="25720" length="9"/>
        <text>uric acid</text>
      </annotation>
      <annotation id="400">
        <infon key="identifier">MESH:D007669</infon>
        <infon key="type">Disease</infon>
        <location offset="25614" length="13"/>
        <text>kidney stones</text>
      </annotation>
      <annotation id="401">
        <infon key="identifier">MESH:D030342</infon>
        <infon key="type">Disease</infon>
        <location offset="25017" length="18"/>
        <text>hereditary disease</text>
      </annotation>
      <annotation id="402">
        <infon key="identifier">MESH:D003553</infon>
        <infon key="type">Chemical</infon>
        <location offset="25251" length="7"/>
        <text>cystine</text>
      </annotation>
      <annotation id="403">
        <infon key="identifier">MESH:D030342</infon>
        <infon key="type">Disease</infon>
        <location offset="25349" length="19"/>
        <text>hereditary disorder</text>
      </annotation>
      <annotation id="404">
        <infon key="identifier">MESH:D030342</infon>
        <infon key="type">Disease</infon>
        <location offset="25165" length="19"/>
        <text>hereditary disorder</text>
      </annotation>
      <annotation id="405">
        <infon key="identifier">MESH:D006959</infon>
        <infon key="type">Disease</infon>
        <location offset="25384" length="13"/>
        <text>hyperoxaluria</text>
      </annotation>
      <annotation id="406">
        <infon key="identifier">MESH:D030342</infon>
        <infon key="type">Disease</infon>
        <location offset="24919" length="20"/>
        <text>hereditary disorders</text>
      </annotation>
      <annotation id="407">
        <infon key="identifier">MESH:D007669</infon>
        <infon key="type">Disease</infon>
        <location offset="24995" length="13"/>
        <text>kidney stones</text>
      </annotation>
      <annotation id="408">
        <infon key="identifier">MESH:D000141</infon>
        <infon key="type">Disease</infon>
        <location offset="25037" length="22"/>
        <text>renal tubular acidosis</text>
      </annotation>
      <annotation id="409">
        <infon key="identifier">MESH:D003555</infon>
        <infon key="type">Disease</infon>
        <location offset="25149" length="10"/>
        <text>Cystinuria</text>
      </annotation>
      <annotation id="410">
        <infon key="identifier">MESH:D014527</infon>
        <infon key="type">Chemical</infon>
        <location offset="25664" length="9"/>
        <text>uric acid</text>
      </annotation>
      <annotation id="411">
        <infon key="identifier">MESH:D007669</infon>
        <infon key="type">Disease</infon>
        <location offset="25134" length="13"/>
        <text>kidney stones</text>
      </annotation>
      <annotation id="412">
        <infon key="identifier">MESH:D053565</infon>
        <infon key="type">Disease</infon>
        <location offset="25517" length="14"/>
        <text>Hypercalciuria</text>
      </annotation>
      <annotation id="413">
        <infon key="identifier">MESH:D010070</infon>
        <infon key="type">Chemical</infon>
        <location offset="25430" length="12"/>
        <text>oxalate salt</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>25738</offset>
      <text>Diet, in terms of animal protein (52 g / day), sodium (50 mg / day) and the oxalate (200 mg / day) with a normal intake of calcium (1,200 mg / day), reduced recurrent stones for almost 50% and more, within five years, compared to a diet low in calcium (400 mg / day) and oxalate.</text>
      <annotation id="419">
        <infon key="identifier">MESH:D010070</infon>
        <infon key="type">Chemical</infon>
        <location offset="26009" length="7"/>
        <text>oxalate</text>
      </annotation>
      <annotation id="420">
        <infon key="identifier">MESH:D012964</infon>
        <infon key="type">Chemical</infon>
        <location offset="25785" length="6"/>
        <text>sodium</text>
      </annotation>
      <annotation id="421">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="25982" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="422">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="25861" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="423">
        <infon key="identifier">MESH:D010070</infon>
        <infon key="type">Chemical</infon>
        <location offset="25814" length="7"/>
        <text>oxalate</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>26018</offset>
      <text>Our results show that the proportion of respondents who did not have positive personal and family history of urolithiasis was 44.94%, and patients who had a positive family history of urolithiasis, but he had a personal history was 50.05%. The share of respondents, who had a family history, and negative personal history of urolithiasis, was 42 (30.88%), while the number of respondents who had a positive to families and personal history was 136 (33.74%). There was a significant frequency dependence of family and personal history (chi2 = 7.41, p = 0.006), i.e. Higher incidence of recurrence in patients who have a positive family history of urolithiasis.</text>
      <annotation id="430">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26156" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="431">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26617" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="432">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="26202" length="12"/>
        <text>urolithiasis</text>
      </annotation>
      <annotation id="433">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="26664" length="12"/>
        <text>urolithiasis</text>
      </annotation>
      <annotation id="434">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="26127" length="12"/>
        <text>urolithiasis</text>
      </annotation>
      <annotation id="435">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="26343" length="12"/>
        <text>urolithiasis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>26678</offset>
      <text>Similar results were presented by the study Koyuncu and associates, which showed a significant correlation recurring calculi and positive family history. The authors also found that the time interval between the onset of recurrence was significantly shorter in patients who had a positive family history of urolithiasis. By analyzing the patients according to sex, the authors noted that the incidence of recurrence was more frequent in males than females respondents. The authors believe that the information positivity family history is very important and can provide valuable information about the possibility of future attacks as well as the severity of the disease.</text>
      <annotation id="439">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26939" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="440">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27016" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="441">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="26985" length="12"/>
        <text>urolithiasis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>27349</offset>
      <text>Epidemiological and randomized studies have shown greater security ESWL treatment methods in breaking stones when it starts with applying lower energy sequences of the same, with a gradual increase energy sequences, resulting in a vasoconstriction which prevents renal damage and the difference in the fragmentation is not significant despite the fact that whether amplification is carried out or not.</text>
      <annotation id="443">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="27612" length="12"/>
        <text>renal damage</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>27751</offset>
      <text>Previous clinical and epidemiological studies have shown that as an indication of ESWL treatment of urolythiasis depends on several factors, including the size, localization, consistency and other histological characteristics of calculi. Pregnancy and specific internship and urological diseases, with an emphasis on acute urinary infection, contraindications to perform of ESWL.</text>
      <annotation id="447">
        <infon key="identifier">MESH:D014570</infon>
        <infon key="type">Disease</infon>
        <location offset="28027" length="19"/>
        <text>urological diseases</text>
      </annotation>
      <annotation id="448">
        <infon key="identifier">MESH:D001745</infon>
        <infon key="type">Disease</infon>
        <location offset="28074" length="17"/>
        <text>urinary infection</text>
      </annotation>
      <annotation id="449">
        <infon key="identifier">MESH:D019966</infon>
        <infon key="type">Disease</infon>
        <location offset="27851" length="20"/>
        <text>urolythiasis depends</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>28131</offset>
      <text>7. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>28145</offset>
      <text>From a total of 404 patients included in the study there was 57.92% male and 42.8% female respondents, or male : female ration of 1.2 : 1, while the most common age group in a sample of patients with urolithiasis was between 35 and 45 years(27%). The mean size of the stones in men and in women was 12 mm.</text>
      <annotation id="455">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28165" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="456">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28331" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="457">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28423" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="458">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28434" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="459">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="28345" length="12"/>
        <text>urolithiasis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>28451</offset>
      <text>Most frequent type of calculi both in female and male subjects was of calcium type. In younger patients the most common are calcium stones, with increase in respondents age calcium and infectious stones frequencies were equalized.</text>
      <annotation id="464">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28546" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="465">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="28624" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="466">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="28575" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="467">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="28521" length="7"/>
        <text>calcium</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>28682</offset>
      <text>There was a significant correlation between the size of the stone and its localization in renal pole. The incidence of stones was significantly greater in the top half, but the size of large stones (over 10 mm) were significantly more present in the lower kidney pole.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>28951</offset>
      <text>There was no statistically significant relationship between the size of stones and personal history, but statistically significant correlation is determined between the size of the stone and family history of urolithiasis.</text>
      <annotation id="469">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="29160" length="12"/>
        <text>urolithiasis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>29174</offset>
      <text>Also there was significant correlation between the size of the stone and its localization (medial / pyelon). Stones up to 10 mm are more frequently localized medially, and those larger than 10 mm are somewhat more common in the pyelon.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>29410</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>29447</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kovacevic-Prstojevic;given-names:J</infon>
      <infon key="year">2014</infon>
      <infon key="source">Magistarski rad</infon>
      <infon key="type">ref</infon>
      <offset>29458</offset>
      <text>Broj vantjelesnih razbijanja kamenaca u odnosu na velicinu kamenca, njegovu lokalizaciju u urinarnom traktu, te morfolosku strukturu kamenca</text>
    </passage>
    <passage>
      <infon key="volume">22</infon>
      <infon key="name_1">surname:Kovacevic-Prstojevic;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Junuzovic;given-names:Dz</infon>
      <infon key="fpage">309</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="comment">doi: 105455/aim.2014.22.309-314</infon>
      <infon key="source">Acta Inform Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">314</infon>
      <offset>29601</offset>
      <text>Evaluation of Extracorporeal Shock Wave Lithotripsy (ESWL): Efficasy in Treatment of Urinary System Stones</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Tanagho;given-names:EA</infon>
      <infon key="name_2">surname:McAninch;given-names:JW</infon>
      <infon key="name_1">surname:Tanagho;given-names:EA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Marshall;given-names:LS</infon>
      <infon key="year">2004</infon>
      <infon key="source">Smith's General Urology</infon>
      <infon key="type">ref</infon>
      <offset>29708</offset>
      <text>Urinary Stone Disease</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="comment">Dostupno na: </infon>
      <infon key="type">ref</infon>
      <offset>29730</offset>
      <text>European Association of Urology. Guidelines 2012 edition</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Urologija;given-names:I</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Markovic;given-names:V</infon>
      <infon key="year">1997</infon>
      <infon key="type">ref</infon>
      <offset>29787</offset>
      <text>Hirurgija mokracnih organa</text>
    </passage>
    <passage>
      <infon key="volume">16</infon>
      <infon key="name_1">surname:Perkovic;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Galic;given-names:J</infon>
      <infon key="fpage">180</infon>
      <infon key="issue">91</infon>
      <infon key="year">2010</infon>
      <infon key="source">MEDIX</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">184</infon>
      <offset>29815</offset>
      <text>Pristup lijecenju urolitijaze</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Zhang;given-names:SL</infon>
      <infon key="name_2">surname:Zhang;given-names:Q</infon>
      <infon key="name_1">surname:Fan;given-names:YZ</infon>
      <infon key="name_0">surname:Li;given-names:LP</infon>
      <infon key="fpage">295</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">23927804</infon>
      <infon key="year">2013</infon>
      <infon key="source">Zhonghua Er Ke Za Zhi</infon>
      <infon key="type">ref</infon>
      <infon key="volume">51</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">297</infon>
      <offset>29846</offset>
      <text>Clinical analysis of 41 children's urinary calculus and acute renal failure</text>
      <annotation id="473">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="29870" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="474">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="29889" length="8"/>
        <text>calculus</text>
      </annotation>
      <annotation id="475">
        <infon key="identifier">MESH:D058186</infon>
        <infon key="type">Disease</infon>
        <location offset="29902" length="19"/>
        <text>acute renal failure</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">350</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Teichman;given-names:JMH</infon>
      <infon key="fpage">684</infon>
      <infon key="issue">7</infon>
      <infon key="pub-id_pmid">14960744</infon>
      <infon key="year">2004</infon>
      <infon key="source">N Engl J Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">693</infon>
      <offset>29922</offset>
      <text>Acute Renall Colic from Ureteal Calculus</text>
      <annotation id="477">
        <infon key="identifier">MESH:D002137</infon>
        <infon key="type">Disease</infon>
        <location offset="29946" length="16"/>
        <text>Ureteal Calculus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_2">surname:Vrhovac;given-names:B</infon>
      <infon key="name_1">surname:Radonic;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hadzic;given-names:N</infon>
      <infon key="year">1990</infon>
      <infon key="source">Prirucnik interne medicine</infon>
      <infon key="type">ref</infon>
      <offset>29963</offset>
      <text>i sur</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Partin;given-names:AW</infon>
      <infon key="name_2">surname:Novick;given-names:AC</infon>
      <infon key="name_1">surname:Kavoussi;given-names:LR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Wein;given-names:AJ</infon>
      <infon key="year">2011</infon>
      <infon key="type">ref</infon>
      <offset>29969</offset>
      <text>Campbell-Walsh Urology</text>
    </passage>
    <passage>
      <infon key="volume">47</infon>
      <infon key="name_2">surname:Alken;given-names:P</infon>
      <infon key="name_1">surname:Kohrmann;given-names:KU</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kalble;given-names:T</infon>
      <infon key="fpage">537</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">18379747</infon>
      <infon key="year">2008</infon>
      <infon key="comment">doi: 10.1007/s00120-008-1732-1733</infon>
      <infon key="source">Urologe A</infon>
      <infon key="type">ref</infon>
      <offset>29992</offset>
      <text>Clinically relevant facets of urolithiasis</text>
      <annotation id="479">
        <infon key="identifier">MESH:D052878</infon>
        <infon key="type">Disease</infon>
        <location offset="30022" length="12"/>
        <text>urolithiasis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Saad;given-names:H</infon>
      <infon key="name_2">surname:Belgith;given-names:M</infon>
      <infon key="name_1">surname:Nouri;given-names:A</infon>
      <infon key="name_0">surname:Alaya;given-names:A</infon>
      <infon key="fpage">177</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">22563551</infon>
      <infon key="year">2012</infon>
      <infon key="source">Ann Lab Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">32</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">183</infon>
      <infon key="name_5">surname:Najjar;given-names:MF</infon>
      <infon key="name_4">surname:Jouini;given-names:R</infon>
      <offset>30035</offset>
      <text>Changes in urinary stone composition in the Tunisian population: a retrospective study of 1,301 cases</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Saigal;given-names:CS</infon>
      <infon key="volume">62</infon>
      <infon key="name_2">surname:Hanley;given-names:JM</infon>
      <infon key="name_1">surname:Smith;given-names:AC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Scales;given-names:CD;suffix:Jr</infon>
      <infon key="fpage">160</infon>
      <infon key="year">2012</infon>
      <infon key="source">Eur Url</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">165</infon>
      <offset>30137</offset>
      <text>Urologic Diseases in America Project. Prevalence of kidney stones in the United States Source</text>
      <annotation id="481">
        <infon key="identifier">MESH:D007669</infon>
        <infon key="type">Disease</infon>
        <location offset="30189" length="13"/>
        <text>kidney stones</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">239</infon>
      <infon key="name_1">surname:Jungers;given-names:P</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Daudon;given-names:M</infon>
      <infon key="fpage">37</infon>
      <infon key="year">2001</infon>
      <infon key="source">Feuillets de Biologie</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">39</infon>
      <offset>30231</offset>
      <text>Diabetes and calculations</text>
      <annotation id="483">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="30231" length="8"/>
        <text>Diabetes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Rofe;given-names:AM</infon>
      <infon key="name_2">surname:Bais;given-names:R</infon>
      <infon key="name_1">surname:Coyle;given-names:P</infon>
      <infon key="name_0">surname:Baker;given-names:PW</infon>
      <infon key="fpage">390</infon>
      <infon key="issue">6</infon>
      <infon key="pub-id_pmid">8377690</infon>
      <infon key="year">1993</infon>
      <infon key="source">Med J Aust</infon>
      <infon key="type">ref</infon>
      <infon key="volume">159</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">392</infon>
      <offset>30257</offset>
      <text>Influence of season, age, and sex on renal stone formation in South Australia</text>
    </passage>
    <passage>
      <infon key="volume">363</infon>
      <infon key="name_1">surname:Coe;given-names:FL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Worcester;given-names:EM</infon>
      <infon key="fpage">954</infon>
      <infon key="issue">10</infon>
      <infon key="pub-id_pmid">20818905</infon>
      <infon key="year">2010</infon>
      <infon key="source">N Engl J Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">963</infon>
      <offset>30335</offset>
      <text>Clinical practice. Calcium kidney stones</text>
      <annotation id="486">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="30354" length="7"/>
        <text>Calcium</text>
      </annotation>
      <annotation id="487">
        <infon key="identifier">MESH:D007669</infon>
        <infon key="type">Disease</infon>
        <location offset="30362" length="13"/>
        <text>kidney stones</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Sarica;given-names:K</infon>
      <infon key="name_2">surname:Eryildirim;given-names:B</infon>
      <infon key="name_1">surname:Yencilek;given-names:F</infon>
      <infon key="name_0">surname:Koyuncu;given-names:HH</infon>
      <infon key="fpage">105</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">20077110</infon>
      <infon key="year">2010</infon>
      <infon key="source">Urol Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">38</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">109</infon>
      <offset>30376</offset>
      <text>Family history in stone disease: how important is it for the onset of the disease and the incidence of recurrence?</text>
      <annotation id="489">
        <infon key="identifier">MESH:D007669</infon>
        <infon key="type">Disease</infon>
        <location offset="30394" length="13"/>
        <text>stone disease</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272832</id>
    <passage>
      <infon key="name_2">surname:Agincic;given-names:Alija</infon>
      <infon key="name_1">surname:Cvorak;given-names:Alemko</infon>
      <infon key="article-id_pmid">25568583</infon>
      <infon key="name_0">surname:Rustempasic;given-names:Nedzad</infon>
      <infon key="fpage">329</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272832</infon>
      <infon key="article-id_publisher-id">AIM-22-329</infon>
      <infon key="article-id_doi">10.5455/aim.2014.22.329-332</infon>
      <infon key="type">front</infon>
      <infon key="volume">22</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Acta Inform Med; 2014 Oct; 22(5) 329-32. doi:10.5455/aim.2014.22.329-332</infon>
      <infon key="kwd">varicose veins EVLA surgical treatment comparison</infon>
      <infon key="lpage">332</infon>
      <infon key="authors">Rustempasic N, Cvorak A, Agincic A</infon>
      <offset>0</offset>
      <text>Outcome of Endovenous Laser Ablation of Varicose Veins</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>55</offset>
      <text>ABSTRACT</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>64</offset>
      <text>Introduction:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>78</offset>
      <text>In Bosnia and Herzegovina according to available data, treatment of incompetent superficial lower extremity varicose veins by endovenous laser ablation (EVLA) has been introduced two years ago and so far no paper has been published regarding results of EVLA treatment of patients from our country. We wanted to present our results with EVLA treatment.</text>
      <annotation id="5">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="349" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="6">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="331" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="7">
        <infon key="type">Disease</infon>
        <location offset="81" length="6"/>
        <text>Bosnia</text>
      </annotation>
      <annotation id="8">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="414" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="9">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="231" length="4"/>
        <text>EVLA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>430</offset>
      <text>Aim of study:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>444</offset>
      <text>to evaluate and compare primary posttreatment outcomes of endovenous laser ablation (EVLA) with classical surgical method of varicose vein treatment.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>594</offset>
      <text>Patients and methods:</text>
      <annotation id="11">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="594" length="8"/>
        <text>Patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>616</offset>
      <text>The study was clinical and prospective. It was carried out at Clinic for vascular surgery in Sarajevo where fifty-eight (58) patients received surgical treatment for varicose veins and in Aesthetic Surgery Center "Nasa mala klinika" in Sarajevo were sixty-one (61) patients with varicose veins were treated by endovenous laser ablation. Total 119 patients (limbs) with pathologic reflux only in great saphenous vein were evaluated between 1st of January 2013 and 31st of April 2014. Following primary outcome endpoints were evaluated smean day of return to normal everyday activities, patient subjective quantification of pain during first seven days after intervention, incidence of deep venous thrombosis (DVT), incidence of wound bleeding requiring surgical intervention, incidence of peri-saphenous vein hematoma and infection rate.</text>
      <annotation id="20">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="741" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="21">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="881" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="22">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="963" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="23">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1201" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="24">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="1349" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="25">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="1300" length="22"/>
        <text>deep venous thrombosis</text>
      </annotation>
      <annotation id="26">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="1419" length="27"/>
        <text>vein hematoma and infection</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="1238" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1457</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1466</offset>
      <text>Mean of return to normal activities (expressed in days after intervention); EVLA vs. stripping (surgery) =1.21vs12.24, T test 13,619; p=0, 000, p&lt;0,05. T test was used for comparing Mean value of visual pain analog scale for the first 7 days between groups, for all seven days pain was significantly higher in surgical group of patients as compared to EVLA group; p&lt;0,05. Incidence of hematoma greater than 1% of total body surface area was significantly higher in patients receiving surgical treatment; Pearson Chi Square=23,830, p&lt;0,05; odds ratio:10,453. Incidences of infection, deep venous thrombosis and posttreatment bleeding were not statistically different between analyzed groups; EVLA vs Surgery (Pearson Chi Square =3,237; p&gt;0,05; Pearson Chi Square=2,139, p&gt;0,05, Pearson Chi Square=2,139, p&gt;0,05, respectively.)</text>
      <annotation id="37">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1794" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="38">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1931" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="39">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="2049" length="22"/>
        <text>deep venous thrombosis</text>
      </annotation>
      <annotation id="40">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="1818" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="41">
        <infon key="identifier">MESH:D014786</infon>
        <infon key="type">Disease</infon>
        <location offset="1662" length="11"/>
        <text>visual pain</text>
      </annotation>
      <annotation id="42">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="2038" length="9"/>
        <text>infection</text>
      </annotation>
      <annotation id="43">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="1743" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="44">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="1851" length="8"/>
        <text>hematoma</text>
      </annotation>
      <annotation id="45">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="2090" length="8"/>
        <text>bleeding</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>2292</offset>
      <text>Conclusion:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>2304</offset>
      <text>EVLA offers better patient recovery in terms of significantly lower post treatment pain, faster return to everyday activities and lower incidence of bruising (hematomas).</text>
      <annotation id="51">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2323" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="52">
        <infon key="identifier">MESH:D003288</infon>
        <infon key="type">Disease</infon>
        <location offset="2453" length="8"/>
        <text>bruising</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="2463" length="9"/>
        <text>hematomas</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="2304" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="2387" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>2475</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2491</offset>
      <text>In the recent past the gold standard in the treatment of lower extremity varicose veins with incompetent great saphenous vein (GSV) or small saphenous vein (SSV) was classical surgicall method of ligation and stripping of incompetent saphenous vein along with varicectomies. However, during the last decade other minimal invasive techniques have been invented and introduced to treat the incompetent saphenous vein and varicosities. Endovenous laser ablation (EVLA) is one of them and it has been used as minimally invasive replacement to classical surgical way of treating varicose veins for many years (Figure 1, Figure 2). Avoiding surgical incisions, mechanical disruption of the sapheno-femoral junction (SFJ) as well as aggressiveness of avulsion of saphenous vein, EVLA may offer reduced postoperative pain, post intervention bleeding and peri-saphenous vein hematoma along with decreased rate of wound infection and potentially shorter periods of absenteeism from work. In addition neo-vascularisation is significantly reduced which in turn might cause decreased incidence of varicose vein recurrence.</text>
      <annotation id="61">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="3352" length="13"/>
        <text>vein hematoma</text>
      </annotation>
      <annotation id="62">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="3324" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="63">
        <infon key="identifier">MESH:D010149</infon>
        <infon key="type">Disease</infon>
        <location offset="3286" length="18"/>
        <text>postoperative pain</text>
      </annotation>
      <annotation id="64">
        <infon key="identifier">MESH:D001523</infon>
        <infon key="type">Disease</infon>
        <location offset="3217" length="26"/>
        <text>aggressiveness of avulsion</text>
      </annotation>
      <annotation id="65">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="3401" length="9"/>
        <text>infection</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-329-g001.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>3601</offset>
      <text>Varicose veins before treatment</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-329-g002.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption</infon>
      <offset>3633</offset>
      <text>Same patient after EVLA treatment</text>
      <annotation id="68">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3638" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="69">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="3652" length="4"/>
        <text>EVLA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3667</offset>
      <text>In Bosnia and Herzegovina according to available data, endovascular laser ablation of incompetent superficial lower extremity veins has been introduced two years ago and so far no paper has been published regarding EVLA treatment of patients from our country. Since many papers on this topic have certain contradictory results we wanted to present our experience with these two methods of varicose vein tretament.</text>
      <annotation id="73">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3900" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="3882" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="75">
        <infon key="type">Disease</infon>
        <location offset="3670" length="6"/>
        <text>Bosnia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>4081</offset>
      <text>2. AIM OF STUDY</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4097</offset>
      <text>To evaluate and compare primary posttreatment outcomes of endovenous laser ablation (EVLA) with classical surgical method of varicose vein treatment</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>4246</offset>
      <text>3. PATIENTS AND METHODS</text>
      <annotation id="77">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4249" length="8"/>
        <text>PATIENTS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4270</offset>
      <text>The study was clinical and prospective. It was carried out at Clinic for vascular surgery in Sarajevo where patients received surgical treatment for varicose veins and in Aesthetic Surgery Center "Nasa mala klinika" were endovenous laser treatment of varicose vein was performed. Total 119 patients with pathologic reflux only in great saphenous vein were evaluated between 1st of January 2013 and 31st of April 2014. Sixty-one (61) patients who received endovenous laser treatment for varicose veins in Aesthetic Surgery Center "Nasa mala klinika" were assigned to group A, while fifty-eight (58) patients that received surgical treatment of varicose veins at the Clinic for Vascular surgery were assigned to Group B.</text>
      <annotation id="82">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4378" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="83">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4560" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="84">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4703" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4868" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4998</offset>
      <text>Primary outcome endpoints were evaluated: mean day of return to normal everyday activities, patient subjective quantification of pain during first seven days after intervention, incidence of deep venous thrombosis (DVT), incidence of wound bleeding requiring surgical intervention, incidence of peri-saphenous vein hematoma and infection rate. Every day activities were defined as ability for self-care and all other professional, recreational, household or outdoor physical activities that used to be carried out before varicose vein treatment. Return to those activities was advised to all patients to be as soon as possible and the information about the day of return to those activities were recorded when patient resumed them without any difficulty ie pain. Infection was defined as redness of skin around wound (phlebectomy site) along with presence of pus in the wound (site of intervention) with or without patient being febrile. Hematoma along the direction of treated saphenous vein was examined on 7th day and its surface area estimated by comparing its total surface to the surface area of the palm of individual patient (1% of total body surface area)-procedure similar to the method used in assessment of burned skin surface area. Patients were then categorized either as having hematoma less than 1% or having hematoma &gt;= 1% of total body surface area. Pain score was measured using a visual analogue scale ranging from 0 (no pain) to 5 (most severe pain) (Figure 3).</text>
      <annotation id="103">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5090" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="104">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5590" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="105">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5708" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="106">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5913" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="107">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6123" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="108">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6243" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="109">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="5238" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="110">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="6439" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="111">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="5127" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="112">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="5936" length="8"/>
        <text>Hematoma</text>
      </annotation>
      <annotation id="113">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="5308" length="27"/>
        <text>vein hematoma and infection</text>
      </annotation>
      <annotation id="114">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="5189" length="22"/>
        <text>deep venous thrombosis</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="6463" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="116">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="6366" length="4"/>
        <text>Pain</text>
      </annotation>
      <annotation id="117">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="6323" length="8"/>
        <text>hematoma</text>
      </annotation>
      <annotation id="118">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="5755" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="119">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="6291" length="8"/>
        <text>hematoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-329-g003.jpg</infon>
      <infon key="id">F3</infon>
      <infon key="type">fig_caption</infon>
      <offset>6484</offset>
      <text>Visual analog scale pain estimation</text>
      <annotation id="121">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="6504" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6520</offset>
      <text>In case of presence of clinical signs of lower extremity deep venous thrombosis (DVT) Color Doppler examination was performed. Any bleeding after intervention that required surgical intervention either in the form of surgical revision of bleeding or need for additional surgical suture were noted and defined as postintervention bleeding. Return to normal activities were recorded taking 30 days after intervention as maximum period. This period was sufficient for full mobilization of patient even in the case of unwanted outcome endpoints like DVT. Each patient had a pre-operative duplex ultrasound examination that was performed in order to identify the site of pathologic reflux and evaluate suitability for intervention on superficial venous system. Ultrasonography was performed by vascular surgeon using Mindray 6 apparatus for group of patients treated surgically or GE ultrasound for patients treated by endovascular laser ablation. Ultrasonographic mapping of the venous systems was performed in all patients in standing position. Incompetence of the GSV was defined as reflux &gt; 0.5 s in duration following calf compression. Exclusion criteria were: previous surgical treatment of the GSV, GSV diameter &gt;= 2 cm, pregnancy, allergy to lidocaine, active superficial phlebitis, presence of any dermatologic phlebostatic changes in leg like hyperpigmentation or skin ulcer, positive history of previous deep venous thrombosis, diabetes mellitus and arterial disease. Mechanical stripping of great saphenous vein was performed in general anesthesia. After a groin incision, high ligation of the GSV and ligation of all tributaries were performed. Access to distal part of GSV was achieved through a small incision at the level of knee joint. GSV stripping was performed by metalic stripper. Varicosities were removed by minimal stab avulsion technique (Klapp/Smetana method). In the EVLA group of patients, endovascular access for laser fiber introduction into GSV was ultrasonically guided and performed at the knee level. The laser fiber tip was positioned 1 cm distal to the SFJ. Before laser ablation was started tumescent anesthetic (25 ml Lidocaine 2% in 500 ml of normal saline 0,9%) was injected all around GSV under ultrasound guidance. Thermal ablation of great saphenous vein was performed by Biolitec 1470 nm radial fiber with energy 70J/cm at 10 watts. Varicosities were removed by microphlebectomy technique. Post procedurally elastic venous compression was applied to both group of patients for 30 days in surgically treated group and for only 7 days in group of patients that received laser ablation treatment. Wound dressings were changed every three days and wounds were disinfected with povidone-iodine solution and sutures removed on 10th postoperative day in surgical group of patients. Wound dressing in EVLA group of patients was left intact for total 7 days and then removed along with compressive stocking.</text>
      <annotation id="147">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7006" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="148">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7076" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="149">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7365" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="150">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7414" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="151">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7531" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="152">
        <infon key="identifier">9913</infon>
        <infon key="type">Species</infon>
        <location offset="7638" length="4"/>
        <text>calf</text>
      </annotation>
      <annotation id="153">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8423" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="154">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9023" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="155">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9104" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="156">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9324" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="157">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9366" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="158">
        <infon key="identifier">MESH:D004342</infon>
        <infon key="type">Disease</infon>
        <location offset="7754" length="7"/>
        <text>allergy</text>
      </annotation>
      <annotation id="159">
        <infon key="identifier">MESH:D002539</infon>
        <infon key="type">Disease</infon>
        <location offset="7976" length="16"/>
        <text>arterial disease</text>
      </annotation>
      <annotation id="160">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="7930" length="22"/>
        <text>deep venous thrombosis</text>
      </annotation>
      <annotation id="161">
        <infon key="identifier">MESH:D010689</infon>
        <infon key="type">Disease</infon>
        <location offset="7795" length="9"/>
        <text>phlebitis</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="6651" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">MESH:D008012</infon>
        <infon key="type">Chemical</infon>
        <location offset="8671" length="9"/>
        <text>Lidocaine</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">MESH:D012883</infon>
        <infon key="type">Disease</infon>
        <location offset="7889" length="10"/>
        <text>skin ulcer</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">MESH:D017495</infon>
        <infon key="type">Disease</infon>
        <location offset="7868" length="17"/>
        <text>hyperpigmentation</text>
      </annotation>
      <annotation id="166">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="6577" length="22"/>
        <text>deep venous thrombosis</text>
      </annotation>
      <annotation id="167">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="6758" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="168">
        <infon key="identifier">MESH:D011206</infon>
        <infon key="type">Chemical</infon>
        <location offset="9232" length="15"/>
        <text>povidone-iodine</text>
      </annotation>
      <annotation id="169">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="6849" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="170">
        <infon key="identifier">MESH:D008012</infon>
        <infon key="type">Chemical</infon>
        <location offset="7765" length="9"/>
        <text>lidocaine</text>
      </annotation>
      <annotation id="171">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="7954" length="17"/>
        <text>diabetes mellitus</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>9461</offset>
      <text>4. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9472</offset>
      <text>Statistical data analysis was performed using the IBM SPSS version 22.0. In this study we analyzed continuous and categorical (dichotomous) variables. Statistical data analysis was performed using mainly methods of inferential statistics. For continuous variables, parametric independent-samples t-test was performed. Non-parametric chi-square test was performed for testing hypothesis for categorical variables. Both tests were calculated on the basis of 95% confidence level. Odds ratio was calculated only for the incidence of hematoma. For other variables odds ratio calculation was not possible because of zero frequencies in the cross tabulation cells. Mean of return to normal activities was expressed in days after intervention ei EVLA vs surgery (stripping) =1.21vs12.24, T test 13,619; p=0, 000, p&lt;0,05 (Table 1). T test was used for comparing Mean value of visual pain analog scale (figure 3) for first 7 days between groups, for all seven days pain was significantly higher in surgical group of patients as compared to EVLA group; EVLA vs Surgery: 1st day T test= -17.900, p&lt;0.05; 2nd day T test=-19,817, p&lt;0.05; 3rd day T test=-21.986, p&lt;0.05; 4th day T test=-4.898, p&lt;0.05; 5th day T test=-4.355, p&lt;0.05; 6th day T test -3,643, p&lt;0.05; 7th day T test=2.386, p&lt;0.05.</text>
      <annotation id="176">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10479" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="177">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="10002" length="8"/>
        <text>hematoma</text>
      </annotation>
      <annotation id="178">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="10428" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="179">
        <infon key="identifier">MESH:D014786</infon>
        <infon key="type">Disease</infon>
        <location offset="10340" length="11"/>
        <text>visual pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>10752</offset>
      <text>Mean of return to normal activities in days after intervention</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>10815</offset>
      <text>Mean value of visual pain scale for first seven days after intervention</text>
      <annotation id="181">
        <infon key="identifier">MESH:D014786</infon>
        <infon key="type">Disease</infon>
        <location offset="10829" length="11"/>
        <text>visual pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10887</offset>
      <text>Incidence of hematoma greater than 1% of total body surface area was significantly higher in patients receiving surgical treatment; Pearson Chi Square=23,830, p&lt;0,05; odds ratio:10,453 (Table 3). Incidences of infection, deep venous thrombosis and posttreatment bleeding were not statistically different between analyzed groups; EVLA vs Surgery: (Pearson Chi Square =3,237; p&gt;0,05; Pearson Chi Square=2,139, p&gt;0,05, Pearson Chi Square=2,139, p&gt;0,05, respectively (Table 4, Table 5 and Table 6).</text>
      <annotation id="184">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10980" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="185">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="10900" length="8"/>
        <text>hematoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T3.xml</infon>
      <infon key="id">T3</infon>
      <infon key="type">table_caption</infon>
      <offset>11382</offset>
      <text>Incidence of hematoma greater than 1% of total body surface area</text>
      <annotation id="187">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="11395" length="8"/>
        <text>hematoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T4.xml</infon>
      <infon key="id">T4</infon>
      <infon key="type">table_caption</infon>
      <offset>11447</offset>
      <text>Incidence of infection</text>
      <annotation id="189">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="11460" length="9"/>
        <text>infection</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T5.xml</infon>
      <infon key="id">T5</infon>
      <infon key="type">table_caption</infon>
      <offset>11470</offset>
      <text>Incidence of wound bleeding after intervention</text>
      <annotation id="191">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="11489" length="8"/>
        <text>bleeding</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T6.xml</infon>
      <infon key="id">T6</infon>
      <infon key="type">table_caption</infon>
      <offset>11517</offset>
      <text>Incidence of deep venous thrombosis after intervention</text>
      <annotation id="193">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="11530" length="22"/>
        <text>deep venous thrombosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>11572</offset>
      <text>5. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11586</offset>
      <text>Return to normal everyday activities in EVLA group was on first day after intervention (mean) while in surgical group it was on 12th day (Mean: 1.23 vs. 12. 24); (Table 1). The difference was statistically significant p&lt;0.05. All patients immediately after EVLA procedure was finished, left Clinic walking without any difficulties and regular every day walking was advised as only measure for prevention of DVT in this group.</text>
      <annotation id="196">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11816" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="11626" length="4"/>
        <text>EVLA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12012</offset>
      <text>Pain was quantified every day (for all seven days after intervention/operation) by each patient on scale from 0-5 (Figure 1) based on mean value of visual pain scale. In EVLA group for all seven days after intervention mean value of pain intensity was significantly less than in surgical group (Table 2). Less pain is probably related to avoiding trauma to skin (groin incisions) and trauma to subcutaneous tissue caused by avulsion (mechanical stripping of great saphenous vein). These results are opposite to results published by Pronk et al. where EVLA patient had more pain in second week as compared to surgical group of patients. Underlying reason for greater pain in their EVLA group is probably the type of laser apparatus they used (older type) because new Laser systems with higher wavelengths like 1470 nm have a better absorption in water and cause less pain and bruising after the procedure because they cause less vein wall perforation. This is in accordance with recommendation that low-energy EVLA with the use of a 1,470-nm laser fiber with linear endovenous energy density (LEED) of 80 J/cm or less is advisable option for the treatment of incompetent saphenous veins. Regarding post intervention hematoma, in our study there were 5 cases of hematoma in EVLA group and 28 cases being &gt;= 1% of total body surface area in surgical group. This difference was statistically significant, p&lt;0.05 (Table 3). Similar results were obtained by study of Siribumrungwong et al in which they had statistically significant advantage of EVLA method over surgery in hematoma appearance. Postoperative hematomas were also significantly smaller after EVLA than those after stripping in the study of Kalteis et al..</text>
      <annotation id="219">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12100" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="220">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12568" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="221">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12638" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="222">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="13272" length="8"/>
        <text>hematoma</text>
      </annotation>
      <annotation id="223">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="12322" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="224">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="12678" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="225">
        <infon key="identifier">MESH:D003288</infon>
        <infon key="type">Disease</infon>
        <location offset="12887" length="8"/>
        <text>bruising</text>
      </annotation>
      <annotation id="226">
        <infon key="identifier">MESH:D010149</infon>
        <infon key="type">Disease</infon>
        <location offset="13601" length="23"/>
        <text>Postoperative hematomas</text>
      </annotation>
      <annotation id="227">
        <infon key="identifier">MESH:D014947</infon>
        <infon key="type">Disease</infon>
        <location offset="12396" length="6"/>
        <text>trauma</text>
      </annotation>
      <annotation id="228">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="12563" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="229">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="12012" length="4"/>
        <text>Pain</text>
      </annotation>
      <annotation id="230">
        <infon key="identifier">MESH:D014786</infon>
        <infon key="type">Disease</infon>
        <location offset="12160" length="11"/>
        <text>visual pain</text>
      </annotation>
      <annotation id="231">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="12857" length="5"/>
        <text>water</text>
      </annotation>
      <annotation id="232">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="12182" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="233">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="12585" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="234">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="13663" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="235">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="13227" length="8"/>
        <text>hematoma</text>
      </annotation>
      <annotation id="236">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="12245" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="237">
        <infon key="identifier">MESH:D014947</infon>
        <infon key="type">Disease</infon>
        <location offset="12359" length="6"/>
        <text>trauma</text>
      </annotation>
      <annotation id="238">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="13580" length="8"/>
        <text>hematoma</text>
      </annotation>
      <annotation id="239">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="12878" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13728</offset>
      <text>Incidence of infection in this study was smaller in EVLA group (0 patients) as compared to surgical group of patients (3 patients) but this difference was not statistically significant, p&gt;0.05 (Table 4). These findings have similar correlation with results of meta-analysis on 2245 limbs by Pan et al. which reported also fewer complications with EVLA as compared to high ligation and stripping in case of bleeding and hematoma (1.28% versus 4.83%) as well as wound infection (0.33% versus 1.91%). Striping itself is mechanically tissue destructive procedure which after removal of saphenous vein leaves avulsed tributaries that are left to bleed into subcutaneous tissue and amount of bleeding can be controlled only by subsequent compression. In that regard we had to additionally control bleeding after operations in 2 patients while there was no need to control any unwanted bleeding in patients after EVLA, (Table 5). However, this difference was not statistically relevant, p&gt;0.05. We had no cases of DVT in EVLA group while 2 cases of crural DVT were recorded in surgical group of patients that were confirmed by color Doppler. Both of them received low molecular weight heparin therapy with switch to oral anticoagulation according to standard protocol for DVT treatment. Recovery was uneventful. This difference in incidence of DVT between groups was not statistically significant, (Table 6), p&gt;0.05. Incidence of deep vein thrombosis (DVT) after varicose vein surgery vary between 0.4% historically and 5.7% while after EVLA from 0 to 7.7%. We administered LMWH prevention for surgical group of patients during their hospital stay although according to some authors there is no superiority of a short-term regimen of LMWH, early ambulation and compression therapy as compared with early ambulation and compression therapy alone. This decision was guided by idea that mobilization of patient after surgery due to general anesthesia was delayed as compared to EVLA group. EVLA treatment is rarely related to possible endovenous heat-induced thrombosis (EHIT) that leads to clinically significant DVT. EHIT may be caused by heat that is delivered by laser catheter placed in the saphenous vein. This brings about closure of the vein by denaturing the vessel wall with consequent thrombus formation. There are no relevant guidelines regarding advice for routine anticoagulation for EVLA patients.</text>
      <annotation id="271">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13794" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="272">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13837" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="273">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13849" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="274">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14550" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="275">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14619" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="276">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14816" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="277">
        <infon key="identifier">1214577</infon>
        <infon key="type">Species</infon>
        <location offset="15270" length="4"/>
        <text>to 7</text>
      </annotation>
      <annotation id="278">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15333" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="279">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15621" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="280">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16121" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="281">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="15696" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="282">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="14147" length="8"/>
        <text>hematoma</text>
      </annotation>
      <annotation id="283">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="13780" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="284">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="14519" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="285">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="14742" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="286">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="14134" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="287">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="14607" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="288">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="15258" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="289">
        <infon key="type">Disease</infon>
        <location offset="15837" length="4"/>
        <text>EHIT</text>
      </annotation>
      <annotation id="290">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="14414" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="291">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="14634" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="292">
        <infon key="identifier">MESH:D006495</infon>
        <infon key="type">Chemical</infon>
        <location offset="15455" length="4"/>
        <text>LMWH</text>
      </annotation>
      <annotation id="293">
        <infon key="identifier">MESH:D006493</infon>
        <infon key="type">Chemical</infon>
        <location offset="14906" length="7"/>
        <text>heparin</text>
      </annotation>
      <annotation id="294">
        <infon key="identifier">MESH:D006495</infon>
        <infon key="type">Chemical</infon>
        <location offset="15295" length="4"/>
        <text>LMWH</text>
      </annotation>
      <annotation id="295">
        <infon key="identifier">MESH:D010291</infon>
        <infon key="type">Disease</infon>
        <location offset="14770" length="10"/>
        <text>crural DVT</text>
      </annotation>
      <annotation id="296">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="13741" length="9"/>
        <text>infection</text>
      </annotation>
      <annotation id="297">
        <infon key="type">Disease</infon>
        <location offset="15789" length="4"/>
        <text>EHIT</text>
      </annotation>
      <annotation id="298">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="14194" length="9"/>
        <text>infection</text>
      </annotation>
      <annotation id="299">
        <infon key="identifier">MESH:D013927</infon>
        <infon key="type">Disease</infon>
        <location offset="15777" length="10"/>
        <text>thrombosis</text>
      </annotation>
      <annotation id="300">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="15708" length="4"/>
        <text>EVLA</text>
      </annotation>
      <annotation id="301">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="15151" length="20"/>
        <text>deep vein thrombosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>16131</offset>
      <text>6. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>16145</offset>
      <text>According to obtained results this endovenous laser ablation (EVLA) enables patients after treatment of varicose veins with better recovery in terms of significantly lower post treatment pain, faster return to everyday activities and lower incidence of bruising (hematomas).</text>
      <annotation id="306">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16221" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="307">
        <infon key="identifier">MESH:D006406</infon>
        <infon key="type">Disease</infon>
        <location offset="16408" length="9"/>
        <text>hematomas</text>
      </annotation>
      <annotation id="308">
        <infon key="identifier">MESH:D003288</infon>
        <infon key="type">Disease</infon>
        <location offset="16398" length="8"/>
        <text>bruising</text>
      </annotation>
      <annotation id="309">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="16332" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>16420</offset>
      <text>It has also shown that EVLA had offered no advantages in terms of significantly lower incidence of post intervention bleeding, infection rate or DVT.</text>
      <annotation id="313">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="16537" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="314">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="16547" length="9"/>
        <text>infection</text>
      </annotation>
      <annotation id="315">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="16443" length="4"/>
        <text>EVLA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>16570</offset>
      <text>LIMITATIONS: Study was carried out on patients with varicose veins without dermatologic complications so further evaluation is required especially regarding need for inclusion of patients with C3 level of disease or higher according to CEAP classification. In addition patient expectations might have had influence on subjective pain score scale since they have received information about so far published advantages of EVLA before intervention was performed.</text>
      <annotation id="322">
        <infon key="identifier">282991</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">45479</infon>
        <location offset="16806" length="4"/>
        <text>CEAP</text>
      </annotation>
      <annotation id="323">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16608" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="324">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16749" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="325">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16839" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="326">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="16899" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="327">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="16990" length="4"/>
        <text>EVLA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>17030</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>17067</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="volume">9</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McBride;given-names:KD</infon>
      <infon key="fpage">150</infon>
      <infon key="pub-id_pmid">21550521</infon>
      <infon key="year">2011</infon>
      <infon key="source">Surgeon</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">159</infon>
      <offset>17078</offset>
      <text>Changing to endovenous treatments for varicose veins: how much more evidence is needed?</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Forrestal;given-names:M</infon>
      <infon key="volume">2</infon>
      <infon key="name_2">surname:Isaacs;given-names:M</infon>
      <infon key="name_1">surname:Zimmet;given-names:SE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Min;given-names:RJ</infon>
      <infon key="fpage">167</infon>
      <infon key="year">2001</infon>
      <infon key="source">J Vasc Interv Radiol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1171</infon>
      <offset>17166</offset>
      <text>Endovenous laser treatment of the incompetent greater saphenous vein</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Lissens;given-names:P</infon>
      <infon key="volume">21</infon>
      <infon key="name_2">surname:Audenaert;given-names:EA</infon>
      <infon key="name_1">surname:Vanden;given-names:Bussche D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Vuylsteke;given-names:M</infon>
      <infon key="fpage">80</infon>
      <infon key="year">2006</infon>
      <infon key="source">Phlebology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">87</infon>
      <offset>17235</offset>
      <text>Endovenous laser obliteration for the treatment of primary varicose veins</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Mavor;given-names:AID</infon>
      <infon key="name_2">surname:Dellagrammaticas;given-names:D</infon>
      <infon key="name_1">surname:Theivacumar;given-names:N</infon>
      <infon key="name_0">surname:Darwood;given-names:RJ</infon>
      <infon key="fpage">294</infon>
      <infon key="pub-id_pmid">18278775</infon>
      <infon key="year">2008</infon>
      <infon key="source">Br J Surg</infon>
      <infon key="type">ref</infon>
      <infon key="volume">95</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">301</infon>
      <infon key="name_4">surname:Gough;given-names:MJ</infon>
      <offset>17309</offset>
      <text>Randomized clinical trial comparing endovenous laser ablation with surgery for the treatment of primary great saphenous veins</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Gaastra;given-names:MTW</infon>
      <infon key="name_2">surname:Mooij;given-names:MC</infon>
      <infon key="name_1">surname:Gauw;given-names:SA</infon>
      <infon key="name_0">surname:Pronk;given-names:P</infon>
      <infon key="fpage">649</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">20888274</infon>
      <infon key="year">2010</infon>
      <infon key="source">European Journal of Vascular and Endovascular Surgery</infon>
      <infon key="type">ref</infon>
      <infon key="volume">40</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">656</infon>
      <infon key="name_4">surname:Lawson;given-names:JA</infon>
      <offset>17435</offset>
      <text>Randomised Controlled Trial Comparing Sapheno-Femoral Ligation and Stripping of the Great Saphenous Vein with Endovenous Laser Ablation (980 nm) Using Local Tumescent Anaesthesia: One Year Results</text>
    </passage>
    <passage>
      <infon key="volume">40</infon>
      <infon key="name_1">surname:Demirkilic;given-names:U</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Doganci;given-names:S</infon>
      <infon key="fpage">254</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">20547079</infon>
      <infon key="year">2010</infon>
      <infon key="source">European Journal of Vascular and Endovascular Surgery</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">259</infon>
      <offset>17632</offset>
      <text>Comparison of 980 nm Laser and Bare-tip Fibre with 1470 nm Laser and Radial Fibre in the Treatment of Great Saphenous Vein Varicosities: A Prospective Randomised Clinical Trial</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Mauriello;given-names:J</infon>
      <infon key="name_2">surname:Javier;given-names:J</infon>
      <infon key="name_1">surname:Mackay;given-names:E</infon>
      <infon key="name_0">surname:Almeida;given-names:J</infon>
      <infon key="fpage">467</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">19628516</infon>
      <infon key="year">2009</infon>
      <infon key="source">Vasc Endovascular Surg</infon>
      <infon key="type">ref</infon>
      <infon key="volume">43</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">472</infon>
      <infon key="name_4">surname:Raines;given-names:J</infon>
      <offset>17809</offset>
      <text>Saphenous laser ablation at 1470 nm targets the vein wall, not blood</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Hwang;given-names:JJ</infon>
      <infon key="name_2">surname:Chang;given-names:IS</infon>
      <infon key="name_1">surname:Park;given-names:SW</infon>
      <infon key="name_0">surname:Park;given-names:JA</infon>
      <infon key="year">2014</infon>
      <infon key="source">J Vasc Interv Radiol</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">Epub ahead of print</infon>
      <infon key="name_7">surname:Yun;given-names:IJ</infon>
      <infon key="name_6">surname:Chee;given-names:HK</infon>
      <infon key="name_5">surname:Kim;given-names:JS</infon>
      <infon key="name_4">surname:Lee;given-names:SA</infon>
      <offset>17878</offset>
      <text>The 1470-nm Bare-Fiber Diode Laser Ablation of the Great Saphenous Vein and Small Saphenous Vein at 1-Year Follow-up Using 8-12 W and a Mean Linear Endovenous Energy Density of 72 J/cm</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Attia;given-names:J</infon>
      <infon key="name_2">surname:Wilasrusmee;given-names:C</infon>
      <infon key="name_1">surname:Noorit;given-names:P</infon>
      <infon key="name_0">surname:Siribumrungwong;given-names:B</infon>
      <infon key="fpage">214</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">22705163</infon>
      <infon key="year">2012</infon>
      <infon key="source">Eur J Vasc Endovasc Surg</infon>
      <infon key="type">ref</infon>
      <infon key="volume">44</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">223</infon>
      <infon key="name_4">surname:Thakkinstian;given-names:A</infon>
      <offset>18063</offset>
      <text>A systematic review and meta-analysis of randomised controlled trials comparing endovenous ablation and surgical intervention in patients with varicose vein</text>
      <annotation id="329">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18192" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Pistrich;given-names:R</infon>
      <infon key="name_2">surname:Messie-Werndl;given-names:S</infon>
      <infon key="name_1">surname:Berger;given-names:I</infon>
      <infon key="name_0">surname:Kalteis;given-names:M</infon>
      <infon key="fpage">822</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">18295441</infon>
      <infon key="year">2008</infon>
      <infon key="source">J Vasc Surg</infon>
      <infon key="type">ref</infon>
      <infon key="volume">47</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">829</infon>
      <infon key="name_6">surname:Hieller;given-names:F</infon>
      <infon key="name_5">surname:Polz;given-names:W</infon>
      <infon key="name_4">surname:Schimetta;given-names:W</infon>
      <offset>18220</offset>
      <text>High ligation combined with stripping and endovenous laser ablation of the great saphenous vein: early results of a randomized controlled study</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Shao;given-names:M</infon>
      <infon key="name_2">surname:Mei;given-names:J</infon>
      <infon key="name_1">surname:Zhao;given-names:J</infon>
      <infon key="name_0">surname:Pan;given-names:Y</infon>
      <infon key="fpage">109</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">23390218</infon>
      <infon key="year">2014</infon>
      <infon key="source">Phlebology</infon>
      <infon key="type">ref</infon>
      <infon key="volume">29</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">119</infon>
      <infon key="name_4">surname:Zhang;given-names:J</infon>
      <offset>18364</offset>
      <text>Comparison of endovenous laser ablation and high ligation and stripping for varicose vein treatment: a meta-analysis</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Harrison;given-names:C</infon>
      <infon key="name_2">surname:Holdstock;given-names:J</infon>
      <infon key="name_1">surname:Price;given-names:BA</infon>
      <infon key="name_0">surname:Marsh;given-names:P</infon>
      <infon key="fpage">521</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">20655773</infon>
      <infon key="year">2010</infon>
      <infon key="source">European Journal of Vascular and Endovascular Surgery</infon>
      <infon key="type">ref</infon>
      <infon key="volume">40</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">527</infon>
      <infon key="name_4">surname:Whiteley;given-names:MS</infon>
      <offset>18481</offset>
      <text>Deep Vein Thrombosis (DVT) after Venous Thermoablation Techniques: Rates of Endovenous Heat-induced Thrombosis (EHIT) and Classical DVT after Radiofrequency and Endovenous Laser Ablation in a Single Centre</text>
      <annotation id="333">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="18481" length="20"/>
        <text>Deep Vein Thrombosis</text>
      </annotation>
      <annotation id="334">
        <infon key="type">Disease</infon>
        <location offset="18593" length="4"/>
        <text>EHIT</text>
      </annotation>
      <annotation id="335">
        <infon key="identifier">MESH:D013927</infon>
        <infon key="type">Disease</infon>
        <location offset="18581" length="10"/>
        <text>Thrombosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Vizcaino;given-names:I</infon>
      <infon key="name_2">surname:Taylor;given-names:JH</infon>
      <infon key="name_1">surname:Merino;given-names:B</infon>
      <infon key="name_0">surname:San Norberto;given-names:Garcia EM</infon>
      <infon key="fpage">940</infon>
      <infon key="issue">7</infon>
      <infon key="pub-id_pmid">23993109</infon>
      <infon key="year">2013</infon>
      <infon key="source">Ann Vasc Surg</infon>
      <infon key="type">ref</infon>
      <infon key="volume">27</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">946</infon>
      <infon key="name_4">surname:Vaquero;given-names:C</infon>
      <offset>18687</offset>
      <text>Low-molecular-weight heparin for prevention of venous thromboembolism after varicose veinsurgery in moderate-risk patients: a randomized, controlled trial</text>
      <annotation id="339">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18801" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="340">
        <infon key="identifier">MESH:D054556</infon>
        <infon key="type">Disease</infon>
        <location offset="18734" length="22"/>
        <text>venous thromboembolism</text>
      </annotation>
      <annotation id="341">
        <infon key="identifier">MESH:D006493</infon>
        <infon key="type">Chemical</infon>
        <location offset="18708" length="7"/>
        <text>heparin</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Christie;given-names:RA</infon>
      <infon key="name_2">surname:Hill;given-names:GB</infon>
      <infon key="name_1">surname:Chai;given-names:J</infon>
      <infon key="name_0">surname:Van Rij;given-names:AM</infon>
      <infon key="fpage">1582</infon>
      <infon key="issue">12</infon>
      <infon key="pub-id_pmid">15386324</infon>
      <infon key="year">2004</infon>
      <infon key="source">Br J Surg</infon>
      <infon key="type">ref</infon>
      <infon key="volume">91</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1585</infon>
      <offset>18842</offset>
      <text>Incidence of deep vein thrombosis after varicose vein surgery</text>
      <annotation id="343">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="18855" length="20"/>
        <text>deep vein thrombosis</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272833</id>
    <passage>
      <infon key="name_3">surname:Spahovic;given-names:Hajrudin</infon>
      <infon key="name_2">surname:Avdagic;given-names:Edin</infon>
      <infon key="name_1">surname:Schefe;given-names:L.</infon>
      <infon key="article-id_pmid">25568577</infon>
      <infon key="name_0">surname:Jaganjac;given-names:Suad</infon>
      <infon key="fpage">302</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272833</infon>
      <infon key="article-id_publisher-id">AIM-22-302</infon>
      <infon key="article-id_doi">10.5455/aim.2014.22.302-305</infon>
      <infon key="type">front</infon>
      <infon key="volume">22</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Acta Inform Med; 2014 Oct; 22(5) 302-5. doi:10.5455/aim.2014.22.302-305</infon>
      <infon key="kwd">kidney preoperative tumor embolization</infon>
      <infon key="lpage">305</infon>
      <infon key="name_4">surname:Hiros;given-names:Mustafa</infon>
      <infon key="authors">Jaganjac S, Schefe L, Avdagi&#196;&#135; E, Spahovi&#196;&#135; H, Hiros M</infon>
      <offset>0</offset>
      <text>Preoperative Kidney Tumor Embolization as Procedure for Therapy of Advanced Kidney Cancer</text>
      <annotation id="2">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="13" length="12"/>
        <text>Kidney Tumor</text>
      </annotation>
      <annotation id="3">
        <infon key="identifier">MESH:D007680</infon>
        <infon key="type">Disease</infon>
        <location offset="67" length="22"/>
        <text>Advanced Kidney Cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>90</offset>
      <text>ABSTRACT</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>99</offset>
      <text>Introduction:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>113</offset>
      <text>Preoperative kidney tumor embolization is standard procedure for therapy in advanced kidney cancer. Preoperative embolization has a goal to reduce intraoperative bleeding and also to shorten the time of surgery.</text>
      <annotation id="7">
        <infon key="identifier">MESH:D016063</infon>
        <infon key="type">Disease</infon>
        <location offset="260" length="23"/>
        <text>intraoperative bleeding</text>
      </annotation>
      <annotation id="8">
        <infon key="identifier">MESH:D007680</infon>
        <infon key="type">Disease</infon>
        <location offset="198" length="13"/>
        <text>kidney cancer</text>
      </annotation>
      <annotation id="9">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="126" length="12"/>
        <text>kidney tumor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>325</offset>
      <text>Materials and methods:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>348</offset>
      <text>We retrospectively observed 50 patients between 2000-2011, in which the preoperative embolization was performed. Mean age of patients was 64 years. All patients with preoperative embolization were compared with the group of 51 patients from Urology Sarajevo, who underwent nephrectomy without preoperative embolization.</text>
      <annotation id="14">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="379" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="15">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="473" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="16">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="500" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="17">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="575" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>668</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>677</offset>
      <text>Symptoms that are dominating among patients were haematuria and pain. Analysis of mean size of tumors based on CT evaluation showed statistically significance in between the biggest size of tumors in group from Hamburg (9.11+-3cm) and the smallest size of tumors in Sarajevo group (4.94+-1.6cm) p=0.0001. Reason for this is difference in selection of patients for treatment in Hamburg from Sarajevo.</text>
      <annotation id="25">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="712" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="26">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1028" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="867" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="28">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="772" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="29">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="933" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="30">
        <infon key="identifier">MESH:D006417</infon>
        <infon key="type">Disease</infon>
        <location offset="726" length="10"/>
        <text>haematuria</text>
      </annotation>
      <annotation id="31">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="741" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1077</offset>
      <text>Conclusion</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1088</offset>
      <text>Kidney as functional finishing organ is extremely suitable for transcatheter therapeutic procedures. The gold standard in the treatment of advanced and metastatic tumor is the nephrectomy. As preparation for nephrectomy in metastatic cancer total capillary embolization is performed. After embolization, surgery is shorter, procedure can be done 24-48 hours after embolization or delayed nephrectomy done 2-3 weeks after the intervention.</text>
      <annotation id="34">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="1251" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="1322" length="6"/>
        <text>cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1527</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1543</offset>
      <text>Kidney cancer is the most common kidney tumor and the third one by the frequency in urology. Comparing to other malignancy, 2% of all tumors is the kidney cancer. In end stage kidney cancer therapy of choice is radically nephrectomy, which means and adrenalectomy with removing fat kidney capsule and proximal urethra.</text>
      <annotation id="42">
        <infon key="identifier">MESH:D007676</infon>
        <infon key="type">Disease</infon>
        <location offset="1709" length="23"/>
        <text>end stage kidney cancer</text>
      </annotation>
      <annotation id="43">
        <infon key="identifier">MESH:D007680</infon>
        <infon key="type">Disease</infon>
        <location offset="1691" length="13"/>
        <text>kidney cancer</text>
      </annotation>
      <annotation id="44">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="1677" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="45">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="1655" length="10"/>
        <text>malignancy</text>
      </annotation>
      <annotation id="46">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="1576" length="12"/>
        <text>kidney tumor</text>
      </annotation>
      <annotation id="47">
        <infon key="identifier">MESH:D007680</infon>
        <infon key="type">Disease</infon>
        <location offset="1543" length="13"/>
        <text>Kidney cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1862</offset>
      <text>Kidney tumor embolization is the standard procedure in therapy of kidney cancer, due to embolization whole kidney or its parts should be exclude from the function. First experimental embolization was performed by lang in 1971. He used radioactive particles to induce tumor necrosis. On humans, first embolization was performed in 1973, by Almagard. From that time the technique has been changed a lot, also diagnostic procedures for detecting the tumors were fulfilled with CT and MRI. In the same time the new operative techniques were introduced laparoscopic nephrectomy, organoprotective resection and extracorporal Work-Bench procedures.</text>
      <annotation id="53">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2148" length="6"/>
        <text>humans</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="1862" length="12"/>
        <text>Kidney tumor</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="2309" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="56">
        <infon key="identifier">MESH:D007680</infon>
        <infon key="type">Disease</infon>
        <location offset="1928" length="13"/>
        <text>kidney cancer</text>
      </annotation>
      <annotation id="57">
        <infon key="identifier">MESH:D009336</infon>
        <infon key="type">Disease</infon>
        <location offset="2129" length="14"/>
        <text>tumor necrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2504</offset>
      <text>Preoperative tumor embolization is performed in patients with:</text>
      <annotation id="60">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2552" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="61">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="2517" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2567</offset>
      <text>Advanced stage of tumor</text>
      <annotation id="63">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="2585" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2591</offset>
      <text>Tumor rich in retroperitoneal collateralize</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2635</offset>
      <text>Infiltration of venous system</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2665</offset>
      <text>Tumor in close range of kidney hillus</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2703</offset>
      <text>Metastatic tumors and</text>
      <annotation id="65">
        <infon key="identifier">MESH:C538445</infon>
        <infon key="type">Disease</infon>
        <location offset="2703" length="17"/>
        <text>Metastatic tumors</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2725</offset>
      <text>Patients who are not treatable to become treatable.</text>
      <annotation id="67">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2725" length="8"/>
        <text>Patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2777</offset>
      <text>Preoperative embolization has the goal to reduce intraoperative bleeding and to reduce the time of surgical procedure, by making preparation of tumor easier. This is particularly important for T3 and T4 tumors, with infiltration of renal vein and vena cava inferior.</text>
      <annotation id="72">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="2921" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="2993" length="26"/>
        <text>infiltration of renal vein</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">MESH:D016063</infon>
        <infon key="type">Disease</infon>
        <location offset="2826" length="23"/>
        <text>intraoperative bleeding</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="2980" length="6"/>
        <text>tumors</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>3044</offset>
      <text>2. MATERIALS AND METHODS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>3069</offset>
      <text>We retrospectively observed 50 patients between 2000-2011, in which the preoperative embolization was performed. The majority of patients were treated in Eilbek Clinic in Hamburg and few in Clinical Center Sarajevo. Mean age of patients was 64 years, range between 3 and 86 years. 19 patients were female and 31 patients were male. Patients that were enrolled on study were the patients with the tumor larger than 8cm on the upper pole of left kidney, and patients wit proven bilateral kidney tumor.</text>
      <annotation id="86">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3100" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="87">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3198" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="88">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3297" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="89">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3353" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="90">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3381" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="91">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3401" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="92">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3447" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="93">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3525" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="94">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="3465" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="95">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="3555" length="12"/>
        <text>kidney tumor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>3569</offset>
      <text>Patients that were excluded from study were the patients with tumor smaller than 8cm, if the tumor was good for surgical procedure. Embolised patient were compared with the group of 51 patients from Urology Clinic Sarajevo, which were performed surgical nephrectomy without embolization. This group has been concised from 19 female and 32 male. Mean age was 61 years, range between 32 and 80 years. The total number of patients was 101. Patients were diagnosed with CT or MRI, as outpatients and small amount of patients we diagnosed in our Institution (CT siemens Somatom duo and MRI Unit 1.5T Symphonie).</text>
      <annotation id="105">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3569" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="106">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3617" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="107">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3711" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="108">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3754" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="109">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3988" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="110">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4006" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="111">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4081" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="112">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="3662" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="113">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="3631" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4176</offset>
      <text>Conventional angiography was performed on Siemens Polystar, 2 frames/sec. Angiography was performed by Seldinger technique, with contrast agent Xenetix 300. Angiography was performed to determine the blood supply of tumors in attacked kidney; we performed first aortography followed by selective angiography of renal arteries. Once done selective angiography, we approached embolization. Embolization is done first on the capillary level. As embolization material at the capillary level in the course of the study we used alcohol or Ivalon 150-250 mu particles. Alcohol is the cheapest and most efficient means of embolization. The disadvantage is that alcohol is the only means of embolization during one embolization must be applied in a blocked blood vessel in order to prevent reflux. We used 96% alcohol. In some patients inhibit the supply vessel is impossible, and then we performed a combined embolization with alcohol and Ivalon or just Ivalon particle embolization. The advantage in using Ivalon that supply blood vessel may not be blocked. Upon completion of the capillary embolization, we performed control angiography, and if the tumor / kidney is embolised we performed the central embolization of supply vessel with metal spirals. In the course of the study, Tornado spirals (COOK) were used. After that is done aortography to confirm complete embolization and showed situation surrounding blood vessels that were not aimed by embolization.</text>
      <annotation id="125">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4994" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="126">
        <infon key="identifier">MESH:C026699</infon>
        <infon key="type">Chemical</infon>
        <location offset="5107" length="6"/>
        <text>Ivalon</text>
      </annotation>
      <annotation id="127">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="4977" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="128">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="4738" length="7"/>
        <text>Alcohol</text>
      </annotation>
      <annotation id="129">
        <infon key="identifier">MESH:C026699</infon>
        <infon key="type">Chemical</infon>
        <location offset="4709" length="6"/>
        <text>Ivalon</text>
      </annotation>
      <annotation id="130">
        <infon key="identifier">MESH:C026699</infon>
        <infon key="type">Chemical</infon>
        <location offset="5122" length="6"/>
        <text>Ivalon</text>
      </annotation>
      <annotation id="131">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="5095" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="132">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="4392" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="4698" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="134">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="4829" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="5319" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5632</offset>
      <text>Besides angiographies findings, we were processed operating protocols and protocols of anesthesia. To test the existence of the correlation between the groups for each parameter was used Pearson correlation test. In all tests of statistical significance was considered at p &lt;0.05 or at the level of 95%. All data were analyzed using statistical software SPSS version 13.0 for Windows, while the resulting tables and graphs subsequently processed using Microsoft Word 2003.</text>
      <annotation id="137">
        <infon key="identifier">MESH:D008569</infon>
        <infon key="type">Disease</infon>
        <location offset="6094" length="4"/>
        <text>Word</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>6105</offset>
      <text>3. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6116</offset>
      <text>Symptomatology that led the patient's physician is shown in Figure 1 and 2. A small number of patients reported the loss of body weight, 11 patients from the Hamburg group (H) and 7 patients in the Sarajevo group (S). Infiltration of the kidney hollow system has been registered with 5 (H) patients and in 7 (S) patients. Infiltration of veins, tumor thrombus was found in a total of 16 patients (10 H and 6 S) and the infiltration of adjacent organs was found in 15 patients (8 H 7 and S). AV-shunt was diagnosed in only one patient at Hamburg group. Analysis of the average size of the tumor based on CT findings showed a statistically significant difference in terms of the maximum average size of tumors in patients from Hamburg (9.11 +- 3 cm) and minimum size in patients in Sarajevo (4.94 +- 1.6 cm), p = 0.0001. The reason for this is in the selection of patients in Hamburg preoperative group compared to Sarajevo operative group. The presence of metastases in regional lymph nodes showed statistically significant differences between groups p = 0.030. It is evident that the invasion of local lymph nodes at least recorded in patients in Sarajevo (7.8%), and patients from Hamburg (22%). Distant metastases were found in 4 (H) and in 2 (S) patients.</text>
      <annotation id="158">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6144" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="159">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6210" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="160">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6256" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="161">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6298" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6406" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6428" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6503" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6583" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="166">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6642" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="167">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6827" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="168">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6884" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="169">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6978" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="170">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7251" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="171">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7284" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="172">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7365" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="173">
        <infon key="identifier">MESH:D009362</infon>
        <infon key="type">Disease</infon>
        <location offset="7321" length="10"/>
        <text>metastases</text>
      </annotation>
      <annotation id="174">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="6817" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="6704" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="176">
        <infon key="identifier">MESH:D013927</infon>
        <infon key="type">Disease</infon>
        <location offset="6461" length="14"/>
        <text>tumor thrombus</text>
      </annotation>
      <annotation id="177">
        <infon key="identifier">MESH:D009362</infon>
        <infon key="type">Disease</infon>
        <location offset="7071" length="10"/>
        <text>metastases</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-302-g001.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>7375</offset>
      <text>Number cases of Haematuria in our sample</text>
      <annotation id="179">
        <infon key="identifier">MESH:D006417</infon>
        <infon key="type">Disease</infon>
        <location offset="7391" length="10"/>
        <text>Haematuria</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-302-g002.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption</infon>
      <offset>7416</offset>
      <text>Presence of pain in our patients</text>
      <annotation id="181">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="7428" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7449</offset>
      <text>Embolization was repeated in two patients. Patohistological classification is shown in Figure 3.</text>
      <annotation id="183">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7482" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-302-g003.jpg</infon>
      <infon key="id">F3</infon>
      <infon key="type">fig_caption</infon>
      <offset>7546</offset>
      <text>Pathohistological classifi cation</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7580</offset>
      <text>The most common t stage was pT3a with 28% (H) and pT1a (S), and the least represented pT4 and pT2 with 6% in the Hamburg group and pT4 in Sarajevo group with 2%.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7742</offset>
      <text>Histological determination of tumor size confirms previous statement on CT tumor size that the same was higher in patients from Hamburg (8.2 +- 3.4 cm), compared to patients in Sarajevo (3.89 +- 1.5 cm). Analysis of variance also showed statistically significant differences p = 0.0001 in favor of more specific histopatological tumor size in patients from Hamburg.</text>
      <annotation id="190">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7856" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="191">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7907" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="192">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8085" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="193">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="8071" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="194">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="7772" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="195">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="7817" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8108</offset>
      <text>The average length of surgery was very similar and it was 105.6 +- 23 minutes in patients from Hamburg, and 101.4 +- 38 minutes in patients in Sarajevo. Minimum duration of the procedure was recorded in Sarajevo on 45 minutes, which was recorded as well as the maximum duration of treatment of 195 minutes. There were no statistically significant differences. The Hamburg group's surgery was done on average 23 days after embolization. Blood transfusion during and after surgery are shown in Table 1. With statistical significance, the difference can be seen that the operations carried out in Sarajevo was used more units of blood during the same. Figure 4 presents the case of preoperative embolization, which was done in so called sandwich-technique alcohol mixed with lipiodol and Ivalon particle. Central occlusion was performed with Tornado spirals.</text>
      <annotation id="202">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8189" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="203">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8239" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="204">
        <infon key="identifier">MESH:C026699</infon>
        <infon key="type">Chemical</infon>
        <location offset="8893" length="6"/>
        <text>Ivalon</text>
      </annotation>
      <annotation id="205">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="8861" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="206">
        <infon key="identifier">MESH:D004998</infon>
        <infon key="type">Chemical</infon>
        <location offset="8880" length="8"/>
        <text>lipiodol</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">MESH:D015356</infon>
        <infon key="type">Disease</infon>
        <location offset="8910" length="17"/>
        <text>Central occlusion</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>8964</offset>
      <text>Blood transfusion intra-post op. chi2=5,492, p=0,040</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-302-g005.jpg</infon>
      <infon key="id">F4</infon>
      <infon key="type">fig_caption</infon>
      <offset>9017</offset>
      <text>a), b) present angiographic findings of kidney tumor; c) and d) present angiographic findings after embolisation.</text>
      <annotation id="209">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="9057" length="12"/>
        <text>kidney tumor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>9131</offset>
      <text>4. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9145</offset>
      <text>Treatment of choice for kidney cancer is surgical resection. In early stage of TU and with favorable localization is sufficient to perform enucleation or partially nephrectomy, and in advanced disease should be done radical nephrectomy.</text>
      <annotation id="211">
        <infon key="identifier">MESH:D007680</infon>
        <infon key="type">Disease</infon>
        <location offset="9169" length="13"/>
        <text>kidney cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9382</offset>
      <text>By age, group of our patients who were preoperatively embolised, was very heterogeneous. We performed one embolization of Wilms tumor. Wilms tumor occurs at the age of 2-4 years. After 10 years of appearing less frequently. In addition to Wilms tumor in children is possible occurrence of renal cancer. Incidence of 3- 6%.</text>
      <annotation id="218">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9403" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9636" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="220">
        <infon key="identifier">MESH:D009396</infon>
        <infon key="type">Disease</infon>
        <location offset="9621" length="11"/>
        <text>Wilms tumor</text>
      </annotation>
      <annotation id="221">
        <infon key="identifier">MESH:D009396</infon>
        <infon key="type">Disease</infon>
        <location offset="9504" length="11"/>
        <text>Wilms tumor</text>
      </annotation>
      <annotation id="222">
        <infon key="identifier">MESH:D007680</infon>
        <infon key="type">Disease</infon>
        <location offset="9671" length="12"/>
        <text>renal cancer</text>
      </annotation>
      <annotation id="223">
        <infon key="identifier">MESH:D009396</infon>
        <infon key="type">Disease</infon>
        <location offset="9517" length="11"/>
        <text>Wilms tumor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9705</offset>
      <text>Reasons for blood loss during nephrectomy are: hypervascularisation of tumor, atypical blood vessels and hilar lymph nodes that hamper visibility of blood vessels.</text>
      <annotation id="226">
        <infon key="identifier">MESH:D006473</infon>
        <infon key="type">Disease</infon>
        <location offset="9717" length="10"/>
        <text>blood loss</text>
      </annotation>
      <annotation id="227">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="9776" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9869</offset>
      <text>For decisive loss of blood atypical blood vessels are the main reason, which are often fulfilled with the blood. In violation of these vascular structures, Intraoperative bleeding is abundant because these vessels are less contractile. Another disadvantage is that these blood vessels are retroperitoneal positioned which makes preparation of large tumors very difficulty. With preoperative embolization, we have to occlude not only renal artery and capillary circulation, but must be able to occlude all atypical arteries to reduce blood loss to a minimum.</text>
      <annotation id="231">
        <infon key="identifier">MESH:D016063</infon>
        <infon key="type">Disease</infon>
        <location offset="10025" length="23"/>
        <text>Intraoperative bleeding</text>
      </annotation>
      <annotation id="232">
        <infon key="identifier">MESH:D006473</infon>
        <infon key="type">Disease</infon>
        <location offset="10402" length="10"/>
        <text>blood loss</text>
      </annotation>
      <annotation id="233">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="10218" length="6"/>
        <text>tumors</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10427</offset>
      <text>Craven study showed minimal blood loss in delayed nephrectomy after embolization even with advanced stages of cancer with vascularized thrombus in the inferior vena cava. Delayed nephrectomy stimulates tumor regression as well as venous thrombosis, which significantly facilitates op procedure. In our group's average delay was 23 days. Some authors recommend a delay of less than 48 hours between embolization and surgery because postinfarctus syndromes do not develop fully. The same authors as Lanigian et al. suggest that a longer interval between embolization and surgery lead to the development of collateral that hamper preparation. These data from the literature do not agree with our experience. In most of our patients, we performed delayed nephrectomy. In these patients, there was no collateral development in the periphery.</text>
      <annotation id="240">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11147" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="241">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11200" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="242">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="10537" length="6"/>
        <text>cancer</text>
      </annotation>
      <annotation id="243">
        <infon key="identifier">MESH:D020246</infon>
        <infon key="type">Disease</infon>
        <location offset="10657" length="17"/>
        <text>venous thrombosis</text>
      </annotation>
      <annotation id="244">
        <infon key="identifier">MESH:D006473</infon>
        <infon key="type">Disease</infon>
        <location offset="10455" length="10"/>
        <text>blood loss</text>
      </annotation>
      <annotation id="245">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="10629" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11264</offset>
      <text>Our first embolization we performed only with the alcohol, in 96%. Alcohol is very potent and very cheap embolisaton material. If it is used in combination with distal balloon occlusion, the rate of complications such as migration is very low. Alcohol is very powerful embolization material, and destruction of capillary system is very powerful, better than any other embolization material. Destruction of capillary system lead to tumor necrosis. Tolle and Cramer performed 20 embolisations with very low rate of the complications. Those authors claim that alcohol is very safe to use, and percent of recanalization is almost zero. We also performed majority of our embolisations with same techniques. The volume of alcohol that we used was determined for every patient individually. After balloon occlusion, angiography was performed. The volume of contrast material that was necessary for demarcation of whole kidney is the volume of alcohol that we used. Occlusion was performed 40 minutes after alcohol injection. In our study the rate of complication was zero. With lack of occlusion catheters we abandoned this technique. Some authors reported severe complications after alcohol embolization. Laarmann at all. reported two cases of testicular damage, as reason of anatomical variation where art. testiculariswas the branch of renal artery. Same group of authors performed alcohol embolization in 44 patients with no distal balloon occlusion. The volume of alcohol that was used was 14-22ml. Timmerman performed capillary embolization in combination of alcohol and Etiblock.</text>
      <annotation id="265">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12026" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="266">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12669" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="267">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="12263" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="268">
        <infon key="identifier">MESH:D054549</infon>
        <infon key="type">Disease</infon>
        <location offset="11432" length="17"/>
        <text>balloon occlusion</text>
      </annotation>
      <annotation id="269">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="12834" length="8"/>
        <text>Etiblock</text>
      </annotation>
      <annotation id="270">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="12441" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="271">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="11508" length="7"/>
        <text>Alcohol</text>
      </annotation>
      <annotation id="272">
        <infon key="identifier">MESH:D054549</infon>
        <infon key="type">Disease</infon>
        <location offset="12054" length="17"/>
        <text>balloon occlusion</text>
      </annotation>
      <annotation id="273">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="11331" length="7"/>
        <text>Alcohol</text>
      </annotation>
      <annotation id="274">
        <infon key="identifier">MESH:D009336</infon>
        <infon key="type">Disease</infon>
        <location offset="11695" length="14"/>
        <text>tumor necrosis</text>
      </annotation>
      <annotation id="275">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="12822" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="276">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="11980" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="277">
        <infon key="identifier">MESH:D054549</infon>
        <infon key="type">Disease</infon>
        <location offset="12693" length="17"/>
        <text>balloon occlusion</text>
      </annotation>
      <annotation id="278">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="12726" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="279">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="11314" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="280">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="11821" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="281">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="12642" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="282">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="12200" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="283">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="12586" length="22"/>
        <text>branch of renal artery</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12845</offset>
      <text>Several publications confirmed severe complications after alcohol embolization, so the use of alcohol was diminished and Etiblock was introduced as main embolization material. Initial results with Etiblock determined vasospasm after its use, so results were incomplete embolization. After another embolization materials were introduced, such as Ivalon 150-250 microns. Ivalon embolization does not need use of occlusion balloons, and application is very simple over microcatheter. Ivalon also has very good X ray visibility. In our series we had two case of recanalization after Ivalon embolization, so embolization had to be repeated. After this we started with so called sandwich embolization technique alcohol and Ivalon particles 150-250 microns. Central embolization was performed with Tornado colils. We had no complication with these technique.</text>
      <annotation id="291">
        <infon key="identifier">MESH:C026699</infon>
        <infon key="type">Chemical</infon>
        <location offset="13562" length="6"/>
        <text>Ivalon</text>
      </annotation>
      <annotation id="292">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="13550" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="293">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="12939" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="294">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="12903" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="295">
        <infon key="identifier">MESH:D020301</infon>
        <infon key="type">Disease</infon>
        <location offset="13062" length="9"/>
        <text>vasospasm</text>
      </annotation>
      <annotation id="296">
        <infon key="identifier">MESH:D054549</infon>
        <infon key="type">Disease</infon>
        <location offset="13255" length="18"/>
        <text>occlusion balloons</text>
      </annotation>
      <annotation id="297">
        <infon key="identifier">MESH:C026699</infon>
        <infon key="type">Chemical</infon>
        <location offset="13190" length="6"/>
        <text>Ivalon</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13697</offset>
      <text>With preoperative embolization there is significant reduce of blood transfusion during surgery, comparing to patients with no embolization. Volume of blood in group of embolised patients was around 250ml, and in group of non embolised patients was around 800ml.</text>
      <annotation id="301">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13806" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="302">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13875" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="303">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13932" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13959</offset>
      <text>Zielinski et al. in their work compare rate of surveillance of five and ten years between group of 118 patients that were embolised and group of 116 patients with no embolization prior to surgery. The both groups had same demographics. Five and ten year's surveillance was statistically significant in first group 62%, and in the second group 35%.</text>
      <annotation id="306">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14062" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="307">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14108" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>14307</offset>
      <text>Kauffmann in his work showed reduction of blood loss during surgery in the group of patients preoperatively embolised. Vogel et al. published the same results as Kauffmann with loss of blood of 600ml in patients that were preoperatively embolised. Embolization was performed with 2-6ml Histoacril mixed with 50 % Lipiodol. Danish group of authors with Christensen published that they had smaller loss of blood during surgery in group of patients who were embolised prior to surgery, and the time of surgery was shorter, comparing with the group of patients with no embolization prior to surgery. Embolization was performed only with coils. The surgery was performed five days after embolization. Surveillance rate of embolised patients was better than in patients with no embolization.</text>
      <annotation id="317">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14391" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="318">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14510" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="319">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14744" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="320">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14855" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="321">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15034" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="322">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15062" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="323">
        <infon key="identifier">MESH:D006473</infon>
        <infon key="type">Disease</infon>
        <location offset="14336" length="23"/>
        <text>reduction of blood loss</text>
      </annotation>
      <annotation id="324">
        <infon key="identifier">MESH:D004998</infon>
        <infon key="type">Chemical</infon>
        <location offset="14620" length="8"/>
        <text>Lipiodol</text>
      </annotation>
      <annotation id="325">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="14593" length="10"/>
        <text>Histoacril</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>15093</offset>
      <text>Stosslein at all. published that blood volume loss during surgery was in average 300ml. They had 92 patients. There were no significant shortening it time of surgery between two groups of patients. Surveillance rate was much higher in group of patient with embolization than in another group.</text>
      <annotation id="329">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15193" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="330">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15281" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="331">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15337" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>15387</offset>
      <text>Latal at all published that there were no statistically significance in surveillance rate between patients who were embolised prior to surgery comparing with patients who had only surgical nephrectomy.</text>
      <annotation id="334">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15485" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="335">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15545" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>15589</offset>
      <text>5. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>15603</offset>
      <text>Kidney cancer is the rare tumor considering other malignancies. Kidney as the organ is very suitable for all transcatheter procedures as for percutaneous procedures. The gold standard for treatment of kidney cancer in advanced stage is surgical procedure with nephrectomy, and for small tumor is enucleation of tumor. Full capillary embolization is method of choice to prepare surgical nephrectomy. The most potent embolization material is alcohol, but its is the most dangerous one. Because of that, alcohol should be administered over the occlusion or in small portions with conjunction of Lipiodol to be visible. The goal of this embolization is to make surgical procedure easier, thru less bleeding during the surgical procedure. On other goal is to make surgery less time consuming. The surgery can be made 24-48 h after the embolization, or it can be made as late nephrectomy after 2-3 weeks. Some percent of patients who were inoperable before the embolization, become operative after the procedure. It is a fact that the cost of treatment of those patients are bigger than with patients who are treated only with the surgery.</text>
      <annotation id="349">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16518" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="350">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16659" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="351">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16689" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="352">
        <infon key="identifier">MESH:D007680</infon>
        <infon key="type">Disease</infon>
        <location offset="15603" length="13"/>
        <text>Kidney cancer</text>
      </annotation>
      <annotation id="353">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="15914" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="354">
        <infon key="identifier">MESH:D007680</infon>
        <infon key="type">Disease</infon>
        <location offset="15804" length="13"/>
        <text>kidney cancer</text>
      </annotation>
      <annotation id="355">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="16297" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="356">
        <infon key="identifier">MESH:D058405</infon>
        <infon key="type">Disease</infon>
        <location offset="15884" length="11"/>
        <text>small tumor</text>
      </annotation>
      <annotation id="357">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="15653" length="12"/>
        <text>malignancies</text>
      </annotation>
      <annotation id="358">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="16104" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="359">
        <infon key="identifier">MESH:D000438</infon>
        <infon key="type">Chemical</infon>
        <location offset="16043" length="7"/>
        <text>alcohol</text>
      </annotation>
      <annotation id="360">
        <infon key="identifier">MESH:D004998</infon>
        <infon key="type">Chemical</infon>
        <location offset="16195" length="8"/>
        <text>Lipiodol</text>
      </annotation>
      <annotation id="361">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="15629" length="5"/>
        <text>tumor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>16737</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>16774</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Becker;given-names:N</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Holzheimer;given-names:S</infon>
      <infon key="year">1998</infon>
      <infon key="type">ref</infon>
      <offset>16785</offset>
      <text>Krebsatlas</text>
    </passage>
    <passage>
      <infon key="volume">98</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Lang;given-names:EK</infon>
      <infon key="fpage">391</infon>
      <infon key="pub-id_pmid">5541057</infon>
      <infon key="year">1971</infon>
      <infon key="source">Radiology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">399</infon>
      <offset>16796</offset>
      <text>Superselective arterial catheterization as a vehicle for delivering radioactive infarct particles to tumors</text>
      <annotation id="364">
        <infon key="identifier">MESH:D007238</infon>
        <infon key="type">Disease</infon>
        <location offset="16876" length="7"/>
        <text>infarct</text>
      </annotation>
      <annotation id="365">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="16897" length="6"/>
        <text>tumors</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">45</infon>
      <infon key="name_2">surname:Haverling;given-names:M</infon>
      <infon key="name_1">surname:Fernstrom;given-names:I</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Almgard;given-names:LE</infon>
      <infon key="fpage">474</infon>
      <infon key="pub-id_pmid">4748393</infon>
      <infon key="year">1973</infon>
      <infon key="source">Br J Urol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">479</infon>
      <offset>16904</offset>
      <text>Treatment of renal adenocarcinoma by embolic occlusion of the renal circulation</text>
      <annotation id="367">
        <infon key="identifier">MESH:C538614</infon>
        <infon key="type">Disease</infon>
        <location offset="16917" length="66"/>
        <text>renal adenocarcinoma by embolic occlusion of the renal circulation</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">39</infon>
      <infon key="name_2">surname:Aretz;given-names:K</infon>
      <infon key="name_1">surname:Hallscheidt;given-names:P</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hansmann;given-names:HJ</infon>
      <infon key="fpage">783</infon>
      <infon key="pub-id_pmid">10525637</infon>
      <infon key="year">1999</infon>
      <infon key="source">Radiologe</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">789</infon>
      <offset>16984</offset>
      <text>Nierentumoremboisation</text>
    </passage>
    <passage>
      <infon key="volume">162</infon>
      <infon key="name_2">surname:Takeda;given-names:M</infon>
      <infon key="name_1">surname:Nakai;given-names:H</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Asanuma;given-names:H</infon>
      <infon key="fpage">1402</infon>
      <infon key="pub-id_pmid">10492224</infon>
      <infon key="year">1999</infon>
      <infon key="source">J Urol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1405</infon>
      <offset>17007</offset>
      <text>Renal cell carcinoma in children: experience at a single institution in Japan</text>
      <annotation id="370">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17031" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="371">
        <infon key="identifier">MESH:C538614</infon>
        <infon key="type">Disease</infon>
        <location offset="17007" length="20"/>
        <text>Renal cell carcinoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">155</infon>
      <infon key="name_2">surname:Stewart;given-names:T</infon>
      <infon key="name_1">surname:Vates;given-names:TS</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Freedman;given-names:AL</infon>
      <infon key="fpage">1708</infon>
      <infon key="pub-id_pmid">8627866</infon>
      <infon key="year">1996</infon>
      <infon key="source">J Urol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1710</infon>
      <offset>17085</offset>
      <text>Renal cell carcinoma in children: the Detroit experience</text>
      <annotation id="374">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17109" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="375">
        <infon key="identifier">MESH:C538614</infon>
        <infon key="type">Disease</infon>
        <location offset="17085" length="20"/>
        <text>Renal cell carcinoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Rubben;given-names:H</infon>
      <infon key="volume">5</infon>
      <infon key="name_2">surname:Rubben;given-names:H</infon>
      <infon key="name_1">surname:Goeppel;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hawers;given-names:W</infon>
      <infon key="fpage">568</infon>
      <infon key="year">2001</infon>
      <infon key="source">(Hrsg) Uroonkologie</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">587</infon>
      <offset>17142</offset>
      <text>Nephroblastom</text>
    </passage>
    <passage>
      <infon key="volume">42</infon>
      <infon key="name_2">surname:Stumpfl;given-names:M</infon>
      <infon key="name_1">surname:Gravou;given-names:C</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Ebert;given-names:A</infon>
      <infon key="fpage">263</infon>
      <infon key="pub-id_pmid">12733509</infon>
      <infon key="year">2003</infon>
      <infon key="source">Urologe A</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">268</infon>
      <offset>17156</offset>
      <text>Das Nierenzellkarzinom im Kindesalter</text>
    </passage>
    <passage>
      <infon key="volume">17</infon>
      <infon key="name_2">surname:Belgrano;given-names:E</infon>
      <infon key="name_1">surname:Carmignani;given-names:G</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Giuliani;given-names:L</infon>
      <infon key="fpage">431</infon>
      <infon key="pub-id_pmid">7233655</infon>
      <infon key="year">1981</infon>
      <infon key="source">Urology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">434</infon>
      <offset>17194</offset>
      <text>Usefulness of preopertive transcatheter embolisaton in kidney tumors</text>
      <annotation id="377">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="17234" length="28"/>
        <text>embolisaton in kidney tumors</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">146</infon>
      <infon key="name_2">surname:Mendez;given-names:R</infon>
      <infon key="name_1">surname:Choop;given-names:RT</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Singsaas;given-names:MW</infon>
      <infon key="fpage">704</infon>
      <infon key="year">1979</infon>
      <infon key="source">Urology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">708</infon>
      <offset>17263</offset>
      <text>Preopertive renal embolization as adjunct to radical Nephrectomy</text>
      <annotation id="379">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="17263" length="30"/>
        <text>Preopertive renal embolization</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">146</infon>
      <infon key="name_2">surname:Kumpe;given-names:DA</infon>
      <infon key="name_1">surname:Redmond;given-names:Pl</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Craven;given-names:WM</infon>
      <infon key="fpage">704</infon>
      <infon key="pub-id_pmid">1875477</infon>
      <infon key="year">1991</infon>
      <infon key="source">J Urol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">708</infon>
      <offset>17328</offset>
      <text>Planned delayed nephrectomy after ethanol embolization of renal carcinoma</text>
      <annotation id="382">
        <infon key="identifier">MESH:C538614</infon>
        <infon key="type">Disease</infon>
        <location offset="17386" length="15"/>
        <text>renal carcinoma</text>
      </annotation>
      <annotation id="383">
        <infon key="identifier">MESH:D000431</infon>
        <infon key="type">Chemical</infon>
        <location offset="17362" length="7"/>
        <text>ethanol</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">33</infon>
      <infon key="name_1">surname:Varenhorst;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kalman;given-names:D</infon>
      <infon key="fpage">162</infon>
      <infon key="pub-id_pmid">10452291</infon>
      <infon key="year">1999</infon>
      <infon key="source">Scand J Urol Nephrol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">170</infon>
      <offset>17402</offset>
      <text>The role of arterial embolization in renal cell carcinoma</text>
      <annotation id="385">
        <infon key="identifier">MESH:C538614</infon>
        <infon key="type">Disease</infon>
        <location offset="17439" length="20"/>
        <text>renal cell carcinoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">46</infon>
      <infon key="name_2">surname:Hammonds;given-names:JC</infon>
      <infon key="name_1">surname:Jurrians;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Lanigan;given-names:D</infon>
      <infon key="fpage">176</infon>
      <infon key="pub-id_pmid">1395422</infon>
      <infon key="year">1992</infon>
      <infon key="source">Clin Radiol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">178</infon>
      <offset>17460</offset>
      <text>The current status of embolization in renal cell carcinoma - a survey of local and national practice</text>
      <annotation id="387">
        <infon key="identifier">MESH:C538614</infon>
        <infon key="type">Disease</infon>
        <location offset="17498" length="20"/>
        <text>renal cell carcinoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">22</infon>
      <infon key="name_1">surname:Cramer;given-names:BM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Tolle;given-names:E</infon>
      <infon key="fpage">208</infon>
      <infon key="pub-id_pmid">6684344</infon>
      <infon key="year">1983</infon>
      <infon key="source">Urologe A</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">212</infon>
      <offset>17561</offset>
      <text>Klinische Erfahrungen mit der arteriellen Embolization von Nierentumoren mit Athanol</text>
      <annotation id="390">
        <infon key="identifier">MESH:D004617</infon>
        <infon key="type">Disease</infon>
        <location offset="17603" length="16"/>
        <text>Embolization von</text>
      </annotation>
      <annotation id="391">
        <infon key="identifier">MESH:D000431</infon>
        <infon key="type">Chemical</infon>
        <location offset="17638" length="7"/>
        <text>Athanol</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">26</infon>
      <infon key="name_2">surname:Timmermann;given-names:J</infon>
      <infon key="name_1">surname:Straube;given-names:W</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Laarmann;given-names:S</infon>
      <infon key="fpage">94</infon>
      <infon key="pub-id_pmid">3590441</infon>
      <infon key="year">1987</infon>
      <infon key="source">Urologe A</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">95</infon>
      <offset>17647</offset>
      <text>Alkoholtoxische Gonadenschadigung durch Alkoholembolisation bei Nierenmalignomen</text>
    </passage>
    <passage>
      <infon key="volume">23</infon>
      <infon key="name_2">surname:Straube;given-names:W</infon>
      <infon key="name_1">surname:Schlake;given-names:W</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Timmermann;given-names:J</infon>
      <infon key="fpage">275</infon>
      <infon key="pub-id_pmid">6542268</infon>
      <infon key="year">1984</infon>
      <infon key="source">Urologe A</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">277</infon>
      <offset>17729</offset>
      <text>Der absolute Alkohol, ein steuerbares Embolisationsmaterial bei Nierentumoren</text>
      <annotation id="394">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="17755" length="11"/>
        <text>steuerbares</text>
      </annotation>
      <annotation id="395">
        <infon key="identifier">MESH:D000431</infon>
        <infon key="type">Chemical</infon>
        <location offset="17742" length="7"/>
        <text>Alkohol</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">24</infon>
      <infon key="name_2">surname:Schlake;given-names:W</infon>
      <infon key="name_1">surname:Straube;given-names:W</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Timmermann;given-names:J</infon>
      <infon key="fpage">260</infon>
      <infon key="pub-id_pmid">2414892</infon>
      <infon key="year">1985</infon>
      <infon key="source">Urologe A</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">263</infon>
      <offset>17807</offset>
      <text>Klinische Beobachtungen bei dem Gefassverschluss des Nierentumors durch absoluten Alkohol</text>
    </passage>
    <passage>
      <infon key="volume">21</infon>
      <infon key="name_2">surname:Schwartmann;given-names:KP</infon>
      <infon key="name_1">surname:Greipel;given-names:V</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Boeminghaus;given-names:F</infon>
      <infon key="fpage">201</infon>
      <infon key="year">1982</infon>
      <infon key="source">Urologie A</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">204</infon>
      <offset>17898</offset>
      <text>Analyse der Langzeitergebnisse nach Nephrektomie wegen Hypernephrom anhand 442 Fallen</text>
      <annotation id="397">
        <infon key="identifier">MESH:D014890</infon>
        <infon key="type">Disease</infon>
        <location offset="17934" length="31"/>
        <text>Nephrektomie wegen Hypernephrom</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">46</infon>
      <infon key="name_2">surname:Hammond's;given-names:JC</infon>
      <infon key="name_1">surname:Jurriaans;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Lanigan;given-names:D</infon>
      <infon key="fpage">176</infon>
      <infon key="pub-id_pmid">1395422</infon>
      <infon key="year">1992</infon>
      <infon key="source">Clinical Radiology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">178</infon>
      <offset>17985</offset>
      <text>The current status of embolization in renal cell carcinoma-a survey of local and national practice</text>
      <annotation id="399">
        <infon key="identifier">MESH:C538614</infon>
        <infon key="type">Disease</infon>
        <location offset="18023" length="20"/>
        <text>renal cell carcinoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">4</infon>
      <infon key="name_2">surname:Lakritz;given-names:PS</infon>
      <infon key="name_1">surname:Cynamon;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bakal;given-names:CW</infon>
      <infon key="fpage">727</infon>
      <infon key="pub-id_pmid">8280991</infon>
      <infon key="year">1993</infon>
      <infon key="source">J Vasc Interv Radiol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">731</infon>
      <offset>18084</offset>
      <text>Value of preoperative renal artery embolization in Reducing blood transfusion requirements during nephrectomy for renal cell carcinoma</text>
      <annotation id="402">
        <infon key="identifier">MESH:C538614</infon>
        <infon key="type">Disease</infon>
        <location offset="18198" length="20"/>
        <text>renal cell carcinoma</text>
      </annotation>
      <annotation id="403">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="18106" length="25"/>
        <text>renal artery embolization</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">33</infon>
      <infon key="name_2">surname:Pomer;given-names:S</infon>
      <infon key="name_1">surname:Dhremer;given-names:I</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Staehler;given-names:G</infon>
      <infon key="fpage">116</infon>
      <infon key="pub-id_pmid">8178405</infon>
      <infon key="year">1994</infon>
      <infon key="source">Urologe A</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">121</infon>
      <offset>18219</offset>
      <text>Tumorbefall der Vena cava beim Nierenzellkarzinom. Operationstechnik, Ergebnisse und Prognose</text>
    </passage>
    <passage>
      <infon key="volume">23</infon>
      <infon key="name_2">surname:Petrovich;given-names:Z</infon>
      <infon key="name_1">surname:Szmigelski;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Zielinski;given-names:H</infon>
      <infon key="fpage">6</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">10683065</infon>
      <infon key="year">2000</infon>
      <infon key="source">Am J Clin Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">12</infon>
      <offset>18313</offset>
      <text>Comparison of preoperative embolization followed by radical nephrectomy with radical neprectomy alone for renal cell carcinoma</text>
      <annotation id="405">
        <infon key="identifier">MESH:C538614</infon>
        <infon key="type">Disease</infon>
        <location offset="18419" length="20"/>
        <text>renal cell carcinoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">29</infon>
      <infon key="name_1">surname:Richter;given-names:GM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kauffmann;given-names:GW</infon>
      <infon key="fpage">205</infon>
      <infon key="pub-id_pmid">2426999</infon>
      <infon key="year">1986</infon>
      <infon key="source">Ann Radiol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">207</infon>
      <offset>18440</offset>
      <text>Palliative capillary embolization renal carcinoma</text>
      <annotation id="407">
        <infon key="identifier">MESH:C538614</infon>
        <infon key="type">Disease</infon>
        <location offset="18440" length="49"/>
        <text>Palliative capillary embolization renal carcinoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">5</infon>
      <infon key="name_2">surname:Ahlen;given-names:H</infon>
      <infon key="name_1">surname:Gorich;given-names:Jv</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Vogel;given-names:J</infon>
      <infon key="fpage">301</infon>
      <infon key="year">1995</infon>
      <infon key="source">Akt Radiol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">304</infon>
      <offset>18490</offset>
      <text>Ergebnisse nach Katheterembolization bei Nierenzellkarzinom</text>
    </passage>
    <passage>
      <infon key="volume">12</infon>
      <infon key="name_2">surname:Rohrbach;given-names:R</infon>
      <infon key="name_1">surname:Richter;given-names:GM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kauffmann;given-names:GW</infon>
      <infon key="fpage">22</infon>
      <infon key="year">1989</infon>
      <infon key="source">Cardiovas Interv Radiol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">28</infon>
      <offset>18550</offset>
      <text>Prolonged survival following palliative renal tumor embolization by capillary occlusion</text>
      <annotation id="409">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="18590" length="11"/>
        <text>renal tumor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">133</infon>
      <infon key="name_2">surname:Andersen;given-names:JF</infon>
      <infon key="name_1">surname:Dyreborg;given-names:U</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Christensen;given-names:K</infon>
      <infon key="fpage">191</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">3968730</infon>
      <infon key="year">1985</infon>
      <infon key="source">J Urol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">193</infon>
      <offset>18638</offset>
      <text>The value of transvascular embolization in the treatment of renal carcinoma</text>
      <annotation id="411">
        <infon key="identifier">MESH:C538614</infon>
        <infon key="type">Disease</infon>
        <location offset="18698" length="15"/>
        <text>renal carcinoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">80</infon>
      <infon key="name_2">surname:Munster;given-names:W</infon>
      <infon key="name_1">surname:Schwenke;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Stosslein;given-names:F</infon>
      <infon key="fpage">577</infon>
      <infon key="pub-id_pmid">3433986</infon>
      <infon key="year">1987</infon>
      <infon key="source">Z Urol Nephrol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">586</infon>
      <offset>18714</offset>
      <text>Verbesserung der Prognose des Nierenzellkarzinoms durch perkutane transvasale Embolization</text>
    </passage>
    <passage>
      <infon key="volume">83</infon>
      <infon key="name_2">surname:Wanek;given-names:R</infon>
      <infon key="name_1">surname:Kautzky;given-names:W</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Latal;given-names:D</infon>
      <infon key="fpage">27</infon>
      <infon key="pub-id_pmid">2330762</infon>
      <infon key="year">1990</infon>
      <infon key="source">Z Urol Nephrol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">31</infon>
      <offset>18805</offset>
      <text>Einfluss der Nierenocclusion auf die Uberlebensrate beim Nierenzellkarzinom: Eine retrospektive 10-Jahres-Studie</text>
      <annotation id="413">
        <infon key="identifier">MESH:C535733</infon>
        <infon key="type">Disease</infon>
        <location offset="18805" length="32"/>
        <text>Einfluss der Nierenocclusion auf</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="name_1">surname:Wojtowicz;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Karwowski;given-names:A</infon>
      <infon key="fpage">533</infon>
      <infon key="issue">4</infon>
      <infon key="year">1987</infon>
      <infon key="source">Radiol Diagn</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">535</infon>
      <offset>18919</offset>
      <text>Long-term results of embolization in renal tumors</text>
      <annotation id="415">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="18956" length="12"/>
        <text>renal tumors</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">99</infon>
      <infon key="name_2">surname:Trost;given-names:DW</infon>
      <infon key="name_1">surname:Smith;given-names:EB</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Schwartz;given-names:MJ</infon>
      <infon key="fpage">881</infon>
      <infon key="year">2006</infon>
      <infon key="source">BJU</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">886</infon>
      <offset>18969</offset>
      <text>Renal artery embolization: clnical indication and experience from over 100 cases</text>
      <annotation id="417">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="18969" length="25"/>
        <text>Renal artery embolization</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272834</id>
    <passage>
      <infon key="name_3">surname:Krstevska;given-names:Svetlana</infon>
      <infon key="name_2">surname:Genadieva-Stavric;given-names:Sonja</infon>
      <infon key="name_1">surname:Stojanovic;given-names:Aleksandar</infon>
      <infon key="article-id_pmid">25568624</infon>
      <infon key="name_0">surname:Sotirova;given-names:Tatjana</infon>
      <infon key="fpage">292</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272834</infon>
      <infon key="article-id_publisher-id">MSM-26-292</infon>
      <infon key="article-id_doi">10.5455/msm.2014.26.292-296</infon>
      <infon key="type">front</infon>
      <infon key="volume">26</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Mater Sociomed; 2014 Oct; 26(5) 292-6. doi:10.5455/msm.2014.26.292-296</infon>
      <infon key="kwd">myelodysplastic syndromes prognostic factors overall survival</infon>
      <infon key="lpage">296</infon>
      <infon key="name_5">surname:Balkanov;given-names:Trajan</infon>
      <infon key="name_4">surname:Spasovski;given-names:Dejan</infon>
      <infon key="authors">Sotirova T, Stojanovic A, Genadieva-Stavric S, Krstevska S, Spasovski D, Balkanov T</infon>
      <offset>0</offset>
      <text>Influence of Prognostic Factors on OverallSurvival in Myelodysplastic Syndromes</text>
      <annotation id="1">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="54" length="15"/>
        <text>Myelodysplastic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>80</offset>
      <text>Background:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>92</offset>
      <text>Accurate prediction of a patient's prognosis is useful to define the risk posed by the disease. Age, gender, peripheral blood cytopenia, proportion of bone marrow (BM) blasts, performance status, comorbidities, transfusion dependence, specific karyotype abnormalities and molecular biomarkers can refine the prediction of prognosis in MDS.</text>
      <annotation id="5">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="117" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="6">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="427" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="7">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="201" length="26"/>
        <text>peripheral blood cytopenia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>432</offset>
      <text>Aim:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>437</offset>
      <text>to assess the influence of the some prognostic factors like age, gender, cytopenia, BM blast percentage, transfusion dependence, ferritin, hemoglobin (Hb), lactate dehydrogenase (LDH), albumin and specific karyotype abnormalities in myelodysplastic syndromes on overall survival (OS).</text>
      <annotation id="10">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="510" length="9"/>
        <text>cytopenia</text>
      </annotation>
      <annotation id="11">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="670" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>722</offset>
      <text>Patients and methods:</text>
      <annotation id="13">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="722" length="8"/>
        <text>Patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>744</offset>
      <text>we retrospectively analyzed the cohort of 108 patients diagnosed between 1.1.2011 and 31.12.2013 at the University Clinic of Hematology, Ss Cyril and Methodius University, Skopje, Macedonia. They were evaluated for clinical and hematologic features at diagnosis and at leukemic transformation.</text>
      <annotation id="16">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="790" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="17">
        <infon key="identifier">MESH:D007938</infon>
        <infon key="type">Disease</infon>
        <location offset="1013" length="23"/>
        <text>leukemic transformation</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1038</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1047</offset>
      <text>in the study group 62 were man and 46 women. Male to female ratio was 1.35 to 1. The differences in OS between men and women were significant (p = .03015). The mean age at diagnosis was 66,6 years. According to the age OS was 16,4 months. FAB subtypes influenced OS significantly (p = .03015). OS inversely correlated with BM blast percentage (p= .02327). Cytopenia had no impact on OS (p=.33755). Hb as a whole and groups with different levels of Hb had no influence on OS (p = .12142) and (p= .07535), respectively. The group with ferritin &lt;500 microg/L had better OS (p=.04720). Transfusion dependence, LDH and albumin had no impact on OS. Leukemic transformation was noticed in 10 (9,3%) patients. Mortality was 36,1%.</text>
      <annotation id="26">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1074" length="3"/>
        <text>man</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1085" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="28">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1158" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="29">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1166" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="30">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1739" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="31">
        <infon key="identifier">MESH:D007938</infon>
        <infon key="type">Disease</infon>
        <location offset="1690" length="8"/>
        <text>Leukemic</text>
      </annotation>
      <annotation id="32">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="1614" length="2"/>
        <text>OS</text>
      </annotation>
      <annotation id="33">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="1403" length="9"/>
        <text>Cytopenia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1770</offset>
      <text>Conclusion:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1782</offset>
      <text>gender, FAB subtypes, BM blast percentage and the serum levels of ferritin had an influence on OS, while age, hemoglobin level, transfusion dependence, LDH and albumin had no impact on OS.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1971</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1987</offset>
      <text>Myelodysplastic syndromes (MDSs) are a heterogeneous group of disorders characterized by dysplasia in one or more cell lines, followed by a progressive impairment in the ability to differentiate, manifested with peripheral cytopenia and an increasing risk of evolution into acute myeloid leukemia (AML).</text>
      <annotation id="39">
        <infon key="identifier">MESH:D015470</infon>
        <infon key="type">Disease</infon>
        <location offset="2261" length="22"/>
        <text>acute myeloid leukemia</text>
      </annotation>
      <annotation id="40">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="1987" length="25"/>
        <text>Myelodysplastic syndromes</text>
      </annotation>
      <annotation id="41">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="2199" length="20"/>
        <text>peripheral cytopenia</text>
      </annotation>
      <annotation id="42">
        <infon key="identifier">MESH:D004476</infon>
        <infon key="type">Disease</infon>
        <location offset="2076" length="9"/>
        <text>dysplasia</text>
      </annotation>
      <annotation id="43">
        <infon key="identifier">MESH:D015470</infon>
        <infon key="type">Disease</infon>
        <location offset="2285" length="3"/>
        <text>AML</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2291</offset>
      <text>The clinical course is variable so much effort has been focused on methods for predicting prognosis. Accurately predicting the prognosis once a malignancy has been diagnosed is of great importance to both patients and their physicians alike. From a patient's perspective, the prognosis helps define the severity of disease and sets expectations as to how it is likely to impact them. In contrast, prognostic information from a physician's standpoint is essentially a means of staging the disease in a manner that can be used to help direct therapy. For both patients and physicians, the estimation of prognosis is a continual process that does not happen just at the time of diagnosis. Reevaluating the prognosis may be useful when a patient shows signs of progression or after they have become refractory to standard treatment. The vast majority of cases (80% to 90%) occur 'de novo', whereas 10% to 20% of cases are secondary. French-American British (FAB) classification for MDS is still in use, based on morphologic findings. The standard prognostic tool for prognosis in MDS is the International Prognostic Scoring System (IPSS) which classifies patients into low-, intermediate-1, intermediate-2 and high-risk categories. IPSS takes into account BM blast percentage, number of cytopenia and cytogenetic abnormalities. Beside the known prognosis factors included in the IPSS, other variables that have an impact on prognosis in MDS were studied: age, gender, FAB subtypes, degree of anemia and RBC transfusion dependence, ferritin (, LDH, albumins, mutations and comorbidities.</text>
      <annotation id="53">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2496" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2540" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2849" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="56">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3025" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="57">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3442" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="58">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="3574" length="9"/>
        <text>cytopenia</text>
      </annotation>
      <annotation id="59">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="3367" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="60">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="3269" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="61">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="2435" length="10"/>
        <text>malignancy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3878</offset>
      <text>Diagnosis requires BM examination and cytogenetic studies, and lately molecular studies. The consensual minimum criterion for diagnosis is the presence of erythroid, granulocyte or megakaryocyte dysplasia in 10% or more of informative cells. One must exclude the possibility of erythroid dysplasia associated with vitamin B12/folate/copper deficiency, viral infections, chemotherapy, or lead/arsenic poisoning.</text>
      <annotation id="69">
        <infon key="identifier">4709</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37630</infon>
        <location offset="4200" length="3"/>
        <text>B12</text>
      </annotation>
      <annotation id="70">
        <infon key="identifier">MESH:D001102</infon>
        <infon key="type">Disease</infon>
        <location offset="4230" length="16"/>
        <text>viral infections</text>
      </annotation>
      <annotation id="71">
        <infon key="identifier">MESH:D004476</infon>
        <infon key="type">Disease</infon>
        <location offset="4073" length="9"/>
        <text>dysplasia</text>
      </annotation>
      <annotation id="72">
        <infon key="identifier">MESH:C535468</infon>
        <infon key="type">Disease</infon>
        <location offset="4211" length="17"/>
        <text>copper deficiency</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">MESH:D005492</infon>
        <infon key="type">Chemical</infon>
        <location offset="4204" length="6"/>
        <text>folate</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">MESH:C538442</infon>
        <infon key="type">Disease</infon>
        <location offset="4156" length="19"/>
        <text>erythroid dysplasia</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">MESH:D020261</infon>
        <infon key="type">Disease</infon>
        <location offset="4270" length="17"/>
        <text>arsenic poisoning</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4289</offset>
      <text>The incidence of MDS increases with age (median about 70 years). MDS is rare in children Age had a significant effect on OS of the MDS population analyzed as a whole and stratified by subgroups-the older the age, the worse the prognosis. During the analysis on the subgroups, the effect of age was statistically relevant within RA and RARS patients, whereas it was not significant within and RAEB subgroup.</text>
      <annotation id="82">
        <infon key="identifier">5917</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">68281</infon>
        <location offset="4624" length="4"/>
        <text>RARS</text>
      </annotation>
      <annotation id="83">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4369" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="84">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4629" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="4354" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="86">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="4420" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="87">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="4306" length="3"/>
        <text>MDS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4698</offset>
      <text>A significant influence of sex on OS was observed in several studies. The overall incidence of MDS is slightly higher in males than in females (1.5-2 to 1). Male patients had worse prognosis. Considering subgroups, the effect of sex was relevant in refractory cytopenia, but did not affect the outcome in patients with RAEB.</text>
      <annotation id="92">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4860" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="93">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5003" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="94">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="4958" length="9"/>
        <text>cytopenia</text>
      </annotation>
      <annotation id="95">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="4793" length="3"/>
        <text>MDS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>5025</offset>
      <text>According to the multivariate analysis peripheral cytopenia did not reach a statistical significance on OS in MDS patients. FAB subtypes can worsen the prognosis in MDS in terms of OS, with differences among subtypes. Refractory anemia had the best and RAEB-T the worst prognosis.</text>
      <annotation id="102">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5139" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="103">
        <infon key="identifier">MESH:D000754</infon>
        <infon key="type">Disease</infon>
        <location offset="5278" length="6"/>
        <text>RAEB-T</text>
      </annotation>
      <annotation id="104">
        <infon key="identifier">MESH:D000740</infon>
        <infon key="type">Disease</infon>
        <location offset="5254" length="6"/>
        <text>anemia</text>
      </annotation>
      <annotation id="105">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="5135" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="106">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="5190" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="107">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="5075" length="9"/>
        <text>cytopenia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>5306</offset>
      <text>Blast count showed a significant predictive value on OS in MDS patients. More than 5% blasts in BM are considered as a bad prognostic factor for OS and leukemic transformation.</text>
      <annotation id="111">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5369" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="112">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="5365" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="113">
        <infon key="identifier">MESH:D007938</infon>
        <infon key="type">Disease</infon>
        <location offset="5458" length="8"/>
        <text>leukemic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>5483</offset>
      <text>Red blood cell (RBC) transfusions are a commonly used therapy to treat symptomatic anemia that affects most patients with MDS. Transfusion dependence is defined by the MDS International Study Group (2000) as requiring transfusion of at least one RBC at 8 weeks for 4 months. Transfusion-dependent patients had shorter survival rate than those who received less than 18 units of blood over a period of 36 months (37).</text>
      <annotation id="119">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5591" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="120">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5780" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">MESH:D000740</infon>
        <infon key="type">Disease</infon>
        <location offset="5566" length="6"/>
        <text>anemia</text>
      </annotation>
      <annotation id="122">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="5651" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="123">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="5605" length="3"/>
        <text>MDS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>5900</offset>
      <text>Serum ferritin level &gt;=500 microg/l at diagnosis was a strong independent predictor of survival. Serum ferritin was significantly correlated with OS in Chinese patients. These patients suffer from comorbidities such as heart failure, diabetes, infections, disorders of the thyroid gland and liver, shortening their survival.</text>
      <annotation id="129">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6060" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="130">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6076" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="131">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="6134" length="8"/>
        <text>diabetes</text>
      </annotation>
      <annotation id="132">
        <infon key="identifier">MESH:D006333</infon>
        <infon key="type">Disease</infon>
        <location offset="6119" length="13"/>
        <text>heart failure</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="6144" length="10"/>
        <text>infections</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>6225</offset>
      <text>Lactate dehydrogenase (LDH) is a parameter that should be recognized as a prognostic factor in MDS. One German study pointed out the correlation between LDH level and OS. Serum albumin is an independent prognostic factor that influences OS in patients with MDS. Hypoalbuminemia is a marker for shorter OS in MDS.</text>
      <annotation id="139">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6468" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="140">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="6533" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="141">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="6320" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="142">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="6482" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">MESH:D034141</infon>
        <infon key="type">Disease</infon>
        <location offset="6487" length="15"/>
        <text>Hypoalbuminemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>6538</offset>
      <text>Recurrent chromosomal abnormalities have been identified in 40-70% of the 'de novo' MDS and 95% of secondary MDS. These chromosomal aberrations include 5q-, 7q-/-7, +8, 20q-, 12p-, abnormalities in 17p, 11q23 and chromosome 3. Favorable prognostic markers according to IPSS include: a normal karyotype, 5q-as an isolated anomaly, 20q-as an isolated anomaly and -Y chromosome. Karyotype findings associated with poor prognosis include complex karyotype and abnormalities of chromosome 7. Other cytogenetic abnormalities confer an intermediate prognosis. Abnormal karyotype correlates with poor prognosis and shorter OS. According to the multivariate analysis, cytogenetics showed a significant predictive value on OS.</text>
      <annotation id="149">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="6647" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="150">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="6622" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="151">
        <infon key="identifier">MESH:D000014</infon>
        <infon key="type">Disease</infon>
        <location offset="6887" length="7"/>
        <text>anomaly</text>
      </annotation>
      <annotation id="152">
        <infon key="identifier">MESH:D000014</infon>
        <infon key="type">Disease</infon>
        <location offset="6859" length="7"/>
        <text>anomaly</text>
      </annotation>
      <annotation id="153">
        <infon key="identifier">MESH:D002869</infon>
        <infon key="type">Disease</infon>
        <location offset="6548" length="25"/>
        <text>chromosomal abnormalities</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>7263</offset>
      <text>Somatic mutations are identified in more than 70% of patients with MDS, including more of the patients with normal karyotype. These mutations are major predictors of the clinical phenotype, and could also be predictors of prognosis.</text>
      <annotation id="157">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7316" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="158">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7357" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="159">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="7330" length="3"/>
        <text>MDS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>7496</offset>
      <text>The incidence of MDS increases with the age, so does the prevalence of comorbidities. About 50% of MDS patients have one or more comorbidities. Congestive heart disease, hypertension, lung diseases, diabetes, liver failure, bleeding and solid tumors are cited as the most often reasons for non-leukemic dead. Comorbidities are significant and independent predictors in MDS. Congestive heart disease and chronic obstructive lung disease are associated with shorter OS, while diabetes and cerebro-vascular diseases do not change prognosis in MDS.</text>
      <annotation id="177">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7599" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="178">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="7733" length="12"/>
        <text>solid tumors</text>
      </annotation>
      <annotation id="179">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="7513" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="180">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="7899" length="32"/>
        <text>chronic obstructive lung disease</text>
      </annotation>
      <annotation id="181">
        <infon key="identifier">MESH:D006973</infon>
        <infon key="type">Disease</infon>
        <location offset="7666" length="12"/>
        <text>hypertension</text>
      </annotation>
      <annotation id="182">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="8036" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="183">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="7970" length="8"/>
        <text>diabetes</text>
      </annotation>
      <annotation id="184">
        <infon key="identifier">MESH:D006333</infon>
        <infon key="type">Disease</infon>
        <location offset="7640" length="24"/>
        <text>Congestive heart disease</text>
      </annotation>
      <annotation id="185">
        <infon key="identifier">MESH:D017093</infon>
        <infon key="type">Disease</infon>
        <location offset="7705" length="13"/>
        <text>liver failure</text>
      </annotation>
      <annotation id="186">
        <infon key="identifier">MESH:D000783</infon>
        <infon key="type">Disease</infon>
        <location offset="7983" length="25"/>
        <text>cerebro-vascular diseases</text>
      </annotation>
      <annotation id="187">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="7865" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="188">
        <infon key="identifier">MESH:D007938</infon>
        <infon key="type">Disease</infon>
        <location offset="7786" length="12"/>
        <text>non-leukemic</text>
      </annotation>
      <annotation id="189">
        <infon key="identifier">MESH:D006333</infon>
        <infon key="type">Disease</infon>
        <location offset="7870" length="24"/>
        <text>Congestive heart disease</text>
      </annotation>
      <annotation id="190">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="7720" length="8"/>
        <text>bleeding</text>
      </annotation>
      <annotation id="191">
        <infon key="identifier">MESH:D008171</infon>
        <infon key="type">Disease</infon>
        <location offset="7680" length="13"/>
        <text>lung diseases</text>
      </annotation>
      <annotation id="192">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="7595" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="193">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="7695" length="8"/>
        <text>diabetes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>8041</offset>
      <text>The median OS in MDS is 2.5 years. Prognosis is poor for patients with MDS, with 3-year survival rates estimated at less than 50%. The median survival rates according to IPSS are estimated at 8, 5.3, 2.2, and 0.9 years, respectfully.</text>
      <annotation id="197">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8098" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="8112" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="8058" length="3"/>
        <text>MDS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>8275</offset>
      <text>2. AIM</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>8282</offset>
      <text>The aim of this study was to assess the influence of the some prognostic factors in myelodysplastic syndromes (age, gender, cytopenia, BM blast percentage, transfusion dependence, serum levels of hemoglobin, ferritin, lactate dehydrogenase and albumin, and specific karyotype abnormalities) on OS.</text>
      <annotation id="202">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="8406" length="9"/>
        <text>cytopenia</text>
      </annotation>
      <annotation id="203">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="8366" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>8580</offset>
      <text>3. PATIENTS AND METHODS</text>
      <annotation id="205">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8583" length="8"/>
        <text>PATIENTS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>8604</offset>
      <text>We retrospectively analyzed the cohort of 108 patients (62 male and 46 female) diagnosed between 1.1.2011 and 31.12.2013 at the University Clinic of Hematology, Ss Cyril and Methodius University, Skopje, Macedonia. They were evaluated for clinical and hematologic features at diagnosis and leukemic transformation. Observation time was 36 months. Diagnosis was made upon dysplastic changes in peripheral blood smear and bone marrow aspirate. Confirmation analysis included bone marrow aspirate, cytochemical stain, immunohistochemical tests, cytochemical stain of medullar iron and karyotype analysis in some cases. We evaluated some parameters that could influence OS: age, gender, cytopenia, BM blast percentage, transfusion dependence, serum levels of Hb, ferritin, LDH and albumin as well as specific karyotype abnormalities. Chromosomal analysis was performed only in 5 patients using BM aspirate, according to laboratory procedures. IPSS was not calculated in the vast majority of patients, because we could not perform cytogenetic analysis in all patients. Most patients (pts) received supportive care: transfusion of RBC and platelets, red cell and granulocyte growth factors (21 pts), vitamins, corticosteroids, iron chelatation therapy (7 pts), some received chemotherapy (4pts) and few patients allogeneic transplantation (3 pts). OS was estimated in months including the period from the date of diagnosis to the time of death / time of last visit. Leukemic transformation was noticed in 10 (9,3%) patients. Mortality was 36,1%. Infectious and hemorrhagic complications as well as BM failure were considered causes of MDS-related deaths.</text>
      <annotation id="228">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8650" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="229">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9479" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="230">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9591" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="231">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9658" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="232">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9673" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="233">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9901" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="234">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10113" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="235">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9683" length="3"/>
        <text>pts</text>
      </annotation>
      <annotation id="236">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9792" length="3"/>
        <text>pts</text>
      </annotation>
      <annotation id="237">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9853" length="3"/>
        <text>pts</text>
      </annotation>
      <annotation id="238">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9888" length="3"/>
        <text>pts</text>
      </annotation>
      <annotation id="239">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9940" length="3"/>
        <text>pts</text>
      </annotation>
      <annotation id="240">
        <infon key="identifier">MESH:D007501</infon>
        <infon key="type">Chemical</infon>
        <location offset="9825" length="4"/>
        <text>iron</text>
      </annotation>
      <annotation id="241">
        <infon key="identifier">MESH:D007501</infon>
        <infon key="type">Chemical</infon>
        <location offset="9177" length="4"/>
        <text>iron</text>
      </annotation>
      <annotation id="242">
        <infon key="identifier">MESH:D007938</infon>
        <infon key="type">Disease</infon>
        <location offset="8894" length="23"/>
        <text>leukemic transformation</text>
      </annotation>
      <annotation id="243">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="10233" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="244">
        <infon key="identifier">MESH:D007938</infon>
        <infon key="type">Disease</infon>
        <location offset="10064" length="8"/>
        <text>Leukemic</text>
      </annotation>
      <annotation id="245">
        <infon key="identifier">MESH:D006470</infon>
        <infon key="type">Disease</infon>
        <location offset="10159" length="25"/>
        <text>hemorrhagic complications</text>
      </annotation>
      <annotation id="246">
        <infon key="identifier">MESH:D017093</infon>
        <infon key="type">Disease</infon>
        <location offset="10196" length="10"/>
        <text>BM failure</text>
      </annotation>
      <annotation id="247">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="9287" length="9"/>
        <text>cytopenia</text>
      </annotation>
      <annotation id="248">
        <infon key="identifier">MESH:D003643</infon>
        <infon key="type">Disease</infon>
        <location offset="10036" length="5"/>
        <text>death</text>
      </annotation>
      <annotation id="249">
        <infon key="identifier">MESH:D004416</infon>
        <infon key="type">Disease</infon>
        <location offset="8975" length="10"/>
        <text>dysplastic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>10253</offset>
      <text>4. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10264</offset>
      <text>Mean age at diagnosis was 66,6 years (range 18-89) (SD 14.2). Mean OS depending on age was 16,4 months, and it was not statistically significant (p= .46375). In our study, 62 (57.4%) patients were men, 46 (42.6%) women. Male to female ratio was 1.35 to 1. Women had better OS than men (p = .00819). (Figure 1). According to the FAB classification patients were classified as follows: 75 patients as having refractory anemia (RA; 69.4%), 1-RA with ringed sideroblasts (RARS; 0.9%), 21-RA with excess of blasts (RAEB; 19.4%), 3-RAEB in transformation (RAEB-T 2.8%), and 8 as having chronic myelomonocytic leukemia (CMML 8.2%). (Table 1)</text>
      <annotation id="261">
        <infon key="identifier">5917</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">68281</infon>
        <location offset="10732" length="4"/>
        <text>RARS</text>
      </annotation>
      <annotation id="262">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10447" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="263">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10461" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="264">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10477" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="265">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10520" length="5"/>
        <text>Women</text>
      </annotation>
      <annotation id="266">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10545" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="267">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10611" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="268">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10651" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="269">
        <infon key="identifier">MESH:D054429</infon>
        <infon key="type">Disease</infon>
        <location offset="10852" length="23"/>
        <text>myelomonocytic leukemia</text>
      </annotation>
      <annotation id="270">
        <infon key="identifier">MESH:D000754</infon>
        <infon key="type">Disease</infon>
        <location offset="10814" length="6"/>
        <text>RAEB-T</text>
      </annotation>
      <annotation id="271">
        <infon key="identifier">MESH:D000740</infon>
        <infon key="type">Disease</infon>
        <location offset="10681" length="6"/>
        <text>anemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">MSM-26-292-g001.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>10905</offset>
      <text>OS depending on gender</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>10928</offset>
      <text>Distribution of patients according to the FAB classification</text>
      <annotation id="273">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10944" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10989</offset>
      <text>Statistically significant differences in OS were found among patients with RA, RAEB, RAEB-T and CMML (p = .03015). (Figure 2)</text>
      <annotation id="276">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11050" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="277">
        <infon key="identifier">MESH:D000754</infon>
        <infon key="type">Disease</infon>
        <location offset="11074" length="6"/>
        <text>RAEB-T</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">MSM-26-292-g003.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption</infon>
      <offset>11115</offset>
      <text>OS depending on FAB subtypes</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11144</offset>
      <text>Cytopenia had no influence on OS (p=.09340). In our group 23 patients (21.3%) presented with one cytopenia, 46 patients (42.6) with bicytopenia and 39 patients (36.1%) with pancytopenia. There was no statistically significant difference in OS among patients with different cytopenia (p = .33755).</text>
      <annotation id="287">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11205" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="288">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11255" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="289">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11295" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="290">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11393" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="291">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="11144" length="9"/>
        <text>Cytopenia</text>
      </annotation>
      <annotation id="292">
        <infon key="identifier">MESH:D010198</infon>
        <infon key="type">Disease</infon>
        <location offset="11317" length="12"/>
        <text>pancytopenia</text>
      </annotation>
      <annotation id="293">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="11407" length="19"/>
        <text>different cytopenia</text>
      </annotation>
      <annotation id="294">
        <infon key="type">Disease</infon>
        <location offset="11276" length="11"/>
        <text>bicytopenia</text>
      </annotation>
      <annotation id="295">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="11241" length="9"/>
        <text>cytopenia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11441</offset>
      <text>Percentage of BM blasts correlated with OS (p=.02327). Mean OS in the group with &lt; 5% blasts was 17,8 months, in the group with blasts 5-9%-17.7 months, with blasts 10-19%-9.7 months and in the group with 20-30% blasts - 9.5 months. The differences among groups were statistically significant (p&lt;0.05).</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11750</offset>
      <text>Mean Hb level in our cohort was 85,1 g/L (range 41-150). Hb had no impact on OS (16.4 months) (p=.12142). The patients were grouped in three categories according to the severity of anemia: severe anemia (Hb &lt;70 g/L), moderate anemia (Hb 70-100 g/L) and patients with Hb &gt;100 g/L. OS was highest in patients with Hb &gt;100 g/L-21.6 months, in moderate anemia-14,8 months and in severe anemia-15.2 months, being not statistically significant (p=0.07535).</text>
      <annotation id="304">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11860" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="305">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12003" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="306">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12048" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="307">
        <infon key="identifier">MESH:D000740</infon>
        <infon key="type">Disease</infon>
        <location offset="11931" length="6"/>
        <text>anemia</text>
      </annotation>
      <annotation id="308">
        <infon key="identifier">MESH:D000740</infon>
        <infon key="type">Disease</infon>
        <location offset="12132" length="9"/>
        <text>anemia-15</text>
      </annotation>
      <annotation id="309">
        <infon key="identifier">MESH:D000740</infon>
        <infon key="type">Disease</infon>
        <location offset="12099" length="9"/>
        <text>anemia-14</text>
      </annotation>
      <annotation id="310">
        <infon key="identifier">MESH:D000740</infon>
        <infon key="type">Disease</infon>
        <location offset="11976" length="6"/>
        <text>anemia</text>
      </annotation>
      <annotation id="311">
        <infon key="identifier">MESH:D000740</infon>
        <infon key="type">Disease</infon>
        <location offset="11946" length="6"/>
        <text>anemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12207</offset>
      <text>Mean level of serum ferritin in our group was 3826.1microg/L. Serum ferritin had no impact on OS - 16,5 months (p=.13178). But, groups with ferritin &lt;500 microg/L (17 months) and &gt;500 microg /L (16 months) had significant differences in OS (p= .04720). (Figure 3).</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">MSM-26-292-g004.jpg</infon>
      <infon key="id">F3</infon>
      <infon key="type">fig_caption</infon>
      <offset>12472</offset>
      <text>OS in groups with different serum ferritin levels</text>
      <annotation id="313">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="12472" length="2"/>
        <text>OS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12522</offset>
      <text>Transfusion dependence is defined by the MDS International Group (2000) study as requiring transfusion of at least one packed red blood cells (RBC) at 8 weeks for 4 months OS depending on transfusion as a whole was 16.2 months, being not statistically significant (p= .16298). OS in the group without RBC was 16.5 months, in the group that received &lt;= 18 RBC had OS 15.4 months, and the group that received &gt;18 RBC had OS 19.8 months. Mean transfused doses in this cohort were 13.2 RBC (St.dev.-16.8). Transfusion dependent patients with &gt;18 doses RBC had shorter survival than patients who required &lt;= 18 doses RBC, being not statistically significant (p=.72185).</text>
      <annotation id="317">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13046" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="318">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13100" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="319">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="12563" length="3"/>
        <text>MDS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13189</offset>
      <text>Mean serum level of LDH was 809 IU/L. There was no statistical significance in OS between the two groups with different LDH (&lt;423 IU/L and &gt;423 IU/L) (p = .48310).</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13353</offset>
      <text>Mean albumin level in the study group was 39g/L. Albumins had no influence on OS - 20 months (p= .25087). There was no statistical significance in OS between the two groups with different levels of albumins (&lt;40 g/L and &gt;40 g/L) (p= .18986).</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13597</offset>
      <text>When testing mutual influence of several parameters on OS, we found that age, gender, FAB subtypes, bone marrow blast percentage, hemoglobin level and transfusion dependence had statistically significant impact on OS (p=.01628).</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13826</offset>
      <text>We were unable to perform cytogenetic analysis in all patients. From those 5 patients who underwent cytogenetic tests, 3 had normal karyotype, one patient had +8 and one inv16. We could not show survival curves due to the small number of patients in whom cytogenetic analysis was performed.</text>
      <annotation id="324">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13880" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="325">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13903" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="326">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13973" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="327">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14064" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>14117</offset>
      <text>5. STATISTICAL ANALYSIS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>14141</offset>
      <text>The statistical analysis was performed using statistical package SSPS 16.0. For the parameters or variables used in this paper, the range, mean and standard deviation were presented. Differences among variables were evaluated by the Chi-square test. The determinations of correlations between different variables was based on the Pearson correlation coefficient in all cases where the variables had a normal distribution, and a certain correlation was considered statistically significant if p &lt;0.05. Overall survival was defined as the time interval between diagnosis date and death date. Patients who were alive were censored at the last follow-up date. The probabilities of OS were estimated using the method of Kaplan and Meier. Cox proportional hazards regression models were used to assess the association between prognostic factors and OS.</text>
      <annotation id="331">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14731" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="332">
        <infon key="identifier">MESH:D003643</infon>
        <infon key="type">Disease</infon>
        <location offset="14719" length="5"/>
        <text>death</text>
      </annotation>
      <annotation id="333">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="14818" length="2"/>
        <text>OS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>14988</offset>
      <text>6. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>15002</offset>
      <text>Our results considering age (66.6 years) correspond with those in the literature. Age in this group did not affect OS neither as a whole nor stratified by subgroups, similar with some studies. Considering gender, men had worse OS than women, corresponding with the data in the literature. FAB subtypes had a significant effect on OS. Considering subtypes, the worst results were observed in RAEB-T, than in CMML, RAEB and RA subtype, similar with those in the literature. There was only one patient with RARS and he was not taken in consideration. Cytopenia had no impact on OS, corresponding with some data in the literature. But, others showed opposite results. OS correlated inversely with BM blast percentage, showed in other studies. Hemoglobin as a whole and stratified into subgroups did not show any impact on OS. Transfusion dependence could be an independent prognostic factor for bad prognosis, although in our study group the influence on OS was not significant. Serum ferritin level &gt;=500 microg/L at presentation is an independent poor predictor for OS. The group with ferritin &lt;500 microg/L had better OS. LDH is a factor sited as having predictive value, although we could not prove that. Hypoalbuminemia is an independent poor prognostic factor in MDS patients, but in our study group it was not significant.</text>
      <annotation id="345">
        <infon key="identifier">5917</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">68281</infon>
        <location offset="15506" length="4"/>
        <text>RARS</text>
      </annotation>
      <annotation id="346">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15215" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="347">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15237" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="348">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15493" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="349">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16271" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="350">
        <infon key="identifier">MESH:D000754</infon>
        <infon key="type">Disease</infon>
        <location offset="15393" length="6"/>
        <text>RAEB-T</text>
      </annotation>
      <annotation id="351">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="16119" length="2"/>
        <text>OS</text>
      </annotation>
      <annotation id="352">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="16267" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="353">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="15117" length="2"/>
        <text>OS</text>
      </annotation>
      <annotation id="354">
        <infon key="identifier">MESH:D034141</infon>
        <infon key="type">Disease</infon>
        <location offset="16207" length="15"/>
        <text>Hypoalbuminemia</text>
      </annotation>
      <annotation id="355">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="15550" length="9"/>
        <text>Cytopenia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16328</offset>
      <text>Cytogenetics in other studies showed a significant predictive value on OS and patients were accordingly stratified in groups with different IPSS score. Only 5 patients were analyzed for cytogenetic abnormalities, three of them with good prognosis, and two of them (+8, inv16) with intermediate prognosis.</text>
      <annotation id="358">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16406" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="359">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16487" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16633</offset>
      <text>Limitations in our study include retrospective analysis, insufficient data on cytogenetic analysis and impossibility to stratify patients according to IPSS score, lack of data on comorbidities, insufficient data on ferritin, LDH and albumins, that probably reflected on the results making some of them different than those cited in the literature.</text>
      <annotation id="363">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16762" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="364">
        <infon key="identifier">MESH:D000309</infon>
        <infon key="type">Disease</infon>
        <location offset="16690" length="12"/>
        <text>insufficient</text>
      </annotation>
      <annotation id="365">
        <infon key="identifier">MESH:D000309</infon>
        <infon key="type">Disease</infon>
        <location offset="16827" length="12"/>
        <text>insufficient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">footnote</infon>
      <offset>16981</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>17018</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="volume">96</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Cazzola;given-names:M</infon>
      <infon key="fpage">349</infon>
      <infon key="pub-id_pmid">21357714</infon>
      <infon key="year">2011</infon>
      <infon key="source">Haematologica</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">351</infon>
      <offset>17029</offset>
      <text>Risk assessment in myelodysplastic syndromes and myelodysplastic/ myeloproliferative neoplasms</text>
      <annotation id="369">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="17078" length="15"/>
        <text>myelodysplastic</text>
      </annotation>
      <annotation id="370">
        <infon key="identifier">MESH:D009196</infon>
        <infon key="type">Disease</infon>
        <location offset="17095" length="28"/>
        <text>myeloproliferative neoplasms</text>
      </annotation>
      <annotation id="371">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="17048" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">352</infon>
      <infon key="name_1">surname:Malcovati;given-names:L</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Cazzola;given-names:M</infon>
      <infon key="fpage">536</infon>
      <infon key="year">2005</infon>
      <infon key="source">N Eng J Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">538</infon>
      <offset>17124</offset>
      <text>Myelodysplastic syndromes-coping with ineffective hematopoiesis</text>
      <annotation id="374">
        <infon key="identifier">MESH:C536227</infon>
        <infon key="type">Disease</infon>
        <location offset="17174" length="13"/>
        <text>hematopoiesis</text>
      </annotation>
      <annotation id="375">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="17124" length="15"/>
        <text>Myelodysplastic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">99</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bejar;given-names:R</infon>
      <infon key="fpage">956</infon>
      <infon key="issue">6</infon>
      <infon key="year">2014</infon>
      <infon key="comment">management/mds</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">964</infon>
      <offset>17188</offset>
      <text>Clinical and Genetic Predictors of Prognosis in Myelodysplastic Syndromes</text>
      <annotation id="377">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="17236" length="15"/>
        <text>Myelodysplastic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">51</infon>
      <infon key="name_2">surname:Daniel;given-names:MT</infon>
      <infon key="name_1">surname:Catovsky;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bennett;given-names:JM</infon>
      <infon key="fpage">189</infon>
      <infon key="pub-id_pmid">6952920</infon>
      <infon key="year">1982</infon>
      <infon key="source">Br J Haematol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">199</infon>
      <offset>17262</offset>
      <text>Proposals for the classification of the myelodysplastic syndromes</text>
      <annotation id="379">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="17302" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">89</infon>
      <infon key="name_2">surname:LeBeau;given-names:MM</infon>
      <infon key="name_1">surname:Cox;given-names:C</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Greenberg;given-names:P</infon>
      <infon key="fpage">2079</infon>
      <infon key="pub-id_pmid">9058730</infon>
      <infon key="year">1997</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2088</infon>
      <offset>17328</offset>
      <text>International scoring system for evaluating prognosis in myelodysplastic syndromes</text>
      <annotation id="381">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="17385" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">90</infon>
      <infon key="name_2">surname:Ille;given-names:S</infon>
      <infon key="name_1">surname:Leto di;given-names:Priolo S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Giagounidis;given-names:A</infon>
      <infon key="fpage">667</infon>
      <infon key="pub-id_pmid">21327403</infon>
      <infon key="year">2011</infon>
      <infon key="source">Ann Hematol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">673</infon>
      <offset>17411</offset>
      <text>A European survey on the detection and management of iron overload in transfusion-dependent patients with MDS</text>
      <annotation id="385">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17503" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="386">
        <infon key="identifier">MESH:D007501</infon>
        <infon key="type">Chemical</infon>
        <location offset="17464" length="4"/>
        <text>iron</text>
      </annotation>
      <annotation id="387">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="17517" length="3"/>
        <text>MDS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">96</infon>
      <infon key="name_1">surname:Tefferi;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Pardanani;given-names:A</infon>
      <infon key="fpage">8</infon>
      <infon key="pub-id_pmid">21193428</infon>
      <infon key="year">2011</infon>
      <infon key="source">Haematologica</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">9</infon>
      <offset>17521</offset>
      <text>Prognostic relevance of anemia and transfusion dependency in myelodysplastic syndromes and primary myelofibrosis</text>
      <annotation id="391">
        <infon key="identifier">MESH:D000740</infon>
        <infon key="type">Disease</infon>
        <location offset="17545" length="6"/>
        <text>anemia</text>
      </annotation>
      <annotation id="392">
        <infon key="identifier">MESH:D055728</infon>
        <infon key="type">Disease</infon>
        <location offset="17620" length="13"/>
        <text>myelofibrosis</text>
      </annotation>
      <annotation id="393">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="17556" length="51"/>
        <text>transfusion dependency in myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">32</infon>
      <infon key="name_1">surname:Depalma;given-names:L</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Codispoti;given-names:KET</infon>
      <infon key="fpage">443</infon>
      <infon key="pub-id_pmid">20041967</infon>
      <infon key="year">2010</infon>
      <infon key="source">Int J Lab Hematol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">448</infon>
      <offset>17634</offset>
      <text>Myelodysplastic syndrome in elderly patients: correlation of CBC with cytogenetic and FISH analysis</text>
      <annotation id="396">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17670" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="397">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="17634" length="24"/>
        <text>Myelodysplastic syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">61</infon>
      <infon key="name_1">surname:Deeg;given-names:HJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Scott;given-names:Bl</infon>
      <infon key="fpage">345</infon>
      <infon key="year">2010</infon>
      <infon key="source">Annual Review of Medicine</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">358</infon>
      <offset>17734</offset>
      <text>Myelodysplastic syndromes</text>
      <annotation id="399">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="17734" length="25"/>
        <text>Myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">83</infon>
      <infon key="name_2">surname:Greenberg;given-names:P</infon>
      <infon key="name_1">surname:Sanz;given-names:MA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sanz;given-names:GF</infon>
      <infon key="fpage">358</infon>
      <infon key="year">1998</infon>
      <infon key="source">Haematol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">368</infon>
      <offset>17760</offset>
      <text>Prognostic factors and scoring systems in myelodysplastic syndromes</text>
      <annotation id="401">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="17802" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ambaglio;given-names:I</infon>
      <infon key="name_2">surname:Strupp;given-names:C</infon>
      <infon key="name_1">surname:Della-Porta;given-names:MG</infon>
      <infon key="name_0">surname:Malcovati;given-names:L</infon>
      <infon key="fpage">1433</infon>
      <infon key="issue">10</infon>
      <infon key="pub-id_pmid">21659359</infon>
      <infon key="year">2011</infon>
      <infon key="source">Haematologica</infon>
      <infon key="type">ref</infon>
      <infon key="volume">96</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1440</infon>
      <infon key="name_5">surname:Nahtkamp;given-names:K</infon>
      <infon key="name_4">surname:Kuendgen;given-names:A</infon>
      <offset>17828</offset>
      <text>Impact of the degree of anemia on the outcome of patients with myelodysplastic syndromes and its integration into the WHO Classification-based Prognostic Scoring System (WPSS)</text>
      <annotation id="405">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17877" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="406">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="17891" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
      <annotation id="407">
        <infon key="identifier">MESH:D000740</infon>
        <infon key="type">Disease</infon>
        <location offset="17852" length="6"/>
        <text>anemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">61</infon>
      <infon key="name_2">surname:Julia;given-names:A</infon>
      <infon key="name_1">surname:Torrabadella;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Vallespi;given-names:T</infon>
      <infon key="fpage">83</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">3863667</infon>
      <infon key="year">1985</infon>
      <infon key="source">Br J Haematol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">92</infon>
      <offset>18004</offset>
      <text>Myelodysplastic syndromes: a study of 101 cases according to the FAB classification</text>
      <annotation id="409">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="18004" length="25"/>
        <text>Myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Qin;given-names:T</infon>
      <infon key="name_2">surname:Gale;given-names:R.P</infon>
      <infon key="name_1">surname:Xu;given-names:Z</infon>
      <infon key="name_0">surname:Li;given-names:B</infon>
      <infon key="fpage">243</infon>
      <infon key="pub-id_pmid">23328695</infon>
      <infon key="year">2013</infon>
      <infon key="source">Acta Haematol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">129</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">250</infon>
      <infon key="name_5">surname:Xiao;given-names:Z</infon>
      <infon key="name_4">surname:Zhang;given-names:Y</infon>
      <offset>18088</offset>
      <text>Serum Ferritin Is an Independent Prognostic Factor in Chinese with Myelodysplastic Syndromes Classified as IPSS Intermediate-1</text>
      <annotation id="411">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="18155" length="15"/>
        <text>Myelodysplastic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">114</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Pullarkat;given-names:V</infon>
      <infon key="fpage">5251</infon>
      <infon key="issue">26</infon>
      <infon key="pub-id_pmid">19710499</infon>
      <infon key="year">2009</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">5255</infon>
      <offset>18215</offset>
      <text>Objectives of iron chelation in myelodysplastic syndromes: more than meets the eye?</text>
      <annotation id="414">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="18247" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
      <annotation id="415">
        <infon key="identifier">MESH:D007501</infon>
        <infon key="type">Chemical</infon>
        <location offset="18229" length="4"/>
        <text>iron</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Goldberg;given-names:SL</infon>
      <infon key="fpage">2847</infon>
      <infon key="pub-id_pmid">20421543</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Clin Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2852</infon>
      <offset>18299</offset>
      <text>Incidence and Clinical Complications of Myelodysplastic Syndromes among United States Medicare Beneficiaries</text>
      <annotation id="417">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="18339" length="25"/>
        <text>Myelodysplastic Syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">78</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Takatoku;given-names:M</infon>
      <infon key="fpage">487</infon>
      <infon key="year">2007</infon>
      <infon key="source">Eur J Hematol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">494</infon>
      <offset>18408</offset>
      <text>Retrospective nationwide surv1077y of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality</text>
      <annotation id="422">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18455" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="423">
        <infon key="identifier">MESH:D000741</infon>
        <infon key="type">Disease</infon>
        <location offset="18499" length="15"/>
        <text>aplastic anemia</text>
      </annotation>
      <annotation id="424">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="18491" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="425">
        <infon key="identifier">MESH:D007501</infon>
        <infon key="type">Chemical</infon>
        <location offset="18549" length="4"/>
        <text>iron</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Krstevska-Balkanov;given-names:S</infon>
      <infon key="name_2">surname:Stojanovski;given-names:Z</infon>
      <infon key="name_1">surname:Georgievski;given-names:B</infon>
      <infon key="name_0">surname:Genadieva-Stavric;given-names:S</infon>
      <infon key="fpage">295</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">21822196</infon>
      <infon key="year">2011</infon>
      <infon key="source">Prilozi</infon>
      <infon key="type">ref</infon>
      <infon key="volume">32</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Serafimovski;given-names:V</infon>
      <infon key="lpage">304</infon>
      <infon key="name_6">surname:Genadieva-Dimitrova;given-names:M</infon>
      <infon key="name_5">surname:Trajkova;given-names:S</infon>
      <infon key="name_4">surname:Pivkova;given-names:A</infon>
      <offset>18586</offset>
      <text>Iron overload in patients with transfusion dependent myelodysplastic syndrome</text>
      <annotation id="429">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18603" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="430">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="18639" length="24"/>
        <text>myelodysplastic syndrome</text>
      </annotation>
      <annotation id="431">
        <infon key="identifier">MESH:D007501</infon>
        <infon key="type">Chemical</infon>
        <location offset="18586" length="4"/>
        <text>Iron</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">19</infon>
      <infon key="name_2">surname:Kundi;given-names:M</infon>
      <infon key="name_1">surname:Sperr;given-names:WR</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Wimazal;given-names:F</infon>
      <infon key="fpage">970</infon>
      <infon key="pub-id_pmid">18272915</infon>
      <infon key="year">2008</infon>
      <infon key="source">Ann Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">976</infon>
      <offset>18664</offset>
      <text>Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the foolow-up of patients with myelodysplastic syndromes</text>
      <annotation id="434">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18764" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="435">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="18778" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">87</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Komrokji;given-names:RS</infon>
      <infon key="fpage">1006</infon>
      <infon key="year">2012</infon>
      <infon key="source">Am J Haematol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1009</infon>
      <offset>18804</offset>
      <text>Hypoalbuminenemia is an independent prognostic factor for overall survival in myelodysplastic syndromes</text>
      <annotation id="438">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="18882" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
      <annotation id="439">
        <infon key="type">Disease</infon>
        <location offset="18804" length="17"/>
        <text>Hypoalbuminenemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">99</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bejar;given-names:R</infon>
      <infon key="fpage">956</infon>
      <infon key="pub-id_pmid">24881041</infon>
      <infon key="year">2014</infon>
      <infon key="source">Haematologica</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">964</infon>
      <offset>18908</offset>
      <text>Clinical and genetic predictors of prognosis in myelodysplastic syndromes</text>
      <annotation id="441">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="18956" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">10</infon>
      <infon key="name_2">surname:rouplin;given-names:VT</infon>
      <infon key="name_1">surname:Carbuccia;given-names:N</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rocquain;given-names:J</infon>
      <infon key="fpage">401</infon>
      <infon key="pub-id_pmid">20678218</infon>
      <infon key="year">2010</infon>
      <infon key="source">Biomed Central Cancer</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">408</infon>
      <offset>18982</offset>
      <text>Combined mutations of ASXL1, CBL, FLT3, IDH1,IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias</text>
      <annotation id="456">
        <infon key="identifier">171023</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">9098</infon>
        <location offset="19004" length="5"/>
        <text>ASXL1</text>
      </annotation>
      <annotation id="457">
        <infon key="identifier">867</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3802</infon>
        <location offset="19011" length="3"/>
        <text>CBL</text>
      </annotation>
      <annotation id="458">
        <infon key="identifier">2322</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3040</infon>
        <location offset="19016" length="4"/>
        <text>FLT3</text>
      </annotation>
      <annotation id="459">
        <infon key="identifier">3417</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">21195</infon>
        <location offset="19022" length="4"/>
        <text>IDH1</text>
      </annotation>
      <annotation id="460">
        <infon key="identifier">3418</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37590</infon>
        <location offset="19027" length="4"/>
        <text>IDH2</text>
      </annotation>
      <annotation id="461">
        <infon key="identifier">3717</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">21033</infon>
        <location offset="19033" length="4"/>
        <text>JAK2</text>
      </annotation>
      <annotation id="462">
        <infon key="identifier">3845</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37990</infon>
        <location offset="19039" length="4"/>
        <text>KRAS</text>
      </annotation>
      <annotation id="463">
        <infon key="identifier">4869</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">81697</infon>
        <location offset="19045" length="4"/>
        <text>NPM1</text>
      </annotation>
      <annotation id="464">
        <infon key="identifier">4893</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">55661</infon>
        <location offset="19051" length="4"/>
        <text>NRAS</text>
      </annotation>
      <annotation id="465">
        <infon key="identifier">861</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">1331</infon>
        <location offset="19057" length="5"/>
        <text>RUNX1</text>
      </annotation>
      <annotation id="466">
        <infon key="identifier">54790</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">49498</infon>
        <location offset="19064" length="4"/>
        <text>TET2</text>
      </annotation>
      <annotation id="467">
        <infon key="identifier">7490</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">11536</infon>
        <location offset="19073" length="3"/>
        <text>WT1</text>
      </annotation>
      <annotation id="468">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="19086" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
      <annotation id="469">
        <infon key="identifier">MESH:D015470</infon>
        <infon key="type">Disease</infon>
        <location offset="19116" length="23"/>
        <text>acute myeloid leukemias</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">11</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Grenberg;given-names:PL</infon>
      <infon key="fpage">877</infon>
      <infon key="pub-id_pmid">23847221</infon>
      <infon key="year">2013</infon>
      <infon key="source">J Natl Compr Canc Netw</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">885</infon>
      <offset>19140</offset>
      <text>The Multifaceted Nature of Myelodysplastic Syndromes: Clinical, Molecular and Biological Prognostic Features</text>
      <annotation id="471">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="19167" length="15"/>
        <text>Myelodysplastic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Oh;given-names:J</infon>
      <infon key="name_2">surname:Sardesai;given-names:S</infon>
      <infon key="name_1">surname:Garcia-Manero;given-names:G</infon>
      <infon key="name_0">surname:Naqvi;given-names:K</infon>
      <infon key="fpage">2240</infon>
      <infon key="issue">16</infon>
      <infon key="pub-id_pmid">21537048</infon>
      <infon key="year">2011</infon>
      <infon key="source">J Clin Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">29</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Suarez-Almazor;given-names:ME</infon>
      <infon key="name_8">surname:Kantarjian;given-names:HM</infon>
      <infon key="name_7">surname:Shan;given-names:J</infon>
      <infon key="name_6">surname:Lei;given-names:X</infon>
      <infon key="name_5">surname:Pierce;given-names:S</infon>
      <infon key="name_4">surname:Vigil;given-names:CE</infon>
      <offset>19249</offset>
      <text>Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic model</text>
      <annotation id="473">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="19303" length="24"/>
        <text>myelodysplastic syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">114</infon>
      <infon key="name_2">surname:Arber;given-names:DA</infon>
      <infon key="name_1">surname:Thiele;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Vardiman;given-names:JW</infon>
      <infon key="fpage">937</infon>
      <infon key="pub-id_pmid">19357394</infon>
      <infon key="year">2009</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">951</infon>
      <offset>19363</offset>
      <text>The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes</text>
      <annotation id="475">
        <infon key="identifier">MESH:D015470</infon>
        <infon key="type">Disease</infon>
        <location offset="19438" length="36"/>
        <text>myeloid neoplasms and acute leukemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">85</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Tefferi</infon>
      <infon key="fpage">1042</infon>
      <infon key="issue">11</infon>
      <infon key="pub-id_pmid">20861462</infon>
      <infon key="year">2010</infon>
      <infon key="source">Mayo Clin Proc</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1045</infon>
      <offset>19508</offset>
      <text>Myelodysplastic syndromes - Many New Drugs, Little Therapeutic Progress</text>
      <annotation id="477">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="19508" length="15"/>
        <text>Myelodysplastic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Cornelison;given-names:AM</infon>
      <infon key="name_2">surname:Wang;given-names:X</infon>
      <infon key="name_1">surname:Takahashi;given-names:K</infon>
      <infon key="name_0">surname:Jabbour;given-names:E</infon>
      <infon key="pub-id_pmid">23760779</infon>
      <infon key="year">2013</infon>
      <infon key="source">Am J Hematol</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">837</infon>
      <infon key="fpage">831</infon>
      <infon key="issue">10</infon>
      <infon key="volume">88</infon>
      <infon key="name_10">surname:Wierda;given-names:W</infon>
      <infon key="name_13">surname:Chen;given-names:R</infon>
      <infon key="name_14">surname:Kantarjan;given-names:H</infon>
      <infon key="name_11">surname:Pierce;given-names:S</infon>
      <infon key="name_12">surname:Wei;given-names:F</infon>
      <infon key="name_15">surname:Garcia-Manero;given-names:G</infon>
      <infon key="name_9">surname:Mallo;given-names:M</infon>
      <infon key="name_8">surname:O'Brien;given-names:S</infon>
      <infon key="name_7">surname:Estrov;given-names:Z</infon>
      <infon key="name_6">surname:Borthakur;given-names:G</infon>
      <infon key="name_5">surname:Kadia;given-names:T</infon>
      <infon key="name_4">surname:Abruzzo;given-names:L</infon>
      <offset>19582</offset>
      <text>Acquisition of cytogenetic abnormalities in patients with IPSS defined lower-risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia</text>
      <annotation id="481">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19626" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="482">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="19664" length="24"/>
        <text>myelodysplastic syndrome</text>
      </annotation>
      <annotation id="483">
        <infon key="identifier">MESH:D015470</infon>
        <infon key="type">Disease</infon>
        <location offset="19745" length="26"/>
        <text>acute myelogenous leukemia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">87</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Haase;given-names:D</infon>
      <infon key="fpage">515</infon>
      <infon key="issue">7</infon>
      <infon key="year">2008</infon>
      <infon key="source">Ann Haematol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">526</infon>
      <offset>19772</offset>
      <text>Cytogenetic features in myelodysplastic syndromes</text>
      <annotation id="485">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="19796" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">29</infon>
      <infon key="name_2">surname:Ebert;given-names:BL</infon>
      <infon key="name_1">surname:Levine;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bejar;given-names:R</infon>
      <infon key="fpage">504</infon>
      <infon key="pub-id_pmid">21220588</infon>
      <infon key="year">2011</infon>
      <infon key="source">J Clin Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">515</infon>
      <offset>19822</offset>
      <text>Unraveling the molecular pathophysiology of myelodysplastic syndromes</text>
      <annotation id="487">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="19866" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">112</infon>
      <infon key="name_2">surname:Smith;given-names:MT</infon>
      <infon key="name_1">surname:Howlader;given-names:N</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rollison;given-names:DE</infon>
      <infon key="fpage">45</infon>
      <infon key="pub-id_pmid">18443215</infon>
      <infon key="year">2008</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">52</infon>
      <offset>19892</offset>
      <text>Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States 2001-2004, using data from the NAACCR and SEER programs</text>
      <annotation id="490">
        <infon key="identifier">MESH:D009196</infon>
        <infon key="type">Disease</infon>
        <location offset="19946" length="28"/>
        <text>myeloproliferative disorders</text>
      </annotation>
      <annotation id="491">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="19908" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">19</infon>
      <infon key="name_2">surname:Pfeilstocker;given-names:M</infon>
      <infon key="name_1">surname:Hildebrandt;given-names:B</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Germing;given-names:U</infon>
      <infon key="fpage">2223</infon>
      <infon key="pub-id_pmid">16193087</infon>
      <infon key="year">2005</infon>
      <infon key="source">Leukemia</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2231</infon>
      <offset>20052</offset>
      <text>Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)</text>
      <annotation id="495">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20201" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="496">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="20250" length="3"/>
        <text>MDS</text>
      </annotation>
      <annotation id="497">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="20215" length="33"/>
        <text>primary myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Sperr;given-names:WR</infon>
      <infon key="name_2">surname:Germing;given-names:U</infon>
      <infon key="name_1">surname:Tuchler;given-names:H</infon>
      <infon key="name_0">surname:Nosslinger;given-names:T</infon>
      <infon key="fpage">120</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">19605511</infon>
      <infon key="year">2010</infon>
      <infon key="source">Ann Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">21</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Valent;given-names:P</infon>
      <infon key="name_8">surname:Giagounidis;given-names:A</infon>
      <infon key="name_7">surname:Stauder;given-names:R</infon>
      <infon key="lpage">125</infon>
      <infon key="name_6">surname:Lubbert;given-names:M</infon>
      <infon key="name_5">surname:Haase;given-names:D</infon>
      <infon key="name_4">surname:Krieger;given-names:O</infon>
      <offset>20255</offset>
      <text>Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes</text>
      <annotation id="500">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20308" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="501">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="20330" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Nomdedeu;given-names:B</infon>
      <infon key="name_2">surname:Such;given-names:E</infon>
      <infon key="name_1">surname:Cordoba;given-names:I</infon>
      <infon key="name_0">surname:Gonzalez-Porras;given-names:JR</infon>
      <infon key="fpage">5529</infon>
      <infon key="issue">24</infon>
      <infon key="pub-id_pmid">21638279</infon>
      <infon key="year">2011</infon>
      <infon key="source">Cancer</infon>
      <infon key="type">ref</infon>
      <infon key="volume">117</infon>
      <infon key="name_10">surname:Gomez;given-names:V</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_13">surname:Sanz;given-names:GF</infon>
      <infon key="name_14">surname:Del Canizo;given-names:AC</infon>
      <infon key="name_11">surname:de Paz;given-names:R</infon>
      <infon key="name_12">surname:Sanchez-Barba;given-names:M</infon>
      <infon key="name_9">surname:Pedro;given-names:C</infon>
      <infon key="name_8">surname:Ramos;given-names:F</infon>
      <infon key="name_7">surname:Ardanaz;given-names:M</infon>
      <infon key="name_6">surname:Luno;given-names:E</infon>
      <infon key="name_5">surname:Carbonell;given-names:F</infon>
      <infon key="name_4">surname:Vallespi;given-names:T</infon>
      <offset>20356</offset>
      <text>Spanish Myelodysplastic Syndrome Registry, Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome</text>
      <annotation id="505">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="20456" length="24"/>
        <text>myelodysplastic syndrome</text>
      </annotation>
      <annotation id="506">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="20364" length="15"/>
        <text>Myelodysplastic</text>
      </annotation>
      <annotation id="507">
        <infon key="identifier">MESH:D013921</infon>
        <infon key="type">Disease</infon>
        <location offset="20427" length="16"/>
        <text>thrombocytopenia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">2</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Cheson;given-names:BD</infon>
      <infon key="fpage">28</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">10388027</infon>
      <infon key="year">1997</infon>
      <infon key="source">The Oncologist</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">39</infon>
      <offset>20481</offset>
      <text>The Myelodysplastic Syndromes</text>
      <annotation id="509">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="20485" length="15"/>
        <text>Myelodysplastic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Dreyfus;given-names:F</infon>
      <infon key="name_2">surname:Quesnel;given-names:B</infon>
      <infon key="name_1">surname:Thepot;given-names:S</infon>
      <infon key="name_0">surname:Itzykson;given-names:R</infon>
      <infon key="fpage">403</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">20940414</infon>
      <infon key="year">2011</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="volume">117</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">411</infon>
      <infon key="name_5">surname:Turlure;given-names:P</infon>
      <infon key="name_4">surname:Beyne-Rauzy;given-names:O</infon>
      <offset>20511</offset>
      <text>Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine</text>
      <annotation id="513">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20571" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="514">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="20597" length="25"/>
        <text>myelodysplastic syndromes</text>
      </annotation>
      <annotation id="515">
        <infon key="identifier">MESH:D001374</infon>
        <infon key="type">Chemical</infon>
        <location offset="20636" length="11"/>
        <text>azacitidine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Invernizzi;given-names:R</infon>
      <infon key="name_2">surname:Pascutto;given-names:C</infon>
      <infon key="name_1">surname:Della;given-names:Porta MG</infon>
      <infon key="name_0">surname:Malcovati;given-names:l</infon>
      <infon key="fpage">7594</infon>
      <infon key="issue">30</infon>
      <infon key="year">2005</infon>
      <infon key="source">JCO</infon>
      <infon key="type">ref</infon>
      <infon key="volume">23</infon>
      <infon key="name_10">surname:Lazzarino;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_11">surname:Cazzola;given-names:M</infon>
      <infon key="name_9">surname:Bernasconi;given-names:P</infon>
      <infon key="name_8">surname:Maffioli;given-names:M</infon>
      <infon key="name_7">surname:Arcaini;given-names:L</infon>
      <infon key="lpage">7603</infon>
      <infon key="name_6">surname:Passamonti;given-names:F</infon>
      <infon key="name_5">surname:Travaglino;given-names:E</infon>
      <infon key="name_4">surname:Boni;given-names:M</infon>
      <offset>20648</offset>
      <text>Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making</text>
      <annotation id="517">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="20690" length="15"/>
        <text>Myelodysplastic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Lupu;given-names:AR</infon>
      <infon key="name_2">surname:Stanca;given-names:O</infon>
      <infon key="name_1">surname:Ciobanu;given-names:A</infon>
      <infon key="name_0">surname:Triantafyllidis;given-names:I</infon>
      <infon key="fpage">295</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">23483702</infon>
      <infon key="year">2012</infon>
      <infon key="source">Maedica (Buchar)</infon>
      <infon key="type">ref</infon>
      <infon key="volume">7</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">302</infon>
      <offset>20791</offset>
      <text>Prognostic factors in Myelodysplastic syndromes</text>
      <annotation id="519">
        <infon key="identifier">MESH:D009190</infon>
        <infon key="type">Disease</infon>
        <location offset="20813" length="25"/>
        <text>Myelodysplastic syndromes</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272835</id>
    <passage>
      <infon key="name_1">surname:Vrecko;given-names:Helena</infon>
      <infon key="article-id_pmid">25568575</infon>
      <infon key="name_0">surname:Klemenc-Ketis;given-names:Zalika</infon>
      <infon key="fpage">292</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272835</infon>
      <infon key="article-id_publisher-id">AIM-22-292</infon>
      <infon key="article-id_doi">10.5455/aim.2014.22.292-296</infon>
      <infon key="type">front</infon>
      <infon key="volume">22</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Acta Inform Med; 2014 Oct; 22(5) 292-6. doi:10.5455/aim.2014.22.292-296</infon>
      <infon key="kwd">medical ethics medical students qualitative study</infon>
      <infon key="lpage">296</infon>
      <infon key="authors">Klemenc-Ketis Z, Vrecko H</infon>
      <offset>0</offset>
      <text>The Perceptions of Professionalism by 1st and 5th Grade Medical Students</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>73</offset>
      <text>ABSTRACT</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>82</offset>
      <text>Introduction:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>96</offset>
      <text>Professionalism is essential for the development of mature physicians but not much education is devoted to that theme. Aim: We aimed to determine the views of undergraduate medical students on medical professionalism.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>314</offset>
      <text>Methods:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>323</offset>
      <text>This was a qualitative study, based on focus groups of the first and fifth-year undergraduate medical students. Transcripts of the focus groups were independently evaluated by two researches. Segments of transcripts, identified as important, were marked as verbatims. A grounded theory method with open coding was applied. A list of codes was developed and reviewed by both researchers until the consensus was reached. Then, the codes were reviewed and put into the categories and dimensions.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>816</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>825</offset>
      <text>Students recognized 10 main medical professionalism dimensions (empathy, respect, responsibility, autonomy, trust, communication, difference between professional and private life, team work, partnership) and two dimensions associated with it (physician's characteristics, external factors). Slight change of the attitudes towards a more self-centred future physicians' figure was observed in the fifth-year medical students.</text>
      <annotation id="1">
        <infon key="type">Disease</infon>
        <location offset="889" length="7"/>
        <text>empathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1252</offset>
      <text>Conclusion:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1264</offset>
      <text>The students have an appropriate picture of the physicians' figure even at the beginning of their medical studies but still needs an education in professionalism. It seems that the fifth-year students perceive physicians as more self-centred when compared to their first-year colleagues.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1554</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1570</offset>
      <text>In the era of sophisticated medical technology, family physicians should use technological advances but continue to practice comprehensive medicine in spite of health policy demands for more focus on public than individual outcomes. Consequently, the medical professionalism is slowly finding its way back to medical education. It is widely acknowledged that medical professionalism can be learned and taught. However, usually it is a part of a so called hidden curriculum: it is incorporated into teaching different subjects without setting clear learning objectives. There are voices that medical students besides communication skills, team work, practice organization, and knowledge management also should be taught in humanism, accountability and altruism. However, not much is known about the role of medical education in building a future physician who will possess the appropriate professional values, attitudes and behaviors. Even a unifying theoretical or practical model to use as a format for developing a professionalism teaching curriculum does not exist yet.</text>
      <annotation id="3">
        <infon key="type">Disease</infon>
        <location offset="2321" length="8"/>
        <text>altruism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2643</offset>
      <text>There is neither an unified definition nor theoretical model of medical professionalism at the moment. The American Board of Internal Medicine suggested that professionalism has six components: altruism, accountability, excellence, duty, honour/integrity and respect. A model from USA and Europe declared that professionalism consists of three fundamental principles (patient welfare, patient autonomy and social justice) with ten professional responsibilities. The model from UK suggests that medical professionalism consists of integrity, compassion, altruism, continuous improvement, excellence and working in partnership with team members.</text>
      <annotation id="8">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3011" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="9">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3028" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="10">
        <infon key="type">Disease</infon>
        <location offset="2837" length="8"/>
        <text>altruism</text>
      </annotation>
      <annotation id="11">
        <infon key="type">Disease</infon>
        <location offset="3196" length="8"/>
        <text>altruism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3287</offset>
      <text>So far, several studies have tried to determine the views of undergraduate medical student regarding the professionalism. They showed that undergraduate students in general have a clear perception of what medical professionalism was. On the other hand, a recent qualitative study from Australia showed that undergraduate students have had some difficulties with perceiving what a professional physician was; they differentiated between the term "good" doctor and professional doctor as they perceived professionalism as an external and imposed construct. It also seems that some differences exist regarding the perceptions of medical professionalism in undergraduate students of different study years. Students in higher years of education reported the decline of professionalism in terms of idealism, empathy, the perception of physicians' status and income and the rise of the negative views on primary care and the importance of lifestyle and family. This change of attitudes seems to be largely dependent on the curriculum and the teaching method applied. The shift from informal to formal teaching of professionalism resulted in higher sensitivity to professionalism and the early patient contact and small groups in professionalism enhanced the understanding of professionalism.</text>
      <annotation id="14">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4473" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="15">
        <infon key="type">Disease</infon>
        <location offset="4089" length="7"/>
        <text>empathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4578</offset>
      <text>Medical faculty Maribor is a young faculty which was established in 2003. The study of medicine lasts for six years and is consistent with the Bologna principles. No formal subject in the undergraduate study is devoted to professionalism therefore we can say that professionalism is a part of a hidden curriculum.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>4892</offset>
      <text>2. GOAL</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4900</offset>
      <text>The aim of this study was to determine the views of undergraduate medical students on medical professionalism and recognise any potential qualitative differences in their views according to the study year.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>5106</offset>
      <text>3. METHODS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>5117</offset>
      <text>3.1. Study design and settings</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5148</offset>
      <text>This was a qualitative study, based on focus groups. It took part on the Faculty of Medicine in Maribor, Slovenia and was performed in June 2014. The study was approved by the National Ethics Board (No. 226/09/13).</text>
      <annotation id="17">
        <infon key="type">Disease</infon>
        <location offset="5253" length="8"/>
        <text>Slovenia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>5363</offset>
      <text>3.2. Participants and focus groups</text>
      <annotation id="19">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5368" length="12"/>
        <text>Participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5398</offset>
      <text>The first and fifth-year undergraduate medical students took part in this study. They were recruited by the researchers through the personal contact. In the study year 2013/2014, there were 89 students in the first year and 90 students in the fifth year.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5653</offset>
      <text>The students were included in two focus groups. The first one consisted of the five first-year medical students (three women and two men), each 19 years old. The second one consisted of seven fifth-year medical students (two men and five women), each 23 years old. Both focus groups were moderated by one of the researchers (HV) and observed by the second researcher (ZKK). The focus groups participants discussed upon the several questions (Box 1).</text>
      <annotation id="25">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5772" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="26">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5786" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5878" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="28">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5891" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="29">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6044" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-292-g001.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>6103</offset>
      <text>The questions discussed in focus groups</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6143</offset>
      <text>Focus groups were audio-recorded. Oral informed consent was sought from the participants prior to the session.</text>
      <annotation id="31">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6219" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_2</infon>
      <offset>6254</offset>
      <text>3.3. Analysis</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6268</offset>
      <text>The interviews were typed to word documents. Transcripts were independently evaluated by both researches (HV and ZKK). Segments of transcripts, identified as important, were marked as verbatim. A grounded theory method with open coding was applied. A list of codes was developed and reviewed by both researchers until the consensus was reached. Then, the codes were reviewed and put into the categories and dimensions.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>6687</offset>
      <text>4. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6698</offset>
      <text>Students recognized 10 main medical professionalism dimensions (Table 1) and two dimensions associated with it (Table 2).</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>6820</offset>
      <text>4.1. Objectivity</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6837</offset>
      <text>Students of both study years expressed the importance of setting a clear line between objectivity and subjectivity in order not to let the subjective feelings influence the management of the patients.</text>
      <annotation id="33">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7028" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7038</offset>
      <text>"The sympathy towards a patient should not blur your professional objectivity." (Fifth-year female student)</text>
      <annotation id="35">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7062" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7150</offset>
      <text>"...exactly here...in the attitude towards the patient...to set the line between subjective and objective." (First-year female student)</text>
      <annotation id="37">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7197" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>7290</offset>
      <text>4.2. Empathy</text>
      <annotation id="39">
        <infon key="type">Disease</infon>
        <location offset="7295" length="7"/>
        <text>Empathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7303</offset>
      <text>First-year students perceived empathy as something you could learn but not in order to really become an empathic person but in to make an impression that you are an empathic person.</text>
      <annotation id="43">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7416" length="6"/>
        <text>person</text>
      </annotation>
      <annotation id="44">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7477" length="6"/>
        <text>person</text>
      </annotation>
      <annotation id="45">
        <infon key="type">Disease</infon>
        <location offset="7333" length="7"/>
        <text>empathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7485</offset>
      <text>"I think it is important that the physicians do not feel sorry for the patient as their primary goal is to cure the patients" (First-year female student)</text>
      <annotation id="48">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7556" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7601" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7643</offset>
      <text>"I think it is important to ask the patients how they are feeling. Not because you are really interested but to show them that you care. (First-year female student)</text>
      <annotation id="51">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7679" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7810</offset>
      <text>"...(empathy) is learned not innate...you can act that you care for someone but you really don't." (First-year male student)</text>
      <annotation id="53">
        <infon key="type">Disease</infon>
        <location offset="7815" length="7"/>
        <text>empathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7941</offset>
      <text>Fifth-year students were more concerned with how to draw a line between being too empathic and being not empathic at all.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8063</offset>
      <text>"It is necessary to find a healthy line between taking the emotional stuff home and not being able to sleep and between being a misanthrope and a cold person." (Fifth-year female student)</text>
      <annotation id="55">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8214" length="6"/>
        <text>person</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8255</offset>
      <text>"Not only that we write in the patient's record that we will keep him for another week in the hospital because he has nowhere to go but also to understand his situation and to adjust the management and communication." (Fifth-year male student)</text>
      <annotation id="57">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8286" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>8503</offset>
      <text>4.3. Respect</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8516</offset>
      <text>Students of both study years recognized the importance of a respectful relationship towards coworkers and patients.</text>
      <annotation id="59">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8622" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8632</offset>
      <text>"I cannot imagine the relationship my colleague will have towards patients if he is not able to say hi to me when we meet even though he has been my classmate for the last five years. " (Fifth-year female student)</text>
      <annotation id="61">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8698" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8850</offset>
      <text>"To show respect to the patients by addressing them with sir or madam." (First-year female student)</text>
      <annotation id="63">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8874" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>8954</offset>
      <text>4.4. Responsibility</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8974</offset>
      <text>Students expressed the need for responsibility in form of continuous professional education and being able to recognize your limits.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9107</offset>
      <text>"...to engage in continuous education, to try to follow guidelines, not to rest on laureates." (Fifth-year female student)</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9234</offset>
      <text>"...being responsible to your patients in a way to be able to help them as much as you can." (Fifth-year female student)</text>
      <annotation id="65">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9264" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9359</offset>
      <text>"If the physician does not know what is wrong with you he refers you to other physicians." (First-year female student)</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>9482</offset>
      <text>4.5. Autonomy</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9496</offset>
      <text>The first-year students perceived autonomy as the right of patients to make their own decisions and also as their obligation for taking more responsibility. The fifth-year students referred also to the autonomy of the physicians.</text>
      <annotation id="67">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9555" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9726</offset>
      <text>"I think that nowadays patients have way to much autonomy and very little responsibility and this is not right." (First-year female student)</text>
      <annotation id="69">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9749" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>9871</offset>
      <text>"...that you do not let the patient to control you i.e. to tell you which drug to prescribe, to set this line." (Fifth-year female student)</text>
      <annotation id="71">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9899" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10015</offset>
      <text>"That the explanatory duty/informed consent does not become some kind of a blackmail and a form of persuasion that your truth is the only truth for this patient but that you only try to explain and present different treatment options." (Fifth-year female student)</text>
      <annotation id="73">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10168" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>10283</offset>
      <text>4.6. Trust</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10294</offset>
      <text>The students agreed that trust and confidentiality were essential parts of medical professionalism.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10394</offset>
      <text>"I perceive professionalism as the relationship where patient's problems stay between you and him. That you do not talk about them outside your office." (First-year male student)</text>
      <annotation id="75">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10448" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10577</offset>
      <text>"You have to gain confidence, that he trust you, that your knowledge is sufficient and he can put his health into your hands." (First-year female student)</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10736</offset>
      <text>Communication</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10750</offset>
      <text>Students perceived communication as an essential part of professionalism practice. They considered that patient should understand physician and also physician should understand patient.</text>
      <annotation id="78">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10854" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="79">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10927" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10936</offset>
      <text>"It is important to now that nowadays patients read a lot and then they can mislead their physician that they understand something but they really don't. They just talk about something they've read somewhere and do not understand it." (Fifth-year female student)</text>
      <annotation id="81">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10974" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11207</offset>
      <text>"I think that medicine has become a service activity ad people seek service when they go to the doctor. They sometimes forget how good it felt when physicians took the time and listened to them." (Fifth-year male student)</text>
      <annotation id="83">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11263" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11433</offset>
      <text>"Professionalism is being able to communicate in such a way that the patient understands you. If he comes from low social class you communicate in a more lay language and if he comes from a high class you can communicate in a more sophisticate way." (First-year male student)</text>
      <annotation id="85">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11502" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11713</offset>
      <text>Difference between professional and private life</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>11762</offset>
      <text>The students recognized the importance of drawing the line between professional and private life. First-year students were very strict about it, whereas fifth-year students allowed the possibility to do so but being aware of the consequences.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12005</offset>
      <text>"...if you take this home as a luggage then this can limit your ability to perform your work. Which also affects the patients." (Fifth-year female student)</text>
      <annotation id="87">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12122" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12165</offset>
      <text>"When you come home you must leave your work at work. There is no other way." (First-year female student)</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>12275</offset>
      <text>4.7. Team work</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12290</offset>
      <text>Team work as a part of professionalism was only recognized by fifth-year students.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12373</offset>
      <text>"...meaning that there is not any gossiping and malicious imputation in the team so you can focus on work. This is what patients deserve." (Fifth-year male student)</text>
      <annotation id="89">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12493" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12542</offset>
      <text>"For example, the patients can see if there are some disputes within the team and this is a sign for them that they will not receive a quality management." (Fifth-year female student)</text>
      <annotation id="91">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12560" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>12730</offset>
      <text>4.8. Partnership</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12747</offset>
      <text>Partner relationship with patients was only recognized by fifth-year students.</text>
      <annotation id="93">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12773" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12826</offset>
      <text>"That you do not give the patient the feeling that he has no clue and that you do not place yourself above him." (Fifth-year female student)</text>
      <annotation id="95">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12852" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>12971</offset>
      <text>"I think that the patient has to feel as he has the possibility to participate in the decisions but that is our duty to present out professional opinion in such a way that he will agree with it and still think that it was solely his decision." (Fifth-year female student)</text>
      <annotation id="97">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12989" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>13247</offset>
      <text>4.9. Physician's characteristics</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13280</offset>
      <text>Physician's personality</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13304</offset>
      <text>Students perceived the personality of the physician to be an important part of professionalism. However, they thought it was greatly a matter of family patterns.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13466</offset>
      <text>"I think that this is a thing that people bring it from their childhood, from their families." (Fifth-year female student)</text>
      <annotation id="99">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13501" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13593</offset>
      <text>"Some people always ignore those who for example fall on the street while others always stop and help. This is not something you could learn." (Fifth-year female student)</text>
      <annotation id="101">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13599" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>13768</offset>
      <text>"Professionalism largely depends on the personality. Some are more collegial and help their colleagues even now and lend them their notes while others keep the things to themselves. You know that they will be like that with their patients : they will not be willing to listen to anybody or to recognize their mistakes." (First-year male student)</text>
      <annotation id="104">
        <infon key="identifier">651272</infon>
        <infon key="type">Species</infon>
        <location offset="13924" length="10"/>
        <text>the things</text>
      </annotation>
      <annotation id="105">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13998" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14120</offset>
      <text>Role modelling</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14135</offset>
      <text>This was recognized only by fifth-year students.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14184</offset>
      <text>"To be a good mentor to students and trainees and others you ought to educate. Nowadays, many are involved in the education process as teachers but they fail to remember that." (Fifth-year male student)</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14391</offset>
      <text>Expertise</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14401</offset>
      <text>Students perceived expertise to be a part of medical professionalism but not necessary a positive part.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14505</offset>
      <text>"Someone can be a great expert but has a very low professional relationship towards patients." (Fifth-year female student)</text>
      <annotation id="107">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14589" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14632</offset>
      <text>"I think that there are also doctors who are not very professional but are great experts. They can diagnose a patient very good but are not considered to be good doctors by patients." (First-year female student)</text>
      <annotation id="110">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14742" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="111">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14805" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_2</infon>
      <offset>14848</offset>
      <text>4.10. External factors</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14871</offset>
      <text>Education</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>14881</offset>
      <text>According to fifth-year students, professionalism can be learned and the education system can affect it, especially in a negative way.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>15016</offset>
      <text>"I think that professionalism or at least one part of it, can be learned." (Fifth-year male student)</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>15121</offset>
      <text>"I think that the medical profession can soon become inhuman. So, the humanistic part of it should be constantly a part of education. Otherwise, we can quickly start regarding patients as objects and not humans." (Fifth-year male student)</text>
      <annotation id="114">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15297" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15325" length="6"/>
        <text>humans</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>15364</offset>
      <text>"I think that you change a lot during your study. You start to hate people." (Fifth-year female student)</text>
      <annotation id="117">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15432" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>15473</offset>
      <text>Health care system</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>15492</offset>
      <text>Students regarded health care system as an obstacle to professionalism.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>15564</offset>
      <text>"The problem is the health care system itself. You do not have time to engage in a humanistic and professional relationship." (Fifth-year female student)</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>15722</offset>
      <text>"I still think that the health care system made the people to perceive the health care workers as their slaves or as salesmen in the store - they expect to get some kind of drug each time they go to the doctor." (First-year female student)</text>
      <annotation id="119">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15774" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>15968</offset>
      <text>5. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>15982</offset>
      <text>Students in this study recognized the majority of professionalism components as recognized in several theoretical models. The also recognized some external and internal factors that were associated with or could in their opinion affect the medical professionalism. Although there were no significant differences in the attitudes towards medical professionalism between first-and fifth-year students, a change in the perceptions of the fifth-year medical students was observed in terms of recognizing more professionalism categories and more self-centred perceptions about the physician figure.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16576</offset>
      <text>As previously stated, there is no unified theoretical model of medical professionalism and it is therefore difficult to relate our results to the theoretical concepts. If we compare the medical professionalism categories recognized by the undergraduate students to the aforementioned theoretical models (Table 1), we can see that the main professionalism components have been recognized: altruism, autonomy, integrity, relationship, empathy and confidentiality. Of course, the wording and the terms of some components are sometimes different but the meaning is similar, i.e. objectivity and responsibility relate to altruism and autonomy relates to integrity. However, the students failed to recognize some professionalism components, i.e. continuous improvement, quality of care, access to care, distribution of finite resources and scientific knowledge. If we take a look at some studies that dealt with professionalism attitudes in undergraduate students, we can see that students recognized a very wide range of professionalism components and some of them are comparable to the categories in our study. For example, five out of seven components reported by Blackall et al were recognized in our study: accountability, altruism, duty, honour and integrity and respect. In another study, similar to our study, respect, relationship and partnership were recognized. Yet another study put forward confidentiality - similar to our study. However, the students in our study also recognized empathy, communication, team work and difference between professional and private life which other studies failed to recognize.</text>
      <annotation id="126">
        <infon key="type">Disease</infon>
        <location offset="18064" length="7"/>
        <text>empathy</text>
      </annotation>
      <annotation id="127">
        <infon key="type">Disease</infon>
        <location offset="16964" length="8"/>
        <text>altruism</text>
      </annotation>
      <annotation id="128">
        <infon key="type">Disease</infon>
        <location offset="17798" length="8"/>
        <text>altruism</text>
      </annotation>
      <annotation id="129">
        <infon key="type">Disease</infon>
        <location offset="17192" length="8"/>
        <text>altruism</text>
      </annotation>
      <annotation id="130">
        <infon key="type">Disease</infon>
        <location offset="17009" length="7"/>
        <text>empathy</text>
      </annotation>
      <annotation id="131">
        <infon key="identifier">MESH:D008569</infon>
        <infon key="type">Disease</infon>
        <location offset="17053" length="7"/>
        <text>wording</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>18194</offset>
      <text>Some factors which are not professionalism components but rather relate to professionalism or even affect it were recognized by the students in our study. These were physician's characteristics and external factors (Table 2). These factors act either as facilitators or inhibitors of professionalism. They are also not recognized in the aforementioned theoretical models. However, some of them were recognized in some other studies on students' attitudes to professionalism, i.e. physician's self-development. Also, some of them were recognized in some studies as the possible influences on professionalism (i.e. role modelling). In our study, the students recognized the expertise of the physicians to be among possible influential factors whilst in some other studies and/or theoretical models this entity was one of professionalism components. In our study, the students also expressed the role of external factors. One of them is the role of education which has already been studies and agreed that professionalism can be learned and taught. Also, the students recognized a very important role of the health care system which can have a (mainly) negative influence on professionalism.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>19385</offset>
      <text>In this study, some differences were detected between the first-and fifth-year students' attitudes towards professionalism. First of all, some categories were recognized only by the fifth-year students: teamwork, partnership, role modelling and education. It seems that students do learn about professionalism through their medical studies. Also, they seem to grasp the importance of education in developing a figure of a professional physician. Additionally, there were some qualitative differences in perception of several professionalism components. Although the students of both study years recognized empathy as one of the components, first-year students expressed a very pragmatic attitude towards it whereas fifth-year students were concerned about how to cope with too much empathy. Similar findings were reported regarding drawing the line between personal and professional life. Several studies reported on the decline of empathy through the medical studies. Although our study was qualitative and hence the differences are hard to detect, our results suggest that the students become more sensible to empathy as they move towards the end of their studies. Based on the results of our study, we cannot claim that they become more or less empathic; we can only say that they become aware of potential harm empathy could have on their personal lives. This finding relates also to the finding about the autonomy. Namely, the fifth-year students also recognized the autonomy of the physician not only of the patient.</text>
      <annotation id="138">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20899" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="139">
        <infon key="type">Disease</infon>
        <location offset="19991" length="7"/>
        <text>empathy</text>
      </annotation>
      <annotation id="140">
        <infon key="type">Disease</infon>
        <location offset="20167" length="7"/>
        <text>empathy</text>
      </annotation>
      <annotation id="141">
        <infon key="type">Disease</infon>
        <location offset="20317" length="7"/>
        <text>empathy</text>
      </annotation>
      <annotation id="142">
        <infon key="type">Disease</infon>
        <location offset="20700" length="7"/>
        <text>empathy</text>
      </annotation>
      <annotation id="143">
        <infon key="type">Disease</infon>
        <location offset="20497" length="7"/>
        <text>empathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>20910</offset>
      <text>The finding that the first-year students recognized the majority of the professionalism components points to the fact that the students have an appropriate picture of the physicians' figure even at the beginning of their medical studies. The finding that the fifth-year students recognized more components then their first-year colleagues confirms the need for professionalism education. A slight change of the attitudes detected in our study might point to the development of a more self-centred future physicians' figure which is also consistent with other studies. There is a need for quantitative prospective studies which will evaluate these qualitative findings and critically assess the role of education.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>21627</offset>
      <text>This study had a qualitative methodology which was appropriate for determination of the attitudes but less appropriate for the evaluation of differences between first-and fifth-year medical students. With qualitative methodology, we cannot detect quantitative differences in attitudes but only the substantive differences. However, the study gave us the insight to the attitudes of students towards professionalism and will serve for the development of a quantitative tool for measuring these attitudes.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>22131</offset>
      <text>6. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>22145</offset>
      <text>The students seem to have an appropriate picture of the physicians' figure even at the beginning of their medical studies. It seems that the fifth-year students perceive physicians as more self-centred when compared to their first-year colleagues. Therefore, an education on professionalism is essential also at the undergraduate level. Further studies are needed to assess the differences in attitudes among medical students in different study years.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>22599</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>22636</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="volume">18</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kersnik;given-names:J</infon>
      <infon key="fpage">199</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">23205965</infon>
      <infon key="year">2012</infon>
      <infon key="source">Eur J Gen Pract</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">200</infon>
      <offset>22647</offset>
      <text>Learning and teaching to educate future GPs</text>
    </passage>
    <passage>
      <infon key="volume">58</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Mueller;given-names:PS</infon>
      <infon key="fpage">133</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">19826207</infon>
      <infon key="year">2009</infon>
      <infon key="source">Keio J Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">143</infon>
      <offset>22691</offset>
      <text>Incorporating professionalism into medical education: the Mayo Clinic experience</text>
      <annotation id="145">
        <infon key="identifier">162683</infon>
        <infon key="type">Species</infon>
        <location offset="22749" length="4"/>
        <text>Mayo</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">58</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hilton;given-names:S</infon>
      <infon key="fpage">353</infon>
      <infon key="issue">550</infon>
      <infon key="pub-id_pmid">18482490</infon>
      <infon key="year">2008</infon>
      <infon key="source">Br J Gen Pract</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">361</infon>
      <offset>22772</offset>
      <text>Education and the changing face of medical professionalism: from priest to mountain guide?</text>
    </passage>
    <passage>
      <infon key="volume">11</infon>
      <infon key="name_1">surname:Kersnik;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Klemenc-Ketis;given-names:Z</infon>
      <infon key="fpage">60</infon>
      <infon key="pub-id_pmid">21861900</infon>
      <infon key="year">2011</infon>
      <infon key="source">BMC Med Educ</infon>
      <infon key="type">ref</infon>
      <offset>22863</offset>
      <text>Using movies to teach professionalism to medical students</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Cedilnik-Gorup;given-names:E</infon>
      <infon key="volume">53</infon>
      <infon key="name_2">surname:Petek;given-names:D</infon>
      <infon key="name_1">surname:Ster;given-names:B</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Petek-Ster;given-names:M</infon>
      <infon key="fpage">89</infon>
      <infon key="issue">1</infon>
      <infon key="year">2014</infon>
      <infon key="source">Zdrav Var</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">100</infon>
      <offset>22921</offset>
      <text>Validation of Slovenian version of Jefferson scale of empathy for students</text>
      <annotation id="147">
        <infon key="type">Disease</infon>
        <location offset="22975" length="7"/>
        <text>empathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Omona;given-names:K</infon>
      <infon key="name_2">surname:Galukande;given-names:M</infon>
      <infon key="name_1">surname:Nakasujja;given-names:N</infon>
      <infon key="name_0">surname:Baingana;given-names:RK</infon>
      <infon key="fpage">76</infon>
      <infon key="pub-id_pmid">21050457</infon>
      <infon key="year">2010</infon>
      <infon key="source">BMC Med Educ</infon>
      <infon key="type">ref</infon>
      <infon key="volume">10</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_5">surname:Sewankambo;given-names:NK</infon>
      <infon key="name_4">surname:Mafigiri;given-names:DK</infon>
      <offset>22996</offset>
      <text>Learning health professionalism at Makerere University: an exploratory study amongst undergraduate students</text>
    </passage>
    <passage>
      <infon key="volume">45</infon>
      <infon key="name_2">surname:Hu;given-names:W</infon>
      <infon key="name_1">surname:Rees;given-names:CE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Monrouxe;given-names:LV</infon>
      <infon key="fpage">585</infon>
      <infon key="issue">6</infon>
      <infon key="pub-id_pmid">21564198</infon>
      <infon key="year">2011</infon>
      <infon key="source">Med Educ</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">602</infon>
      <offset>23104</offset>
      <text>Differences in medical students' explicit discourses of professionalism: acting, representing, becoming</text>
    </passage>
    <passage>
      <infon key="volume">44</infon>
      <infon key="name_2">surname:Sawdon;given-names:M</infon>
      <infon key="name_1">surname:Garner;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Finn;given-names:G</infon>
      <infon key="fpage">814</infon>
      <infon key="issue">8</infon>
      <infon key="pub-id_pmid">20633221</infon>
      <infon key="year">2010</infon>
      <infon key="source">Med Educ</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">825</infon>
      <offset>23210</offset>
      <text>'You' re judged all the time! 'Students' views on professionalism: a multicentre study</text>
    </passage>
    <passage>
      <infon key="volume">51</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Svab;given-names:I</infon>
      <infon key="fpage">225</infon>
      <infon key="year">2012</infon>
      <infon key="source">Zdrav Var</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">226</infon>
      <offset>23305</offset>
      <text>Education in medicine</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Fantone;given-names:JC</infon>
      <infon key="name_2">surname:Ross;given-names:PT</infon>
      <infon key="name_1">surname:Kumagai;given-names:AK</infon>
      <infon key="name_0">surname:White;given-names:CB</infon>
      <infon key="fpage">597</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">19704192</infon>
      <infon key="year">2009</infon>
      <infon key="source">Acad Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">84</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">603</infon>
      <offset>23327</offset>
      <text>A qualitative exploration of how the conflict between the formal and informal curriculum influences student values and behaviors</text>
    </passage>
    <passage>
      <infon key="volume">18</infon>
      <infon key="name_1">surname:Wensing;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kersnik;given-names:J</infon>
      <infon key="fpage">238</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">23205967</infon>
      <infon key="year">2012</infon>
      <infon key="source">Eur J Gen Pract</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">241</infon>
      <offset>23456</offset>
      <text>Improving the quality of care for patients with chronic diseases: what research and education in family medicine can contribute</text>
      <annotation id="150">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23490" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="151">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="23504" length="16"/>
        <text>chronic diseases</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Meador;given-names:KG</infon>
      <infon key="name_2">surname:Newton;given-names:WP</infon>
      <infon key="name_1">surname:Kinghorn;given-names:WA</infon>
      <infon key="name_0">surname:Daaleman;given-names:TP</infon>
      <infon key="fpage">325</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">21557101</infon>
      <infon key="year">2011</infon>
      <infon key="source">Fam Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">43</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">329</infon>
      <offset>23584</offset>
      <text>Rethinking professionalism in medical education through formation</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Harrison;given-names:M</infon>
      <infon key="name_2">surname:Wilson;given-names:I</infon>
      <infon key="name_1">surname:Glass;given-names:N</infon>
      <infon key="name_0">surname:Birden;given-names:H</infon>
      <infon key="fpage">e1252</infon>
      <infon key="issue">7</infon>
      <infon key="pub-id_pmid">23829342</infon>
      <infon key="year">2013</infon>
      <infon key="source">Med Teach</infon>
      <infon key="type">ref</infon>
      <infon key="volume">35</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">e66</infon>
      <infon key="name_5">surname:Nass;given-names:D</infon>
      <infon key="name_4">surname:Usherwood;given-names:T</infon>
      <offset>23650</offset>
      <text>Teaching professionalism in medical education: a Best Evidence Medical Education (BEME) systematic review. BEME Guide. No. 25</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Thistlethwaite;given-names:J</infon>
      <infon key="volume">1</infon>
      <infon key="name_2">surname:Peile;given-names:E</infon>
      <infon key="name_1">surname:Doug;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Passi;given-names:V</infon>
      <infon key="fpage">19</infon>
      <infon key="year">2010</infon>
      <infon key="source">Int J Med Educ</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">29</infon>
      <infon key="name_4">surname:Johnson;given-names:N</infon>
      <offset>23776</offset>
      <text>Developing medical professionalism in future doctors: a systematic review</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="year">1995</infon>
      <infon key="type">ref</infon>
      <offset>23850</offset>
      <text>American Board of Internal Medicine Project Professionalism</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Merino;given-names:J</infon>
      <infon key="name_2">surname:McDonald;given-names:W</infon>
      <infon key="name_1">surname:Kimball;given-names:H</infon>
      <infon key="name_0">surname:Blank;given-names:L</infon>
      <infon key="fpage">839</infon>
      <infon key="issue">10</infon>
      <infon key="pub-id_pmid">12755556</infon>
      <infon key="year">2003</infon>
      <infon key="source">Ann Intern Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">138</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">841</infon>
      <offset>23910</offset>
      <text>Medical professionalism in the new millennium: a physician charter 15 months later</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="year">2005</infon>
      <infon key="source">Report of a Working Party of the RCP</infon>
      <infon key="type">ref</infon>
      <offset>23993</offset>
      <text>Anon. Doctors in society: Medical professionalism in a changing world</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Sawdon;given-names:MA</infon>
      <infon key="name_2">surname:McLachlan;given-names:J</infon>
      <infon key="name_1">surname:O'Flynn;given-names:S</infon>
      <infon key="name_0">surname:Kelly;given-names:M</infon>
      <infon key="fpage">1218</infon>
      <infon key="issue">9</infon>
      <infon key="pub-id_pmid">22836848</infon>
      <infon key="year">2012</infon>
      <infon key="source">Acad Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">87</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1224</infon>
      <offset>24063</offset>
      <text>The clinical conscientiousness index: a valid tool for exploring professionalism in the clinical undergraduate setting</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Steele;given-names:K</infon>
      <infon key="name_2">surname:McGlade;given-names:KJ</infon>
      <infon key="name_1">surname:Cupples;given-names:ME</infon>
      <infon key="name_0">surname:Johnston;given-names:JL</infon>
      <infon key="fpage">321</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">22005490</infon>
      <infon key="year">2011</infon>
      <infon key="source">Educ Prim Care</infon>
      <infon key="type">ref</infon>
      <infon key="volume">22</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">327</infon>
      <offset>24182</offset>
      <text>Medical students' attitudes to professionalism: an opportunity for the GP tutor?</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Violato;given-names:C</infon>
      <infon key="name_2">surname:Harasym;given-names:PH</infon>
      <infon key="name_1">surname:Lin;given-names:CH</infon>
      <infon key="name_0">surname:Tsai;given-names:TC</infon>
      <infon key="fpage">128</infon>
      <infon key="issue">2-3</infon>
      <infon key="pub-id_pmid">17701622</infon>
      <infon key="year">2007</infon>
      <infon key="source">Med Teach</infon>
      <infon key="type">ref</infon>
      <infon key="volume">29</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">134</infon>
      <offset>24265</offset>
      <text>Students'perception on medical professionalism: the psychometric perspective</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Playford;given-names:P</infon>
      <infon key="volume">14</infon>
      <infon key="name_2">surname:Johnson;given-names:P</infon>
      <infon key="name_1">surname:Auret;given-names:K</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Cuesta-Briand;given-names:B</infon>
      <infon key="fpage">77</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">24725303</infon>
      <infon key="year">2014</infon>
      <infon key="source">BMC Med Educ</infon>
      <infon key="type">ref</infon>
      <offset>24344</offset>
      <text>'A world of difference': a qualitative study of medical students' views on professionalism and the 'good doctor'</text>
    </passage>
    <passage>
      <infon key="volume">10</infon>
      <infon key="name_2">surname:Abel;given-names:P</infon>
      <infon key="name_1">surname:Gatter;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Gale-Grant;given-names:G</infon>
      <infon key="fpage">165</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">23656678</infon>
      <infon key="year">2013</infon>
      <infon key="source">Clin Teach</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">169</infon>
      <offset>24467</offset>
      <text>Developing ideas of professionalism</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Zabar;given-names:S</infon>
      <infon key="name_2">surname:Ark;given-names:T</infon>
      <infon key="name_1">surname:Paik;given-names:S</infon>
      <infon key="name_0">surname:Gillespie;given-names:C</infon>
      <infon key="fpage">208</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">21975980</infon>
      <infon key="year">2009</infon>
      <infon key="source">J Grad Med Educ</infon>
      <infon key="type">ref</infon>
      <infon key="volume">1</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">215</infon>
      <infon key="name_4">surname:Kalet;given-names:A</infon>
      <offset>24503</offset>
      <text>Residents' perceptions of their own professionalism and the professionalism of their learning environment</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Villarreal;given-names:AL</infon>
      <infon key="volume">18</infon>
      <infon key="name_2">surname:Smith;given-names:JA</infon>
      <infon key="name_1">surname:Roseamelia;given-names:C</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Morley;given-names:CP</infon>
      <infon key="fpage">21194</infon>
      <infon key="pub-id_pmid">23968751</infon>
      <infon key="year">2013</infon>
      <infon key="source">Med Educ Online</infon>
      <infon key="type">ref</infon>
      <offset>24611</offset>
      <text>Decline of medical student idealism in the first and second year of medical school: a survey of pre-clinical medical students at one institution</text>
    </passage>
    <passage>
      <infon key="volume">38</infon>
      <infon key="name_2">surname:Nasca;given-names:TJ</infon>
      <infon key="name_1">surname:Mangione;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hojat;given-names:M</infon>
      <infon key="fpage">934</infon>
      <infon key="issue">9</infon>
      <infon key="pub-id_pmid">15327674</infon>
      <infon key="year">2004</infon>
      <infon key="source">Med Educ</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">41</infon>
      <offset>24756</offset>
      <text>An empirical study of decline in empathy in medical school</text>
      <annotation id="153">
        <infon key="type">Disease</infon>
        <location offset="24789" length="7"/>
        <text>empathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">29</infon>
      <infon key="name_2">surname:Shoop;given-names:GH</infon>
      <infon key="name_1">surname:Melnick;given-names:SA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Blackall;given-names:GF</infon>
      <infon key="fpage">e58</infon>
      <infon key="issue">2-3</infon>
      <infon key="pub-id_pmid">17701611</infon>
      <infon key="year">2007</infon>
      <infon key="source">Med Teach</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">e62</infon>
      <offset>24815</offset>
      <text>Professionalism in medical education: the development and validation of a survey instrument to assess attitudes toward professionalism</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Moineau;given-names:G</infon>
      <infon key="volume">12</infon>
      <infon key="name_2">surname:McGuinty;given-names:C</infon>
      <infon key="name_1">surname:Hendelman;given-names:W</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Byszewski;given-names:A</infon>
      <infon key="fpage">115</infon>
      <infon key="pub-id_pmid">23153359</infon>
      <infon key="year">2012</infon>
      <infon key="source">BMC Med Educ</infon>
      <infon key="type">ref</infon>
      <offset>24950</offset>
      <text>Wanted: role models - medical students' perceptions of professionalism</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Deepak;given-names:KK</infon>
      <infon key="name_2">surname:Al-Sheikh;given-names:M</infon>
      <infon key="name_1">surname:Al-Umran;given-names:KU</infon>
      <infon key="name_0">surname:Adkoli;given-names:BV</infon>
      <infon key="fpage">840</infon>
      <infon key="issue">10</infon>
      <infon key="pub-id_pmid">21355690</infon>
      <infon key="year">2011</infon>
      <infon key="source">Med Teach</infon>
      <infon key="type">ref</infon>
      <infon key="volume">33</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">5</infon>
      <infon key="name_4">surname:Al-Rubaish;given-names:AM</infon>
      <offset>25025</offset>
      <text>Medical students' perception of professionalism: a qualitative study from Saudi Arabia</text>
    </passage>
    <passage>
      <infon key="volume">298</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Relman;given-names:AS</infon>
      <infon key="fpage">2668</infon>
      <infon key="issue">22</infon>
      <infon key="pub-id_pmid">18073363</infon>
      <infon key="year">2007</infon>
      <infon key="source">JAMA</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">70</infon>
      <offset>25114</offset>
      <text>Medical professionalism in a commercialized health care market</text>
    </passage>
  </document>
  <document>
    <id>4272836</id>
    <passage>
      <infon key="name_3">surname:Saban;given-names:Orhan</infon>
      <infon key="name_2">surname:Karamehic;given-names:Jasenko</infon>
      <infon key="name_1">surname:Ridic;given-names:Ognjen</infon>
      <infon key="article-id_pmid">25568628</infon>
      <infon key="name_0">surname:Saban;given-names:Aida</infon>
      <infon key="fpage">309</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272836</infon>
      <infon key="article-id_publisher-id">MSM-26-309</infon>
      <infon key="article-id_doi">10.5455/msm.2014.26.309-312</infon>
      <infon key="type">front</infon>
      <infon key="volume">26</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Mater Sociomed; 2014 Oct; 26(5) 309-12. doi:10.5455/msm.2014.26.309-312</infon>
      <infon key="kwd">assessment socioeconomic status status of oral health school children</infon>
      <infon key="name_8">surname:Panjeta;given-names:Mirsad</infon>
      <infon key="name_7">surname:Ridic;given-names:Goran</infon>
      <infon key="lpage">312</infon>
      <infon key="name_6">surname:Coric;given-names:Jozo</infon>
      <infon key="name_5">surname:Dzananovic;given-names:Nejra</infon>
      <infon key="name_4">surname:Delic-Sarac;given-names:Marina</infon>
      <infon key="authors">Saban A, Ridic O, Karamehic J, Saban O, Delic-Sarac M, Dzananovic N, Coric J, Ridic G, Panjeta M</infon>
      <offset>0</offset>
      <text>Assessments of the Socioeconomic Status and Diet on the Prevalence of Dental Caries at School Children in Central Bosnian Canton</text>
      <annotation id="1">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="94" length="8"/>
        <text>Children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>129</offset>
      <text>Aim:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>134</offset>
      <text>The main aim of this research was to determine the influence of socioeconomic status and residence/living conditions on the status of oral health (e.g. health of mouth and teeth) in primary school students residing in Canton Central Bosnia.</text>
      <annotation id="3">
        <infon key="identifier">MESH:D012607</infon>
        <infon key="type">Disease</infon>
        <location offset="352" length="21"/>
        <text>Canton Central Bosnia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>375</offset>
      <text>Methods:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>384</offset>
      <text>The study was designed as a cross-sectional study. Our research included two-phased stratified random sample of 804 participants. The quantitative research method and newly designed survey instrument were utilized in order to provide data on the oral health of the examined children. The alternate hypothesis foresaw that "there were significant statistical differences between the levels of incidence of dental caries in comparison to the incidence in children of different socioeconomic status.</text>
      <annotation id="7">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="500" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="8">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="658" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="9">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="837" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>883</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>892</offset>
      <text>The Chi square  of 22.814, degree of freedom (Df) = 8, coefficient of contingency of 0.163 and T-test (Stat) of-0.18334 showed that there were no significant statistical differences at p &lt; 0.05 level between the primary school children from urban and rural areas. The obtained results showed that the caries indexes in elementary schools in Central Bosnia Canton were fairly uniform. Research showed that there were a difference in the attitudes towards a regular dental visits, which correlated with social-educational structure of the children's' families.</text>
      <annotation id="13">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1119" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="14">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1429" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="15">
        <infon key="identifier">MESH:D012607</infon>
        <infon key="type">Disease</infon>
        <location offset="1233" length="21"/>
        <text>Central Bosnia Canton</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1457</offset>
      <text>Conclusion:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1469</offset>
      <text>According to the results, we can see that the socioeconomic status of patients had an effect on the occurrence of dental caries and oral hygiene in patients in relation to the rural and urban areas, because we can see that by the number of respondents, the greater unemployment of parents in both, rural and urban areas, caused a host of other factors, which were, either, directly or indirectly connected with the development of caries.</text>
      <annotation id="18">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1539" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="19">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1617" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1907</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1923</offset>
      <text>Oral health (i.e. health of mouth and teeth) of school children represents a significant social and economic value of the modern world. Retrospective research data show that there is a difference in attitudes of examined children regarding the regular control of oral health, which is in correlation with social and educational structure of their families. The opinion that by practicing a regular preventive controls diseases of mouth and teeth can be prevented, obviously and unfortunately is not prevalent as life practice in many of primary school children's families Even though the children are exposed to the oral health at the fairly young age and although the parents are increasingly aware of the importance of the oral health for the entire well-being of their children, in many instances the role of parents and children in maintaining health of mouth and teeth is not sufficient, so the necessity arises to seek the professional help. It is best to seek help of dental professionals preventively, even then when everything seems to be well with the health of mouth and teeth.</text>
      <annotation id="27">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1978" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="28">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2144" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="29">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2475" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="30">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2511" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="31">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2695" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="32">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2747" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="33">
        <infon key="identifier">MESH:D009059</infon>
        <infon key="type">Disease</infon>
        <location offset="2341" length="17"/>
        <text>diseases of mouth</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3012</offset>
      <text>In 2005, as an answer to the rather poor state of primary school children's oral health in Federation entity of Bosnia and Herzegovina (F.B&amp;H), within all of its ten Cantons, a promotional-preventive activities have been carried out with the main objective to familiarize the matriculated first grade children with the importance of proper oral hygiene and its correct application. This ambitious program was carried out in cooperation with Federal Ministry of Health, Federal Institute for Public Health, Federal Institute for Insurance and Re-insurance and primary health care institutions in F.B&amp;H. In the academic school year 2004/2005 this program included 99.5 percent of all primary schools in F.B&amp;H (i.e. 398 of central primary schools and majority of regional schools), while, at the same time education 89.2 percent of first grade children. In the academic school year 2006/2007 this program was additionally carried out to the first and second grade primary school pupils in Federation of Bosnia and Herzegovina.</text>
      <annotation id="39">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3077" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="40">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3313" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="41">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3853" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="42">
        <infon key="type">Disease</infon>
        <location offset="3998" length="20"/>
        <text>Federation of Bosnia</text>
      </annotation>
      <annotation id="43">
        <infon key="type">Disease</infon>
        <location offset="3124" length="6"/>
        <text>Bosnia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4036</offset>
      <text>The progress of the infection process is exemplified by the penetration into the tissue around the tooth's root and development of periodontitis. Each hole in the tooth represents an additional place for keeping food, plaque formation and propagation of a large number of bacteria.</text>
      <annotation id="46">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="4056" length="9"/>
        <text>infection</text>
      </annotation>
      <annotation id="47">
        <infon key="identifier">MESH:D010518</infon>
        <infon key="type">Disease</infon>
        <location offset="4167" length="13"/>
        <text>periodontitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4318</offset>
      <text>The treatment actually consists in detecting caries damage and removing softened dentin, followed by the appropriate treatment and disinfection of the oral cavity and eventually sealing.</text>
      <annotation id="49">
        <infon key="identifier">MESH:D003731</infon>
        <infon key="type">Disease</infon>
        <location offset="4363" length="13"/>
        <text>caries damage</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4505</offset>
      <text>While there are many theories about the origin of caries none of them give a complete answer to all the questions that come to mind when it comes to the etiopathogenesis of dental caries. According to contemporary views, some factors have greater importance in its origination, namely:</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4791</offset>
      <text>a) The structure and roughness of enamel;</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4833</offset>
      <text>b) Dental plaque;</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4851</offset>
      <text>c) Properties of saliva; and</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4880</offset>
      <text>d) Carbohydrates.</text>
      <annotation id="51">
        <infon key="identifier">MESH:D002241</infon>
        <infon key="type">Chemical</infon>
        <location offset="4883" length="13"/>
        <text>Carbohydrates</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4898</offset>
      <text>Dental plaque is of great importance, both in the development of caries, as well as in the pathogenesis of parondotopathy. It consists of desquamated epithelium of the oral mucosa, microorganisms and mucin (constituents of saliva).</text>
      <annotation id="54">
        <infon key="identifier">100508689</infon>
        <infon key="type">Gene</infon>
        <location offset="5098" length="5"/>
        <text>mucin</text>
      </annotation>
      <annotation id="55">
        <infon key="type">Disease</infon>
        <location offset="5005" length="14"/>
        <text>parondotopathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>5130</offset>
      <text>The accumulation of plaque on the tooth surfaces on which the physiological self-cleaning and cleaning with a brush is rather inefficient, is preceded and followed by caries. A special attention should be paid to microorganisms that are found in plaque, especially cariogenic strains of streptococci (Streptococcus mutans and sangus). Their biochemical activities carry out decomposition of carbohydrates to simple acids and synthesize different polysaccharides (i.e. dextran, levan and amylopectin).</text>
      <annotation id="60">
        <infon key="identifier">1309</infon>
        <infon key="type">Species</infon>
        <location offset="5431" length="20"/>
        <text>Streptococcus mutans</text>
      </annotation>
      <annotation id="61">
        <infon key="identifier">MESH:D003911</infon>
        <infon key="type">Chemical</infon>
        <location offset="5598" length="7"/>
        <text>dextran</text>
      </annotation>
      <annotation id="62">
        <infon key="identifier">MESH:D011134</infon>
        <infon key="type">Chemical</infon>
        <location offset="5576" length="15"/>
        <text>polysaccharides</text>
      </annotation>
      <annotation id="63">
        <infon key="identifier">MESH:D002241</infon>
        <infon key="type">Chemical</infon>
        <location offset="5521" length="13"/>
        <text>carbohydrates</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>5631</offset>
      <text>2. MATERIALS AND METHODS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5656</offset>
      <text>The study was designed as a cross-sectional study. The survey instrument was used for the survey interview and clinical examination of the mouth and teeth to provide data on oral health of the examined children. The survey was conducted in all units of observation, in selected schools in the stage of choice within these departments-selected groups of students. This also meant that two phases stratified sample of compatible groups, where 804 students were surveyed in elementary schools and where 355 students were from urban and 449 from rural schools.</text>
      <annotation id="65">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5858" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6213</offset>
      <text>  Creating questionnaires and publicity materials;</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6266</offset>
      <text>  Working team members' education;</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6305</offset>
      <text>  Members were familiarized with the available data on oral hygiene habits and their impact on oral health, various techniques and tools for proper oral hygiene, and tools and techniques for the determination of OHI (e.g. index hygiene oral).</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6550</offset>
      <text>  Data were collected by conducting surveys in several classrooms (i.e. one class from each age group selected among primary schools) and filling out questionnaires with the assistance of members of the survey team, in order to help to determine the status and oral hygiene index.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6833</offset>
      <text>  At the end, the data analysis and evaluation of the project was carried out.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>6914</offset>
      <text>3. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6925</offset>
      <text>Below is presented the analysis of the data that we received after interviewing 804 students in elementary schools, where 355 students were from urban and 449 students from rural schools, the following results were obtained:</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7150</offset>
      <text>Assessment of the socioeconomic status in children from urban and rural areas was carried out on the basis of the group questions in the application form, which were related to employment and qualifications of father / mother, the place of residence, and on the basis of their financial status. The Chi squared had the value of 22.814, the Level of Significance of P = 0.0001 and Contingency Coefficient of 0.163.</text>
      <annotation id="67">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7192" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7564</offset>
      <text>The obtained responses from this group of questions are presented in the table 1 below:</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>7652</offset>
      <text>t-Test according to the Socioeconomic status in examinees residing in rural and urban areas.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7745</offset>
      <text>No statistical significance was observed at p &lt; 0.05, and therefore there is no statistically significant difference between urban and rural primary school children according to the socioeconomic status.</text>
      <annotation id="69">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7901" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7949</offset>
      <text>From total amount of 72.37 percent of surveyed children listed that their father was employed, (i.e. 44.00 percent in urban and 28.37 percent in rural areas), 25.75 listed that their father was unemployed (i.e. 14.00 percent from urban and 11.37% from rural areas). Situation with mothers' employment status was quite different; whereas 52.5 percent of surveyed children listed (i.e. 22.25 percent in urban and 30.25 percent from rural areas) listed that their mother was employed, while 66.62 percent (i.e. 18.5 percent from urban and 48.125 percent from rural areas) listed that their mother was unemployed. 86.5 percent of examinees listed to reside in their own house or apartment (e.g. 34.37 percent in urban and 52.12 percent in rural areas). 40.50 percent of surveyed answered to have at disposal its own room, while 53.75 percent listed to share the room with brother or sister. By taking into consideration the answers regarding employment and socioeconomic status of examined children, where are clearly visible changed in rural and urban areas, we can ascertain that socioeconomic status (as an independent variable) was in causal relationship with the causation and development of dental caries and adverse changes in oral hygiene of examinees. Poorer socioeconomic status seems to have caused the incidence of the increasing number of examinees from rural areas who have visited dentist(s) more than four times; (i.e. 19.75 percent) in comparison to the examinees from the urban areas measured at 16.5 percent. At the same time there were not a single examinee residing in the urban areas who had reported to have visited a dentist more than ten times, while there were 1.5 percent of surveyed from the rural areas who visited a dentist more than ten times.</text>
      <annotation id="73">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7996" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8311" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8935" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">MSM-26-309-g002.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>9722</offset>
      <text>Graphical representation of prevalence of CAP Index (includes the prevalence of: caries, filling and extractions)</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>9836</offset>
      <text>4. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9850</offset>
      <text>When defining the socioeconomic status we can clearly see that the majority of respondents from rural and urban areas stated that their father was employed. In a small number of answers the unemployment was viewed as a direct impact on the socioeconomic status of respondents, as well as the position of the mother's employment where it was clear that there was a difference between respondents in urban and rural, where a much larger number of respondents answered that the mother was not employed, which was not the case in the urban environment. Accordingly, the city center had a much larger number of respondents who reported that their parents were employed compared to rural population.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10544</offset>
      <text>Most of the respondents in urban and rural areas stated to have their own house / apartment, while in the middle of both had the same number of responses for respondents who were living as tenants. The largest number of respondents shared his/her room with some brother / sister, while the rural areas had a higher number of respondents who had their own room. In the city, although the higher the number was higher than in the rural areas, statistically speaking there was some difference in favor of the respondents' rural areas.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11078</offset>
      <text>The second group of questions related to hygiene and diet and nutrition in relation to the hypotheses of this study gave some interesting answers. When asked how often they were having breakfast on weekends most of the respondents answered that they had breakfast on both days of the weekend, in both the city and rural areas.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11405</offset>
      <text>Most of the respondents stated that they were pleased with his/her weight and that there was no need or feeling the need to dedicate to a diet, and that a large number of respondents regularly consumed meals. A large number of respondents stated that they most commonly consumed fast food, and that having in mind its composition it was felt as a predictor for the occurrence of various diseases, including dental caries.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11827</offset>
      <text>It is important to note that this factor had an impact on the status of oral hygiene in our patients, and that our sample consisted of a very large number of respondents who consumed sweets and snacks, each day and several times a day. Encouraging responses were in the forms of answers where the fruits were consumed more than three times in the last three days, although it was directly linked with socioeconomic status of respondents.</text>
      <annotation id="77">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11919" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12265</offset>
      <text>The high prevalence of dental caries was caused by certain safe factors, so in this case we consider diet and place of residence (e.g. rural and urban environment), where the respondents from urban areas were more susceptible to the influence of factors that lead to tooth decay, such as fast food and sugary treats, with 64.48% of the urban environment usually taking fast food during the big break at school, but also, a large number of children from rural areas at 80.95%, which meant that the predominant factors were no longer tied to regional-geographical determination (e.g. in rural and urban communities).</text>
      <annotation id="79">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12704" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12882</offset>
      <text>In our sample, 45.25% of respondents from urban areas have been consuming candy daily, while 68.5% of them from rural areas also consumed sweets every day, which indicated that the predominant factors were not specific geographical locality.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>13124</offset>
      <text>5. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>13138</offset>
      <text>On the basis of this research the following conclusions can be drawn:</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>13208</offset>
      <text>  Conditions of oral hygiene habits' among school children was on a satisfactory level and no large differences were observed between respondents in urban and rural areas;</text>
      <annotation id="81">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13258" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>13384</offset>
      <text>  The age group that comes to improving oral hygiene in the second half of elementary education, with a number of information, etc.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>13518</offset>
      <text>  Factors that were predominant in relation to residence and caries were: eating poor quality food during the big break at school, and in urban areas more than in rural areas, one of the essential factors of consuming sweets and snacks was equally represented in all areas. Regular brushing was the factor that had an impact on the formation of cavities, but it could not be correlated with the geographic distribution. Taking diet that was supposed to improve tooth nutrition, such as drinking glasses of milk, gave no statistically significant results in both groups, but, rather favored the rural areas.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>14127</offset>
      <text>According to the results, we can see that the socioeconomic status of patients was affected by the occurrence of dental caries and oral hygiene, in patients, in relation to their rural and urban residence areas, because we could observe that by the number of respondents and greater unemployment in both parents in rural areas than in the city, which caused a host of other factors that were directly and indirectly connected with the development of caries.</text>
      <annotation id="84">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14197" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14275" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>14585</offset>
      <text>According to the type of food consumed we could see that in urban and rural areas the responses were fairly balanced, with the city where the larger number of respondents ate foods that posed a risk factors for tooth decay and deterioration of an oral hygiene than in rural areas, while the answers to the sample size and the use of a healthy diet were conditioned with the geographical position, (i.e. housing in rural areas where fruits and vegetables more available than in the city center).</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>15080</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>15117</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="volume">172</infon>
      <infon key="name_1">surname:Ekstrand;given-names:K Qvist</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Twetman;given-names:S</infon>
      <infon key="fpage">3026</infon>
      <infon key="issue">44</infon>
      <infon key="pub-id_pmid">21044558</infon>
      <infon key="year">2010</infon>
      <infon key="comment">Danish</infon>
      <infon key="source">Ugeskr Laeger</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">3029</infon>
      <offset>15128</offset>
      <text>Dental caries in an ecological perspective</text>
      <annotation id="87">
        <infon key="identifier">MESH:D003731</infon>
        <infon key="type">Disease</infon>
        <location offset="15128" length="13"/>
        <text>Dental caries</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">16</infon>
      <infon key="section_type">REF</infon>
      <infon key="fpage">1</infon>
      <infon key="year">1994-1995</infon>
      <infon key="source">Pediatr Dent</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">96</infon>
      <offset>15171</offset>
      <text>American Academy of Paediatric Dentistry, Special issue: reference manual</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Lozano;given-names:MP</infon>
      <infon key="name_2">surname:Lemos;given-names:MI</infon>
      <infon key="name_1">surname:Ekstrand;given-names:KR</infon>
      <infon key="name_0">surname:Martignon;given-names:S</infon>
      <infon key="fpage">133</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">21046903</infon>
      <infon key="year">2010</infon>
      <infon key="source">Community Dent Health</infon>
      <infon key="type">ref</infon>
      <infon key="volume">27</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">138</infon>
      <infon key="name_4">surname:Higuera;given-names:C</infon>
      <offset>15245</offset>
      <text>Plaque caries level and oral hygiene habits in young patients receiving orthodontic treatment</text>
      <annotation id="89">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15298" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">21</infon>
      <infon key="name_2">surname:Blinkhorn;given-names:AS</infon>
      <infon key="name_1">surname:Phelan;given-names:C</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Cashmore;given-names:AW</infon>
      <infon key="fpage">184</infon>
      <infon key="issue">7-8</infon>
      <infon key="year">2010</infon>
      <infon key="source">NSW Public Health Bull</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">185</infon>
      <offset>15339</offset>
      <text>Dental caries in children</text>
      <annotation id="91">
        <infon key="identifier">MESH:D003731</infon>
        <infon key="type">Disease</infon>
        <location offset="15339" length="13"/>
        <text>Dental caries</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">141</infon>
      <infon key="name_2">surname:Glick;given-names:M</infon>
      <infon key="name_1">surname:Bay;given-names:RC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Patel;given-names:S</infon>
      <infon key="fpage">527</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">20436100</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Am Dent Assoc</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">539</infon>
      <offset>15365</offset>
      <text>A systematic review of dental recall intervals and incidence of dental caries</text>
    </passage>
    <passage>
      <infon key="volume">44</infon>
      <infon key="name_1">surname:Sabbah;given-names:W</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sheiham;given-names:A</infon>
      <infon key="fpage">141</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">20389069</infon>
      <infon key="year">2010</infon>
      <infon key="source">Caries Res</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">150</infon>
      <offset>15443</offset>
      <text>Using universal patterns of caries for planning and evaluating dental care</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Pitts;given-names:NB</infon>
      <infon key="name_2">surname:Wolff;given-names:MA</infon>
      <infon key="name_1">surname:Young;given-names:DA</infon>
      <infon key="name_0">surname:Fontana;given-names:M</infon>
      <infon key="fpage">423</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">20630187</infon>
      <infon key="year">2010</infon>
      <infon key="source">Dent Clin North Am</infon>
      <infon key="type">ref</infon>
      <infon key="volume">54</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">440</infon>
      <infon key="name_4">surname:Longbotttom;given-names:C</infon>
      <offset>15518</offset>
      <text>Defining dental caries for 2010 and beyond</text>
    </passage>
    <passage>
      <infon key="volume">208</infon>
      <infon key="name_2">surname:Kidd;given-names:EA</infon>
      <infon key="name_1">surname:Weld;given-names:JA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Page;given-names:J</infon>
      <infon key="fpage">449</infon>
      <infon key="issue">10</infon>
      <infon key="pub-id_pmid">20489764</infon>
      <infon key="year">2010</infon>
      <infon key="source">Br Dent J</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">450</infon>
      <offset>15561</offset>
      <text>Caries control in health service practice</text>
    </passage>
    <passage>
      <infon key="volume">141</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Muehleis;given-names:P</infon>
      <infon key="fpage">500</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">20436091</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Am Dent Assoc</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">501</infon>
      <offset>15603</offset>
      <text>Social engineering</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Grabus;given-names:J</infon>
      <infon key="name_2">surname:Babacic;given-names:R</infon>
      <infon key="name_1">surname:Filipovic;given-names:M</infon>
      <infon key="name_0">surname:Deljo;given-names:E</infon>
      <infon key="fpage">25</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">23322951</infon>
      <infon key="year">2012</infon>
      <infon key="source">Acta Inform Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">20</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.5455/aim.2012.20.25-31</infon>
      <infon key="lpage">32</infon>
      <offset>15622</offset>
      <text>Correlation Analysis of the Hyoid Bone Position in Relation to the Cranial Base, Mandible and Cervical part of Vertebra with Particular Reference to Bimaxillary Relations/Teleroentgram Analysis</text>
    </passage>
    <passage>
      <infon key="volume">117</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Veerkamp;given-names:J</infon>
      <infon key="fpage">366</infon>
      <infon key="issue">7-8</infon>
      <infon key="pub-id_pmid">20726493</infon>
      <infon key="year">2010</infon>
      <infon key="source">Ned Tijdschr Tandheelkd</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">367</infon>
      <offset>15816</offset>
      <text>Nutritional advice of great importance to prevent dental caries</text>
    </passage>
    <passage>
      <infon key="volume">141</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Muehleis;given-names:P</infon>
      <infon key="fpage">500</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">20436091</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Am Dent Assoc</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">501</infon>
      <offset>15880</offset>
      <text>Social engineering</text>
    </passage>
    <passage>
      <infon key="volume">32</infon>
      <infon key="name_1">surname:Lennon;given-names:MA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Petersen;given-names:PE</infon>
      <infon key="fpage">319</infon>
      <infon key="pub-id_pmid">15341615</infon>
      <infon key="year">2004</infon>
      <infon key="source">Community Dent Oral Epidemiol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">321</infon>
      <offset>15899</offset>
      <text>Effective use of fluorides for the preventions of dental caries in the 21st century: the WHO approach</text>
      <annotation id="93">
        <infon key="identifier">MESH:D005459</infon>
        <infon key="type">Chemical</infon>
        <location offset="15916" length="9"/>
        <text>fluorides</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Markovic;given-names:N</infon>
      <infon key="name_2">surname:Kobaslija;given-names:S</infon>
      <infon key="name_1">surname:Muratbegovic;given-names:A</infon>
      <infon key="name_0">surname:Zukanovic;given-names:A</infon>
      <infon key="fpage">118</infon>
      <infon key="issue">3</infon>
      <infon key="year">2008</infon>
      <infon key="source">Eur J Paediatric Dent</infon>
      <infon key="type">ref</infon>
      <infon key="volume">9</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">124</infon>
      <infon key="name_5">surname:Beslagic;given-names:E</infon>
      <infon key="name_4">surname:Ganibegovic;given-names:M</infon>
      <offset>16001</offset>
      <text>The relationship between socioeconomic backgrounds, caries associated micro flora and caries experience in 12-year-olds in Bosnia and Herzegovina in 2004</text>
      <annotation id="95">
        <infon key="type">Disease</infon>
        <location offset="16124" length="6"/>
        <text>Bosnia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">117</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Veerkamp;given-names:J</infon>
      <infon key="fpage">366</infon>
      <infon key="issue">7-8</infon>
      <infon key="pub-id_pmid">20726493</infon>
      <infon key="year">2010</infon>
      <infon key="source">Ned Tijdschr Tandheelkd</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">367</infon>
      <offset>16155</offset>
      <text>Nutritional advice of great importance to prevent dental caries</text>
    </passage>
    <passage>
      <infon key="volume">57</infon>
      <infon key="name_1">surname:Kondo;given-names:K</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Aida;given-names:J</infon>
      <infon key="fpage">410</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">20726175</infon>
      <infon key="year">2010</infon>
      <infon key="source">Nippon Koshu Eisei Zasshi</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">414</infon>
      <offset>16219</offset>
      <text>Social factors affecting health (2) Dental diseases</text>
    </passage>
    <passage>
      <infon key="volume">114</infon>
      <infon key="name_2">surname:Maxim;given-names:A</infon>
      <infon key="name_1">surname:Antohe;given-names:ME</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rediu;given-names:SC</infon>
      <infon key="fpage">542</infon>
      <infon key="issue">2</infon>
      <infon key="year">2010</infon>
      <infon key="source">Romania Rev Med Chir Soc Med Nat Lasi</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">546</infon>
      <offset>16271</offset>
      <text>Epidemiological aspects of frontal edentation of child and adolescent</text>
      <annotation id="97">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16320" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_2">surname:Meskovic;given-names:Belma</infon>
      <infon key="name_1">surname:Cavaljuga;given-names:S</infon>
      <infon key="name_0">surname:Deljo;given-names:E</infon>
      <infon key="fpage">163</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">24167427</infon>
      <infon key="year">2013</infon>
      <infon key="source">Mater Sociomed</infon>
      <infon key="type">ref</infon>
      <infon key="volume">25</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.5455/msm.2013.25.163-166</infon>
      <infon key="lpage">166</infon>
      <offset>16341</offset>
      <text>Prevalence of Dental Caries in the Municipality Gorazde During the Period 2007-2012</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Grabus;given-names:J</infon>
      <infon key="name_2">surname:Meskovic;given-names:B</infon>
      <infon key="name_1">surname:Babacic;given-names:R</infon>
      <infon key="name_0">surname:Deljo;given-names:E</infon>
      <infon key="fpage">220</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">23408145</infon>
      <infon key="year">2011</infon>
      <infon key="source">Acta Inform Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">19</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.5455/aim.2011.19.220-223</infon>
      <infon key="lpage">223</infon>
      <offset>16425</offset>
      <text>Impact of Continous Education About Oral Hygiene on the Changes of CPI-index for 12-15-year-old Schoolchildren</text>
    </passage>
    <passage>
      <infon key="volume">8</infon>
      <infon key="name_2">surname:de Lira;given-names:PI</infon>
      <infon key="name_1">surname:Rodrigues;given-names:CS</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Jamelli;given-names:SR</infon>
      <infon key="fpage">77</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">20480058</infon>
      <infon key="year">2010</infon>
      <infon key="source">Oral Health Prev Dent</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">84</infon>
      <offset>16536</offset>
      <text>Nutritional status and prevalence of dental caries amon 12-year-old childer at public schools: a case - control study</text>
    </passage>
    <passage>
      <infon key="volume">141</infon>
      <infon key="name_2">surname:Glick;given-names:M</infon>
      <infon key="name_1">surname:Bay;given-names:RC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Patel;given-names:S</infon>
      <infon key="fpage">527</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">20436100</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Am Dent Assoc</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">539</infon>
      <offset>16656</offset>
      <text>A systematix review of dental recall intervals and incidence of dental caries</text>
    </passage>
    <passage>
      <infon key="volume">141</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Muehleis;given-names:P</infon>
      <infon key="fpage">500</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">20436091</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Am Dent Assoc</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">501</infon>
      <offset>16734</offset>
      <text>Social engineering</text>
    </passage>
    <passage>
      <infon key="volume">44</infon>
      <infon key="name_1">surname:Sabbah;given-names:W</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sheiham;given-names:A</infon>
      <infon key="fpage">141</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">20389069</infon>
      <infon key="year">2010</infon>
      <infon key="source">Caries Res</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">150</infon>
      <offset>16753</offset>
      <text>Using universal patterns of caries for planning and evaluating dental care</text>
    </passage>
  </document>
  <document>
    <id>4272837</id>
    <passage>
      <infon key="article-id_pmid">25568585</infon>
      <infon key="name_0">surname:Karami;given-names:Mahtab</infon>
      <infon key="fpage">341</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272837</infon>
      <infon key="article-id_publisher-id">AIM-55-341</infon>
      <infon key="article-id_doi">10.5455/aim.2014.22.341-346</infon>
      <infon key="type">front</infon>
      <infon key="volume">22</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Acta Inform Med; 2014 Oct; 22(5) 341-6. doi:10.5455/aim.2014.22.341-346</infon>
      <infon key="kwd">Dashboards Protocol Radiology Department Design</infon>
      <infon key="lpage">346</infon>
      <infon key="authors">Karami M</infon>
      <offset>0</offset>
      <text>A Design Protocol to Develop Radiology Dashboards</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>50</offset>
      <text>ABSTRACT</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>59</offset>
      <text>Aim:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>64</offset>
      <text>The main objective of this descriptive and development research was to introduce a design protocol to develop radiology dashboards.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>196</offset>
      <text>Material and methods:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>218</offset>
      <text>The first step was to determine key performance indicators for radiology department. The second step was to determine required infrastructure for implementation of radiology dashboards. Infrastructure was extracted from both data and technology perspectives. The third step was to determine main features of the radiology dashboards. The fourth step was to determine the key criteria for evaluating the dashboards. In all these steps, non-probability sampling methods including convenience and purposive were employed and sample size determined based on a persuasion model.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>792</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>801</offset>
      <text>Results showed that there are 92 KPIs, 10 main features for designing dashboards and 53 key criteria for dashboards evaluation. As well as, a Prototype of radiology management dashboards in four aspects including services, clients, personnel and cost-income were implemented and evaluated. Applying such dashboards could help managers to enhance performance, productivity and quality of services in radiology department.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1222</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1238</offset>
      <text>The field of radiology is continuously growing. Since imaging services are widely used and affect on patient care in the hospital, much attention has been paid to quality assurance in radiology departments. Since, measuring the quality of imaging services is inherently difficult, standard sets of KPIs should be used as key tools for evaluating and improving departmental processes. In traditional method, the monitoring of indicators involved the review of patient records to document the effect of diagnostic imaging on the care outcome is costly in staff time and labor.</text>
      <annotation id="3">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1339" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="4">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1697" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="5">
        <infon key="identifier">MESH:D048949</infon>
        <infon key="type">Disease</infon>
        <location offset="1806" length="5"/>
        <text>labor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1813</offset>
      <text>With the modernization of radiology departments, along with using electronic information systems such as PACS, RIS, speech recognition systems, preliminary report systems, hospital information systems, and electronic health records, workflow and informatics infrastructure supporting them became very complex. This is because it requires combining many computerized systems with different user environments to provide quality efficient services in less time.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2272</offset>
      <text>Since within this complexity, close monitoring the operational and financial data is an essential element for the management; Traditional methods of data involving review of Key Performance Indicators become quickly outdated and changed to use new technologies. In recent year, a variety of management tools have been introduced to digitally monitor essential data under the general name of dashboards.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2675</offset>
      <text>Dashboards is an intellectual and visual tool for monitoring of KPI which can capture key data from different systems and represent them summarized and useful in real-time with easier reading and interpretation for users. This business intelligence tool can applied in radiology department as used in other sections such as operation rooms, emergency rooms, diabetes, and hospital infection control.</text>
      <annotation id="9">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="3033" length="8"/>
        <text>diabetes</text>
      </annotation>
      <annotation id="10">
        <infon key="identifier">MESH:D056987</infon>
        <infon key="type">Disease</infon>
        <location offset="2999" length="15"/>
        <text>operation rooms</text>
      </annotation>
      <annotation id="11">
        <infon key="identifier">MESH:D003428</infon>
        <infon key="type">Disease</infon>
        <location offset="3047" length="18"/>
        <text>hospital infection</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3075</offset>
      <text>In radiology department, workflow are optimized when radiologists have real-time information to make informed decisions, and the capacity to efficiently act on that information. Dashboards technology can facilitate informed, optimized decisions about workflow by link directly to the electronic information systems and provide the right information in a right format at the right time to monitor productivity in order to improve in performance and effectiveness of activity. In this research, a design protocol to develop radiology dashboards in order to enhance performance, productivity and quality of services in this department, has been proposed. As well, a prototype of radiology management dashboards were implemented and evaluated using data obtained from a selected hospital affiliated to Tehran University of Medical Sciences.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>3912</offset>
      <text>2. RESEARCH METHOD</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>3931</offset>
      <text>This descriptive and development research has been done in 4 steps during 2012 up to 2014.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4022</offset>
      <text>Determine Key Performance Indicators for radiology department: This descriptive study was conducted using the Delphi technique. In this step, study population was including 30 radiologists who were members of Iranian Radiology Association and had professional experience in managing of radiology department. Non-probability sampling method including convenience and purposive were employed. Electronic questionnaire was used to collect information. At the end of the two-stage Delphi technique 92 key indicators to assess the performance of the radiology department into 7 main categories including "safety, service, internal and external customers, teaching and research, resource utilization, financial performance and excellence in the workplace" was determined.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4792</offset>
      <text>Determine a comprehensive model for designing of dashboards: This step of the research is descriptive. The study population was composed of 15 specialists in the field of informatics who had experience in creating dashboards. Non-probability sampling method including convenience and purposive were employed. Electronic questionnaire was used to collect information. At the end of this stage, 10 main features including" determining the goal of dashboards design, aligning with organizational goals, determining KPIs, setting a time frame, extracting the accurate data, flexibility, drilling-down capabilities, security, how to representation and display alert" were determined as a model for designing dashboards.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5511</offset>
      <text>Determine required infrastructure for implementation of Radiology Management Dashboards: Infrastructure was extracted from both data and technology perspectives and the following steps are performed:</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5711</offset>
      <text>Determining the goals of the dashboards design in order to determine the KPIs</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5789</offset>
      <text>Defining the target group who are authorized to use dashboards</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5852</offset>
      <text>Determining whether the dashboards show the retrospective data or real-time data?</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5934</offset>
      <text>Determining KPIs to achieve defined goals and how to calculate them</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6002</offset>
      <text>Identifying the required data to achieve these indicators and sources of data</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6080</offset>
      <text>Setting intervals to update the information</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6124</offset>
      <text>Identifying the reporting format of the data resource</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6178</offset>
      <text>Specifying how to extract data</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6209</offset>
      <text>Determine the key criteria for assessing the dashboards: In this step, a total of 46 specialists from medical informatics, health information management, software engineering, and radiology field who had experience in the field of business intelligence were chosen as study population. Non-probability sampling method including convenience and purposive were employed. Electronic questionnaire was used to collect information. At the end of this stage, 53 key criteria in seven categories including"user-customization, knowledge discovery, security, information delivery, visual design, alerts, connectivity and integration" were determined for dashboards evaluation.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>6881</offset>
      <text>3. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6892</offset>
      <text>The findings based on the research steps are the following: In first step, as shown in Table, 92 key indicators to assess the performance of the radiology department at the seven categories were determined. In the second step, a comprehensive model for the design of the dashboards as shown in Table was determined. In the third step, to prepare prototype radiology management of dashboards, QlikView software as open source integration software that is executable in a hospital operating systems including Windows XP, Windows 7 and Windows 8 are from Microsoft, was used. As well as, some KPI as shown in table was selected from table to display in radiology management dashboards, the data was captured form radiology information system, financial information system and personnel information system and the time interval for updating was monthly. In the fourth step, the dashboards evaluation criteria were determined which are presented in Tables 1-4.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>7848</offset>
      <text>Key performance indicators in radiology department</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>7899</offset>
      <text>A Comprehensive Model for Designing Radiology Dashboards</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T3.xml</infon>
      <infon key="id">T3</infon>
      <infon key="type">table_caption</infon>
      <offset>7956</offset>
      <text>Selected KPIs for radiology department management dashboards</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T4.xml</infon>
      <infon key="id">T4</infon>
      <infon key="type">table_caption</infon>
      <offset>8017</offset>
      <text>key criteria for the dashboards evaluation</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>8060</offset>
      <text>4. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>8074</offset>
      <text>Given the above it can be concluded that the field of radiology is faced with the challenges of increasing service use, declining reimbursements, and staff shortages. In such an economically challenging environment, it becomes crucial for radiology departments to monitor their performance so that they can provide a high quality of services while staying within operational boundaries. Accordingly, in this research, enhancement of performance, productivity and quality of services in radiology department as the aims of dashboards designing was considered.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>8633</offset>
      <text>In this field, Performance improvement is a process that differs from analyses made in commercial companies, where increased revenue is the major goal. In healthcare, the benefit to the individual patient is the main goal, with less emphasis being placed on economic implications. So to improve the quality required to ensure the proper planning done. A key element to planning is to select required data, and then adopt appropriate methods to collect data actively, consistently and effectively and represent them in performance indicator format.</text>
      <annotation id="13">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8830" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9181</offset>
      <text>Therefore it is necessary to instill a culture to determine necessary data to calculate the KPIs, the ways to collect these data and appropriate tools should be used for data analysis and trending. However, it should be noted that quality is not a goal at the radiology department but it is responsibility and accountability of and necessary to create a shared vision by hospital and radiology practice leadership that centers on patient.</text>
      <annotation id="15">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9611" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9620</offset>
      <text>About Dashboards design, because of radiology department is complex environment and has a variety of services, clients, personnel, equipment, technologies, data and information which are generated, the following key points need to be considered:</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9866</offset>
      <text>Organizational culture: Organizational culture is the normal behaviors dominating an organization and can be an important factor in successful implementation of technology. Implementing dashboards requires organizational culture to accept objective data as the basis for decision making.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10154</offset>
      <text>Determining the goal of dashboards design: Experts believe that dashboards objectives should be limited in order for the managers to allocate the resources to critical issues and divide the objectives into three groups: financial, operational and quality. Therefore, the goals of dashboards design for the department should be clear; whether it is for workflow consolidation, workload distribution, urgency evaluation, capacity and workflow management, surveillance, or financial reporting.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10645</offset>
      <text>Involving users: in designing a comprehensive dashboards, it is necessary to involve users in the design and development processes because expectations will closely match to functionality and users provide suggestions based on their needs which can reduce the time of development and dashboards redesign after implementation as feedbacks and evaluations are provided.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11013</offset>
      <text>Aligning with organizational goals: Dashboards should be designed based on overall goals and objectives of organization in such a way that each department by monitoring its KPIs facilitates achieving its objectives besides the strategic goals of organization.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11273</offset>
      <text>Determining KPIs and benchmark standards: Selecting the type of indicators which should be included in dashboards is important. Depending on its situation, each department needs to measure the indicators related to its own area of performance, not all the indicators, in other words, indicators which are critical and special to the quality of their performance. Each indicator is selected according to business purpose and the ability to be gathered easily through standard business functions and besides accurate measurement of the indicator, we should identify dashboards metrics from regulatory standards which we need for accreditation or credentials. In designing an effective dashboards, the number of measurements should be limited, at least 15 to 25, in order to be viewed at a glance.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12068</offset>
      <text>Data: A well designed dashboards should include accurate data which is related to business process from different sources and based on acceptable and standard definitions in order to be used in benchmarking process. In addition, data storage should be based on standard format and coding to be able to manipulate them easily, to facilitate sharing them, and reduce their processing time while updating and querying from dashboards.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12500</offset>
      <text>Knowledge discovery: It is necessary that the structure of data storage be in a logical hierarchy and with required granularity for data mining and online analytical processing (OLAP) in order to extract knowledge from the data in dashboards. This will enable the user to drill down data with clicking on operational indicator to gain deep analysis of that indicator to prospectively predict the effects of decisions and preparing the reports in the form of pdf and Excel. Regarding knowledge extraction, considering the time of search, number of clicks, and the precision and accuracy of data are critical.</text>
      <annotation id="17">
        <infon key="identifier">9568</infon>
        <infon key="type">Species</infon>
        <location offset="12772" length="5"/>
        <text>drill</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13108</offset>
      <text>Flexibility: According to dashboards should have the ability to be optimized, customized, workflow-integrated, and context-specified. This feature is also important for determining indicators such that the user can have access to the information for specific purposes and can organize them according to his or her preferences and save them to reuse in future. In designing dashboards it is also important that dashboards would have the capability to add required metrics or make change in it.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13601</offset>
      <text>Security: It is important to make sure about the security of data at all times because in radiology department, dashboards data is the result of integration of a number of information systems and also based on the internet or intranet. According to it is necessary to consider a unique accession number for connecting data parts together and a secure log-in to have access to pages containing personal health information. In addition, utilizing 'single sign -on' technology for the user to have access to each application is suggested.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>14141</offset>
      <text>Time frame: The frequency of measurement of indicators depends on the nature of indicator and its effectiveness and importance on operation of department. The focus of measurement should change from period to period. Updating information based on users' view, type of use, and importance of task can be from every second to every month.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>14480</offset>
      <text>Representation: Since dashboards is a tool for quick, brief, and real-time representation of data, organizing and displaying data should be such that it could be easily read and interpreted and the user does not need to scroll the pages. Depending on the type of indicators and their numbers, we can use tables or graphs to display for users to understand and make decisions. It is better to provide visualization in the form of graphs according to the type of indicator to show benchmarking comparison because tables cannot be easily and quickly read. What is critical is that the direct representation should be able to alert by color coding to show levels of threats. These alerts are based on performance target thresholds which are derived from the yearly goals and objectives. According to user interface dashboards in radiology department should be divided into three groups: User, Division, and System. They can be represented in different colors based on the priority of alerts like the traffic light (a red, yellow, or green circle).</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>15524</offset>
      <text>Dashboards Assessment: assessment should be considered based on two aspects. One is the verification of dashboards and other side is evaluation of dashboards itself to find out its effect on the department performance which can be done through questionnaires given to users. The results can be published in the form of newsletter in order for the users to make a general evaluation of their own and the department's performance over time.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>15963</offset>
      <text>About dashboards implementation, for achieve to a comprehensive set of dashboards that contain managerial and clinical operations of the radiology department So as to be able to create the accountability and strategic value in all aspects of financial, quality and clinical, the following technical infrastructure is necessary to be considered:</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16308</offset>
      <text>Designing data warehouse for gathering data from a variety of systems such as clinical information system and financial information system in order to get a comprehensive view of operations </text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16499</offset>
      <text>Using back-end algorithm of indicators or statistics for providing general and detailed reports </text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16596</offset>
      <text>Accessibility to Internet or Intranet in order to facilitate sharing data and maintain data dynamism </text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16698</offset>
      <text>Utilizing SOA architecture to encapsulate data in middle ware layer to be of use in different systems </text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16801</offset>
      <text>Using API to create a hyperlink in dashboards alert to load a study when clicked by the user </text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16895</offset>
      <text>Using relational database with a web service interface for modifying and querying state </text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16984</offset>
      <text>Utilizing interoperability standards such as HL7 messaging standards and DICOM to make connections and data exchange among different systems </text>
      <annotation id="19">
        <infon key="identifier">CVCL:2492</infon>
        <infon key="type">CellLine</infon>
        <location offset="17029" length="3"/>
        <text>HL7</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>17126</offset>
      <text>Using agents in data models for registering and managing alerts if alerts are to be shown in groups or individual </text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>17241</offset>
      <text>Designing dashboards in. Net environment because it will result in flexibility, ease and integration with the system </text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>17359</offset>
      <text>Utilizing web based interfaces for visualizing information </text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>17419</offset>
      <text>Displaying graphics using server based web control which is much faster than the client based control </text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>17522</offset>
      <text>5. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>17536</offset>
      <text>In this research, the key performance indicators were determined in order to performance assessment of academic radiology departments. On top of this, a comprehensive model for designing of dashboards and a checklist including key criteria for assessing of dashboards were provided. It should be noted that the model and assessment checklist could be used for all types of dashboards.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>17921</offset>
      <text>Finally a prototype of radiology management dashboards was implemented in four aspects including services, clients, personnel and cost-income. Applying such dashboards could help managers to evaluate radiology department from desirable or undesirable stance of performance, resource consumption and distribution of manpower at a glance, as well as identifying problems, root cause analysis and solving them using valid information driven from dashboards. In addition, it allows enhancing performance, productivity and quality of services in radiology department.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>18484</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>18521</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Thrall;given-names:JH</infon>
      <infon key="name_2">surname:Asfaw;given-names:BA</infon>
      <infon key="name_1">surname:Kaewlai;given-names:R</infon>
      <infon key="name_0">surname:Abujudeh;given-names:HH</infon>
      <infon key="fpage">571</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">20219841</infon>
      <infon key="year">2010</infon>
      <infon key="source">Radiographics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">30</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">580</infon>
      <offset>18532</offset>
      <text>Quality initiatives: Key performance indicators for measuring and improving radiology department performance</text>
    </passage>
    <passage>
      <infon key="volume">34</infon>
      <infon key="name_1">surname:Chang;given-names:PJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Morgan;given-names:MB</infon>
      <infon key="fpage">17</infon>
      <infon key="issue">5</infon>
      <infon key="year">2005</infon>
      <infon key="source">Applied Radiology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">21</infon>
      <offset>18641</offset>
      <text>The radiology dashboards: A user's guide to a "high-performance" PACS</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Richardson;given-names:JS</infon>
      <infon key="name_2">surname:Lionetti;given-names:DM</infon>
      <infon key="name_1">surname:Branstetter;given-names:BFt</infon>
      <infon key="name_0">surname:Morgan;given-names:MB</infon>
      <infon key="fpage">50</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">17334871</infon>
      <infon key="year">2008</infon>
      <infon key="source">J Digit Imaging</infon>
      <infon key="type">ref</infon>
      <infon key="volume">21</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">58</infon>
      <infon key="name_4">surname:Chang;given-names:PJ</infon>
      <offset>18715</offset>
      <text>The radiology digital dashboards: effects on report turnaround time</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Ros;given-names:PR</infon>
      <infon key="name_2">surname:Sivit;given-names:CJ</infon>
      <infon key="name_1">surname:Novak;given-names:RD</infon>
      <infon key="name_0">surname:Mansoori;given-names:B</infon>
      <infon key="fpage">283</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">23545086</infon>
      <infon key="year">2013</infon>
      <infon key="source">J Am Coll Radiol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">10</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">288</infon>
      <offset>18783</offset>
      <text>Utilization of dashboards technology in academic radiology departments: results of a national survey</text>
    </passage>
    <passage>
      <infon key="volume">35</infon>
      <infon key="name_2">surname:Rahimi;given-names:A</infon>
      <infon key="name_1">surname:Safdari;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Karami;given-names:M</infon>
      <infon key="fpage">42</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">23638580</infon>
      <infon key="year">2013</infon>
      <infon key="source">Radiol Manage</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">45</infon>
      <offset>18884</offset>
      <text>Effective radiology dashboardss: key research findings</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Souba;given-names:W</infon>
      <infon key="name_2">surname:McFadden;given-names:D</infon>
      <infon key="name_1">surname:Smaltz;given-names:D</infon>
      <infon key="name_0">surname:Park;given-names:KW</infon>
      <infon key="fpage">294</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">20006345</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Surg Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">164</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">300</infon>
      <offset>18939</offset>
      <text>The operating room dashboards</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Korwek;given-names:KM</infon>
      <infon key="name_2">surname:Cheung;given-names:D</infon>
      <infon key="name_1">surname:Englebright;given-names:JD</infon>
      <infon key="name_0">surname:Stone-Griffith;given-names:S</infon>
      <infon key="fpage">167</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">22724375</infon>
      <infon key="year">2012</infon>
      <infon key="source">J Healthc Manag</infon>
      <infon key="type">ref</infon>
      <infon key="volume">57</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">180</infon>
      <infon key="name_4">surname:Perlin;given-names:JB</infon>
      <offset>18969</offset>
      <text>Data-driven process and operational improvement in the emergency department: the ED Dashboards and Reporting Application</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Mehr;given-names:DR</infon>
      <infon key="name_2">surname:Moore;given-names:JL</infon>
      <infon key="name_1">surname:Kochendorfer;given-names:KM</infon>
      <infon key="name_0">surname:Koopman;given-names:RJ</infon>
      <infon key="fpage">398</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">21911758</infon>
      <infon key="year">2011</infon>
      <infon key="source">Ann Fam Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">9</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">405</infon>
      <infon key="name_5">surname:Yadamsuren;given-names:B</infon>
      <infon key="name_4">surname:Wakefield;given-names:DS</infon>
      <offset>19090</offset>
      <text>A diabetes dashboards and physician efficiency and accuracy in accessing data needed for high-quality diabetes care</text>
      <annotation id="22">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="19090" length="21"/>
        <text>A diabetes dashboards</text>
      </annotation>
      <annotation id="23">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="19192" length="8"/>
        <text>diabetes</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">12</infon>
      <infon key="name_2">surname:Rousseau;given-names:L</infon>
      <infon key="name_1">surname:Champagne;given-names:F</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Blais;given-names:R</infon>
      <infon key="fpage">161</infon>
      <infon key="issue">Spec No Patient</infon>
      <infon key="pub-id_pmid">19667795</infon>
      <infon key="year">2009</infon>
      <infon key="source">Healthc Q</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">167</infon>
      <offset>19206</offset>
      <text>TOCSIN: a proposed dashboards of indicators to control healthcare-associated infections</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Karami;given-names:M</infon>
      <infon key="year">2012</infon>
      <infon key="source">28th Iranian congress of Radiology</infon>
      <infon key="type">ref</infon>
      <offset>19294</offset>
      <text>Operational Radiology Dashboards: A Tool for Optimizing Workflow Management</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Nathanson;given-names:E</infon>
      <infon key="name_2">surname:Zou;given-names:KH</infon>
      <infon key="name_1">surname:Bhagwat;given-names:JG</infon>
      <infon key="name_0">surname:Ondategui-Parra;given-names:S</infon>
      <infon key="fpage">214</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">15983069</infon>
      <infon key="year">2005</infon>
      <infon key="source">Radiology</infon>
      <infon key="type">ref</infon>
      <infon key="volume">236</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">219</infon>
      <infon key="name_5">surname:Ros;given-names:PR</infon>
      <infon key="name_4">surname:Gill;given-names:IE</infon>
      <offset>19370</offset>
      <text>Use of productivity and financial indicators for monitoring performance in academic radiology departments: U.S. nationwide survey</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Sosna;given-names:J</infon>
      <infon key="name_2">surname:Yam;given-names:CS</infon>
      <infon key="name_1">surname:Anderson;given-names:S</infon>
      <infon key="name_0">surname:Kruskal;given-names:JB</infon>
      <infon key="fpage">315</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">19168762</infon>
      <infon key="year">2009</infon>
      <infon key="source">Radiographics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">29</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">329</infon>
      <offset>19500</offset>
      <text>Strategies for establishing a comprehensive quality and performance improvement program in a radiology department</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Rosen;given-names:MP</infon>
      <infon key="name_2">surname:Pascal;given-names:L</infon>
      <infon key="name_1">surname:Reedy;given-names:A</infon>
      <infon key="name_0">surname:Kruskal;given-names:JB</infon>
      <infon key="fpage">573</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">22323617</infon>
      <infon key="year">2012</infon>
      <infon key="source">Radiographics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">32</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">587</infon>
      <infon key="name_4">surname:Boiselle;given-names:PM</infon>
      <offset>19614</offset>
      <text>Quality initiatives: learn approach to improving performance and efficiency in a radiology department</text>
    </passage>
    <passage>
      <infon key="volume">1</infon>
      <infon key="name_2">surname:Haghi;given-names:A</infon>
      <infon key="name_1">surname:Moloudi;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Yaghoubi;given-names:N</infon>
      <infon key="fpage">8</infon>
      <infon key="issue">1</infon>
      <infon key="year">2010</infon>
      <infon key="source">EMQR</infon>
      <infon key="type">ref</infon>
      <offset>19716</offset>
      <text>Relationship of organizational culture and organization intelligence in public organization</text>
    </passage>
    <passage>
      <infon key="volume">79</infon>
      <infon key="name_1">surname:Dowding;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Randell;given-names:R</infon>
      <infon key="fpage">10</infon>
      <infon key="issue">6</infon>
      <infon key="year">2010</infon>
      <infon key="source">Int J Med Inform</infon>
      <infon key="type">ref</infon>
      <offset>19808</offset>
      <text>Organisational influences on nurses' use of clinical decision support systems</text>
    </passage>
    <passage>
      <infon key="volume">9</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hardee;given-names:S</infon>
      <infon key="fpage">13</infon>
      <infon key="issue">3</infon>
      <infon key="year">2003</infon>
      <infon key="source">SSM</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">17</infon>
      <offset>19888</offset>
      <text>Magnet hospitals and benchmarking: The Perioperative dashboards</text>
    </passage>
    <passage>
      <infon key="volume">85</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Serb;given-names:C</infon>
      <infon key="fpage">8</infon>
      <infon key="issue">6</infon>
      <infon key="pub-id_pmid">21793257</infon>
      <infon key="year">2011</infon>
      <infon key="source">Hosp Health Netw</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">40</infon>
      <offset>19952</offset>
      <text>Effective dashboardss. What to measure and how to show it</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Chang;given-names:PJ</infon>
      <infon key="name_2">surname:Mates;given-names:J</infon>
      <infon key="name_1">surname:Branstetter;given-names:BFt</infon>
      <infon key="name_0">surname:Morgan;given-names:MB</infon>
      <infon key="fpage">69</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">16249835</infon>
      <infon key="year">2006</infon>
      <infon key="source">J Digit Imaging</infon>
      <infon key="type">ref</infon>
      <infon key="volume">19</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">75</infon>
      <offset>20010</offset>
      <text>Flying blind: using a digital dashboards to navigate a complex PACS environment</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Martin;given-names:DP</infon>
      <infon key="name_2">surname:Avery;given-names:C</infon>
      <infon key="name_1">surname:Zaver;given-names:F</infon>
      <infon key="name_0">surname:McLeod;given-names:B</infon>
      <infon key="fpage">1383</infon>
      <infon key="issue">12</infon>
      <infon key="pub-id_pmid">21122023</infon>
      <infon key="year">2010</infon>
      <infon key="source">Acad Emerg Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">17</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1389</infon>
      <infon key="name_5">surname:Jessen;given-names:K</infon>
      <infon key="name_4">surname:Wang;given-names:D</infon>
      <offset>20090</offset>
      <text>Matching capacity to demand: a regional dashboards reduces ambulance avoidance and improves accessibility of receiving hospitals</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Ho;given-names:LM</infon>
      <infon key="name_2">surname:Cowling;given-names:BJ</infon>
      <infon key="name_1">surname:Ip;given-names:DK</infon>
      <infon key="name_0">surname:Cheng;given-names:CK</infon>
      <infon key="fpage">e85</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">22001082</infon>
      <infon key="year">2011</infon>
      <infon key="source">J Med Internet Res</infon>
      <infon key="type">ref</infon>
      <infon key="volume">13</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_5">surname:Lau;given-names:EH</infon>
      <infon key="name_4">surname:Leung;given-names:GM</infon>
      <offset>20219</offset>
      <text>Digital dashboards design using multiple data streams for disease surveillance with influenza surveillance as an example</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Danciu;given-names:I</infon>
      <infon key="name_2">surname:McCoy;given-names:AB</infon>
      <infon key="name_1">surname:Phillips;given-names:IE</infon>
      <infon key="name_0">surname:Waitman;given-names:LR</infon>
      <infon key="fpage">326</infon>
      <infon key="issue">7</infon>
      <infon key="year">2011</infon>
      <infon key="source">The Joint Commission Journal on Quality and Patient Safety</infon>
      <infon key="type">ref</infon>
      <infon key="volume">37</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">332</infon>
      <infon key="name_5">surname:Nelsen;given-names:CL</infon>
      <infon key="name_4">surname:Halpenny;given-names:RM</infon>
      <offset>20340</offset>
      <text>Adopting Real-Time Surveillance Dashboardss as a Component of an Enterprisewide Medication Safety Strategy</text>
    </passage>
    <passage>
      <infon key="volume">27</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Cleverley;given-names:WO</infon>
      <infon key="fpage">30</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">14680031</infon>
      <infon key="year">2001</infon>
      <infon key="source">J Health Care Finance</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">40</infon>
      <offset>20447</offset>
      <text>Financial dashboards reporting for the hospital industry</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Harrison;given-names:A</infon>
      <infon key="name_2">surname:Glass;given-names:S</infon>
      <infon key="name_1">surname:Graves;given-names:B</infon>
      <infon key="name_0">surname:Wadsworth;given-names:T</infon>
      <infon key="fpage">68</infon>
      <infon key="pub-id_pmid">19810655</infon>
      <infon key="year">2009</infon>
      <infon key="source">Healthcare Financial Management</infon>
      <infon key="type">ref</infon>
      <infon key="volume">63</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">78</infon>
      <infon key="name_5">surname:Proctor;given-names:A</infon>
      <infon key="name_4">surname:Donovan;given-names:C</infon>
      <offset>20504</offset>
      <text>using business intelligence to improve performance</text>
    </passage>
    <passage>
      <infon key="volume">79</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bannon;given-names:E</infon>
      <infon key="fpage">16</infon>
      <infon key="issue">10</infon>
      <infon key="pub-id_pmid">16333995</infon>
      <infon key="year">2005</infon>
      <infon key="source">Hospitals &amp; Health Networks</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">8</infon>
      <offset>20555</offset>
      <text>Clinical Dashboards</text>
    </passage>
    <passage>
      <infon key="volume">63</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Loeb;given-names:BB</infon>
      <infon key="fpage">35</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">20349809</infon>
      <infon key="year">2010</infon>
      <infon key="source">Trustee</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">36</infon>
      <offset>20575</offset>
      <text>A dashboards for medical staff goals</text>
    </passage>
    <passage>
      <infon key="volume">16</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Clarke;given-names:S</infon>
      <infon key="fpage">51</infon>
      <infon key="issue">2</infon>
      <infon key="year">2005</infon>
      <infon key="source">Journal of Corporate Accounting &amp; Finance</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">54</infon>
      <offset>20612</offset>
      <text>Your business dashboards: Knowing when to change the oil</text>
      <annotation id="25">
        <infon key="identifier">MESH:D009821</infon>
        <infon key="type">Chemical</infon>
        <location offset="20665" length="3"/>
        <text>oil</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Gravel;given-names:JW;suffix:Jr</infon>
      <infon key="name_2">surname:Carr;given-names:S</infon>
      <infon key="name_1">surname:Abercrombie;given-names:S</infon>
      <infon key="name_0">surname:Hoekzema;given-names:G</infon>
      <infon key="fpage">470</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">20843893</infon>
      <infon key="year">2010</infon>
      <infon key="source">Ann Fam Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">8</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_5">surname:Kozakowski;given-names:S</infon>
      <infon key="name_4">surname:Hall;given-names:KL</infon>
      <offset>20669</offset>
      <text>Residency "dashboards": family medicine GME's step towards transparency and accountability?</text>
    </passage>
    <passage>
      <infon key="volume">44</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Barta;given-names:RA</infon>
      <infon key="fpage">228</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">20715352</infon>
      <infon key="year">2010</infon>
      <infon key="source">Biomed Instrum Technol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">230</infon>
      <offset>20765</offset>
      <text>Dashboardss: a required business management tool</text>
    </passage>
    <passage>
      <infon key="volume">41</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Mick;given-names:J</infon>
      <infon key="fpage">391</infon>
      <infon key="issue">10</infon>
      <infon key="pub-id_pmid">21934423</infon>
      <infon key="year">2011</infon>
      <infon key="source">J Nurs Adm</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">393</infon>
      <offset>20814</offset>
      <text>Data-driven decision making: a nursing research and evidence-based practice dashboards</text>
    </passage>
    <passage>
      <infon key="volume">40</infon>
      <infon key="name_2">surname:Sewell;given-names:JP</infon>
      <infon key="name_1">surname:Anderson;given-names:F</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Frith;given-names:KH</infon>
      <infon key="fpage">10</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">20010372</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Nurs Adm</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">16</infon>
      <offset>20901</offset>
      <text>Assessing and selecting data for a nursing services dashboards</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Brown;given-names:DS</infon>
      <infon key="name_2">surname:Donaldson;given-names:N</infon>
      <infon key="name_1">surname:Bolton;given-names:LB</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Aydin;given-names:CE</infon>
      <infon key="year">2008</infon>
      <infon key="type">ref</infon>
      <infon key="name_4">surname:Mukerji;given-names:A</infon>
      <offset>20964</offset>
      <text>Beyond Nursing Quality Measurement: The Nation's First Regional Nursing Virtual Dashboards Assessment</text>
    </passage>
    <passage>
      <infon key="volume">32</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Lindberg;given-names:MC</infon>
      <infon key="fpage">24</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">21650137</infon>
      <infon key="year">2011</infon>
      <infon key="source">Health Manag Technol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">25</infon>
      <offset>21066</offset>
      <text>Real-time analytics increase early discharges. Dashboards lowers cost per case, improves patient satisfaction and minimizes staff frustration</text>
      <annotation id="27">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21155" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Toland;given-names:C</infon>
      <infon key="name_2">surname:Daly;given-names:M</infon>
      <infon key="name_1">surname:Warnock;given-names:MJ</infon>
      <infon key="name_0">surname:Nagy;given-names:PG</infon>
      <infon key="fpage">1897</infon>
      <infon key="issue">7</infon>
      <infon key="pub-id_pmid">19734469</infon>
      <infon key="year">2009</infon>
      <infon key="source">Radiographics</infon>
      <infon key="type">ref</infon>
      <infon key="volume">29</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1906</infon>
      <infon key="name_5">surname:Mezrich;given-names:RS</infon>
      <infon key="name_4">surname:Meenan;given-names:CD</infon>
      <offset>21208</offset>
      <text>Informatics in radiology: automated Web-based graphical dashboards for radiology operational business intelligence</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Linder</infon>
      <infon key="name_2">surname:Jeffrey;given-names:A</infon>
      <infon key="name_1">surname:Eunice;given-names:Jung</infon>
      <infon key="name_0">surname:Maya;given-names:Olsha-Yehiav JSE</infon>
      <infon key="fpage">1052</infon>
      <infon key="year">2006</infon>
      <infon key="source">AMIA</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">Symposium Proceedings</infon>
      <infon key="name_8">surname:Blackford;given-names:Middleton</infon>
      <infon key="name_7">surname:Schnipper</infon>
      <infon key="name_6">surname:Jeffrey;given-names:L</infon>
      <infon key="name_5">surname:Qi;given-names:Li</infon>
      <infon key="name_4">surname:Julie;given-names:Greim RN</infon>
      <offset>21323</offset>
      <text>Quality Dashboardss: Technical and Architectural Considerations of an Actionable Reporting Tool for Population Management</text>
    </passage>
    <passage>
      <infon key="volume">9</infon>
      <infon key="name_1">surname:Singer;given-names:PA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Masum;given-names:H</infon>
      <infon key="fpage">e32</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">17951216</infon>
      <infon key="year">2007</infon>
      <infon key="source">J Med Internet Res</infon>
      <infon key="type">ref</infon>
      <offset>21445</offset>
      <text>A visual dashboards for moving health technologies from "lab to village"</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Few;given-names:S</infon>
      <infon key="year">2006</infon>
      <infon key="type">ref</infon>
      <offset>21522</offset>
      <text>Information Dashboards Design: The Effective Visual Communication of Data</text>
    </passage>
    <passage>
      <infon key="volume">27</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Woodcock;given-names:EW</infon>
      <infon key="fpage">70</infon>
      <infon key="issue">1</infon>
      <infon key="year">2006</infon>
      <infon key="source">Dermatology Times</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">77</infon>
      <offset>21596</offset>
      <text>Practice dashboards</text>
    </passage>
  </document>
  <document>
    <id>4272838</id>
    <passage>
      <infon key="article-id_pmid">25568636</infon>
      <infon key="name_0">surname:Radic-Hozo;given-names:Endica</infon>
      <infon key="fpage">343</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272838</infon>
      <infon key="article-id_publisher-id">MSM-26-343</infon>
      <infon key="article-id_doi">10.5455/msm.2014.26.343-347</infon>
      <infon key="type">front</infon>
      <infon key="volume">26</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Mater Sociomed; 2014 Oct; 26(5) 343-7. doi:10.5455/msm.2014.26.343-347</infon>
      <infon key="kwd">Preschool education of children communication patterns</infon>
      <infon key="lpage">347</infon>
      <infon key="authors">Radic-Hozo E</infon>
      <offset>0</offset>
      <text>Communication Patterns in Preschool Education Institutions - Practical Examples</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>82</offset>
      <text>Introduction:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>96</offset>
      <text>Proper communication in pre-school institutions for education is undeniable importance to the development of the child, as evidenced by numerous studies. After the child's birth follows the most complex phase in its early phases - preschool education. Only high-quality, synergistic relationship triad: parent-child-educator and the modern postulates of preschool child education, warrants successful preschool child education.</text>
      <annotation id="5">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="209" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="6">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="260" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="7">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="406" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="8">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="460" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="9">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="507" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>524</offset>
      <text>Methods and materials:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>547</offset>
      <text>Description, with examples from daily practice in a large institution for preschool education, marked were the critical points on the complex way in child education, many pitfalls encountered by both parents and educators. Considered are the errors in communication with the proposed solution to avoid the same in practice.</text>
      <annotation id="12">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="696" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="13">
        <infon key="type">Disease</infon>
        <location offset="718" length="8"/>
        <text>pitfalls</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>871</offset>
      <text>Conclusion:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>883</offset>
      <text>Proper, daily communication in the preschool institution for education, within a relationship between parent-child-educator, mutual consultation, respect, acceptance, facilitation, resulting in successful common goal - the proper education and socialization of children in institutions for preschool education.</text>
      <annotation id="16">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="992" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="17">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1144" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1194</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1210</offset>
      <text>Children speak the truth ...</text>
      <annotation id="19">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1210" length="8"/>
        <text>Children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1239</offset>
      <text>:Chinese saying</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1257</offset>
      <text>Regarding the structure of communication models related to the whole system of preschool education, especially the institutions in which the system is implemented (Kindergartens or "Child House") are the basic communication patterns within and outside the institutions of preschool education. In addressing communication models in kindergarten, it is necessary to consider the needs of all participants are meeting within the communication in kindergarten. Communication in the context of human needs means meeting the needs together with other people, and with child population. Communication can be improved by the satisfaction of their needs, but not at the expense of others to meet their needs. The concept of communicative competence implies the possibility of achieving personal and relational objectives of communication, so that the objectives are achieved alone or together with others.</text>
      <annotation id="25">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1439" length="5"/>
        <text>Child</text>
      </annotation>
      <annotation id="26">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1647" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1746" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="28">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1802" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="29">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1819" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2158</offset>
      <text>It is important to mention Waclavek rules on the communication process:</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2230</offset>
      <text>  It is impossible not to communicate:</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2271</offset>
      <text>  Every communication has content and relational aspects.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2331</offset>
      <text>  Relationship characteristics are determined by the interpretation of the communication relations.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2433</offset>
      <text>Interpersonal intelligence is the ability to understand others, what motivates them, how they work, how to cooperate with them. Interpersonal (internal) intelligence (is the basis of interpersonal): balance in changes of personal thoughts and emotions (personal satisfaction and self-acceptance) so that we can access others without prejudice; empathize with someone else; help another person in a way that it appropriate for that person.</text>
      <annotation id="32">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2819" length="6"/>
        <text>person</text>
      </annotation>
      <annotation id="33">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2864" length="6"/>
        <text>person</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>2872</offset>
      <text>2. COMMUNICATION BETWEEN PARENTS-CHILD-EDUCATOR</text>
      <annotation id="35">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2905" length="5"/>
        <text>CHILD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2924</offset>
      <text>If we now shift the focus to the area of educating a child, there is no doubt that the most important link in the educational process of the child is parental care, communication between parent and child. Ideally, the child should grow in a family surrounded by parental care, in the company of brothers and sisters. This, idyllic, image was possible previously, before the industrial revolution when there was no institution of kindergartens, and when the kids all the time was at home under the supervision of other family members. In accordance with the new circumstances, today's parents are preoccupied with work to provide needs for the family, there is less time to socialize with the child (children). Therefore, the logical replacement for parental home and parental care, is the institution in which the child (children) stay while their parents are occupied with work in their workplaces. Their new home is a preschool (kindergarten) in which teacher/educator takes parental powers and becomes a "surrogate parent" for a group of children entrusted with their education and care. History of kindergarten just coincides with the development of society and the era of industrialization, so the first kindergartens were organized in Western countries. It also showed a critical need for them because the workers' families during their stay on the job had to find a substitute for the care of the child. On the other hand, communication cooperation and participation of parents in the program, early childhood education for long time has been questionable because of Hawkins paradigm "that parents will offer sooner the subjective assessment than expert opinions or objective observations". Finally, the fact that parents are responsible for their child, according to some eminent experts, parents should also have a voice in program evaluation.</text>
      <annotation id="47">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2977" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3065" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3122" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="50">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3142" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="51">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3616" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="52">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3623" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3738" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3745" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3965" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="56">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4328" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="57">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4679" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4787</offset>
      <text>Bronfenbrenner argued that for better efficiency of the early childhood programs for upbringing and education and their lasting impact on children, there is the need to involve parents of children and the community, and that they should work together to promote same goals.</text>
      <annotation id="60">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4925" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="61">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4975" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>5061</offset>
      <text>In practice, until the beginning of the 90' school partnerships in relation kindergarten-family was more the exception than the rule. Since then, however, provided there is growing evidence that parental involvement has a positive effect on the quality of education of children and their success in school. Higher levels of parental involvement in their child's upbringing is not due to the legal framework and regulations, but also due to the simple realization that parents are best acquainted with all the characteristics of their child. Reform moves from the mid-eighties, parents communicate daily with preschools staff, which are entitled to inform them about child development while choosing the right kindergarten. Some studies confirm that parental involvement also contributes to better relations between children and between children and educators. Finally, good communication between staff and parents is a prerequisite for quality care and education of young children. Growth of the child, after which family care and communication in the family, transforms into kindergarten or preschool, some new communication relationships arises so now is recognized triad parent-child-educator.</text>
      <annotation id="71">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5330" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="72">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5415" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5595" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5727" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5876" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="76">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5897" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="77">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6033" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="78">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6057" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="79">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6242" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>6260</offset>
      <text>3. COMMUNICATION RELATIONS IN KINDERGARTEN</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>6303</offset>
      <text>This relation reflects the essence of communication processes in institutions where child, "little man" is for the first time faced with the collective ("children's house"), in which applies some new rules in relation to life in home. Synergy of proper parental and teachers approach to the child, communication of the parents, educators and child care, between children, is of crucial importance for the further development of the child. A child who comes from a healthy, unencumbered, families in which it grows with love and attention relative to adapt quickly to new rules of community life. In contrast, a child that carries the frustration of the home from many, different, reason will have great difficulty to adjust. Especially for such children is reflected knowledge and experience of educators to identify such children and select them adequate (preferably individualized) approach. Important component is communication with children, hard work on the "opening" of the introverted child, learning to live in a collective, rules of life and finally, open communication with other children. The child is at the center of all communication patterns in pre-school institutions, and it focused all other relations, the primary communication applies in kindergarten are shown in Diagram 1.</text>
      <annotation id="95">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6387" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="96">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6402" length="3"/>
        <text>man</text>
      </annotation>
      <annotation id="97">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6457" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="98">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6594" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="99">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6645" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="100">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6665" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="101">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6735" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="102">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6744" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="103">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6914" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="104">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7048" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="105">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7125" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="106">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7239" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="107">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7295" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="108">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7393" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="109">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7407" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>7610</offset>
      <text>If we are consider coming to kindergarten from child's perspective, first visit to the nursery for them is a violent separation from parents, therefore, from the environment in which to feel safe, in a new, unknown space and handed over to strangers. It is understandable that a child in these circumstances is experiencing the frustrations that can manifest in different forms of behavioral changes and mood (energetic protest, crying and withdrawal, denial of communication with the teacher or, paradoxically, "stick" to teacher, refusing food, frantically holding objects which are associated to the house, waking, not sleeping, express anger and disobedience to the new conditions, manifest aggression towards the environment...).</text>
      <annotation id="113">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7657" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="114">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7889" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">MESH:D001523</infon>
        <infon key="type">Disease</infon>
        <location offset="8305" length="10"/>
        <text>aggression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>8349</offset>
      <text>The first days of the child's stay in the kindergarten are stressful for children and parents, and of course, for educators. Since kindergarten, is surrogate home and family environment, the child educator needs to develop a sense of security and belonging to a new family that is kindergarten. The task of the kindergarten, therefore, is to provide a safe and stable environment, an atmosphere which understand, accept and support the child's feelings</text>
      <annotation id="120">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8371" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8422" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="122">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8540" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="123">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8785" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>8802</offset>
      <text>If these communication relationships are observed from the parent's point of view (whether or not the educator take care of my child in the way I do, to understand its personality and its needs, "bugs", will have patience with my child, along with many other children, whether to accept it, finally, whether the child will be fine in the new environment), it is clear what is the responsibility of educators as well as the difficulties they will encounter during the upbringing of children. To respond to the complex requirements of parent educators will use an appropriate form of communication in order to achieve a harmonious relationship, with communication as a fundamental feature of mutual trust and understanding.</text>
      <annotation id="129">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8929" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="130">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9032" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="131">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9061" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="132">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9114" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9283" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>9528</offset>
      <text>Finally, a view of the educators on parents (monitors the extent to which parents are under stress due to separation from the child, how to recognize stress and frustration of parents, how to handle a parent who is frustrated because of the child's frustration, the way of feed and removal of the child, views and nonverbal communication, which sometimes speak louder than words, restraint in communication, (not) a rare and aggression by parents...) are all signs that the teacher should be recognized and interpreted in order to be properly set according to each parent by building specific communication form.</text>
      <annotation id="138">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9654" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="139">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9769" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="140">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9825" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="141">
        <infon key="identifier">MESH:D001523</infon>
        <infon key="type">Disease</infon>
        <location offset="9953" length="10"/>
        <text>aggression</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>10141</offset>
      <text>The parent is the first and most important link in the upbringing of the child. For the child's emotional stability and proper development it is most important that parents establish proper communication with the child from its earliest years. A warm family environment in the home, harmonious parental relations, relationships among siblings and other family members (grandparents) contributes to the proper development of the child, without the stress and frustration. The aforementioned departure of a child to kindergarten is the first stress to the child's psyche, which is why parents need to be prepared to that milestone in a child's life. In the first place, it is essential that their positive attitude towards kindergarten and confidence in educators, shortening the stay of a child in kindergarten the first day, parent involvement in all activities related to kindergarten, establishing a precise rhythm of arrival and departure from the kindergarten, and in the interim period adaptations allow the child to the brings his/hers toys, pacifier, bottle, etc.., which remind the child to home. Period of adjustment of the child is different and depends on the age group, of course, to quickly adapt to children older groups. A sudden separation from home child interprets as treason by parents and often reacts with anger, disapproval and aggression, often regressive behavior (crawling, bedwetting, etc.). For all these options parent should be ready to answer them with stronger affection, conversation and rationalization, of course, to the extent that to the child is understandable. Before kindergarten, a child needs to prepare and get used to this act, an occasional visit to a kindergarten, observing children at play, talking with staff, to be able to eat independently and possibly self-dresser. It is useful to occasionally leave the child with her grandparents or people who kept the diet for a few hours or a whole day to get the child used to the occasional separation from parents. Also, it is very important to build a relationship of trust and mutual respect with educators, proper communication and collaborative partnership because they are for parents and educators directed towards a common goal-successful adaptation of the child in the new circumstances.</text>
      <annotation id="164">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10214" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10229" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="166">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10354" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="167">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10569" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="168">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10646" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="169">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10695" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="170">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10775" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="171">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10929" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="172">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11154" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="173">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11231" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="174">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11274" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11354" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="176">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11407" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="177">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11715" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="178">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11763" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="179">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11861" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="180">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11997" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="181">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12028" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="182">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12095" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="183">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12398" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="184">
        <infon key="identifier">MESH:D001523</infon>
        <infon key="type">Disease</infon>
        <location offset="11491" length="10"/>
        <text>aggression</text>
      </annotation>
      <annotation id="185">
        <infon key="type">Disease</infon>
        <location offset="10703" length="6"/>
        <text>psyche</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>12432</offset>
      <text>Educator is the next link in the educational process of the child. To educator belongs a fundamental and very responsible role, "surrogate parent" for parents employed because they due to the workload have less time to socialize with the child, which are increasingly leaving the work in kindergarten (full day, 10-hour programs).</text>
      <annotation id="188">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12492" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="189">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12670" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>12767</offset>
      <text>Certainly in the educational process in the kindergarten equally affect the other participants: psychologist, pedagogue, special education teacher, speech therapist, and others who are important to the upbringing of the child (assistant, cooks, other staff), therefore all complementary to achieve complex missions in child-rearing.</text>
      <annotation id="193">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12849" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="194">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12987" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="195">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13085" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>13100</offset>
      <text>4. COMMUNICATION PATTERNS - WAYS OF COMMUNICATION </text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>13151</offset>
      <text>As stated above word, verbal communication is the foundation of every communication, including with pre-school children, some of which are still learning to speak. Proper verbal communication seeks calm approach to child, educator's equidistance towards other children in kindergarten (not favoring one child, so the other would not feel neglected) and finally individual approach, if necessary (e.g., children with special needs). Apart from this, regular communication, according to psychological divisions, there are also non-verbal communication ("body language"), and paraverbal communication (mode of speech, facial expressions, tone of voice). Like adults, children are very well understood by all three forms of communication, so that the educator in her work has extremely careful in all three forms (in) direct communication with the child. Child communication seeks educator's attention, equal relationship and the need for him to tutor his full attention to the conversation, i.e. that it is not in any way neglected.</text>
      <annotation id="204">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13262" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="205">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13366" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="206">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13411" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13454" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="208">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13553" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="209">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13815" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="210">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13995" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="211">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14002" length="5"/>
        <text>Child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>14185</offset>
      <text>So, if the educator is occupied some other business (e.g. preparation of workbooks, or other activities) and the child spoke, educator should stop working and devote its full attention. This means, not with some other work, it is necessary to look into the eyes of a child, to patiently hear its question or comment.</text>
      <annotation id="214">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14298" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="215">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14452" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>14502</offset>
      <text>Also, body language-gestures that betray impatience (tapping a pencil, interrupting the conversation, watching over the child, non-listening...) and the desire to talk or request as soon as possible, lead to poor communication between educators and child.</text>
      <annotation id="218">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14622" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14751" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>14760</offset>
      <text>Finally, the raised voices in conversation with the child, threatening expression (paraverbal communication) at the start eliminate child's desire to communicate, to which particular must watch every educator.</text>
      <annotation id="222">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14812" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="223">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14892" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>14970</offset>
      <text>It should be noted that the child during the entire stay in the kindergarten assess teacher's person, personality, way of communicating, and vice-versa, in a similar way to educator evaluate children in behavior and adoption of knowledge.</text>
      <annotation id="227">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14998" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="228">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15064" length="6"/>
        <text>person</text>
      </annotation>
      <annotation id="229">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15161" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>15209</offset>
      <text>The most important part of a successful adaptation of the child to kindergarten makes teachers. During the period of adjustment child educator needs to know, as a group, parents and children, recognize the individual needs of each child. Also, as a token of good communication relations educators need to be accepted by the child, through their activities, providing support to the child and parents. Educators monitor, observe the child during his stay in kindergarten take notes, plan activities and design child room to learn, play and other activities.</text>
      <annotation id="238">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15267" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="239">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15337" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="240">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15391" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="241">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15440" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="242">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15533" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="243">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15591" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="244">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15641" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="245">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15718" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>15766</offset>
      <text>What is the key moment in relation educator-child is that the everything that child is going through in kindergarten transmits to parents, or independently of its, spontaneous narratives, parents questioned in detail about (every)day stay in kindergarten and events (the ratio of educators to child, other children, food hygiene, etc.). Follow every move, every educator's raised voice, or some other form of punishment of the child (rough handling, pushing, pulling hair, etc..) Which may lead to very poor communication form educator-child. From such, disturbed, relations subsequently followed poor communication parent-educator, because any change in the relationship between child communications signals to parents. Of course, the relationship between educators and parents (the child's testimony parents often exaggerates!) Two vital components in preschool, thereby permanently disrupted. According to the findings of misfortunate events in kindergarten, and after talking with the child, the parents immediately, ultimately the director of the institution seeking punishment or removal of educators for the sake of the child's testimony.</text>
      <annotation id="256">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15810" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="257">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15844" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="258">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16059" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="259">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16072" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="260">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16193" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="261">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16302" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="262">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16446" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="263">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16550" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="264">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16755" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="265">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16893" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>16914</offset>
      <text>The above triad is the subject of numerous studies, psychological, pedagogical, as well as in the field of communication sciences, and they all agree with the fundamental postulates of communication, which in relation to the child has its specificities. So, parents and educators, spending time with your child should adhere to the following postulates:</text>
      <annotation id="268">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17139" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="269">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17219" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>17268</offset>
      <text>  Talk with child-teach introvert child to talk, encourage it to conversation, avoid conversation with the answers yes and no.</text>
      <annotation id="272">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17280" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="273">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17302" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>17397</offset>
      <text>  Call child by name-if you call them by the name, the child interprets this intimacy with a sense of responsibility, contrary to anonymous communication which means indifference.</text>
      <annotation id="276">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17404" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="277">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17452" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>17581</offset>
      <text>  Look child in the eyes: a direct sight means that you are interested in it (not too long, because fixed look achieve the opposite effect, watching manner means indifference or its absence).</text>
      <annotation id="279">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17588" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>17775</offset>
      <text>  Touch of a hand, touch child's hair: intimacy, commitment, "reward" for a completed task.</text>
      <annotation id="281">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17800" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>17873</offset>
      <text>  Diction, voice tonality of voice, facial expression-bland calm voice, without elevated tones, soothing facial expression.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>18001</offset>
      <text>  Short, simple communication, understandable words.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>18056</offset>
      <text>  Repetition-repeat your request, if you are ignored.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>18114</offset>
      <text>  Award him (your choice award) if it met your expectations.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>18177</offset>
      <text>  Deprive him an award if you it does not fulfill their task, it was his worst punishment Teach him the eighth decency, "please" and "thank you"-mandatory in communication.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>18362</offset>
      <text>  Point out errors, teach the child conversation.</text>
      <annotation id="283">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18392" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>18414</offset>
      <text>  If you mad tell him that you are sorrowful and sad because he did, do not allow yourself to be provoked or shout at a child.</text>
      <annotation id="285">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18534" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>18543</offset>
      <text>5. EXAMPLES FROM DAILY PRACTICE IN THE INSTITUTION FOR PRESCHOOL EDUCATION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>18618</offset>
      <text>Although Chinese proverb (quoted at the beginning of the text) says that children are telling the truth, we know from experience that it cannot be true. Reason false accusations may be because of relations between parents, (the so-called. Said syndrome sexual allegations in divorce) but also false allegations that the child expresses (invent). What happened was that children of parents accuse educators for (not) work that the same is not really so.</text>
      <annotation id="290">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18691" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="291">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18938" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="292">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18987" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="293">
        <infon key="identifier">MESH:D016097</infon>
        <infon key="type">Disease</infon>
        <location offset="18857" length="32"/>
        <text>Said syndrome sexual allegations</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>19071</offset>
      <text>Example. (Statement of an educator). "Peter was lively and happy child often would come in my lap. He was not always willing to fulfill the tasks, but with a little persuasion he gets them done. One morning he came with his father, corpulent worker from shipyard and very rudely attacked me, because if I had yesterday beaten child. I told him it was not true, and that such a thing has never happened in our kindergarten, but the father was insistent, saying that his Peter never lies. Immediately I called Peter and asked him in front of his father: "Did I beat you yesterday?" He embarrassingly said that I did not, and that he invented it so he does not have to do a task that for him was so hard. Parent immediately pounced the child, but now with a story that is a little liar and that his house does not believe anything. "</text>
      <annotation id="298">
        <infon key="identifier">7939</infon>
        <infon key="type">Gene</infon>
        <location offset="19165" length="3"/>
        <text>lap</text>
      </annotation>
      <annotation id="299">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19136" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="300">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19397" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="301">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19804" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>19910</offset>
      <text>In some cases the child, out of fear, hides a traumatic event in kindergarten fearing retaliation of the educators. Example: (testimony of parents) ... My Igor, a boy with signs of mild MCD, which required a special, individual approach because it is often obstinately persisting in their demands. Educator obviously had no patience with him, because the lady who earlier came by my child said that he is an educator led him to the bathroom and well beaten because he in a loud voice yelled. I have noticed that since that day my son did not want to go to kindergarten, he was afraid, he was crying but he would not say why, I guess out of fear. Of course ... I'm also reported the director of the kindergarten "...</text>
      <annotation id="307">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19928" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="308">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20073" length="3"/>
        <text>boy</text>
      </annotation>
      <annotation id="309">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20293" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="310">
        <infon key="identifier">MESH:D012514</infon>
        <infon key="type">Disease</infon>
        <location offset="20096" length="3"/>
        <text>MCD</text>
      </annotation>
      <annotation id="311">
        <infon key="identifier">MESH:D014947</infon>
        <infon key="type">Disease</infon>
        <location offset="19956" length="9"/>
        <text>traumatic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>20630</offset>
      <text>These cases are sporadic, rare, but should be assiduously investigated, because the truth always eventually came to light. For example after talks with parents who report changes in child behavior (frustration, fear, anxiety ...) followed by psychological testing (processing, drawing, etc..) That reveal educators / woman who got lost in the water for their upbringing and that systematically punish children in kindergarten. These cases are rare, but there are some, an example of a case where educators are parents set up a hidden camera that has discovered what all the kids did and how they were punished.</text>
      <annotation id="317">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20812" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="318">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20947" length="5"/>
        <text>woman</text>
      </annotation>
      <annotation id="319">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21031" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="320">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="20847" length="7"/>
        <text>anxiety</text>
      </annotation>
      <annotation id="321">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="20973" length="5"/>
        <text>water</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>21242</offset>
      <text>However, in most cases by children honestly convey to parents all events, was pleasant and unpleasant, and the knowledge and application relevant to kindergarten every case non pedagogic work with the child should be thoroughly investigated and, if necessary, sanctioned.</text>
      <annotation id="324">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21268" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="325">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21443" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>21514</offset>
      <text>Without a doubt, these situations are extreme, because the vast majority of educators do their job responsibly, and finally themselves have chosen the honorable invitation educators. Therefore, any case report violations of the child's integrity and personality (login parents or third parties, public or anonymously) should be accepted, checked thoroughly investigated and, if necessary, conduct psychological testing or other actions that would not have occurred cases which, needless, throw filth the honorable job of educators. A child who is developing normally, during his stay in kindergarten, collective, rapidly improves your vocabulary, speech impediments, talking with other children and with the teacher. However, the unconscious child can take on some negative qualities of speech and facial expressions (drawl, mispronounced words, tics) of children with these problems, imitating them.</text>
      <annotation id="331">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21742" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="332">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="22048" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="333">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="22200" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="334">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="22256" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="335">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="22369" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>22415</offset>
      <text>Example: Mirko child from highly educated family, whose parents are alternately brought and taken away from the nursery. (testimony of parents)... "In the beginning was staying in kindergarten flowed really well, Mirko quickly adapted and played with children. The problem arose when we noticed that Mirko weird talking, delaying and modulating voice in a special way, which has never before been done. I'm a little bothered, questioned and found that Mirko most endeared and hung out with the boy John, (a boy with Down syndrome), which, when we checked spoke in the same manner as is now saying our Mirko! "</text>
      <annotation id="340">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="22430" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="341">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="22666" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="342">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="22909" length="3"/>
        <text>boy</text>
      </annotation>
      <annotation id="343">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="22922" length="3"/>
        <text>boy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>23031</offset>
      <text>All these are the moments that must be observed educator who, as a corrective, talking with parents, seeks to correct the child's behavior, to direct it and to give special attention to such children. Because once mistakenly learned, it is difficult to correct. Kids play, learn unencumbered through the game, absorbing every word of educators, even if they do not know the true meaning of the word, but according to the sense and context are decrypted.</text>
      <annotation id="346">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23153" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="347">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23222" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>23485</offset>
      <text>Every word spoken, remembered the child may return like a boomerang, if a parent mechanically in a situation or someone send a curse, the child will remember and reproduce in approximately similar situation (anxiety, anger, resentment). Child resonates: If dad (or mom) so saying it is wrong and can also say in front of other people. So can it happen in a completely unmanageable situation juicy cursed child, even if you do not know the meaning of swearing, because it is a situation where it occurs associated with parental cursing in a similar situation.</text>
      <annotation id="354">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23519" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="355">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23623" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="356">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23722" length="5"/>
        <text>Child</text>
      </annotation>
      <annotation id="357">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23812" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="358">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23889" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="359">
        <infon key="identifier">MESH:D001008</infon>
        <infon key="type">Disease</infon>
        <location offset="23693" length="7"/>
        <text>anxiety</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>24044</offset>
      <text>Example 1: (testimony of parents) "The car journey with us was a little Ida, in her chair tied in last place. While driving in front of us carelessly, high speed from the side street crashed driver who almost hit us. I admit I slipped a juicy curse, but it all ended well. Next time driving, when I slammed on the brakes, Ida repeated cursing in the same way as I did I previously spoke".</text>
      <annotation id="362">
        <infon key="identifier">3425</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">170</infon>
        <location offset="24116" length="3"/>
        <text>Ida</text>
      </annotation>
      <annotation id="363">
        <infon key="identifier">3425</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">170</infon>
        <location offset="24366" length="3"/>
        <text>Ida</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>24437</offset>
      <text>Example 2 (testimony of parents). "We looked at (wife, little Emma) TV with an entertainment show in which he participated in one of our show biz stars be rampant. I quietly (not to hear me daughter!) Told the woman to switch the channel because I cannot watch that bitch..... Ok, a woman had done a few days back on TV appeared the same stars from the entertainment industry. Emma immediately cried loudly: There goes that son of a ... immediately shut down the TV."</text>
      <annotation id="366">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="24647" length="5"/>
        <text>woman</text>
      </annotation>
      <annotation id="367">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="24720" length="5"/>
        <text>woman</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>24909</offset>
      <text>This will also happen in relation to the teacher: child will house use phrases that he heard from educators, was in communication with him or with other children.</text>
      <annotation id="370">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="24959" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="371">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25062" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>25072</offset>
      <text>6. IMPORTANCE OF PROPER COMMUNICATION WITHIN THE FAMILY</text>
      <annotation id="373">
        <infon key="identifier">MESH:D001929</infon>
        <infon key="type">Disease</infon>
        <location offset="25110" length="6"/>
        <text>WITHIN</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>25128</offset>
      <text>Immeasurable importance of proper communication relation child and parents. Famous aphorism Earl of Rochester's (I had six theories about raising children when I had no child, now I have six of them and no theories ...) confirms this. Parents with a debut child learn communication and education on the forms that they experienced in their youth when they were raised by their parents. Parents who grew up as an only child, unconsciously accepted patterns of his youth, and almost identical to convey the paradigm of education to their child. Parents who grew up in a large family with different forms of education and communication with the child. What is now clear, the economic situation in the society, parents are reluctant to have another child, let alone more: partly out of conformism, but more for economic reasons. In families with one child, a kindergarten is a surrogate for a large family, and as such is necessary in the education of an individual, especially as parents occupied a job cannot be adequately measured participate in the upbringing of the child. Of course it is necessary nursery with large families in which the parents work, and the parents were all agree that education is the first child toughest. This is partly from inexperience and partly because of a family with one child unconsciously, exaggerated care, such children spared all possible situations in which a child could possibly be the endangered (e.g. Child is not sent to the nursery or day care due to the risk of transmission of infections, keeping the cold, rain, presvalacenje several times a day, especially feeding, mixed foods, avoiding the society of other children in the building where they live or work outside of a possible infection, avoidance of vaccination for the possible consequences, avoid rooms which housed more people, etc ...). 14 Because over care and isolation of the child, in such families are left only for parents, lonely, eager to socialize with other children. Company other kids did milieu in which the child is developing normally, realizes communication relationships with children their own age, and through the game with the children a feeling of satisfaction and happiness. Children who are only children in the family, "condemned" the only parents that if he wanted to, I cannot provide what the child wants, subconsciously are lonely and dissatisfied, because it is the day in the house monotonous and uneventful, until now the prevailing mood state. All knowledge about the life of children from their parents and in the best case of the second generation (today's increasingly rare!) Grandparents, who take the role of the nursery. So evident is the discrepancy between the generations, the generation gap, it is questionable as a good solution in education of a child. That is why the kindergarten indeed the solution for their situation, the postulation of kindergarten (kindergarten), which was established in 1840 by Frobel and remains very topical today, of course, in the new, modern conditions.</text>
      <annotation id="404">
        <infon key="identifier">54922</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">9847</infon>
        <location offset="26681" length="4"/>
        <text>rain</text>
      </annotation>
      <annotation id="405">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25185" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="406">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25274" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="407">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25297" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="408">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25384" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="409">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25545" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="410">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25664" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="411">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25770" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="412">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25873" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="413">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25974" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="414">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26195" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="415">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26342" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="416">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26431" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="417">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26475" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="418">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26526" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="419">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26571" length="5"/>
        <text>Child</text>
      </annotation>
      <annotation id="420">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26785" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="421">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26953" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="422">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27013" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="423">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27102" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="424">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27155" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="425">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27227" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="426">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27281" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="427">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27331" length="8"/>
        <text>Children</text>
      </annotation>
      <annotation id="428">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27353" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="429">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27454" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="430">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27642" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="431">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27924" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="432">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="26651" length="10"/>
        <text>infections</text>
      </annotation>
      <annotation id="433">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="26856" length="9"/>
        <text>infection</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">footnote</infon>
      <offset>28168</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>28205</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="volume">54</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sindik;given-names:J</infon>
      <infon key="fpage">9</infon>
      <infon key="year">2008/2009</infon>
      <infon key="source">Dijete, Vrtic, Obitelj</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">11</infon>
      <offset>28216</offset>
      <text>Jesu li profesionalci socijalno kompetentni?</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Goleman;given-names:D</infon>
      <infon key="year">1995</infon>
      <infon key="type">ref</infon>
      <offset>28261</offset>
      <text>Emocionalna inteligencija</text>
    </passage>
    <passage>
      <infon key="volume">24</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hawkins;given-names:Robert P</infon>
      <infon key="fpage">205</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">1890041</infon>
      <infon key="year">1991</infon>
      <infon key="source">Journal of Applied Behavior Analysis</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">213</infon>
      <offset>28287</offset>
      <text>Is social validity what we are interested in? Argument for a functional approach</text>
    </passage>
    <passage>
      <infon key="volume">9</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Guralnick;given-names:MJ</infon>
      <infon key="fpage">1</infon>
      <infon key="issue">3</infon>
      <infon key="year">1989</infon>
      <infon key="source">Topics in Early Childhood Special Education</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">17</infon>
      <offset>28368</offset>
      <text>Recent developments in early intervention efficacy research: Implications for family involvement</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bronfenbrenner;given-names:U</infon>
      <infon key="year">1979</infon>
      <infon key="type">ref</infon>
      <offset>28465</offset>
      <text>The ecology of human development: Experiments by design and nature</text>
      <annotation id="435">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28480" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Downey;given-names:G</infon>
      <infon key="name_2">surname:Caspi;given-names:A</infon>
      <infon key="name_1">surname:Bolger;given-names:N</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bronfenbrenner;given-names:U</infon>
      <infon key="fpage">25</infon>
      <infon key="year">1988</infon>
      <infon key="source">Persons in context: Developmental processes</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">49</infon>
      <infon key="name_4">surname:Moorehouse;given-names:M</infon>
      <offset>28532</offset>
      <text>Interacting systems in human development. Research paradigms: Present and future</text>
      <annotation id="437">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28555" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">10</infon>
      <infon key="name_1">surname:Walters;given-names:LH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Amirali;given-names:Jinnah H</infon>
      <infon key="fpage">1</infon>
      <infon key="issue">1</infon>
      <infon key="year">2008</infon>
      <infon key="source">ERCP</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">7</infon>
      <offset>28613</offset>
      <text>Including Parents in Evaluation of a Child Development Program: Relevance of Parental Involvement</text>
      <annotation id="439">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28650" length="5"/>
        <text>Child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">1</infon>
      <infon key="name_1">surname:MacNaughton;given-names:G</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hughes;given-names:P</infon>
      <infon key="fpage">241</infon>
      <infon key="issue">3</infon>
      <infon key="year">2000</infon>
      <infon key="source">Contemporary Issues in Early Childhood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">258</infon>
      <offset>28711</offset>
      <text>Consensus, dissensus or community: The politics of parent involvement in early childhood education</text>
    </passage>
    <passage>
      <infon key="name_2">surname:Milkie;given-names:MA</infon>
      <infon key="name_1">surname:Robinson;given-names:JP</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bianchi;given-names:SM</infon>
      <infon key="year">2006</infon>
      <infon key="type">ref</infon>
      <offset>28810</offset>
      <text>Changing Rhythms of American Family Life</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Ney;given-names:T</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Walker;given-names:Perry N</infon>
      <infon key="fpage">73</infon>
      <infon key="year">1995</infon>
      <infon key="source">True and False Allegations of Child Sexual Abuse: Assessment and Case Management</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">98</infon>
      <offset>28851</offset>
      <text>Childrens's comprehension od truths, lies and false belifs</text>
    </passage>
    <passage>
      <infon key="volume">8</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Faller;given-names:KC</infon>
      <infon key="fpage">473</infon>
      <infon key="pub-id_pmid">6542819</infon>
      <infon key="year">1984</infon>
      <infon key="source">Child Abuse and Neglect</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">481</infon>
      <offset>28910</offset>
      <text>Is the child victim of sexual abuse telling the truth?</text>
      <annotation id="442">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28917" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="443">
        <infon key="identifier">MESH:D012735</infon>
        <infon key="type">Disease</infon>
        <location offset="28933" length="20"/>
        <text>sexual abuse telling</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Ney;given-names:T</infon>
      <infon key="fpage">3</infon>
      <infon key="year">1995</infon>
      <infon key="source">An owrwiew</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">23</infon>
      <offset>28965</offset>
      <text>True and False Allegations of Child Sexual Abuse: Assessment and Case Management</text>
      <annotation id="445">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28995" length="5"/>
        <text>Child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_2">surname:Reece;given-names:RM</infon>
      <infon key="name_1">surname:Drotar;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Frank;given-names:DA</infon>
      <infon key="fpage">298</infon>
      <infon key="year">1994</infon>
      <infon key="source">Child abuse: Medical diagnosis and management</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">324</infon>
      <offset>29046</offset>
      <text>Failure to thrive</text>
    </passage>
    <passage>
      <infon key="volume">156</infon>
      <infon key="name_1">surname:Dodge;given-names:K</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Lansford;given-names:JE</infon>
      <infon key="fpage">824</infon>
      <infon key="issue">8</infon>
      <infon key="pub-id_pmid">12144375</infon>
      <infon key="year">2002</infon>
      <infon key="source">Arch Pediatr Adolesc Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">830</infon>
      <offset>29064</offset>
      <text>A 12-Year Prospective Study of the Long-term Effects of Early Child Physical Maltreatment on Psychological, Behavioral, and Academic Problems in Adolescence</text>
      <annotation id="447">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="29126" length="5"/>
        <text>Child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Connell;given-names:HL</infon>
      <infon key="year">2000</infon>
      <infon key="type">ref</infon>
      <offset>29221</offset>
      <text>The Childcare Answer Book</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Giesecke;given-names:J</infon>
      <infon key="name_2">surname:Hermanssonn;given-names:G</infon>
      <infon key="name_1">surname:Tegnell;given-names:A</infon>
      <infon key="name_0">surname:Dannetun;given-names:E</infon>
      <infon key="fpage">149</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">16162466</infon>
      <infon key="year">2005</infon>
      <infon key="source">Scandinavian Journal of Primary Health Care</infon>
      <infon key="type">ref</infon>
      <infon key="volume">23</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">153</infon>
      <offset>29247</offset>
      <text>Parents' reported reasons for avoiding MMR vaccination. A telephone survey</text>
    </passage>
    <passage>
      <infon key="volume">35</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Taylor;given-names:Allen A</infon>
      <infon key="fpage">173</infon>
      <infon key="year">2006</infon>
      <infon key="source">Journal of the History of Education Society</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">188</infon>
      <offset>29324</offset>
      <text>The Kindergarten in Germany and the United States, 1840 - 1914: A Comparative Perspective, History of Education</text>
    </passage>
  </document>
  <document>
    <id>4272839</id>
    <passage>
      <infon key="name_3">surname:Spahic;given-names:Emina</infon>
      <infon key="name_2">surname:Biscevic;given-names:Mirza</infon>
      <infon key="name_1">surname:Krupic;given-names:Ferid</infon>
      <infon key="article-id_pmid">25568584</infon>
      <infon key="name_0">surname:Tiric-Campara;given-names:Merita</infon>
      <infon key="fpage">333</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272839</infon>
      <infon key="article-id_publisher-id">AIM-55-333</infon>
      <infon key="article-id_doi">10.5455/aim.2014.22.333-340</infon>
      <infon key="type">front</infon>
      <infon key="volume">22</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Acta Inform Med; 2014 Oct; 22(5) 333-40. doi:10.5455/aim.2014.22.333-340</infon>
      <infon key="kwd">technological diseases carpal tunnel syndrome mouse shoulder cervical pain syndrome</infon>
      <infon key="name_7">surname:Masic;given-names:Izet</infon>
      <infon key="lpage">340</infon>
      <infon key="name_6">surname:Zunic;given-names:Lejla</infon>
      <infon key="name_5">surname:Masic;given-names:Zlatan</infon>
      <infon key="name_4">surname:Maglajlija;given-names:Kerima</infon>
      <infon key="authors">Tiric-Campara M, Krupic F, Biscevic M, Spahic E, Maglajlija K, Masic Z, Zunic L, Masic I</infon>
      <offset>0</offset>
      <text>Occupational Overuse Syndrome (Technological Diseases): Carpal Tunnel Syndrome, a Mouse Shoulder, Cervical Pain Syndrome</text>
      <annotation id="3">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="82" length="5"/>
        <text>Mouse</text>
      </annotation>
      <annotation id="4">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="107" length="4"/>
        <text>Pain</text>
      </annotation>
      <annotation id="5">
        <infon key="identifier">MESH:D012090</infon>
        <infon key="type">Disease</infon>
        <location offset="0" length="29"/>
        <text>Occupational Overuse Syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>121</offset>
      <text>ABSTRACT</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>130</offset>
      <text>Technological diseases are diseases of the modern era. Some are caused by occupational exposures, and are marked with direct professional relation, or the action of harmful effects in the workplace. Due to the increasing incidence of these diseases on specific workplaces which may be caused by one or more causal factors present in the workplace today, these diseases are considered as professional diseases. Severity of technological disease usually responds to the level and duration of exposure, and usually occurs after many years of exposure to harmful factor. Technological diseases occur due to excessive work at the computer, or excessive use of keyboards and computer mice, especially the non-ergonomic ones. This paper deals with the diseases of the neck, shoulder, elbow and wrist (cervical radiculopathy, mouse shoulder and carpal tunnel syndrome), as is currently the most common diseases of technology in our country and abroad. These three diseases can be caused by long-term load and physical effort, and are tied to specific occupations, such as occupations associated with prolonged sitting, working at the computer and work related to the fixed telephone communication, as well as certain types of sports (tennis, golf and others).</text>
      <annotation id="10">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="808" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="11">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="948" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="12">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="967" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
      <annotation id="13">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="924" length="22"/>
        <text>cervical radiculopathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1382</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1398</offset>
      <text>Computers are considered as an integral part of everyday life in today's work and life. They are used in a wide variety of professions from banking, health, communication to entertainment and leisure time. "Thanks to the" great use of computers, occurs the diseases of the modern era, which one of the authors of this article named "Technological diseases" - Carpal Tunnel Syndrome (CTS), a Mouse Shoulder (MS) and Cervical Pain Syndrome (CPS). Within past a few decades rapidly increased automation of offices and very few authors in the scientific literature have reported about positive association between computer use and musculoskeletal symptoms as consequences. Under term of"Technological diseases" we mean the diseases caused by the harmful influence of the job in the first place, the working position in which it is involved excessive work on a computer, such as the banking sector, the health sector and many others who are directly or indirectly connected with the work on the computer and overuse of keyboard and computer mice, which are in large number of cases of non-ergonomic, and inappropriate for a hand. It is therefore recommended to use ergonomic computer mice. Using them can prevent diseases of the modern era, technological diseases associated with prolonged sitting and working on a computer such as Carpal Tunnel Syndrome, Cervical syndrome, and certainly the most interesting for the many unknown, but not less important disease, mouse shoulder an increasingly common diagnosis in clinics of family medicine. These diseases are described in more detail in this paper. In Bosnia and Herzegovina to overuse injuries has not paid enough attention from the medical nor the social and economic aspects, although it is evident that large amounts of funds are allocated for treatment and rehabilitation of these diseases. In Clinical Center University of Sarajevo in the cabinet for EMNG of the Neurology clinic, monthly are diagnosed 10 cases with carpal tunnel syndrome, while cases of cervical syndrome is in a significant expansion during last 5 years which more and more represent not only a medical but also social economic problem.</text>
      <annotation id="25">
        <infon key="identifier">7276</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">317</infon>
        <location offset="1781" length="3"/>
        <text>CTS</text>
      </annotation>
      <annotation id="26">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="1789" length="5"/>
        <text>Mouse</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="2434" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="28">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="2577" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="29">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="2857" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="30">
        <infon key="identifier">MESH:D002575</infon>
        <infon key="type">Disease</infon>
        <location offset="3408" length="17"/>
        <text>cervical syndrome</text>
      </annotation>
      <annotation id="31">
        <infon key="identifier">MESH:D020165</infon>
        <infon key="type">Disease</infon>
        <location offset="1837" length="3"/>
        <text>CPS</text>
      </annotation>
      <annotation id="32">
        <infon key="identifier">MESH:D019547</infon>
        <infon key="type">Disease</infon>
        <location offset="1813" length="13"/>
        <text>Cervical Pain</text>
      </annotation>
      <annotation id="33">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="3369" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
      <annotation id="34">
        <infon key="identifier">MESH:D012090</infon>
        <infon key="type">Disease</infon>
        <location offset="2998" length="42"/>
        <text>Bosnia and Herzegovina to overuse injuries</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">MESH:D002575</infon>
        <infon key="type">Disease</infon>
        <location offset="2749" length="17"/>
        <text>Cervical syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>3573</offset>
      <text>2. CARPAL TUNNEL SYNDROME</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3599</offset>
      <text>Carpal tunnel syndrome (CTS) is the most common canaliculus syndrome resulting from pressure on the central nerve (median nerve) in the carpal tunnel (lat. canalis carpi) and reflected in reduction of sensation, pain, paresthesia (numbness, tingling), and muscle weakness in the hands and forearms.</text>
      <annotation id="43">
        <infon key="identifier">27040</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7811</infon>
        <location offset="3750" length="3"/>
        <text>lat</text>
      </annotation>
      <annotation id="44">
        <infon key="identifier">7276</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">317</infon>
        <location offset="3623" length="3"/>
        <text>CTS</text>
      </annotation>
      <annotation id="45">
        <infon key="identifier">MESH:D018908</infon>
        <infon key="type">Disease</infon>
        <location offset="3855" length="15"/>
        <text>muscle weakness</text>
      </annotation>
      <annotation id="46">
        <infon key="identifier">MESH:D006987</infon>
        <infon key="type">Disease</infon>
        <location offset="3830" length="8"/>
        <text>numbness</text>
      </annotation>
      <annotation id="47">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="3811" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="3599" length="22"/>
        <text>Carpal tunnel syndrome</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">MESH:D013577</infon>
        <infon key="type">Disease</infon>
        <location offset="3647" length="20"/>
        <text>canaliculus syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3898</offset>
      <text>The median nerve in its course passes through the carpal canal (Figure 1). The bones of the hand (lat. ossa carpi) make gutter channels, and rectangular connection (lat. retinaculum flexorum) covers the channel. In the channel along with the nerve are located tendon flexor muscle of fingers, m. pronator teres, m. pronator quadrates, m. flexor carpi radialis, m. palmaris longus, m. flexor carpi ulnaris, m. flexor digitorum superficialis et profundus and m. flexor policis longus. All these muscles supplying the median nerve. Carpi ulnaris M.flexor the inner half, m. Flexor digitorum profundus is innervated by n. ulnaris.</text>
      <annotation id="52">
        <infon key="identifier">27040</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7811</infon>
        <location offset="4063" length="3"/>
        <text>lat</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">27040</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">7811</infon>
        <location offset="3996" length="3"/>
        <text>lat</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-333-g001.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>4525</offset>
      <text>The muscles of the forearm.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4553</offset>
      <text>Carpal tunnel syndrome (CTS) was first described in the mid-1800 by James Paget's (Figure 1). The world's best known as peripheral compressive neuropathy and one of the fastest growing technology diseases in the United States. At least 1 out of 10 people develop this disorder or suffering from the symptoms of this syndrome. This is one of the most common causes of absenteeism in the workplace and disability in the United States </text>
      <annotation id="59">
        <infon key="identifier">7276</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">317</infon>
        <location offset="4577" length="3"/>
        <text>CTS</text>
      </annotation>
      <annotation id="60">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4801" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="61">
        <infon key="identifier">MESH:D010523</infon>
        <infon key="type">Disease</infon>
        <location offset="4673" length="33"/>
        <text>peripheral compressive neuropathy</text>
      </annotation>
      <annotation id="62">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="4553" length="22"/>
        <text>Carpal tunnel syndrome</text>
      </annotation>
      <annotation id="63">
        <infon key="type">Disease</infon>
        <location offset="4920" length="11"/>
        <text>absenteeism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4986</offset>
      <text>Signs and symptoms are: a) pain in the palm of the hand, especially near the thumb and first two fingers; b) numbness and tingling often occur in the thumb and first two fingers; and c) weakness, usually thenar eminence (muscles at the base of the thumb), can occur when a severe clinical picture (Figure 2).</text>
      <annotation id="67">
        <infon key="identifier">MESH:D006987</infon>
        <infon key="type">Disease</infon>
        <location offset="5095" length="8"/>
        <text>numbness</text>
      </annotation>
      <annotation id="68">
        <infon key="identifier">MESH:D018908</infon>
        <infon key="type">Disease</infon>
        <location offset="5172" length="8"/>
        <text>weakness</text>
      </annotation>
      <annotation id="69">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="5013" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-333-g002.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption</infon>
      <offset>5295</offset>
      <text>Sensory innervation of the median nerve in a hand</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>5345</offset>
      <text>Compression of the nerve in the carpal tunnel (carpal tunnel syndrome) is recognized as the impact of trauma and attributed to tenosynovitis of the rheumatoid arthritis. Even since 1954, Albert and his colleagues concluded that there are numerous reports describing the spontaneous development of carpal tunnel syndrome of unknown pathogenesis.</text>
      <annotation id="74">
        <infon key="identifier">MESH:D014947</infon>
        <infon key="type">Disease</infon>
        <location offset="5447" length="6"/>
        <text>trauma</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">MESH:D001172</infon>
        <infon key="type">Disease</infon>
        <location offset="5472" length="41"/>
        <text>tenosynovitis of the rheumatoid arthritis</text>
      </annotation>
      <annotation id="76">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="5642" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
      <annotation id="77">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="5392" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>5690</offset>
      <text>In case of a longer duration of illness and long-term nerve compression, there is an unnecessary prolongation of the patient discomfort, severe nerve damage, prolonged recovery time after surgery, and generally reduced chances for successful surgical treatment. Thereby reducing the working ability of the patient, leading both to the individual and to the socioeconomic consequences.</text>
      <annotation id="82">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5807" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="83">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5996" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="84">
        <infon key="identifier">MESH:D004194</infon>
        <infon key="type">Disease</infon>
        <location offset="5834" length="12"/>
        <text>nerve damage</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="5722" length="7"/>
        <text>illness</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>6075</offset>
      <text>At the Department of Orthopedic Surgery, Faculty of Medicine, University of Zagreb, and Zagreb University Hospital Center is conducted a retrospective study on 114 patients and 154 hands with CTS that were surgically treated between 1999 and 2004. In this study, it was found that patients in only 52% of cases within one year since reporting to the physician were referred to an orthopedist. In the period prior to surgical treatment, 96.1% of patients were treated by physical therapy, although all eventually underwent a surgical procedure, and 42% of patients in the same time period it was on sick leave, usually from three to six months. The results demonstrate that the timeliness of surgical treatment is essential to the success of the outcome of the procedure, and that the time which elapses from entering the patient's health care system to the surgical treatment of unnecessary cost.</text>
      <annotation id="92">
        <infon key="identifier">7276</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">317</infon>
        <location offset="6267" length="3"/>
        <text>CTS</text>
      </annotation>
      <annotation id="93">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6239" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="94">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6356" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="95">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6520" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="96">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6630" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="97">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6896" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>6972</offset>
      <text>This situation, besides being detrimental for the patient, and leads to unnecessary economic losses include the expense of physical therapy and absenteeism. The patients involved in the study in question is estimated that these economic losses, in the period prior to surgical treatment, for several hundred thousand Euros higher than in the postoperative period.</text>
      <annotation id="102">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7022" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="103">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7133" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="104">
        <infon key="identifier">9319</infon>
        <infon key="type">Species</infon>
        <location offset="7289" length="5"/>
        <text>Euros</text>
      </annotation>
      <annotation id="105">
        <infon key="type">Disease</infon>
        <location offset="7116" length="11"/>
        <text>absenteeism</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>7336</offset>
      <text>From this stems the need for shortening the period of time that has elapsed since entering the patient in the health care system to its referral to an orthopedic clinic, so as to accelerate the processing and diagnosis of the patient, i.e. shortened unnecessarily long period of nonsurgical treatment. Accordingly, physical therapy is helpful in the treatment.</text>
      <annotation id="108">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7431" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="109">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7562" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>7697</offset>
      <text>In the diagnosis of CTS we also use provoking tests of which we will mention four that are suitable for use in general practice. These are the Tinel, Phalen, Bilic and Tourniquet test. Tinel's test is positive if the percussion in the carpal ligament is followed with occurrence of pain and/or paresthesia. Phalen's test is performed so that the wrist is placed in the second forced palmar flexion for 60 seconds, and is positive if within this time span occurs pain and/or parasthesias (Figure 2). Compression of median nerve in this position with carpal tunnel syndrome causes the characteristic symptoms of burning and tingling.</text>
      <annotation id="114">
        <infon key="identifier">7276</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">317</infon>
        <location offset="7717" length="3"/>
        <text>CTS</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="7979" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="116">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="8246" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
      <annotation id="117">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="8159" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>8329</offset>
      <text>Bilic test is performed in palmar flexion of the wrist by 45 degrees by pressing above the median nerve in the distal ridges and mid wrist for 30 seconds. The test is positive if within this time span occurs pain and/or paresthesia. Tourniquet test is performed so that the cuff pressure gauge is mounted on the upper arm and inflated above the systolic pressure value. The test is positive during 60 seconds occurs pain and/or paresthesia in the innervation area of median nerve.</text>
      <annotation id="120">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="8745" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="8537" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>8810</offset>
      <text>Alongside this symptom, electrical neurophysiological diagnostic is the"gold standard" in the diagnosis of carpal tunnel syndrome, in order to determine the exact location of nerve compression, and in order to set the indication for surgical treatment (Figure 3, 4, 5).</text>
      <annotation id="123">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="8917" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-333-g003.jpg</infon>
      <infon key="id">F3</infon>
      <infon key="type">fig_caption</infon>
      <offset>9084</offset>
      <text>EMNG median nerve recording procedure</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-333-g004.jpg</infon>
      <infon key="id">F4</infon>
      <infon key="type">fig_caption</infon>
      <offset>9122</offset>
      <text>EMNG: Motor Conduction Velocity of nervus medianus</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-333-g005.jpg</infon>
      <infon key="id">F5</infon>
      <infon key="type">fig_caption</infon>
      <offset>9173</offset>
      <text>EMNG: Sensory Conduction Velocity of nervus medianus</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>9226</offset>
      <text>In the case of known primary disease that caused Carpal tunnel syndrome the primary disease is treated first. The conservative methods of treatment include immobilization, local application of corticosteroids and avoidance of chronic, repeated trauma. If the cause of the syndrome is mechanical compression, the treatment is surgical (cutting of retinaculum flexorum).</text>
      <annotation id="126">
        <infon key="identifier">MESH:D014947</infon>
        <infon key="type">Disease</infon>
        <location offset="9470" length="6"/>
        <text>trauma</text>
      </annotation>
      <annotation id="127">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="9275" length="42"/>
        <text>Carpal tunnel syndrome the primary disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>9595</offset>
      <text>In Turkey was conducted a study that suggests that treatment with vitamin B6 improves clinical symptoms as well as sensory and electro diagnostic results in patients with carpal tunnel syndrome, and therefore it is advisable to treat carpal tunnel syndrome with vitamin B6.</text>
      <annotation id="134">
        <infon key="identifier">9103</infon>
        <infon key="type">Species</infon>
        <location offset="9598" length="6"/>
        <text>Turkey</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9752" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="136">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="9829" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
      <annotation id="137">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="9766" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
      <annotation id="138">
        <infon key="identifier">MESH:D025101</infon>
        <infon key="type">Chemical</infon>
        <location offset="9661" length="10"/>
        <text>vitamin B6</text>
      </annotation>
      <annotation id="139">
        <infon key="identifier">MESH:D025101</infon>
        <infon key="type">Chemical</infon>
        <location offset="9857" length="10"/>
        <text>vitamin B6</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>9869</offset>
      <text>Another study in Turkey was carried out at the Institute of Neurology in cooperation with the Clinic for Physiotherapy in which patients were included with carpal tunnel syndrome. They are divided into two groups, one in the treatment arm used immobilization and massages, while the other control group used only immobilized arm.</text>
      <annotation id="143">
        <infon key="identifier">9103</infon>
        <infon key="type">Species</infon>
        <location offset="9886" length="6"/>
        <text>Turkey</text>
      </annotation>
      <annotation id="144">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9997" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="145">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="10025" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>10199</offset>
      <text>The study results showed that the massage of the painful area only in patients with carpal tunnel syndrome is sufficient for mild cases.</text>
      <annotation id="148">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10269" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="149">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="10283" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>10336</offset>
      <text>This was also one of the biggest studies with massage treatment in patients with carpal tunnel syndrome. The researchers recommend self-administration of massage methods, and this would reduce the time to go to the doctor and rehabilitation centers, and thereby save money, both for health funds, and patients.</text>
      <annotation id="153">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10403" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="154">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10637" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="155">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="10417" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>10647</offset>
      <text>Manipulation (effleurage): Thirty seconds smoothing the skin's surface, from distal to proximal forearm. Friction: sixty seconds, massaging the deep tissues from the distal to proximal. </text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>10834</offset>
      <text>3. CERVICAL PAIN SYNDROME</text>
      <annotation id="158">
        <infon key="identifier">MESH:D000699</infon>
        <infon key="type">Disease</infon>
        <location offset="10846" length="4"/>
        <text>PAIN</text>
      </annotation>
      <annotation id="159">
        <infon key="identifier">MESH:D002575</infon>
        <infon key="type">Disease</infon>
        <location offset="10837" length="8"/>
        <text>CERVICAL</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>10860</offset>
      <text>Cervical pain syndrome (CPS) refers to a range of disorders caused by changes in the cervical spine and soft tissue surrounding it, with pain as the predominant symptom. Neck pain is a common problem for a large portion of today's population.</text>
      <annotation id="164">
        <infon key="identifier">MESH:D019547</infon>
        <infon key="type">Disease</infon>
        <location offset="11030" length="9"/>
        <text>Neck pain</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">MESH:D020165</infon>
        <infon key="type">Disease</infon>
        <location offset="10884" length="3"/>
        <text>CPS</text>
      </annotation>
      <annotation id="166">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="10869" length="13"/>
        <text>pain syndrome</text>
      </annotation>
      <annotation id="167">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="10997" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>11103</offset>
      <text>Factors contributing to this problem are the modern way of life, prolonged sitting and inadequate, fixed or artificial positions. The root of these problems is found in the mechanical disorders of the cervical spine, poor posture and quick movements of the body.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>11366</offset>
      <text>Anatomical specificity of the cervical spinal column are: a small side vertebral joints that cervical spine provide great mobility, transversaria foramina through which the vertebral artery (C6-C2) and the spinal cord enters in the vertebral canal.</text>
      <annotation id="170">
        <infon key="identifier">OMIM:217000</infon>
        <infon key="type">Disease</infon>
        <location offset="11557" length="5"/>
        <text>C6-C2</text>
      </annotation>
      <annotation id="171">
        <infon key="identifier">MESH:D007592</infon>
        <infon key="type">Disease</infon>
        <location offset="11426" length="27"/>
        <text>small side vertebral joints</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>11615</offset>
      <text>Cervical radiculopathy causes symptoms that radiate from the neck. Although the problem is in the spine, the symptoms can be felt in the shoulder or arm. Symptoms will be felt in the area where the nerve is in its path.</text>
      <annotation id="174">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="11624" length="13"/>
        <text>radiculopathy</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">MESH:D004194</infon>
        <infon key="type">Disease</infon>
        <location offset="11659" length="7"/>
        <text>radiate</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>11835</offset>
      <text>By clinical examination of the spine the specialist can usually determine which nerve is involved. Symptoms include pain, stiffness and weakness. Reflexes on the upper arm may be affected..</text>
      <annotation id="178">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="11951" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="179">
        <infon key="identifier">MESH:D018908</infon>
        <infon key="type">Disease</infon>
        <location offset="11957" length="22"/>
        <text>stiffness and weakness</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>12025</offset>
      <text>Risk factors for radiculopathy are activities that put excessive or repetitive load on the spine. Patients involved in heavy work or are in contact sports, are more prone to the development of those with radiculopathy more sedentary. A family history of radiculopathy or other spine disorders also increase the risk of developing radiculopathy (Figure 6).</text>
      <annotation id="186">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12123" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="187">
        <infon key="identifier">MESH:D016135</infon>
        <infon key="type">Disease</infon>
        <location offset="12302" length="15"/>
        <text>spine disorders</text>
      </annotation>
      <annotation id="188">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="12355" length="13"/>
        <text>radiculopathy</text>
      </annotation>
      <annotation id="189">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="12279" length="13"/>
        <text>radiculopathy</text>
      </annotation>
      <annotation id="190">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="12229" length="13"/>
        <text>radiculopathy</text>
      </annotation>
      <annotation id="191">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="12042" length="13"/>
        <text>radiculopathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-333-g006.jpg</infon>
      <infon key="id">F6</infon>
      <infon key="type">fig_caption</infon>
      <offset>12381</offset>
      <text>Example of cervical syndrome caused by disc herniation with reduction of liquor space (Source: I.M.)</text>
      <annotation id="193">
        <infon key="identifier">MESH:D002575</infon>
        <infon key="type">Disease</infon>
        <location offset="12392" length="17"/>
        <text>cervical syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>12482</offset>
      <text>In the younger population, cervical radiculopathy is the result of disc herniation or acute injury. In the older population, cervical radiculopathy is often the result of foramen narrowing and the formation of osteophytes then reduced the amount of disk and degenerative changes in the joints.</text>
      <annotation id="197">
        <infon key="identifier">MESH:D058186</infon>
        <infon key="type">Disease</infon>
        <location offset="12568" length="12"/>
        <text>acute injury</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="12509" length="22"/>
        <text>cervical radiculopathy</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="12616" length="13"/>
        <text>radiculopathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>12776</offset>
      <text>Cervical syndrome classification:</text>
      <annotation id="201">
        <infon key="identifier">MESH:D002575</infon>
        <infon key="type">Disease</infon>
        <location offset="12776" length="17"/>
        <text>Cervical syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>12810</offset>
      <text>CERVICAL SYNDROME patients complain of pain in the neck that occurs gradually or abruptly, after taking a certain position, rapid or uncontrolled movements of the neck or cooling.</text>
      <annotation id="205">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12828" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="206">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="12849" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">MESH:D002575</infon>
        <infon key="type">Disease</infon>
        <location offset="12810" length="8"/>
        <text>CERVICAL</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>12990</offset>
      <text>CERVICOCEPHALIC SYNDROME usually develops as a result of irritation or compression of the nerve roots C1-C3. The main symptom is headache of varying character and intensity. Headache is localized in the neck with a tendency to spread to the shoulders, the face, orbital or auricular region.</text>
      <annotation id="211">
        <infon key="identifier">MESH:D006261</infon>
        <infon key="type">Disease</infon>
        <location offset="13164" length="8"/>
        <text>Headache</text>
      </annotation>
      <annotation id="212">
        <infon key="identifier">MESH:D006261</infon>
        <infon key="type">Disease</infon>
        <location offset="13119" length="8"/>
        <text>headache</text>
      </annotation>
      <annotation id="213">
        <infon key="identifier">MESH:D001523</infon>
        <infon key="type">Disease</infon>
        <location offset="13047" length="10"/>
        <text>irritation</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>13281</offset>
      <text>CERVOCOBRACHIAL SYNDROME result is irritation or compression of the nerve roots C4-C8, mostly due to prolapse of the intervertebral discus, severe degenerative changes or injury.</text>
      <annotation id="217">
        <infon key="identifier">MESH:D001523</infon>
        <infon key="type">Disease</infon>
        <location offset="13316" length="10"/>
        <text>irritation</text>
      </annotation>
      <annotation id="218">
        <infon key="type">Disease</infon>
        <location offset="13281" length="15"/>
        <text>CERVOCOBRACHIAL</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">MESH:D058186</infon>
        <infon key="type">Disease</infon>
        <location offset="13452" length="6"/>
        <text>injury</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>13460</offset>
      <text>VERTEBROBASILAR SYNDROME occurs as a result of irritation of the last cervical sympathetic with fiber mesh wrap vertebral artery, causing reflex vascular disorders in the vertebrobasilar basin.</text>
      <annotation id="222">
        <infon key="identifier">MESH:D001523</infon>
        <infon key="type">Disease</infon>
        <location offset="13507" length="10"/>
        <text>irritation</text>
      </annotation>
      <annotation id="223">
        <infon key="identifier">MESH:D000783</infon>
        <infon key="type">Disease</infon>
        <location offset="13605" length="18"/>
        <text>vascular disorders</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>13654</offset>
      <text>Irritation commonly caused by degenerative changes in the cervical spine: spondylosis (osteophytes), uncarthrosis, spondylosis. Atherosclerosis can worsen symptoms.</text>
      <annotation id="228">
        <infon key="identifier">MESH:D050197</infon>
        <infon key="type">Disease</infon>
        <location offset="13782" length="15"/>
        <text>Atherosclerosis</text>
      </annotation>
      <annotation id="229">
        <infon key="identifier">MESH:D055009</infon>
        <infon key="type">Disease</infon>
        <location offset="13769" length="11"/>
        <text>spondylosis</text>
      </annotation>
      <annotation id="230">
        <infon key="type">Disease</infon>
        <location offset="13755" length="12"/>
        <text>uncarthrosis</text>
      </annotation>
      <annotation id="231">
        <infon key="identifier">MESH:D055009</infon>
        <infon key="type">Disease</infon>
        <location offset="13728" length="11"/>
        <text>spondylosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>13819</offset>
      <text>The typical clinical presentation of patients with cervical syndrome is characterized by the presence of pain and sensitivity in the muscles back of the neck with the spread of pain in the back of the head, shoulders or scapular region (Figure 6). The sensitivity of the muscle can occur during execution of one or more movements, and the headache is a common symptom.</text>
      <annotation id="237">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13856" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="238">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="13996" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="239">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="13924" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="240">
        <infon key="identifier">MESH:D006261</infon>
        <infon key="type">Disease</infon>
        <location offset="14158" length="8"/>
        <text>headache</text>
      </annotation>
      <annotation id="241">
        <infon key="identifier">MESH:D002575</infon>
        <infon key="type">Disease</infon>
        <location offset="13870" length="17"/>
        <text>cervical syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>14188</offset>
      <text>Symptoms and signs are: a) pain in the neck, which may be sharp or blunt; b) the tension in the neck; c) painful and limited mobility; d) inability to perform daily duties due to stiffness in the neck; e) pain in the shoulders and arms associated with pain in the neck; f) fainting; g) dizziness; h) tinnitus; i) blurred vision; j) headache; k) diplopia; l) weakness; m) feeling of heaviness, tenderness and paresthesia in the upper extremities; n) impaired concentration and memory, etc..</text>
      <annotation id="253">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="14215" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="254">
        <infon key="type">Disease</infon>
        <location offset="14581" length="10"/>
        <text>tenderness</text>
      </annotation>
      <annotation id="255">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="14393" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="256">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="14440" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="257">
        <infon key="identifier">MESH:D008595</infon>
        <infon key="type">Disease</infon>
        <location offset="14570" length="9"/>
        <text>heaviness</text>
      </annotation>
      <annotation id="258">
        <infon key="identifier">MESH:D004244</infon>
        <infon key="type">Disease</infon>
        <location offset="14474" length="9"/>
        <text>dizziness</text>
      </annotation>
      <annotation id="259">
        <infon key="identifier">MESH:D004172</infon>
        <infon key="type">Disease</infon>
        <location offset="14533" length="8"/>
        <text>diplopia</text>
      </annotation>
      <annotation id="260">
        <infon key="identifier">MESH:D014786</infon>
        <infon key="type">Disease</infon>
        <location offset="14501" length="14"/>
        <text>blurred vision</text>
      </annotation>
      <annotation id="261">
        <infon key="identifier">MESH:D018908</infon>
        <infon key="type">Disease</infon>
        <location offset="14546" length="8"/>
        <text>weakness</text>
      </annotation>
      <annotation id="262">
        <infon key="identifier">MESH:D014012</infon>
        <infon key="type">Disease</infon>
        <location offset="14488" length="8"/>
        <text>tinnitus</text>
      </annotation>
      <annotation id="263">
        <infon key="identifier">MESH:D006261</infon>
        <infon key="type">Disease</infon>
        <location offset="14520" length="8"/>
        <text>headache</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>14678</offset>
      <text>Diagnostic imaging such as magnetic resonance imaging, computerized tomography, or myelography should be used as a strategy for assessment. Electromyography is useful in differentiating between the various entities when distinguishing clinical diagnosis. Treatment of this disorder has not been studied systematically in a controlled manner. However, using a variety of treatments, radiculopathy usually improves without the need for surgery. Indications for surgery were persistent pain, increased weakness, or new or progressive process. Future studies evaluating different treatment options will be helpful in guiding practitioners towards optimal economic evaluation.</text>
      <annotation id="267">
        <infon key="identifier">MESH:D018908</infon>
        <infon key="type">Disease</infon>
        <location offset="15177" length="8"/>
        <text>weakness</text>
      </annotation>
      <annotation id="268">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="15060" length="13"/>
        <text>radiculopathy</text>
      </annotation>
      <annotation id="269">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="15161" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>15350</offset>
      <text>The goal of treatment is absolutely the same as for any other illness. Always seeks the same goal, or cure, and if this is not possible, at least alleviate symptoms and apply palliative care. Since we are talking about a technological disease that affects more and more to older and younger people should therefore work on the prevention of disease. It is very important to advise patients about lifestyle, how to maintain mobility and that despite the difficult situation improve the quality of life.</text>
      <annotation id="273">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15641" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="274">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15731" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="275">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="15412" length="7"/>
        <text>illness</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>15852</offset>
      <text>Treatment without medicationshould be: a) massage hot/cold; b) rest; c) exercises with light stretching (gently stretch your neck to one, then the other aside and keep 30 seconds); d) exercises for neck recommended by physiologists; e) transcutaneous electrical stimulation (TENS); f) short-term immobilization; g) surgical treatment; h) acupuncture; i) traction (enlargement of the intervertebral space), j) medicamentous treatment:</text>
      <annotation id="277">
        <infon key="identifier">137872</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">5865</infon>
        <location offset="15902" length="3"/>
        <text>hot</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>16286</offset>
      <text>Early and adequate treatment with analgesics, anti-inflammatory drugs, muscle relaxants and help with sleep problems are carriers of pharmacological treatment in patients with neck pain.</text>
      <annotation id="280">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16448" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="281">
        <infon key="identifier">MESH:D019547</infon>
        <infon key="type">Disease</infon>
        <location offset="16462" length="9"/>
        <text>neck pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>16473</offset>
      <text>Performed is a study on how the steroid injections affect the reduction of pain in patients with cervical syndrome, who are waiting for surgery discus, and whether the possible suspension of surgical treatment.</text>
      <annotation id="286">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16556" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="287">
        <infon key="identifier">MESH:D002575</infon>
        <infon key="type">Disease</infon>
        <location offset="16570" length="17"/>
        <text>cervical syndrome</text>
      </annotation>
      <annotation id="288">
        <infon key="identifier">MESH:D013256</infon>
        <infon key="type">Chemical</infon>
        <location offset="16505" length="7"/>
        <text>steroid</text>
      </annotation>
      <annotation id="289">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="16548" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>16684</offset>
      <text>Transforaminal injection of steroids has gained popularity with the explanation that the inflammation of nerve roots causing radicular pain, and because steroids are placed on the local level should relieve symptoms.</text>
      <annotation id="294">
        <infon key="identifier">MESH:D013256</infon>
        <infon key="type">Chemical</infon>
        <location offset="16712" length="8"/>
        <text>steroids</text>
      </annotation>
      <annotation id="295">
        <infon key="identifier">MESH:D007249</infon>
        <infon key="type">Disease</infon>
        <location offset="16773" length="12"/>
        <text>inflammation</text>
      </annotation>
      <annotation id="296">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="16809" length="14"/>
        <text>radicular pain</text>
      </annotation>
      <annotation id="297">
        <infon key="identifier">MESH:D013256</infon>
        <infon key="type">Chemical</infon>
        <location offset="16837" length="8"/>
        <text>steroids</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>16901</offset>
      <text>Prospective-cohort study indicates a decrease in the need for surgical treatment because of treatment-injection steroid injections. The clinical effect is measurable and statistically significant improvement registered radicular pain.</text>
      <annotation id="300">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="17130" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="301">
        <infon key="identifier">MESH:D013256</infon>
        <infon key="type">Chemical</infon>
        <location offset="17013" length="7"/>
        <text>steroid</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>17138</offset>
      <text>Another in a series of studies on the treatment of cervical syndrome confirmed the effectiveness of acupuncture in the cervical region of patients with radicular symptoms. Favorable results have been seen in almost 90% of cases. These results indicate that treatment of acupuncture cervical region can be effective as the conservative therapy for the treatment of cervical radiculopathy.</text>
      <annotation id="305">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17276" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="306">
        <infon key="identifier">MESH:D002575</infon>
        <infon key="type">Disease</infon>
        <location offset="17189" length="17"/>
        <text>cervical syndrome</text>
      </annotation>
      <annotation id="307">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="17502" length="22"/>
        <text>cervical radiculopathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>17526</offset>
      <text>4. MOUSE SHOULDER</text>
      <annotation id="309">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="17529" length="5"/>
        <text>MOUSE</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>17544</offset>
      <text>Computers are considered as an integral part of everyday life. They are used in education, health and medicine, science, banking, recreation and entertainment, politically engaged people. Approximately 75% of jobs are dependent on the work on the computer.</text>
      <annotation id="311">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17724" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>17801</offset>
      <text>Chen and colleagues examined the effect of five computer mice made at different angles in 12 respondents employed in the business sector in Taiwan. They concluded that too frequent use of non ergonomic computer mice causes extreme discomfort in the muscle and tendon system of the hand along with various manifest symptoms in the shoulder and forearm. The use of ergonomic mice custom hand shape, thanks to the different corners of the obliquity have less adverse effect on the activity of the forearm and shoulder. </text>
      <annotation id="315">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="17858" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="316">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="18012" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="317">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="18174" length="4"/>
        <text>mice</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-333-g007.jpg</infon>
      <infon key="id">F7</infon>
      <infon key="type">fig_caption</infon>
      <offset>18318</offset>
      <text>Recommended proper position of the neck, torso, arms and legs when working at a computer</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>18407</offset>
      <text>The shoulder belt is common, even among the most frequent localization of musculoskeletal pain after pain in the back and knees.</text>
      <annotation id="320">
        <infon key="identifier">MESH:D059352</infon>
        <infon key="type">Disease</infon>
        <location offset="18481" length="20"/>
        <text>musculoskeletal pain</text>
      </annotation>
      <annotation id="321">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="18508" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>18536</offset>
      <text>The long-term work at the computer leads to inflammation of tendons and exchanges shoulder joint, and in severe cases can lead to tearing of tendons and muscles "rotator cuff". If inflammation persists, the capsule and ligaments of the shoulder joint becomes stiffer and limited mobility. Inappropriate placement of computers may have adverse effects on posture in children.</text>
      <annotation id="326">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18901" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="327">
        <infon key="identifier">MESH:D052256</infon>
        <infon key="type">Disease</infon>
        <location offset="18677" length="7"/>
        <text>tendons</text>
      </annotation>
      <annotation id="328">
        <infon key="identifier">MESH:D007249</infon>
        <infon key="type">Disease</infon>
        <location offset="18716" length="12"/>
        <text>inflammation</text>
      </annotation>
      <annotation id="329">
        <infon key="identifier">MESH:D007249</infon>
        <infon key="type">Disease</infon>
        <location offset="18580" length="23"/>
        <text>inflammation of tendons</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>18915</offset>
      <text>Limited and painful mobility is especially pronounced when raising your arms above your head or behind your back. Long-term pain becomes stronger and leads to the development of muscle weakness areas of the shoulder belt through a series of hands, and preventing further activities.</text>
      <annotation id="332">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="19039" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="333">
        <infon key="identifier">MESH:D018908</infon>
        <infon key="type">Disease</infon>
        <location offset="19093" length="15"/>
        <text>muscle weakness</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>19198</offset>
      <text>Symptoms of pain in the shoulder differently vary from intense that it can spread to other parts of the body, to moderate that lingers on the shoulder belt, but still hinder the function of the hinge, and can even lead to sleep disorders.</text>
      <annotation id="336">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="19210" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="337">
        <infon key="identifier">MESH:D012893</infon>
        <infon key="type">Disease</infon>
        <location offset="19420" length="15"/>
        <text>sleep disorders</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>19437</offset>
      <text>The anatomy of the shoulder is a specific because the shoulder joint consists of primary, secondary and ancillary wrist joints. The anatomical structure makes the most complex joint of the body. Joints shoulders: glenohumeral joint (shoulder joint primary), Scapulothoracic joint (secondary shoulder joint), and sternoclavicular joint (extra joints).</text>
      <annotation id="339">
        <infon key="identifier">MESH:D007592</infon>
        <infon key="type">Disease</infon>
        <location offset="19749" length="22"/>
        <text>sternoclavicular joint</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>19788</offset>
      <text>Muscle groups that may be a potential source of pain are rotator cuff (responsible for balance of the glenohumeral joint), stabilizing the scapula (responsible for the position of the scapula) the primary drivers (responsible for the strong movements).</text>
      <annotation id="341">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="19836" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>20041</offset>
      <text>For the diagnosis of mouse shoulder, the most important is detailed history with regard to occupation and profession of the patient and physical review. We should not forget to examine whether the patient has in the past had a shoulder injury, or some localized inflammation in the same.</text>
      <annotation id="347">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="20062" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="348">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20165" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="349">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="20238" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="350">
        <infon key="identifier">MESH:D007249</infon>
        <infon key="type">Disease</infon>
        <location offset="20303" length="12"/>
        <text>inflammation</text>
      </annotation>
      <annotation id="351">
        <infon key="identifier">MESH:D058186</infon>
        <infon key="type">Disease</infon>
        <location offset="20277" length="6"/>
        <text>injury</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>20329</offset>
      <text>Information about the character, pain intensity and directions of its expansion are of great importance. In fact it is necessary to establish that the primary cause of shoulder pain, and that the anatomical structure of the shoulder is affected. It is known that the pain can be transmitted from the adjacent region to the shoulders, for example. The cervical region, or by visceral fibers of the heart.</text>
      <annotation id="355">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="20596" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="356">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="20362" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="357">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="20506" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>20733</offset>
      <text>In equivocal cases, x-rays of the shoulder joint may help in differentiating existing inflammation of the joints and structure surrounding joint of a possible slight shoulder dislocation.</text>
      <annotation id="360">
        <infon key="identifier">255564</infon>
        <infon key="type">Species</infon>
        <location offset="20755" length="4"/>
        <text>rays</text>
      </annotation>
      <annotation id="361">
        <infon key="identifier">MESH:D007249</infon>
        <infon key="type">Disease</infon>
        <location offset="20819" length="26"/>
        <text>inflammation of the joints</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>20921</offset>
      <text>The primary method for the treatment of mouse shoulder in a timely manner to reduce the strain on shoulders, mostly working with computer mouse.</text>
      <annotation id="364">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="20961" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="365">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="21059" length="5"/>
        <text>mouse</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>21066</offset>
      <text>If the patient is in question, and cannot make a break, they definitely need the to replace old with new ergonomic computer mouse that is adapted to grip and allows the natural position of the hand during mouse use.</text>
      <annotation id="369">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21073" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="370">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="21190" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="371">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="21271" length="5"/>
        <text>mouse</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>21282</offset>
      <text>NSAIDs are the first drugs of choice. In the long-term intractable pain states and may prescribe therapy application of corticosteroid injections in the shoulder joint. An indispensable aspect of therapy is physical therapy. Physical therapy is appropriate in the chronic phase of the disease, which aims to stabilize and strengthen the muscles of the shoulder belt, and the resultant reduction in pain.</text>
      <annotation id="374">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="21349" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="375">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="21680" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>21686</offset>
      <text>Jan C. Winters and colleagues came to the conclusion that only 50% of patients with newly diagnosed painful condition experience a full recovery within the first 6 months. This percentage rises to 60% in the first year of the onset of pain. They also proved that speaking to the long-term treatment, at the end of treatment, there was no difference in effect between the corticosteroid and physical therapy.</text>
      <annotation id="378">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="21756" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="379">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="21921" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>22094</offset>
      <text>Onyebeke LC investigated the effects of props during the use of the mouse on the palm, forearm and upper extremities, and came to the result that 90% of respondents who have used the support arm had less pain in the shoulder girdles of those who are not used to. The use of any support results in less tension, and less applied force to a computer mouse during operation, and therefore less hassle and pain in the shoulder.</text>
      <annotation id="384">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="22162" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="385">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="22442" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="386">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="22496" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="387">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="22298" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>22518</offset>
      <text>5. PHYSICAL REHABILITATION AND PREVENTION OF TECHNOLOGICAL DISEASES</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_2</infon>
      <offset>22586</offset>
      <text>5.1. The role and organization of the Centers for Physical Rehabilitation (CBR)</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>22666</offset>
      <text>If the patient required outpatient treatment, family doctor referred him Physiotherapy in CBR (Community based rehabilitation) i.e. the center for rehabilitation in the community. CBR's are organized within the framework of primary health care and are located within the health centers. CBR-rehabilitation in the community-the definition of a Joint Paper, ILO, UNESCO, WHO, in 1994.</text>
      <annotation id="390">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="22673" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="391">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="22690" length="10"/>
        <text>outpatient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>23053</offset>
      <text>Community rehabilitation strategy based on community development for the rehabilitation, equalization of opportunities and social integration of people with disabilities, their families and communities and the appropriate health of educational, professional and social services.</text>
      <annotation id="393">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23198" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>23332</offset>
      <text>Community rehabilitation allows people with disabilities to take initiative and improve their own lives, and to contribute to the community, and not just use the funds and resources that are available. Thus, the entire community and all its members are winners.</text>
      <annotation id="395">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23364" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>23594</offset>
      <text>CBR became the backbone of the carrier non-institutional organization of the program in physical medicine and rehabilitation of persons with disabilities as well as a large number of chronically ill patients in the prevention of disability.</text>
      <annotation id="398">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23722" length="7"/>
        <text>persons</text>
      </annotation>
      <annotation id="399">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="23793" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_2</infon>
      <offset>23835</offset>
      <text>5.2. The forms of work in the CBR</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>23869</offset>
      <text>Rehabilitation system reaches into every community rehabilitation team becomes more flexible and actively participate in all aspects of rehabilitation. Rehabilitation includes all age groups.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>24061</offset>
      <text>Treatment in the community increases the accessibility and quality of services for people with disabilities and their families.</text>
      <annotation id="401">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="24144" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>24189</offset>
      <text>Services include primary treatment damage and disability in the center and at home, as well as patient education, health promotion and prevention of disease and disability.</text>
      <annotation id="403">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="24284" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>24362</offset>
      <text>CBR Team composition: a) 1 medical doctor specialist in physical medicine and rehabilitation; b) 1 physiotherapist; c) 1 occupational therapist; d) 2 medical technicians-physiotherapist; e) Medical technician-general direction; f) 0.5 Social Worker; g) 0.4 special education teacher-speech therapist.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_2</infon>
      <offset>24667</offset>
      <text>5.3. The most common reasons for referral of patients in the CBR</text>
      <annotation id="405">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="24712" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>24732</offset>
      <text>The most common reasons due to which family physician refers patients to the ambulance treatment in rehabilitation centers in the community are:</text>
      <annotation id="407">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="24793" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>24877</offset>
      <text>Adult patients: a) Cervical pain syndrome; b) Lumbar pain syndrome; c) Rheumatic diseases; d) Rehabilitation after stroke. Children and young people: a) Neurorisk children; b) Deformities of the spinal column; c) Deformities of the lower extremities; d) Rehabilitation after injuries of the locomotor apparatus</text>
      <annotation id="416">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="24883" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="417">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25000" length="8"/>
        <text>Children</text>
      </annotation>
      <annotation id="418">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25019" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="419">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25040" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="420">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="24930" length="13"/>
        <text>pain syndrome</text>
      </annotation>
      <annotation id="421">
        <infon key="identifier">MESH:D020521</infon>
        <infon key="type">Disease</infon>
        <location offset="24992" length="6"/>
        <text>stroke</text>
      </annotation>
      <annotation id="422">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="24905" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="423">
        <infon key="identifier">MESH:D012216</infon>
        <infon key="type">Disease</infon>
        <location offset="24948" length="18"/>
        <text>Rheumatic diseases</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>25188</offset>
      <text>6. ACCREDITATION STANDARDS RELATED TO PHYSICAL REHABILITATION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>25250</offset>
      <text>Standard 5I: Center/Service for Physical Rehabilitation</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>25306</offset>
      <text>Health Center promotes the concept of active participation of disabled people and their families in identifying needs and resources in rehabilitation develop a shared vision of their life in society, the implementation of the vision and the monitoring and evaluation of implementation.</text>
      <annotation id="425">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25377" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>25592</offset>
      <text>Criteria</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>25601</offset>
      <text>5I.295 Within the health center there is a center for the rehabilitation of disabled persons (CBR) with support groups and self-help.</text>
      <annotation id="427">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="25686" length="7"/>
        <text>persons</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>25735</offset>
      <text>5I.296 center is managed by the appointed specialist in physical medicine and rehabilitation.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>25829</offset>
      <text>5I.297 Depending on the systematization of jobs, the Centre employed physiotherapy technicians, occupational therapists, nurses, general direction.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>25977</offset>
      <text>5I.298 Physical therapists adhere to the Code Company physiotherapists with permission to work in practice.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>26085</offset>
      <text>5I.299 specialist in physical medicine and rehabilitation therapists are members professional organizations that provide guidance on continuing professional development.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>26255</offset>
      <text>5I.300 All employed staff in service has a documented plan for ongoing personal professional development that includes measurable goals for learning.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>26405</offset>
      <text>5I.301 There is evidence in writing of actions taken on the permanent professional development that reflects the plan.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>26524</offset>
      <text>5I.302 There are dated, documented criteria for referring patients to physical therapy. The criteria are written/reviewed in the past three years.</text>
      <annotation id="429">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="26582" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>26671</offset>
      <text>5I.303 There are dated, documented procedures on granting new cases to team members for physical therapy. The procedure is written/rewritten in the past three years. Instructions: Cases should be awarded according to the skills and experience required for the indicated treatment, together with the need for equitable distribution of the number of cases.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>27026</offset>
      <text>5I.304 There are documented procedures on the regulation of proper completion of the treatment of patients having implemented the rehabilitation plan. The procedure is written/rewritten in the past three years.</text>
      <annotation id="431">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27124" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>27237</offset>
      <text>5I.305 estimated needs of the patient/user for the physical treatment by physical examination which receives measurable data for evaluation.</text>
      <annotation id="433">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27267" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>27378</offset>
      <text>5I.306 Each patient was referred to physical therapy has an individual rehabilitation plan for the implementation of physical therapy.</text>
      <annotation id="435">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27390" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>27513</offset>
      <text>5I.307 Before each procedure/treatment is carried out risk assessments. Note: This includes risk assessment, contraindications to treatment and precautions. Also, include the verification of hazards such as wet floors, and the provision of suitable clothing and shoes worn by therapists and patients/users.</text>
      <annotation id="437">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="27804" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>27820</offset>
      <text>5I.308 rehabilitation program undertaken only after the results of the risk assessment.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>27908</offset>
      <text>5I.309 risks associated with the use of electrical equipment reduces the use of safety switches.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>28005</offset>
      <text>5I.310 Before using the apparatus and its application to a patient, is made visual and physical verification of security equipment.</text>
      <annotation id="439">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28064" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>28137</offset>
      <text>5I.311 There is plenty of space and are available partitions/curtains in the room/rooms for physiotherapy treatment that patients provide visual privacy when using the equipment.</text>
      <annotation id="441">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28258" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>28316</offset>
      <text>5I.312 equipment is kept in a place where not to interfere with access to fire exits, entrances, hallways and other equipment.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>28443</offset>
      <text>5I.313 Health Centre organizes regular meetings for people with disabilities and their family members, performs basic assessment of their needs and implements early education and basic rehabilitation programs under the guidance of an appropriate therapist.</text>
      <annotation id="443">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="28495" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>28700</offset>
      <text>5I.314 health center, or CBR, is developing a multi-sectoral cooperation and contracts with appropriate institutions for labor and social policy, education, institutes Employment, sports institutions, etc. Panel evidence-based clinical practice guidelines on musculoskeletal rehabilitation interventions,</text>
      <annotation id="445">
        <infon key="identifier">MESH:D048949</infon>
        <infon key="type">Disease</infon>
        <location offset="28821" length="5"/>
        <text>labor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>29005</offset>
      <text>7. DISCUSSION AND RECCOMENDATIONS ON THERAPEUTIC MODALITIES</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>29065</offset>
      <text>Several studies have reported possitive or negative association between computer use and musculosceletal symptoms. The prevalence of Computer Carpal Syndrome (CTS) among computer professionals based on clinical signs and sympoms is approximately 13,1% and almost 1 out of every computer professional suffers from this condition. Very few data published about this topic - studies about CTS prevalence based on clinical signs and symptoms, according to Ali KM and Sathiyasekaran BWC, ranging from 3 to 6 %b only, but we think real situation is much worse. Postural stress due to inadeqauate workstation ergonomics (inappropriate location of monitor, keyboard or mouse) discussed as cause of all mentioned technological diseases in this text (Figure 7). Aydan Oral et al. Had written paper about Evidence Based Physical Medicine and Rehabilitation strategies for patients with cervical radiculopathy due to disc herniation. They reported that neck pain affected 4,82% of the world population in 2010, ranks second after low back pain among musculoskeletal disorders as one of the leading causes of years lived with disability, with contribution of 33,6 million years. Physical medicine and rehabilitation interventions in radicular neck pain and their evidence based are: a) educational interventions; b) exercise; c) workplace interventions/ergonomics; d) phyasical agents (TENS, therapeutic ultrasound, low-level laser therapy) pulsed electromagnetic field therapy, non-invasive brain stimulation techniques, etc); e) injection therapy (epidural steroids, botulinum toxin, ozone); f) cervical collars; g) traction; manual therapies (massage, manipulation and mobilization (commonly used in the management of discogenic neck pain); complementary and alternative medicine treatments (acupuncture, herbal medicine, etc.). Much research efforts have been spent and several risk factors such as heavy lifting, lifestyle, psichosocial factors identified, but the etiology of technological diseases are still or not enough unclear. Recurrences and functional limitations can be minimized limitations with appropriate conservative management, including medications, physical therapy, exercise and patient education. But, these subgroup of developing chronic and disabling symptoms generating large social costs.</text>
      <annotation id="459">
        <infon key="identifier">7276</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">317</infon>
        <location offset="29224" length="3"/>
        <text>CTS</text>
      </annotation>
      <annotation id="460">
        <infon key="identifier">7276</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">317</infon>
        <location offset="29451" length="3"/>
        <text>CTS</text>
      </annotation>
      <annotation id="461">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="29726" length="5"/>
        <text>mouse</text>
      </annotation>
      <annotation id="462">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="29926" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="463">
        <infon key="identifier">1407750</infon>
        <infon key="type">Species</infon>
        <location offset="30860" length="15"/>
        <text>herbal medicine</text>
      </annotation>
      <annotation id="464">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="31254" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="465">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="30789" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="466">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="29198" length="24"/>
        <text>Computer Carpal Syndrome</text>
      </annotation>
      <annotation id="467">
        <infon key="identifier">MESH:D009140</infon>
        <infon key="type">Disease</infon>
        <location offset="30103" length="25"/>
        <text>musculoskeletal disorders</text>
      </annotation>
      <annotation id="468">
        <infon key="identifier">MESH:D019547</infon>
        <infon key="type">Disease</infon>
        <location offset="30006" length="9"/>
        <text>neck pain</text>
      </annotation>
      <annotation id="469">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="30087" length="9"/>
        <text>back pain</text>
      </annotation>
      <annotation id="470">
        <infon key="identifier">MESH:D019547</infon>
        <infon key="type">Disease</infon>
        <location offset="30285" length="19"/>
        <text>radicular neck pain</text>
      </annotation>
      <annotation id="471">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="29940" length="22"/>
        <text>cervical radiculopathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>31371</offset>
      <text>According to the Panel evidence-based clinical practice guidelines on musculoskeletal rehabilitation interventions the key points to clinicians are (Table 1 and 2):</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>31536</offset>
      <text>Summary grid of neck pain guidelines. *Adapted from the Philadelphia Panel Members and Ottawa Methods Group.2. A, benefit demonstrated; C, no benefit demonstrated; EMG, electromyographic; ID, insufficient or no data; TENS, transcutaneous electrical nerve stimulation</text>
      <annotation id="474">
        <infon key="identifier">MESH:D000309</infon>
        <infon key="type">Disease</infon>
        <location offset="31728" length="12"/>
        <text>insufficient</text>
      </annotation>
      <annotation id="475">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="31557" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>31803</offset>
      <text>Summary grid of shoulder pain guidelines. *Adapted from the Philadelphia Panel Members and Ottawa Methods Group.1A, benefit demonstrated; C, no benefit demonstrated; EMG, electromyographic; ID, insufficient or no data; TENS, transcutaneous electrical nerve stimulation.</text>
      <annotation id="478">
        <infon key="identifier">MESH:D000309</infon>
        <infon key="type">Disease</infon>
        <location offset="31997" length="12"/>
        <text>insufficient</text>
      </annotation>
      <annotation id="479">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="31828" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>32073</offset>
      <text>The Philadelphia Panel recommends continued normal activities for acute, uncomplicated low back pain and therapeutic exercise for chronic, subacute, and postsurgical low back pain.</text>
      <annotation id="482">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="32239" length="13"/>
        <text>low back pain</text>
      </annotation>
      <annotation id="483">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="32160" length="13"/>
        <text>low back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>32254</offset>
      <text>The Philadelphia Panel also recommends transcutaneous electrical nerve stimulation and</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>32341</offset>
      <text>exercise for knee osteoarthritis.</text>
      <annotation id="485">
        <infon key="identifier">MESH:D010003</infon>
        <infon key="type">Disease</infon>
        <location offset="32359" length="14"/>
        <text>osteoarthritis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>32375</offset>
      <text>For chronic neck pain, the Philadelphia Panel recommends proprioceptive and thera-peutic exercise.</text>
      <annotation id="487">
        <infon key="identifier">MESH:D019547</infon>
        <infon key="type">Disease</infon>
        <location offset="32387" length="9"/>
        <text>neck pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>32474</offset>
      <text>The Philadelphia Panel found evidence to sup-port the use of therapeutic ultrasound in thetreatment of calcific tendonitis of the shoulder.</text>
      <annotation id="489">
        <infon key="identifier">MESH:D052256</infon>
        <infon key="type">Disease</infon>
        <location offset="32577" length="19"/>
        <text>calcific tendonitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>32614</offset>
      <text>The main difficulty in determining the effec-tiveness of rehabilitation interventions is the lack of well-designed, prospective, random-ized, controlled trials.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>32775</offset>
      <text>Acute neck pain is often associated with injury or accident, whereas chronic neck pain is related to repetitive injury. Neck pain is commonly managed with analgesics and rest, but referrals to rehabilitation are increasing. The Philadelphia Panel sought to improve the appropriate use of rehabilitation interventions for neck pain by providing evidence-based guidelines. A summary of the Panel's recommendations can be found in Table 2.</text>
      <annotation id="496">
        <infon key="identifier">MESH:D019547</infon>
        <infon key="type">Disease</infon>
        <location offset="32895" length="9"/>
        <text>Neck pain</text>
      </annotation>
      <annotation id="497">
        <infon key="identifier">MESH:D019547</infon>
        <infon key="type">Disease</infon>
        <location offset="32852" length="9"/>
        <text>neck pain</text>
      </annotation>
      <annotation id="498">
        <infon key="identifier">MESH:D000081084</infon>
        <infon key="type">Disease</infon>
        <location offset="32816" length="18"/>
        <text>injury or accident</text>
      </annotation>
      <annotation id="499">
        <infon key="identifier">MESH:D019547</infon>
        <infon key="type">Disease</infon>
        <location offset="32781" length="9"/>
        <text>neck pain</text>
      </annotation>
      <annotation id="500">
        <infon key="identifier">MESH:D012090</infon>
        <infon key="type">Disease</infon>
        <location offset="32876" length="17"/>
        <text>repetitive injury</text>
      </annotation>
      <annotation id="501">
        <infon key="identifier">MESH:D019547</infon>
        <infon key="type">Disease</infon>
        <location offset="33096" length="9"/>
        <text>neck pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>33212</offset>
      <text>Rehabilitation specialists offer several conservative interventions for the management of shoulder pain. There are few published guidelines for the management of shoulder pain.</text>
      <annotation id="504">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="33383" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="505">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="33311" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>33389</offset>
      <text>8. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>33403</offset>
      <text>Thanks to the high use of computers, resulting diseases of the modern era, known as the"Technological disease." Under this term we mean the diseases caused by the harmful influence of the job in the first place, the working position in which it is involved excessive work for a computer, such as the banking sector, the health sector and many others who are directly or indirectly connected with the work on the computer and overuse keyboards and computer mice, which are in a number of cases of non-ergonomic, and inappropriate for a handful. Establishing the diagnosis of diseases of technology is an interdisciplinary process that requires special knowledge in medicine and related fields related to health and safety at work. Determining the causes and diagnosis of occupational diseases is carried out according to the criteria of modern medicine work.</text>
      <annotation id="508">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="33859" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="509">
        <infon key="identifier">MESH:D009784</infon>
        <infon key="type">Disease</infon>
        <location offset="34173" length="21"/>
        <text>occupational diseases</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>34265</offset>
      <text>First, we identify the clinical picture of the disease on the one hand and identification in the working process on the other side, and their immediate connections. Medical history is the gold standard, because without it, it would be possible to find information on working conditions and the duration and intensity of exposure to a particular hazard from the workplace. The intensity and length of exposure to harmful factor must be that level that is known and proven scientific research that can damage health. Prevention would involve, educate employees by computers to ensure better and more regular position of the spine and shoulder while working at the computer, as well as the use of stylish ergonomic mice in hand. Of course, adequate work breaks are required, in order to avoid fatigue and exhaustion syndrome, but today it is difficult to appreciate the extent and speed of work. No less important and efficient are exercises to strengthen the shoulder belt, as well as exercises for posture.</text>
      <annotation id="513">
        <infon key="identifier">10090</infon>
        <infon key="type">Species</infon>
        <location offset="34977" length="4"/>
        <text>mice</text>
      </annotation>
      <annotation id="514">
        <infon key="identifier">MESH:D005221</infon>
        <infon key="type">Disease</infon>
        <location offset="35055" length="7"/>
        <text>fatigue</text>
      </annotation>
      <annotation id="515">
        <infon key="identifier">MESH:D006359</infon>
        <infon key="type">Disease</infon>
        <location offset="35067" length="19"/>
        <text>exhaustion syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>35271</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>35308</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="volume">3</infon>
      <infon key="name_2">surname:Ashalatha;given-names:STL</infon>
      <infon key="name_1">surname:Sebastian;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Pereira;given-names:M</infon>
      <infon key="fpage">73</infon>
      <infon key="issue">11</infon>
      <infon key="year">2013</infon>
      <infon key="source">IJHSR</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">79</infon>
      <offset>35319</offset>
      <text>Body Mechanics and Perceived Physical Health Problems among Computer Users</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Ganos;given-names:D</infon>
      <infon key="name_2">surname:Janevski;given-names:P</infon>
      <infon key="name_1">surname:Holsbeeck;given-names:M</infon>
      <infon key="name_0">surname:Lee;given-names:D</infon>
      <infon key="fpage">859</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">10442084</infon>
      <infon key="year">1999</infon>
      <infon key="source">Radiologic Clinics of North America</infon>
      <infon key="type">ref</infon>
      <infon key="volume">37</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">872</infon>
      <infon key="name_5">surname:Darian;given-names:V</infon>
      <infon key="name_4">surname:Ditmars;given-names:D</infon>
      <offset>35394</offset>
      <text>Diagnosis of carpal tunnel syndrome</text>
      <annotation id="517">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="35407" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Golub;given-names:R</infon>
      <infon key="volume">306</infon>
      <infon key="name_2">surname:Robert;given-names:M</infon>
      <infon key="name_1">surname:Lynm;given-names:C</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Torpy;given-names:JM</infon>
      <infon key="fpage">2283</infon>
      <infon key="issue">20</infon>
      <infon key="pub-id_pmid">22110111</infon>
      <infon key="year">2011</infon>
      <infon key="source">JAMA</infon>
      <infon key="type">ref</infon>
      <offset>35430</offset>
      <text>Carpal Tunnel Syndrome</text>
    </passage>
    <passage>
      <infon key="volume">155</infon>
      <infon key="name_1">surname:Demartini;given-names:FE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Grokoest;given-names:AW</infon>
      <infon key="fpage">635</infon>
      <infon key="issue">7</infon>
      <infon key="year">1954</infon>
      <infon key="source">JAMA</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">637</infon>
      <offset>35453</offset>
      <text>Sistemic disease and the carpal tunnel syndrome</text>
      <annotation id="519">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="35478" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">38</infon>
      <infon key="name_2">surname:Kolundzic;given-names:R</infon>
      <infon key="name_1">surname:Bilic;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Crnkovic;given-names:T</infon>
      <infon key="issue">3-4</infon>
      <infon key="year">2008</infon>
      <infon key="source">Medica Jadertina</infon>
      <infon key="type">ref</infon>
      <offset>35501</offset>
      <text>Syndrome carpal tunnel</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Meholjic;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Vavra-Hadziahmetovic;given-names:N</infon>
      <infon key="fpage">64</infon>
      <infon key="year">2011</infon>
      <infon key="source">Medicinski fakultet Univerziteta u Sarajevu</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">65</infon>
      <offset>35524</offset>
      <text>Osnove klinickog pregleda u fizijatriji</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Ayromlou;given-names:H</infon>
      <infon key="name_2">surname:Bakhti;given-names:S</infon>
      <infon key="name_1">surname:Andalib;given-names:S</infon>
      <infon key="name_0">surname:Talebi;given-names:M</infon>
      <infon key="fpage">283</infon>
      <infon key="issue">2</infon>
      <infon key="year">2013</infon>
      <infon key="source">Neurosciences Research Center</infon>
      <infon key="type">ref</infon>
      <infon key="volume">3</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">288</infon>
      <infon key="name_5">surname:Talebi;given-names:A</infon>
      <infon key="name_4">surname:Aghili;given-names:A</infon>
      <offset>35565</offset>
      <text>Effect of vitamin B6 on clinical symptoms and electrodiagnostic results of patients with carpal tunnel sndrome</text>
      <annotation id="522">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="35640" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="523">
        <infon key="identifier">MESH:D025101</infon>
        <infon key="type">Chemical</infon>
        <location offset="35575" length="10"/>
        <text>vitamin B6</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Mustafa;given-names:Yilmaz</infon>
      <infon key="name_2">surname:Koca;given-names:I</infon>
      <infon key="name_1">surname:Altindag;given-names:O</infon>
      <infon key="name_0">surname:Madenci;given-names:E</infon>
      <infon key="fpage">3171</infon>
      <infon key="issue">10</infon>
      <infon key="pub-id_pmid">21953301</infon>
      <infon key="year">2011</infon>
      <infon key="source">Rheumatology International</infon>
      <infon key="type">ref</infon>
      <infon key="volume">32</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">3179</infon>
      <infon key="name_4">surname:Gur;given-names:A</infon>
      <offset>35676</offset>
      <text>Reliability and efficacy of the new massage technique on the treatment in the patients with carpal tunnel syndrome</text>
      <annotation id="526">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="35754" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="527">
        <infon key="identifier">MESH:D002349</infon>
        <infon key="type">Disease</infon>
        <location offset="35768" length="22"/>
        <text>carpal tunnel syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Osmanovic;given-names:J</infon>
      <infon key="volume">67</infon>
      <infon key="name_2">surname:Gorcevic;given-names:S</infon>
      <infon key="name_1">surname:Gorcevic;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kasumovic;given-names:M</infon>
      <infon key="fpage">414</infon>
      <infon key="issue">6</infon>
      <infon key="year">2013</infon>
      <infon key="source">Med Arh</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">417</infon>
      <offset>35791</offset>
      <text>Cervical Syndrome - the Effectiveness of Physical Therapy Interventions</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Klinicka;given-names:neurologija</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kantardzic;given-names:Dz</infon>
      <infon key="fpage">460</infon>
      <infon key="year">2001</infon>
      <infon key="source">Sarajevo</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">461</infon>
      <offset>35863</offset>
      <text>IP "Svjetlost" d.d., Zavod za udzbenike i nastavna sredstva</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Vavra-Hadziahmetovic;given-names:N</infon>
      <infon key="name_2">surname:Masic;given-names:I</infon>
      <infon key="name_1">surname:Talic;given-names:A</infon>
      <infon key="name_0">surname:Karic-Skrijelj;given-names:M</infon>
      <infon key="fpage">25</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">24109153</infon>
      <infon key="year">2008</infon>
      <infon key="source">Acta Inform Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">16</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.5455/aim.2008.16.25-28</infon>
      <infon key="lpage">28</infon>
      <infon key="name_5">surname:Suljic-Mehmedika;given-names:E</infon>
      <infon key="name_4">surname:Pandza;given-names:H</infon>
      <offset>35928</offset>
      <text>Cervical Pain Syndrome as Consequence of Computer Use in Daily Practice</text>
      <annotation id="529">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="35937" length="4"/>
        <text>Pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>36000</offset>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>36001</offset>
    </passage>
    <passage>
      <infon key="name_2">surname:Treanor;given-names:WJ</infon>
      <infon key="name_1">surname:Honet;given-names:JC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Ellenberg;given-names:MR</infon>
      <infon key="fpage">MI 48235</infon>
      <infon key="year">1994</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2899</infon>
      <offset>36002</offset>
      <text>Cervical radiculopathy</text>
      <annotation id="531">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="36011" length="13"/>
        <text>radiculopathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">147</infon>
      <infon key="name_2">surname:Nygaard;given-names:OP</infon>
      <infon key="name_1">surname:Leivseth;given-names:G</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kolstad;given-names:F</infon>
      <infon key="fpage">1065</infon>
      <infon key="issue">10</infon>
      <infon key="year">2005</infon>
      <infon key="source">A prospective outcome study. Acta Neurochir (Wien)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1070</infon>
      <offset>36025</offset>
      <text>Transforaminal steroid injections in the treatment of cervical radiculopathy</text>
      <annotation id="534">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="36088" length="13"/>
        <text>radiculopathy</text>
      </annotation>
      <annotation id="535">
        <infon key="identifier">MESH:D013256</infon>
        <infon key="type">Chemical</infon>
        <location offset="36040" length="7"/>
        <text>steroid</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Kitakoji;given-names:H</infon>
      <infon key="volume">31</infon>
      <infon key="name_2">surname:Itoi;given-names:M</infon>
      <infon key="name_1">surname:Inoue;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Nakajima;given-names:M</infon>
      <infon key="fpage">364</infon>
      <infon key="pub-id_pmid">23965301</infon>
      <infon key="year">2013</infon>
      <infon key="source">Acupunct Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">367</infon>
      <offset>36102</offset>
      <text>Clinical effect of acupuncture on cervical spondylotic radiculopathy: results of a case series</text>
      <annotation id="537">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="36145" length="25"/>
        <text>spondylotic radiculopathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>36197</offset>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>36198</offset>
    </passage>
    <passage>
      <infon key="volume">22</infon>
      <infon key="name_1">surname:Leung;given-names:CT</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Chen;given-names:HM</infon>
      <infon key="fpage">518</infon>
      <infon key="issue">5</infon>
      <infon key="year">2007</infon>
      <infon key="source">Clin Biomech (Bristol, Avon)</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">523</infon>
      <offset>36199</offset>
      <text>The effect on forearm and shoulder muscle activity in using different slanted computer mice</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">ref</infon>
      <offset>36291</offset>
    </passage>
    <passage>
      <infon key="volume">102</infon>
      <infon key="name_1">surname:Schouten;given-names:JS</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Picavet;given-names:HS</infon>
      <infon key="fpage">167</infon>
      <infon key="pub-id_pmid">12620608</infon>
      <infon key="year">2003</infon>
      <infon key="source">Pain</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">178</infon>
      <offset>36292</offset>
      <text>Musculoskeletal pain in the Netherlands: prevalences, consequences and risk groups, the DMC(3)-study</text>
      <annotation id="540">
        <infon key="identifier">MESH:C023025</infon>
        <infon key="type">Chemical</infon>
        <location offset="36380" length="3"/>
        <text>DMC</text>
      </annotation>
      <annotation id="541">
        <infon key="identifier">MESH:D059352</infon>
        <infon key="type">Disease</infon>
        <location offset="36292" length="20"/>
        <text>Musculoskeletal pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Arendzen;given-names:HJ</infon>
      <infon key="name_2">surname:Groenier;given-names:KH</infon>
      <infon key="name_1">surname:Sobel;given-names:JS</infon>
      <infon key="name_0">surname:Winters;given-names:JC</infon>
      <infon key="fpage">1320</infon>
      <infon key="pub-id_pmid">9158469</infon>
      <infon key="year">1997</infon>
      <infon key="source">BMJ</infon>
      <infon key="type">ref</infon>
      <infon key="volume">314</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1325</infon>
      <infon key="name_4">surname:Meyboom-de Jong;given-names:B</infon>
      <offset>36393</offset>
      <text>Comparison of physiotherapy, manipulation, and corticosteroid injection for treating shoulder complaints in general practice: randomised, single blind study</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Chain;given-names:IS</infon>
      <infon key="name_2">surname:Sze;given-names:WW</infon>
      <infon key="name_1">surname:Tsui;given-names:MM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sheto;given-names:GP</infon>
      <infon key="comment">available on. </infon>
      <infon key="source">DRC</infon>
      <infon key="type">ref</infon>
      <infon key="name_5">surname:Lee;given-names:FW</infon>
      <infon key="name_4">surname:Chung;given-names:CC</infon>
      <offset>36550</offset>
      <text>Issues about home computer workstations and primary school children in Hong Kong: A pilot study</text>
      <annotation id="543">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="36609" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">60</infon>
      <infon key="name_2">surname:Ketenci;given-names:A</infon>
      <infon key="name_1">surname:Sindel;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Oral;given-names:A</infon>
      <infon key="fpage">47</infon>
      <infon key="year">2014</infon>
      <infon key="comment">Doi: 10.5152/tftrd.2014.76735</infon>
      <infon key="source">Turk J Phys Med Rehab</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">53</infon>
      <offset>36646</offset>
      <text>Evidence-Based Physical Medicine and Rehabilitatio Strategies for Patients with Cervical Radiculopathy Due to Disc Herniation</text>
      <annotation id="546">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="36712" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="547">
        <infon key="identifier">MESH:D011843</infon>
        <infon key="type">Disease</infon>
        <location offset="36726" length="22"/>
        <text>Cervical Radiculopathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">12</infon>
      <infon key="name_1">surname:Sathiyasekaran;given-names:BWC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Ali;given-names:Mohamad K</infon>
      <infon key="fpage">319</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">16984790</infon>
      <infon key="year">2006</infon>
      <infon key="source">JOSE</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">325</infon>
      <offset>36772</offset>
      <text>Computer Professionals and Carpal Tunel Syndrome (CTS)</text>
      <annotation id="549">
        <infon key="identifier">7276</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">317</infon>
        <location offset="36822" length="3"/>
        <text>CTS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Mustafa;given-names:A</infon>
      <infon key="name_2">surname:Haxhiu;given-names:B</infon>
      <infon key="name_1">surname:Murtezani;given-names:A</infon>
      <infon key="name_0">surname:Ibraimi;given-names:Z</infon>
      <infon key="fpage">410</infon>
      <infon key="issue">6</infon>
      <infon key="year">2013</infon>
      <infon key="source">Med Arch</infon>
      <infon key="type">ref</infon>
      <infon key="volume">67</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">Doi. 10.5455/medarh.2013.67.419-413</infon>
      <infon key="lpage">413</infon>
      <infon key="name_4">surname:Martinaj;given-names:M</infon>
      <offset>36827</offset>
      <text>Prevalence and Pharmacologic Treatment of Patients with Low Back Pain Treated at Kosovo Energetic Corporation</text>
      <annotation id="552">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="36869" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="553">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="36883" length="13"/>
        <text>Low Back Pain</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272840</id>
    <passage>
      <infon key="name_3">surname:Genadieva-Stavric;given-names:Sonja</infon>
      <infon key="name_2">surname:Balkanov;given-names:Trajan</infon>
      <infon key="name_1">surname:Sotirova;given-names:Tatjana</infon>
      <infon key="article-id_pmid">25568637</infon>
      <infon key="name_0">surname:Krstevska;given-names:Svetlana B.</infon>
      <infon key="fpage">348</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272840</infon>
      <infon key="article-id_publisher-id">MSM-26-348</infon>
      <infon key="article-id_doi">10.5455/msm.2014.26.348-351</infon>
      <infon key="type">front</infon>
      <infon key="volume">26</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Mater Sociomed; 2014 Oct; 26(5) 348-51. doi:10.5455/msm.2014.26.348-351</infon>
      <infon key="kwd">multiple myeloma treatment transplant noneligible patients</infon>
      <infon key="lpage">351</infon>
      <infon key="authors">Krstevska SB, Sotirova T, Balkanov T, Genadieva-Stavric S</infon>
      <offset>0</offset>
      <text>Tretatment Approach of Nontransplant Patients with Multiple Myeloma</text>
      <annotation id="2">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="37" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="3">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="51" length="16"/>
        <text>Multiple Myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>68</offset>
      <text>Multiple myeloma is still an incurable disease with pattern of regression and remission followed by multiple relapses raising from the residual myeloma cells surviving even in the patients who achieve complete clinical response to treatment. In recent years there is a huge improvement in treatment of patients with multiple myeloma. The milestones of these improvement are: autologous transplantation and high-dose melphalan, imunomodulating drugs (thalidomide, lenalidomide), proteosom inhibitors (bortesomib, carfilzomib). The most significant improvement in overall survival has been achieved in the patients younger than 65 years. So, the major challenge for hematologist is to translate this improvement in the elderly patients with multiple myeloma. Today, physicians are able to offer wider variety of treatment options for elderly patients with multiple myeloma. Therapeutic options should be tailored and personalized according to patient's characteristics by balancing efficacy and toxicity of each drug which is especially important for elderly patients. In the mode of sequencing treatment for elderly patients with multiple myeloma, our goal is to achieve and maintain maximal response while limiting treatment -related toxicities as much as possible. Second-generation novel agent, such as carfilzomib, pomalidomide, elotuzumab, bendamustine are currently being evaluated as an option to improve treatment outcome in elderly patients.</text>
      <annotation id="30">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="248" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="31">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="370" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="32">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="672" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="33">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="793" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="34">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="908" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1009" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="36">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1125" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="37">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1183" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="38">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1508" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="39">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="568" length="10"/>
        <text>bortesomib</text>
      </annotation>
      <annotation id="40">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="384" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="41">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="484" length="9"/>
        <text>melphalan</text>
      </annotation>
      <annotation id="42">
        <infon key="identifier">MESH:D000069461</infon>
        <infon key="type">Chemical</infon>
        <location offset="1412" length="12"/>
        <text>bendamustine</text>
      </annotation>
      <annotation id="43">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="1061" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="44">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="68" length="16"/>
        <text>Multiple myeloma</text>
      </annotation>
      <annotation id="45">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="1197" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="46">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="531" length="12"/>
        <text>lenalidomide</text>
      </annotation>
      <annotation id="47">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="807" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">MESH:C524865</infon>
        <infon key="type">Chemical</infon>
        <location offset="580" length="11"/>
        <text>carfilzomib</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">MESH:C467566</infon>
        <infon key="type">Chemical</infon>
        <location offset="1386" length="12"/>
        <text>pomalidomide</text>
      </annotation>
      <annotation id="50">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="518" length="11"/>
        <text>thalidomide</text>
      </annotation>
      <annotation id="51">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="1302" length="10"/>
        <text>toxicities</text>
      </annotation>
      <annotation id="52">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="922" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="212" length="7"/>
        <text>myeloma</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">MESH:C546027</infon>
        <infon key="type">Chemical</infon>
        <location offset="1400" length="10"/>
        <text>elotuzumab</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">MESH:C524865</infon>
        <infon key="type">Chemical</infon>
        <location offset="1373" length="11"/>
        <text>carfilzomib</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1518</offset>
      <text>Myeloma multiplex is a malignant disorder first recognized in the 19th century and at that time point was described as "mollities ossium" accompanied by the presence of Bence Jones protein in urine. At that time there was no effective treatment and median overall survival was only short: a few months. Over the time, especially over the past decade, many advances in myeloma treatment have been made and improvement of the median overall survival have been achieved. But, myeloma multiplex is still considered incurable disease.</text>
      <annotation id="60">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="1518" length="17"/>
        <text>Myeloma multiplex</text>
      </annotation>
      <annotation id="61">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="1886" length="7"/>
        <text>myeloma</text>
      </annotation>
      <annotation id="62">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="1991" length="7"/>
        <text>myeloma</text>
      </annotation>
      <annotation id="63">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="1541" length="18"/>
        <text>malignant disorder</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2052</offset>
      <text>Myeloma multiplex is a malignant disorder that arises from the malignant proliferation of plasma cell and is characterized by the presence of at least 10% clonal bone marrow plasma cells and serum and/or urinary monoclonal protein. Myeloma multiplex accounts for 1% of all types of cancers and is the second most common hematologic neoplasm, approximately 13% for all hematologic malignances. Myeloma multiplex is considered as a disease of elderly reflected by the average age at diagnosis 70 years, with 37% of patients younger than 65 years, 26% aged 65 to 74 years, and 37% older than 75years.</text>
      <annotation id="71">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2565" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="72">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="2334" length="7"/>
        <text>cancers</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="2284" length="7"/>
        <text>Myeloma</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">MESH:D019337</infon>
        <infon key="type">Disease</infon>
        <location offset="2372" length="20"/>
        <text>hematologic neoplasm</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="2075" length="18"/>
        <text>malignant disorder</text>
      </annotation>
      <annotation id="76">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="2052" length="17"/>
        <text>Myeloma multiplex</text>
      </annotation>
      <annotation id="77">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="2445" length="7"/>
        <text>Myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2650</offset>
      <text>Patient with myeloma multiplex could be diagnosed as symptomatic or asymptomatic disease. Patients with a symptomatic disease should be treated immediately, and the mainstay of asymptomatic disease is still an observation. Symptomatic disease could be defined with so called CRAB features: C-hypercalcemia (&gt;11.5mg/dl (2.65mmol/l); R-renal failure (serum creatinin &gt;mg/dl; 1.73mmol/l); A-anemia (hemoglobin &lt;10g/dl; 12.5 mmol/l) or 2 g/dl; 1.25mmol/l below the lower limit of normal; and B-bone disease (lytic lesions, severe osteopenia, or pathologic fractures). Patients are stratified into three risk groups according to the International Staging system (ISS). This system defines three risk groups based on serum beta 2 micro globulin and albumin levels at diagnosis. High-risk disease and poor prognosis are defined with the presence of high levels of serum beta2 micro globulin (stage III).</text>
      <annotation id="84">
        <infon key="identifier">10242</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4257</infon>
        <location offset="3367" length="6"/>
        <text>beta 2</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">10242</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4257</infon>
        <location offset="3513" length="5"/>
        <text>beta2</text>
      </annotation>
      <annotation id="86">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2650" length="7"/>
        <text>Patient</text>
      </annotation>
      <annotation id="87">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2740" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="88">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3214" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="89">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="2663" length="7"/>
        <text>myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3547</offset>
      <text>Nowadays, chromosomal abnormalities t(4;14), t(14;16) and t(14;20) chomosome 1 abnormalities and del17 detected by fluorescent in situ hybridization (FISH) are associated with poor prognosis. Hiperdiplpdy, t (11;14), t, are associated with good prognosis and can be considered "standard risk".</text>
      <annotation id="92">
        <infon key="identifier">MESH:D002869</infon>
        <infon key="type">Disease</infon>
        <location offset="3557" length="25"/>
        <text>chromosomal abnormalities</text>
      </annotation>
      <annotation id="93">
        <infon key="type">Disease</infon>
        <location offset="3739" length="12"/>
        <text>Hiperdiplpdy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3845</offset>
      <text>Initial therapy for multiple myeloma depends to a certain extent on patients characteristics such as: eligibility for autologous stem cell transplantation per se; age and co-morbidities. The role of induction therapy is to induce remission, but patient's characteristics have a significant role in the initial treatment approach. Goals of treatment are: to eradicate the tumor clone, including cancer stem cell, to search for an appropriate balance between efficacy and toxicity with three different but complementary aims: quality of life, survival prolongation and eventually the dream of cure. This can be achieved if we use appropriate tools to evaluate treatment efficacy. Achieving the lowest level of minimal residual disease can be an important goal of therapy, a step in the path to cure.</text>
      <annotation id="100">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3913" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="101">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4090" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="102">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="4216" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="103">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="4239" length="6"/>
        <text>cancer</text>
      </annotation>
      <annotation id="104">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="4315" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="105">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="3865" length="24"/>
        <text>multiple myeloma depends</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>4643</offset>
      <text>Today, treatment goals in myeloma patients are shifting and the goal of therapy in elderly patients is to achieve and maintain maximal response. Many believe that multiple myeloma can be converted into a chronic disease and that a functional cure maybe a realistic goal. Attainment of complete remission at any time point during treatment is associated with improvement outcome; so it is likely to be established as a goal of therapy. The increasing number of treatment possibilities as an optimal therapeutic strategy improve patient outcome. Physicians have the opportunity to choose the best treatment regimen according to patient characteristics, while limiting treatment - related toxicities as much as possible. In elderly patients optimal treatment should be always balance efficacy and toxicity.</text>
      <annotation id="116">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4677" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="117">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4734" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="118">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5170" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="119">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5269" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="120">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5372" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="5329" length="10"/>
        <text>toxicities</text>
      </annotation>
      <annotation id="122">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="5437" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="123">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="4847" length="15"/>
        <text>chronic disease</text>
      </annotation>
      <annotation id="124">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="4806" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="125">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="4669" length="7"/>
        <text>myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>5449</offset>
      <text>Initial therapy for multiple myeloma depends on eligibility for high-dose therapy and autologous stem cell transplant (HDT-ASCT). In many European countries, elderly patients (older than 65) are generally considered ineligible for autologous stem cell transplantation (ASCT). In past times in practice, patients were stratified to those who are transplant eligible and consolidated with high-dose melphalan/SCT and those who were transplant ineligible and received oral melphalan with prednisolone (MP). This stratification has been made in the era of conventional therapy where response rates to the induction therapy were poor and the goal was achievement of partial response and prevention of organ damage. So, in contrast, today we considered that biological age and chronological age do not always correspond, and a greater emphasis should be placed on the former rather than the latter. CR is a good surrogate end point for survival in transplant-ineligible patients and novel drugs have been incorporated into the treatment of non-transplant candidates. Patients are generally considered eligible for ASCT if they have good performance status, no-comorbidities, and normal cardiac, pulmonary, liver and renal function. Patients older than 75 years or vulnerable ones are more susceptible to adverse events and in this setting we are looking for less toxic regimens and appropriate dose reductions should be adopted. Even, ASCT with a reduced melpahlan conditioning dose is well tolerated by the selected population of patients up to the age of 75 in good clinical conditions. Until novel agents were introduced, for more than 40 years the combination of melpahalan and prednisone (MP) was considered the standard approach for transplant -ineligible patients, with PFS of approximately 18 months and 2-3 years (at best) overall survival in the population treated with MP. A meta-analysis including 27 randomized studies compared MP with other chemotherapy-containing regimens. The introduction of novel agents has challenged this combination and new and more effective combination is available.</text>
      <annotation id="140">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5615" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="141">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5752" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="142">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6413" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6510" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="144">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6675" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="145">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6974" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="146">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7205" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="147">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="5919" length="9"/>
        <text>melphalan</text>
      </annotation>
      <annotation id="148">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="7125" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="149">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="5948" length="2"/>
        <text>MP</text>
      </annotation>
      <annotation id="150">
        <infon key="identifier">MESH:D011239</infon>
        <infon key="type">Chemical</infon>
        <location offset="5934" length="12"/>
        <text>prednisolone</text>
      </annotation>
      <annotation id="151">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="7110" length="10"/>
        <text>melpahalan</text>
      </annotation>
      <annotation id="152">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="5478" length="15"/>
        <text>myeloma depends</text>
      </annotation>
      <annotation id="153">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="7137" length="2"/>
        <text>MP</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>7552</offset>
      <text>Six randomized phase III studies have shown that the combination melphalan-prednisone-thalidomide (MPT) is superior to MP in terms of response and progression-free survival, but it was translated into improved survival in the 2 IFM studies. An efficacy meta-analysis of the six MPT trials including 1685 patients was conducted and has showed that the addition of thalidomide to MP significantly prolonged both PFS and extended OS by 20%-39 months compared to MP-33 months. The meta-analysis further confirmed the progression-free survival advantage achieved with MPT. So, MPT is therefore regarded as a new standard of care in transplant ineligible patients.</text>
      <annotation id="161">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7856" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8201" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="7915" length="11"/>
        <text>thalidomide</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="7627" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="7617" length="9"/>
        <text>melphalan</text>
      </annotation>
      <annotation id="166">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="7638" length="11"/>
        <text>thalidomide</text>
      </annotation>
      <annotation id="167">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="7651" length="3"/>
        <text>MPT</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>8215</offset>
      <text>For selected elderly patients, particularly for standard risk patients with favorable FISH, CTD is a feasible approach. A phase III assessed the role of thalidomide in combination with different alkylating agent and steroid than those commonly used, respectively cyclophosphamide and dexamethasone with an attenuated schedule (CTDa). Despite a deeper response, no differences were noted in median PFS and OS between patients treated with CTDa and MP.</text>
      <annotation id="177">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8236" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="178">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8277" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="179">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8631" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="180">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="8368" length="11"/>
        <text>thalidomide</text>
      </annotation>
      <annotation id="181">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="8542" length="4"/>
        <text>CTDa</text>
      </annotation>
      <annotation id="182">
        <infon key="identifier">MESH:D013256</infon>
        <infon key="type">Chemical</infon>
        <location offset="8431" length="7"/>
        <text>steroid</text>
      </annotation>
      <annotation id="183">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="8653" length="4"/>
        <text>CTDa</text>
      </annotation>
      <annotation id="184">
        <infon key="identifier">MESH:D003907</infon>
        <infon key="type">Chemical</infon>
        <location offset="8499" length="13"/>
        <text>dexamethasone</text>
      </annotation>
      <annotation id="185">
        <infon key="identifier">MESH:D003520</infon>
        <infon key="type">Chemical</infon>
        <location offset="8478" length="16"/>
        <text>cyclophosphamide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>8666</offset>
      <text>Lenalidomide is an immunomodulatory drug with higher potency than its analogue thalidomide and without sedative or neurotoxic adverse effects. Lenalidomide showed to be safe and effective in relapsed/refractory multiple myeloma patients, as well as in newly diagnosed multiple myeloma patients.</text>
      <annotation id="194">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8894" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="195">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8951" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="196">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="8809" length="12"/>
        <text>Lenalidomide</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="8745" length="11"/>
        <text>thalidomide</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="8886" length="7"/>
        <text>myeloma</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="8934" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="200">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="8666" length="12"/>
        <text>Lenalidomide</text>
      </annotation>
      <annotation id="201">
        <infon key="identifier">MESH:D020258</infon>
        <infon key="type">Disease</infon>
        <location offset="8781" length="10"/>
        <text>neurotoxic</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>8961</offset>
      <text>The phase III trial RD (lenalidomide plus high-dose dexamethason) versus Rd (lenalidomide plus low-dose dexamethason) included newly diagnosed multiple myeloma patients both eligible and ineligible for autologus stem cell transplantation. Rd seems preferable for elderly patients because has significantly longer 1-year overall survival, particularly evident in patients older than 65 years of age and can be considered a valid therapeutic option for elderly newly diagnosed myeloma patients. RD remains a good option for patients with renal failure, hypercalcemia, pain or spinal cord compression because more adverse events occurred when RD was given compared with Rd.</text>
      <annotation id="216">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9121" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="217">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9232" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="218">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9323" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9444" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="220">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9483" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="221">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="8985" length="12"/>
        <text>lenalidomide</text>
      </annotation>
      <annotation id="222">
        <infon key="identifier">MESH:D006934</infon>
        <infon key="type">Disease</infon>
        <location offset="9512" length="13"/>
        <text>hypercalcemia</text>
      </annotation>
      <annotation id="223">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="9436" length="7"/>
        <text>myeloma</text>
      </annotation>
      <annotation id="224">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="9527" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="225">
        <infon key="identifier">MESH:D051437</infon>
        <infon key="type">Disease</infon>
        <location offset="9497" length="13"/>
        <text>renal failure</text>
      </annotation>
      <annotation id="226">
        <infon key="identifier">MESH:D003907</infon>
        <infon key="type">Chemical</infon>
        <location offset="9013" length="12"/>
        <text>dexamethason</text>
      </annotation>
      <annotation id="227">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="9038" length="12"/>
        <text>lenalidomide</text>
      </annotation>
      <annotation id="228">
        <infon key="identifier">MESH:D003907</infon>
        <infon key="type">Chemical</infon>
        <location offset="9065" length="12"/>
        <text>dexamethason</text>
      </annotation>
      <annotation id="229">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="9104" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>9632</offset>
      <text>The role of lenalidomide was assessed in a recent phase III study that compared melphalan-prednisone-lenalidomide followed by lenalidomide maintenance (MPR-R), with MPR and MP. MPR-R significantly improved median progression-free survival compared with MPR and MP (31 months versus 14 months vs. 13 months; p&lt;0.001), which means that MPR-R reduced the risk of progression by 51% and 60% compared with MPR and MP. Lenalidomide maintenance was well tolerated with few reported incidence of grade 3/4 adverse events and second cancer. However the benefit associated with MPR-R outweigh the increased risk of second primary malignancies.</text>
      <annotation id="238">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="9644" length="12"/>
        <text>lenalidomide</text>
      </annotation>
      <annotation id="239">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="9758" length="12"/>
        <text>lenalidomide</text>
      </annotation>
      <annotation id="240">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="9733" length="12"/>
        <text>lenalidomide</text>
      </annotation>
      <annotation id="241">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="10156" length="6"/>
        <text>cancer</text>
      </annotation>
      <annotation id="242">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="9722" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="243">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="9712" length="9"/>
        <text>melphalan</text>
      </annotation>
      <annotation id="244">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="10045" length="12"/>
        <text>Lenalidomide</text>
      </annotation>
      <annotation id="245">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="10252" length="12"/>
        <text>malignancies</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>10266</offset>
      <text>VISTA study compared MP versus VMP and proved that addition of bortezomib to MP is rational, because responses, time to progression and survival were significantly higher with VMP.</text>
      <annotation id="248">
        <infon key="identifier">64115</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">81923</infon>
        <location offset="10266" length="5"/>
        <text>VISTA</text>
      </annotation>
      <annotation id="249">
        <infon key="identifier">MESH:D000069286</infon>
        <infon key="type">Chemical</infon>
        <location offset="10329" length="10"/>
        <text>bortezomib</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>10447</offset>
      <text>In the Spanish PETHEMA trial a cohort of 260 patients older than 65, transplant ineligible, were randomized to receive induction treatment with 6 cycles of bortezomib-thalidomeide-prednisone VTP, or VMP considered as more gentle approach where melphalan is used instead of thalidomide. Both regimens led to high ORR rate (81%and 80%), but there were more adverse events among patients with VDT. VMP with once-weekly schedule of botezomib should be preferred to VTP as induction for elderly multiple myeloma patients. One-weekly bortezomib was scheduled instead of standard twice-weekly administration to reduce adverse events, especially neuropathy associated with bortezomib administration.</text>
      <annotation id="265">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10492" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="266">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10823" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="267">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10954" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="268">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="10627" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="269">
        <infon key="identifier">MESH:C562515</infon>
        <infon key="type">Disease</infon>
        <location offset="11074" length="21"/>
        <text>especially neuropathy</text>
      </annotation>
      <annotation id="270">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="10720" length="11"/>
        <text>thalidomide</text>
      </annotation>
      <annotation id="271">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="10875" length="9"/>
        <text>botezomib</text>
      </annotation>
      <annotation id="272">
        <infon key="identifier">MESH:D000069286</infon>
        <infon key="type">Chemical</infon>
        <location offset="11112" length="10"/>
        <text>bortezomib</text>
      </annotation>
      <annotation id="273">
        <infon key="identifier">MESH:D000069286</infon>
        <infon key="type">Chemical</infon>
        <location offset="10975" length="10"/>
        <text>bortezomib</text>
      </annotation>
      <annotation id="274">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="10691" length="9"/>
        <text>melphalan</text>
      </annotation>
      <annotation id="275">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="10638" length="3"/>
        <text>VTP</text>
      </annotation>
      <annotation id="276">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="10937" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="277">
        <infon key="identifier">MESH:D000069286</infon>
        <infon key="type">Chemical</infon>
        <location offset="10603" length="10"/>
        <text>bortezomib</text>
      </annotation>
      <annotation id="278">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="10614" length="12"/>
        <text>thalidomeide</text>
      </annotation>
      <annotation id="279">
        <infon key="type">Disease</infon>
        <location offset="10837" length="3"/>
        <text>VDT</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>11139</offset>
      <text>The combination of bortezomib-lenalidomide-dexamethasone (VRD) was evaluated in both young and elderly patients with multiple myeloma.</text>
      <annotation id="284">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11242" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="285">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="11256" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="286">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="11197" length="3"/>
        <text>VRD</text>
      </annotation>
      <annotation id="287">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="11158" length="37"/>
        <text>bortezomib-lenalidomide-dexamethasone</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>11274</offset>
      <text>The addition of thalidomide to the new treatment standard with VMP followed by bortezomib-thalidomide maintenance is valid alternative with 3-years overall survival 565 with VMP-VT compared with 41% with VMP. VMP-VT with once weekly bortezomib seems to be a valid alternative for elderly patients particularly those younger than 75 years, where there is the same efficacy, but without additional toxicity, particular peripheral neuropathy.</text>
      <annotation id="296">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11562" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="297">
        <infon key="identifier">MESH:D010523</infon>
        <infon key="type">Disease</infon>
        <location offset="11680" length="32"/>
        <text>particular peripheral neuropathy</text>
      </annotation>
      <annotation id="298">
        <infon key="identifier">MESH:D017180</infon>
        <infon key="type">Disease</infon>
        <location offset="11452" length="2"/>
        <text>VT</text>
      </annotation>
      <annotation id="299">
        <infon key="identifier">MESH:D000069286</infon>
        <infon key="type">Chemical</infon>
        <location offset="11507" length="10"/>
        <text>bortezomib</text>
      </annotation>
      <annotation id="300">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="11353" length="22"/>
        <text>bortezomib-thalidomide</text>
      </annotation>
      <annotation id="301">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="11670" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="302">
        <infon key="identifier">MESH:D017180</infon>
        <infon key="type">Disease</infon>
        <location offset="11487" length="2"/>
        <text>VT</text>
      </annotation>
      <annotation id="303">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="11290" length="11"/>
        <text>thalidomide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>11714</offset>
      <text>A sequential approach consisting of an induction regimen associated with a high rate of complete response, followed by consolidation, maintenance therapy, induce a profound cytoreduction and delays relapse, thus improving survival as a therapy approach that minimized toxicity maximized quality of life and emphasized patient's preference. This choice of treatment strategy improve outcome and prevent the occurrence of relapse with a continuous treatment keeping residual disease under control. The international MM015 phase III study assessed the role of lenalidomide given in maintenance. Having this in mind MPR followed by lenalidomide maintenance emerges as a new standard treatment option for elderly multiple myeloma patients. Another treatment option for elderly patients with impressive result is more intensive regimen VMPT followed by VT maintenance. Bortezomib showed same efficacy with decreased toxicity administrated in a new schedule from twice to once weekly.</text>
      <annotation id="314">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12032" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="315">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12439" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="316">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12486" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="317">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="12422" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="318">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="12271" length="12"/>
        <text>lenalidomide</text>
      </annotation>
      <annotation id="319">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="12624" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="320">
        <infon key="identifier">MESH:D000069286</infon>
        <infon key="type">Chemical</infon>
        <location offset="12577" length="10"/>
        <text>Bortezomib</text>
      </annotation>
      <annotation id="321">
        <infon key="identifier">MESH:D017180</infon>
        <infon key="type">Disease</infon>
        <location offset="12561" length="2"/>
        <text>VT</text>
      </annotation>
      <annotation id="322">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="11982" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="323">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="12342" length="12"/>
        <text>lenalidomide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>12692</offset>
      <text>As we already emphasized, the choice among these regimens should be based on the patient's characteristics. For elderly patients with renal impairment bortezomib or thalidomide containing regiment is considered the best treatment option, because lenalidomide is excreted by the kidneys. In such a case dose of lenalidomide should be reduced according to creatinin clearance. Despite that, for patients with peripheral neuropathy lenalidomide is considered as the best treatment option because of the reduced neurological toxicity. In elderly patients there is an increased risk of treatment-related adverse events in response to novel agent-containing regimens. Clinicians should be aware and proposed guidelines for dose reduction of novel agents and protocol modification in elderly should be followed in clinical practice for elderly patients with multiple myeloma to optimize outcome. So, there is an attempt to personalize the therapy in multiple myeloma according to patient age and vulnerability proposed by European Myeloma Network (EMN).</text>
      <annotation id="340">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12773" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="341">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12812" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="342">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13085" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="343">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13234" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="344">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13529" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="345">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13665" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="346">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="12938" length="12"/>
        <text>lenalidomide</text>
      </annotation>
      <annotation id="347">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="12857" length="11"/>
        <text>thalidomide</text>
      </annotation>
      <annotation id="348">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="13543" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="349">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="13002" length="12"/>
        <text>lenalidomide</text>
      </annotation>
      <annotation id="350">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="13716" length="7"/>
        <text>Myeloma</text>
      </annotation>
      <annotation id="351">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="13121" length="12"/>
        <text>lenalidomide</text>
      </annotation>
      <annotation id="352">
        <infon key="identifier">MESH:D010523</infon>
        <infon key="type">Disease</infon>
        <location offset="13099" length="21"/>
        <text>peripheral neuropathy</text>
      </annotation>
      <annotation id="353">
        <infon key="identifier">MESH:D020258</infon>
        <infon key="type">Disease</infon>
        <location offset="13200" length="21"/>
        <text>neurological toxicity</text>
      </annotation>
      <annotation id="354">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="12826" length="27"/>
        <text>renal impairment bortezomib</text>
      </annotation>
      <annotation id="355">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="13635" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>13739</offset>
      <text>Multiple myeloma is still an incurable disease with pattern of regression and remission followed by multiple relapses raising from the residual myeloma cells surviving even in the patients who achieve complete clinical response to treatment. New anti-myeloma drugs change treatment paradigm providing both tumor reduction and tumor suppression. There is so much progress, but still many unsolved questions. Today, physicians are able to offer wider variety of treatment options for both young and elderly patients with multiple myeloma. Therapeutic options should be tailored and personalized according to patient's characteristics by balancing efficacy and toxicity of each drug which is especially important for elderly patients. In the mode of sequencing treatment for elderly patients with multiple myeloma, our goal is to achieve and maintain maximal response while limiting treatment -related toxicities as much as possible. Second-generation novel agent, such as carfilzomib, pomalidomide, elotuzumab, bendamustine are currently being evaluated as an option to improve treatment outcome in elderly pateints.</text>
      <annotation id="373">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13919" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="374">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14244" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="375">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14345" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="376">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14461" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="377">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14519" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="378">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="14638" length="10"/>
        <text>toxicities</text>
      </annotation>
      <annotation id="379">
        <infon key="identifier">MESH:D064420</infon>
        <infon key="type">Disease</infon>
        <location offset="14397" length="8"/>
        <text>toxicity</text>
      </annotation>
      <annotation id="380">
        <infon key="identifier">MESH:C467566</infon>
        <infon key="type">Chemical</infon>
        <location offset="14722" length="12"/>
        <text>pomalidomide</text>
      </annotation>
      <annotation id="381">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="14533" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="382">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="13883" length="7"/>
        <text>myeloma</text>
      </annotation>
      <annotation id="383">
        <infon key="identifier">MESH:D000069461</infon>
        <infon key="type">Chemical</infon>
        <location offset="14748" length="12"/>
        <text>bendamustine</text>
      </annotation>
      <annotation id="384">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="13739" length="16"/>
        <text>Multiple myeloma</text>
      </annotation>
      <annotation id="385">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="14258" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="386">
        <infon key="identifier">MESH:C524865</infon>
        <infon key="type">Chemical</infon>
        <location offset="14709" length="11"/>
        <text>carfilzomib</text>
      </annotation>
      <annotation id="387">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="14045" length="25"/>
        <text>tumor reduction and tumor</text>
      </annotation>
      <annotation id="388">
        <infon key="identifier">MESH:C546027</infon>
        <infon key="type">Chemical</infon>
        <location offset="14736" length="10"/>
        <text>elotuzumab</text>
      </annotation>
      <annotation id="389">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="13990" length="7"/>
        <text>myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">footnote</infon>
      <offset>14854</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>14891</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="volume">111</infon>
      <infon key="name_1">surname:Rajkumar;given-names:SV</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kyle;given-names:RA</infon>
      <infon key="fpage">2962</infon>
      <infon key="pub-id_pmid">18332230</infon>
      <infon key="year">2008</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2972</infon>
      <offset>14902</offset>
      <text>Multiple myeloma</text>
      <annotation id="391">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="14902" length="16"/>
        <text>Multiple myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">15</infon>
      <infon key="name_2">surname:Palumbo;given-names:A</infon>
      <infon key="name_1">surname:Cavallo;given-names:F</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Genadieva;given-names:Stavric S</infon>
      <infon key="fpage">157</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">24578203</infon>
      <infon key="year">2014</infon>
      <infon key="source">Curr Treat Options Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">170</infon>
      <offset>14919</offset>
      <text>New approaches to management of multiple myeloma</text>
      <annotation id="393">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="14951" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">364</infon>
      <infon key="name_1">surname:Anderson;given-names:K</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Palumbo;given-names:A</infon>
      <infon key="fpage">1046</infon>
      <infon key="pub-id_pmid">21410373</infon>
      <infon key="year">2011</infon>
      <infon key="source">N Engl J Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1060</infon>
      <offset>14968</offset>
      <text>Multiple myeloma</text>
      <annotation id="395">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="14968" length="16"/>
        <text>Multiple myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">23</infon>
      <infon key="name_2">surname:Durie;given-names:BGM</infon>
      <infon key="name_1">surname:San Miguel;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Greipp;given-names:PR</infon>
      <infon key="fpage">3412</infon>
      <infon key="year">2005</infon>
      <infon key="source">J Clin Oncol Off J Am Soc Clin Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">3420</infon>
      <offset>14985</offset>
      <text>International staging system for multiple myeloma</text>
      <annotation id="397">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15018" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">23</infon>
      <infon key="name_1">surname:Rajkumar;given-names:SV</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kyle;given-names:RA</infon>
      <infon key="fpage">3</infon>
      <infon key="year">2009</infon>
      <infon key="source">Leuk Off J Leuk Soc Am Leuk Res Fund UK</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">9</infon>
      <offset>15035</offset>
      <text>Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma</text>
      <annotation id="399">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15124" length="7"/>
        <text>myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">43</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Suzuki;given-names:K</infon>
      <infon key="fpage">116</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">23293370</infon>
      <infon key="year">2013</infon>
      <infon key="source">Jpn J Clin Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">124</infon>
      <offset>15132</offset>
      <text>Current Threpautic Starategy for Multiple myeloma</text>
      <annotation id="401">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15165" length="16"/>
        <text>Multiple myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">23</infon>
      <infon key="name_2">surname:Drach;given-names:J</infon>
      <infon key="name_1">surname:Bergsagel;given-names:PL</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Fonseca;given-names:R</infon>
      <infon key="fpage">2210</infon>
      <infon key="pub-id_pmid">19798094</infon>
      <infon key="year">2009</infon>
      <infon key="source">Leukemia</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2221</infon>
      <offset>15182</offset>
      <text>International Myeloma Working Group molecular classification of multiple myeloma: spotlight review</text>
      <annotation id="404">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15246" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="405">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15196" length="15"/>
        <text>Myeloma Working</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">27</infon>
      <infon key="name_2">surname:Cavo;given-names:M</infon>
      <infon key="name_1">surname:Durie;given-names:BGM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Avet-Loiseau;given-names:H</infon>
      <infon key="fpage">711</infon>
      <infon key="pub-id_pmid">23032723</infon>
      <infon key="year">2013</infon>
      <infon key="source">Leukemia</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">717</infon>
      <offset>15281</offset>
      <text>Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project</text>
      <annotation id="408">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15375" length="7"/>
        <text>myeloma</text>
      </annotation>
      <annotation id="409">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15401" length="15"/>
        <text>Myeloma Working</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">32</infon>
      <infon key="name_2">surname:San Miguel;given-names:F</infon>
      <infon key="name_1">surname:Rajkumar;given-names:V</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Palumbo;given-names:A</infon>
      <infon key="fpage">587</infon>
      <infon key="pub-id_pmid">24419113</infon>
      <infon key="year">2014</infon>
      <infon key="source">J Clin Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">600</infon>
      <offset>15445</offset>
      <text>International Myeloma Working Group Consensus Stateet for the Managmnent, treatment, and Supportive Care of Patients with myeloma not eligible for standard Autologous Stem-Cell transplantation</text>
      <annotation id="413">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15553" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="414">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15567" length="7"/>
        <text>myeloma</text>
      </annotation>
      <annotation id="415">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15459" length="15"/>
        <text>Myeloma Working</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">92</infon>
      <infon key="name_2">surname:Kleber;given-names:M</infon>
      <infon key="name_1">surname:Trepos;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Engelhardt;given-names:M</infon>
      <infon key="fpage">232</infon>
      <infon key="issue">2</infon>
      <infon key="pub-id_pmid">24497560</infon>
      <infon key="year">2014</infon>
      <infon key="source">Haematologica</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">242</infon>
      <offset>15638</offset>
      <text>European myeloma network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma </text>
      <annotation id="419">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15730" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="420">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15744" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="421">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15647" length="7"/>
        <text>myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_1">surname:San Miguel;given-names:JF</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Mateos;given-names:MV</infon>
      <infon key="fpage">488</infon>
      <infon key="pub-id_pmid">24319223</infon>
      <infon key="year">2013</infon>
      <infon key="source">Hematology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">495</infon>
      <offset>15762</offset>
      <text>How should we treat newly diagnosed multple myeloma patients?</text>
      <annotation id="424">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15814" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="425">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15806" length="7"/>
        <text>myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_1">surname:Gay;given-names:F</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Palumbo;given-names:A</infon>
      <infon key="fpage">566</infon>
      <infon key="pub-id_pmid">20008241</infon>
      <infon key="year">2009</infon>
      <infon key="source">Hematology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">577</infon>
      <offset>15824</offset>
      <text>How to treat elderly patients with multiple myeloma: combination of therapy or sequencing</text>
      <annotation id="428">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15845" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="429">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15859" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="name_1">surname:Cerrato;given-names:C</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Palumbo;given-names:A</infon>
      <infon key="fpage">263</infon>
      <infon key="pub-id_pmid">23682217</infon>
      <infon key="year">2013</infon>
      <infon key="source">Korean J Intern Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">273</infon>
      <offset>15914</offset>
      <text>Diagnosis and therapy of multiple myeloma</text>
      <annotation id="431">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="15948" length="7"/>
        <text>myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="name_1">surname:Anderson;given-names:KC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Lional;given-names:S</infon>
      <infon key="fpage">258</infon>
      <infon key="pub-id_pmid">23868105</infon>
      <infon key="year">2014</infon>
      <infon key="source">Leukemia</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">268</infon>
      <offset>15956</offset>
      <text>Association of response endpoints with survival outomes in multiple myeloma</text>
      <annotation id="433">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="16024" length="7"/>
        <text>myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">111</infon>
      <infon key="name_2">surname:Dispenzieri;given-names:A</infon>
      <infon key="name_1">surname:Rajkumar;given-names:SV</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kumar;given-names:SK</infon>
      <infon key="fpage">2516</infon>
      <infon key="pub-id_pmid">17975015</infon>
      <infon key="year">2008</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2520</infon>
      <offset>16032</offset>
      <text>Improved survival in multiple myeloma and the impact of novel therapies</text>
      <annotation id="435">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="16062" length="7"/>
        <text>myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">118</infon>
      <infon key="name_2">surname:Ludwig;given-names:H</infon>
      <infon key="name_1">surname:Bringhen;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Palumbo;given-names:A</infon>
      <infon key="fpage">4519</infon>
      <infon key="issue">17</infon>
      <infon key="pub-id_pmid">21841166</infon>
      <infon key="year">2011</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">4529</infon>
      <offset>16104</offset>
      <text>Personalized therapy in multiple myeloma according to p[atient age and vulnerability: a report of the Eouropean Myeloma Network (EMN)</text>
      <annotation id="438">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="16128" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="439">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="16216" length="7"/>
        <text>Myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">99</infon>
      <infon key="name_2">surname:Bringhen;given-names:S</infon>
      <infon key="name_1">surname:Palumbo;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Zweegman;given-names:S</infon>
      <infon key="fpage">1133</infon>
      <infon key="issue">7</infon>
      <infon key="pub-id_pmid">24986875</infon>
      <infon key="year">2014</infon>
      <infon key="source">Haematologica</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1137</infon>
      <offset>16238</offset>
      <text>Age and aging in blood disoreders: multiple myeloma</text>
      <annotation id="442">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="16282" length="7"/>
        <text>myeloma</text>
      </annotation>
      <annotation id="443">
        <infon key="identifier">MESH:D006402</infon>
        <infon key="type">Disease</infon>
        <location offset="16255" length="16"/>
        <text>blood disoreders</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">25</infon>
      <infon key="name_1">surname:Palumbo;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Gay;given-names:F</infon>
      <infon key="fpage">65</infon>
      <infon key="pub-id_pmid">21295387</infon>
      <infon key="year">2011</infon>
      <infon key="source">Blood Reviews</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">73</infon>
      <offset>16290</offset>
      <text>Management of older patients with multiple myeloma</text>
      <annotation id="446">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16310" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="447">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="16324" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">124</infon>
      <infon key="name_1">surname:Dingli;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Gertz;given-names:MA</infon>
      <infon key="fpage">882</infon>
      <infon key="issue">6</infon>
      <infon key="pub-id_pmid">24973360</infon>
      <infon key="year">2014</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">890</infon>
      <offset>16341</offset>
      <text>How we manage autologous stem cell transplantation for patients with multiple myeloma</text>
      <annotation id="450">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16396" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="451">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="16410" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">40</infon>
      <infon key="name_2">surname:Laubach;given-names:J</infon>
      <infon key="name_1">surname:Jasielec;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rosenbaum;given-names:C</infon>
      <infon key="fpage">592</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">24135404</infon>
      <infon key="year">2013</infon>
      <infon key="source">Seminars in Oncology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">601</infon>
      <offset>16427</offset>
      <text>Evolving Starategies in the Initial Treatment of multiple myeloma</text>
      <annotation id="453">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="16476" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">40</infon>
      <infon key="name_1">surname:Palumbo;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Cerrato;given-names:C</infon>
      <infon key="fpage">577</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">24135402</infon>
      <infon key="year">2013</infon>
      <infon key="source">Seminars in Oncology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">584</infon>
      <offset>16493</offset>
      <text>Initial treatment of nontransplant patients With Multiple myeloma</text>
      <annotation id="456">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16528" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="457">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="16542" length="16"/>
        <text>Multiple myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">16</infon>
      <infon key="section_type">REF</infon>
      <infon key="fpage">3832</infon>
      <infon key="pub-id_pmid">9850028</infon>
      <infon key="year">1998</infon>
      <infon key="source">J Clin Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">3842</infon>
      <offset>16559</offset>
      <text>Myeloma trialist Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment for myltiple myeloma: an overview of 6,633 patients from 27 randomized trials</text>
      <annotation id="463">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16711" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="464">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="16672" length="16"/>
        <text>myltiple myeloma</text>
      </annotation>
      <annotation id="465">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="16559" length="7"/>
        <text>Myeloma</text>
      </annotation>
      <annotation id="466">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="16644" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="467">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="16629" length="9"/>
        <text>melphalan</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">370</infon>
      <infon key="name_2">surname:Hulin;given-names:C</infon>
      <infon key="name_1">surname:Mary;given-names:JY</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Facon;given-names:T</infon>
      <infon key="fpage">1209</infon>
      <infon key="pub-id_pmid">17920916</infon>
      <infon key="year">2007</infon>
      <infon key="source">Lancet</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1218</infon>
      <offset>16746</offset>
      <text>Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomized trial</text>
      <annotation id="475">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16895" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="476">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="16795" length="9"/>
        <text>melphalan</text>
      </annotation>
      <annotation id="477">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="16760" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="478">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="16746" length="9"/>
        <text>Melphalan</text>
      </annotation>
      <annotation id="479">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="16909" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="480">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="16809" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="481">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="16776" length="11"/>
        <text>thalidomide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">27</infon>
      <infon key="name_2">surname:Rodon;given-names:P</infon>
      <infon key="name_1">surname:Facon;given-names:T</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hulin;given-names:C</infon>
      <infon key="fpage">3664</infon>
      <infon key="pub-id_pmid">19451428</infon>
      <infon key="year">2009</infon>
      <infon key="source">J Clin Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">3670</infon>
      <offset>16958</offset>
      <text>Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM01/01 trial</text>
      <annotation id="487">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17015" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="488">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="16970" length="9"/>
        <text>melphalan</text>
      </annotation>
      <annotation id="489">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="17000" length="11"/>
        <text>thalidomide</text>
      </annotation>
      <annotation id="490">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="17065" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="491">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="16984" length="10"/>
        <text>prednisone</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">86</infon>
      <infon key="name_2">surname:Firatli-Tuglular;given-names:T</infon>
      <infon key="name_1">surname:Haznedar;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Beksac;given-names:M</infon>
      <infon key="fpage">16</infon>
      <infon key="year">2011</infon>
      <infon key="source">Eur J Hematol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">22</infon>
      <offset>17098</offset>
      <text>Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: result of a randomized trial from tha Turkish Myeloma Study Group</text>
      <annotation id="498">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17154" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="499">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="17168" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="500">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="17140" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="501">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="17265" length="7"/>
        <text>Myeloma</text>
      </annotation>
      <annotation id="502">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="17110" length="11"/>
        <text>thalidomide</text>
      </annotation>
      <annotation id="503">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="17130" length="9"/>
        <text>melphalan</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">116</infon>
      <infon key="name_2">surname:Fayers;given-names:P</infon>
      <infon key="name_1">surname:Gimsing;given-names:P</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Waage;given-names:A</infon>
      <infon key="fpage">1405</infon>
      <infon key="pub-id_pmid">20448107</infon>
      <infon key="year">2010</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1412</infon>
      <offset>17285</offset>
      <text>Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma</text>
      <annotation id="509">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17349" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="510">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="17315" length="11"/>
        <text>thalidomide</text>
      </annotation>
      <annotation id="511">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="17285" length="9"/>
        <text>Melphalan</text>
      </annotation>
      <annotation id="512">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="17363" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="513">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="17299" length="10"/>
        <text>prednisone</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="name_2">surname:Termorshuizzen;given-names:F</infon>
      <infon key="name_1">surname:Schaafsma;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Wijermans;given-names:P</infon>
      <infon key="fpage">3160</infon>
      <infon key="pub-id_pmid">20516439</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Clin Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">3166</infon>
      <offset>17380</offset>
      <text>Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study</text>
      <annotation id="519">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17470" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="520">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="17448" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="521">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="17500" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="522">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="17433" length="9"/>
        <text>melphalan</text>
      </annotation>
      <annotation id="523">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="17412" length="11"/>
        <text>thalidomide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">112</infon>
      <infon key="name_2">surname:Liberati;given-names:AM</infon>
      <infon key="name_1">surname:Bringen;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Palumbo;given-names:A</infon>
      <infon key="fpage">3107</infon>
      <infon key="pub-id_pmid">18505783</infon>
      <infon key="year">2008</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">3114</infon>
      <offset>17537</offset>
      <text>Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: update results oa a randomized controlled trial</text>
      <annotation id="529">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17592" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="530">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="17542" length="9"/>
        <text>melphalan</text>
      </annotation>
      <annotation id="531">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="17553" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="532">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="17606" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="533">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="17569" length="11"/>
        <text>thalidomide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">98</infon>
      <infon key="name_2">surname:Hulin;given-names:C</infon>
      <infon key="name_1">surname:Waage;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Palumbo;given-names:A</infon>
      <infon key="fpage">87</infon>
      <infon key="year">2013</infon>
      <infon key="source">Hematologica</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">94</infon>
      <offset>17672</offset>
      <text>Safety of thalidomide in newly diagnosed elderly myeloma patients: a mata-analysis of data from individual patients in six randomized trials</text>
      <annotation id="538">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17729" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="539">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17779" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="540">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="17721" length="7"/>
        <text>myeloma</text>
      </annotation>
      <annotation id="541">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="17682" length="11"/>
        <text>thalidomide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">118</infon>
      <infon key="name_2">surname:Gregory;given-names:WM</infon>
      <infon key="name_1">surname:Davies;given-names:FE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Morgan;given-names:GJ</infon>
      <infon key="fpage">1231</infon>
      <infon key="pub-id_pmid">21652683</infon>
      <infon key="year">2011</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1238</infon>
      <offset>17813</offset>
      <text>Cyclophosphamide, thalidomide and dexamathasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation</text>
      <annotation id="548">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17890" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="549">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="17862" length="3"/>
        <text>CTD</text>
      </annotation>
      <annotation id="550">
        <infon key="identifier">MESH:D003520</infon>
        <infon key="type">Chemical</infon>
        <location offset="17813" length="16"/>
        <text>Cyclophosphamide</text>
      </annotation>
      <annotation id="551">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="17831" length="11"/>
        <text>thalidomide</text>
      </annotation>
      <annotation id="552">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="17904" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="553">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="17847" length="13"/>
        <text>dexamathasone</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">11</infon>
      <infon key="name_2">surname:Callander;given-names:NS</infon>
      <infon key="name_1">surname:Jacobus;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rajkumar;given-names:SV</infon>
      <infon key="fpage">29</infon>
      <infon key="pub-id_pmid">19853510</infon>
      <infon key="year">2010</infon>
      <infon key="source">Lancet.Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">37</infon>
      <offset>17963</offset>
      <text>lenalidomide plus high-dose dexamathasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma : an open - lablel randomized controlled trial</text>
      <annotation id="559">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="18092" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="560">
        <infon key="identifier">MESH:D003907</infon>
        <infon key="type">Chemical</infon>
        <location offset="18039" length="13"/>
        <text>dexamethasone</text>
      </annotation>
      <annotation id="561">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="17991" length="13"/>
        <text>dexamathasone</text>
      </annotation>
      <annotation id="562">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="18012" length="12"/>
        <text>lenalidomide</text>
      </annotation>
      <annotation id="563">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="17963" length="12"/>
        <text>lenalidomide</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">366</infon>
      <infon key="name_2">surname:Delforge;given-names:M</infon>
      <infon key="name_1">surname:Hajek;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Palumbo;given-names:A</infon>
      <infon key="fpage">1759</infon>
      <infon key="issue">19</infon>
      <infon key="pub-id_pmid">22571200</infon>
      <infon key="year">2012</infon>
      <infon key="source">N Engl J Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1769</infon>
      <offset>18158</offset>
      <text>Continuos lenalidomide treatment for newly diagnosed multiple myeloma</text>
      <annotation id="566">
        <infon key="identifier">MESH:D000077269</infon>
        <infon key="type">Chemical</infon>
        <location offset="18168" length="12"/>
        <text>lenalidomide</text>
      </annotation>
      <annotation id="567">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="18220" length="7"/>
        <text>myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">371</infon>
      <infon key="name_2">surname:Gay;given-names:F</infon>
      <infon key="name_1">surname:Cavallo;given-names:F</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Palumbo;given-names:A</infon>
      <infon key="fpage">895</infon>
      <infon key="pub-id_pmid">25184862</infon>
      <infon key="year">2014</infon>
      <infon key="source">N Engl J Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">905</infon>
      <offset>18228</offset>
      <text>Autologous Transplantation and Maintenance Therapy in Multiple Myeloma</text>
      <annotation id="569">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="18282" length="16"/>
        <text>Multiple Myeloma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">359</infon>
      <infon key="name_2">surname:Khuageva;given-names:NK</infon>
      <infon key="name_1">surname:Schlag;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:San-Miguel;given-names:JF</infon>
      <infon key="fpage">906</infon>
      <infon key="pub-id_pmid">18753647</infon>
      <infon key="year">2008</infon>
      <infon key="source">N Engl J Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">917</infon>
      <offset>18299</offset>
      <text>Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma</text>
      <annotation id="573">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="18365" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="574">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="18329" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="575">
        <infon key="identifier">MESH:D007625</infon>
        <infon key="type">Disease</infon>
        <location offset="18299" length="25"/>
        <text>Bortezomib plus melphalan</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="name_2">surname:Schlag;given-names:R</infon>
      <infon key="name_1">surname:Richardson;given-names:PG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Mateos;given-names:MV</infon>
      <infon key="fpage">2259</infon>
      <infon key="pub-id_pmid">20368561</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Clin Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2266</infon>
      <offset>18382</offset>
      <text>Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untretated multiple myeloma: update follow-up and impact of subsequent therapy in phase III VISTA trial</text>
      <annotation id="582">
        <infon key="identifier">64115</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">81923</infon>
        <location offset="18568" length="5"/>
        <text>VISTA</text>
      </annotation>
      <annotation id="583">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="18412" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="584">
        <infon key="identifier">MESH:D007625</infon>
        <infon key="type">Disease</infon>
        <location offset="18382" length="25"/>
        <text>Bortezomib plus melphalan</text>
      </annotation>
      <annotation id="585">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="18451" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="586">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="18476" length="27"/>
        <text>untretated multiple myeloma</text>
      </annotation>
      <annotation id="587">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="18437" length="9"/>
        <text>melphalan</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">11</infon>
      <infon key="name_2">surname:Martinez-Lopez;given-names:J</infon>
      <infon key="name_1">surname:Oriol;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Mateos;given-names:MV</infon>
      <infon key="fpage">934</infon>
      <infon key="pub-id_pmid">20739218</infon>
      <infon key="year">2010</infon>
      <infon key="source">Lancet Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">941</infon>
      <offset>18580</offset>
      <text>Bortezomib, melphalan, and prednisone versuis bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomized trial</text>
      <annotation id="600">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="18797" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="601">
        <infon key="identifier">MESH:D000069286</infon>
        <infon key="type">Chemical</infon>
        <location offset="18580" length="10"/>
        <text>Bortezomib</text>
      </annotation>
      <annotation id="602">
        <infon key="identifier">MESH:D000069286</infon>
        <infon key="type">Chemical</infon>
        <location offset="18726" length="10"/>
        <text>bortezomib</text>
      </annotation>
      <annotation id="603">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="18655" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="604">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="18741" length="11"/>
        <text>thalidomide</text>
      </annotation>
      <annotation id="605">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="18607" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="606">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="18592" length="9"/>
        <text>melphalan</text>
      </annotation>
      <annotation id="607">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="18821" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="608">
        <infon key="identifier">MESH:D000069286</infon>
        <infon key="type">Chemical</infon>
        <location offset="18760" length="10"/>
        <text>bortezomib</text>
      </annotation>
      <annotation id="609">
        <infon key="identifier">MESH:D013792</infon>
        <infon key="type">Chemical</infon>
        <location offset="18638" length="11"/>
        <text>thalidomide</text>
      </annotation>
      <annotation id="610">
        <infon key="identifier">MESH:D000069286</infon>
        <infon key="type">Chemical</infon>
        <location offset="18626" length="10"/>
        <text>bortezomib</text>
      </annotation>
      <annotation id="611">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="18775" length="10"/>
        <text>prednisone</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="name_2">surname:Rossi;given-names:D</infon>
      <infon key="name_1">surname:Bringhen;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Palumbo;given-names:A</infon>
      <infon key="fpage">5101</infon>
      <infon key="pub-id_pmid">20940200</infon>
      <infon key="year">2010</infon>
      <infon key="source">J Clin Oncol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">5109</infon>
      <offset>18858</offset>
      <text>Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial</text>
      <annotation id="619">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="18869" length="32"/>
        <text>melphalan-prednisone-thalidomide</text>
      </annotation>
      <annotation id="620">
        <infon key="identifier">MESH:D011241</infon>
        <infon key="type">Chemical</infon>
        <location offset="18989" length="10"/>
        <text>prednisone</text>
      </annotation>
      <annotation id="621">
        <infon key="identifier">MESH:D008558</infon>
        <infon key="type">Chemical</infon>
        <location offset="18979" length="9"/>
        <text>melphalan</text>
      </annotation>
      <annotation id="622">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="18931" length="22"/>
        <text>bortezomib-thalidomide</text>
      </annotation>
      <annotation id="623">
        <infon key="identifier">MESH:D000069286</infon>
        <infon key="type">Chemical</infon>
        <location offset="18858" length="10"/>
        <text>Bortezomib</text>
      </annotation>
      <annotation id="624">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="19025" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="625">
        <infon key="identifier">MESH:D000069286</infon>
        <infon key="type">Chemical</infon>
        <location offset="18968" length="10"/>
        <text>bortezomib</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">116</infon>
      <infon key="name_2">surname:Rossi;given-names:D</infon>
      <infon key="name_1">surname:Larocca;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bringhen;given-names:S</infon>
      <infon key="fpage">4745</infon>
      <infon key="pub-id_pmid">20807892</infon>
      <infon key="year">2010</infon>
      <infon key="source">Blood</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">4753</infon>
      <offset>19073</offset>
      <text>Efficacy and safety of once- weekly bortezomib in multiple myeloma patients</text>
      <annotation id="628">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="19123" length="16"/>
        <text>multiple myeloma</text>
      </annotation>
      <annotation id="629">
        <infon key="identifier">MESH:D000069286</infon>
        <infon key="type">Chemical</infon>
        <location offset="19109" length="10"/>
        <text>bortezomib</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">98</infon>
      <infon key="name_2">surname:Zweegman;given-names:S</infon>
      <infon key="name_1">surname:Victoria;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bringhen;given-names:S</infon>
      <infon key="fpage">6</infon>
      <infon key="year">2013</infon>
      <infon key="source">Haematologica</infon>
      <infon key="type">ref</infon>
      <offset>19149</offset>
      <text>Age and organ damage correlate with poor survival in myeloma patients: meta - analysis of 1435 individual patient data from 4 randomiuzed trials</text>
      <annotation id="633">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19210" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="634">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19255" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="635">
        <infon key="identifier">MESH:D009101</infon>
        <infon key="type">Disease</infon>
        <location offset="19202" length="7"/>
        <text>myeloma</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272841</id>
    <passage>
      <infon key="article-id_pmid">25568587</infon>
      <infon key="name_0">surname:Masic;given-names:Izet</infon>
      <infon key="fpage">350</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272841</infon>
      <infon key="article-id_publisher-id">AIM-55-350</infon>
      <infon key="article-id_doi">10.5455/aim.2014.22.350-350</infon>
      <infon key="type">front</infon>
      <infon key="volume">22</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Acta Inform Med; 2014 Oct; 22(5) 350. doi:10.5455/aim.2014.22.350-350</infon>
      <infon key="lpage">350</infon>
      <infon key="authors">Masic I</infon>
      <offset>0</offset>
      <text>The Most Influential Scientists in the Development of the Medical Informatics (2): Morris F. Collen</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>100</offset>
      <text>MORRIS F. COLLEN (1913-2014)</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>129</offset>
      <text>Morris F. Collen was born in St. Paul, Minnesota. He attended the University of Minnesota, where he earned a bachelor's degree in electrical engineering in 1935. In 1938 he earned his MD "with distinction" from the School of Medicine and completed a residency in internal medicine at USC/Los Angeles County General Hospital.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>458</offset>
      <text>Dr. Morris Collen has had a profound influence, not only on the creation of the field of informatics, but also on health-care delivery and the creation of new models of payment and prevention. Dr. Collen's remarkable career began in 1942 when he was selected by Dr. Sidney Garfield, a surgeon, to join him as an internist in a California group practice. Drs Garfield and Collen subsequently worked with the industrialist Henry Kaiser, who is credited with creating one of the first comprehensive prepaid health plans for both office and hospital care. This led to the establishment of Kaiser Perma-nente in the post-World War II period plus a comprehensive infrastructure of hospitals in the Bay Area near San Francisco and near Portland, Oregon. In the subsequent decades, the Kaiser organization grew to become a nationwide healthcare provider with millions of enrollees.</text>
      <annotation id="1">
        <infon key="identifier">8406</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4598</infon>
        <location offset="812" length="3"/>
        <text>Drs</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1332</offset>
      <text>Collen became a nationally recognized authority on the treatment of pneumonia during World War II. His gift for research showed early in his published studies in The Permanente Foundation Medical Bulletin of which he was long-time editor. After two decades as an internist with Kaiser Permanente, his career took a turn into early medical information technology. Morris Collen and his team set to work to automate the 10-year-old multiphasic health screening exam to develop a prototype electronic health record. Within a decade, Dr. Collen accumulated several millions of health checkup data sets on more than a million subjects, creating in the process not only a prototype electronic health record, but also a phenomenal and unique basis for research, and this despite the immaturity of the technology available in the fifties and sixties. For the pursuit of the scientific aspects of his work, Dr. Collen founded the Medical Methods Research Division within Kaiser Permanente in Oakland, to which he added the Division of Technology Assessment in 1979 that he directed until his retirement in 1983, at age 70.</text>
      <annotation id="3">
        <infon key="identifier">MESH:D011014</infon>
        <infon key="type">Disease</infon>
        <location offset="1400" length="9"/>
        <text>pneumonia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2446</offset>
      <text>He was elected to membership in the Institute of Medicine of the National Academy of Sciences (1971), and has served in many capacities on many committees of the National Library of Medicine.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2638</offset>
      <text>By the time of his retirement that year, Dr. Collen listed some 150 publications in his scientific output and had held appointments at multiple first-class universities, including Johns Hopkins and Stanford. His work ,,Hospital Information Systems" and ,,Multiphasic Health Testing Services", both became classics. The Morris F. Collen Award is given each year, when appropriate, to pioneers in the field of medical informatics who best exemplify the teaching and practice of Morrie Collen.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">footnote</infon>
      <offset>3133</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>3170</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Masic;given-names:I</infon>
      <infon key="fpage">236</infon>
      <infon key="year">2014</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">237</infon>
      <offset>3181</offset>
      <text>Contributions to the History of Medical Informatics</text>
    </passage>
    <passage>
      <infon key="volume">52</infon>
      <infon key="name_2">surname:Morris;given-names:F</infon>
      <infon key="name_1">surname:Ball;given-names:MJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Lindberg;given-names:DA</infon>
      <infon key="fpage">371</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">24114266</infon>
      <infon key="year">2013</infon>
      <infon key="source">Methods Inf Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">373</infon>
      <offset>3233</offset>
      <text>Collen at 100: A Trib ute to "The Father of Medical Informatics"</text>
      <annotation id="5">
        <infon key="identifier">26150</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">9230</infon>
        <location offset="3250" length="4"/>
        <text>Trib</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_2">surname:Masic;given-names:I</infon>
      <infon key="name_1">surname:Lindberg;given-names:D</infon>
      <infon key="name_0">surname:Ball;given-names:M</infon>
      <infon key="fpage">4</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">24648612</infon>
      <infon key="year">2014</infon>
      <infon key="source">Acta Inform Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">22</infon>
      <infon key="section_type">REF</infon>
      <infon key="comment">doi: 10.5455/aim.2014.22.4-5</infon>
      <infon key="lpage">5</infon>
      <offset>3303</offset>
      <text>Special Tribute on Morris F. Collen: Charismatic Leader of Medical Informatics</text>
    </passage>
  </document>
  <document>
    <id>4272842</id>
    <passage>
      <infon key="name_3">surname:Cai;given-names:Liuhong</infon>
      <infon key="name_2">surname:Xing;given-names:Weijie</infon>
      <infon key="name_1">surname:Tao;given-names:Xin</infon>
      <infon key="article-id_pmid">25568631</infon>
      <infon key="name_0">surname:Zhang;given-names:Erhong</infon>
      <infon key="fpage">321</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272842</infon>
      <infon key="article-id_publisher-id">MSM-26-321</infon>
      <infon key="article-id_doi">10.5455/msm.2014.26.321-323</infon>
      <infon key="type">front</infon>
      <infon key="volume">26</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Mater Sociomed; 2014 Oct; 26(5) 321-3. doi:10.5455/msm.2014.26.321-323</infon>
      <infon key="kwd">Intrauterine insemination Male factor infertility Semen analysis</infon>
      <infon key="lpage">323</infon>
      <infon key="name_4">surname:Zhang;given-names:Bin</infon>
      <infon key="authors">Zhang E, Tao X, Xing W, Cai L, Zhang B</infon>
      <offset>0</offset>
      <text>Effect of Sperm Count on Success of Intrauterine Insemination in Couples Diagnosed with Male Factor Infertility</text>
      <annotation id="1">
        <infon key="identifier">MESH:D007248</infon>
        <infon key="type">Disease</infon>
        <location offset="88" length="23"/>
        <text>Male Factor Infertility</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>112</offset>
      <text>Objective:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>123</offset>
      <text>To exam semen parameters in predicting intrauterine insemination (IUI) outcomes in couples with male factor.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>232</offset>
      <text>Study design:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>246</offset>
      <text>This retrospective study was performed at department of infertility and sexual medicine from September 2007 to February 2014. 307 couples with male factor infertility were included and 672 IUI cycles were analyzed.</text>
      <annotation id="4">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="302" length="11"/>
        <text>infertility</text>
      </annotation>
      <annotation id="5">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="401" length="11"/>
        <text>infertility</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>461</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>470</offset>
      <text>From 672 inseminations performed on 307 couples, there are 27.36% couples get pregnancy (84 out of 307) and the overall pregnancy rate was 12.95% (87 out of 672) of IUI. With the increase of post total progressive sperm count, the clinical pregnancy rate increased. When the initial progressive sperm count was lower than 5*106, there was no pregnant in the IUI cycle. At the end of the third cycle, 85 clinical pregnancies had been achieved (97.70%).</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>922</offset>
      <text>Conclusions:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>935</offset>
      <text>The initial total progressive sperm count lower than 5*106 means the poor outcome of IUI in the infertile couples with male factor. If the infertile couples with male factor don't get pregnancy after three IUI cycles, the couples should receive re-assessment or other artificial reproductive technology.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1241</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1257</offset>
      <text>Intrauterine insemination (IUI) is a widely used fertility treatment for couples with infertility and is a simple, non-invasive, and a cost-effective technique. IUI is often suggested to infertile couples in which the woman has at least one permeable fallopian tube. This method is indicated in cases of cervical infertility, male factor infertility, anovulation, endometriosis, and unexplained infertility.</text>
      <annotation id="12">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1475" length="5"/>
        <text>woman</text>
      </annotation>
      <annotation id="13">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="1561" length="20"/>
        <text>cervical infertility</text>
      </annotation>
      <annotation id="14">
        <infon key="identifier">MESH:D004715</infon>
        <infon key="type">Disease</infon>
        <location offset="1621" length="13"/>
        <text>endometriosis</text>
      </annotation>
      <annotation id="15">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="1640" length="23"/>
        <text>unexplained infertility</text>
      </annotation>
      <annotation id="16">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="1343" length="11"/>
        <text>infertility</text>
      </annotation>
      <annotation id="17">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="1595" length="11"/>
        <text>infertility</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1665</offset>
      <text>There are certain variables that are currently known to be predictive of IUI success, most of which relate to the female partner including follicle number, endometrial thickness, duration of infertility, and sperm motility. Pregnancy rate after IUI differ between studies according to patient selection criteria, the presence of various infertility factors, ovarian stimulation methods, number of cycles performed, different sperm parameters and preparation technique.</text>
      <annotation id="21">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1950" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="22">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="1856" length="11"/>
        <text>infertility</text>
      </annotation>
      <annotation id="23">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="2002" length="19"/>
        <text>infertility factors</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2134</offset>
      <text>Semen analysis is the first step to accurately diagnose male infertility. Sperm count, sperm motility and the percentage of sperm with normal morphology are the main criteria for the quality of semen and number of motile sperm and normal morphology have been shown to correlate with IUI outcome. Others found that male factors were not found to correlate with the treatment outcome. The aim of this retrospective study is to exam the use of semen parameters in predicting IUI outcomes in couples diagnosed with male factor infertility.</text>
      <annotation id="26">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="2657" length="11"/>
        <text>infertility</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">MESH:D007248</infon>
        <infon key="type">Disease</infon>
        <location offset="2190" length="16"/>
        <text>male infertility</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>2670</offset>
      <text>2. MATERIAL AND METHODS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>2694</offset>
      <text>In this retrospective cohort study, all couples undergoing intrauterine insemination at department of infertility and sexual medicine from September 2007 to February 2014 were retrospectively enrolled into our database for evaluation of a diagnosis of male factor infertility. Before each course of treatment, infertile couples underwent the following tests: hysterosalpingography, hormone concentrations, semen analysis and postcoital test. Male factor infertility was diagnosed if the male had at least two pre-treatment semen analyses which were abnormal. In this analysis 672 IUI were performed in couples which fit the criteria listed above for male factor infertility. Clinical features of couples, pre and post processing semen analysis parameters at the time of IUI were included in the analyses.</text>
      <annotation id="32">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="3148" length="11"/>
        <text>infertility</text>
      </annotation>
      <annotation id="33">
        <infon key="identifier">MESH:D007248</infon>
        <infon key="type">Disease</infon>
        <location offset="2946" length="23"/>
        <text>male factor infertility</text>
      </annotation>
      <annotation id="34">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="3356" length="11"/>
        <text>infertility</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="2796" length="11"/>
        <text>infertility</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>3499</offset>
      <text>Patients who underwent natural cycles have regular menstrual cycle and ovulation. Clomiphene citrate (50 or 100 mg daily) and letrozole (2.5 mg or 5 mg daily) were administered orally for 5 days stating on cycle day 3 to 5. Gonadotropin injections were performed daily starting on cycle day 3 to 5 and titrated to develop 2 to 3 mature follicles. When the lead follicle reached at least 16 mm (usually 18 mm) in diameter 10000IU of human chorionic gonadotropin (hCG, livzon pharmaceutical Co.Ltd, China) subcutaneously to induce ovulation. Washed sperm was inseminated 24-36 hours after hCG injection according the LH level on HCG day. All patients were monitored with either ultrasound or both serum LH, estradiol and progesterone levels.</text>
      <annotation id="47">
        <infon key="identifier">93659</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37338</infon>
        <location offset="4086" length="3"/>
        <text>hCG</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">93659</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37338</infon>
        <location offset="4126" length="3"/>
        <text>HCG</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">93659</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37338</infon>
        <location offset="3961" length="3"/>
        <text>hCG</text>
      </annotation>
      <annotation id="50">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3499" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="51">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3931" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="52">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4139" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">MESH:D011374</infon>
        <infon key="type">Chemical</infon>
        <location offset="4218" length="12"/>
        <text>progesterone</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">MESH:D002996</infon>
        <infon key="type">Chemical</infon>
        <location offset="3581" length="18"/>
        <text>Clomiphene citrate</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">MESH:D000077289</infon>
        <infon key="type">Chemical</infon>
        <location offset="3625" length="9"/>
        <text>letrozole</text>
      </annotation>
      <annotation id="56">
        <infon key="identifier">MESH:D004958</infon>
        <infon key="type">Chemical</infon>
        <location offset="4204" length="9"/>
        <text>estradiol</text>
      </annotation>
      <annotation id="57">
        <infon key="identifier">MESH:D007986</infon>
        <infon key="type">Chemical</infon>
        <location offset="4200" length="2"/>
        <text>LH</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4239</offset>
      <text>For the purpose of semen collection, individuals were asked to refrain from ejaculating for two to four days prior to collection of the specimen. Specimens were produced with masturbation in a collection room adjacent to the laboratory. Freshly ejaculated sperm was allowed to liquefy before initial semen analysis. Liquefied semen was thoroughly mixed before an aliquot was placed on a standard count slide for the pre-processing analysis. The samples were assessed by CASA system (Sperm Class Analyzer, V4.0.0, Spain) and at least four random fields were evaluated for each analysis.</text>
      <annotation id="59">
        <infon key="identifier">1446</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48054</infon>
        <location offset="4709" length="4"/>
        <text>CASA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4825</offset>
      <text>After place semen sample in a discontinuous density (40%-80%) gradient column (SpermGrad TM, SpermRinse, Vitrolife Sweden AB, Sweden), the gradient was centrifuged for 20 min at 400g and subsequently, the 40% layer and the seminal plasma fraction were removed from the test tube, leaving the 80% layer undisturbed. Approximately 6-8 ml of sperm-washing medium was added to the 80% layer and centrifuged for 5 min at 400g. The sperm pellet was then reconstituted to approximately 0.5 ml. The analysis of an aliquot of the processed sample was performed as previously. The insemination was performed in a sterile fashion, using a flexible plastic catheter with the patient in the dorsal lithotomy position. The patient did not assume a prone position for at least thirty minutes after the end of the insemination.</text>
      <annotation id="62">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5488" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="63">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5534" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5639</offset>
      <text>Serum beta-human chorionic gonadotropin (beta-hCG) levels were analyzed 14 to 17 days after IUI to determine pregnancy status. A level greater than 5 mIU/ml was considered positive for pregnancy including biochemical pregnancy and clinical pregnancy. Clinical pregnancies were defined as those with a gestational sac on ultrasound. In this article, we use clinical pregnancy rate to analyze.</text>
      <annotation id="66">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5650" length="5"/>
        <text>human</text>
      </annotation>
      <annotation id="67">
        <infon key="identifier">93659</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37338</infon>
        <location offset="5685" length="3"/>
        <text>hCG</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6031</offset>
      <text>Statistical methods</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6051</offset>
      <text>All statistical analyses were done using the statistical package for social sciences 13.0 (SPSS, Inc, Chicago, IL). Results are reported as mean value+-standard deviation (SD). Statistical significance was accepted as a two-sided P&lt;0.05.</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>6289</offset>
      <text>3. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6300</offset>
      <text>From 672 IUI cycles performed on 307 couples, there are 27.36% couples get pregnancy (84 out of 307) and the overall pregnancy rate was 12.95% (87 out of 672) of inseminations. At the primary infertile group pregnancy rate was found as 14.29% (68 out of 475). In a group of patients with secondary infertility pregnancy rate was observed as 9.69% (19 out of 197). There were more dominant preovulatory follicles (&gt;= 16mm) in pregnant group than that in not pregnant groups (1.72+-0.89 vs 1.50+-0.77, P&lt;0.05). The mean age of couple, duration of infertility were compared between two groups. When comparing the semen analysis parameters between the two outcome groups, we found that the initial motile and progressive sperm count and post motile and progressive sperm count was higher in the pregnant and not pregnant groups, whereas the post motile sperm count has no significant difference between two groups (Table 1).</text>
      <annotation id="71">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6574" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="72">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="6598" length="11"/>
        <text>infertility</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="6845" length="11"/>
        <text>infertility</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>7222</offset>
      <text>Comparison of the baseline characteristics and sperm parameters of subjects</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7298</offset>
      <text>Table 2 shows that with the increase of post total progressive sperm count, the clinical pregnancy rate increased. There was no pregnant in the cycles which the pre total progressive sperm count lower than 5*106. The clinical pregnancy rate per cycle was 12.95%. At the end of the third cycle, 85 clinical pregnancies had been achieved (97.70%). There was no clinical pregnancies occurred in these cases after five attempts (Table 3).</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>7733</offset>
      <text>Initial and post total progressive sperm count with pregnancy rate</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T3.xml</infon>
      <infon key="id">T3</infon>
      <infon key="type">table_caption</infon>
      <offset>7800</offset>
      <text>Pregnancy rate in different number of IUI cycles</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>7849</offset>
      <text>4. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>7863</offset>
      <text>Intrauterine insemination using the husband's sperm is commonly performed to overcome male factor problems, as well as to enhance the probability of conception in various other infertility conditions. The pregnancy rate depends on sperm parameters, female factors, and the number of dominant preovulatory follicles. In Stephanie M. Luco's study, the total pregnancy rate observed is 5.3% in 356 IUI cycles. In Ahmed Badawy's study, Seventy-nine clinical pregnancies followed 714 IUI cycles, for a clinical pregnancy rate per cycle of 11.06% and a clinical pregnancy rate per couple of 20.1%. The total clinical pregnancy rate observed in this study, 12.95% per cycle, is considerably higher than Stephanie M. Luco's study and is comparable with Ahmed Badawy's study.</text>
      <annotation id="75">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="8040" length="22"/>
        <text>infertility conditions</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>8630</offset>
      <text>Miller et al. reported a pregnancy rate per cycle of 12.4% when the total number of collected motile spermatozoa (TMS) is over 20 million, compared with 7.4% when it is between 10 and 20 million. For a value under 10 million, he suggests steering the couple towards IVF. In the same sense, Dickey et al. and Van Voorhis et al. reported the best pregnancy rates when more than 10 million motile spermatozoa were selected. It has been suggested that the number of motile spermatozoa inseminated is a potential predictive factor. In our study, when comparing the semen analysis parameters between the two outcome groups, we found that the initial and post progressive sperm count and the initial motile sperm count was higher in the pregnant group than not pregnant group. These results mean that the semen parameters were related to the outcome of IUI in the current study. In this study, when initial total progressive sperm count was &gt;=5x106, the pregnancy rate was higher than in the group with initial total progressive sperm count &lt;5x106 and the pregnancy rate was compared among the groups with initial total progressive sperm count 5-9.9x106, 10-19.9x106 and &gt;=20x106 (12.73%, 11.11%, and 13.68%, respectively (Table 2). There was no pregnant in the cycles which the initial total progressive sperm count was lower than 5*106, so we should told these infertile couples the poor outcome of IUI and suggested them receive in vitro fertilization (IVF).</text>
      <annotation id="81">
        <infon key="identifier">MESH:C537182</infon>
        <infon key="type">Disease</infon>
        <location offset="8896" length="3"/>
        <text>IVF</text>
      </annotation>
      <annotation id="82">
        <infon key="type">Disease</infon>
        <location offset="8744" length="3"/>
        <text>TMS</text>
      </annotation>
      <annotation id="83">
        <infon key="identifier">MESH:D000072660</infon>
        <infon key="type">Disease</infon>
        <location offset="9017" length="18"/>
        <text>motile spermatozoa</text>
      </annotation>
      <annotation id="84">
        <infon key="identifier">MESH:D000072660</infon>
        <infon key="type">Disease</infon>
        <location offset="9092" length="18"/>
        <text>motile spermatozoa</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">MESH:D000072660</infon>
        <infon key="type">Disease</infon>
        <location offset="8724" length="18"/>
        <text>motile spermatozoa</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10096</offset>
      <text>The findings in Stephanie Marticle indicated that post processing semen analysis parameters are not more predictive of pregnancy than are preprocessing semen analysis results in couples with male factor infertility. Tan et al. found that post washed total progressively motile sperm count (TPMSC) is an independent predictor of pregnancy test result and TPMSC of half million or greater is adequate to achieve statistically similar pregnancy test results after non-donor IUI cycles. The predicted odd of positive pregnancy result is statistically significantly higher when TPMSC is &gt;0.51 million compared to the TPMSC of &lt;0.51 million (OR = 1.68, 95 % CI: 1.04-2.71). Ok EK found that an average TPMSC of 10x106 may be a useful threshold value for IUI success. In this study, there was no pregnancy occurred when TPMSC was &lt;4 million (0/20). Our results also showed that with the increase of post total progressive sperm count, the clinical pregnancy rate increased, similar with the results of those articles (Table 2).</text>
      <annotation id="88">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10561" length="5"/>
        <text>donor</text>
      </annotation>
      <annotation id="89">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="10299" length="11"/>
        <text>infertility</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11118</offset>
      <text>In the present study, 85 clinical pregnancies had been achieved (97.70%) at the end of the third cycle (Table 3). Plosker and Amato advised infertile couples to received IVF after three unsuccessful IUI. Nuoja-Huttunen et al noted that the highest pregnancy rate in 811 cycles (18%) was seen during the first cycle and that 97% of all pregnancies result from the first four cycles. In cases of unexplained infertility, Aboulghar et al found a cumulative pregnancy rate of 39.2% after three cycles and 48.5% after six cycles in a study of 1112 IUI cycles (16.4% per cycle). At present, it is generally admitted that IUI should be limited to four or six cycles and that IVF should be performed. Our results supported the opinion that three inseminations prior to IVF treatments have been usually performed in couples where the cause of infertility was unexplained, due to unilateral tubal factor, mild endometriosis or mild male factor infertility.</text>
      <annotation id="97">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="12052" length="11"/>
        <text>infertility</text>
      </annotation>
      <annotation id="98">
        <infon key="identifier">MESH:C537182</infon>
        <infon key="type">Disease</infon>
        <location offset="11288" length="3"/>
        <text>IVF</text>
      </annotation>
      <annotation id="99">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="11952" length="11"/>
        <text>infertility</text>
      </annotation>
      <annotation id="100">
        <infon key="identifier">MESH:C537182</infon>
        <infon key="type">Disease</infon>
        <location offset="11786" length="3"/>
        <text>IVF</text>
      </annotation>
      <annotation id="101">
        <infon key="identifier">MESH:D004715</infon>
        <infon key="type">Disease</infon>
        <location offset="12018" length="13"/>
        <text>endometriosis</text>
      </annotation>
      <annotation id="102">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="11512" length="23"/>
        <text>unexplained infertility</text>
      </annotation>
      <annotation id="103">
        <infon key="identifier">MESH:C537182</infon>
        <infon key="type">Disease</infon>
        <location offset="11879" length="3"/>
        <text>IVF</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>12065</offset>
      <text>5. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>12079</offset>
      <text>IUI is a powerful method to deal with infertile couple with male factors. The initial total progressive sperm count lower than 5*106 means the poor outcome of IUI in the infertile couples with male factor. If the couples with male factor infertility don't get pregnancy after three IUI cycles, the couple should receive re-assessment or other artificial reproductive technology.</text>
      <annotation id="105">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="12317" length="11"/>
        <text>infertility</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>12460</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>12497</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="name_2">surname:Al-Inany;given-names:H</infon>
      <infon key="name_1">surname:Cohlen;given-names:BJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Cantineau;given-names:AE</infon>
      <infon key="fpage">CD001502</infon>
      <infon key="pub-id_pmid">15266448</infon>
      <infon key="year">2004</infon>
      <infon key="source">Cochrane Database Syst Rev</infon>
      <infon key="type">ref</infon>
      <offset>12508</offset>
      <text>Intrauterine insemination versus fallopian tube sperm perfusion for non tubal infertility</text>
      <annotation id="108">
        <infon key="identifier">MESH:D005184</infon>
        <infon key="type">Disease</infon>
        <location offset="12508" length="47"/>
        <text>Intrauterine insemination versus fallopian tube</text>
      </annotation>
      <annotation id="109">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="12580" length="17"/>
        <text>tubal infertility</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Kasraie;given-names:JL</infon>
      <infon key="name_2">surname:Thompson;given-names:KA</infon>
      <infon key="name_1">surname:Amissah-Arthur;given-names:JB</infon>
      <infon key="name_0">surname:Tomlison;given-names:MJ</infon>
      <infon key="fpage">1892</infon>
      <infon key="issue">9</infon>
      <infon key="pub-id_pmid">8921060</infon>
      <infon key="year">1996</infon>
      <infon key="source">Hum Reprod</infon>
      <infon key="type">ref</infon>
      <infon key="volume">11</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1896</infon>
      <infon key="name_4">surname:Bentick;given-names:B</infon>
      <offset>12598</offset>
      <text>Prognostic indicators for intrauterine insemination (IUI): statistical model for IUI success</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Hassiakos;given-names:D</infon>
      <infon key="name_2">surname:Makrakis;given-names:E</infon>
      <infon key="name_1">surname:Pantos;given-names:K</infon>
      <infon key="name_0">surname:Grigoriou;given-names:O</infon>
      <infon key="fpage">773</infon>
      <infon key="pub-id_pmid">15749516</infon>
      <infon key="year">2005</infon>
      <infon key="source">Fertil Steril</infon>
      <infon key="type">ref</infon>
      <infon key="volume">83</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">775</infon>
      <infon key="name_5">surname:Creatsas;given-names:G</infon>
      <infon key="name_4">surname:Konidaris;given-names:S</infon>
      <offset>12691</offset>
      <text>Impact of isolated teratozoospermia on the outcome of intrauterine insemination</text>
      <annotation id="111">
        <infon key="identifier">MESH:D000072660</infon>
        <infon key="type">Disease</infon>
        <location offset="12710" length="16"/>
        <text>teratozoospermia</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">91</infon>
      <infon key="name_2">surname:Eltotongy;given-names:M</infon>
      <infon key="name_1">surname:Elnashar;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Badawy;given-names:A</infon>
      <infon key="fpage">777</infon>
      <infon key="pub-id_pmid">18304534</infon>
      <infon key="year">2009</infon>
      <infon key="source">Fertil Steril</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">781</infon>
      <offset>12771</offset>
      <text>Effect of sperm morphology and number on success of intrauterine insemination</text>
    </passage>
    <passage>
      <infon key="volume">93</infon>
      <infon key="name_2">surname:Grenier;given-names:N</infon>
      <infon key="name_1">surname:Heraud;given-names:MH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Merviel;given-names:P</infon>
      <infon key="fpage">79</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">18996517</infon>
      <infon key="year">2010</infon>
      <infon key="source">Fertil Steril</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">88</infon>
      <offset>12849</offset>
      <text>Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1038 cycles and a review of the literature</text>
    </passage>
    <passage>
      <infon key="volume">45</infon>
      <infon key="name_1">surname:Amiri;given-names:I</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Farimani;given-names:M</infon>
      <infon key="fpage">101</infon>
      <infon key="issue">2</infon>
      <infon key="year">2012</infon>
      <infon key="source">Acta Med Iran</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">106</infon>
      <offset>12979</offset>
      <text>Analysis of prognostic factors for successful outcome in patients undergoing intrauterine insemination</text>
      <annotation id="113">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13036" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">19</infon>
      <infon key="name_2">surname:Dorion;given-names:A</infon>
      <infon key="name_1">surname:Albert;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Wainer;given-names:R</infon>
      <infon key="fpage">2060</infon>
      <infon key="pub-id_pmid">15243004</infon>
      <infon key="year">2004</infon>
      <infon key="source">Hum Reprod</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2065</infon>
      <offset>13082</offset>
      <text>Influence of the number of motile spermatozoa inseminated and of their morphology on the success of intrauterine insemination</text>
      <annotation id="115">
        <infon key="identifier">MESH:D000072660</infon>
        <infon key="type">Disease</infon>
        <location offset="13109" length="18"/>
        <text>motile spermatozoa</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Barry;given-names:Behr</infon>
      <infon key="volume">179</infon>
      <infon key="name_2">surname:Chioma;given-names:Agbo</infon>
      <infon key="name_1">surname:Luco</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Stephanie;given-names:M</infon>
      <infon key="fpage">159</infon>
      <infon key="pub-id_pmid">24965998</infon>
      <infon key="year">2014</infon>
      <infon key="source">European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">162</infon>
      <offset>13208</offset>
      <text>The evaluation of pre and post processing semen analysis parameters at the time of intrauterine insemination in couples diagnosed with male factor infertility and pregnancy rates based on stimulation agent. A retrospective cohort study</text>
      <annotation id="117">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="13355" length="11"/>
        <text>infertility</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">60</infon>
      <infon key="name_2">surname:Randolph;given-names:JF</infon>
      <infon key="name_1">surname:Smith;given-names:GD</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Miller;given-names:DC</infon>
      <infon key="fpage">497</infon>
      <infon key="pub-id_pmid">12350496</infon>
      <infon key="year">2002</infon>
      <infon key="source">Urology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">501</infon>
      <offset>13444</offset>
      <text>Processed total motile sperm count correlates with pregnancy outcome afterintra-uterine insemination</text>
    </passage>
    <passage>
      <infon key="volume">71</infon>
      <infon key="name_2">surname:Taylor;given-names:SN</infon>
      <infon key="name_1">surname:Lu;given-names:PY</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Dickey;given-names:RP</infon>
      <infon key="fpage">684</infon>
      <infon key="pub-id_pmid">10202879</infon>
      <infon key="year">1999</infon>
      <infon key="source">Fertil Steril</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">689</infon>
      <offset>13545</offset>
      <text>Comparison of the sperm qualitynecessary for successful intra-uterine insemination with World HealthOrganization threshold values for normal sperm</text>
    </passage>
    <passage>
      <infon key="volume">75</infon>
      <infon key="name_2">surname:Sparks;given-names:AE</infon>
      <infon key="name_1">surname:Barnett;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Van Voorhis;given-names:BJ</infon>
      <infon key="fpage">661</infon>
      <infon key="pub-id_pmid">11287015</infon>
      <infon key="year">2001</infon>
      <infon key="source">Fertil Steril</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">668</infon>
      <offset>13692</offset>
      <text>Effect of the total motile sperm count on the efficacy and cost-effectiveness of intrauterine insemination and in vitro fertilization</text>
      <annotation id="119">
        <infon key="identifier">MESH:D005317</infon>
        <infon key="type">Disease</infon>
        <location offset="13751" length="47"/>
        <text>cost-effectiveness of intrauterine insemination</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">31</infon>
      <infon key="name_2">surname:Carr;given-names:BR</infon>
      <infon key="name_1">surname:Ha;given-names:T</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Tan;given-names:O</infon>
      <infon key="fpage">1147</infon>
      <infon key="issue">9</infon>
      <infon key="pub-id_pmid">25106939</infon>
      <infon key="year">2014</infon>
      <infon key="source">J Assist Reprod Genet</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1153</infon>
      <offset>13826</offset>
      <text>Predictive value of postwashed total progressively motile sperm count using CASA estimates in 6871 non-donor intrauterine insemination cycles</text>
      <annotation id="122">
        <infon key="identifier">1446</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48054</infon>
        <location offset="13902" length="4"/>
        <text>CASA</text>
      </annotation>
      <annotation id="123">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13929" length="5"/>
        <text>donor</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">14</infon>
      <infon key="name_2">surname:Okyay;given-names:RE</infon>
      <infon key="name_1">surname:Dogan;given-names:OE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Ok;given-names:EK</infon>
      <infon key="fpage">142</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">24592093</infon>
      <infon key="year">2013</infon>
      <infon key="source">J Turk Ger Gynecol Assoc</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">145</infon>
      <offset>13968</offset>
      <text>The effect of post-wash total progressive motile sperm count and semen volume on pregnancy outcomes in intrauterine insemination cycles: a retrospective study</text>
    </passage>
    <passage>
      <infon key="volume">9</infon>
      <infon key="name_1">surname:Amato;given-names:P</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Plosker;given-names:S</infon>
      <infon key="fpage">2014</infon>
      <infon key="pub-id_pmid">7868666</infon>
      <infon key="year">1994</infon>
      <infon key="source">Hum Reprod</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">2021</infon>
      <offset>14127</offset>
      <text>Predicting and optimizing success in an intra-uterine stimulation program</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Tuomivaara;given-names:L</infon>
      <infon key="name_2">surname:Bloigu;given-names:R</infon>
      <infon key="name_1">surname:Tomas;given-names:C</infon>
      <infon key="name_0">surname:Nuojua-Huttunen;given-names:S</infon>
      <infon key="fpage">698</infon>
      <infon key="pub-id_pmid">10221698</infon>
      <infon key="year">1999</infon>
      <infon key="source">Hum Reprod</infon>
      <infon key="type">ref</infon>
      <infon key="volume">14</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">703</infon>
      <infon key="name_4">surname:Martikainen;given-names:H</infon>
      <offset>14201</offset>
      <text>Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome</text>
    </passage>
    <passage>
      <infon key="volume">75</infon>
      <infon key="name_2">surname:Serour;given-names:G</infon>
      <infon key="name_1">surname:Mansour;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Aboulghar;given-names:M</infon>
      <infon key="fpage">88</infon>
      <infon key="pub-id_pmid">11163821</infon>
      <infon key="year">2001</infon>
      <infon key="source">Fertil Steril</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">91</infon>
      <offset>14295</offset>
      <text>Controlled ovarian hyperstimulation and intrauterine insemination for treatment of unexplained infertility should be limited to a maximum of three trials</text>
      <annotation id="125">
        <infon key="identifier">MESH:D007247</infon>
        <infon key="type">Disease</infon>
        <location offset="14378" length="23"/>
        <text>unexplained infertility</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">15</infon>
      <infon key="section_type">REF</infon>
      <infon key="fpage">265</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">19240042</infon>
      <infon key="year">2009</infon>
      <infon key="source">Hum Reprod Update</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">277</infon>
      <offset>14449</offset>
      <text>The ESHRE Capri Workshop Group. Intrauterine insemination</text>
    </passage>
  </document>
  <document>
    <id>4272843</id>
    <passage>
      <infon key="name_1">surname:Karami;given-names:Mahtab</infon>
      <infon key="article-id_pmid">25568582</infon>
      <infon key="name_0">surname:Barzekar;given-names:Hosein</infon>
      <infon key="fpage">325</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272843</infon>
      <infon key="article-id_publisher-id">AIM-22-325</infon>
      <infon key="article-id_doi">10.5455/aim.2014.22.325-328</infon>
      <infon key="type">front</infon>
      <infon key="volume">22</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Acta Inform Med; 2014 Oct; 22(5) 325-8. doi:10.5455/aim.2014.22.325-328</infon>
      <infon key="kwd">Organizational factors Information technology Managers Implementation</infon>
      <infon key="lpage">328</infon>
      <infon key="authors">Barzekar H, Karami M</infon>
      <offset>0</offset>
      <text>Organizational Factors that Affect the Implementation of Information Technology: Perspectives of Middle Managers in Iran</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>121</offset>
      <text>ABSTRACT</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>130</offset>
      <text>Objective:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>141</offset>
      <text>to examine the organizational factors affecting the application of information technology in hospitals. Since the organizational factors are one of the most important determinants of successful projects, by understanding their impact and identifying them it can help planning a systematic IT implementation.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>449</offset>
      <text>Methods:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>458</offset>
      <text>In this cross-sectional descriptive study 110 middle managers were chosen from teaching hospitals. Structured questionnaire was used for the data collection.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>616</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>625</offset>
      <text>There was a significant relationship between organization resource, organizational knowledge, process, management structure and values and goals with implementation of information technology.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>817</offset>
      <text>Conclusion:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>829</offset>
      <text>Findings showed that organizational factors had a considerable impact on implementation of information technology. Top managers must consider the important aspects of effective organizational factors.</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1030</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1046</offset>
      <text>Nowadays, organizations perform in an environment which the economy, politics and society constantly change. With such aggressive perspective, organizations should be adaptable in order to maintain the competitive market conditions, increase productivity and re-configure due to changing workforce, the global business environment and e-commerce development. Studies indicate that one of the most important reasons that differentiated organizations from each other is the degree of information technology application in their organizational activities. Accordingly, the organizations that use widespread and optimized information technology have sustainable competitive advantages, and in the view of stakeholders are more distinguished than the other organizations. Based on a research conducted between 100 companies between 1980 and 1995 the average cost to implement the changes has been estimated to be a million dollars. Since after 1980, almost %50 of the investments within the organizations are spent on development and deployment of information technology. It is believed that IT can increase the capabilities of organizations. Furthermore, Health system is not excluded from these changes, and many countries utilize Information Technology in order to enhance the health level and to improve the outcomes. Research shows that application of information technology in different countries brings various benefits to the health systems such as improving service delivery, reduction of medical errors, it supports the healthcare personnel in inpatient and outpatient units, enhances the effectiveness of healthcare (by reduction of waiting times for the patients and improving patient care).</text>
      <annotation id="3">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2609" length="10"/>
        <text>outpatient</text>
      </annotation>
      <annotation id="4">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2707" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="5">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2730" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2745</offset>
      <text>Successful implementation and use of IT in health care systems and any other system is influenced by various factors like economic, political, social, cultural, etc. Identifying the factors resulting in increased use of information technology leads to enhanced accuracy and it accelerates the application of this technology. Attention to organizational factors is one factor in the application of information technology that plays an important role in health systems. Nowadays organizations live in an active and dynamic environment which is influenced by internal and external factors of the organization. Some external factors affecting the performance of organizations include economic, political, social, cultural, etc. Implementation of Information Technology in Health Care systems often requires changes in work duties and processes either simultaneously or before application of the new technology, However, studies show that almost %70 of IT implementation projects failed. Mostly, failure to utilize and incompatibility with the needs of IT users were the reasons that IT projects failed. The present study sought to examine the organizational factors affecting the application of information technology in hospitals. Since the organizational factors are one of the most important determinants of successful projects, by understanding their impact and identifying them it can help planning a systematic IT implementation.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>4177</offset>
      <text>2. METHODS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4188</offset>
      <text>This descriptive-analytic study is a cross-sectional kind and it is done in the second half of 2012. The study population included middle managers of the teaching hospitals of Tehran University of Medical Sciences (hospital administrator, nursing services director, staffing and recruiting office, finance, medical records, laboratory and pathology, radiology and pharmacy). Total statistical population was 110 middle managers that 89 people answered to the questionnaire. The data collection was done by a questionnaire that its validity was confirmed by the experts and its reliability was examined by Cronbach's alpha coefficient of 20 samples that were selected randomly from the population. The questionnaire included an introduction at the beginning in order to show the goals of the research. The first section of the questionnaire was about demographic information of the population like age, sex, name of hospital, length of occupation, educational degree and organizational position. The second part consists of nine questions related to computer use. In the third part there are questions related to organizational factors and is composed of 5 parts: the first section includes organizational resources. The second section is regarding the organizational knowledge. The third section is about organizational processes. The fourth one is about managerial structure and the last section is about values and goal of the organization. The scores given to the responses are according to a five-option Likert-type ranking number one as "totally disagree" to number five as "totally agree". Overall, the degree of importance for each item was made and calculated. In order to determine a relationship between each of the variables with information technology the test of Pearson's correlation coefficient, independent T and analysis of one-way Variance was used and then multiple regressions was used to study all factors' effect on information technology usage. Also the data were analyzed using SPSS 16 software. At the beginning of the research the ethical consideration authorization was obtained from the Deputy office of research in the university. Afterwards, the goal of the research was explained and people were assured that their information stays confidential and it is only for the sake of doing the research.</text>
      <annotation id="8">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4624" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="9">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6403" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>6526</offset>
      <text>3. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6537</offset>
      <text>From 110 questionnaires distributed, 89 questionnaires were returned that %37.1 was woman and %62.9 was men. The average age of the people participating in the study was 42+-15.6 years old. %56.2 of the participants had a bachelor's degree, %12.4 had master's degree, %6.7 had a PhD and %24.7 was physicians. The average length of their occupation was 15+-5.91 and more than %83 of them had more than 5 years working record. %82 of the participants used computer several times a day.</text>
      <annotation id="15">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6621" length="5"/>
        <text>woman</text>
      </annotation>
      <annotation id="16">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6641" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="17">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6669" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="18">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6740" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="19">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6973" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7021</offset>
      <text>As shown in Table 1 there is a meaningful difference regarding the sex of the participants in case of average usage of computer (t= -2.815, p&lt;0.05) average scores gained from the usage of computer by men (33.58) and women (37.45) indicates this difference. Nevertheless, Variance analysis test shows that between the age of the participants with usage of computer (F=0.718, and education with usage of computer (F=1.613, there is no meaningful difference.</text>
      <annotation id="24">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7099" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="25">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7221" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="26">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7237" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="27">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7349" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>7477</offset>
      <text>Middle managers use of computer according to age, sex and education</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7545</offset>
      <text>In table 2 the results of Pearson correlation test is provided about the relationship of resources of the organizations, organizational knowledge, processes, managerial structure, values and goals with use of computer. It can be seen that between each of these variables and use of computer there is a meaningful relationship: resources of the organizations (p&lt;0.01, r=0.297), organizational knowledge (p&lt;0.01, r=0.297), processes (p&lt;0.01, r=0.409), managerial structure (p&lt;0.01, r=0.789), values and goals (p&lt;0.05, r=0.246).</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>8071</offset>
      <text>Correlation coefficient of middle managers' attitude toward each of the variables</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8155</offset>
      <text>In table 3 Linear Regression was used for mass observation of the organizational factors about Information technology application. The results of the regression test showed a meaningful relationship between managerial structure and attitude (p&lt;0.001, beta= 0.760), resources of the organizations and attitude (p&lt;0.05, beta=0.153); in this regression model the affect of the variables decreased and the only variables remained are managerial structure and the resources of the organization.</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T3.xml</infon>
      <infon key="id">T3</infon>
      <infon key="type">table_caption</infon>
      <offset>8645</offset>
      <text>Linear Regression for mass observation of the organizational factors associated with Information technology application</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>8765</offset>
      <text>4. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>8779</offset>
      <text>Information Technology application in health systems is associated with a variety of factors. Identifying these factors will result in faster implementation of the technology since they play a significant role in information technology application in health systems. Some factors to name are economic, social and cultural factors. Our goal in this study is to find and review the organizational factors affecting the information technology implementation in the teaching hospitals of Tehran University of Medical Sciences.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9302</offset>
      <text>This research shows that there is a significant and meaningful relationship between the sexes of users and using computer systems; thus, female middle manager show more utilization of the computer systems than male managers and this finding is consistent with the finding of Al-Gahtani, 2004 and Meade, et al., 2009. In this research between the age and the education level of the participants with computer usage system did not show any meaningful relationship, while in the studies of Marchewka and Al-Gahtani it showed a significant relationship.</text>
      <annotation id="29">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9683" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9852</offset>
      <text>In a Level of %95 between organizational resources and IT implementation there is a significant relationship which showed a correlation intensity of r= 0.297. Regarding the relationship between these two variables it can be said that due to some facts like accessible financial and human resources, enough budget for the application of new technologies, strategic planning of the organizations' resources that can lead the managers to realize the mission and targets of the organizational resources, the attitude of the users might be influenced and it is concluded that the more available resources is provided for the users, the more tendency they show in application of Information technology.</text>
      <annotation id="31">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10134" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10551</offset>
      <text>The above theory is confirmed due to a significant relationship between the users' attitude toward IT application and organizational knowledge with a level of %99 and a correlation coefficient of (r= 0.297). Therefore, it can be inferred however the organizational knowledge is not in a technology oriented category, information technology application is a necessity for knowledge management projects to succeed. Hence some organizations seek knowledge management systems for executing their organizational knowledge management projects. In this way they might become confused because of lack of deep and correct understanding of capabilities and abilities of the organizations and susceptible areas for knowledge technology products. Considering the main three factors of knowledge management (individuals, contents, processes) an organization should identify the proper technology for itself. Accordingly, the tools for knowledge management should be determined based on the needs of the organization. Thus, it can be generally stated that when organizational knowledge in an organizations is used properly, people tend to use more of information technology because it facilitates the access and management of this knowledge. These findings are in agreement with previous researches like Armenakis&amp;Bernerth in 2007 and Bartunek&amp; Rousseau in 2006.</text>
      <annotation id="33">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11661" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11902</offset>
      <text>The relationship between processes and the attitude toward application of information technology is confirmed with a level of %99 and a correlation coefficient of (r= 0.409) that approves the above theory. Therefore, it can be concluded that in organizations in which processes are shorter and easier beside shorter organizational communication and fewer organizational levels, they show more flexibility in case of facing with environmental and technological changes. In other words, staff in organizations with horizontal structure can communicate with managers easier and they participate in decision makings more effectively. So, organizations with the least division of responsibilities and informal processes have an organic structure in which people tend to use information technology more. This finding is also in consistent with Armenakis Schraeder &amp; Tsiknakis &amp;Kouroubali, 2009 and Yu li H, P, 2009.</text>
      <annotation id="35">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12652" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12812</offset>
      <text>Between managerial structure and attitude toward using IT there is a correlation of (r=0.789) with a level of 99%. However management is similar to leadership, on the whole in any organization they have similar strategies and they can be different in some specifications. It is clear that although all managers cope with leading a small or large group for reaching determined goals, this trend can be performed through various methods which each of them counts as a specific kind of management style. Results indicate that the managerial structure and leadership method that top managers practice can greatly effective in the level of using IT as one of high technologies of nowadays. In turn, the results of this study is compatible with the previous studies of MarchewkaLiu 2007 and Jimmieson 2008.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13613</offset>
      <text>The relationship between values and goals and the attitude toward application of information technology is confirmed with a level of %95 and a correlation coefficient of (r= 0.246) in this regard, it can be stated that goals and strategies are as the main framework of planning. Any plan requires a goal which explains the philosophy of existence and it also elaborates the needs, the objectives and the final results in order to support the subordinate goals of the organization. In fact, the goals create a kind of network or a hierarchy system. In addition, just like the need to know the tradition for a better understanding of organizational behavior, noting the values would be another aspect that can affect people's behavior in the organizations. Values have great influence on career decision makings, directions, behaviors, relationships and the attitudes of the staffs. According to the findings in this research, when implementation and application of information technology becomes a priority in the organizations' goals, there should be a strategy and it also ought to be valued in order to be relatively effective in application of information technology. This is in accordance with Simpson &amp; Dansereau, 2007.</text>
      <annotation id="37">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14328" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>14840</offset>
      <text>Among the variables included in the equation, managerial structure (beta= 0.760) and then human resources (beta=0.153) have the strongest affect on information technology application, so it is concluded that senior managers should focus more attention to these variables since they are the main important variables.</text>
      <annotation id="39">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14930" length="5"/>
        <text>human</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>15156</offset>
      <text>5. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>15170</offset>
      <text>In order to improve the measures to successful implementation of information technology in health systems, identification of effective and various factors such as social factors, humanitarian factors, organizational culture, simplification of occupational relationships, enhancing the communication and reduction of bureaucracy, designing a strategic plan for implementation of information technology in the organization for its correct application is of a great importance.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>15645</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>15682</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="name_1">surname:van de Wijngaert;given-names:L</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bouwman;given-names:H</infon>
      <infon key="year">2005</infon>
      <infon key="type">ref</infon>
      <offset>15693</offset>
      <text>Information and communication technology in organizations: adoption, implementation, use and effects</text>
    </passage>
    <passage>
      <infon key="volume">78</infon>
      <infon key="name_1">surname:Kouroubali;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Tsiknakis;given-names:M</infon>
      <infon key="fpage">39</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">18723389</infon>
      <infon key="year">2009</infon>
      <infon key="source">International Journal of Medical Informatics</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">52</infon>
      <offset>15794</offset>
      <text>Organizational factors affecting successful adoption of innovative eHealth services: A case study employing the FITT framework</text>
      <annotation id="41">
        <infon key="identifier">MESH:C043685</infon>
        <infon key="type">Chemical</infon>
        <location offset="15906" length="4"/>
        <text>FITT</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Arlington;given-names:V</infon>
      <infon key="year">2008</infon>
      <infon key="source">The global information economy</infon>
      <infon key="type">ref</infon>
      <offset>15921</offset>
      <text>World Information Technology and Service Alliance</text>
    </passage>
    <passage>
      <infon key="volume">45</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Benamati;given-names:J</infon>
      <infon key="fpage">833</infon>
      <infon key="issue">4</infon>
      <infon key="year">2008</infon>
      <infon key="source">Decision Support Systems</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">844</infon>
      <offset>15971</offset>
      <text>Decision support systems unfrastructure: The root problems of the management of changing IT</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Maglione;given-names:M</infon>
      <infon key="name_2">surname:Wu;given-names:S</infon>
      <infon key="name_1">surname:Wang;given-names:J</infon>
      <infon key="name_0">surname:Chaudhry;given-names:B</infon>
      <infon key="fpage">742</infon>
      <infon key="issue">10</infon>
      <infon key="pub-id_pmid">16702590</infon>
      <infon key="year">2006</infon>
      <infon key="source">Annals of internal medicine</infon>
      <infon key="type">ref</infon>
      <infon key="volume">144</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_5">surname:Roth;given-names:E</infon>
      <infon key="name_4">surname:Mojica;given-names:W</infon>
      <offset>16063</offset>
      <text>Systematic review: impact of health information technology on quality, efficiency, and costs of medical care</text>
    </passage>
    <passage>
      <infon key="name_3">surname:George;given-names:B</infon>
      <infon key="name_2">surname:Placide;given-names:PN</infon>
      <infon key="name_1">surname:Claude;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Guy;given-names:P</infon>
      <infon key="fpage">6</infon>
      <infon key="source">Implementation Science</infon>
      <infon key="type">ref</infon>
      <offset>16172</offset>
      <text>Clinicians' perceptions of organizational readiness for change in the context of clinical information system projects: insights from two cross-sectional surveys</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Harris;given-names:S</infon>
      <infon key="volume">43</infon>
      <infon key="name_2">surname:Feild;given-names:H</infon>
      <infon key="name_1">surname:Armenakis;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Holt;given-names:D</infon>
      <infon key="fpage">232</infon>
      <infon key="issue">2</infon>
      <infon key="year">2007</infon>
      <infon key="source">The Journal of applied behavioral science</infon>
      <infon key="type">ref</infon>
      <offset>16335</offset>
      <text>Readiness for organizational change: The systematic development of a scale</text>
    </passage>
    <passage>
      <infon key="volume">78</infon>
      <infon key="name_2">surname:Speedie;given-names:SM</infon>
      <infon key="name_1">surname:Pannarunothai;given-names:S</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kijsanayotin;given-names:B</infon>
      <infon key="fpage">404</infon>
      <infon key="issue">6</infon>
      <infon key="pub-id_pmid">19196548</infon>
      <infon key="year">2009</infon>
      <infon key="source">International Journal of Medical Informatics</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">416</infon>
      <offset>16410</offset>
      <text>Factors influencing health information technology adoption in Thailand's community health centers: applying the UTAUT model</text>
    </passage>
    <passage>
      <infon key="volume">15</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Oreg;given-names:S</infon>
      <infon key="fpage">73</infon>
      <infon key="issue">1</infon>
      <infon key="year">2006</infon>
      <infon key="source">European Journal of Work and Organizational Psychology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">101</infon>
      <offset>16534</offset>
      <text>Personality, context, and resistance to organizational change</text>
    </passage>
    <passage>
      <infon key="volume">76</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Anderson;given-names:J</infon>
      <infon key="fpage">480</infon>
      <infon key="issue">5</infon>
      <infon key="pub-id_pmid">17064955</infon>
      <infon key="year">2007</infon>
      <infon key="source">International Journal of Medical Informatics</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">483</infon>
      <offset>16596</offset>
      <text>Social, ethical and legal barriers to e-health</text>
    </passage>
    <passage>
      <infon key="volume">7</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Al-Gahtani;given-names:S</infon>
      <infon key="fpage">5</infon>
      <infon key="issue">1</infon>
      <infon key="year">2004</infon>
      <infon key="source">Journal of Global Information Technology Management</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">29</infon>
      <offset>16643</offset>
      <text>Computer technology acceptance success factors in Saudi Arabia: an exploratory study</text>
    </passage>
    <passage>
      <infon key="volume">78</infon>
      <infon key="name_2">surname:Boland;given-names:M</infon>
      <infon key="name_1">surname:Buckley;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Meade;given-names:B</infon>
      <infon key="fpage">551</infon>
      <infon key="issue">8</infon>
      <infon key="pub-id_pmid">19375381</infon>
      <infon key="year">2009</infon>
      <infon key="source">International Journal of Medical Informatics</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">558</infon>
      <offset>16728</offset>
      <text>What factors affect the use of electronic patient records by Irish GPs?</text>
      <annotation id="43">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16770" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">8</infon>
      <infon key="name_2">surname:Morris;given-names:M</infon>
      <infon key="name_1">surname:Davis;given-names:F</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Venkatesh;given-names:V</infon>
      <infon key="fpage">267</infon>
      <infon key="issue">4</infon>
      <infon key="year">2007</infon>
      <infon key="source">Journal of the Association for Information Systems</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">286</infon>
      <offset>16800</offset>
      <text>Dead or alive? The development, trajectory and future of technology adoption research</text>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="name_1">surname:Grover;given-names:V</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kettinger;given-names:WJ</infon>
      <infon key="fpage">513</infon>
      <infon key="issue">3</infon>
      <infon key="year">1997</infon>
      <infon key="source">Decision Sciences</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">555</infon>
      <offset>16886</offset>
      <text>The Use of Computer mediated Communication in an Interorganizational Context</text>
    </passage>
    <passage>
      <infon key="volume">7</infon>
      <infon key="name_2">surname:Kostiwa;given-names:K</infon>
      <infon key="name_1">surname:Liu;given-names:C</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Marchewka;given-names:J</infon>
      <infon key="fpage">93</infon>
      <infon key="issue">2</infon>
      <infon key="year">2007</infon>
      <infon key="source">Communications of the IIMA</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">104</infon>
      <offset>16963</offset>
      <text>An Application of the UTAUT Model for Understanding Student Perceptions. Using Course Management Software</text>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="name_2">surname:Gurbaxani;given-names:V</infon>
      <infon key="name_1">surname:Kraemer;given-names:K</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Melville;given-names:N</infon>
      <infon key="fpage">283</infon>
      <infon key="issue">2</infon>
      <infon key="year">2004</infon>
      <infon key="source">Mis Quarterly</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">322</infon>
      <offset>17069</offset>
      <text>Review: Information technology and organizational performance: An integrative model of IT business value</text>
    </passage>
    <passage>
      <infon key="volume">31</infon>
      <infon key="name_1">surname:Salisbury;given-names:W</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bloodgood;given-names:JM</infon>
      <infon key="fpage">55</infon>
      <infon key="issue">1</infon>
      <infon key="year">2001</infon>
      <infon key="source">Decision Support Systems</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">69</infon>
      <offset>17174</offset>
      <text>Understanding the influence of organizational change strategies on information technology and knowledge management strategies</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Walker;given-names:H</infon>
      <infon key="volume">43</infon>
      <infon key="name_2">surname:Pitts;given-names:J</infon>
      <infon key="name_1">surname:Bernerth;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Armenakis;given-names:A</infon>
      <infon key="fpage">481</infon>
      <infon key="issue">4</infon>
      <infon key="year">2007</infon>
      <infon key="source">The Journal of Applied Behavioral Science</infon>
      <infon key="type">ref</infon>
      <offset>17300</offset>
      <text>Organizational Change Recipients' Beliefs Scale: Development of an Assessment Instrument</text>
    </passage>
    <passage>
      <infon key="name_3">surname:DePalma;given-names:J</infon>
      <infon key="volume">42</infon>
      <infon key="name_2">surname:Rudolph;given-names:J</infon>
      <infon key="name_1">surname:Rousseau;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bartunek;given-names:J</infon>
      <infon key="fpage">182</infon>
      <infon key="issue">2</infon>
      <infon key="year">2006</infon>
      <infon key="source">The Journal of applied behavioral science</infon>
      <infon key="type">ref</infon>
      <offset>17391</offset>
      <text>On the receiving end: Sensemaking, emotion, and assessments of an organizational change initiated by others</text>
    </passage>
    <passage>
      <infon key="volume">78</infon>
      <infon key="name_2">surname:Gagnon;given-names:M</infon>
      <infon key="name_1">surname:Li;given-names:H</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Yu;given-names:P</infon>
      <infon key="fpage">219</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">18768345</infon>
      <infon key="year">2009</infon>
      <infon key="source">International Journal of Medical Informatics</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">229</infon>
      <offset>17499</offset>
      <text>Health IT acceptance factors in long-term care facilities: A cross-sectional survey</text>
    </passage>
    <passage>
      <infon key="volume">117</infon>
      <infon key="name_2">surname:Hitt;given-names:LM</infon>
      <infon key="name_1">surname:Brynjolfsson;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bresnahan;given-names:TF</infon>
      <infon key="fpage">339</infon>
      <infon key="issue">1</infon>
      <infon key="year">2002</infon>
      <infon key="source">Quarterly Journal of Economics</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">376</infon>
      <offset>17583</offset>
      <text>Information Technology, Workplace Organization, and the Demand for Skilled Labor: Firm-Level Evidence</text>
    </passage>
    <passage>
      <infon key="volume">52</infon>
      <infon key="name_2">surname:Chowa;given-names:C</infon>
      <infon key="name_1">surname:Jeyaraj;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sabherwal;given-names:R</infon>
      <infon key="fpage">1849</infon>
      <infon key="issue">12</infon>
      <infon key="year">2006</infon>
      <infon key="source">Management science</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1864</infon>
      <offset>17685</offset>
      <text>Information system success: Individual and organizational determinants</text>
    </passage>
    <passage>
      <infon key="volume">44</infon>
      <infon key="name_2">surname:White;given-names:K</infon>
      <infon key="name_1">surname:Peach;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Jimmieson;given-names:N</infon>
      <infon key="fpage">237</infon>
      <infon key="issue">2</infon>
      <infon key="year">2008</infon>
      <infon key="source">The Journal of Applied Behavioral Science</infon>
      <infon key="type">ref</infon>
      <offset>17756</offset>
      <text>Utilizing the Theory of Planned Behavior to Inform Change Management: An Investigation of Employee Intentions to Support Organizational Change</text>
    </passage>
    <passage>
      <infon key="volume">31</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Henri;given-names:JF</infon>
      <infon key="fpage">77</infon>
      <infon key="issue">1</infon>
      <infon key="year">2006</infon>
      <infon key="source">Accounting, Organizations and Society</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">103</infon>
      <offset>17899</offset>
      <text>Organizational culture and performance measurement systems</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Shook;given-names:CL</infon>
      <infon key="volume">62</infon>
      <infon key="name_2">surname:Armenakis;given-names:AA</infon>
      <infon key="name_1">surname:Harris;given-names:SG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Gregory;given-names:BT</infon>
      <infon key="fpage">673</infon>
      <infon key="issue">7</infon>
      <infon key="year">2009</infon>
      <infon key="source">Journal of Business Research</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">679</infon>
      <offset>17958</offset>
      <text>Organizational culture and effectiveness: A study of values, attitudes, and organizational outcomes</text>
    </passage>
    <passage>
      <infon key="volume">3</infon>
      <infon key="name_1">surname:Dansereau;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Simpson;given-names:D</infon>
      <infon key="fpage">20</infon>
      <infon key="issue">2</infon>
      <infon key="year">2007</infon>
      <infon key="type">ref</infon>
      <offset>18058</offset>
      <text>Assessing organizational functioning as a step toward innovation</text>
    </passage>
  </document>
  <document>
    <id>4272844</id>
    <passage>
      <infon key="name_3">surname:Parikh;given-names:Kartik</infon>
      <infon key="name_2">surname:Singh;given-names:Varun Pratap</infon>
      <infon key="name_1">surname:Kulkarni;given-names:Narayan</infon>
      <infon key="article-id_pmid">25568586</infon>
      <infon key="name_0">surname:Patel;given-names:Kunal S.</infon>
      <infon key="fpage">347</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272844</infon>
      <infon key="article-id_publisher-id">AIM-55-347</infon>
      <infon key="article-id_doi">10.5455/aim.2014.22.347-349</infon>
      <infon key="type">front</infon>
      <infon key="volume">22</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Acta Inform Med; 2014 Oct; 22(5) 347-9. doi:10.5455/aim.2014.22.347-349</infon>
      <infon key="kwd">Apical base Cephalometrics Point A</infon>
      <infon key="lpage">349</infon>
      <infon key="authors">Patel KS, Kulkarni N, Singh VP, Parikh K</infon>
      <offset>0</offset>
      <text>Identification of an Alternate Maxillary Apical Base Landmark from Pre-existing Substitutions</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>94</offset>
      <text>ABSTRACT</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>103</offset>
      <text>Background:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>115</offset>
      <text>Cephalometrically the position of maxilla is usually assessed by point A, which is one of the most common cephalometric landmarks used for spatial analysis of maxilla, however in certain scenarios we require a alternative landmark.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>347</offset>
      <text>Aims:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>353</offset>
      <text>In this study a nearest alternative maxillary apical base landmark was identified for Point A substitutions given by different authors.</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>489</offset>
      <text>Methods and Material:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>511</offset>
      <text>A cross sectional study was conducted on thirty (30) good quality lateral cephalograms. Only those lateral cephalograms were selected where Point A was easily identified. Landmarks: Sella (S), Nasion (N), Point A and three substitution points Y, L, X were traced. Angles formed by SN with Point A (Angle SNA) and three substitution points (Angle SNY, SNX, SNL) were measured. Correlation of angle SNA with angles SNY, SNX and SNL were derived. Statistical analysis used</text>
      <annotation id="6">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="867" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="7">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="937" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="8">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="929" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="9">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="862" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="10">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="908" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="11">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="815" length="3"/>
        <text>SNA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>981</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>990</offset>
      <text>Mean and standard deviation for Angles SNA, SNY, SNL and SNX were calculated individually for males and females. 'T' Test was applied to determine statistical significance for all the parameters i.e Age, Angles SNA, SNY, SNL and SNX respectively. Karl Pearson correlation coefficient was carried out to determine the statistical significant correlation for Angle SNA with SNY, SNL and SNX. Results: A mean value of 82.8  +-1.9 , 83.1  +-1.8 , 78.3  +-2.9  and 78.7  +-2.7  for Angle's SNA, SNY, SNL and SNX respectively was observed. A statistically significant correlation was observed between angles SNA &amp; SNY, SNL, SNX &amp; strong positive correlation was observed with angle SNY. Conclusions: We conclude that Point Y is the most nearing maxillary apical base landmark to Point A. Hence maxillary apical base landmark can be substituted by Point Y where identification of point A is not obvious.</text>
      <annotation id="27">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="1039" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="28">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="1211" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="29">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="1367" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="30">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="1485" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="31">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="1603" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="32">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="1592" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="33">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="1475" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="34">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="1201" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="35">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="1029" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="36">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="1608" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="37">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="1493" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="38">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="1375" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="39">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="1219" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="40">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="1047" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="41">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="1353" length="3"/>
        <text>SNA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1899</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1915</offset>
      <text>Cephalometric assessment of patients is an essential adjunct to achieve an accurate orthodontic diagnosis aiding for comprehensive orthodontic treatment planning. The extreme range or radiolucency between bone and soft tissues makes it impossible to locate consistently all landmarks on routine radiographs. Studies regarding the reliability of cephalometric landmarks have been differentiated by (a) differences between two films of the same subject, (b) observed differences in locating the points, and (c) variations in measuring the distance between two marked points. The factors influencing accurate identification were quoted as distinctness of structural detail, noise from adjacent structures due to superimposition of conflicting anatomic details, and conceptual judgment, a factor which is largely based on the past experience and radiological knowledge of the observer. In spite of improved techniques, occasionally certain landmarks are still difficult to locate, among them Point A or Subspinale is one such landmark. Point A is a midline point whose relationship to the anterior teeth in a lateral head film may be influenced by head position. Almost all cephalometric analysis such as Steiner's, Down's, Wit's Appraisal, Mc Namara to name a few use point A or the NA plane as a reference point or plane. Because of difficulty in locating point A various authors i.e Van der Linden, Jarabak and Fizzel, Jacobson R. and Jacobson A have given different substitutions for Point A. The aim of this study was to identify the most nearing alternate maxillary apical base landmark from pre-existing cephalometric points given by different authors.</text>
      <annotation id="43">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1943" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>3571</offset>
      <text>2. MATERIAL AND METHODS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>3595</offset>
      <text>The study was started after obtaining the approval from the Ethical Committee. A cross-sectional study was conducted on 30 (12 males; 18 females) pretreatment good quality lateral cephalograms from patients visiting to Department of Orthodontics and Dentofacial Orthopedics. The lateral cephalograms were selected such that the Point A could be accurately located. A purposive convenience sampling technique was utilized for our study. Patients of age more than 16 yrs only were included in the sample. Patients with tooth agenesis or supernumeraries, any developmental anomalies, traumatic injuries or fractured upper and lower incisors and molars, complex craniofacial deformities or syndromes, Patients who have undergone any orthodontic treatment were excluded from our study. The lateral cephalograms (Kodak 8000C Digital Panoramic and Cephalometric Systems) utilized in our study were of true size (1:1) and any faulty radiographs with image distortion were excluded. The exposure time ranged from 12.8 to 13.9 seconds with kV 69-71 and m/A 10-12. All the cephalograms were manually traced for landmark by one investigator.</text>
      <annotation id="52">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3793" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4031" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4098" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4292" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="56">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="4176" length="37"/>
        <text>traumatic injuries or fractured upper</text>
      </annotation>
      <annotation id="57">
        <infon key="identifier">MESH:D000848</infon>
        <infon key="type">Disease</infon>
        <location offset="4112" length="14"/>
        <text>tooth agenesis</text>
      </annotation>
      <annotation id="58">
        <infon key="identifier">MESH:D019465</infon>
        <infon key="type">Disease</infon>
        <location offset="4253" length="24"/>
        <text>craniofacial deformities</text>
      </annotation>
      <annotation id="59">
        <infon key="identifier">MESH:D000014</infon>
        <infon key="type">Disease</infon>
        <location offset="4151" length="23"/>
        <text>developmental anomalies</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4725</offset>
      <text>Identification of landmarks</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4753</offset>
      <text>After categorization of the cephalograms, on an acetate tracing paper the following landmarks were traced, Sella (S), Nasion (N), Point A, Point B, Point Y, Point L and Point X (Table 1, Figure 1) were located and the angles SNA, SNY, SNL and SNX were measured (Figure 2).</text>
      <annotation id="64">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="4988" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="65">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="4978" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="66">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="4996" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="67">
        <infon key="identifier">MESH:D000085</infon>
        <infon key="type">Chemical</infon>
        <location offset="4801" length="7"/>
        <text>acetate</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>5026</offset>
      <text>Various landmarks utilized in the study.</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-347-g002.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>5067</offset>
      <text>Various substitutions given by diff erent authors</text>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-347-g003.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption</infon>
      <offset>5117</offset>
      <text>Various angles formed a: Angle SNA, b: Angle SNY, c: Angle SNL, d: Angle SNX</text>
      <annotation id="70">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="5176" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="71">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="5148" length="3"/>
        <text>SNA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5194</offset>
      <text>Satistical analysis</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5214</offset>
      <text>All the statistical tests were conducted using SPSS (version 19.0) Mean and standard deviation for Angles SNA, SNY, SNL and SNX were calculated individually for males and females. 'T' Test was applied to determine statistical significance for all the parameters i.e Age, Angles SNA, SNY, SNL and SNX respectively. Karl Pearson correlation coefficient was carried out to determine the statistical significant correlation for Angle SNA with SNY, SNL and SNX.</text>
      <annotation id="81">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="5330" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="82">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="5502" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="83">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="5658" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="84">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="5492" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="5320" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="86">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="5666" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="87">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="5510" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="88">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="5338" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="89">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="5644" length="3"/>
        <text>SNA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>5675</offset>
      <text>3. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>5686</offset>
      <text>Males: A mean value of 22.1 +-4.3 years for Age was observed. A mean value of 82.80 +-1.950 for Angle SNA was observed. A mean value of 83.10 +-1.80 was observed with Angle SNY. A mean value of 78.30 +-2.90 was observed with Angle SNL. A mean value of 78.70 +-2.70 was observed with Angle SNX (Table 2).</text>
      <annotation id="93">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="5917" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="94">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="5788" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="95">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="5975" length="3"/>
        <text>SNX</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>5990</offset>
      <text>Measured angles of SNA, SNY, SNL and SNX in our study</text>
      <annotation id="99">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="6019" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="100">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="6027" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="101">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="6009" length="3"/>
        <text>SNA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6044</offset>
      <text>Females: A mean value of 19.8 +-3.2 years of Age was observed. A mean value of 80.90 +-2.40 was observed for Angle SNA. A mean value of 81.10 +-2.50 was observed with Angle SNY. A mean value of 77.30 +-3.40 was observed with Angle SNL. A mean value of 77.90 +-3.40 was observed with Angle SNX (Table 2). T test was carried out to determine significance amongst all the parameter Age, SNA, SNY, SNL and SNX. Angles SNA (P&lt;0.033) and SNY (P&lt;0.023) revealed statistical significance (Table 3).</text>
      <annotation id="109">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="6438" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="110">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="6275" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="111">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="6458" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="112">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="6428" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="113">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="6446" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="114">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="6333" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="6159" length="3"/>
        <text>SNA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T3.xml</infon>
      <infon key="id">T3</infon>
      <infon key="type">table_caption</infon>
      <offset>6535</offset>
      <text>Determination of statistical signifi cance for parameters SNA, SNY, SNL, SNX and Age</text>
      <annotation id="119">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="6603" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="120">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="6608" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="6593" length="3"/>
        <text>SNA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6620</offset>
      <text>A correlation of age, SNA, SNY, SNL and SNX was calculated. Age had a non significant correlation with all the parameters utilized in the study. SNA revealed a strong statistically significant correlation with SNY&gt;SNX&gt;SNL (Table 4).</text>
      <annotation id="128">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="6642" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="129">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="6652" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="130">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="6838" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="131">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="6765" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="132">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="6834" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="6660" length="3"/>
        <text>SNX</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T4.xml</infon>
      <infon key="id">T4</infon>
      <infon key="type">table_caption</infon>
      <offset>6853</offset>
      <text>Determination of overall correlation coeffi cient for parameters SNA, SNY, SNL, SNX and Age</text>
      <annotation id="137">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="6928" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="138">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="6933" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="139">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="6918" length="3"/>
        <text>SNA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6945</offset>
      <text>In males correlation of age, SNA, SNY, SNL and SNX was calculated. Age had a non significant correlation with all the parameters utilized in the study. Only SNA revealed a strong statistically significant correlation with SNY only. (Table 5).</text>
      <annotation id="144">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="6974" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="145">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="6984" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="146">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="7102" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="147">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="6992" length="3"/>
        <text>SNX</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T5.xml</infon>
      <infon key="id">T5</infon>
      <infon key="type">table_caption</infon>
      <offset>7188</offset>
      <text>Determination of correlation coefficient for parameters SNA, SNY, SNL, SNX and Age for females.</text>
      <annotation id="151">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="7254" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="152">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="7244" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="153">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="7259" length="3"/>
        <text>SNX</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7284</offset>
      <text>In females correlation of age, SNA, SNY, SNL and SNX was calculated. Age had a non significant correlation with all the parameters utilized in the study. SNA revealed a strong statistically significant correlation with SNY, SNL and SNX (Table 6).</text>
      <annotation id="160">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="7315" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="161">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="7325" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="7508" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="7438" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="7516" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="7333" length="3"/>
        <text>SNX</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T6.xml</infon>
      <infon key="id">T6</infon>
      <infon key="type">table_caption</infon>
      <offset>7531</offset>
      <text>Determination of correlation coefficient for parameters SNA, SNY, SNL, SNX and Age for males</text>
      <annotation id="169">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="7597" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="170">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="7587" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="171">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="7602" length="3"/>
        <text>SNX</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>7624</offset>
      <text>4. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>7638</offset>
      <text>Apical base of maxilla and mandible help in determining the spatial relation of both maxilla and mandible to the cranial base. It also determines the limit of placement of incisors in the anteroposterior position. Numerous controversies exist in landmarks which are difficult to identify. Among those points, Point A is the most common point which encounters difficulty in identification. The cephalometric landmark, Point A, was investigated with regard to definition, location and usefulness in cephalometric analysis. Point A or Subspinale represents the maxillary apical base; the projection of cheeks frequently obscures this landmark in lateral cephalogram. Due to shortcomings of Point A various substitute landmarks have been sought by different authors by keeping the root apex of maxillary central incisor as a stable landmark. Van der Linden, suggested the use of point L, which is located on the anterior surface of the image of the labial lamella at the region of the apex of the maxillary incisors Jarabak and Fizzel identified a Point X 2mm ahead of the root apex as a redefinition of point A. Another Point Y plotted 3mm labial to a point between upper and lower two-thirds of the long axis of the root of the maxillary central incisor as suggested by Jacobson R. and Jacobson A. Comparison of mean values of Angle SNA with Angles SNY, SNL and SNX When the mean values of angles SNA, SNL, SNX and SNY were compared we observed the mean value of SNY was more in comparison to SNA, SNL and SNX. The mean values of SNL and SNX was less in comparison to SNA. Probable cause for such an observation could be attributed the variation in the definition of those cephalometric landmarks. When T test was carried out to determine significance amongst all the parameters individually like Age, SNA, SNY, SNL and SNX, Angles SNA and SNY revealed statistical significance (Table 3). This suggested that angles SNA and SNY were more specific for all the samples included in the study. On an overall SNA and SNY; SNX and SNL revealed strong statistical correlation between each other. Clear visibility of maxillary central incisor would act as a guide for marking the landmarks as require for Point Y could be attributed for such an observation. In males there was high correlation of angle SNA with angle SNY. In females, angle SNA correlated with Angle SNY, SNL and SNX, as we had observed that all the angles were less in comparison to males, which resulted in such an observation. However a further study has to be conducted on females to ascertain the probable cause for such an observation.</text>
      <annotation id="196">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="8990" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="9038" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="9129" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="9134" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="200">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="9166" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="201">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="9448" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="202">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="10000" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="203">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="10008" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="204">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="9640" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="205">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="9552" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="206">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="9468" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="9438" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="208">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="9204" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="209">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="9033" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="210">
        <infon key="identifier">6624</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">48164</infon>
        <location offset="9661" length="3"/>
        <text>SNL</text>
      </annotation>
      <annotation id="211">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="9653" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="212">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="9456" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="213">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="9174" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="214">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="9142" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="215">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="9043" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="216">
        <infon key="identifier">310</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">36149</infon>
        <location offset="8998" length="3"/>
        <text>SNX</text>
      </annotation>
      <annotation id="217">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="9969" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="218">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="9931" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="8969" length="3"/>
        <text>SNA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10237</offset>
      <text>In almost all cases the angles SNA and SNY were equal and showed high statistical significant correlation. Abdwani et al stated that the effects of incisal inclination changes, due to orthodontic treatment, are of no clinical relevance to the position of Point A and B, even though they may be statistically significant. However Kazem et al reported that the position of Point A is affected by local bone remodeling associated with proclination of the upper incisor in Class II division 2 malocclusion, but this minor change does not significantly affect the SNA angle. According to Jacobson a point closer to the center of the root of a tooth is less vulnerable to displacement than, say, a point close to the root apex during crown tipping procedures. Point Y represents closer to center of the tooth root hence point Y can be used more precisely as a substitute for point A. Whereas Point L and Point X are located in relation to the root apex, which can change if the tooth is proclined or retroclined.</text>
      <annotation id="222">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="10796" length="3"/>
        <text>SNA</text>
      </annotation>
      <annotation id="223">
        <infon key="identifier">6615</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">4363</infon>
        <location offset="10268" length="3"/>
        <text>SNA</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>11244</offset>
      <text>5. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>11258</offset>
      <text>The situation of Point A is rather complex, and its location depend on a number of variables. Thus from the present study the following conclusions can be drawn: Age had no significance on identification of maxillary apical base; Overall Point; A showed strong statistically significant correlation with Point Y.; In males Point A and Point Y showed strong statistically significant correlation.; In females, Point A showed statistical significant correlation with Point Y, L and X.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>11741</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>11778</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="volume">59</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:der;given-names:Linden V</infon>
      <infon key="fpage">111</infon>
      <infon key="pub-id_pmid">5276196</infon>
      <infon key="year">1971</infon>
      <infon key="source">Am J Orthod</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">125</infon>
      <offset>11789</offset>
      <text>A study of roentgenographic bony landmarks</text>
    </passage>
    <passage>
      <infon key="volume">60</infon>
      <infon key="name_1">surname:Frantz;given-names:RC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Baumrind;given-names:S</infon>
      <infon key="fpage">111</infon>
      <infon key="pub-id_pmid">5283996</infon>
      <infon key="year">1971</infon>
      <infon key="source">Am J Orthod</infon>
      <infon key="type">ref</infon>
      <offset>11832</offset>
      <text>The reliability of head film measurements. 1. Landmark identification</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Fizzel;given-names:JR</infon>
      <infon key="fpage">146</infon>
      <infon key="year">1963</infon>
      <infon key="type">ref</infon>
      <offset>11902</offset>
      <text>Technique and Treatment with the Light wire appliance</text>
    </passage>
    <passage>
      <infon key="volume">77</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rick;given-names:L</infon>
      <infon key="issue">1</infon>
      <infon key="year">1980</infon>
      <infon key="source">Am J Orthod</infon>
      <infon key="type">ref</infon>
      <offset>11956</offset>
      <text>Jacobson and Alex Jacobson, Point A revisited</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Jacobson;given-names:A</infon>
      <infon key="year">2006</infon>
      <infon key="type">ref</infon>
      <offset>12002</offset>
      <text>Radiographic cephalometry</text>
    </passage>
    <passage>
      <infon key="volume">34</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Downs;given-names:WB</infon>
      <infon key="fpage">812</infon>
      <infon key="pub-id_pmid">18882558</infon>
      <infon key="year">1948</infon>
      <infon key="source">Am J Orthod</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">840</infon>
      <offset>12028</offset>
      <text>Variations in facial relationship. Their significance in treatment and prognosis</text>
    </passage>
    <passage>
      <infon key="volume">38</infon>
      <infon key="name_1">surname:Kronman;given-names:JH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kalafa;given-names:JA</infon>
      <infon key="fpage">225</infon>
      <infon key="issue">3</infon>
      <infon key="pub-id_pmid">5242882</infon>
      <infon key="year">1968</infon>
      <infon key="source">The Angle Orthodontist</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">230</infon>
      <offset>12109</offset>
      <text>A Critical Evaluation of Cephalometric "A" Point and Proposal of a More Significant Landmark</text>
    </passage>
    <passage>
      <infon key="volume">79</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Al-Abdwani;given-names:R</infon>
      <infon key="fpage">462</infon>
      <infon key="pub-id_pmid">19413385</infon>
      <infon key="year">2009</infon>
      <infon key="source">Angle Orthod</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">467</infon>
      <offset>12206</offset>
      <text>Change of Incisor Inclination Effects on Points A and B</text>
    </passage>
    <passage>
      <infon key="volume">79</infon>
      <infon key="name_1">surname:Al-Nimri</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kazem;given-names:S</infon>
      <infon key="fpage">880</infon>
      <infon key="pub-id_pmid">19705940</infon>
      <infon key="year">2009</infon>
      <infon key="source">Angle Orthod</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">884</infon>
      <offset>12262</offset>
      <text>Maxillary Incisor Proclination Effect on the Position of Point A in Class II division 2 Malocclusion</text>
    </passage>
  </document>
  <document>
    <id>4272845</id>
    <passage>
      <infon key="name_2">surname:Mirzaeian;given-names:Razieh</infon>
      <infon key="name_1">surname:Mobasheri;given-names:Mahmoud</infon>
      <infon key="article-id_pmid">25568630</infon>
      <infon key="name_0">surname:Jafari;given-names:Fatemeh</infon>
      <infon key="fpage">318</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272845</infon>
      <infon key="article-id_publisher-id">MSM-26-318</infon>
      <infon key="article-id_doi">10.5455/msm.2014.26.318-320</infon>
      <infon key="type">front</infon>
      <infon key="volume">26</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Mater Sociomed; 2014 Oct; 26(5) 318-20. doi:10.5455/msm.2014.26.318-320</infon>
      <infon key="kwd">Hemodialysis Diet Education Blood Pressure Change Weight</infon>
      <infon key="lpage">320</infon>
      <infon key="authors">Jafari F, Mobasheri M, Mirzaeian R</infon>
      <offset>0</offset>
      <text>Effect of Diet Education on Blood Pressure Changes and Interdialytic Weight in Hemodialysis Patients Admitted in Hajar Hospital in Shahrekord</text>
      <annotation id="1">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="92" length="8"/>
        <text>Patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>142</offset>
      <text>Background and aim:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>162</offset>
      <text>Nutrition is a key factor in the treatment of patients with chronic kidney disease because kidney burden decrease causes uremic reduction and its side effects. The aim of this research is to examine the effect of diet education on blood pressure changes and interdialytic weight in Hemodialysis patients admitted to Hemodialysis ward of Hajar hospital in Shahrekord.</text>
      <annotation id="6">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="208" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="7">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="457" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="8">
        <infon key="identifier">MESH:D051437</infon>
        <infon key="type">Disease</infon>
        <location offset="253" length="46"/>
        <text>kidney burden decrease causes uremic reduction</text>
      </annotation>
      <annotation id="9">
        <infon key="identifier">MESH:D051436</infon>
        <infon key="type">Disease</infon>
        <location offset="222" length="22"/>
        <text>chronic kidney disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>529</offset>
      <text>Methods:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>538</offset>
      <text>This quasi-experimental and interventional study of 100 dialysis patients referred to Hemodialysis ward of Hajar hospital was performed in a pre-test and post-test in 2011. Diet education, including face to face training with instruction booklets, were conducted in the two sessions. Having carried out the educational program, blood pressure and interdialytic weight gain were measured and recorded one month before and during three stages and after the educational program by researcher-designed checklists. The data were analyzed through Spss16 software by Paired t-test and ANOVA.</text>
      <annotation id="12">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="603" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="13">
        <infon key="identifier">MESH:D015430</infon>
        <infon key="type">Disease</infon>
        <location offset="885" length="25"/>
        <text>interdialytic weight gain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1123</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1132</offset>
      <text>The results showed that mean of primary weight of the patients increase from 66.15+-15.10 to 64.43+-14.67. Mean of Systolic and diastolic blood pressure in patients in three stages were reduced to 6.65+-1.51 mmg 2.24+-1.82 mmg respectively. There was a significant difference between the creatinine amount in patients before and after of training (p&lt;=0.01) but no meaningful difference was observed between the BUN amount before and after of training (p&lt;=0.031).</text>
      <annotation id="18">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1186" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="19">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1288" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="20">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1441" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="21">
        <infon key="identifier">MESH:D003404</infon>
        <infon key="type">Chemical</infon>
        <location offset="1420" length="10"/>
        <text>creatinine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1597</offset>
      <text>Conclusion:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1609</offset>
      <text>Training to patients underwent hemodialysis in order to observe diet and its effects on improvement in treatment are of significant importance.</text>
      <annotation id="23">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1621" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1753</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1769</offset>
      <text>Advanced chronic renal failure is a progressive and irreversible impairment where the kidney's ability to filter metabolic waste products from the blood, and maintain water and electrolyte balance disappears, hence resulting in uremia. In patients with advanced chronic renal failure, it is impossible for them to live without adequate alternative treatment. Nowadays, the best alternative treatment is hemodialysis. Renal failure is highly prevalent in the world and in Iran. Nowadays, 242 out of 1000 people in the world suffer from renal failure; besides, about 8% are added to this figure annually. Although hemodialyses has improved renal disease and prolong patients' lives, without the proper diet and medication, it is not highly efficient. Following diet, fluid restriction and drugs are essential in care and health maintenance of renal dialysis patients. For these patients, the purpose of diet is the reduction of kidney burden, prevention of renal complications, maintaining proper nutrition, and prevention of uremia and its complications. Evidence indicates that many patients undergoing hemodialysis do not adhere to proper diet and fluid intake restrictions. It seems that many patients are not aware of diet and fluid restriction. Dialysis alone cannot provide the health and survival to the patients in long term. Besides hemodialysis, therefore, diet, fluid restriction, and drug therapies are essential treatments for chronic renal failure. Poor diet, and lack of fluid restriction can have serious consequences for patients, including impaired physical abilities, depression, acute pulmonary edema, congestive heart failure, and premature death. A poor dietary habit is associated with low quality of life, and morbidity and mortality of dialysis patients. Further, malnutrition and inflammation increase cardiovascular risk and mortality in hemodialysis patients, while following the diet and restricting fluid intake decrease the risk of complications and increase quality of life. Yet, many patients do not follow their diet. Previous studies on the role of nurses in the renal failure patients' diet plan show that the most important objectives in hemodialysis patient care are preventing malnutrition and maintaining good nutrition, edema control, delaying renal osteodystrophy by controlling phosphorus and calcium levels, and finally encouraging the patient to consume tolerable foods which are in accordance with lifestyle changes. Lack of awareness regarding the effects of diet on blood pressure made hemodialysis patients always suffer from its complications. Since this matter is of vital importance, the present study aims to determine the effect of diet on the interdialytic blood pressure and weight in patients undergoing hemodialysis treatment.</text>
      <annotation id="61">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2008" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="62">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2272" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="63">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2433" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="64">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2625" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="65">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2645" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="66">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2852" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="67">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2964" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="68">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3079" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="69">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3306" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="70">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3538" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="71">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3646" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="72">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3785" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3880" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3956" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4148" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="76">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4315" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="77">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4509" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="78">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="1936" length="5"/>
        <text>water</text>
      </annotation>
      <annotation id="79">
        <infon key="identifier">MESH:D000275</infon>
        <infon key="type">Disease</infon>
        <location offset="3355" length="10"/>
        <text>depression</text>
      </annotation>
      <annotation id="80">
        <infon key="identifier">MESH:D014511</infon>
        <infon key="type">Disease</infon>
        <location offset="1997" length="6"/>
        <text>uremia</text>
      </annotation>
      <annotation id="81">
        <infon key="identifier">MESH:D051437</infon>
        <infon key="type">Disease</infon>
        <location offset="3866" length="13"/>
        <text>renal failure</text>
      </annotation>
      <annotation id="82">
        <infon key="identifier">MESH:D051437</infon>
        <infon key="type">Disease</infon>
        <location offset="2186" length="13"/>
        <text>Renal failure</text>
      </annotation>
      <annotation id="83">
        <infon key="identifier">MESH:D007676</infon>
        <infon key="type">Disease</infon>
        <location offset="3208" length="21"/>
        <text>chronic renal failure</text>
      </annotation>
      <annotation id="84">
        <infon key="identifier">MESH:D051437</infon>
        <infon key="type">Disease</infon>
        <location offset="2304" length="13"/>
        <text>renal failure</text>
      </annotation>
      <annotation id="85">
        <infon key="identifier">MESH:D007676</infon>
        <infon key="type">Disease</infon>
        <location offset="1778" length="21"/>
        <text>chronic renal failure</text>
      </annotation>
      <annotation id="86">
        <infon key="identifier">MESH:D004487</infon>
        <infon key="type">Disease</infon>
        <location offset="4029" length="5"/>
        <text>edema</text>
      </annotation>
      <annotation id="87">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="2724" length="19"/>
        <text>renal complications</text>
      </annotation>
      <annotation id="88">
        <infon key="identifier">MESH:D006333</infon>
        <infon key="type">Disease</infon>
        <location offset="3390" length="24"/>
        <text>congestive heart failure</text>
      </annotation>
      <annotation id="89">
        <infon key="identifier">MESH:D010758</infon>
        <infon key="type">Chemical</infon>
        <location offset="4089" length="10"/>
        <text>phosphorus</text>
      </annotation>
      <annotation id="90">
        <infon key="identifier">MESH:D012080</infon>
        <infon key="type">Disease</infon>
        <location offset="4044" length="29"/>
        <text>delaying renal osteodystrophy</text>
      </annotation>
      <annotation id="91">
        <infon key="identifier">MESH:D002118</infon>
        <infon key="type">Chemical</infon>
        <location offset="4104" length="7"/>
        <text>calcium</text>
      </annotation>
      <annotation id="92">
        <infon key="identifier">MESH:D007676</infon>
        <infon key="type">Disease</infon>
        <location offset="2031" length="21"/>
        <text>chronic renal failure</text>
      </annotation>
      <annotation id="93">
        <infon key="identifier">MESH:D014511</infon>
        <infon key="type">Disease</infon>
        <location offset="2793" length="6"/>
        <text>uremia</text>
      </annotation>
      <annotation id="94">
        <infon key="identifier">MESH:D003643</infon>
        <infon key="type">Disease</infon>
        <location offset="3420" length="15"/>
        <text>premature death</text>
      </annotation>
      <annotation id="95">
        <infon key="identifier">MESH:D002318</infon>
        <infon key="type">Disease</infon>
        <location offset="3574" length="36"/>
        <text>inflammation increase cardiovascular</text>
      </annotation>
      <annotation id="96">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="2407" length="13"/>
        <text>renal disease</text>
      </annotation>
      <annotation id="97">
        <infon key="identifier">MESH:D011654</infon>
        <infon key="type">Disease</infon>
        <location offset="3367" length="21"/>
        <text>acute pulmonary edema</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>4557</offset>
      <text>2. MATERIAL AND METHOD</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4580</offset>
      <text>This quasi-experimental and interventional study of 100 dialysis patients admitted in Hemodialysis ward of Hajar hospital was conducted in 2011 where a pretest as well as a post test took place. Patients were enrolled after giving informed consent. The patients who intended to undergo a kidney transplant during the educational program, or leave the place of dialysis, or those who are frequently ill and unable to afford a full time hemodialysis or those who suffer from another known disease besides advanced chronic kidney failure were excluded from the study. The instrument used for data collection was a two-part researcher-designed checklist which consisted of questions on demographic information, knowledge of consumption of food, systolic and diastolic hypertension control, as well as the weight control of the patients. The reliability of this checklist was determined by nutritionists. Before starting the educational program, data on weight, blood pressure and the results of Cr and BUN tests were recorded. The educational program was conducted during two months for the patients. Carried out through face to face interview, bulletins, pamphlets and educational CD, this program was concerned with the control of salt and fluid intake, and the right way of food consumption. Two weeks after beginning of the educational program, weight and blood pressure changes were measured, then at the end of the first month of program, a questionnaire was given to patients through which demographic data were recorded. Their knowledge of proper diet and nutrition was evaluated, as well. Two weeks later and at the end of the second month, weight and blood pressure were measured, and again the patients were given the questionnaire, then data obtained from the questionnaires, including weight, blood pressure and other variables were recorded. The data were entered into SPSS 16, and then the results were analyzed by using descriptive statistics, paired t-test and ANOVA.</text>
      <annotation id="108">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4645" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="109">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4775" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="110">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4833" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="111">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5403" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="112">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5667" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="113">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6050" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="114">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6281" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="115">
        <infon key="identifier">MESH:D012492</infon>
        <infon key="type">Chemical</infon>
        <location offset="5809" length="4"/>
        <text>salt</text>
      </annotation>
      <annotation id="116">
        <infon key="identifier">MESH:C563897</infon>
        <infon key="type">Disease</infon>
        <location offset="5334" length="22"/>
        <text>diastolic hypertension</text>
      </annotation>
      <annotation id="117">
        <infon key="identifier">MESH:D007676</infon>
        <infon key="type">Disease</infon>
        <location offset="5092" length="22"/>
        <text>chronic kidney failure</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>6561</offset>
      <text>3. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>6572</offset>
      <text>Results showed that patients were between 13-80 years old with a mean age of 56.2+- 15.14. Of them, 69% were male and the rest 31% were female. In terms of education, the majority of the subjects (81.4%) were illiterate or educated below the 9th grade, and 18.6% were educated beyond this grade. The mean duration of dialysis was 40.7+- 36.40. The maximum and minimum of duration for the subjects undergoing dialysis were 20 years and 4 month, respectively. Further, the mean frequency of dialysis was 22.40+- 2.9 times a week.</text>
      <annotation id="119">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6592" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7100</offset>
      <text>According to the patient's medical record, which was filled by the physician regarding muscle mass and cardiovascular problems each month, the initial mean weight of the patients was 66.15 +- 15.10. The lightest patient was 31.5 kg and the heaviest one 105 kg. After the first stage of educational program, the mean of weight become 64.43 +- 14.67.</text>
      <annotation id="123">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7117" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="124">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7270" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="125">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7312" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7449</offset>
      <text>Results showed that the mean of BUN and Cr for patients before training were 77.98 +- 21.74 and 9.47 +- 2.80 respectively, which become 66.14 +- 12.13 and 8.48 +- 2.36 after the first stage of training. There was a significant difference between the Cr of the patients before and after training (P &lt;= 0/01). However, the BUN of the patients were not significantly different before and after the training (P &lt;= 0/31).</text>
      <annotation id="131">
        <infon key="identifier">5714</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">37686</infon>
        <location offset="7854" length="9"/>
        <text>P &lt;= 0/31</text>
      </annotation>
      <annotation id="132">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7496" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="133">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7709" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="134">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7781" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">MESH:D002857</infon>
        <infon key="type">Chemical</infon>
        <location offset="7489" length="2"/>
        <text>Cr</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7868</offset>
      <text>Moreover, the findings represented that the mean systolic and diastolic blood pressure in the three stages of the research reduced to 6.65 +- 1.51 mmHg and 2.24 +- 1.82 mmHg, respectively. The mean systolic blood pressure before and after the test was significantly different (P &lt;= 0/05). However, there was no significant difference between the mean diastolic blood pressure before and after the test (P &lt;= 0/20) (Table 1).</text>
      <annotation id="138">
        <infon key="identifier">51673</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">32659</infon>
        <location offset="8271" length="9"/>
        <text>P &lt;= 0/20</text>
      </annotation>
      <annotation id="139">
        <infon key="identifier">106479023</infon>
        <infon key="type">Gene</infon>
        <location offset="8145" length="9"/>
        <text>P &lt;= 0/05</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>8295</offset>
      <text>Weight, creatinine, urea, and systolic and diastolic blood pressure in stages of study</text>
      <annotation id="142">
        <infon key="identifier">MESH:D003404</infon>
        <infon key="type">Chemical</infon>
        <location offset="8303" length="10"/>
        <text>creatinine</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">MESH:D014508</infon>
        <infon key="type">Chemical</infon>
        <location offset="8315" length="4"/>
        <text>urea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>8382</offset>
      <text>Comparison of laboratory indices in two genders</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8430</offset>
      <text>Findings on the determination and comparison of the problems of the patients undergoing hemodialysis (with regard to the systolic and diastolic blood pressure, weight gain, and the changes before and after training including the changes in Urea, creatinine, blood pressure and weight) are important indicators and have a huge role in creating problems and reducing the quality of life. These findings indicated that there was no significant difference in the Cr means of males and females after diet education in the experimental investigation (P=0.2). The relationship between gender and BUN showed a difference in males and females after training (P=0.026). Further, males and females significantly differed from each other in terms of interdialytic weight gain and systolic blood pressure. (P=0. 003), but no significant difference was observed between diastolic blood pressure (P=0.4).</text>
      <annotation id="149">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8498" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="150">
        <infon key="identifier">MESH:D015430</infon>
        <infon key="type">Disease</infon>
        <location offset="9168" length="25"/>
        <text>interdialytic weight gain</text>
      </annotation>
      <annotation id="151">
        <infon key="identifier">MESH:D015430</infon>
        <infon key="type">Disease</infon>
        <location offset="8590" length="11"/>
        <text>weight gain</text>
      </annotation>
      <annotation id="152">
        <infon key="identifier">MESH:D003404</infon>
        <infon key="type">Chemical</infon>
        <location offset="8676" length="10"/>
        <text>creatinine</text>
      </annotation>
      <annotation id="153">
        <infon key="identifier">MESH:D014508</infon>
        <infon key="type">Chemical</infon>
        <location offset="8670" length="4"/>
        <text>Urea</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>9320</offset>
      <text>4. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9334</offset>
      <text>The findings represented that educating patients with a special emphasis on diet can have a positive effect on their attitude. Interdialytic weight loss indicated that training had an effect on patients and enabled them to make adjustments in their diet. Toolabi has investigated the effect of diet education on the knowledge and practice of Hemodialysis Patients in Lorestan, which indicated a significant increase in knowledge of patients after training.</text>
      <annotation id="159">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9374" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="160">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9528" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="161">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9689" length="8"/>
        <text>Patients</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9766" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">MESH:D015431</infon>
        <infon key="type">Disease</infon>
        <location offset="9475" length="11"/>
        <text>weight loss</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9791</offset>
      <text>One of the common problems to these patients is Uremia that can cause poor appetite, memory loss, drowsiness, misjudgment and poor concentration. Interdialytic weight gain increases blood pressure by 3 mm Hg per kg of body weight. Results of nutritional evaluation of 99 hemodialysis patients in Tehran represented a significant positive correlation between protein intake through the correct way of nutrition, and body weight. Therefore, nutrition education is an important variable in increasing awareness and health status of hemodialysis patients. Previous research showed that it is necessary to educate patients with high blood pressure to follow a good diet and restrict the use of fat and sodium. Lack of attention to the patient education regarding drug use, and food and fluid restriction has adverse consequences. Considering the persistent problems as well as their kinds, inefficiency of dialysis in complete resolution of these problems, and the need for continuous care, education can provide an informed and active participation of the patient to care for themselves. The subjects in this study had a low level of awareness before training. This was due to the insufficient diet education which is consistent with the study carried out by Toulabi entitled Impact of education on knowledge and practice of dialysis patients in Lorestan. In this study, there was a significant relationship between education and weight after training which was consistent with Alipour's findings on knowledge, attitude and practice of renal dialysis patients' nutrition. In the study entitled the effect of diet education on dialysis efficacy which is conducted in Zanjan, Talebipour in three stages of training showed that after training, there was an increase in the tendency of these patients to follow an efficient diet. The results of Talebipour's study is similar to those of the current research. Shab Bidar, et al. in their study of dialysis adequacy and prevalence of malnutrition in hemodialysis patients have suggested that in 23% of patients albumin level was below 3 (severe malnutrition), and in 32% of them albumin was in the range of 3-3.5 (medium malnutrition). Moreover, 75 to 80% of hemodialysis patients have high blood pressure, and despite using various drugs, the major cause of hypertension in these patients is the increase in blood volume, which is due to water and salt retention in the body; therefore, withdrawing fluid in a short period from these patients has had a significant effect on blood pressure. Durose, et al have shown that educating patients about diet and alternative consumption can lead to the fluid intake restriction and subsequently to weight loss. Based on the findings, there was a significant association between the weight of the subjects and their level of education that is consistent with the findings of the study conducted by Alipour representing a positive correlation between the knowledge and practice of the subjects, and their level of education. The main achievement in this study was that education is positively effective since the goal of education is to enable us to establish an assuring relationship between patients and nurses:considering education and support of the patients. This is implemented if once patients are allowed to actively participate in decision-making and planning for themselves.</text>
      <annotation id="192">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9827" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="193">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10075" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="194">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10333" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="195">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10400" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="196">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10521" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10843" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11121" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11338" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="200">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11575" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="201">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11794" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="202">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11833" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="203">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12003" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="204">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12112" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="205">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12266" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="206">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12363" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12965" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="208">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13026" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="209">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13064" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="210">
        <infon key="identifier">MESH:D000309</infon>
        <infon key="type">Disease</infon>
        <location offset="10968" length="12"/>
        <text>insufficient</text>
      </annotation>
      <annotation id="211">
        <infon key="identifier">MESH:D012492</infon>
        <infon key="type">Chemical</infon>
        <location offset="12180" length="4"/>
        <text>salt</text>
      </annotation>
      <annotation id="212">
        <infon key="identifier">MESH:D015430</infon>
        <infon key="type">Disease</infon>
        <location offset="9951" length="27"/>
        <text>weight gain increases blood</text>
      </annotation>
      <annotation id="213">
        <infon key="identifier">MESH:D014511</infon>
        <infon key="type">Disease</infon>
        <location offset="9839" length="6"/>
        <text>Uremia</text>
      </annotation>
      <annotation id="214">
        <infon key="identifier">MESH:D015431</infon>
        <infon key="type">Disease</infon>
        <location offset="12472" length="11"/>
        <text>weight loss</text>
      </annotation>
      <annotation id="215">
        <infon key="identifier">MESH:D008569</infon>
        <infon key="type">Disease</infon>
        <location offset="9876" length="11"/>
        <text>memory loss</text>
      </annotation>
      <annotation id="216">
        <infon key="identifier">MESH:D014867</infon>
        <infon key="type">Chemical</infon>
        <location offset="12170" length="5"/>
        <text>water</text>
      </annotation>
      <annotation id="217">
        <infon key="identifier">MESH:D012964</infon>
        <infon key="type">Chemical</infon>
        <location offset="10488" length="6"/>
        <text>sodium</text>
      </annotation>
      <annotation id="218">
        <infon key="identifier">MESH:D006970</infon>
        <infon key="type">Disease</infon>
        <location offset="9889" length="10"/>
        <text>drowsiness</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">MESH:D006973</infon>
        <infon key="type">Disease</infon>
        <location offset="12090" length="12"/>
        <text>hypertension</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>13165</offset>
      <text>5. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>13179</offset>
      <text>Diet and drug therapy besides hemodialysis can improve health condition and therapeutic effectiveness for patients with renal failure. However, it seems that many patients are not fully aware of diet and fluid intake restriction. This study showed that periodic educational programs can play a significant role in the health of patients and their attitude and knowledge of nutrition.</text>
      <annotation id="224">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13285" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="225">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13342" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="226">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13507" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="227">
        <infon key="identifier">MESH:D051437</infon>
        <infon key="type">Disease</infon>
        <location offset="13299" length="13"/>
        <text>renal failure</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>13563</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>13600</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Bare;given-names:BG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Smeltezer;given-names:SC</infon>
      <infon key="fpage">1326</infon>
      <infon key="year">2004</infon>
      <infon key="source">Textbook of medical - Surgical nursing</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1334</infon>
      <offset>13611</offset>
      <text>Brunner and Suddarth S</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Bare;given-names:BG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Smeltzer;given-names:SC</infon>
      <infon key="fpage">1110</infon>
      <infon key="year">2006</infon>
      <infon key="source">Text book of medical-surgical nursing</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1150</infon>
      <offset>13634</offset>
      <text>Brunner and Suddarth S</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Braunwald;given-names:E</infon>
      <infon key="name_2">surname:Brenner;given-names:BM</infon>
      <infon key="name_1">surname:Green;given-names:J</infon>
      <infon key="name_0">surname:Skorecki;given-names:K</infon>
      <infon key="fpage">1653</infon>
      <infon key="year">2005</infon>
      <infon key="source">Harrison principle of internal medicine</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Jameson;given-names:JL</infon>
      <infon key="name_7">surname:Hauser;given-names:SL</infon>
      <infon key="lpage">1667</infon>
      <infon key="name_6">surname:Longo;given-names:DL</infon>
      <infon key="name_5">surname:Kasper;given-names:D</infon>
      <infon key="name_4">surname:Fauci;given-names:AS</infon>
      <offset>13657</offset>
      <text>Chronic renal failure</text>
      <annotation id="229">
        <infon key="identifier">MESH:D007676</infon>
        <infon key="type">Disease</infon>
        <location offset="13657" length="21"/>
        <text>Chronic renal failure</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">20</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Vinpound;given-names:GM</infon>
      <infon key="fpage">161</infon>
      <infon key="issue">9</infon>
      <infon key="year">1991</infon>
      <infon key="source">Dialysis and Transplantation</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">163</infon>
      <offset>13679</offset>
      <text>Intervention on Strategies for improving fluid restriction compliance in chronic hemodialysis patients</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Stump;given-names:SE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kattleen;given-names:ML</infon>
      <infon key="year">2000</infon>
      <infon key="source">Philadelphia</infon>
      <infon key="type">ref</infon>
      <offset>13782</offset>
      <text>Food, nutrition &amp; diet therapy</text>
    </passage>
    <passage>
      <infon key="name_1">surname:Ing;given-names:TS</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Daugirdas;given-names:JT</infon>
      <infon key="year">1989</infon>
      <infon key="source">Handbook of Hemodialysis</infon>
      <infon key="type">ref</infon>
      <offset>13813</offset>
    </passage>
    <passage>
      <infon key="volume">20</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Jones;given-names:K</infon>
      <infon key="fpage">67</infon>
      <infon key="issue">2</infon>
      <infon key="year">1996</infon>
      <infon key="source">ANNA Journal</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">68</infon>
      <offset>13814</offset>
      <text>Are hemodialysis patient population at risk</text>
      <annotation id="231">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13831" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">30</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Wells;given-names:C</infon>
      <infon key="fpage">637</infon>
      <infon key="issue">6</infon>
      <infon key="pub-id_pmid">14730784</infon>
      <infon key="year">2003</infon>
      <infon key="source">Nephrology Nursing Journal</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">646</infon>
      <offset>13858</offset>
      <text>Optimizing nutrition in patients with chronic kidney disease</text>
      <annotation id="234">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13882" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="235">
        <infon key="identifier">MESH:D051436</infon>
        <infon key="type">Disease</infon>
        <location offset="13896" length="22"/>
        <text>chronic kidney disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Bartucci;given-names:MR</infon>
      <infon key="name_2">surname:Morgan;given-names:J</infon>
      <infon key="name_1">surname:Marek;given-names:JF</infon>
      <infon key="name_0">surname:Marantides;given-names:DK</infon>
      <infon key="fpage">1465</infon>
      <infon key="year">2003</infon>
      <infon key="source">Medical surgical nursing concept &amp; clinical practice</infon>
      <infon key="type">ref</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">1477</infon>
      <infon key="name_6">surname:Marker;given-names:J</infon>
      <infon key="name_5">surname:Sands;given-names:J</infon>
      <infon key="name_4">surname:Phipps;given-names:W</infon>
      <offset>13919</offset>
      <text>Management of persons with renal failure</text>
      <annotation id="238">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13933" length="7"/>
        <text>persons</text>
      </annotation>
      <annotation id="239">
        <infon key="identifier">MESH:D051437</infon>
        <infon key="type">Disease</infon>
        <location offset="13946" length="13"/>
        <text>renal failure</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Rizza;given-names:GM</infon>
      <infon key="name_2">surname:Morelli;given-names:E</infon>
      <infon key="name_1">surname:D'Alessandro;given-names:C</infon>
      <infon key="name_0">surname:Cupisti;given-names:A</infon>
      <infon key="fpage">127</infon>
      <infon key="issue">3</infon>
      <infon key="year">2004</infon>
      <infon key="source">Journal of Nutrition</infon>
      <infon key="type">ref</infon>
      <infon key="volume">14</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">133</infon>
      <infon key="name_5">surname:Franzoni;given-names:F</infon>
      <infon key="name_4">surname:Galetta;given-names:F</infon>
      <offset>13960</offset>
      <text>Nutritional status and dietary manipulation in predialysis chronic renal failure patients</text>
      <annotation id="241">
        <infon key="identifier">MESH:D007676</infon>
        <infon key="type">Disease</infon>
        <location offset="14019" length="21"/>
        <text>chronic renal failure</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Boeschoten;given-names:EW</infon>
      <infon key="name_2">surname:Dekker;given-names:FW</infon>
      <infon key="name_1">surname:Jager;given-names:KJ</infon>
      <infon key="name_0">surname:Merkus;given-names:MP</infon>
      <infon key="fpage">584</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">9100049</infon>
      <infon key="year">1997</infon>
      <infon key="source">American Journal of Kidney Diseases</infon>
      <infon key="type">ref</infon>
      <infon key="volume">29</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">592</infon>
      <infon key="name_5">surname:Krediet;given-names:RT</infon>
      <infon key="name_4">surname:Stevens;given-names:P</infon>
      <offset>14050</offset>
      <text>Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment</text>
      <annotation id="243">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14069" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_1">surname:Stump;given-names:PSE</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Kattreen;given-names:ML</infon>
      <infon key="fpage">46</infon>
      <infon key="year">2000</infon>
      <infon key="source">Nutrition</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">49</infon>
      <offset>14153</offset>
      <text>Diet Therapy &amp; Food</text>
    </passage>
    <passage>
      <infon key="volume">1</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Toulabi;given-names:T</infon>
      <infon key="fpage">36</infon>
      <infon key="issue">2</infon>
      <infon key="year">2001</infon>
      <infon key="source">Lorestan University of Medical Sciences</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">47</infon>
      <offset>14173</offset>
      <text>Response of patients undergoing Hemodialysis</text>
      <annotation id="245">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14185" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">21</infon>
      <infon key="name_2">surname:Heyka;given-names:RJ</infon>
      <infon key="name_1">surname:Yan;given-names:G</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Rocco;given-names:MV</infon>
      <infon key="fpage">280</infon>
      <infon key="pub-id_pmid">11509799</infon>
      <infon key="year">2001</infon>
      <infon key="source">Am J Nephrol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">288</infon>
      <offset>14218</offset>
      <text>Risk factors for hypertension in chronichemodialysis patients: baseline data from the HEMO study</text>
      <annotation id="248">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14271" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="249">
        <infon key="identifier">MESH:D006973</infon>
        <infon key="type">Disease</infon>
        <location offset="14235" length="12"/>
        <text>hypertension</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Borazjani;given-names:A</infon>
      <infon key="year">2000</infon>
      <infon key="type">ref</infon>
      <offset>14315</offset>
      <text>Evaluating the hemodialysis patients based on nutrition</text>
      <annotation id="251">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14343" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">1</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bashardoost;given-names:B</infon>
      <infon key="fpage">13</infon>
      <infon key="issue">7</infon>
      <infon key="year">2007</infon>
      <infon key="source">Ardabil Journal of Ardabil University of Medical Sciences</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">16</infon>
      <offset>14371</offset>
      <text>Evaluatin the relationship between the weight during the hemodialys session in hemodialysis patients and hypertension increasing in Booali hospital</text>
      <annotation id="254">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14463" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="255">
        <infon key="identifier">MESH:D006973</infon>
        <infon key="type">Disease</infon>
        <location offset="14476" length="12"/>
        <text>hypertension</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Alipour;given-names:S</infon>
      <infon key="volume">56</infon>
      <infon key="name_2">surname:Alipour;given-names:fard A</infon>
      <infon key="name_1">surname:Koshavar;given-names:H</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Alipour;given-names:B</infon>
      <infon key="fpage">57</infon>
      <infon key="year">2002</infon>
      <infon key="source">Medical Journal of Tabriz University of Medical Sciences</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">62</infon>
      <offset>14519</offset>
      <text>Study of knowledge, attitude and practice of nutrition for kidney patients undergoing hemodialysis</text>
      <annotation id="257">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14585" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">36</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Talebipoor;given-names:B</infon>
      <infon key="fpage">28</infon>
      <infon key="issue">1</infon>
      <infon key="year">2001</infon>
      <infon key="source">Gynecologist Journal of Medical Sciences</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">36</infon>
      <offset>14618</offset>
      <text>Establishment of dietary education in hemodialysis efficacy in dialysis patients in Dr. Reisi hospital</text>
      <annotation id="259">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14690" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="year">2005</infon>
      <infon key="type">ref</infon>
      <offset>14721</offset>
      <text>Estimating the efficience of dialysis and malnutrition prevalence in hemodialysis patients. Razi training and treatment center of Rasht</text>
      <annotation id="261">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14803" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Przygrodzka;given-names:F</infon>
      <infon key="volume">104</infon>
      <infon key="name_2">surname:Watson;given-names:V</infon>
      <infon key="name_1">surname:Holdsworth;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Durose;given-names:CL</infon>
      <infon key="fpage">35</infon>
      <infon key="issue">1</infon>
      <infon key="year">2004</infon>
      <infon key="source">Journal of American Diet Association</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">42</infon>
      <offset>14857</offset>
      <text>Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on Hemodialysis are not predictive of dietary compliance</text>
      <annotation id="263">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14940" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272846</id>
    <passage>
      <infon key="name_3">surname:Jaafreh;given-names:Amany</infon>
      <infon key="name_2">surname:Kawar;given-names:Jane</infon>
      <infon key="name_1">surname:Ghuweri;given-names:Ali AL</infon>
      <infon key="article-id_pmid">25568576</infon>
      <infon key="name_0">surname:Alkhawaldeh;given-names:Khaled</infon>
      <infon key="fpage">297</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272846</infon>
      <infon key="article-id_publisher-id">AIM-22-297</infon>
      <infon key="article-id_doi">10.5455/aim.2014.22.297-301</infon>
      <infon key="type">front</infon>
      <infon key="volume">22</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Acta Inform Med; 2014 Oct; 22(5) 297-301. doi:10.5455/aim.2014.22.297-301</infon>
      <infon key="kwd">Bone scan back pain pediatric 99mTc-MDP</infon>
      <infon key="lpage">301</infon>
      <infon key="authors">Alkhawaldeh K, Ghuweri AA, Kawar J, Jaafreh A</infon>
      <offset>0</offset>
      <text>Back Pain in Children and Diagnostic Value of 99mTc MDP Bone Scintigraphy</text>
      <annotation id="3">
        <infon key="identifier">1800</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">80192</infon>
        <location offset="52" length="3"/>
        <text>MDP</text>
      </annotation>
      <annotation id="4">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13" length="8"/>
        <text>Children</text>
      </annotation>
      <annotation id="5">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="5" length="4"/>
        <text>Pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>74</offset>
      <text>ABSTRACT</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>83</offset>
      <text>Aim:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>88</offset>
      <text>The aim of our study is to assess the diagnostic value of Technituim-99m-Methyle diphosphonate (99mTc-MDP) Bone scintigraphy in the assessment of children with back pain.</text>
      <annotation id="10">
        <infon key="identifier">1800</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">80192</infon>
        <location offset="190" length="3"/>
        <text>MDP</text>
      </annotation>
      <annotation id="11">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="234" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="12">
        <infon key="identifier">-</infon>
        <infon key="type">Chemical</infon>
        <location offset="146" length="36"/>
        <text>Technituim-99m-Methyle diphosphonate</text>
      </annotation>
      <annotation id="13">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="248" length="9"/>
        <text>back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>259</offset>
      <text>Methods:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>268</offset>
      <text>Included in this retrospective study were 68 child referred to us complaining of back pain (mean age of 13+ 2). There were 45 boys and 23 girls. All children have been investigated with conventional x-ray which revealed normal or inconclusive result. All underwent bone scintigraphy after the injection of 99mTc-MDP with calculated doses according to there body weights.</text>
      <annotation id="20">
        <infon key="identifier">1800</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">80192</infon>
        <location offset="580" length="3"/>
        <text>MDP</text>
      </annotation>
      <annotation id="21">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="313" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="22">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="394" length="4"/>
        <text>boys</text>
      </annotation>
      <annotation id="23">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="406" length="5"/>
        <text>girls</text>
      </annotation>
      <annotation id="24">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="417" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="25">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="349" length="9"/>
        <text>back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>639</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>648</offset>
      <text>Bone scintigraphy revealed 17 (25%) abnormal scans in 11 boys and 6 girls. Scans findings were suggestive of spondylolysis (n=4); malignancy including primary tumors and metastases (n=3); infection including osteomyelitis and discitis (n=3); sacroiliitis (n=2); benign tumors (n=2); pseudo fractures in ribs (n=1); necrosis in femoral head epiphysis(n=1) and nonskeletal-renal retention due to hydronephrosis (n=1). Sensitivity, specificity and accuracy of bone scan in detecting gross skeletal abnormality as a cause for back pain were 94% and 100% and 99% respectively.</text>
      <annotation id="41">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="705" length="4"/>
        <text>boys</text>
      </annotation>
      <annotation id="42">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="716" length="5"/>
        <text>girls</text>
      </annotation>
      <annotation id="43">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="836" length="9"/>
        <text>infection</text>
      </annotation>
      <annotation id="44">
        <infon key="identifier">MESH:C538496</infon>
        <infon key="type">Disease</infon>
        <location offset="1134" length="20"/>
        <text>skeletal abnormality</text>
      </annotation>
      <annotation id="45">
        <infon key="identifier">MESH:D009362</infon>
        <infon key="type">Disease</infon>
        <location offset="818" length="10"/>
        <text>metastases</text>
      </annotation>
      <annotation id="46">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="1170" length="9"/>
        <text>back pain</text>
      </annotation>
      <annotation id="47">
        <infon key="identifier">MESH:D007674</infon>
        <infon key="type">Disease</infon>
        <location offset="1007" length="27"/>
        <text>nonskeletal-renal retention</text>
      </annotation>
      <annotation id="48">
        <infon key="identifier">MESH:D015299</infon>
        <infon key="type">Disease</infon>
        <location offset="856" length="26"/>
        <text>osteomyelitis and discitis</text>
      </annotation>
      <annotation id="49">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="778" length="10"/>
        <text>malignancy</text>
      </annotation>
      <annotation id="50">
        <infon key="identifier">MESH:D058566</infon>
        <infon key="type">Disease</infon>
        <location offset="890" length="12"/>
        <text>sacroiliitis</text>
      </annotation>
      <annotation id="51">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="910" length="13"/>
        <text>benign tumors</text>
      </annotation>
      <annotation id="52">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="807" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="53">
        <infon key="identifier">MESH:D006869</infon>
        <infon key="type">Disease</infon>
        <location offset="1042" length="14"/>
        <text>hydronephrosis</text>
      </annotation>
      <annotation id="54">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="938" length="9"/>
        <text>fractures</text>
      </annotation>
      <annotation id="55">
        <infon key="identifier">MESH:D009336</infon>
        <infon key="type">Disease</infon>
        <location offset="963" length="8"/>
        <text>necrosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1220</offset>
      <text>Conclusion:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1232</offset>
      <text>Bone isotope scan is a sensitive imaging modality in the assessment of pediatric patients with back pain. It is a reliable modality to detect and role out most benign and aggressive serious etiologies.</text>
      <annotation id="58">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1313" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="59">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="1327" length="9"/>
        <text>back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1434</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1450</offset>
      <text>Back pain in relatively less common in children than in adults. Most cases of back pain in children clear up in a few days without medical attention. In few cases the symptoms will persist for a longer time which may indicate underlying serious problem more than just a simple backache. Causes can range from serious malignant causes to just benign lesions. Therefore, it is important to start with sensitive and cost effective imaging modality that is capable of distinguishing simple back pain from serious underlying diseases.</text>
      <annotation id="65">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1489" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="66">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1541" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="67">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="1455" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="68">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="1936" length="9"/>
        <text>back pain</text>
      </annotation>
      <annotation id="69">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="1528" length="9"/>
        <text>back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1980</offset>
      <text>A variety of imaging techniques has been used to confirm the cause of back pain. A conventional x-ray is often the first imaging technique which has been used. Unfortunately; this technique suffers from low sensitivity, and can miss most causes of back pain including serious pathologies. On the other hand, advanced imaging modalities like computerized tomography (CT scan) and magnetic resonance imaging (MRI) can be ordered. However, such modalities are not cost effective, and not used routinely to image the whole body.</text>
      <annotation id="72">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="2228" length="9"/>
        <text>back pain</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="2050" length="9"/>
        <text>back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2505</offset>
      <text>Bone scintigraphy (BS) has been used in the diagnostic work-up of unexplained bone pain. The technique is sensitive and allows visualization of the whole skeleton in a short time. This modality is more sensitive than x-rays, since early or non-aggressive lesions generally cannot be seen on radiographs until significant bone mineral matrix has been lost.</text>
      <annotation id="76">
        <infon key="identifier">255564</infon>
        <infon key="type">Species</infon>
        <location offset="2724" length="4"/>
        <text>rays</text>
      </annotation>
      <annotation id="77">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="2583" length="9"/>
        <text>bone pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2861</offset>
      <text>Our study will assess the diagnostic value of BS in children presented with back pain. We will try to emphasize on efficiency of this modality in localizing many pathologies that would have been missed by conventional x-ray study. Also, we will make an overview for scan findings in some lesions encountered during our study.</text>
      <annotation id="80">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2913" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="81">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="2937" length="9"/>
        <text>back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>3187</offset>
      <text>2. PATIENTS AND METHODS</text>
      <annotation id="83">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3190" length="8"/>
        <text>PATIENTS</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>3211</offset>
      <text>Included in this retrospective study were 68 children with ages ranging from 4 to 15 years (mean age of 11+- 3). There were 45 boys and 23 girls. All children presented with back pain of 7 to 88 days duration with a mean value of 18+-5 days. All children underwent BS for assessment of back pain. There initial laboratories and conventional radiological investigation failed to define or localize any possible etiology. All patients underwent 99mTc MDP BS which has been carried out two hours after intravenous administration of radioisotope tracer with calculated dose according to body weights by the formula: Pediatric dose = age (in years)/age+12 x adult dose (20 mCi).</text>
      <annotation id="93">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3256" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="94">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3338" length="4"/>
        <text>boys</text>
      </annotation>
      <annotation id="95">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3350" length="5"/>
        <text>girls</text>
      </annotation>
      <annotation id="96">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3361" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="97">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3457" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="98">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3635" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="99">
        <infon key="identifier">1800</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">80192</infon>
        <location offset="3660" length="3"/>
        <text>MDP</text>
      </annotation>
      <annotation id="100">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="3497" length="9"/>
        <text>back pain</text>
      </annotation>
      <annotation id="101">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="3385" length="9"/>
        <text>back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>3885</offset>
      <text>Whole body BS was performed, using G.E Millennium dual head gamma camera with low energy high resolution collimators. Matrix set for 128 x 128 and time set for 30 minutes. For better assessment of any suspected or equivocal abnormality in the whole body scans, all children had additional static views by 500,000 counts performed after whole body scans, and additional SPECT images for the spine.</text>
      <annotation id="103">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4150" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4282</offset>
      <text>All scans were reported by two nuclear medicine specialists. The abnormal scan finding was defined as either single or multiple foci of increase or reduced tracer uptake in the spine or pelvic area; or any extra skeletal soft issue activity within chest or abdomen that can explain the etiology of back pain.</text>
      <annotation id="105">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="4580" length="9"/>
        <text>back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4591</offset>
      <text>Final diagnosis was established using histopathology and other imaging modalities (MRI and CT scan). Patients with normal scans had clinical follow up for 6 months to 1 year, or until relieve of symptoms.</text>
      <annotation id="107">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4692" length="8"/>
        <text>Patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>4796</offset>
      <text>3. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>4807</offset>
      <text>Bone scintigraphy revealed 17 (25%) abnormal scans in 11 boys and 6 girls. Abnormal scans were described according to anatomical sites which were congruent with the site of pathology in all cases. Table 1 shows anatomical distribution of scan abnormalities in 17 abnormal scans. Scans findings were suggestive of spondylolysis (n=4); malignancy including primary tumors and metastases (n=3); sacroiliitis (n=2); infection including osteomyelitis and discitis (n=3); benign tumors (n=2); pseudofracture (ribs) (n=1); necrosis in femoral head epiphysis (n=1) and nonskeletal (renal) (n=1). Table 2 shows BS findings and diagnosis in 17 abnormal scans encountered during our study. BS failed to detect one case of disc herniation.</text>
      <annotation id="118">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4864" length="4"/>
        <text>boys</text>
      </annotation>
      <annotation id="119">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4875" length="5"/>
        <text>girls</text>
      </annotation>
      <annotation id="120">
        <infon key="identifier">MESH:D009336</infon>
        <infon key="type">Disease</infon>
        <location offset="5323" length="8"/>
        <text>necrosis</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="5273" length="13"/>
        <text>benign tumors</text>
      </annotation>
      <annotation id="122">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="5219" length="9"/>
        <text>infection</text>
      </annotation>
      <annotation id="123">
        <infon key="identifier">MESH:D058566</infon>
        <infon key="type">Disease</infon>
        <location offset="5199" length="12"/>
        <text>sacroiliitis</text>
      </annotation>
      <annotation id="124">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="5170" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="125">
        <infon key="identifier">MESH:D009362</infon>
        <infon key="type">Disease</infon>
        <location offset="5181" length="10"/>
        <text>metastases</text>
      </annotation>
      <annotation id="126">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="5141" length="10"/>
        <text>malignancy</text>
      </annotation>
      <annotation id="127">
        <infon key="identifier">MESH:D015299</infon>
        <infon key="type">Disease</infon>
        <location offset="5239" length="26"/>
        <text>osteomyelitis and discitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>5535</offset>
      <text>Anatomical distribution of bone scans abnormalities</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>5587</offset>
      <text>Bone scintigraphy fi ndings and diagnosis in 17 abnormal scans</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>5650</offset>
      <text>Sensitivity, specificity and accuracy of bone scan in detecting gross skeletal abnormality as a cause for back pain were 94% and 100% and 99% respectively. Positive predictive value (PPV) and negative predictive value (NPV) were found to be 100% and 98% respectively.</text>
      <annotation id="130">
        <infon key="identifier">MESH:C538496</infon>
        <infon key="type">Disease</infon>
        <location offset="5720" length="20"/>
        <text>skeletal abnormality</text>
      </annotation>
      <annotation id="131">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="5756" length="9"/>
        <text>back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>5918</offset>
      <text>4. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>5932</offset>
      <text>Back pain is uncommon in children younger than 3 years, increasing its frequency with age until reaching a plateau during early adolescence. Most often, back pain is benign and self-limited. However, it is occasionally the presenting symptom of systemic diseases as cancer or infection. Thus, the major diagnostic task is to distinguish the patients with simple back pain from those with serious underlying diseases.</text>
      <annotation id="140">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="5957" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="141">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6273" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="142">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="6294" length="9"/>
        <text>back pain</text>
      </annotation>
      <annotation id="143">
        <infon key="identifier">MESH:D034721</infon>
        <infon key="type">Disease</infon>
        <location offset="6177" length="17"/>
        <text>systemic diseases</text>
      </annotation>
      <annotation id="144">
        <infon key="identifier">MESH:D007239</infon>
        <infon key="type">Disease</infon>
        <location offset="6208" length="9"/>
        <text>infection</text>
      </annotation>
      <annotation id="145">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="6085" length="9"/>
        <text>back pain</text>
      </annotation>
      <annotation id="146">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="5937" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="147">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="6198" length="6"/>
        <text>cancer</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>6349</offset>
      <text>Low cost and availability make plain radiography the most common spinal imaging test. Conventional x-ray is often the first imaging technique which has been used. Unfortunately, the interpretation of spine X-ray in children is more difficult than in adults due to the presence of epiphyseal and apophyseal growth center. Also conventional x-ray is lack the sensitivity and would miss most causes of back pain including serious pathologies. The limitation of plain radiography was obvious in our study group, in which most x-ray studies were negative or inconclusive.</text>
      <annotation id="150">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6564" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="151">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="6748" length="9"/>
        <text>back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>6916</offset>
      <text>In our study, bone scintigraphy was able to detect many benign and malignant conditions in 25% of children (Table 2). Our results for scintigraphy with 99mTc-MDP showed an overall sensitivity, specificity values of 94%, 100% respectively.</text>
      <annotation id="154">
        <infon key="identifier">1800</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">80192</infon>
        <location offset="7074" length="3"/>
        <text>MDP</text>
      </annotation>
      <annotation id="155">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7014" length="8"/>
        <text>children</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>7155</offset>
      <text>Skeletal scintigraphy is highly sensitive for detecting stress-induced changes in bone and is an important part in the evaluation of the young athlete with low back pain. Spondylolysis is an osseous defect of the pars interarticularis, thought to be a developmental or acquired stress fracture secondary to chronic low-grade trauma. Most patients with spondylolysis present with either acute or chronic pain. It can be found in as many as 47% of adolescent athletes with low back pain. Most of pars defects (90%) occur at the L5 level and unilateral defect found in 30% of cases. Spondylolysis will show focal tracer accumulation in the region of the pars interarticularis during delayed BS (Figure 1). SPECT BS is more sensitive than planar images and can detect abnormalities in about one third of individuals with normal planar exams.</text>
      <annotation id="164">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7493" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">MESH:D015775</infon>
        <infon key="type">Disease</infon>
        <location offset="7433" length="15"/>
        <text>stress fracture</text>
      </annotation>
      <annotation id="166">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="7626" length="13"/>
        <text>low back pain</text>
      </annotation>
      <annotation id="167">
        <infon key="identifier">MESH:D015868</infon>
        <infon key="type">Disease</infon>
        <location offset="7649" length="12"/>
        <text>pars defects</text>
      </annotation>
      <annotation id="168">
        <infon key="identifier">MESH:D014947</infon>
        <infon key="type">Disease</infon>
        <location offset="7480" length="6"/>
        <text>trauma</text>
      </annotation>
      <annotation id="169">
        <infon key="identifier">MESH:D015868</infon>
        <infon key="type">Disease</infon>
        <location offset="7346" length="43"/>
        <text>osseous defect of the pars interarticularis</text>
      </annotation>
      <annotation id="170">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="7558" length="4"/>
        <text>pain</text>
      </annotation>
      <annotation id="171">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="7311" length="13"/>
        <text>low back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-297-g003.jpg</infon>
      <infon key="id">F1</infon>
      <infon key="type">fig_caption</infon>
      <offset>7993</offset>
      <text>Whole body scan in 14 years old male boy with LBP of 3 weeks duration; scan showed focus with abnormal activity at L5 level (arrow); finding was suggestive of spondylolysis.</text>
      <annotation id="174">
        <infon key="identifier">3929</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">3055</infon>
        <location offset="8039" length="3"/>
        <text>LBP</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8030" length="3"/>
        <text>boy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>8167</offset>
      <text>Also, BS is a very sensitive exam for the detection of acute bone fractures, and it does have increased sensitivity for the detection of rib fractures compared to plain radiographs. BS can be the modality of choice in the assessment of suspected child abuse cases. Also, findings can sometimes draw attention to possible underlying metabolic bone disease (Figure 2).</text>
      <annotation id="180">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8413" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="181">
        <infon key="identifier">MESH:D001851</infon>
        <infon key="type">Disease</infon>
        <location offset="8499" length="22"/>
        <text>metabolic bone disease</text>
      </annotation>
      <annotation id="182">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="8308" length="9"/>
        <text>fractures</text>
      </annotation>
      <annotation id="183">
        <infon key="identifier">MESH:D050723</infon>
        <infon key="type">Disease</infon>
        <location offset="8228" length="14"/>
        <text>bone fractures</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-297-g004.jpg</infon>
      <infon key="id">F2</infon>
      <infon key="type">fig_caption</infon>
      <offset>8534</offset>
      <text>10 years old male child with multiple pseudofractures invoving multiple ribs and lower tibii.</text>
      <annotation id="185">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8552" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>8628</offset>
      <text>Other causes of low back pain in children like Spinal process apophysitis, Lumbosacral transitional vertebra, Facet Syndrome, Schuermann's Disease and disc herniation can have nonspecific findings during BS. For instant; spinal process apophysitis produces uptake of tracer along the lumbar spinous process and is due to a hyperextension overuse injury. A lumbosacral transitional vertebra is a common anomaly characterized by a large transverse process that follows the contour of the sacral ala and forms a non-ossified articulation with the sacrum. Bertolotti syndrome refers to increased tracer uptake along the transverse process pseudoarthrosis of a transitional vertebrae which is indicative of stress change. This finding can be seen in about 80% of patients with a transitional vertebra and low back pain.</text>
      <annotation id="195">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8661" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="196">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9386" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">MESH:D010300</infon>
        <infon key="type">Disease</infon>
        <location offset="8754" length="20"/>
        <text>Schuermann's Disease</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">MESH:D000014</infon>
        <infon key="type">Disease</infon>
        <location offset="9030" length="7"/>
        <text>anomaly</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">MESH:D012090</infon>
        <infon key="type">Disease</infon>
        <location offset="8951" length="29"/>
        <text>hyperextension overuse injury</text>
      </annotation>
      <annotation id="200">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="8644" length="13"/>
        <text>low back pain</text>
      </annotation>
      <annotation id="201">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="9428" length="13"/>
        <text>low back pain</text>
      </annotation>
      <annotation id="202">
        <infon key="identifier">MESH:D011542</infon>
        <infon key="type">Disease</infon>
        <location offset="9263" length="15"/>
        <text>pseudoarthrosis</text>
      </annotation>
      <annotation id="203">
        <infon key="identifier">MESH:D013577</infon>
        <infon key="type">Disease</infon>
        <location offset="9180" length="19"/>
        <text>Bertolotti syndrome</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9443</offset>
      <text>Facet Syndrome can produce both local and radiating pain. SPECT BS will usually detect an abnormality (sensitivity 100%), but with poor specificity (70%). However, a normal exam can rule out facet syndrome.</text>
      <annotation id="205">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="9495" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9650</offset>
      <text>Schuermann's Disease is relatively uncommon disorder, occurring in 3 to 5% of adolescents. The diagnosis is established when the radiographs demonstrate anterior wedging greater than 5 degrees with involvement of 3 or more contiguous vertebral bodies and a structural kyphosis of greater than 40 degrees plate.</text>
      <annotation id="209">
        <infon key="identifier">MESH:D007738</infon>
        <infon key="type">Disease</infon>
        <location offset="9918" length="8"/>
        <text>kyphosis</text>
      </annotation>
      <annotation id="210">
        <infon key="identifier">MESH:D010300</infon>
        <infon key="type">Disease</infon>
        <location offset="9650" length="20"/>
        <text>Schuermann's Disease</text>
      </annotation>
      <annotation id="211">
        <infon key="identifier">MESH:D025063</infon>
        <infon key="type">Disease</infon>
        <location offset="9873" length="27"/>
        <text>contiguous vertebral bodies</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>9961</offset>
      <text>An acute herniated nucleus pulposus may not have any changes on BS until there has been excessive stress placed on the adjacent vertebrae. When this occurs, mild increased activity can be seen in the end-plates of the vertebral bodies on either side of the disc. In our study BS failed to detect any abnormalities in one case of disc herniation.</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10307</offset>
      <text>Early stage of Perth's disease has a characteristic appearance during BS with photopenic defect within femoral epiphysis. On the other hand; slipped Capital Femoral Epiphysis in the absence of avascular necrosis the bone scan findings is nonspecific and consist of mildly increased activity about the hip and widening and blurring of the growth plate activity.</text>
      <annotation id="215">
        <infon key="identifier">MESH:D010020</infon>
        <infon key="type">Disease</infon>
        <location offset="10500" length="18"/>
        <text>avascular necrosis</text>
      </annotation>
      <annotation id="216">
        <infon key="identifier">MESH:D007873</infon>
        <infon key="type">Disease</infon>
        <location offset="10322" length="15"/>
        <text>Perth's disease</text>
      </annotation>
      <annotation id="217">
        <infon key="identifier">MESH:D001929</infon>
        <infon key="type">Disease</infon>
        <location offset="10385" length="42"/>
        <text>photopenic defect within femoral epiphysis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>10668</offset>
      <text>99mTc-MDP BS can detect osteomyelitis one to two weeks before radiologic changes. For the detection of osteomyelitis in non-violated bone, the 3 phase bone scan has a reported sensitivity of 90-100% and a specificity of 70-95%. Osteomyelitis has characteristic appearance in 3 phase BS with abnormal increase in flow, blood pool and delayed radiotracer uptake.</text>
      <annotation id="222">
        <infon key="identifier">1800</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">80192</infon>
        <location offset="10674" length="3"/>
        <text>MDP</text>
      </annotation>
      <annotation id="223">
        <infon key="identifier">MESH:D010019</infon>
        <infon key="type">Disease</infon>
        <location offset="10896" length="13"/>
        <text>Osteomyelitis</text>
      </annotation>
      <annotation id="224">
        <infon key="identifier">MESH:D010019</infon>
        <infon key="type">Disease</infon>
        <location offset="10771" length="13"/>
        <text>osteomyelitis</text>
      </annotation>
      <annotation id="225">
        <infon key="identifier">MESH:D010019</infon>
        <infon key="type">Disease</infon>
        <location offset="10692" length="13"/>
        <text>osteomyelitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11029</offset>
      <text>There is a higher incidence of discitis in children with peaks seen between the ages of 1 to 4, and 12 to 15 years. In young children, the higher incidence is felt to be related to the vascular supply of the spine. In children subchondral vessels are present until age of 8 and supply the disc, and may persist until teenage years. During BS delayed images; discitis will show increased tracer activity in the disc space and the contiguous vertebral bodies (Figure 3).</text>
      <annotation id="232">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11072" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="233">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11154" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="234">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11247" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="235">
        <infon key="identifier">MESH:D025063</infon>
        <infon key="type">Disease</infon>
        <location offset="11458" length="27"/>
        <text>contiguous vertebral bodies</text>
      </annotation>
      <annotation id="236">
        <infon key="identifier">MESH:D015299</infon>
        <infon key="type">Disease</infon>
        <location offset="11387" length="8"/>
        <text>discitis</text>
      </annotation>
      <annotation id="237">
        <infon key="identifier">MESH:D015299</infon>
        <infon key="type">Disease</infon>
        <location offset="11060" length="8"/>
        <text>discitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-297-g005.jpg</infon>
      <infon key="id">F3</infon>
      <infon key="type">fig_caption</infon>
      <offset>11498</offset>
      <text>14 years old girl with back pain; bone scan revealed intervertebral disc activity at level of T12-L1 extending to adjacent vertebral end plates (arrow). Finding was consistent with discitis.</text>
      <annotation id="241">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11511" length="4"/>
        <text>girl</text>
      </annotation>
      <annotation id="242">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="11521" length="9"/>
        <text>back pain</text>
      </annotation>
      <annotation id="243">
        <infon key="identifier">MESH:D015299</infon>
        <infon key="type">Disease</infon>
        <location offset="11679" length="8"/>
        <text>discitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11689</offset>
      <text>99mTc-MDP BS can detect synovial inflammations of rheumatoid arthritis and ankylosing spondylitis. Sacroiliitis can have prominent unilateral or bilateral uptake within sacroiliac joints (Figure 4). However; bilateral sacroiliitis, can be difficult to detect due to the normal increased activity within the SI joints. SI joint to sacrum (SIJ index) of greater than 1.35 can have value in this case.</text>
      <annotation id="253">
        <infon key="identifier">1800</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">80192</infon>
        <location offset="11695" length="3"/>
        <text>MDP</text>
      </annotation>
      <annotation id="254">
        <infon key="identifier">MESH:C563037</infon>
        <infon key="type">Disease</infon>
        <location offset="11858" length="17"/>
        <text>sacroiliac joints</text>
      </annotation>
      <annotation id="255">
        <infon key="identifier">MESH:D001172</infon>
        <infon key="type">Disease</infon>
        <location offset="11722" length="37"/>
        <text>inflammations of rheumatoid arthritis</text>
      </annotation>
      <annotation id="256">
        <infon key="identifier">MESH:D013167</infon>
        <infon key="type">Disease</infon>
        <location offset="11764" length="22"/>
        <text>ankylosing spondylitis</text>
      </annotation>
      <annotation id="257">
        <infon key="type">Disease</infon>
        <location offset="12027" length="3"/>
        <text>SIJ</text>
      </annotation>
      <annotation id="258">
        <infon key="identifier">MESH:D007592</infon>
        <infon key="type">Disease</infon>
        <location offset="12007" length="8"/>
        <text>SI joint</text>
      </annotation>
      <annotation id="259">
        <infon key="identifier">MESH:D058566</infon>
        <infon key="type">Disease</infon>
        <location offset="11788" length="12"/>
        <text>Sacroiliitis</text>
      </annotation>
      <annotation id="260">
        <infon key="identifier">MESH:D007592</infon>
        <infon key="type">Disease</infon>
        <location offset="11996" length="9"/>
        <text>SI joints</text>
      </annotation>
      <annotation id="261">
        <infon key="identifier">MESH:D058566</infon>
        <infon key="type">Disease</infon>
        <location offset="11897" length="22"/>
        <text>bilateral sacroiliitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-297-g006.jpg</infon>
      <infon key="id">F4</infon>
      <infon key="type">fig_caption</infon>
      <offset>12088</offset>
      <text>15 years old boy with low back pain of one month duration. Bone scan revealed prominent activity in both SIJs which is more prominent in the left side. Finding was consistent with sacroiliitis.</text>
      <annotation id="266">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12101" length="3"/>
        <text>boy</text>
      </annotation>
      <annotation id="267">
        <infon key="identifier">MESH:D058566</infon>
        <infon key="type">Disease</infon>
        <location offset="12268" length="12"/>
        <text>sacroiliitis</text>
      </annotation>
      <annotation id="268">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="12110" length="13"/>
        <text>low back pain</text>
      </annotation>
      <annotation id="269">
        <infon key="type">Disease</infon>
        <location offset="12193" length="4"/>
        <text>SIJs</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12282</offset>
      <text>99mTc-MDP BS is 50 to 80% more sensitive than radiographs in detecting skeletal metastases. This is probably because about 30-75% of the bone mineral content must be lost before a metastasis is evident on a radiograph. In contrast, as little as a 5-10% change is required to detect an abnormality on BS. The sensitivity for BS in detecting bone metastases is between 62%-100%. About 90% of patients with skeletal metastases present with multiple lesions which increase its specificity of this modality. Nearly 80% of all metastatic lesions are in the axial skeleton. Multiplicity of active lesions can help to define metastatic bone lesions and tracer uptake involving both the vertebral body and pedicles is usually indicative of metastatic disease.</text>
      <annotation id="277">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12672" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="278">
        <infon key="identifier">1800</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">80192</infon>
        <location offset="12288" length="3"/>
        <text>MDP</text>
      </annotation>
      <annotation id="279">
        <infon key="identifier">MESH:D009362</infon>
        <infon key="type">Disease</infon>
        <location offset="12622" length="15"/>
        <text>bone metastases</text>
      </annotation>
      <annotation id="280">
        <infon key="identifier">MESH:D009362</infon>
        <infon key="type">Disease</infon>
        <location offset="12695" length="10"/>
        <text>metastases</text>
      </annotation>
      <annotation id="281">
        <infon key="identifier">MESH:D009362</infon>
        <infon key="type">Disease</infon>
        <location offset="12362" length="10"/>
        <text>metastases</text>
      </annotation>
      <annotation id="282">
        <infon key="identifier">MESH:C538445</infon>
        <infon key="type">Disease</infon>
        <location offset="13013" length="18"/>
        <text>metastatic disease</text>
      </annotation>
      <annotation id="283">
        <infon key="identifier">MESH:C536543</infon>
        <infon key="type">Disease</infon>
        <location offset="12960" length="14"/>
        <text>vertebral body</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13035</offset>
      <text>Primary bone tumors also can present with back pain in children since more than 80% of the Ewing's sarcomas occur in patients under 20 years of age. The tumor usually arises in the diaphysis of a long bone, but 20% arise in the pelvis. Bone scan can show gross abnormality during the three phases of bone scan; and hardly differentiated from osteomyelitis in some cases (Figure 5).</text>
      <annotation id="291">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13090" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="292">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13152" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="293">
        <infon key="identifier">MESH:D010019</infon>
        <infon key="type">Disease</infon>
        <location offset="13377" length="13"/>
        <text>osteomyelitis</text>
      </annotation>
      <annotation id="294">
        <infon key="identifier">MESH:C563168</infon>
        <infon key="type">Disease</infon>
        <location offset="13126" length="16"/>
        <text>Ewing's sarcomas</text>
      </annotation>
      <annotation id="295">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="13188" length="5"/>
        <text>tumor</text>
      </annotation>
      <annotation id="296">
        <infon key="identifier">MESH:D001859</infon>
        <infon key="type">Disease</infon>
        <location offset="13035" length="19"/>
        <text>Primary bone tumors</text>
      </annotation>
      <annotation id="297">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="13077" length="9"/>
        <text>back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-297-g007.jpg</infon>
      <infon key="id">F5</infon>
      <infon key="type">fig_caption</infon>
      <offset>13417</offset>
      <text>13 years old child with low back pain of 2 months duration; bone scan revealed prominent activity within left iliac bone suggestive of aggressive bone pathology. Biopsy revealed primary malignant Ewing sarcoma.</text>
      <annotation id="301">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13430" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="302">
        <infon key="identifier">MESH:C563168</infon>
        <infon key="type">Disease</infon>
        <location offset="13603" length="23"/>
        <text>malignant Ewing sarcoma</text>
      </annotation>
      <annotation id="303">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="13441" length="13"/>
        <text>low back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13628</offset>
      <text>Benign lesions like osteoblastomas and osteoid osteoma can involve the posterior elements of the spine and they have characteristic appearance during 3 phase bone scan, osteoblastomas and ostioid osteomas will be hot on both blood pool and delayed images. Osteoblastomas are typically larger than 2 cm and possess both sclerotic and lytic features. Osteoid osteoma may occur in the spine (10-20% of cases), it most commonly involves the lumbar spine, nearly always occurs in the posterior elements (50%); only 10% of lesions involve the vertebral body, and is frequently associated with a painful scoliosis with the convexity of the curve oriented away from the side of the lesion.</text>
      <annotation id="312">
        <infon key="identifier">MESH:D010016</infon>
        <infon key="type">Disease</infon>
        <location offset="13816" length="16"/>
        <text>ostioid osteomas</text>
      </annotation>
      <annotation id="313">
        <infon key="identifier">MESH:C538213</infon>
        <infon key="type">Disease</infon>
        <location offset="13947" length="9"/>
        <text>sclerotic</text>
      </annotation>
      <annotation id="314">
        <infon key="identifier">MESH:D018215</infon>
        <infon key="type">Disease</infon>
        <location offset="13797" length="14"/>
        <text>osteoblastomas</text>
      </annotation>
      <annotation id="315">
        <infon key="identifier">MESH:D018215</infon>
        <infon key="type">Disease</infon>
        <location offset="13628" length="54"/>
        <text>Benign lesions like osteoblastomas and osteoid osteoma</text>
      </annotation>
      <annotation id="316">
        <infon key="identifier">MESH:D010017</infon>
        <infon key="type">Disease</infon>
        <location offset="13977" length="15"/>
        <text>Osteoid osteoma</text>
      </annotation>
      <annotation id="317">
        <infon key="identifier">MESH:C536543</infon>
        <infon key="type">Disease</infon>
        <location offset="14165" length="14"/>
        <text>vertebral body</text>
      </annotation>
      <annotation id="318">
        <infon key="identifier">MESH:D018215</infon>
        <infon key="type">Disease</infon>
        <location offset="13884" length="14"/>
        <text>Osteoblastomas</text>
      </annotation>
      <annotation id="319">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="14217" length="17"/>
        <text>painful scoliosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>14310</offset>
      <text>99mTc-MDP B.S showed nonskeletal abnormalities that would have been missed by conventional imaging. Retention of tracer in the kidney due to Hydronephrosis is frequently encountered, which can draw attention to presence of obstructive uropathy as a possible etiology (Figure 6).</text>
      <annotation id="323">
        <infon key="identifier">1800</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">80192</infon>
        <location offset="14316" length="3"/>
        <text>MDP</text>
      </annotation>
      <annotation id="324">
        <infon key="identifier">MESH:D006869</infon>
        <infon key="type">Disease</infon>
        <location offset="14451" length="14"/>
        <text>Hydronephrosis</text>
      </annotation>
      <annotation id="325">
        <infon key="identifier">MESH:C536483</infon>
        <infon key="type">Disease</infon>
        <location offset="14533" length="20"/>
        <text>obstructive uropathy</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">FIG</infon>
      <infon key="file">AIM-22-297-g008.jpg</infon>
      <infon key="id">F6</infon>
      <infon key="type">fig_caption</infon>
      <offset>14589</offset>
      <text>6 years old girl with back pain; scan revealed radiotracer retention within left kidney. Finding was suggestive of hydronephrosis-PUJ stenosis.</text>
      <annotation id="329">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14601" length="4"/>
        <text>girl</text>
      </annotation>
      <annotation id="330">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="14611" length="9"/>
        <text>back pain</text>
      </annotation>
      <annotation id="331">
        <infon key="identifier">MESH:D006869</infon>
        <infon key="type">Disease</infon>
        <location offset="14704" length="27"/>
        <text>hydronephrosis-PUJ stenosis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>14733</offset>
      <text>Finally we believe that plain x-ray can miss serious pathologies in pediatric patients with back pain, causing delay and unnecessary radiation exposure to this group of patients. Bone isotope scan has high negative predictive value in this study (98%), and consequently it can be safe to proceed into clinical follow up and maybe symptomatic management without the need to do any advanced investigations. We do not recommend the use bone isotope scan in each child with back pain, but when we have clinical data suggestive of an underlying bony pathology, bone isotope scan should be the first line of radiological investigation, before proceeding to CT or MRI. Also, Bone scintigraphy SPECT/CT which includes optimized CT as part of the study, provide improved diagnostic accuracy for back pain and oncology compared to routine BS, which may decrease the number of studies an individual child may need. This imaging modality, however, must be tailored on an individual basis as the addition of the CT study can increase exposure to the child and should only be performed after appropriate justification and with adherence to optimized low dose pediatric protocols.</text>
      <annotation id="342">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14811" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="343">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14902" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="344">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15192" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="345">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15621" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="346">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15770" length="5"/>
        <text>child</text>
      </annotation>
      <annotation id="347">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="15519" length="9"/>
        <text>back pain</text>
      </annotation>
      <annotation id="348">
        <infon key="identifier">MESH:D001847</infon>
        <infon key="type">Disease</infon>
        <location offset="15289" length="12"/>
        <text>bone isotope</text>
      </annotation>
      <annotation id="349">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="14825" length="9"/>
        <text>back pain</text>
      </annotation>
      <annotation id="350">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="15203" length="9"/>
        <text>back pain</text>
      </annotation>
      <annotation id="351">
        <infon key="identifier">MESH:D001847</infon>
        <infon key="type">Disease</infon>
        <location offset="15166" length="12"/>
        <text>bone isotope</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>15899</offset>
      <text>5. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>15913</offset>
      <text>Bone isotope scan is a non-invasive, highly sensitive and reliable imaging modality in the assessment of pediatric patients with back pain and in detecting most possible bony pathologies. We recommend this investigation as first imaging procedure to avoid any delay in the diagnosis and to avoid unnecessary investigations.</text>
      <annotation id="354">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16028" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="355">
        <infon key="identifier">MESH:D001416</infon>
        <infon key="type">Disease</infon>
        <location offset="16042" length="9"/>
        <text>back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>16237</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>16274</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="volume">46</infon>
      <infon key="name_1">surname:McGrath;given-names:PJ</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Goodman;given-names:JE</infon>
      <infon key="fpage">247</infon>
      <infon key="pub-id_pmid">1758709</infon>
      <infon key="year">1991</infon>
      <infon key="source">Pain</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">264</infon>
      <offset>16285</offset>
      <text>The epidemiology of pain in children and adolescents: a review</text>
      <annotation id="358">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16313" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="359">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="16305" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">20</infon>
      <infon key="name_2">surname:Waldburger;given-names:M</infon>
      <infon key="name_1">surname:Dutoit;given-names:G</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Balague;given-names:F</infon>
      <infon key="fpage">175</infon>
      <infon key="pub-id_pmid">2976526</infon>
      <infon key="year">1988</infon>
      <infon key="source">Scand J Rehabil Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">179</infon>
      <offset>16348</offset>
      <text>Low back pain in school children. An epidemiological study</text>
      <annotation id="362">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16372" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="363">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="16348" length="13"/>
        <text>Low back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">14</infon>
      <infon key="name_2">surname:Galasko;given-names:GSB</infon>
      <infon key="name_1">surname:Green;given-names:JH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Turner;given-names:PG</infon>
      <infon key="fpage">812</infon>
      <infon key="pub-id_pmid">2528813</infon>
      <infon key="year">1989</infon>
      <infon key="source">Spine</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">814</infon>
      <offset>16407</offset>
      <text>Back pain in children</text>
      <annotation id="365">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="16412" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Javid;given-names:MJ</infon>
      <infon key="name_2">surname:Turski;given-names:PA</infon>
      <infon key="name_1">surname:Fryback;given-names:DG</infon>
      <infon key="name_0">surname:Thornbury;given-names:JR</infon>
      <infon key="fpage">731</infon>
      <infon key="pub-id_pmid">8267688</infon>
      <infon key="year">1993</infon>
      <infon key="source">Radiology</infon>
      <infon key="type">ref</infon>
      <infon key="volume">186</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">738</infon>
      <infon key="name_5">surname:Beinlich;given-names:BR</infon>
      <infon key="name_4">surname:McDonald;given-names:JV</infon>
      <offset>16429</offset>
      <text>Disk-caused nerve compression in patients with acute low-back pain: diagnosis with MR, CT myelography, and plain CT</text>
      <annotation id="369">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16462" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="370">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="16482" length="13"/>
        <text>low-back pain</text>
      </annotation>
      <annotation id="371">
        <infon key="identifier">MESH:C564570</infon>
        <infon key="type">Disease</infon>
        <location offset="16512" length="2"/>
        <text>MR</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Dahlstrom;given-names:S</infon>
      <infon key="name_2">surname:Kuusela;given-names:T</infon>
      <infon key="name_1">surname:Erkintalo;given-names:M</infon>
      <infon key="name_0">surname:Paajanen;given-names:H</infon>
      <infon key="fpage">982</infon>
      <infon key="issue">9</infon>
      <infon key="pub-id_pmid">2528827</infon>
      <infon key="year">1989</infon>
      <infon key="source">Spine</infon>
      <infon key="type">ref</infon>
      <infon key="volume">14</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">985</infon>
      <infon key="name_4">surname:Kormano;given-names:M</infon>
      <offset>16545</offset>
      <text>Magnetic Resonance Study of Disc Degeneration in Young Low Back Pain Patients</text>
      <annotation id="373">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="16600" length="13"/>
        <text>Low Back Pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">79</infon>
      <infon key="name_1">surname:Majd;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Meulen;given-names:DC</infon>
      <infon key="fpage">587</infon>
      <infon key="pub-id_pmid">3822680</infon>
      <infon key="year">1987</infon>
      <infon key="source">Pediatrics</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">592</infon>
      <offset>16623</offset>
      <text>Bone scintigraphy in the evaluation of children with obscure skeletal pain</text>
      <annotation id="376">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16662" length="8"/>
        <text>children</text>
      </annotation>
      <annotation id="377">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="16693" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Micheli;given-names:LJ</infon>
      <infon key="volume">180</infon>
      <infon key="name_2">surname:Treves;given-names:ST</infon>
      <infon key="name_1">surname:Summerville;given-names:DA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Bellah;given-names:RD</infon>
      <infon key="fpage">509</infon>
      <infon key="pub-id_pmid">1829845</infon>
      <infon key="year">1991</infon>
      <infon key="source">Radiology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">512</infon>
      <offset>16698</offset>
      <text>Low-back pain in adolescent athletes: detection of stress injury to the pars interarticularis with SPECT</text>
      <annotation id="380">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="16698" length="13"/>
        <text>Low-back pain</text>
      </annotation>
      <annotation id="381">
        <infon key="identifier">MESH:D015775</infon>
        <infon key="type">Disease</infon>
        <location offset="16749" length="13"/>
        <text>stress injury</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">21</infon>
      <infon key="name_2">surname:Luk;given-names:KD</infon>
      <infon key="name_1">surname:Ho;given-names:WY</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Peh;given-names:WC</infon>
      <infon key="fpage">54</infon>
      <infon key="pub-id_pmid">9117933</infon>
      <infon key="year">1997</infon>
      <infon key="source">Clin Imaging</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">62</infon>
      <offset>16803</offset>
      <text>Applications of bone scintigraphy in ankylosing spondylitis</text>
      <annotation id="383">
        <infon key="identifier">MESH:D013167</infon>
        <infon key="type">Disease</infon>
        <location offset="16840" length="22"/>
        <text>ankylosing spondylitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Caride;given-names:VJ</infon>
      <infon key="volume">12</infon>
      <infon key="name_2">surname:Gahbauer;given-names:H</infon>
      <infon key="name_1">surname:Blecker;given-names:I</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Swanson;given-names:D</infon>
      <infon key="fpage">210</infon>
      <infon key="pub-id_pmid">3493875</infon>
      <infon key="year">1987</infon>
      <infon key="source">Clin Nucl Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">211</infon>
      <offset>16863</offset>
      <text>Diagnosis of discitis by SPECT technetium-99m MDP scintigram. A case report</text>
      <annotation id="386">
        <infon key="identifier">1800</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">80192</infon>
        <location offset="16909" length="3"/>
        <text>MDP</text>
      </annotation>
      <annotation id="387">
        <infon key="identifier">MESH:D015299</infon>
        <infon key="type">Disease</infon>
        <location offset="16876" length="8"/>
        <text>discitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">316</infon>
      <infon key="name_1">surname:Bomanji;given-names:JB</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Prvulovich;given-names:EM</infon>
      <infon key="fpage">1140</infon>
      <infon key="pub-id_pmid">9552956</infon>
      <infon key="year">1998</infon>
      <infon key="source">BMJ</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1146</infon>
      <offset>16939</offset>
      <text>The role of nuclear medicine in clinical investigation</text>
    </passage>
    <passage>
      <infon key="volume">44</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Connolly;given-names:LP</infon>
      <infon key="fpage">909</infon>
      <infon key="pub-id_pmid">12791818</infon>
      <infon key="year">2003</infon>
      <infon key="source">J Nucl Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">914</infon>
      <offset>16994</offset>
      <text>Skeletal scintigraphy of young patients with low-back pain and a lumbrosacral transitional vertebra</text>
      <annotation id="390">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17025" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="391">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="17039" length="13"/>
        <text>low-back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Magarelli;given-names:N</infon>
      <infon key="name_2">surname:Cerase;given-names:A</infon>
      <infon key="name_1">surname:Cianfoni;given-names:A</infon>
      <infon key="name_0">surname:Leone;given-names:A</infon>
      <infon key="fpage">683</infon>
      <infon key="issue">6</infon>
      <infon key="pub-id_pmid">20440613</infon>
      <infon key="year">2011</infon>
      <infon key="source">Skeletal Radiol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">40</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">700</infon>
      <infon key="name_4">surname:Bonomo;given-names:L</infon>
      <offset>17094</offset>
      <text>Lumbar spondylolysis: a review</text>
    </passage>
    <passage>
      <infon key="name_2">surname:Beattie;given-names:TF</infon>
      <infon key="name_1">surname:Shaw;given-names:PC</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Roy;given-names:SL</infon>
      <infon key="year">2014</infon>
      <infon key="comment">Epub ahead of print, PubMed PMID: 24756086</infon>
      <infon key="source">Eur J Emerg Med</infon>
      <infon key="type">ref</infon>
      <offset>17125</offset>
      <text>Low back pain in the paediatric athlete</text>
      <annotation id="393">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="17125" length="13"/>
        <text>Low back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">32</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Jaimes;given-names:C</infon>
      <infon key="fpage">537</infon>
      <infon key="pub-id_pmid">22411948</infon>
      <infon key="year">2012</infon>
      <infon key="source">Radiographics</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">555</infon>
      <offset>17165</offset>
      <text>Taking the stress out of evaluating stress injuries in children</text>
      <annotation id="395">
        <infon key="identifier">MESH:D015775</infon>
        <infon key="type">Disease</infon>
        <location offset="17201" length="15"/>
        <text>stress injuries</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">23</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Sty;given-names:JR</infon>
      <infon key="fpage">296</infon>
      <infon key="pub-id_pmid">8256138</infon>
      <infon key="year">1993</infon>
      <infon key="source">Semin Nucl Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">320</infon>
      <offset>17229</offset>
      <text>Spine pain in children</text>
      <annotation id="397">
        <infon key="identifier">MESH:D010146</infon>
        <infon key="type">Disease</infon>
        <location offset="17235" length="4"/>
        <text>pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">28</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Zwas;given-names:ST</infon>
      <infon key="fpage">452</infon>
      <infon key="pub-id_pmid">3572532</infon>
      <infon key="year">1987</infon>
      <infon key="source">J Nucl Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">457</infon>
      <offset>17252</offset>
      <text>Interpretation and classification of bone scintigraphic findings in stress fractures</text>
      <annotation id="399">
        <infon key="identifier">MESH:D015775</infon>
        <infon key="type">Disease</infon>
        <location offset="17320" length="16"/>
        <text>stress fractures</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">23</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Conway;given-names:JJ</infon>
      <infon key="fpage">321</infon>
      <infon key="issue">4</infon>
      <infon key="pub-id_pmid">8256139</infon>
      <infon key="year">1993</infon>
      <infon key="source">Semin Nucl Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">333</infon>
      <offset>17337</offset>
      <text>The role of bone scintigraphy in detecting child abuse</text>
      <annotation id="401">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17380" length="5"/>
        <text>child</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">44</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Connolly;given-names:LP</infon>
      <infon key="fpage">909</infon>
      <infon key="pub-id_pmid">12791818</infon>
      <infon key="year">2003</infon>
      <infon key="source">J Nucl Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">914</infon>
      <offset>17392</offset>
      <text>Skeletal scintigraphy of young patients with low-back pain and a lumbrosacral transitional vertebra</text>
      <annotation id="404">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17423" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="405">
        <infon key="identifier">MESH:D017116</infon>
        <infon key="type">Disease</infon>
        <location offset="17437" length="13"/>
        <text>low-back pain</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">36</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Holder;given-names:LE</infon>
      <infon key="fpage">37</infon>
      <infon key="issue">1</infon>
      <infon key="pub-id_pmid">7799079</infon>
      <infon key="year">1995</infon>
      <infon key="source">J Nucl Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">44</infon>
      <offset>17492</offset>
      <text>Planar and high-resolution SPECT bone imaging in the diagnosis of facet syndrome</text>
    </passage>
    <passage>
      <infon key="volume">22</infon>
      <infon key="name_1">surname:Alavi;given-names:A</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Wegener;given-names:WA</infon>
      <infon key="fpage">401</infon>
      <infon key="year">1991</infon>
      <infon key="source">Ortho Clin N Am</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">417</infon>
      <offset>17573</offset>
      <text>Diagnostic imaging of musculoskeletal infection. Roentgenography;gallium, indium-labeled white blood cell, gammaglobulin, bone scintigraphy;and MRI</text>
      <annotation id="409">
        <infon key="identifier">MESH:D007204</infon>
        <infon key="type">Chemical</infon>
        <location offset="17647" length="6"/>
        <text>indium</text>
      </annotation>
      <annotation id="410">
        <infon key="identifier">MESH:D005708</infon>
        <infon key="type">Chemical</infon>
        <location offset="17638" length="7"/>
        <text>gallium</text>
      </annotation>
      <annotation id="411">
        <infon key="identifier">MESH:D009140</infon>
        <infon key="type">Disease</infon>
        <location offset="17595" length="25"/>
        <text>musculoskeletal infection</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">155</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Al-Sheikh;given-names:W</infon>
      <infon key="fpage">501</infon>
      <infon key="pub-id_pmid">3157204</infon>
      <infon key="year">1985</infon>
      <infon key="source">Radiology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">506</infon>
      <offset>17721</offset>
      <text>Subacute and chronic bone infections: Diagnosis using In-111, Ga-67 and Tc-99m MDP bone scintigraphy, and radiography</text>
      <annotation id="415">
        <infon key="identifier">1800</infon>
        <infon key="type">Gene</infon>
        <infon key="NCBI Homologene">80192</infon>
        <location offset="17800" length="3"/>
        <text>MDP</text>
      </annotation>
      <annotation id="416">
        <infon key="identifier">MESH:D001847</infon>
        <infon key="type">Disease</infon>
        <location offset="17742" length="15"/>
        <text>bone infections</text>
      </annotation>
      <annotation id="417">
        <infon key="identifier">MESH:D005708</infon>
        <infon key="type">Chemical</infon>
        <location offset="17783" length="2"/>
        <text>Ga</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">21</infon>
      <infon key="name_2">surname:Luk;given-names:KD</infon>
      <infon key="name_1">surname:Ho;given-names:WY</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Peh;given-names:WC</infon>
      <infon key="fpage">54</infon>
      <infon key="pub-id_pmid">9117933</infon>
      <infon key="year">1997</infon>
      <infon key="source">Clin Imaging</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">62</infon>
      <offset>17839</offset>
      <text>Applications of bone scintigraphy in ankylosing spondylitis</text>
      <annotation id="419">
        <infon key="identifier">MESH:D013167</infon>
        <infon key="type">Disease</infon>
        <location offset="17876" length="22"/>
        <text>ankylosing spondylitis</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">46</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Even-Sapir;given-names:E</infon>
      <infon key="fpage">1356</infon>
      <infon key="pub-id_pmid">16085595</infon>
      <infon key="year">2005</infon>
      <infon key="source">J Nucl Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1367</infon>
      <offset>17899</offset>
      <text>Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities</text>
    </passage>
    <passage>
      <infon key="volume">23</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Love;given-names:C</infon>
      <infon key="fpage">341</infon>
      <infon key="pub-id_pmid">12640151</infon>
      <infon key="year">2003</infon>
      <infon key="source">Radiographics</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">358</infon>
      <offset>17990</offset>
      <text>Radionuclide bone imaging: an illustrative review</text>
    </passage>
    <passage>
      <infon key="volume">33</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Murphey;given-names:MD</infon>
      <infon key="fpage">803</infon>
      <infon key="pub-id_pmid">23674776</infon>
      <infon key="year">2013</infon>
      <infon key="source">Radiographics</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">831</infon>
      <offset>18040</offset>
      <text>From the radiologic pathology archives. Ewing sarcoma family of tumors: radiologic-pathologic correlation</text>
      <annotation id="422">
        <infon key="identifier">MESH:D009369</infon>
        <infon key="type">Disease</infon>
        <location offset="18104" length="6"/>
        <text>tumors</text>
      </annotation>
      <annotation id="423">
        <infon key="identifier">MESH:C563168</infon>
        <infon key="type">Disease</infon>
        <location offset="18080" length="13"/>
        <text>Ewing sarcoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">1</infon>
      <infon key="name_2">surname:Khan;given-names:A</infon>
      <infon key="name_1">surname:Epstein;given-names:JA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Janin;given-names:Y</infon>
      <infon key="fpage">31</infon>
      <infon key="pub-id_pmid">7207770</infon>
      <infon key="year">1981</infon>
      <infon key="source">Neurosurgery</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">38</infon>
      <offset>18146</offset>
      <text>Osteoid osteomas and osteoblastoma of the spine</text>
      <annotation id="426">
        <infon key="identifier">MESH:D010017</infon>
        <infon key="type">Disease</infon>
        <location offset="18146" length="16"/>
        <text>Osteoid osteomas</text>
      </annotation>
      <annotation id="427">
        <infon key="identifier">MESH:D018215</infon>
        <infon key="type">Disease</infon>
        <location offset="18167" length="13"/>
        <text>osteoblastoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">198</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Iyer;given-names:RS</infon>
      <infon key="fpage">1039</infon>
      <infon key="pub-id_pmid">22528893</infon>
      <infon key="year">2012</infon>
      <infon key="source">AJR</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1052</infon>
      <offset>18194</offset>
      <text>Pediatric bone imaging: diagnostic imaging of osteoid osteoma</text>
      <annotation id="429">
        <infon key="identifier">MESH:D010017</infon>
        <infon key="type">Disease</infon>
        <location offset="18240" length="15"/>
        <text>osteoid osteoma</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">29</infon>
      <infon key="name_2">surname:Konerding;given-names:KF</infon>
      <infon key="name_1">surname:Katz;given-names:PG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Haden;given-names:HT</infon>
      <infon key="fpage">1781</infon>
      <infon key="issue">11</infon>
      <infon key="pub-id_pmid">3183746</infon>
      <infon key="year">1988</infon>
      <infon key="source">J Nucl Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1785</infon>
      <offset>18256</offset>
      <text>Detection of obstructive uropathy by bone scintigraphy</text>
      <annotation id="431">
        <infon key="identifier">MESH:C536483</infon>
        <infon key="type">Disease</infon>
        <location offset="18269" length="20"/>
        <text>obstructive uropathy</text>
      </annotation>
    </passage>
  </document>
  <document>
    <id>4272847</id>
    <passage>
      <infon key="name_3">surname:Roupa;given-names:Zoe</infon>
      <infon key="name_2">surname:Hatzoglou;given-names:Chryssi</infon>
      <infon key="name_1">surname:Gourgoulianis;given-names:Konstantinos</infon>
      <infon key="article-id_pmid">25568580</infon>
      <infon key="name_0">surname:Koulouri;given-names:Agoritsa</infon>
      <infon key="fpage">315</infon>
      <infon key="issue">5</infon>
      <infon key="year">2014</infon>
      <infon key="article-id_pmc">4272847</infon>
      <infon key="article-id_publisher-id">AIM-22-315</infon>
      <infon key="article-id_doi">10.5455/aim.2014.22.315-319</infon>
      <infon key="type">front</infon>
      <infon key="volume">22</infon>
      <infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon>
      <infon key="section_type">TITLE</infon>
      <infon key="journal">Acta Inform Med; 2014 Oct; 22(5) 315-9. doi:10.5455/aim.2014.22.315-319</infon>
      <infon key="kwd">Chronic Obstructive Pulmonary Disease Quality of life Telemetry</infon>
      <infon key="lpage">319</infon>
      <infon key="authors">Koulouri A, Gourgoulianis K, Hatzoglou C, Roupa Z</infon>
      <offset>0</offset>
      <text>Telemetric Detection of Chronic Obstructive Pulmonary Disease and Investigation of Quality of Life for People Working in Shipbuilding Industry</text>
      <annotation id="2">
        <infon key="identifier">MESH:D006212</infon>
        <infon key="type">Disease</infon>
        <location offset="103" length="14"/>
        <text>People Working</text>
      </annotation>
      <annotation id="3">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="24" length="37"/>
        <text>Chronic Obstructive Pulmonary Disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>143</offset>
      <text>ABSTRACT</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>152</offset>
      <text>Introduction:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>166</offset>
      <text>Chronic Obstructive Pulmonary Disease (COPD) has a significant impact on quality of life-related health.</text>
      <annotation id="6">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="205" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="7">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="166" length="37"/>
        <text>Chronic Obstructive Pulmonary Disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>271</offset>
      <text>Aim:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>276</offset>
      <text>It was the detection of Chronic Obstructive Pulmonary Disease by using telemetric methods and the investigation of the quality of life for people working in Shipbuilding Industry compared with a control group.</text>
      <annotation id="10">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="415" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="11">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="300" length="37"/>
        <text>Chronic Obstructive Pulmonary Disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>486</offset>
      <text>Methods:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>495</offset>
      <text>A group of one hundred men working in the shipbuilding industry aged 51.8 +- 8.2 years old and a control group of one hundred men of the general population aged 51.1 +- 6.4 years were studied. All participants completed the General Health Questionnaire - 28, the Fagerstrom test and a form with demographic characteristics. Pulmonary function test results were electronically sent to a specialist for evaluation.</text>
      <annotation id="15">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="518" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="16">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="621" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="17">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="692" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>910</offset>
      <text>Results:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>919</offset>
      <text>People working in the shipbuilding zone had significantly lower values (p&lt;0.001) in FVC, FEV1 and FEV1/FVC compared with the general population participants. Worse social functionality was exhibited by workers in the shipbuilding zone, people with elementary education, unemployed and by those suffering from comorbidities (p &lt;0.001).</text>
      <annotation id="21">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="919" length="6"/>
        <text>People</text>
      </annotation>
      <annotation id="22">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1063" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="23">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1155" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract_title_1</infon>
      <offset>1254</offset>
      <text>Conclusions:</text>
    </passage>
    <passage>
      <infon key="section_type">ABSTRACT</infon>
      <infon key="type">abstract</infon>
      <offset>1267</offset>
      <text>Health level and its individual dimensions are both associated with health self-assessment and occupational and economic status. The coexistence of chronic diseases and smoking dependence affects emotion and social functioning of individuals.</text>
      <annotation id="25">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="1415" length="16"/>
        <text>chronic diseases</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">title_1</infon>
      <offset>1510</offset>
      <text>1. INTRODUCTION</text>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>1526</offset>
      <text>Chronic Obstructive Pulmonary Disease (COPD) is a life-threatening disease characterized by airflow limitation, which is not fully reversible. The World Health Organization (WHO) estimates that 210 million people worldwide suffer from COPD. Despite prevention efforts, the disease appears to be increasing and predictions show that in 2030 it will be the third cause of death. COPD is responsible for a large number of visits to doctors, outpatient departments and hospitals. It has been recorded as the 8th leading cause of years lived with disability in men and 7th in women in the United States of America. Reduction in expiratory flow is slow, progressive and associated with an abnormal inflammatory response of the lungs to irritating particles or gases.</text>
      <annotation id="35">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="1565" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="36">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="1903" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="37">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="1761" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="38">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1732" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="39">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="1964" length="10"/>
        <text>outpatient</text>
      </annotation>
      <annotation id="40">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2082" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="41">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="2097" length="5"/>
        <text>women</text>
      </annotation>
      <annotation id="42">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="1526" length="37"/>
        <text>Chronic Obstructive Pulmonary Disease</text>
      </annotation>
      <annotation id="43">
        <infon key="identifier">MESH:D003643</infon>
        <infon key="type">Disease</infon>
        <location offset="1896" length="5"/>
        <text>death</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>2287</offset>
      <text>COPD affects the entire body and nowadays is considered a multi systemic disease, since it is one of the leading causes of death in the world with high levels of hospitalization and significant financial cost. Smoking is the main causative factor of COPD, while other factors deemed to act aggravatingly and contribute to its occurrence is air pollution and occupational exposure to industrial pollutants (dust, chemicals, fumes, irritant gases, smoke). Hnizdo E. et al., found that COPD percentage caused by the working environment was calculated as 19.2% overall and 31.1% among those who never smoked. The diagnosis of COPD is done by spirometry which is a simple but basic examination in the context of respiratory function testing. The use of spirometry with telemetric data transmission may allow early diagnosis of the disease and facilitate the initiation of medication. In patients with chronic diseases such as asthma, diabetes and COPD, the use of telehealth methods can reduce hospital admissions without increasing mortality, but with increasing people's quality of life.</text>
      <annotation id="56">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="2537" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="57">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="3229" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="58">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="2909" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="59">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="2770" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="60">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="2287" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="61">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3169" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="62">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3346" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="63">
        <infon key="identifier">MESH:D001249</infon>
        <infon key="type">Disease</infon>
        <location offset="3208" length="6"/>
        <text>asthma</text>
      </annotation>
      <annotation id="64">
        <infon key="identifier">MESH:C564969</infon>
        <infon key="type">Disease</infon>
        <location offset="2345" length="22"/>
        <text>multi systemic disease</text>
      </annotation>
      <annotation id="65">
        <infon key="identifier">MESH:D003643</infon>
        <infon key="type">Disease</infon>
        <location offset="2410" length="5"/>
        <text>death</text>
      </annotation>
      <annotation id="66">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="3216" length="8"/>
        <text>diabetes</text>
      </annotation>
      <annotation id="67">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="3183" length="16"/>
        <text>chronic diseases</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">INTRO</infon>
      <infon key="type">paragraph</infon>
      <offset>3372</offset>
      <text>Quality of life is a highly individualized concept associated with health and formed mainly by health status (physical and psychological), functionality, knowledge of the disease, health habits, use of services, social support system and by the individual's adaptive capacity, financial situation and educational level. We can quantify it by using measurement tools, such as questionnaires, and find the correlation that probably exists between the objective laboratory data on the health status of people with COPD and the subjective perception that affects one's personality. The purpose of this study was the detection of Chronic Obstructive Pulmonary Disease by using telemetric methods and investigation of the quality of life for people working in Shipbuilding Industry by a control group.</text>
      <annotation id="72">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="3883" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="73">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="3871" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="74">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4108" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="75">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="3997" length="37"/>
        <text>Chronic Obstructive Pulmonary Disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">title_1</infon>
      <offset>4168</offset>
      <text>2. METHODS</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4179</offset>
      <text>Sample - Participants</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4203</offset>
      <text>A group of one hundred people working in the Shipbuilding Industry (SI) was studied as well as a control group of one hundred people of the general population. All were middle aged men and constituted a convenience sample.</text>
      <annotation id="80">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4226" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="81">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4329" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="82">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="4384" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="83">
        <infon key="type">Disease</infon>
        <location offset="4271" length="2"/>
        <text>SI</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>4426</offset>
      <text>Data were collected on demographic characteristics, education, marital status, smoking dependence and personal medical history. Additionally, data were collected on employment status, self-assessment of health and use of health services. Independence in everyday life activities and quality of life were assessed by using St. George's Respiratory Questionnaire and smoking habit by using Fagerstrom test. St. George's Respiratory Questionnaire is a questionnaire designed to assess the relationship of pulmonary disease with quality of life associated with health and wellbeing. The average time to fill it out ranges from 10 to 15 minutes depending on age and educational level of the individual. The questionnaire provides a sum total and scores for individual symptoms (cough, sputum, wheezing, dyspnea, their frequency and duration), activities (which cause or are limited by dyspnea) and impacts (in a wide range of social functioning and mental disorders as a result of airway obstruction). The lowest score represents a better quality of life.</text>
      <annotation id="90">
        <infon key="identifier">MESH:D003371</infon>
        <infon key="type">Disease</infon>
        <location offset="5199" length="5"/>
        <text>cough</text>
      </annotation>
      <annotation id="91">
        <infon key="identifier">MESH:D004417</infon>
        <infon key="type">Disease</infon>
        <location offset="5224" length="7"/>
        <text>dyspnea</text>
      </annotation>
      <annotation id="92">
        <infon key="identifier">MESH:D001523</infon>
        <infon key="type">Disease</infon>
        <location offset="5370" length="16"/>
        <text>mental disorders</text>
      </annotation>
      <annotation id="93">
        <infon key="identifier">MESH:D012135</infon>
        <infon key="type">Disease</infon>
        <location offset="5214" length="8"/>
        <text>wheezing</text>
      </annotation>
      <annotation id="94">
        <infon key="identifier">MESH:D004417</infon>
        <infon key="type">Disease</infon>
        <location offset="5306" length="7"/>
        <text>dyspnea</text>
      </annotation>
      <annotation id="95">
        <infon key="identifier">MESH:D008171</infon>
        <infon key="type">Disease</infon>
        <location offset="4928" length="17"/>
        <text>pulmonary disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5477</offset>
      <text>The questionnaire assessing the degree of nicotine dependence (Fagerstrom test) was used to provide a meaningful picture of smoking habit. It is a questionnaire easy to fill out, with its composite score of 10 points indicating the maximum nicotine dependence.</text>
      <annotation id="98">
        <infon key="identifier">MESH:D009538</infon>
        <infon key="type">Chemical</infon>
        <location offset="5717" length="8"/>
        <text>nicotine</text>
      </annotation>
      <annotation id="99">
        <infon key="identifier">MESH:D009538</infon>
        <infon key="type">Chemical</infon>
        <location offset="5519" length="8"/>
        <text>nicotine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5738</offset>
      <text>Study Design -Research Tools</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>5769</offset>
      <text>All individuals underwent spirometry and wireless medical devices were used in conjunction with means of web access and software for biomedical parameters telemetry service. The telemetry system used is a web application based on the new generation telemedical devices of automatic measurement and wireless transmission of biological signals.</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6112</offset>
      <text>Data were stored in an electronic page which was accessed by the specialist physician who recorded the COPD diagnosis. Diagnosis was based on symptoms and spirometry findings and airway obstruction was staged according to GOLD guidelines. Participants were asked to make at least three attempts and the highest values of FEV1 and FVC were used to classify the severity of the degree of airway obstruction.</text>
      <annotation id="102">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="6215" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="103">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="6351" length="12"/>
        <text>Participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6518</offset>
      <text>Statistical analysis</text>
    </passage>
    <passage>
      <infon key="section_type">METHODS</infon>
      <infon key="type">paragraph</infon>
      <offset>6539</offset>
      <text>Descriptive and inferential analysis was performed Depending on indications, Student's t-test or Mann-Whitney nonparametric test was used to compare quantitative variables between two groups. Respectively, parametric analysis of variance (ANOVA) or Kruskal-Wallis nonparametric test was used to compare quantitative variables between more than two groups. Bonferroni correction was used to counteract type I error Pearson's chi-squared test or Fisher's exact test was used to compare proportions where necessary. Spearman's or Pearson's (r) correlation coefficient was used to control the relationship between two quantitative variables. The level of statistical significance was set at 0.05 and SPSS 17.0 statistical software was used in the analysis.</text>
      <annotation id="105">
        <infon key="identifier">MESH:C536353</infon>
        <infon key="type">Disease</infon>
        <location offset="6940" length="20"/>
        <text>type I error Pearson</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">title_1</infon>
      <offset>7292</offset>
      <text>3. RESULTS</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7303</offset>
      <text>Characteristics of Participants</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7335</offset>
      <text>The mean age of workers and general population group was 51.8 +- 8.2 and 51.1 +- 6.4 years with 25.1 +- 11.5 and 25.46 +- 10 years duration of smoking, respectively. There was a significantly higher percentage of workers in the general population (75%) compared with the corresponding percentage in the group of people who worked in the shipbuilding zone (62%). The working years in the two groups were 10 +- 3 and 25.4 +- 8.7 respectively.</text>
      <annotation id="107">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7647" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7776</offset>
      <text>Fagerstrom score of participants did not differ between the two groups, as well as their smoking dependence level.</text>
      <annotation id="109">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="7796" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>7891</offset>
      <text>The following diseases were found in the general population in order of frequency: arterial hypertension 12%, COPD 10%, heart diseases 9%, orthopedic problems 2%, diabetes mellitus 6% and other 7%. Respectively, in the shipbuilding industry workers were found: arterial hypertension 7%, COPD 13%, heart diseases 4%, orthopedic problems 7%, diabetes mellitus 4% and other 7%.</text>
      <annotation id="118">
        <infon key="identifier">544442</infon>
        <infon key="type">Gene</infon>
        <location offset="8001" length="7"/>
        <text>COPD 10</text>
      </annotation>
      <annotation id="119">
        <infon key="identifier">544417</infon>
        <infon key="type">Gene</infon>
        <location offset="8178" length="7"/>
        <text>COPD 13</text>
      </annotation>
      <annotation id="120">
        <infon key="identifier">MESH:D006331</infon>
        <infon key="type">Disease</infon>
        <location offset="8188" length="14"/>
        <text>heart diseases</text>
      </annotation>
      <annotation id="121">
        <infon key="identifier">MESH:D006331</infon>
        <infon key="type">Disease</infon>
        <location offset="8011" length="14"/>
        <text>heart diseases</text>
      </annotation>
      <annotation id="122">
        <infon key="identifier">MESH:D006973</infon>
        <infon key="type">Disease</infon>
        <location offset="7983" length="12"/>
        <text>hypertension</text>
      </annotation>
      <annotation id="123">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="8231" length="17"/>
        <text>diabetes mellitus</text>
      </annotation>
      <annotation id="124">
        <infon key="identifier">MESH:D003920</infon>
        <infon key="type">Disease</infon>
        <location offset="8054" length="17"/>
        <text>diabetes mellitus</text>
      </annotation>
      <annotation id="125">
        <infon key="identifier">MESH:D006973</infon>
        <infon key="type">Disease</infon>
        <location offset="8161" length="12"/>
        <text>hypertension</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8266</offset>
      <text>No participant was found in stage IV in the general population group and 3 persons respectively were found in the group of people working in the shipbuilding industry, according to GOLD guidelines. The workers in the shipbuilding zone had significantly lower values (p &lt; 0.001) in FVC, FEV1 and FEV1/FVC compared with the participants of the general population. There was no significant difference in COPD stage of participants depending on their workplace, although most workers in the zone had advanced-stage COPD compared with the general population (Table 1).</text>
      <annotation id="133">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="8777" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="134">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="8667" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="135">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8269" length="11"/>
        <text>participant</text>
      </annotation>
      <annotation id="136">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8341" length="7"/>
        <text>persons</text>
      </annotation>
      <annotation id="137">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8389" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="138">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8588" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="139">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="8681" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T1.xml</infon>
      <infon key="id">T1</infon>
      <infon key="type">table_caption</infon>
      <offset>8830</offset>
      <text>Spirometric findings in cases and controls. *Student's t-test **Pearson's x test +Fisher's exact test</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8932</offset>
      <text>Quality of life</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>8948</offset>
      <text>Significantly higher score in "Symptoms and Activity" dimensions was found in the workers in the shipbuilding industry, those with basic education and non-actively working during this period. Health evaluation as moderate/poor and comorbidity are also associated with high score in these particular dimensions of life quality (p &lt; 0.001). Also, people who were hospitalized during the last year and those diagnosed with III-IV COPD stage had significantly higher values in Symptoms and Activity score, compared to participants with I-II stage. There was a significant difference in Symptoms score depending on smoking dependence. Participants with low smoking dependence had significantly lower scores compared with participants with high smoking dependence (p = 0.016). Participants who visited a general practitioner more than 3 times during the last year had significantly higher values in Activity score compared to participants who visited him/her 1-2 times and to participants who did not visit him/her at all (p = 0.002 and p = 0.008 respectively) (Table 2).</text>
      <annotation id="148">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="9375" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="149">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9293" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="150">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9462" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="151">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9578" length="12"/>
        <text>Participants</text>
      </annotation>
      <annotation id="152">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9664" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="153">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9719" length="12"/>
        <text>Participants</text>
      </annotation>
      <annotation id="154">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9868" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="155">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="9918" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T2.xml</infon>
      <infon key="id">T2</infon>
      <infon key="type">table_caption</infon>
      <offset>10018</offset>
      <text>Symptoms score, Activity score, self-reported health and use of health services indicators. *Kruskal-Wallis test</text>
    </passage>
    <passage>
      <infon key="section_type">RESULTS</infon>
      <infon key="type">paragraph</infon>
      <offset>10131</offset>
      <text>In "Impact score" dimension, a significantly higher score (p &lt; 0.001), corresponding to more problems of social conciliation, was exhibited by those who considered their health as moderate/poor, suffered from a chronic disease and were diagnosed with III-IV COPD stage. In "Total score", participants who had visited a general practitioner more than three times during the last year had significantly higher values in Total score compared both to participants who had visited him/her 1-2 times and to those who had not visited him/her at all (p = 0.004 and p = 0.001 respectively) (Table 3). A significant positive correlation was observed between the score of participants in dimensions under study of quality of life with age, years of smoking and values of FVC, FEV1, FEV1/FVC and Fagerstrom score (p &lt; 0.001) (Table 4).</text>
      <annotation id="161">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="10389" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="162">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10419" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="163">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10578" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="164">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="10792" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="165">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="10342" length="15"/>
        <text>chronic disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T3.xml</infon>
      <infon key="id">T3</infon>
      <infon key="type">table_caption</infon>
      <offset>10963</offset>
      <text>Impact score, Total score, self-reported health and use of health services indicators. *Kruskal-Wallis test</text>
    </passage>
    <passage>
      <infon key="section_type">TABLE</infon>
      <infon key="file">T4.xml</infon>
      <infon key="id">T4</infon>
      <infon key="type">table_caption</infon>
      <offset>11071</offset>
      <text>Demograhic and spirometric correlations</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">title_1</infon>
      <offset>11111</offset>
      <text>4. DISCUSSION</text>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11125</offset>
      <text>Health professionals have recognized the need for early detection of COPD and introduced new ways to facilitate its diagnosis by using modern telehealth methods such as telemetric data transfer. Masa et al. argue that, if high quality spirometry could be performed online through a connection of the specialist to the Pulmonary Laboratory and the patient in a PHC structure by qualified personnel and high quality spirometer, possibly the problem of performing a reliable and qualitative spirometry would be resolved.</text>
      <annotation id="168">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="11194" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="169">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11472" length="7"/>
        <text>patient</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>11643</offset>
      <text>Spirometry with telemetric data transmission method was used in the present study and it was found that the prevalence of COPD in the general population was 10%. Similarly, in their study Tzanakis et al., found a prevalence of 11.6% in men and in an epidemiological study conducted by Sichleridis et al the prevalence of COPD was also estimated at 8.2% among men.</text>
      <annotation id="174">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="11964" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="175">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="11765" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="176">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="11879" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="177">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12002" length="3"/>
        <text>men</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>12007</offset>
      <text>The results of an epidemiological study conducted in Ireland from 1999 to 2001 on a sample of the general population aged 40-69 years showed that the prevalence of obstructive lung disease was 6.3%. In order to estimate the prevalence of COPD in this study, medical history, spirometry, a special respiratory symptoms questionnaire as in ours and dermal tests were used. Also, the BOLD (Burden of Obstructive Lung Disease) study that attempted to identify the prevalence of COPD by using population sample from 12 different countries found that the prevalence of COPD was 11.8 +- 7.9% in men. It is noted that in our study the prevalence of COPD was estimated at 10% in the general population and 13% in people working in the shipbuilding industry and no statistically significant difference was observed between the two groups. It is well known that there are many factors responsible for COPD such as environmental pollution, occupation, place of residence and respiratory infections during childhood. In this study, it was not possible to study the effects of each of these factors, but probably the highest prevalence of COPD in the group of people working in the shipbuilding industry is due to overburdened environment because of occupational exposure. Although it is known that air pollution has a serious impact on respiratory symptoms, the relationship between pollution and COPD remains to be elucidated.</text>
      <annotation id="190">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="13132" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="191">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="13391" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="192">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="12897" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="193">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="12648" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="194">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="12570" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="195">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="12481" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="196">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="12245" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="197">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12595" length="3"/>
        <text>men</text>
      </annotation>
      <annotation id="198">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="12711" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="199">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13153" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="200">
        <infon key="identifier">MESH:D012131</infon>
        <infon key="type">Disease</infon>
        <location offset="12970" length="22"/>
        <text>respiratory infections</text>
      </annotation>
      <annotation id="201">
        <infon key="identifier">MESH:D008173</infon>
        <infon key="type">Disease</infon>
        <location offset="12171" length="24"/>
        <text>obstructive lung disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>13422</offset>
      <text>The results of our research showed that there was a significant positive correlation of the participants' score in the SGRQ scales with age, years of smoking and Fagerstrom Score. Regarding the presence of respiratory symptoms, limitation of activities and their impacts which affect the field of social functioning, results were similar in a research of Xydeas-Kikemenis et al. in a sample of 203 people working in the construction industry. It was observed that age and duration of working activity were strong determinants of mental problems incidence affected by the workload and the negative characteristics of the workplace. Pierrakos et al., in their work concerning the quality of life related to smokers and non-smokers health, find that high smoking dependence negatively affects the quality of life which is exacerbated when tobacco consumption increases.</text>
      <annotation id="205">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13514" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="206">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="13820" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="207">
        <infon key="identifier">4097</infon>
        <infon key="type">Species</infon>
        <location offset="14258" length="7"/>
        <text>tobacco</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>14291</offset>
      <text>In contrast, SGRQ scales showed a high negative correlation with spirometric results (FEV1%, FVC% and FEV1/FVC) and thus, as values of the above measurements of the participants increase, the respective score implying better quality of life decreases. The studies of Stahl  . and Ketelaars CA., in patients with COPD also demonstrate that the quality of life is positively correlated with good respiratory function while it is burdened with advancing age and disease. A moderate correlation of FEV1 values with health level and life quality emerges from the studies of Aibar Arregui et al., and Pereira et al..</text>
      <annotation id="211">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="14603" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="212">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14456" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="213">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="14589" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>14905</offset>
      <text>In our study, comorbidities showed a significant positive correlation with all subscales of quality of life, as supported by many researchers, to the extent that the disease has physical and psychosocial impacts on the overall situation of the individual and chronic patient is observed living under conditions acting bindingly as to his/her quality of life. Overall, the coexistence of chronic diseases burdens the person mainly with organic and functional problems, frequent hospitalizations, continuous medical visits and examinations and secondarily with social, psychological and occupational problems that affect his/her quality of life.</text>
      <annotation id="218">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15172" length="7"/>
        <text>patient</text>
      </annotation>
      <annotation id="219">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15321" length="6"/>
        <text>person</text>
      </annotation>
      <annotation id="220">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="15292" length="24"/>
        <text>chronic diseases burdens</text>
      </annotation>
      <annotation id="221">
        <infon key="identifier">MESH:C535569</infon>
        <infon key="type">Disease</infon>
        <location offset="15096" length="12"/>
        <text>psychosocial</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>15549</offset>
      <text>Educational level and occupational status have significant positive correlation with all SGRQ scales. Participants with basic educational level had higher scores in scales of symptoms, impacts, activities and overall, as in the study of Dimitropoulos et al., in which people with lower educational level had a more aggravated symptoms scale compared to the more educated participants. Based on that, people with low educational level tend to occupy lower-paid jobs in the labor market and often those associated with exposure to harmful for health factors.</text>
      <annotation id="226">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15651" length="12"/>
        <text>Participants</text>
      </annotation>
      <annotation id="227">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15817" length="6"/>
        <text>people</text>
      </annotation>
      <annotation id="228">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15920" length="12"/>
        <text>participants</text>
      </annotation>
      <annotation id="229">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="15949" length="6"/>
        <text>people</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16106</offset>
      <text>In our study, admission to hospital during the last year is significantly correlated with the quality of life scales and is partially consistent with the studies of Dimitropoulos et al., and Miravitlles et al., where patients with more than two admissions to hospital during the last year had worse scores in all scales, but without statistical correlation.</text>
      <annotation id="231">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16323" length="8"/>
        <text>patients</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16464</offset>
      <text>The contact frequency of participants (&gt; 3 times) with a general practitioner in the last 6 to 12 months was positively correlated with the quality of life scales and is consistent with the results of the study of Tountas et al., of whom 37% of the sample under study had visited a doctor &gt;1 time in the previous month.</text>
      <annotation id="233">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="16489" length="12"/>
        <text>participants</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">DISCUSS</infon>
      <infon key="type">paragraph</infon>
      <offset>16784</offset>
      <text>The loss of employment (unemployment) and self-assessment of health as moderate/poor in our study were statistically significantly associated with higher score in almost all scales of the quality of life questionnaire. Our findings are consistent with those of Zimmer et al., who argue that active employment is a determinant of subjective evaluation of health status.</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">title_1</infon>
      <offset>17153</offset>
      <text>5. CONCLUSION</text>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">paragraph</infon>
      <offset>17167</offset>
      <text>Educational level, occupational status and presence of chronic diseases affect the quality of life of individuals, while "low" self-assessment of health, increased frequency of visits to a general practitioner and repeated admissions to hospital are associated with social dysfunction and reduced quality of life. Telemetric diagnosis of COPD can become a method of choice in a community environment, but requires enhancement of education and training of health professionals that are going to perform it.</text>
      <annotation id="237">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="17505" length="4"/>
        <text>COPD</text>
      </annotation>
      <annotation id="238">
        <infon key="identifier">MESH:D000067404</infon>
        <infon key="type">Disease</infon>
        <location offset="17433" length="18"/>
        <text>social dysfunction</text>
      </annotation>
      <annotation id="239">
        <infon key="identifier">MESH:D002908</infon>
        <infon key="type">Disease</infon>
        <location offset="17222" length="16"/>
        <text>chronic diseases</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">CONCL</infon>
      <infon key="type">footnote</infon>
      <offset>17677</offset>
      <text>CONFLICT OF INTEREST: NONE DECLARED.</text>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="type">title</infon>
      <offset>17714</offset>
      <text>REFERENCES</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Kilgert;given-names:K</infon>
      <infon key="name_2">surname:Lippert;given-names:B</infon>
      <infon key="name_1">surname:Berger;given-names:K</infon>
      <infon key="name_0">surname:Nowak;given-names:D</infon>
      <infon key="fpage">381</infon>
      <infon key="pub-id_pmid">16336024</infon>
      <infon key="year">2005</infon>
      <infon key="source">Treat Respir Med</infon>
      <infon key="type">ref</infon>
      <infon key="volume">4</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">395</infon>
      <infon key="name_5">surname:Sandtmann;given-names:R</infon>
      <infon key="name_4">surname:Caeser;given-names:M</infon>
      <offset>17725</offset>
      <text>Epidemiology and health economics of COPD across Europe: a critical analysis</text>
      <annotation id="241">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="17762" length="4"/>
        <text>COPD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="year">2004</infon>
      <infon key="type">ref</infon>
      <offset>17802</offset>
      <text>GOLD, Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the diagnosis, management and prevention of COPD</text>
      <annotation id="243">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="17830" length="32"/>
        <text>Chronic Obstructive Lung Disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">163</infon>
      <infon key="name_2">surname:Sherwood;given-names:Burge P</infon>
      <infon key="name_1">surname:Cleverly;given-names:PM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Spencer;given-names:S</infon>
      <infon key="fpage">122</infon>
      <infon key="pub-id_pmid">11208636</infon>
      <infon key="year">2001</infon>
      <infon key="source">Am J Respir Crit Care Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">128</infon>
      <offset>17933</offset>
      <text>Health status deterioration in patients with chronic obstructive pulmonary disease</text>
      <annotation id="246">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="17964" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="247">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="17978" length="37"/>
        <text>chronic obstructive pulmonary disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Wagner;given-names:G</infon>
      <infon key="volume">156</infon>
      <infon key="name_2">surname:Bang;given-names:KM</infon>
      <infon key="name_1">surname:Sullivan;given-names:PA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Hnizdo;given-names:E</infon>
      <infon key="fpage">738</infon>
      <infon key="pub-id_pmid">12370162</infon>
      <infon key="year">2002</infon>
      <infon key="source">American Journal of Epidemiology</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">746</infon>
      <offset>18016</offset>
      <text>Association between COPD and Employment by Industry and Occupation in the US Population: A Study of Data from the Third National Health and Nutrition Examination Survey</text>
      <annotation id="249">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="18036" length="4"/>
        <text>COPD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Tate;given-names:S</infon>
      <infon key="volume">179</infon>
      <infon key="name_2">surname:McKeown;given-names:GC</infon>
      <infon key="name_1">surname:Hanna;given-names:BM</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McDowell;given-names:JE</infon>
      <infon key="fpage">A238</infon>
      <infon key="year">2009</infon>
      <infon key="source">Am J Respir Crit Care Med</infon>
      <infon key="type">ref</infon>
      <offset>18185</offset>
      <text>Telehealth: A Useful Strategy in the Management of COPD?</text>
      <annotation id="251">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="18236" length="4"/>
        <text>COPD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">342</infon>
      <infon key="name_2">surname:Sheikh;given-names:A</infon>
      <infon key="name_1">surname:Protti;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:McLean;given-names:S</infon>
      <infon key="fpage">374</infon>
      <infon key="year">2011</infon>
      <infon key="source">BMJ</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">378</infon>
      <offset>18242</offset>
      <text>Telehealthcare for long term conditions</text>
    </passage>
    <passage>
      <infon key="volume">18</infon>
      <infon key="name_1">surname:Sarris;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Yfantopoulos;given-names:J</infon>
      <infon key="fpage">218</infon>
      <infon key="year">2001</infon>
      <infon key="source">Archives of Hellenic Medicine</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">229</infon>
      <offset>18282</offset>
      <text>Health related quality of life. Measurement methodology</text>
    </passage>
    <passage>
      <infon key="volume">85</infon>
      <infon key="name_2">surname:Baveystock;given-names:CM</infon>
      <infon key="name_1">surname:Quirk;given-names:FH</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Jones;given-names:PW</infon>
      <infon key="fpage">25</infon>
      <infon key="year">1991</infon>
      <infon key="source">Resp Med</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">31</infon>
      <offset>18338</offset>
      <text>The St. George's Respiratory Questionnaire</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Fagerstrom;given-names:K</infon>
      <infon key="volume">86</infon>
      <infon key="name_2">surname:Frecker;given-names:RC</infon>
      <infon key="name_1">surname:Kozlowski;given-names:LT</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Heatherton;given-names:TF</infon>
      <infon key="fpage">1119</infon>
      <infon key="pub-id_pmid">1932883</infon>
      <infon key="year">1991</infon>
      <infon key="source">British Journal of Addiction</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">1127</infon>
      <offset>18381</offset>
      <text>The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire</text>
      <annotation id="253">
        <infon key="identifier">MESH:D009538</infon>
        <infon key="type">Chemical</infon>
        <location offset="18405" length="8"/>
        <text>Nicotine</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Field;given-names:MJ</infon>
      <infon key="fpage">239</infon>
      <infon key="year">1996</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">252</infon>
      <offset>18479</offset>
      <text>Telemedicine: A guide to assessing telecommunications in health care</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Mota;given-names:M</infon>
      <infon key="name_2">surname:Pereira;given-names:R</infon>
      <infon key="name_1">surname:Gonzalez;given-names:MT</infon>
      <infon key="name_0">surname:Masa;given-names:JF</infon>
      <infon key="fpage">911</infon>
      <infon key="pub-id_pmid">20650985</infon>
      <infon key="year">2011</infon>
      <infon key="source">Eur Respir J</infon>
      <infon key="type">ref</infon>
      <infon key="volume">37</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_9">surname:Farre;given-names:R</infon>
      <infon key="name_8">surname:Teran;given-names:J</infon>
      <infon key="name_7">surname:Rubio;given-names:M</infon>
      <infon key="lpage">918</infon>
      <infon key="name_6">surname:Zamorano;given-names:J</infon>
      <infon key="name_5">surname:Corral;given-names:J</infon>
      <infon key="name_4">surname:Riesco;given-names:JA</infon>
      <offset>18548</offset>
      <text>Validity of spirometry performed online</text>
    </passage>
    <passage>
      <infon key="volume">125</infon>
      <infon key="name_2">surname:Filaditaki;given-names:V</infon>
      <infon key="name_1">surname:Anagnostopoulou;given-names:U</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Tzanakis;given-names:Nu</infon>
      <infon key="fpage">892</infon>
      <infon key="pub-id_pmid">15006947</infon>
      <infon key="year">2010</infon>
      <infon key="source">Chest</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">900</infon>
      <offset>18588</offset>
      <text>Prevalence of COPD in Greece</text>
      <annotation id="255">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="18602" length="4"/>
        <text>COPD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Kottakis;given-names:I</infon>
      <infon key="name_2">surname:Tsiotsios;given-names:I</infon>
      <infon key="name_1">surname:Chloros;given-names:D</infon>
      <infon key="name_0">surname:Sichletidis;given-names:LT</infon>
      <infon key="fpage">92</infon>
      <infon key="pub-id_pmid">16701767</infon>
      <infon key="year">2006</infon>
      <infon key="source">Prim Care Respir J</infon>
      <infon key="type">ref</infon>
      <infon key="volume">15</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_8">surname:Posporelis;given-names:S</infon>
      <infon key="name_7">surname:Kalkanis;given-names:D</infon>
      <infon key="lpage">97</infon>
      <infon key="name_6">surname:Karamanlidis;given-names:A</infon>
      <infon key="name_5">surname:Kaouri;given-names:S</infon>
      <infon key="name_4">surname:Kaiafa;given-names:O</infon>
      <offset>18617</offset>
      <text>High prevalence of smoking in Northern Greece</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Shepherd;given-names:R</infon>
      <infon key="name_2">surname:Gingles;given-names:J</infon>
      <infon key="name_1">surname:Heaney;given-names:L</infon>
      <infon key="name_0">surname:Murtagh;given-names:E</infon>
      <infon key="fpage">443</infon>
      <infon key="pub-id_pmid">16080593</infon>
      <infon key="year">2005</infon>
      <infon key="source">Eur J Epidemiol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">20</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">453</infon>
      <infon key="name_6">surname:MacMahon;given-names:J</infon>
      <infon key="name_5">surname:Patterson;given-names:C</infon>
      <infon key="name_4">surname:Kee;given-names:F</infon>
      <offset>18663</offset>
      <text>Prevalence of obstructive lung disease in a general population sample: the NICECOPD study</text>
      <annotation id="257">
        <infon key="identifier">MESH:D008173</infon>
        <infon key="type">Disease</infon>
        <location offset="18677" length="24"/>
        <text>obstructive lung disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_1">surname:Elias;given-names:JA</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Fishman;given-names:AP</infon>
      <infon key="year">2008</infon>
      <infon key="type">ref</infon>
      <offset>18753</offset>
      <text>Fishman's Pulmonary Diseases and Disorders</text>
      <annotation id="259">
        <infon key="identifier">MESH:C535736</infon>
        <infon key="type">Disease</infon>
        <location offset="18753" length="28"/>
        <text>Fishman's Pulmonary Diseases</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="comment">Available at: </infon>
      <infon key="source">BOLD Study</infon>
      <infon key="type">ref</infon>
      <offset>18796</offset>
      <text>BOLD Study</text>
    </passage>
    <passage>
      <infon key="volume">277</infon>
      <infon key="name_1">surname:Weinmann;given-names:GG</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Petty;given-names:TL</infon>
      <infon key="fpage">246</infon>
      <infon key="pub-id_pmid">9005275</infon>
      <infon key="year">1997</infon>
      <infon key="source">JAMA</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">253</infon>
      <offset>18807</offset>
      <text>Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute workshop summary</text>
      <annotation id="261">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="18889" length="37"/>
        <text>chronic obstructive pulmonary disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Ktenas;given-names:E</infon>
      <infon key="name_2">surname:George;given-names:G</infon>
      <infon key="name_1">surname:Aloumanis;given-names:P</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Xydea-Kikemeni;given-names:A</infon>
      <infon key="year">2003</infon>
      <infon key="source">Greek Medical Journal</infon>
      <infon key="type">ref</infon>
      <offset>18987</offset>
      <text>Workers' in the construction sector morbidity</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Ganas;given-names:A</infon>
      <infon key="volume">50</infon>
      <infon key="name_2">surname:Kondili;given-names:I</infon>
      <infon key="name_1">surname:Michopoulou;given-names:E</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Pierrakos;given-names:G</infon>
      <infon key="fpage">203</infon>
      <infon key="year">2011</infon>
      <infon key="source">NOSILEFTIKI</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">213</infon>
      <infon key="name_4">surname:Sarris;given-names:M</infon>
      <offset>19035</offset>
      <text>Health-related Quality of Life of Smokers and Non-Smokers</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Ronmark;given-names:E</infon>
      <infon key="name_2">surname:Jansson;given-names:SA</infon>
      <infon key="name_1">surname:Lindberg;given-names:Alpha</infon>
      <infon key="name_0">surname:Stahl;given-names:Epsilon</infon>
      <infon key="fpage">56</infon>
      <infon key="pub-id_pmid">16153294</infon>
      <infon key="year">2005</infon>
      <infon key="source">Health and Quality of Life Outcomes</infon>
      <infon key="type">ref</infon>
      <infon key="volume">3</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Lundback;given-names:B</infon>
      <infon key="name_6">surname:Lofdahl;given-names:CG</infon>
      <infon key="name_5">surname:Andersson;given-names:F</infon>
      <infon key="name_4">surname:Svensson;given-names:K</infon>
      <offset>19093</offset>
      <text>Health-related quality of life is related to COPD disease severity</text>
      <annotation id="263">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="19138" length="12"/>
        <text>COPD disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Huyer Abu-Saad;given-names:H</infon>
      <infon key="name_2">surname:Mostert;given-names:R</infon>
      <infon key="name_1">surname:Schlosser;given-names:MA</infon>
      <infon key="name_0">surname:Ketelaars;given-names:CA</infon>
      <infon key="fpage">39</infon>
      <infon key="pub-id_pmid">8658367</infon>
      <infon key="year">1996</infon>
      <infon key="source">Thorax</infon>
      <infon key="type">ref</infon>
      <infon key="volume">51</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">43</infon>
      <infon key="name_5">surname:Wouters;given-names:EF</infon>
      <infon key="name_4">surname:Halfens;given-names:RJ</infon>
      <offset>19160</offset>
      <text>Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease</text>
      <annotation id="266">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19210" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="267">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="19224" length="37"/>
        <text>chronic obstructive pulmonary disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">24</infon>
      <infon key="name_2">surname:Conget;given-names:Lopez F</infon>
      <infon key="name_1">surname:Laborda;given-names:Ezquerra K</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Aibar;given-names:Arregui MA</infon>
      <infon key="fpage">473</infon>
      <infon key="pub-id_pmid">18271650</infon>
      <infon key="year">2007</infon>
      <infon key="source">An Med Interna</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">477</infon>
      <offset>19262</offset>
      <text>Relationship between objective data and health-related quality of life in COPD patients</text>
      <annotation id="269">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="19336" length="4"/>
        <text>COPD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Medeiros;given-names:M</infon>
      <infon key="name_2">surname:Alcantara;given-names:M</infon>
      <infon key="name_1">surname:Pinto;given-names:R</infon>
      <infon key="name_0">surname:Pereira;given-names:ED</infon>
      <infon key="fpage">730</infon>
      <infon key="pub-id_pmid">19750324</infon>
      <infon key="year">2009</infon>
      <infon key="source">J Bras Pneumol</infon>
      <infon key="type">ref</infon>
      <infon key="volume">35</infon>
      <infon key="section_type">REF</infon>
      <infon key="lpage">736</infon>
      <infon key="name_4">surname:Mota;given-names:RM</infon>
      <offset>19350</offset>
      <text>Influence of respiratory function parameters on the quality of life of COPD patients</text>
      <annotation id="271">
        <infon key="identifier">260431</infon>
        <infon key="type">Gene</infon>
        <location offset="19421" length="4"/>
        <text>COPD</text>
      </annotation>
    </passage>
    <passage>
      <infon key="volume">11</infon>
      <infon key="name_1">surname:Simmons;given-names:R</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Dew;given-names:HA</infon>
      <infon key="fpage">23</infon>
      <infon key="year">1990</infon>
      <infon key="source">Scand J Urol Nephrol</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">30</infon>
      <offset>19435</offset>
      <text>The advantage of multiple measures of quality of life</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Skopelitou;given-names:M</infon>
      <infon key="volume">8</infon>
      <infon key="name_2">surname:Sotiropoulou;given-names:P</infon>
      <infon key="name_1">surname:Roupa;given-names:Z</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Koulouri;given-names:A</infon>
      <infon key="fpage">255</infon>
      <infon key="year">2009</infon>
      <infon key="source">Rostrum of Asclepius</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">269</infon>
      <offset>19489</offset>
      <text>Mood disorders and handling of daily routine in patients with diabetes mellitus type II</text>
      <annotation id="275">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19537" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="276">
        <infon key="identifier">MESH:D003924</infon>
        <infon key="type">Disease</infon>
        <location offset="19551" length="25"/>
        <text>diabetes mellitus type II</text>
      </annotation>
      <annotation id="277">
        <infon key="identifier">MESH:D019964</infon>
        <infon key="type">Disease</infon>
        <location offset="19489" length="14"/>
        <text>Mood disorders</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_3">surname:Nikolaou;given-names:A</infon>
      <infon key="name_2">surname:Kopitopoulou;given-names:A</infon>
      <infon key="name_1">surname:Theodorakopoulou;given-names:E</infon>
      <infon key="name_0">surname:Dimitropoulos;given-names:C</infon>
      <infon key="fpage">127</infon>
      <infon key="year">2013</infon>
      <infon key="source">PNEUMON</infon>
      <infon key="type">ref</infon>
      <infon key="volume">2</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_7">surname:Kosmas;given-names:E</infon>
      <infon key="lpage">151</infon>
      <infon key="name_6">surname:Ntanos;given-names:I</infon>
      <infon key="name_5">surname:Koulouris;given-names:N</infon>
      <infon key="name_4">surname:Tsapas;given-names:C</infon>
      <offset>19577</offset>
      <text>The health related quality of life of Greekpatients with chronic obstructive pulmonary disease</text>
      <annotation id="279">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="19634" length="37"/>
        <text>chronic obstructive pulmonary disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="name_2">surname:Scambler;given-names:G</infon>
      <infon key="name_1">surname:Blane;given-names:D</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Scambler;given-names:G</infon>
      <infon key="fpage">107</infon>
      <infon key="year">2003</infon>
      <infon key="source">Sociology as applied to medicine</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">123</infon>
      <offset>19672</offset>
      <text>Inequality and social class</text>
    </passage>
    <passage>
      <infon key="volume">59</infon>
      <infon key="name_2">surname:Pont;given-names:A</infon>
      <infon key="name_1">surname:Ferrer;given-names:M</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Miravitlles;given-names:M</infon>
      <infon key="fpage">387</infon>
      <infon key="pub-id_pmid">15115864</infon>
      <infon key="year">2004</infon>
      <infon key="source">Thorax</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">395</infon>
      <offset>19700</offset>
      <text>Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study</text>
      <annotation id="282">
        <infon key="identifier">9606</infon>
        <infon key="type">Species</infon>
        <location offset="19746" length="8"/>
        <text>patients</text>
      </annotation>
      <annotation id="283">
        <infon key="identifier">MESH:D029424</infon>
        <infon key="type">Disease</infon>
        <location offset="19760" length="37"/>
        <text>chronic obstructive pulmonary disease</text>
      </annotation>
    </passage>
    <passage>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Tountas;given-names:Y</infon>
      <infon key="year">2008</infon>
      <infon key="type">ref</infon>
      <offset>19824</offset>
      <text>Health services in Greece (1996-2006) Athens: Center for Health Services Research</text>
    </passage>
    <passage>
      <infon key="name_3">surname:Chayovan;given-names:N</infon>
      <infon key="volume">41</infon>
      <infon key="name_2">surname:Lin;given-names:H</infon>
      <infon key="name_1">surname:Natividad;given-names:J</infon>
      <infon key="section_type">REF</infon>
      <infon key="name_0">surname:Zimmer;given-names:Z</infon>
      <infon key="fpage">465</infon>
      <infon key="pub-id_pmid">11198569</infon>
      <infon key="year">2000</infon>
      <infon key="source">Journal of health and Social Behavior</infon>
      <infon key="type">ref</infon>
      <infon key="lpage">481</infon>
      <offset>19906</offset>
      <text>A cross-national examination of the determinants of self-assessed health</text>
    </passage>
  </document>
</collection>
